PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Wang, C; Wang, P; Zeng, W; Li, WX				Wang, Chao; Wang, Peng; Zeng, Wen; Li, Weixin			Tetramethylpyrazine improves the recovery of spinal cord injury via Akt/Nrf2/HO-1 pathway	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Spinal cord injury; Tetramethylpyrazine; Akt; Nrf2; HO-1	OXIDATIVE STRESS; HEME OXYGENASE-1; BRAIN; NRF2; NEUROPROTECTION; SULFORAPHANE; INFLAMMATION; BARRIER; MODEL; RATS	Spinal cord injury (SCI) is one of the most severe traumatic conditions, resulting in postoperative complications. Our results and other reports have shown that tetramethylpyrazine (TMP) is able to exhibit neuro-protective effects after SCI. In the current study, we aimed to examine the possible mechanism underlying the neuro-protective effect of TMP in rat model of SCI. TMP improved locomotor functions and decreased permeability of blood-spinal cord barrier in rats with SCI, as evidenced by increase of Basso-Beattie-Bresnahan scores and decrease of Evans blue leakage. In addition, TMP decreased the expression of several proinflammatory cytokines, including IL-1 beta, TNF alpha and IL-18, reduced TUNEL-positive cells and caspase 3 and 9 activities, decreased thiobarbituric acid reactive substances content and increased glutathione level and superoxide dismutase activity in rats. All these effects were inhibited by zinc protoporphyrin IX (ZnPP), an inhibitor of HO-1, and LY294002, an inhibitor of Akt. Moreover, TMP inhibited the decrease of mRNA expression of HO-1 which was suppressed by ZnPP and LY294002. TMP inhibited the decrease of Akt phosphorylation in rats after SCI, which was suppressed by LY294002, but not ZnPP. Furthermore, LY294002, but not ZnPP, significantly inhibited TMP-induced increase of mRNA expression of Nrf2 and DNA binding activity of Nrf2 in HO-1 promoters in rat model of SCI. The data suggested that TMP induced neuro-protective effects against injury of spinal cord through the activation of Akt/ Nrf2/HO-1 signaling pathway. These results have appointed a new path toward the understanding of pathogenesis and TMP-related therapy of SCI and associated neurodegenerative diseases. (C) 2016 Elsevier Ltd. All rights reserved.	[Wang, Chao; Wang, Peng; Zeng, Wen; Li, Weixin] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Peoples R China		Li, WX (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Peoples R China.	weixin_li111@163.com					Alkabie S, 2015, WORLD NEUROSURG; Au ALS, 2003, EUR J PHARMACOL, V468, P199, DOI 10.1016/S0014-2999(03)01691-1; Benedict AL, 2012, J NEUROTRAUM, V29, P2576, DOI 10.1089/neu.2012.2474; Bijjem KRV, 2013, N-S ARCH PHARMACOL, V386, P79, DOI 10.1007/s00210-012-0816-1; Cheaib B, 2015, CHIN J CANCER, V34, P4, DOI 10.5732/cjc.014.10289; Chen SY, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-1; Cheng XR, 2007, CELL BIOL INT, V31, P438, DOI 10.1016/j.cellbi.2006.10.001; Dionyssiotis Yannis, 2014, Folia Med (Plovdiv), V56, P237, DOI 10.1515/folmed-2015-0002; Edwards WB, 2014, OSTEOPOROSIS INT, V25, P1005, DOI 10.1007/s00198-013-2557-5; Giuliano F, 1999, ANN NEUROL, V46, P15, DOI 10.1002/1531-8249(199907)46:1<15::AID-ANA5>3.0.CO;2-U; Guan DS, 2015, J NEUROCHEM, V134, P551, DOI 10.1111/jnc.13161; Hagg T., 2015, J NEUROTRAUMA; Henke D., 2015, SPINE J; HO WKK, 1989, STROKE, V20, P96, DOI 10.1161/01.STR.20.1.96; Hu JZ, 2013, J NEUROL SCI, V324, P94, DOI 10.1016/j.jns.2012.10.009; Kieseier B, 2015, ACTA NEUROPATHOL, V130, P297, DOI 10.1007/s00401-015-1457-5; Koushki D, 2015, J SPINAL CORD MED, V38, P13, DOI 10.1179/2045772314Y.0000000215; KWAN CY, 1994, STEM CELLS, V12, P64, DOI 10.1002/stem.5530120111; KWAN CY, 1990, J CARDIOVASC PHARM, V15, P157, DOI 10.1097/00005344-199001000-00025; Lin Y, 2007, J CEREBR BLOOD F MET, V27, P1010, DOI 10.1038/sj.jcbfm.9600412; LIU SF, 1990, EUR J PHARMACOL, V191, P345, DOI 10.1016/0014-2999(90)94167-V; Luo Y., 2015, MOL MED REP; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Sharma HS, 2011, J NEURAL TRANSM, V118, P87, DOI 10.1007/s00702-010-0486-4; Sothmann J, 2015, SAMJ, S. Afr. med. j., V105, P835, DOI [10.7196/SAMJnew.8072, 10.7196/SAMJNEW.8072]; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Wang W, 2015, INT J CLIN EXP MED, V8, P3514; Wang XQ, 2014, J NEUROSCI, V34, P8585, DOI 10.1523/JNEUROSCI.2935-13.2014; Winkler EA, 2014, P NATL ACAD SCI USA, V111, pE1035, DOI 10.1073/pnas.1401595111; Wu W, 2013, BEHAV BRAIN RES, V253, P212, DOI 10.1016/j.bbr.2013.07.052; Xia B., 2015, INT J MOL MED; Xiao XL, 2010, NEUROL RES, V32, P547, DOI 10.1179/174313209X414533; Yip PY, 2015, TRANSL LUNG CANCER R, V4, P165, DOI 10.3978/j.issn.2218-6751.2015.01.04; Zhang J, 2015, CLIN CHIM ACTA, V444, P182, DOI 10.1016/j.cca.2014.12.041; Zhao TF, 2012, MOL BIOL REP, V39, P3541, DOI 10.1007/s11033-011-1127-1	35	19	22	2	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 15	2016	26	4					1287	1291		10.1016/j.bmcl.2016.01.015			5	Chemistry, Medicinal; Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Chemistry	DC7CZ	WOS:000369377700038	26786697				2022-02-06	
J	Bombardier, CH; Adams, LM; Fann, JR; Hoffman, JM				Bombardier, Charles H.; Adams, Leah M.; Fann, Jesse R.; Hoffman, Jeanne M.			Depression Trajectories During the First Year After Spinal Cord Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Depression; Longitudinal studies; Prognosis; Rehabilitation; Resilience; psychological; Spinal cord injuries	RANDOMIZED CLINICAL-TRIAL; TRAUMATIC BRAIN-INJURY; PSYCHOLOGICAL OUTCOMES; MAJOR DEPRESSION; SUBSTANCE USE; RISK-FACTORS; RESILIENCE; REHABILITATION; ALCOHOL; ANXIETY	Objective: To determine the number and type of longitudinal depression trajectories during the first year after spinal cord injury (SCI) and to identify baseline predictors of these trajectories. Design: Cohort study. Setting: Rehabilitation and postacute community settings. Participants: Of 168 consecutive admissions to inpatient rehabilitation for acute SCI, 141 (115 men, 26 women) patients were enrolled in a randomized controlled trial telephone follow-up intervention, which showed no outcome differences, and completed assessments on at least 2 of the 4 follow-up occasions (3, 6, 9, and 12 months after SCI). Participants were on average 41 years old, most were non-Hispanic (96%) and white (86%), and 61.7% had tetraplegia. Interventions: Data were drawn from the ineffective randomized controlled trial. Main Outcome Measure: Patient Health Questionnaire-9 (PHQ-9). Results: Unconditional linear latent class growth analysis models of PHQ-9 total scores revealed an optimal 3-class solution: stable low depression (63.8%), mild to moderate depression (29.1%), and persistent moderate to severe depression (7.1%). Preinjury mental health history and baseline pain, quality of life, and grief predicted class membership. Conclusions: The modal response to SCI was stable low depression, whereas persistent moderate to severe depression primarily represented a continuation or relapse of preinjury depression. This line of research has the potential to improve identification of subgroups destined for poor outcomes and to inform early intervention studies. (C) 2016 by the American Congress of Rehabilitation Medicine	[Bombardier, Charles H.; Fann, Jesse R.; Hoffman, Jeanne M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Adams, Leah M.] Grp Hlth Res Inst, Seattle, WA USA; [Fann, Jesse R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Bombardier, CH (corresponding author), Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Box 359612,325 9th Ave, Seattle, WA 98104 USA.	chb@uw.edu	Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283	Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems [H133N060033, H133N110009]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5T32AG027677]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG027677] Funding Source: NIH RePORTER	Supported by the Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems (grant nos. H133N060033 and H133N110009) and the National Institute on Aging (grant no. 5T32AG027677).	Adamson BC, 2015, ARCH PHYS MED REHAB, V96, P1329, DOI 10.1016/j.apmr.2015.01.005; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andrews F. M., 1976, SOCIAL INDICATORS WE; Banerjea R, 2009, SPINAL CORD, V47, P789, DOI 10.1038/sc.2009.42; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1488, DOI 10.1016/j.apmr.2003.10.010; Bombardier CH, 2012, ARCH PHYS MED REHAB, V93, P1838, DOI 10.1016/j.apmr.2012.04.019; Bombardier CH, 2012, ARCH PHYS MED REHAB, V93, P775, DOI 10.1016/j.apmr.2011.12.020; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Cairns DM, 1996, ARCH PHYS MED REHAB, V77, P329, DOI 10.1016/S0003-9993(96)90079-9; Cardenas DD, 2013, NEUROLOGY, V80, P533, DOI 10.1212/WNL.0b013e318281546b; Catalano D, 2011, REHABIL PSYCHOL, V56, P200, DOI 10.1037/a0024571; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; CRAIG AR, 1994, PARAPLEGIA, V32, P675, DOI 10.1038/sc.1994.109; Craig AR, 1997, ARCH PHYS MED REHAB, V78, P33, DOI 10.1016/S0003-9993(97)90006-X; Dorstyn D, 2012, ARCH PHYS MED REHAB, V93, P2100, DOI 10.1016/j.apmr.2012.06.002; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; Duchnick JJ, 2009, REHABIL PSYCHOL, V54, P123, DOI 10.1037/a0015571; ELLIOTT TR, 1992, REHABIL PSYCHOL, V37, P37, DOI 10.1037/h0079091; Fann JR, 2015, JAMA PSYCHIAT, V72, P247, DOI 10.1001/jamapsychiatry.2014.2482; Fann JR, 2011, ARCH PHYS MED REHAB, V92, P352, DOI 10.1016/j.apmr.2010.05.016; Ginis KAM, 2010, SPINAL CORD, V48, P65, DOI 10.1038/sc.2009.87; Hoffman JM, 2011, ARCH PHYS MED REHAB, V92, P411, DOI 10.1016/j.apmr.2010.10.036; Hoffman JM, 2013, AM SPIN INJ ASS ANN; JUDD FK, 1989, BRIT J PSYCHIAT, V154, P668, DOI 10.1192/bjp.154.5.668; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kalpakjian CZ, 2014, J SPINAL CORD MED, V37, P218, DOI 10.1179/2045772313Y.0000000169; Kemp BJ, 2004, J SPINAL CORD MED, V27, P22, DOI 10.1080/10790268.2004.11753726; Kennedy P, 2003, BRIT J CLIN PSYCHOL, V42, P41, DOI 10.1348/014466503762842002; King C, 1999, BRIT J CLIN PSYCHOL, V38, P5, DOI 10.1348/014466599162629; KISHI Y, 1994, J NEUROPSYCH CLIN N, V6, P237; Klyce DW, 2015, ARCH PHYS MED REHAB, V96, P1419, DOI 10.1016/j.apmr.2015.02.018; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; MCCRAE RR, 1986, J GERONTOL, V41, P390, DOI 10.1093/geronj/41.3.390; Monden KR, 2014, SPINAL CORD, V52, P197, DOI 10.1038/sc.2013.159; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Quale AJ, 2010, REHABIL PSYCHOL, V55, P12, DOI 10.1037/a0018415; Shear MK, 2014, JAMA PSYCHIAT, V71, P1287, DOI 10.1001/jamapsychiatry.2014.1242; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; The EuroQol Group, 1990, HLTH POLICY ED, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9	47	19	19	0	21	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2016	97	2					196	203		10.1016/j.apmr.2015.10.083			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DC4RH	WOS:000369207500003	26525525	Green Accepted			2022-02-06	
J	Custer, A; Sufrinko, A; Elbin, RJ; Covassin, T; Collins, M; Kontos, A				Custer, Aimee; Sufrinko, Alicia; Elbin, R. J.; Covassin, Tracey; Collins, Micky; Kontos, Anthony			High Baseline Postconcussion Symptom Scores and Concussion Outcomes in Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; baseline testing; neurocognitive impairment	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL PERFORMANCE; SPORT; RECOVERY; CARE; SEX	Context: Some healthy athletes report high levels of baseline concussion symptoms, which may be attributable to several factors (eg, illness, personality, somaticizing). However, the role of baseline symptoms in outcomes after sport-related concussion (SRC) has not been empirically examined. Objective: To determine if athletes with high symptom scores at baseline performed worse than athletes without baseline symptoms on neurocognitive testing after SRC. Design: Cohort study. Setting: High school and collegiate athletic programs. Patients or Other Participants: A total of 670 high school and collegiate athletes participated in the study. Participants were divided into groups with either no baseline symptoms (Postconcussion Symptom Scale [PCSS] score = 0, n = 247) or a high level of baseline symptoms (PCSS score > 18 [top 10% of sample], n = 68). Main Outcome Measure(s): Participants were evaluated at baseline and 2 to 7 days after SRC with the Immediate Postconcussion Assessment and Cognitive Test and PCSS. Outcome measures were Immediate Post-concussion Assessment and Cognitive Test composite scores (verbal memory, visual memory, visual motor processing speed, and reaction time) and total symptom score on the PCSS. The groups were compared using repeated-measures analyses of variance with Bonferroni correction to assess interactions between group and time for symptoms and neurocognitive impairment. Results: The no-symptoms group represented 38% of the original sample, whereas the high-symptoms group represented 11% of the sample. The high-symptoms group experienced a larger decline from preinjury to postinjury than the no-symptoms group in verbal (P = .03) and visual memory (P = .05). However, total concussion-symptom scores increased from preinjury to postinjury for the no-symptoms group (P = .001) but remained stable for the high-symptoms group. Conclusions: Reported baseline symptoms may help identify athletes at risk for worse outcomes after SRC. Clinicians should examine baseline symptom levels to better identify patients for earlier referral and treatment for their injury. Additional investigation of baseline symptoms is warranted to help delineate the type and severity of premorbid symptoms.	[Custer, Aimee; Sufrinko, Alicia; Collins, Micky; Kontos, Anthony] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA; [Elbin, R. J.] Univ Arkansas, Fayetteville, AR 72701 USA; [Covassin, Tracey] Michigan State Univ, E Lansing, MI 48824 USA		Kontos, A (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310	University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders [1K01DC012332-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	This research was supported in part by grants to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) to Dr Kontos.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Deary, 2009, PERSONALITY TRAITS; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; IVERSON G, 2014, BRAIN INJURY, V28, P667; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Kit KA, 2014, J INT NEUROPSYCH SOC, V20, P157, DOI 10.1017/S1355617713001264; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; LARSEN RJ, 1991, J PERS, V59, P387, DOI 10.1111/j.1467-6494.1991.tb00254.x; MACLEOD C, 1991, International Review of Psychiatry, V3, P279, DOI 10.3109/09540269109110407; Manassis K, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-4; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Michal M, 2011, J AFFECT DISORDERS, V134, P396, DOI 10.1016/j.jad.2011.05.033; Owens M, 2014, BRIT J PSYCHOL, V105, P92, DOI 10.1111/bjop.12009; Pennebaker JW., 1982, PSYCHOL PHYS SYMPTOM; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8	33	19	19	1	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2016	51	2					136	141		10.4085/1062-6050-51.2.12			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	DK2OW	WOS:000374755300005	26885702	Green Published			2022-02-06	
J	Malec, JF; Whiteneck, GG; Bogner, JA				Malec, James F.; Whiteneck, Gale G.; Bogner, Jennifer A.			Another Look at the PART-O Using the Traumatic Brain Injury Model Systems National Database: Scoring to Optimize Psychometrics	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Community participation; Outcome assessment (health care); Rehabilitation	PARTICIPATION ASSESSMENT; OUTCOMES MEASUREMENT; ISSUES	Objective: To integrate previous approaches to scoring the Participation Assessment with Recombined Tools-Objective (PART-O) in a unidimensional scale. Design: Retrospective analysis of PART-O data from the Traumatic Brain Injury Model Systems. Setting: Community. Participants: Data from individuals (N=469) selected randomly from participants who completed 1-year follow-up in the Traumatic Brain Injury Model Systems were used in Rasch model development. The model was subsequently tested on data from additional random samples of similar size at 1-, 2-, 5-, 10-, and >15-year follow-ups. Interventions: Not applicable. Main Outcome Measure: PART-O. Results: After combining items for productivity and social interaction, the initial analysis at 1-year follow-up indicated relatively good fit to the Rasch model (person reliability=.80) but also suggested item misfit and that the 0-to-5 scale used for most items did not consistently show clear separation between rating levels. Reducing item rating scales to 3 levels (except combined and dichotomous items) resolved these issues and demonstrated good item level discrimination, fit, and person reliability (.81), with no evidence of multidimensionality. These results replicated in analyses at each additional follow-up period. Conclusions: Modifications to item scoring for the PART-O resulted in a unidimensional parametric equivalent measure that addresses previous concerns about competing item relations, and it fit the Rasch model consistently across follow-up periods. The person-item map shows a progression toward greater community participation from solitary and dyadic activities, such as leaving the house and having a friend through social and productivity activities, to group activities with others who share interests or beliefs. (C) 2016 by the American Congress of Rehabilitation Medicine	[Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Malec, James F.] Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Whiteneck, Gale G.] Craig Hosp, Englewood, CO USA; [Bogner, Jennifer A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Malec, JF (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.; Malec, JF (corresponding author), Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	jmalec@rhin.com			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [USDE-90DP0036-01-00]; Rocky Mountain Regional Brain Injury System at Craig Hospital, Englewood, CO [USDE-90DP0034-01-00]; Ohio Regional Traumatic Brain Injury Model System at Ohio State University, Columbus, OH [USDE-90DP0040-01-00]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000036, U48DP000040, U48DP000034] Funding Source: NIH RePORTER	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the Indiana University/Rehabilitation Hospital of Indiana Traumatic Brain Injury Model System (grant no. USDE-90DP0036-01-00); Rocky Mountain Regional Brain Injury System at Craig Hospital, Englewood, CO (grant no. USDE-90DP0034-01-00); and the Ohio Regional Traumatic Brain Injury Model System at Ohio State University, Columbus, OH (grant no. USDE-90DP0040-01-00). NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this report do not necessarily represent the policy of NIDILRR, ACL, and HHS, and you should not assume endorsement by the federal government.	Alonso J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-210; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Dijkers M, 2009, ARCH PHYS MED REHAB, V90, pe39, DOI DOI 10.1016/j.apmr.2009.08.123; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Heinemann AW, 2010, ARCH PHYS MED REHAB, V91, pS72, DOI 10.1016/j.apmr.2009.11.031; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS1, DOI 10.1016/j.apmr.2011.07.202; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; World Health Organization, 1993, INT CLASS IMP DIS HA; World Health Organization, 1997, ICIDH 2 INT CLASS IM; World Health Organization, 2007, INT CLASS FUNCT DIS	16	19	19	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2016	97	2					211	217		10.1016/j.apmr.2015.09.001			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DC4RH	WOS:000369207500005	26381059				2022-02-06	
J	Wong, JC; Linn, KA; Shinohara, RT; Mateen, FJ				Wong, J. C.; Linn, K. A.; Shinohara, R. T.; Mateen, F. J.			Traumatic brain injury in Africa in 2050: a modeling study	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						acute brain injury; adolescent; adult; epidemiology	KENYA	Background and purposeOur aim was to provide estimates of traumatic brain injury (TBI) in 2050 for the African population by region, sex and age strata. MethodsA literature search was performed in October 2014 in PubMed for population-based studies of TBI in different geographical locations. Articles were selected from Kenya (model 1), New Zealand (model 2) and the USA (model 3). In model 1, rates of road traffic injury in Kenya were used to estimate TBI rates in the African continent. Models 2 and 3 used existing TBI incidence estimates from other locations to estimate the burden of TBI for Africa in 2050. The 2050 African population, as projected by the United Nations, was used as a base population. ResultsBased on rates from model 1, the estimated total TBI count in Africa in 2050 is 5.98 0.03 million, with the highest count in eastern (2.04 +/- 0.01 million) and lowest count in southern (0.15 +/- 0.00 million) Africa. A higher TBI count is predicted by models 2 (14.25 +/- 0.75 million) and 3 (10.40 +/- 0.02 million). Estimated TBI count is highest for males aged 15-34 (5.47 +/- 0.55 million in model 2 and 3.21 +/- 0.13 million in model 3). ConclusionsProjected estimates of TBI in Africa are high, with a burden of anywhere between approximately 6 and 14 million new cases in 2050. This emphasizes the importance of developing accurate surveillance systems of TBI at a population level and public health measures to mitigate the risk and burden of TBI.	[Wong, J. C.; Mateen, F. J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Wong, J. C.; Mateen, F. J.] Harvard Univ, Sch Med, Boston, MA USA; [Wong, J. C.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Linn, K. A.; Shinohara, R. T.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA		Mateen, FJ (corresponding author), Massachusetts Gen Hosp, Neurol Clin Res Inst, Dept Neurol, 165 Cambridge St,627, Boston, MA 02114 USA.	fmateen@partners.org		Mateen, Farrah/0000-0002-4293-8115			Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; [Anonymous], STAK AFF SAMRC; Bachani AM, 2012, TRAFFIC INJ PREV, V13, P24, DOI 10.1080/15389588.2011.633136; Chinda J Y, 2013, Afr J Paediatr Surg, V10, P358, DOI 10.4103/0189-6725.125448; Department of Economic and Social Affairs PD, 2012, WORLD POP PROSP 2012; Department of Economic and Social Affairs PD, 2004, WORLD POP 2300; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Mbakile-Mahlanza L, 2015, NEUROPSYCHOL REHABIL, V25, P936, DOI 10.1080/09602011.2014.999000; Muyembe VM, 1999, E AFR MED J, V76, P200; Saidi Hassan, 2014, J Trauma Manag Outcomes, V8, P4, DOI 10.1186/1752-2897-8-4; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043	16	19	19	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	FEB	2016	23	2					382	386		10.1111/ene.12877			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB8WE	WOS:000368797100034	26435298				2022-02-06	
J	Hu, H; Zhou, Y; Wang, Q; Su, SS; Qiu, YM; Ge, JW; Wang, Z; Xiao, ZP				Hu, Hao; Zhou, Yan; Wang, Qian; Su, Shanshan; Qiu, Yongming; Ge, Jianwei; Wang, Zhen; Xiao, Zeping			Association of abnormal white matter integrity in the acute phase of motor vehicle accidents with post-traumatic stress disorder	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Motor vehicle accidents; Post-traumatic stress disorder; Diffusion tensor Imaging	TRAUMATIC BRAIN-INJURY; CORPUS-CALLOSUM; FUNCTIONAL CONNECTIVITY; PSYCHOMETRIC PROPERTIES; NETWORK CONNECTIVITY; COMBAT VETERANS; PTSD; COMORBIDITY; EXTINCTION; CINGULATE	Background: A small portion of the Motor vehicle accidents (MVA) survivors would develop post-traumatic stress disorder (PTSD), which would cause substantial social function loss. How to identify those high-risk MVA survivors in the acute phase of the trauma is the first step to prevent the onset of PTSD. In the present study, we studied white matter integrity of subjects post to MVA by diffusional tensor imaging (DTI). Methods: To investigate whether the integrity of the white matter was impaired in the acute phase of the MVA among survivors who later develop PTSD and whether it could predict the severity of PTSD while being diagnosed. MVA Survivors were recruited to get trauma-specific clinical assessments and received DTI scan within 2 days from the MVA. These survivors were divided into 2 groups, PTSD group and trauma control (TC) group based on the clinical follow-up interview. Tract-Based Spatial Statistics (TBSS) was carried out to investigate difference in white matter integrity between 2 groups within DTI parameter maps. White matter integrity was measured by using fractional anisotropy (FA), axial diffusivity (AD), mean diffusivity (MD), and radical diffusivity (RD). Results: Compared with TC group, PTSD group showed lower FA value in multiple regions of both hemispheres, mainly involving anterior thalamic radiation, cortico-spinal tract, forceps minor, uncinate, inferior fronto-occipital fasciculus, inferior longitudinal fasciculus, cingulum and superior longitudinal fasciculus. Increased RD was also detected in PTSD group in the posterior part of right hemisphere, involving forceps major, inferior fronto-occipital fasciculus, inferior longitudinal fasciculus, cingulum, hippocampus and superior longitudinal fasciculus. The baseline FA and RD values correlated with Clinician-Administered PTSD Scale scores at clinical follow up. Conclusion: MVA survivors who later developed PTSD had more abnormalities in white matter integrity in the acute phase than those non-PTSD MVA survivors. Imaging markers of white matter integrity might be helpful in early identification of MVA survivors at high risk of PTSD. Limitations: Larger sample size in our extensive study is needed to confer a robust inference and image data at follow up are needed to observe the longitudinal changes of white matter integrity. (C) 2015 Elsevier B.V. All rights reserved.	[Hu, Hao; Su, Shanshan; Wang, Zhen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Hu, Hao; Su, Shanshan; Wang, Zhen] Shanghai Key Lab Psychot Disorders, Shanghai, Peoples R China; [Zhou, Yan] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Wang, Qian] Shanghai Jiao Tong Univ, MedX Res Inst, Shanghai 200030, Peoples R China; [Qiu, Yongming; Ge, Jianwei] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China; [Xiao, Zeping] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China		Wang, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	wangzhen@smhc.org.cn; xiaozeping88@163.com	Wang, Zhen/A-2389-2011; Wang, Qian/AAY-9494-2020	Wang, Zhen/0000-0003-4319-5314; Wang, Qian/0000-0002-3490-3836	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371486]; Shanghai Rising-Star Program [13QA1403200]; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500]	The research was supported by grants from the National Natural Science Foundation of China (No.81371486), the Shanghai Rising-Star Program (No.13QA1403200), and the Shanghai Key Laboratory of Psychotic Disorders (No.13dz2260500). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared no conflict of interest.	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bierer LM, 2015, PSYCHONEUROENDOCRINO, V51, P567, DOI 10.1016/j.psyneuen.2014.11.007; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Brown VM, 2014, NEUROPSYCHOPHARMACOL, V39, P351, DOI 10.1038/npp.2013.197; Bruce SE, 2013, NEUROIMAGE-CLIN, V2, P43, DOI 10.1016/j.nicl.2012.11.003; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Chossegros L, 2011, ACCIDENT ANAL PREV, V43, P471, DOI 10.1016/j.aap.2010.10.004; Cohen, 1977, STAT POWER ANAL BEHA; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Felmingham KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103653; Freedman S.A., 2015, EUR J PSYCHOTRAUMATO, V6, P2508; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hall T, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-21; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jin C, 2014, PSYCHOL MED, V44, P1927, DOI 10.1017/S003329171300250X; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Jorm AF, 2005, AM J PSYCHIAT, V162, P699, DOI 10.1176/appi.ajp.162.4.699; Kennis M, 2015, NEUROPSYCHOPHARMACOL, V40, P2434, DOI 10.1038/npp.2015.94; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kitayama N, 2007, J NERV MENT DIS, V195, P1027, DOI 10.1097/NMD.0b013e31815c044f; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mirza KAH, 1998, BRIT J PSYCHIAT, V172, P443, DOI 10.1192/bjp.172.5.443; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Moser DA, 2015, SOC COGN AFFECT NEUR, V10, P645, DOI 10.1093/scan/nsu099; Murray J, 2002, BRIT J PSYCHIAT, V180, P363, DOI 10.1192/bjp.180.4.363; Nardo D, 2011, PSYCHOL MED, V41, P2549, DOI 10.1017/S0033291711000912; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Qin LD, 2012, BRAIN RES, V1484, P50, DOI 10.1016/j.brainres.2012.09.029; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Rougemont-Bucking A, 2011, CNS NEUROSCI THER, V17, P227, DOI 10.1111/j.1755-5949.2010.00152.x; Saar-Ashkenazy R, 2014, J TRAUMA STRESS, V27, P18, DOI 10.1002/jts.21887; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Simmons AN, 2013, J AFFECT DISORDERS, V146, P426, DOI 10.1016/j.jad.2012.08.006; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stein MB, 2001, J AFFECT DISORDERS, V66, P133, DOI 10.1016/S0165-0327(00)00301-3; Sun YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083473; Tursich M, 2015, ACTA PSYCHIAT SCAND, V132, P29, DOI 10.1111/acps.12387; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zhang L, 2012, ACTA NEUROPSYCHIATR, V24, P34, DOI 10.1111/j.1601-5215.2011.00580.x; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121095; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046833	60	19	19	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	JAN 15	2016	190						714	722		10.1016/j.jad.2015.09.044			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	CY5QT	WOS:000366463000096	26600413				2022-02-06	
J	Adhikari, U; Goliaei, A; Berkowitz, ML				Adhikari, Upendra; Goliaei, Ardeshir; Berkowitz, Max L.			Nanobubbles, cavitation, shock waves and traumatic brain injury	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							ULTRASOUND-INDUCED CAVITATION; INTENSITY FOCUSED ULTRASOUND; ATOMIC-FORCE MICROSCOPY; MOLECULAR-DYNAMICS; BARRIER DISRUPTION; DRUG-DELIVERY; GENE DELIVERY; FOLDING SIMULATIONS; PRIMARY BLAST; CANCER-CELLS	Collapse of bubbles, microscopic or nanoscopic, due to their interaction with the impinging pressure wave produces a jet of particles moving in the direction of the wave. If there is a surface nearby, the high-speed jet particles hit it, and as a result damage to the surface is produced. This cavitation effect is well known and intensely studied in case of microscopic sized bubbles. It can be quite damaging to materials, including biological tissues, but it can also be beneficial when controlled, like in case of sonoporation of biological membranes for the purpose of drug delivery. Here we consider recent simulation work performed to study collapse of nanobubbles exposed to shock waves, in order to understand the detailed mechanism of the cavitation induced damage to soft materials, such as biological membranes. We also discuss the connection of the cavitation effect with the traumatic brain injury caused by blasts. Specifically, we consider possible damage to model membranes containing lipid bilayers, bilayers with embedded ion channel proteins like the ones found in neural cells and also protein assemblies found in the tight junction of the blood brain barrier.	[Adhikari, Upendra; Berkowitz, Max L.] Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC 27599 USA; [Goliaei, Ardeshir] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Goliaei, Ardeshir] Univ North Carolina Chapel Hill, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA		Berkowitz, ML (corresponding author), Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC 27599 USA.	maxb@unc.edu		Berkowitz, Max/0000-0002-9116-0362	Office of Naval ResearchOffice of Naval Research [N00014-14-1-0241]	The support by a grant N00014-14-1-0241 from the Office of Naval Research is gratefully acknowledged. MLB wants to thank Dr T Bentley who introduced him to the fascinating subject of cavitation and also for his constant encouragement and support. The authors express their gratitude to their collaborators, Dr E. Lau and E. Schwegler from the Lawrence Livermore National Laboratory and are also grateful to Dr Santo, a former member of the group, who performed initial simulations and who constantly helped with valuable advice after he left the group. We also thank Professors Wei Han and Yun-Dong Wu for providing us the PACE force-field parameters.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adhikari U, 2015, J PHYS CHEM B, V119, P6225, DOI 10.1021/acs.jpcb.5b02218; Amabile PG, 2001, J AM COLL CARDIOL, V37, P1975, DOI 10.1016/S0735-1097(01)01253-0; Aryal M, 2014, ADV DRUG DELIVER REV, V72, P94, DOI 10.1016/j.addr.2014.01.008; Ball P, 2012, CHEMPHYSCHEM, V13, P2173, DOI 10.1002/cphc.201200119; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bazan-Peregrino M, 2012, J CONTROL RELEASE, V157, P235, DOI 10.1016/j.jconrel.2011.09.086; Bellmann C, 2014, ANTIOXID REDOX SIGN, V20, P855, DOI 10.1089/ars.2013.5288; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOURNE NK, 1992, J FLUID MECH, V244, P225, DOI 10.1017/S0022112092003045; Brennen CE, 2014, CAVITATION AND BUBBLE DYNAMICS, P1; Brennen CE, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0022; Bunkin NF, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739530; Bunkin NF, 2016, J PHYS CHEM B, V120, P1291, DOI 10.1021/acs.jpcb.5b11103; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Choubey A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3518472; Clement GT, 2004, ULTRASONICS, V42, P1087, DOI 10.1016/j.ultras.2004.04.003; Coussios C. C., 2009, INT J HYPERTHER, V23, P105; Craig VSJ, 2011, SOFT MATTER, V7, P40, DOI 10.1039/c0sm00558d; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; DEAR JP, 1988, J FLUID MECH, V190, P409, DOI 10.1017/S0022112088001387; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; Ferrara KW, 2008, ADV DRUG DELIVER REV, V60, P1097, DOI 10.1016/j.addr.2008.03.002; Flannigan DJ, 2005, NATURE, V434, P52, DOI 10.1038/nature03361; Fu HH, 2015, J PHYS CHEM LETT, V6, P413, DOI 10.1021/jz502513w; Giesecke T, 2003, ULTRASOUND MED BIOL, V29, P1359, DOI 10.1016/S0301-5629(03)00980-3; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goiaei A, 2015, ACS CHEM NEUROSCI, V6, P1296, DOI 10.1021/acschemneuro.5b00116; Gong CL, 1998, J ACOUST SOC AM, V104, P2675, DOI 10.1121/1.423851; Han W, 2012, J CHEM THEORY COMPUT, V8, P4413, DOI 10.1021/ct300696c; Han W, 2010, J CHEM THEORY COMPUT, V6, P3373, DOI 10.1021/ct1003127; Han W, 2010, J CHEM THEORY COMPUT, V6, P3390, DOI 10.1021/ct100313a; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoekstra A, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0377; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hosseinkhah N, 2015, IEEE T BIO-MED ENG, V62, P1293, DOI 10.1109/TBME.2014.2385651; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2003, ACT NEUR S, V86, P555; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Ibsen S, 2013, DRUG DES DEV THER, V7, P375, DOI 10.2147/DDDT.S31564; Ishida N, 2000, LANGMUIR, V16, P6377, DOI 10.1021/la000219r; Junge L, 2003, ULTRASOUND MED BIOL, V29, P1769, DOI 10.1016/j.ultrasmedbio.2003.08.010; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Konofagou EE, 2012, CURR PHARM BIOTECHNO, V13, P1332; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Larina IV, 2005, TECHNOL CANCER RES T, V4, P217, DOI 10.1177/153303460500400211; Larina IV, 2005, ANTICANCER RES, V25, P149; Lau EY, 2016, BIOPHYS J, V110, P147, DOI 10.1016/j.bpj.2015.11.030; Lauer E, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4719142; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; Liu YW, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4896937; Lohse D, 2015, REV MOD PHYS, V87, P981, DOI 10.1103/RevModPhys.87.981; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lou ST, 2000, J VAC SCI TECHNOL B, V18, P2573, DOI 10.1116/1.1289925; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019; Mehier-Humbert S, 2005, J CONTROL RELEASE, V104, P203, DOI 10.1016/j.jconrel.2005.01.011; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nielsen SO, 2010, PHYS CHEM CHEM PHYS, V12, P12401, DOI 10.1039/c004111d; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Ohgaki K, 2010, CHEM ENG SCI, V65, P1296, DOI 10.1016/j.ces.2009.10.003; Ohl CD, 2003, BBA-GEN SUBJECTS, V1624, P131, DOI 10.1016/j.bbagen.2003.10.005; Ohl CD, 2006, BIOPHYS J, V91, P4285, DOI 10.1529/biophysj.106.075366; Ohl SW, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0019; Paliwal Sumit, 2006, Expert Opin Drug Deliv, V3, P713, DOI 10.1517/17425247.3.6.713; Pan G, 2016, LANGMUIR, V32, P11133, DOI 10.1021/acs.langmuir.6b01483; Pardridge William M, 2005, NeuroRx, V2, P3; PARKER JL, 1994, J PHYS CHEM-US, V98, P8468, DOI 10.1021/j100085a029; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peng H, 2015, ADV COLLOID INTERFAC, V222, P573, DOI 10.1016/j.cis.2014.09.004; Peshkovsky SL, 2008, ULTRASON SONOCHEM, V15, P618, DOI 10.1016/j.ultsonch.2007.07.006; Praprotnik M, 2008, ANNU REV PHYS CHEM, V59, P545, DOI 10.1146/annurev.physchem.59.032607.093707; Rae J, 2005, ULTRASON SONOCHEM, V12, P325, DOI 10.1016/j.ultsonch.2004.06.007; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYBAKOV AP, 1995, EUR J MECH B-FLUID, V14, P323; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Santo KP, 2015, J PHYS CHEM B, V119, P8879, DOI 10.1021/jp505720d; Santo KP, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862987; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Steinhauser MO, 2014, SOFT MATTER, V10, P4778, DOI 10.1039/c4sm00407h; Sun DD, 2016, J PHYS CHEM C, V120, P18803, DOI 10.1021/acs.jpcc.6b04086; Sun YJ, 2016, COLLOID SURFACE A, V495, P176, DOI 10.1016/j.colsurfa.2016.01.050; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Treat LH, 2009, AIP CONF PROC, V1113, P443; Tung YS, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580763; Tung YS, 2010, PHYS MED BIOL, V55, P6141, DOI 10.1088/0031-9155/55/20/007; Uchida T, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6020031; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vedadi M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.014503; Vogel A, 1996, J ACOUST SOC AM, V100, P148, DOI 10.1121/1.415878; Vykhodtseva N, 2008, ULTRASONICS, V48, P279, DOI 10.1016/j.ultras.2008.04.004; Wan CK, 2012, J CHEM THEORY COMPUT, V8, P300, DOI 10.1021/ct2004275; Wang S, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/18/184007; Weijs JH, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.054501; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zhang XH, 2013, LANGMUIR, V29, P1017, DOI 10.1021/la303837c; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	113	19	19	1	44	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2016	18	48					32638	32652		10.1039/c6cp06704b			15	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Physics	EF6IY	WOS:000390435800001	27883130				2022-02-06	
J	Andelic, N; Arango-Lasprilla, JC; Perrin, PB; Sigurdardottir, S; Lu, J; Landa, LO; Forslund, MV; Roe, C				Andelic, Nada; Carlos Arango-Lasprilla, Juan; Perrin, Paul B.; Sigurdardottir, Solrun; Lu, Juan; Landa, Laiene Olabarrieta; Forslund, Marit V.; Roe, Cecilie			Modeling of Community Integration Trajectories in the First Five Years after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						outcome measures; recovery; rehabilitation; traumatic brain injury	QUALITY-OF-LIFE; MINORITY STATUS; OUTCOMES; REHABILITATION; PARTICIPATION; MODERATE; IMPACT; INDIVIDUALS; PREDICTION; BEHAVIOR	The aims of this study were to assess the trajectories of community integration in individuals with traumatic brain injury (TBI) through one, two, and five years post-injury and to examine whether those trajectories could be predicted by demographic and injury characteristics. A longitudinal cohort study was conducted with 105 individuals with moderate-to-severe TBI admitted to a trauma referral center in 2005-2007. Demographics and injury-related factors were extracted from medical records. At the one-, two- and five-year follow-ups, community integration was measured by the Community Integration Questionnaire (CIQ). A hierarchical linear model (HLM) examined whether longitudinal trajectories of community integration could be predicted by: time, sex, age, relationship status, education, employment status, occupation, acute Glasgow Coma Scale score, cause of injury, days in post-traumatic amnesia (PTA), computed tomography Marshall Score, and Injury Severity Score. CIQ scores improved across the three time-points (p<0.001). Additionally, higher trajectories of community integration were predicted by being single at the time of injury (p<.001), higher level of education (p=0.006), employment (p<0.001), and a shorter length of PTA (p<0.001). In a follow-up HLM with interaction terms, time*PTA was statistically significant (p<0.001), suggesting that participants with longer PTA increased in community integration more rapidly than those with shorter PTA. The longitudinal course of community integration described in this study may help rehabilitation professionals to plan more extensive follow-ups and targeted rehabilitation programs in the early stage of recovery for patients with specific demographic and injury characteristics.	[Andelic, Nada; Forslund, Marit V.; Roe, Cecilie] Oslo Univ Hosp Ulleval, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada; Sigurdardottir, Solrun] Univ Oslo, Fac Med, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv, Oslo, Norway; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Sigurdardottir, Solrun] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA USA; [Lu, Juan] Sunnaas Rehabil Hosp Trust, Akershus, Norway; [Landa, Laiene Olabarrieta] Univ Deusto, Dept Psychol, Bilbao, Spain; [Forslund, Marit V.; Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway		Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.	nadand@ous-hf.no	Arango-Lasprilla, Juan Carlos/AAB-5407-2019; Landa, Laiene Olabarrieta/V-6207-2017; Perrin, Paul/L-5373-2015	Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; Landa, Laiene Olabarrieta/0000-0002-8305-8720; Andelic, Nada/0000-0002-3719-4406; Perrin, Paul/0000-0003-2070-215X; Lu, Juan/0000-0002-5389-7603	Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo	The authors would like to thank all the patients for their participation. Special thanks to Nini Hammergren for assistance with patient registrations during the first two years post-injury. This study was funded by grant from The Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2013, J REHABIL MED, V45, P708, DOI [10.2340/16501977-1224, 10.2340/16501977-1216]; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Fleming J, 1999, BRAIN INJURY, V13, P417; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Linden MA, 2005, DISABIL REHABIL, V27, P1353, DOI 10.1080/09638280500164180; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Rike PO, 2014, BRAIN INJURY, V28, P1687, DOI 10.3109/02699052.2014.947632; Romoren TI, 2011, INT J INTEGR CARE, V11; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Sigurdardottir S, 2014, BRAIN INJURY, V28, P1542, DOI 10.3109/02699052.2014.934285; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; TEASDALE G, 1974, LANCET, V2, P81; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	45	19	19	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					95	100		10.1089/neu.2014.3844			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200012	25897980				2022-02-06	
J	Chen, Q; Tian, S; Zhu, J; Li, KT; Yu, TH; Yu, LH; Bai, DQ				Chen, Qing; Tian, Si; Zhu, Jing; Li, Kai-Ting; Yu, Ting-He; Yu, Le-Hua; Bai, Ding-Qun			Exploring a Novel Target Treatment on Breast Cancer: Aloe-emodin Mediated Photodynamic Therapy Induced Cell Apoptosis and Inhibited Cell Metastasis	ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY			English	Article						Aloe-emodin; cell death; endoplasmic reticulum; mitochondrial; oxidative stress; photodynamic therapy	TRAUMATIC BRAIN-INJURY; MATRIX METALLOPROTEINASES; MOLECULAR-MECHANISMS; HYPERICUM-PERFORATUM; INSIGHTS; PATHWAY; STRESS; PHOTOSENSITIZERS; ELECTROPHILES; ACTIVATION	Photodynamic therapy (PDT) as a clinical cancer therapy, is a mild therapy, which involves application of photosensitizers (PSs) located in target cells and then irradiated by corresponding wavelength. The activation of PSs generates radical oxygen species (ROS) to exert a selective cytotoxic activity for the target cells. Aloe-emodin (AE) has been found to be an anti-tumor agent in many studies, and has also been demonstrated as a photosensitizer, in the recent years. In order to study the mechanisms of aloe-emodin as a photosensitizer, we investigated the mechanisms of photo-cytotoxicity induced by aloe-emodin in breast cancer MCF-7 cells in the present study. Analysis of cell proliferation evidenced that there was a drastic depression after photodynamic treatment with a series of aloe-emodin concentrations and light doses. We observed changes in apoptosis and demonstrated that the mechanisms of apoptosis were involved in mitochondrial and endoplasmic reticulum death pathways. The capacity of adhesion, migration and invasion of breast cells was measured using WST8 and transwell assay and demonstrated that AE-PDT significantly inhibited adhesion, migration and invasion of MCF-7cells. The expression of MMP2, MMP9, VEGF and Nrf2 demonstrated that the metastasis was related to oxidative stress. Analysis of changes in cytoskeleton components (F-actin) evidenced cytoskeleton disorganization after treatment with AE-PDT. Taken together, the present results indicated that PDT with aloe-emodin effectively suppressed cancer development in MCF-7cells, suggesting the potential of AE as a new photosensitizer in PDT which can provide a new modility for treating cancer.	[Chen, Qing; Tian, Si; Li, Kai-Ting; Bai, Ding-Qun] Chongqing Med Univ, Affiliated Hosp 1, Dept Rehabil, Chongqing, Peoples R China; [Zhu, Jing; Yu, Le-Hua] Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil, Chongqing, Peoples R China; [Yu, Ting-He] Chongqing Med Univ, Affiliated Hosp 2, Dept Gynaecol & Obstet, Chongqing, Peoples R China		Bai, DQ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Rehabil, Chongqing, Peoples R China.	baidingqun2014@163.com		Yu, T/0000-0002-9014-7967	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81101692, 81171859]; Natural Science Foundation Project of CQ CSTCNatural Science Foundation Project of CQ CSTC [2011BB5136]	We recognize the valuable contribution of Prof. TH Yu (Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China) and Mr Chen (Flow Cytometry, Centro Nacional de Biotecnologi'a, Madrid). This work was supported by the National Natural Science Foundation of China (81101692); National Natural Science Foundation of China (81171859) and Natural Science Foundation Project of CQ CSTC (2011BB5136).	Acedo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.77; Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Allison RR, 2013, PHOTODIAGN PHOTODYN, V10, P331, DOI 10.1016/j.pdpdt.2013.03.011; Bais HP, 2003, J BIOL CHEM, V278, P32413, DOI 10.1074/jbc.M301681200; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Du J, 2012, BREAST CANCER RES TR, V131, P65, DOI 10.1007/s10549-011-1396-3; Hartmann S, 2011, CLIN BREAST CANCER, V11, P196, DOI 10.1016/j.clbc.2011.06.001; Hu ZW, 2011, BREAST CANCER RES TR, V126, P589, DOI 10.1007/s10549-010-0957-1; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Josefsen LB, 2012, THERANOSTICS, V2, P916, DOI 10.7150/thno.4571; Jozkowicz A, 2002, ANTIOXID REDOX SIGN, V4, P577, DOI 10.1089/15230860260220076; Ke MS, 2008, PHOTOCHEM PHOTOBIOL, V84, P407, DOI 10.1111/j.1751-1097.2007.00278.x; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lai JC, 2006, CANCER BIOL THER, V5, P413, DOI 10.4161/cbt.5.4.2513; Lee HZ, 2010, EUR J PHARMACOL, V648, P50, DOI 10.1016/j.ejphar.2010.08.033; Lee MS, 2001, CYTOTECHNOLOGY, V36, P61, DOI 10.1023/A:1014032701800; Mohammadpour H, 2015, PHOTODIAGN PHOTODYN, V12, P238, DOI 10.1016/j.pdpdt.2015.02.004; O'Malley CD, 2003, CANCER, V97, P1303, DOI 10.1002/cncr.11160; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Schonthal AH, 2009, CANCER LETT, V275, P163, DOI 10.1016/j.canlet.2008.07.005; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang L, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/47/475103; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wilcken N, 2014, ASIA-PAC J CLIN ONCO, V10, P1, DOI 10.1111/ajco.12206; Xue LY, 2003, ONCOGENE, V22, P9197, DOI 10.1038/sj.onc.1207019; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; Yoo JO, 2012, INT REV CEL MOL BIO, V295, P139, DOI 10.1016/B978-0-12-394306-4.00010-1; Zhao JF, 2012, ANTI-CANCER AGENT ME, V12, P604; Zhao MY, 2015, AM J PHYSIOL-CELL PH, V308, pC665, DOI 10.1152/ajpcell.00369.2014; Zobayed SMA, 2006, ANN BOT-LONDON, V98, P793, DOI 10.1093/aob/mcl169	42	19	19	4	29	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1871-5206	1875-5992		ANTI-CANCER AGENT ME	Anti-Cancer Agents Med. Chem.		2016	16	6					763	770		10.2174/1871520615666150821093323			8	Oncology; Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Pharmacology & Pharmacy	DK7WR	WOS:000375138000010	26295333				2022-02-06	
J	Daniele, G; Weinstein, RN; Wallace, PW; Palmieri, V; Bianco, M				Daniele, Gianlorenzo; Weinstein, Richard N.; Wallace, Paul Wesley; Palmieri, Vincenzo; Bianco, Massimiliano			Rapid weight gain in professional boxing and correlation with fight decisions: analysis from 71 title fights	PHYSICIAN AND SPORTSMEDICINE			English	Article						Combat sport; martial art; hydration; traumatic brain injury; concussion	MIXED MARTIAL ARTS; COMBAT SPORTS; PERFORMANCE; SUCCESS; INJURY; BOXERS; IMPACT; MASS	Objectives: Boxing is a sport where athletes compete in several weight categories. Professional boxers typically dehydrate to cut their weight for the weigh-in (24 h before the contest) and then rehydrate before the fight. The International Boxing Federation (IBF) mandates a second weigh-in 12 h before the fight. Our objectives were: 1) To quantify the weight gain (WG) from the 1st to the 2nd weigh-in; 2) to investigate whether rapid WG affects boxing performance (win/loss rate) and 3) whether weight discrepancy (WD) 15 between boxers exposes them to increased health risks (rate of fights ended before time limit). Methods: From official weigh-in reports of 71 IBF fights (142 fighters) the following data were gathered/calculated for each boxer: age, weight division, 1st weight, 2nd weight, WG between weigh-ins (kg and %), WD between opponents, and fight decision. Results: Between the weigh-ins, the average WG was 2.52 +/- 1.37kg (range -0.3/6.4kg) and 3.8 +/- 2.2% of the initial body weight (range -0.4/9.3%) and the average WD 1.94 +/- 1.50kg (maximum 7.10kg). Both WG and WD did not affect match outcomes. We observed tendencies for higher loss rate among boxers gaining more weight, and for higher victory rate in boxers with larger WD, however without reaching significance. A significant negative correlation was found between the 1st weight and the WG, both in absolute (r=-0.278, p=0.001) and relative value (r=-0.497, p<0.0001). Conclusions: Although correlations between WG, WD and boxing performance were not found, single cases with an alarming high WG and WD were noted.	[Daniele, Gianlorenzo; Palmieri, Vincenzo; Bianco, Massimiliano] Univ Cattolica Sacro Cuore, Internal Med & Geriatr Inst, Sports Med Unit, Largo Agostino Gemelli 8, I-00168 Rome, Italy; [Weinstein, Richard N.] Westchester Hlth Associates, White Plains, NY USA; [Wallace, Paul Wesley] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA		Bianco, M (corresponding author), Univ Cattolica Sacro Cuore, Internal Med & Geriatr Inst, Sports Med Unit, Largo Agostino Gemelli 8, I-00168 Rome, Italy.	massimiliano.bianco@fastwebnet.it	Bianco, Massimiliano/M-9907-2019	Bianco, Massimiliano/0000-0002-0587-5899			Artioli GG, 2016, SPORTS MED; Artioli GG, 2010, J SPORT SCI, V28, P21, DOI 10.1080/02640410903428574; Artioli GG, 2010, MED SCI SPORT EXER, V42, P436, DOI 10.1249/MSS.0b013e3181ba8055; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Baird LC, 2010, NEUROSURGERY, V67, P1444, DOI 10.1227/NEU.0b013e3181e5e2cd; Berkovich BE, 2016, INT J SPORT NUTR EXE, V26, P276, DOI 10.1123/ijsnem.2015-0196; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; Brito CJ, 2012, INT J SPORT NUTR EXE, V22, P89, DOI 10.1123/ijsnem.22.2.89; Chaabene H, 2015, SPORTS MED, V45, P337, DOI 10.1007/s40279-014-0274-7; Crighton B, 2016, BRIT J SPORT MED, V50, P446, DOI 10.1136/bjsports-2015-094732; Davis P, 2015, INT J SPORT PHYSIOL, V10, P53, DOI 10.1123/ijspp.2013-0474; Peron APDN, 2009, MUNDO SAUDE, V33, P352; Degoutte F, 2006, INT J SPORTS MED, V27, P9, DOI 10.1055/s-2005-837505; Franchini E, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-52; FREISCHLAG J, 1984, PHYSICIAN SPORTSMED, V12, P121; Gonzalez-Alonso J, 2008, J PHYSIOL-LONDON, V586, P45, DOI 10.1113/jphysiol.2007.142158; Hall CJ, 2001, BRIT J SPORT MED, V35, P390, DOI 10.1136/bjsm.35.6.390; HORSWILL CA, 1992, SPORTS MED, V14, P114, DOI 10.2165/00007256-199214020-00004; HORSWILL CA, 1994, MED SCI SPORT EXER, V26, P1290; Jetton AM, 2013, J STRENGTH COND RES, V27, P1322, DOI 10.1519/JSC.0b013e31828a1e91; Kazemi M, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-26; Khodaee M, 2015, CURR SPORT MED REP, V14, P435, DOI 10.1249/JSR.0000000000000206; Langan-Evans C, 2011, STRENGTH COND J, V33, P25, DOI 10.1519/SSC.0b013e318231bb64; Mendes SH, 2013, BRIT J SPORT MED, V47, P1155, DOI 10.1136/bjsports-2013-092689; Nybo L, 2014, COMPR PHYSIOL, V4, P657, DOI 10.1002/cphy.c130012; Periard JD, 2011, EXP PHYSIOL, V96, P134, DOI 10.1113/expphysiol.2010.054213; Pettersson S, 2013, J ATHL TRAINING, V48, P99, DOI 10.4085/1062-6050-48.1.04; Racinais S, 2015, SPORTS MED, V45, P925, DOI 10.1007/s40279-015-0343-6; Reljic D, 2015, J SPORT SCI, V33, P437, DOI 10.1080/02640414.2014.949825; Reljic D, 2013, J ATHL TRAINING, V48, P109, DOI 10.4085/1062-6050-48.1.05; STEEN SN, 1990, MED SCI SPORT EXER, V22, P762, DOI 10.1249/00005768-199012000-00005; Wroble RR, 1998, MED SCI SPORT EXER, V30, P949, DOI 10.1097/00005768-199806000-00026; 1990, B PAN AM HLTH ORG, V24, P606	33	19	22	1	31	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2016	44	4					349	354		10.1080/00913847.2016.1228421			6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	EC0HN	WOS:000387780200006	27564844				2022-02-06	
J	Darling, T; Muthuswamy, J; Rajan, SD				Darling, T.; Muthuswamy, J.; Rajan, S. D.			Finite element modeling of human brain response to football helmet impacts	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Football helmet; finite element analysis; mTBI; brain injury; concussion; sports injury; brain tissue	ENGINE FAN BLADE; IN-VITRO; HEAD; DESIGN; TISSUE; BIOMECHANICS; CONCUSSION; VIVO	The football helmet is used to help mitigate the occurrence of impact-related traumatic (TBI) and minor traumatic brain injuries (mTBI) in the game of American football. While the current helmet design methodology may be adequate for reducing linear acceleration of the head and minimizing TBI, it however has had less effect in minimizing mTBI. The objectives of this study are (a) to develop and validate a coupled finite element (FE) model of a football helmet and the human body, and (b) to assess responses of different regions of the brain to two different impact conditions - frontal oblique and crown impact conditions. The FE helmet model was validated using experimental results of drop tests. Subsequently, the integrated helmet-human body FE model was used to assess the responses of different regions of the brain to impact loads. Strain-rate, strain, and stress measures in the corpus callosum, midbrain, and brain stem were assessed. Results show that maximum strain-rates of 27 and 19s(-1) are observed in the brain-stem and mid-brain, respectively. This could potentially lead to axonal injuries and neuronal cell death during crown impact conditions. The developed experimental-numerical framework can be used in the study of other helmet-related impact conditions.	[Darling, T.] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ USA; [Muthuswamy, J.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA; [Rajan, S. D.] Arizona State Univ, Sch Sustainable Engn & Built Environm, Civil Mech & Aerosp Engn, Tempe, AZ 85281 USA		Rajan, SD (corresponding author), Arizona State Univ, Sch Sustainable Engn & Built Environm, Civil Mech & Aerosp Engn, Tempe, AZ 85281 USA.	s.rajan@asu.edu		Muthuswamy, Jit/0000-0003-3924-9869			Altair Engineering Inc, 2011, HYPERMESH VERS 110 P; Bansal S, 2009, J AEROSPACE ENG, V22, P249, DOI 10.1061/(ASCE)0893-1321(2009)22:3(249); Bilston LE, 2011, STUD MECHANOBIOL TIS, V3, P11, DOI 10.1007/8415_2010_36; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Deck C, 2006, INT J CRASHWORTHINES, V11, P561, DOI 10.1533/ijcr.2006.0149; Deivanayagam A, 2013, ASCE J AEROSP ENG, V27, P484, DOI [10.1061/(ASCE)AS.1943-5525, DOI 10.1061/(ASCE)AS.1943-5525]; efunda Inc, 2014, POL MAT PROP; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hodgson RV, 1970, 14 STAPP CAR CRASH; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Jazi MS, 2014, COMPUT METHOD BIOMEC, V17, P1368, DOI 10.1080/10255842.2012.748755; LSTC, 2015, LS DYNA VERS 971; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Moss WC, 2011, IMPACT RESPONSE US A, DOI [10.2172/1021058, DOI 10.2172/1021058]; Nahum AM, 1977, P 21 STAPP CAR CRASH; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pinnoji PK, 2007, SADHANA-ACAD P ENG S, V32, P445, DOI 10.1007/s12046-007-0034-6; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Roache P.J., 1998, VERIFICATION VALIDAT; Roper WW, 1927, FOOTBALL TODAY TOMOR, P155; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rueda MAF, 2012, P I MECH ENG P-J SPO, V226, P208, DOI 10.1177/1754337112439171; SolidWorks Education Edition, 2014, DESS SYST; Stahlecker Z, 2009, INT J IMPACT ENG, V36, P447, DOI 10.1016/j.ijimpeng.2008.08.004; Tinard V, 2012, MATER DESIGN, V37, P79, DOI 10.1016/j.matdes.2011.12.005; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Zhang L, 2001, THESIS; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	37	19	20	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2016	19	13					1432	1442		10.1080/10255842.2016.1149574			11	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	DS8CS	WOS:000381011100010	26867124	Green Submitted			2022-02-06	
J	Eakman, AM; Schelly, C; Henry, KL				Eakman, Aaron M.; Schelly, Catherine; Henry, Kimberly L.			Protective and Vulnerability Factors Contributing to Resilience in Post-9/11 Veterans With Service-Related Injuries in Postsecondary Education	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; educational status; health status; protective factors; resilience, psychological; veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; OCCUPATIONAL-THERAPY; DEPRESSION; ASSOCIATION; NEEDS; MEMBERS/VETERANS; PRODUCTIVITY; PERFORMANCE	OBJECTIVE. To examine differences in psychosocial protective factors (social support, meaningful occupation, and academic self-efficacy) and health-related vulnerability factors (posttraumatic stress, depression, and somatic symptoms) contributing to resilience in post-9/11 veterans with service-related injuries and nonveterans in postsecondary education. METHOD. A cross-sectional, matched-participants design using propensity score matching was used to test differences in mean levels of protective and vulnerability factors between injured veterans (n = 26) and nonveterans (n = 19); zero-order correlations explored relationships among study variables. RESULTS. The veteran sample demonstrated lower levels of psychosocial protective factors and higher levels of health-related vulnerability factors compared with nonveterans (10.491 to 11.561). Psychosocial protective factors were consistently negatively associated with health-related vulnerability factors (-.27 to -.63). CONCLUSION. Post-9/11 veterans with service-related injuries are at a substantial disadvantage in terms of resilience; lower protective factors and elevated vulnerability factors may increase their risk for poor campus integration and impede academic achievement.	[Eakman, Aaron M.; Schelly, Catherine] Colorado State Univ, Dept Occupat Therapy, New Start Student Vet, Ft Collins, CO 80523 USA; [Eakman, Aaron M.] Colorado State Univ, Dept Occupat Therapy, Res, Ft Collins, CO 80523 USA; [Henry, Kimberly L.] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Henry, Kimberly L.] Colorado State Univ, Colorado Sch Publ Hlth, Ft Collins, CO 80523 USA		Eakman, AM (corresponding author), Colorado State Univ, Dept Occupat Therapy, New Start Student Vet, Ft Collins, CO 80523 USA.	aaron.eakman@colostate.edu		Henry, Kimberly/0000-0002-2303-3759	NSSV program	Funding for the current study was provided through philanthropic support of the NSSV program by a private donor. We thank NSSV student veteran coordinators Joshua Burns and Erica Schelly and graduate research assistants Cara Nippert and Michelle Sutherland for their assistance with data collection and manuscript preparation and David MacPhee for comments on an earlier draft of the manuscript.	Amaker Robinette J, 2009, Am J Occup Ther, V63, P845; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arbesman M, 2011, AM J OCCUP THER, V65, P238, DOI 10.5014/ajot.2011.001289; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bandura A., 1997, SELF EFFICACY EXERCI; Barry AE, 2014, J STUD AFF RES PRACT, V51, P30, DOI 10.1515/jsarp-2014-0003; Barry AE, 2012, J AM COLL HEALTH, V60, P562, DOI 10.1080/07448481.2012.721427; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Bryan CJ, 2014, J REHABIL RES DEV, V51, P1035, DOI 10.1682/JRRD.2014.01.0012; Chemers MM, 2001, J EDUC PSYCHOL, V93, P55, DOI 10.1037//0022-0663.93.1.55; Cogan AM, 2014, OTJR-OCCUP PART HEAL, V34, P150, DOI 10.3928/15394492-20140617-01; Durdella NR., 2012, J STUD ED, V2, P109; Eakman AM, 2014, OTJR-OCCUP PART HEAL, V34, P93, DOI 10.3928/15394492-20140211-01; Eakman Aaron M, 2012, Am J Occup Ther, V66, pe20, DOI 10.5014/ajot.2012.001867; Eakman AM, 2015, OCCUPATIONAL THERAPY, P313; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; FINE SB, 1991, AM J OCCUP THER, V45, P493, DOI 10.5014/ajot.45.6.493; Glynn S. M., 2009, EFFECTIVE TREATMENTS, V2, P388, DOI DOI 10.1002/PON.660; Goldberg B., 2002, OCCUP THER MENT HEAL, V18, P17, DOI [10.1300/J004v18n02_03, DOI 10.1300/J004V18N02_03, DOI 10.1300/J004V18N02_]; Hammell KW, 2009, CAN J OCCUP THER, V76, P107, DOI 10.1177/000841740907600208; Hasselkus BR, 2011, MEANING OF EVERYDAY OCCUPATION, SECOND EDITION, P1; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hysenbegasi A, 2005, J MENT HEALTH POLICY, V8, P145; King DW, 2006, J APPL SOC PSYCHOL, V36, P2980, DOI 10.1111/j.0021-9029.2006.00138.x; King GA, 2004, AM J ORTHOPSYCHIAT, V74, P72, DOI 10.1037/0002-9432.74.1.72; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Maher JM, 2013, CBE-LIFE SCI EDUC, V12, P345, DOI 10.1187/cbe.13-04-0082; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Markoulakis R, 2013, REV HIGH EDUC, V37, P77, DOI 10.1353/rhe.2013.0073; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McBain L., 2012, SOLDIER STUDENT; Obama B, 2011, STRENGTHENING OUR MI; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Radomski MV, 2014, AM J OCCUP THER, V68, P379, DOI 10.5014/ajot.2014.013060; Radomski MV, 2009, AM J OCCUP THER, V63, P646, DOI 10.5014/ajot.63.5.646; Rudd MD, 2011, PROF PSYCHOL-RES PR, V42, P354, DOI 10.1037/a0025164; Rutter M., 1990, PSYCHOSOCIAL RESILIE; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Smith-Osborne A., 2012, ADV SOCIAL WORK, V31, P34, DOI DOI 10.18060/1870; Smith-Osborne A., 2007, ADV SOCIAL WORK, V8, P152; Smith-Osborne A, 2012, J REHABIL, V78, P4; Steele JL., 2010, SERVICE MEMBERS SCH; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Thoemmes F., 2012, PROPENSITY SCORE MAT; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tomar N, 2014, AM J OCCUP THER, V68, P430, DOI 10.5014/ajot.2014.011163; Vogt D., 2012, MANUAL DEPLOYMENT RI; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Whiteman SD, 2013, J COUNS PSYCHOL, V60, P265, DOI 10.1037/a0031650; Wilcock A. A., 2006, OCCUPATIONAL PERSPEC, V2nd; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yerxa EJ, 1998, AM J OCCUP THER, V52, P412, DOI 10.5014/ajot.52.6.412	60	19	19	0	14	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2016	70	1							7001260010	10.5014/ajot.2016.016519			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	DA2QH	WOS:000367640400008	26709427	Bronze			2022-02-06	
J	Humble, SS; Wilson, LD; Leath, TC; Marshall, MD; Sun, DZ; Pandharipande, PP; Patel, MB				Humble, Stephen S.; Wilson, Laura D.; Leath, Taylor C.; Marshall, Matthew D.; Sun, Daniel Z.; Pandharipande, Pratik P.; Patel, Mayur B.			ICU sedation with dexmedetomidine after severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; dexmedetomidine; sedation	CRITICALLY-ILL PATIENTS; CONTROLLED-TRIAL; INTENSIVE-CARE; MIDAZOLAM; PROPOFOL; PATIENT	Objective: To comprehensively describe the use of dexmedetomidine in a single institutional series of adult ICU patients with severe TBI. This study describes the dexmedetomidine dosage and infusion times, as well as the physiological parameters, neurological status and daily narcotic requirements before, during and after dexmedetomidine infusion.Methods: This study identified 85 adult patients with severe TBI who received dexmedetomidine infusions in the Trauma ICU at Vanderbilt University Medical Center between 2006-2010. Demographic, haemodynamic, narcotic use and sedative use data were systematically obtained from the medical record and analysed for changes associated with dexmedetomidine infusion.Results: During infusion with dexmedetomidine, narcotic and sedative use decreased significantly (p < 0.001 and p < 0.05). Median MAP, SBP, DBP and HR also decreased significantly during infusion when compared to pre-infusion values (p < 0.001). Despite the use of dexmedetomidine, RASS and GCS scores improved from pre-infusion to infusion time periods.Conclusions: The findings demonstrate that initiation of dexmedetomidine infusion is not associated with a decline in neurological functioning in adults with severe TBI. Although there was an observed decrease in haemodynamic parameters during infusion with dexmedetomidine, the change was not clinically significant and the requirements for narcotics and additional sedatives were minimized.	[Humble, Stephen S.; Leath, Taylor C.; Patel, Mayur B.] Vanderbilt Univ, Dept Surg, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN 37240 USA; [Humble, Stephen S.; Leath, Taylor C.; Patel, Mayur B.] Vanderbilt Univ, Dept Neurosurg, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN USA; [Wilson, Laura D.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN USA; [Wilson, Laura D.] Univ Tulsa, Dept Commun Sci & Disorders, Tulsa, OK 74104 USA; [Marshall, Matthew D.] Vanderbilt Univ, Med Ctr, Dept Pharmaceut Serv, Nashville, TN USA; [Sun, Daniel Z.] Cleveland Clin, Dept Urol, Glickman Urol Kidney Inst, Cleveland, OH 44106 USA; [Pandharipande, Pratik P.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA; [Pandharipande, Pratik P.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [Pandharipande, Pratik P.] Vanderbilt Univ, Dept Biomed Informat, Med Ctr, Nashville, TN USA; [Pandharipande, Pratik P.; Patel, Mayur B.] Nashville VA Med Ctr, Vet Affairs VA Tennessee Valley Healthcare Syst, Nashville, TN USA		Patel, MB (corresponding author), 1211 21st Ave South,404 Med Arts Bldg, Nashville, TN 37212 USA.	mayur.b.patel@Vanderbilt.edu		Pandharipande, Pratik/0000-0002-1389-8580	REDCap; NCATS/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG027472, R01HL111111, R01AG035117]; AHRQ Health Services [5T32HS013833-08]; AHRQUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality; Vanderbilt Faculty Research Scholars Program; Eastern Association for the Surgery of Trauma Foundation Research Scholarship; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [T32HS013833] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000448, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL111111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG035117, R01AG027472] Funding Source: NIH RePORTER	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper. Financial support was provided by: REDCap, UL1 TR000445 from NCATS/NIH (all authors); NIH grants R01AG027472 (PPP), R01HL111111(MBP/PPP), R01AG035117 (PPP); AHRQ Health Services 5T32HS013833-08, AHRQ (MBP); Vanderbilt Faculty Research Scholars Program (MBP); and the Eastern Association for the Surgery of Trauma Foundation Research Scholarship (MBP).	[Anonymous], FULL PRESCR INF PREC; Aryan HE, 2006, BRAIN INJURY, V20, P791, DOI 10.1080/02699050600789447; FLOWER O, 2012, EMERG MED INT, V2012, DOI DOI 10.1155/2012/637171; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; James ML, 2012, ANAESTH INTENS CARE, V40, P949, DOI 10.1177/0310057X1204000605; Kuhmonen J, 2001, J NEURAL TRANSM, V108, P261, DOI 10.1007/s007020170071; MAIER C, 1993, ANESTHESIOLOGY, V79, P306, DOI 10.1097/00000542-199308000-00016; Martin Eike, 2003, J Intensive Care Med, V18, P29, DOI 10.1177/0885066602239122; Mirski MA, 2008, SEMIN NEUROL, V28, P611, DOI 10.1055/s-0028-1105970; Nakano T, 2009, J ANESTH, V23, P378, DOI 10.1007/s00540-009-0777-9; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; Tarabrin O., 2014, CRIT CARE, V18, pP416; Triltsch AE, 2002, CRIT CARE MED, V30, P1007, DOI 10.1097/00003246-200205000-00009; Venn RM, 2000, CRIT CARE, V4, P302, DOI 10.1186/cc712; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130	19	19	21	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1266	1270		10.1080/02699052.2016.1187289			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300016	27458990	Green Accepted			2022-02-06	
J	Sveen, U; Soberg, HL; Ostensjo, S				Sveen, Unni; Soberg, Helene Lundgaard; Ostensjo, Sigrid			Biographical disruption, adjustment and reconstruction of everyday occupations and work participation after mild traumatic brain injury. A focus group study	DISABILITY AND REHABILITATION			English	Article						Daily life; work; occupations; participation; qualitative interviews; vocational rehabilitation	QUALITATIVE CONTENT-ANALYSIS; LIFE BALANCE; REHABILITATION; SEVERITY; PERCEPTIONS; DISABILITY; EXPERIENCE; THERAPY; FATIGUE; SLEEP	Purpose: To explore traumatic brain injury (TBI) as a biographical disruption and to study the reconstruction of everyday occupations and work participation among individuals with mild TBI. Methods: Seven focus groups were conducted with 12 women and 8 men (22-60 years) who had sustained mild TBI and participated in a return-to-work program. Interviews were analyzed using qualitative content analysis. Results: Four interrelated themes emerged: disruption of occupational capacity and balance; changes in self-perceptions; experience of time; and occupational adjustment and reconstruction. The meaning of the impairments lies in their impact on the individual's everyday occupations. The abandonment of meaningful daily occupations and the feeling of not recognizing oneself were experienced as threats to the sense of self. Successful integration of the past, present and future was paramount to continuing life activities. The unpredictability of the future seemed to permeate the entire process of adjustment and reconstruction of daily life. Conclusions: Our findings show that the concept of time is important in understanding and supporting the reconstruction of daily life after TBI. The fundamental work of rehabilitation is to ameliorate the disruptions caused by the injury, restoring a sense of personal narrative and supporting the ability to move forward with life. IMPLICATIONS FOR REHABILITATION Individuals with a protracted recovery after a mild traumatic brain injury must reconstruct a new way of being and acting in the world to achieve biographical continuity. The perceived anxiety regarding changes in self and occupational identity, as well as loss of control over the future, can be attenuated through informational sessions during the hospital stay and at follow-up visits. The significant personal costs of returning to full-time employment too early indicate the need for early and ongoing vocational support in achieving a successful return to work.	[Sveen, Unni; Soberg, Helene Lundgaard] Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4950, N-0424 Oslo, Norway; [Sveen, Unni; Soberg, Helene Lundgaard; Ostensjo, Sigrid] Oslo & Akershus Univ Coll, Fac Hlth Sci, Oslo, Norway		Sveen, U (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4950, N-0424 Oslo, Norway.	unni.sveen@hioa.no			Norwegian Ministry of Health and Care Services	The study is part of a 'return to work' project initiated by the Norwegian Directorate of Health and the Ministry of Labour and Social Affairs and funded by the Norwegian Ministry of Health and Care Services. The authors report no conflicts of interest.	Agan J, 2008, WORK, V31, P259; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Bryson-Campbell M, 2013, WORK, V44, P57, DOI [10.3233/WOR-2012-1561, 10.3233/WOR-2012-01561]; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; CORBIN J, 1987, RES SOCIOLOGY HLTH C, V6, P249, DOI DOI 10.1046/J.1365-2648.2001.01767.X; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Darnell R., 2002, J OCCUP SCI, V9, P5, DOI [10.1080/14427591.2002.9686488, DOI 10.1080/14427591.2002.9686488]; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gullestad M., 1996, EVERYDAY LIFE PHILOS; Hammell K.W., 2006, PERSPECTIVES DISABIL; Hammell Karen Whalley, 2004, Can J Occup Ther, V71, P296; Holzberg Emily, 2001, Work, V16, P245; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Kantartzis S, 2011, J OCCUP SCI, V18, P62, DOI 10.1080/14427591.2011.566917; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kielhofner G., 2008, MODEL HUMAN OCCUPATI; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Livneh H, 2013, REHABIL COUNS BULL, V56, P71, DOI 10.1177/0034355212447878; Matuska KM, 2008, J OCCUP SCI, V15, P9, DOI 10.1080/14427591.2008.9686602; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Prigatano GP, 2003, INT REV PSYCHIATR, V15, P371, DOI 10.1080/09540260310001606755; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rudman DL, 2002, J OCCUP SCI, V9, P12, DOI DOI 10.1080/14427591.2002.9686489; Soeker MS, 2012, WORK, V43, P313, DOI 10.3233/WOR-2012-1412; Soeker MS, 2012, WORK, V42, P589, DOI 10.3233/WOR-2012-1414; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; TEASDALE G, 1974, LANCET, V2, P81; Townsend E. A., 2007, ENABLING OCCUPATION; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Wagman P, 2012, SCAND J OCCUP THER, V19, P322, DOI 10.3109/11038128.2011.596219; Wagman P, 2012, SCAND J OCCUP THER, V19, P377, DOI 10.3109/11038128.2011.645552; Wagman P, 2011, QUAL HEALTH RES, V21, P410, DOI 10.1177/1049732310379240; World Health Organization, 2007, INT CLASS FUNCT DIS	43	19	19	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2016	38	23					2296	2304		10.3109/09638288.2015.1129445			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DU1AO	WOS:000381937400005	27007064				2022-02-06	
J	Theadom, A; Starkey, N; Jones, K; Cropley, M; Parmar, P; Barker-Collo, S; Feigin, VL				Theadom, Alice; Starkey, Nicola; Jones, Kelly; Cropley, Mark; Parmar, Priya; Barker-Collo, Suzanne; Feigin, Valery L.			Sleep difficulties and their impact on recovery following mild traumatic brain injury in children	BRAIN INJURY			English	Article						Epidemiology; traumatic brain injury; sleep; longitudinal; children	HEAD-INJURY; DISORDERS; OUTCOMES; DISTURBANCES; INTERVENTION; ADOLESCENTS; PREVALENCE; SYMPTOMS; QUALITY	Objective: To determine the frequency of sleep difficulties in children following mild traumatic brain injury (TBI) over time and explore the role of sleep on recovery and behaviour.Methods: Longitudinal study of 109 children aged between 8-16 years who had experienced a mild TBI, with an embedded case control study. Parents completed assessments of the child's sleep quality, symptoms and behaviour at baseline, 1, 6 and 12 months post-injury. Regression analyses explored the impact of poor sleep on 12-month outcomes. Healthy control children were assessed at one time point for comparison to determine the longer-term impact of brain injury on sleep.Results: The number of children experiencing poor sleep quality peaked 1-month post-injury (39%), reducing to 28% 12-months post-injury. Poor sleep quality at 1-month was associated with increased frequency and severity of symptoms and poorer behavioural outcomes 1 year post-TBI. Cases with TBI were significantly more likely to have sleep difficulties 1-year post-injury than controls (Odds ratio = 3.09).Conclusions: Sleep difficulties are common following mild TBI in children and are predictive of longer-term outcomes. Identifying children with sleep difficulties post-injury and providing support to facilitate sleep may improve their longer-term functioning.	[Theadom, Alice; Jones, Kelly; Parmar, Priya; Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [Cropley, Mark] Univ Surrey, Sch Psychol, Surrey, England; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand		Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, AA254C,90 Akoranga Dr,Northcote 0627, Auckland 1142, New Zealand.	alice.theadom@aut.ac.nz	Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019; Cropley, Mark/V-2296-2019; Starkey, Nicola/AAJ-3795-2020	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740; Parmar, Priya/0000-0001-6001-9326	Health Research Council of New ZealandHealth Research Council of New Zealand [09/063A, 11/192]; ABI Management Rehabilitation	This work was funded by the Health Research Council of New Zealand (09/063A, 11/192). Alice Theadom was co-funded by ABI Management Rehabilitation and Kathryn McPherson held the Laura Fergusson Trust Chair. The authors report no conflicts of interest.	Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Buxton OM, 2015, SLEEP HEALTH, V1, P15, DOI 10.1016/j.sleh.2014.12.002; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catroppa C, 2009, FUTUR NEUROL, V4, P811, DOI 10.2217/FNL.09.52; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gregory AM, 2012, SLEEP MED REV, V16, P129, DOI 10.1016/j.smrv.2011.03.007; Hiscock H, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h68; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Matricciani L, 2013, SLEEP, V36, P527, DOI 10.5665/sleep.2538; Mindell Jodi A, 2003, J Pediatr Health Care, V17, P324, DOI 10.1016/j.pedhc.2003.09.003; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Paavonen EJ, 2015, BEHAV SLEEP MED, V17, P1; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Stores G, 2013, DEV MED CHILD NEUROL, V55, P797, DOI 10.1111/dmcn.12163; Tan E, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-189; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Ucer O, 2014, WORLD J UROL, V32, P239, DOI 10.1007/s00345-013-1193-1; Werner H, 2015, J CLIN SLEEP MED, V11, P241, DOI 10.5664/jcsm.4536; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	19	19	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1243	1248		10.1080/02699052.2016.1183171			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300012	27391449				2022-02-06	
J	Wei, ZZ; Lee, JH; Zhang, YB; Zhu, YB; Deveau, TC; Gu, XH; Winter, MM; Li, JM; Wei, L; Yu, SP				Wei, Zheng Zachory; Lee, Jin Hwan; Zhang, Yongbo; Zhu, Yan Bing; Deveau, Todd C.; Gu, Xiaohuan; Winter, Megan M.; Li, Jimei; Wei, Ling; Yu, Shan Ping			Intracranial Transplantation of Hypoxia-Preconditioned iPSC-Derived Neural Progenitor Cells Alleviates Neuropsychiatric Defects After Traumatic Brain Injury in Juvenile Rats	CELL TRANSPLANTATION			English	Article						Induced pluripotent stem cell-derived neural progenitor cells (iPSC-NPCs); Hypoxic preconditioning; Regeneration; Juveniles; Traumatic brain injury (TBI); Posttraumatic disorders	PHARMACOLOGICALLY INDUCED HYPOTHERMIA; COMBINING ENRICHED ENVIRONMENT; EMBRYONIC STEM-CELLS; CLOSED-HEAD-INJURY; NEURONAL DIFFERENTIATION; INTRANASAL DELIVERY; CEREBRAL-ISCHEMIA; OXYTOCIN RELEASE; STROKE; VASOPRESSIN	Traumatic brain injury (TBI) is a common cause of mortality and long-term morbidity in children and adolescents. Posttraumatic stress disorder (PTSD) frequently develops in these patients, leading to a variety of neuropsychiatric syndromes. Currently, few therapeutic strategies are available to treat juveniles with PTSD and other developmental neuropsychiatric disorders. In the present investigation, postnatal day 14 (P14) Wistar rats were subjected to TBI induced by a controlled cortical impact (CCI) (velocity = 3 m/s, depth = 2.0 mm, contact time = 150 ms). This TBI injury resulted in not only cortical damages, but also posttrauma social behavior deficits. Three days after TBI, rats were treated with intracranial transplantation of either mouse iPSC-derived neural progenitor cells under normal culture conditions (N-iPSC-NPCs) or mouse iPSC-derived neural progenitor cells pretreated with hypoxic preconditioning (HP-iPSC-NPCs). Compared to TBI animals that received N-iPSC-NPCs or vehicle treatment, HP-iPSC-NPC-transplanted animals showed a unique benefit of improved performance in social interaction, social novelty, and social transmission of food preference tests. Western blotting showed that HP-iPSC-NPCs expressed significantly higher levels of the social behavior -related genes oxytocin and the oxytocin receptor. Overall, HP-iPSC-NPC transplantation exhibits a great potential as a regenerative therapy to improve neuropsychiatric outcomes after juvenile TBI.	[Wei, Zheng Zachory; Zhang, Yongbo; Zhu, Yan Bing; Li, Jimei; Wei, Ling] Capital Med Univ, Beijing Friendship Hosp, Expt Res Ctr, Dept Neurol,Labs Stem Cell Biol & Regenerat Med, Beijing, Peoples R China; [Wei, Zheng Zachory; Zhang, Yongbo; Zhu, Yan Bing; Li, Jimei; Wei, Ling] Capital Med Univ, Beijing Friendship Hosp, Ctr Neurol Dis, Beijing, Peoples R China; [Wei, Zheng Zachory; Lee, Jin Hwan; Deveau, Todd C.; Gu, Xiaohuan; Winter, Megan M.; Wei, Ling; Yu, Shan Ping] Emory Univ, Sch Med, Dept Anesthesiol, 101 Woodruff Circle WMRB Suite 620, Atlanta, GA 30322 USA; [Yu, Shan Ping] Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA USA		Yu, SP (corresponding author), Emory Univ, Sch Med, Dept Anesthesiol, 101 Woodruff Circle WMRB Suite 620, Atlanta, GA 30322 USA.	spyu@emory.edu	Wei, Zheng Zachory/I-2109-2019	Wei, Zheng Zachory/0000-0001-7682-9286	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS091585, NS062097, NS085568]; AHAAmerican Heart Association [12GRNT12060222]; VA National Merit grant [RX000666]; AHA Predoctoral/Postdoctoral Fellowships [15POST25710112, 15POST 25680013, 14PRE18830026]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371355/81500989]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7142045]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS085568, R01NS062097, R01NS091585] Funding Source: NIH RePORTER	This work was supported by NIH grants NS091585 (L.W), NS062097 (LW), and NS085568 (LW.); AHA Grant-in-Aid 12GRNT12060222 (S.P.Y.); VA National Merit grant RX000666 (S.P.Y.); AHA Predoctoral/Postdoctoral Fellowships 15POST25710112 (Z.Z.W.), 15POST 25680013 (J.H.L.), and 14PRE18830026 (T.C.D.); National Natural Science Foundation of China 81371355/81500989 (Y.Z.); and Beijing Natural Science Foundation 7142045 (Y.Z.). The authors declare no conflicts of interest.	Adriani W, 2006, PSYCHOPHARMACOLOGY, V184, P155, DOI 10.1007/s00213-005-0223-0; All AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116933; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Baharnoori M, 2012, SCHIZOPHRENIA BULL, V38, P444, DOI 10.1093/schbul/sbq098; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Chau MJ, 2014, STEM CELLS, V32, P3075, DOI 10.1002/stem.1802; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dunkerson J, 2014, RESTOR NEUROL NEUROS, V32, P675, DOI 10.3233/RNN-140408; Eckert A, 2015, STEM CELL TRANSL MED, V4, P841, DOI 10.5966/sctm.2014-0184; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; GALEF BG, 1987, DEV PSYCHOBIOL, V20, P209, DOI 10.1002/dev.420200209; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Harbert MJ, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/914546; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Lam J, 2014, ADV FUNCT MATER, V24, P7053, DOI 10.1002/adfm.201401483; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee JH, 2015, AM J PHYSIOL-CELL PH, V308, pC570, DOI 10.1152/ajpcell.00353.2014; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Lepperhof V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107363; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; Mason Christine Narad, 2013, Pediatr Nurs, V39, P267; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; McDonald S, 2014, SOCIAL COMMUNICATION; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Mohamad O, 2013, DIFFERENTIATION, V86, P149, DOI 10.1016/j.diff.2013.12.002; Mohamad O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064160; Mu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101185; Nudi ET, 2015, J NEUROTRAUM, V32, P1117, DOI 10.1089/neu.2014.3618; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Qin I., 2015, PLOS ONE, V10; Romanyuk N, 2015, CELL TRANSPLANT, V24, P1781, DOI 10.3727/096368914X684042; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Sun JM, 2015, EXP NEUROL, V272, P78, DOI 10.1016/j.expneurol.2015.03.011; Szeto A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1495, DOI 10.1152/ajpendo.90718.2008; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; van Handel M, 2010, J PEDIATR PSYCHOL, V35, P286, DOI 10.1093/jpepsy/jsp049; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wang Z, 2015, ACS NANO, V9, P6683, DOI 10.1021/acsnano.5b00690; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Wei ZZ, 2015, CELL TRANSPLANT, V24, P391, DOI 10.3727/096368915X686887; Wei ZZ, 2014, CELL MOL NEUROBIOL, V34, P881, DOI 10.1007/s10571-014-0067-4; Weitzdoerfer R, 2004, SEMIN PERINATOL, V28, P249, DOI 10.1053/j.semperi.2004.08.001; Wrenn C. C., 2004, CURR PROTOC NEUROSCI, V28; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0	55	19	19	4	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2016	25	5					797	809		10.3727/096368916X690403			13	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	DL0UY	WOS:000375349300003	26766038	Bronze			2022-02-06	
J	Buunk, AM; Groen, RJM; Veenstra, WS; Spikman, JM				Buunk, Anne M.; Groen, Rob J. M.; Veenstra, Wencke S.; Spikman, Jacoba M.			Leisure and social participation in patients 4-10 years after aneurysmal subarachnoid haemorrhage	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; EXECUTIVE DYSFUNCTION; FOLLOW-UP; HEALTH; SATISFACTION; IMPAIRMENT; PREDICTORS; DEPRESSION; COMPLAINTS		[Buunk, Anne M.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, NL-9700 RB Groningen, Netherlands; [Groen, Rob J. M.; Veenstra, Wencke S.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, NL-9700 RB Groningen, Netherlands		Spikman, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1,Poortweg 4,2nd Floor,Room V2-210, NL-9700 RB Groningen, Netherlands.	j.m.spikman@umcg.nl		Groen, Rob J.M./0000-0003-3067-763X; Spikman, Jacoba/0000-0002-6477-0763	Stichting Catharina Heerdt	We gratefully acknowledge the financial support of Stichting Catharina Heerdt; this study is supported by funds of this charitable foundation. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bhogal Sanjit K, 2003, Top Stroke Rehabil, V10, P107; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 2005, EFFECTIVENESS REHABI, P211, DOI DOI 10.1093/ACPROF:OSO/9780198526544.001.0001; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Carter BS, 2000, NEUROSURGERY, V46, P1326, DOI 10.1097/00006123-200006000-00008; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dombovy ML, 1998, BRAIN INJURY, V12, P887; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Escartin G, 2012, NEUROPSYCHOLOGY, V26, P172, DOI 10.1037/a0024336; Fertl E, 1999, ACTA NEUROCHIR, V141, P571, DOI 10.1007/s007010050345; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hartman-Maeir A, 2007, DISABIL REHABIL, V29, P559, DOI 10.1080/09638280600924996; HOLM S, 1979, SCAND J STAT, V6, P65; Hutter BO, 2001, J NEUROSURG, V94, P241, DOI 10.3171/jns.2001.94.2.0241; Johansson Ulla, 2007, Scand J Occup Ther, V14, P116, DOI 10.1080/11038120601095093; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Manning L, 2005, EUR J NEUROL, V12, P466, DOI 10.1111/j.1468-1331.2005.01012.x; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Morris PG, 2004, NEUROSURGERY, V54, P47, DOI 10.1227/01.NEU.0000097198.94828.E1; O'Sullivan C, 2010, AUST OCCUP THER J, V57, P159, DOI 10.1111/j.1440-1630.2009.00833.x; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; Passier PECA, 2013, QUAL LIFE RES, V22, P1027, DOI 10.1007/s11136-012-0236-1; Passier PECA, 2012, NEUROREHABILITATION, V30, P137, DOI 10.3233/NRE-2012-0737; Passier PECA, 2011, J NEUROL, V258, P1091, DOI 10.1007/s00415-010-5891-y; Passier PECA, 2010, CEREBROVASC DIS, V29, P557, DOI 10.1159/000306642; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Teasdale TW, 2005, BRAIN INJURY, V19, P1049, DOI 10.1080/02699050500110421; Toomela A, 2004, J REHABIL MED, V36, P63, DOI 10.1080/16501970310017414; Uchikawa K, 2014, BRAIN INJURY, V28, P15, DOI 10.3109/02699052.2013.847209; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Verhage F, 1964, INTELLIGENTIE LEEFTI; Vetkas A, 2013, ACTA NEUROCHIR, V155, P1107, DOI 10.1007/s00701-013-1683-3; Vilkki JS, 2004, NEUROSURGERY, V55, P790, DOI 10.1227/01.NEU.0000137629.17424.6D; Vilkki J, 2012, ACTA NEUROCHIR, V154, P1437, DOI 10.1007/s00701-012-1417-y; Visser-Meily JMA, 2013, CEREBROVASC DIS, V36, P126, DOI 10.1159/000353642; Wermer MJH, 2007, NEUROSURGERY, V60, P91, DOI 10.1227/01.NEU.0000249215.19591.86; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	19	19	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1589	1596		10.3109/02699052.2015.1073789			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800009	26362688				2022-02-06	
J	Bodley-Scott, SEM; Riley, GA				Bodley-Scott, Sarah E. M.; Riley, Gerard A.			How Partners Experience Personality Change After Traumatic Brain Injury - Its Impact on Their Emotions and their Relationship	BRAIN IMPAIRMENT			English	Article						neurobehavioural changes; personality changes; couple relationship	FAMILY CAREGIVERS; HEAD-INJURY; ADJUSTMENT; TBI; REHABILITATION; SATISFACTION; DEPRESSION; DISTRESS; RECOVERY; STRESS	Objective: The aim of this qualitative study was to explore how spouses/partners experience social, emotional and behavioural changes in persons following traumatic brain injury (TBI), with a particular focus on their emotional impact and the effect on the couple relationship. Method: Interpretative phenomenological analysis (IPA) of interview data explored five women's experiences of these changes in their partners following TBI. Results: Themes describe the direct emotional impact of living with the changes as well as the emotional impact of attempts to manage and make sense of the changes (identity change, managing the changes and making sense of the changes). The impact on the couple relationship is described under the themes of feeling love and receiving love. Changes led three of the participants to experience their partner as having been replaced by a new person; they actively disliked this new person; they felt unable to love the new person in the same way as the old person; and their love was defined in terms of a caring relationship, rather than a spousal relationship. Conclusions: The study provides insight into why social, emotional and behavioural changes might be so consistently associated with reduced emotional wellbeing and lower levels of relationship quality and satisfaction.	[Bodley-Scott, Sarah E. M.; Riley, Gerard A.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England		Riley, GA (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	G.A.Riley@bham.ac.uk	Riley, Gerard Anthony/J-1646-2012; riley, gerard/AAP-1439-2020	Riley, Gerard Anthony/0000-0002-1167-8023; 			Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bowen C., 2010, RELATIONAL APPROACH; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; CHESLA C, 1994, FAM RELAT, V43, P3, DOI 10.2307/585135; CONNOLLY D, 2001, BR J OCCUP THER, V64, P41, DOI DOI 10.1177/030802260106400108; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Gosling J, 1999, BRAIN INJURY, V13, P785; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Layman DE, 2005, BRAIN INJURY, V19, P909, DOI 10.1080/02699050500109928; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McDonald S., 2003, BRAIN IMPAIR, V4, P36, DOI [10.1375/brim.4.1.36.27032, DOI 10.1375/BRIM.4.1.36.27032, DOI 10.1375/brim.4.1.36.27032]; McDonald S, 2012, BRAIN IMPAIR, V13, P256, DOI 10.1017/BrImp.2012.21; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Minnes P, 2000, BRAIN INJURY, V14, P737; Murray J, 1998, AGEING SOC, V18, P659, DOI 10.1017/S0144686X98007120; ODDY M, 1995, TRAUMATIC BRAIN INJU, P167; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Polkinghorne DE, 2005, J COUNS PSYCHOL, V52, P137, DOI 10.1037/0022-0167.52.2.137; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Riley GA, 2013, INT PSYCHOGERIATR, V25, P263, DOI 10.1017/S1041610212001743; Ruston A., 2007, SOCIAL SCI, V2, P159; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Smith J.A., 2009, INTERPRETATIVE PHENO; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Walters A.H., 2010, DEMENTIA, V9, P169, DOI [https://doi.org/10.1177/1471301209354027, DOI 10.1177/1471301209354027, 10.1177/1471301209354027]; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Willig C., 2008, INTRO QUALITATIVE RE; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 2005, PSYCHOLOGIST, V18, P138; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532	43	19	19	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2015	16	3					205	220		10.1017/BrImp.2015.22			16	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DD4KV	WOS:000369892700005		Green Published			2022-02-06	
J	Resch, JE; Brown, CN; Macciocchi, SN; Cullum, CM; Blueitt, D; Ferrara, MS				Resch, Jacob E.; Brown, Cathleen N.; Macciocchi, Stephen N.; Cullum, C. Munro; Blueitt, Damond; Ferrara, Michael S.			A Preliminary Formula to Predict Timing of Symptom Resolution for Collegiate Athletes Diagnosed With Sport Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; prediction; prolonged recovery; symptom severity; symptom duration	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; PROLONGED RECOVERY; FOOTBALL PLAYERS; BASE-LINE; DEPRESSION; FEMALE; AGE; PATHOPHYSIOLOGY	Context: Symptom presentation and recovery after sport concussion (SC) are variable. Empirically based models documenting typical symptom duration would assist health care providers in managing return to play after SC. Objective: To develop a prediction model for SC symptom duration. Design: Cross-sectional study. Setting: Two National Collegiate Athletic Association Division I university laboratories. Patients or Other Participants: Seventy-six (51 male and 25 female) concussed athletes with an average age of 19.5 +/- 1.65 years who were evaluated within 24 hours of diagnosis. Intervention(s): Participants completed the Revised Head Injury Scale (HIS-r), Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), and Sensory Organization Test within 24 hours of SC diagnosis. Main Outcome Measure(s): A stepwise multivariate regression incorporating ImPACT and Sensory Organization Test composites and HIS-r symptom severity-duration was used to predict the number of days athletes reported symptoms after SC. The resulting regression formula was cross-validated using the Stine cross-validation coefficient. Results: The final formula consisted of the HIS-r's self-reported neck pain, drowsiness, tingling, and nervousness duration and ImPACT total symptom severity (R = 0.62, R-2 = 39%, R-adj(2) = 34.2%, P < .001). Approximately 29% (R-cv(2) = 29%) of the variance associated with total days symptomatic after SC was explained by our preliminary formula when cross-validated. The current formula correctly identified 76% of participants who recovered within 10 days of injury. Conclusions: Our results suggest that self-reported duration of 4 symptoms during the initial 24 hours after injury along with total symptom severity as measured by ImPACT accounted for a considerable amount of variance associated with days symptomatic after SC in collegiate athletes. Until the formula is cross-validated in a college-aged sample, caution is warranted in using it clinically.	[Resch, Jacob E.] Univ Virginia, Dept Kinesiol, Exercise & Sport Injury Lab, Charlottesville, VA 22904 USA; [Brown, Cathleen N.] Univ Georgia, Athens, GA 30602 USA; [Macciocchi, Stephen N.] Atlanta Neuropsychol LLC, Atlanta, GA USA; [Cullum, C. Munro] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Blueitt, Damond] Orthoped Specialty Associates, Ft Worth, TX USA; [Ferrara, Michael S.] Univ New Hampshire, Durham, NH 03824 USA		Resch, JE (corresponding author), Univ Virginia, Dept Kinesiol, Exercise & Sport Injury Lab, Mem Gymnasium, Off 223A, Charlottesville, VA 22904 USA.	jer6x@virginia.edu	Cullum, C. Munro/AAC-2496-2019	Cullum, C. Munro/0000-0001-9706-5465; Resch, Jacob/0000-0001-6031-3197			Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; De La Rue-Evans L, 2013, REHABIL NURS, V38, P2, DOI 10.1002/rnj.66; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Huberty C. J., 2006, APPL MANOVA DISCRIMI, V2nd; Kelly JP, 1997, NEUROLOGY, V48, P581; Klossner D, 2013, 2013 14 NCAA SPORTS; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Pedhazur, 1997, MULTIPLE REGRESSION; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Venes D, 2005, TABERS CYCLOPEDIC ME, V20th	45	19	19	0	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2015	50	12					1292	1298		10.4085/1062-6050-50.12.03			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DK2OS	WOS:000374754900011	26565424	Green Published			2022-02-06	
J	Barbierato, M; Facci, L; Marinelli, C; Zusso, M; Argentini, C; Skaper, SD; Giusti, P				Barbierato, Massimo; Facci, Laura; Marinelli, Carla; Zusso, Morena; Argentini, Carla; Skaper, Stephen D.; Giusti, Pietro			Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells	SCIENTIFIC REPORTS			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; MAMMALIAN TARGET; CNS MYELINATION; OXIDATIVE STRESS; RAPAMYCIN MTOR; MAST-CELLS; DIFFERENTIATION; LUTEOLIN; NEUROINFLAMMATION	Oligodendrocytes have limited ability to repair the damage to themselves or to other nerve cells, as seen in demyelinating diseases like multiple sclerosis. An important strategy may be to replace the lost oligodendrocytes and/or promote the maturation of undifferentiated oligodendrocyte precursor cells (OPCs). Recent studies show that a composite of co-ultramicronized N-palmitoylethanolamine (PEA) and luteolin (co-ultramicronized PEA/luteolin, 10: 1 by mass) is efficacious in improving outcome in experimental models of spinal cord and traumatic brain injuries. Here, we examined the ability of co-ultramicronized PEA/luteolin to promote progression of OPCs into a more differentiated phenotype. OPCs derived from newborn rat cortex were placed in culture and treated the following day with 10 mu M co-ultramicronized PEA/luteolin. Cells were collected 1, 4 and 8 days later and analyzed for expression of myelin basic protein (MBP). qPCR and Western blot analyses revealed a time-dependent increase in expression of both mRNA for MBP and MBP content, along with an increased expression of genes involved in lipid biogenesis. Ultramicronized PEA or luteolin, either singly or in simple combination, were ineffective. Further, co-ultramicronized PEA/luteolin promoted morphological development of OPCs and total protein content without affecting proliferation. Co-ultramicronized PEA/luteolin may represent a novel pharmacological strategy to promote OPC maturation.	[Barbierato, Massimo; Facci, Laura; Marinelli, Carla; Zusso, Morena; Argentini, Carla; Skaper, Stephen D.; Giusti, Pietro] Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35131 Padua, Italy		Skaper, SD (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35131 Padua, Italy.	stephen.skaper@unipd.it		GIUSTi, Pietro/0000-0001-9352-4046	MIUR, PON 'Ricerca e Competitivita projectMinistry of Education, Universities and Research (MIUR); Regione Veneto project [103173COF/14/LR52001C2/000051]	This study was supported in part by MIUR, PON 'Ricerca e Competitivita 2007-2013' project PON01_02512, and by Regione Veneto project protocol 103173COF/14/LR52001C2/000051.	Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P1632, DOI 10.1016/j.drudis.2014.06.007; BARBARESE E, 1988, J NEUROCHEM, V51, P1737, DOI 10.1111/j.1471-4159.1988.tb01153.x; Barbierato M, 2013, CNS NEUROL DISORD-DR, V12, P608; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Brown MA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00147; Bsibsi M, 2014, ACTA NEUROPATHOL, V128, P215, DOI 10.1007/s00401-014-1317-8; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chang AS, 2012, ANN NEUROL, V72, P918, DOI 10.1002/ana.23693; Coleta M, 2008, BEHAV BRAIN RES, V189, P75, DOI 10.1016/j.bbr.2007.12.010; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Crupi R, 2013, CNS NEUROL DISORD-DR, V12, P989, DOI 10.2174/18715273113129990084; Damasceno A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096193; DEROSBO NK, 1993, J CLIN INVEST, V92, P2602, DOI 10.1172/JCI116875; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Filippini G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008933.pub2; Finkelsztejn A, 2014, PERSPECT MED CHEM, V6, P65, DOI 10.4137/PMC.S13213; Fraussen J, 2014, AUTOIMMUN REV, V13, P1126, DOI 10.1016/j.autrev.2014.07.002; Gomez O, 2011, BRIT J PHARMACOL, V163, P1520, DOI 10.1111/j.1476-5381.2011.01414.x; Gravel M, 1996, MOL CELL NEUROSCI, V7, P453, DOI 10.1006/mcne.1996.0033; GRIFFITHS IR, 1995, NEUROPATH APPL NEURO, V21, P85, DOI 10.1111/j.1365-2990.1995.tb01034.x; Grosso C, 2013, CURR MED CHEM, V20, P4694, DOI 10.2174/09298673113209990155; Guardiola-Diaz HM, 2012, GLIA, V60, P476, DOI 10.1002/glia.22281; Hammond E, 2015, J NEUROSCI, V35, P5007, DOI 10.1523/JNEUROSCI.4787-14.2015; Hartline DK, 2007, CURR BIOL, V17, pR29, DOI 10.1016/j.cub.2006.11.042; Kamm CP, 2014, EUR NEUROL, V72, P132, DOI 10.1159/000360528; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P506, DOI 10.2174/187152712801661248; KOUL O, 1980, BIOCHEM J, V186, P959, DOI 10.1042/bj1860959; Kremer D, 2015, MULT SCLER J, V21, P541, DOI 10.1177/1352458514566419; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047; Luessi F, 2014, EXPERT REV NEUROTHER, V14, P1315, DOI 10.1586/14737175.2014.969241; Michailidou I, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00454; MODELL JG, 1989, J CLIN PSYCHOPHARM, V9, P347; Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; NOBLE PG, 1994, BRAIN RES, V633, P83, DOI 10.1016/0006-8993(94)91525-3; Norrmen C, 2013, BIOCHEM SOC T, V41, P944, DOI 10.1042/BST20130046; Olsen JA, 2015, J NEUROSCI RES, V93, P687, DOI 10.1002/jnr.23493; Paterniti I, 2014, CNS NEUROL DISORD-DR, V13, P1530, DOI 10.2174/1871527313666140806124322; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Petrosino S, 2010, BIOCHIMIE, V92, P724, DOI 10.1016/j.biochi.2010.01.006; Ransohoff RM, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.14; Rosin C, 2004, J NEUROCHEM, V90, P1173, DOI 10.1111/j.1471-4159.2004.02584.x; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Skaper SD, 2014, INFLAMMOPHARMACOLOGY, V22, P79, DOI 10.1007/s10787-013-0191-7; Skaper SD, 2014, IMMUNOLOGY, V141, P314, DOI 10.1111/imm.12170; Skaper SD, 2012, PHILOS T R SOC B, V367, P3312, DOI 10.1098/rstb.2011.0391; Skaper Stephen D, 2012, Methods Mol Biol, V846, P67, DOI 10.1007/978-1-61779-536-7_7; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Stahnke T, 2007, J MOL NEUROSCI, V32, P25, DOI 10.1007/s12031-007-0005-8; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Theoharides TC, 2012, INT J IMMUNOPATH PH, V25, P317, DOI 10.1177/039463201202500201; Thone J, 2013, DRUG HEALTHC PATIENT, V5, P37, DOI 10.2147/DHPS.S28822; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; Wahl SE, 2014, J NEUROSCI, V34, P4453, DOI 10.1523/JNEUROSCI.4311-13.2014; WAXMAN SG, 1977, ARCH NEUROL-CHICAGO, V34, P585, DOI 10.1001/archneur.1977.00500220019003; Winking H, 2004, CYTOGENET GENOME RES, V105, P251, DOI 10.1159/000078196; Xu B, 2010, EUR J PHARMACOL, V627, P99, DOI 10.1016/j.ejphar.2009.10.038	66	19	19	3	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 18	2015	5								16676	10.1038/srep16676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW2UC	WOS:000364847400001	26578323	gold, Green Published			2022-02-06	
J	Timaru-Kast, R; Herbig, EL; Luh, C; Engelhard, K; Thal, SC				Timaru-Kast, Ralph; Herbig, Elina L.; Luh, Clara; Engelhard, Kristin; Thal, Serge C.			Influence of Age on Cerebral Housekeeping Gene Expression for Normalization of Quantitative Polymerase Chain Reaction after Acute Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						aging; control genes; housekeeping; normalization; quantitative real-time RT-PCR; reference genes; traumatic brain injury	MESSENGER-RNA EXPRESSION; TIME RT-PCR; REAL-TIME; MOUSE HIPPOCAMPUS; RIBOSOMAL-RNA; QUANTIFICATION; VALIDATION; SELECTION; MODEL; EPIDEMIOLOGY	To prevent methodological errors of quantitative PCR (qPCR) normalization with reference genes is obligatory. Although known to influence gene expression, impact of age on housekeeping gene expression has not been determined after acute brain lesions such as traumatic brain injury (TBI). Therefore, expression of eight common control genes was investigated at 15min, 24h, and 72h after experimental TBI in 2- and 21-month-old C57Bl6 mice. Expression of (2)-microglobulin (B2M), -actin (ActB), and porphobilinogen deaminase (PBGD) increased after TBI in both ages. 2M demonstrated age-dependent differences and highest inter- and intragroup variations. Expression of cyclophilin A, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hypoxanthine ribosyltransferase (HPRT), S100B, and 18SrRNA remained stable. Cyclophilin A and HPRT demonstrated strongest inter- and intragroup stability. The data indicate that the expression of most but not all control genes is stable during aging. The correct choice of housekeeping genes is of key importance to ensure adequate normalization of qPCR data. With respect to insult and age, normalization strategies should consider cyclophilin A as a single normalizer. Normalization with two reference genes is recommended with cyclophilin A and HPRT in young mice and in mixed age studies and with cyclophilin A and GAPDH in old mice. In addition, the present study suggests not to use (2)-microglobulin, -actin or PBGD as single control genes because of strong regulation after CCI in 2- and 21-month-old mice.	[Timaru-Kast, Ralph; Herbig, Elina L.; Luh, Clara; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Med Ctr, D-55131 Mainz, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729	German Research FoundationGerman Research Foundation (DFG) [DFG TH1430/3-1, CRC1080/A9]; Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01EO1003]	This work was financially supported by a grant from the German Research Foundation (DFG TH1430/3-1) to SCT and to KE (CRC1080/A9) and to KE (CRC1080/A9) and by the Federal Ministry of Education and Research (BMBF 01EO1003) to SCT.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Boda E, 2009, J MOL NEUROSCI, V37, P238, DOI 10.1007/s12031-008-9128-9; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Harris JL, 2009, J NEUROTRAUM, V26, P1669, DOI [10.1089/neu.2009.0875, 10.1089/neu.2009-0875]; Harrison DC, 2000, MOL BRAIN RES, V75, P143, DOI 10.1016/S0169-328X(99)00305-8; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nishida Y, 2006, J PHARMACOL SCI, V101, P52, DOI 10.1254/jphs.FP0050881; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; Rhinn H, 2008, ANAL BIOCHEM, V372, P116, DOI 10.1016/j.ab.2007.08.023; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sieber MW, 2010, NEUROBIOL AGING, V31, P654, DOI 10.1016/j.neurobiolaging.2008.05.023; Somel M, 2006, CURR BIOL, V16, pR359, DOI 10.1016/j.cub.2006.04.024; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Staib-Lasarzik I, 2014, J NEUROTRAUM, V31, P1664, DOI 10.1089/neu.2013.3243; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Talaat AM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf103; Tanic N, 2007, J MOL NEUROSCI, V32, P38, DOI 10.1007/s12031-007-0006-7; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Touchberry Chad D, 2006, J Biomol Tech, V17, P157; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; van den Berg GJ, 2015, J HEALTH ECON, V40, P141, DOI 10.1016/j.jhealeco.2014.02.004; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Weiss J., 2014, VERSUCHSTIERKUNDE TI; Zampieri M, 2010, MECH AGEING DEV, V131, P89, DOI 10.1016/j.mad.2009.12.005	57	19	19	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2015	32	22					1777	1788		10.1089/neu.2014.3784			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV6ST	WOS:000364401500008	26102571				2022-02-06	
J	Maiti, TK; Konar, S; Bir, S; Kalakoti, P; Bollam, P; Nanda, A				Maiti, Tanmoy Kumar; Konar, Subhas; Bir, Shyamal; Kalakoti, Piyush; Bollam, Papireddy; Nanda, Anil			Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review	NEUROSURGICAL FOCUS			English	Article						apolipoprotein E; Alzheimer's disease; traumatic brain injury; neurodegenerative disease	AMYOTROPHIC-LATERAL-SCLEROSIS; EPSILON 4 ALLELE; CEREBRAL AMYLOID ANGIOPATHY; ONSET ALZHEIMERS-DISEASE; APOE GENE POLYMORPHISMS; E GENOTYPE; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; PROMOTER POLYMORPHISMS	OBJECT The difference in course and outcome of several neurodegenerative conditions and traumatic injuries of the nervous system points toward a possible role of genetic and environmental factors as prognostic markers. Apolipoprotein E (Apo-E), a key player in lipid metabolism, is recognized as one of the most powerful genetic risk factors for dementia and other neurodegenerative diseases. In this article, the current understanding of APOE polymorphism in various neurological disorders is discussed. METHODS The English literature was searched for various studies describing the role of APOE polymorphism as a prognostic marker in neurodegenerative diseases and traumatic brain injury. The wide ethnic distribution of APOE polymorphism was discussed, and the recent meta-analyses of role of APOE polymorphism in multiple diseases were analyzed and summarized in tabular form. RESULTS Results from the review of literature revealed that the distribution of APOE is varied in different ethnic populations. APOE polymorphism plays a significant role in pathogenesis of neurodegeneration, particularly in Alzheimer's disease. APOE epsilon 4 is considered a marker for poor prognosis in various diseases, but APOE epsilon 2 rather than APOE e4 has been associated with cerebral amyloid angiopathy-related bleeding and sporadic Parkinson's disease. The role of APOE polymorphism in various neurological diseases has not been conclusively elucidated. CONCLUSIONS Apo-E is a biomarker for various neurological and systemic diseases. Therefore, while analyzing the role of APOE polymorphism in neurological diseases, the interpretation should be done after adjusting all the confounding factors. A continuous quest to look for associations with various neurological diseases and wide knowledge of available literature are required to improve the understanding of the role of APOE polymorphism in these conditions and identify potential therapeutic targets.	[Maiti, Tanmoy Kumar; Konar, Subhas; Bir, Shyamal; Kalakoti, Piyush; Bollam, Papireddy; Nanda, Anil] LSU Hlth Shreveport, Dept Neurosurg, Shreveport, LA 71130 USA		Nanda, A (corresponding author), LSU Hlth Shreveport, Dept Neurosurg, 1501 Kings Hwy, Shreveport, LA 71130 USA.	ananda@lsuhsc.edu	Kalakoti, Piyush/J-5269-2015	Kalakoti, Piyush/0000-0002-9169-7418			AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; AlChalabi A, 1996, LANCET, V347, P159, DOI 10.1016/S0140-6736(96)90343-8; Arendt T, 1997, J NEUROSCI, V17, P516; Bedlack RS, 2000, ARCH NEUROL-CHICAGO, V57, P1561, DOI 10.1001/archneur.57.11.1561; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Brat DJ, 2001, NEUROPATH APPL NEURO, V27, P197, DOI 10.1046/j.1365-2990.2001.00311.x; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Caselli RJ, 2001, J NEUROL SCI, V189, P93, DOI 10.1016/S0022-510X(01)00577-9; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Corder EH, 1998, NAT MED, V4, P1182, DOI 10.1038/2677; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Egensperger R, 1996, BIOCHEM BIOPH RES CO, V224, P484, DOI 10.1006/bbrc.1996.1053; Enzinger C, 2004, ANN NEUROL, V55, P563, DOI 10.1002/ana.20027; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Galasko D, 2007, NEUROLOGY, V68, P1772, DOI 10.1212/01.wnl.0000262028.16738.64; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Govone F, 2014, AMYOTROPH LAT SCL FR, V15, P551, DOI 10.3109/21678421.2014.918149; Greenberg SM, 1998, NEUROLOGY, V50, P961, DOI 10.1212/WNL.50.4.961; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; HARDY J, 1994, NEUROSCI LETT, V182, P1, DOI 10.1016/0304-3940(94)90190-2; HARRINGTON CR, 1995, NEUROSCI LETT, V183, P35, DOI 10.1016/0304-3940(94)11108-U; Huang XM, 2004, NEUROLOGY, V62, P2198, DOI 10.1212/01.WNL.0000130159.28215.6A; Itzhaki RF, 2004, ANN NY ACAD SCI, V1019, P15, DOI 10.1196/annals.1297.003; Jha A, 2008, J SPINAL CORD MED, V31, P171, DOI 10.1080/10790268.2008.11760708; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kehoe P, 1999, J MED GENET, V36, P108; Kokubo Y, 2000, STROKE, V31, P1299, DOI 10.1161/01.STR.31.6.1299; Lanterna LA, 2005, NEUROLOGY, V64, P1238, DOI 10.1212/01.WNL.0000156523.77347.B4; Laws SM, 2003, J NEUROCHEM, V84, P1215, DOI 10.1046/j.1471-4159.2003.01615.x; Li YJ, 2004, NEUROGENETICS, V5, P209, DOI 10.1007/s10048-004-0193-0; Liu Y, 2015, J NEUROL NEUROSUR PS, V86, P127, DOI 10.1136/jnnp-2014-307719; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MARTINS RN, 1995, NEUROREPORT, V6, P1513, DOI 10.1097/00001756-199507310-00012; McCarron MO, 1999, STROKE, V30, P1643, DOI 10.1161/01.STR.30.8.1643; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Morris CM, 1996, J NEURAL TRANSM-SUPP, P205; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Moulard B, 1996, J NEUROL SCI, V139, P34, DOI 10.1016/0022-510X(96)00085-8; MUI S, 1995, ANN NEUROL, V38, P460, DOI 10.1002/ana.410380318; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Niino M, 2003, MULT SCLER J, V9, P382, DOI 10.1191/1352458503ms934oa; NOGUCHI S, 1993, LANCET, V342, P737, DOI 10.1016/0140-6736(93)91728-5; Olichney JM, 1996, NEUROLOGY, V47, P190, DOI 10.1212/WNL.47.1.190; Poirier J, 1999, MOL DIAGN, V4, P335, DOI 10.1016/S1084-8592(99)80010-1; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Praline J, 2011, EUR J NEUROL, V18, P1046, DOI 10.1111/j.1468-1331.2010.03330.x; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; ROSES AD, 1995, ANN NEUROL, V38, P6, DOI 10.1002/ana.410380105; Sadigh-Eteghad S, 2012, NEUROSCIENCES, V17, P321; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; Savettieri G, 2003, J NEUROL, V250, P1094, DOI 10.1007/s00415-003-0163-8; Schilling S, 2013, NEUROLOGY, V81, P292, DOI 10.1212/WNL.0b013e31829bfda4; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Schurhoff F, 2003, AM J MED GENET B, V119B, P18, DOI 10.1002/ajmg.b.20007; Seet WT, 2004, CLIN CHIM ACTA, V340, P201, DOI 10.1016/j.cccn.2003.11.001; Setzer M, 2008, SPINE, V33, P497, DOI 10.1097/BRS.0b013e3181657cf7; Setzer M, 2009, J NEUROSURG-SPINE, V11, P659, DOI 10.3171/2009.7.SPINE08667; Siddique T, 1998, NEUROGENETICS, V1, P213, DOI 10.1007/s100480050031; SIEST G, 1995, CLIN CHEM, V41, P1068; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Sudlow C, 2006, STROKE, V37, P364, DOI 10.1161/01.STR.0000199065.12908.62; Takeda M, 2010, PSYCHIAT CLIN NEUROS, V64, P592, DOI 10.1111/j.1440-1819.2010.02148.x; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Tsuzuki S, 1998, Rinsho Byori, V46, P829; Verpillat P, 2002, EUR J HUM GENET, V10, P399, DOI 10.1038/sj.ejhg.5200820; WARING SC, 1994, LANCET, V343, P611, DOI 10.1016/S0140-6736(94)91568-7; Wei YF, 2014, J CLIN NEUROSCI, V21, P390, DOI 10.1016/j.jocn.2013.07.019; WEST HL, 1994, NEUROSCI LETT, V175, P46, DOI 10.1016/0304-3940(94)91074-X; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; Xin XY, 2010, J ALZHEIMERS DIS, V19, P1283, DOI 10.3233/JAD-2010-1329; YAMANOUCHI Y, 1994, JPN J HUM GENET, V39, P315, DOI 10.1007/BF01874050; Yang DS, 1997, J NEUROCHEM, V68, P721; Yang DS, 1999, NEUROSCIENCE, V90, P1217, DOI 10.1016/S0306-4522(98)00561-2; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zetterberg H, 2008, J NEUROL SCI, V273, P67, DOI 10.1016/j.jns.2008.06.025; Zhang RJ, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-47; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	87	19	19	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2015	39	5							E3	10.3171/2015.8.FOCUS15329			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CV8DM	WOS:000364508000003	26646927	Bronze			2022-02-06	
J	Mendenhall, SK; Sivaganesan, A; Mistry, A; Sivasubramaniam, P; McGirt, MJ; Devin, CJ				Mendenhall, Stephen K.; Sivaganesan, Ahilan; Mistry, Akshitkumar; Sivasubramaniam, Priya; McGirt, Matthew J.; Devin, Clinton J.			Traumatic atlantooccipital dislocation: comprehensive assessment of mortality, neurologic improvement, and patient-reported outcomes at a Level 1 trauma center over 15 years	SPINE JOURNAL			English	Article						Trauma; Cervical spine; Outcomes; Diagnosis; Treatment; Craniocervical junction	ATLANTO-OCCIPITAL DISLOCATION; CERVICAL-SPINE INJURIES; OCCIPITOVERTEBRAL RELATIONSHIPS; OCCIPITOATLANTAL DISLOCATION; RADIOLOGIC-DIAGNOSIS; LATERAL RADIOGRAPHS; SUPINE SUBJECTS; BRAIN-INJURY; SURVIVAL; DISSOCIATION	BACKGROUND CONTEXT: Only Level 3 evidence exists for the diagnosis and treatment of atlantooccipital dislocation (AOD) with few studies examining mortality, neurologic improvement, and patient-reported outcomes (PROs). PURPOSE: First, the aim was to determine: the incidence of AOD, 90-day surgical morbidity and mortality after AOD, patient factors that may be associated with delayed or missed diagnosis, and factors that were associated with mortality and neurologic improvement after AOD. Secondly, the aim was to quantify the pain, disability, and quality of life experienced by patients surviving AOD. STUDY DESIGN/SETTING: This was a retrospective cohort study. PATIENT SAMPLE: A total of 5,337 consecutive spine computed tomography traumagrams from 1997 to 2012 were included. OUTCOME MEASURES: Mortality, neurologic improvement, complications, EuroQol five dimensions (EQ-5D), Neck Disability Index (NDI), Numeric Rating Scale (NRS)-neck, NRS-arm, and return-to-work were the outcome measures. METHODS: Patients were considered to have AOD if they met one of the following radiographic criteria: basion-dens interval greater than 10 mm; basion-axial interval: anterior displacement greater than 12 mm or posterior displacement greater than 4 mm between the basion and posterior C2 line; and condyle to C1 interval greater than 1.4 mm. Linear regression analysis was performed to identify factors associated with 90-day mortality, neurologic improvement, and missed diagnosis. Patient-reported outcomes were assessed via phone interview. RESULTS: Thirty-one patients met radiographic criteria for AOD; an incidence of 0.6% over 15 years. Twenty-one (68%) patients were treated with occipital cervical fusion. At 90 days postoperatively, there were no new neurologic deficits or reoperations. Eight (26%) patients died within 90 days. All patients who died had no documented AOD diagnosis and were not treated surgically. Missed AOD diagnosis was the strongest predictor of mortality. Younger age, lower Glasgow Coma Score, lower Injury Severity Score (ISS) score, and worse initial American Spinal Injury Association (ASIA) score were significantly associated with greater neurologic improvement. Higher ISS score and better ASIA score were significantly associated with missed AOD diagnosis. The average PROs metrics at time of telephone follow-up were as follows: EQ-5D=0.73 +/- 0.19, NDI=30.89 +/- 18.57, NRS-neck=2.33 +/- 2.21, NRS-arm=2.00 +/- 2.54. Of the patients with follow-up data, four were employed full-time, and five were receiving disability. CONCLUSIONS: Our work suggests that failure to diagnose AOD is a powerful predictor of mortality. Higher ISS scores and better neurologic presentation were significantly associated with missed diagnosis. Craniocervical arthrodesis preserved neurologic function with low complication rate and unexpectedly high PROs and return-to-work. These results must be carefully interpreted because it is unclear whether missed AOD diagnosis accompanies another death-causing injury (eg, traumatic brain injury) or if failure to treat AOD contributes to mortality in a multifactorial manner. (C) 2015 Elsevier Inc. All rights reserved.	[Mendenhall, Stephen K.; Sivaganesan, Ahilan; Mistry, Akshitkumar; McGirt, Matthew J.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA; [Sivasubramaniam, Priya; Devin, Clinton J.] Vanderbilt Univ, Med Ctr, Dept Orthoped Surg, Nashville, TN 37232 USA; [McGirt, Matthew J.] Carolina Neurosurg & Spine Associates, Charlotte, NC 28204 USA		Devin, CJ (corresponding author), Vanderbilt Spine Ctr, Vanderbilt Dept Orthopaed Surg, Med Ctr East, South Tower,Suite 4200, Nashville, TN 37232 USA.	clintondevin@gmail.com		Mistry, Akshitkumar/0000-0002-7918-5153	National Institute of Arthritis and Musculoskeletal diseaseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	SKM: Nothing to disclose. AS: Nothing to disclose. AM: Nothing to disclose. PS: Nothing to disclose. MJM: Consulting: Depuy and Stryker (C and A, respectively). CJD: Grants: National Institute of Arthritis and Musculoskeletal disease (F).	ALKER GJ, 1975, RADIOLOGY, V114, P611; ANTONELLI M, 1994, CHEST, V105, P224, DOI 10.1378/chest.105.1.224; Bellabarba C, 2006, J NEUROSURG-SPINE, V4, P429, DOI 10.3171/spi.2006.4.6.429; Blackwood NJ, 1908, ANN SURG, V47, P654, DOI 10.1097/00000658-190805000-00003; BOHLMAN HH, 1979, J BONE JOINT SURG AM, V61, P1119, DOI 10.2106/00004623-197961080-00001; BOOLS JC, 1986, AM J NEURORADIOL, V7, P901; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; BUCHOLZ RW, 1979, J BONE JOINT SURG AM, V61, P248, DOI 10.2106/00004623-197961020-00014; Cavalcanti M, 2006, CRIT CARE MED, V34, P1067, DOI 10.1097/01.CCM.0000206471.44161.A0; CHAN RNW, 1980, J TRAUMA, V20, P684, DOI 10.1097/00005373-198008000-00009; Chaput CD, 2011, J TRAUMA, V71, P393, DOI 10.1097/TA.0b013e3181eb6a31; Como JJ, 2009, J TRAUMA, V67, P651, DOI 10.1097/TA.0b013e3181ae583b; Cooper Z, 2010, J SURG RES, V160, P3, DOI 10.1016/j.jss.2009.04.004; DAVIS D, 1971, J NEUROSURG, V34, P603, DOI 10.3171/jns.1971.34.5.0603; DAVIS JW, 1993, J TRAUMA, V34, P342, DOI 10.1097/00005373-199303000-00006; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; DEBEER JD, 1988, J BONE JOINT SURG BR, V70, P652, DOI 10.1302/0301-620X.70B4.3403618; Diaz JJ, 2003, J TRAUMA, V55, P658, DOI 10.1097/01.TA.0000088120.99247.4A; DIBENEDETTO T, 1990, SPINE, V15, P595, DOI 10.1097/00007632-199006000-00031; DICKMAN CA, 1993, J SPINAL DISORD, V6, P300, DOI 10.1097/00002517-199306040-00004; DUBLIN AB, 1980, J NEUROSURG, V52, P541, DOI 10.3171/jns.1980.52.4.0541; Dziurzynski K, 2005, SPINE, V30, P1427, DOI 10.1097/01.brs.0000166524.88394.b3; EVARTS CM, 1970, J BONE JOINT SURG AM, VA 52, P1653, DOI 10.2106/00004623-197052080-00017; FARTHING J W, 1948, N C Med J, V9, P34; FINNEY HL, 1978, J NEUROSURG, V48, P636, DOI 10.3171/jns.1978.48.4.0636; Fisher CG, 2001, CAN J SURG, V44, P412; FRUIN AH, 1977, J NEUROSURG, V46, P663, DOI 10.3171/jns.1977.46.5.0663; GABRIELS.TO, 1966, AMER J ROENTGENOL RA, V97, P624, DOI 10.2214/ajr.97.3.624; GERRELTS BD, 1991, J TRAUMA, V31, P1622, DOI 10.1097/00005373-199112000-00010; Govender S, 2003, J BONE JOINT SURG BR, V85B, P875, DOI 10.1302/0301-620X.85B6.14092; Guigui P, 1995, Eur Spine J, V4, P242, DOI 10.1007/BF00303419; Hadley MN, 2002, NEUROSURGERY, V50, pS105; HARRIS JH, 1994, AM J ROENTGENOL, V162, P881, DOI 10.2214/ajr.162.4.8141012; HARRIS JH, 1994, AM J ROENTGENOL, V162, P887, DOI 10.2214/ajr.162.4.8141013; Horn EM, 2007, J NEUROSURG-SPINE, V6, P113, DOI 10.3171/spi.2007.6.2.113; HOSONO N, 1993, SPINE, V18, P786, DOI 10.1097/00007632-199305000-00023; Jansson KA, 2011, ACTA ORTHOP, V82, P82, DOI 10.3109/17453674.2010.548026; JONSSON H, 1991, J SPINAL DISORD, V4, P251, DOI 10.1097/00002517-199109000-00001; Kool DR, 2007, EMERG RADIOL, V14, P135, DOI 10.1007/s10140-007-0633-x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MATAVA MJ, 1993, SPINE, V18, P1897, DOI 10.1097/00007632-199310000-00030; MONTANE I, 1991, SPINE, V16, P112, DOI 10.1097/00007632-199116020-00002; Mueller FJ, 2013, EUR SPINE J, V22, P65, DOI 10.1007/s00586-012-2543-1; Nunley PD, 2009, SPINE J, V9, P121, DOI 10.1016/j.spinee.2007.11.009; PAGE CP, 1973, J NEUROSURG, V39, P394, DOI 10.3171/jns.1973.39.3.0394; Pang D, 2007, NEUROSURGERY, V61, P995, DOI 10.1227/01.neu.0000303196.87672.78; POWERS B, 1979, NEUROSURGERY, V4, P12, DOI 10.1097/00006123-197901000-00004; Rojas CA, 2007, AM J NEURORADIOL, V28, P1819, DOI 10.3174/ajnr.A0660; Theodore N, 2013, NEUROSURGERY S, V72, P114; TRAYNELIS VC, 1986, J NEUROSURG, V65, P863, DOI 10.3171/jns.1986.65.6.0863; VANDENBOUT AH, 1986, SPINE, V11, P174, DOI 10.1097/00007632-198603000-00017; Vender John R, 2004, Neurosurg Focus, V16, pE9; Wafaisade A, 2011, CRIT CARE MED, V39, P621, DOI 10.1097/CCM.0b013e318206d3df; WOODRING JH, 1981, AM J ROENTGENOL, V137, P21, DOI 10.2214/ajr.137.1.21; Yuksel KZ, 2008, SPINE, V33, P2066, DOI 10.1097/BRS.0b013e31817e2cfc; ZIGLE JE, 1986, SPINE, V11, P645, DOI 10.1097/00007632-198607000-00026	56	19	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	NOV 1	2015	15	11					2385	2395		10.1016/j.spinee.2015.07.003			11	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	CV3QO	WOS:000364173900033	26165481				2022-02-06	
J	Peterson, TC; Maass, WR; Anderson, JR; Anderson, GD; Hoane, MR				Peterson, Todd C.; Maass, William R.; Anderson, Jordan R.; Anderson, Gail D.; Hoane, Michael R.			A behavioral and histological comparison of fluid percussion injury and controlled cortical impact injury to the rat sensorimotor cortex	BEHAVIOURAL BRAIN RESEARCH			English	Article						Animal studies; Assessment tools; Fluid percussion injury; Cortical contusion injury; Behavior; Sensorimotor function	TRAUMATIC BRAIN-INJURY; IMPROVES FUNCTIONAL RECOVERY; NICOTINAMIDE TREATMENT; CONTUSION INJURY; PROGESTERONE; PERFORMANCE; MODELS; DEATH	Our primary goal was to evaluate the behavioral and histological outcome of fluid percussion injury (FPI) and cortical contusion injury (CCI) to the sensorimotor cortex (SMC). The SMC has been used to evaluate neuroplasticity following CCI, but has not been extensively examined with FPI. In both the CCI and FPI models, a mechanical force of 4 mm in diameter was applied over the SMC, allowing for a direct comparison to measure the relative rates of histology and recovery of function in these models. Gross behavioral deficits were found on the sensory task (tactile adhesive removal task) and multiple motor assessments (forelimb asymmetry task, forelimb placing task, and rotorod). These sensorimotor deficits occurred in the absence of cognitive deficits in the water maze. The CCI model creates focal damage with a localized injury wheras the FPI model creates a more diffuse injury causing widespread damage. Both behavioral and histological deficits ensued following both models of injury to the SMC. The neuroplastic changes and ease at which damage to this area can be measured behaviorally make this an excellent location to assess traumatic brain injury (TBI) treatments. No injury model can completely mimic the full spectrum of human TBI and any potential treatments should be validated across both focal and diffuse injury models. Both of these injury models to the SMC produce severe and enduring behavioral deficits, which are ideal for evaluating treatment options. (C) 2015 Elsevier B.V. All rights reserved.	[Peterson, Todd C.; Maass, William R.; Anderson, Jordan R.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Carbondale, IL 62901 USA; [Anderson, Gail D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Life Sci 2, MC 6502, Carbondale, IL 62901 USA.	tcpeters@stanford.edu; bmaass@siu.edu; j.anderson822@siu.edu; gaila@u.washington.edu; mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657	National Institutes of Health/National Institute of Child, Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 HD061944-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061944] Funding Source: NIH RePORTER	The authors would like to thank Lynn Moore for her assistance on this project. The research was supported by a grant from the National Institutes of Health/National Institute of Child, Health and Development (R01 HD061944-01).	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Allegri RF, 2001, REV NEUROLOGIA, V32, P449, DOI 10.33588/rn.3205.2000167; Allred RP, 2008, FUTUR NEUROL, V3, P189, DOI 10.2217/14796708.3.2.189; Barense MD, 2002, LEARN MEMORY, V9, P191, DOI 10.1101/lm.48602; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; CDC, 2010, INJ PREV CONTR TRAUM; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gersh Isidore, 1943, JOUR CELL AND COMP PHYSIOL, V21, P253, DOI 10.1002/jcp.1030210305; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; GREGERSEN N, 1986, ACTA PAEDIATR SCAND, V75, P676, DOI 10.1111/j.1651-2227.1986.tb10272.x; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 1998, BEHAV BRAIN RES, V97, P89, DOI 10.1016/S0166-4328(98)00030-8; Krantz K P, 1986, Acta Neurochir Suppl (Wien), V36, P47; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Peterson TC, 2015, J NEUROTRAUM, V32, P765, DOI 10.1089/neu.2014.3530; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Peterson TC, 2012, BEHAV NEUROSCI, V126, P551, DOI 10.1037/a0028701; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; Ryou Jae-Wook, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P430, DOI 10.3758/CABN.4.4.430; Schallert T, 2005, BEHAV LAB RAT, P129; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Stoica BA, 2010, ACUTE NEURONAL INJURY: THE ROLE OF EXCITOTOXIC PROGRAMMED CELL DEATH MECHANISMS, P169, DOI 10.1007/978-0-387-73226-8_12; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099	49	19	20	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	NOV 1	2015	294						254	263		10.1016/j.bbr.2015.08.007			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CS2WZ	WOS:000361934000029	26275924	Green Accepted			2022-02-06	
J	Rael, LT; Bar-Or, R; Kelly, MT; Carrick, MM; Bar-Or, D				Rael, Leonard T.; Bar-Or, Raphael; Kelly, Michael T.; Carrick, Matthew M.; Bar-Or, David			Assessment of Oxidative Stress in Patients with an Isolated Traumatic Brain Injury Using Disposable Electrochemical Test Strips	ELECTROANALYSIS			English	Article						Isolated traumatic brain injury; Oxidative stress; Human plasma; Redox chemistry; Sensors	CEREBROSPINAL-FLUID; ASCORBIC-ACID; ANTIOXIDANT STATUS; FREE-RADICALS; PLASMA; BLOOD; SEPSIS; SERUM; DYSFUNCTION; CHILDREN	The barriers to using plasma redox potential as a measure of oxidative stress in patients are the use of specialized equipment, necessity of sterilization between tests, and inconsistent electrode surfaces and cell geometry. These problems are resolved using disposable test strips with built in electrochemical cells. Measuring the electrode potential at a small current yields a stable value that is similar to 50 mV higher for isolated traumatic brain injury (ITBI) patients than for healthy individuals. Even with natural variations within blood chemistry, this simple method may be clinically useful for assessing the degree of oxidative stress and injury severity in ITBI patients.	[Rael, Leonard T.; Bar-Or, Raphael; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80113 USA; [Rael, Leonard T.; Bar-Or, Raphael; Bar-Or, David] St Anthony Hosp, Lakewood, CO USA; [Rael, Leonard T.; Bar-Or, Raphael; Carrick, Matthew M.; Bar-Or, David] Med Ctr Plano, Plano, TX USA; [Rael, Leonard T.; Bar-Or, Raphael; Bar-Or, David] Aytu BioSci Inc, Englewood, CO USA; [Kelly, Michael T.] Princeton Univ, Princeton, NJ 08544 USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Dept, 501 E Hampden Ave,Room 4-454, Englewood, CO 80113 USA.	dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020	Rael, Leonard/0000-0003-3282-7072			Apak R, 2007, MOLECULES, V12, P1496, DOI 10.3390/12071496; Batra S, 2000, ANN TROP PAEDIATR, V20, P27, DOI 10.1080/02724930092039; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Cowley HC, 1996, CRIT CARE MED, V24, P1179, DOI 10.1097/00003246-199607000-00019; CROSS CE, 1990, J LAB CLIN MED, V115, P396; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; Ernst H, 2001, ANAL CHIM ACTA, V449, P129, DOI 10.1016/S0003-2670(01)01350-2; Evseev AK, 2014, PROT MET PHYS CHEM+, V50, P553, DOI 10.1134/S2070205114040029; Gaetani P, 1998, J NEUROSURG, V89, P748, DOI 10.3171/jns.1998.89.5.0748; Galley HF, 1996, CRIT CARE MED, V24, P1649, DOI 10.1097/00003246-199610000-00008; GOODE HF, 1995, CRIT CARE MED, V23, P646, DOI 10.1097/00003246-199504000-00011; GROSZ HJ, 1967, NATURE, V213, P717, DOI 10.1038/213717a0; Ido Y, 1997, DIABETOLOGIA, V40, pS115, DOI 10.1007/s001250051422; Khubutiya MS, 2010, RUSS J ELECTROCHEM+, V46, P537, DOI 10.1134/S1023193510050071; Lemasters JJ, 1997, BIOSCIENCE REP, V17, P281, DOI 10.1023/A:1027332611839; Manevich Y, 2014, FREE RADICAL BIO MED, V72, P210, DOI 10.1016/j.freeradbiomed.2014.04.002; MARMASSE C, 1964, NATURE, V202, P94, DOI 10.1038/202094a0; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; PEPPER JR, 1994, FREE RADICAL RES, V21, P377, DOI 10.3109/10715769409056590; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI 10.1089/neu.2008-0816; Rael LT, 2009, J TRAUMA, V66, P76, DOI 10.1097/TA.0b013e318191bfe0; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Rock Cheryl L., 1997, Journal of Burn Care and Rehabilitation, V18, P269; Sanchez-Moreno C, 2004, STROKE, V35, P163, DOI 10.1161/01.STR.0000105391.62306.2E; Schlesier K, 2002, FREE RADICAL RES, V36, P177, DOI 10.1080/10715760290006411; Sharma P., 2013, J FOOD TECH, V8, P83; Szczepanska-Szerej A, 2011, CLIN NEUROPHARMACOL, V34, P191, DOI 10.1097/WNF.0b013e3182309418; TURYAN YI, 1995, J ELECTROANAL CHEM, V380, P273, DOI 10.1016/0022-0728(94)03524-7; VANDERJAGT DJ, 1987, AM J CLIN NUTR, V46, P290, DOI 10.1093/ajcn/46.2.290; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; WARNER A, 1995, CLIN CHEM, V41, P867; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869	34	19	20	0	8	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1040-0397	1521-4109		ELECTROANAL	Electroanalysis	NOV	2015	27	11					2567	2573		10.1002/elan.201500178			7	Chemistry, Analytical; Electrochemistry	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Electrochemistry	DB2LI	WOS:000368339700009					2022-02-06	
J	Wang, HH; Wang, XK; Qu, J; Yue, Q; Hu, YN; Zhang, HX				Wang, Huihui; Wang, Xingkai; Qu, Jing; Yue, Qing; Hu, Ya'nan; Zhang, Huanxiang			VEGF Enhances the Migration of MSCs in Neural Differentiation by Regulating Focal Adhesion Turnover	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; TYROSINE KINASE; STROKE RATS; BETA-PIX; PHOSPHORYLATION; ACTIN	Mesenchymal stem cells (MSCs) hold great promise in neural regeneration, due to their intrinsic neuronal potential and migratory tropism to damaged nervous tissues. However, the chemotactic signals mediating the migration of MSCs remain poorly understood. Here, we investigated the regulatory roles for focal adhesion kinase (FAK) and Rac1 in vascular endothelial growth factor (VEGF)-stimulated migration of MSCs in neural differentiation. We found that MSCs in various differentiation states show significant different chemotactic responses to VEGF and cells in 24-h preinduction state possess the highest migration speed and efficiency. FAK, as the downstream signaling molecule, is involved in the VEGF-induced migration by regulating the assembly and distribution of focal adhesions (FAs) and reorganization of F-actin. The features of FAs and cytoskeletons and the ability of lamellipodia formation are closely related to the neural differentiation states of MSCs. VEGF promotes FA formation with an asymmetric distribution of FAs and induces the activation of Y397-FAK and Y31/118-paxillin of undifferentiated and 24-h preinduced MSCs in a time-dependent manner. Inhibition of FAK by PF-228 or expressing FAK-Y397F mutant impairs the dynamics of FAs in MSCs during VEGF-induced migration. Furthermore, Rac1 regulates FA formation in a FAK-dependent manner. Overexpression of constitutive activated mutants of Rac1 increases the number of FAs in undifferentiated and 24-h preinduced MSCs, while VEGF-induced increase of FA formation is decreased by inhibiting FAK by PF-228. Collectively, these results demonstrate that FAK and Rac1 signalings coordinately regulate the dynamics of FAs during VEGF-induced migration of MSCs in varying neural differentiation states. J. Cell. Physiol. 9999: 2728-2742, 2015. (c) 2015 Wiley Periodicals, Inc.	[Wang, Huihui; Wang, Xingkai; Qu, Jing; Yue, Qing; Hu, Ya'nan; Zhang, Huanxiang] Soochow Univ, Coll Med, Jiangsu Key Lab Stem Cell Res, Dept Cell Biol, Suzhou 215123, Peoples R China		Zhang, HX (corresponding author), Soochow Univ, Coll Med, Jiangsu Key Lab Stem Cell Res, Dept Cell Biol, Ren Ai Rd 199,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	hzhang@suda.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31371407, 31071220]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20141198]	Contract grant sponsor: National Natural Science Foundation of China;; Contract grant numbers: 31371407, 31071220.; Contract grant sponsor: Natural Science Foundation of Jiangsu Province;; Contract grant number: BK20141198.	Alexanian AR, 2008, STEM CELLS DEV, V17, P1123, DOI 10.1089/scd.2007.0212; Angelucci A, 2007, CURR PHARM DESIGN, V13, P2129; Avraham HK, 2003, J BIOL CHEM, V278, P36661, DOI 10.1074/jbc.M301253200; Bae KS, 2011, YONSEI MED J, V52, P401, DOI 10.3349/ymj.2011.52.3.401; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Birnbaum T, 2007, J NEURO-ONCOL, V83, P241, DOI 10.1007/s11060-007-9332-4; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Choi CK, 2011, BIOPHYS J, V100, P583, DOI 10.1016/j.bpj.2010.12.3719; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Doucette T, 2011, NEOPLASIA, V13, P716, DOI 10.1593/neo.101680; Glavaski-Joksimovic A, 2013, EXP NEUROL, V247, P25, DOI 10.1016/j.expneurol.2013.03.016; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hayakawa K, 2011, J NEUROSCI, V31, P10666, DOI 10.1523/JNEUROSCI.1944-11.2011; Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kao AP, 2011, FERTIL STERIL, V95, P1308, DOI 10.1016/j.fertnstert.2010.09.064; Kawakami K, 2001, J CELL SCI, V114, P3125; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee J, 2005, EXP CELL RES, V307, P315, DOI 10.1016/j.yexcr.2005.03.028; Liao WX, 2010, ENDOCRINOLOGY, V151, P3432, DOI 10.1210/en.2009-1305; Lyu JY, 2013, J CELL BIOCHEM, V114, P1744, DOI 10.1002/jcb.24517; Matsuura S, 2011, J HISTOCHEM CYTOCHEM, V59, P864, DOI 10.1369/0022155411413929; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Pisati F, 2007, CELL TRANSPLANT, V16, P41, DOI 10.3727/000000007783464443; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romanova LY, 2004, J CELL SCI, V117, P3759, DOI 10.1242/jcs.01206; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Schichor C, 2006, EXP NEUROL, V199, P301, DOI 10.1016/j.expneurol.2005.11.027; Shyu WC, 2007, STROKE, V38, P367, DOI 10.1161/01.STR.0000254463.24655.14; Takahashi N, 1999, CIRC RES, V84, P1194, DOI 10.1161/01.RES.84.10.1194; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Uccelli A, 2011, CURR STEM CELL RES T, V6, P69, DOI 10.2174/157488811794480744; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Webb SE, 1996, J CELL SCI, V109, P793; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xu XY, 2011, CELL TRANSPLANT, V20, P1065, DOI 10.3727/096368910X544906; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Yeo MG, 2006, MOL CELL BIOL, V26, P4399, DOI 10.1128/MCB.01147-05; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zheng B, 2013, J CELL PHYSIOL, V228, P149, DOI 10.1002/jcp.24114; Zhu XH, 2013, GASTRIC CANCER, V16, P155, DOI 10.1007/s10120-012-0166-1; ZICHA D, 1991, J CELL SCI, V99, P769	56	19	20	0	26	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	NOV	2015	230	11					2728	2742		10.1002/jcp.24997			15	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	CN8LS	WOS:000358692700017	25820249				2022-02-06	
J	Doulames, VM; Vilcans, M; Lee, S; Shea, TB				Doulames, Vanessa M.; Vilcans, Meghan; Lee, Sangmook; Shea, Thomas B.			Social interaction attenuates the extent of secondary neuronal damage following closed head injury in mice	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						Traumatic Brain Injury; neurodegeneration; cognitive impairment; oxidative damage; socialization; secondary injury	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; RISK-FACTOR; ENVIRONMENTAL ENRICHMENT; CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; COGNITIVE DECLINE; AMYLOID-BETA	Recovery following Traumatic Brain Injury (TBI) can vary tremendously among individuals. Lifestyle following injury, including differential social interactions, may modulate the extent of secondary injury following TBI. To examine this possibility under controlled conditions, closed head injury (CHI) was induced in C57BI6 mice using a standardized weight drop device after which mice were either housed in isolation or with their original cagemates ("socially housed") for 4 weeks. CHI transiently impaired novel object recognition (NOR) in both isolated and social mice, confirming physical and functional injury. By contrast, Y maze navigation was impaired in isolated but not social mice at 1-4 weeks post CHI. CHI increased excitotoxic signaling in hippocampal slices from all mice, which was transiently exacerbated by isolation at 2 weeks post CHI. CHI slightly increased reactive oxygen species and did not alter levels of amyloid beta (Abeta), total or phosphotau, total or phosphorylated neurofilaments. CHI increased serum corticosterone in both groups, which was exacerbated by isolation. These findings support the hypothesis that socialization may attenuate secondary damage following TBI. In addition, a dominance hierarchy was noted among socially-housed mice, in which the most submissive mouse displayed indices of stress in the above analyses that were statistically identical to those observed for isolated mice. This latter finding underscores that the nature and extent of social interaction may need to vary among individuals to provide therapeutic benefit.	[Doulames, Vanessa M.; Vilcans, Meghan; Lee, Sangmook; Shea, Thomas B.] UMass Lowell, Ctr Neurobiol & Neurodegenerat Res, Lowell, MA 01854 USA; [Doulames, Vanessa M.; Shea, Thomas B.] Univ Massachusetts, Biomed & Biotechnol Program, Lowell, MA USA; [Vilcans, Meghan; Lee, Sangmook; Shea, Thomas B.] Univ Massachusetts, Dept Biol Sci, Lowell, MA USA		Shea, TB (corresponding author), UMass Lowell, Ctr Neurobiol & Neurodegenerat Res, Lowell, MA 01854 USA.	Thomas_shea@uml.edu	Doulames, Vanessa/AAG-8828-2021	Monfils, Marie-H./0000-0001-8971-6651; Lee, Hongjoo/0000-0002-0110-5432	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21 MH086805, R01 MH091147] Funding Source: Medline		Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Bowen A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007039.pub2; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Daulatzai MA, 2013, NEUROTOX RES, V24, P216, DOI 10.1007/s12640-013-9379-2; Doulames V, 2014, INT J NEUROSCI, V124, P369, DOI 10.3109/00207454.2013.848441; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gilbert F., 2011, AJOB NEUROSCIENCE, V2, P48, DOI [DOI 10.1080/21507740.2011.611125, https://doi.org/10.1080/21507740.2011.611125]; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Hellweg S, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/768456; Huang HJ, 2011, BRAIN RES, V1371, P150, DOI 10.1016/j.brainres.2010.11.043; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Huong NTT, 2005, BIOL PHARM BULL, V28, P1389, DOI 10.1248/bpb.28.1389; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Lee S, 2012, J ALZHEIMERS DIS, V28, P497, DOI 10.3233/JAD-2011-111562; LEVINE S, 1964, ENDOCRINOLOGY, V75, P142, DOI 10.1210/endo-75-1-142; LOUCH CD, 1967, GEN COMP ENDOCR, V8, P441, DOI 10.1016/S0016-6480(67)80006-6; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Miura H, 2002, SYNAPSE, V46, P116, DOI 10.1002/syn.10133; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Moller M, 2011, EUR NEUROPSYCHOPHARM, V21, P471, DOI 10.1016/j.euroneuro.2010.09.006; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NELSON W, 1975, J NUTR, V105, P171, DOI 10.1093/jn/105.2.171; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PAVLIDES C, 1993, HIPPOCAMPUS, V3, P183, DOI 10.1002/hipo.450030210; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Salim S, 2011, BRAIN RES, V1404, P63, DOI 10.1016/j.brainres.2011.06.024; Sapolsky R., 2011, COMPR PHYSL, P517, DOI [10.1002/cphy.cp070423, DOI 10.1002/CPHY.CP070423, 10.1002/cphy.cp070423.]; Sapolsky RM, 1997, ARCH GEN PSYCHIAT, V54, P1137; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; SCHUHR B, 1987, PHYSIOL BEHAV, V40, P689, DOI 10.1016/0031-9384(87)90269-1; Serra M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026009; Shea TB, 2014, DIET NUTR DEMENTIA C, P837; Shea TB, 2014, J ALZHEIMERS DIS, V41, P667, DOI 10.3233/JAD-132675; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Taylor CA, 1999, AM J MED GENET, V88, P742, DOI 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; van der Ploeg ES, 2013, INT PSYCHOGERIATR, V25, P565, DOI 10.1017/S1041610212002128; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YARNELL PR, 1970, LANCET, V1, P863; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zemianek JM, 2013, INT J DEV NEUROSCI, V31, P308, DOI 10.1016/j.ijdevneu.2013.03.011; Zemianek JM, 2013, INT J DEV NEUROSCI, V31, P131, DOI 10.1016/j.ijdevneu.2012.11.003; Zemianek JM, 2012, INT J DEV NEUROSCI, V30, P602, DOI 10.1016/j.ijdevneu.2012.08.001; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	72	19	19	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	OCT 15	2015	9								275	10.3389/fnbeh.2015.00275			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CT5GT	WOS:000362837700001	26834596	gold, Green Published			2022-02-06	
J	Dardiotis, E; Paterakis, K; Siokas, V; Tsivgoulis, G; Dardioti, M; Grigoriadis, S; Simeonidou, C; Komnos, A; Kapsalaki, E; Fountas, K; Hadjigeorgiou, GM				Dardiotis, Efthimios; Paterakis, Konstantinos; Siokas, Vasileios; Tsivgoulis, Georgios; Dardioti, Maria; Grigoriadis, Savas; Simeonidou, Constantina; Komnos, Apostolos; Kapsalaki, Eftychia; Fountas, Kostas; Hadjigeorgiou, Georgios M.			Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury	PHARMACOGENETICS AND GENOMICS			English	Article						angiotensin-converting enzyme; polymorphism; tag single nucleotide polymorphisms; traumatic brain injury	CEREBRAL-BLOOD-FLOW; GENETIC ASSOCIATION; SUBSTANCE-P; ACE; AUTOREGULATION; NEUROTRAUMA; DEFICITS; DAMAGE; EDEMA	BackgroundGenetic variants appear to influence, at least to some degree, the extent of brain injury and the clinical outcome of patients who have sustained a traumatic brain injury (TBI). Angiotensin-converting enzyme (ACE) is a zinc metallopeptidase that is implicated in the regulation of blood pressure and cerebral circulation. ACE gene polymorphisms were found to regulate serum ACE enzyme activity.ObjectiveThe present study aimed to investigate possible influence of ACE gene region variants on patients' outcome after TBI.Patients and methodsIn total, 363 TBI patients prospectively enrolled in the study were genotyped for five tag single nucleotide polymorphisms (SNPs) across the ACE gene. Using logistic regression analyses, tag SNPs and their constructed haplotypes were tested for associations with 6-month Glasgow Outcome Scale scores, after adjustment for age, sex, Glasgow Coma Scale scores at admission, and the presence of a hemorrhagic event in the initial computed tomography scan.ResultsSignificant effects on TBI outcome were found for three neighboring tag SNPs in the codominant (genotypic) model of inheritance [rs4461142: odds ratio (OR) 0.26, 95% confidence interval (CI) 0.12-0.57, P=0.0001; rs7221780: OR 2.67, 95% CI 1.25-5.72, P=0.0003; and rs8066276: OR 3.82, 95% CI 1.80-8.13, P=0.0002; for the heterozygous variants compared with the common alleles]. None of the constructed common tag SNPs haplotypes was associated with TBI outcome.ConclusionThe present study provides evidence of the possible influence of genetic variations in a specific region of the ACE gene on the outcome of TBI patients. This association may have pharmacogenetic implications in identifying those TBI patients who may benefit from ACE inhibition.	[Dardiotis, Efthimios; Siokas, Vasileios; Dardioti, Maria; Hadjigeorgiou, Georgios M.] Univ Thessaly, Univ Hosp Larissa, Fac Med, Lab Neurogenet,Dept Neurol, Larisa 41100, Greece; [Paterakis, Konstantinos; Fountas, Kostas] Univ Thessaly, Univ Hosp Larissa, Fac Med, Dept Neurosurg, Larisa 41100, Greece; [Komnos, Apostolos] Gen Hosp Larissa, Intens Care Unit, Larisa, Greece; [Kapsalaki, Eftychia] Univ Thessaly, Sch Med, Dept Radiol, Larisa, Greece; [Tsivgoulis, Georgios] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Neurol 2, GR-11527 Athens, Greece; [Grigoriadis, Savas] Hippokrat Univ Hosp, Dept Neurosurg 2, Thessaloniki, Greece; [Simeonidou, Constantina] Aristotle Univ Thessaloniki, Dept Physiol, GR-54006 Thessaloniki, Greece; [Tsivgoulis, Georgios] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic		Hadjigeorgiou, GM (corresponding author), Univ Thessaly, Univ Hosp Larissa, Fac Med, Lab Neurogenet,Dept Neurol, Mezourlo Hill, Larisa 41100, Greece.	gmhadji@med.uth.gr	Tsivgoulis, Georgios/AAD-5360-2020; Tsivgoulis, Georgios/AAD-7467-2019; Paterakis, Konstantinos/AAH-4554-2019	Tsivgoulis, Georgios/0000-0002-0640-3797; Dardiotis, Efthimios/0000-0003-2957-641X	Research Committee of the University of Thessaly, Greece [2845]	This study was supported in part by a research grant from the Research Committee of the University of Thessaly, Greece (code: 2845).	Ariza M, 2006, J NEUROPSYCH CLIN N, V18, P39, DOI 10.1176/appi.neuropsych.18.1.39; Baranov D, 2003, ANESTHESIOLOGY, V99, P1118, DOI 10.1097/00000542-200311000-00018; Carter KW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-557; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Dardiotis E, 2006, SURG NEUROL, V66, P334, DOI 10.1016/j.surneu.2006.05.042; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Dardiotis E, 2011, PHARMACOGENET GENOM, V21, P136, DOI 10.1097/FPC.0b013e328343ab15; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; DEMOLIS P, 1993, J CARDIOVASC PHARM, V22, P373, DOI 10.1097/00005344-199309000-00005; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Friedman A, 2014, EXPERT REV NEUROTHER, V14, P1365, DOI 10.1586/14737175.2014.972945; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Namsolleck P, 2013, NEUROBIOL DIS, V51, P177, DOI 10.1016/j.nbd.2012.11.008; Oba R, 2005, EUR J NEUROSCI, V21, P733, DOI 10.1111/j.1460-9568.2005.03912.x; Panahpour H, 2014, CLIN EXP PHARMACOL P, V41, P220, DOI 10.1111/1440-1681.12210; Sayed-Tabatabaei FA, 2006, CIRC RES, V98, P1123, DOI 10.1161/01.RES.0000223145.74217.e7; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; YOKOSAWA H, 1983, BIOCHEM BIOPH RES CO, V116, P735, DOI 10.1016/0006-291X(83)90586-7; Zhu XF, 2000, AM J HUM GENET, V67, P1144	28	19	19	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1744-6872	1744-6880		PHARMACOGENET GENOM	Pharmacogenet. Genomics	OCT	2015	25	10					485	490		10.1097/FPC.0000000000000161			6	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology & Pharmacy	CR6SB	WOS:000361476500002	26181640				2022-02-06	
J	Lequerica, A; Jasey, N; Tremont, JNP; Chiaravalloti, ND				Lequerica, Anthony; Jasey, Neil; Tremont, Jaclyn N. Portelli; Chiaravalloti, Nancy D.			Pilot Study on the Effect of Ramelteon on Sleep Disturbance After Traumatic Brain Injury: Preliminary Evidence From a Clinical Trial	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cognition; Rehabilitation; Sleep	CHRONIC PRIMARY INSOMNIA; OLDER-ADULTS; TRANSIENT INSOMNIA; RECEPTOR AGONIST; DOUBLE-BLIND; EFFICACY; PLACEBO; SAFETY; MELATONIN; MOOD	Objective: To investigate the effect of ramelteon on sleep and daytime functioning among individuals with traumatic brain injury (TBI). Design: A double-blind, placebo-controlled study with a crossover design. Setting: A research facility attached to an acute rehabilitation hospital. Participants: Individuals with TBI (N=13) complaining of sleep difficulties with a Pittsburgh Sleep Quality Index score >5. Interventions: A nightly dosage of ramelteon (8mg) was given over a period of 3 weeks. Main Outcome Measures: An actigraph and a daily sleep log were used to measure sleep/wake patterns. Daytime functioning was measured after 3 weeks of treatment using a computer-administrated neuropsychological test battery in conjunction with subjective questionnaires measuring mood, daytime sleepiness, and fatigue. Results: A significant increase in objectively measured total sleep time and a small increase in sleep latency were observed after 3 weeks of treatment compared with placebo. Treatment also showed a significant increase in standardized neuropsychological test scores, with a particular improvement on an index of executive functioning. Conclusions: Preliminary evidence for the effectiveness of 8mg of ramelteon taken nightly over a 3-week period was found in the treatment of sleep difficulties among individuals with TBI. Improvements in total sleep time and some aspects of cognitive functioning are discussed. (C) 2015 by the American Congress of Rehabilitation Medicine	[Lequerica, Anthony; Chiaravalloti, Nancy D.] Kessler Fdn, W Orange, NJ 07052 USA; [Lequerica, Anthony; Chiaravalloti, Nancy D.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Rutgers, Newark, NJ 07103 USA; [Jasey, Neil] Kessler Inst Rehabil, W Orange, NJ USA; [Tremont, Jaclyn N. Portelli] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA		Lequerica, A (corresponding author), Kessler Fdn, Traumat Brain Injury Res, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	alequerica@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567			Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Aton SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006078; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bellon Alfredo, 2006, J Psychiatr Pract, V12, P229, DOI 10.1097/00131746-200607000-00005; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Erman M, 2006, SLEEP MED, V7, P17, DOI 10.1016/j.sleep.2005.09.004; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Gooneratne NS, 2010, J CLIN SLEEP MED, V6, P572; Greenblatt DJ, 2007, J CLIN PHARMACOL, V47, P485, DOI 10.1177/0091270006298602; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Johnson MW, 2006, ARCH GEN PSYCHIAT, V63, P1149, DOI 10.1001/archpsyc.63.10.1149; Karim A, 2006, J CLIN PHARMACOL, V46, P140, DOI 10.1177/0091270005283461; Kato K, 2005, NEUROPHARMACOLOGY, V48, P301, DOI 10.1016/j.neuropharm.2004.09.007; Kohsaka M, 2011, EXPERT REV NEUROTHER, V11, P1389, DOI [10.1586/ERN.11.128, 10.1586/ern.11.128]; Laustsen G, 2006, NURSE PRACT, V31, P52, DOI 10.1097/00006205-200604000-00011; Mayer G, 2009, SLEEP, V32, P351, DOI 10.1093/sleep/32.3.351; McNair DM, 1992, MANUAL PROFILE MOOD; Mets MAJ, 2011, SLEEP, V34, P1327, DOI 10.5665/SLEEP.1272; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Pandi-Perumal SR, 2005, EXP GERONTOL, V40, P911, DOI 10.1016/j.exger.2005.08.009; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; PASSOUANT P, 1972, REV NEUROL-FRANCE, V127, P173; Richardson GS, 2002, J CLIN PSYCHOPHARM, V22, P511, DOI 10.1097/00004714-200210000-00012; Roth T, 2005, SLEEP, V28, P303; Roth T, 2007, CURR MED RES OPIN, V23, P1005, DOI 10.1185/030079907X178874; Roth T, 2006, SLEEP MED, V7, P312, DOI 10.1016/j.sleep.2006.01.003; SHARPLEY AL, 1995, BIOL PSYCHIAT, V37, P85, DOI 10.1016/0006-3223(94)00135-P; SKOWRON DM, 1992, PHARMACOTHERAPY, V12, P18; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Terry PC, 1999, J SPORT SCI, V17, P861, DOI 10.1080/026404199365425; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-8; Uchimura N, 2011, EXPERT REV NEUROTHER, V11, P215, DOI [10.1586/ern.10.197, 10.1586/ERN.10.197]; Uchiyama M, 2011, SLEEP MED, V12, P127, DOI 10.1016/j.sleep.2010.10.006; Uchiyama M, 2011, SLEEP MED, V12, P119, DOI 10.1016/j.sleep.2010.08.010; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Zammit G, 2007, J CLIN SLEEP MED, V3, P495; Zammit G, 2009, SLEEP MED, V10, P55, DOI 10.1016/j.sleep.2008.04.010	42	19	19	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2015	96	10					1802	1809		10.1016/j.apmr.2015.05.011			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CT2GX	WOS:000362621100008	26026580				2022-02-06	
J	Yuan, RR; Wang, B; Lu, W; Maeda, Y; Dowling, P				Yuan, RuiRong; Wang, Bo; Lu, Wei; Maeda, Yasuhiro; Dowling, Peter			A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection	NEUROTHERAPEUTICS			English	Article						Multiple sclerosis; Experimental autoimmune encephalomyelitis; Immunomodulation; Erythropoietin; Peptide	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CD8(+) T-CELLS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; MYELIN PROTEOLIPID PROTEIN; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ENCEPHALITOGENIC DETERMINANT; CARBAMYLATED ERYTHROPOIETIN; IMMUNE-RESPONSES	Beneficial effects of short-term whole-molecule erythropoietin (EPO) therapy have been demonstrated on several animal models of diverse central nervous system pathology. However, the increased hematocrit induced by EPO-driven marrow stimulation greatly limits its potential for side effect-free therapy. We created a library of EPO-derived fragments based on the hypothesis that 2 distinct functions, erythropoiesis and tissue protection, reside in different regions of the molecule. Several small EPO-derived peptides within the A beta loop of whole EPO molecule were screened for tissue protection in EAE mice. The 19-mer JM-4 peptide that contains 2 cysteine molecules consistently demonstrated the most potent clinical beneficial effects without producing hematocrit alterations in animal models of EAE. The JM-4-induced tissue protection was associated with modulation of the immunoregulatory process that drives inflammation and provokes subsequent autoimmune damage. Like the whole EPO molecule, JM-4 effectively modulated immune/inflammatory reaction within both the peripheral lymphatic tissue and central nervous system. The major effects induced by JM-4 include blocked expansion of monocyte/dendritic antigen presenting cell and T helper 17 cell populations, decreased proinflammatory cytokine production, and sharply enhanced expansion of the regulatory T-cell population. JM-4 shows promise for treatment of a broad spectrum of neural and non-neural conditions associated with inflammation.	[Yuan, RuiRong; Wang, Bo; Lu, Wei; Maeda, Yasuhiro; Dowling, Peter] VA Med Ctr East Orange, Neurol Serv, E Orange, NJ 07018 USA; [Yuan, RuiRong; Wang, Bo; Maeda, Yasuhiro; Dowling, Peter] Rutgers New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA		Dowling, P (corresponding author), VA Med Ctr East Orange, Neurol Serv, E Orange, NJ 07018 USA.	dowlinpc@njms.rutgers.edu	Wang, Bo/ABC-5571-2020		Veterans Affairs Office of Research and Development [IO1 RX000220-01, RX001305-01A2]; Segal Fund; National Institutes of Health Bridging Interventional Development Gaps award [1 X01 NS0073526-01A1]; Veterans AffairsUS Department of Veterans Affairs [I01RX001305, I01RX000220] Funding Source: NIH RePORTER	This work was supported by grants from the Veterans Affairs Office of Research and Development (IO1 RX000220-01; PD and RX001305-01A2; PD), the Segal Fund, and a National Institutes of Health Bridging Interventional Development Gaps (formerly National Institutes of Health RAID) award (1 X01 NS0073526-01A1; PD). Full conflict of interest disclosure is available in the electronic supplementary material for this article.	Abdul-Majid KB, 2003, J NEUROIMMUNOL, V141, P10, DOI 10.1016/S0165-5728(03)00210-8; Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Ahmet I, 2011, MOL MED, V17, P194, DOI 10.2119/molmed.2010.00235; Battistini L, 2003, BLOOD, V101, P4775, DOI 10.1182/blood-2002-10-3309; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bohlius J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007303.pub2; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Buemi M, 2003, J NEUROPATH EXP NEUR, V62, P228, DOI 10.1093/jnen/62.3.228; Buemi M, 2002, CLIN SCI, V103, P275, DOI 10.1042/cs1030275; Campana WM, 1998, INT J MOL MED, V1, P235; Chen SJ, 2010, CLIN EXP IMMUNOL, V162, P210, DOI 10.1111/j.1365-2249.2010.04238.x; Chou YK, 2004, J NEUROSCI RES, V77, P670, DOI 10.1002/jnr.20201; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Crawford MP, 2004, BLOOD, V103, P4222, DOI 10.1182/blood-2003-11-4025; Dandekar AA, 2004, AM J PATHOL, V164, P363, DOI 10.1016/S0002-9440(10)63126-4; Davidson MG, 2013, J IMMUNOL, V191, P1175, DOI 10.4049/jimmunol.1203201; Dicato M, 2008, ONCOLOGIST, V13, P11, DOI 10.1634/theoncologist.13-S3-11; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Faunce DE, 2004, J IMMUNOL, V172, P1991, DOI 10.4049/jimmunol.172.4.1991; Fontoura P, 2005, INT REV IMMUNOL, V24, P415, DOI 10.1080/08830180500379655; Ford ML, 2005, EUR J IMMUNOL, V35, P76, DOI 10.1002/eji.200425660; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; GREER JM, 1992, J IMMUNOL, V149, P783; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Isaksson M, 2009, EUR J IMMUNOL, V39, P2925, DOI 10.1002/eji.200839179; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li WP, 2004, ANN NEUROL, V56, P767, DOI 10.1002/ana.20274; Linker RA, 2005, NEUROBIOL DIS, V19, P218, DOI 10.1016/j.nbd.2004.12.017; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Montero E, 2004, J AUTOIMMUN, V23, P1, DOI 10.1016/j.jaut.2004.05.001; Mun KC, 2000, BLOOD PURIFICAT, V18, P13, DOI 10.1159/000014403; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Savino C, 2006, J NEUROIMMUNOL, V172, P27, DOI 10.1016/j.jneuroim.2005.10.016; Shanmugam G, 2004, BIOPHYS J, V87, P622, DOI 10.1529/biophysj.104.040907; Siren AL, 2001, EUR ARCH PSY CLIN N, V251, P179, DOI 10.1007/s004060170038; SOBEL RA, 1986, J IMMUNOL, V136, P157; Sun DM, 2003, INT IMMUNOL, V15, P261, DOI 10.1093/intimm/dxg023; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Trajkovic V, 2004, GLIA, V47, P168, DOI 10.1002/glia.20046; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; TUOHY VK, 1989, J IMMUNOL, V142, P1523; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; WEN DY, 1994, J BIOL CHEM, V269, P22839; Xiong Y, 2009, NEUROL RES, V31, P496, DOI 10.1179/174313208X353703; YOSHIMURA T, 1985, J NEUROL SCI, V69, P47, DOI 10.1016/0022-510X(85)90006-1; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Yuan RR, 2008, PLOS ONE, P3; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036	53	19	20	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	OCT	2015	12	4					850	861		10.1007/s13311-015-0379-1			12	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CT6XG	WOS:000362955800016	26271954	Bronze, Green Published			2022-02-06	
J	Hernandez, F; Shull, PB; Camarillo, DB				Hernandez, Fidel; Shull, Peter B.; Camarillo, David B.			Evaluation of a laboratory model of human head impact biomechanics	JOURNAL OF BIOMECHANICS			English	Article						Mild traumatic brain injury (mTBI); Six degree of freedom (6DOF) kinematics; Twin-wire drop testing; Head impact model; Rotational acceleration and velocity	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; HIGH-SCHOOL; CEREBRAL CONCUSSION; FOOTBALL PLAYERS; ACCELERATION; PERFORMANCE; KINEMATICS; FORM	This work describes methodology for evaluating laboratory models of head impact biomechanics. Using this methodology, we investigated: how closely does twin-wire drop testing model head rotation in American football impacts? Head rotation is believed to cause mild traumatic brain injury (mTBI) but helmet safety standards only model head translations believed to cause severe TBI. It is unknown whether laboratory head impact models in safety standards, like twin-wire drop testing, reproduce six degree-of-freedom (6DOF) head impact biomechanics that may cause mTBI. We compared 6DOF measurements of 421 American football head impacts to twin-wire drop tests at impact sites and velocities weighted to represent typical field exposure. The highest rotational velocities produced by drop testing were the 74th percentile of non-injury field impacts. For a given translational acceleration level, drop testing underestimated field rotational acceleration by 46% and rotational velocity by 72%. Primary rotational acceleration frequencies were much larger in drop tests (similar to 100 Hz) than field impacts (similar to 10 Hz). Drop testing was physically unable to produce acceleration directions common in field impacts. Initial conditions of a single field impact were highly resolved in stereo high-speed video and reconstructed in a drop test. Reconstruction results reflected aggregate trends of lower amplitude rotational velocity and higher frequency rotational acceleration in drop testing, apparently due to twin-wire constraints and the absence of a neck. These results suggest twin-wire drop testing is limited in modeling head rotation during impact, and motivate continued evaluation of head impact models to ensure helmets are tested under conditions that may cause mTBI. (C) 2015 Elsevier Ltd. All rights reserved.	[Hernandez, Fidel; Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Shull, Peter B.; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Shull, Peter B.] Shanghai Jiao Tong Univ, Sch Mech Engn, State Key Lab Mech Syst & Vibrat, Shanghai 200240, Peoples R China		Camarillo, DB (corresponding author), Stanford Univ, Dept Bioengn, 443 Via Ortega,Room 205, Stanford, CA 94305 USA.	dcamarillo@stanford.edu		Hernandez, Fidel/0000-0002-6078-0518	National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [3R21EB01761101S1]; David and Lucile Packard FoundationThe David & Lucile Packard Foundation [38454]; NIH Clinical and Translational Science AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1UL1 RR025744]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB017611] Funding Source: NIH RePORTER	We thank the Stanford Department of Athletics (Palo Alto, CA) for enabling this research, notably Scott Anderson, Director of Athletic Training, and Mike Gleeson, Video Director. We thank Rebecca Shultz and James Mattson for collecting high speed video data. We thank X2 Biosystems (Seattle, WA) for sharing mouthguard architecture and the twin-wire system. The study was supported by the National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB) 3R21EB01761101S1, David and Lucile Packard Foundation 38454, and by the NIH Clinical and Translational Science Award 1UL1 RR025744 for the Stanford Center for Clinical and Translational Education and Research (Spectrum).	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bartsch A., 2013, P SPIE SENS TECHNOL, V8723, P1; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Beusenberg MC., 2000, P INT RES C BIOM IMP; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cantu R, 2012, J NEUROSURG, V117, P187, DOI 10.3171/2011.12.JNS112108; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Duma SM, 2009, IEEE ENG MED BIO, P1123, DOI 10.1109/IEMBS.2009.5333423; Forbes JA, 2013, PEDIATR NEUROSURG, V49, P43, DOI 10.1159/000355121; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Heikkila J, 1997, PROC CVPR IEEE, P1106, DOI 10.1109/CVPR.1997.609468; Hernandez E, 2013, P 2013 ASME SUMM BIO, P1; Hernandez F., 2014, ANN BIOMED ENG, V43, P1; Holbourn AHS, 1943, LANCET, V2, P438; HORN BKP, 1988, J OPT SOC AM A, V5, P1127, DOI 10.1364/JOSAA.5.001127; Ji S., 2014, ANN BIOMED ENG, P1; Johnson JR, 2014, SPACE SCI REV, V184, P1, DOI 10.1007/s11214-014-0085-z; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; King AI, 2012, ANN BIOMED ENG, V40, P2510, DOI 10.1007/s10439-012-0659-4; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; National Committee on Standards for Athletic Equipment, 2006, 08104M04 NOCSAE DOC, P1; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2012, ND00111M12 NOCSAE, P1; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; Newman J A, 2000, Stapp Car Crash J, V44, P215; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson B., 2015, ANN BIOMED IN PRESS, P1; Rowson S, 2013, J NEUROSURG, V119, P805, DOI 10.3171/2013.3.JNS121735; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P2512, DOI 10.1007/s10439-012-0660-y; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhengyou Zhang, 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P666, DOI 10.1109/ICCV.1999.791289	56	19	20	0	15	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	SEP 18	2015	48	12					3469	3477		10.1016/j.jbiomech.2015.05.034			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CT8ME	WOS:000363069900073	26117075	Green Accepted			2022-02-06	
J	Ilie, G; Boak, A; Mann, RE; Adlaf, EM; Hamilton, H; Asbridge, M; Rehm, J; Cusimano, MD				Ilie, Gabriela; Boak, Angela; Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Asbridge, Mark; Rehm, Juergen; Cusimano, Michael D.			Energy Drinks, Alcohol, Sports and Traumatic Brain Injuries among Adolescents	PLOS ONE			English	Article							EXECUTIVE FUNCTION; UNITED-STATES; CONSUMPTION; RISK; CONSEQUENCES; PATTERNS; BEHAVIOR	Importance The high prevalence of traumatic brain injuries (TBI) among adolescents has brought much focus to this area in recent years. Sports injuries have been identified as a main mechanism. Although energy drinks, including those mixed with alcohol, are often used by young athletes and other adolescents they have not been examined in relation to TBI. Objective We report on the prevalence of adolescent TBI and its associations with energy drinks, alcohol and energy drink mixed in with alcohol consumption. Design, Settings and Participants Data were derived from the Centre for Addiction and Mental Health's 2013 Ontario Student Drug Use and Health Survey (OSDUHS). This population-based cross-sectional school survey included 10,272 7th to 12th graders (ages 11-20) who completed anonymous selfadministered questionnaires in classrooms. Main Outcome Measures Mild to severe TBI were defined as those resulting in a loss of consciousness for at least five minutes, or being hospitalized for at least one night. Mechanism of TBI, prevalence estimates of TBI, and odds of energy drink consumption, alcohol use, and consumption of energy drinks mixed with alcohol are assessed. Results Among all students, 22.4%(95% CI: 20.7, 24.1) reported a history of TBI. Sports injuries remain the main mechanism of a recent (past year) TBI (45.5%, 95% CI: 41.0, 50.1). Multinomial logistic regression showed that relative to adolescents who never sustained a TBI, the odds of sustaining a recent TBI were greater for those consuming alcohol, energy drinks, and energy drinks mixed in with alcohol than abstainers. Odds ratios were higher for these behaviors among students who sustained a recent TBI than those who sustained a former TBI (lifetime but not past 12 months). Relative to recent TBI due to other causes of injury, adolescents who sustained a recent TBI while playing sports had higher odds of recent energy drinks consumption than abstainers. Conclusions and Relevance TBI remains a disabling and common condition among adolescents and the consumption of alcohol, energy drinks, and alcohol mixed with energy drinks further increase the odds of TBI among adolescents. These associations warrant further investigation.	[Ilie, Gabriela] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Boak, Angela; Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen] Ctr Addict & Mental Hlth, Social & Epidemiol Res, Toronto, ON, Canada; [Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Halifax, NS, Canada; [Cusimano, Michael D.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada		Ilie, G (corresponding author), St Michaels Hosp, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Meijer, Anna/K-5118-2016; Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR103946]; Ontario Neurotrauma Foundation [AUTO21]; Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Social Sciences and Humanities Research Council (SSHRC)Social Sciences and Humanities Research Council of Canada (SSHRC); Industry Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario	This work was financially supported by a Team Grant (TIR103946) from Canadian Institutes of Health Research and by funds from the Ontario Neurotrauma Foundation, AUTO21, a member of the Networks of Centres of Excellence (NCE) program that is administered and funded by the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), and the Social Sciences and Humanities Research Council (SSHRC), in partnership with Industry Canada. Drs. RM, HH and JR also acknowledge ongoing funding support from the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Active Healthy Kids Canada, 2014, IS CAN RUNN 2014 ACT; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x; Azagba Sunday, 2013, CMAJ Open, V1, pE19, DOI 10.9778/cmajo.20120017; Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003; Cherpitel CJ, 2007, DRUG ALCOHOL REV, V26, P201, DOI 10.1080/09595230601146686; Cook LG, 2013, J INT NEUROPSYCH SOC, V19, P508, DOI 10.1017/S1355617712001452; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Dicker BG, 1989, HEAD TRAUMA REHABIL, V4, P73; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Faul M, 2010, TRAUMATIC BRAIN INJU; Frances A, DSM 4 CLASSIFICATION; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamilton HA, 2013, CAN J PUBLIC HEALTH, V104, pE496, DOI 10.17269/cjph.104.3998; Heeringa S., 2010, APPL SURVEY DATA ANA; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kenny DT, 2007, CONT ISSUES CRIME JU, V107, P1; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; MacDonald N, 2010, CAN MED ASSOC J, V182, P1597, DOI 10.1503/cmaj.100953; Meier B, 2012, NY TIMES; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller KE, 2008, J AM COLL HEALTH, V56, P481, DOI 10.3200/JACH.56.5.481-490; National Center for Injury Prevention & Control, REP C MILD TRAUM BRA; Paglia-Boak A, 2013, CAMH RES DOCUMENT SE, V36; Peacock A, 2013, ALCOHOL CLIN EXP RES, V37, P1234, DOI 10.1111/acer.12086; Pharo H, 2011, BEHAV NEUROSCI, V125, P970, DOI 10.1037/a0025768; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Terry-McElrath YM, 2014, J ADDICT MED, V8, P6, DOI 10.1097/01.ADM.0000435322.07020.53; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Wolk BJ, 2012, CURR OPIN PEDIATR, V24, P243, DOI 10.1097/MOP.0b013e3283506827; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112	40	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2015	10	9							e0135860	10.1371/journal.pone.0135860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR8NH	WOS:000361610200009	26375286	Green Submitted, Green Published, gold			2022-02-06	
J	Drijkoningen, D; Caeyenberghs, K; Vander Linden, C; Van Herpe, K; Duysens, J; Swinnen, SP				Drijkoningen, David; Caeyenberghs, Karen; Vander Linden, Catharine; Van Herpe, Katrin; Duysens, Jacques; Swinnen, Stephan P.			Associations between Muscle Strength Asymmetry and Impairments in Gait and Posture in Young Brain-Injured Patients	JOURNAL OF NEUROTRAUMA			English	Article						balance control; traumatc brain injury; muscle strength; posture; gait	HAND-HELD DYNAMOMETRY; MILD HEAD-INJURY; BALANCE PERFORMANCE; HEMIPLEGIC GAIT; CEREBRAL-PALSY; CHILDREN; WALKING; STROKE; IMPROVEMENTS; VARIABILITY	Traumatic brain injury (TBI) can lead to deficits in gait and posture, which are often asymmetric. A possible factor mediating these deficits may be asymmetry in strength of the leg muscles. However, muscle strength in the lower extremities has rarely been investigated in (young) TBI patients. Here, we investigated associations between lower-extremity muscle weakness, strength asymmetry, and impairments in gait and posture in young TBI patients. A group of young patients with moderate-to-severe TBI (n=19; age, 14 years 11 months +/- 2 years) and a group of typically developing subjects (n=31; age, 14 years 1 month +/- 3 years) participated in this study. A force platform was used to measure postural sway to quantify balance control during normal standing and during conditions of compromised visual and/or somatosensory feedback. Spatiotemporal gait parameters were assessed during comfortable and fast-speed walking, using an electronic walkway. Muscle strength in four lower-extremity muscle groups was measured bilaterally using a handheld dynamometer. Findings revealed that TBI patients had poorer postural balance scores across all sensory conditions, as compared to typically developing subjects. During comfortable and fast gait, TBI patients demonstrated a lower gait velocity, longer double-support phase, and increased step-length asymmetry. Further, TBI patients had a reduced strength of leg muscles and an increased strength asymmetry. Correlation analyses revealed that asymmetry in muscle strength was predictive of a poorer balance control and a more variable and asymmetric gait. To the best of our knowledge, this is the first study to measure strength asymmetry in leg muscles of a sample of TBI patients and illustrate the importance of muscular asymmetry as a potential marker and possible risk factor of impairments in control of posture and gait.	[Drijkoningen, David; Duysens, Jacques; Swinnen, Stephan P.] Katholieke Univ Leuven, Grp Biomed Sci, Movement Control & Neuroplast Res Grp, Leuven, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Melbourne, Vic, Australia; [Caeyenberghs, Karen] Ghent Univ Hosp, Dept Phys Med & Rehabil, Child Rehabil Ctr, Ghent, Belgium; [Vander Linden, Catharine] Pulderbos Rehabil Ctr, Zandhoven, Belgium; [Van Herpe, Katrin] Leuven Res Inst Neurosci & Dis LIND, Leuven, Belgium		Swinnen, SP (corresponding author), Movement Control & Neuroplast Res Grp, Tervuursevest 101, B-3001 Louvain, Belgium.	stephan.swinnen@faber.kuleuven.be		Duysens, Jacques/0000-0002-0043-8817; Caeyenberghs, Karen/0000-0001-7009-6843	Research Foundation-Flanders (FWO)FWO [Levenslijn G.0482.10, G.A114.11, G.0721.12]; KU LeuvenKU Leuven [OT/11/071]; Belgian federal government [P7/11]	This work was supported by a grant from the Research Program of the Research Foundation-Flanders (FWO; Levenslijn G.0482.10 and G.A114.11 and G.0721.12). Additional support was provided by the Research Fund KU Leuven (OT/11/071) and the Interuniversity Attraction Poles program of the Belgian federal government [P7/11]. These funding sources had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Barbieri FA, 2014, GAIT POSTURE, V39, P985, DOI 10.1016/j.gaitpost.2013.12.021; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BRANDSTATER ME, 1983, ARCH PHYS MED REHAB, V64, P583; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Crompton J, 2007, DEV MED CHILD NEUROL, V49, P106, DOI 10.1111/j.1469-8749.2007.00106.x; Daubney ME, 1999, PHYS THER, V79, P1177, DOI 10.1093/ptj/79.12.1177; de Oliveira CB, 2008, J REHABIL RES DEV, V45, P1215, DOI 10.1682/JRRD.2007.09.0150; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Flansbjer UB, 2006, ARCH PHYS MED REHAB, V87, P974, DOI 10.1016/j.apmr.2006.03.008; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Granacher U, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-56; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; Katz-Leurer Michal, 2008, Pediatr Phys Ther, V20, P259, DOI 10.1097/PEP.0b013e3181824782; Katz-Leurer M, 2009, CLIN REHABIL, V23, P714, DOI 10.1177/0269215509335293; Katz-Leurer M, 2009, GAIT POSTURE, V29, P154, DOI 10.1016/j.gaitpost.2008.06.013; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lomaglio MJ, 2005, GAIT POSTURE, V22, P126, DOI 10.1016/j.gaitpost.2004.08.002; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; NAKAMURA R, 1985, TOHOKU J EXP MED, V145, P335, DOI 10.1620/tjem.145.335; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Patterson KK, 2008, ARCH PHYS MED REHAB, V89, P304, DOI 10.1016/j.apmr.2007.08.142; Pollock CL, 2011, CLIN REHABIL, V25, P693, DOI 10.1177/0269215510397394; RIDDLE DL, 1989, PHYS THER, V69, P182, DOI 10.1093/ptj/69.3.182; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roth EJ, 1997, AM J PHYS MED REHAB, V76, P128, DOI 10.1097/00002060-199703000-00008; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Toebes MJP, 2014, GAIT POSTURE, V40, P215, DOI 10.1016/j.gaitpost.2014.03.194; Tyson SF, 2006, PHYS THER, V86, P30, DOI 10.1093/ptj/86.1.30; Van Impe A, 2012, NEUROBIOL AGING, V33, P1900, DOI 10.1016/j.neurobiolaging.2011.06.013; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; Vasudevan EVL, 2014, J NEUROL PHYS THER, V38, P172, DOI 10.1097/NPT.0000000000000049; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3	47	19	19	0	28	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2015	32	17					1324	1332		10.1089/neu.2014.3787			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CP0KP	WOS:000359564500006	25738975				2022-02-06	
J	Elbogen, EB; Wolfe, JR; Cueva, M; Sullivan, C; Johnson, J				Elbogen, Eric B.; Wolfe, James R.; Cueva, Michelle; Sullivan, Connor; Johnson, Jacqueline			Longitudinal Predictors of Criminal Arrest After Traumatic Brain Injury: Results From the Traumatic Brain Injury Model System National Database	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol abuse; criminal behavior; drug abuse; motor function; traumatic brain injury	SUBSTANCE-ABUSE; HEAD-INJURY; AGGRESSION; POPULATION; PREVALENCE; BEHAVIOR; CRIME	Objective: To examine how pre-traumatic brain injury (TBI) variables and TBI-related characteristics predict post-TBI criminal arrest, using longitudinal data from the Traumatic Brain Injury Model System National Database. Settings: Medical hospitals; rehabilitation facilities. Participants: Participants with documented TBI and nonmissing Traumatic Brain Injury Model System data, resulting in N = 6315 at 1 year post-TBI, N = 4982 at 2 years post-TBI, and N = 2690 at 5 years post-TBI. Design: Prospective cohort study with secondary data analysis of the relationship between pre-TBI/TBI factors and post-TBI criminal arrest as measured at 3 time points. Main Measures: Self-report of post-TBI criminal arrest. Results: Post-TBI criminal arrest was associated with gender, age, marital status, educational attainment, pre-TBI felony, pre-TBI drug abuse, pre-TBI alcohol abuse, and violent cause of TBI. Frontal, temporal, parietal, or occipital lobe lesions from computed tomographic scans did not predict post-TBI criminal arrests. Higher numbers of post-TBI arrests were predicted by loss of consciousness (>= 24 hours), combined with retention of motor function. Conclusion: Premorbid variables, especially pre-TBI felonies, were strongly linked to post-TBI criminal arrests. The relationship between TBI and arrest was complex, and different brain functions (eg, physical mobility) should be considered when understanding this association. Findings highlight that for post-TBI criminal behavior, many risk factors mirror those of the non-TBI general population.	[Elbogen, Eric B.; Wolfe, James R.; Cueva, Michelle; Sullivan, Connor; Johnson, Jacqueline] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA; [Elbogen, Eric B.] Durham VA Med Ctr, Mid Atlantic Mental Illness Res Educ & Clin Ctr M, Durham, NC USA		Elbogen, EB (corresponding author), Univ N Carolina, Sch Med, Dept Psychiat, Forens Psychiat Program & Clin, Chapel Hill, NC 27599 USA.	eric.elbogen@unc.edu			U.S. Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR)US Department of Education; TBI Model Systems Centers; Department of DefenseUnited States Department of Defense [W81XWH1110796]	The TBI Model Systems National Database is supported by the U.S. Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR) in collaboration with the TBI Model Systems Centers. However, these contents do not necessarily reflect the opinions or views of the TBI Model Systems Centers, NIDRR or the U.S. Department of Education. Preparation of the manuscript was supported by funding from the Department of Defense (W81XWH1110796). The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Defense.	Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Colantonio A, 2007, BRAIN INJURY, V21, P1353, DOI 10.1080/02699050701785054; Corrigan J.D., 2003, TECHNICAL REPORT PRO; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; FARRINGTON DP, 1973, J CRIM LAW CRIM, V64, P99, DOI 10.2307/1142661; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Filley CM, 2001, NEUROPSY NEUROPSY BE, V14, P1; HOLM S, 1979, SCAND J STAT, V6, P65; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kolakowsky-Hayner SA, 2001, BRAIN INJURY, V15, P53, DOI 10.1080/02699050150209138; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Luiselli JK, 2000, INT J OFFENDER THER, V44, P647, DOI 10.1177/0306624X00446002; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Miller E, 1999, J FORENSIC PSYCHIATR, V10, P157, DOI 10.1080/09585189908402146; Miller E, 1999, PSYCHOL CRIME LAW, V5, P297, DOI 10.1080/10683169908401774; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Nieves K., 2000, J OFFENDER REHABIL, V30, P133, DOI DOI 10.1300/J076V30N03_07; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Schiltz K., 2011, MINERVA PSICHIAT, V52, P187; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; VIRKKUNEN M, 1977, DIS NERV SYST, V38, P907; Volavka J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001148; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274	34	19	19	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2015	30	5					E3	E13		10.1097/HTR.0000000000000083			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JE	WOS:000369605400002	25310290				2022-02-06	
J	Li, J; Yu, C; Sun, Y; Li, YY				Li, Jian; Yu, Chao; Sun, Yang; Li, Yuyuan			Serum ubiquitin C-terminal hydrolase L1 as a biomarker for traumatic brain injury: a systematic review and meta-analysis	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							ALPHA-II-SPECTRIN; DIAGNOSIS; PROTEIN; PROGNOSIS; MODERATE; UTILITY; PLASMA; IMPACT; MILD	Objective: Serum ubiquitin C-terminal hydrolase L1 (UCH-L1) has been proposed as a biomarker of traumatic brain injury (TBI). However, previous studies on levels of UCH-L1 in serum remain inconsistent. This systematic review andmeta-analysis were conducted on observational studies that reported the association between serum UCH-L1 levels and TBI. Methods: Studies were identified by searching PubMed and ISI Web of Science up to February 2015. For the continuous outcomes, we calculated the weighted mean difference and 95% confidence interval. The statistical analysis was performed by RevMan 5.1 and Stata 12 software. Only case-control studies were included if they had data on serum UCH-L1 levels in TBI patients and healthy controls. Funnel plot and Egger's regression test were applied to assess the potential publication bias. Results: Of the 145 selected studies, 11 observational studies (including 9 case-control and 2 case-crossover studies) met the selection criteria, containing a total of 1138 TBI cases and 1373 controls. Finally, 5 case-control studies (including 673 TBI and 1004 controls) were eligible for the present meta-analysis. The results of our study showed that there was a significant increase in serum UCH-L1 levels in patients with TBI compared to controls (weighted mean difference, 0.96; 95% confidence interval, 0.31-1.61; P = .004). Conclusion: In conclusion, TBI cases had higher serum UCH-L1 concentrations than matched controls. This reinforces the conceptualization of UCH-L1 as a potential biomarker of TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Li, Jian] Dalian Univ, Xinhua Hosp, Dept Orthopaed, Dalian 116021, Peoples R China; [Yu, Chao] Dalian Univ, Coll Life Sci & Technol, Dalian 116622, Peoples R China; [Sun, Yang; Li, Yuyuan] Dalian Med Univ, Inst Brain Disorders, Liaoning Prov Key Lab Cerebral Dis, Dalian 116044, Peoples R China		Li, YY (corresponding author), Dalian Med Univ, Inst Brain Disorders, Liaoning Prov Key Lab Brain Dis, Dalian 116044, Peoples R China.	liyuyuan831221@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61302030]; Educational Commission of Liaoning Province of China [L2012320]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA141479] Funding Source: NIH RePORTER	This work was supported by the National Natural Science Foundation of China (no. 61302030) and the Educational Commission of Liaoning Province of China (no. L2012320).	Aleksovska K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106342; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Pang L, 2014, CLIN BIOCHEM, V47, P72, DOI 10.1016/j.clinbiochem.2013.09.015; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Plog BA, 2015, EXPERT REV NEUROTHER, V30, P1; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Ren CH, 2013, BRAIN RES, V1540, P84, DOI 10.1016/j.brainres.2013.09.051; Roger VL, 1997, CIRCULATION, V95, P405; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2015, MOL CELL NEUROSCI, V66, P99, DOI 10.1016/j.mcn.2015.02.003	33	19	20	3	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	SEP	2015	33	9					1191	1196		10.1016/j.ajem.2015.05.023			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CQ9GG	WOS:000360920700015	26087705				2022-02-06	
J	Raj, SP; Antonini, TN; Oberjohn, KS; Cassedy, A; Makoroff, KL; Wade, SL				Raj, Stacey P.; Antonini, Tanya N.; Oberjohn, Karen S.; Cassedy, Amy; Makoroff, Kathi L.; Wade, Shari L.			Web-Based Parenting Skills Program for Pediatric Traumatic Brain Injury Reduces Psychological Distress Among Lower-Income Parents	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						closed head injury; parent-child relations; pediatrics; psychological well-being; socioeconomic factors; treatment outcomes	CHILD INTERACTION THERAPY; FAMILY OUTCOMES; INITIAL YEAR; BURDEN; INTERVENTIONS; ADAPTATION; PREDICTORS; EFFICACY	Objective: To examine changes in parent depression, psychological distress, parenting stress, and self-efficacy among participants in a randomized trial of a Web-based parent training program for pediatric traumatic brain injury (TBI). Methods: Primary caregivers of 37 children aged 3 to 9 years who sustained a moderate/complicated mild to severe TBI were randomly assigned to the intervention or control group, and both groups were equipped with home Internet access. The online parent training program was designed to increase positive parenting skills and improve caregiver stress management. It consisted of 10 core sessions and up to 4 supplemental sessions. Each session included self-guided Web content, followed by a videoconference call with a therapist to discuss content and practice parenting skills with live feedback. Families in the control group received links to TBI Web resources. Results: Parent income moderated treatment effects on parent functioning. Specifically, lower-income parents in the parenting skills group reported significant reductions in psychological distress compared with lower-income parents in the control group. No differences were found among higher-income parents for depression, parenting stress, or caregiver efficacy. Conclusions: Parent training interventions post-TBI may be particularly valuable for lower-income parents who are vulnerable to both environmental and injury-related stresses.	[Raj, Stacey P.; Antonini, Tanya N.; Oberjohn, Karen S.; Cassedy, Amy; Makoroff, Kathi L.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA; [Raj, Stacey P.] Miami Univ, Dept Psychol, Oxford, OH 45056 USA; [Antonini, Tanya N.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org			National Institute on Disability and Rehabilitation Research, Department of Education [H133G060167, H133B090010]	This work was supported by the National Institute on Disability and Rehabilitation Research, Department of Education (grant nos. H133G060167 and H133B090010 to S.L.W.).	Abidin, 1995, PARENTING STRESS IND; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Bothroyd R, 1997, PRELIMINARY MANUAL C; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Derogatis L. R., 1994, USE PSYCHOL TESTING, P217; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Eyberg S., 1988, CHILD FAMILY BEHAV T, V10, P33, DOI [10.1300/J019v10n01_04, DOI 10.1300/J019V10N01_04]; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Lyons AM, 2010, J CHILD FAM STUD, V19, P516, DOI 10.1007/s10826-009-9323-5; New Freedom Commission on Mental Health, 2004, NEW FREED COMM MENT; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ritterband LM, 2003, PROF PSYCHOL-RES PR, V34, P527, DOI 10.1037/0735-7028.34.5.527; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2005, REHABIL PSYCHOL, V50, P337, DOI 10.1037/0090-5550.50.4.337; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Webster-Stratton C, 2008, J CHILD PSYCHOL PSYC, V49, P471, DOI 10.1111/j.1469-7610.2007.01861.x; Werba BE, 2006, BEHAV MODIF, V30, P618, DOI 10.1177/0145445504272977; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	28	19	19	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2015	30	5					347	356		10.1097/HTR.0000000000000052			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JE	WOS:000369605400012	24842588				2022-02-06	
J	Sirianni, AC; Jiang, JY; Zeng, J; Mao, LL; Zhou, SH; Sugarbaker, P; Zhang, XM; Li, W; Friedlander, RM; Wang, X				Sirianni, Ana C.; Jiang, Jiying; Zeng, Jiang; Mao, Lilly L.; Zhou, Shuanhu; Sugarbaker, Peter; Zhang, Xinmu; Li, Wei; Friedlander, Robert M.; Wang, Xin			N-acetyl-l-tryptophan, but not N-acetyl-d-tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis	JOURNAL OF NEUROCHEMISTRY			English	Article						amyotrophic lateral sclerosis; mitochondrial death pathway; N-acetyl-l-tryptophan; neuroprotection; structure-bioactivity relationship; substance P	TRAUMATIC BRAIN-INJURY; TRANSGENIC MOUSE MODEL; CYTOCHROME-C RELEASE; SUBSTANCE-P IMMUNOREACTIVITY; DELAYS DISEASE ONSET; SPINAL-CORD-INJURY; NEURODEGENERATIVE DISEASES; RECEPTOR ANTAGONISTS; NK1 RECEPTOR; IN-VITRO	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive motor neuron loss. Evidence suggests that mitochondrial dysfunction, apoptosis, oxidative stress, inflammation, glutamate excitotoxicity, and proteasomal dysfunction are all responsible for ALS pathogenesis. N-acetyl-tryptophan has been identified as an inhibitor of mitochondrial cytochrome c release and therefore is a potential neuroprotective agent. By quantifying cell death, we demonstrate that N-acetyl-l-tryptophan (L-NAT) and N-acetyl-DL-tryptophan are neuroprotective in NSC-34 motor neuron-like cells and/or primary motor neurons, while their isomer N-acetyl-d-tryptophan has no protective effect. These findings are consistent with energy minimization and molecular modeling analysis, confirming that L-NAT generates the most stable complex with the neurokinin-1 receptor (NK-1R). L-NAT inhibits the secretion of Substance P and IL-1 (Enzyme-Linked Immunosorbent Assay and/or dot blots) and mitochondrial dysfunction by effectively inhibiting the release of cytochrome c/Smac/AIF from mitochondria into the cytoplasm and activation of apoptotic pathways, including the activation of caspase-1, -9, and -3, as well as proteasomal dysfunction through restoring chymotrypsin-like, trypsin-like, and caspase-like proteasome activity. These data provide insight into the molecular mechanisms by which L-NAT offers neuroprotection in models of ALS and suggest its potential as a novel therapeutic strategy for ALS.	[Sirianni, Ana C.; Jiang, Jiying; Sugarbaker, Peter; Zhang, Xinmu; Li, Wei; Wang, Xin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; [Jiang, Jiying] Weifang Med Univ, Dept Anat, Weifang, Shandong, Peoples R China; [Zeng, Jiang] Nantong Univ, Inst Analyt Chem Life Sci, Sch Publ Hlth, Nantong, Jiangsu, Peoples R China; [Mao, Lilly L.] Aimcan Pharma Res & Technol, Guelph, ON, Canada; [Zhou, Shuanhu] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA; [Friedlander, Robert M.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA		Wang, X (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, 221 Longwood Ave, Boston, MA 02115 USA.	friedlanderr@upmc.edu; xwang@rics.bwh.harvard.edu	Zhou, Shuanhu/Q-7137-2019; Friedlander, Robert M/A-2845-2016; Zhou, Shuanhu/AAW-4405-2021; Zhang, Xinmu/G-8128-2018	Friedlander, Robert M/0000-0003-4423-9219; Zhou, Shuanhu/0000-0003-4745-5347	Muscular Dystrophy AssociationMuscular Dystrophy Association; ALS Therapy Alliance; Bill & Melinda Gates FoundationBill & Melinda Gates Foundation; National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	We thank Dr Gerhard Klebe (Philipps-University Marburg, Germany) for providing the 3D model of NK-1R. We thank Drs. Lei Lv and Akiko Maekawa for experimental discussion. This work was supported by grants from the Muscular Dystrophy Association (to X. W.), the ALS Therapy Alliance (to X. W.), Bill & Melinda Gates Foundation (To X. W.), and the National Institutes of Health/National Institute of Neurological Disorders and Stroke (X. W., R.M.F.).	Bang R, 2004, J PHARMACOL EXP THER, V308, P1174, DOI 10.1124/jpet.103.059329; Bishop A, 1999, FREE RADICAL BIO MED, V26, P978, DOI 10.1016/S0891-5849(98)00284-6; Caioli S, 2011, NEUROBIOL DIS, V44, P92, DOI 10.1016/j.nbd.2011.06.008; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Castro-Obregon S, 2004, J BIOL CHEM, V279, P17543, DOI 10.1074/jbc.M312363200; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chi L, 2007, NEUROSCIENCE, V144, P991, DOI 10.1016/j.neuroscience.2006.09.064; Czeh B, 2006, EXPERT OPIN INV DRUG, V15, P479, DOI 10.1517/13543784.15.5.479; Del Signore SJ, 2009, AMYOTROPH LATERAL SC, V10, P85, DOI 10.1080/17482960802226148; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Duan QH, 2006, J PINEAL RES, V41, P351, DOI 10.1111/j.1600-079X.2006.00374.x; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; FUJITA Y, 1980, J NUTR SCI VITAMINOL, V26, P381, DOI 10.3177/jnsv.26.381; Gao YQ, 2010, STROKE, V41, P166, DOI 10.1161/STROKEAHA.109.561852; Goswami A, 2006, BIOCHEM BIOPH RES CO, V342, P184, DOI 10.1016/j.bbrc.2006.01.136; Guegan C, 2002, MOL CELL NEUROSCI, V20, P553, DOI 10.1006/mcne.2002.1136; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Herpter I, 2003, WORLD J BIOL PSYCHIA, V4, P56, DOI 10.3109/15622970309167952; Jordan J, 2003, J PHYSIOL BIOCHEM, V59, P129, DOI 10.1007/BF03179878; Kabashi E, 2008, J NEUROCHEM, V105, P2353, DOI 10.1111/j.1471-4159.2008.05317.x; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kang MH, 2009, WOUND REPAIR REGEN, V17, P216, DOI 10.1111/j.1524-475X.2009.00456.x; Kenkyu I., 1980, STUDY MED S, V11, P635; KOWALL NW, 1993, REGUL PEPTIDES, V46, P174, DOI 10.1016/0167-0115(93)90028-7; Leonard AV, 2013, J NEUROTRAUM, V30, P1812, DOI 10.1089/neu.2013.2993; Leonard Anna V, 2013, Acta Neurochir Suppl, V118, P303, DOI 10.1007/978-3-7091-1434-6_59; Li L, 2007, BRAIN RES, V1159, P8, DOI 10.1016/j.brainres.2007.04.066; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Li W, 2015, NEUROBIOL DIS, V80, P93, DOI 10.1016/j.nbd.2015.05.002; Liu RG, 2002, J NEUROCHEM, V80, P488, DOI 10.1046/j.0022-3042.2001.00720.x; Lv L, 2012, EXP NEUROL, V233, P783, DOI 10.1016/j.expneurol.2011.11.042; Ma J, 2010, AM J PHYSIOL-GASTR L, V299, pG791, DOI 10.1152/ajpgi.00160.2010; Macdonald R L, 1981, Adv Biochem Psychopharmacol, V28, P159; Mantyh PW, 2002, J CLIN PSYCHIAT, V63, P6; Matsuishi T, 1999, J NEURAL TRANSM, V106, P943, DOI 10.1007/s007020050214; Monk PN, 2006, NAT MED, V12, P885, DOI 10.1038/nm0806-885; Pandya Rachna S., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P15; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Peters EMJ, 2005, BRAIN BEHAV IMMUN, V19, P252, DOI 10.1016/j.bbi.2004.08.005; Pieri M, 2010, NEUROPHARMACOLOGY, V58, P268, DOI 10.1016/j.neuropharm.2009.06.029; Pinter E, 2002, NEUROSCI LETT, V318, P13, DOI 10.1016/S0304-3940(01)02468-5; Puttaparthi K, 2007, EXP NEUROL, V206, P53, DOI 10.1016/j.expneurol.2007.03.024; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Saria A, 1999, EUR J PHARMACOL, V375, P51, DOI 10.1016/S0014-2999(99)00259-9; SHARMA HS, 1990, NEUROSCIENCE, V38, P205, DOI 10.1016/0306-4522(90)90386-I; Skorupa A, 2012, J NEUROSCI, V32, P5024, DOI 10.1523/JNEUROSCI.6366-11.2012; Sterner-Kock A, 1999, J LEUKOCYTE BIOL, V65, P834, DOI 10.1002/jlb.65.6.834; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Thornton E, 2014, PARKINSONISM RELAT D, V20, P508, DOI 10.1016/j.parkreldis.2014.02.008; Thornton E, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034138, 10.1371/journal.pone.0042630]; Thornton E, 2010, NEUROSCI LETT, V481, P64, DOI 10.1016/j.neulet.2010.06.057; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner R. J., 2005, J CEREB BLOOD FLOW M, V25, pS32; Turner R, 2007, DRUG NEWS PERSPECT, V20, P221, DOI 10.1358/dnp.2007.20.4.1103527; Vink R, 2004, J AM COLL NUTR, V23, p538S, DOI 10.1080/07315724.2004.10719398; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Wang HY, 2007, EUR J NEUROSCI, V26, P633, DOI 10.1111/j.1460-9568.2007.05663.x; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wang X, 2008, J NEUROSCI, V28, P9473, DOI 10.1523/JNEUROSCI.1867-08.2008; Wang X, 2006, BBA-MOL BASIS DIS, V1762, P742, DOI 10.1016/j.bbadis.2006.06.015; Wang X, 2011, J NEUROSCI, V31, P14496, DOI 10.1523/JNEUROSCI.3059-11.2011; Wang X, 2009, CNS NEUROSCI THER, V15, P345, DOI 10.1111/j.1755-5949.2009.00105.x; Wang X, 2009, STROKE, V40, P1877, DOI 10.1161/STROKEAHA.108.540765; WEGMANN H, 1979, HELV PAEDIATR ACTA, V34, P497; Weishaupt JH, 2006, J PINEAL RES, V41, P313, DOI 10.1111/j.1600-079X.2006.00377.x; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yu ZF, 1997, NEUROREPORT, V8, P2117, DOI 10.1097/00001756-199707070-00006; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39; Zhang GL, 2004, BRAIN RES, V1028, P225, DOI 10.1016/j.brainres.2004.09.017; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zhang X, 2008, NEUROPHARMACOLOGY, V54, P1143, DOI 10.1016/j.neuropharm.2008.03.005; Zhang Y, 2013, NEUROBIOL DIS, V55, P26, DOI 10.1016/j.nbd.2013.03.008; Zhang Y, 2011, NEUROSURGERY, V69, P942, DOI 10.1227/NEU.0b013e318222afb2; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Zhu YJ, 2015, DRUG DISCOV TODAY, V20, P65, DOI 10.1016/j.drudis.2014.08.016	81	19	19	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	SEP	2015	134	5					956	968		10.1111/jnc.13190			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CO7ZO	WOS:000359383500015	26031348				2022-02-06	
J	Khaksari, M; Hajializadeh, Z; Shahrokhi, N; Esmaeili-Mahani, S				Khaksari, Mohammad; Hajializadeh, Zahra; Shahrokhi, Nader; Esmaeili-Mahani, Saeed			Changes in the gene expression of estrogen receptors involved in the protective effect of estrogen in rat's trumatic brain injury	BRAIN RESEARCH			English	Article						Estrogen; Traumatic brain injury; ER alpha; ER beta; Gene expression; Female rats	SEX STEROID-HORMONES; CEREBRAL-CORTEX; ANIMAL-MODELS; ER-BETA; ALPHA; NEUROPROTECTION; ISCHEMIA; LIGAND; 17-BETA-ESTRADIOL; PROGESTERONE	It has been demonstrated that estradiol has neuroprotective effects after traumatic brain injury (TBI) in female rats. Since estrogen receptors have an important role in estradiol effects at the cellular level and the exact mechanism(s) of estradiol-induced neuroprotection has not yet been fully clarified, the present study was designed to determine the changes in the levels of estrogen receptors mRNAs and proteins involved in this phenomenon. All experiments were carried out on female Wistar rats. The brain edema and blood-brain-barrier (BBB) disruption were assessed. The TBI method was diffuse type and induced by the Marmarou method. Semiquantitative RT-PCR and immunoblotting were used to assess ER a and ER beta gene expression. The data showed that the level of brain water content was significantly increased in TBI group. The increased water content was significantly attenuated in estradiol-treated (1 mg/kg) TBI rats. Disruption of BBB after TBI was significantly inhibited just by estradiol treatment. Estrogen-treated animals showed a significant increase in ER alpha mRNA (18%) and protein (35%) levels in the brain tissue. Furthermore, in the brain-injured rats the levels of ER beta mRNA were lower than those in control rats. Following estrogen treatment, the protein levels of ER beta were closed to those in control group. In conclusion, the data demonstrate that estrogen treatment can protect brain against traumatic brain injury. Estrogen treatment increases ER mRNA and protein levels which were coincident with its protective effects. It seems that such phenomenon participates in the induction of neuroprotective effects of estrogen. This article is part of a Special Issue entitled 1618. (C) 2015 Published by Elsevier B.V.	[Khaksari, Mohammad] Kerman Univ Med Sci, Inst Neuropharmacol, Physiol Res Ctr, Kerman, Iran; [Hajializadeh, Zahra] Kerman Univ Med Sci, Inst Neuropharrnacol, Neurosci Res Ctr, Lab Mol Neurosci, Kerman, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Esmaeili-Mahani, Saeed] Shahid Bahonar Univ Kerman, Dept Biol, Fac Sci, Kerman, Iran		Khaksari, M (corresponding author), Kerman Univ Med Sci, Inst Neuropharmacol, Physiol Res Ctr, POB 76135-133, Kerman, Iran.	khaksar38@yahoo.co.uk	Shahrokhi, Nader/AAV-3747-2020; Haddad, Mohammad Khaksari/AAB-9025-2019	Shahrokhi, Nader/0000-0002-0149-7819; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Esmaeili Mahani, Saeed/0000-0001-5550-9806	Kerman Neuroscience Research Center [KNRC/88/127]	This work was supported by funds (KNRC/88/127) from Kerman Neuroscience Research Center.	Afrazi S, 2014, J STEROID BIOCHEM, V139, P98, DOI 10.1016/j.jsbmb.2013.10.010; Almey A, 2012, ENDOCRINOLOGY, V153, P5373, DOI 10.1210/en.2012-1458; Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; Ausubel FM., 1999, SHORT PROTOCOLS MOL; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Chakraborti A, 2007, REV NEUROSCIENCE, V18, P395; Chang YJ, 2009, HIPPOCAMPUS, V19, P1142, DOI 10.1002/hipo.20581; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Clipperton AE, 2008, NEUROPSYCHOPHARMACOL, V33, P2362, DOI 10.1038/sj.npp.1301625; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Esmaeili-Mahani S, 2008, NEUROPEPTIDES, V42, P169, DOI 10.1016/j.npep.2007.12.002; Ezquer ME, 2008, BRAIN RES, V1214, P73, DOI 10.1016/j.brainres.2008.03.029; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; Giatti S, 2012, J MOL ENDOCRINOL, V49, pR125, DOI 10.1530/JME-12-0127; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Gottfried-Blackmore A, 2007, BRAIN RES, V1186, P41, DOI 10.1016/j.brainres.2007.10.033; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hamilton KJ, 2014, REPROD BIOL, V14, P3, DOI 10.1016/j.repbio.2013.12.002; Ikeda Y, 2003, ENDOCRINOLOGY, V144, P5098, DOI 10.1210/en.2003-0267; Inagaki T, 2013, STEROIDS, V78, P597, DOI 10.1016/j.steroids.2012.12.015; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Mazzucco CA, 2006, NEUROSCIENCE, V141, P1793, DOI 10.1016/j.neuroscience.2006.05.032; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; Mitterling KL, 2010, J COMP NEUROL, V518, P2729, DOI 10.1002/cne.22361; Morales LBJ, 2006, J NEUROSCI, V26, P6823, DOI 10.1523/JNEUROSCI.0453-06.2006; Raval AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060716; Sampei K, 2000, STROKE, V31, P738, DOI 10.1161/01.STR.31.3.738; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sawada M, 2000, J CEREBR BLOOD F MET, V20, P112, DOI 10.1097/00004647-200001000-00015; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; SIMERLY RB, 1991, MOL ENDOCRINOL, V5, P424, DOI 10.1210/mend-5-3-424; Sinkevicius KW, 2008, ENDOCRINOLOGY, V149, P2970, DOI 10.1210/en.2007-1526; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Suzuki S, 2006, ENDOCRINE, V29, P209, DOI 10.1385/ENDO:29:2:209; Thakur MK, 2007, NEUROCHEM INT, V50, P314, DOI 10.1016/j.neuint.2006.08.019; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Wang CF, 2014, REV NEUROSCIENCE, V25, P255, DOI 10.1515/revneuro-2013-0055; Westberry JM, 2008, NEUROSCIENCE, V152, P982, DOI 10.1016/j.neuroscience.2008.01.048	42	19	19	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 27	2015	1618						1	8		10.1016/j.brainres.2015.05.017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CP5XB	WOS:000359957600001	26003937	Green Accepted			2022-02-06	
J	Zhang, JL; Feng, GJ; Bao, GF; Xu, GH; Sun, YY; Li, WD; Wang, LL; Chen, JJ; Jin, HRC; Cui, ZM				Zhang, Jinlong; Feng, Guijuan; Bao, Guofeng; Xu, Guanhua; Sun, Yuyu; Li, Weidong; Wang, Lingling; Chen, Jiajia; Jin, Huricha; Cui, Zhiming			Nuclear translocation of PKM2 modulates astrocyte proliferation via p27 and beta-catenin pathway after spinal cord injury	CELL CYCLE			English	Article						astrocyte proliferation; -catenin; p27; PKM2; spinal cord injury	CELL-CYCLE; PYRUVATE-KINASE; EXPRESSION; REGENERATION; APOPTOSIS; RECOVERY; TARGET; BRAIN; DEATH; M2	Aberrant functionality of the cell cycle has been implicated in the pathology of traumatic SCI. Although it has been reported that the expressions of various cell cycle related proteins were altered significantly following SCI, detailed information on the subject remains largely unclear. The embryonic pyruvate kinase M2 (PKM2) is an important metabolic kinase in aerobic glycolysis or the warburg effect, however, its functions in central nervous system (CNS) injury remains elusive. Here we demonstrate that PKM2 was not only significantly upregulated by western blot and immunohistochemistry but certain traumatic stimuli also induced translocation of PKM2 into the nucleus in astrocytes following spinal cord injury (SCI). Furthermore, the expression levels and localization of p--catenin, p27, cyclin D1 and PCNA were correlated with PKM2 after SCI. In vitro, we also found that PKM2 co-immunoprecipitation with p--catenin and p27 respectively. Knockdown of PKM2 apparently decreased the level of PCNA, cyclinD1, p27 in primary astrocyte cells. Taken together, our findings indicate that nuclear translocation of PKM2 promotes astrocytes proliferation after SCI through modulating cell cycle signaling. These discoveries firstly uncovered the role of PKM2 in spinal cord injury and provided a potential therapeutic target for CNS injury and repair.	[Zhang, Jinlong; Bao, Guofeng; Xu, Guanhua; Sun, Yuyu; Li, Weidong; Wang, Lingling; Chen, Jiajia; Jin, Huricha; Cui, Zhiming] Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Jiangsu, Peoples R China; [Feng, Guijuan] Nantong Univ, Affiliated Hosp, Dept Stomatol, Nantong 226001, Jiangsu, Peoples R China		Cui, ZM (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Jiangsu, Peoples R China.	cuizhiming2012@hotmail.com	xu, guanhua/AAU-4594-2021		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271367]	This work was supported by the National Natural Science Foundation of China (No. 81271367).	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bramanti Vincenzo, 2010, Front Biosci (Schol Ed), V2, P558; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Cheng P, 2014, NEUROPHARMACOLOGY, V85, P408, DOI 10.1016/j.neuropharm.2014.06.004; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Cui ZM, 2014, J MOL NEUROSCI, V54, P252, DOI 10.1007/s12031-014-0282-y; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Fan FT, 2014, ASIAN PAC J CANCER P, V15, P1961, DOI 10.7314/APJCP.2014.15.5.1961; Fillies T, 2007, ONCOL REP, V17, P355; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu W, 2015, ONCOTARGET, V6, P6570, DOI 10.18632/oncotarget.3262; Huang Y, 2009, CELL MOL NEUROBIOL, V29, P403, DOI 10.1007/s10571-008-9332-8; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Li W, 2009, P NATL ACAD SCI USA, V106, P486, DOI 10.1073/pnas.0804177106; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Park J, 2014, NEURAL REGEN RES, V9, P677, DOI 10.4103/1673-5374.131564; Rivadeneira DB, 2010, GASTROENTEROLOGY, V138, P1920, DOI 10.1053/j.gastro.2010.01.007; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; Shen AU, 2008, NEUROCHEM INT, V52, P1266, DOI 10.1016/j.neuint.2008.01.011; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tang L, 2013, CELL CYCLE, V12, P2665, DOI 10.4161/cc.25728; Tator CH, 2002, INJURY PREV, V8, pIV33, DOI 10.1136/ip.8.suppl_4.iv33; Tawfik VL, 2006, GLIA, V54, P193, DOI 10.1002/glia.20365; Wu JF, 2012, CELL CYCLE, V11, P1782, DOI 10.4161/cc.20153; Xia MS, 2014, J NEUROSCI RES, V92, P1078, DOI 10.1002/jnr.23384; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang JL, 2013, J MOL NEUROSCI, V49, P417, DOI 10.1007/s12031-012-9914-2; Zhang SW, 2013, J CELL BIOCHEM, V114, P354, DOI 10.1002/jcb.24371; Zhao JA, 2011, NEUROCHEM RES, V36, P549, DOI 10.1007/s11064-010-0377-y	46	19	20	2	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4101	1551-4005		CELL CYCLE	Cell Cycle	AUG 18	2015	14	16					2609	2618		10.1080/15384101.2015.1064203			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CQ0OG	WOS:000360295400020	26151495	Bronze, Green Published			2022-02-06	
J	Albrecht, JS; Kiptanui, Z; Tsang, Y; Khokhar, B; Smith, GS; Zuckerman, IH; Simoni-Wastila, L				Albrecht, Jennifer S.; Kiptanui, Zippora; Tsang, Yuen; Khokhar, Bilal; Smith, Gordon S.; Zuckerman, Ilene H.; Simoni-Wastila, Linda			Patterns of Depression Treatment in Medicare Beneficiaries with Depression after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						antidepressants; depression; older adults; traumatic brain injury	LATE-LIFE DEPRESSION; CLAIMS DATABASE ANALYSIS; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; NATURAL-HISTORY; UNITED-STATES; OLDER; RISK; METAANALYSIS; MORTALITY	There are no clinical guidelines addressing the management of depression after traumatic brain injury (TBI). The objectives of this study were to (1) describe depression treatment patterns among Medicare beneficiaries with a diagnosis of depression post-TBI; (2) compare them with depression treatment patterns among beneficiaries with a diagnosis of depression pre-TBI; and (3) quantify the difference in prevalence of use. We conducted a retrospective analysis of Medicare beneficiaries hospitalized with TBI during 2006-2010. We created two cohorts: beneficiaries with a new diagnosis of depression pre-TBI (n=4841) and beneficiaries with a new diagnosis of depression post-TBI (n=4668). We searched for antidepressant medications in Medicare Part D drug event files and created variables indicating antidepressant use in each 30-day period after diagnosis of depression. We used provider specialty and current procedural terminology to identify psychotherapy in any location. We used generalized estimating equations to quantify the effect of TBI on receipt of depression treatment during the year after diagnosis of depression. Average monthly prevalence of antidepressant use was 42% among beneficiaries with a diagnosis of depression pre-TBI and 36% among those with a diagnosis post-TBI (p<0.001). Beneficiaries with a diagnosis of depression post-TBI were less likely to receive antidepressants compared with a depression diagnosis pre-TBI (adjusted odds ratio [OR] 0.87; 95% confidence interval [CI] 0.82, 0.92). There was no difference in receipt of psychotherapy between the two groups (OR 1.08; 95% CI 0.93, 1.26). Depression after TBI is undertreated among older adults. Knowledge about reasons for this disparity and its long-term effects on post-TBI outcomes is limited and should be examined in future work.	[Albrecht, Jennifer S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Kiptanui, Zippora; Zuckerman, Ilene H.] IMPAQ Int LLC, Columbia, MD USA; [Tsang, Yuen; Khokhar, Bilal; Zuckerman, Ilene H.; Simoni-Wastila, Linda] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, STAR Organized Res Ctr, Natl Study Ctr Trauma & Emergency Med Serv, Baltimore, MD 21201 USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA.	jalbrecht@epi.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274; Smith, Gordon/0000-0002-2911-3071; Kiptanui, Zippora/0000-0003-1212-7642	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 AG042768-01, T32AG000262-14]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000262, R21AG042768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018313] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grant R21 AG042768-01 (Zuckerman, PI). Dr. Albrecht and Mr. Khokhar are supported by National Institutes of Health grant T32AG000262-14 (Magaziner, PI).	Albrecht JS, 2015, J HEAD TRAUMA REHAB; Barry LC, 2012, J AFFECT DISORDERS, V136, P789, DOI 10.1016/j.jad.2011.09.038; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Centers for Medicare & Medicaid Services, 2011, CHRON COND MED BEN; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Faul M, 2010, TRAUMATIC BRAIN INJU; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Gubler KD, 1997, ARCH SURG-CHICAGO, V132, P1010; Hollon SD, 2005, J CLIN PSYCHIAT, V66, P455, DOI 10.4088/JCP.v66n0408; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Marr A., 2004, CENTRAL NERVOUS SYST; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Milea D, 2010, CLIN THER, V32, P2057, DOI 10.1016/j.clinthera.2010.11.011; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nelson JC, 2008, AM J GERIAT PSYCHIAT, V16, P558, DOI 10.1097/JGP.0b013e3181693288; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Qian JJ, 2013, J AM GERIATR SOC, V61, P754, DOI 10.1111/jgs.12220; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Sanglier T, 2011, J AM GERIATR SOC, V59, P1197, DOI 10.1111/j.1532-5415.2011.03457.x; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Steffens DC, 2000, ARCH GEN PSYCHIAT, V57, P601, DOI 10.1001/archpsyc.57.6.601; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tedeschini E, 2011, J CLIN PSYCHIAT, V72, P1660, DOI 10.4088/JCP.10r06531; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Thurman DJ., 1995, GUIDELINES SURVEILLA; Trifiro G, 2010, J CLIN PSYCHOPHARM, V30, P252, DOI 10.1097/JCP.0b013e3181dca10a; Turner-Stokes L, 2002, CLIN REHABIL, V16, P261, DOI 10.1191/0269215502cr489oa; Unutzer J, 2007, NEW ENGL J MED, V357, P2269, DOI 10.1056/NEJMcp073754; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Valuck RJ, 2009, J CLIN PSYCHIAT, V70, P1069, DOI 10.4088/JCP.08m04943; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whenlan-Goodinson R., 2009, J HEAD TRAUMA REHAB, V24, P324; Wilson KCM, 1999, BRIT J PSYCHIAT, V175, P439, DOI 10.1192/bjp.175.5.439; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064	48	19	19	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1223	1229		10.1089/neu.2014.3651			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400006	25526613	Green Published			2022-02-06	
J	Brenner, LA; Bahraini, N; Homaifar, BY; Monteith, LL; Nagamoto, H; Dorsey-Holliman, B; Forster, JE				Brenner, Lisa A.; Bahraini, Nazanin; Homaifar, Beeta Y.; Monteith, Lindsey L.; Nagamoto, Herbert; Dorsey-Holliman, Brooke; Forster, Jeri E.			Executive Functioning and Suicidal Behavior Among Veterans With and Without a History of Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Rehabilitation; Suicide; Veterans	GAMBLING TASK-PERFORMANCE; PREFRONTAL CORTEX; ATTEMPTERS; IDEATION; SCALE; RELIABILITY; IMPULSIVITY; DYSFUNCTION; POPULATION; PREVALENCE	Objective: To examine the relationship between executive dysfunction, as a multidimensional construct (ie, decision-making, impulsivity, aggression, concept formation), and suicide attempt (SA) history in a high-risk sample of veterans with moderate to severe traumatic brain injury (TBI). Design: Observational, 2 x 2 factorial design. To estimate group differences, linear regression was used to model the primary and secondary outcomes of interest as a function of history of SA, TBI, and the interaction between the 2 variables. Additionally, to determine the pattern of performance over the course of the Iowa Gambling Test (IGT), scores were modeled across the 5 IGT blocks by using a varying-coefficient model. Setting: Veterans Health Administration. Participants: Veterans (N=133; no SA/no TBI, n=48; no SA/yes TBI, n=51; yes SA/no TBI, n=12; yes SA/yes TBI, n=22) completed the study measures. Interventions: Not applicable. Main Outcome Measures: IGT, Immediate and Delayed Memory Test, State-Trait Anger Expression Inventory-2, Wisconsin Card Sorting Test. Results: All groups demonstrated learning over the course of the IGT, except for veterans with a history of both SA and TBI. No group differences were identified on other measures of executive functioning. Conclusions: These findings highlight the potential, unique decision-making challenges faced by veterans with a history of TBI and SA. Specialized interventions focused on overall distress reduction and means restriction may be required to prevent future self-directed violence. (C) 2015 by the American Congress of Rehabilitation Medicine	[Brenner, Lisa A.; Bahraini, Nazanin; Homaifar, Beeta Y.; Monteith, Lindsey L.; Dorsey-Holliman, Brooke; Forster, Jeri E.] Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, Denver, CO USA; [Brenner, Lisa A.; Bahraini, Nazanin; Homaifar, Beeta Y.; Monteith, Lindsey L.; Nagamoto, Herbert] Univ Colorado Denver, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Dept Neurol, Aurora, CO USA; [Brenner, Lisa A.; Bahraini, Nazanin; Homaifar, Beeta Y.; Forster, Jeri E.] Univ Colorado Denver, Dept Phys Med & Rehabil, Aurora, CO USA; [Nagamoto, Herbert] Eastern Colorado Hlth Care Syst, Vet Hlth Adm, Denver, CO 80220 USA		Brenner, LA (corresponding author), Eastern Colorado Hlth Care Syst, Rocky Mt MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	lisa.brenner@va.gov	Brenner, Lisa A./AAG-2442-2019; Monteith, Lindsey L./X-3658-2019	Monteith, Lindsey L./0000-0002-8104-5280	Veterans Health Administration Rehabilitation Research and Development Merit Review [D7210R]; Rocky Mountain Mental Illness Research, Education, and Clinical Center	Supported by the Veterans Health Administration Rehabilitation Research and Development Merit Review (grant no. D7210R) and the Rocky Mountain Mental Illness Research, Education, and Clinical Center. The views, opinions and/or findings contained in this article are those of the author(s) and should not be construed as an official Department of Defense or Veterans Affairs position, policy, or decision unless so designated by other documentation.	Allen LM, 2004, CARB COMPUTERIZED AS; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Barnes SM, 2015, J HEALTH CARE POOR U, V26, P92, DOI 10.1353/hpu.2015.0010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; Blair RJR, 2008, PHILOS T R SOC B, V363, P2557, DOI 10.1098/rstb.2008.0027; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Brenner LA, 2011, J CLIN PSYCHOL MED S, V18, P116, DOI 10.1007/s10880-011-9240-9; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dougherty DM, 2004, SUICIDE LIFE-THREAT, V34, P374, DOI 10.1521/suli.34.4.374.53738; Dougherty DM, 2002, BEHAV RES METH INS C, V34, P391, DOI 10.3758/BF03195467; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Gorlyn M, 2013, PSYCHIAT RES, V207, P150, DOI 10.1016/j.psychres.2013.01.030; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Homaifar BY, 2012, REHABIL PSYCHOL, V57, P337, DOI 10.1037/a0030480; Jollant F, 2005, AM J PSYCHIAT, V162, P304, DOI 10.1176/appi.ajp.162.2.304; Jollant F, 2011, WORLD J BIOL PSYCHIA, V12, P319, DOI 10.3109/15622975.2011.556200; JORDAN BK, 1991, ARCH GEN PSYCHIAT, V48, P207, DOI 10.1001/archpsyc.1991.01810270019002; Keilp JG, 2001, AM J PSYCHIAT, V158, P735, DOI 10.1176/appi.ajp.158.5.735; Keilp JG, 2014, PSYCHIAT RES, V219, P129, DOI 10.1016/j.psychres.2014.04.050; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lambert M. J., 1996, ADM SCORING MANUAL O; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Linehan MM, 2006, PSYCHOL ASSESSMENT, V18, P303, DOI 10.1037/1040-3590.18.3.303; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Spielberger C. D., 1999, STATE TRAIT ANGER EX; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; U. S. Department of Veterans Affairs, 2009, CLIN PRACT GUID MAN; Wortzel HS, 2014, J PSYCHIATR PRACT, V20, P63, DOI 10.1097/01.pra.0000442940.46328.63; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	37	19	19	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8					1411	1418		10.1016/j.apmr.2015.04.010			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CO3CU	WOS:000359035000006	25933916				2022-02-06	
J	Luo, CL; Li, QQ; Gao, Y; Shen, X; Ma, L; Wu, Q; Wang, ZF; Zhang, MY; Zhao, ZQ; Chen, XP; Tao, LY				Luo, Chengliang; Li, Qianqian; Gao, Yuan; Shen, Xi; Ma, Lu; Wu, Qiong; Wang, Zufeng; Zhang, Mingyang; Zhao, Ziqin; Chen, Xiping; Tao, Luyang			Poloxamer 188 Attenuates Cerebral Hypoxia/Ischemia Injury in Parallel with Preventing Mitochondrial Membrane Permeabilization and Autophagic Activation	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Oxygen-glucose deprivation; Primary cortical neurons; Middle cerebral artery occlusion; Apoptosis; Autophagy	TRAUMATIC BRAIN-INJURY; ENDOPLASMIC-RETICULUM STRESS; CONTROLLED CORTICAL IMPACT; INDUCED CELL-DEATH; MAMMALIAN TARGET; IN-VITRO; RAPAMYCIN PROTECTS; ARTERY OCCLUSION; NEURONAL INJURY; ISCHEMIA	While the previous studies have shown poloxamer 188 (P188)'s neuroprotection in cultured HT22 cells under oxygen-glucose deprivation (OGD) insults, we investigated whether P188 is a potential neuroprotective agent in primary cortical neurons (PCNs) and in cerebral ischemia in vivo and whether the possible underlying mechanisms correlate with regulating mitochondrial membrane permeability (MMP) and autophagy. The protective effects of P188 were tested in PCNs in vitro exposed to OGD, as well as in cerebral ischemia in vivo. Cell death and viability were detected with LDH and MTT assay, and mitochondrial membrane potential was assessed using fluorescence microscopy. The apoptosis and autophagy of PCNs were investigated by expressions of cytc, caspase-3, light chain 3 (LC3), and Beclin-1. In addition, a mouse middle cerebral artery occlusion (MCAO) model was used to produce focal ischemia, and mice were treated with P188 and rapamycin after MCAO 10 min. The infarct volume, neurological scores, and phosphorylation of mammalian target of rapamycin (mTOR) were evaluated. The in vitro results showed that P188 prevented OGD-induced primary cerebrocortical neuron death and inhibited loss of mitochondrial membrane potential, the release of mitochondrial apoptogenic factor cytochrome c from mitochondria to the cytoplasm, and activation of caspase-3. P188 suppressed the activation of autophagy by decreasing LC3-II and Beclin-1 levels under OGD accordingly. Moreover, the in vivo results showed that P188 and rapamycin remarkably reduced the infarct volume and neurological deficits in the MCAO mouse model of cerebral ischemia, respectively. Both P188 and rapamycin induced phosphorylation of mTOR and reversed the decreased level upon MCAO. These data indicate that P188 prevents neuronal cell death resulting from ischemic brain injury and that its neuroprotective effects are mediated by preventing mitochondrial membrane integrity damage and autophagic activation. Given that it has low toxicity, P188 might become a potential novel therapy for ischemic injury.	[Luo, Chengliang; Gao, Yuan; Shen, Xi; Ma, Lu; Wu, Qiong; Wang, Zufeng; Zhang, Mingyang; Chen, Xiping; Tao, Luyang] Soochow Univ, Coll Med, Dept Forens Med, Suzhou 215123, Peoples R China; [Li, Qianqian] Wannan Med Coll, Dept Forens Med, Wuhu 241002, Peoples R China; [Zhao, Ziqin] Fudan Univ, Shanghai Med Coll, Dept Forens Med, Shanghai 200032, Peoples R China		Chen, XP (corresponding author), Soochow Univ, Coll Med, Dept Forens Med, Suzhou 215123, Peoples R China.	xipingchen@suda.edu.cn; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763; Shen, Xi/0000-0001-7568-7335	National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400999, 81172911, 81373251, 81301039]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2014M551660]; National High Technology Research and Development Program of China (863 Program)National High Technology Research and Development Program of China [2015AA020503]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Science Foundation of China (No.81400999, No.81172911, No.81373251, No.81301039), China Postdoctoral Science Foundation (No.2014M551660), National High Technology Research and Development Program of China (863 Program, No.2015AA020503), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Borgens RB, 2004, J NEUROSCI RES, V76, P141, DOI 10.1002/jnr.20053; Cadichon SB, 2007, J NEUROSURG, V106, P36, DOI 10.3171/ped.2007.106.1.36; Carloni S, 2014, EXP NEUROL, V255, P103, DOI 10.1016/j.expneurol.2014.03.002; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chang LK, 2002, J CELL BIOL, V157, P771, DOI 10.1083/jcb.200112130; Chauhan A, 2011, BEHAV BRAIN RES, V225, P603, DOI 10.1016/j.bbr.2011.08.035; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Cui DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035324; Curry DJ, 2004, NEUROSURGERY, V55, P943, DOI 10.1227/01.NEU.0000137890.29862.2C; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Gera J, 2011, LEUKEMIA LYMPHOMA, V52, P1857, DOI 10.3109/10428194.2011.580478; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Gu LJ, 2012, STROKE, V43, P1941, DOI 10.1161/STROKEAHA.112.656611; Gupta YK, 2011, INDIAN J MED RES, V133, P15; Hu ZP, 2015, MOL NEUROBIOL, V52, P1190, DOI 10.1007/s12035-014-8921-4; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lu Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-44; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Sheng R, 2012, AUTOPHAGY, V8, P310, DOI 10.4161/auto.18673; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wang JY, 2011, J NEUROPATH EXP NEUR, V70, P314, DOI 10.1097/NEN.0b013e31821352bd; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Zhang HL, 2011, NEUROSCIENCE, V176, P381, DOI 10.1016/j.neuroscience.2010.12.029; Zhang WH, 2008, STROKE, V39, P455, DOI 10.1161/STROKEAHA.107.496810	39	19	20	0	19	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	AUG	2015	56	4					988	998		10.1007/s12031-015-0568-8			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CP7MU	WOS:000360073100028	25966641				2022-02-06	
J	Olsen, A; Brunner, JF; Evensen, KAI; Finnanger, TG; Vik, A; Skandsen, T; Landro, NI; Haberg, AK				Olsen, Alexander; Brunner, Jan Ferenc; Evensen, Kari Anne Indredavik; Finnanger, Torun Gangaune; Vik, Anne; Skandsen, Toril; Landro, Nils Inge; Haberg, Asta Kristine			Altered Cognitive Control Activations after Moderate-to-Severe Traumatic Brain Injury and Their Relationship to Injury Severity and Everyday-Life Function	CEREBRAL CORTEX			English	Article						cognitive control; compensation; continuous performance test; executive function; fMRI; time-on-task	WORKING-MEMORY; ATTENTION DEFICITS; EXECUTIVE FUNCTION; TEST-PERFORMANCE; TASK CONTROL; FATIGUE; FMRI; NETWORKS; ROBUST; TBI	This study investigated how the neuronal underpinnings of both adaptive and stable cognitive control processes are affected by traumatic brain injury (TBI). Functional magnetic resonance imaging (fMRI) was undertaken in 62 survivors of moderate-to-severe TBI (> 1 year after injury) and 68 healthy controls during performance of a continuous performance test adapted for use in a mixed block- and event-related design. Survivors of TBI demonstrated increased reliance on adaptive task control processes within an a priori core region for cognitive control in the medial frontal cortex. TBI survivors also had increased activations related to time-on-task effects during stable task-set maintenance in right inferior parietal and prefrontal cortices. Increased brain activations in TBI survivors had a dose-dependent linear positive relationship to injury severity and were negatively correlated with self-reported cognitive control problems in everyday-life situations. Results were adjusted for age, education, and fMRI task performance. In conclusion, evidence was provided that the neural underpinnings of adaptive and stable control processes are differently affected by TBI. Moreover, it was demonstrated that increased brain activations typically observed in survivors of TBI might represent injury-specific compensatory adaptations also utilized in everyday-life situations.	[Olsen, Alexander] Norwegian Univ Sci & Technol, MI Lab, N-7491 Trondheim, Norway; [Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7491 Trondheim, Norway; [Brunner, Jan Ferenc; Vik, Anne; Skandsen, Toril; Haberg, Asta Kristine] Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway; [Evensen, Kari Anne Indredavik] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7491 Trondheim, Norway; [Evensen, Kari Anne Indredavik] Norwegian Univ Sci & Technol, Dept Lab Med, Childrens & Womens Hlth, N-7491 Trondheim, Norway; [Finnanger, Torun Gangaune] Norwegian Univ Sci & Technol, Reg Ctr Child & Youth Mental Hlth & Child Welf RK, N-7491 Trondheim, Norway; [Olsen, Alexander; Brunner, Jan Ferenc; Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Finnanger, Torun Gangaune] Univ Trondheim Hosp, St Olavs Hosp, Childrens Clin, Trondheim, Norway; [Vik, Anne] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Landro, Nils Inge] Univ Trondheim Hosp, St Olavs Hosp, Natl Competence Ctr Complex Symptom Disorders, Trondheim, Norway; [Haberg, Asta Kristine] Univ Trondheim Hosp, St Olavs Hosp, Dept Radiol, Trondheim, Norway; [Evensen, Kari Anne Indredavik] Trondheim Municipal, Dept Physiotherapy, Trondheim, Norway; [Landro, Nils Inge] Univ Oslo, Dept Psychol, Clin Neurosci Res Grp, Oslo, Norway		Olsen, A (corresponding author), Norwegian Univ Sci & Technol, MI Lab, Postboks 8905, N-7491 Trondheim, Norway.	alexander.olsen@ntnu.no	Olsen, Alexander/P-5235-2019	Olsen, Alexander/0000-0001-8691-3860; Brunner, Jan Ferenc/0000-0002-8576-678X	Norwegian Research Council through Medical Imaging Laboratory (MI-LAB) at the Norwegian University of Science and Technology	This study was supported by the Norwegian Research Council through Medical Imaging Laboratory (MI-LAB) at the Norwegian University of Science and Technology. Funding to pay the Open Access publication charges for this article was provided by the Norwegian Research Council through Medical Imaging Laboratory (MI-Lab) at the Norwegian University of Science and Technology.	Altmann EM, 2002, PSYCHOL SCI, V13, P27, DOI 10.1111/1467-9280.00405; Anderson J, 2007, NONLINEAR REGISTRATI; Anderson J., 2007, NONLINEAR OPTIMISATI; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cazalis Fabienne, 2011, Front Neurol, V1, P158, DOI 10.3389/fneur.2010.00158; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Conners CK, 2003, J ABNORM CHILD PSYCH, V31, P555, DOI 10.1023/A:1025457300409; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Desmet C, 2011, J NEUROSCI, V31, P1366, DOI 10.1523/JNEUROSCI.5371-10.2011; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Edwards BG, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00032; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00024; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Jahfari S, 2012, J NEUROSCI, V32, P10870, DOI 10.1523/JNEUROSCI.0902-12.2012; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Lannoo E, 1998, ACTA NEUROCHIR, V140, P245, DOI 10.1007/s007010050091; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Majid DSA, 2013, J NEUROSCI, V33, P13259, DOI 10.1523/JNEUROSCI.5651-12.2013; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Nee DE, 2011, NEUROIMAGE, V54, P528, DOI 10.1016/j.neuroimage.2010.08.027; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Ogg RJ, 2008, MAGN RESON IMAGING, V26, P504, DOI 10.1016/j.mri.2007.09.004; Olsen A, 2013, J COGNITIVE NEUROSCI, V25, P903, DOI 10.1162/jocn_a_00358; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Petersen SE, 2012, NEUROIMAGE, V62, P1177, DOI 10.1016/j.neuroimage.2011.09.084; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Tana MG, 2010, COMPUT INTELL NEUROS; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	65	19	20	0	12	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	AUG	2015	25	8					2170	2180		10.1093/cercor/bhu023			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CO7DU	WOS:000359320000015	24557637	Green Submitted, Green Published			2022-02-06	
J	Santo, KP; Berkowitz, ML				Santo, Kolattukudy P.; Berkowitz, Max L.			Shock Wave Induced Collapse of Arrays of Nanobubbles Located Next to a Lipid Membrane: Coarse-Grained Computer Simulations	JOURNAL OF PHYSICAL CHEMISTRY B			English	Article							TRAUMATIC BRAIN-INJURY; MOLECULAR-DYNAMICS; FORCE-FIELD; BIOLOGICAL-MEMBRANES; MODEL; CAVITIES; WATER	We used molecular dynamics simulations to study creation of pores in lipid bilayer membranes by inducing shock waves in systems containing arrays of nanobubbles next to these membranes. Shock waves impinged on the bubbles imploding them and produced nanojets that subsequently hit the bilayers making pores in them. Our simulations were performed using the MARTINI coarse-grained force field. The emphasis in our study was on the interaction of shock waves with two-bubble arrays when the bubbles were placed in different alignments. We observed that the largest damage to the bilayer was produced when two bubbles were positioned in a serial alignment and the bubbles touched each other. When two touching each other bubbles were located parallel to the membrane surface and at the same distance from the surface, the membrane damage was reduced, compared to the damage done by explosion of two independent nanobubbles. When two nanobubbles were placed in slanted configurations, the damage was intermediate between damages produced by two bubbles in parallel or serial alignment. Damage to the membrane produced by arrays containing more than two bubbles can be understood as a combination of damage produced by all three alignments of two bubbles.	[Santo, Kolattukudy P.; Berkowitz, Max L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA		Santo, KP (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	santotheophys@gmail.com; maxb@unc.edu	Poulose, Santo/AAC-7499-2021	Poulose, Santo/0000-0001-6817-737X; Berkowitz, Max/0000-0002-9116-0362	Office of Naval ResearchOffice of Naval Research [N00014-14-1-0241]	The support by a grant N00014-14-1-0241 from the Office of Naval Research is gratefully acknowledged. Simulations were performed using the supercomputing facility at the Lawrence Livermore National Laboratory, Livermore, California.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bisazza A, 2011, SOFT MATTER, V7, P10590, DOI 10.1039/c1sm06070h; Bourne NK, 2002, SHOCK WAVES, V11, P447, DOI 10.1007/s001930200128; Brennen CE, 2014, CAVITATION AND BUBBLE DYNAMICS, P1; Choubey A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3518472; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; DEAR JP, 1988, NATURE, V332, P505, DOI 10.1038/332505a0; DEAR JP, 1988, J FLUID MECH, V190, P409, DOI 10.1017/S0022112088001387; Drikakis D, 2009, J COMPUT THEOR NANOS, V6, P1437, DOI 10.1166/jctn.2009.1190; Espinosa S, 2014, MICROFLUID NANOFLUID, V16, P613, DOI 10.1007/s10404-013-1258-x; Feller SE, 1997, LANGMUIR, V13, P6555, DOI 10.1021/la970746j; Ganzenmuller GC, 2011, SOFT MATTER, V7, P4307, DOI 10.1039/c0sm01296c; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Henderson L. F., 2001, HDB SHOCK WAVES, V1, P143; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Lauer E, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4719142; Lukianova-Hleb EY, 2012, BIOMATERIALS, V33, P5441, DOI 10.1016/j.biomaterials.2012.03.077; Lukianova-Hleb EY, 2011, J CONTROL RELEASE, V152, P286, DOI 10.1016/j.jconrel.2011.02.006; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; Marrink SJ, 2010, PHYS CHEM CHEM PHYS, V12, P2254, DOI 10.1039/b915293h; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Ng KY, 2002, MED RES REV, V22, P204, DOI 10.1002/med.10004; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RYBAKOV AP, 1995, EUR J MECH B-FLUID, V14, P323; Santo KP, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862987; TOMITA Y, 1984, J APPL PHYS, V56, P125, DOI 10.1063/1.333745; Vedadi M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.014503; ZHANG YH, 1995, J CHEM PHYS, V103, P10252, DOI 10.1063/1.469927	33	19	19	1	34	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1520-6106			J PHYS CHEM B	J. Phys. Chem. B	JUL 23	2015	119	29					8879	8889		10.1021/jp505720d			11	Chemistry, Physical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	CN7OM	WOS:000358623900007	25117111				2022-02-06	
J	Haring, RS; Canner, JK; Asemota, AO; George, BP; Selvarajah, S; Haider, AH; Schneider, EB				Haring, R. Sterling; Canner, Joseph K.; Asemota, Anthony O.; George, Benjamin P.; Selvarajah, Shalini; Haider, Adil H.; Schneider, Eric B.			Trends in incidence and severity of sports-related traumatic brain injury (TBI) in the emergency department, 2006-2011	BRAIN INJURY			English	Article						Emergency department; epidemiology; sport; TBI		Objective: To characterize and identify trends in sports-related traumatic brain injury (TBI) emergency department (ED) visits from 2006-2011. Methods: This study reviewed data on sports-related TBI among individuals under age 65 from the Nationwide Emergency Department Sample from 2006-2011. Visits were stratified by age, sex, injury severity, payer status and other criteria. Variations in incidence. and severity were examined both between groups and over time. Odds of inpatient admission were calculated using regression modelling. Results: Over the period examined, 489 572 sports-related TBI ED visits were reported. The majority (62.2%) of these visits occurred among males under the age of 18. The average head Abbreviated Injury Severity score among these individuals was 1.93 (95% CI = 1.93-1.94) and tended to be lowest among those in middle school and high school age groups; these were also less likely to be admitted. The absolute annual number of visits grew 65.9% from 2006 until 2011, with the majority of this growth occurring among children under age 15. Hospitalization rates dropped 35.6% over the same period. Conclusion: Changes in year-over-year presentation rates vs. hospitalization rates among young athletes suggest that players, coaches and parents may be more aware of sports-related TBI and have developed lower thresholds for seeking medical attention.	[Haring, R. Sterling] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Haring, R. Sterling] Lake Erie Coll Osteopath Med, Bradenton, FL USA; [Haring, R. Sterling; Canner, Joseph K.; Asemota, Anthony O.; George, Benjamin P.; Selvarajah, Shalini; Schneider, Eric B.] Johns Hopkins Univ, CSTOR, Baltimore, MD USA; [Asemota, Anthony O.] Johns Hopkins Univ, Dept Neurol & Neurosurg, Baltimore, MD USA; [George, Benjamin P.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Haider, Adil H.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA		Haring, RS (corresponding author), 600 N Wolfe St,Blalock 618, Baltimore, MD 21287 USA.	sharing1@jhu.edu	Meijer, Anna/K-5118-2016		Patient Centered Outcomes Research Institute, the American College of SurgeonsPatient-Centered Outcomes Research Institute - PCORI; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS); World Health Organization, Geneva, SwitzerlandWorld Health Organization; Karolinska Institutet, Stockholm, Sweden; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093112] Funding Source: NIH RePORTER	R. Sterling Haring, MPH: No competing interests exist. Joseph K. Canner, MHS: No competing interests exist. Anthony O. Asemota, MBBS, MPH: No competing interests exist. Benjamin P. George, MPH: No competing interests exist. Shalini Selvarajah, MD, MPH: No competing interests exist. Adil H. Haider, MD, MPH: receives funding from the Patient Centered Outcomes Research Institute, the American College of Surgeons and the National Institute of General Medical Sciences. Eric B. Schneider, PhD: has pending patents regarding CNS trauma, is a member of Bergeim, LLC, receives consulting fees from the World Health Organization, Geneva, Switzerland and Karolinska Institutet, Stockholm, Sweden. This research was not funded. The authors report no conflicts of interest.	CDC Injury Center, 2013, HEADS CONC YOUTH SPO; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Esquivel A, 2013, SPORTS HEALTH, V5, P258, DOI 10.1177/1941738113476850; Faul M, 2010, TRAUMATIC BRAIN INJU; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; National Federation of State High School Associations, 2014, CONC SPORTS 2 0; Redding R., 2013, TARGETING CROWN OF H; US Census Bureau DID, POP EST	10	19	20	1	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					989	992		10.3109/02699052.2015.1033014			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800027	25962926	Green Submitted			2022-02-06	
J	Bernhard, M; Hossfeld, B; Bein, B; Bottiger, BW; Bohn, A; Fischer, M; Grasner, JT; Hinkelbein, J; Kill, C; Lott, C; Popp, E; Roessler, M; Schaumberg, A; Wenzel, V				Bernhard, Michael; Hossfeld, Bjoern; Bein, Berthold; Boettiger, Bernd W.; Bohn, Andreas; Fischer, Matthias; Graesner, Jan-Thorsten; Hinkelbein, Jochen; Kill, Clemens; Lott, Carsten; Popp, Erik; Roessler, Markus; Schaumberg, Alin; Wenzel, Volker			Policy Recommendation: Prehospital Emergency Anesthesia in Adults	ANASTHESIOLOGIE & INTENSIVMEDIZIN			German	Article						Guideline; Emergency Medicine; Emergency Anaesthesia; Management; Complications	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; AIRWAY-MANAGEMENT; TRACHEAL INTUBATION; SUCCESS RATES; ADRENAL INSUFFICIENCY; VIDEO LARYNGOSCOPES; ETOMIDATE; MULTICENTER; GUIDELINES	Inducing anaesthesia outside the hospital is an important therapeutic intervention in emergency medicine and much more difficult to accomplish than inside the hospital. Its primary goals include hypnosis, and analgesia and it enables airway management to achieve mechanical ventilation and adequate oxygenation. Secondary goals of emergency anaesthesia include amnesia, anxiolysis, reduced oxygen consumption and work of breathing, and thus protection of vital organs and avoidance of secondary myocardial injury or cerebral injuries. Factors specific to the individual patient, the site of intervention and the operator need to be considered prior to prehospital induction of anaesthesia. The rapid sequence induction procedure comprises basic monitoring, pre-oxygenation, standardised preparation of drugs and equipment, administration of drugs, removal of the cervical collar and manual in-line stabilisation during an intubation attempt (if needed), intubation and confirmation of endotracheal intubation, Every spontaneously breathing emergency patient should receive pre-oxygenation at a rate of 12-15 I oxygen per minute for at least 3-4 minutes, using a tight-sealing face mask or a demand valve. The standardised preparation process includes preparation and labelling drugs/syringes, checking the bag-valve mask, preparing the endotracheal tube with a stylet and blocking syringe, as well as having a stethoscope and material to secure the tube at hand, as well as alternative airway devices. It also includes immediate access to alternative means of airway management, as well as a suction unit, ventilator and monitoring devices including capnography. Basic monitoring in prehospital emergency anaesthesia includes ECG equipment, an automatic/manual blood pressure cuff and pulse oximetry. Continuous capnography is used without exception to confirm ventilation, detect possible disconnections/dislocations, and indirectly monitor haemodynamics. Prior to induction of prehospital emergency anaesthesia, two peripheral IV catheters should be placed, if possible.	[Bernhard, Michael] Univ Klinikum Leipzig AoR, Zentrale Notaufnahme, D-04103 Leipzig, Germany; [Hossfeld, Bjoern] Bundeswehrkrankenhaus Ulm, Klin Anasthesiol & Intens Med, Ulm, Germany; [Bein, Berthold] Asklepios Klin St Georg, Klin Anasthesiol & Operat Intens Med, Hamburg, Germany; [Boettiger, Bernd W.; Hinkelbein, Jochen] Univ Klinikum Koln AoR, Klin Anasthesiol & Operat Intens Med, Cologne, Germany; [Bohn, Andreas] Feuerwehr Munster, Munster, Germany; [Fischer, Matthias] ALB FILS KLINIKEN GmbH, Klin Eichert, Klin Anasthesiol & Operat Intens Med, Goppingen, Germany; [Graesner, Jan-Thorsten] Christian Albrechts Univ Kiel Klinikum, Klin Anasthesiol & Operat Intens Med, Kiel, Germany; [Kill, Clemens] Univ Klinikum Giessen & Marburg, Zentrum Notfallmed, Standort Marburg, Germany; [Lott, Carsten] Univ Med Mainz, Anasthesiol Klin, Mainz, Germany; [Popp, Erik] Univ Klinikum Heidelberg, Sekt Notfallmed, Anasthesiol Klin, Heidelberg, Germany; [Roessler, Markus] Univ Med Gottingen, Zentrum Anasthesiol Rettungs & Intens Med, Anasthesiol Klin, Gottingen, Germany; [Schaumberg, Alin] Univ Klinikum Giessen & Marburg, Klin Anasthesiol & Operat Intens Med, Standort Giessen, Germany; [Wenzel, Volker] Med Univ Innsbruck, Univ Klin Anasthesie & Intens Med, A-6020 Innsbruck, Austria		Bernhard, M (corresponding author), Univ Klinikum Leipzig AoR, Zentrale Notaufnahme, Liebigstr 26, D-04103 Leipzig, Germany.	Michael.Bernhard@medizin.uni-leipzig.de	Hinkelbein, Jochen/AAA-8801-2021; Roessler, Markus Soeren/I-7834-2013				Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; [Anonymous], 2009, ANASTH INTENSIVMED, V50, pS489; Barnard EBG, RAPID SEQUENCE INDUC, DOI [10.1136/emermed-2014-203740, DOI 10.1136/EMERMED-2014-203740]; Benumof JL, 1997, ANESTHESIOLOGY, V87, P979, DOI 10.1097/00000542-199710000-00034; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; Bernhard M, 2006, ANAESTHESIST, V55, P1157, DOI 10.1007/s00101-006-1106-4; Bernhard M, 2014, ANAESTHESIST, V63, P589, DOI 10.1007/s00101-014-2348-1; Bernhard M, 2011, NOTFALL RETTUNGSMED, V14, P554, DOI 10.1007/s10049-010-1402-z; Bernhard M, 2010, ANASTH INTENSIVMED, V51, pS615; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS7, DOI DOI 10.1089/NEU.2007.9995; Braun P, 2010, CURR OPIN ANESTHESIO, V23, P500, DOI 10.1097/ACO.0b013e32833bc135; Breckwoldt J, 2012, RESUSCITATION, V83, P434, DOI 10.1016/j.resuscitation.2011.10.011; Bretschneider I, 2011, NOTARZT, V27, P270, DOI 10.1055/s-0031-1276960; Cavus E, 2011, EMERG MED J, V28, P650, DOI 10.1136/emj.2010.098707; Chan CM, 2012, CRIT CARE MED, V40, P2945, DOI 10.1097/CCM.0b013e31825fec26; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Christ M., 2010, Intensivmedizin und Notfallmedizin, V47, P83, DOI 10.1007/s00390-009-0140-2; Connor CW, 2014, ANESTH ANALG, V118, P419, DOI 10.1213/ANE.0000000000000012; Cook T, 2012, CURR OPIN ANESTHESIO, V25, P461, DOI 10.1097/ACO.0b013e32835528b1; Cotton BA, 2008, ARCH SURG-CHICAGO, V143, P62, DOI 10.1001/archsurg.143.1.62; Cowan GM, 2012, EMERG MED J, V29, P136, DOI 10.1136/emj.2010.105304; Easby J, 2004, J TRAUMA, V6, P217; Edlow JA, 2014, LANCET, V384, P2064, DOI 10.1016/S0140-6736(13)62184-4; Eich C, 2009, RESUSCITATION, V80, P1371, DOI 10.1016/j.resuscitation.2009.09.004; El-Orbany M, 2010, ANESTH ANALG, V110, P1318, DOI 10.1213/ANE.0b013e3181d5ae47; ELBEHEIRY H, 1995, CAN J ANAESTH, V42, P875, DOI 10.1007/BF03011034; Genzwurker HV, 2010, ANASTH INTENSIVMED, V51, P202; Grasner JT, 2007, NOTFALLMEDIZIN UP2DA, V2, P197; Gries A, 2006, ANAESTHESIST, V55, P1080, DOI 10.1007/s00101-006-1051-2; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Hedenstierna G, 2005, INTENS CARE MED, V31, P1327, DOI 10.1007/s00134-005-2761-7; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Helm M, 2013, ACTA ANAESTH SCAND, V57, P199, DOI 10.1111/aas.12032; Helm M, 2010, ANAESTHESIST, V59, P896, DOI 10.1007/s00101-010-1759-x; Helm M, 2005, BEST PRACT RES-CLIN, V19, P623, DOI 10.1016/j.bpa.2005.06.002; Henderson JJ, 2004, ANAESTHESIA, V59, P675, DOI 10.1111/j.1365-2044.2004.03831.x; Herff H, 2009, ANESTH ANALG, V109, P303, DOI 10.1213/ane.0b013e3181ad8a1e; Heuer JF, 2012, ANAESTH INTENS CARE, V40, P120, DOI 10.1177/0310057X1204000113; Hossfeld B, 2011, NOTFALL RETTUNGSMED, V14, P15, DOI 10.1007/s10049-010-1355-2; Hossfeld B, 2011, NOTFALL RETTUNGSMED, V14, P10, DOI 10.1007/s10049-010-1354-3; HUG CC, 1993, ANESTH ANALG, V77, pS21; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jacoby J, 2006, ANN EMERG MED, V47, P525, DOI 10.1016/j.annemergmed.2005.12.009; Kheterpal S, 2013, ANESTHESIOLOGY, V119, P1360, DOI 10.1097/ALN.0000435832.39353.20; Koenig SJ, 2014, J INTENSIVE CARE MED; Kuhnigk H, 2007, NARKOSE NOTFALLMEDIZ; Liccardi G, 2009, CURR MED RES OPIN, V25, P1621, DOI 10.1185/03007990903010474; Lockey D, AAGBI SAFETY GUIDE P; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; Luxen J, 2014, ANAESTHESIST, V63, P331, DOI 10.1007/s00101-014-2303-1; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; Messelken M, 2010, DTSCH ARZTEBL INT, V107, P523, DOI 10.3238/arztebl.2010.0523; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; MRUGALLA H, 2003, NOTFALL RETTUNGSMED, V6, P233; Neumayr A, 2014, NOTFALL RETTUNGSMED, V17, P25, DOI 10.1007/s10049-013-1816-5; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Niven AS, 2013, CURR OPIN CRIT CARE, V19, P9, DOI 10.1097/MCC.0b013e32835c6014; Paal P, 2010, RESUSCITATION, V81, P148, DOI 10.1016/j.resuscitation.2009.10.023; Patanwala AE, 2014, ACAD EMERG MED, V21, P87, DOI 10.1111/acem.12292; Pehbock D, 2010, ANESTHESIOLOGY, V113, P593, DOI 10.1097/ALN.0b013e3181e73f07; Perry JJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub2; Reinhart K, 2010, ANAESTHESIST, V59, P347, DOI 10.1007/s00101-010-1719-5; Rortgen D, 2011, ANAESTHESIST, V60, P312, DOI 10.1007/s00101-010-1812-9; Rognas L, 2014, EUR J EMERG MED, V21, P418, DOI 10.1097/MEJ.0000000000000103; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Schlechtriemen T, 2004, NOTFALL RETTUNGSMED, V7, P231; Schmidt J, 2007, ANASTH INTENSIVMED, V48, pS88; Sefrin P, 2014, NOTARZT, V30, P73, DOI 10.1055/s-0034-1369910; Sitzwohl C, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5943; Sorensen MK, 2012, BRIT J ANAESTH, V108, P682, DOI 10.1093/bja/aer503; Steinmann D, 2009, ANAESTHESIST, V58, P695, DOI 10.1007/s00101-009-1548-6; Stollings JL, 2014, ANN PHARMACOTHER, V48, P62, DOI 10.1177/1060028013510488; Swanson Eric R, 2004, Prehosp Emerg Care, V8, P273; Thierbach A, 2004, ANAESTHESIST, V53, P543, DOI 10.1007/s00101-004-0679-z; Timmermann A, 2012, ANASTH INTENSIVMED, V53, P294; Timmermann A, 2009, ANAESTHESIST, V58, P663, DOI 10.1007/s00101-009-1570-8; van den Heuvel I, 2013, CURR OPIN ANESTHESIO, V26, P404, DOI 10.1097/ACO.0b013e328362a84c; VANDERWALT J, 1995, PAEDIATR ANAESTH, V5, P257; Voelckel WG, 2004, ANAESTHESIST, V53, P1151, DOI 10.1007/s00101-004-0771-4; von Goedecke A, 2007, ANESTH ANALG, V104, P481, DOI 10.1213/01.ane.0000255964.86086.63; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; Weller D, 2006, AKTUEL NEUROL, V33, pP532; Werdan K, 2011, KARDIOLOGE, V5, P166, DOI 10.1007/s12181-011-0349-8; Wetsch WA, 2013, EUR J ANAESTH, V30, P537, DOI 10.1097/EJA.0b013e3283614119; Wetsch WA, 2011, EUR J ANAESTH, V28, P849, DOI 10.1097/EJA.0b013e32834c7c7f; Wilbur K, 2001, CJEM, V3, P302; Zollinger A, 2012, DIE ANAESTHESIOLOGIE	89	19	21	0	8	AKTIV DRUCK & VERLAG GMBH	EBELSBACH	AN DER LOHWIESE 36, EBELSBACH, 97500, GERMANY	0170-5334	1439-0256		ANASTH INTENSIVMED	Anasthesiol. Intensivmed.	JUN	2015	56						317	335					19	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	CM7BY	WOS:000357846600012					2022-02-06	
J	Choi, JL; Tan, JKY; Sellers, DL; Wei, H; Horner, PJ; Pun, SH				Choi, Jennifer L.; Tan, James-Kevin Y.; Sellers, Drew L.; Wei, Hua; Horner, Philip J.; Pun, Suzie H.			Guanidinylated block copolymers for gene transfer: A comparison with amine-based materials for in vitro and in vivo gene transfer efficiency	BIOMATERIALS			English	Article						Gene delivery; Guanidine; Brain; Polymer	TRAUMATIC BRAIN INJURY; CELL-PROLIFERATION; PLASMID DELIVERY; NERVOUS-SYSTEM; NEUROGENESIS; ARGININE; BINDING; HIPPOCAMPUS; PEPTIDES; LYSINE	There is currently no cure for neuron loss in the brain, which can occur due to traumatic injury or neurodegenerative disease. One proposed method to enhance brain neurogenesis is gene transfer to neural progenitor cells. In this work, a guanidine-based copolymer was synthesized and compared to an amine-based copolymer analog previously shown to effectively deliver genes in the murine brain. The guanidine-based copolymer was more efficient at gene transfer to immortalized, cultured cell lines; however, the amine-based copolymer was more effective at gene transfer in the brain. DNA condensation studies revealed that the nucleic acid complexes formed with the guanidine-based copolymer were more susceptible to unpackaging in the presence of anionic proteoglycans compared to complexes formed with the amine-based copolymer. Therefore, polyplexes formed from the amine-based copolymer may be more resistant to destabilization by the heparan sulfate proteoglycans present in the stem cell niches of the brain. (C) 2015 Elsevier Ltd. All rights reserved.	[Choi, Jennifer L.; Tan, James-Kevin Y.; Wei, Hua; Pun, Suzie H.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Choi, Jennifer L.; Tan, James-Kevin Y.; Wei, Hua; Pun, Suzie H.] Univ Washington, Mol Engn & Sci Inst, Seattle, WA 98195 USA; [Sellers, Drew L.; Horner, Philip J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA		Pun, SH (corresponding author), Univ Washington, 3720 15th Ave NE,Box 355061, Seattle, WA 98195 USA.	phorner@u.washington.edu; spun@u.washington.edu	Wei, Hua-liang/AAX-4771-2020; Horner, Philip J./AAF-7012-2021	Wei, Hua-liang/0000-0002-4704-7346; Pun, Suzie/0000-0003-1443-4996	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2R01NS064404]; NSF GRFPNational Science Foundation (NSF)NSF - Office of the Director (OD) [2011128558]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064404] Funding Source: NIH RePORTER	This work was supported by NIH 2R01NS064404; JKYT was supported by NSF GRFP (2011128558). We are grateful to Prof. Wei Zheng (Purdue University) for the generous donation of the Z310 cell line. We thank Prof. Patrick Stayton (University of Washington) for use of his ZetaPALS analyzer and Prof. Shaoyi Jiang (University of Washington) for use of his Malvern Zetasizer. We would also like to thank Jevin Chan for encouraging and supporting us throughout this work.	Bergen JM, 2008, PHARM RES-DORDR, V25, P983, DOI 10.1007/s11095-007-9439-5; Brancia FL, 2000, RAPID COMMUN MASS SP, V14, P2070, DOI 10.1002/1097-0231(20001115)14:21<2070::AID-RCM133>3.0.CO;2-G; Burke RS, 2008, BIOCONJUGATE CHEM, V19, P693, DOI 10.1021/bc700388u; Carlson PM, 2013, BIOMATER SCI-UK, V1, P736, DOI 10.1039/c3bm60079c; Cheng Q, 2013, BIOMATERIALS, V34, P3120, DOI 10.1016/j.biomaterials.2013.01.043; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Choi JS, 2004, J CONTROL RELEASE, V99, P445, DOI 10.1016/j.jconrel.2004.07.027; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GUND P, 1972, J CHEM EDUC, V49, P100, DOI 10.1021/ed049p100; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; JUHASZ P, 1994, P NATL ACAD SCI USA, V91, P4333, DOI 10.1073/pnas.91.10.4333; Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082; Kim ID, 2010, J CONTROL RELEASE, V142, P422, DOI 10.1016/j.jconrel.2009.11.011; Kim I, 2012, SPACE, P20; Kim TI, 2009, BIOMATERIALS, V30, P658, DOI 10.1016/j.biomaterials.2008.10.009; Kwon EJ, 2010, BIOMATERIALS, V31, P2417, DOI 10.1016/j.biomaterials.2009.11.086; Mascotti DP, 1997, BIOCHEMISTRY-US, V36, P7272, DOI 10.1021/bi970272n; Mercier F, 2012, NEUROSCI LETT, V510, P67, DOI 10.1016/j.neulet.2011.12.046; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Schug KA, 2005, CHEM REV, V105, P67, DOI 10.1021/cr040603j; STANDKE KH, 1975, NUCLEIC ACIDS RES, V2, P1839, DOI 10.1093/nar/2.10.1839; Weber CJ, 1928, J BIOL CHEM, V78, P465; WEHLING K, 1975, NUCLEIC ACIDS RES, V2, P799, DOI 10.1093/nar/2.6.799; Wei H, 2013, ANGEW CHEM INT EDIT, V52, P5377, DOI 10.1002/anie.201301896; Wender PA, 2008, ADV DRUG DELIVER REV, V60, P452, DOI 10.1016/j.addr.2007.10.016; Wernersson E, 2010, J PHYS CHEM B, V114, P11934, DOI 10.1021/jp1054342; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang RJ, 2014, BIOMATERIALS, V35, P3443, DOI 10.1016/j.biomaterials.2013.12.097	34	19	19	4	65	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JUN	2015	54						87	96		10.1016/j.biomaterials.2015.03.008			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	CI2QD	WOS:000354591200009	25907042	Green Accepted			2022-02-06	
J	Davies, SC; Bird, BM				Davies, Susan C.; Bird, Brenna M.			Motivations for Underreporting Suspected Concussion in College Athletics	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						concussion; traumatic brain injury; sports; motivations; underreporting	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; ENCEPHALOPATHY; SEQUELAE; COACHES; IMPACT; COHORT; RETURN; MODEL	Student-athletes often fail to report concussion signs and symptoms, thereby putting themselves at risk for delayed recovery and permanent impairment. The present study examined motivations for underreporting concussion symptoms among college athletes enrolled at an NCAA Division I university. One hundred and ninety-three student-athletes in high-risk sports completed a multiple-choice survey related to self-reporting of suspected concussion symptoms and reporting of teammates' symptoms. Results indicated that 45% of participants did not report their own suspected concussions during the present season and 50% did not report suspected concussions in teammates. Responses revealed that the primary reason for underreporting a suspected concussion was the belief that the blow to the head was not serious enough. Suggestions are provided for athletes, athletic staff, and coaches to improve players' awareness of the signs, symptoms, and consequences of concussions, as well as how to report suspected concussions appropriately.	[Davies, Susan C.; Bird, Brenna M.] Univ Dayton, Dayton, OH 45469 USA		Davies, SC (corresponding author), Univ Dayton, Dayton, OH 45469 USA.	sdavies1@udayton.edu					Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Centers for Disease Control and Prevention, 2011, NONF TRAUM BRAIN INJ; Centers for Disease Control and Prevention, 2010, CONC; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Comper P, 2012, J CLIN SPORT PSYCHOL, V6, P231, DOI 10.1123/jcsp.6.3.231; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Goldberger A., 2014, SPORTS LITIGATION AL, V11, P12; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Institute of Medicine, 2013, SOD CONT POP ASS EV, P1; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS REL CONC YOUT; Johnson LSM, 2012, J SCHOOL HEALTH, V82, P180, DOI 10.1111/j.1746-1561.2011.00684.x; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lewandowski LJ, 2009, J APPL SCH PSYCHOL, V25, P95, DOI 10.1080/15377900802484547; Mainwaring L, 2012, J CLIN SPORT PSYCHOL, V6, P247, DOI 10.1123/jcsp.6.3.247; McAvoy K, 2013, RETURN LEARNING GOIN; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Neumann L, 2010, SPORT J, V14; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Saffary R, 2012, J CLIN SPORT PSYCHOL, V6, P351, DOI 10.1123/jcsp.6.4.351; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	35	19	19	1	16	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	JUN	2015	9	2					101	115		10.1123/jcsp.2014-0037			15	Psychology, Applied	Social Science Citation Index (SSCI)	Psychology	CX7EZ	WOS:000365866200001					2022-02-06	
J	Katzenberger, RJ; Loewen, CA; Bockstruck, RT; Woods, MA; Ganetzky, B; Wassarman, DA				Katzenberger, Rebeccah J.; Loewen, Carin A.; Bockstruck, R. Tayler; Woods, Mikal A.; Ganetzky, Barry; Wassarman, David A.			A Method to Inflict Closed Head Traumatic Brain Injury in Drosophila	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 100; Drosophila melanogaster; High-Impact Trauma device; mortality; traumatic brain injury	MODELS	Traumatic brain injury (TBI) affects millions of people each year, causing impairment of physical, cognitive, and behavioral functions and death. Studies using Drosophila have contributed important breakthroughs in understanding neurological processes. Thus, with the goal of understanding the cellular and molecular basis of TBI pathologies in humans, we developed the High Impact Trauma (HIT) device to inflict closed head TBI in flies. Flies subjected to the HIT device display phenotypes consistent with human TBI such as temporary incapacitation and progressive neurodegeneration. The HIT device uses a spring-based mechanism to propel flies against the wall of a vial, causing mechanical damage to the fly brain. The device is inexpensive and easy to construct, its operation is simple and rapid, and it produces reproducible results. Consequently, the HIT device can be combined with existing experimental tools and techniques for flies to address fundamental questions about TBI that can lead to the development of diagnostics and treatments for TBI. In particular, the HIT device can be used to perform large-scale genetic screens to understand the genetic basis of TBI pathologies.	[Katzenberger, Rebeccah J.; Bockstruck, R. Tayler; Wassarman, David A.] Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Loewen, Carin A.; Ganetzky, Barry] Univ Wisconsin Madison, Dept Genet, Madison, WI 53706 USA; [Woods, Mikal A.] Univ Puerto Rico Aguadilla, Dept Nat Sci, Aguadilla, PR 00603 USA		Wassarman, DA (corresponding author), Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.	dawassarman@wisc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG033620]; Robert Draper Technology Innovation Funding; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033620] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grant, R01 AG033620 (BG) and by Robert Draper Technology Innovation Funding (DAW).	Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Babcock DT, 2014, JOVE-J VIS EXP, DOI 10.3791/51223; Balsiger Z, 2014, HIT DEVICE HIGH SPEE; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Davceva N, 2012, J FORENSIC LEG MED, V19, P480, DOI 10.1016/j.jflm.2012.04.022; Fang YS, 2012, ANNU REV CELL DEV BI, V28, P575, DOI 10.1146/annurev-cellbio-101011-155836; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	14	19	19	1	15	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUN	2015		100							e52905	10.3791/52905			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR7NB	WOS:000361536000066	26168076	Green Published			2022-02-06	
J	Knutson, KM; Dal Monte, O; Schintu, S; Wassermann, EM; Raymont, V; Grafman, J; Krueger, F				Knutson, Kristine M.; Dal Monte, Olga; Schintu, Selene; Wassermann, Eric M.; Raymont, Vanessa; Grafman, Jordan; Krueger, Frank			Areas of Brain Damage Underlying Increased Reports of Behavioral Disinhibition	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							FRONTAL-LOBE DAMAGE; VOXEL-BASED LESION; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; INHIBITION; CORTEX; APATHY; SELF; DEGENERATION; INTELLIGENCE	Disinhibition, the inability to inhibit inappropriate behavior, is seen in frontal-temporal degeneration, Alzheimer's disease, and stroke. Behavioral disinhibition leads to social and emotional impairments, including impulsive behavior and disregard for social conventions. The authors investigated the effects of lesions on behavioral disinhibition measured by the Neuropsychiatric Inventory in 177 veterans with traumatic brain injuries. The authors performed voxel-based lesion-symptom mapping using MEDx. Damage in the frontal and temporal lobes, gyrus rectus, and insula was associated with greater behavioral disinhibition, providing further evidence of the frontal lobe's involvement in behavioral inhibition and suggesting that these regions are necessary to inhibit improper behavior.	[Knutson, Kristine M.; Wassermann, Eric M.] NINDS, Behav Neurol Unit, NIH, Bethesda, MD 20892 USA; [Dal Monte, Olga] Univ Turin, Dept Neuropsychol, Turin, Italy; [Schintu, Selene] INSERM, CNRS, Lyon Neurosci Res Ctr, ImpAct Team,U1028,UMR5292, F-69008 Lyon, France; [Raymont, Vanessa] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Sch Med, Dept Phys Med & Rehabil Psychiat & Behav Sci & Co, Chicago, IL USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA		Krueger, F (corresponding author), George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA.	jgrafman@northwestern.edu; fkrueger@gmu.edu	Wassermann, Eric M./AAC-9064-2020; Schintu, Selene/ABF-7032-2020; Dal Monte, Olga/P-3759-2018	Wassermann, Eric M./0000-0003-0628-0210; Schintu, Selene/0000-0002-6362-3905; Dal Monte, Olga/0000-0002-7823-4769	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke, intramural research program; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD17-01-1-0675]; National Naval Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977] Funding Source: NIH RePORTER	This work was supported by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke, intramural research program, and a project grant from the U.S. Army Medical Research and Material Command administrated by the Henry M. Jackson Foundation (Grant DAMD17-01-1-0675). The authors thank the Vietnam War veterans who participated in this study; the National Naval Medical Center for support and provision of their facilities; and S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for invaluable help with the testing of participants and organization of this study.	Anderson ND, 2011, J COGNITIVE NEUROSCI, V23, P3804, DOI 10.1162/jocn_a_00050; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Caruso D.R., 2002, MAYER SALOVEY CARUSO; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cohen J.R., 2010, SELF CONTROL SOC MIN, P141, DOI DOI 10.1093/ACPROF:OSO/9780195391381.003.0008; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Dillon DG, 2007, APPL PREV PSYCHOL, V12, P99, DOI 10.1016/j.appsy.2007.09.004; Dimitrov M, 2003, BRAIN COGNITION, V52, P258, DOI 10.1016/S0278-2626(03)00080-0; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 2006, BRAIN RES, V1105, P130, DOI 10.1016/j.brainres.2006.03.029; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Harnishfeger KK, 1995, DEV COGNITIVE INHIBI, P175; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; Heflin LH, 2011, NEUROPSYCHOLOGY, V25, P655, DOI 10.1037/a0023863; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Jurado MA, 1998, J CLIN EXP NEUROPSYC, V20, P353, DOI 10.1076/jcen.20.3.353.816; Krueger CE, 2011, NEUROPSYCHOLOGY, V25, P249, DOI 10.1037/a0021681; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Litvan I, 1998, J NEUROL NEUROSUR PS, V65, P717, DOI 10.1136/jnnp.65.5.717; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Massimo L, 2009, DEMENT GERIATR COGN, V27, P96, DOI 10.1159/000194658; McKinlay A, 2008, AGING MENT HEALTH, V12, P647, DOI 10.1080/13607860802343225; Mehrabian A, 1996, MANUAL BALANCED EMOT; Muraven M, 2006, J PERS SOC PSYCHOL, V91, P524, DOI 10.1037/0022-3514.91.3.524; Perri R, 2014, J ALZHEIMERS DIS, V39, P669, DOI 10.3233/JAD-131337; Peters F, 2006, DEMENT GERIATR COGN, V21, P373, DOI 10.1159/000091898; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Schintu S, 2014, CORTEX, V57, P244, DOI 10.1016/j.cortex.2014.04.009; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Serra L, 2010, J ALZHEIMERS DIS, V21, P627, DOI 10.3233/JAD-2010-100048; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Szatkowska I, 2007, EXP BRAIN RES, V181, P109, DOI 10.1007/s00221-007-0906-3; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; Zamboni G, 2008, NEUROLOGY, V71, P736, DOI 10.1212/01.wnl.0000324920.96835.95; 1997, WECHSLER ADULT INTEL	48	19	19	0	11	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2015	27	3					193	198		10.1176/appi.neuropsych.14060126			6	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	CR7LK	WOS:000361531000013	25959040	Green Accepted, Green Submitted, Bronze			2022-02-06	
J	Marina, D; Klose, M; Nordenbo, A; Liebach, A; Feldt-Rasmussen, U				Marina, Djordje; Klose, Marianne; Nordenbo, Annette; Liebach, Annette; Feldt-Rasmussen, Ulla			Early endocrine alterations reflect prolonged stress and relate to 1-year functional outcome in patients with severe brain injury	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							ANTERIOR-PITUITARY FUNCTION; GROWTH-HORMONE DEFICIENCY; HYPOTHALAMOPITUITARY DYSFUNCTION; SUBARACHNOID HEMORRHAGE; BODY-COMPOSITION; CRITICAL ILLNESS; FREE CORTISOL; ACUTE-PHASE; HIGH-RISK; HYPOPITUITARISM	Objective: Severe brain injury may increase the risk of developing acute and chronic hypopituitarism. Pituitary hormone alterations developed in the early recovery phase after brain injury may have implications for long-term functional recovery. The objective of the present study was to assess the pattern and prevalence of pituitary hormone alterations 3 months after a severe brain injury with relation to functional outcome at a 1-year follow-up. Design: Prospective study at a tertiary university referral centre. Methods: A total of 163 patients admitted to neurorehabilitation after severe traumatic brain injury (TBI, n=111) or non-TBI (n=52) were included. The main outcome measures were endocrine alterations 3.3 months (median) after the brain injury and their relationship to the functioning and ability of the patients at a 1-year follow-up, as measured by the Functional Independence Measure and the Glasgow Outcome Scale-Extended. Results: Three months after the injury, elevated stress hormones (i.e. 30 min stimulated cortisol, prolactin and/or IGF1) and/or suppressed gonadal or thyroid hormones were recorded in 68 and 32% of the patients respectively. At 1 year after the injury, lower functioning level (Functional Independence Measure) and lower capability of performing normal life activities (Glasgow Outcome Scale-Extended) were related to both the elevated stress hormones (P <= 0.01) and the reduced gonadal and/or thyroid hormones (P <= 0.01) measured at 3 months. Conclusion: The present study suggests that brain injury-related endocrine alterations that mimic secondary hypogonadism and hypothyroidism and that occur with elevated stress hormones most probably reflect a prolonged stress response 2-5 months after severe brain injury, rather than pituitary insufficiency per se. These endocrine alterations thus seem to reflect a more severe disease state and relate to 1-year functional outcome.	[Marina, Djordje; Klose, Marianne; Feldt-Rasmussen, Ulla] Copenhagen Univ Hosp, Rigshosp, Dept Med Endocrinol PE2131, Copenhagen, Denmark; Copenhagen Univ Hosp, Glostrup Hosp, Dept Neurorehabil, Traumat Brain Injury Unit, Glostrup, Denmark		Feldt-Rasmussen, U (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Med Endocrinol PE2131, Copenhagen, Denmark.	ufeldt@rh.dk	Feldt-Rasmussen, Ulla/AAB-9218-2021	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Marina, Djordje/0000-0002-0367-9114	Arvid Nilsson's fund; Novo Nordisk FondenNovo Nordisk Foundation [NNF15OC0014622] Funding Source: researchfish	U Feldt-Rasmussen's research salary was supported by a grant from Arvid Nilsson's fund. We thank Lars Westergaard for his assistance in collecting data and constructing the patient database used in the present study.	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bondanelli M, 2010, J CLIN ENDOCR METAB, V95, P4660, DOI 10.1210/jc.2010-0611; Boonen E, 2014, J CLIN ENDOCR METAB, V99, P1569, DOI 10.1210/jc.2013-4115; Boonen E, 2013, NEW ENGL J MED, V368, P1477, DOI 10.1056/NEJMoa1214969; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Carroll TB, 2010, REV ENDOCR METAB DIS, V11, P147, DOI 10.1007/s11154-010-9143-3; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Hana V, 2012, PHYSIOL RES, V61, P161, DOI 10.33549/physiolres.932290; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2007, J CLIN ENDOCR METAB, V92, P1326, DOI 10.1210/jc.2006-1791; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Mesotten D, 2006, ENDOCRIN METAB CLIN, V35, P793, DOI 10.1016/j.ecl.2006.09.010; Pavlovic D, 2010, EUR J NEUROL, V17, P696, DOI 10.1111/j.1468-1331.2009.02910.x; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P699, DOI 10.1530/eje.1.02131; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Spratt DI, 2001, BEST PRACT RES CL EN, V15, P479, DOI 10.1053/beem.2001.0165; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Van den Berghe G, 2003, ENDOCRIN METAB CLIN, V32, P385, DOI 10.1016/S0889-8529(03)00005-7; van der Eerden AW, 2010, EUR J ENDOCRINOL, V162, P19, DOI 10.1530/EJE-09-0436; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Young TP, 2007, BRAIN INJURY, V21, P645, DOI 10.1080/02699050701210426	41	19	21	0	1	BIOSCIENTIFICA LTD	BRISTOL	STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	JUN	2015	172	6					813	822		10.1530/EJE-14-1152			10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	CL8GR	WOS:000357212600025	25825347	Bronze			2022-02-06	
J	Tse, KM; Tan, LB; Lee, SJ; Lim, SP; Lee, HP				Tse, Kwong Ming; Tan, Long Bin; Lee, Shu Jin; Lim, Siak Piang; Lee, Heow Pueh			Investigation of the relationship between facial injuries and traumatic brain injuries using a realistic subject-specific finite element head model	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Finite element; Concomitant injury; Facial trauma; Traumatic brain injury (TBI); Blunt impacts	INTRACRANIAL-PRESSURE; DYNAMIC-RESPONSE; TOLERANCE LIMITS; FE MODEL; FRACTURES; IMPACT; BONE; VALIDATION; DEFORMATION; MECHANISMS	In spite of anatomic proximity of the facial skeleton and cranium, there is lack of information in the literature regarding the relationship between facial and brain injuries. This study aims to correlate brain injuries with facial injuries using finite element method (FEM). Nine common impact scenarios of facial injuries are simulated with their individual stress wave propagation paths in the facial skeleton and the intracranial brain. Fractures of cranio-facial bones and intracranial injuries are evaluated based on the tolerance limits of the biomechanical parameters. General trend of maximum intracranial biomechanical parameters found in nasal bone and zygomaticomaxillary impacts indicates that severity of brain injury is highly associated with the proximity of location of impact to the brain. It is hypothesized that the midface is capable of absorbing considerable energy and protecting the brain from impact. The nasal cartilages dissipate the impact energy in the form of large scale deformation and fracture, with the vomer-ethmoid diverging stress to the "crumpling zone" of air-filled sphenoid and ethmoidal sinuses; in its most natural manner, the face protects the brain. This numerical study hopes to provide surgeons some insight in what possible brain injuries to be expected in various scenarios of facial trauma and to help in better diagnosis of unsuspected brain injury, thereby resulting in decreasing the morbidity and mortality associated with facial trauma. (C) 2015 Elsevier Ltd. All rights reserved.	[Tse, Kwong Ming; Tan, Long Bin; Lim, Siak Piang; Lee, Heow Pueh] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore; [Lee, Shu Jin] Natl Univ Hlth Syst, Div Plast Reconstruct & Aesthet Surg, Singapore 119074, Singapore; [Lee, Heow Pueh] Natl Univ Singapore, Suzhou Res Inst, Suzhou 215123, Jiangsu, Peoples R China		Tse, KM (corresponding author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.	tsekm.research@yahoo.com; mpeleehp@nus.edu.sg	Lee, Heow Pueh/I-7834-2014; Tse, Kwong Ming/D-8669-2011	Lee, Heow Pueh/0000-0002-4380-3888; Tse, Kwong Ming/0000-0002-8170-0775; Tan, Long Bin/0000-0002-3897-7365	Swiss-based CMF Clinical Priority Program of the AO Foundation [C-09-2L]	The authors would like to acknowledge the support by a grant from the Swiss-based CMF Clinical Priority Program of the AO Foundation under the project no. C-09-2L.	Al-Bsharat AS, 2000, COMPUTATIONAL ANAL B; Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; Autuori B, 2006, IEEE T BIO-MED ENG, V53, P1225, DOI 10.1109/TBME.2006.872812; Bar-Kochba E, 2012, SIMULIA COMM C SCC P, P10; Baumgartner D, 2005, SOLID MECH APPL, V124, P195; Baumgartner D, 2005, EUR J COMPUT MECH, V14, P421; Beusenberg MC., 2000, P INT RES C BIOM IMP; Chan M., 1980, P 24 STAPP CAR CRASH, P347; CHANG CJ, 1994, J TRAUMA, V37, P807, DOI 10.1097/00005373-199411000-00017; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Cormier J., 2011, J BIOMECH ENG, V133; Cormier J.M, 2009, EPIDEMIOLOGY BIOMECH; Cormier Joseph, 2010, Ann Adv Automot Med, V54, P3; Dassault Systems Simulia Corp, 2013, AB AN US MAN; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; DiMasi F., 1991, 13 INT TECHN C EXP S; Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Grellmann W, 2006, J BIOMED MATER RES A, V78A, P168, DOI 10.1002/jbm.a.30625; GWYN PP, 1971, PLAST RECONSTR SURG, V47, P225, DOI 10.1097/00006534-197103000-00004; Hardt N, 2010, CRANIOFACIAL TRAUMA: DIAGNOSIS AND MANAGEMENT, P31, DOI 10.1007/978-3-540-33041-7_3; HARDY CH, 1973, J APPL MECH-T ASME, V40, P838, DOI 10.1115/1.3423172; HARRISON DH, 1979, BRIT J PLAST SURG, V32, P57, DOI 10.1016/0007-1226(79)90063-8; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; HAYTER JP, 1991, BRIT J ORAL MAX SURG, V29, P370, DOI 10.1016/0266-4356(91)90003-N; Ho J, 2009, INT J CRASHWORTHINES, V14, P555, DOI 10.1080/13588260902895708; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Kang HS, 1997, P STAPP CAR CRASH J, V41, P329; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Khalighi Sigaroudi S. A., 2012, J DENT SHIRAZ, V13, P18; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Lee SJ, 2010, LARYNGOSCOPE, V120, P1931, DOI 10.1002/lary.21072; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; LUCE EA, 1979, PLAST RECONSTR SURG, V63, P26, DOI 10.1097/00006534-197901000-00005; Mansfield R. T., 1995, PEDIAT TRANSPORT MED, P285; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Martin RCG, 2002, AM SURGEON, V68, P477; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Miller R.T., 1998, STAPP CAR CRASH J, P155; Nahum A. M., 1977, P 21 STAPP CAR CRASH, P339; NICKELL RE, 1974, J ENG IND-T ASME, V96, P490, DOI 10.1115/1.3438355; Oberascher G, 1993, Eur Arch Otorhinolaryngol Suppl, V1, P347; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Payan Y, 1998, LECT NOTES COMPUT SC, V1496, P688; Pietruszczak S, 1999, J BIOMECH, V32, P1071, DOI 10.1016/S0021-9290(99)00096-2; Ruan J. S., 1994, IMPACT BIOMECHANICS; Ruan J. S., 1997, J TRAFFIC MED, V25, P33; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Saladin K. S., 2007, HUMAN ANATOMY, P414; Schaller A, 2012, INT J ORAL MAX SURG, V41, P66, DOI 10.1016/j.ijom.2011.09.004; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Stalnaker R.L., 1969, MECH PROPERTIES HEAD; Stranc M F, 1979, Ann Plast Surg, V2, P468, DOI 10.1097/00000637-197906000-00004; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; TANNE K, 1989, AM J ORTHOD DENTOFAC, V95, P200, DOI 10.1016/0889-5406(89)90050-4; Tse KM, 2014, INT J NUMER METH BIO, V30, P397, DOI 10.1002/cnm.2609; Turquier F, 1996, STAPP CAR C, VP-30, P283; Wanyura H., 2011, J STOMA, V64, P411; WARD CC, 1975, P 19 STAPP CAR CRASH, P641; Weller MD, 2006, TRAUMA, V8, P21, DOI 10.1191/1460408606ta355oa; Westreich RW, 2007, ARCH FACIAL PLAST S, V9, P264, DOI 10.1001/archfaci.9.4.264; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Zandi M., 2012, ORAL MAXILLOFAC SURG, P1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C., 1995, P STAPP CAR CRASH J, P121	72	19	20	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUN	2015	79						13	32		10.1016/j.aap.2015.03.012			20	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	CJ2ZF	WOS:000355352500002	25795050				2022-02-06	
J	Stevanovic, A; Schmitz, S; Rossaint, R; Schurholz, T; Coburn, M				Stevanovic, Ana; Schmitz, Sabine; Rossaint, Rolf; Schuerholz, Tobias; Coburn, Mark			CONSORT Item Reporting Quality in the Top Ten Ranked Journals of Critical Care Medicine in 2011: A Retrospective Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; INTERVENTION; STATEMENT; ADHERENCE; GUIDELINES; REVIEWS	Introduction Reporting randomised controlled trials is a key element in order to disseminate research findings. The CONSORT statement was introduced to improve the reporting quality. We assessed the adherence to the CONSORT statement of randomised controlled trials published 2011 in the top ten ranked journals of critical care medicine (ISI Web of Knowledge 2011, Thomson Reuters, London UK). Methods Design. We performed a retrospective cross sectional data analysis. Setting. This study was executed at the University Hospital of RWTH, Aachen. Participants. We selected the following top ten listed journals according to ISI Web of Knowledge (Thomson Reuters, London, UK) critical care medicine ranking in the year 2011: American Journal of Respiratory and Critical Care Medicine, Critical Care Medicine, Intensive Care Medicine, CHEST, Critical Care, Journal of Neurotrauma, Resuscitation, Pediatric Critical Care Medicine, Shock and Minerva Anestesiologica. Main outcome measures. We screened the online table of contents of each included journal, to identify the randomised controlled trials. The adherence to the items of the CONSORT Checklist in each trial was evaluated. Additionally we correlated the citation frequency of the articles and the impact factor of the respective journal with the amount of reported items per trial. Results We analysed 119 randomised controlled trials and found, 15 years after the implementation of the CONSORT statement, that a median of 61,1% of the checklist-items were reported. Only 55.5% of the articles were identified as randomised trials in their titles. The citation frequency of the trials correlated significantly (rs = 0,433; p<0,001 and r = 0,331; p<0,001) to the CONSORT statement adherence. The impact factor showed also a significant correlation to the CONSORT adherence (r = 0,386; p<0,001). Conclusion The reporting quality of randomised controlled trials in the field of critical care medicine remains poor and needs considerable improvement.	[Stevanovic, Ana; Schmitz, Sabine; Rossaint, Rolf; Coburn, Mark] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Schuerholz, Tobias] Univ Hosp Aachen, Dept Intens Care & Intermediate Care, Aachen, Germany		Coburn, M (corresponding author), Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany.	mcoburn@ukaachen.de	Schuerholz, Tobias/E-8071-2011	Schuerholz, Tobias/0000-0003-3830-3499; Coburn, Mark/0000-0002-7930-0270			Ahmadzadeh J., 2013, Shiraz E Medical Journal, V14, P130; Altman DG, 2005, BMJ-BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Dechartres A, 2011, J CLIN EPIDEMIOL, V64, P136, DOI 10.1016/j.jclinepi.2010.04.015; Elia N, 2011, EUR J ANAESTH, V28, P478, DOI 10.1097/EJA.0b013e3283461868; Geha NN, 2013, RESP CARE, V58, P1899, DOI 10.4187/respcare.02379; Gray R, 2012, ANN ROY COLL SURG, V94, P388, DOI 10.1308/003588412X13171221592339; Hill CL, 2002, J CLIN EPIDEMIOL, V55, P783, DOI 10.1016/S0895-4356(02)00440-7; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hopewell S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c723; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Latronico N, 2013, INTENS CARE MED, V39, P1386, DOI 10.1007/s00134-013-2947-3; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Munter NH, 2015, EUR J ANAESTH, V32, P117, DOI 10.1097/EJA.0000000000000176; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sibbald B, 1998, BRIT MED J, V316, P201; Silverman B W, 1998, DENSITY ESTIMATION S; To MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084779; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wager E, 2014, EUR J ANAESTH, V31, P397, DOI 10.1097/EJA.0000000000000084	29	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128061	10.1371/journal.pone.0128061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	WOS:000355187300076	26020246	Green Published, gold, Green Submitted			2022-02-06	
J	Fortress, AM; Heisler, JD; Frick, KM				Fortress, Ashley M.; Heisler, John D.; Frick, Karyn M.			The mTOR and Canonical Wnt Signaling Pathways Mediate the Mnemonic Effects of Progesterone in the Dorsal Hippocampus	HIPPOCAMPUS			English	Article						progesterone receptors; memory; ERK; mTOR; Wnt	RECOGNITION MEMORY CONSOLIDATION; TRAUMATIC BRAIN-INJURY; ESTRADIOL-INDUCED ENHANCEMENT; REGULATED KINASE ACTIVATION; LONG-TERM POTENTIATION; BREAST-CANCER CELLS; OBJECT RECOGNITION; RECEPTOR ISOFORMS; NERVOUS-SYSTEM; FEMALE MICE	Although much is known about the neural mechanisms responsible for the mnemonic effects of 17-estradiol (E-2), very little is understood about the mechanisms through which progesterone (P-4) regulates memory. We previously showed that intrahippocampal infusion of P-4 in ovariectomized female mice enhances object recognition (OR) memory consolidation in a manner dependent on activation of dorsal hippocampal ERK and mTOR signaling. However, the role of specific progesterone receptors (PRs) in mediating the effects of progesterone on memory consolidation and hippocampal cell signaling are unknown. Therefore, the goals of this study were to investigate the roles of membrane-associated and intracellular PRs in mediating hippocampal memory consolidation, and identify downstream cell signaling pathways activated by PRs. Membrane-associated PRs were targeted using bovine serum albumin-conjugated progesterone (BSA-P), and intracellular PRs (PR-A, PR-B) were targeted using the intracellular PR agonist R5020. Immediately after OR training, ovariectomized mice received bilateral dorsal hippocampal infusion of vehicle, P-4, BSA-P, or R5020. OR memory consolidation was enhanced by P-4, BSA-P, and R5020. However, only P-4 and BSA-P activated ERK and mTOR signaling. Furthermore, dorsal hippocampal infusion of the ERK inhibitor U0126 blocked the memory-enhancing effects of BSA-P, but not R5020. The intracellular PR antagonist RU486 blocked the memory-enhancing effects of R5020, but not BSA-P. Interestingly, P-4 robustly activated canonical Wnt signaling in the dorsal hippocampus, which is consistent with our recent findings that canonical Wnt signaling is necessary for OR memory consolidation. R5020, but not BSA-P, also elicited a modest increase in canonical Wnt signaling. Collectively, these data suggest that activation of ERK signaling is necessary for membrane-associated PRs to enhance OR, and indicate a role for canonical Wnt signaling in the memory-enhancing effects of intracellular PRs. This study provides the first evidence that membrane and intracellular PRs may employ different molecular mechanisms to enhance hippocampal memory. (c) 2014 Wiley Periodicals, Inc.	[Fortress, Ashley M.; Heisler, John D.; Frick, Karyn M.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53211 USA		Frick, KM (corresponding author), Univ Wisconsin, Dept Psychol, 2441 E Hartford Ave, Milwaukee, WI 53211 USA.	frickk@uwm.edu		Frick, Karyn/0000-0002-4237-0208	University of Wisconsin-Milwaukee; Ellison Medical Foundation/AFAR Postdoctoral Fellowship in Aging	Grant sponsors: University of Wisconsin-Milwaukee and an Ellison Medical Foundation/AFAR Postdoctoral Fellowship in Aging (to A.M.F.).	Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Barron Anna M, 2012, Front Biosci (Elite Ed), V4, P976; Ben-Yehoshua LJ, 2007, MOL ENDOCRINOL, V21, P664, DOI 10.1210/me.2006-0256; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bimonte-Nelson HA, 2004, BEHAV NEUROSCI, V118, P707, DOI 10.1037/0735-7044.118.4.707; BITRAN D, 1991, BEHAV NEUROSCI, V105, P653, DOI 10.1037/0735-7044.105.5.653; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; Boras-Granic K, 2013, J MAMMARY GLAND BIOL, V18, P155, DOI 10.1007/s10911-013-9280-x; Boulware MI, 2013, J NEUROSCI, V33, P15184, DOI 10.1523/JNEUROSCI.1716-13.2013; Bove R, 2014, NEUROLOGY, V82, P222, DOI 10.1212/WNL.0000000000000033; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; BROGDEN RN, 1993, DRUGS, V45, P384, DOI 10.2165/00003495-199345030-00007; Bychowski ME, 2012, HORM BEHAV, V61, P598, DOI 10.1016/j.yhbeh.2012.02.009; Camacho-Arroyo I, 1998, NEUROREPORT, V9, P3993, DOI 10.1097/00001756-199812210-00001; Chen DY, 2012, NAT NEUROSCI, V15, P1707, DOI 10.1038/nn.3266; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Cherrier MM, 2009, FRONT HORM RES, V37, P150, DOI 10.1159/000176051; Chesler EJ, 2000, HORM BEHAV, V38, P234, DOI 10.1006/hbeh.2000.1626; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cohen SJ, 2013, CURR BIOL, V23, P1685, DOI 10.1016/j.cub.2013.07.002; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Dong ZF, 2006, HIPPOCAMPUS, V16, P809, DOI 10.1002/hipo.20216; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; FARR SA, 1995, PHYSIOL BEHAV, V58, P715, DOI 10.1016/0031-9384(95)00124-2; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Fernandez SM, 2008, J NEUROSCI, V28, P8660, DOI 10.1523/JNEUROSCI.1968-08.2008; Fortress AM, 2014, FRONT NEUROENDOCRIN, V35, P530, DOI 10.1016/j.yfrne.2014.05.001; Fortress AM, 2013, J NEUROSCI, V33, P12619, DOI 10.1523/JNEUROSCI.0659-13.2013; Fortress AM, 2013, LEARN MEMORY, V20, P147, DOI 10.1101/lm.026732.112; Foy MR, 2011, NEUROBIOL LEARN MEM, V95, P134, DOI 10.1016/j.nlm.2010.11.003; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Frye CA, 2008, NEUROBIOL LEARN MEM, V90, P171, DOI 10.1016/j.nlm.2008.03.005; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Frye CA, 2013, NEUROSCI LETT, V551, P53, DOI 10.1016/j.neulet.2013.07.002; Frye CA, 2010, NEUROSCI LETT, V472, P38, DOI 10.1016/j.neulet.2010.01.051; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Gregory CW, 2001, J ANDROL, V22, P537; Gresack JE, 2007, NEUROBIOL LEARN MEM, V88, P393, DOI 10.1016/j.nlm.2007.07.015; Guennoun R, J STEROID B IN PRESS; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Guerra-Araiza C, 2002, BRAIN RES BULL, V59, P105, DOI 10.1016/S0361-9230(02)00845-6; Hagan CR, 2012, MOL CELL ENDOCRINOL, V357, P43, DOI 10.1016/j.mce.2011.09.017; Harburger LL, 2009, NEUROSCIENCE, V160, P6, DOI 10.1016/j.neuroscience.2009.02.024; Harburger LL, 2008, BEHAV BRAIN RES, V194, P174, DOI 10.1016/j.bbr.2008.07.014; He L, 2011, ARCH MED SCI, V7, P397, DOI 10.5114/aoms.2011.23402; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; HURD C, 1988, BIOCHEMISTRY-US, V27, P3618, DOI 10.1021/bi00410a014; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Karteris E, 2006, MOL ENDOCRINOL, V20, P1519, DOI 10.1210/me.2005-0243; Kato A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00149; KATO J, 1994, HORM BEHAV, V28, P454, DOI 10.1006/hbeh.1994.1043; Lamb R, 2007, E SCHERING FDN S P, V1, P1; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Luine VN, 2003, ENDOCRINOLOGY, V144, P2836, DOI 10.1210/en.2003-0004; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meffre D, 2014, CELL MOL LIFE SCI, V71, P1123, DOI 10.1007/s00018-013-1378-1; Melcangi RC, 2014, PROG NEUROBIOL, V113, P56, DOI 10.1016/j.pneurobio.2013.07.006; Mitterling KL, 2010, J COMP NEUROL, V518, P2729, DOI 10.1002/cne.22361; Molenda-Figueira HA, 2008, ENDOCRINOLOGY, V149, P5272, DOI 10.1210/en.2008-0048; Moore MR, 1997, J STEROID BIOCHEM, V62, P243, DOI 10.1016/S0960-0760(97)00036-8; Oliva CA, 2013, AGEING RES REV, V12, P786, DOI 10.1016/j.arr.2013.03.006; Orr PI, 2009, PHARMACOL BIOCHEM BE, V93, P177, DOI 10.1016/j.pbb.2009.05.012; Orr PT, 2012, HORM BEHAV, V61, P487, DOI 10.1016/j.yhbeh.2012.01.004; Ortiz-Matamoros A, 2013, CURR NEUROPHARMACOL, V11, P465, DOI 10.2174/1570159X11311050001; Phan A, 2012, NEUROPSYCHOPHARMACOL, V37, P2299, DOI 10.1038/npp.2012.82; PITHA J, 1986, J PHARM SCI, V75, P165, DOI 10.1002/jps.2600750213; Proietti C, 2005, MOL CELL BIOL, V25, P4826, DOI 10.1128/MCB.25.12.4826-4840.2005; Purro SA, 2014, J MOL CELL BIOL, V6, P75, DOI 10.1093/jmcb/mjt049; Qu QH, 2013, MOL CELL BIOL, V33, P2551, DOI 10.1128/MCB.00325-13; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Robinson GW, 2000, GENE DEV, V14, P889; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Sani G, 2012, CURR NEUROPHARMACOL, V10, P239, DOI 10.2174/157015912803217279; Satterfield MC, 2008, REPROD FERT DEVELOP, V20, P935, DOI 10.1071/RD08069; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Scott EL, 2013, BRAIN RES, V1514, P63, DOI 10.1016/j.brainres.2012.12.015; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; Skildum A, 2005, MOL ENDOCRINOL, V19, P327, DOI 10.1210/me.2004-0306; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tabatadze N, 2012, HIPPOCAMPUS, V22, P1228, DOI 10.1002/hipo.20991; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Tuscher JJ, BEHAV BRAIN IN PRESS; Varea O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005153; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014; Walf AA, 2006, NEUROBIOL LEARN MEM, V86, P35, DOI 10.1016/j.nlm.2006.01.004; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yoshiya M, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00191; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang Z, 2010, HIPPOCAMPUS, V20, P402, DOI 10.1002/hipo.20642; Zhao ZR, 2012, J NEUROSCI, V32, P2344, DOI 10.1523/JNEUROSCI.5819-11.2012	99	19	19	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	MAY	2015	25	5					616	629		10.1002/hipo.22398			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CH4BF	WOS:000353975200007	25483228				2022-02-06	
J	Legarreta, M; Graham, J; North, L; Bueler, CE; McGlade, E; Yurgelun-Todd, D				Legarreta, Margaret; Graham, Jessica; North, Lindsey; Bueler, C. Elliott; McGlade, Erin; Yurgelun-Todd, Deborah			DSM-5 Posttraumatic Stress Disorder Symptoms Associated With Suicide Behaviors in Veterans	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article						suicide; PTSD; DSM-5; trauma; veterans	TRAUMATIC BRAIN-INJURY; AFGHANISTAN WAR VETERANS; RATING-SCALE; THERAPY BCBT; US VETERANS; RISK-FACTOR; IDEATION; PTSD; IRAQ; DEPRESSION	A connection between suicidality and posttraumatic stress disorder (PTSD) has been consistently demonstrated; however, the underlying relationship between suicidality and PTSD remains unclear. The aim of this study was to examine patterns of DSM-5 PTSD symptom endorsement that differentiated veteran participants with and without a history of suicide behaviors. We enrolled 95 veterans, 32 of whom reported no suicide ideation (SI) or suicide attempts (SA). The 63 remaining participants reported a history of SI, with 28 of the 63 also reporting a historical SA. Participants completed a standardized diagnostic interview (Structured Clinical Interview for DSM-IV-TR; First, Spitzer, Gibbon, & Williams, 2002), structured interview of suicidal behaviors (Columbia-Suicide Severity Rating Scale; Posner et al., 2011), and selected clinical measures. Veterans who reported SI and/or SA were more likely to meet criteria for PTSD on DSM-5 than were veterans who reported neither SI nor SA. Participants who reported SA were more likely to meet criteria for clusters C and D. Finally, at the symptom level, those who reported SI were more likely to report experiencing feelings of alienation. Those who reported a SA were more likely to report avoidance of thoughts and feelings, inability to recall an important aspect of their trauma, persistent negative beliefs, diminished interest, and feelings of alienation. These findings suggest that targeting specific symptoms of PTSD may aid in treatment of suicidal thoughts and behaviors associated with PTSD.	[Legarreta, Margaret; North, Lindsey] Univ Utah, VA Salt Lake City Hlth Care Syst, Rocky Mt Network Mental Illness Res Educ & Clin C, MIRECC,VISN 19,Sch Med, Salt Lake City, UT 84112 USA; [Legarreta, Margaret; North, Lindsey] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; [Graham, Jessica] VA Salt Lake City Hlth Care Syst, Rocky Mt Network Mental Illness Res Educ & Clin C, MIRECC, VISN 19, Salt Lake City, UT USA; [Bueler, C. Elliott; Yurgelun-Todd, Deborah] Univ Utah, Sch Med, Inst Brain, Salt Lake City, UT 84112 USA; [Yurgelun-Todd, Deborah] Univ Utah, VA Salt Lake City Hlth Care Syst, Rocky Mt Network Mental Illness Res Educ & Clin C, MIRECC,VISN 19,Sch Med,Dept Psychiat, Salt Lake City, UT 84112 USA		Legarreta, M (corresponding author), 500 Foothill Dr,Mail Code 116M, Salt Lake City, UT 84148 USA.	margaret.legarreta@va.gov	McGlade, Erin C/K-1157-2016	McGlade, Erin C/0000-0003-2234-1984	Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs; Medical Research Service of the Veterans Affairs Salt Lake City Health Care System; Department of Veterans Affairs Rocky Mountain Network Mental Illness Research, Education, and Clinical Center; Veterans Health Administration Merit Review Grant [5I01CX000253-02]	This research is supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment, the Medical Research Service of the Veterans Affairs Salt Lake City Health Care System, the Department of Veterans Affairs Rocky Mountain Network Mental Illness Research, Education, and Clinical Center, and Veterans Health Administration Merit Review Grant 5I01CX000253-02.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Briere J., 1995, TRAUMA SYMPTOM INVEN; Bryan CJ, 2012, PROF PSYCHOL-RES PR, V43, P130, DOI 10.1037/a0026307; Calabrese JR, 2011, J CLIN PSYCHIAT, V72, P1072, DOI 10.4088/JCP.11m06956; Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Gradus JL, 2013, DEPRESS ANXIETY, V30, P1046, DOI 10.1002/da.22117; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hellmuth JC, 2012, J TRAUMA STRESS, V25, P527, DOI 10.1002/jts.21732; Iannuzzo RW, 2006, PSYCHIAT RES, V145, P21, DOI 10.1016/j.psychres.2005.10.009; Ilgen MA, 2013, JAMA PSYCHIAT, V70, P692, DOI 10.1001/jamapsychiatry.2013.908; Jakupcak M, 2011, J NERV MENT DIS, V199, P272, DOI 10.1097/NMD.0b013e3182124604; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kotler M, 2001, J NERV MENT DIS, V189, P162, DOI 10.1097/00005053-200103000-00004; McCall WV, 2011, SLEEP, V34, P1149, DOI 10.5665/SLEEP.1222; Nye EC, 2007, MIL MED, V172, P1144; Oquendo MA, 2009, CRISIS, V30, P171, DOI 10.1027/0227-5910.30.4.171; Panagioti M, 2013, PSYCHIAT RES, V209, P55, DOI 10.1016/j.psychres.2013.02.018; POLLOCK V, 1979, J NERV MENT DIS, V167, P612, DOI 10.1097/00005053-197910000-00004; Pompili M, 2013, J NERV MENT DIS, V201, P802, DOI 10.1097/NMD.0b013e3182a21458; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Rudd MD, 2012, MIL PSYCHOL, V24, P592, DOI 10.1080/08995605.2012.736325; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Tarrier N, 2004, SOC PSYCH PSYCH EPID, V39, P655, DOI 10.1007/s00127-004-0799-4; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Wilcox HC, 2009, ARCH GEN PSYCHIAT, V66, P305, DOI 10.1001/archgenpsychiatry.2008.557; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	34	19	19	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma	MAY	2015	7	3					277	285		10.1037/tra0000026			9	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	CH8YS	WOS:000354323400010	25793399	Bronze			2022-02-06	
J	Poon, W; Vos, P; Muresanu, D; Vester, J; von Wild, K; Homberg, V; Wang, E; Lee, TMC; Matula, C				Poon, Wai; Vos, Pieter; Muresanu, Dafin; Vester, Johannes; von Wild, Klaus; Hoemberg, Volker; Wang, Ernest; Lee, Tatia M. C.; Matula, Christian			Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery: Design and Methods	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; Cerebrolysin; recovery; multidimensional; neuroprotection	GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; CLINICAL-TRIALS; PEPTIDE PREPARATION; COMA SCALE; NEUROPROTECTION; RECOMMENDATIONS; REHABILITATION; MANAGEMENT; VETERANS	Traumatic brain injury (TBI) is one of the leading causes of injury-related death. In the United States alone, an estimated 1.7 million people sustain a TBI each year, and approximately 5.3 million people live with a TBI-related disability. The direct medical costs and indirect costs such as lost productivity of TBIs totaled an estimated $76.5 billion in the U.S. in the year 2000. Improving the limited treatment options for this condition remains challenging. However, recent reports from interdisciplinary working groups (consisting primarily of neurologists, neurosurgeons, neuropsychologists, and biostatisticians) have stated that to improve TBI treatment, important methodological lessons from the past must be taken into account in future clinical research. An evaluation of the neuroprotection intervention studies conducted over the last 30 years has indicated that a limited understanding of the underlying biological concepts and methodological design flaws are the major reasons for the failure of pharmacological agents to demonstrate efficacy. Cerebrolysin is a parenterally-administered neuro-peptide preparation that acts in a manner similar to endogenous neurotrophic factors. Cerebrolysin has a favorable adverse effect profile, and several meta-analyses have suggested that Cerebrolysin is beneficial as a dementia treatment. CAPTAIN is a randomized, double-blind, placebo-controlled, multi-center, multinational trial of the effects of Cerebrolysin on neuroprotection and neurorecovery after TBI using a multidimensional ensemble of outcome scales. The CAPTAIN trial will be the first TBI trial with a 'true' multidimensional approach based on full outcome scales, while avoiding prior weaknesses, such as loss of information through "dichotomization," or unrealistic assumptions such as "normal distribution."	[Poon, Wai] Chinese Univ Hong Kong, Prince Wales Hosp, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Vos, Pieter] Slingeland Ziekenhuis, Dept Neurol, Doetinchem, Netherlands; [Muresanu, Dafin] Iuliu Hatieganu Univ Med & Pharm, Dept Clin Neurosci, Cluj Napoca, Romania; [Vester, Johannes] Idv Data Anal & Study Planning, Dept Biometry & Clin Res, Krailling, Germany; [von Wild, Klaus] Univ Munster, Fac Med, D-48149 Munster, Germany; [Hoemberg, Volker] SHR Gesundheitszentrum Bad Wimpfen, Wad Wimpfen, Germany; [Wang, Ernest] Natl Neurosci Inst, Dept Neurosurg, Singapore, Singapore; [Lee, Tatia M. C.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Matula, Christian] Med Univ Vienna, Dept Neurosurg, Vienna, Austria		Muresanu, D (corresponding author), Univ Med & Pharm Iuliu Hatieganu, Dept Clin Neurosci, Victor Babes St 8, Cluj Napoca 400012, Romania.	dafinm@ssnn.ro	Muresanu, Fior-Dafin/AAI-8120-2021				AKAI F, 1992, HISTOL HISTOPATHOL, V7, P213; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Banik N, 1996, BIOMETRICAL J, V38, P25, DOI 10.1002/bimj.4710380103; Bauer P, 1999, STAT MED, V18, P1833, DOI 10.1002/(SICI)1097-0258(19990730)18:14<1833::AID-SIM221>3.3.CO;2-V; BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bretz F, 2009, STAT MED, V28, P1181, DOI 10.1002/sim.3538; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Cohen J., 2013, STAT POWER ANAL BEHA; Colditz G A, 1988, Int J Technol Assess Health Care, V4, P637; Coronado V.G., EPIDEMIOLOG IN PRESS; D'Agostino RB, 2006, STAT MED, V25, P541, DOI 10.1002/sim.2508; D'Elia LF., 1996, COLOR TRIALS TEST PR; Degracia Donald J, 2010, J Exp Stroke Transl Med, V3, P59; Dimitrenko A., 2009, MULTIPLE TESTING PRO; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frick H, 1997, BIOMETRICAL J, V39, P125, DOI 10.1002/bimj.4710390112; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Ginsberg MD, 1997, CEREBROVASC DIS, V7, P7, DOI 10.1159/000108237; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hedges L.V., 1985, STAT METHODS META AN; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Huang P, 2008, STAT MED, V27, P3084, DOI 10.1002/sim.3182; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson SC, 2000, BNI Q, P16; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; LACHIN JM, 1992, STAT MED, V11, P1151, DOI 10.1002/sim.4780110903; Lachin JM., 2000, WILEY SER PROB STAT; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaVange LM, 2005, STAT METHODS MED RES, V14, P281, DOI 10.1191/0962280205sm397oa; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P465, DOI 10.1076/1380-3395(200008)22:4;1-0;FT465; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lombardi VRM, 1999, METHOD FIND EXP CLIN, V21, P331, DOI 10.1358/mf.1999.21.5.541910; Lu M, 2001, STAT MED, V20, P1891, DOI 10.1002/sim.841.abs; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MAHONEY F I, 1965, Md State Med J, V14, P61; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Masliah E, 1999, PHARMACOL BIOCHEM BE, V62, P239, DOI 10.1016/S0091-3057(98)00144-0; MAURER W, 1995, BIOMED CHEM PHARM IN, V6, P3; Mitrushina MN, 1999, HDB NORMATIVE DATA N; Muresanu DF, 2012, J CELL MOL MED, V16, P2861, DOI 10.1111/j.1582-4934.2012.01605.x; Muresanu DF, 2010, ACTA NEUROCHIR SUPPL, V106, P291, DOI 10.1007/978-3-211-98811-4_54; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nijboer JMM, 2007, J TRAUMA, V63, P670, DOI 10.1097/01.ta.0000228890.65522.53; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Riley C, 2006, J NEURAL TRANSM, V113, P103, DOI 10.1007/s00702-005-0302-8; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Satou T, 2000, J NEURAL TRANSM, V107, P1253, DOI 10.1007/s007020070015; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sugita Y, 1993, No To Shinkei, V45, P325; TANG DI, 1989, J AM STAT ASSOC, V84, P776, DOI 10.2307/2289665; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; WECHSLER D, 1997, ADULT INTELLIGENCE S, V21; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolfson, 1993, HALSTEAD REITAN NEUR; Wronski R, 2000, J NEURAL TRANSM, V107, P145, DOI 10.1007/s007020050013; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zollikofer CPE, 2002, P NATL ACAD SCI USA, V99, P6444, DOI 10.1073/pnas.082111899; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	87	19	19	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2015	32	8					571	580		10.1089/neu.2014.3558			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CF2BS	WOS:000352352900007	25222349				2022-02-06	
J	Arbour, C; Khoury, S; Lavigne, GJ; Gagnon, K; Poirier, G; Montplaisir, JY; Carrier, J; Gosselin, N				Arbour, Caroline; Khoury, Samar; Lavigne, Gilles J.; Gagnon, Katia; Poirier, Gaetan; Montplaisir, Jacques Y.; Carrier, Julie; Gosselin, Nadia			Are NREM sleep characteristics associated to subjective sleep complaints after mild traumatic brain injury?	SLEEP MEDICINE			English	Article						Brain injury; Electroencephalography; Sleep; Slow oscillations; Sleep spindles	SLOW-WAVE ACTIVITY; EEG ACTIVITY; QUALITY INDEX; SPINDLES; DISTURBANCE; FREQUENCY; INSOMNIA; AGE	Introduction: Sleep complaints are common after mild traumatic brain injury (mTBI). While recent findings suggest that sleep macro-architecture is preserved in mTBI, features of non-rapid eye movement (NREM) sleep micro-architecture including electroencephalography (EEG) spectral power, slow waves (SW), and sleep spindles could be affected. This study aimed to compare NREM sleep in mTBI and healthy controls, and explore whether NREM sleep characteristics correlate with sleep complaints in these groups. Methods: Thirty-four mTBI participants (mean age: 34.2 +/- 11.9 yrs; post-injury delay: 10.5 +/- 10.4 weeks) and 29 age-matched controls (mean age: 32.4 +/- 8.2 yrs) were recruited for two consecutive nights of polysomnographic (PSG) recording. Spectral power was computed and SW and spindles were automatically detected in three derivations (F3, C3, O1) for the first three sleep cycles. Subjective sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI). Results: mTBI participants reported significant poorer sleep quality than controls on the PSQI and showed significant increases in beta power during NREM sleep at the occipital derivation only. Conversely, no group differences were found in SW and spindle characteristics. Interestingly, changes in NREM sleep characteristics were not associated with mTBI estimation of sleep quality. Conclusions: Compared to controls, mTBI were found to have enhanced NREM beta power. However, these changes were not found to be associated with the subjective evaluation of sleep. While increases in beta bands during NREM sleep may be attributable to the occurrence of a brain injury, they could also be related to the presence of pain and anxiety as suggested in one prior study. Crown Copyright (C) 2014 Published by Elsevier B.V. All rights reserved.	[Arbour, Caroline; Khoury, Samar; Lavigne, Gilles J.; Gagnon, Katia; Poirier, Gaetan; Montplaisir, Jacques Y.; Carrier, Julie; Gosselin, Nadia] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Arbour, Caroline; Carrier, Julie; Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Khoury, Samar] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Lavigne, Gilles J.] Univ Montreal, Fac Med Dent, Montreal, PQ H3C 3J7, Canada; [Gagnon, Katia] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Montplaisir, Jacques Y.] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada		Gosselin, N (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada.	nadia.gosselin@umontreal.ca		Carrier, Julie/0000-0001-5311-2370	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec - Sante (FRQ-S); FRQS's Quebec Pain Research Network; Research Centre of the study setting; Canada Research Chair on Pain, Sleep, and Traumatic Injuries; Canada Research Chair on Sleep Medicine	The authors would like to thank Dr Jean-Francois Giguere for his work in the confirmation of participants' mTBI diagnosis. This research was partially supported by the Canadian Institutes of Health Research (CIHR) and by the Fonds de Recherche du Quebec - Sante (FRQ-S) - both for Dr Gosselin. Part of this study was also funded by the FRQS's Quebec Pain Research Network and the Research Centre of the study setting. Dr. Lavigne holds a Canada Research Chair on Pain, Sleep, and Traumatic Injuries. Dr Montplaisir holds a Canada Research Chair on Sleep Medicine.	AASM, 2005, INT CLASS SLEEP DIS; AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Anderer P, 2001, NEUROSCIENCE, V103, P581, DOI 10.1016/S0306-4522(01)00028-8; [Anonymous], 1974, Electroencephalogr Clin Neurophysiol, V37, P538; Armitage R, 2007, SLEEP, V30, P657, DOI 10.1093/sleep/30.5.657; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bader K, 2013, J CLIN NEUROPHYSIOL, V30, P188, DOI 10.1097/WNP.0b013e3182767c4a; Baker FC, 2012, J SLEEP RES, V21, P535, DOI 10.1111/j.1365-2869.2012.01007.x; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carrier J, 2011, EUR J NEUROSCI, V33, P758, DOI 10.1111/j.1460-9568.2010.07543.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Castellanos NP, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00090; Cohen BH, 2008, EXPLAINING PSYCHOL S; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Martin N, 2013, NEUROBIOL AGING, V34, P468, DOI 10.1016/j.neurobiolaging.2012.05.020; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Spiegelhalder K, 2012, BIOL PSYCHOL, V91, P329, DOI 10.1016/j.biopsycho.2012.08.009; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Tsuno N, 2002, J SLEEP RES, V11, P43, DOI 10.1046/j.1365-2869.2002.00288.x; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718	35	19	20	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	APR	2015	16	4					534	539		10.1016/j.sleep.2014.12.002			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CF6TM	WOS:000352689200015	25747335	Green Submitted			2022-02-06	
J	Jackson, TC; Du, LN; Janesko-Feldman, K; Vagni, VA; Dezfulian, C; Poloyac, SM; Jackson, EK; Clark, RSB; Kochanek, PM				Jackson, Travis C.; Du, Lina; Janesko-Feldman, Keri; Vagni, Vincent A.; Dezfulian, Cameron; Poloyac, Samuel M.; Jackson, Edwin K.; Clark, Robert S. B.; Kochanek, Patrick M.			The nuclear splicing factor RNA binding motif 5 promotes caspase activation in human neuronal cells, and increases after traumatic brain injury in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain; neuron; RBM5; RBM10; splicing factors; traumatic brain injury	CANDIDATE TUMOR-SUPPRESSOR; MESSENGER-RNA; MEDIATED APOPTOSIS; SIGNALING COMPLEX; CEREBRAL-CORTEX; IN-VIVO; DEATH; PROTEIN; FLIP; APLP2	Splicing factors (SFs) coordinate nuclear intron/exon splicing of RNA. Splicing factor disturbances can cause cell death. RNA binding motif 5 (RBM5) and 10 (RBM10) promote apoptosis in cancer cells by activating detrimental alternative splicing of key death/survival genes. The role(s) of RBM5/10 in neurons has not been established. Here, we report that RBM5 knockdown in human neuronal cells decreases caspase activation by staurosporine. In contrast, RBM10 knockdown augments caspase activation. To determine whether brain injury alters RBM signaling, we measured RBM5/10 protein in mouse cortical/hippocampus homogenates after controlled cortical impact (CCI) traumatic brain injury (TBI) plus hemorrhagic shock (CCI+HS). The RBM5/10 staining was higher 48 to 72 hours after injury and appeared to be increased in neuronal nuclei of the hippocampus. We also measured levels of other nuclear SFs known to be essential for cellular viability and report that splicing factor 1 (SF1) but not splicing factor 3A (SF3A) decreased 4 to 72 hours after injury. Finally, we confirm that RBM5/10 regulate protein expression of several target genes including caspase-2, cellular FLICE-like inhibitory protein (c-FLIP), LETM1 Domain-Containing Protein 1 (LETMD1), and amyloid precursor-like protein 2 (APLP2) in neuronal cells. Knockdown of RBM5 appeared to increase expression of c-FLIP(s), LETMD1, and APLP2 but decrease caspase-2.	[Jackson, Travis C.; Du, Lina; Janesko-Feldman, Keri; Vagni, Vincent A.; Dezfulian, Cameron; Clark, Robert S. B.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Sch Med, Pittsburgh, PA 15260 USA; [Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Jackson, Edwin K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA		Jackson, TC (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Sch Med, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	jacksontc@upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Jackson, Edwin/0000-0002-8101-6009; Dezfulian, Cameron/0000-0002-4486-0446	NIH/NINDS grant [1R21NS088145, R01NS087978]; US Army grant [W81XWH-10-1-0623]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088145, R01NS087978] Funding Source: NIH RePORTER	This work was supported by NIH/NINDS grant 1R21NS088145 to TCJ, US Army grant W81XWH-10-1-0623 to PMK, and NIH/NINDS grant R01NS087978 to PMK and EKJ.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Bin LH, 2002, FEBS LETT, V510, P37, DOI 10.1016/S0014-5793(01)03222-7; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Carlsson Y, 2011, ANN NEUROL, V70, P781, DOI 10.1002/ana.22431; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cho GW, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-50; Covini N, 1999, EUR J NEUROSCI, V11, P781, DOI 10.1046/j.1460-9568.1999.00485.x; Fushimi K, 2008, P NATL ACAD SCI USA, V105, P15708, DOI 10.1073/pnas.0805569105; Hainsworth AH, 2005, J CEREBR BLOOD F MET, V25, P1030, DOI 10.1038/sj.jcbfm.9600104; Han CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067033; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Inoue A, 2014, FEBS LETT, V588, P942, DOI 10.1016/j.febslet.2014.01.052; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Mourtada-Maarabouni M, 2002, APOPTOSIS, V7, P421, DOI 10.1023/A:1020083008017; O'Bryan MK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003628; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rintala-Maki ND, 2004, APOPTOSIS, V9, P475, DOI 10.1023/B:APPT.0000031455.79352.57; Salon C, 2006, CELL DEATH DIFFER, V13, P260, DOI 10.1038/sj.cdd.4401739; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shariati SAM, 2013, J CELL SCI, V126, P1268, DOI 10.1242/jcs.122440; Solier S, 2005, CELL DEATH DIFFER, V12, P687, DOI 10.1038/sj.cdd.4401594; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Taoufik E, 2007, J NEUROSCI, V27, P6633, DOI 10.1523/JNEUROSCI.1091-07.2007; Ueffing N, 2008, CELL DEATH DIFFER, V15, P773, DOI 10.1038/sj.cdd.4402314; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang K, 2011, RESPIROLOGY, V16, P187; Wang Ke, 2012, J Cell Death, V5, P1, DOI 10.4137/JCD.S9073; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang YB, 2013, EMBO MOL MED, V5, P1431, DOI 10.1002/emmm.201302663; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061198	40	19	20	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	APR	2015	35	4					655	666		10.1038/jcbfm.2014.242			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CE7NF	WOS:000352027900016	25586139	Green Published			2022-02-06	
J	Sun, J; Chen, W				Sun, J.; Chen, W.			Music therapy for coma patients: preliminary results	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Coma; Traumatic brain injury (TBI); Music therapy; Electroencephalography (QEEG)	TRAUMATIC BRAIN-INJURY; STIMULATION	OBJECTIVE: The application of quantitative EEG (delta+theta/alpha+beta value) and GCS value to evaluate the role of music therapy for traumatic brain injury coma patients. PATIENTS AND METHODS: Forty patients of traumatic brain injury coma were selected to meet the inclusion criteria. Twenty cases were selected for the rehabilitation, neurology and neurosurgery ward, whose families could actively cooperate with, and the patients could receive a long-term fixed nursing staff with formal music therapy (music group). Twenty cases were in the intensive care unit of the rehabilitation, neurology and neurosurgery ward. Their families members cooperated poorly, had often changing nursing staff, and without a formal music therapy (control group). After a one monthe follow up, the GCS value and quantitative EEG (delta+theta/alpha+beta value) were compared between the two groups. Between the two groups, except for the presence or absence of formal music therapy, the rest of treatment had no significant difference and was matched by age, gender, and injury types. RESULTS: In 40 cases of traumatic brain injury patients, the GCS value increased in the music group after treatment when compared to the control group. The difference between the two groups was significant (p < 0.05). The quantitative EEG value (delta+theta/alpha+beta value) of music group values were decreased after treatment, and the difference was significant compared with the control group (p < 0.05). CONCLUSIONS: Through the quantitative EEG (delta+theta/alpha+beta value) and the GCS observation score, music therapy in patients with craniocerebral trauma coma has obviously an effect on promoting to regain consciousness. The quantitative EEG (delta+theta/alpha+beta value) can be used as an objective index to evaluate the state of brain function.	[Sun, J.; Chen, W.] Xuzhou Cent Hosp, Dept Rehabil Med, Xuzhou, Jiangsu, Peoples R China		Chen, W (corresponding author), Xuzhou Cent Hosp, Dept Rehabil Med, Xuzhou, Jiangsu, Peoples R China.	chenwei2339@163.com					Abend NS, 2008, PEDIATR CRIT CARE ME, V9, P32, DOI 10.1097/01.PCC.0000288714.61037.56; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Bos S, 1997, ONLINE J KNOWL SYN N, V4, pU3, DOI 10.1111/j.1524-475X.1997.00001.x; Bu C, 2002, JILIN MED J, V23, P161; Celesia GG, 1999, CLIN NEUROPHYSIOL, V110, P203; Chen C, 2011, TODAY NURSE SPECIAL, V2, P54; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; Chen Z, 2011, J MODERN ELECTROPHYS, V18, P60; Dong H, 2013, CHIN J NEUROMED, V12, P296; Fei L, 2007, MED J NATL DEFENDING, V17, P573; Fei W, 2013, HEBEI J TRAD CHIN ME, V35, P31; Gerber CS, 2005, CRIT CARE NURS Q, V28, P94, DOI 10.1097/00002727-200504000-00002; Horn J, 2008, Ned Tijdschr Geneeskd, V152, P308; Huang W, 2007, MODERN CLIN NURSING, V6, P4; Huang W, 2009, CHIN J CRIT CARE MED, V2, P6; Jiaxi L., 2013, GUIDING J TRAD CHIN, V19, P79; Juan L, 2011, SIGNIFICANCE AMBULAT; Kaplan PW, 2000, CLIN NEUROPHYSIOL, V111, P584, DOI 10.1016/S1388-2457(99)00303-X; Karma D, 2006, INDIAN PEDIATR, V43, P856; Kui Z, 2010, SICHUAN MED J, V31, P1425; Le Meifen WS, 2001, SHANGHAI NURSING J, V1, P1; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li S, 2012, MED J CHIN PEOPLES A, V23, P14; Liang F, 2008, CHIN MED GUIDES, V5, P146; Liang Q, 2010, MODERN J INTEGR TRAD, V19, P2967; Liu X, 2004, CLIN ELECTROPHYSIOLO, P288; Lu Z, 2011, RES PROGNOSIS FORECA; Magis D, 2013, CEPHALALGIA, V33, P526, DOI 10.1177/0333102413477739; Man Li GM, 2003, CHIN J NURSING ED, V38, P205; Masdeu JC, 2005, J NEUROL SCI, V236, P55, DOI 10.1016/j.jns.2005.05.001; Ming Y, 2012, PREV TREAT CARDIOCER, V12, P376; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Qing X, 2013, CHIN GEN PRACT, V16, P2584; Qiuli B, 2011, J NURS SCI, V26, P26; Shen Y, 2008, CHIN J PRACT NERVOUS, V11, P17; Shuangyi F, 2009, J EPILEPSY ELECTRONE, V18, P13; Tan X, 1996, CHIN J MODERN MED, V6, P17; Tao Z, 2013, CHIN J NAUTICAL MED, V20, P76; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Wenjian P, 2011, CHIN J CLIN REHABIL, V26, P192; Xiaoying T, 2008, CHIN J REHABIL, V23, P241; Xiuling P, 2013, SHAANXI MED J, V42, P305; Xue X, 2001, J NURS SCI, V16, P484; Yanwei C, 2011, CHIN J NEUROSURG, V27, P56; 陈玉宝, 2012, [中国全科医学, Chinese General Practice], V15, P209; 张丽华, 2008, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V23, P76	47	19	25	2	23	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	APR	2015	19	7					1209	1218					10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CG8TX	WOS:000353587000015	25912580				2022-02-06	
J	Tang, A; Pandit, V; Fennell, V; Jones, T; Joseph, B; O'Keeffe, T; Friese, RS; Rhee, P				Tang, Andrew; Pandit, Viraj; Fennell, Vernard; Jones, Trevor; Joseph, Bellal; O'Keeffe, Terence; Friese, Randall S.; Rhee, Peter			Intracranial pressure monitor in patients with traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Intracranial pressure monitoring; Brain trauma foundation; Mortality after traumatic brain injury	SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; OUTCOMES; GUIDELINES	Background: Brain Trauma Foundation (BTF) guidelines recommend intracranial pressure (ICP) monitoring for traumatic brain injury(TBI) patients with a Glasgow Coma Scale score of 8 or less with an abnormal head computed tomography, or a normal head computed tomography scan with systolic blood pressure <= 90 mm Hg, posturing, or in patients of age >= 40. The benefits of these guidelines on outcome remain unproven. We hypothesized that adherence to BTF guidelines for ICP monitoring does not improve outcomes in patients with TBI. Methods: All TBI patients with an admission Glasgow Coma Scale <= 8 admitted to our level I trauma center over a 3-y period were identified. Adherence to the individual components of our institutional TBI Bundle (ICP monitoring, SpO(2) >= 95%, PaCO2 30-39 mm Hg, systolic blood pressure >= 90 mm Hg, cerebral perfusion pressure >= 60 mm Hg, ICP <= 25mm Hg, and temperature 36 degrees C-37 degrees C) was assessed. Patients were stratified into two groups as follows: patients with ICP monitoring (ICP) and patients without ICP monitoring (no-ICP). Outcome measures were survival and discharge disposition. Multivariate regression analysis was performed. Results: We identified 2618 TBI patients, 261 of whom met the BTF criteria for ICP monitoring. After excluding those with nonsurvivable injuries (n = 67), 194 patients were available for analysis. The two groups were similar in demographics and severity of head injury. Survival rate was higher in the no-ICP group compared with that in the ICP group (98% versus 76%, P < 0.004). Non-monitored patients were discharged with higher levels of function per discharge location (28% home versus 4% home; P < 0.001). Patients without ICP monitoring were 1.21 times more likely to survive compared with that of patients with ICP monitoring (odds ratio: 1.21, 95% confidence interval [1.1-1.9], P = 0.01). In the ICP group, the overall compliance rate to the ICP and cerebral perfusion pressure goals as required by the BTF guidelines was poor. Conclusions: Our data suggest that there is a subset of patients meeting BTF criteria for ICP monitoring that do well without ICP monitoring. This finding should provoke reevaluation of the indication and utility of ICP monitoring in TBI patients. (C) 2015 Elsevier Inc. All rights reserved.	[Tang, Andrew; Pandit, Viraj; Fennell, Vernard; Jones, Trevor; Joseph, Bellal; O'Keeffe, Terence; Friese, Randall S.; Rhee, Peter] Univ Arizona, Div Trauma Emergency Surg Crit Care & Burns, Dept Surg, Tucson, AZ 85724 USA		Tang, A (corresponding author), Univ Arizona, Div Trauma Crit Care & Emergency Surg, Dept Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	atang@surgery.arizona.edu					Akopian G, 2007, AM SURGEON, V73, P447; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; CDC IPaC, 2014, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Lane PL, 2000, CAN J SURG, V43, P442; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255	15	19	20	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2015	194	2					565	570		10.1016/j.jss.2014.11.017			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CD4OC	WOS:000351061900034	25553841				2022-02-06	
J	Xie, HY; Cui, Y; Deng, F; Feng, JC				Xie, Hong-yan; Cui, Yu; Deng, Fang; Feng, Jia-chun			Connexin: a potential novel target for protecting the central nervous system?	NEURAL REGENERATION RESEARCH			English	Article						connexin; gap junction; biosynthetic pathways; biodegradation; brain; central nervous system diseases	SPINAL-CORD-INJURY; GAP-JUNCTION CHANNELS; HEREDITARY SPASTIC PARAPLEGIA; MERZBACHER-LIKE-DISEASE; ALZHEIMERS-DISEASE; PLASMA-MEMBRANE; AMYLOID PLAQUES; GLIOMA-CELLS; ASTROCYTE DYSFUNCTION; TRIGEMINAL GANGLION	Connexin subunits are proteins that form gap junction channels, and play an important role in communication between adjacent cells. This review article discusses the function of connexins/hemichannels/gap junctions under physiological conditions, and summarizes the findings regarding the role of connexins/hemichannels/gap junctions in the physiological and pathological mechanisms underlying central nervous system diseases such as brain ischemia, traumatic brain and spinal cord injury, epilepsy, brain and spinal cord tumor, migraine, neuroautoimmune disease, Alzheimer's disease, Parkinson's disease, X-linked Charcot-Marie-Tooth disease, Pelizaeus-Merzbacher-like disease, spastic paraplegia and maxillofacial dysplasia. Connexins are considered to be a potential novel target for protecting the central nervous system.	[Xie, Hong-yan; Deng, Fang; Feng, Jia-chun] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin Province, Peoples R China; [Cui, Yu] First Peoples Hosp Xianyang, Dept Neurosurg, Xianyang, Shaanxi, Peoples R China		Feng, JC (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin Province, Peoples R China.	defrances2000@163.com; clinicalted@gmail.com			National Natural Science Foundation of China (General Program)National Natural Science Foundation of China (NSFC) [81271293]; National Science Foundation for Young Scientists of China [81000490]	This study was supported by the National Natural Science Foundation of China (General Program), No. 81271293 and the National Science Foundation for Young Scientists of China, No. 81000490.	Abrams CK, 2012, BBA-BIOMEMBRANES, V1818, P2030, DOI 10.1016/j.bbamem.2011.08.015; Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Anders S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0600; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; Bicego M, 2006, NEUROBIOL DIS, V21, P607, DOI 10.1016/j.nbd.2005.09.005; Bruzzone R., 1997, EJB REV, P135; Burra S, 2010, P NATL ACAD SCI USA, V107, P13648, DOI 10.1073/pnas.1009382107; Caltabiano R, 2010, ACTA HISTOCHEM, V112, P529, DOI 10.1016/j.acthis.2009.05.008; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; Damodaram S, 2009, HEADACHE, V49, P5, DOI 10.1111/j.1526-4610.2008.01262.x; De Bock M, 2014, BBA-MOL CELL RES, V1843, P2211, DOI 10.1016/j.bbamcr.2014.04.016; De Bock M, 2014, FEBS LETT, V588, P1259, DOI 10.1016/j.febslet.2014.02.060; Decrock E, 2011, CELL CALCIUM, V50, P310, DOI 10.1016/j.ceca.2011.05.007; Edvinsson L, 2005, BRAIN RES REV, V48, P438, DOI 10.1016/j.brainresrev.2004.09.007; Eugenin EA, 2012, J NEUROIMMUNE PHARM, V7, P499, DOI 10.1007/s11481-012-9352-5; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; Falk MM, 2000, J CELL SCI, V113, P4109; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Fiori MC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00071; Froger N, 2010, MOL CELL NEUROSCI, V45, P37, DOI 10.1016/j.mcn.2010.05.007; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Goadsby PJ, 2009, NEUROSCIENCE, V161, P327, DOI 10.1016/j.neuroscience.2009.03.019; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Guo YH, 2003, AM J PHYSIOL-LUNG C, V285, pL1213, DOI 10.1152/ajplung.00066.2003; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hesketh GG, 2010, CIRC RES, V106, P1153, DOI 10.1161/CIRCRESAHA.108.182147; Huang RP, 1999, J SURG ONCOL, V70, P21, DOI 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.0.CO;2-0; Jamsheer A, 2014, GENE, V539, P157, DOI 10.1016/j.gene.2014.01.066; Johnson RG, 2002, EXP CELL RES, V275, P67, DOI 10.1006/excr.2002.5480; Jordan K, 2001, J CELL SCI, V114, P763; Kameritsch P, 2012, BBA-BIOMEMBRANES, V1818, P1993, DOI 10.1016/j.bbamem.2011.11.016; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Kawasaki A, 2009, NEUROSCIENCE, V160, P61, DOI 10.1016/j.neuroscience.2009.01.080; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Kim MS, 2013, BIOCHEM J, V452, P249, DOI 10.1042/BJ20121821; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Loewenstein Y, 2002, MOL PSYCHIATR, V7, P129, DOI 10.1038/sj.mp.4000994; Long MA, 2002, J NEUROSCI, V22, P10898; Vega JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/589130; Masaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072919; Matsuuchi L, 2013, BBA-BIOMEMBRANES, V1828, P94, DOI 10.1016/j.bbamem.2012.05.014; Mei X, 2010, NEUROSCIENCE, V171, P92, DOI 10.1016/j.neuroscience.2010.08.001; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; Moinfar Z, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00186; Moon Y, 2010, NEUROREPORT, V21, P1135, DOI 10.1097/WNR.0b013e32834051c7; Mylvaganam S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00172; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nagy JI, 1996, BRAIN RES, V717, P173, DOI 10.1016/0006-8993(95)01526-4; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; O'Carroll SJ, 2013, NEUROSCI RES, V75, P256, DOI 10.1016/j.neures.2013.01.004; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Olbina G, 2003, MOL CANCER RES, V1, P690; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Orthmann-Murphy JL, 2007, MOL CELL NEUROSCI, V34, P629, DOI 10.1016/j.mcn.2007.01.010; Orthmann-Murphy JL, 2009, BRAIN, V132, P426, DOI 10.1093/brain/awn328; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Pizzuti Antonio, 2004, Hum Mutat, V23, P286, DOI 10.1002/humu.9220; Pu PY, 2004, CLIN NEUROL NEUROSUR, V107, P49, DOI 10.1016/j.clineuro.2004.03.006; Retamal MA, 2007, J MEMBRANE BIOL, V218, P49, DOI 10.1007/s00232-007-9043-y; REVEL JP, 1967, J CELL BIOL, V33, pC7, DOI 10.1083/jcb.33.3.C7; Roscoe WA, 2007, CELL COMMUN ADHES, V14, P57, DOI 10.1080/15419060701459569; Rufer M, 1996, J NEUROSCI RES, V46, P606, DOI 10.1002/(SICI)1097-4547(19961201)46:5<606::AID-JNR9>3.3.CO;2-2; Schalper KA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00237; Scherer Steven S, 2012, J Peripher Nerv Syst, V17 Suppl 3, P9, DOI 10.1111/j.1529-8027.2012.00424.x; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SEVERS NJ, 1989, CIRC RES, V65, P22, DOI 10.1161/01.RES.65.1.22; Shy ME, 2007, NEUROLOGY, V68, P849, DOI 10.1212/01.wnl.0000256709.08271.4d; Silberstein SD, 2009, CEPHALALGIA, V29, P28, DOI 10.1111/j.1468-2982.2009.01973.x; Sin WC, 2012, BBA-BIOMEMBRANES, V1818, P2058, DOI 10.1016/j.bbamem.2011.10.022; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Soroceanu L, 2001, GLIA, V33, P107, DOI 10.1002/1098-1136(200102)33:2<107::AID-GLIA1010>3.0.CO;2-4; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Spray David C, 2013, Wiley Interdiscip Rev Membr Transp Signal, V2, P1; Stancanelli C, 2012, J PERIPHER NERV SYST, V17, P407, DOI 10.1111/j.1529-8027.2012.00439.x; Steinhauser C, 2012, GLIA, V60, P1192, DOI 10.1002/glia.22313; Stout C, 2004, CURR OPIN CELL BIOL, V16, P507, DOI 10.1016/j.ceb.2004.07.014; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; Theis M, 2003, J NEUROSCI, V23, P766; Thomas Jayakar, 2013, Indian J Dermatol, V58, P383, DOI 10.4103/0019-5154.117311; Tress O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002146; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Wang XY, 2013, CELL MOL NEUROBIOL, V33, P401, DOI 10.1007/s10571-013-9906-y; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Zhang W, 1999, CANCER RES, V59, P1994	105	19	20	2	12	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2015	10	4					659	666		10.4103/1673-5374.155444			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CH6OP	WOS:000354156200032	26170830	Green Published, gold			2022-02-06	
J	Freeman, A; Adams, M; Ashworth, F				Freeman, Anita; Adams, Malcolm; Ashworth, Fiona			An exploration of the experience of self in the social world for men following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Self-conscious emotions; Self-identity; Neuropsychological rehabilitation; Traumatic brain injury	IDENTITY; PEOPLE; SHAME; CONSTRUCTION; DEPRESSION; HEALTH; ANGER	This study explores the lived experience of male survivors of traumatic brain injury (TBI) in relation to perceived changes in their personal and social identity. The aim was to provide an understanding of the individuals' sense of self and sources of emotional distress and growth following injury. Semi-structured interviews were conducted with nine male survivors of TBI (aged 22-59 years). These men were 17 months to 21 years post-injury and were recruited through a UK holistic neuropsychological rehabilitation centre. Transcripts of their accounts were analysed using thematic analysis. Identified dominant themes related to the men's described experience of changes in self relating to their social world, were titled: "abnormality", "hidden", "the old-me-new-me" and "others treat me differently". In response to these emotional experiences the themes of "self-criticism", "need to be as others want me to be" and "withdrawal" emerged. The identified themes are considered alongside the alternative narrative of "positive growth" in relation to current understanding of identity and "self-conscious" emotions. Future research and clinical implications are suggested.	[Freeman, Anita] South London & Maudsley NHS Fdn Trust, London, England; [Adams, Malcolm] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Ashworth, Fiona] Anglia Ruskin Univ, Cambridge, England		Freeman, A (corresponding author), Maudsley Hosp & Inst Psychiat, CASCAID, Community Link Centre, Ground Floor,Douglas Bennett House, London SE5 8AZ, England.	anitafreeman@nhs.net			Oliver Zangwill Centre, Cambridge	The authors gratefully acknowledge the support of the Oliver Zangwill Centre, Cambridge and extend our gratitude to the men who participated in this study. Anita Freeman would also like to thank Prof Malcolm Adams' family for consenting to his authorship following his sad death in 2013 whilst this article was being written.	Antaki C., 2003, DISCOURSE ANAL ONLIN, V1; Ashworth F., 2011, BRAIN IMPAIR, V4, P3272; Baumeister Roy F, 1998, HDB SOCIAL PSYCHOL, V1, P680, DOI DOI 10.1002/PITS.20162; Blinder BJ, 2007, PSYCHIAT ANN, V37, P276; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Burr V, 1995, INTRO SOCIAL CONSTRU; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chiovitti RF, 2003, J ADV NURS, V44, P427, DOI 10.1046/j.0309-2402.2003.02822.x; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Conneeley AL., 2003, BRIT J OCCUP THER, V66, P440; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; DENZIN R, 1989, RES ACT THEORETICAL; Douglas J., 2012, SOCIAL CURE IDENTITY; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Evans J. J., 2006, OL ZANGW CTR 10 ANN; Gilbert P, 2000, PERS INDIV DIFFER, V29, P757, DOI 10.1016/S0191-8869(99)00230-5; GILBERT P, 1994, BRIT J CLIN PSYCHOL, V33, P295, DOI 10.1111/j.2044-8260.1994.tb01125.x; Gilbert P., 2007, PSYCHOTHERAPY COUNSE; Gilbert P, 2006, CLIN PSYCHOL PSYCHOT, V13, P353, DOI 10.1002/cpp.507; Gracey F., 2012, SOCIAL CURE IDENTITY; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Jetten J., 2012, SOCIAL CURE IDENTITY; Jobson L, 2009, CLIN PSYCHOL REV, V29, P368, DOI 10.1016/j.cpr.2009.03.002; Jones J. A., 2011, DISABILITY REHABILIT, V33, P17; Jones J. M., 2010, PSYCHOL HEALTH, V1, P1; Karlovits T, 1999, BRAIN INJURY, V13, P845; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.psych.46.1.209; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lewis M., 1993, HDB EMOTIONS, P353; Mason J., 2002, QUALITATIVE RES; Morgan A., 2000, WHAT IS NARRATIVE TH; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Mukherjee D, 2003, WOMEN THER, V26, P3, DOI 10.1300/J015v26n01_01; Neidenthal P. M., 2006, PSYCHOL EMOTION INTE; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Postmes T., 2006, INDIVIDUALITY GROUP; Power M., 2008, COGNITION EMOTION OR; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Silverman D., 2001, INTERPRETING QUALITA; Slavich GM, 2010, NEUROSCI BIOBEHAV R, V35, P39, DOI 10.1016/j.neubiorev.2010.01.003; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Tajfel H., 1986, PSYCHOL INTERGROUP R, P2; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33; TANGNEY JP, 1992, J PERS SOC PSYCHOL, V62, P669, DOI 10.1037/0022-3514.62.4.669; Tangney JP., 2002, SHAME GUILT; Turner J. C, 1987, REDISCOVERING SOCIAL; TURNER JC, 1994, PERS SOC PSYCHOL B, V20, P454, DOI 10.1177/0146167294205002; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Vogenthaler D R, 1987, Brain Inj, V1, P113; Williams W. H., 2003, NEUROPSYCHOL REHABIL, V8, P43; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	67	19	20	0	33	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 4	2015	25	2					189	215		10.1080/09602011.2014.917686			27	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AZ6BY	WOS:000348304600002	24848538				2022-02-06	
J	Teel, EF; Slobounov, SM				Teel, Elizabeth F.; Slobounov, Semyon M.			Validation of a Virtual Reality Balance Module for Use in Clinical Concussion Assessment and Management	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; VR balance; force plate; BESS; SOT; validation	POSTURAL STABILITY; TASK CONSTRAINTS; DEFICITS; PLAYERS; SKILL	Objective: To determine the criterion and content validity of a virtual reality (VR) balance module for use in clinical practice. Design: Retrospective, VR balance module completed by participants during concussion baseline or assessment testing session. Setting: A Pennsylvania State University research laboratory. Participants: A total of 60 control and 28 concussed students and athletes from the Pennsylvania State University. Interventions: None. Main Outcome Measures: This study examined: (1) the relationship between VR composite balance scores (final, stationary, yaw, pitch, and roll) and area of the center-of-pressure (eyes open and closed) scores and (2) group differences (normal volunteers and concussed student-athletes) on VR composite balance scores. Results: With the exception of the stationary composite score, all other VR balance composite scores were significantly correlated with the center of pressure data obtained from a force platform. Significant correlations ranged from r = -0.273 to -0.704 for the eyes open conditions and from r = -0.353 to -0.876 for the eyes closed condition. When examining group differences on the VR balance composite modules, the concussed group did significantly (P < 0.01) worse on all measures compared with the control group. Conclusions: The VR balance module met or exceeded the criterion and content validity standard set by the current balance tools and may be appropriate for use in a clinical concussion setting.	[Teel, Elizabeth F.; Slobounov, Semyon M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Teel, Elizabeth F.; Slobounov, Semyon M.] Penn State Ctr Sport Concuss Res & Serv, University Pk, PA USA		Slobounov, SM (corresponding author), Penn State Univ, 276 Recreat Bldg, University Pk, PA 16802 USA.	sms18@psu.edu		Teel, Elizabeth/0000-0002-2846-5884	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2R01 NS056227-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056227] Funding Source: NIH RePORTER	Supported by the National Institutes of Health Grant 2R01 NS056227-06 to "The Effects of Mild Traumatic Brain Injury on Neuropsychological Test Scores, Postural Stability and General Brain Function."	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cochrane JL, 2010, MED SCI SPORT EXER, V42, P1535, DOI 10.1249/MSS.0b013e3181d03ba0; Guskiewicz KM, 2011, PM&R, V3, pS445, DOI 10.1016/j.pmrj.2011.08.009; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; IBM Corp, 2010, REL 2010 IBM SPSS ST; Mansell JL, 2012, BRAIN INJURY, V24, P1070; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Newell K, 1994, GAIT POSTURE, V2, P85, DOI [10.1016/0966-6362(94)90097-3, DOI 10.1016/0966-6362(94)90097-3]; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Vaeyens R, 2007, J SPORT EXERCISE PSY, V29, P147, DOI 10.1123/jsep.29.2.147; Valovich TC, 2003, J ATHL TRAINING, V38, P51	19	19	19	2	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2015	25	2					144	148		10.1097/JSM.0000000000000109			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	CD3RP	WOS:000350998200011	24905539	Green Accepted			2022-02-06	
J	Nichol, A; French, C; Little, L; Presneill, J; Cooper, DJ; Haddad, S; Duranteau, J; Huet, O; Skrifvars, M; Arabi, Y; Bellomo, R				Nichol, Alistair; French, Craig; Little, Lorraine; Presneill, Jeffrey; Cooper, D. James; Haddad, Samir; Duranteau, Jacques; Huet, Olivier; Skrifvars, Markus; Arabi, Yaseen; Bellomo, Rinaldo		EPO-TBI Investigators; New Zealand Intensive Care Soc	Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial	TRIALS			English	Article						Traumatic brain injury; Erythropoietin; Outcome; Critical care; Randomised controlled trials	RECOMBINANT-HUMAN-ERYTHROPOIETIN; GLASGOW OUTCOME SCALE; QUALITY-OF-LIFE; CRITICALLY-ILL; BLOOD-TRANSFUSION; EPOETIN-ALPHA; ANEMIA; EFFICACY	Background: Traumatic brain injury is a leading cause of death and disability worldwide. Laboratory and clinical studies demonstrate a possible beneficial effect of erythropoietin in improving outcomes in the traumatic brain injury cohort. However, there are concerns regarding the association of erythropoietin and thrombosis in the critically ill. A large-scale, multi-centre, blinded, parallel-group, placebo-controlled, randomised trial is currently underway to address this hypothesis. Methods/design: The erythropoietin in traumatic brain injury trial is a stratified prospective, multi-centre, randomised, blinded, parallel-group, placebo-controlled phase III trial. It aims to determine whether the administration of erythropoietin compared to placebo improves neurological outcome in patients with moderate or severe traumatic brain injury at six months after injury. The trial is designed to recruit 606 patients between 15 and 65 years of age with severe (Glasgow Coma Score: 3 to 8) or moderate (Glasgow Coma Score: 9 to 12) traumatic brain injury in Australia, New Zealand, Kingdom of Saudi Arabia, France, Finland, Germany and Ireland. Trial patients will receive either subcutaneous erythropoietin or placebo within 24 hours of injury, and weekly thereafter for up to three doses during the intensive care unit admission. The primary outcome will be the combined proportion of unfavourable neurological outcomes at six months: severe disability or death. Secondary outcomes will include the rate of proximal deep venous thrombosis detected by compression Doppler ultrasound, six-month mortality, the proportion of patients with composite vascular events (deep venous thrombosis, pulmonary embolism, myocardial infarction, cardiac arrest and cerebrovascular events) at six months and quality of life with health economic evaluations. Discussion: When completed, the trial aims to provide evidence on the efficacy and safety of erythropoietin in traumatic brain injury patients, and to provide clear guidance for clinicians in their management of this devastating condition.	[Nichol, Alistair; Little, Lorraine; Presneill, Jeffrey; Cooper, D. James; Haddad, Samir; Duranteau, Jacques; Arabi, Yaseen; Bellomo, Rinaldo] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Nichol, Alistair; Cooper, D. James] The Alfred, Dept Intens Care Med, Melbourne, Vic 3004, Australia; [Nichol, Alistair] St Vincents Univ Hosp, Dept Anaesthesia & Intens Care Med, Dublin 4, Ireland; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [French, Craig] Western Hlth, Dept Intens Care, Footscray, Vic 3011, Australia; [French, Craig] Univ Melbourne, North West Acad Ctr, Dept Med, Parkville, Vic 3052, Australia; [Presneill, Jeffrey] Mater Hlth Serv, Dept Intens Care, South Brisbane, Qld 4101, Australia; [Haddad, Samir] King Abdul Aziz Med City, Dept Intens Care, Riyadh 11426, Saudi Arabia; [Duranteau, Jacques] Hop Univ Paris Sud, Hop Bicetre, Assistance Publ Hop Paris, Serv Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France; [Huet, Olivier] Univ Bretagne Ouest, Ctr Hosp Univ Cavale Blanche, Dept Anesthesiol & Intens Care Med, F-29609 Brest, France; [Skrifvars, Markus] Helsinki Univ Hosp, Dept Anaesthesiol & Intens Care Med, FIN-00029 Helsinki, Finland; [Arabi, Yaseen] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Intens Care Dept, Riyadh 11426, Saudi Arabia; [Arabi, Yaseen] King Abdullah Int Med Res Ctr, Riyadh 11426, Saudi Arabia; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Heidelberg, Vic 3084, Australia		Bellomo, R (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	rinaldo.bellomo@austin.org.au	Arabi, Yaseen/ABF-3316-2020; Cooper, D. James/G-7961-2013; French, Craig/ABF-5087-2020; Presneill, Jeffrey J/B-4894-2012	Arabi, Yaseen/0000-0001-5735-6241; Cooper, D. James/0000-0002-5872-9051; French, Craig/0000-0003-1363-9711; Presneill, Jeffrey J/0000-0001-7177-7667; Huet, Olivier/0000-0001-7345-0334; Nichol, Alistair Dualta/0000-0002-4771-5615; Bellomo, Rinaldo/0000-0002-1650-8939; Nichol, Alistair/0000-0002-4689-1238; Micallef, Sharon/0000-0002-8496-2324	Australian National Health and Medical Research Council ProjectNational Health and Medical Research Council of Australia [545901]; Victorian Transport Accident Commission [D162]	EPO-TBI is funded by the Australian National Health and Medical Research Council Project (project grant ID 545901), and the Victorian Transport Accident Commission (project grant ID D162 - formerly, the Victorian Neurotrauma Initiative). The cost of Epoetin alfa was reimbursed to hospital pharmacy departments by using project grant funds. Neither funding agencies nor the manufacturer of Epoetin alfa had any role in the trial design, data collection or analysis. EPO-TBI trial is coordinated by the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Australia and endorsed by the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) and the Irish Critical Care Trials Group. The members of Management Committee are listed in Appendix 3	Abrishamkar S, 2012, J RES MED SCI, V17, P51; Access Economics , 2009, EC COST SPIN CORD IN; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coleman T, 2004, CRIT CARE, V8, P337, DOI 10.1186/cc2897; Cook D, 2008, CAN MED ASSOC J, V178, P1181, DOI 10.1503/cmaj.071366; Cook DJ, 2005, J CRIT CARE, V20, P364, DOI 10.1016/j.jcrc.2005.09.010; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Cummings P, 2014, BMJ-BRIT MED J, V348; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; EuroQol Group, 2014, EQ 5D INSTR DESCR VA; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Grant RL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7450; Jennison C., 2000, GROUP SEQUENTIAL MET; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lykissas MG, 2007, CLIN NEUROL NEUROSUR, V109, P639, DOI 10.1016/j.clineuro.2007.05.013; Marshall LF, J NEUROTRAUMA; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Talving P, 2012, ARCH SURG-CHICAGO, V147, P251, DOI 10.1001/archsurg.2011.1838; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tonia T, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD003407.PUB5; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	34	19	20	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	FEB 8	2015	16								39	10.1186/s13063-014-0528-6			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CB9BT	WOS:000349927000001	25884605	Green Published, gold			2022-02-06	
J	Chohan, MO; Bragina, O; Kazim, SF; Statom, G; Baazaoui, N; Bragin, D; Iqbal, K; Nemoto, E; Yonas, H				Chohan, Muhammad Omar; Bragina, Olga; Kazim, Syed Faraz; Statom, Gloria; Baazaoui, Narjes; Bragin, Denis; Iqbal, Khalid; Nemoto, Edwin; Yonas, Howard			Enhancement of Neurogenesis and Memory by a Neurotrophic Peptide in Mild to Moderate Traumatic Brain Injury	NEUROSURGERY			English	Article						Ciliary neurotrophic factor; Dentate gyrus; Memory; Neurogenesis; Neural stem cells; Therapeutics; Traumatic brain injury	ADULT HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS NEUROGENESIS; LATERAL FLUID PERCUSSION; FIBROBLAST-GROWTH-FACTOR; FOOTBALL-LEAGUE PLAYER; ALZHEIMERS-DISEASE; COGNITIVE RECOVERY; MOUSE MODEL; RISK-FACTOR; REGIONAL DIFFERENCES	BACKGROUND: Traumatic brain injury (TBI) is a risk factor for Alzheimer disease (AD), a neurocognitive disorder with similar cellular abnormalities. We recently discovered a small molecule (Peptide 6) corresponding to an active region of human ciliary neurotrophic factor, with neurogenic and neurotrophic properties in mouse models of AD and Down syndrome. OBJECTIVE: To describe hippocampal abnormalities in a mouse model of mild to moderate TBI and their reversal by Peptide 6. METHODS: TBI was induced in adult C57Bl6 mice using controlled cortical impact with 1.5 mm of cortical penetration. The animals were treated with 50 nmol/d of Peptide 6 or saline solution for 30 days. Dentate gyrus neurogenesis, dendritic and synaptic density, and AD biomarkers were quantitatively analyzed, and behavioral tests were performed. RESULTS: Ipsilateral neuronal loss in CA1 and the parietal cortex and increase in Alzheimer-type hyperphosphorylated tau and A-beta were seen in TBI mice. Compared with saline solution, Peptide 6 treatment increased the number of newborn neurons, but not uncommitted progenitor cells, in dentate gyrus by 80%. Peptide 6 treatment also reversed TBI-induced dendritic and synaptic density loss while increasing activity in trisynaptic hippocampal circuitry, ultimately leading to improvement in memory recall on behavioral testing. CONCLUSION: Long-term treatment with Peptide 6 enhances the pool of newborn neurons in the dentate gyrus, prevents neuronal loss in CA1 and parietal cortex, preserves the dendritic and synaptic architecture in the hippocampus, and improves performance on a hippocampus-dependent memory task in TBI mice. These findings necessitate further inquiry into the therapeutic potential of small molecules based on neurotrophic factors.	[Chohan, Muhammad Omar; Bragina, Olga; Statom, Gloria; Bragin, Denis; Nemoto, Edwin; Yonas, Howard] Univ New Mexico Hosp, Dept Neurosurg, Albuquerque, NM USA; [Kazim, Syed Faraz; Baazaoui, Narjes; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Kazim, Syed Faraz] Suny Downstate Med Ctr, Neural & Behav Sci Grad Program, Brooklyn, NY 11203 USA		Chohan, MO (corresponding author), 1 Univ New Mexico, Dept Neurosurg, MSC 10-5615, Albuquerque, NM 87131 USA.	mchohan@salud.unm.edu	Bragin, Denis/E-5494-2016; Chohan, Muhammad/ABG-1163-2021; Bragina, Olga A/H-6696-2016	Bragin, Denis/0000-0003-4894-0061; Chohan, Muhammad/0000-0003-4542-4651; Bragina, Olga A/0000-0003-2810-9764	Dedicated Health Research Funds from the University of New Mexico; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089, P30GM103400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS091600] Funding Source: NIH RePORTER	The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. This study was supported in part by Dedicated Health Research Funds from the University of New Mexico.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; AITKEN PG, 1986, NEUROSCI LETT, V67, P92, DOI 10.1016/0304-3940(86)90215-6; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Blanchard J, 2011, J NEUROPATH EXP NEUR, V70, P1070, DOI 10.1097/NEN.0b013e318236e9ad; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Chen ZY, 2001, CURR PROTEIN PEPT SC, V2, P261, DOI 10.2174/1389203013381125; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chohan MO, 2005, J NEURAL TRANSM, V112, P1035, DOI 10.1007/s00702-004-0241-9; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; CREPEL V, 1992, NEUROSCIENCE, V47, P579, DOI 10.1016/0306-4522(92)90167-Z; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dodart JC, 2002, GENES BRAIN BEHAV, V1, P142, DOI 10.1034/j.1601-183X.2002.10302.x; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Emerich DF, 2006, CURR GENE THER, V6, P147, DOI 10.2174/156652306775515547; Emsley JG, 2003, EXP NEUROL, V183, P298, DOI 10.1016/S0014-4886(03)00129-8; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Florian C, 2004, BEHAV BRAIN RES, V154, P365, DOI 10.1016/j.bbr.2004.03.003; GAO X, 2011, PLOS ONE, P6; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; INOUE M, 1995, P NATL ACAD SCI USA, V92, P8579, DOI 10.1073/pnas.92.19.8579; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Jiang T, 2013, CURR ALZHEIMER RES, V10, P852; KASS IS, 1986, J PHYSIOL-LONDON, V378, P313, DOI 10.1113/jphysiol.1986.sp016221; Kazim SF, 2014, NEUROBIOL DIS, V71, P110, DOI 10.1016/j.nbd.2014.07.001; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Kreisman NR, 2000, J NEUROPHYSIOL, V83, P1031, DOI 10.1152/jn.2000.83.2.1031; Laeremans A, 2014, BRAIN STRUCT FUNCT; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Magen I, 2014, CURR MED CHEM, V21, P2591, DOI 10.2174/0929867321666140217124945; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Masliah E, 1996, J NEUROSCI, V16, P5795; Miller RG, 2004, AMYOTROPH LATERAL SC, V5, P121, DOI 10.1080/17434470410019988; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Price RD, 2007, PHARMACOL THERAPEUT, V115, P292, DOI 10.1016/j.pharmthera.2007.03.005; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; STOPA EG, 1990, BIOCHEM BIOPH RES CO, V171, P690, DOI 10.1016/0006-291X(90)91201-3; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	88	19	20	0	17	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	FEB	2015	76	2					201	214		10.1227/NEU.0000000000000577			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AZ3SR	WOS:000348147500039	25255260	Green Accepted			2022-02-06	
J	Lu, HY; Li, TC; Tu, YK; Tsai, JC; Lai, HS; Kuo, LT				Lu, Hsueh-Yi; Li, Tzu-Chi; Tu, Yong-Kwang; Tsai, Jui-Chang; Lai, Hong-Shiee; Kuo, Lu-Ting			Predicting Long-Term Outcome After Traumatic Brain Injury Using Repeated Measurements of Glasgow Coma Scale and Data Mining Methods	JOURNAL OF MEDICAL SYSTEMS			English	Article						Glasgow coma scale; Traumatic brain injury; Mortality; Data mining; Projections and predictions	SEVERE HEAD-INJURY; LIKELIHOOD RATIOS; PROGNOSIS; CLASSIFICATION; VALIDATION; MODELS; IMPACT; COMPONENTS; REGRESSION; MORTALITY	Previous studies have identified some clinical parameters for predicting long-term functional recovery and mortality after traumatic brain injury (TBI). Here, data mining methods were combined with serial Glasgow Coma Scale (GCS) scores and clinical and laboratory parameters to predict 6-month functional outcome and mortality in patients with TBI. Data of consecutive adult patients presenting at a trauma center with moderate-to-severe head injury were retrospectively analyzed. Clinical parameters including serial GCS measurements at emergency department, 7th day, and 14th day and laboratory data were included for analysis (n=115). We employed artificial neural network (ANN), naive Bayes (NB), decision tree, and logistic regression to predict mortality and functional outcomes at 6 months after TBI. Favorable functional outcome was achieved by 34.8 % of the patients, and overall 6-month mortality was 25.2 %. For 6-month functional outcome prediction, ANN was the best model, with an area under the receiver operating characteristic curve (AUC) of 96.13 %, sensitivity of 83.50 %, and specificity of 89.73 %. The best predictive model for mortality was NB with AUC of 91.14 %, sensitivity of 81.17 %, and specificity of 90.65 %. Sensitivity analysis demonstrated GCS measurements on the 7th and 14th day and difference between emergency room and 14th day GCS score as the most influential attributes both in mortality and functional outcome prediction models. Analysis of serial GCS measurements using data mining methods provided additional predictive information in relation to 6-month mortality and functional outcome in patients with moderate-to-severe TBI.	[Lu, Hsueh-Yi] Natl Yunlin Univ Sci & Technol, Dept Ind Engn & Management, Douliou City 640, Yun Lin County, Taiwan; [Li, Tzu-Chi] Natl Taiwan Univ Hosp, Dept Nursing, Yun Lin Branch, Taipei 640, Yun Lin County, Taiwan; [Tu, Yong-Kwang; Tsai, Jui-Chang; Kuo, Lu-Ting] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Tu, Yong-Kwang; Tsai, Jui-Chang; Kuo, Lu-Ting] Coll Med, Taipei 100, Taiwan; [Lai, Hong-Shiee] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan		Kuo, LT (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, 7 Chungshan S Rd, Taipei 100, Taiwan.	hylu@yuntech.edu.tw; ci6964@yahoo.com.tw; yktu@ntu.edu.tw; jctsai@ntu.edu.tw; hslai@ntu.edu.tw; kuoluting@gmail.com	Kuo, Lu-Ting/AAU-3205-2021	Lai, Hong-Shiee/0000-0002-7958-2183; Tu, Yong-kwang/0000-0003-2113-1176; TSAI, JUI-CHANG/0000-0003-2723-6841; Kuo, Lu-Ting/0000-0002-1405-8700			Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; [Anonymous], 2010, NAT METHODS, V7, P331, DOI 10.1038/nmeth0510-331; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; Bengio Y, 2004, J MACH LEARN RES, V5, P1089; BOWERS SA, 1980, NEUROSURGERY, V6, P237; Breiman L., 1984, CLASSIFICATION REGRE; Breiman L., 1984, WADSWORTH STAT PROBA; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; CODE C, 1994, CORTEX, V30, P527, DOI 10.1016/S0010-9452(13)80348-6; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; DUJARDIN B, 1994, EUR J EPIDEMIOL, V10, P29, DOI 10.1007/BF01717448; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Frawley W. J., 1996, DATA MIN KNOWL DISC, P661; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gill CJ, 2005, BRIT MED J, V330, P1080, DOI 10.1136/bmj.330.7499.1080; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Jain S, 2008, INJURY, V39, P598, DOI 10.1016/j.injury.2007.06.003; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kamber, 2006, DATA MINING CONCEPTS; Keltch B, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0060-y; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lee SY, 2012, J CLIN NEUROL, V8, P224, DOI 10.3988/jcn.2012.8.3.224; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Lin CC, 2010, INJURY, V41, P869, DOI 10.1016/j.injury.2010.04.023; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Meisel S, 2010, EUR J OPER RES, V206, P1, DOI 10.1016/j.ejor.2009.10.017; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Nelson DW, 2012, J NEUROTRAUM, V29, P2613, DOI 10.1089/neu.2012.2468; OVERGAARD J, 1973, LANCET, V2, P631; Patterson D., 1996, ARTIFICIAL NEURAL NE; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perez R, 2010, SENSORS-BASEL, V10, P10733, DOI 10.3390/s101210733; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; Polat K, 2006, EXPERT SYST APPL, V31, P264, DOI 10.1016/j.eswa.2005.09.019; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1023/A:1022643204877; Quinlan J.R., 2014, C4 5 PROGRAMS MACHIN; Ramesh AN, 2004, ANN ROY COLL SURG, V86, P334, DOI 10.1308/147870804290; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Segal ME, 2006, J HEAD TRAUMA REHAB, V21, P298, DOI 10.1097/00001199-200607000-00003; Sen B, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0018-0; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; TEASDALE G, 1974, LANCET, V2, P81; Ting H, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0094-1; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	69	19	19	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0148-5598	1573-689X		J MED SYST	J. Med. Syst.	FEB	2015	39	2							14	10.1007/s10916-014-0187-x			10	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	CA6EG	WOS:000349001200014	25637541				2022-02-06	
J	Nichols, J; Perez, R; Wu, C; Adelson, PD; Anderson, T				Nichols, Joshua; Perez, Roxy; Wu, Chen; Adelson, P. David; Anderson, Trent			Traumatic Brain Injury Induces Rapid Enhancement of Cortical Excitability in Juvenile Rats	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Cerebral cortex; Epilepsy; Neurophysiology; Synaptic plasticity; Traumatic brain injury	IMMEDIATE POSTTRAUMATIC SEIZURES; PEDIATRIC HEAD-INJURY; METHYL-D-ASPARTATE; IMPACT INJURY; SYNAPTIC INHIBITION; NEURAL INFORMATION; IMMATURE RAT; ADULT MICE; IN-VITRO; EPILEPSY	AimsFollowing a traumatic brain injury (TBI), 5-50% of patients will develop posttraumatic epilepsy (PTE) with children being particularly susceptible. Currently, PTE cannot be prevented and there is limited understanding of the underlying epileptogenic mechanisms. We hypothesize that early after TBI the brain undergoes distinct cellular and synaptic reorganization that facilitates cortical excitability and promotes the development of epilepsy. MethodsTo examine the effect of pediatric TBI on cortical excitability, we performed controlled cortical impact (CCI) on juvenile rats (postnatal day 17). Following CCI, animals were monitored for the presence of epileptiform activity by continuous in vivo electroencephalography (EEG) and/or sacrificed for in vitro whole-cell patch-clamp recordings. ResultsFollowing a short latent period, all animals subjected to CCI developed spontaneous recurrent epileptiform activity within 14days. Whole-cell patch-clamp recordings of layer V pyramidal neurons showed no changes in intrinsic excitability or spontaneous excitatory postsynaptic currents (sEPSCs) properties. However, the decay of spontaneous inhibitory postsynaptic currents (sIPSCs) was significantly increased. In addition, CCI induced over a 300% increase in excitatory and inhibitory synaptic bursting. Synaptic bursting was prevented by blockade of Na+-dependent action potentials or select antagonism of glutamate or GABA-A receptors, respectively. ConclusionOur results demonstrate that CCI in juvenile rats rapidly induces epileptiform activity and enhanced cortical synaptic bursting. Detection of epileptiform activity early after injury suggests it may be an important pathophysiological component and potential indicator of developing PTE.	[Nichols, Joshua; Perez, Roxy; Wu, Chen; Anderson, Trent] Univ Arizona, Coll Med Phoenix, Phoenix, AZ 85004 USA; [Nichols, Joshua] Arizona State Univ, Sch Life Sci, Phoenix, AZ USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA		Anderson, T (corresponding author), Univ Arizona, Coll Med Phoenix, 425 N 5th St, Phoenix, AZ 85004 USA.	andersot@email.arizona.edu	Adelson, David/W-2083-2019		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS087031] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087031] Funding Source: NIH RePORTER		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bauer J, 2001, SEIZURE-EUR J EPILEP, V10, P239, DOI 10.1053/seiz.2000.0499; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Calcagnotto ME, 2005, J NEUROSCI, V25, P9649, DOI 10.1523/JNEUROSCI.2687-05.2005; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cuccurullo S., 2004, PHYS MED REHABILITAT; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Evans R., 2006, NEUROLOGY AND TRAUMA; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; Gajda Z, 2006, EPILEPSIA, V47, P1009, DOI 10.1111/j.1528-1167.2006.00573.x; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gill R, 2013, EUR J NEUROSCI, V38, P3554, DOI 10.1111/ejn.12367; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; GUATTEO E, 1994, NEUROSCI LETT, V175, P117, DOI 10.1016/0304-3940(94)91093-6; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Holmes JF, 2004, ANN EMERG MED, V43, P706, DOI 10.1016/j.annemergmed.2003.11.008; HORITA H, 1991, BRAIN DEV-JPN, V13, P200, DOI 10.1016/S0387-7604(12)80032-5; Houston CM, 2009, J NEUROSCI, V29, P10416, DOI 10.1523/JNEUROSCI.1670-09.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Liu NK, 2013, BRAIN RES, V1499, P121, DOI 10.1016/j.brainres.2012.12.031; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; Peters A., 1984, CEREBRAL CORTEX, V1; Prince D A, 1986, Adv Neurol, V44, P275; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Ramantani G, 2013, EPILEPTIC DISORD, V15, P365, DOI 10.1684/epd.2013.0619; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; SATO H, 1979, FOLIA PSYCHIAT NEU J, V33, P323; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Telfeian AE, 1998, EPILEPSIA, V39, P700, DOI 10.1111/j.1528-1157.1998.tb01154.x; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; WISE SP, 1975, BRAIN RES, V90, P139, DOI 10.1016/0006-8993(75)90688-5; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zayachkivsky A, 2013, J NEUROPHYSIOL, V109, P900, DOI 10.1152/jn.00593.2012; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003	81	19	20	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	FEB	2015	21	2			SI		193	203		10.1111/cns.12351			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CA3YL	WOS:000348841000013	25475223	Green Submitted, Green Accepted, Green Published			2022-02-06	
J	Lauro, C; Catalano, M; Di Paolo, E; Chece, G; de Costanzo, I; Trettel, F; Limatola, C				Lauro, Clotilde; Catalano, Myriam; Di Paolo, Eleonora; Chece, Giuseppina; de Costanzo, Ida; Trettel, Flavia; Limatola, Cristina			Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						CX3CL1; NMDA; A(2A)R; D-serine; neuroprotection; excitotoxicity	METHYL-D-ASPARTATE; RAT HIPPOCAMPAL-NEURONS; CORTICAL CELL-CULTURE; NMDA RECEPTORS; D-SERINE; MOLECULAR-MECHANISMS; ADENOSINE RECEPTORS; NR2 SUBUNITS; BRAIN; EXPRESSION	Neuronal death induced by overactivation of N-methyl-d-aspartate receptors (NMDARs) is implicated in the pathophysiology of many neurodegenerative diseases such as stroke, epilepsy and traumatic brain injury. This toxic effect is mainly mediated by NR2B-containing extrasynaptic NMDARs, while NR2A-containing synaptic NMDARs contribute to cell survival, suggesting the possibility of therapeutic approaches targeting specific receptor subunits. We report that fractalkine/CX3CL1 protects hippocampal neurons from NMDA-induced cell death with a mechanism requiring the adenosine receptors type 2(A) (A(2A)R). This is different from CX3CL1-induced protection from glutamate (Glu)-induced cell death, that fully depends on A(1)R and requires in part A(3)R. We show that CX3CL1 neuroprotection against NMDA excitotoxicity involves D-serine, a co-agonist of NR2A/NMDAR, resulting in cyclic AMP-dependent transcription factor cyclic-AMP response element-binding protein (CREB) phosphorylation.	[Lauro, Clotilde; Catalano, Myriam; Chece, Giuseppina; de Costanzo, Ida; Trettel, Flavia; Limatola, Cristina] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Catalano, Myriam; Limatola, Cristina] Ist Ricovero & Cura Carattere Sci Neuro Med, Pozzilli, Italy; [Di Paolo, Eleonora] Univ Milan, Dept Biosci, Milan, Italy		Lauro, C (corresponding author), Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dept Physiol & Pharmacol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	clotilde.lauro@uniroma1.it	Lauro, Clotilde/Q-6110-2016	DI PAOLO, ELEONORA/0000-0003-4798-6631; Catalano, Myriam/0000-0003-4638-9202; trettel, flavia/0000-0002-7983-2955	Associazione Italiana Ricerca sul Cancro (AIRC) Investigator GrantFondazione AIRC per la ricerca sul cancro [IG12774]	We thanks Prof. Bertil B. Fredholm for critical reading and suggestions and for providing us A<INF>1</INF>R<SUP>-/-</SUP>, A<INF>2A</INF>R<SUP>-/-</SUP> and A<INF>3</INF>R<SUP>-/-</SUP> mice. This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC) Investigator Grant IG12774.	Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1987, J NEUROSCI, V7, P369; Deiva K, 2004, EUR J NEUROSCI, V20, P3222, DOI 10.1111/j.1460-9568.2004.03800.x; Ghasemi M, 2014, NEUROSCI BIOBEHAV R, V47, P336, DOI 10.1016/j.neubiorev.2014.08.017; Grabb MC, 1999, J NEUROSCI, V19, P1657; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hetman M, 2000, ACTA NEUROBIOL EXP, V60, P531; IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jiang XY, 2005, J NEUROCHEM, V94, P713, DOI 10.1111/j.1471-4159.2005.03200.x; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Koles L, 2001, NEUROCHEM RES, V26, P925, DOI 10.1023/A:1012380416876; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Lauro C, 2008, J IMMUNOL, V180, P7590, DOI 10.4049/jimmunol.180.11.7590; Lauro C, 2010, NEUROPSYCHOPHARMACOL, V35, P1550, DOI 10.1038/npp.2010.26; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Li X, 2014, CNS NEUROSCI THER, V20, P951, DOI 10.1111/cns.12308; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martire A, 2010, NEUROBIOL DIS, V37, P99, DOI 10.1016/j.nbd.2009.09.012; MATSUI T, 1995, J NEUROCHEM, V65, P454; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Navon H, 2012, J MOL NEUROSCI, V46, P100, DOI 10.1007/s12031-011-9532-4; Nicotera P, 1999, BIOCHEM SOC SYMP, V66, P69, DOI 10.1042/bss0660069; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Rosito M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00193; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scianni M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-108; Shimazaki K, 1998, NEUROREPORT, V9, P1875, DOI 10.1097/00001756-199806010-00038; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tebano MT, 2005, J NEUROCHEM, V95, P1188, DOI 10.1111/j.1471-4159.2005.03455.x; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 1999, J NEUROSCI, V19, P4180; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; VOLONTE C, 1994, CYTOMETRY, V17, P274, DOI 10.1002/cyto.990170311; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Yang ZJ, 2013, J CEREBR BLOOD F MET, V33, P1612, DOI 10.1038/jcbfm.2013.117; Zhou Q, 2013, NEUROPHARMACOLOGY, V74, P69, DOI 10.1016/j.neuropharm.2013.03.030	59	19	19	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JAN 21	2015	8								472	10.3389/fncel.2014.00472			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA7CG	WOS:000349074300001	25653593	Green Published, gold			2022-02-06	
J	Peterson, JR; Eboda, ON; Brownley, RC; Cilwa, KE; Pratt, LE; De La Rosa, S; Agarwal, S; Buchman, SR; Cederna, PS; Morris, MD; Wang, SC; Levi, B				Peterson, Jonathan R.; Eboda, Oluwatobi N.; Brownley, R. Cameron; Cilwa, Katherine E.; Pratt, Lauren E.; De La Rosa, Sara; Agarwal, Shailesh; Buchman, Steven R.; Cederna, Paul S.; Morris, Michael D.; Wang, Stewart C.; Levi, Benjamin			Effects of Aging on Osteogenic Response and Heterotopic Ossification Following Burn Injury in Mice	STEM CELLS AND DEVELOPMENT			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS; DIFFERENTIATION; PROLIFERATION; PATHWAYS; GROWTH; MOUSE; TUMOR	Heterotopic ossification (HO) is a common and debilitating complication of burns, traumatic brain injuries, and musculoskeletal trauma and surgery. Although the exact mechanism of ectopic bone formation is unknown, mesenchymal stem cells (MSCs) capable of osteogenic differentiation are known to play an essential role. Interestingly, the prevalence of HO in the elderly population is low despite the high overall occurrence of musculoskeletal injury and orthopedic procedures. We hypothesized that a lower osteogenicity of MSCs would be associated with blunted HO formation in old compared with young mice. In vitro osteogenic differentiation of adipose-derived MSCs from old (18-20 months) and young (6-8 weeks) C57/BL6 mice was assessed, with or without preceding burn injury. In vivo studies were then performed using an Achilles tenotomy with concurrent burn injury HO model. HO formation was quantified using mu CT scans, Raman spectroscopy, and histology. MSCs from young mice had more in vitro bone formation, upregulation of bone formation pathways, and higher activation of Smad and nuclear factor kappa B (NF-kappa B) signaling following burn injury. This effect was absent or blunted in cells from old mice. In young mice, burn injury significantly increased HO formation, NF-kappa B activation, and osteoclast activity at the tenotomy site. This blunted, reactive osteogenic response in old mice follows trends seen clinically and may be related to differences in the ability to mount acute inflammatory responses. This unique characterization of HO and MSC osteogenic differentiation following inflammatory insult establishes differences between age populations and suggests potential pathways that could be targeted in the future with therapeutics.	[Peterson, Jonathan R.; Eboda, Oluwatobi N.; Brownley, R. Cameron; Pratt, Lauren E.; De La Rosa, Sara; Agarwal, Shailesh; Buchman, Steven R.; Cederna, Paul S.; Levi, Benjamin] Univ Michigan, Div Plast Surg, Dept Surg, Ann Arbor, MI 48109 USA; [Cilwa, Katherine E.; Morris, Michael D.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Wang, Stewart C.; Levi, Benjamin] Univ Michigan, Dept Surg, Div Burn Surg, Ann Arbor, MI 48109 USA		Levi, B (corresponding author), Univ Michigan, Div Plast Surg, Dept Surg, 1500 East Med Ctr Dr,Room A552 MSRB2, Ann Arbor, MI 48109 USA.	benlevimd@gmail.com	Cilwa, Katherine/N-3840-2016	Cilwa, Katherine/0000-0003-3828-884X	Plastic Surgery Foundation National Endowment Award;  [R01 AR055222];  [1K08GM109105-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR055222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM109105] Funding Source: NIH RePORTER	The authors thank Kevin Heist, Benjamin Hoff, Amanda Fair, and the staff of the Center for Molecular Imaging at UM for their assistance with animal care and mu CT scanning. Source of funding: R01 AR055222, 1K08GM109105-01, and Plastic Surgery Foundation National Endowment Award.	Alfieri KA, 2012, BONE JOINT RES, V1, P174, DOI 10.1302/2046-3758.18.2000102; Chakkalakal SA, 2012, J BONE MINER RES, V27, P1746, DOI 10.1002/jbmr.1637; Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x; Chen SQ, 2001, J BIOL CHEM, V276, P39259, DOI 10.1074/jbc.M105335200; Culbert AL, 2014, STEM CELLS, V32, P1289, DOI 10.1002/stem.1633; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eguchi Y, 2010, J BONE MINER METAB, V28, P157, DOI 10.1007/s00774-009-0127-x; Finnerty CC, 2008, MOL MED, V14, P553, DOI 10.2119/2007-00132.Finnerty; Fleet JC, 1996, ENDOCRINOLOGY, V137, P4605, DOI 10.1210/en.137.11.4605; Flurkey K, 2007, MOUSE BIOMEDICAL RES, V2, P637; Gala K, 2011, CELL BIOL INT, V35, P1055, DOI 10.1042/CBI20100586; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; HCUP Nationwide Inpatient Sample (NIS), 2010, HCUP NAT INP SAMPL N; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Ipaktchi K, 2007, SURGERY, V142, P86, DOI 10.1016/j.surg.2007.02.007; James AW, 2008, PLAST RECONSTR SURG, V122, P53, DOI 10.1097/PRS.0b013e31817747b5; Janicki P, 2011, EUR CELLS MATER, V21, P488, DOI 10.22203/eCM.v021a37; Kamiya N, 2008, J BONE MINER RES, V23, P2007, DOI 10.1359/JBMR.080809; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Levi B, 2011, STEM CELLS, V29, P2018, DOI 10.1002/stem.757; Levi B, 2011, PLAST RECONSTR SURG, V128, P373, DOI 10.1097/PRS.0b013e31821e6e49; Levi B, 2011, STEM CELLS, V29, P1241, DOI 10.1002/stem.670; Levi B, 2011, STEM CELLS DEV, V20, P243, DOI 10.1089/scd.2010.0250; Levi B, 2010, PLAST RECONSTR SURG, V126, P41, DOI 10.1097/PRS.0b013e3181da8858; Mace JE, 2012, BURNS, V38, P599, DOI 10.1016/j.burns.2011.10.013; Medici D, 2012, J BONE MINER RES, V27, P1619, DOI 10.1002/jbmr.1691; Nelson ER, 2012, J BURN CARE RES, V33, P463, DOI 10.1097/BCR.0b013e31825af547; Niederbichler AD, 2011, J SURG RES, V165, P128, DOI 10.1016/j.jss.2009.06.012; Patel SA, 2009, J INFLAMM RES, V2, P13; Peterson JR, 2014, ANN SURG, V259, P993, DOI 10.1097/SLA.0b013e318291da85; Peterson JR, 2013, BONE, V54, P28, DOI 10.1016/j.bone.2013.01.002; Potter BK, 2010, J BONE JOINT SURG AM, V92A, P74, DOI 10.2106/JBJS.J.00776; Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517; Shore EM, 2011, J BONE MINER RES, V26, P1163, DOI 10.1002/jbmr.404; Song DS, 2011, J PERIODONTAL RES, V46, P193, DOI 10.1111/j.1600-0765.2010.01328.x; Sun XF, 2007, HISTOL HISTOPATHOL, V22, P1387, DOI 10.14670/HH-22.1387; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wosczyna MN, 2012, J BONE MINER RES, V27, P1004, DOI 10.1002/jbmr.1562; Xu Y, 2008, PLAST RECONSTR SURG, V122, P1649, DOI 10.1097/PRS.0b013e31818cbf44	41	19	22	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	JAN 15	2015	24	2					205	213		10.1089/scd.2014.0291			9	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	AY4IR	WOS:000347542000007	25122460	Green Published, Green Submitted			2022-02-06	
J	Duff, MC; Stuck, S				Duff, Melissa C.; Stuck, Sarah			Paediatric concussion: Knowledge and practices of school speech-language pathologists	BRAIN INJURY			English	Article						Assessment; concussion; management; mild traumatic brain injury; speech language pathology	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; SEX-DIFFERENCES; EPIDEMIOLOGY; LONG; AGE	Primary objective: To characterize paediatric concussion knowledge and the management practices of school-based speech-language pathologists (SLPs) in the US to establish a baseline upon which changes in SLP training, knowledge and best practices can be measured. Research design: A survey was developed to assess current knowledge and management of paediatric concussion allowing for comparison to previous and future surveys on SLP knowledge and practice in other areas of brain injury. Methods and procedures: One thousand surveys were distributed to school-based SLPs from 10 states. Two hundred and eighty SLPs from Minnesota, Wisconsin, New York, Massachusetts, Georgia, Florida, Texas, Tennessee, California and Arizona responded to the survey. Main outcomes and results: Compared to previous survey results, SLPs from the current sample indicate an increase in general brain injury training, but confidence in providing clinical services to brain-injured students remains low. SLPs have a mix of accurate and inaccurate concussion knowledge and uncertainty about their role in concussion management. Conclusions: Findings suggest that increasing communication with other school personnel about concussion, increased training in paediatric TBI and concussion improved access to appropriate assessments tools and implementation of long-term concussion management will improve service delivery to school-aged children with concussion.	[Duff, Melissa C.; Stuck, Sarah] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Duff, Melissa C.] Univ Iowa, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA		Duff, MC (corresponding author), Univ Iowa, Dept Commun Sci & Disorders, 250 Hawkins Dr, Iowa City, IA 52242 USA.	melissa-duff@uiowa.edu					American Speech-Language Hearing Association, 2010, 2010 SCH SURV REP SU; American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; American Speech-Language-Hearing Association, 2007, SCOP PRACT SPEECH LA; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Binder LM, 2006, J CLIN EXPT NEUROPSY, V8, P323; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Collins Michael W, 2002, Curr Sports Med Rep, V1, P12; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Duff M. C., 2009, ASHA LEADER; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duff MC, 2003, AM SPEECH LANG HEAR; Echenmend R, 2006, SPORTS NEUROPSYCHOLO; Fjordak BS, 2011, PROTECTING STUDENT A; Frank EM, 1997, J CHILDRENS COMMUNIC, V18, P49, DOI 10.1177/152574019701800206; Gamino JF, 2009, TOP LANG DISORD, V24, P1; Haarauer-Krupa J., 2012, SCH TBI SERVICE PROV; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Hux K, 1996, INTERV SCH CLIN, V31, P158, DOI 10.1177/105345129603100305; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Kay T, 2006, MINOR HEAD INJURY IN; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Lovell M. R., 2004, TRAUMATIC BRAIN INJU; McCrea M, 2008, TRAUMATIC BRAIN INJU; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McGrane SA, 2000, BRAIN INJURY, V14, P975; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Russell N, 1993, LANG SPEECH HEAR SER, V24, P67; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Todis B., 2007, BRAIN INJURY PROFESS, V3, P33; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; Webb C, 1996, BRAIN INJURY, V10, P303, DOI 10.1080/026990596124476; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P222	43	19	19	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					64	77		10.3109/02699052.2014.965747			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000009	25313854				2022-02-06	
J	Hendricks, DJ; Sampson, E; Rumrill, P; Leopold, A; Elias, E; Jacobs, K; Nardone, A; Scherer, M; Stauffer, C				Hendricks, Deborah J.; Sampson, Elaine; Rumrill, Phillip; Leopold, Anne; Elias, Eileen; Jacobs, Karen; Nardone, Amanda; Scherer, Marcia; Stauffer, Callista			Activities and interim outcomes of a multi-site development project to promote cognitive support technology use and employment success among postsecondary students with traumatic brain injuries	NEUROREHABILITATION			English	Article						Cognitive support technology; traumatic brain injury	AFGHANISTAN; COMPUTER; PEOPLE; IRAQ	BACKGROUND: This article describes the activities and interim outcomes of a multi-site development project called Project Career, designed to promote cognitive support technology (CST) use and employment success for college and university students with traumatic brain injuries (TBIs). OBJECTIVES: To obtain early intervention results from participants in Project Career's first 18 months of operation. METHODS: Fifty-six students with TBI have participated to date across three implementation sites in Massachusetts, Ohio, and West Virginia, with 25 of these participants being military veterans. Descriptive analyses provide information regarding the participants, the barriers they face due to their TBI in obtaining a post-secondary education, and the impact services provided by Project Career have had to date in ameliorating those difficulties. Inferential statistical analyses provide preliminary results regarding program effectiveness. RESULTS: Preliminary results indicate the program is encouraging students to use CST strategies in the form of iPads and cognitive enhancement applications (also known as 'apps'). Significant results indicate participants are more positive, independent, and social; participants have a more positive attitude toward technology after six months in the program; and participants reported significantly improved experiences with technology during their first six months in the program. CONCLUSION: Participating students are actively preparing for their careers after graduation through a wide range of intensive vocational supports provided by project staff members.	[Hendricks, Deborah J.; Sampson, Elaine] W Virginia Univ, Morgantown, WV 26506 USA; [Rumrill, Phillip; Stauffer, Callista] Kent State Univ, Kent, OH 44242 USA; [Leopold, Anne; Elias, Eileen] JBS Int Inc, North Bethesda, MD USA; [Jacobs, Karen; Nardone, Amanda] Boston Univ, Boston, MA 02215 USA; [Scherer, Marcia] Univ Rochester, Rochester, NY USA		Hendricks, DJ (corresponding author), W Virginia Univ, POB 6080, Morgantown, WV 26506 USA.	hendricks@jan.wvu.edu		Jacobs, Karen/0000-0002-4718-990X; Scherer, Marcia/0000-0001-8374-6526	United States Department of Education, NIDRRUS Department of Education [H133A130066]	The contents of this article were developed under a grant from the United States Department of Education, NIDRR grant #H133A130066. However, those contents do not necessarily represent the policy of the Department of Education, and readers should not assume endorsement by the Federal Government.	BETZ NE, 2001, MANUAL CAREER DECISI; Bureau of Labor Statistics, 2011, USDL121125 BUR LAB S; CARROLL JM, 1993, INTERACT COMPUT, V5, P3, DOI 10.1016/0953-5438(93)90022-L; Centers for Disease Control and Prevention (CDC), 2014, RAT TBI REL EM DEP V; Crites J. O., 2011, CAREER MATURITY INVE; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Garber B., 2015, TRAUMATIC BRAIN INJU; Gilchrist J., 2011, NONFATAL TRAUMATIC B; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; ROESSLER RT, 2006, CASE MANAGEMENT REHA; Rumrill P., J OCCUPATIONAL REHAB; Sauer A. L., 2010, DISABILITY REHABILIT, V5, P1; Scherer M. J., 2012, ASSISTIVE TECHNOLOGI; Scherer MJ, 2005, MATCHING PERSON TECH; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; United States Army, 2015, US NATO PARTN MEET D; US Department of Education National Center for Education Statistics, 2014, 2014083 NCES US DEP; Wagner M., 2005, HIGH SCH 1 LOOK POST; Wehman P., 2013, LIFE CLASSROOM; Wehman P, 2014, NEUROREHABILITATION, V34, P365, DOI 10.3233/NRE-131029; Wehmeyer M. L., 2003, INT REV RES MENTAL R; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; World Health Organization, 2006, NEUROLOGICAL DISORDE, P164; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006	28	19	19	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	37	3					449	458		10.3233/NRE-151273			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY3QH	WOS:000366324100010	26484525				2022-02-06	
J	McKenzie, ED; Spiegel, P; Khalifa, A; Mateen, FJ				McKenzie, Erica D.; Spiegel, Paul; Khalifa, Adam; Mateen, Farrah J.			Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012-2013	CONFLICT AND HEALTH			English	Article						Refugees; Health services; Syria; Iraq; Humanitarian emergencies; Psychiatry		Background: The burden of neuropsychiatric disorders in refugees is likely high, but little has been reported on the neuropsychiatric disorders that affect Syrian and Iraqi refugees in a country of first asylum. This analysis aimed to study the cost and burden of neuropsychiatric disorders among refugees from Syria and Iraq requiring exceptional, United Nations-funded care in a country of first asylum. Methods: The United Nations High Commissioner for Refugees works with multi-disciplinary, in-country exceptional care committees to review refugees' applications for emergency or exceptional medical care. Neuropsychiatric diagnoses among refugee applicants were identified through a retrospective review of applications to the Jordanian Exceptional Care Committee (2012-2013). Diagnoses were made using International Classification of Disease-10th edition codes rendered by treating physicians. Results: Neuropsychiatric applications accounted for 11% (264/2526) of all Exceptional Care Committee applications, representing 223 refugees (40% female; median age 35 years; 57% Syrian, 36% Iraqi, 7% other countries of origin). Two-thirds of neuropsychiatric cases were for emergency care. The total amount requested for neuropsychiatric disorders was 925,674 USD. Syrian refugees were significantly more likely to request neurotrauma care than Iraqis (18/128 vs. 3/80, p = 0.03). The most expensive care per person was for brain tumor (7,905 USD), multiple sclerosis (7,502 USD), and nervous system trauma (6,466 USD), although stroke was the most frequent diagnosis. Schizophrenia was the most costly and frequent diagnosis among the psychiatric disorders (2,269 USD per person, 27,226 USD total). Conclusions: Neuropsychiatric disorders, including those traditionally considered outside the purview of refugee health, are an important burden to health among Iraqi and Syrian refugees. Possible interventions could include stroke risk factor reduction and targeted medication donations for multiple sclerosis, epilepsy, and schizophrenia.	[McKenzie, Erica D.; Mateen, Farrah J.] Massachusetts Gen Hosp, Dept Neurol, 165 Cambridge St,627, Boston, MA 02114 USA; [McKenzie, Erica D.] Queens Univ, Sch Med, Kingston, ON, Canada; [Spiegel, Paul] United Nations High Commissioner Refugees, Geneva, Switzerland; [Khalifa, Adam] United Nations High Commissioner Refugees, Damascus, Syria; [Mateen, Farrah J.] Harvard Med Sch, Boston, MA USA		Mateen, FJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, 165 Cambridge St,627, Boston, MA 02114 USA.	fmateen@partners.org	Spiegel, Paul/AAL-3238-2021	McKenzie, Erica/0000-0003-4369-413X; Mateen, Farrah/0000-0002-4293-8115			Aylward RB, 2014, LANCET, V383, P489, DOI 10.1016/S0140-6736(14)60132-X; Doocy S, 2013, INT J HEALTH PLAN M, V28, pe1, DOI 10.1002/hpm.2119; Editorial L, 2013, LANCET, V381; Mateen FJ, 2012, NEUROLOGY, V79, P937, DOI 10.1212/WNL.0b013e318266fcf1; Mateen FJ, 2012, J NEUROL, V259, P694, DOI 10.1007/s00415-011-6248-x; Murshidi MM, 2013, LANCET, V382, P206, DOI 10.1016/S0140-6736(13)61506-8; Sherlock R., 2014, JORDAN REPEALS FREE; Spiegel P, 2014, LANCET ONCOL, V15, pE290, DOI 10.1016/S1470-2045(14)70067-1; UNHCR Jordan Public Health Unit, 2011, GUID UNHCR SUPP HLTH; UNHCR-Public Health and HIV Section, 2008, UNHCR PRINC GUID REF; Yanni EA, 2013, J IMMIGR MINOR HEALT, V15, P1, DOI 10.1007/s10903-012-9578-6	11	19	19	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1752-1505			CONFL HEALTH	Confl. Health		2015	9								10	10.1186/s13031-015-0038-5			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	V1N0K	WOS:000217052500009	25904979	Green Published, gold, Green Submitted			2022-02-06	
J	Odgaard, L; Poulsen, I; Kammersgaard, LP; Johnsen, SP; Nielsen, JF				Odgaard, Lene; Poulsen, Ingrid; Kammersgaard, Lars Peter; Johnsen, Soren Paaske; Nielsen, Jorgen Feldbeak			Surviving severe traumatic brain injury in Denmark: incidence and predictors of highly specialized rehabilitation	CLINICAL EPIDEMIOLOGY			English	Article						database; health care disparities; registries; validity		Purpose: To identify all hospitalized patients surviving severe traumatic brain injury (TBI) in Denmark and to compare these patients to TBI patients admitted to highly specialized rehabilitation (HS-rehabilitation). Patients and methods: Patients surviving severe TBI were identified from The Danish National Patient Registry and The Danish Head Trauma Database. Overall incidence rates of surviving severe TBI and incidence rates of admission to HS-rehabilitation after severe TBI were estimated and compared. Patient-related predictors of no admission to HS-rehabilitation among patients surviving severe TBI were identified using multivariable logistic regression. Results: The average incidence rate of surviving severe TBI was 2.3 per 100,000 person years. Incidence rates of HS-rehabilitation were generally stable around 2.0 per 100,000 person years. Overall, 84% of all patients surviving severe TBI were admitted to HS-rehabilitation. Female sex, older age, and non-working status pre-injury were independent predictors of no HS-rehabilitation among patients surviving severe TBI. Conclusion: The incidence rate of hospitalized patients surviving severe TBI was stable in Denmark and the majority of the patients were admitted to HS-rehabilitation. However, potential inequity in access to HS-rehabilitation may still be present despite a health care system based on equal access for all citizens.	[Odgaard, Lene; Nielsen, Jorgen Feldbeak] Aarhus Univ, Hammel Neurorehabil Ctr, Aarhus, Denmark; [Odgaard, Lene; Nielsen, Jorgen Feldbeak] Aarhus Univ, Univ Res Clin, Aarhus, Denmark; [Poulsen, Ingrid; Kammersgaard, Lars Peter] Copenhagen Univ Hosp, Dept Neurorehabil, TBI, Copenhagen, Denmark; [Poulsen, Ingrid; Kammersgaard, Lars Peter] Copenhagen Univ Hosp, Glostrup, Res Unit Brain Injury Rehabil RUBRIC, Copenhagen, Denmark; [Johnsen, Soren Paaske] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark		Odgaard, L (corresponding author), Hammel Neurorehabil Ctr, Voldbyvej 14, DK-8450 Hammel, Denmark.; Odgaard, L (corresponding author), Univ Res Clin, Voldbyvej 14, DK-8450 Hammel, Denmark.	lenhel@rm.dk	Poulsen, ingrid/AAH-2052-2019; Odgaard, Lene/AAF-1909-2020; Nielsen, Jorgen Feldbak/AAR-6384-2021	Poulsen, ingrid/0000-0002-0342-017X; Odgaard, Lene/0000-0002-9830-3282; Nielsen, Jorgen Feldbak/0000-0001-5339-171X			Ahlgren A, 2004, INT J REHABIL RES, V27, P171, DOI 10.1097/00004356-200409000-00001; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Annoni J M, 1992, Disabil Rehabil, V14, P23; Ashley Mark J, 2012, Cerebrum, V2012, P8; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Holm LV, 2013, ACTA ONCOL, V52, P410, DOI 10.3109/0284186X.2012.745014; Holm LV, 2012, SUPPORT CARE CANCER, V20, P2913, DOI 10.1007/s00520-012-1420-0; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Lidwall U., 2006, SWEDISH SOCIAL INSUR; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Oliver A, 2004, J EPIDEMIOL COMMUN H, V58, P655, DOI 10.1136/jech.2003.017731; Organisation for Economic Co-Operation and Development (OECD), 2013, OECD REV HLTH CAR QU; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Sundhedsstyrelsen [National Board of Health], 1997, BEH TRAUM HJERN TILG	30	19	19	1	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1349			CLIN EPIDEMIOL	Clin. Epidemiol.		2015	7						225	234		10.2147/CLEP.S78141			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	V46UY	WOS:000209910300024	25848317	Green Published, gold			2022-02-06	
J	Pedersen, K; Fahlstedt, M; Jacobsson, A; Kleiven, S; von Holst, H				Pedersen, Kyrre; Fahlstedt, Madelen; Jacobsson, Anders; Kleiven, Svein; von Holst, Hans			A National Survey of Traumatic Brain Injuries Admitted to Hospitals in Sweden from 1987 to 2010	NEUROEPIDEMIOLOGY			English	Article						Traumatic brain injury; Epidemiology; Age; Gender; Primary prevention	EPIDEMIOLOGY; POPULATION; TRENDS; SEVERITY	Background: With an increasing and aging population, there is a global demand for improving the primary prevention strategies aimed at reducing traumatic brain injuries (TBIs). The objective of the present epidemiological study was to evaluate the pattern of TBI in Sweden over a 24 years period (1987-2010). Methods: The Swedish Hospital Discharge Register was used, where in-patient care with a main diagnosis of TBI according to ICD9/10 was included. External factors, age and gender distribution was evaluated. Results: A decreasing number of annual incidence was observed, that is, from 230 to 156 per 100,000 inhabitants. A steady decrease of concussion was observed while other intracranial injuries increased especially traumatic subdural hemorrhage and subarachnoid hemorrhage. The study identified 3 groups of patients young, adults and elderly. The highest incidence and the largest increase of incidence were seen in the oldest age group (85+ years) while the population under 65 years had a decreasing incidence of TBI. The most frequent etiology was fall accidents (57%) with a relative constant trend over the study period. Conclusions: More effort should be focused on different strategies for different age groups, especially the elderly group. A well-planned strategy for primary prevention guidelines for different age groups will have the chance to further reduce not only the health-care costs but also complications among elderly care. (C) 2015 S. Karger AG, Basel	[Pedersen, Kyrre; von Holst, Hans] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Fahlstedt, Madelen; Kleiven, Svein; von Holst, Hans] KTH Royal Inst Technol, Dept Neuron Engn, Stockholm, Sweden; [Jacobsson, Anders] Natl Board Hlth & Welf, Dept Epidemiol, Stockholm, Sweden		Fahlstedt, M (corresponding author), Royal Inst Technol, STH, Dept Neuron Engn, Alfred Nobels Alle 10, SE-14152 Huddinge, Sweden.	madelen.fahlstedt@sth.kth.se			Swedish VINNOVAVinnova [IHF 2013 - 05118]	The present study was sponsored by the Swedish VINNOVA, IHF 2013 - 05118.	Alaranta H, 2000, Wien Med Wochenschr, V150, P444; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; [Anonymous], 2010, SAMH KOSTN FALL; Bonander C, 2014, J SAFETY RES, V51, P15, DOI 10.1016/j.jsr.2014.07.001; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chung P, 2013, J NEUROL NEUROPHYSIO, V5, P1; Ekman R, 2001, ACCIDENT ANAL PREV, V33, P793, DOI 10.1016/S0001-4575(00)00093-2; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Firsching R, 2001, WORLD J SURG, V25, P1221; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Servadei F, 2002, J Neurosurg Sci, V46, P111; Socialstyrelsen, 2008, KODN PAT SLUT; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430	22	19	19	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2015	45	1					20	27		10.1159/000381780			8	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	CP4VX	WOS:000359881800003	26201267				2022-02-06	
J	Seo, JP; Jang, SH				Seo, Jeong Pyo; Jang, Sung Ho			Traumatic axonal injury of the corticospinal tract in the subcortical white matter in patients with mild traumatic brain injury	BRAIN INJURY			English	Article						Axonal injury; corticospinal tract; diffusion tensor imaging; mild traumatic brain injury	TRACTOGRAPHY; STIMULATION; MULTICENTER; IMPAIRMENT; RECOVERY; HUMANS	Background: Little is known about injury of the corticospinal tract (CST) in patients with mild traumatic brain injury (TBI). This study reports on patients with mild TBI who showed traumatic axonal injury of the CST in the sub-cortical white matter, as demonstrated by diffusion tensor tractography (DTT). Methods: Four patients with mild TBI who complained of motor weakness and had DTT parameters within the normal range, including fractional anisotropy, apparent diffusion coefficient and fibre number of the CST, and 10 normal control subjects were recruited for this study. Results: All four patients showed partial tearing of the CSTs in a portion of the sub-cortical white matter in both hemispheres on DTT. However, three patients showed low amplitude on motor evoked potential obtained from both hand muscles by transcranial magnetic stimulation and two patients revealed abnormality of hand motor function in terms of grip strength or Purdue Pegboard score. Conclusions: This study demonstrated traumatic axonal injury of the CST using configurational evaluation of DTT in patients with mild TBI. It is believed that configurational evaluation using DTT would be a useful technique for detection of localized traumatic axonal injury in patients with mild TBI.	[Seo, Jeong Pyo; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A4A01001873]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Brown AW, 2007, BRAIN INJURY, V21, P673, DOI 10.1080/02699050701468925; Cho HK, 2011, BRAIN INJURY, V25, P1005, DOI 10.3109/02699052.2011.605095; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; DAVIDOFF RA, 1990, NEUROLOGY, V40, P332; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2011, NEUROREHABILITATION, V29, P339, DOI 10.3233/NRE-2011-0710; Jang SH, 2011, YONSEI MED J, V52, P553, DOI 10.3349/ymj.2011.52.4.553; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kim YT, 1994, J KOREAN ACAD REHAB, V18, P780; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; YORK DH, 1987, NEUROSURGERY, V20, P70	26	19	19	0	12	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					110	114		10.3109/02699052.2014.973447			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000015	25356741				2022-02-06	
J	Andrews, G; Halford, GS; Chappell, M; Maujean, A; Shum, DHK				Andrews, Glenda; Halford, Graeme S.; Chappell, Mark; Maujean, Annick; Shum, David H. K.			Planning following stroke: a relational complexity approach using the Tower of London	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						Tower of London; planning; moves to solution; search depth; goal ambiguity; relational complexity; stroke; frontal lobes	TRAUMATIC BRAIN-INJURY; PREMISE INTEGRATION; YOUNG-CHILDREN; TRANSITIVE INFERENCE; PREFRONTAL CORTEX; 4-DISK VERSION; OF-LONDON; TASK; CAPACITY; PERFORMANCE	Planning on the 4-disk version of the Tower of London (TOL4) was examined in stroke patients and unimpaired controls. Overall TOL4 solution scores indicated impaired planning in the frontal stroke but not non-frontal stroke patients. Consistent with the claim that processing the relations between current states, intermediate states, and goal states is a key process in planning, the domain-general relational complexity metric was a good indicator of the experienced difficulty of TOL4 problems. The relational complexity metric shared variance with task-specific metrics of moves to solution and search depth. Frontal stroke patients showed impaired planning compared to controls on problems at all three complexity levels, but at only two of the three levels of moves to solution, search depth and goal ambiguity. Non-frontal stroke patients showed impaired planning only on the most difficult quaternary-relational and high search depth problems. An independent measure of relational processing (viz., Latin square task) predicted TOL4 solution scores after controlling for stroke status and location, and executive processing (Trail Making Test). The findings suggest that planning involves a domain-general capacity for relational processing that depends on the frontal brain regions.	[Andrews, Glenda] Griffith Univ, Sch Appl Psychol, Griffith Hlth Inst, Behav Basis Hlth Program, Gold Coast, Qld 4222, Australia; [Halford, Graeme S.; Chappell, Mark; Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Griffith Hlth Inst, Behav Basis Hlth Program, Brisbane, Qld, Australia; [Maujean, Annick] Griffith Univ, Griffith Hlth Inst, Ctr Natl Res Disabil & Rehabil Med CONROD, Meadowbrook, Qld 4131, Australia		Andrews, G (corresponding author), Griffith Univ, Sch Appl Psychol, Parklands Dr, Gold Coast, Qld 4222, Australia.	g.andrews@griffith.edu.au	Shum, David/A-3914-2008; Andrews, Glenda/H-5665-2012	Shum, David/0000-0002-4810-9262; Andrews, Glenda/0000-0001-8047-9151; Maujean, Annick/0000-0002-9623-1369	Australian Research Council DiscoveryAustralian Research Council [DPO452547]	We are grateful to the organizations that assisted with recruitment of the stroke and control groups and to participants themselves. This research was funded by an Australian Research Council Discovery Grant (DPO452547) awarded to Halford, Andrews, Birney, Chappell, and Shum.	Andrews G, 2002, COGNITIVE PSYCHOL, V45, P153, DOI 10.1016/S0010-0285(02)00002-6; Andrews G, 2003, CHILD DEV, V74, P1476, DOI 10.1111/1467-8624.00618; Andrews G, 1998, COGNITIVE DEV, V13, P479, DOI 10.1016/S0885-2014(98)90004-1; Andrews G, 2012, PSYCHOL POWER, P1; Andrews G., 2008, PSYCHOL GAMBLING, P111; Andrews G, 2008, NEW RES SHORT TERM M, P93; Andrews G, 2006, MEM COGNITION, V34, P1325, DOI 10.3758/BF03193275; Andrews G, 2014, J COGN PSYCHOL, V26, P588, DOI 10.1080/20445911.2014.909434; Andrews G, 2013, BRAIN COGNITION, V81, P44, DOI 10.1016/j.bandc.2012.09.003; Andrews G, 2012, J EXP CHILD PSYCHOL, V112, P84, DOI 10.1016/j.jecp.2011.12.004; Andrews G, 2011, COGNITIVE DEVELOPMENT AND WORKING MEMORY: A DIALOGUE BETWEEN NEO-PIAGETIAN THEORIES AND COGNITIVE APPROACHES, P47; Andrews G, 2010, MEM COGNITION, V38, P928, DOI 10.3758/MC.38.7.928; Andrews G, 2009, COGNITIVE DEV, V24, P49, DOI 10.1016/j.cogdev.2008.07.005; Birney D. P., 2002, Thinking & Reasoning, V8, P109, DOI 10.1080/13546780143000161; Birney DP, 2012, EUR J PSYCHOL ASSESS, V28, P216, DOI 10.1027/1015-5759/a000146; Birney DP, 2006, EDUC PSYCHOL MEAS, V66, P146, DOI 10.1177/0013164405278570; Bunch KM, 2007, COGNITIVE DEV, V22, P376, DOI 10.1016/j.cogdev.2007.01.004; Bunch KM, 2012, DEV NEUROPSYCHOL, V37, P134, DOI 10.1080/87565641.2011.632457; Cocchi L, 2014, CEREB CORTEX, V24, P2283, DOI 10.1093/cercor/bht075; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P55, DOI 10.1111/j.1467-7687.2008.00743.x; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; English L. D., 1995, MATH ED MODELS PROCE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gentner D, 2011, CHILD DEV, V82, P1173, DOI 10.1111/j.1467-8624.2011.01599.x; Halford GS, 2007, TRENDS COGN SCI, V11, P236, DOI 10.1016/j.tics.2007.04.001; Halford GS, 2007, COGNITIVE DEV, V22, P384, DOI 10.1016/j.cogdev.2006.12.001; Halford GS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00682; Halford GS, 2002, J COGN DEV, V3, P143, DOI 10.1207/S15327647JCD0302_2; Halford GS, 2010, TRENDS COGN SCI, V14, P497, DOI 10.1016/j.tics.2010.08.005; Halford GS, 2002, J EXP CHILD PSYCHOL, V81, P417, DOI 10.1006/jecp.2002.2665; Halford GS, 1998, BEHAV BRAIN SCI, V21, P803, DOI 10.1017/S0140525X98001769; Halford GS, 2005, PSYCHOL SCI, V16, P70, DOI 10.1111/j.0956-7976.2005.00782.x; HALFORD GS, 1989, PROCEEDINGS OF THE XXIV INTERNATIONAL CONGRESS OF PSYCHOLOGY, VOL 7, P151; HALFORD GS, 1984, COGNITIVE PSYCHOL, V16, P65, DOI 10.1016/0010-0285(84)90004-5; Hribar A, 2012, J EXP CHILD PSYCHOL, V111, P490, DOI 10.1016/j.jecp.2011.11.004; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Kaller CP, 2012, PSYCHOL ASSESSMENT, V24, P46, DOI 10.1037/a0025174; Kaller CP, 2011, BEHAV BRAIN RES, V216, P1, DOI 10.1016/j.bbr.2010.07.029; Knox K., 2010, ASCS09 P 9 C AUSTR S; Kostering L, 2014, DEV PSYCHOL, V50, P293, DOI 10.1037/a0032467; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Muller LD, 2014, NEUROPSYCHOLOGIA, V56, P271, DOI 10.1016/j.neuropsychologia.2014.01.019; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Perret P, 2011, COGNITIVE DEV, V26, P127, DOI 10.1016/j.cogdev.2010.12.003; Rasmussen IA, 2006, ACTA NEUROPSYCHIATR, V18, P216, DOI 10.1111/j.1601-5215.2006.00145.x; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shum D, 2000, BRAIN COGNITION, V44, P59; Shum D, 2009, BRAIN IMPAIR, V10, P320, DOI 10.1375/brim.10.3.320; Son JY, 2011, J EXP CHILD PSYCHOL, V108, P260, DOI 10.1016/j.jecp.2010.08.011; Tunstall J., 1999, THESIS GRIFFITH U BR; Unterrainer JM, 2006, J PHYSIOL-PARIS, V99, P308, DOI 10.1016/j.jphysparis.2006.03.014; Viskontas IV, 2005, THINK REASONING, V11, P390, DOI 10.1080/13546780542000014; Waltz JA, 1999, PSYCHOL SCI, V10, P119, DOI 10.1111/1467-9280.00118; Waltz JA, 2004, NEUROPSYCHOLOGY, V18, P296, DOI 10.1037/0894-4105.18.2.296; Ward G, 1997, Q J EXP PSYCHOL-A, V50, P49, DOI 10.1080/027249897392224; Zielinski TA, 2010, EUR J COGN PSYCHOL, V22, P391, DOI 10.1080/09541440902830509	58	19	20	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	DEC 23	2014	8								1032	10.3389/fnhum.2014.01032			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AX1IF	WOS:000346700300003	25566042	Green Published, gold			2022-02-06	
J	Pavlova, MA; Weber, S; Simoes, E; Sokolov, AN				Pavlova, Marina A.; Weber, Susanna; Simoes, Elisabeth; Sokolov, Alexander N.			Gender Stereotype Susceptibility	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; DIAGNOSIS THREAT; TEST-PERFORMANCE; MENTAL ROTATION; COGNITIVE PERFORMANCE; MATH; WOMEN; IMPACT; AGE	Gender affects performance on a variety of cognitive tasks, and this impact may stem from socio-cultural factors such as gender stereotyping. Here we systematically manipulated gender stereotype messages on a social cognition task on which no initial gender gap has been documented. The outcome reveals: (i) Stereotyping affects both females and males, with a more pronounced impact on females. Yet an explicit negative message for males elicits a striking paradoxical deterioration in performance of females. (ii) Irrespective of gender and directness of message, valence of stereotype message affects performance: negative messages have stronger influence than positive ones. (iii) Directness of stereotype message differentially impacts performance of females and males: females tend to be stronger affected by implicit than explicit negative messages, whereas in males this relationship is opposite. The data are discussed in the light of neural networks underlying gender stereotyping. The findings provide novel insights into the sources of gender related fluctuations in cognition and behavior.	[Pavlova, Marina A.] Univ Tubingen, Dept Biomed Magnet Resonance, Sch Med, Tubingen, Germany; [Weber, Susanna] Univ Zurich, Dept Econ, Zurich, Switzerland; [Simoes, Elisabeth; Sokolov, Alexander N.] Univ Tubingen, Univ Hosp, Ctr Womens Hlth, Tubingen, Germany		Pavlova, MA (corresponding author), Univ Tubingen, Dept Biomed Magnet Resonance, Sch Med, Tubingen, Germany.	marina.pavlova@uni-tuebingen.de		Pavlova, Marina/0000-0001-8239-3589	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG); Open Access Publishing Fund of Eberhard Karls University of Tubingen	We are grateful to the students of the University of Tubingen for participation and assistance with testing, Dr. Christel Bidet-Ildei, Dr. Arseny A. Sokolov, and Samuel Kruger for assistance and valuable comments, Franziska Hosl for administrative assistance, and Bernd Kardatzki for technical support. The authors acknowledge support toward open access publishing by Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Eberhard Karls University of Tubingen.	Abrams D, 2006, PSYCHOL AGING, V21, P691, DOI 10.1037/0882-7974.21.4.691; Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Anderson LC, 2013, NEUROIMAGE, V83, P751, DOI 10.1016/j.neuroimage.2013.07.040; Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; BARONCOHEN S, 1986, BRIT J DEV PSYCHOL, V4, P113, DOI 10.1111/j.2044-835X.1986.tb01003.x; Blaine H, 2013, J NEUROTRAUM, V30, P1405, DOI 10.1089/neu.2013.2865; Brownlow S, 2008, PERCEPT MOTOR SKILL, V107, P307, DOI 10.2466/PMS.107.1.307-316; Cadinu M, 2005, PSYCHOL SCI, V16, P572, DOI 10.1111/j.0956-7976.2005.01577.x; Cadinu M, 2003, EUR J SOC PSYCHOL, V33, P267, DOI 10.1002/ejsp.145; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Cattaneo Z, 2011, NEUROIMAGE, V56, P1839, DOI 10.1016/j.neuroimage.2011.02.037; Chalabaev A, 2008, J SPORT EXERCISE PSY, V30, P143, DOI 10.1123/jsep.30.2.143; Cvencek D, 2014, J EXP CHILD PSYCHOL, V117, P73, DOI 10.1016/j.jecp.2013.07.018; Dunst B, 2013, PERS INDIV DIFFER, V55, P744, DOI 10.1016/j.paid.2013.06.007; Ford TE, 2004, PERS SOC PSYCHOL B, V30, P643, DOI 10.1177/0146167203262851; Good C, 2012, J PERS SOC PSYCHOL, V102, P700, DOI 10.1037/a0026659; Gustafsson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2713; Halim ML, 2013, BRIT J DEV PSYCHOL, V31, P128, DOI 10.1111/j.2044-835X.2012.02084.x; Hamilton C, 2008, COGNITION SEX DIFFER; Hartley BL, 2013, CHILD DEV, V84, P1716, DOI 10.1111/cdev.12079; Hausmann M, 2009, PSYCHONEUROENDOCRINO, V34, P389, DOI 10.1016/j.psyneuen.2008.09.019; Hess TM, 2004, PSYCHOL AGING, V19, P495, DOI 10.1037/0882-7974.19.3.495; Hess TM, 2003, J GERONTOL B-PSYCHOL, V58, pP3, DOI 10.1093/geronb/58.1.P3; Johns M, 2005, PSYCHOL SCI, V16, P175, DOI 10.1111/j.0956-7976.2005.00799.x; Kana RK, 2012, SOC COGN AFFECT NEUR, V7, P446, DOI 10.1093/scan/nsr022; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Kit KA, 2014, J INT NEUROPSYCH SOC, V20, P157, DOI 10.1017/S1355617713001264; Kray LJ, 2001, J PERS SOC PSYCHOL, V80, P942, DOI 10.1037/0022-3514.80.6.942; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kret ME, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00003; Kruger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081716; Leyens JP, 2000, PERS SOC PSYCHOL B, V26, P1189, DOI 10.1177/0146167200262002; Lippa RA, 2010, ARCH SEX BEHAV, V39, P990, DOI 10.1007/s10508-008-9460-8; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; Nguyen HHD, 2008, J APPL PSYCHOL, V93, P1314, DOI 10.1037/a0012702; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Pavlova M, 2008, J COGNITIVE NEUROSCI, V20, P494, DOI 10.1162/jocn.2008.20034; Pavlova M, 2010, NEUROIMAGE, V50, P1327, DOI 10.1016/j.neuroimage.2009.12.096; Pavlova MA, 2015, CEREB CORTEX, V25, P3468, DOI 10.1093/cercor/bhu175; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pavlova MA, 2010, BRAIN RES, V1311, P81, DOI 10.1016/j.brainres.2009.11.046; Quadflieg S, 2009, J COGNITIVE NEUROSCI, V21, P1560, DOI 10.1162/jocn.2009.21091; Reuben E, 2014, P NATL ACAD SCI USA, V111, P4403, DOI 10.1073/pnas.1314788111; Rydell RJ, 2014, PERS SOC PSYCHOL B, V40, P377, DOI 10.1177/0146167213513475; Schmader T, 2002, J EXP SOC PSYCHOL, V38, P194, DOI 10.1006/jesp.2001.1500; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Seibt B, 2004, J PERS SOC PSYCHOL, V87, P38, DOI 10.1037/0022-3514.87.1.38; Shih M, 2002, J PERS SOC PSYCHOL, V83, P638, DOI 10.1037//0022-3514.83.3.638; Simoes E, 2013, GEBURTSH FRAUENHEILK, V73, P239, DOI 10.1055/s-0032-1328303; Sokolov AA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00016; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stone J, 1999, J PERS SOC PSYCHOL, V77, P1213, DOI 10.1037/0022-3514.77.6.1213; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wechsler D, 1997, WECHSLER INTELLIGENZ; Wheeler SC, 2001, PSYCHOL BULL, V127, P797, DOI 10.1037//0033-2909.127.6.797; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Wolf C, 2009, PSYCHOL RES, V74, P429; Wraga M, 2007, SOC COGN AFFECT NEUR, V2, P12, DOI 10.1093/scan/nsl041; Wraga M, 2006, PSYCHON B REV, V13, P813, DOI 10.3758/BF03194002; Yeung NCJ, 2008, ACCIDENT ANAL PREV, V40, P667, DOI 10.1016/j.aap.2007.09.003	63	19	19	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114802	10.1371/journal.pone.0114802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	WOS:000347215600028	25517903	Green Published, gold, Green Submitted			2022-02-06	
J	Heinzelmann, M; Lee, H; Rak, H; Livingston, W; Barr, T; Baxter, T; Scattergood-Keepper, L; Mysliwiec, V; Gill, J				Heinzelmann, Morgan; Lee, Hyunhwa; Rak, Hannah; Livingston, Whitney; Barr, Taura; Baxter, Tristin; Scattergood-Keepper, Lindsay; Mysliwiec, Vincent; Gill, Jessica			Sleep restoration is associated with reduced plasma C-reactive protein and depression symptoms in military personnel with sleep disturbance after deployment	SLEEP MEDICINE			English	Article						CRP; Inflammation; Depression; HRQOL; Military; PTSD; IL-6	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; IMMUNE ACTIVATION; HEART-DISEASE; PTSD; INFLAMMATION; MORTALITY; BIOMARKERS; VETERANS; INCREASE	Background: Deployed military personnel are vulnerable to chronic sleep disturbance, which is highly comorbid with post-traumatic stress disorder (PTSD) and depression, as well as declines in health related quality of life (HRQOL). Inflammation is associated with HRQOL declines and sleep-related comorbidities; however, the impact of sleep changes on comorbid symptoms and inflammation in this population is unknown. Methods: In this observational study, we examined the relationship between reported sleep changes and concentrations of inflammatory biomarkers, interleukin 6 (IL-6), and C-reactive protein (CRP) in peripheral blood. The sample was dichotomized into two groups: (1) decrease in Pittsburgh Sleep Quality Index (PSQI; restorative sleep) and (2) no change or increase in PSQI (no change). Mixed between-within subjects analysis of variance tests were used to determine group differences on changes of inflammation and comorbid symptoms. Results: In our sample of 66 recently deployed military personnel with insomnia, 34 participants reported restorative sleep whereas 32 reported no sleep changes. The two groups did not differ in demographic or clinical characteristics, with the exception of PTSD diagnosis at baseline. The restorative sleep group had significant reductions in CRP concentrations and depression symptoms, as well as reduced fatigue and improvements in emotional well-being, social functioning, and physical functioning at follow-up. Conclusions: Military personnel who report sleep restoration after deployment have reduced CRP concentrations, decreased severity of depression, and improved HRQOL. These findings suggest that treatment for sleep disturbances may be associated with improvements in mental and physical health, thereby supporting continued study in this line of research. (C) 2014 Elsevier B.V. All rights reserved.	[Heinzelmann, Morgan; Rak, Hannah; Livingston, Whitney; Scattergood-Keepper, Lindsay; Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [Lee, Hyunhwa] Univ Nevada, Las Vegas, NV 89154 USA; [Barr, Taura] W Virginia Univ, Morgantown, WV 26506 USA; [Baxter, Tristin; Mysliwiec, Vincent] Madigan Army Med Ctr, Tacoma, WA 98431 USA		Lee, H (corresponding author), Univ Nevada, 4505 Maryland Pkwy,Box 453018, Las Vegas, NV 89154 USA.	hyunhwa.lee@unlv.edu	Gill, Gill M/Q-2020-2017	Heinzelmann, Morgan/0000-0002-4399-6229; Lee, Hyunhwa/0000-0002-5625-3141	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027] Funding Source: NIH RePORTER	This study was funded, in part, by the Center for Neuroscience and Regenerative Medicine (Grant 60855). Additionally, Taura Barr is a 2012 Robert Wood Johnson Foundation Nurse Faculty Scholar.	Abazyan B, 2010, BIOL PSYCHIAT, V68, P1172, DOI 10.1016/j.biopsych.2010.09.022; Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Aversa LH, 2013, QUAL LIFE RES, V22, P1381, DOI 10.1007/s11136-012-0280-x; Axelsson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082291; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Boscarino JA, 2010, PSYCHOSOM MED, V72, P481, DOI 10.1097/PSY.0b013e3181d9a80c; Bot M, 2011, J PSYCHOSOM RES, V71, P13, DOI 10.1016/j.jpsychores.2010.11.006; Boyko EJ, 2010, DIABETES CARE, V33, P1771, DOI 10.2337/dc10-0296; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Capuron L, 2001, PSYCHONEUROENDOCRINO, V26, P797, DOI 10.1016/S0306-4530(01)00030-0; Chennaoui M, 2011, CYTOKINE, V56, P318, DOI 10.1016/j.cyto.2011.06.002; Edwards RD, 2010, NATL BUREAU EC RES W; Fear NT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-797; FERRER CF, 1995, AVIAT SPACE ENVIR MD, V66, P571; Germain A, 2012, J PSYCHOSOM RES, V72, P89, DOI 10.1016/j.jpsychores.2011.11.010; Gill J, 2010, BIOL PSYCHIAT, V68, P999, DOI 10.1016/j.biopsych.2010.07.033; Gill JM, 2013, J PSYCHOSOM RES, V74, P301, DOI 10.1016/j.jpsychores.2012.10.013; GILL JS, 2014, BJU INT S, V113, P2; Grandner MA, 2013, SLEEP, V36, P769, DOI 10.5665/sleep.2646; Hamer M, 2011, BRAIN BEHAV IMMUN, V25, P168, DOI 10.1016/j.bbi.2010.09.013; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Laugsand LE, 2012, PSYCHOSOM MED, V74, P543, DOI 10.1097/PSY.0b013e31825904eb; Lopresti AL, 2014, PROG NEURO-PSYCHOPH, V48, P102, DOI 10.1016/j.pnpbp.2013.09.017; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; MacKenzie EJ, 2002, QUAL LIFE RES, V11, P797, DOI 10.1023/A:1020820017658; Maes M, 2012, PROG NEURO-PSYCHOPH, V36, P169, DOI 10.1016/j.pnpbp.2011.09.006; Miller NL, 2010, SLEEP, V33, P1623, DOI 10.1093/sleep/33.12.1623; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Office of the Surgeon General United States Army Medical Command, 2011, JOINT MENT HLTH ADV; Paulus EJ, 2013, J TRAUMA STRESS, V26, P169, DOI 10.1002/jts.21785; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Phillips AC, 2009, PSYCHOSOM MED, V71, P395, DOI 10.1097/PSY.0b013e31819e6706; Pizzi C, 2009, CLIN PHARMACOL THER, V86, P527, DOI 10.1038/clpt.2009.121; Powell ND, 2009, BRAIN BEHAV IMMUN, V23, P225, DOI 10.1016/j.bbi.2008.09.010; Rusiecki Jennifer A, 2013, Front Psychiatry, V4, P56, DOI 10.3389/fpsyt.2013.00056; Scherrer JF, 2010, AM HEART J, V159, P772, DOI 10.1016/j.ahj.2010.02.033; Shanahan L, 2014, PSYCHONEUROENDOCRINO, V40, P76, DOI 10.1016/j.psyneuen.2013.10.019; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wium-Andersen MK, 2013, JAMA PSYCHIAT, V70, P176, DOI 10.1001/2013.jamapsychiatry.102; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Xue Y, 2012, AM J CARDIOL, V109, P1215, DOI 10.1016/j.amjcard.2011.11.063; Zen AL, 2012, HEALTH PSYCHOL, V31, P194, DOI 10.1037/a0025989	48	19	21	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	DEC	2014	15	12					1565	1570		10.1016/j.sleep.2014.08.004			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AW1YG	WOS:000346084100020	25311836				2022-02-06	
J	Mitchell, SJ; Bennett, MH				Mitchell, Simon J.; Bennett, Michael H.			Unestablished indications for hyperbaric oxygen therapy	DIVING AND HYPERBARIC MEDICINE			English	Article						Hyperbaric oxygen therapy; hyperbaric research; trauma and stress; central nervous system; children; evidence; ethics; review article	POST-CONCUSSION SYNDROME; CEREBRAL-PALSY; DOUBLE-BLIND; CHILDREN; DESIGN	Unestablished indications are conditions in which systematic clinical use of hyperbaric oxygen treatment (HBOT) is not supported by adequate proof of benefit. HBOT is vulnerable to use in many such conditions for various reasons, perhaps the most important being that a placebo or participation effect may create an impression of efficacy. The systematic use of HBOT in unestablished indications raises ethical concerns about provision of misleading information, giving false hope, and taking payment for therapy of doubtful benefit. Any practice perceived as unethical or unscientific has the potential to draw the wider field into disrepute. Of substantial contemporary relevance is the use of HBOT in treatment of various forms of chronic brain injury; in particular, cerebral palsy in children and the sequelae of mild traumatic brain injury in adults. There are now multiple, randomised, blinded, sham-controlled trials of HBOT in both indications. None of these studies showed benefit of HBOT when compared to sham control, though the sham and HBOT groups often both improved, indicating that a placebo or participation effect influenced outcomes. These results almost certainly explain those of open-label trials (lacking sham controls) in which HBOT frequently seems beneficial. Advocates for HBOT in chronic brain injury claim that the sham treatments (usually 1.3 ATA* pressure exposure whilst air breathing) in the blinded trials are actually active treatments; however, the same dose of oxygen can be achieved at 1 ATA breathing 27% oxygen. To counter this argument, advocates also claim that the extra 0.3 ATA of pressure is somehow independently beneficial, but this notion has limited biological plausibility and there is little supporting evidence. Chronic brain injuries remain unestablished indications at this time and, in our opinion, should not be systematically treated with HBOT.	[Mitchell, Simon J.] Auckland City Hosp, Auckland, New Zealand; [Mitchell, Simon J.] Univ Auckland, Dept Anaesthesiol, Auckland, New Zealand; [Bennett, Michael H.] Prince Wales Hosp, Sydney, NSW, Australia		Mitchell, SJ (corresponding author), Univ Auckland, Sch Med, Dept Anaesthesiol, Private Bag 92019, Auckland, New Zealand.	sj.mitchell@auckland.ac.nz		Mitchell, Simon/0000-0002-5149-6371			Bennett MH, 2011, HARRISONS PRINCIPLES; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Clarke D, 2008, PHYSL MED HYPERBARIC, P3; Collet JP, 2001, LANCET, V357, P582, DOI 10.1016/S0140-6736(00)04054-X; Current Comment, 1942, JAMA-J AM MED ASSOC, V118, P1300; Dean JB, 2003, J APPL PHYSIOL, V95, P883, DOI 10.1152/japplphysiol.00920.2002; Efrati S, 2014, UNDERSEA HYPERBAR M, V41, P71; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Federal Drug Administration, HYP OX THER DONT BE; GABB G, 1987, CHEST, V92, P1074, DOI 10.1378/chest.92.6.1074; Harch PG, 2013, UNDERSEA HYPERBAR M, V40, P469; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Joo EP, 2008, J SLEEP RES, V17, P82, DOI 10.1111/j.1365-2869.2008.00624.x; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Lacey DJ, 2012, ANN NEUROL, V72, P695, DOI 10.1002/ana.23681; Macdonald AG, 1999, COMP BIOCHEM PHYS A, V122, P13, DOI 10.1016/S1095-6433(98)10173-3; Miller RS, 2014, JAMA INT MED    1117, DOI P10.1001/JAMAinternmed.2014.5479; Mukherjee A, 2014, UNDERSEA HYPERBAR M, V41, P77; Newberg AB, 2011, CLIN THER, V33, P1894, DOI 10.1016/j.clinthera.2011.10.013; *SCI ADV COMM, 2000, REP HYP OX THER CHIL; The College of Physicians and Surgeons of Saskatchewan, STAND UNPR UNC TREAT; Undersea and Hyperbaric Medical Society Committee Report, 2014, HYPERBARIC OXYGEN TH; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549	29	19	22	0	10	SOUTH PACIFIC UNDERWATER MED SOC	MELBOURNE	C/O AUSTRALIAN & NEW ZEALAND COLL ANAESTHETISTS, 630 ST KILDA RD, MELBOURNE, VIC 3004, AUSTRALIA	1833-3516			DIVING HYPERB MED	Diving Hyperb. Med.	DEC	2014	44	4					228	234					7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	AW5EX	WOS:000346299800010	25596836				2022-02-06	
J	Rognas, L; Hansen, TM; Kirkegaard, H; Tonnesen, E				Rognas, Leif; Hansen, Troels M.; Kirkegaard, Hans; Tonnesen, Else			Anaesthesiologist-provided prehospital airway management in patients with traumatic brain injury: an observational study	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						airway management; critical care; emergency medical services; prehospital emergency care; traumatic brain injury	RAPID-SEQUENCE INTUBATION; HEMODYNAMIC-RESPONSE; HEAD-INJURY; DESATURATION; SERVICE	Background Guidelines recommend that patients with brain trauma with a Glasgow Coma Scale (GCS) score of less than 9 should have an airway established. Hypoxia, hypotension and hypertension as well as hypoventilation and hyperventilation may worsen outcome in these patients. Objectives The objectives were to investigate guideline adherence, reasons for nonadherence and the incidences of complications related to prehospital advanced airway management in patients with traumatic brain injury. Materials and methods We prospectively collected data from eight anaesthesiologist-staffed prehospital critical care teams in the Central Denmark Region according to the Utstein-style template. Results Among 1081 consecutive prehospital advanced airway management patients, we identified 54 with a traumatic brain injury and an initial GCS score of less than 9. Guideline adherence in terms of airway management was 92.6%. The reasons for nonadherence were the patient's condition, anticipated difficult airway management and short distance to the emergency department. Following rapid sequence intubation (RSI), 11.4% developed oxygen saturation below 90%, 9.1% had a first post-RSI systolic blood pressure below 90mmHg and 48.9% had a first post-RSI systolic blood pressure below 120 mmHg. The incidence of hypertension following prehospital RSI was 4.5%. The incidence of postendotracheal intubation hyperventilation was as high as 71.1%. Conclusion The guideline adherence was high. The incidences of post-RSI hypoxia and systolic blood pressure below 90 compare with the results reported from other physician-staffed prehospital services. The incidence of systolic blood pressure below 120 as well as that of hyperventilation following prehospital endotracheal intubation in patients with traumatic brain injury call for a change in our current practice. (c) 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Rognas, Leif] Norwegian Air Ambulance Fdn, Dept Res & Dev, Drobak, Denmark; [Rognas, Leif] Viborg Reg Hosp, Prehosp Crit Care Team, Dept Anaesthesiol, Viborg, Denmark; [Rognas, Leif; Hansen, Troels M.] Aarhus Univ Hosp, Cent Denmark Reg, Dept Prehosp Med Serv, DK-8000 Aarhus N, Denmark; [Rognas, Leif; Hansen, Troels M.] Aarhus Univ Hosp, Prehosp Crit Care Team, DK-8000 Aarhus N, Denmark; [Kirkegaard, Hans] Aarhus Univ Hosp, Ctr Emergency Med Res, DK-8000 Aarhus N, Denmark; [Tonnesen, Else] Aarhus Univ Hosp, Dept Anaesthesiol, DK-8000 Aarhus N, Denmark		Rognas, L (corresponding author), Trindsovej 4-10, DK-8100 Aarhus C, Denmark.	leifrogn@rm.dk	Rognas, Leif/AAI-9373-2020; Rognas, Leif/AAF-6182-2020	Rognas, Leif/0000-0002-2542-565X; 	Norwegian Air Ambulance Foundation; Laerdal Foundation for Acute Medicine	L.R. received funding from The Norwegian Air Ambulance Foundation and the Laerdal Foundation for Acute Medicine. For the remaining authors there are no conflicts of interest.	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Chesters A, 2013, EMERG MED J; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Eich C, 2009, ACTA ANAESTH SCAND, V53, P1167, DOI 10.1111/j.1399-6576.2009.02060.x; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Helm M, 2013, ACTA ANAESTH SCAND, V57, P199, DOI 10.1111/aas.12032; Holmes J, 2012, PREHOSP EMERG CARE, V16, P210, DOI 10.3109/10903127.2011.640416; Juul Niels, 2008, Ugeskr Laeger, V170, P2337; Lockey DJ, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-21; Nakstad AR, 2011, AM J EMERG MED, V29, P639, DOI 10.1016/j.ajem.2010.01.013; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Perkins ZB, 2013, INJURY, V44, P618, DOI 10.1016/j.injury.2012.03.019; Perkins ZB, 2013, J TRAUMA ACUTE CARE, V74, P1074, DOI 10.1097/TA.0b013e3182827305; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Rognas LK, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-10; Sollid SJM, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-58; von Vopelius-Feldt J, 2013, EUR J EMERG MED, V20, P382, DOI 10.1097/MEJ.0b013e32835b08b7; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002	21	19	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	DEC	2014	21	6					418	423		10.1097/MEJ.0000000000000103			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AT2SZ	WOS:000344787600005	24368407	Green Published			2022-02-06	
J	Zhou, Y; Cui, ZM; Xia, XP; Liu, C; Zhu, XH; Cao, JH; Wu, YY; Zhou, L; Ben, ZY; Song, Y; Zhang, HY; Zhang, DM				Zhou, Ying; Cui, Zhiming; Xia, Xiaopeng; Liu, Chun; Zhu, Xinhui; Cao, Jianhua; Wu, Yuanyuan; Zhou, Li; Ben, Zhiyun; Song, Yan; Zhang, Haiyan; Zhang, Dongmei			Matrix Metalloproteinase-1 (MMP-1) Expression in Rat Spinal Cord Injury Model	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury (SCI); Matrix metalloproteinase-1 (MMP-1); Astrocyte proliferation; Neuronal apoptosis	CELL-DEATH; FUNCTIONAL RECOVERY; SIGNALING SYSTEM; APOPTOSIS; ACTIVATION; INHIBITION; SCAR; GENE; PAR1; NEURODEGENERATION	Matrix metalloproteinase-1 (MMP-1), a member of the matrix metalloproteinases family, plays an integral role in extracellular matrix degradation and has been reportedly involved in the regulation of the brain or spinal cord traumatic neurovascular remodeling. Although the critical involvement of MMP-1 in the metastasis of tumors has been extensively documented, the role of MMP-1 in the pathology of neurological diseases remains largely elusive. In the present study, we established an adult rat spinal cord injury (SCI) model and investigated a potential role of MMP-1 in the pathological process of SCI. Using Western blot analysis, we identified notable expression change of MMP-1 after SCI. Immunohistochemistry showed that MMP-1 was distributed widely in rat spinal cord. Double immunofluorescence staining revealed that MMP-1 immunoreactivity was predominantly increased in neurons and astrocytes following SCI. Moreover, after injury, colocalization of MMP-1/active caspase-3 in neurons (NeuN-positive), and colocalization of MMP-1/PCNA in astrocytes (GFAP-positive) were clearly observed. We also examined the protein expression of PCNA, active caspase-3, Bcl-2, and Bax and found that the expression of the proteins was closely correlated with that of MMP-1. Taken together, our findings indicate that MMP-1 might play an important role in the regulation of neuronal apoptosis and astrocyte proliferation after SCI.	[Zhou, Ying; Zhou, Li; Ben, Zhiyun; Song, Yan; Zhang, Haiyan] Nantong Univ, Dept Immunol, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Peoples R China; [Cui, Zhiming; Zhu, Xinhui; Cao, Jianhua] Nantong Univ, Dept Osteol, Affiliated Hosp 2, Nantong 226001, Peoples R China; [Xia, Xiaopeng] Nantong Tradit Chinese Med Hosp, Dept Osteol, Nantong 226001, Peoples R China; [Liu, Chun] Nantong Univ, Lab Anim Ctr, Nantong 226001, Peoples R China; [Wu, Yuanyuan; Zhang, Dongmei] Nantong Univ, Coll Med, Dept Pathogen Biol, Nantong 226001, Peoples R China		Zhang, DM (corresponding author), Nantong Univ, Coll Med, Dept Pathogen Biol, Nantong 226001, Peoples R China.	sidezuoyinyuan@126.com			National Basic Research Program of China (973 Program)National Basic Research Program of China [2012CB822104]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170766]; Natural Science Foundation of Jiangsu University and College [11KJA310002]; Nantong City Social Development Projects [HS2012032]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (973 Program, No. 2012CB822104); National Natural Science Foundation of China (31170766); Key Project Natural Science Foundation of Jiangsu University and College (No. 11KJA310002); Nantong City Social Development Projects funds (HS2012032); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Agapova OA, 2003, BRAIN RES, V967, P132, DOI 10.1016/S0006-8993(02)04234-8; Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Agarwal A, 2010, CANCER RES, V70, P5880, DOI 10.1158/0008-5472.CAN-09-4341; Bao Y, 2012, J CEREBR BLOOD F MET, V32, P1567, DOI 10.1038/jcbfm.2012.52; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Casha S, 2005, EXP NEUROL, V196, P390, DOI 10.1016/j.expneurol.2005.08.020; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chen JJ, 2013, J MOL NEUROSCI, V51, P82, DOI 10.1007/s12031-013-0003-y; Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003; Dang ABC, 2008, SPINE, V33, pE576, DOI 10.1097/BRS.0b013e31817ecc87; DUCKER TB, 1971, J NEUROSURG, V35, P700, DOI 10.3171/jns.1971.35.6.0700; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; FAIRHOLM D, 1970, Surgical Forum (Chicago), V21, P453; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feng LX, 1999, J CELL BIOCHEM, V74, P576, DOI 10.1002/(SICI)1097-4644(19990915)74:4<576::AID-JCB7>3.3.CO;2-E; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hang QL, 2014, GLYCOBIOLOGY, V24, P292, DOI 10.1093/glycob/cwt110; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Khalatbary AR, 2012, IRAN RED CRESCENT ME, V14, P229; Kiaei M, 2007, EXP NEUROL, V205, P74, DOI 10.1016/j.expneurol.2007.01.036; Kunapuli P, 2004, J BIOL CHEM, V279, P23151, DOI 10.1074/jbc.M314192200; Lee SR, 2004, J NEUROSCI, V24, P671, DOI 10.1523/JNEUROSCI.4243-03.2004; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Marriott JB, 2003, CANCER RES, V63, P593; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Noel A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00140; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rahman MA, 2012, MOL CELL BIOCHEM, V369, P95, DOI 10.1007/s11010-012-1372-1; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2008, CURR OPIN PHARMACOL, V8, P82, DOI 10.1016/j.coph.2007.12.001; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Ryu B, 2011, J INVEST DERMATOL, V131, P1579, DOI 10.1038/jid.2011.65; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; SENTER HJ, 1978, J NEUROSURG, V49, P569, DOI 10.3171/jns.1978.49.4.0569; Shang L, 2009, CLIN EXP PHARMACOL P, V36, P912, DOI 10.1111/j.1440-1681.2009.05171.x; Soell M, 2002, J DENT RES, V81, P174, DOI 10.1177/154405910208100306; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sunkaria A, 2012, CHEM RES TOXICOL, V25, P1762, DOI 10.1021/tx300234n; Tang MJ, 2007, J BIOL CHEM, V282, P34457, DOI 10.1074/jbc.M704459200; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Ullah N, 2011, NEUROPHARMACOLOGY, V61, P1248, DOI 10.1016/j.neuropharm.2011.06.031; Vos CMP, 2000, EXP NEUROL, V163, P324, DOI 10.1006/exnr.2000.7388; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Woessner JF, 1998, CONNECT TISSUE RES, V39, P69, DOI 10.3109/03008209809023913; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Xiao XY, 2012, TUMOR BIOL, V33, P2385, DOI 10.1007/s13277-012-0502-4; Xu DW, 2011, J NEUROL SCI, V309, P141, DOI 10.1016/j.jns.2011.06.024; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051853, 10.1371/journal.pone.0038381]; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zhang JL, 2013, J MOL NEUROSCI, V49, P417, DOI 10.1007/s12031-012-9914-2; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	73	19	20	0	17	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2014	34	8					1151	1163		10.1007/s10571-014-0090-5			13	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AQ9XJ	WOS:000343211900009	25073870				2022-02-06	
J	Kreitzer, N; Lyons, MS; Hart, K; Lindsell, CJ; Chung, S; Yick, A; Bonomo, J				Kreitzer, Natalie; Lyons, Michael S.; Hart, Kim; Lindsell, Cristopher J.; Chung, Sora; Yick, Andrew; Bonomo, Jordan			Repeat Neuroimaging of Mild Traumatic Brain-injured Patients With Acute Traumatic Intracranial Hemorrhage: Clinical Outcomes and Radiographic Features	ACADEMIC EMERGENCY MEDICINE			English	Article							CRANIAL COMPUTED-TOMOGRAPHY; SUBARACHNOID HEMORRHAGE; PREDICTORS; EVOLUTION	ObjectivesEmergency department (ED) management of mild traumatic brain injury (TBI) patients with any form of traumatic intracranial hemorrhage (ICH) is variable. Since 2000, our center's standard practice has been to obtain a repeat head computed tomography (CT) at least 6 hours after initial imaging. Patients are eligible for discharge if clinical and CT findings are stable. Whether this practice is safe is unknown. This study characterized clinical outcomes in mild TBI patients with acute traumatic ICH seen on initial ED neuroimaging. MethodsThis retrospective cohort study included patients presenting to the ED with blunt mild TBI with Glasgow Coma Scale (GCS) scores of 14 or 15 and stable vital signs, during the period from January 2001 to January 2010. Patients with any ICH on initial head CT and repeat head CT within 24 hours were eligible. Cases were excluded for initial GCS < 14, injury > 24 hours old, pregnancy, concomitant nonminor injuries, and coagulopathy. A single investigator abstracted data from records using a standardized case report form and data dictionary. Primary endpoints included death, neurosurgical procedures, and for discharged patients, return to the ED within 7 days. Differences in proportions were computed with 95% confidence intervals (CIs). ResultsOf 1,011 patients who presented to the ED and had two head CTs within 24 hours, 323 (32%) met inclusion criteria. The median time between CT scans was 6 hours (interquartile range = 5 to 7 hours). A total of 153 (47%) patients had subarachnoid hemorrhage, 132 (41%) patients had subdural hemorrhage, 11 (3%) patients had epidural hemorrhage, 78 (24%) patients had cerebral contusions, and 59 (18%) patients had intraparenchymal hemorrhage. Four of 323 (1.2%, 95% CI = 0.3% to 3.2%) patients died within 2 weeks of injury. Three of the patients who died had been admitted from the ED on their initial visits, and one had been discharged home. There were 206 patients (64%) discharged from the ED, 28 (13.6%) of whom returned to the ED within 1 week. Of the 92 who were hospitalized, three (0.9%, 95% CI = 0.2% to 2.7%) required neurosurgical intervention. ConclusionDischarge after a repeat head CT and brief period of observation in the ED allowed early discharge of a cohort of mild TBI patients with traumatic ICH without delayed adverse outcomes. Whether this justifies the cost and radiation exposure involved with this pattern of practice requires further study. Resumen ObjetivosEl manejo de los pacientes con traumatismo craneoencefalico leve (TCEL) en el servicio de urgencias (SU) con cualquier forma de hemorragia intracraneal traumatica (HICT) es variable. Desde el ano 2000, la practica habitual de nuestro centro ha sido obtener una nueva tomografia computarizada (TC) craneal al menos seis horas tras la prueba de imagen inicial. Los pacientes son candidatos para el alta si los hallazgos clinicos y de la TC son estables. No se sabe si esta practica es segura. Este estudio determino los resultados clinicos en los pacientes con TCEL con HICT aguda diagnosticada en la prueba de imagen inicial del SU. MetodologiaEstudio de cohorte retrospectivo que incluyo a los pacientes que acudieron al SU con TCEL cerrado con una puntuacion de 14 o 15 en la Escala del Coma de Glasgow (ECG) y estabilidad hemodinamica durante el periodo de enero de 2001 a enero de 2010. Se incluyeron los pacientes con cualquier HICT en la TC craneal inicial y un TC craneal repetido en las primeras 24 horas. Se excluyeron casos con puntuacion inicial en la ECG <14, traumatismo hacia mas de 24 horas, embarazo, lesiones no leves concomitantes y coagulopatia. Un unico investigador recogio los datos de las historias clinicas usando un formulario estandarizado del informe del caso y un diccionario de datos. Los resultados principales incluyeron muerte, procedimientos neuroquirurgicos y, para los pacientes dados de alta, revisita al SU en los primeros siete dias. Se calcularon las diferencias en las proporciones con sus intervalos de confianza (IC) del 95%. ResultadosDe los 1.011 paciente que acudieron al SU y tuvieron dos TC craneales en las primeras 24 horas, 323 (32%) cumplieron los criterios de inclusion. La mediana de tiempo entre los TC fue de 6 horas (rango intercuartilico [RIC] de 2 horas). Los hallazgos del TC inicial fueron: hematoma epidural, contusion cerebral, hematoma subdural, hemorragia intraparenquimatosa, hemorragia subaracnoidea o su combinacion. Ciento cincuenta y tres (47%) pacientes tuvieron hemorragia subaracnoidea, 132 (41%) hematoma subdural, 11 (3%) hematoma epidural, 78 (24%) contusion cerebral y 59 (18%) hemorragia intraparenquimatosa. Cuatro de 323 (1,2%, IC 95% = 0,3% a 3,2%) pacientes fallecieron en las primeras 2 semanas del traumatismo. Tres de los pacientes que murieron se habian ingresado desde el SU en la visita inicial y uno habia sido dado de alta al domicilio. Hubo 206 pacientes (64%) dados de alta desde el SU, 28 (1,6%) de los cuales revisitaron el SU en la primera semana. De los 92 que se ingresaron, 3 (0,9%, IC 95% = 0,2% a 2,7%) requirieron una intervencion neuroquirurgica. ConclusionesEl alta tras un TC craneal repetido y un breve periodo de observacion en el SU permitio altas precoces en una cohorte de pacientes con TCEL con HICT sin resultados adversos diferidos. Se requieren futuros estudios si esta forma de actuar justifica los costes y la exposicion a la radiacion.ACADEMIC EMERGENCY MEDICINE 2014; 21: 1084-1091 (C) 2014 by the Society for Academic Emergency Medicine	[Kreitzer, Natalie; Lyons, Michael S.; Hart, Kim; Lindsell, Cristopher J.; Chung, Sora; Yick, Andrew; Bonomo, Jordan] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45220 USA		Kreitzer, N (corresponding author), Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45220 USA.	kreitzne@ucmail.uc.edu			NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR026314, 5UL1RR026314-03] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS047996] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS047996] Funding Source: NIH RePORTER		Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Bugaev N, 2013, J TRAUMA ACUTE CARE, V74, P1151, DOI 10.1097/TA.0b013e3182827191; Centers for Disease Control and Prevention, HEADS FACTS PHYS MIL; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kisat M, 2012, J SURG RES, V173, P31, DOI 10.1016/j.jss.2011.04.059; Leiner Tim, 2013, Ned Tijdschr Geneeskd, V157, pA6711; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; REINUS WR, 1993, ANN EMERG MED, V22, P1148, DOI 10.1016/S0196-0644(05)80981-3; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Valadka A. B., 2004, TRAUMA, P385; Verma RK, 2013, EUR J RADIOL, V82, P1539, DOI 10.1016/j.ejrad.2013.03.021; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	22	19	20	3	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	OCT	2014	21	10					1084	1091		10.1111/acem.12479			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AR8KA	WOS:000343822800002	25308130	Green Accepted			2022-02-06	
J	Ma, L; Roberts, JS; Pihoker, C; Richards, TL; Shaw, DWW; Marro, KI; Vavilala, MS				Ma, Li; Roberts, Joan S.; Pihoker, Catherine; Richards, Todd L.; Shaw, Dennis W. W.; Marro, Ken I.; Vavilala, Monica S.			Transcranial Doppler-Based Assessment of Cerebral Autoregulation in Critically Ill Children During Diabetic Ketoacidosis Treatment	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						cerebral autoregulation; cerebral blood flow; cerebral edema; cerebral perfusion; diabetic ketoacidosis	CAUSE-SPECIFIC MORTALITY; TRAUMATIC BRAIN-INJURY; BLOOD-FLOW VELOCITY; GENDER-DIFFERENCES; EDEMA; HYPEREMIA; ANTERIOR	Objectives: Impaired cerebral autoregulation may be associated with poor outcome in diabetic ketoacidosis. We examined change in cerebral autoregulation during diabetic ketoacidosis treatment. Design: Prospective observational cohort study. Setting: Tertiary care children's hospital. Patients/Subjects: Children admitted to the ICU with diabetic ketoacidosis (venous pH < 7.3, glucose > 300 mg/dL, Hco(3) < 15 mEq/L, and ketonuria) constituted cases, and children with type I diabetes without diabetic ketoacidosis constituted controls. Interventions: None. Measurements and Main Results: Between 2005 and 2009, 32 cases and 50 controls were enrolled. Transcranial Doppler ultrasonography was used to measure middle cerebral artery flow velocities, and cerebral autoregulation testing was achieved via tilt-table testing. Cases underwent two and controls underwent one cerebral autoregulation test. Cerebral autoregulation was quantified by the autoregulatory index (autoregulatory index < 0.4 = impaired and autoregulatory index 0.4-1.0 = intact autoregulation). The first autoregulation test was obtained early (time 1, 12-24 hr; median [interquartile range], 8 hr [5-18 hr]) during diabetic ketoacidosis treatment, and a second autoregulation test was obtained during recovery (time 2, 36-72 hr; median [-interquartile range], 46 hr [40-59 hr]) from time 0 (defined as time of insulin start). Cases had lower autoregulatory index at time 1 than time 2 (p < 0.001) as well lower autoregulatory index than control subjects (p < 0.001). Cerebral autoregulation was impaired in 40% (n = 13) of cases at time 1 and in 6% (n = 2) of cases at time 2. Five cases (17%) showed persistent impairment of cerebral autoregulation between times 1 and 2 of treatment. All control subjects had intact cerebral autoregulation. Conclusions: Impaired cerebral autoregulation was common early during diabetic ketoacidosis treatment. Although the majority improved during diabetic ketoacidosis treatment, 17% of subjects had impairment between 36 and 72 hours after start of insulin therapy. The observed impaired cerebral autoregulation appears specific to the diabetic ketoacidosis process in patients with type I diabetes.	[Ma, Li; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Roberts, Joan S.; Pihoker, Catherine; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Roberts, Joan S.; Pihoker, Catherine; Shaw, Dennis W. W.] Seattle Childrens Hosp, Seattle, WA USA; [Richards, Todd L.; Marro, Ken I.; Vavilala, Monica S.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA		Vavilala, MS (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	vavilala@uw.edu			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD049832-02]; Department of Anesthesiology and Pain Medicine, University of WashingtonUniversity of Washington; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); JDRFJuvenile Diabetes Research Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD049832] Funding Source: NIH RePORTER	Supported, in part, by National Institute of Child Health and Human Development (R21HD049832-02) and Department of Anesthesiology and Pain Medicine, University of Washington.; Dr. Vavilala received support for article research from the National Institutes of Health (NIH). Her institution received grant support from the NIH. Dr. Roberts is employed by LUMG. Dr. Pihoker's institution received funding from CDC, NIDDK, and JDRF for diabetes grants. Dr. Richards consults for a company to review scientific grants, receives royalties from a book on brain and learning, received support for travel from a NIH grant, and received support for article research from the NIH. Dr. Richards and his institution have a patent on DTI imaging. His institution received grant support from the NIH grants and contract and is employed by the University of Washington. Dr. Marro received support for article research from the NIH. His institution received grant support from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Aoi MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046794; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Deeter KH, 2011, PEDIATR DIABETES, V12, P295, DOI 10.1111/j.1399-5448.2010.00695.x; Dillon ES, 1936, AM J MED SCI, V192, P360, DOI 10.1097/00000441-193609000-00007; Edge JA, 1999, ARCH DIS CHILD, V81, P318, DOI 10.1136/adc.81.4.318; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; Glaser NS, 2013, J PEDIATR-US, V163, P1111, DOI 10.1016/j.jpeds.2013.06.008; HOFFMAN WH, 1995, J CLIN ULTRASOUND, V23, P517, DOI 10.1002/jcu.1870230903; Laing SP, 1999, DIABETIC MED, V16, P466, DOI 10.1046/j.1464-5491.1999.00076.x; Levin DL, 2008, PEDIATR CRIT CARE ME, V9, P320, DOI 10.1097/PCC.0b013e31816c7082; ORCHARD TJ, 1991, DIABETES CARE, V14, P55; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Roberts JS, 2006, CRIT CARE MED, V34, P2217, DOI 10.1097/01.CCM.0000227182.51591.21; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Tontisirin N, 2007, PEDIATRICS, V119, pE610, DOI 10.1542/peds.2006-2110; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2011, PEDIATR CRIT CARE ME, V12, pE344, DOI 10.1097/PCC.0b013e3182196c9c; Vavilala MS, 2010, PEDIATR CRIT CARE ME, V11, P332, DOI 10.1097/PCC.0b013e3181c013f4; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Yuen N, 2008, DIABETES, V57, P2588, DOI 10.2337/db07-1410	25	19	19	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	OCT	2014	15	8					742	749		10.1097/PCC.0000000000000197			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	AQ8CD	WOS:000343049200012	25072475				2022-02-06	
J	Sperry, JL; Zolin, S; Zuckerbraun, BS; Vodovotz, Y; Namas, R; Neal, MD; Ferrell, RE; Rosengart, MR; Peitzman, AB; Billiar, TR				Sperry, Jason L.; Zolin, Samuel; Zuckerbraun, Brian S.; Vodovotz, Yoram; Namas, Rami; Neal, Matthew D.; Ferrell, Robert E.; Rosengart, Matthew R.; Peitzman, Andrew B.; Billiar, Timothy R.			X Chromosome-Linked IRAK-1 Polymorphism Is a Strong Predictor of Multiple Organ Failure and Mortality Postinjury	ANNALS OF SURGERY			English	Article							TOLL-LIKE RECEPTOR-4; CARE RAPID THROMBELASTOGRAPHY; ACUTE TRAUMATIC COAGULOPATHY; KAPPA-B ACTIVATION; GENDER DIMORPHISM; SYSTEMIC INFLAMMATION; SEXUAL-DIMORPHISM; HEMORRHAGIC-SHOCK; SEVERE INJURY; BLUNT TRAUMA	Objective(s): Clinical research characterizing the mechanisms responsible for sex-based outcome differences postinjury remain conflicting. We sought to characterize an X chromosome-linked IRAK-1 (IL-1 receptor-associated kinase) polymorphism as an alternative mechanism responsible for sex differences postinjury. IRAK-1 is key intermediate in the toll-like receptor (TLR) pathway thought to drive inflammation postinjury. Methods: A prospective cohort study was performed over a 24-month period. Bluntly injured patients requiring intensive care unit admission were enrolled, whereas patients with isolated brain and spinal cord injuries were excluded. Outcomes of interest included multiple organ failure (MOF, Marshall MOD score > 5) and mortality. Logistic regression was utilized to determine the independent risk of poor outcome associated with the IRAK-1 variant after controlling for important differences. Results: In an enrolled cohort of 321 patients, the IRAK-1 variant was common (12.5%). Patients with and without the variant were similar in age, injury severity, and 24hr blood transfusion. After controlling for important confounders, the IRAK1 variant was independently associated with more than eightfold (OR = 8.4, P = 0.005, 95% CI: 1.9-37.1) and 11-fold (OR = 11.8, P = 0.037, 95% CI: 1.1-121) greater risk of MOF and mortality, respectively. These differences were most prominent in men, whereas women heterozygous for the variant demonstrated worse outcome in a dose-dependent fashion. Conclusions: The IRAK1 polymorphism is a strong independent predictor of MOF and mortality postinjury and represents a common variant with prognostic potential. These data demonstrate the importance of TLR signaling postinjury and supports that a genetic mechanism may drive sex outcome differences postinjury.	[Sperry, Jason L.; Zolin, Samuel; Zuckerbraun, Brian S.; Vodovotz, Yoram; Namas, Rami; Neal, Matthew D.; Ferrell, Robert E.; Rosengart, Matthew R.; Peitzman, Andrew B.; Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Div Trauma & Gen Surg, Pittsburgh, PA 15213 USA		Sperry, JL (corresponding author), Univ Pittsburgh, Dept Surg, Div Trauma & Gen Surg, 200 Lothrop St,Suite F1268, Pittsburgh, PA 15213 USA.	sperryjl@upmc.edu	Namas, Rami/AAD-5796-2020; Namas, Rami/AAD-5793-2020	Namas, Rami/0000-0002-8582-5321; Zolin, Samuel/0000-0001-6347-4260	NIH NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093032]; National Trauma Institute [NTI-NTI-TRA-09-030]; Department of the Army [W81XWH-10-1-0924]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093032] Funding Source: NIH RePORTER	This work was funded by NIH NIGMS K23GM093032 and Award NTI-NTI-TRA-09-030 from the National Trauma Institute and sponsored by the Department of the Army W81XWH-10-1-0924. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense. The authors declare no conflicts of interest.	Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; Arcaroli J, 2006, AM J RESP CRIT CARE, V173, P1335, DOI 10.1164/rccm.200603-341OC; Armant MA, 2002, GENOME BIOL, V3; Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; Bowles BJ, 2003, INJURY, V34, P27; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P1395, DOI 10.1097/TA.0b013e31825b9f05; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; Choudhry Mashkoor A., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P127; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Cotton BA, 2011, J TRAUMA, V71, P407, DOI 10.1097/TA.0b013e31821e1bf0; Croce MA, 2002, J TRAUMA, V53, P889, DOI 10.1097/00005373-200211000-00013; Cuschieri J, 2010, SHOCK, V34, P346, DOI 10.1097/SHK.0b013e3181d8e687; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Dossett LA, 2008, SURG INFECT, V9, P41, DOI 10.1089/sur.2007.037; Fan J, 2007, J IMMUNOL, V178, P6573, DOI 10.4049/jimmunol.178.10.6573; George RL, 2003, J TRAUMA, V54, P464, DOI 10.1097/01.TA.0000051939.95039.E6; George RL, 2003, SHOCK, V19, P28, DOI 10.1097/00024382-200301000-00006; Gunst Mark, 2010, Proc (Bayl Univ Med Cent), V23, P349; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kashuk JL, 2012, TRANSFUSION, V52, P23, DOI 10.1111/j.1537-2995.2011.03264.x; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Kashuk JL, 2009, J SURG RES, V156, P133, DOI 10.1016/j.jss.2009.03.046; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Levy RM, 2006, AM J PHYSIOL-REG I, V291, pR970, DOI 10.1152/ajpregu.00793.2005; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Liu G, 2008, FASEB J, V22, P2285, DOI 10.1096/fj.07-101816; MacLeod JBA, 2004, AM SURGEON, V70, P805; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; MANSHIP L, 1984, AM SURGEON, V50, P94; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Marshall JC, 1999, EUR J SURG, V163, P62; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Migeon BR, 2008, J AM SOC NEPHROL, V19, P2052, DOI 10.1681/ASN.2008020198; Migeon BR, 2006, JAMA-J AM MED ASSOC, V295, P1428, DOI 10.1001/jama.295.12.1428; MIGEON BR, 1994, TRENDS GENET, V10, P230, DOI 10.1016/0168-9525(94)90169-4; Migeon BR, 2002, CYTOGENET GENOME RES, V99, P8, DOI 10.1159/000071568; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Mollen KP, 2008, J LEUKOCYTE BIOL, V83, P80, DOI 10.1189/jlb.0407201; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Nathens AB, 1996, WORLD J SURG, V20, P386, DOI 10.1007/s002689900061; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Oberholzer A, 2000, J TRAUMA, V48, P932, DOI 10.1097/00005373-200005000-00019; Offner PJ, 1999, ARCH SURG-CHICAGO, V134, P935, DOI 10.1001/archsurg.134.9.935; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Prince JM, 2006, J AM COLL SURGEONS, V202, P407, DOI 10.1016/j.jamcollsurg.2005.11.021; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; ROUMEN RMH, 1995, CRIT CARE MED, V23, P474, DOI 10.1097/00003246-199503000-00010; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sperry JL, 2008, J LEUKOCYTE BIOL, V83, P499, DOI 10.1189/jlb.0607360; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Sperry JL, 2012, J AM COLL SURGEONS, V214, P973, DOI 10.1016/j.jamcollsurg.2012.02.020; Toubiana J, 2010, CRIT CARE MED, V38, P2287, DOI 10.1097/CCM.0b013e3181f9f9c7; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yang SL, 2009, J LEUKOCYTE BIOL, V85, P1015, DOI 10.1189/jlb.0508288; Yokoyama Y, 2002, IMMUNOL RES, V26, P63, DOI 10.1385/IR:26:1-3:063	65	19	21	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	OCT	2014	260	4					698	705		10.1097/SLA.0000000000000918			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AP3LL	WOS:000341977400016	25203887	Green Accepted			2022-02-06	
J	Harrison, JL; Rowe, RK; O'Hara, BF; Adelson, PD; Lifshitz, J				Harrison, Jordan L.; Rowe, Rachel K.; O'Hara, Bruce F.; Adelson, P. David; Lifshitz, Jonathan			Acute over-the-counter pharmacological intervention does not adversely affect behavioral outcome following diffuse traumatic brain injury in the mouse	EXPERIMENTAL BRAIN RESEARCH			English	Article						TBI Inflammation; NSAID; Sleep; Mouse; Analgesic	ANTIINFLAMMATORY CYTOKINES; INFLAMMATION; MICE; PATHOPHYSIOLOGY; NEUROPROTECTION; EPIDEMIOLOGY; PARACETAMOL; ACTIVATION; EXPRESSION; RECEPTORS	Following mild traumatic brain injury (TBI), patients may self-treat symptoms of concussion, including post-traumatic headache, taking over-the-counter (OTC) analgesics. Administering one dose of OTC analgesics immediately following experimental brain injury mimics the at-home treated population of concussed patients and may accelerate the understanding of the relationship between brain injury and OTC pharmacological intervention. In the current study, we investigate the effect of acute administration of OTC analgesics on neurological function and cortical cytokine levels after experimental diffuse TBI in the mouse. Adult, male C57BL/6 mice were injured using a midline fluid percussion (mFPI) injury model of concussion (6-10 min righting reflex time for brain-injured mice). Experimental groups included mFPI paired with either ibuprofen (60 mg/kg, i.p.; n = 16), acetaminophen (40 mg/kg, i.p.; n = 9), or vehicle (15 % ethanol (v/v) in 0.9 % saline; n = 13) and sham injury paired OTC medicine or vehicle (n = 7-10 per group). At 24 h after injury, functional outcome was assessed using the rotarod task and a modified neurological severity score. Following behavior assessment, cortical cytokine levels were measured by multiplex ELISA at 24 h post-injury. To evaluate efficacy on acute inflammation, cortical cytokine levels were measured also at 6 h post-injury. In the diffuse brain-injured mouse, immediate pharmacological intervention did not attenuate or exacerbate TBI-induced functional deficits. Cortical cytokine levels were affected by injury, time, or their interaction. However, levels were not affected by treatment at 6 or 24 h post-injury. These data indicate that acute administration of OTC analgesics did not exacerbate or attenuate brain-injury deficits which may inform clinical recommendations for the at-home treated mildly concussed patient.	[Harrison, Jordan L.; Rowe, Rachel K.; Adelson, P. David; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA; [Harrison, Jordan L.; Rowe, Rachel K.; Adelson, P. David; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Harrison, Jordan L.; Adelson, P. David; Lifshitz, Jonathan] Arizona State Univ, Interdisciplinary Grad Program Neurosci, Tempe, AZ USA; [Rowe, Rachel K.] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA; [Rowe, Rachel K.; O'Hara, Bruce F.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY USA; [O'Hara, Bruce F.] Univ Kentucky, Coll Arts & Sci, Dept Biol, Lexington, KY USA; [Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ USA		Harrison, JL (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA.	harrisonj@email.arizona.edu; jlifshitz@email.arizona.edu	Adelson, David/W-2083-2019	Rowe, Rachel/0000-0002-9034-3159	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052, R01NS065052-S, R21NS072611, KSCHIRT 10-5A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052, R21NS072611] Funding Source: NIH RePORTER	Research reported in this publication was supported, in part, by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS065052, R01NS065052-S, R21NS072611, and KSCHIRT 10-5A.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Dania M, 2007, EUR J PHARMACOL, V573, P214, DOI 10.1016/j.ejphar.2007.07.012; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Faul M., 2010, CTR DIS CONTROL PREV; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Maiese K, 2008, MERCK MANUAL HOME HL; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Ottani A, 2006, EUR J PHARMACOL, V531, P280, DOI 10.1016/j.ejphar.2005.12.015; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Thau-Zuchman O, 2012, J NEUROTRAUM, V29, P375, DOI 10.1089/neu.2010.1673; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	41	19	19	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	SEP	2014	232	9					2709	2719		10.1007/s00221-014-3948-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN4KO	WOS:000340556800001	24760409				2022-02-06	
J	Joseph, B; Pandit, V; Meyer, D; Butvidas, L; Kulvatunyou, N; Khalil, M; Tang, A; Zangbar, B; O'Keeffe, T; Gries, L; Friese, RS; Rhee, P				Joseph, Bellal; Pandit, Viraj; Meyer, David; Butvidas, Lynn; Kulvatunyou, Narong; Khalil, Mazhar; Tang, Andrew; Zangbar, Bardiya; O'Keeffe, Terence; Gries, Lynn; Friese, Randall S.; Rhee, Peter			The significance of platelet count in traumatic brain injury patients on antiplatelet therapy	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Antiplatelet therapy; traumatic brain injury; platelet count; platelet transfusion; neurosurgical intervention	SERIAL LABORATORY EXAMINATION; SEVERE HEAD-INJURY; INTRACRANIAL HEMORRHAGE; SUBSEQUENT DEVELOPMENT; PREINJURY CLOPIDOGREL; THROMBOCYTOPENIA; COAGULOPATHY; PROGRESSION; MANAGEMENT; MODERATE	BACKGROUND: Platelet dysfunction has been attributed to progression of initial intracranial hemorrhage (ICH) on repeat head computed tomographic (RHCT) scans in patients on prehospital antiplatelet therapy. However, there is little emphasis on the effect of platelet count and progression of ICH in patients with traumatic brain injury. The aim of this study was to determine the platelet count cutoff for progression on RHCT and neurosurgical intervention in patients on antiplatelet therapy. METHODS: We performed a prospective cohort analysis of all traumatic brain injury patients with an ICH on prehospital antiplatelet therapy. Antiplatelet therapy was defined as aspirin, clopidogrel, or a combination of both. Admission platelet count was recorded and used for analysis. Receiver operating characteristic curves were plotted to identify the optimal platelet count for progression on RHCT scan and neurosurgical intervention in patients on antiplatelet therapy. RESULTS: A total of 264 patients were enrolled. Platelet count of 135,000/mu L or less (area under the curve, 0.80) and platelet count of 95,000/mu L or less (area under the curve, 0.92) were the optimal threshold points for progression on RHCT scan and neurosurgical intervention, respectively. Patients with platelet count of 135,000/mu L or less were 12.4 times (95% confidence interval, 7.1-18.4) more likely to have progression on RHCT scan and patients with platelet count 95,000/mu L or less were 31.5 times (95% confidence interval, 19.7-96.2) more likely to require neurosurgical intervention. CONCLUSION: A platelet count of less than 135,000/mu L in patients on antiplatelet therapy is predictive of both radiographic and clinical worsening. This is a clinically relevant target intended to help tailor and improve management in patients on antiplatelet therapy. (Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Joseph, Bellal; Pandit, Viraj; Meyer, David; Butvidas, Lynn; Kulvatunyou, Narong; Khalil, Mazhar; Tang, Andrew; Zangbar, Bardiya; O'Keeffe, Terence; Gries, Lynn; Friese, Randall S.; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Emergency Surg Crit Care & Burns, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu		Meyer, David/0000-0002-3816-0160			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; HARKER LA, 1972, NEW ENGL J MED, V287, P155, DOI 10.1056/NEJM197207272870401; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Joseph B, 2014, J SURG RES, V186, P287, DOI 10.1016/j.jss.2013.08.009; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Stansbury LG, 2013, TRANSFUSION, V53, P783, DOI 10.1111/j.1537-2995.2012.03828.x; Wiles CE, 2005, J TRAUMA, V58, P729; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	19	19	20	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2014	77	3					417	421		10.1097/TA.0000000000000372			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AO2BJ	WOS:000341120200006	25159244				2022-02-06	
J	Quatman-Yates, C; Hugentobler, J; Ammon, R; Mwase, N; Kurowski, B; Myer, GD				Quatman-Yates, Catherine; Hugentobler, Jason; Ammon, Robin; Mwase, Najima; Kurowski, Brad; Myer, Gregory D.			The Utility of the Balance Error Scoring System for Mild Brain Injury Assessments in Children and Adolescents	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; balance; postural control; Balance Error Scoring System (BESS); children and adolescents	SPORT-RELATED CONCUSSION; 4TH INTERNATIONAL-CONFERENCE; COLLEGIATE FOOTBALL PLAYERS; POSTURAL CONTROL; RECURRENT CONCUSSION; CEREBRAL CONCUSSION; CONSENSUS STATEMENT; HIGH-SCHOOL; RECOVERY; KNEE	The Balance Error Scoring System (BESS) is widely recognized as an acceptable assessment of postural control for adult patients following a mild traumatic brain injury (mTBI) or concussion. However, the measurement properties of the BESS as a post-mTBI assessment test for younger patients are not well understood. The purpose of this study was to evaluate the utility of the BESS as a post-mTBI assessment test for children and adolescents aged 8 to 18 years through 2 investigations: (1) a retrospective medical records review of the relationship among age, BESS scores, and other common post-mTBI assessment tests; and (2) a prospective study comparing BESS scores for a cohort of children with a recent mTBI and BESS scores for a cohort of matched healthy peers. Age was found to be significantly correlated with several of the BESS measures and the total BESS score (P < 0.05). Significant differences were observed between the injured and healthy cohorts for 3 of the BESS measures and the total BESS score. However, the observed differences were not likely to be clinically meaningful. Cumulatively, evidence from the literature and the results of these studies indicate that the BESS may be limited for producing accurate assessments of younger athletes' post-mTBI postural control abilities. Future research recommendations include testing of modified versions of the BESS or other alternatives for post-mTBI postural control assessments with younger individuals.	[Quatman-Yates, Catherine; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Quatman-Yates, Catherine; Hugentobler, Jason] Cincinnati Childrens Hosp Med Ctr, Div Occupat & Phys Therapy, Cincinnati, OH 45229 USA; [Ammon, Robin] Univ S Dakota, Sport Management Program Coordinator, Vermillion, SD 57069 USA; [Mwase, Najima] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Kurowski, Brad] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat,Div Phys Med & Rehabil, Cincinnati, OH USA; [Kurowski, Brad] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Neurol, Cincinnati, OH USA; [Kurowski, Brad] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Phys Med & Rehabil, Cincinnati, OH USA; [Kurowski, Brad] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Phys Med & Rehabil, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat & Orthopaed Surg, Cincinnati, OH USA		Quatman-Yates, C (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Sports Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Catherine.quatman@cchmc.org	Quatman-Yates, Catherine/U-9580-2019; Quatman-Yates, Catherine/AAK-4507-2021; Myer, Gregory/H-6572-2016	Myer, Gregory/0000-0002-9983-8422	NIH-K23United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K23HD074683-01A1]; Cincinnati Children's Hospital Research in Patient Services PS2 Award; University Research Council Post-Doctoral Fellowship Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER	The authors acknowledge the following: NIH-K23: 1K23HD074683-01A1, Cincinnati Children's Hospital Research in Patient Services PS2 Award, University Research Council Post-Doctoral Fellowship Grant.	Andrish J T, 2001, Am J Orthop (Belle Mead NJ), V30, P103; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Concussion in Sports Group, 2013, BRIT J SPORT MED, V47, P263; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Faul M, 2010, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Ford KR, 2008, BRIT J SPORT MED, V42, P561, DOI 10.1136/bjsm.2007.044883; Ford KR, 2010, MED SCI SPORT EXER, V42, P1923, DOI 10.1249/MSS.0b013e3181dc99b1; Ford KR, 2010, AM J SPORT MED, V38, P1829, DOI 10.1177/0363546510367425; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Gribble PA, 2004, J ELECTROMYOGR KINES, V14, P641, DOI 10.1016/j.jelekin.2004.05.001; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haddad JM, 2008, EXP BRAIN RES, V190, P431, DOI 10.1007/s00221-008-1483-9; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hewett TE, 2004, J BONE JOINT SURG AM, V86A, P1601, DOI 10.2106/00004623-200408000-00001; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Lee SP, 2014, GAIT POSTURE, V39, P933, DOI 10.1016/j.gaitpost.2013.12.004; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Olson B., 2012, ATHLETIC TRAIN SPORT, V4, P141; Quatman-Yates CC, 2013, PEDIATR PHYS THER, V25, P271, DOI 10.1097/PEP.0b013e31828e1e9d; Quatman-Yates CC, 2012, BRIT J SPORT MED, V46, P649, DOI 10.1136/bjsm.2010.079616; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sheehan DP, 2011, MEAS PHYS EDUC EXERC, V15, P234, DOI 10.1080/1091367X.2011.568368; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Sport Concussion Assessment Tool 3rd edition (SCAT3), 2013, BRIT J SPORT MED, V47, P259; Takacs J, 2012, J BIOMECH, V45, P2791, DOI 10.1016/j.jbiomech.2012.08.041; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; WOOLLACOTT MH, 1990, PHYS THER, V70, P799, DOI 10.1093/ptj/70.12.799	51	19	19	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	SEP	2014	42	3					32	38		10.3810/psm.2014.09.2073			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	AR2FQ	WOS:000343399400004	25295764	Green Accepted			2022-02-06	
J	Larson, MJ; Mohr, BA; Adams, RS; Wooten, NR; Williams, TV				Larson, Mary Jo; Mohr, Beth A.; Adams, Rachel Sayko; Wooten, Nikki R.; Williams, Thomas V.			Missed Opportunity for Alcohol Problem Prevention Among Army Active Duty Service Members Postdeployment	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							MENTAL-HEALTH PROBLEMS; TRAUMATIC BRAIN-INJURY; MILITARY PERSONNEL; BINGE DRINKING; SUBSTANCE USE; PRIMARY-CARE; AUDIT-C; DIAGNOSTIC EFFICIENCY; SEPTEMBER 11; COMBAT	Objectives. We identified to what extent the Department of Defense post-deployment health surveillance program identifies at-risk drinking, alone or in conjunction with psychological comorbidities, and refers service members who screen positive for additional assessment or care. Methods. We completed a cross-sectional analysis of 333 803 US Army active duty members returning from Iraq or Afghanistan deployments in fiscal years 2008 to 2011 with a postdeployment health assessment. Alcohol measures included 2 based on self-report quantity-frequency items-at-risk drinking (positive Alcohol Use Disorders Identification Test alcohol consumption questions [AUDIT-C] screen) and severe alcohol problems (AUDIT-C score of 8 or higher)- and another based on the interviewing provider's assessment. Results. Nearly 29% of US Army active duty members screened positive for at-risk drinking, and 5.6% had an AUDIT-C score of 8 or higher. Interviewing providers identified potential alcohol problems among only 61.8% of those screening positive for at-risk drinking and only 74.9% of those with AUDIT-C scores of 8 or higher. They referred for a follow-up visit to primary care or another setting only 29.2% of at-risk drinkers and only 35.9% of those with AUDIT-C scores of 8 or higher. Conclusions. This study identified missed opportunities for early intervention for at-risk drinking. Future research should evaluate the effect of early intervention on long-term outcomes.	[Larson, Mary Jo; Adams, Rachel Sayko] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, Waltham, MA 02454 USA; [Mohr, Beth A.] Brandeis Univ, Heller Sch Social Policy & Management, Schneider Inst Hlth Policy, Waltham, MA 02454 USA; [Wooten, Nikki R.] Univ S Carolina, Coll Social Work, Mil Social Work Res & Practice, Columbia, SC 29208 USA; [Williams, Thomas V.] Def Hlth Agcy, Dept Def, Def Hlth Cost Assessment, Falls Church, VA USA; [Williams, Thomas V.] Def Hlth Agcy, Dept Def, Program Evaluat, Falls Church, VA USA		Larson, MJ (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St,MS 035, Waltham, MA 02454 USA.	larson@brandeis.edu	Wooten, Nikki/R-7071-2019; Adams, Rachel/AAH-4653-2020	Wooten, Nikki/0000-0002-6319-8224	National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA030150]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K01DA037412, R01DA030150] Funding Source: NIH RePORTER	This study was funded by the National Institute on Drug Abuse (NIDA; grant R01DA030150).	Adams RS, 2013, SUBST USE MISUSE, V48, P821, DOI 10.3109/10826084.2013.797995; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Ames G, 2004, ALCOHOL RES HEALTH, V28, P252; Armed Forces Health Surveillance Center, 2012, MSMR, V19, P1; Army Suicide Prevention Task Force, 2010, ARMY HEALTH PROMOTIO; Barlas FM, 2011, 2011 DEPARTMENT OF D; Ben-Zeev D, 2012, J MENT HEALTH, V21, P264, DOI 10.3109/09638237.2011.621468; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bliese PD, 2011, DEPLOYMENT PSYCHOL E, P175; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bradley Katharine A, 2007, Subst Abus, V28, P133, DOI 10.1300/J465v28n04_05; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Brown MC, 2011, J NERV MENT DIS, V199, P797, DOI 10.1097/NMD.0b013e31822fc9bf; Brown R L, 2001, J Am Board Fam Pract, V14, P95; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Calhoun PS, 2010, PSYCHIAT RES, V178, P330, DOI 10.1016/j.psychres.2009.11.009; Center for Substance Abuse Research, MILITARY PERSONNEL M, V182009; Clarke-Walper K, 2014, ADDICT BEHAV, V39, P414, DOI 10.1016/j.addbeh.2013.05.001; Crawford EF, 2013, DRUG ALCOHOL DEPEN, V132, P101, DOI 10.1016/j.drugalcdep.2013.01.012; Department of Defense, 2013, INSTRUCTION 6490 12; Department of Defense, 2010, OFFICE OF FORCE HEAL; Department of Defense, 2011, INSTRUCTION 6490 08; Department of Defense, 1997, IMPLEMENTATION AND A; Department of the Navy DoD. Letter of instruction for the Marine Corps Alcohol Screening Program, 2013, 5300 MFC4; Department of the Navy DoD. Use of Hand- Held Alcohol Detection Devices, 2013, OPNAVINST 5350 8; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLINICAL PRAC; Deployment Health Clinical Center, ENHANCED POST DEPLOY; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Funderburk JS, 2013, MIL MED, V178, P1071, DOI 10.7205/MILMED-D-13-00165; Gibbs DA, 2011, MIL PSYCHOL, V23, P36, DOI 10.1080/08995605.2011.534409; Gibbs DA, 2011, MIL PSYCHOL, V23, P97, DOI 10.1080/08995605.2011.534418; Harmon SC, 2012, MIL MED, V177, P366, DOI 10.7205/MILMED-D-11-00343; Harwood HJ, 2009, MIL MED, V174, P728, DOI 10.7205/MILMED-D-03-9008; Hoge C. W., 2011, DEPLOYMENT PSYCHOL E, P17, DOI DOI 10.1037/12300-001; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hourani L, 2012, MIL MED, V177, P643, DOI 10.7205/MILMED-D-11-00421; Institute of Medicine, 2013, SUBSTANCE USE DISORD; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; Kinder LS, 2009, J STUD ALCOHOL DRUGS, V70, P253, DOI 10.15288/jsad.2009.70.253; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lande RG, 2008, J ADDICT DIS, V27, P115, DOI 10.1080/10550880802122711; Larson MJ, 2012, J SOC WORK PRACT ADD, V12, P6, DOI 10.1080/1533256X.2012.647586; Larson MJ, 2013, SUBST USE MISUSE, V48, P863, DOI 10.3109/10826084.2013.794840; Luxton DD, 2012, DODSER DEPARTMENT OF; Mattiko MJ, 2011, ADDICT BEHAV, V36, P608, DOI 10.1016/j.addbeh.2011.01.023; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Milliken CS, 2011, ACCESS TO SUD CARE C; National Institute on Alcohol Abuse and Alcoholism, 2005, NIH PUBLICATION, V05-3769; Ong AL, 2008, MIL MED, V173, P871, DOI 10.7205/MILMED.173.9.871; Polen MR, 2008, AHRQ PUBLICATION; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; Rona RJ, 2005, JAMA-J AM MED ASSOC, V293, P1257, DOI 10.1001/jama.293.10.1257; Rubinsky AD, 2010, DRUG ALCOHOL DEPEN, V108, P29, DOI 10.1016/j.drugalcdep.2009.11.009; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Simon S, 2013, THE RELIABILITY OF A; Skopp NA, 2012, J CLIN PSYCHOL, V68, P1253, DOI 10.1002/jclp.21887; Spera C, 2011, J STUD ALCOHOL DRUGS, V72, P5, DOI 10.15288/jsad.2011.72.5; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; The Management of Substance Use Disorders Working Group, 2009, DOD CLINICAL PRACTIC; United States Government Accountability Office, 2008, GAO 08 276; Veterans Health Administration, 2007, SCREENING AND EVALUA; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Williams J, 2010, ADDICT BEHAV, V35, P444, DOI 10.1016/j.addbeh.2009.12.012	71	19	19	0	13	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	AUG	2014	104	8					1402	1412		10.2105/AJPH.2014.301901			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AP1EY	WOS:000341811000037	24922163	Green Published			2022-02-06	
J	Lee, SW; Gerdes, L; Tegeler, CL; Shaltout, HA; Tegeler, CH				Lee, Sung W.; Gerdes, Lee; Tegeler, Catherine L.; Shaltout, Hossam A.; Tegeler, Charles H.			A bihemispheric autonomic model for traumatic stress effects on health and behavior	FRONTIERS IN PSYCHOLOGY			English	Article						autonomic nervous system; hemispheric asymmetry; trauma; traumatic brain injury; post-traumatic stress disorder; polyvagal theory; violence; RDoC	BRAIN ELECTRICAL-ACTIVITY; NERVOUS-SYSTEM; HEMISPHERE ASYMMETRY; EEG; AROUSAL; DISORDER; VIOLENCE	A bihemispheric autonomic model (BHAM) may support advanced understanding of traumatic stress effects on physiology and behavior. The model builds on established data showing hemispheric lateralization in management of the autonomic nervous system, and proposes that traumatic stress can produce dominant asymmetry in activity of bilateral homologous brain regions responsible for autonomic management. Rightward and leftward dominant asymmetries are associated with sympathetic high arousal or parasympathetic freeze tendencies, respectively, and return to relative symmetry is associated with improved autonomic regulation. Autonomic auto-calibration for recovery (inverse of Jacksonian dissolution proposed by polyvagal theory) has implications for risk behaviors associated with traumatic life stress. Trauma-induced high arousal may be associated with risk for maladaptive behaviors to attenuate arousal (including abuse of alcohol or sedative-hypnotics). Trauma-induced freeze mode (including callous-unemotional trait) may be associated with low resting heart rate and risk for conduct disorders. The model may explain higher prevalence of leftward hemispheric abnormalities reported in studies of violence. Implications of the BHAM are illustrated through case examples of a military special operations officer with history of traumatic brain injury and post-traumatic stress disorder, and a university student with persisting post-concussion symptoms. Both undertook use of a noninvasive closed-loop neurotechnology high-resolution, relational, resonance-based, electroencephalic mirroring with ensuing decrease in hemispheric asymmetry, improvement in heart rate variability, and symptom reduction. Finally, the BHAM aligns with calls for researchers to use brain-behavioral constructs (research domain criteria or RDoC, proposed by the National Institutes of Mental Health) as building blocks for assessment and intervention in mental health science.	[Lee, Sung W.; Gerdes, Lee] Brain State Technol LLC, 15150 North Hayden Rd,Suite 106, Scottsdale, AZ 85260 USA; [Tegeler, Catherine L.; Tegeler, Charles H.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC USA; [Shaltout, Hossam A.] Wake Forest Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC USA; [Shaltout, Hossam A.] Wake Forest Sch Med, Dept Obstet & Gynecol, Winston Salem, NC USA		Lee, SW (corresponding author), Brain State Technol LLC, 15150 North Hayden Rd,Suite 106, Scottsdale, AZ 85260 USA.	sung.lee@brainstatetech.com	Shaltout, hossam/F-6903-2013; Tegeler, Charles/R-3623-2019	Shaltout, hossam/0000-0001-7948-3815; Tegeler, Catherine/0000-0002-2943-6719			Avnon Y, 2004, BRAIN, V127, P2099, DOI 10.1093/brain/awh236; Balle M, 2013, BIOL PSYCHOL, V93, P257, DOI 10.1016/j.biopsycho.2013.02.012; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Britton JW, 2006, EPILEPSIA, V47, P737, DOI 10.1111/j.1528-1167.2006.00509.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Cechetto DF, 2009, NEUROIMAGE, V47, P795, DOI 10.1016/j.neuroimage.2009.05.024; Chang JS, 2012, PSYCHOSOM MED, V74, P495, DOI 10.1097/PSY.0b013e31824d0da0; CONVIT A, 1991, BIOL PSYCHIAT, V30, P363, DOI 10.1016/0006-3223(91)90292-T; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Cuthbert BN, 2014, WORLD PSYCHIATRY, V13, P28, DOI 10.1002/wps.20087; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Daniele Ornella, 2002, J Stroke Cerebrovasc Dis, V11, P28, DOI 10.1053/jscd.2002.123972; Davis Telsie A, 2013, J Psychol Psychother, VSuppl 7, DOI 10.4172/2161-0487.S7-006; Engdahl B, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066005; Foster PS, 2008, CLIN NEUROPHYSIOL, V119, P2846, DOI 10.1016/j.clinph.2008.08.021; Gainotti G, 1972, Cortex, V8, P41; Gerdes L, 2013, BRAIN BEHAV, V3, P193, DOI 10.1002/brb3.116; Glenn AL, 2014, NAT REV NEUROSCI, V15, P54, DOI 10.1038/nrn3640; Gray MA, 2007, P NATL ACAD SCI USA, V104, P6818, DOI 10.1073/pnas.0609509104; HEILMAN KM, 1978, NEUROLOGY, V28, P229, DOI 10.1212/WNL.28.3.229; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hilz MJ, 2001, ANN NEUROL, V49, P575, DOI 10.1002/ana.1006; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Kerig PK, 2012, J TRAUMA STRESS, V25, P272, DOI 10.1002/jts.21700; Kuhn T., 1962, STRUCTURE SCI REVOLU; Maniglio R, 2015, TRAUMA VIOLENCE ABUS, V16, P241, DOI 10.1177/1524838014526068; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; McMahon RJ, 2010, J ABNORM PSYCHOL, V119, P752, DOI 10.1037/a0020796; Montenegro RA, 2011, NEUROSCI LETT, V497, P32, DOI 10.1016/j.neulet.2011.04.019; Morin CM, 1993, INSOMNIA PSYCHOL ASS; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; Nachson I., 1987, CAUSES CRIME NEW BIO, P185; Okano AH, 2015, BRIT J SPORT MED, V49, P1213, DOI 10.1136/bjsports-2012-091658; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Ostrosky-Solis F, 2008, J FORENSIC SCI, V53, P1223, DOI 10.1111/j.1556-4029.2008.00803.x; Pillmann F, 1999, J NEUROPSYCH CLIN N, V11, P454, DOI 10.1176/jnp.11.4.454; Porges S. P., 2011, POLYVAGAL THEORY; Rabe S, 2008, PSYCHOSOM MED, V70, P13, DOI 10.1097/PSY.0b013e31815aa325; Rabe S, 2006, J ABNORM PSYCHOL, V115, P687, DOI 10.1037/0021-843X.115.4.687; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raine A, 2002, J CHILD PSYCHOL PSYC, V43, P417, DOI 10.1111/1469-7610.00034; Raine A., 1996, NEUROBIOLOGICAL APPR; Rees CA, 2014, ARCH DIS CHILD, V99, P552, DOI 10.1136/archdischild-2012-301863; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Sterling P, 2012, PHYSIOL BEHAV, V106, P5, DOI 10.1016/j.physbeh.2011.06.004; Tegeler C, 2013, NEUROLOGY, V80; Tegeler CH, 2014, JAMA PSYCHIAT, V71, P336, DOI 10.1001/jamapsychiatry.2013.3507; Tegeler CH, 2012, BRAIN BEHAV, V2, P814, DOI 10.1002/brb3.101; VOLKOW ND, 1987, BRIT J PSYCHIAT, V151, P668, DOI 10.1192/bjp.151.5.668; Weathers F.W., 1993, ANN M INT SOC TRAUM; WEILER BL, 1996, CRIMINAL BEHAV MENTA, V0006; WITTLING W, 1990, NEUROPSYCHOLOGIA, V28, P457, DOI 10.1016/0028-3932(90)90072-V; Wittling W, 1998, NEUROPSYCHOLOGIA, V36, P461, DOI 10.1016/S0028-3932(97)00129-2; Wittling W, 1998, BRAIN COGNITION, V38, P17, DOI 10.1006/brcg.1998.1000; WONG MTH, 1994, ACTA PSYCHIAT SCAND, V90, P97, DOI 10.1111/j.1600-0447.1994.tb01562.x; Yoon BW, 1997, ARCH NEUROL-CHICAGO, V54, P741, DOI 10.1001/archneur.1997.00550180055012; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408	57	19	19	1	25	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	AUG 1	2014	5								1	10.3389/fpsyg.2014.00843			14	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	AN6LE	WOS:000340705200001	25136325	Green Published, gold			2022-02-06	
J	Nielsen, TH; Schalen, W; Stahl, N; Toft, P; Reinstrup, P; Nordstrom, CH				Nielsen, T. H.; Schalen, W.; Stahl, N.; Toft, P.; Reinstrup, P.; Nordstrom, C. H.			Bedside Diagnosis of Mitochondrial Dysfunction After Malignant Middle Cerebral Artery Infarction	NEUROCRITICAL CARE			English	Article						Mitochondrial dysfunction; Cerebral metabolism; Microdialysis; Malignant middle cerebral artery infarction	TRAUMATIC BRAIN-INJURY; CORTICAL SPREADING DEPRESSION; ENERGY-METABOLISM; CYCLOSPORINE-A; INTRACEREBRAL MICRODIALYSIS; GLYCOLYTIC METABOLITES; AMINO-ACIDS; ISCHEMIA; DEPOLARIZATIONS; CYCLE	The study explores whether the cerebral biochemical pattern in patients treated with hemicraniectomy after large middle cerebral artery infarcts reflects ongoing ischemia or non-ischemic mitochondrial dysfunction. The study includes 44 patients treated with decompressive hemicraniectomy (DCH) due to malignant middle cerebral artery infarctions. Chemical variables related to energy metabolism obtained by microdialysis were analyzed in the infarcted tissue and in the contralateral hemisphere from the time of DCH until 96 h after DCH. Reperfusion of the infarcted tissue was documented in a previous report. Cerebral lactate/pyruvate ratio (L/P) and lactate were significantly elevated in the infarcted tissue compared to the non-infarcted hemisphere (p < 0.05). From 12 to 96 h after DCH the pyruvate level was significantly higher in the infarcted tissue than in the non-infarcted hemisphere (p < 0.05). After a prolonged period of ischemia and subsequent reperfusion, cerebral tissue shows signs of protracted mitochondrial dysfunction, characterized by a marked increase in cerebral lactate level with a normal or increased cerebral pyruvate level resulting in an increased LP-ratio. This biochemical pattern contrasts to cerebral ischemia, which is characterized by a marked decrease in cerebral pyruvate. The study supports the hypothesis that it is possible to diagnose cerebral mitochondrial dysfunction and to separate it from cerebral ischemia by microdialysis and bed-side biochemical analysis.	[Nielsen, T. H.; Nordstrom, C. H.] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense C, Denmark; [Schalen, W.; Stahl, N.] Univ Lund Hosp, Dept Neurosurg, S-22363 Lund, Sweden; [Toft, P.] Odense Univ Hosp, Dept Anesthesiol, DK-5000 Odense C, Denmark; [Reinstrup, P.] Univ Lund Hosp, Dept Anesthesiol, S-22363 Lund, Sweden		Nielsen, TH (corresponding author), Odense Univ Hosp, Dept Neurosurg, Sdr Blvd 29, DK-5000 Odense C, Denmark.	troels.nielsen@ouh.regionsyddanmark.dk	Nielsen, Troels Halfeld/G-3456-2015	Nielsen, Troels Halfeld/0000-0002-3943-8128; Toft, Palle/0000-0002-3188-449X	Lund University Hospital; Odense University Hospital; University of Southern Denmark	We thank Katarina Nielsen, Department of Neurosurgery, Lund University Hospital, for help with the microdialysis equipment and biochemical analyses. The study was supported by Grants from Lund University Hospital, Odense University Hospital and University of Southern Denmark.	Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Amer-Wahlin I, 2010, J MATERN-FETAL NEO M, V23, P158, DOI 10.3109/14767050903067360; Bains R, 2006, ACTA ANAESTH SCAND, V50, P572, DOI 10.1111/j.1399-6576.2006.00988.x; Bains R, 2009, ACTA ANAESTH SCAND, V53, P1354, DOI 10.1111/j.1399-6576.2009.02047.x; CHAPMAN AG, 1977, J NEUROCHEM, V28, P1025, DOI 10.1111/j.1471-4159.1977.tb10665.x; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; Gardenfors A, 2002, ACTA NEUROCHIR WIEN, V144, P8; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Hwang JH, 2010, BRAIN RES, V1359, P208, DOI 10.1016/j.brainres.2010.08.047; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P229, DOI 10.1111/j.1399-6576.2012.02783.x; Nielsen TH, 2012, ACTA NEUROL SCAND, V126, P404, DOI 10.1111/j.1600-0404.2012.01664.x; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; NORBERG K, 1975, BRAIN RES, V86, P31, DOI 10.1016/0006-8993(75)90635-6; Nordstrom CH, 2010, CHILD NERV SYST, V26, P465, DOI 10.1007/s00381-009-1035-z; NORDSTROM CH, 1978, J NEUROCHEM, V30, P479, DOI 10.1111/j.1471-4159.1978.tb06553.x; NORDSTROM CH, 1978, STROKE, V9, P335, DOI 10.1161/01.STR.9.4.335; NORDSTROM CH, 1978, STROKE, V9, P327, DOI 10.1161/01.STR.9.4.327; PETTERSEN JC, 1993, J APPL TOXICOL, V13, P9, DOI 10.1002/jat.2550130104; Piilgaard H, 2011, J CEREBR BLOOD F MET, V31, P1588, DOI 10.1038/jcbfm.2011.28; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Reinstrup P, 2011, NEUROCRIT CARE, V14, P441, DOI 10.1007/s12028-010-9486-3; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Siesj? BK., 1978, BRAIN ENERGY METABOL; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Vary TC, 1996, SHOCK, V6, P89, DOI 10.1097/00024382-199608000-00002; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x	41	19	19	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2014	21	1					35	42		10.1007/s12028-013-9875-5			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AL7XP	WOS:000339350500006	23860668				2022-02-06	
J	Thomas, EJ; Levack, WMM; Taylor, WJ				Thomas, Emily J.; Levack, William M. M.; Taylor, William J.			Self-Reflective Meaning Making in Troubled Times: Change in Self-Identity After Traumatic Brain Injury	QUALITATIVE HEALTH RESEARCH			English	Article						brain injury; concept analysis; recovery; rehabilitation; self; social identity	QUALITY-OF-LIFE; HEAD-INJURY; REHABILITATION; EXPERIENCE; NARRATIVES; RECOVERY; MEMORY; INTERVENTIONS; CONSTRUCTION; IMPAIRMENT	Our aim with this article is to clarify the concept of change in self-identity following traumatic brain injury (TBI). We used concept analysis methodology-predominantly concept clarification. We identified 110 articles using a systematic literature search, and used critical appraisal, content analysis, and analytical questioning to explore attributes and boundaries. A reported change in self-identity is the ultimate expression of a variety of cognitive, psychological, and social sequelae of TBI. We present an integrative model of this process, identifying three potential levels of change: (a) component parts (egocentric self, sociocentric self, and "identity as shared with others"); (b) integral processes (self-awareness and expression via meaningful occupation and narratives); and (c) whole-system disruption. Change in self-identity after TBI is a highly individualistic process. The driver of this process is "self-reflective meaning making," giving a purpose and direction in life, providing motivation and goals for future behavior.	[Thomas, Emily J.; Levack, William M. M.; Taylor, William J.] Univ Otago, Wellington, New Zealand		Thomas, EJ (corresponding author), Univ Otago Wellington, RTRU, POB 7343, Wellington, New Zealand.	em@doctors.org.uk	Levack, William Mark Magnus/F-9607-2018	Levack, William Mark Magnus/0000-0001-6631-908X; Taylor, William/0000-0001-6075-8479			Abrams LS, 2011, QUAL HEALTH RES, V21, P373, DOI 10.1177/1049732310385123; Addis DR., 2008, SELF CONTINUITY INDI, P71, DOI DOI 10.4324/9780203888513; [Anonymous], 2013, OXFORD ENGLISH DICT; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barnes-Holmes Y, 2001, ADV CHILD DEV BEHAV, V28, P101; Ben-Yishay Y, 2000, INT HDB NEUROPSYCHOL, P127, DOI DOI 10.1007/978-1-4757-5569-5_8; Biderman D, 2006, INT J PSYCHOL, V41, P355, DOI 10.1080/00207590500345963; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brown D, 2006, BRAIN INJURY, V20, P937, DOI 10.1080/02699050600909821; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Charmaz K, 1995, SOCIOL QUART, V36, P657, DOI 10.1111/j.1533-8525.1995.tb00459.x; Christiansen CH, 1999, AM J OCCUP THER, V53, P547, DOI 10.5014/ajot.53.6.547; Christman J, 2004, METAPHILOSOPHY, V35, P695, DOI 10.1111/j.1467-9973.2004.00345.x; Cloute K, 2008, NEUROPSYCHOL REHABIL, V18, P651, DOI 10.1080/09602010701306989; Coetzer BR, 2001, J COGN REHABIL, V19, P8; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Conneeley AL., 2002, BRIT J OCCUP THER, V65, P356; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Cooley C. H., 1902, HUMAN NATURE SOCIAL; Crisp R, 1992, Aust Occup Ther J, V39, P15, DOI 10.1111/j.1440-1630.1992.tb01730.x; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; DAMON W, 1982, CHILD DEV, V53, P841, DOI 10.1111/j.1467-8624.1982.tb01347.x; Douglas Jacinta M., 2010, Seminars in Speech and Language, V31, P197, DOI 10.1055/s-0030-1257536; Erikson E. H., 1963, CHILDHOOD SOC; Fitts WH., 1996, TENNESSEE SELF CONCE; Gazzaniga M. S., 2005, ETHICAL BRAIN; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Gracey F., 2012, THE SOCIAL CURE, P273; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P522, DOI 10.1080/09602010802141509; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Gutman SA, 1996, AM J OCCUP THER, V50, P535, DOI 10.5014/ajot.50.7.535; Hammell KW, 2007, SPINAL CORD, V45, P124, DOI 10.1038/sj.sc.3101992; Heller W, 2006, J REHABIL, V72, P44; Hogan BA, 1999, NEUROREHABILITATION, V13, P21; James W, 1890, PRINCIPLES PSYCHOL B; Jetten J., 2012, SOCIAL CURE IDENTITY, P3, DOI [10.4324/9780203813195, DOI 10.4324/9780203813195]; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Jones J, 2010, QUAL HEALTH RES, V20, P942, DOI 10.1177/1049732310365501; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; Lawson S, 2008, THER RECREAT J, V42, P236; Leary M, 2012, HDB SELF IDENTITY, V2; Leplege A, 2007, DISABIL REHABIL, V29, P1555, DOI 10.1080/09638280701618661; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; LEVINE MJ, 1993, BRAIN INJURY, V7, P153, DOI 10.3109/02699059309008169; LINVILLE PW, 1987, J PERS SOC PSYCHOL, V52, P663, DOI 10.1037/0022-3514.52.4.663; Locke J, 1690, ESSAY HUMAN UNDERSTA; Man DWK, 2003, BRAIN INJURY, V17, P775, DOI 10.1080/0269905031000088577; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; Mattingly C., 1998, HEALING DRAMAS CLIN; McAdams DP., 1999, HDB PERSONALITY THEO, V2, P478; McGrath J, 2004, CLIN REHABIL, V18, P767, DOI 10.1191/0269215504cr802oa; MCGRATH JC, 2008, TRAUMA RECOVERY GROW, P259; Mead G.H., 1934, MIND SELF SOC STANDP; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; MORRIS SD, 2004, J COGN REHABIL, V22, P15; Morse J M, 1996, Sch Inq Nurs Pract, V10, P253; MORSE JM, 1995, ADV NURS SCI, V17, P31, DOI 10.1097/00012272-199503000-00005; Morse JM, 1996, J ADV NURS, V24, P385, DOI 10.1046/j.1365-2648.1996.18022.x; Morse JM, 2000, CONCEPT DEV NURSING, P333; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Noggle R, 1999, PHILOS STUD, V96, P303; Oke M, 2008, AUST N Z J FAM THER, V29, P148, DOI 10.1375/anft.29.3.148; Ownsworth T, 2011, BRAIN IMPAIR, V12, P79; Padilla R, 2003, AM J OCCUP THER, V57, P413, DOI 10.5014/ajot.57.4.413; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; Patterson FL, 2009, J MENT HLTH COUNS, V31, P149; Perna R. B., 2004, J COGNITIVE REHABILI, V22, P10; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; PriceLackey P, 1996, AM J OCCUP THER, V50, P306, DOI 10.5014/ajot.50.4.306; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rathbone CJ, 2009, NEUROCASE, V15, P405, DOI 10.1080/13554790902849164; RICOEUR PAUL, 1984, TIME NARRATIVE, V1; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Rubin D., 1988, AUTOBIOGRAPHICAL MEM, P202; Schechtman Marya, 1996, CONSTITUTION SELVES; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Smith C., 2008, FORUM QUALITATIVE SO, V9; Soeker MS, 2011, J OCCUP SCI, V18, P81, DOI 10.1080/14427591.2011.554155; Strawson G, 2004, RATIO, V17, P428, DOI 10.1111/j.1467-9329.2004.00264.x; Taylor C., 1989, SOURCES SELF MAKING; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Witt K, 2013, NEUROETHICS-NETH, V6, P499, DOI 10.1007/s12152-011-9100-1; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	99	19	19	1	26	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	AUG	2014	24	8			SI		1033	1047		10.1177/1049732314542809			15	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	AQ2OB	WOS:000342625100002	25015780				2022-02-06	
J	Sykora, M; Steinmacher, S; Steiner, T; Poli, S; Diedler, J				Sykora, Marek; Steinmacher, Sahra; Steiner, Thorsten; Poli, Sven; Diedler, Jennifer			Association of intracranial pressure with outcome in comatose patients with intracerebral hemorrhage	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Intracerebral hemorrhage; Outcome; Intracranial pressure; Cerebral perfusion pressure; ICP; CPP	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; ABC/2 ESTIMATION TECHNIQUE; REACTIVITY; HEMATOMAS	Background: Therapeutic targets for intracranial pressure (ICP) in patients with severe intracerebral hemorrhage (ICH) are approximated from data of traumatic brain injury. However, specific data for ICH are lacking. Here, we aimed to investigate the association between ICP, mortality and functional outcome following severe ICH. Methods: We analyzed consecutive comatose patients with ICH in whom ICP monitoring was applied. Outcome at 3 months was assessed using the modified Rankin scale (mRS). Multivariate logistic regression including pre-defined predictors was used in order to identify the effects of ICP on outcome. Results: 121 patients with ICH and ICP monitoring were analyzed. Mean ICP (OR 12, Cl 1.08-1.45,p = 0.003), ICP variability (OR 13, Cl 1.03-1.73, p = 0.03) and relative frequency of ICP values >20 mm Hg (OR 1.1, CI 1.02-1.15, p = 0.008) were independently associated with mortality at 3 months. Relative frequency of ICP values > 20 mm Hg (OR 1.1, CI 1.001-1.3, p = 0.04) was associated also with poor functional outcome at 3 months. Conclusions: Our data suggest that in the context of other predictors as age, admission clinical status, hemorrhage volume and intraventricular hemorrhage, average ICP, ICP variability and the frequency of ICP values >20 mm Hg are independently associated with mortality and poor outcome after ICH. Further studies and prospective validations of ICP thresholds for ICH patients are highly warranted. (C) 2014 Elsevier B.V. All rights reserved.	[Sykora, Marek; Steinmacher, Sahra; Poli, Sven; Diedler, Jennifer] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany; [Steiner, Thorsten] Klinikum Frankfurt Hochst, Dept Neurol, Frankfurt, Germany; [Poli, Sven; Diedler, Jennifer] Univ Tubingen, Dept Neurol, Tubingen, Germany; [Diedler, Jennifer] Univ Tubingen, Dept Neurosurg, Tubingen, Germany		Sykora, M (corresponding author), Heidelberg Univ, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	marek.sykora@med.uni-heidelberg.de	Steiner, Thorsten/L-2868-2018; Steiner, Thorsten/A-7391-2014	Steiner, Thorsten/0000-0002-5080-8222; 			Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Diedler J, 2009, STROKE, V40, P815, DOI 10.1161/STROKEAHA.108.531020; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Fernandes HM, 2000, ACT NEUR S, V76, P463; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; Hamani C, 2003, ARQ NEURO-PSIQUIAT, V61, P376, DOI 10.1590/S0004-282X2003000300010; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Ko SB, 2011, STROKE, V42, P3087, DOI 10.1161/STROKEAHA.111.623165; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nikaina I, 2012, J CRIT CARE, V27, P83, DOI 10.1016/j.jcrc.2011.04.004; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Tian Y, 2013, J NEUROL SCI, V330, P38, DOI 10.1016/j.jns.2013.04.001; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	17	19	24	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUL 15	2014	342	1-2					141	145		10.1016/j.jns.2014.05.012			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK4SN	WOS:000338414500022	24857761				2022-02-06	
J	Cui, QJ; Wang, LY; Wei, ZX; Qu, WS				Cui, Qun-jian; Wang, Li-yi; Wei, Zhi-xuan; Qu, Wen-sheng			Continual Naringin Treatment Benefits the Recovery of Traumatic Brain Injury in Rats Through Reducing Oxidative and Inflammatory Alterations	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; Naringin; Oxidative stress; Inflammation	NITRIC-OXIDE SYNTHASE; HEAD-INJURY; ANTIOXIDANT THERAPIES; INDUCED NEUROTOXICITY; SELECTIVE-INHIBITION; REPLACEMENT THERAPY; CLINICAL-TRIALS; FEMALE RATS; MODEL; NEUROPROTECTION	Naringin is neuroprotective in ischemia and other disease models. However, the effects of naringin are unknown after traumatic brain injury (TBI). The present study explored the role of naringin for neuroprotection in TBI rats. TBI was performed with the weight drop technique, and naringin was given orally at a dose of 100 mg/kg/day. The neurological scores, tissue edema, and oxidative stress/inflammation parameters [malondialdehyde (MDA), superoxide dismutase, nitric oxide, inducible nitric oxide synthase (iNOS), as well as interleukin-1 beta (IL-1 beta)] were measured. Compared to sham controls, TBI rats displayed obvious sensorimotor dysfunction, significant brain edema, and elevated oxidative and inflammatory molecules. Although a 7-day pre-treatment of naringin was unable to reverse these pathological changes, a 14-day continual treatment (7 days before and 7 days after the TBI) attenuated the increases in MDA and nitric oxide; enhanced the activation of superoxide dismutase; depressed the over-activation of iNOS; down-regulated the over-expression of IL-1 beta; and reduced the cortex edema. Additionally, the TBI-induced behavioral dysfunction was reduced. These results suggest that naringin treatment can attenuate cellular and histopathological alterations and improve the sensorimotor dysfunction of TBI rats, which may be partly due to the attenuation of oxidative and inflammatory damages.	[Cui, Qun-jian; Wang, Li-yi] Nanyang Med Collage, Dept Neurosurg, Affiliated Hosp 1, Nanyang 473000, Henan, Peoples R China; [Wei, Zhi-xuan] Nanyang Med Collage, Dept Gen Surg, Affiliated Hosp 1, Nanyang 473000, Henan, Peoples R China; [Qu, Wen-sheng] Huazhong Univ Sci & Technol, Dept Neurol, Tongji Hosp, Tongji Med Collage, Wuhan 430030, Hunan, Peoples R China		Qu, WS (corresponding author), Huazhong Univ Sci & Technol, Dept Neurol, Tongji Hosp, Tongji Med Collage, 1095 Rd Jiefang, Wuhan 430030, Hunan, Peoples R China.	qws0309@163.com					Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Boto GR, 2005, NEUROCIRUGIA, V16, P39; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Chanet A, 2012, J NUTR BIOCHEM, V23, P469, DOI 10.1016/j.jnutbio.2011.02.001; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dajas F, 2003, BRAZ J MED BIOL RES, V36, P1613, DOI 10.1590/S0100-879X2003001200002; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FUHR U, 1995, CLIN PHARMACOL THER, V58, P365, DOI 10.1016/0009-9236(95)90048-9; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Gaur V, 2009, EUR J PHARMACOL, V616, P147, DOI 10.1016/j.ejphar.2009.06.056; Golechha M, 2011, BIOL PHARM BULL, V34, P360, DOI 10.1248/bpb.34.360; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Gopinath K, 2012, NEUROSCIENCE, V227, P134, DOI 10.1016/j.neuroscience.2012.07.060; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Heo HJ, 2004, J AGR FOOD CHEM, V52, P1520, DOI 10.1021/jf035079g; Hwang SL, 2012, J AGR FOOD CHEM, V60, P877, DOI 10.1021/jf204452y; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jagetia A, 2007, J APPL TOXICOL, V27, P122, DOI 10.1002/jat.1175; JUDD HL, 1983, ANN INTERN MED, V98, P195, DOI 10.7326/0003-4819-98-2-195; Kalayci M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-75; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043; Liu Y, 2012, MOL MED REP, V6, P1343, DOI 10.3892/mmr.2012.1072; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Mazur W, 1998, BAILLIERE CLIN ENDOC, V12, P729, DOI 10.1016/S0950-351X(98)80013-X; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Menze ET, 2012, NEUROTOXICOLOGY, V33, P1265, DOI 10.1016/j.neuro.2012.07.007; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nones J, 2011, NEUROCHEM RES, V36, P1776, DOI 10.1007/s11064-011-0493-3; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Potts Mathew B, 2006, NeuroRx, V3, P143; Prakash A, 2013, INT J NEUROSCI, V123, P636, DOI 10.3109/00207454.2013.785542; Raafat AM, 2001, AM J OBSTET GYNECOL, V184, P340, DOI 10.1067/mob.2001.110447; Rong W, 2012, NEUROCHEM RES, V37, P1615, DOI 10.1007/s11064-012-0756-7; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Tsai TH, 2002, J AGR FOOD CHEM, V50, P6669, DOI 10.1021/jf020603p; Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vavilala MS, 2001, ANESTH ANALG, V93, P351, DOI 10.1097/00000539-200108000-00023; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Youdim KA, 2002, BIOL CHEM, V383, P503, DOI 10.1515/BC.2002.052; Youdim KA, 2004, FREE RADICAL BIO MED, V36, P592, DOI 10.1016/j.freeradbiomed.2003.11.023; Zbarsky V, 2005, FREE RADICAL RES, V39, P1119, DOI 10.1080/10715760500233113	60	19	19	1	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUL	2014	39	7					1254	1262		10.1007/s11064-014-1306-2			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AM3BU	WOS:000339727300009	24728904				2022-02-06	
J	Diaz, AP; Schwarzbold, ML; Thais, ME; Cavallazzi, GG; Schmoeller, R; Nunes, JC; Hohl, A; Guarnieri, R; Linhares, MN; Walz, R				Diaz, Alexandre P.; Schwarzbold, Marcelo L.; Thais, Maria E.; Cavallazzi, Gisele G.; Schmoeller, Roseli; Nunes, Jean C.; Hohl, Alexandre; Guarnieri, Ricardo; Linhares, Marcelo N.; Walz, Roger			Personality changes and return to work after severe traumatic brain injury: a prospective study	REVISTA BRASILEIRA DE PSIQUIATRIA			English	Article						Traumatic brain injury; return to work; mental disorders	HEAD-INJURY; PSYCHIATRIC-DISORDERS; ACUTE PREDICTORS; MORTALITY; RECOVERY; IMPACT; AGE; EPIDEMIOLOGY; MULTICENTER; APATHY	Objective: To evaluate predictors of non-return to work (nRTW) among social, demographic, clinical, and psychiatric variables after severe traumatic brain injury (TBI) in a cohort of Brazilian patients. Methods: Prospective study. Forty-three community-dwelling individuals treated at a Level I trauma center at the time of TBI were evaluated 18 months after trauma. Measures included DSM-IV-TR criteria for personality changes after TBI and Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) to assess psychiatric diagnosis. Hospitalization variables included Glasgow Coma Scale scores, pupil examination findings, associated limb trauma, Marshall computed tomography classification, and blood glucose levels. Results: After multiple logistic regression analysis, only the diagnosis of personality changes was found to be independently associated with nRTW, with an adjusted odds ratio of 10.92 (p = 0.02, 95% confidence interval 1.41-84.28). Conclusions: In this study, personality changes were an independent predictor of nRTW after severe TBI. Ways to predict risk factors associated with personality changes after severe brain injury could aid in identification of early and effective interventions that might ease the burden associated with this condition.	[Diaz, Alexandre P.; Schwarzbold, Marcelo L.; Thais, Maria E.; Cavallazzi, Gisele G.; Schmoeller, Roseli; Nunes, Jean C.; Hohl, Alexandre; Guarnieri, Ricardo; Linhares, Marcelo N.; Walz, Roger] Univ Fed Santa Catarina, HU, Ctr Appl Neurosci CeNAp, Florianopolis, SC, Brazil; [Diaz, Alexandre P.; Guarnieri, Ricardo; Linhares, Marcelo N.] Hosp Governador Celso Ramos, Neurosurg Serv, Florianopolis, SC, Brazil; [Walz, Roger] Univ Fed Santa Catarina, HU, Dept Clin Med, Florianopolis, SC, Brazil		Diaz, AP (corresponding author), Univ Fed Santa Catarina, Ctr Neurociencias Aplicadas CENAP, BR-88040970 Florianopolis, SC, Brazil.	alexandrepaimdiaz@gmail.com	Diaz, Alexandre Paim/AAD-8323-2019; Walz, Roger/K-9096-2013; Hohl, Alexandre/R-9269-2019; Diaz, Alexandre Paim/J-9042-2014; Schwarzbold, Marcelo Liborio/J-8960-2014	Diaz, Alexandre Paim/0000-0002-6591-6648; Walz, Roger/0000-0002-9875-6687; Hohl, Alexandre/0000-0002-8073-5837; 	PRONEX Program (NENASC Project); PPSUS Program of Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC); National Science and Technology Institute for Translational Medicine (INCT-TM)	This work was supported by PRONEX Program (NENASC Project) and PPSUS Program of Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) and the National Science and Technology Institute for Translational Medicine (INCT-TM).	Alonso J, 2012, REV BRAS PSIQUIATR, V34, P7, DOI 10.1590/S1516-44462012000100003; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Botega NJ, 1998, J BRAS PSIQUIAT, V47, P285; Brooks N, 1988, Acta Neurochir Suppl (Wien), V44, P59; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Druss BG, 2009, MOL PSYCHIATR, V14, P728, DOI 10.1038/mp.2008.13; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; First M.B., 1996, STRUCTURED CLIN INTE; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Koizumi MS, 2000, ARQ NEURO-PSIQUIAT, V58, P81, DOI 10.1590/S0004-282X2000000100013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Masini M, 1994, J BRAS NEUROCIRURG, V5, P61; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruiz Pedro, 2009, COMPREHENSIVE TXB PS; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tavares M., 1996, CLIN ESTRUCTURADA DS; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Viana MC, 2012, REV BRAS PSIQUIATR, V34, P249, DOI 10.1016/j.rbp.2012.03.001; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	19	19	1	8	ASSOC BRASILEIRA PSIQUIATRIA	SAO PAULO	SUBSCRIPTION DEPARTMENT, RUA PEDRO DE TOLEDO, 967 - CASA 01, SAO PAULO, SP 04039-032  A, BRAZIL	1516-4446	1809-452X		REV BRAS PSIQUIATR	Rev. Bras. Psiquiatr.	JUL-SEP	2014	36	3					213	219		10.1590/1516-4446-2013-1303			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	AN2PD	WOS:000340426900006	24770655	gold, Green Submitted			2022-02-06	
J	Sakurai, A; Tamvacakis, AN; Katz, PS				Sakurai, Akira; Tamvacakis, Arianna N.; Katz, Paul S.			Hidden synaptic differences in a neural circuit underlie differential behavioral susceptibility to a neural injury	ELIFE			English	Article						Individual variability; synapse; central pattern generator; dynamic clamp; neural injury	TRAUMATIC BRAIN-INJURY; AXONAL SPIKE INITIATION; CENTRAL NERVOUS SYSTEMS; WHITE-MATTER STROKE; MOTOR PATTERNS; DYNAMIC CLAMP; FUNCTIONAL-ORGANIZATION; IMMUNOREACTIVE NEURONS; ACTION-POTENTIALS; VARIABILITY	Individuals vary in their responses to stroke and trauma, hampering predictions of outcomes. One reason might be that neural circuits contain hidden variability that becomes relevant only when those individuals are challenged by injury. We found that in the mollusc, Tritonia diomedea, subtle differences between animals within the neural circuit underlying swimming behavior had no behavioral relevance under normal conditions but caused differential vulnerability of the behavior to a particular brain lesion. The extent of motor impairment correlated with the site of spike initiation in a specific neuron in the neural circuit, which was determined by the strength of an inhibitory synapse onto this neuron. Artificially increasing or decreasing this inhibitory synaptic conductance with dynamic clamp correspondingly altered the extent of motor impairment by lesion without affecting normal operation. The results suggest that neural circuit differences could serve as hidden phenotypes for predicting the behavioral outcome of neural damage.	[Sakurai, Akira; Tamvacakis, Arianna N.; Katz, Paul S.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA		Sakurai, A (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.		Sakurai, Akira/A-6755-2008	Sakurai, Akira/0000-0003-2858-1620	Brains and Behavior Seed Grant Program Georgia State University; March of Dimes FoundationMarch of Dimes;  [NSF-IOS-1120950]	Supported by NSF-IOS-1120950, Brains and Behavior Seed Grant Program Georgia State University, and March of Dimes Foundation	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andreasen M, 1998, J PHYSIOL-LONDON, V507, P441, DOI 10.1111/j.1469-7793.1998.441bt.x; Antic S, 2000, J PHYSIOL-LONDON, V527, P55, DOI 10.1111/j.1469-7793.2000.00055.x; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Berg RW, 2007, SCIENCE, V315, P390, DOI 10.1126/science.1134960; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Blasi F, 2014, STROKE, V45, P1468, DOI 10.1161/STROKEAHA.114.005324; Brown GG, 2010, CURR TOP BEHAV NEURO, V4, P181, DOI 10.1007/7854_2010_54; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; Bukalo O, 2013, P NATL ACAD SCI USA, V110, P5175, DOI 10.1073/pnas.1210735110; BULLOCK TH, 1957, J PHYSIOL-LONDON, V138, P341, DOI 10.1113/jphysiol.1957.sp005855; Cai LL, 2006, PHILOS T R SOC B, V361, P1635, DOI 10.1098/rstb.2006.1884; CALABRESE RL, 1980, J NEUROPHYSIOL, V44, P878, DOI 10.1152/jn.1980.44.5.878; CALABRESE RL, 1974, BRAIN RES, V82, P316, DOI 10.1016/0006-8993(74)90612-X; Calabrese RL, 2011, INTEGR COMP BIOL, V51, P845, DOI 10.1093/icb/icr074; Calin-Jageman RJ, 2007, J NEUROPHYSIOL, V98, P2382, DOI 10.1152/jn.00572.2007; COMBES D, 1993, J PHYSIOL-LONDON, V460, P581, DOI 10.1113/jphysiol.1993.sp019488; Cramer SC, 2003, NEUROL RES, V25, P811, DOI 10.1179/016164103771953899; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Darwin Charles, 1876, ORIGIN SPECIES NATUR; Daur N, 2009, EUR J NEUROSCI, V30, P808, DOI 10.1111/j.1460-9568.2009.06866.x; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Dougherty KJ, 2010, ANN NY ACAD SCI, V1198, P85, DOI 10.1111/j.1749-6632.2010.05502.x; Essen Van, 2012, PNAS, P788; Fickbohm DJ, 2000, J NEUROSCI, V20, P1622; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Frost WN, 1996, NEUROBIOL LEARN MEM, V65, P125, DOI 10.1006/nlme.1996.0015; Getting P., 1989, METHODS NEURONAL MOD, P171; Getting P. A., 1989, NEURONAL CELLULAR OS, P215; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; GETTING PA, 1983, J NEUROPHYSIOL, V49, P1036, DOI 10.1152/jn.1983.49.4.1036; GETTING PA, 1980, J NEUROPHYSIOL, V44, P151, DOI 10.1152/jn.1980.44.1.151; GETTING PA, 1981, J NEUROPHYSIOL, V46, P65, DOI 10.1152/jn.1981.46.1.65; GETTING PA, 1983, J NEUROPHYSIOL, V49, P1017, DOI 10.1152/jn.1983.49.4.1017; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; Gunaratne CA, 2014, J COMP NEUROL, V522, P794, DOI 10.1002/cne.23446; Hansen BJ, 2012, NEURON, V76, P590, DOI 10.1016/j.neuron.2012.08.029; HEITLER WJ, 1978, J EXP BIOL, V76, P63; Hill ES, 2007, J NEUROPHYSIOL, V97, P2204, DOI 10.1152/jn.01244.2006; HUGHES GM, 1960, J EXP BIOL, V37, P291; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Katz P. S., 2007, SCHOLARPEDIA, V2, P3504; Katz P. S., 2009, SCHOLARPEDIA, V4, P3638, DOI DOI 10.4249/SCHOLARPEDIA.3638; Katz PS, 2007, CURR OPIN NEUROBIOL, V17, P59, DOI 10.1016/j.conb.2006.12.003; Katz PS, 2004, J NEUROPHYSIOL, V92, P1904, DOI 10.1152/jn.00864.2003; Kemenes I, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.200; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Killian KA, 2000, J EXP ZOOL, V286, P350, DOI 10.1002/(SICI)1097-010X(20000301)286:4&lt;350::AID-JEZ3&gt;3.0.CO;2-3; Kim JH, 2014, NEUROSCI LETT, V564, P6, DOI 10.1016/j.neulet.2014.01.054; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; LLINAS R, 1968, SCIENCE, V160, P1132, DOI 10.1126/science.160.3832.1132; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Luebke AE, 2002, J NEUROSCI, V22, P4241, DOI 10.1523/JNEUROSCI.22-10-04241.2002; Magoski NS, 1999, J NEUROPHYSIOL, V81, P1330, DOI 10.1152/jn.1999.81.3.1330; Magoski NS, 2000, J NEUROBIOL, V42, P410; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; MEYRAND P, 1992, J NEUROSCI, V12, P2803; MOULINS M, 1979, NEUROSCI LETT, V13, P231, DOI 10.1016/0304-3940(79)91499-X; Nenadic I, 2012, NEUROPSYCHOBIOLOGY, V66, P44, DOI 10.1159/000338547; Newcomb JM, 2006, J COMP NEUROL, V499, P485, DOI 10.1002/cne.21111; Norris BJ, 2011, J NEUROSCI, V31, P4663, DOI 10.1523/JNEUROSCI.5072-10.2011; OSHEA M, 1975, BRAIN RES, V96, P93, DOI 10.1016/0006-8993(75)90577-6; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petersen PC, 2014, J NEUROSCI, V34, P2774, DOI 10.1523/JNEUROSCI.3349-13.2014; Prasad KM, 2008, SCHIZOPHRENIA BULL, V34, P774, DOI 10.1093/schbul/sbn017; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313; Riddle A, 2012, STROKE, V43, P178, DOI 10.1161/STROKEAHA.111.632265; Rinberg A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002857; Roffman RC, 2012, J NEUROPHYSIOL, V107, P1681, DOI 10.1152/jn.00903.2011; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sakurai A, 2003, J NEUROSCI, V23, P10745; Sakurai A, 2009, J NEUROSCI, V29, P13115, DOI 10.1523/JNEUROSCI.3485-09.2009; Sakurai A, 2009, J NEUROSCI, V29, P268, DOI 10.1523/JNEUROSCI.4456-08.2009; Sasaki K, 2009, J NEUROSCI, V29, P11732, DOI 10.1523/JNEUROSCI.3051-09.2009; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SHARP AA, 1992, J NEUROPHYSIOL, V67, P1691, DOI 10.1152/jn.1992.67.6.1691; Sharp AA, 1996, J NEUROPHYSIOL, V76, P867, DOI 10.1152/jn.1996.76.2.867; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Smarandache CR, 2007, J EXP BIOL, V210, P2912, DOI 10.1242/jeb.006874; Smith DV, 2014, NEUROIMAGE, V95, P1, DOI 10.1016/j.neuroimage.2014.03.042; Sozmen EG, 2009, J NEUROSCI METH, V180, P261, DOI 10.1016/j.jneumeth.2009.03.017; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Tang LS, 2012, J NEUROSCI, V32, P10075, DOI 10.1523/JNEUROSCI.1443-12.2012; TAUC L., 1963, JOUR GEN PHYSIOL, V46, P533; Thuma JB, 2009, BRAIN BEHAV EVOLUT, V73, P26, DOI 10.1159/000202988; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Walhovd KB, 2014, CURR OPIN NEUROL, V27, P176, DOI 10.1097/WCO.0000000000000074; WHITAKER HA, 1976, ANN NY ACAD SCI, V280, P844, DOI 10.1111/j.1749-6632.1976.tb25547.x; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zecevic D, 1996, NATURE, V381, P322, DOI 10.1038/381322a0	102	19	19	0	9	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	JUN 11	2014	3								e02598	10.7554/eLife.02598			45	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	AK8ZM	WOS:000338717300002	24920390	Green Submitted, gold, Green Published			2022-02-06	
J	Mahmood, G; Mei, Z; Hojjat, H; Pace, E; Kallakuri, S; Zhang, JS				Mahmood, G.; Mei, Z.; Hojjat, H.; Pace, E.; Kallakuri, S.; Zhang, J. S.			THERAPEUTIC EFFECT OF SILDENAFIL ON BLAST-INDUCED TINNITUS AND AUDITORY IMPAIRMENT	NEUROSCIENCE			English	Article						tinnitus; blast; traumatic brain injury; sildenafil (Viagra, Revatio); hyperacusis; rat	TRAUMATIC BRAIN-INJURY; DORSAL COCHLEAR NUCLEUS; INDUCED HEARING-LOSS; INTENSE SOUND EXPOSURE; SALICYLATE-INDUCED TINNITUS; QUININE-INDUCED TINNITUS; FUNCTIONAL RECOVERY; ACOUSTIC TRAUMA; NEURAL ACTIVITY; GAP DETECTION	Blast-induced tinnitus, along with associated auditory impairment and traumatic brain injury, is a primary concern facing military service members. To search for treatment, we investigated the therapeutic effects of sildenafil, a phosphodiesterase-5 inhibitor, given its vasodilatory effects and evidence suggesting its beneficial effects on noise-induced hearing loss. Rats were subjected to three consecutive blast exposures at 22 psi and were monitored for tinnitus using a gap-detection acoustic startle reflex paradigm. Hearing thresholds and detection were tested using auditory brainstem responses and prepulse inhibition, respectively. Blasted rats were either treated with sildenafil or tap water following blast exposure, while age-matched sham control rats were treated with sildenafil and no blast exposure. Our results showed that sildenafil did not effectively prevent acute tinnitus onset and hearing impairment. Instead, sildenafil significantly suppressed high-frequency tinnitus from 3 to 6 weeks after blast exposure and reduced hearing impairment during the first week after blast exposure. Complex results were observed in the startle force data, where sildenafil-treated rats displayed significantly reduced startle force compared to the untreated blasted group, suggesting possible mitigation of traumatic brain injury and suppression of hyperacusis-like percepts. Taken together, sildenafil showed a therapeutic effect on blastinduced tinnitus and audiological impairment in a time-dependent manner. Other regimens such as higher dosage prior to blast exposure and combination with other treatments deserve further investigation to optimize the therapeutic effects. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Mahmood, G.; Mei, Z.; Hojjat, H.; Pace, E.; Zhang, J. S.] Wayne State Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Detroit, MI 48201 USA; [Kallakuri, S.] Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI 48201 USA; [Zhang, J. S.] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48201 USA		Zhang, JS (corresponding author), Wayne State Univ, Sch Med, 5E-UHC,4201 St Antoine, Detroit, MI 48201 USA.	jinzhang@med.wayne.edu			US Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]	This work was supported by the US Department of Defense (Grant award # W81XWH-11-2-0031).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Administration VB, 2011, ANN BEN REP; Angrilli A, 2008, NEUROPSYCHOLOGIA, V46, P1179, DOI 10.1016/j.neuropsychologia.2007.10.018; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Attias J., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P117; Baguley DM, 2005, OTOL NEUROTOL, V26, P169, DOI 10.1097/00129492-200503000-00007; Baldo P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003853.pub2; Bauer C.A., 2008, J NEUROSCI RES; Bauer CA, 2006, LARYNGOSCOPE, V116, P675, DOI 10.1097/01.MLG.0000216812.65206.CD; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Boolell M, 1996, Int J Impot Res, V8, P47; CAHANI M, 1983, AUDIOLOGY, V22, P357; Cazals Y, 2000, PROG NEUROBIOL, V62, P583, DOI 10.1016/S0301-0082(00)00027-7; Chen G, 2013, JARO-J ASSOC RES OTO, V14, P413, DOI 10.1007/s10162-013-0375-2; CHEN GD, 1995, HEARING RES, V82, P158, DOI 10.1016/0378-5955(94)00174-O; Chen W, 2013, INT J CLIN EXP PATHO, V6, P375; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Chiueh CC, 1999, ANN NY ACAD SCI, V890, P301, DOI 10.1111/j.1749-6632.1999.tb08007.x; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2007, HEARING RES, V229, P69, DOI 10.1016/j.heares.2007.01.008; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Franz P, 1996, ACTA OTO-LARYNGOL, V116, P726, DOI 10.3109/00016489609137914; Giuliano F, 2010, INT J CLIN PRACT, V64, P240, DOI 10.1111/j.1742-1241.2009.02254.x; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; GOODWIN PE, 1980, ACTA OTO-LARYNGOL, V90, P353, DOI 10.3109/00016488009131736; Gosepath K, 1997, BRAIN RES, V747, P26, DOI 10.1016/S0006-8993(96)01149-3; HALLAM RS, 1985, ACTA OTO-LARYNGOL, V99, P501, DOI 10.3109/00016488509182253; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Hebert S, 2011, J SLEEP RES, V20, P38, DOI 10.1111/j.1365-2869.2010.00860.x; Hess A, 2006, EUR ARCH OTO-RHINO-L, V263, P75, DOI 10.1007/s00405-005-0953-y; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Hiller W, 1999, INT J BEHAV MED, V6, P312, DOI 10.1207/s15327558ijbm0604_2; Hong BN, 2008, BIOL PHARM BULL, V31, P1981, DOI 10.1248/bpb.31.1981; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Ison JR, 2003, JARO-J ASSOC RES OTO, V4, P495, DOI 10.1007/s10162-002-3046-2; JASTREBOFF PJ, 1991, ARCH OTOLARYNGOL, V117, P1162; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kaltenbach JA, 2000, HEARING RES, V147, P282, DOI 10.1016/S0378-5955(00)00138-6; Kaltenbach JA, 2002, J NEUROPHYSIOL, V88, P699, DOI 10.1152/jn.2002.88.2.699; Khan AS, 2011, LARYNGOSCOPE, V121, P1049, DOI 10.1002/lary.21450; Kimura M, 1999, HEARING RES, V135, P146, DOI 10.1016/S0378-5955(99)00104-5; Kraus KS, 2011, NEUROSCIENCE, V194, P309, DOI 10.1016/j.neuroscience.2011.07.056; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lamm K, 1999, ANN NY ACAD SCI, V884, P233, DOI 10.1111/j.1749-6632.1999.tb08645.x; Langguth B, 2012, EXPERT OPIN PHARMACO, V13, P2495, DOI 10.1517/14656566.2012.739608; LENARZ T, 1986, SCAND AUDIOL, P49; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Lobarinas E, 2006, ACTA OTO-LARYNGOL, V126, P13, DOI 10.1080/03655230600895408; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Lu J, 2011, NEUROSCIENCE, V189, P187, DOI 10.1016/j.neuroscience.2011.04.073; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; Luo H, 2012, NEUROSCI LETT, V522, P16, DOI 10.1016/j.neulet.2012.05.072; Ma WLD, 2006, HEARING RES, V212, P9, DOI 10.1016/j.heares.2005.10.003; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maddox PT, 2009, LARYNGOSCOPE, V119, P1586, DOI 10.1002/lary.20511; Mahlke C, 2004, HEARING RES, V195, P17, DOI 10.1016/j.heares.2004.03.005; Mammi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014542; MAN A, 1981, AUDIOLOGY, V20, P72; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Mazurek B, 2009, J NEGAT RESULTS BIOM, V8, DOI 10.1186/1477-5751-8-3; McGwin G, 2010, ARCH OTOLARYNGOL, V136, P488, DOI 10.1001/archoto.2010.51; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Mukherjee B, 2007, J LARYNGOL OTOL, V121, P395, DOI 10.1017/S0022215106005512; Myers SA, 2012, J NEUROTRAUM, V29, P528, DOI 10.1089/neu.2011.2036; Nelson Jeffrey J, 2004, Ear Nose Throat J, V83, P472; Norman M, 2012, HEARING RES, V290, P64, DOI 10.1016/j.heares.2012.03.015; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Nowotny M, 2011, J ACOUST SOC AM, V130, P2827, DOI 10.1121/1.3646902; Oishi N, 2010, AUDIOL NEURO-OTOL, V15, P187, DOI 10.1159/000251916; Okuyucu S, 2009, J LARYNGOL OTOL, V123, P718, DOI 10.1017/S002221510900423X; Otake H, 2009, ACTA OTO-LARYNGOL, V129, P127, DOI 10.1080/00016480802078119; Pace E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075011; Peiffer AM, 2004, DEV BRAIN RES, V152, P93, DOI 10.1016/j.devbrainres.2004.06.003; Pifarre P, 2010, J NEUROCHEM, V112, P807, DOI 10.1111/j.1471-4159.2009.06518.x; Prabhu Latha V, 2013, Int J Appl Basic Med Res, V3, P84, DOI 10.4103/2229-516X.117056; Ren TY, 1995, HEARING RES, V92, P30, DOI 10.1016/0378-5955(95)00192-1; Reyes SA, 2002, HEARING RES, V171, P43, DOI 10.1016/S0378-5955(02)00346-5; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Rybalko N, 2011, PHYSIOL BEHAV, V102, P453, DOI 10.1016/j.physbeh.2010.12.010; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; SCHEIBE F, 1993, EUR ARCH OTO-RHINO-L, V250, P281; SCHEIBE F, 1992, HEARING RES, V63, P19, DOI 10.1016/0378-5955(92)90069-Y; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Shao ZH, 2009, J CELL BIOCHEM, V107, P697, DOI 10.1002/jcb.22170; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Shin HS, 2006, INT J PHARM, V320, P64, DOI 10.1016/j.ijpharm.2006.04.005; Shulman, 1995, Int Tinnitus J, V1, P13; Snodgrass Amanda J, 2010, Pharmacotherapy, V30, P112, DOI 10.1592/phco.30.1.112; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Sun W, 2012, BRAIN RES, V1485, P108, DOI 10.1016/j.brainres.2012.02.008; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Swetter BJ, 2010, BEHAV NEUROSCI, V124, P370, DOI 10.1037/a0019519; Temmel AFP, 1999, WIEN KLIN WOCHENSCHR, V111, P891; Test T, 2011, SLEEP, V34, P25, DOI 10.1093/sleep/34.1.25; Thakur JS, 2013, LARYNGOSCOPE, V123, P1527, DOI 10.1002/lary.23865; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang H, 2000, Zhonghua Er Bi Yan Hou Ke Za Zhi, V35, P420; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Wang HN, 2011, HEARING RES, V279, P111, DOI 10.1016/j.heares.2011.04.004; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; Wu Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/384627; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yuan ZX, 2008, INVEST OPHTH VIS SCI, V49, P720, DOI 10.1167/iovs.07-1208; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z; Zhang JS, 2003, EXP BRAIN RES, V153, P655, DOI 10.1007/s00221-003-1612-4; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang L, 2006, BRAIN RES, V1118, P192, DOI 10.1016/j.brainres.2006.08.028; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang Shu-jun, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P844; Zheng YW, 2012, NEUROPHARMACOLOGY, V62, P940, DOI 10.1016/j.neuropharm.2011.09.027	135	19	20	1	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 6	2014	269						367	382		10.1016/j.neuroscience.2014.03.020			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AH1TL	WOS:000335903900034	24662845				2022-02-06	
J	Hald, ES; Alford, PW				Hald, Eric S.; Alford, Patrick W.			Smooth Muscle Phenotype Switching in Blast Traumatic Brain Injury-Induced Cerebral Vasospasm	TRANSLATIONAL STROKE RESEARCH			English	Article						Blast traumatic brain injury; Cerebral vasospasm; Vascular smooth muscle cells; Phenotype transformation; Subarachnoid hemorrhage; Biomechanics	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; ENDOTHELIN RECEPTOR ANTAGONIST; GROWTH-FACTOR; CELL DIFFERENTIATION; ARTERIES; MODEL; SUPPRESSION; DYSFUNCTION; CLAZOSENTAN; INHIBITOR	Due to increased survival rates among soldiers exposed to explosive blasts, blast-induced traumatic brain injury (bTBI) has become much more prevalent in recent years. Cerebral vasospasm (CVS) is a common manifestation of brain injury whose incidence is significantly increased in bTBI. CVS is characterized by initial vascular smooth muscle cell (VSMC) hypercontractility, followed by prolonged vessel remodeling and lumen occlusion, and is traditionally associated with subarachnoid hemorrhage (SAH), but recent results suggest that mechanical injury during bTBI can cause mechanotransduced VSMC hypercontractility and phenotype switching necessary for CVS development, even in the absence of SAH. Here, we review the mechanisms by which mechanical stimulation and SAH can synergistically drive CVS progression, complicating treatment options in bTBI patients.	[Hald, Eric S.; Alford, Patrick W.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA		Alford, PW (corresponding author), Univ Minnesota, Dept Biomed Engn, 312 Church St SE,7-105 Hasselmo Hall, Minneapolis, MN 55455 USA.	pwalford@umn.edu					Adeoye OO, 2013, AM J PHYSIOL-CELL PH, V304, pC656, DOI 10.1152/ajpcell.00110.2012; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Alford PW, 2008, COMPUT METHOD BIOMEC, V11, P525, DOI 10.1080/10255840801930710; Alford PW, 2008, BIOMECH MODEL MECHAN, V7, P245, DOI 10.1007/s10237-007-0101-2; Alford PW, 2011, INTEGR BIOL-UK, V3, P1063, DOI 10.1039/c1ib00061f; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Amenta F, 2009, J NEUROL SCI, V283, P219, DOI 10.1016/j.jns.2009.02.335; ARMENTANO R, 1991, HYPERTENSION, V18, P657, DOI 10.1161/01.HYP.18.5.657; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Borel CO, 2003, STROKE, V34, P427, DOI 10.1161/01.STR.0000053848.06436.AB; Boron W. F., 2003, MED PHYSL CELLULAR M; Cemak I., 1997, INT REV ARMED FORCES, V70, P114; Cernak I, 1991, Vojnosanit Pregl, V48, P515; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 1996, CHINESE J TRAUMATOL, V12, P28; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Chapman GB, 2000, AM J PHYSIOL-HEART C, V278, pH748, DOI 10.1152/ajpheart.2000.278.3.H748; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039353; Chesler NC, 1999, AM J PHYSIOL-HEART C, V277, pH2002, DOI 10.1152/ajpheart.1999.277.5.H2002; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; CLOWER BR, 1994, ANAT REC, V240, P104, DOI 10.1002/ar.1092400110; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Faul M, 2010, TRAUMATIC BRAIN INJU, P2010; FUNG YC, 1989, CIRC RES, V65, P1340, DOI 10.1161/01.RES.65.5.1340; FUNG YC, 1991, J APPL PHYSIOL, V70, P2455, DOI 10.1152/jappl.1991.70.6.2455; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Gladwin MT, 2003, NAT MED, V9, P496, DOI 10.1038/nm0503-496; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Grasso G, 2004, BRAIN RES REV, V44, P49, DOI 10.1016/j.brainresrev.2003.10.003; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Huang B, 2010, TRANSL STROKE RES, V1, P108, DOI 10.1007/s12975-010-0022-8; Hubbell MC, 2012, AM J PHYSIOL-CELL PH, V303, pC1090, DOI 10.1152/ajpcell.00408.2011; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Humphrey JD, 2007, ANN BIOMED ENG, V35, P1485, DOI 10.1007/s10439-007-9321-y; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Inzitari Domenico, 2005, Aging Clin Exp Res, V17, P16; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Jackson ZS, 2002, CIRC RES, V90, P918, DOI 10.1161/01.RES.0000016481.87703.CC; Jain MK, 1996, J BIOL CHEM, V271, P10194, DOI 10.1074/jbc.271.17.10194; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Keilin D., 1937, NATURE, V139, P548, DOI [10.1038/139548a0, DOI 10.1038/139548A0]; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lehti K, 2009, J CELL SCI, V122, P126, DOI 10.1242/jcs.035279; Li Song, 2003, FASEB Journal, V17, P97; Li XM, 1997, BIOCHEM J, V327, P709, DOI 10.1042/bj3270709; Lin DW, 2008, J BIOL CHEM, V283, P15003, DOI 10.1074/jbc.M801621200; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu GX, 2002, CHINESE MED J-PEKING, V115, P750; LIU SQ, 1988, J BIOMECH ENG-T ASME, V110, P82, DOI 10.1115/1.3108410; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Macdonald RL, 2008, EXPERT OPIN INV DRUG, V17, P1761, DOI [10.1517/13543784.17.11.1761, 10.1517/13543784.17.11.1761 ]; Macdonald RL, 2012, STROKE, V43, P1463, DOI 10.1161/STROKEAHA.111.648980; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Macdonald RL, 2001, ACTA NEUROCHIR SUPPL, V77, P7; Macdonald RL, 2001, CEREBRAL VASOSPASM; MacDonald RL, 2006, NEUROSURGERY, V59, P453, DOI 10.1227/00006123-200608000-00039; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; MAYBERG MR, 1990, J NEUROSURG, V72, P626, DOI 10.3171/jns.1990.72.4.0626; McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003; McGirt MJ, 2002, NEUROSURGERY, V51, P1128, DOI 10.1097/00006123-200211000-00005; Mesis Rachel G, 2006, Neurosurg Focus, V21, pE4; Monson KL, 2011, J MECH BEHAV BIOMED, V4, P9, DOI 10.1016/j.jmbbm.2010.08.003; Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2; Naraoka M, 2013, TRANSL STROKE RES, V4, P368, DOI 10.1007/s12975-012-0247-9; North SH, 2012, ANNU REV ANAL CHEM, V5, P35, DOI 10.1146/annurev-anchem-062011-143105; Ogawa T, 2011, J CEREBR BLOOD F MET, V31, P2231, DOI 10.1038/jcbfm.2011.87; Ostrowski RP, 2011, TRANSL STROKE RES, V2, P316, DOI 10.1007/s12975-011-0069-1; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; RAM Z, 1991, STROKE, V22, P922, DOI 10.1161/01.STR.22.7.922; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Satoh S, 2012, J PHARMACOL SCI, V118, P92, DOI 10.1254/jphs.11075FP; Sazonova OV, 2011, BIOPHYS J, V101, P622, DOI 10.1016/j.bpj.2011.06.051; Schulze PC, 2003, CIRC RES, V93, P1210, DOI 10.1161/01.RES.0000103635.38096.2F; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Soejima Y, 2013, EXP NEUROL, V247, P737, DOI 10.1016/j.expneurol.2013.03.019; Song JN, 2013, BRAIN RES, V1517, P93, DOI 10.1016/j.brainres.2013.01.004; Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004; SUGAWARA T, 2011, ACTA NEUROCHIR SUPPL, V2, P9, DOI DOI 10.1007/978-3-7091-0356-2_2; Vatter H, 2011, ACTA NEUROCHIR SUPPL, V110, P177, DOI 10.1007/978-3-7091-0353-1_31; Vergouwen MDI, 2011, J CEREBR BLOOD F MET, V31, P1545, DOI 10.1038/jcbfm.2011.56; Vergouwen MDI, 2011, STROKE, V42, P924, DOI 10.1161/STROKEAHA.110.597914; Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011; Wu Ying-chen, 2007, Zhonghua Zheng Xing Wai Ke Za Zhi, V23, P335; Yamaguchi-Okada M, 2009, CEREBROVASC DIS, V28, P135, DOI 10.1159/000223439; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zabramski JM, 1997, SUBARACHNOID HEMORRH, P127; Zhang BP, 2003, INT J BIOCHEM CELL B, V35, P1341, DOI 10.1016/S1357-2725(03)00043-8; Zhang ZD, 2006, NEUROL RES, V28, P713, DOI 10.1179/016164106X151990; Zhang ZQ, 2011, TRANSL STROKE RES, V2, P455, DOI 10.1007/s12975-011-0137-6; Zimmermann M, 1998, NEUROSURGERY, V43, P863, DOI 10.1097/00006123-199810000-00083; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	111	19	20	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	JUN	2014	5	3					385	393		10.1007/s12975-013-0300-3			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AH7TD	WOS:000336336200009	24323722				2022-02-06	
J	Little, DM; Geary, EK; Moynihan, M; Alexander, A; Pennington, M; Glang, P; Schulze, ET; Dretsch, M; Pacifico, A; Davis, ML; Stevens, AB; Huang, JH				Little, Deborah M.; Geary, Elizabeth K.; Moynihan, Michael; Alexander, Aristides; Pennington, Michelle; Glang, Patrick; Schulze, Evan T.; Dretsch, Michael; Pacifico, Anthony; Davis, Matthew L.; Stevens, Alan B.; Huang, Jason H.			Imaging chronic traumatic brain injury as a risk factor for neurodegeneration	ALZHEIMERS & DEMENTIA			English	Article						Traumatic brain injury; Repetitive TBI; Dementia; Neuroimaging	MINI-MENTAL-STATE; INTEGRITY	Population-based studies have supported the hypothesis that a positive history of traumatic brain injury (TBI) is associated with an increased incidence of neurological disease and psychiatric comorbidities, including chronic traumatic encephalopathy, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. These epidemiologic studies, however, do not offer a clear definition of that risk, and leave unanswered the bounding criteria for greater lifetime risk of neurodegeneration. Key factors that likely mediate the degree of risk of neurodegeneration include genetic factors, significant premorbid and comorbid medical history (e.g. depression, multiple head injuries and repetitive subconcussive impact to the brain, occupational risk, age at injury, and severity of brain injury). However, given the often-described concerns in self-report accuracy as it relates to history of multiple TBIs, low frequency of patient presentation to a physician in the case of mild brain injuries, and challenges with creating clear distinctions between injury severities, disentangling the true risk for neurodegeneration based solely on population-based studies will likely remain elusive. Given this reality, multiple modalities and approaches must be combined to characterize who are at risk so that appropriate interventions to alter progression of neurodegeneration can be evaluated. This article presents data from a study that highlights uses of neuro-imaging and areas of needed research in the link between TBI and neurodegenerative disease. (C) 2014 Published by Elsevier Inc. on behalf of The Alzheimer's Association.	[Little, Deborah M.; Pennington, Michelle; Davis, Matthew L.; Stevens, Alan B.; Huang, Jason H.] BaylorScott & White Hlth, Temple, TX 75201 USA; [Little, Deborah M.; Davis, Matthew L.; Stevens, Alan B.; Huang, Jason H.] Texas A&M Univ Hlth Sci, Temple, TX USA; [Geary, Elizabeth K.] Northshore Hlth Syst, Evanston, IL USA; [Moynihan, Michael] West Virginia Sch Osteopath Med, Lewisburg, WV USA; [Alexander, Aristides] Advocate Christ Med Ctr, Chicago, IL USA; [Glang, Patrick] Univ Oregon, Eugene, OR 97403 USA; [Schulze, Evan T.] St Louis Univ, St Louis, MO 63103 USA; [Dretsch, Michael] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Pacifico, Anthony] US Army Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA		Little, DM (corresponding author), BaylorScott & White Hlth, Temple, TX 75201 USA.	deborahmlittle@gmail.com	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	Department of Defense/Congressionally Directed Medical Research ProgramUnited States Department of Defense [PT 075675]; Marshall Goldberg Traumatic Brain Injury Fund; Chicago Institute for Neurosurgery and Neuroresearch Foundation	This work is supported in part by a Department of Defense/Congressionally Directed Medical Research Program grant (PT 075675 to DML), the Marshall Goldberg Traumatic Brain Injury Fund (to DML), and a grant from the Chicago Institute for Neurosurgery and Neuroresearch Foundation (to DML). The contents of this article are the sole responsibility of the authors and do not necessarily represent the official views of the University of Illinois at Chicago, Baylor Scott & White Health, Texas A&M University Health Sciences, the U.S. Department of the Army, the Department of Defense, or the National Institutes of Health.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Assistant Secretary of Defense for Health Affairs, 2007, HLTH AFF MEM TRAUM B; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benton A., 1976, MULTILINGUAL APHASIA; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Conners D. K., 2000, CONTINUOUS PERFORMAN; Delis D.C., 2000, CALIFORNIA VERBAL LE; Fiszbein A, 1986, POSITIVE NEGATIVE SY; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Golden CJ., 2002, STROOP COLOR WORD TE; Hamsher K., 1989, MULTILINGUAL APHASIA; Jensen A R, 1965, Acta Psychol (Amst), V24, P398; Kelly JP, 1997, NEUROLOGY, V48, P581; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ruff RM, 1988, RUFF FIGURAL FLUENCY; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh T. N., 1997, TEST MEMORY MALINGER; Wechsler D, 1997, WMS 3 ADM SCORING MA; WechslerD, 2001, WECHSLER TEST ADULT	25	19	20	2	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	JUN	2014	10	3		1			S188	S195		10.1016/j.jalz.2014.04.002			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CP8GM	WOS:000360130700013	24924670	hybrid			2022-02-06	
J	Sanchez, J; Centanaro, M; Solis, J; Delgado, F; Yepez, L				Sanchez, Javier; Centanaro, Mirella; Solis, Juanita; Delgado, Fabrizio; Yepez, Luis			Factors predicting the outcome following medical treatment of mesial temporal epilepsy with hippocampal sclerosis	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Prognostic factors; Mesial temporal sclerosis; Epilepsy surgery; Hippocampal sclerosis; Outcome	LOBE EPILEPSY; EARLY IDENTIFICATION; SEIZURES; PROGNOSIS; ABNORMALITIES; LOCALIZATION; REMISSION; ETIOLOGY; HISTORY; SURGERY	Purpose: There is a lack of information from South America regarding factors that predict the clinical outcomes of patients treated medically for mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS). This study was conducted to determine which of these factors are the most important. Methods: This study included 110 South American patients with MTLE-HS treated with antiepileptic drugs. The factors considered included age, gender, age of epilepsy onset, interval between the lesion and the first seizure, central nervous system infection, traumatic brain injury, perinatal asphyxia, febrile convulsion, history of status epilepticus, types of seizures, site of hippocampal sclerosis (HS), extrahippocampal pathology, and electroencephalogram (EEG) abnormalities. The patients were divided into two groups based on the response to treatment: Group I, seizure free for at least two years; and Group II, not seizure free. Results: On the multivariate analysis, the factors associated with a poor prognosis in terms of seizure frequency and control following treatment included the presence of an early onset of seizure, more than 10 seizures per month before treatment, and EEG abnormalities. Conclusion: The recognition of risk factors, such as early onset of seizures, more than 10 seizures per month before treatment, and EEG abnormalities, could lead to the identification of risk groups among patients with MTLE-HS and refractory epilepsy, possibly designating these individuals as candidates for early epilepsy surgery. (C) 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Sanchez, Javier; Centanaro, Mirella; Solis, Juanita; Delgado, Fabrizio; Yepez, Luis] Guayaquil Welf Board, Inst Neurosci, Brain Res Ctr, Guayaquil, Ecuador		Sanchez, J (corresponding author), Guayaquil Welf Board, Inst Neurosci, Brain Res Ctr, Guayaquil, Ecuador.	javiersanchez503@yahoo.com					Aguglia U, 2011, J NEUROL NEUROSUR PS, V82, P555, DOI 10.1136/jnnp.2010.217620; Arroyo S, 1997, EPILEPSIA, V38, P1098, DOI 10.1111/j.1528-1157.1997.tb01199.x; Auer T, 2008, EPILEPSIA, V49, P1562, DOI 10.1111/j.1528-1167.2008.01679.x; Babb TL, 1987, SURGICAL TREATMENT E, P511; BEGHI E, 1992, EPILEPSIA, V33, P45; Berg AT, 1996, EPILEPSIA, V37, P126, DOI 10.1111/j.1528-1157.1996.tb00003.x; Berg AT, 2003, EPILEPSIA, V44, P1425, DOI 10.1046/j.1528-1157.2003.24203.x; Bernasconi Andrea, 2006, Adv Neurol, V97, P273; Cendes F, 1997, ANN NEUROL, V42, P737, DOI 10.1002/ana.410420510; Engel J, 2003, EPILEPSIA, V44, P741, DOI 10.1046/j.1528-1157.2003.48202.x; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; FOIS A, 1988, CLIN ELECTROENCEPHAL, V19, P68, DOI 10.1177/155005948801900207; Gasparini S, 2013, EPILEPSY RES, V107, P101, DOI 10.1016/j.eplepsyres.2013.07.004; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Holmes MD, 2000, SEIZURE-EUR J EPILEP, V9, P407, DOI 10.1053/seiz.2000.0423; Kim WJ, 1999, EPILEPSIA, V40, P290, DOI 10.1111/j.1528-1157.1999.tb00706.x; Kumlien E, 2002, SEIZURE-EUR J EPILEP, V11, P413, DOI 10.1053/seiz.2001.0614; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Langfitt JT, 2008, CURR OPIN NEUROL, V21, P179, DOI 10.1097/WCO.0b013e3282f47931; Lee DH, 1998, AM J NEURORADIOL, V19, P19; MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.0.CO;2-U; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MATHERN GW, 1995, J NEUROSURG, V82, P220, DOI 10.3171/jns.1995.82.2.0220; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Pittau F, 2009, EPILEPSIA, V50, P41, DOI 10.1111/j.1528-1167.2008.01969.x; ROWAN AJ, 1980, EPILEPSIA, V21, P219, DOI 10.1111/j.1528-1157.1980.tb04066.x; Schomer DL, 2012, JAMA-J AM MED ASSOC, V307, P966, DOI 10.1001/jama.2012.251; Semah F, 2002, ARCH NEUROL-CHICAGO, V59, P1042, DOI 10.1001/archneur.59.6.1042-a; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; SILLANPAA M, 1993, EPILEPSIA, V34, P930, DOI 10.1111/j.1528-1157.1993.tb02114.x; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x; VanPaesschen W, 1997, NEUROLOGY, V49, P753, DOI 10.1212/WNL.49.3.753; Varoglu AO, 2009, EPILEPSY RES, V85, P206, DOI 10.1016/j.eplepsyres.2009.03.001; Wieser HG, 2004, EPILEPSIA, V45, P32; WILLIAMSON PD, 1993, ANN NEUROL, V34, P781, DOI 10.1002/ana.410340605	37	19	20	0	4	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	JUN	2014	23	6					448	453		10.1016/j.seizure.2014.03.003			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AJ8ZT	WOS:000337997300008	24680551	Bronze			2022-02-06	
J	Senol, N; Naziroglu, M				Senol, Nilgun; Naziroglu, Mustafa			Melatonin reduces traumatic brain injury-induced oxidative stress in the cerebral cortex and blood of rats	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; melatonin; traumatic brain injury; antioxidant; oxidative stress; vitamin E; vitamin C; glutathione; brain; neural regeneration	DORSAL-ROOT GANGLION; VITAMIN-E; MOLECULAR PATHWAYS; NERVOUS-SYSTEM; TRPM2 CHANNELS; ANTIOXIDANT; ACTIVATION; APOPTOSIS; REAGENT; DAMAGE	Free radicals induced by traumatic brain injury have deleterious effects on the function and antioxidant vitamin levels of several organ systems including the brain. Melatonin possesses antioxidant effect on the brain by maintaining antioxidant enzyme and vitamin levels. We investigated the effects of melatonin on antioxidant ability in the cerebral cortex and blood of traumatic brain injury rats. Results showed that the cerebral cortex beta-carotene, vitamin C, vitamin E, reduced glutathione, and erythrocyte reduced glutathione levels, and plasma vitamin C level were decreased by traumatic brain injury whereas they were increased following melatonin treatment. In conclusion, melatonin seems to have protective effects on traumatic brain injury-induced cerebral cortex and blood toxicity by inhibiting free radical formation and supporting antioxidant vitamin redox system.	[Senol, Nilgun] Suleyman Demirel Univ, Dept Neurosurg, Fac Med, TR-32200 Isparta, Turkey; [Naziroglu, Mustafa] Suleyman Demirel Univ, Neurosci Res Ctr, TR-32200 Isparta, Turkey		Naziroglu, M (corresponding author), Suleyman Demirel Univ, Neurosci Res Ctr, TR-32200 Isparta, Turkey.	mustafanaziroglu@sdu.edu.tr					Bowman GL, 2012, BIOFACTORS, V38, P114, DOI 10.1002/biof.1002; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Celik O, 2012, PHYSIOL BEHAV, V107, P458, DOI 10.1016/j.physbeh.2012.09.013; Cherubini A, 2008, CURR MED CHEM, V15, P1236, DOI 10.2174/092986708784310431; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; DESAI ID, 1984, METHOD ENZYMOL, V105, P138, DOI 10.1016/S0076-6879(84)05019-9; Dilek M, 2010, J MEMBRANE BIOL, V233, P135, DOI 10.1007/s00232-010-9233-x; Ekmekcioglu C, 2006, BIOMED PHARMACOTHER, V60, P97, DOI 10.1016/j.biopha.2006.01.002; Espino J, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/670294; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Ishaq GM, 2013, J NEUROSCI RURAL PRA, V4, P292, DOI 10.4103/0976-3147.118784; JAGOTA SK, 1982, ANAL BIOCHEM, V127, P178, DOI 10.1016/0003-2697(82)90162-2; Kayan M, 2012, J MEMBRANE BIOL, V245, P833, DOI 10.1007/s00232-012-9491-x; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lee S, 2009, J PINEAL RES, V46, P43, DOI 10.1111/j.1600-079X.2008.00607.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin M, 2000, FASEB J, V14, P1677; Naziroglu M, 2012, PHYSIOL BEHAV, V105, P683, DOI 10.1016/j.physbeh.2011.10.005; Naziroglu M, 2007, NEUROCHEM RES, V32, P1990, DOI 10.1007/s11064-007-9386-x; Naziroglu M, 2013, J BIOENERG BIOMEMBR, V45, P541, DOI 10.1007/s10863-013-9524-x; Naziroglu M, 2013, CELL MOL NEUROBIOL, V33, P589, DOI 10.1007/s10571-013-9936-5; Naziroglu M, 2013, J NAT MED-TOKYO, V67, P152, DOI 10.1007/s11418-012-0666-7; Naziroglu M, 2012, J RECEPT SIG TRANSD, V32, P290, DOI 10.3109/10799893.2012.737002; Naziroglu M, 2012, J RECEPT SIG TRANSD, V32, P134, DOI 10.3109/10799893.2012.672994; Naziroglu M, 2011, NEUROCHEM RES, V36, P355, DOI 10.1007/s11064-010-0347-4; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Ozdemir D, 2005, PHYSIOL RES, V54, P631; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; Reiter RJ, 1997, ANN NY ACAD SCI, V825, P70, DOI 10.1111/j.1749-6632.1997.tb48415.x; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Senol N, 2014, NEUROCHEM RES, V39, P685, DOI 10.1007/s11064-014-1255-9; SUZUKI J, 1990, JPN J VET SCI, V52, P1282; Tuzcu M, 2006, EUR J PHARMACOL, V537, P106, DOI 10.1016/j.ejphar.2006.03.024; Yatin Servet M., 2000, Journal of Alzheimer's Disease, V2, P123	37	19	20	2	11	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	JUN	2014	9	11					1112	1116		10.4103/1673-5374.135312			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AL0FX	WOS:000338803900007	25206769	Green Published, gold, Green Submitted			2022-02-06	
J	Walker, WC; Franke, LM; Cifu, DX; Hart, BB				Walker, William C.; Franke, Laura Manning; Cifu, David X.; Hart, Brett B.			Randomized, Sham-Controlled, Feasibility Trial of Hyperbaric Oxygen for Service Members With Postconcussion Syndrome: Cognitive and Psychomotor Outcomes 1 Week Postintervention	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						postconcussion syndrome; traumatic brain injury; hyperbaric oxygenation; cognition disorders; psychomotor performance; randomized controlled trial	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYNDROME; MEMORY MALINGERING TOMM; OIF/OEF VETERANS; NORMATIVE DATA; HEAD-INJURIES; CHRONIC PAIN; MILD TBI; SYMPTOMS	Background. Mild traumatic brain injury (mTBI) and residual postconcussion syndrome (PCS) are common among combatants of the recent military conflicts in Iraq and Afghanistan. Hyperbaric oxygen (HBO2) is a proposed treatment but has not been rigorously studied for this condition. Objectives. In a secondary analysis, examine for possible effects on psychomotor (balance and fine motor) and cognitive performance 1 week after an HBO2 intervention in service members with PCS after mTBI. Methods. A randomized, double-blind, sham control, feasibility trial comparing pretreatment and posttreatment was conducted in 60 male active-duty marines with combat-related mTBI and PCS persisting for 3 to 36 months. Participants were randomized to 1 of 3 preassigned oxygen fractions (10.5%, 75%, or 100%) at 2.0 atmospheres absolute (ATA), resulting in respective groups with an oxygen exposure equivalent to (1) breathing surface air (Sham Air), (2) 100% oxygen at 1.5 ATA (1.5 ATAO2), and (3) 100% oxygen at 2.0 ATA (2.0 ATAO2). Over a 10-week period, participants received 40 hyperbaric chamber sessions of 60 minutes each. Outcome measures, including computerized posturography (balance), grooved pegboard (fine motor speed/dexterity), and multiple neuropsychological tests of cognitive performance, were collected preintervention and 1-week postintervention. Results. Despite the multiple sensitive cognitive and psychomotor measures analyzed at an unadjusted 5% significance level, this study demonstrated no immediate postintervention beneficial effect of exposure to either 1.5 ATAO2 or 2.0 ATAO2 compared with the Sham Air intervention. Conclusions. These results do not support the use of HBO2 to treat cognitive, balance, or fine motor deficits associated with mTBI and PCS.	[Walker, William C.; Franke, Laura Manning; Cifu, David X.] Virginia Commonwealth Univ, Richmond, VA 23298 USA; [Walker, William C.; Franke, Laura Manning; Cifu, David X.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Walker, William C.; Franke, Laura Manning] Richmond Def & Vet Brain Injury Ctr, Richmond, VA USA; [Cifu, David X.] Dept Vet Affairs, Washington, DC USA; [Hart, Brett B.] Navy Med Operat Training Ctr, Pensacola, FL USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept PM&R, 1223 East Marshall St, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	Walker, William C/N-3162-2014	Cifu, David/0000-0003-1600-9387	Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-09-2-206]; US Navy Bureau of Medicine and Surgery; US Army Medical Material Development Activity; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding was provided for the primary study by a Defense Advanced Research Projects Agency grant (N66001-09-2-206), US Navy Bureau of Medicine and Surgery for contract funding temporary duty requirements, and the US Army Medical Material Development Activity for end-of-study contract funding. Drs Franke's and Walker's efforts were additionally supported, in part, through contracts from the Defense and Veterans Brain Injury Center. The funding sources had no role in the study design, analysis, interpretation of the data, the writing of the article, or the decision to submit the paper for publication.	Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; BENTON A L, 1981, Journal of Clinical Neuropsychology, V3, P33, DOI 10.1080/01688638108403111; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; Centers for Disease Control and Prevention, DOD VA COD PROP DOD; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cifu DX, J HEAD TRAU IN PRESS; Clarke D, 2009, UNDERSEA HYPERBAR M, V36, P13; Conners C. K., 2000, CONNERS CONTINUOUS P; Cripps A, 2013, J SPORT REHABIL, V22, P67, DOI 10.1123/jsr.22.1.67; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Defense and Veterans Brain Injury Center, 2013, DOD WORLDW NUMB TBI; Delis D.C., 1991, PSYCHOL ASSESS, V3, P19, DOI [10.1037/1040-3590.3.1.19, DOI 10.1037/1040-3590.3.1.19]; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donders J, 2007, J INT NEUROPSYCH SOC, V13, P354, DOI 10.1017/S1355617707070439; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gesell L.B., 2008, HYPERBARIC OXYGEN TH; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harrison JE, 2000, BRIT J CLIN PSYCHOL, V39, P181, DOI 10.1348/014466500163202; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Multiple A, 2012, J REHABIL RES DEV, V49, P971; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Institute of Neurologic Disorders (NINDS), TRAUMATIC BRAIN INJU; NEUBAUER RA, 1990, LANCET, V335, P542, DOI 10.1016/0140-6736(90)90777-3; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Walker WC, 2013, J HEAD TRAUMA REHAB, V28, P68, DOI 10.1097/HTR.0b013e318255dfd0; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Wechsler D., 2008, WECHSLER ADULT INTEL; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549	54	19	20	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUN	2014	28	5					420	432		10.1177/1545968313516869			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	AN6SQ	WOS:000340727700004	24370568				2022-02-06	
J	Vonder Haar, C; Anderson, GD; Elmore, BE; Moore, LH; Wright, AM; Kantor, ED; Farin, FM; Bammler, TK; MacDonald, JW; Hoane, MR				Vonder Haar, Cole; Anderson, Gail D.; Elmore, Brandy E.; Moore, Lynn H.; Wright, Amanda M.; Kantor, Eric D.; Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.; Hoane, Michael R.			Comparison of the Effect of Minocycline and Simvastatin on Functional Recovery and Gene Expression in a Rat Traumatic Brain Injury Model	JOURNAL OF NEUROTRAUMA			English	Article						simvastatin; gene expression; traumatic brain injury; cortical contusion injury model; minocycline	INTRAVENOUS MINOCYCLINE; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; REDUCTASE INHIBITOR; NEUROPROTECTION; PROGESTERONE; NICOTINAMIDE; BEHAVIOR; NEUROGENESIS; APOPTOSIS	The goal of this study was to compare the effects of minocycline and simvastatin on functional recovery and brain gene expression after a cortical contusion impact (CCI) injury. Dosage regimens were designed to provide serum concentrations in a rat model in the range obtained with clinically approved doses; minocycline 60 mg/kg q12h and simvastatin 10 mg/kg q12h for 72 h. Functional recovery was assessed using motor and spatial learning tasks and neuropathological measurements. Microarray-based transcriptional profiling was used to determine the effect on gene expression at 24 h, 72 h, and 7 days post-CCI. Gene Ontology analysis (GOA) was used to evaluate the effect on relevant biological pathways. Both minocycline and simvastatin improved fine motor function, but not gross motor or cognitive function. Minocycline modestly decreased lesion size with no effect of simvastatin. At 24 h post-CCI, GOA identified a significant effect of minocycline on chemotaxis, blood circulation, immune response, and cell to cell signaling pathways. Inflammatory pathways were affected by minocycline only at the 72 h time point. There was a minimal effect of simvastatin on gene expression 24 h after injury, with increasing effects at 72 h and 7 days. GOA identified a significant effect of simvastatin on inflammatory response at 72 h and 7 days. In conclusion, treatment with minocycline and simvastatin resulted in significant effects on gene expression in the brain reflecting adequate brain penetration without producing significant neurorestorative effects.	[Vonder Haar, Cole; Elmore, Brandy E.; Moore, Lynn H.; Wright, Amanda M.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Ctr Integrated Res Cognit & Neural Sci, Restorat Neurosci Lab, Carbondale, IL 62901 USA; [Anderson, Gail D.; Kantor, Eric D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA		Anderson, GD (corresponding author), Univ Washington, Dept Pharm, Box 357630, Seattle, WA 98195 USA.	gaila@washington.edu		Vonder Haar, Cole/0000-0001-7949-2068; Hoane, Michael/0000-0001-7779-2657	National Institutes of Health/National Institute of Child, Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 HD061944-01]; NIEHS Center for Ecogenetics & Environmental Health [P30ES007033]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES007033] Funding Source: NIH RePORTER	The research was supported by a grant from the National Institutes of Health/National Institute of Child, Health and Development (R01 HD061944-01) and by the NIEHS Center for Ecogenetics & Environmental Health (P30ES007033).	Anderson GD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00021; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; CDC, 2010, INJ PREV CONTR TRAUM; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Fagan SC, 2004, EXP NEUROL, V186, P248, DOI 10.1016/j.expneurol.2003.12.006; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Haar CV, 2012, RESTOR NEUROL NEUROS, V30, P291, DOI 10.3233/RNN-2012-110196; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Hermann A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00067; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Kotani N, 1999, ANESTH ANALG, V89, P1250, DOI 10.1213/00000539-199911000-00032; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Laufs U, 2012, J AM COLL CARDIOL, V59, P71, DOI 10.1016/j.jacc.2011.08.063; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; LIGHT RW, 1994, CHEST, V106, P577, DOI 10.1378/chest.106.2.577; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; SINGHVI SM, 1990, BRIT J CLIN PHARMACO, V29, P239, DOI 10.1111/j.1365-2125.1990.tb03626.x; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Switzer JA, 2011, STROKE, V42, P2633, DOI 10.1161/STROKEAHA.111.618215; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9; Wu HT, 2012, BRAIN RES, V1486, P121, DOI 10.1016/j.brainres.2012.09.039; Xu L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-7	56	19	19	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2014	31	10					961	975		10.1089/neu.2013.3119			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AH1ES	WOS:000335863200008	24308531	Green Published			2022-02-06	
J	D'Onofrio, F; Russo, A; Conte, F; Casucci, G; Tessitore, A; Tedeschi, G				D'Onofrio, F.; Russo, A.; Conte, F.; Casucci, G.; Tessitore, A.; Tedeschi, G.			Post-traumatic headaches: an epidemiological overview	NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	6th ANIRCEF National Congress on Headache and Social Context	MAY 29-31, 2014	Asti, ITALY	ANIRCEF		Post-traumatic headache; PTH; Epidemiological aspects; Epidemiology; Trauma	TRAUMATIC BRAIN-INJURY; MILD HEAD TRAUMA; STRESS-DISORDER; POSTCONCUSSION SYNDROME; CHRONIC PAIN; US SOLDIERS; PREVALENCE; CONCUSSION; CHILDREN	Post-traumatic headache (PTH) is the most common secondary headache disorder, corresponding to approximately 4 % of all symptomatic headaches. PTH, a cardinal feature of the post-concussive syndrome, usually shows a phenotype similar to migraine or tension-type headache. However, rare cases of PTH similar to trigeminal autonomic cephalalgias have been described. Many studies have investigated PTH prevalence and potential risk factors for its development and maintenance. In general population, the majority of PTH patients is female and has been involved in vehicle-related accidents. Generally, headache gradually disappears over few weeks or months; however, PTH could become persistent and very disabling in a minority of patients. This brief review will focus on PTH epidemiological aspects.	[D'Onofrio, F.] San G Moscati Hosp, Div Neurol, Avellino, Italy; [Russo, A.; Conte, F.; Tessitore, A.; Tedeschi, G.] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy; [Russo, A.; Tedeschi, G.] IDC Hermitage Capodimonte, SUN FISM Ctr, Naples, Italy; [Casucci, G.] S Francesco Nursing Home, Telese Terme, Benevento, Italy		Tessitore, A (corresponding author), Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy.	alessandro.tessitore@unina2.it	Tessitore, Alessandro/K-3124-2018	Tessitore, Alessandro/0000-0003-1740-8566; Gerardo, Casucci/0000-0001-6137-117X			Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bettucci D, 1998, ITAL J NEUROL SCI, V19, P20, DOI 10.1007/BF03028807; Butler IJ, 2013, JAMA NEUROL, V70, P636, DOI 10.1001/jamaneurol.2013.2801; CHIBNALL JT, 1994, HEADACHE, V34, P357, DOI 10.1111/j.1526-4610.1994.hed3406357.x; de Gray LC, 2005, ANAESTHESIA, V60, P693, DOI 10.1111/j.1365-2044.2005.03997.x; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Evans RW., 2006, NEUROLOGY TRAUMA, P95; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; HICKLING EJ, 1992, HEADACHE, V32, P147, DOI 10.1111/j.1526-4610.1992.hed3203147.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Jennett B, 1990, HDB CLIN NEUROLOGY, V13; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kjeldgaard D, 2014, CEPHALALGIA; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lay CL, 1999, HEADACHE, V39, P275, DOI 10.1046/j.1526-4610.1999.3904275.x; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Obermann M, 2009, EXPERT REV NEUROTHER, V9, P1361, DOI [10.1586/ern.09.84, 10.1586/ERN.09.84]; Peterlin BL, 2009, HEADACHE, V49, P541, DOI 10.1111/j.1526-4610.2009.01368.x; Piovesan EJ, 1996, ARQ NEURO-PSIQUIAT, V54, P494, DOI 10.1590/S0004-282X1996000300022; Schrader H, 1996, LANCET, V347, P1207, DOI 10.1016/S0140-6736(96)90733-3; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Sullivan KA, 2013, BRAIN INJURY, V27, P19, DOI 10.3109/02699052.2012.698360; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Walker Russell W, 2007, Curr Pain Headache Rep, V11, P137, DOI 10.1007/s11916-007-0011-0; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; World Health Organization, 2004, ICD 10 INT STAT CLAS	36	19	20	0	8	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2014	35			1			S203	S206		10.1007/s10072-014-1771-z			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	AI3EZ	WOS:000336744400042	24867867				2022-02-06	
J	Lobel, DA; Lee, KH				Lobel, Darlene A.; Lee, Kendall H.			Brain Machine Interface and Limb Reanimation Technologies: Restoring Function After Spinal Cord Injury Through Development of a Bypass System	MAYO CLINIC PROCEEDINGS			English	Article							COMPUTER INTERFACE; INTRASPINAL MICROSTIMULATION; STIMULATION; MOVEMENT	Functional restoration of limb movement after traumatic spinal cord injury (SCI) remains the ultimate goal in SCI treatment and directs the focus of current research strategies. To date, most investigations in the treatment of SCI focus on repairing the injury site. Although offering some promise, these efforts have met with significant roadblocks because treatment measures that are successful in animal trials do not yield similar results in human trials. In contrast to biologic therapies, there are now emerging neural interface technologies, such as brain machine interface (BMI) and limb reanimation through electrical stimulators, to create a bypass around the site of the SCI. The BMI systems analyze brain signals to allow control of devices that are used to assist SCI patients. Such devices may include a computer, robotic arm, or exoskeleton. Limb reanimation technologies, which include functional electrical stimulation, epidural stimulation, and intraspinal microstimulation systems, activate neuronal pathways below the level of the SCI. We present a concise review of recent advances in the BMI and limb reanimation technologies that provides the foundation for the development of a bypass system to improve functional outcome after traumatic SCI. We also discuss challenges to the practical implementation of such a bypass system in both these developing fields. (C) 2014 Mayo Foundation for Medical Education and Research	[Lobel, Darlene A.] Cleveland Clin, Dept Neurosurg, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [Lee, Kendall H.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA		Lobel, DA (corresponding author), Cleveland Clin, Dept Neurosurg, Ctr Neurol Restorat, 9500 Euclid Ave,S31, Cleveland, OH 44106 USA.	lobeld@ccf.org			Grainger Foundation Grant	This work was supported by The Grainger Foundation Grant awarded to Dr Lee.	Bamford JA, 2011, PROG BRAIN RES, V194, P227, DOI 10.1016/B978-0-444-53815-4.00004-2; Birbaumer N, 2006, PROG BRAIN RES, V159, P369, DOI 10.1016/S0079-6123(06)59024-7; Chang SY, 2013, J NEUROSURG, V119, P1556, DOI 10.3171/2013.8.JNS122142; Charvet G, 2012, IEEE ENG MED BIO, P783, DOI 10.1109/EMBC.2012.6346048; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; CRAGO PE, 1980, IEEE T BIO-MED ENG, V27, P679, DOI 10.1109/TBME.1980.326592; Eliseyev A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046012; Fatourechi M, 2008, J NEURAL ENG, V5, P9, DOI 10.1088/1741-2560/5/1/002; Filli L, 2012, ANN NEUROL, V72, P491, DOI 10.1002/ana.23630; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Holinski BJ, 2011, IEEE ENG MED BIO, P5798, DOI 10.1109/IEMBS.2011.6091435; Jackson A, 2012, NAT REV NEUROL, V8, P690, DOI 10.1038/nrneurol.2012.219; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Loeb GE, 2005, IEEE ENG MED BIOL, V24, P45, DOI 10.1109/MEMB.2005.1511499; Muller-Putz GR, 2006, BIOMED TECH, V51, P57, DOI 10.1515/BMT.2006.011; Peckham PH, 2005, ANNU REV BIOMED ENG, V7, P327, DOI 10.1146/annurev.bioeng.6.040803.140103; Rath SA, 2008, J NEUROSURG-SPINE, V8, P237, DOI 10.3171/SPI/2008/8/3/237; Renard Y, 2010, PRESENCE-TELEOP VIRT, V19, P35, DOI 10.1162/pres.19.1.35; Royer AS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036012; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Troyk PR, 2012, IEEE ENG MED BIO, P900, DOI 10.1109/EMBC.2012.6346077; Troyk PR, 2001, NEUROMODULATION, V4, P196, DOI 10.1046/j.1525-1403.2001.00196.x; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	25	19	20	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0025-6196	1942-5546		MAYO CLIN PROC	Mayo Clin. Proc.	MAY	2014	89	5					708	714		10.1016/j.mayocp.2014.02.003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG6WU	WOS:000335560400019	24797649	Bronze			2022-02-06	
J	Simpson, GK; Sabaz, M; Daher, M; Gordon, R; Strettles, B				Simpson, Grahame K.; Sabaz, Mark; Daher, Maysaa; Gordon, Robert; Strettles, Barbara			Challenging Behaviours, Co-morbidities, Service Utilisation and Service Access among Community-dwelling Adults with Severe Traumatic Brain Injury: A Multicentre Study	BRAIN IMPAIRMENT			English	Article						challenging behaviours; traumatic brain injury; service utilisation; needs; mental health; drug and alcohol abuse	OUTCOME MEASURE; HEALTH-CARE; AGGRESSION; PREVALENCE; PEOPLE; NEEDS; REHABILITATION; INTERVENTIONS; DISORDERS; SCALE	Objective: To examine patterns, predictors and unmet needs of service utilisation and access to mental health and/or drug and alcohol services among community-dwelling adults with severe traumatic brain injury, and compare those who displayed challenging behaviours with those not displaying challenging behaviour. Design: Retrospective multicentre study. Subjects: All active clients (n = 507) of the New South Wales (NSW) Brain Injury Rehabilitation Program (BIRP) community rehabilitation teams. Methods: Clinician-rated data were collected on client challenging behaviours, mental health and functional status, service utilisation and unmet needs. Betweengroups analyses (challenging behaviour versus no challenging behaviours) were conducted to examine patterns of service utilisation and unmet needs. Predictors for service utilisation were tested by multiple linear regression. Results: Challenging behaviours were associated with higher use of BIRP and non-BIRP services and greater levels of unmet needs. Challenging behaviour was an independent predictor of higher levels of service utilisation, in conjunction, with pre-and post-injury mental health and drug and alcohol co-morbidities and geographic location. Only 15.3% of the 111 clients with challenging behaviours and co-morbid drug and alcohol problems accessed a drug and alcohol service, while another 32.4% had unmet needs for such services. Conclusion: Challenging behaviours make an independent contribution to increased levels of service utilisation after severe traumatic brain injury.	[Simpson, Grahame K.; Sabaz, Mark] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney Sch Med, Sydney, NSW 2006, Australia; [Simpson, Grahame K.; Daher, Maysaa; Strettles, Barbara] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Gordon, Robert] Univ Wollongong, Australian Hlth Serv Res Inst, Wollongong, NSW 2522, Australia; [Strettles, Barbara] Agcy Clin Innovat, Sydney, NSW, Australia		Simpson, GK (corresponding author), Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia.	grahame.simpson@sswahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060	New South Wales Agency for Clinical Innovation (ACI)	The New South Wales Agency for Clinical Innovation (ACI) funded the project. Dr Mark Sabaz was employed by ACI while undertaking the project. Thanks to Dr Jeff Rogers, Inika Gillis, the project steering committee and the participating BIRP clinicians.	Agency for Healthcare Research and Quality, 2011, TRAUM BRAIN INJ DEPR; Alderman N, 2007, BRAIN INJURY, V21, P891, DOI 10.1080/02699050701543560; Alderman N, 2013, BRAIN IMPAIR, V14, P5, DOI 10.1017/BrImp.2013.7; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Belanger HG, 2008, ARCH PHYS MED REHAB, V89, P244, DOI 10.1016/j.apmr.2007.08.145; Bogner J, 2013, BRAIN IMPAIR, V14, P77, DOI 10.1017/BrImp.2013.5; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Coetzer R., 2001, PSYCHIATR BULL, V25, P421, DOI [https://doi.org/10.1192/pb.25.11.421, DOI 10.1192/PB.25.11.421]; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colantonio A, 2010, BRAIN IMPAIR, V11, P31, DOI 10.1375/brim.11.1.31; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; Fann JR, 2011, ARCH PHYS MED REHAB, V92, P352, DOI 10.1016/j.apmr.2010.05.016; Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008; Feinstein A, 2002, NEUROLOGY, V59, P674, DOI 10.1212/WNL.59.5.674; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleminger S, 2005, PSYCHIATR BULL, V29, P53, DOI 10.1192/pb.29.2.53; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Jackson H, 2001, NEUROREHABILITATION, V16, P27; James AIW, 2013, BRAIN INJURY, V27, P1162, DOI 10.3109/02699052.2013.804200; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kelly G, 2008, BRAIN IMPAIR, V9, P293, DOI 10.1375/brim.9.3.293; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Manchester D, 1997, BRAIN INJURY, V11, P605, DOI 10.1080/026990597123296; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; National Trauma Research Institute, 2012, DEV RES PROGR ADDR B; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prang KH, 2012, BRAIN INJURY, V26, P441; Price Waterhouse Coopers, 2012, JOIN AG ABI CHALL BE; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sabaz M., 2010, NSW BRAIN INJURY REH; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Simpson G., 2002, AUST SOC WORK, V55, P24, DOI [10.1080/03124070208411669, DOI 10.1080/03124070208411669]; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Turner-Stokes L, 1999, CLIN REHABIL, V13, P253, DOI 10.1191/026921599677787870; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299; Wood R. L., 1987, BRAIN INJURY REHABIL; Wood RL, 2001, NEUROBEHAVIOURAL DIS, P1; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Ylvisaker M., 1998, COLLABORATIVE BRAIN; [No title captured]	51	19	19	1	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2014	15	1					28	42		10.1017/BrImp.2014.7			15	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	AI9NO	WOS:000337259500004		Green Submitted			2022-02-06	
J	Billeter, AT; Miller, FB; Harbrecht, BG; Bowen, W; Stephens, MJ; Postel, GC; Smith, JW; Penta, M; Coleman, R; Franklin, GA; Trunkey, DD; Polk, HC				Billeter, Adrian T.; Miller, Frank B.; Harbrecht, Brian G.; Bowen, Wanda; Stephens, Matthew J.; Postel, Gregory C.; Smith, Jason W.; Penta, Matthew; Coleman, Royce; Franklin, Glen A.; Trunkey, Donald D.; Polk, Hiram C., Jr.			Interhospital transfer of blunt multiply injured patients to a level 1 trauma center does not adversely affect outcome	AMERICAN JOURNAL OF SURGERY			English	Article						Interhospital transfer; Trauma; Head injuries; Referral; Traumatic brain injury; Imaging	BRAIN-INJURY; COMPUTED-TOMOGRAPHY; FIELD TRIAGE; CARE; GUIDELINES; MANAGEMENT; MORTALITY; IMPACT; AGE	BACKGROUND: Stops at nontrauma centers for severely injured patients are thought to increase deaths and costs, potentially because of unnecessary imaging and indecisive/delayed care of traumatic brain injuries (TBIs). METHODS: We studied 754 consecutive blunt trauma patients with an Injury Severity Score greater than 20 with an emphasis on 212 patients who received care at other sites en route to our level 1 trauma center. RESULTS: Referred patients were older, more often women, and had more severe TBI (all P < .05). After correction for age, sex, and injury pattern, there was no difference in the type of TBI, Glasgow Coma Scale (GCS) upon arrival at the trauma center, or overall mortality between referred and directly admitted patients. GCS at the outside institution did not influence promptness of transfer. CONCLUSIONS: Interhospital transfer does not affect the outcome of blunt trauma patients. However, the unnecessarily prolonged stay of low GCS patients in hospitals lacking neurosurgical care is inappropriate. (C) 2014 Elsevier Inc. All rights reserved.	[Billeter, Adrian T.; Miller, Frank B.; Harbrecht, Brian G.; Bowen, Wanda; Smith, Jason W.; Penta, Matthew; Franklin, Glen A.; Polk, Hiram C., Jr.] Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA; [Stephens, Matthew J.; Postel, Gregory C.] Univ Louisville, Sch Med, Dept Diagnost Radiol, Louisville, KY 40292 USA; [Coleman, Royce] Univ Louisville, Sch Med, Dept Emergency Med, Louisville, KY 40292 USA; [Trunkey, Donald D.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR USA		Polk, HC (corresponding author), Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA.	hcpolk01@louisvill.edu	Billeter, Adrian/O-2185-2019	Billeter, Adrian/0000-0001-8724-4793	Price Trust Fund; Joint Royal College of Surgeons of Edinburgh/James; Emmeline Ferguson Research Fellowship Trust	Supported in part by the Price Trust Fund and by the Joint Royal College of Surgeons of Edinburgh/James and Emmeline Ferguson Research Fellowship Trust.	Ball CG, 2009, J TRAUMA, V67, P180, DOI 10.1097/TA.0b013e3181a595c3; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Cuschieri J, 2012, ANN SURG, V255, P993, DOI 10.1097/SLA.0b013e31824f1ebc; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Goh KYC, 1997, CAN J NEUROL SCI, V24, P235, DOI 10.1017/S0317167100021867; Haley Theodore, 2009, Am J Surg, V198, P858, DOI 10.1016/j.amjsurg.2009.05.030; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Hsiao KY, 2012, EMERG MED J, V29, P156, DOI 10.1136/emj.2010.097295; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Janssens L, 2012, J TRAUMA ACUTE CARE, V73, P1284, DOI 10.1097/TA.0b013e318265d0ac; Kejriwal R, 2009, NEW ZEAL MED J, V122, P40; Laack TA, 2011, J TRAUMA, V70, P1362, DOI 10.1097/TA.0b013e3181e1707f; Lee CY, 2008, J TRAUMA, V65, P1359, DOI 10.1097/TA.0b013e31818c10fc; Liepert AE, 2011, J SURG RES, V170, P309, DOI 10.1016/j.jss.2011.06.018; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Mohan D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-103; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Nirula R, 2010, J TRAUMA, V69, P595, DOI 10.1097/TA.0b013e3181ee6e32; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Rivara FP, 2008, J TRAUMA, V64, P1594, DOI 10.1097/TA.0b013e3181493099; Salottolo K, 2009, CRIT CARE MED, V37, P1336, DOI 10.1097/CCM.0b013e31819d6739; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Scheetz Linda J, 2003, J Emerg Nurs, V29, P109, DOI 10.1067/men.2003.59; Scheetz LJ, 2011, PREHOSP EMERG CARE, V15, P83, DOI 10.3109/10903127.2010.514088; Schonenberger A, 2012, ARCH GERONTOL GERIAT, V55, P660, DOI 10.1016/j.archger.2012.02.013; Siman-Tov M, 2012, INJURY; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Tohira Hideo, 2011, Ann Adv Automot Med, V55, P255	34	19	19	0	3	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	APR	2014	207	4					459	466		10.1016/j.amjsurg.2013.04.015			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AD7BN	WOS:000333416100003	24674826				2022-02-06	
J	Hoogmartens, O; Heselmans, A; Van de Velde, S; Castren, M; Sjolin, H; Sabbe, M; Aertgeerts, B; Ramaekers, D				Hoogmartens, Olivier; Heselmans, Annemie; Van de Velde, Stijn; Castren, Maaret; Sjolin, Helena; Sabbe, Marc; Aertgeerts, Bert; Ramaekers, Dirk			EVIDENCE-BASED PREHOSPITAL MANAGEMENT OF SEVERE TRAUMATIC BRAIN INJURY: A COMPARATIVE ANALYSIS OF CURRENT CLINICAL PRACTICE GUIDELINES	PREHOSPITAL EMERGENCY CARE			English	Article						practice guidelines; brain injuries; emergency medical services; evidence-based practice; emergency responders	INTENSIVE INSULIN THERAPY; ADVANCED LIFE-SUPPORT; TIDAL CARBON-DIOXIDE; EMERGENCY; CARE; RECOMMENDATIONS; INTUBATION; MORTALITY; QUALITY	Objective. This study appraised the completeness and level of evidence behind prehospital recommendations in clinical practice guidelines (CPGs) for management of severe traumatic brain injury (TBI). Differences and similarities in key recommendations for prehospital emergency care were assessed between current CPGs. Methods. A systematic search identified current evidence-based CPGs for the management of severe TBI. The identified CPGs were screened for prehospital recommendations. Finally, an evaluation of the completeness and level of evidence for each of the identified recommendations was carried out. A review of the literature identified additional evidence. Designs of the retrieved publications were considered and classified according to the GRADE levels of evidence. Results. This study identified 12 current CPGs for the management of patients after traumatic brain injury. Of these, twenty-one prehospital recommendations were selected. Only a few CPGs made recommendations on temperature management and ventilation patterns. Statements on prehospital transport and advanced airway management were common to all of the guidelines. Statements on initial treatment demonstrated the greatest variability. The literature review identified several relevant publications not included in the CPGs even after we controlled for the indicated time-intervals of their literature search. In addition, evidence from more recent trials published outside the search-interval of the clinical practice guidelines was found. Conclusions. The use of current guidelines on traumatic brain injury will not always facilitate decisions about best or most appropriate practice for prehospital practitioners. The amount of recommended prehospital interventions varied considerably, and there was large content variation in prehospital recommendations in these guidelines. Not all evidence was taken into account and not all CPGs were up-to-date.	[Hoogmartens, Olivier; Heselmans, Annemie; Van de Velde, Stijn; Ramaekers, Dirk] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Louvain, Belgium; [Castren, Maaret; Sjolin, Helena] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Castren, Maaret; Sjolin, Helena] Soder Sjukhuset, Sect Emergency Med, S-10064 Stockholm, Sweden; [Sabbe, Marc] Katholieke Univ Leuven Hosp, Dept Emergency Med, Louvain, Belgium; [Aertgeerts, Bert] Katholieke Univ Leuven, Acad Ctr Gen Practice, Louvain, Belgium		Hoogmartens, O (corresponding author), Dept Publ Hlth & Primary Care, Kapucijnenvoer 33,Blok J Box 7001, Louvain, Belgium.	Olivier.hoogmartens@student.kuleuven.be	Heselmans, Annemie/F-1820-2015; Van de Velde, Stijn/F-6449-2013	Heselmans, Annemie/0000-0002-1686-8168; Van de Velde, Stijn/0000-0001-8908-3823	Falck Foundation	Olivier Hoogmartens received a research grant from the Falck Foundation.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bahtsevani C, 2004, INT J TECHNOL ASSESS, V20, P427, DOI 10.1017/S026646230400131X; Berge LR, 2011, JAMA-J AM MED ASSOC, V305, P203; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Brazier H, 1999, J ACCID EMERG MED, V16, P18; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Care NCCfA, 2007, HEAD INJ TRIAG ASS I, P230; Castren M, 2008, RESUSCITATION, V79, P193, DOI 10.1016/j.resuscitation.2008.07.007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Dewall J, 2010, JEMS, V35, P3; Dewall Jeremy, 2010, JEMS, V35, P54, DOI 10.1016/S0197-2510(10)70095-4; Figgis K, 2010, EMERG MED J, V27, P151, DOI 10.1136/emj.2008.064816; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Graham R, 2011, CLIN PRACTICE GUIDEL, P266; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Group GW, 2000, GRAD QUAL EV STRENGH; Hemphill C, 2012, UPTODATE; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Hussmann B, 2011, CRIT CARE, V15, DOI 10.1186/cc10442; Iedema R, 2012, BMJ QUAL SAF, V21, P627, DOI 10.1136/bmjqs-2011-000766; Jayaraman S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003109.pub2; Junpeng M, 2011, COCHRANE DATABASE SY; Kansagara D, 2011, ANN INTERN MED, V154, P268, DOI 10.7326/0003-4819-154-4-201102150-00008; Kett DH, 2011, LANCET INFECT DIS, V11, P181, DOI 10.1016/S1473-3099(10)70314-5; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Lee SW, 2009, J TRAUMA, V67, P526, DOI 10.1097/TA.0b013e3181866432; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Lugtenberg M, 2009, QUAL SAF HEALTH CARE, V18, P385, DOI 10.1136/qshc.2008.028043; National Guideline C, 2008, NURS MAN AD SEV TRAU; [NSW dept. NSWGH], 2011, CLIN PRACT GUID; NZGG, 2006, TRAUM BRAIN INJ DIAG; Oxman AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2530; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel P, 2012, COCHRANE DB SYST REV, V6; Perel P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007877.pub2; Roberts I, 2011, COCHRANE DATABASE SY; Rusticali B, 2008, MINERVA ANESTESIOL, V74, P583; Ryynanen OP, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-62; Sacco Frank, 2004, Alaska Med, V46, P58; Schneider SM, 2010, J EMERG NURS, V36, P330, DOI 10.1016/j.jen.2010.06.013; Shima Katsuji, 2010, Asian J Neurosurg, V5, P15; [SIGN (SIGN) SIGN], 2009, NAT CLIN GUID, P78; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Van de Velde S, 2011, BMJ QUAL SAF, V20, P747, DOI 10.1136/bmjqs.2010.045435; Wang HE, 2013, EMERG MED J; Williamson B, SYNAPSE GLOBAL PHASE; Wright D, PROTECT PROGESTERONE	57	19	21	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	APR-JUN	2014	18	2					265	273		10.3109/10903127.2013.856506			9	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	AD2WU	WOS:000333098000014	24401184				2022-02-06	
J	Kou, ZF; Iraji, A				Kou, Zhifeng; Iraji, Armin			Imaging brain plasticity after trauma	NEURAL REGENERATION RESEARCH			English	Article						traumatic brain injury; brain plasticity; neuroplasticity; neuroimaging; magnetic resonance imaging; fMRI; diffusion tensor imaging	CONTROLLED CORTICAL IMPACT; NETWORK PLASTICITY; NEURAL PLASTICITY; DEFAULT NETWORK; STROKE RECOVERY; FUNCTIONAL MRI; WORKING-MEMORY; INJURY; ACTIVATION; REORGANIZATION	The brain is highly plastic after stroke or epilepsy; however, there is a paucity of brain plasticity investigation after traumatic brain injury (TBI). This mini review summarizes the most recent evidence of brain plasticity in human TBI patients from the perspective of advanced magnetic resonance imaging. Similar to other forms of acquired brain injury, TBI patients also demonstrated both structural reorganization as well as functional compensation by the recruitment of other brain regions. However, the large scale brain network alterations after TBI are still unknown, and the field is still short of proper means on how to guide the choice of TBI rehabilitation or treatment plan to promote brain plasticity. The authors also point out the new direction of brain plasticity investigation.	[Kou, Zhifeng; Iraji, Armin] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA; [Kou, Zhifeng] Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA		Kou, ZF (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA.	zhifeng_kou@wayne.edu		Iraji, Armin/0000-0002-0605-593X	Department of DefenseUnited States Department of Defense [W81X-WH-11-1-0493]	The work was supported by the Department of Defense, grant number W81X-WH-11-1-0493.	Baranauskas G, 2001, THEORY NEUROPLASTICI; Black JE, 2004, AM J PSYCHIAT, V161, P742, DOI 10.1176/appi.ajp.161.4.742; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Carey LM, 2007, INT J STROKE, V2, P245, DOI 10.1111/j.1747-4949.2007.00164.x; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dijkhuizen RM, 2012, TRANSL STROKE RES, V3, P36, DOI 10.1007/s12975-011-0143-8; Eyo UB, 2013, J NEUROIMMUNE PHARM, V8, P494, DOI 10.1007/s11481-013-9434-z; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kolb B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00204; Kou Z, 2014, GLIA IN PRESS; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Li KM, 2013, HUM BRAIN MAPP, V34, P2494, DOI 10.1002/hbm.22082; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Mattson MP, 2001, THEORY NEUROPLASTICI; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Meinzer M, 2007, NEUROREHABILITATION, V22, P311; Morgan AT, 2013, BRAIN, V136, P646, DOI 10.1093/brain/aws355; Morris GP, 2013, NEUROBIOL LEARN MEM, V105, P40, DOI 10.1016/j.nlm.2013.07.002; Munoz-Cespedes JM, 2005, NEUROPSYCHOL REV, V15, P169, DOI 10.1007/s11065-005-9178-5; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Richter M, 2008, BRAIN, V131, P1391, DOI 10.1093/brain/awn043; Sacco K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00146; Staudt M, 2010, SEMIN PERINATOL, V34, P87, DOI 10.1053/j.semperi.2009.10.009; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Takahashi CD, 2008, BRAIN, V131, P425, DOI 10.1093/brain/awm311; Teskey GC, 2001, THEORY NEUROPLASTICI; Tivarus ME, 2012, BRAIN LANG, V123, P1, DOI 10.1016/j.bandl.2012.06.006; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Voss HU, 2009, PROG BRAIN RES, V175, P483, DOI 10.1016/S0079-6123(09)17532-5; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yeatman JD, 2013, CORTEX, V49, P301, DOI 10.1016/j.cortex.2011.08.006; Yogarajah M, 2010, BRAIN, V133, P2348, DOI 10.1093/brain/awq175; Yu X, 2012, NEURON, V74, P731, DOI 10.1016/j.neuron.2012.04.024; Zhou IY, 2014, NEUROIMAGE, V84, P1, DOI 10.1016/j.neuroimage.2013.08.037; Zhu DJ, 2014, HUM BRAIN MAPP, V35, P2911, DOI 10.1002/hbm.22373; Zhu DJ, 2013, CEREB CORTEX, V23, P786, DOI 10.1093/cercor/bhs072; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	64	19	20	3	25	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2014	9	7					693	700		10.4103/1673-5374.131568			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AH0KF	WOS:000335807100004	25206874	Green Published, gold, Green Submitted			2022-02-06	
J	Seo, JP; Jang, SH				Seo, Jeong Pyo; Jang, Sung Ho			INJURY OF THE SPINOTHALAMIC TRACT IN A PATIENT WITH MILD TRAUMATIC BRAIN INJURY: DIFFUSION TENSOR TRACTOGRAPHY STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						spinothalamic tract; diffusion tensor imaging; head trauma, traumatic axonal injury	CENTRAL POSTSTROKE PAIN; PREVALENCE	Objective: To report on a patient found to have injury of the spinothalamic tract on diffusion tensor tractography following traumatic brain injury. Case description: A 29-year-old male patient with head trauma resulting from a pedestrian car accident presented with pain in multiple areas (both subscapular areas, posterior head and neck, both upper trapezius areas, and the right arm and leg). His pain had not improved with various types of conservative management. Results: Evaluations (conventional brain magnetic resonance imaging, electromyography, and whole spine magnetic resonance imaging), performed 2 years after the head trauma, did not reveal any specific abnormality. Fibromyalgia and myofascial pain syndrome were ruled out by physical examination. Injuries of the spinothalamic tracts in both hemispheres were observed on diffusion tensor imaging in terms of the configuration (thinning) and diffusion tensor tractography parameters (decreased fractional anisotropy or tract volume). Conclusion: Some of the pain in the trunk and extremities in this patient could be ascribed to central pain caused by injury of both spinothalamic tracts. We conclude that diffusion tensor tractography provides a useful means of detecting injury of the spinothalamic tract in patients with traumatic brain injury.	[Seo, Jeong Pyo; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			DGIST R&D Program of the Ministry of Education, Science and Technology of Korea [14-BD-0401]	This work was supported by the DGIST R&D Program of the Ministry of Education, Science and Technology of Korea (14-BD-0401).	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Goto T, 2008, PAIN, V140, P509, DOI 10.1016/j.pain.2008.10.009; Hong JH, 2011, AM J NEURORADIOL, V32, P1358, DOI 10.3174/ajnr.A2497; Hong JH, 2012, EUR NEUROL, V67, P12, DOI 10.1159/000333012; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hong JH, 2010, NEUROSCI LETT, V468, P102, DOI 10.1016/j.neulet.2009.10.075; Lincoln N., 1998, PHYSIOTHERAPY, V84, P358, DOI [10.1016/S0031-9406(05)61454-X, DOI 10.1016/S0031-9406(05)61454-X]; Meek MF, 2003, MICROSURG, V23, P2, DOI 10.1002/micr.10087; Miller M D, 1993, Fam Pract Res J, V13, P15; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Seghier ML, 2005, J PAIN, V6, P208, DOI 10.1016/j.jpain.2004.11.004; Seo JP, 2013, BRAIN INJURY, V27, P749, DOI 10.3109/02699052.2013.771794; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Tenovuo O, 2007, PAIN, V131, P241, DOI 10.1016/j.pain.2007.07.003; Walker WC, 2004, J HEAD TRAUMA REHAB, V19, P72, DOI 10.1097/00001199-200401000-00007; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165	19	19	19	0	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2014	46	4					374	377		10.2340/16501977-1783			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AE7CR	WOS:000334154800013	24577424	Green Submitted, gold			2022-02-06	
J	Sun, WF; Liu, JF; Huan, Y; Zhang, CD				Sun, Weifeng; Liu, Jiafeng; Huan, Yu; Zhang, Chaodong			Intracranial injection of recombinant stromal-derived factor-1 alpha (SDF-1 alpha) attenuates traumatic brain injury in rats	INFLAMMATION RESEARCH			English	Article						TBI; SDF-1 alpha; Neuronal degradation and apoptosis; Inflammation; ERK pathway; NF-kappa B pathway	NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; REGIONAL CEREBRAL EDEMA; BCL-2 FAMILY-MEMBERS; GLUTAMATE-RECEPTOR 5; NITRIC-OXIDE; CHEMOKINE RECEPTOR; NEURONAL APOPTOSIS; CELL-SURVIVAL; INHIBITION	This study was conducted to investigate the role of stromal-derived factor-1 alpha (SDF-1 alpha) in a secondary brain injury after traumatic brain injury (TBI) in rats, and to further elucidate its underlying regulatory mechanisms. Male Sprague-Dawley rats underwent TBI for 30 min, and then received intracranial injections of recombinant SDF-1 alpha, SDF-1 alpha antibody, or saline as a vehicle control. At 24 h after TBI, brain tissues from the experimental animals were subjected to histology, immunohistochemistry, quantitative real-time polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), and western blot analyses. TBI-induced brain edema and blood-brain barrier disruption were ameliorated by post-injury injections of SDF-1 alpha. TBI-induced neuronal degradation and apoptosis, accompanied by increased cleaved caspase-3, cleaved PARP and Bax, and decreased Bcl-2 were found to be attenuated by SDF-1 alpha injection. Nitric oxide (NO) and inducible nitric oxide synthase (iNOS) levels decreased in SDF-1 alpha treated animals after TBI. SDF-1 alpha repressed inflammatory responses by inhibiting the expression of pro-inflammatory cytokines, such as TNF-alpha, IL-1 beta, and IL-6. However, neutralizing the effect of SDF-1 alpha with its antibody abolished these therapeutic alterations in TBI animals. Importantly, SDF-1 alpha attenuated the brain lesion by affecting the ERK and NF-kappa B signaling pathways after mechanical head trauma in rats. SDF-1 alpha ameliorates mechanical trauma-induced pathological changes via its anti-apoptotic and anti-inflammatory action in the brain.	[Sun, Weifeng; Zhang, Chaodong] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Peoples R China; [Sun, Weifeng; Liu, Jiafeng; Huan, Yu] Harbin First Hosp, Dept Neurol, Harbin 150010, Peoples R China		Zhang, CD (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, 155 North Nanjing St, Shenyang 110001, Peoples R China.	cmu1hzhangchaodong@163.com					Bacon KB, 2000, J NEUROIMMUNOL, V104, P92, DOI 10.1016/S0165-5728(99)00266-0; Banisadr Ghazal, 2005, Current Drug Targets - Inflammation and Allergy, V4, P387, DOI 10.2174/1568010054022097; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003; Chen CH, 2006, J CEREBR BLOOD F MET, V26, P951, DOI 10.1038/sj.jcbfm.9600248; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Demir H, 2013, PEPTIDES, V43, P27, DOI 10.1016/j.peptides.2013.02.018; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Huang CY, 2001, J CEREBR BLOOD F MET, V21, P163, DOI 10.1097/00004647-200102000-00008; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Kanbak G, 2013, GENE, V512, P492, DOI 10.1016/j.gene.2012.10.012; Kremer KN, 2013, J BIOL CHEM, V288, P22899, DOI 10.1074/jbc.M113.449926; Kroncke KD, 1997, NITRIC OXIDE-BIOL CH, V1, P107, DOI 10.1006/niox.1997.0118; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Liu XQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054077, 10.1371/journal.pone.0077367, 10.1371/journal.pone.0058489]; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lu J, 2003, NEUROSCI LETT, V339, P147, DOI 10.1016/S0304-3940(03)00003-X; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Mithal DS, 2012, J NEUROIMMUNE PHARM, V7, P820, DOI 10.1007/s11481-011-9336-x; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Qiu RF, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-99; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Savas HA, 2006, WORLD J BIOL PSYCHIA, V7, P51, DOI 10.1080/15622970510029993; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang JW, 2012, BRAIN RES, V1464, P73, DOI 10.1016/j.brainres.2012.05.014; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Werner L, 2013, THERANOSTICS, V3, P40, DOI 10.7150/thno.5135; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3; Yoo J, 2012, NEUROSCIENCE, V209, P171, DOI 10.1016/j.neuroscience.2012.02.031; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zheng H, 2008, ATHEROSCLEROSIS, V201, P36, DOI 10.1016/j.atherosclerosis.2008.02.011; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	58	19	22	0	11	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	APR	2014	63	4					287	297		10.1007/s00011-013-0699-8			11	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	AD0WD	WOS:000332954100005	24352531				2022-02-06	
J	Fujii, DE; Ahmed, L				Fujii, Daryl E.; Ahmed, Iqbal			Psychotic Disorder Caused by Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Psychosis; Mental disorder; Brain; Trauma	PSYCHIATRIC-DISORDERS; NEGATIVE SYMPTOMS; HEAD-INJURY; SCHIZOPHRENIA; RISK; PREVALENCE; EPILEPSY; HALLUCINATIONS; NEUROCOGNITION; OUTPATIENTS	Psychosis is a rare and severe sequela of traumatic brain injury (TBI). This article assists clinicians in differential diagnosis by providing literature-based guidance with regard to use of the Diagnostic and Statistical Manual for Mental Disorders 5 criteria for this condition. This article also describes potential relationships between TBI and the development of a psychosis within the conceptualization of psychosis as a neurobehavioral syndrome.	[Fujii, Daryl E.] Community Living Ctr, Vet Affairs Pacific Isl Hlth Care Serv, Honolulu, HI 96819 USA; [Ahmed, Iqbal] Univ Hawaii, Tripler Army Med Ctr, Dept Psychiat, Honolulu, HI 96859 USA; [Ahmed, Iqbal] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Fujii, DE (corresponding author), Community Living Ctr, Vet Affairs Pacific Isl Hlth Care Serv, 459 Patterson Rd, Honolulu, HI 96819 USA.	dfujii07@gmail.com					ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Ahmed AO, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0345-0; Alper K, 2007, BIOL PSYCHIAT, V62, P345, DOI 10.1016/j.biopsych.2006.09.023; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Arfken C, 2008, SCHIZOPHR RES, V102, P21; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bobes J, 2010, J CLIN PSYCHIAT, V71, P280, DOI 10.4088/JCP.08m04250yel; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; CAZZULLO CL, 1989, PSYCHIAT RES, V29, P257, DOI 10.1016/0165-1781(89)90055-3; Chen YH, 2011, PSYCHOL MED, V41, P1271, DOI 10.1017/S0033291710001819; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Coronado VG, 2006, JAMA-J AM MED ASSOC, V295, P1764; Davison K, 1969, CURRENT PROBLEMS NEU, P113; Dixon LB, 2010, SCHIZOPHRENIA BULL, V36, P48, DOI 10.1093/schbul/sbp115; Elliott B, 2009, EPILEPSY RES, V85, P172, DOI 10.1016/j.eplepsyres.2009.03.017; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Fujii DE, 2007, SPECTRUM OF PSYCHOTIC DISORDERS: NEUROBIOLOGY, ETIOLOGY, AND PATHOGENESIS, P3, DOI 10.1017/CBO9780511543784.002; Fujii DE, 2007, SPECTRUM OF PSYCHOTIC DISORDERS: NEUROBIOLOGY, ETIOLOGY, AND PATHOGENESIS, P535, DOI 10.1017/CBO9780511543784.028; Fujii DE, 2004, SCHIZOPHR RES, V69, P67, DOI 10.1016/S0920-9964(03)00122-1; Fujii DE, 2003, SCHIZOPHR RES, V59, P219, DOI 10.1016/S0920-9964(01)00328-0; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hwu HG, 2002, SCHIZOPHR RES, V56, P105, DOI 10.1016/S0920-9964(01)00251-1; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; KENDLER KS, 1994, AM J PSYCHIAT, V151, P27; Knobel A, 2008, EUR ARCH PSY CLIN N, V258, P76, DOI 10.1007/s00406-008-5008-0; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kotsopoulos IAW, 2002, EPILEPSIA, V43, P1402, DOI 10.1046/j.1528-1157.2002.t01-1-26901.x; Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P69, DOI 10.1016/j.seizure.2009.11.005; Makinen J, 2008, NORD J PSYCHIAT, V62, P334, DOI 10.1080/08039480801959307; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; NASRALLAH HA, 1983, J CLIN PSYCHIAT, V44, P407; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Pearlson GD, 1999, BIOL PSYCHIAT, V46, P627, DOI 10.1016/S0006-3223(99)00071-2; Ritchie E C, 1989, J Neuropsychiatry Clin Neurosci, V1, P449; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith MJ, 2009, COMPR PSYCHIAT, V50, P245, DOI 10.1016/j.comppsych.2008.07.009; VIOLON A, 1987, ACTA NEUROCHIR, V85, P96, DOI 10.1007/BF01456104; VITA A, 1991, AM J PSYCHIAT, V148, P1577; VITA A, 1988, SCHIZOPHR RES, V1, P329, DOI 10.1016/0920-9964(88)90046-1; White C, 2009, PSYCHOL MED, V39, P1447, DOI 10.1017/S003329170800514X; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353	54	19	21	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	MAR	2014	37	1					113	+		10.1016/j.psc.2013.11.006			13	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	AD8UM	WOS:000333541200009	24529427				2022-02-06	
J	Koskinen, EA; Hakulinen, U; Brander, AE; Luoto, TM; Ylinen, A; Ohman, JE				Koskinen, E. A.; Hakulinen, U.; Brander, A. E.; Luoto, T. M.; Ylinen, A.; Ohman, J. E.			Clinical correlates of cerebral diffusion tensor imaging findings in chronic traumatic spinal cord injury	SPINAL CORD			English	Article						traumatic spinal cord injury; magnetic resonance imaging; diffusion tensor imaging; degeneration; cerebral white matter	WALLERIAN DEGENERATION; WHITE-MATTER; INTERNATIONAL STANDARDS; CORTICOSPINAL TRACT; CENTRUM SEMIOVALE; PYRAMIDAL TRACT; WATER DIFFUSION; BRAIN-INJURY; DATA SET; CLASSIFICATION	Study design: Prospective clinical case-control study. Objectives: The aim of this study was to use diffusion tensor imaging (DTI) to assess the state of cerebral white matter tracts after spinal cord injury (SCI). The DTI metrics were evaluated in relation to neurological deficits and to the size and level of the spinal cord lesions. Setting: Tampere University Hospital, Tampere, Finland. Methods: Thirty-four patients (n = 34) with clinically complete and incomplete SCI were evaluated using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI). DTI metrics (fractional anisotropy (FA) and apparent diffusion coefficient (ADC)) were calculated for multiple levels along the course of the corticospinal tract. The state of the spinal cord after injury was assessed using conventional magnetic resonance imaging (MRI). DTI parameters were compared with 40 orthopedically injured control subjects. Results: Statistically significant differences in the DTI values between patients and controls were detected in the posterior area of the centrum semiovale. In this area, the FA values were lower in the patients compared with controls (P = 0.008). For patients with clinically complete injury, the difference was even more significant (P= 0.0005). Motor and sensory scores of the ISNCSCI correlated positively with FA and negatively with ADC values of the centrum semiovale. A moderate association was observed between the macroscopic changes in the spinal cord and the DTI abnormalities in the centrum semiovale. Conclusion: In patients with chronic SCI, DTI changes can be observed in the cerebral white matter. These alterations are associated with the clinical state of the patients.	[Koskinen, E. A.; Luoto, T. M.; Ohman, J. E.] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere 33521, Finland; [Hakulinen, U.; Brander, A. E.] Pirkanmaa Hosp Dist, Med Imaging Ctr, Dept Radiol, Tampere, Finland; [Hakulinen, U.] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Ylinen, A.] Univ Helsinki, Dept Neurol Sci, Helsinki, Finland; [Ylinen, A.] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Ohman, J. E.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland		Koskinen, EA (corresponding author), Tampere Univ Hosp, Dept Neurosci & Rehabil, PL 2000, Tampere 33521, Finland.	eerika.koskinen@uta.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Ohman, Juha/0000-0002-6592-1367	Pirkanmaa Regional Fund of the Finnish Cultural Foundation	We thank our research assistant Anne Simi and our rehabilitation counselors, Raija Pettersson and Eija Vaarala, for their contribution in patient recruitment and our biostatistician Mika Helminen for his assistance in statistical analysis. We are grateful to the Tampere University Hospital staff of the Department of Neuroscience and Rehabilitation and Department of Radiology for their support. This work was supported by funds from the Pirkanmaa Regional Fund of the Finnish Cultural Foundation.	Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Ashley J., 1990, HLTH TRENDS, V1991, P135; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Chang Y, 2010, J NEUROTRAUM, V27, P2033, DOI 10.1089/neu.2009.1265; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; DeVivo M, 2006, SPINAL CORD, V44, P535, DOI 10.1038/sj.sc.3101958; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Guleria S, 2008, J NEUROSCI RES, V86, P2271, DOI 10.1002/jnr.21664; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1471, DOI 10.1016/S0003-9993(99)90260-5; Han BS, 2010, BRAIN RES, V1326, P75, DOI 10.1016/j.brainres.2010.02.050; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mulcahey MJ, 2012, SPINE, V37, pE797, DOI 10.1097/BRS.0b013e3182470a08; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Seo JP, 2012, NEUROSCI LETT, V523, P111, DOI 10.1016/j.neulet.2012.06.053; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Waring WP, 2010, J SPINAL CORD MED, V33, P346, DOI 10.1080/10790268.2010.11689712; Widerstrom-Noga E, 2008, SPINAL CORD, V46, P818, DOI 10.1038/sc.2008.64; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Yamada K, 2007, J MAGN RESON IMAGING, V26, P519, DOI 10.1002/jmri.21006; YAMAMOTO T, 1989, J NEUROL NEUROSUR PS, V52, P382, DOI 10.1136/jnnp.52.3.382; Zarei M, 2007, J MAGN RESON IMAGING, V25, P48, DOI 10.1002/jmri.20810	32	19	24	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAR	2014	52	3					202	208		10.1038/sc.2013.163			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	AC3VX	WOS:000332450500008	24418961	Bronze			2022-02-06	
J	Sakai, K; Fukuda, T; Iwadate, K				Sakai, Kentaro; Fukuda, Takahiro; Iwadate, Kimiharu			Immunohistochemical Analysis of the Ubiquitin Proteasome System and Autophagy Lysosome System Induced After Traumatic Intracranial Injury Association With Time Between the Injury and Death	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						traumatic brain injury; ubiquitin; interval; autophagy	SPINAL-CORD TRAUMA; AXONAL INJURY; UP-REGULATION; BRAIN-INJURY; PROTEIN; DEGRADATION; P62/SQSTM1; P62; ACCUMULATION; COMPONENT	This study aimed to analyze how the ubiquitin proteasome system (UPS) or autophagy lysosome system (autophagy) are induced in brain tissues at different intervals after traumatic intracranial injury in humans. Injured cerebral cortices of 36 forensic autopsy cases were analyzed by immunohistochemistry using antibodies as the UPS marker (ubiquitin and lysine 48-linked polyubiquitin chains [K48]) and autophagy marker (lysine 63-linked polyubiquitin chains [K63], p62/sequestome 1 and microtubule-associated protein 1 light chain 3 [LC3]). The number of neurons and glial cells with cytoplasmic inclusions that stained positive for ubiquitin, K48, and p62 began to increase within 1 hour after intracranial injury, particularly at contusion sites. From 3.5 hours onward, an increase in cytoplasmic inclusions that stained positive for K63 and LC3 began to be detected. LC3-positive cytoplasmic inclusions were not identified after 37 days; however, the increased immunoreactivity to ubiquitin and anti-K48 antibody was maintained for 7 months. These results suggest that the UPS is activated earlier and lasts longer than autophagy, that autophagy is activated for a relatively short term (between a few hours and approximately 1 month), and that the activation occurs especially in severely damaged brain tissues following head trauma in humans.	[Sakai, Kentaro; Iwadate, Kimiharu] Jikei Univ, Sch Med, Res Ctr Med Sci, Dept Forens Med, Tokyo 1058461, Japan; [Fukuda, Takahiro] Jikei Univ, Sch Med, Res Ctr Med Sci, Div Neuropathol,Dept Neurosci, Tokyo 1058461, Japan		Sakai, K (corresponding author), Jikei Univ, Sch Med, Dept Forens Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	kentaro.sakai@jikei.ac.jp					Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Al-Sarraj S, 2004, CLIN NEUROPATHOL, V23, P62; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Chu CT, 2000, MODERN PATHOL, V13, P420, DOI 10.1038/modpathol.3880072; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; DiMaio D., 2000, CRC SER PR CRIM, P230; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Fortun J, 2005, J NEUROCHEM, V92, P1531, DOI 10.1111/j.1471-4159.2004.02987.x; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Ju JS, 2009, J CELL BIOL, V187, P855; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; LAIY H, 2008, J CEREB BLOOD FLOW M, V28, P540; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; LIMKL L, 2011, NEUROBIOL DIS, V43, P9; LIUCL C, 2008, J CEREB BLOOD FLOW M, V28, P674; MARTIN JE, 1990, BRAIN, V113, P1553, DOI 10.1093/brain/113.5.1553; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Sartori S, 2008, J CHILD NEUROL, V23, P912, DOI 10.1177/0883073808316367; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; TANJM W, 2008, AUTOPHAGY, V4, P251; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; ZHUC W, 2005, CELL DEATH DIFFER, V12, P162	53	19	20	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	2014	35	1					38	44		10.1097/PAF.0000000000000067			7	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	AB0YP	WOS:000331518600011	24317096				2022-02-06	
J	Wang, KW; Chen, HJ; Lu, K; Liliang, PC; Liang, CL; Tsai, YD; Cho, CL				Wang, Kuo-Wei; Chen, Han-Jung; Lu, Kang; Liliang, Po-Chou; Liang, Cheng-Loong; Tsai, Yu-Duan; Cho, Chung-Lung			Simvastatin Attenuates the Cerebral Vascular Endothelial Inflammatory Response in a Rat Traumatic Brain Injury	ANNALS OF CLINICAL AND LABORATORY SCIENCE			English	Article						Simvastatin; cerebral vascular endothelial inflammatory response; ICAM-1; traumatic brain injury	CIRCULATING MONOCYTES; ADHESION MOLECULES; ARTERY OCCLUSION; STATINS; ATORVASTATIN; PATHOGENESIS; EXPRESSION; ISCHEMIA; MICE	Traumatic brain injury (TBI) leads to important and deleterious inflammation, as evidenced by edema, cytokine production, induction of nitric oxide synthase, and leukocyte infiltration. After TBI, the activation of cerebral vascular endothelial cells plays a crucial role in the pathogenesis of inflammation. In this study, we hypothesized that the activation of cerebral vascular endothelial cells plays a crucial role in the pathogenesis of inflammation and outcome after TBI. It may represent a key cellular target for statin therapy. Methods. In our study, cortical contusions were induced, and the effect of continuous treatment of simvastatin on behavior and inflammation in adult rats following experimental TBI was evaluated. The treatment group received 15 mg/kg of simvastatin daily for 3 days. Neurological function was assessed with the grip test. Results. The results showed that the non-treatment control group had a significantly greater increase in ICAM-1 expression from pre-injury to the post-injury 72 h time point as compared to the expression in treatment group. The treatment group had better neurological function as evidenced in a grip test performed from baseline to 72 h. The analysis of a western blot test and pathology also demonstrated reduced ICAM-1 expression and a smaller area of damage and tissue loss. Conclusion. Our findings suggest that simvastatin could attenuate the activation of cerebral vascular endothelial inflammatory response and decrease the loss of neurological function and brain tissue.	[Wang, Kuo-Wei; Chen, Han-Jung; Lu, Kang; Liliang, Po-Chou; Liang, Cheng-Loong; Tsai, Yu-Duan] I Shou Univ, E Da Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Cho, Chung-Lung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan		Cho, CL (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, 70 LienHai Rd, Kaohsiung 804, Taiwan.	q1207@ms8.hinet.net			E-DA hospital [EDAHP 99027]	The study was supported by research program of E-DA hospital. (EDAHP 99027)	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; CARLOS TM, 1994, BLOOD, V84, P2068; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Connolly ES, 1996, J CLIN INVEST, V97, P209, DOI 10.1172/JCI118392; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; Pirat A, 2006, ANESTH ANALG, V102, P225, DOI 10.1213/01.ane.0000189554.41095.98; Pleiner J, 2004, CIRCULATION, V110, P3349, DOI 10.1161/01.CIR.0000147774.90396.ED; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rezaie-Majd A, 2003, ARTERIOSCL THROM VAS, V23, P397, DOI 10.1161/01.ATV.0000059384.34874.F0; Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Scalia R, 2001, CIRCULATION, V103, P2598; Shao HT, 2007, ANN THORAC SURG, V84, P2011, DOI 10.1016/j.athoracsur.2007.07.022; Sheu JR, 2008, YB CHINESE MED PHARM, V26, P161; Tang T, 1996, J CLIN INVEST, V97, P2485, DOI 10.1172/JCI118695; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Weber JR, 1995, J NEUROIMMUNOL, V63, P63; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058	27	19	20	0	3	ASSOC CLINICAL SCIENTISTS	MIDDLEBURY	PO BOX 1287, MIDDLEBURY, VT 05753 USA	0091-7370	1550-8080		ANN CLIN LAB SCI	Ann. Clin. Lab. Sci.	SPR	2014	44	2					145	150					6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	AT2HS	WOS:000344755200005	24795052				2022-02-06	
J	Suyama, K; Watanabe, M; Sakabe, K; Otomo, A; Okada, Y; Terayama, H; Imai, T; Mochida, J				Suyama, Kaori; Watanabe, Masahiko; Sakabe, Kou; Otomo, Asako; Okada, Yoshinori; Terayama, Hayato; Imai, Takeshi; Mochida, Joji			GRP78 Suppresses Lipid Peroxidation and Promotes Cellular Antioxidant Levels in Glial Cells following Hydrogen Peroxide Exposure	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SPINAL-CORD-INJURY; UNFOLDED PROTEIN RESPONSE; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; NEUROBLASTOMA-CELLS; EPITHELIAL-CELLS; INDUCTION; NQO1; GLUTATHIONE	Oxidative stress, caused by the over production of reactive oxygen species (ROS), has been shown to contribute to cell damage associated with neurotrauma and neurodegenerative diseases. ROS mediates cell damage either through direct oxidation of lipids, proteins and DNA or by acting as signaling molecules to trigger cellular apoptotic pathways. The 78 kDa glucose-regulated protein (GRP78) is an ER chaperone that has been suggested to protect cells against ROS-induced damage. However, the protective mechanism of GRP78 remains unclear. In this study, we used C6 glioma cells transiently overexpressing GRP78 to investigate the protective effect of GRP78 against oxidative stress (hydrogen peroxide)-induced injury. Our results showed that the overexpression of GRP78 significantly protected cells from ROS-induced cell damage when compared to non-GRP78 overexpressing cells, which was most likely due to GRP78-overexpressing cells having higher levels of glutathione (GSH) and NAD(P)H:quinone oxidoreductase 1 (NQO1), two antioxidants that protect cells against oxidative stress. Although hydrogen peroxide treatment increased lipid peroxidation in non-GRP78 overexpressing cells, this increase was significantly reduced in GRP78-overexpressing cells. Overall, these results indicate that GRP78 plays an important role in protecting glial cells against oxidative stress via regulating the expression of GSH and NQO1.	[Suyama, Kaori; Sakabe, Kou; Terayama, Hayato] Tokai Univ, Sch Med, Dept Anat & Cellular Biol, Isehara, Kanagawa 25911, Japan; [Watanabe, Masahiko; Imai, Takeshi; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthoped Surg, Isehara, Kanagawa 25911, Japan; [Otomo, Asako] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Okada, Yoshinori] Tokai Univ, Teaching & Res Support Ctr, Isehara, Kanagawa, Japan		Watanabe, M (corresponding author), Tokai Univ, Sch Med, Dept Orthoped Surg, Isehara, Kanagawa 25911, Japan.	masahiko@is.icc.u-tokai.ac.jp	Otomo, Asako/AAA-6374-2019	Otomo, Asako/0000-0002-7849-4309	Research and Study Program of Tokai University Educational System General Research Organization; Tokai University School of Medicine Research Aid; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25830040, 26460809] Funding Source: KAKEN	This study was supported in part by the Research and Study Program of Tokai University Educational System General Research Organization and 2012 Tokai University School of Medicine Research Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragno M, 2000, DIABETES, V49, P1924, DOI 10.2337/diabetes.49.11.1924; Bao F, 2004, NEUROSCIENCE, V126, P285, DOI 10.1016/j.neuroscience.2004.03.054; Bar-Am O, 2009, J MOL NEUROSCI, V37, P135, DOI 10.1007/s12031-008-9139-6; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Elmann A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/157598; GOMER CJ, 1991, CANCER RES, V51, P6574; Grant CM, 1998, BIOCHEM BIOPH RES CO, V253, P893, DOI 10.1006/bbrc.1998.9864; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; He SK, 2008, GRAEF ARCH CLIN EXP, V246, P677, DOI 10.1007/s00417-008-0770-2; HEDLEY D, 1992, CYTOMETRY, V13, P686, DOI 10.1002/cyto.990130704; Higo T, 2010, NEURON, V68, P865, DOI 10.1016/j.neuron.2010.11.010; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Jia ZQ, 2008, BRAIN RES, V1197, P159, DOI 10.1016/j.brainres.2007.12.044; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lim JH, 2008, PHARMACOL RES, V57, P325, DOI 10.1016/j.phrs.2008.03.004; Liu DX, 1999, FREE RADICAL BIO MED, V27, P478, DOI 10.1016/S0891-5849(99)00073-8; Long DJ, 2002, CANCER RES, V62, P3030; Lucas JH, 2002, J NEUROTRAUM, V19, P763, DOI 10.1089/08977150260139138; Mohammad MK, 2012, TOXICOL APPL PHARM, V265, P73, DOI 10.1016/j.taap.2012.09.021; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; SCHMIDLEY JW, 1990, STROKE, V21, P1086, DOI 10.1161/01.STR.21.7.1086; Suyama K, 2011, NEUROSCI LETT, V504, P271, DOI 10.1016/j.neulet.2011.09.045; Tiffany-Castiglioni E, 2012, NEUROTOXICOLOGY, V33, P545, DOI 10.1016/j.neuro.2012.02.007; Timblin CR, 1998, FREE RADICAL BIO MED, V24, P632, DOI 10.1016/S0891-5849(97)00325-0; Vladykovskaya E, 2012, J BIOL CHEM, V287, P11398, DOI 10.1074/jbc.M111.320416; Yen CC, 2011, ARCH TOXICOL, V85, P565, DOI 10.1007/s00204-011-0709-y; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Yoshida T, 2008, CANCER CHEMOTH PHARM, V61, P559, DOI 10.1007/s00280-007-0503-y; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507	37	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86951	10.1371/journal.pone.0086951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	WOS:000330339800071	24475200	Green Submitted, Green Published, gold			2022-02-06	
J	Del Turco, D; Schlaudraff, J; Bonin, M; Deller, T				Del Turco, Domenico; Schlaudraff, Jessica; Bonin, Michael; Deller, Thomas			Upregulation of APP, ADAM10 and ADAM17 in the Denervated Mouse Dentate Gyrus	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; ENTORHINAL CORTEX LESION; BETA-SECRETASE ACTIVITY; RAT FASCIA-DENTATA; ALZHEIMERS-DISEASE; ALPHA-SECRETASE; REACTIVE ASTROCYTES; TRANSGENIC MICE; FAMILY-MEMBERS	The disintegrin and metalloproteinases ADAM10 and ADAM17 are regarded as the most important alpha-secretases involved in the physiological processing of amyloid precursor protein (APP) in brain. Since it has been suggested that processing of APP by alpha-secretases could be involved in the reorganization of the brain following injury, we studied mRNA expression of the two alpha-secretases Adam10 and Adam17, the beta-secretase Bace1, and the App-gene family (App, Aplp1, Aplp2) in the dentate gyrus of the mouse following entorhinal denervation. Using laser microdissection, tissue was harvested from the outer molecular layer and the granule cell layer of the denervated dentate gyrus. Expression levels of candidate genes were assessed using Affymetrix GeneChip Mouse Gene 1.0 ST arrays and reverse transcription-quantitative PCR, revealing an upregulation of Adam10 mRNA and Adam17 mRNA in the denervated outer molecular layer and an upregulation of Adam10 mRNA and App mRNA in the dentate granule cell layer. Immunolabeling for ADAM10 or ADAM17 in combination with markers for astro- and microglia revealed an increased labeling of ADAM10 and ADAM17 in the denervated outer molecular layer that was associated with reactive astrocytes but not with microglia. Collectively, these data show that denervation affects the expression level of APP and its two most important alpha-secretases. This suggests that APP-processing could be shifted towards the non-amyloidogenic pathway in denervated areas of the brain and, thus, towards the formation of neuroprotective APP cleavage products, such as APPs alpha.	[Del Turco, Domenico; Schlaudraff, Jessica; Deller, Thomas] Goethe Univ Frankfurt, Inst Clin Neuroanat, Ctr Neurosci, D-60054 Frankfurt, Germany; [Bonin, Michael] Univ Tubingen, Dept Med Genet, Inst Human Genet, Tubingen, Germany		Del Turco, D (corresponding author), Goethe Univ Frankfurt, Inst Clin Neuroanat, Ctr Neurosci, D-60054 Frankfurt, Germany.	DelTurco@em.uni-frankfurt.de			Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DE 551/11-1, DE 551/11-2]	The grant sponsor was Deutsche Forschungsgemeinschaft (http://www.dfg.de), Grant number: DE 551/11-1; DE 551/11-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Burbach GJ, 2003, J NEUROSCI METH, V131, P83, DOI 10.1016/S0165-0270(03)00232-2; Copanaki E, 2010, MOL CELL NEUROSCI, V44, P386, DOI 10.1016/j.mcn.2010.04.007; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Corrigan F, 2012, NEUROSCI LETT, V515, P50, DOI 10.1016/j.neulet.2012.03.017; Del Turco D, 2003, HIPPOCAMPUS, V13, P685, DOI 10.1002/hipo.10118; Deller T, 1997, PROG NEUROBIOL, V53, P687, DOI 10.1016/S0301-0082(97)00044-0; Deller T, 2000, ANN NY ACAD SCI, V911, P207; Deller T, 2007, PROG BRAIN RES, V163, P501, DOI 10.1016/S0079-6123(07)63027-1; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Fahrenholz F, 2007, CURR ALZHEIMER RES, V4, P412, DOI 10.2174/156720507781788837; Fahrenholz F, 2006, NEURODEGENER DIS, V3, P255, DOI 10.1159/000095264; Fahrenholz F, 2010, NEURODEGENER DIS, V7, P190, DOI 10.1159/000295662; Faissner A, 2010, BRAIN RES REV, V63, P26, DOI 10.1016/j.brainresrev.2010.01.001; Finsen B, 1999, ADV EXP MED BIOL, V468, P157; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Freese C, 2009, FEBS J, V276, P1568, DOI 10.1111/j.1742-4658.2009.06889.x; GAGE FH, 1988, EXP NEUROL, V102, P2, DOI 10.1016/0014-4886(88)90073-8; GALL C, 1979, J COMP NEUROL, V183, P539, DOI 10.1002/cne.901830306; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Haas CA, 1999, J NEUROSCI, V19, P9953; Heber S, 2000, J NEUROSCI, V20, P7951; Hiltunen M, 2009, J ALZHEIMERS DIS, V18, P401, DOI 10.3233/JAD-2009-1154; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jensen MB, 1999, NEUROSCIENCE, V93, P507, DOI 10.1016/S0306-4522(99)00139-6; KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; Mattson MP, 1999, J NEUROCHEM, V73, P532, DOI 10.1046/j.1471-4159.1999.0730532.x; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nielsen HH, 2006, GLIA, V54, P105, DOI 10.1002/glia.20357; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2012, J NEUROCHEM, V120, P46, DOI 10.1111/j.1471-4159.2011.07459.x; Prinzen C, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-66; Ramirez MJ, 2001, BRAIN RES, V907, P222, DOI 10.1016/S0006-8993(01)02580-X; Reeves TM, 2003, J NEUROSCI, V23, P10182; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Skovronsky DM, 2001, J NEUROBIOL, V49, P40, DOI 10.1002/neu.1064; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; STEWARD O, 1994, EXP NEUROL, V129, P103, DOI 10.1006/exnr.1994.1151; STEWARD O, 1993, EXP NEUROL, V124, P167, DOI 10.1006/exnr.1993.1187; Steward O., 1991, CEREB CORTEX, V9, P81; Thon N, 2000, EUR J NEUROSCI, V12, P2547, DOI 10.1046/j.1460-9568.2000.00109.x; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tian YA, 2010, J BIOL CHEM, V285, P32549, DOI 10.1074/jbc.M110.128439; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt82; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vuksic M, 2011, EXP NEUROL, V230, P176, DOI 10.1016/j.expneurol.2011.04.011; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	73	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2014	9	1							e84962	10.1371/journal.pone.0084962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IH	WOS:000329460800076	24404197	gold, Green Published, Green Submitted			2022-02-06	
S	Bailes, JE; Dashnaw, ML; Petraglia, AL; Turner, RC		Niranjan, A; Lunsford, LD		Bailes, Julian E.; Dashnaw, Matthew L.; Petraglia, Anthony L.; Turner, Ryan C.			Cumulative Effects of Repetitive Mild Traumatic Brain Injury	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							COLLEGIATE FOOTBALL PLAYERS; MAGNETIC-RESONANCE-SPECTROSCOPY; DEPLOYED MILITARY PERSONNEL; HIGH-SCHOOL FOOTBALL; RECURRENT CONCUSSION; COGNITIVE IMPAIRMENT; SPORTS CONCUSSIONS; LEAGUE PLAYERS; AXONAL INJURY; HEAD-INJURY	The majority of traumatic brain injuries (TBI) in the USA are mild in severity. Sports, particularly American football, and military experience are especially associated with repetitive, mild TBI (mTBI). The consequences of repetitive brain injury have garnered increasing scientific and public attention following reports of altered mood and behavior, as well as progressive neurological dysfunction many years after injury. This report provides an up-to-date review of the clinical, pathological, and pathophysiological changes associated with repetitive mTBI, and their potential for cumulative effects in certain individuals. (C) 2014 S. Karger AG, Basel	[Bailes, Julian E.] Univ Chicago, Pritzker Sch Med, NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL 60201 USA; [Dashnaw, Matthew L.; Petraglia, Anthony L.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Turner, Ryan C.] W Virginia Univ, Sch Med, Ctr Neurosci, Morgantown, WV 26506 USA; [Turner, Ryan C.] W Virginia Univ, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA		Bailes, JE (corresponding author), Univ Chicago, Pritzker Sch Med, NorthShore Univ HealthSyst, Dept Neurosurg, 2650 Ridge Ave,Kellogg 3rd Floor, Evanston, IL 60201 USA.	jbailes@northshore.org		Turner, Ryan/0000-0001-5523-0645			Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Lakhan SE, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-2; Lin A, 2010, RADIOLOGICAL SOC N A; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pardini J, 2011, YOUMANS NEUROLOGICAL, P3380; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Schieder R, 1973, HEAD NECK INJURIES F; Sedney CL, 2011, CLIN SPORT MED, V30, P189, DOI 10.1016/j.csm.2010.08.005; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Talavage TM, 2013, J NEUROTRAUMA; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tshibanda L, 2009, PROG BRAIN RES, V177, P215, DOI 10.1016/S0079-6123(09)17715-4; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003	55	19	19	0	8	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						50	62		10.1159/000358765	10.1159/isbn.978-3-318-02649-8		13	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000006	24923392				2022-02-06	
J	Cernak, I; Wing, ID; Davidsson, J; Plantman, S				Cernak, Ibolja; Wing, Ian D.; Davidsson, Johan; Plantman, Stefan			A novel mouse model of penetrating brain injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; models of injury; penetrating ballistic-like brain injury; animal studies; gliosis; neurodegeneration; histology	CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN; REACTIVE ASTROCYTES; RAT MODEL; ADULT; REGENERATION; MECHANISMS; DEFICITS; BLAST; MOTOR	Penetrating traumatic brain injury (pTBI) has been difficult to model in small laboratory animals, such as rats or mice. Previously, we have established a non-fatal, rat model for pTBI using a modified air-rifle that accelerates a pellet, which hits a small probe that then penetrates the experimental animal's brain. Knockout and transgenic strains of mice offer attractive tools to study biological reactions induced by TBI. Hence, in the present study, we adapted and modified our model to be used with mice. The technical characterization of the impact device included depth and speed of impact, as well as dimensions of the temporary cavity formed in a brain surrogate material after impact. Biologically, we have focused on three distinct levels of severity (mild, moderate, and severe), and characterized the acute phase response to injury in terms of tissue destruction, neural degeneration, and gliosis. Functional outcome was assessed by measuring bodyweight and motor performance on rotarod. The results showed that this model is capable of reproducing major morphological and neurological changes of pTBI; as such, we recommend its utilization in research studies aiming to unravel the biological events underlying injury and regeneration after pTBI.	[Cernak, Ibolja] Univ Alberta, Mil & Vet Clin Rehabil Res, Edmonton, AB, Canada; [Wing, Ian D.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Davidsson, Johan] Chalmers Univ Technol, Div Vehicle Safety, S-41296 Gothenburg, Sweden; [Plantman, Stefan] Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden		Plantman, S (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.	stefan.plantman@ki.se	Davidsson, Johan/A-3229-2016	Davidsson, Johan/0000-0002-1717-1514; Ibolja, Cernak/0000-0003-3214-698X	Karolinska InstitutetKarolinska Institutet; Swedish Brain Foundation; Johns Hopkins University Applied Physics Laboratory (Laurel, Maryland, USA)	This work was supported by Karolinska Institutet, the Swedish Brain Foundation, and the Johns Hopkins University Applied Physics Laboratory (Laurel, Maryland, USA) Internal Research and Development (IRAD) funds. The sponsors did not influence the study design, data collection, analysis and interpretation of data, or the report content.	Agoston Denes V, 2012, Front Neurol, V3, P3, DOI 10.3389/fneur.2012.00003; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asher RA, 2000, J NEUROSCI, V20, P2427; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Cernak I, 2010, MED DATA REV, V2, P297; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Davalos A, 2000, NEUROLOGY, V54, P1568, DOI 10.1212/WNL.54.8.1568; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Esposito DP, 2009, NEUROSURG QUART, V19, P249, DOI 10.1097/WNQ.0b013e3181bd1d53; FAWCETT J, 1994, J NEUROL, V242, pS25, DOI 10.1007/BF00939237; FINNIE JW, 1993, J COMP PATHOL, V108, P93, DOI 10.1016/S0021-9975(08)80231-9; FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Ishikawa E, 2000, NEUROL MED-CHIR, V40, P458, DOI 10.2176/nmc.40.458; Jandial R, 2008, NEUROSURGERY, V62, P472, DOI 10.1227/01.neu.0000316015.05550.7a; Luria AR., 1987, MAN SHATTERED WORLD; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Solmaz I, 2009, TURK NEUROSURG, V19, P216; SQUIRE LR, 1989, EXP NEUROL, V105, P23, DOI 10.1016/0014-4886(89)90168-4; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tan YH, 1998, J ORAL MAXIL SURG, V56, P345, DOI 10.1016/S0278-2391(98)90113-6; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	62	19	19	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								209	10.3389/fneur.2014.00209			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QW	WOS:000209629300196	25374559	Green Published, gold			2022-02-06	
J	Chu, Y; Brown, P; Harniss, M; Kautz, H; Johnson, K				Chu, Yi; Brown, Pat; Harniss, Mark; Kautz, Henry; Johnson, Kurt			Cognitive support technologies for people with TBI: current usage and challenges experienced	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Assistive technology; caregiver; cognitive support technology; psychosocial; support systems; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; ASSISTIVE TECHNOLOGY; REHABILITATION	Purpose: We investigated the current use of off-the-shelf cognitive support technologies (CSTs) by individuals with traumatic brain injury (TBI), the challenges they and their caregivers face when using these technologies, the functional areas where support is needed, and their current experience in learning new technologies. Method: We conducted two focus groups with participants with TBI and their caregivers. Focus group interactions were captured using recordings and a court reporter. Transcripts were analyzed qualitatively. Results: We identified three core themes - consumer and caregiver self-reported needs for support, how support is used on a daily basis and consumer and caregiver attitudes towards the use of support by types of support. We also inferred implications for design of CSTs. Conclusions: Individuals with TBI use consumer available technologies to support cognition. The design of most of these devices is not targeted to meet the needs of people with TBI, and they can be challenging to use independently, but individuals and their caregivers still benefit from their use by embedding technology as one type of support within a broader support network that includes personal assistance.	[Chu, Yi; Kautz, Henry] Univ Rochester, Comp Sci, Rochester, NY 14627 USA; [Brown, Pat; Harniss, Mark; Johnson, Kurt] Univ Washington, Rehabil Med, Seattle, WA 98195 USA		Brown, P (corresponding author), Univ Washington, Box 357920, Seattle, WA 98195 USA.	pabrown@u.washington.edu	Kautz, Henry/AAF-5190-2020; Harniss, Mark/J-3118-2013	Harniss, Mark/0000-0002-7741-2498; Kautz, Henry/0000-0001-5219-2970	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [100056-N]	This study was funded by National Institutes of Health (NIH), award #100056-N. The authors report no declarations of interest. The authors alone are responsible for the content and writing of this article.	[Anonymous], 2007, ABC NEWS; Boger J, 2011, NEUROREHABILITATION, V28, P271, DOI 10.3233/NRE-2011-0655; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Fraser RT, 2000, TRAUMATIC BRAIN INJU; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Jennett B, 1981, MANAGEMENT HEAD INJU, V120; Johnson KL, 2004, J REHABIL, V70, P38; Kapur N, 2004, NEUROPSYCHOL REHABIL, V14, P41, DOI 10.1080/09602010343000138; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lew HL, 2007, J REHABIL RES DEV, V42, pxiii; Litvak S, 2002, HDB DISABILITY STUDI, P711; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; MASON M, 2007, DISCOVER, V28, P54; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; MATEER CA, 1987, J HEAD TRAUMA REHAB, V2, P78; National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; National Council on Disability (U. S.), 1996, ACH IND CHAL 21 CENT; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Sauer AL, 2010, DISABIL REHABIL-ASSI, V5, P377, DOI 10.3109/17483101003746360; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Yorkston KM, 2010, QUAL LIFE RES, V19, P243, DOI 10.1007/s11136-009-9572-1; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	31	19	19	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2014	9	4					279	285		10.3109/17483107.2013.823631			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V07EM	WOS:000213991100002	23919409				2022-02-06	
J	Cooper, DB; Vanderploeg, RD; Armistead-Jehle, P; Lewis, JD; Bowles, AO				Cooper, Douglas B.; Vanderploeg, Rodney D.; Armistead-Jehle, Patrick; Lewis, Jeffrey D.; Bowles, Amy O.			Factors associated with neurocognitive performance in OIF/OEF servicemembers with postconcussive complaints in postdeployment clinical settings	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast injuries; cognitive complaints; combat veterans; mild traumatic brain injury; neuropsychological assessment; OIF/OEF; performance validity; postconcussive symptoms; postdeployment; posttraumatic stress disorder	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL STATUS RBANS; SYMPTOM VALIDITY TESTS; REPEATABLE BATTERY; PSYCHOMETRIC PROPERTIES; EVALUATION CONTEXT; OEF/OIF VETERANS; MILITARY SAMPLE; COMBAT VETERANS	Cognitive difficulties are frequently reported by Operation Iraqi Freedom/Operation Enduring Freedom military personnel who sustained mild traumatic brain injuries (TBIs). The current study examined several potential factors that may contribute to self-reported cognitive difficulties in postdeployment clinical settings. Eighty-four subjects who sustained a mild or moderate TBI and reported cognitive difficulties underwent neurocognitive testing. Multiple regression analyses were used to determine the amount of variance in neurocognitive performance accounted for by the predictor variables (demographic, mechanism of injury, time since injury, headache severity, combat stress, postconcussive complaints, and effort/performance validity). The predictor variables collectively accounted for 51.7% of the variance in cognitive performance (F (8,72) = 11/99, p < 0.001). The most potent predictor of cognitive functioning was performance validity/effort, which uniquely accounted for 16.3% of the variance(p < 0.01). Self-reported symptom severity, including postconcussive complaints, combat stress, and headache intensity, accounted for 7.2% of the variance (p < 0.05). Demographic factors and injury characteristics, such as time since injury and mechanism of injury, were not significant predictive factors of cognitive performance. The findings of the current study underscore the need to include measurement of effort as part of neurocognitive evaluation in postdeployment settings when evaluating cognitive complaints associated with mild TBI.	[Cooper, Douglas B.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Cooper, Douglas B.] San Antonio Mil Med Ctr, Dept Neurol, Ft Sam Houston, TX USA; [Vanderploeg, Rodney D.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, Ft Leavenworth, KS USA; [Lewis, Jeffrey D.] NINDS, Behav Neurol Unit, Bethesda, MD 20892 USA; [Bowles, Amy O.] San Antonio Mil Med Ctr, Traumat Brain Injury Serv, Dept Orthoped & Rehabil, Ft Sam Houston, TX USA		Cooper, DB (corresponding author), MCHE MDU DVBIC, San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA.	douglas.b.cooper.ctr@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432	DVBIC through Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.	This material was based on work supported in part by the DVBIC through contract support provided by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.	Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Beckham JC, 1998, J TRAUMA STRESS, V11, P811, DOI 10.1023/A:1024409903617; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BONNET MH, 1985, PERCEPT MOTOR SKILL, V60, P323, DOI 10.2466/pms.1985.60.1.323; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Casscells S., 2007, HLTH AFFAIRS MEMORAN; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Defense and Veterans Brain Injury Center, DEP DEF NUMB TRAUM B; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Edinger JD, 2003, J SLEEP RES, V12, P43, DOI 10.1046/j.1365-2869.2003.00335.x; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; Kalska H, 1999, Appl Neuropsychol, V6, P96, DOI 10.1207/s15324826an0602_5; Kanagaratnam P, 2007, J ANXIETY DISORD, V21, P510, DOI 10.1016/j.janxdis.2006.06.008; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; King D., 1996, NEUROPSYCHOLOGICAL A, P200; Koso M, 2006, EUR PSYCHIAT, V21, P167, DOI 10.1016/j.eurpsy.2005.06.004; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; MILLER LS, 1991, PSYCHIAT RES, V37, P219, DOI 10.1016/0165-1781(91)90058-W; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Munoz M, 2005, CLIN J PAIN, V21, P287; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Randolph C., 1998, REPEATABLE BATTERY A; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Vasterling JJ, 2002, NEUROPSYCHOLOGY PTSD, P178; Vignola A, 2000, J GERONTOL B-PSYCHOL, V55, pP54; Ware JE, 2000, NEUROLOGY, V54, pA336; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	54	19	19	0	7	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	7					1023	1033		10.1682/JRRD.2013.05.0104			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AU8JB	WOS:000345841300002	25479335	Bronze			2022-02-06	
J	Cullen, N; Krakowski, A; Taggart, C				Cullen, Nora; Krakowski, Aneta; Taggart, Christina			Early neuropsychological tests as correlates of return to driving after traumatic brain injury	BRAIN INJURY			English	Article						Cognition; driving abilities; neuropsychological; prediction; traumatic brain injury	COMMUNITY INTEGRATION; HEAD-INJURY; REHABILITATION; PERFORMANCE; PREDICTION; ATTENTION; RECOVERY; TRAIL	Objective: To assess the ability of neuropsychometric tests administered during inpatient rehabilitation to predict return to driving after traumatic brain injury (TBI). Design: Retrospective, matched case-controlled study. Methods: Sixty-seven participants with TBI, drawn from an existing database, completed a questionnaire that assessed return to driving post-TBI, as measured by reinstatement of the driver's license. Drivers were individually case-matched to non-drivers on age, Glasgow Coma Scale (GCS), Disability Rating Scale (DRS) and the rehabilitation admission interval (RAI). Scores on four neuropsychological tests (Trail-Making A, Trail Making B, Digit Span-forward and Digit Span-backward), administered during the rehabilitation stay, were compared between case-matched drivers and non-drivers. Outcome measure: Return to driving, as defined by reinstatement of the driver's license. Results: Participants who had returned to driving were comparable to those who had not returned to driving with respect to demographic variables, initial injury severity and baseline functioning. Scores on two neuropsychological assessments were significantly better in participants who had returned to driving than in those who had not: Trail-making A (p<0.01) and Trail-making B (p<0.01). Conclusions: The results suggest that neuropsychological measures of processing speed and cognitive flexibility may predict return to driving after TBI.	[Cullen, Nora; Taggart, Christina] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Cullen, Nora] Univ Toronto, Div Physiatry, Toronto, ON, Canada; [Krakowski, Aneta] Univ Toronto, Dept Med, Toronto, ON, Canada		Cullen, N (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	nora.cullen@uhn.ca		Cullen, Nora/0000-0001-6359-9418	Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Province of Ontario	The authors thank the staff members of the Toronto Rehabilitation Institute-University Health Network, ABI Service, for their assistance in data collection. The research assistance of Patricia Aznar and Carolyn Go is also gratefully acknowledged. Equipment and space have been funded with grants from the Canada Foundation for Innovation and the Province of Ontario. The views expressed here do not necessarily reflect those of the Ontario Ministry of Health and Long-Term Care.	[Anonymous], 1999, WECHSLER ABBREVIATED; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; Fisk GD, 2002, J HEAD TRAUMA REHAB, V17, P16, DOI 10.1097/00001199-200202000-00004; Fleming J, 1999, BRAIN INJURY, V13, P417; Fox G K, 1992, Disabil Rehabil, V14, P140; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Johnstone B, 1995, Appl Neuropsychol, V2, P24, DOI 10.1207/s15324826an0201_4; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Ontario Ministry of Transportation, 2010, MED REV SECT FREQ AS; Ontario Neurotrauma Foundation, 2008, ONT NEUR FDN ANN REP; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P29, DOI 10.1016/S0887-6177(96)00015-7; Rossini Paolo M, 2004, Phys Med Rehabil Clin N Am, V15, P263, DOI 10.1016/S1047-9651(03)00124-4; Ryu WHA, 2010, INT J REHABIL RES, V33, P84, DOI 10.1097/MRR.0b013e32832e6b4b; Schneider JJ, 2005, APPL NEUROPSYCHOL, V12, P138, DOI 10.1207/S15324826AN1203_3; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; WANG CC, 2003, PHYS GUIDE ASSESSING; Yale SH, 2006, J CLIN MED RES, V21, P177	38	19	19	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2014	28	1					38	43		10.3109/02699052.2013.849005			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	274CC	WOS:000328581700005	24328798				2022-02-06	
J	Curtis, K; Lam, M; Mitchell, R; Dickson, C; McDonnell, K				Curtis, Kate; Lam, Mary; Mitchell, Rebecca; Dickson, Cara; McDonnell, Karon			Major trauma: the unseen financial burden to trauma centres, a descriptive multicentre analysis	AUSTRALIAN HEALTH REVIEW			English	Article						cost; injury; health economics; health services	INJURY; REIMBURSEMENT; POLYTRAUMA; MORTALITY; VICTORIA; QUALITY; SYSTEM; COSTS; RISK; LIFE	Objective. This research examines the existing funding model for in-hospital trauma patient episodes in New South Wales (NSW), Australia and identifies factors that cause above-average treatment costs. Accurate information on the treatment costs of injury is needed to guide health-funding strategy and prevent inadvertent underfunding of specialist trauma centres, which treat a high trauma casemix. Methods. Admitted trauma patient data provided by 12 trauma centres were linked with financial data for 2008-09. Actual costs incurred by each hospital were compared with state-wide Australian Refined Diagnostic Related Groups (AR-DRG) average costs. Patient episodes where actual cost was higher than AR-DRG cost allocation were examined. Results. There were 16 693 patients at a total cost of AU$178.7 million. The total costs incurred by trauma centres were $14.7 million above the NSW peer-group average cost estimates. There were 10 AR-DRG where the total cost variance was greater than $500 000. The AR-DRG with the largest proportion of patients were the upper limb injury categories, many of whom had multiple body regions injured and/or a traumatic brain injury (P < 0.001). Conclusions. AR-DRG classifications do not adequately describe the trauma patient episode and are not commensurate with the expense of trauma treatment. A revision of AR-DRG used for trauma is needed.	[Curtis, Kate] Univ Sydney, Sydney Nursing Sch, Camperdown, NSW 2050, Australia; [Curtis, Kate; Dickson, Cara] St George Hosp, Kogarah, NSW 2217, Australia; [Curtis, Kate] George Inst Global Hlth, Sydney, NSW 2000, Australia; [Lam, Mary] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2141, Australia; [Mitchell, Rebecca] Univ New S Wales, Kensington, NSW 2033, Australia; [McDonnell, Karon] St Vincents Hosp, Sydney, NSW 2010, Australia		Curtis, K (corresponding author), Univ Sydney, Sydney Nursing Sch, 88 Mallet St, Camperdown, NSW 2050, Australia.	kate.curtis@sydney.edu.au; mary.lam@sydney.edu.au; r.mitchell@unsw.edu.au; cara.dickson@sesiahs.health.nsw.gov.au; kmcdonell@stvincents.com.au	Mitchell, Rebecca/Z-5476-2019	Mitchell, Rebecca/0000-0003-1939-1761	St George Honda Trauma and Critical Care Research program; Sydney Nursing School, University of Sydney	The authors thank the trauma coordinators and data managers of participating centres for assistance with ethics and provision of data. Funding support for statistical analysis was provided by the St George Honda Trauma and Critical Care Research program. Associate Professor Curtis was supported by a Sydney Nursing School, University of Sydney post-doctoral fellowship.	AIHW, 2010, AUSTR HLTH 2010; Association for the Advancement of Automotive Medicine, 2008, ABBR VIAT INJ SCAL 2; *AUSTR I HLTH WELF, 2010, HLTH SERV SER, V17; Australian Institute of Health and Welfare, 2010, HLTH WELF EXP SER, V42; Banfield JM, 2011, J TRAUMA, V70, P732, DOI 10.1097/TA.0b013e31820783a3; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; Callaway DW, 2007, EMERG MED CLIN N AM, V25, P837, DOI 10.1016/j.emc.2007.06.005; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; CAMPBELL AR, 1995, J TRAUMA, V39, P246, DOI 10.1097/00005373-199508000-00010; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Curtis K, 2014, INJURY, V45, P279, DOI 10.1016/j.injury.2012.10.002; Curtis Kate, 2002, Aust Health Rev, V25, P73; Curtis K, 2011, HEALTH INF MANAG J, V40, P7, DOI 10.1177/183335831104000102; Curtis KA, 2012, MED J AUSTRALIA, V197, P233, DOI 10.5694/mja11.11351; Eager K, 2001, HLTH COVER, V10, P52; Forum on Global Violence Prevention Institute of Medicine, 2012, SOC EC COSTS VIOL WO; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Grotz M, 2004, UNFALLCHIRURG, V107, P68, DOI 10.1007/s00113-003-0715-5; Hayen Andrew, 2006, N S W Public Health Bull, V17, P8; Health Education and Training Institute, 2012, CLIN COD WORKF ENH P; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Ivers R, 2006, INJURY PREV, V12, P351, DOI 10.1136/ip.2006.013813; JACOBS BB, 1992, J TRAUMA, V33, P495, DOI 10.1097/00005373-199210000-00002; Krug, 2002, INJURY LEADING CAUSE; Lyons RA, 2010, INT J INJ CONTROL SA, V17, P145, DOI 10.1080/17457300903453104; Moczygemba J, 2012, PERSPEC HLTH INF WIN, P9; NSW Health, 2009, SEL SPEC STAT SERV P; NSW Health Department, 2006, 2006 2007 NSW PROGR; NSW Health Department, 2008, EP FUND POL 2008 200, P1; NSW Health Department, 2010, NSW HLTH EP FUND POL; NSW Institute of Trauma and Injury Management, 2012, NSW TRAUM REG PROF S; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Pape HC, 2009, EUR J TRAUMA EMERG S, V35, P61, DOI 10.1007/s00068-008-8013-0; PowerHealth Solutions, POW MAN AD 2006; Rotondo MF, 2009, J TRAUMA, V67, P915, DOI 10.1097/TA.0b013e3181b848e7; Rowell D, 2011, J TRAUMA, V70, P1086, DOI 10.1097/TA.0b013e3181ed4d29; Santos S, 2008, HEALTH INF MANAG J, V37, P25, DOI 10.1177/183335830803700103; SPSS, 2012, SPSS STAT PROGR SOC; Taheri PA, 1999, J AM COLL SURGEONS, V188, P349, DOI 10.1016/S1072-7515(99)00021-6; Watson W., 1997, COST INJURY VICTORIA; Willenberg L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-267; World Health Organization, 2009, GLOB STAT REP ROAD S	43	19	19	0	3	CSIRO PUBLISHING	COLLINGWOOD	150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA	0156-5788	1449-8944		AUST HEALTH REV	Aust. Health Rev.		2014	38	1					30	37		10.1071/AH13061			8	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	AI0PH	WOS:000336549200006	24240704	Bronze			2022-02-06	
J	Fahlenkamp, AV; Coburn, M; de Prada, A; Gereitzig, N; Beyer, C; Haase, H; Rossaint, R; Gempt, J; Ryang, YM				Fahlenkamp, Astrid V.; Coburn, Mark; de Prada, Antonio; Gereitzig, Nadine; Beyer, Cordian; Haase, Hajo; Rossaint, Rolf; Gempt, Jens; Ryang, Yu-Mi			Expression analysis following argon treatment in an in vivo model of transient middle cerebral artery occlusion in rats	MEDICAL GAS RESEARCH			English	Article						Argon; Noble gas; MCAO; Ischemia; Neuroprotection		Background: Argon treatment following experimental neurotrauma has been found neuroprotective in an array of in vivo and in vitro models. The inherent cellular and molecular mechanisms are still unknown. We seeked to shed light on these processes by examinig the cellular distribution and the expression of inflammatory markers and growth factors in argon treated brain tissue. Methods: Male adult Sprague-Dawley rats were randomly assigned to one of the study groups: sham surgery + placebo, sham surgery + argon, tMCAO + placebo, and tMCAO + argon. Animals underwent 2 h-transient middle cerebral artery occlusion (tMCAO) using the endoluminal thread model or sham surgery without tMCAO. After the first hour of tMCAO or sham surgery a 1 h inhalative argon (50% argon/ 50% O-2) or placebo (50% N-2/50% O-2) treatment was performed. Brains were removed and evaluated after 24 h. RealTime-PCR was performed from biopsies of the penumbra and contralateral corresponding regions. Paraffin sections were immunostained with antibodies against GFAP, NeuN, and Iba1. Cell counts of astrocytes, neurons and microglia in different cortical regions were performed in a double-blinded manner. Results: Fifteen animals per tMCAO group and twelve sham + placebo respectively eleven sham + argon animals completed the interventional procedure. We identified several genes (IL-1 beta, IL-6, iNOS, TGF-beta, and NGF) whose transcription was elevated 24 h after the study intervention, and whose expression levels significantly differed between argon treatment and placebo following tMCAO. Except for the core region of ischemia, cell numbers were comparable between different treatment groups. Conclusion: In our study, we found an elevated expression of several inflammatory markers and growth factors following tMCAO + argon compared to tMCAO + placebo. Although conflicting the previously described neuroprotective effects of argon following experimental ischemia, these findings might still be associated with each other. Further studies will have to evaluate their relevance and potential relationship.	[Fahlenkamp, Astrid V.; Coburn, Mark; de Prada, Antonio; Gereitzig, Nadine; Rossaint, Rolf] Univ Hosp RWTH, Dept Anesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany; [Gempt, Jens; Ryang, Yu-Mi] Tech Univ Munich, Klin Rechts Isar, Dept Neurosurg, Munich, Germany; [Beyer, Cordian] Rhein Westfal TH Aachen, Inst Neuroanat, Fac Med, Aachen, Germany; [Haase, Hajo] Univ Hosp RWTH, Inst Immunol, Aachen, Germany		Coburn, M (corresponding author), Univ Hosp RWTH, Dept Anesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	mcoburn@ukaachen.de	Ryang, Yu-Mi/Q-8373-2016; Haase, Hajo/B-9280-2009	Ryang, Yu-Mi/0000-0002-9045-5038; Haase, Hajo/0000-0002-1622-8718; Gempt, Jens/0000-0003-4123-4690; Coburn, Mark/0000-0002-7930-0270	Rotationsprogramm; START programm; Medical Faculty, RWTH Aachen	This research was conducted with funding by the Rotationsprogramm (YMR, AVF) and the START programm (AVF), both Medical Faculty, RWTH Aachen.	Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Bandera E, 2006, STROKE, V37, P1334, DOI 10.1161/01.STR.0000217418.29609.22; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Behnke AR, 1939, AM J PHYSIOL, V126, P409, DOI 10.1152/ajplegacy.1939.126.2.409; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; David HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030934; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; Dhandapani KM, 2003, CELL BIOCHEM BIOPHYS, V39, P13, DOI 10.1385/CBB:39:1:13; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kidd GA, 2005, STROKE, V36, P2705, DOI 10.1161/01.STR.0000190000.98707.6d; Koizumi, 1986, JPN J STROKE, V8, P8, DOI [10.3995/jstroke.8.1, DOI 10.3995/jstroke.8.1]; Kramer M, 2010, J NEUROSCI METH, V187, P84, DOI 10.1016/j.jneumeth.2009.12.020; Limatola V, 2010, NEUROSCIENCE, V165, P874, DOI 10.1016/j.neuroscience.2009.10.063; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Pruss H, 2008, J CEREBR BLOOD F MET, V28, P526, DOI 10.1038/sj.jcbfm.9600550; Rizvi M, 2010, EXP BIOL MED, V235, P886, DOI 10.1258/ebm.2010.009366; Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Sheng SP, 2012, ANESTHESIOLOGY, V117, P1262, DOI 10.1097/ALN.0b013e3182746b81; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393; TILG H, 1994, BLOOD, V83, P113; WANG XK, 1995, J CEREBR BLOOD F MET, V15, P166, DOI 10.1038/jcbfm.1995.18; WANG XK, 1994, MOL CHEM NEUROPATHOL, V23, P103, DOI 10.1007/BF02815404; Yang JP, 2011, NEUROL SCI, V32, P433, DOI 10.1007/s10072-011-0512-9; Yang JP, 2012, NEUROCHEM INT, V60, P592, DOI 10.1016/j.neuint.2012.02.020; Zhao H, 2013, AM J TRANSPLANT, V13, P2006, DOI 10.1111/ajt.12293; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	34	19	19	2	6	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	2045-9912			MED GAS RES	Med. Gas Res.		2014	4								11	10.1186/2045-9912-4-11			11	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	V32ZG	WOS:000215735100011	25671080	Green Published, hybrid			2022-02-06	
J	Frey, L; Lepkin, A; Schickedanz, A; Huber, K; Brown, MS; Serkova, N				Frey, Lauren; Lepkin, Aaron; Schickedanz, Alyssa; Huber, Kendra; Brown, Mark S.; Serkova, Natalie			ADC mapping and T-1-weighted signal changes on post-injury MRI predict seizure susceptibility after experimental traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Epileptogenesis; Fluid percussion injury; Kainate; MRI; Post-traumatic epilepsy	FLUID PERCUSSION INJURY; HEAD-INJURY; POSTTRAUMATIC EPILEPSY; CEREBRAL EDEMA; RATS; HYPEREXCITABILITY; EPILEPTOGENESIS; MODEL	Objective: Post-traumatic epilepsy (PTE) is a serious complication of traumatic brain injury (TBI). This study is designed to determine the feasibility of using multiparametric MRI endpoints to predict differences in seizure susceptibility after experimental TBI. Methods: MRI imaging and behavioral measurements were performed at multiple time points after lateral fluid percussion injury (FPI) in rats. Seizure susceptibility was determined by video-electroencephalogram (EEG) monitoring and off-line signal analysis after chemoconvulsant challenge. Results: Multiple MRI endpoints, including measures of injury-related brain swelling (normalized interhemispheric volume difference, NIVD) and T1-weighted signal change with contrast enhancement (a measure of blood-brain barrier disruption, BBBD), reliably distinguished between injured and sham-injured animals at 72 hours after injury. ADC (apparent diffusion coefficient) values (a measure of water diffusivity) in injured cortex at 72 hours and 1 week after injury, BBBD in injured cortex at 72 hours after injury and NIVD at 72 hours after injury were significantly correlated with EEG-based measures of seizure susceptibility to chemoconvulsant challenge at 3 months after injury. Conclusions: The correlations between our MRI quantitative endpoints and EEG-based measures of seizure susceptibility to chemoconvulsant challenge in injured animals versus sham-injured animals support the feasibility of these MRI endpoints as potential biomarkers for post-traumatic epileptogenesis.	[Frey, Lauren; Lepkin, Aaron; Schickedanz, Alyssa] Univ Colorado, Dept Neurol, Aurora, CO USA; [Frey, Lauren] Colorado State Univ, Colorado Injury Control & Res Ctr, Ft Collins, CO 80523 USA; [Huber, Kendra; Serkova, Natalie] Univ Colorado, Dept Anesthesiol, Aurora, CO USA; [Huber, Kendra; Brown, Mark S.; Serkova, Natalie] Univ Colorado, Dept Radiol, Aurora, CO USA		Frey, L (corresponding author), Univ Colorado, Aurora, CO 80045 USA.	Lauren.Frey@ucdenver.edu			Colorado Injury Control and Research Center; CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NCI P30 Cancer Center Grant [CA046934]; CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL 1RR025780]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025780] Funding Source: NIH RePORTER	The authors wish to thank the Colorado Injury Control and Research Center for funding support for this project. The authors also wish to thank Archana Shrestha, MD, and Amy Brooks-Kayal, MD, for their invaluable editing assistance. Funding for this project was provided by the CDC and the Colorado Injury Control and Research Center. The Animal Imaging Core is supported through the Animal Imaging Shared Resources Core by the NCI P30 Cancer Center Grant (CA046934) and CTSA award (UL 1RR025780).	Altman D.G., 1990, PRACTICAL STAT MED R; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Farias S, 2009, J NEUROTRAUM, V26, P1977, DOI 10.1089/neu.2009.0877; Faul M, 2010, TRAUMATIC BRAIN INJU; Feldmann H, 1979, Acta Neurochir Suppl (Wien), V28, P74; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Janigro D, 2010, EPILEPSY CURR, V10, P67, DOI 10.1111/j.1535-7511.2010.01359.x; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Lenzlinger PM, 2004, RESTOR NEUROL NEUROS, V22, P73; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; Liang LP, 2000, NEUROSCIENCE, V101, P563, DOI 10.1016/S0306-4522(00)00397-3; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; NAKASU Y, 1995, AM J NEURORADIOL, V16, P1185; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tokumitsu T, 1997, BRAIN RES, V744, P57, DOI 10.1016/S0006-8993(96)01071-2; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006	33	19	20	0	5	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2014	36	1					26	37		10.1179/1743132813Y.0000000269			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI7VH	WOS:000337108300003	24107461	Green Accepted			2022-02-06	
J	Linton, KF; Kim, BJ				Linton, Kristen F.; Kim, Bum Jung			Traumatic brain injury as a result of violence in native American and black communities spanning from childhood to older adulthood	BRAIN INJURY			English	Article						Adult; black; children; Native American; traumatic brain injury; violent	FUNCTIONAL OUTCOMES; CHILDREN	Primary objective: The purpose of this study was to compare the aetiology of TBI between different race, gender and age groups to understand demographic characteristics of people who experience TBI. Research design: A secondary data analysis of the Arizona Trauma Database consisting of 18 868 cases of TBI between 2008-2010 was conducted. Methods and procedures: The sample consisted of patients who ranged in age from 0-79 and were White, Black, Native American, Asian or other race. Cross-tabulations, chi-squares and a logistic regression were conducted. Main outcomes and results: Standardized residuals indicated that Native Americans and Blacks were more likely to experience violent TBI, regardless of gender or age group (p < 0.01). The logistic regression indicated that Native Americans (OR = 3.13), Blacks (OR = 1.95) and other race (OR = 1.56) patients had statistically significantly (p < 0.001) higher odds of experiencing violent TBI compared to Whites. In addition, females (OR = 0.40), children (OR = 0.75) and older adults (OR = 0.17) had statistically significantly (p < 0.001) lower odds of violent TBI. Conclusions: Providers of Native American and Black patients who have experienced violence should encourage them to receive assessments and treatment for TBI.	[Linton, Kristen F.; Kim, Bum Jung] Univ Hawaii Manoa, Myron B Thompson Sch Social Work, Honolulu, HI 96822 USA		Linton, KF (corresponding author), Univ Hawaii Manoa, Myron B Thompson Sch Social Work, 1800 East West Rd, Honolulu, HI 96822 USA.	kfbean@hawaii.edu					Advertising Education Foundation [internet], 2003, SEAT BELT ED 1985 PR; Allen CT, 2010, THESIS U S CAROLINA; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; BERGER LR, 1989, PEDIATRICS, V84, P152; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention, 2010, TRAUMATIC BRAIN INJU; Davis JS, 2013, J SURG RES, pe1; Friedman LS, 2011, J AM GERIATR SOC, V59, P417, DOI 10.1111/j.1532-5415.2010.03313.x; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Kim H, 2013, CAN J OCCUP THER, V80, P49, DOI 10.1177/0008417412473262; Malcoe LH, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-20; Nelson LA, 2007, J HEAD TRAUMA REHAB, V22, P105, DOI 10.1097/01.HTR.0000265098.52306.a9; Perciaccante VJ, 1999, J ORAL MAXIL SURG, V57, P760, DOI 10.1016/S0278-2391(99)90808-X; Schootman M, 2000, J TRAUMA, V48, P70, DOI 10.1097/00005373-200001000-00012; Spivak H., 2013, 141 APHA ANN M NOV 2; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; US Census Bureau, 2013, STAT COUNT QUICK FAC	21	19	19	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1076	1081		10.3109/02699052.2014.901558			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200008	24702677				2022-02-06	
J	Moen, KG; Haberg, AK; Skandsen, T; Finnanger, TG; Vik, A				Moen, Kent Goran; Haberg, Asta Kristine; Skandsen, Toril; Finnanger, Torun Gangaune; Vik, Anne			A Longitudinal Magnetic Resonance Imaging Study of the Apparent Diffusion Coefficient Values in Corpus Callosum during the First Year after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						craniocerebral trauma; GOS; MRI; prospective studies; neuropsychological tests	WHITE-MATTER INTEGRITY; AXONAL INJURY; HEAD-INJURY; TENSOR; MODERATE; MRI	The objective of this study was to explore the evolution of apparent diffusion coefficient (ADC) values in magnetic resonance imaging (MRI) in normal-appearing tissue of the corpus callosum during the 1st year after traumatic brain injury (TBI), and relate findings to outcome. Fifty-seven patients (mean age 34 [range 11-63] years) with moderate to severe TBI were examined with diffusion weighted MRI at three time points (median 7 days, 3 and 12 months), and a sex- and age-matched control group of 47 healthy individuals, were examined once. The corpus callosum was subdivided and the mean ADC values computed blinded in 10 regions of interests without any visible lesions in the ADC map. Outcome measures were Glasgow Outcome Scale Extended (GOSE) and neuropsychological domain scores at 12 months. We found a gradual increase of the mean ADC values during the 12 month follow-up, most evident in the posterior truncus (r=0.19, p<0.001). Compared with the healthy control group, we found higher mean ADC values in posterior truncus both at 3 months (p=0.021) and 12 months (p=0.003) post-injury. Patients with fluid-attenuated inversion recovery (FLAIR) lesions in the corpus callosum in the early MRI, and patients with disability (GOSE score 6) showed evidence of increased mean ADC values in the genu and posterior truncus at 12 months. Mean ADC values in posterior parts of the corpus callosum at 3 months predicted the sensory-motor function domain score (p=0.010-0.028). During the 1st year after moderate and severe TBI, we demonstrated a slowly evolving disruption of the microstructure in normal appearing corpus callosum in the ADC map, most evident in the posterior truncus. The mean ADC values were associated with both outcome and ability to perform speeded, complex sensory-motor action.	[Moen, Kent Goran; Haberg, Asta Kristine; Skandsen, Toril; Vik, Anne] Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway; [Finnanger, Torun Gangaune] Norwegian Univ Sci & Technol, Reg Ctr Child & Adolescence Mental Hlth, Fac Med, N-7491 Trondheim, Norway; [Moen, Kent Goran; Vik, Anne] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Haberg, Asta Kristine] St Olavs Univ Hosp, Dept Med Imaging, Trondheim, Norway; [Skandsen, Toril] St Olavs Univ Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Finnanger, Torun Gangaune] St Olavs Univ Hosp, Dept Child & Adolescent Psychiat, Dept Div Mental Hlth, Trondheim, Norway		Moen, KG (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway.	kent.g.moen@ntnu.no	Skandsen, Toril/P-6767-2014	Skandsen, Toril/0000-0001-5495-9338	Liaison Committee; Norwegian ExtraFoundation for Health and Rehabilitation [2010/2/0105]	We thank Stine Borgen Lund and Beate Holmqvist Karlsen for participating in the management of the database and the GOSE interviews. Drs. Moen, Skandsen, and Finnanger received a research grant from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) during the study period. This work was also supported by the Norwegian ExtraFoundation for Health and Rehabilitation (Dr. Finnanger, grant number 2010/2/0105).	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Aboitiz F, 1992, Biol Res, V25, P51; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Brandstack N, 2011, CLIN NEURORADIOL, V21, P75, DOI 10.1007/s00062-011-0058-5; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Delis DC., 2001, DELIS KAPLAN EXECUTI; Gasparetto EL, 2011, NEUROIMAG CLIN N AM, V21, P115, DOI 10.1016/j.nic.2011.02.003; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kurth F, 2013, HUM BRAIN MAPP, V34, P2259, DOI 10.1002/hbm.22060; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Matthews CG., 1964, INSTRUCTION MANUAL A; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith A., 2002, SYMBOL DIGIT MODALIT; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354	37	19	19	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2014	31	1					56	63		10.1089/neu.2013.3000			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	302WJ	WOS:000330635500006	23837731	Green Published			2022-02-06	
J	Mullen, SJ; Yucel, YH; Cusimano, M; Schweizer, TA; Oentoro, A; Gupta, N				Mullen, Sarah J.; Yuecel, Yeni H.; Cusimano, Michael; Schweizer, Tom A.; Oentoro, Anton; Gupta, Neeru			Saccadic Eye Movements in Mild Traumatic Brain Injury: A Pilot Study	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							HEAD-INJURY; CONCUSSION; RECOVERY; LATENCY; DEPRESSION; EPIDEMIOLOGY; SACCADOMETRY; PERFORMANCE; DYSFUNCTION; GUIDELINES	Objective: To investigate whether repeat saccadic reaction time (SRT) measurements using a portable saccadometer is useful to monitor patients with mild traumatic brain injury (mTBI). Methods: Seven patients with newly-diagnosed mTBI and five age-matched controls were prospectively recruited from an Emergency Department. Saccadic eye movements, symptom self-reporting and neuropsychological tests were performed within one week of injury and again at follow-up three weeks post-injury. Control patients underwent saccade recordings at similar intervals. Results: Median saccade reaction times were significantly prolonged within one week post-injury in mTBI compared to controls. At follow-up assessment there was no significant between-groups difference. Changes in median SRT between the two assessments were not statistically significant. Four of the seven mTBI patients showed significantly increased SRT at follow-up; three of the mTBI patients and all controls showed no significant change. Among the three mTBI patients with persistent decreased SRT, two experienced loss of consciousness and reported the greatest symptoms, while the third was the only subject with significant decrease in neuropsychological testing scores at both assessments. Conclusion: In three of seven mTBI patients, saccadic eye movements remained delayed within three weeks post-injury. These three patients also showed persistent symptoms or no improvement on neuropsychological testing. This pilot study using a portable saccadometer suggests that comparing SRT from three weeks post-injury to that within one week of injury may be useful for early detection of a subpopulation at risk of persistent disability from mTBI. This finding suggests that further investigation in a large study population is warranted.	[Mullen, Sarah J.; Yuecel, Yeni H.; Cusimano, Michael; Schweizer, Tom A.; Oentoro, Anton; Gupta, Neeru] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Mullen, Sarah J.; Yuecel, Yeni H.; Cusimano, Michael; Schweizer, Tom A.; Gupta, Neeru] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Neurosurg, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Gupta, Neeru] St Michaels Hosp, Glaucoma & Nerve Protect Unit, Toronto, ON M5B 1W8, Canada		Yucel, YH (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St,209 LKSKI,Room 409, Toronto, ON M5B 1W8, Canada.	yucely@smh.ca	yucel, yeni/AAX-9628-2020; Cusimano, Michael/X-4059-2019	Gupta, Neeru/0000-0001-8141-7710; Cusimano, Michael/0000-0002-9989-0650	Ontario Neurotrauma Foundation; Glaucoma Research Society of Canada; Dorothy Pitts Research Fund; Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]	This study was supported by the Ontario Neurotrauma Foundation, Glaucoma Research Society of Canada (NG, YY), Dorothy Pitts Research Fund (NG) and Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research # TIR-103946. The authors thank Barbara Thomson MSc for her help with statistical analysis. The authors report no conflicts of interest in this work.	Alessandrini M, 2001, An Otorrinolaringol Ibero Am, V28, P269; Antoniades CA, 2007, NEUROREPORT, V18, P1133, DOI 10.1097/WNR.0b013e32821c560d; Bay E, 2007, ARCH PSYCHIAT NURS, V21, P2, DOI 10.1016/j.apnu.2006.07.005; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; BRIGELL MG, 1988, INVEST OPHTH VIS SCI, V29, P1331; Burrell JR, 2012, NEUROLOGY, V78, P1816, DOI 10.1212/WNL.0b013e318258f75c; Carpenter RHS, 2004, ADV CLIN NEUROSCI RE, V4, P6, DOI DOI 10.1016/J.CUB.2004.08.058; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Falconer EK, 2006, BRAIN INJURY, V20, P1251, DOI 10.1080/02699050601049601; FISCHER B, 1993, EXP BRAIN RES, V92, P528; Fischer B, 1997, BRAIN RES, V754, P285, DOI 10.1016/S0006-8993(97)00094-2; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2005, BRAIN INJURY, V19, P109, DOI 10.1080/02699050410001720095; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Irving EL, 2006, INVEST OPHTH VIS SCI, V47, P2478, DOI 10.1167/iovs.05-1311; Kanjee R, 2012, EYE BRAIN, V4, P63, DOI 10.2147/EB.S38467; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Leigh JR, 1999, NEUROLOGY EYE MOVEME, P101; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Lovell MR, 2011, APPL NEUROPSYCHOL, V18, P197, DOI 10.1080/09084282.2011.595446; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Metrics Becker W., 1989, NEUROBIOLOGY SACCADI, P13; Michell AW, 2006, EXP BRAIN RES, V174, P7, DOI 10.1007/s00221-006-0412-z; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Ober JK, 2003, MODELLING MEASUREMEN, P187; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Preece MHW, 2007, BRAIN INJURY, V21, P951, DOI 10.1080/02699050701481647; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; REULEN JPH, 1984, BIOL CYBERN, V50, P263, DOI 10.1007/BF00337076; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shafiq-Antonacci R, 1999, J GERONTOL B-PSYCHOL, V54, pP361, DOI 10.1093/geronb/54B.6.P361; Sherman EMS, 2006, COMPENDIUM NEUROPSYC, P767; Sparks D, 2000, VISION RES, V40, P2763, DOI 10.1016/S0042-6989(00)00133-4; SWEENEY JA, 1991, J PSYCHIATR NEUROSCI, V16, P247; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2; Winograd-Gurvich C, 2006, NEUROSCI RES, V56, P253, DOI 10.1016/j.neures.2006.07.003	60	19	19	0	16	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JAN	2014	41	1					58	65		10.1017/S0317167100016279			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AY4WK	WOS:000347575700012	24384339	Bronze			2022-02-06	
J	Ruozi, B; Belletti, D; Forni, F; Sharma, A; Muresanu, D; Mossler, H; Vandelli, MA; Tosi, G; Sharma, HS				Ruozi, Barbara; Belletti, Daniela; Forni, Flavio; Sharma, Aruna; Muresanu, Dafin; Moessler, Herbert; Vandelli, Maria A.; Tosi, Giovanni; Sharma, Hari S.			Poly (D, L-Lactide-co-Glycolide) Nanoparticles Loaded with Cerebrolysin Display Neuroprotective Activity in a Rat Model of Concussive Head Injury	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Blood-brain barrier; brain edema; cerebrolysin; closed head injury; Poly (D,L-lactide-co-glycolide) nanoparticles	BLOOD-BRAIN-BARRIER; WHOLE-BODY HYPERTHERMIA; NEUROTROPHIC FACTORS; SOLVENT EVAPORATION; PLGA NANOPARTICLES; MORBIDITY FACTORS; EDEMA FORMATION; DRUG-DELIVERY; PATHOLOGY; DISRUPTION	Cerebrolysin (CBL) is a neuroprotective agent in central nervous system (CNS) injury and stimulates neurorepair processes. Several studies in our laboratory suggest that CBL administered through nanowired technology may have superior neuroprotective efficacy in CNS trauma. In this investigation, we compared the neuroprotective efficacy of poly-lactide-co-glycolide nanoparticles (NPs) loaded with CBL vs free CBL in a rat model of concussive head injury (CHI). Free CBL or CBL loaded NPs was administered 30 min to 1 h after CHI and animals were sacrificed 5 h later. Changes in blood-brain barrier and brain edema formation were measured as parameters of neuroprotection in CHI after giving CBL alone or as the nanodelivered compound. Our results clearly show that delivery of CBL by NPs has superior neuroprotective effects following CHI as compared to normal CBL. This suggests that CBL delivered by NPs could have robust neuroprotective action in CNS trauma. These findings have potential clinical relevance with regard to nanodelivery of CBL, a feature that requires further investigation.	[Ruozi, Barbara; Belletti, Daniela; Forni, Flavio; Vandelli, Maria A.; Tosi, Giovanni] Univ Modena & Reggio Emilia, Dept Life Sci, Lab Pharmaceut Technol, I-41100 Modena, Italy; [Sharma, Aruna; Sharma, Hari S.] Uppsala Univ, Univ Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, Lab Cerebrovasc Res, SE-75421 Uppsala, Sweden; [Muresanu, Dafin] Univ Hosp, Univ Med Pharm, Dept Clin Neurosci, Cluj Napoca, Romania; [Moessler, Herbert] Ever Neuro Pharma, Oberburgau, Austria		Sharma, HS (corresponding author), Uppsala Univ, Univ Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, Lab Cerebrovasc Res, SE-75421 Uppsala, Sweden.	Sharma@surgsci.uu.se	Tosi, Giovanni/D-4547-2011; Forni, Flavio/D-5492-2015; Ruozi, Barbara/D-5500-2015; Muresanu, Fior-Dafin/AAI-8120-2021; Vandelli, Maria Angela/D-5497-2015; Belletti, Daniela/L-5288-2016	Tosi, Giovanni/0000-0001-8318-667X; Forni, Flavio/0000-0001-5974-6286; Ruozi, Barbara/0000-0002-2400-9910; Vandelli, Maria Angela/0000-0003-1462-8133; Belletti, Daniela/0000-0003-2872-445X	Air Force Office of Scientific Research (EOARD, London, UK)United States Department of DefenseAir Force Office of Scientific Research (AFOSR); Air Force Material Command, USAF [FA8655-05-1-3065]	The work reported here was partially supported by grants from the Air Force Office of Scientific Research (EOARD, London, UK), and Air Force Material Command, USAF, under grant number FA8655-05-1-3065 for studies on biological effects of nanoparticles in the CNS. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the U. S. Government. The authors declare no conflict of interest with any agency or organization mentioned above.	[Anonymous], 2013, LANCET, V382, P1536; BODMEIER R, 1987, PHARMACEUT RES, V4, P465, DOI 10.1023/A:1016419303727; Bondioli L, 2010, BIOMATERIALS, V31, P3395, DOI 10.1016/j.biomaterials.2010.01.049; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Costantino L, 2006, BIOMATERIALS, V27, P4635, DOI 10.1016/j.biomaterials.2006.04.026; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; DEY P K, 1984, Indian Journal of Physiology and Pharmacology, V28, P177; Feczko T, 2011, CHEM ENG PROCESS, V50, P757, DOI 10.1016/j.cep.2011.06.008; Ghaderi R, 1996, INT J PHARM, V141, P205, DOI 10.1016/0378-5173(96)04639-X; Gromova OA, 2003, ZH NEVROPATOL PSIKH, V103, P59; Guekht AB, 2011, J STROKE CEREBROVASC, V20, P310, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.012; Hartbauer M, 2001, J NEURAL TRANSM, V108, P459, DOI 10.1007/s007020170067; JOSHI DP, 1979, ANAL CHIM ACTA, V104, P153, DOI 10.1016/S0003-2670(01)83825-3; Liu WM, 2001, SPECTROSC SPECT ANAL, V21, P397; Nguyen T, 2003, ORG LETT, V5, P3245, DOI 10.1021/ol035135z; Park JH, 2005, MOLECULES, V10, P146, DOI 10.3390/10010146; Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Ruozi B, 2012, INT REV NEUROBIOL, V102, P207, DOI 10.1016/B978-0-12-386986-9.00009-0; Ruozi B, 2011, INT J NANOMED, V6, P557, DOI 10.2147/IJN.S14615; Sharma A, 2012, CNS NEUROL DISORD-DR, V11, P7, DOI 10.2174/187152712799960790; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P295, DOI 10.1196/annals.1403.022; Sharma HS, 2010, ACTA NEUROCHIR SUPPL, V106, P301, DOI 10.1007/978-3-211-98811-4_56; Sharma H. S., 2009, HDB NEUROCHEMISTRY M, P363, DOI DOI 10.1007/978-0-387-30375-8_17; Sharma HS, 2013, AMINO ACIDS, V45, P1055, DOI 10.1007/s00726-013-1584-z; Sharma HS, 2011, CURR NEUROPHARMACOL, V9, P223, DOI 10.2174/157015911795017100; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5014, DOI 10.1166/jnn.2009.GR04; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P112, DOI 10.1196/annals.1403.008; Sharma HS, 2012, INT REV NEUROBIOL, V102, P249, DOI 10.1016/B978-0-12-386986-9.00010-7; Sharma HS, 2012, WIRES NANOMED NANOBI, V4, P184, DOI 10.1002/wnan.172; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P138, DOI 10.1111/j.1749-6632.2009.05330.x; Sharma HS, 2010, ACTA NEUROCHIR SUPPL, V106, P321, DOI 10.1007/978-3-211-98811-4_60; Sharma HS., 2009, ACTA U UPSAL, V830, P1; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Vannemreddy P, 2006, ACTA NEUROCHIR SUPPL, V96, P151	36	19	19	1	8	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2014	13	8					1475	1482		10.2174/1871527313666140806145540			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	AU6BE	WOS:000345686300019	25106629				2022-02-06	
J	Russell, KL; Berman, NEJ; Gregg, PRA; Levant, B				Russell, K. L.; Berman, N. E. J.; Gregg, P. R. A.; Levant, B.			Fish oil improves motor function, limits blood-brain barrier disruption, and reduces Mmp9 gene expression in a rat model of juvenile traumatic brain injury	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Traumatic brain injury; Juvenile; Rat; Fish oil; Blood-brain barrier; Matrix metalloproteinase 9	POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; DIETARY SUPPLEMENTATION; CORTICAL IMPACT; KNOCK-OUT; MATRIX-METALLOPROTEINASE-9; OMEGA-3-FATTY-ACIDS; MECHANISMS; DAMAGE; HOMEOSTASIS	The effects of an oral fish oil treatment regimen on sensorimotor, blood-brain barrier, and biochemical outcomes of traumatic brain injury (TBI) were investigated in a juvenile rat model. Seventeen-day old Long-Evans rats were given a 15 mL/kg fish oil (2.01 g/kg EPA, 1.34 g/kg DHA) or soybean oil dose via oral gavage 30 min prior to being subjected to a controlled cortical impact injury or sham surgery, followed by daily doses for seven days. Fish oil treatment resulted in less severe hindlimb deficits after TBI as assessed with the beam walk test, decreased cerebral IgG infiltration, and decreased TBI-induced expression of the Mmp9 gene one day after injury. These results indicate that fish oil improved functional outcome after TBI resulting, at least in part from decreased disruption of the blood-brain barrier through a mechanism that includes attenuation of TBI-induced expression of Mmp9. (C) 2013 Elsevier Ltd. All rights reserved.	[Russell, K. L.; Gregg, P. R. A.; Levant, B.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Berman, N. E. J.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA		Levant, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol, Mail Stop 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	kristinlrussell@gmail.com; nberman@kumc.edu; pragregg@gmail.com; blevant@kumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03 HD059939, P30 HD02528, P20 RR016475, T32 ES007079, T32 HD007523]; University of Kansas Medical Center Biomedical Research Training Program; American Society for Pharmacology and Experimental Therapeutics (ASPET) Zannoni Summer Undergraduate Research Fellow (SURF) Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007523, R03HD059939] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103418] Funding Source: NIH RePORTER	Supported by the NIH R03 HD059939 (BL), P30 HD02528 (BL, NEJB), P20 RR016475 (BL), T32 ES007079 (KLR), T32 HD007523 (KLR), the University of Kansas Medical Center Biomedical Research Training Program (KLR), and the American Society for Pharmacology and Experimental Therapeutics (ASPET) Zannoni Summer Undergraduate Research Fellow (SURF) Program (PRAG).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; AIHARA N, 1994, J COMP NEUROL, V342, P481, DOI 10.1002/cne.903420402; Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; CLANDININ MT, 1980, EARLY HUM DEV, V4, P131, DOI 10.1016/0378-3782(80)90016-X; CLANDININ MT, 1980, EARLY HUM DEV, V4, P121, DOI 10.1016/0378-3782(80)90015-8; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Conroy S, 2000, BRIT J CLIN PHARMACO, V49, P93, DOI 10.1046/j.1365-2125.2000.00125.x; Draper E, 2011, J NUTR BIOCHEM, V22, P784, DOI 10.1016/j.jnutbio.2010.06.009; Eady TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046151; Edmond J, 2001, J MOL NEUROSCI, V16, P181, DOI 10.1385/JMN:16:2-3:181; Faul M, 2010, TRAUMATIC BRAIN INJU; Florent S, 2006, J NEUROCHEM, V96, P385, DOI 10.1111/j.1471-4159.2005.03541.x; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Green P, 1996, LIPIDS, V31, P859, DOI 10.1007/BF02522981; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Harkness KA, 2000, BRAIN, V123, P698, DOI 10.1093/brain/123.4.698; Harris JL, 2009, J NEUROTRAUM, V26, P1669, DOI [10.1089/neu.2009.0875, 10.1089/neu.2009-0875]; Hogyes E, 2003, NEUROSCIENCE, V119, P999, DOI 10.1016/S0306-4522(03)00198-2; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Hossain S, 1998, NEUROSCI LETT, V244, P157, DOI 10.1016/S0304-3940(98)00147-5; Javierre C, 2006, J PHYSIOL BIOCHEM, V62, P271, DOI 10.1007/BF03165756; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Khan SA, 2003, J NUTR BIOCHEM, V14, P554, DOI 10.1016/S0955-2863(03)00098-6; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Levant B, 2006, LIPIDS, V41, P407, DOI 10.1007/s11745-006-5114-6; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann C, 2004, BRAIN RES, V995, P184, DOI 10.1016/j.brainres.2003.10.002; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Novak TE, 2003, AM J PHYSIOL-LUNG C, V284, pL84, DOI 10.1152/ajplung.00077.2002; Ogawa K, 2004, BIOCHEM J, V381, P413, DOI 10.1042/BJ20040058; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Rasband W.S, 1997, IMAGEJ US; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Schumacher M.A., 2012, BASIC CLIN PHARM, P543; SEITZ RJ, 1985, ACTA NEUROPATHOL, V68, P15, DOI 10.1007/BF00688950; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shaikh SR, 2012, J NUTR BIOCHEM, V23, P101, DOI 10.1016/j.jnutbio.2011.07.001; SHERWOOD NM, 1970, STEREOTAXIC ATLAS DE; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; Shinto L, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/134592; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Sinha RA, 2009, INT J DEV NEUROSCI, V27, P377, DOI 10.1016/j.ijdevneu.2009.02.003; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WESTERGA J, 1990, DEV BRAIN RES, V57, P163, DOI 10.1016/0165-3806(90)90042-W; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu JCC, 2013, J SURG RES, V179, P138, DOI 10.1016/j.jss.2012.09.013; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zuniga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028502	71	19	19	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	JAN	2014	90	1					5	11		10.1016/j.plefa.2013.11.003			7	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	AA9LI	WOS:000331414600002	24342130	Green Accepted			2022-02-06	
J	Tramontana, MG; Cowan, RL; Zald, D; Prokop, JW; Guillamondegui, O				Tramontana, Michael G.; Cowan, Ronald L.; Zald, David; Prokop, Jonathan W.; Guillamondegui, Oscar			Traumatic brain injury-related attention deficits: Treatment outcomes with lisdexamfetamine dimesylate (Vyvanse)	BRAIN INJURY			English	Article						Attention-deficit/hyperactivity disorder; head injury; neuropsychological effects; stimulant medication treatment	DEFICIT/HYPERACTIVITY DISORDER; DOUBLE-BLIND; EFFICACY; CHILDREN; METHYLPHENIDATE; PLACEBO; ADOLESCENTS; SAFETY; PREDICTORS; ADULTS	Background and objectives: Attention deficits are often among the most persistent and debilitating impairments resulting from traumatic brain injury (TBI). This study examined the effects of lisdexamfetamine dimesylate (Vyvanse) in treating attention deficits due to moderate-to-severe TBI. It was the first study of lisdexamfetamine dimesylate with this population and, in fact, was the first controlled trial in this area examining a stimulant medication option other than methylphenidate. Methods: This was a 12-week, randomized, double-blind, placebo-controlled, cross-over trial. A total of 22 rigorously selected cases were enrolled, 13 of whom completed the trial. They were 16-42 years of age and had newly acquired attention deficits persisting for 6-34 months post-injury. They were assessed on a broad range of neuropsychological and behavioural measures at baseline, 6-weeks and at 12-weeks. Results and conclusions: Positive treatment effects were found involving selective measures of sustained attention, working memory, response speed stability and endurance and in aspects of executive functioning. No major problems with safety or tolerability were observed. Some moderating treatment effects were found from a broad range of pre-treatment subject characteristics and injury variables examined. Avenues for further research and treatment applications in this area are discussed.	[Tramontana, Michael G.; Cowan, Ronald L.; Zald, David; Prokop, Jonathan W.] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN USA; [Zald, David] Vanderbilt Univ, Med Ctr, Dept Psychol, Nashville, TN USA; [Guillamondegui, Oscar] Vanderbilt Univ, Med Ctr, Dept Surg Trauma, Nashville, TN USA		Tramontana, MG (corresponding author), Village Vanderbilt, Suite 2200,1500 21st Ave South, Nashville, TN 37212 USA.	michael.tramontana@vanderbilt.edu			Shire Pharmaceuticals [IST-ALB-000236]	This study was based on an Investigator Sponsored Trial funded by Shire Pharmaceuticals (IST-ALB-000236), Michael G. Tramontana, PhD, Principal Investigator.	Adler LA, 2008, J CLIN PSYCHIAT, V69, P1364, DOI 10.4088/JCP.v69n0903; Bales James W, 2010, Open Drug Discov J, V2, P119; Barkley Russell Alan, 2006, ATTENTION DEFICIT HY, V3rd; Bates G, 2006, DEV MED CHILD NEUROL, V48, P697, DOI 10.1017/S0012162206001472; Biederman J, 2007, CLIN THER, V29, P450, DOI 10.1016/S0149-2918(07)80083-X; Brams M, 2012, J CLIN PSYCHIAT, V73, P977, DOI 10.4088/JCP.11m07430; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Bush G, 2008, ARCH GEN PSYCHIAT, V65, P102, DOI 10.1001/archgenpsychiatry.2007.16; Bush G, 2006, NAT PROTOC, V1, P308, DOI 10.1038/nprot.2006.48; Coghill D, 2013, EUR NEUROPSYCHOPHARM, V23, P1208, DOI 10.1016/j.euroneuro.2012.11.012; Findling RL, 2011, J AM ACAD CHILD PSY, V50, P395, DOI 10.1016/j.jaac.2011.01.007; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Overtoom CCE, 2003, BEHAV BRAIN RES, V145, P7, DOI 10.1016/S0166-4328(03)00097-4; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Wigal SB, 2009, CHILD ADOLESCENT PSY, V3, P1; Wigal T, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-34; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	29	19	20	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1461	1472		10.3109/02699052.2014.930179			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200016	24988121				2022-02-06	
J	Wortzel, HS; Arciniegas, DB				Wortzel, Hal S.; Arciniegas, David B.			The DSM-5 approach to the evaluation of traumatic brain injury and its neuropsychiatric sequelae	NEUROREHABILITATION			English	Article						Traumatic brain injury; cognition disorders; DSM-5	MONTREAL COGNITIVE ASSESSMENT; MINI-MENTAL-STATE; MILD HEAD-INJURY; COMPUTED-TOMOGRAPHY; POSTCONCUSSIONAL DISORDER; INTRACRANIAL INJURY; UNIFIED DEFINITION; IV CRITERIA; MANAGEMENT; RECOVERY	INTRODUCTION: The advent of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) is accompanied by substantial changes in the approach taken in this manual to traumatic brain injury (TBI) and its neuropsychiatric sequelae. OBJECTIVE: This article reviews the issues pertaining to the treatment of TBI in the DSM-5, and changes relative to the outgoing DSM-IV-TR. The primary context for discussion of TBI in the DSM-5 is the section on Neurocognitive Disorders, where a basic framework is provided for the retrospective diagnosis of TBI and characterization of the clinical presentation as a Mild or Major Neurocognitive Disorder. The distinctions between these conditions rest not on the initial severity of TBI but instead on the severity of posttraumatic cognitive impairments and their effects on everyday function. The text succinctly reviews the epidemiology, phenomenology, and natural history of TBI and highlights the need to consider the differential diagnosis for persistent postconcussive symptoms. CONCLUSION: The approach taken to the diagnosis of TBI and its neuropsychiatric consequences in the DSM-5 is improved substantially over that of the DSM-IV-TR, and it is likely to improve the evaluations of persons with TBI by mental health professionals. However, challenges borne of this approach are likely to be revealed as it is implemented in everyday practice and will guide the development of this section of DSM-5.1.	[Wortzel, Hal S.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Wortzel, Hal S.] Univ Colorado, Sch Med, Dept Psychiat, Div Forens Psychiat, Aurora, CO USA; [Wortzel, Hal S.; Arciniegas, David B.] Univ Colorado, Sch Med, Dept Psychiat, Neuropsychiat Serv, Aurora, CO USA; [Wortzel, Hal S.; Arciniegas, David B.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA; [Arciniegas, David B.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Wortzel, HS (corresponding author), Denver Vet Hosp, VISN 19 MIRECC,1055 Clermont St, Denver, CO 80220 USA.	hal.wortzel@ucdenver.edu			Veterans Health Administration's VISN-19 MIRECC; National Institute on Disability and Rehabilitation Research (NIDRR) [H133A120020, H133A130047]	Support for this work was provided by the Veterans Health Administration's VISN-19 MIRECC (HSW) and National Institute on Disability and Rehabilitation Research (NIDRR) grants H133A120020 and H133A130047 (DBA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs or NIDRR.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arciniegas D. B., 2013, MANAGEMENT ADULTS TR; Arciniegas D. B., 2013, MANAGEMENT ADULTS TR, P25; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Arciniegas DB, 2013, BEHAV NEUROLOGY NEUR, P344; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Department of Veterans Affairs and Department of Defense, 2009, CLIN PRACT GUID MAN; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frances A, 2010, J AM ACAD PSYCHIATRY, V38, P11; Frances A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1168; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Leon-Carrion J, 2002, NEUROREHABILITATION, V17, P115; Malloy PF, 1997, J NEUROPSYCH CLIN N, V9, P189; Marr A., 2002, CTR NERVOUS SYSTEM I; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Institute of Neurological Disorders and Stroke Common Data Elements Team, 2013, TRAUM BRAIN INJ COMM; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Ruff RM, 1999, BRAIN INJURY, V13, P943; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Wortzel HS, 2013, J PSYCHIATR PRACT, V19, P238, DOI 10.1097/01.pra.0000430508.44768.9d; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1	60	19	19	0	21	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	4					613	623		10.3233/NRE-141086			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AK5CY	WOS:000338443100003	24820171				2022-02-06	
J	Xu, FF; Sun, S; Ho, ASW; Lee, D; Kiang, KMY; Zhang, XQ; Wang, AM; Wu, EX; Lui, WM; Liu, BY; Leung, GKK				Xu, Fei-Fan; Sun, Stella; Ho, Amy S. W.; Lee, Derek; Kiang, Karrie M. Y.; Zhang, Xiao-Qin; Wang, Anna M.; Wu, Ed X.; Lui, Wai-Man; Liu, Bai-Yun; Leung, Gilberto K. K.			Effects of progesterone vs. dexamethasone on brain oedema and inflammatory responses following experimental brain resection	BRAIN INJURY			English	Article						Brain oedema; dexamethasone; inflammation; matrix metalloproteinase 9; progesterone; surgical brain injury	GENE KNOCK-OUT; MATRIX METALLOPROTEINASES; INJURY; BARRIER; EXPRESSION; RECOVERY; NEUROPROTECTION; MECHANISMS; ISCHEMIA; ABLATION	Background: Dexamethasone (DEXA) is commonly used to reduce brain swelling during neurosurgical procedures. DEXA, however, has many side-effects that can increase the risks of post-operative complications. In contrast, progesterone (PRO) has fewer side-effects and has been found to be neuroprotective on traumatic brain injury (TBI). Whether PRO may be used as an alternative to DEXA during routine procedures has not been fully explored. Object: To compare the effects of DEXA and PRO on surgical brain injury (SBI). Methods: Seventy-five adult male Sprague Dawley rats were randomized into five groups: (1) SBI + drug vehicle (peanut oil, 1ml kg(-1)); (2) SBI + DEXA (1 mg kg(-1)); (3) SBI + low-dose PRO (10 mg kg(-1)); (4) SBI + high-dose PRO (20 mg kg(-1)); and (5) sham SBI + drug vehicle. Magnetic resonance imaging study and assessments of brain water content (BWC), blood-brain barrier (BBB) permeability, cellular inflammatory responses and matrix metalloproteinase 9 (MMP-9) expression were conducted. Results: This model consistently resulted in increased BWC and BBB disruption. PRO reduced astrocyte and microglia responses and attenuated brain oedema with preservation of BBB. A significant down-regulation of MMP-9 expression occurred in the PRO 20 group. Conclusions: PRO is as effective as DEXA in reducing brain oedema and inflammation following SBI; 10 mg kg(-1) of PRO was demonstrated to be more effective in relieving acute cellular inflammatory responses.	[Xu, Fei-Fan; Sun, Stella; Ho, Amy S. W.; Lee, Derek; Kiang, Karrie M. Y.; Zhang, Xiao-Qin; Lui, Wai-Man; Liu, Bai-Yun; Leung, Gilberto K. K.] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Div Neurosurg,Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Xu, Fei-Fan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wang, Anna M.; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China; [Wang, Anna M.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Liu, Bai-Yun] Beijing Neurosurg Inst, Beijing, Peoples R China; [Liu, Bai-Yun] Chinese Peoples Armed Police Force, Gen Hosp, Dept Neurotrauma, Beijing, Peoples R China		Leung, GKK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Div Neurosurg,Dept Surg, Hong Kong, Hong Kong, Peoples R China.	gilberto@hku.hk	Kiang, Karrie Mei-Yee/ABI-2656-2020; Wu, Ed Xuekui/C-1579-2009; Leung, Gilberto Ka Kit/C-4337-2009	Wu, Ed Xuekui/0000-0001-5581-1546; Leung, Gilberto Ka Kit/0000-0003-3147-3057			Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Barnes PJ, 2005, IMMUNOL ALLERGY CLIN, V25, P451, DOI 10.1016/j.iac.2005.05.003; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Baughman Verna L, 2002, Anesthesiol Clin North Am, V20, P315, DOI 10.1016/S0889-8537(01)00004-9; Bebawy JF, 2012, J NEUROSURG ANESTH, V24, P173, DOI 10.1097/ANA.0b013e3182578bb5; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goldstein LB, 1999, RESTOR NEUROL NEUROS, V15, P39; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Jadhav V, 2007, SURG NEUROL, V67, P15, DOI 10.1016/j.surneu.2006.07.014; Jiang C, 2009, INFLAMM RES, V58, P619, DOI 10.1007/s00011-009-0032-8; Kilts JD, 2010, PAIN MED, V11, P1469, DOI 10.1111/j.1526-4637.2010.00927.x; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; MILLER JD, 1975, J NEUROSURG, V42, P274, DOI 10.3171/jns.1975.42.3.0274; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; Singh M, 2008, FRONT BIOSCI-LANDMRK, V13, P1083, DOI 10.2741/2746; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Un KC, 2013, J CLIN NEUROSCI, V20, P1329, DOI 10.1016/j.jocn.2012.10.032; VECHT CJ, 1994, NEUROLOGY, V44, P675, DOI 10.1212/WNL.44.4.675; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wojtal K, 2006, PHARMACOL REP, V58, P335; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yamaguchi M, 2007, NEUROSURGERY, V61, P1067, DOI 10.1227/01.neu.0000303203.07866.18	53	19	20	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	12					1594	1601		10.3109/02699052.2014.943289			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AR6UD	WOS:000343717700011	25093611				2022-02-06	
J	Yang, B; Tse, KM; Chen, N; Tan, LB; Zheng, QQ; Yang, HM; Hu, M; Pan, G; Lee, HP				Yang, Bin; Tse, Kwong-Ming; Chen, Ning; Tan, Long-Bin; Zheng, Qing-Qian; Yang, Hui-Min; Hu, Min; Pan, Gang; Lee, Heow-Pueh			Development of a Finite Element Head Model for the Study of Impact Head Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; DEFORMATION; SEGMENTATION; BIOMECHANICS; VALIDATION; GENERATION; CARTILAGE; BEHAVIOR; TISSUE; MOTION	This study is aimed at developing a high quality, validated finite element (FE) human head model for traumatic brain injuries (TBI) prediction and prevention during vehicle collisions. The geometry of the FE model was based on computed tomography (CT) and magnetic resonance imaging (MRI) scans of a volunteer close to the anthropometry of a 50th percentile male. The material and structural properties were selected based on a synthesis of current knowledge of the constitutive models for each tissue. The cerebrospinal fluid (CSF) was simulated explicitly as a hydrostatic fluid by using a surface-based fluid modeling method. The model was validated in the loading condition observed in frontal impact vehicle collision. These validations include the intracranial pressure (ICP), brain motion, impact force and intracranial acceleration response, maximum von Mises stress in the brain, and maximum principal stress in the skull. Overall results obtained in the validation indicated improved biofidelity relative to previous FE models, and the change in the maximum von Mises in the brain is mainly caused by the improvement of the CSF simulation. The model may be used for improving the current injury criteria of the brain and anthropometric test devices.	[Yang, Bin; Chen, Ning; Zheng, Qing-Qian; Yang, Hui-Min; Hu, Min; Pan, Gang] Nanjing Forestry Univ, Coll Automobile & Traff Engn, Nanjing 210037, Jiangsu, Peoples R China; [Yang, Bin; Tse, Kwong-Ming; Tan, Long-Bin; Lee, Heow-Pueh] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore		Yang, B (corresponding author), Nanjing Forestry Univ, Coll Automobile & Traff Engn, Nanjing 210037, Jiangsu, Peoples R China.	yangb123@126.com	Tse, Kwong Ming/D-8669-2011; Lee, Heow Pueh/I-7834-2014	Tse, Kwong Ming/0000-0002-8170-0775; Lee, Heow Pueh/0000-0002-4380-3888; Tan, Long Bin/0000-0002-3897-7365	National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [11272159, 11172099]; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-Aged Teachers and Presidents of China	The financial supports from the National Natural Science Foundation (Grant nos. 11272159 and 11172099) and Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-Aged Teachers and Presidents of China are acknowledged. This research was undertaken at the Department of Mechanical Engineering in National University of Singapore.	Al-Bsharat A. S., 2000, THESIS WAYNE STATE U; Allsop D. L., 1988, P 32 STAPP CAR CRASH, P139; Bilston LE, 2011, STUD MECHANOBIOL TIS, V3, P11, DOI 10.1007/8415_2010_36; Boltcheva D, 2009, LECT NOTES COMPUT SC, V5762, P283; Chan M., 1980, P 24 STAPP CAR CRASH, P347; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Ellen Hertz, 1993, 37 ANN P ASS ADV AUT, V37, P303; Farmanzad F, 2007, BIO-MED MATER ENG, V17, P119; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Grellmann W, 2006, J BIOMED MATER RES A, V78A, P168, DOI 10.1002/jbm.a.30625; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Huang SC, 1999, BIO-MED MATER ENG, V9, P61; Kang HS, 1997, P STAPP CAR CRASH J, V41, P329; Kim YH, 2014, COMPUT METHOD BIOMEC, V17, P997, DOI 10.1080/10255842.2012.731594; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S., 2001, P INT C BIOM IMP IRC, P161; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Lin Q. F., 2006, J TRANSPORTATION SYS, V6, P73; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Meyer M, 2008, IEEE T VIS COMPUT GR, V14, P1539, DOI 10.1109/TVCG.2008.154; Monson K. L., 2001, THESIS U CALIFORNIA; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Netter FH, 1997, ATLAS HUMAN ANATOMY; Nyquist G. W., 1986, P 30 STAPP CAR CRASH; Pons JP, 2007, LECT NOTES COMPUT SC, V4584, P198; Rooij L. V., 2003, P 17 INT C ENH SAF V; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Ruan JS, 1993, SAE TECHNICAL PAPERS, DOI [10. 4271/933114, DOI 10.4271/933114]; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Simms C, 2009, SOLID MECH APPL, V166, P75; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Takhounts EG, 2008, STAPP CAR C, V52, P1; Teasdale G. M., 1999, J NEUROL NEUROSUR PS, V558, P526; Tse KM, 2014, INT J NUMER METH BIO, V30, P397, DOI 10.1002/cnm.2609; Turquier F, 1996, STAPP CAR C, VP-30, P283; Westreich RW, 2007, ARCH FACIAL PLAST S, V9, P264, DOI 10.1001/archfaci.9.4.264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Wismans, 1997, P 41 STAPP CAR CRASH, V41, P315, DOI DOI 10.4271/973338; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhang YJ, 2010, COMPUT METHOD APPL M, V199, P405, DOI 10.1016/j.cma.2009.06.007; Zhou C., 1995, P 39 STAPP CAR CRASH, P121	53	19	19	1	28	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								408278	10.1155/2014/408278			14	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AX5RK	WOS:000346984500001	25405201	Green Published, gold, Green Submitted			2022-02-06	
J	Astur, N; Klimo, P; Sawyer, JR; Kelly, DM; Muhlbauer, MS; Warner, WC				Astur, Nelson; Klimo, Paul, Jr.; Sawyer, Jeffrey R.; Kelly, Derek M.; Muhlbauer, Michael S.; Warner, William C., Jr.			Traumatic Atlanto-Occipital Dislocation in Children Evaluation, Treatment, and Outcomes	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article								Background: Advancements in emergency care and diagnostic methods have increased the number of children who survive atlanto-occipital dislocation. We report our experience with one of the largest series of pediatric patients with atlanto-occipital dislocation. Methods: Patients ranging in age from newborn to sixteen years old who had a diagnosis of atlanto-occipital dislocation from 1991 through 2011 were identified. Inclusion criteria were complete radiographic and clinical records and duration of follow-up of at least six months. Basic patient characteristics, mechanism of injury, associated injuries, neurological impairment, surgical treatment and type of implant used for fixation, complications, and clinical and radiographic outcomes were recorded. Results: The fourteen patients who were included (seven male and seven female) had a mean age of 5.2 years at the time of injury. An automobile accident in which the victim was a passenger was the most common mechanism of injury. Twelve patients had associated injuries, with a brain injury in eleven of them, and nearly half sustained a spinal cord injury. According to the Traynelis classification system, eight patients had a type-II (longitudinal) atlanto-occipital dislocation, five had a typed (anterior) dislocation, and one had a type-Ill (posterior) dislocation. All patients had posterior occipitocervical fusion with internal fixation. The mean duration of follow-up was 75.4 months. The most common postoperative complication was hydrocephalus, which occurred in four patients. Spinal fusion occurred in all patients by four to six months postoperatively. At the time of the most recent follow-up evaluation, half of the patients had neurological impairment. Conclusions: More patients with atlanto-occipital dislocation now survive the initial trauma, although most have associated injuries and many have neurological impairment. Our preferred management is early occipitocervical fusion and stabilization. If there is neurological decline after spinal fixation, obstructive hydrocephalus should be suspected.	[Astur, Nelson; Klimo, Paul, Jr.; Sawyer, Jeffrey R.; Kelly, Derek M.; Muhlbauer, Michael S.; Warner, William C., Jr.] Le Bonheur Childrens Hosp, Memphis, TN USA		Astur, N (corresponding author), Le Bonheur Childrens Hosp, Memphis, TN USA.		Astur, Nelson/F-3267-2015	Astur, Nelson/0000-0002-2608-2118				0	19	20	0	3	JOURNAL BONE JOINT SURGERY INC	NEEDHAM	20 PICKERING ST, NEEDHAM, MA 02192 USA	0021-9355			J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	DEC 18	2013	95A	24					2213	2213		10.2106/JBJS.L.01295			1	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	273IG	WOS:000328527900010	24352780				2022-02-06	
J	Liu, S; Shen, GY; Deng, SK; Wang, XB; Wu, QF; Guo, AS				Liu, Su; Shen, Guangyu; Deng, Shukun; Wang, Xiubin; Wu, Qinfeng; Guo, Aisong			Hyperbaric oxygen therapy improves cognitive functioning after brain injury	NEURAL REGENERATION RESEARCH			English	Article						neural regeneration; brain injury; hyperbaric oxygen; magnetic resonance spectroscopy; astrocytes; immunohistochemistry; choline; creatine; N-acetylaspartate; CA3 region; Morris water maze; hippocampus; neuroregeneration	MAGNETIC-RESONANCE SPECTROSCOPY; PROTON MR SPECTROSCOPY; RAT MODEL; HIPPOCAMPUS; IMPAIRMENT; ASTROCYTES; RESPONSES; H-1-MRS; DAMAGE; MOTOR	Hyperbaric oxygen therapy has been widely applied and recognized in the treatment of brain injury; however, the correlation between the protective effect of hyperbaric oxygen therapy and changes of metabolites in the brain remains unclear. To investigate the effect and potential mechanism of hyperbaric oxygen therapy on cognitive functioning in rats, we established traumatic brain injury models using Feeney's free falling method. We treated rat models with hyperbaric oxygen therapy at 0.2 MPa for 60 minutes per day. The Morris water maze test for spatial navigation showed that the average escape latency was significantly prolonged and cognitive function decreased in rats with brain injury. After treatment with hyperbaric oxygen therapy for 1 and 2 weeks, the rats' spatial learning and memory abilities were improved. Hydrogen proton magnetic resonance spectroscopy analysis showed that the N-acetylaspartate/creatine ratio in the hippocampal CA3 region was significantly increased at 1 week, and the N-acetylaspartate/choline ratio was significantly increased at 2 weeks after hyperbaric oxygen therapy. Nissl staining and immunohistochemical staining showed that the number of nerve cells and Nissl bodies in the hippocampal CA3 region was significantly increased, and glial fibrillary acidic protein positive cells were decreased after a 2-week hyperbaric oxygen therapy treatment. Our findings indicate that hyperbaric oxygen therapy significantly improves cognitive functioning in rats with traumatic brain injury, and the potential mechanism is mediated by metabolic changes and nerve cell restoration in the hippocampal CA3 region.	[Liu, Su; Shen, Guangyu; Deng, Shukun; Wu, Qinfeng; Guo, Aisong] Nantong Univ, Affiliated Hosp, Dept Rehabil Med, Nantong 226001, Jiangsu, Peoples R China; [Wang, Xiubin] Nantong Univ, Affiliated Hosp, Dept Imaging, Nantong 226001, Jiangsu, Peoples R China		Shen, GY (corresponding author), Nantong Univ, Affiliated Hosp, Dept Rehabil Med, Nantong 226001, Jiangsu, Peoples R China.	sgyrm@163.com					Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barkovich AJ, 1999, AM J NEURORADIOL, V20, P1399; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Du YL, 2011, NEUROL INDIA, V59, P31, DOI 10.4103/0028-3886.86540; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; [傅敏 FU Min], 2011, [中华航海医学与高气压医学杂志, Chinese Journal of Nautical Medicine and Hyperbaric Medicine], V18, P82; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Giorgio A, 2010, NEUROL SCI, V31, P245, DOI 10.1007/s10072-010-0370-x; Gossett WA, 2010, UNDERSEA HYPERBAR M, V37, P35; HAYAKAWA T, 1971, J NEUROL NEUROSUR PS, V34, P580, DOI 10.1136/jnnp.34.5.580; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Kirov II, 2013, NEUROLOGY, V80, P39, DOI 10.1212/WNL.0b013e31827b1a8c; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Li DF, 2012, INT J NEUROSCI, V122, P200, DOI 10.3109/00207454.2011.639470; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu S, 2008, ZHONGHUA WULI YIXUE, V34, P415; Liu Zhan, 2006, Chin J Traumatol, V9, P168; Lucetti C, 2001, NEUROL SCI, V22, P69, DOI 10.1007/s100720170051; Marjanska M, 2013, PLOS ONE, V8; Metarugcheep Pichest, 2012, Journal of the Medical Association of Thailand, V95, P949; Nicola SD, 2001, J NEUROL, V248, P403; Nie K, 2013, PARKINSONISM RELAT D, V19, P329, DOI 10.1016/j.parkreldis.2012.11.012; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Pang HP, 2010, FANGSHEXUE SHIJIAN, V12, P12; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Semenova NA, 2011, B EXP BIOL MED+, V151, P532, DOI 10.1007/s10517-011-1374-0; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; [孙永安 Sun Yong-an], 2009, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V13, P5098; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vartak-Sharma N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-195; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wang HZ, 2012, CLIN RADIOL, V67, P340, DOI 10.1016/j.crad.2011.09.008; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Ye B, 2010, ZHONGHUA SHENJING YI, V9, P158; Zhang Xiang-Gen, 2010, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V26, P373; [周红 ZHOU Hong], 2009, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V25, P1367	50	19	23	2	10	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	DEC	2013	8	35					3334	3343		10.3969/j.issn.1673-5374.2013.35.008			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	284QX	WOS:000329336500008	25206655				2022-02-06	
J	Russell, LM; Devore, MD; Barnes, SM; Forster, JE; Hostetter, TA; Montgomery, AE; Casey, R; Kane, V; Brenner, LA				Russell, Leah M.; Devore, Maria D.; Barnes, Sean M.; Forster, Jeri E.; Hostetter, Trisha A.; Montgomery, Ann Elizabeth; Casey, Roger; Kane, Vincent; Brenner, Lisa A.			Challenges Associated With Screening for Traumatic Brain Injury Among US Veterans Seeking Homeless Services	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							PREVALENCE; METAANALYSIS; HEALTH	We identified the prevalence of traumatic brain injury (TBI) among homeless veterans and assessed the TBI-4, a screening tool created to identify TBI history. Between May 2010 and October 2011, 800 US veterans from 2 hospitals, one eastern (n = 122) and one western (n = 678) completed some or all measures. Findings suggested that 47% of veterans seeking homeless services had a probable history of TBI (data for prevalence obtained only at the western hospital). However, psychometric results from the screening measure suggested that this may be an underestimate and supported comprehensive assessment of TBI in this population.	[Russell, Leah M.; Devore, Maria D.; Barnes, Sean M.; Forster, Jeri E.; Hostetter, Trisha A.; Brenner, Lisa A.] 19 Mental Illness Res Educ & Clin Ctr MIRECC, VISN, Denver, CO USA; [Montgomery, Ann Elizabeth; Kane, Vincent] Vet Affairs Natl Ctr Homelessness Vet, Philadelphia, PA USA; [Casey, Roger] Vet Affairs Natl Ctr Homelessness Vet, Tampa, FL USA		Brenner, LA (corresponding author), MIRECC, Denver VA Med Ctr, 1055 Clermont St, Denver, CO 80203 USA.	lisa.brenner@va.gov	Brenner, Lisa A./AAG-2442-2019		National Center on Homelessness Among Veterans; VISN 19 MIRECC	This project was funded by the National Center on Homelessness Among Veterans. Additional support was provided by the VISN 19 MIRECC.	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; US Department of Veterans Affairs, STRAT PLAN FY210 201; US Department of Veterans Affairs, HOM VET GRANT DIEM P; US Department of Veterans Affairs, HOM VET DEP HOUS URB; US Department of Veterans Affairs/Department of Defense, CLIN PRACT GUID MAN	12	19	19	0	4	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	DEC	2013	103			2			S211	S213		10.2105/AJPH.2013.301485			4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AA4NP	WOS:000331073100014	24148060	Green Published			2022-02-06	
J	Deepika, A; Munivenkatappa, A; Devi, BI; Shukla, D				Deepika, Akhil; Munivenkatappa, Ashok; Devi, Bhagavatula Indira; Shukla, Dhaval			Does Isolated Traumatic Subarachnoid Hemorrhage Affect Outcome in Patients With Mild Traumatic Brain Injury?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; mild traumatic brain injury; traumatic subarachnoid hemorrhage	HEAD-INJURY; SCALE; QUESTIONNAIRE; RELIABILITY; CONCUSSION; MANAGEMENT; SYMPTOMS	Background: The importance of isolated traumatic subarachnoid hemorrhage (SAH) in relation to functional outcome in patients with mild traumatic brain injury (TBI) has not been frequently studied. The aim of this study was to compare the impact of isolated SAH with normal computed tomographic (CT) scan on outcome of patients with mild TBI. Methods: This is a retrospective study of clinical records and CT scans of all patients with mild TBI (Glasgow Coma Scale score >= 13) evaluated from January 1, 2010, to March 15, 2010, at our institution. The patients were divided into 2 groups: isolated SAH and normal CT scan. The telephonic Glasgow Outcome Scale-Extended, Rivermead Post-Concussion Symptoms Questionnaire (RPCSQ), and Rivermead Head Injury Follow-up Questionnaire (RHFUQ) scores were used to assess outcome after 1 year of injury. Independent sample t test in SPSS was used to assess difference in outcome. Results: A total of 1149 patients with mild TBI were evaluated during study period. Among them, 34 (2.9%) patients had isolated SAH. Twenty-eight patients were male and 6 were female, with a mean age of 36.5 years. Subarachnoid hemorrhage was cortical in 19 (55.9%) patients, interhemispheric in 3 (8.8%) patients, Sylvian fissure in 2 (5.9%) patients, and basal cisternal in 1 (2.9%) patient. Nine (26.5%) patients had SAH at multiple locations. The mean RPCSQ and RHFUQ scores for patients with isolated SAH were 1.38 +/- 2.40 and 1.11 +/- 3.305, respectively. The mean RPCSQ and RHFUQ scores for patients with normal CT scans were 0.40 +/- 1.549 and 0.533 +/- 1.59, respectively. There was no significant difference in the outcome scores between the SAH and the normal CT scan groups (RHFUQ, P = .45; RPCSQ, P = .248). Conclusion: In our study sample of patients with mild TBI, there is no difference in outcome of patients with isolated SAH compared with those with normal CT scans 1 year after injury.	[Deepika, Akhil; Munivenkatappa, Ashok; Devi, Bhagavatula Indira; Shukla, Dhaval] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bangalore 560029, Karnataka, India		Shukla, D (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.	neurodhaval@rediffmail.com	Munivenkatappa, Ashok/ABA-5952-2021				Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; DEMIRCIVI F, 1993, ACTA NEUROCHIR, V122, P45, DOI 10.1007/BF01446985; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Takinami K, 2003, NEUROL SURG TOKYO, V31, P175; Ullman JS, 1996, SUBARACHNOID HEMORRH, P225; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881	20	19	19	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					442	445		10.1097/HTR.0b013e31825e19e5			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200008	22832372				2022-02-06	
J	Gump, WC; Mutchnick, IS; Moriarty, TM				Gump, William C.; Mutchnick, Ian S.; Moriarty, Thomas M.			Selective dorsal rhizotomy for spasticity not associated with cerebral palsy: reconsideration of surgical inclusion criteria	NEUROSURGICAL FOCUS			English	Article						selective dorsal rhizotomy; spasticity; cerebral palsy; hypertonia	GROSS MOTOR FUNCTION; POSTERIOR RHIZOTOMY; CHILDREN; EXPERIENCE; PAINFUL	Children with spastic diplegia from cerebral palsy (CP) experience measurable improvement in their spasticity and motor function following selective dorsal rhizotomy (SDR). The role of this operation in the treatment of other spasticity causes is less well defined. A literature review was undertaken to survey outcomes from SDRs performed outside the CP population. Multiple sclerosis was the most common diagnosis found, accounting for 74 of 145 patients described. Selective dorsal rhizotomies have also been reported in patients with traumatic brain and spinal cord injuries, ischemic and hemorrhagic stroke, neurodegenerative disease, hypoxic encephalopathy, and other causes of spasticity. Outcomes from surgery are generally described as favorable, although postoperative assessments and follow-up times are not standardized across reports. Long-term outcomes are sparsely reported. Larger numbers of patients and more detailed outcomes data have the potential to form a basis for expanding the inclusion criteria for SDR.	[Gump, William C.; Mutchnick, Ian S.; Moriarty, Thomas M.] Norton Neurosci Inst, Div Pediat Neurosurg, Louisville, KY 40202 USA; [Gump, William C.; Mutchnick, Ian S.; Moriarty, Thomas M.] Kosair Childrens Hosp, Louisville, KY USA; [Moriarty, Thomas M.] Univ Kentucky, Coll Med, Dept Neurol Surg, Lexington, KY USA		Gump, WC (corresponding author), Norton Neurosci Inst, Div Pediat Neurosurg, 210 E Gray St,Ste 1102, Louisville, KY 40202 USA.	william.gump@nortonhealthcare.org					Albright AL, 2008, PRINCIPLES PRACTICE, P1121; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; BAROLAT G, 1991, J NEUROSURG, V75, P804, DOI 10.3171/jns.1991.75.5.0804; Bolster EAM, 2013, DEV MED CHILD NEUROL, V55, P610, DOI 10.1111/dmcn.12148; Cole GF, 2007, ARCH DIS CHILD, V92, P781, DOI 10.1136/adc.2006.111559; Crilly MA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6670; Dudley RWR, 2013, J NEUROSURG-PEDIATR, V12, P142, DOI 10.3171/2013.4.PEDS12539; Farmer JP, 2007, CHILD NERV SYST, V23, P991, DOI 10.1007/s00381-007-0398-2; FASANO VA, 1978, CHILD BRAIN, V4, P289; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Foerster O., 1913, SURG GYNECOL OBSTET, V16, P463; Folkerth RD, 2005, J CHILD NEUROL, V20, P940, DOI 10.1177/08830738050200120301; Folkerth RD, 2006, PEDIATR DEVEL PATHOL, V9, P3, DOI 10.2350/06-01-0024.1; Fukuhara T, 2004, NEUROSURGERY, V54, P1268, DOI 10.1227/01.NEU.0000119605.32216.2E; Garcia-Campmany L, 2010, CURR OPIN NEUROBIOL, V20, P116, DOI 10.1016/j.conb.2010.01.002; Grunt S, 2008, J CHILD NEUROL, V23, P818, DOI 10.1177/0883073808316372; LAITINEN LV, 1983, J NEUROSURG, V58, P895, DOI 10.3171/jns.1983.58.6.0895; Langerak NG, 2012, GAIT POSTURE, V35, P244, DOI 10.1016/j.gaitpost.2011.09.014; Macwilliams BA, 2011, DEV MED CHILD NEUROL, V53, P717, DOI 10.1111/j.1469-8749.2011.04010.x; McLaughlin J, 2002, DEV MED CHILD NEUROL, V44, P17, DOI 10.1017/S0012162201001608; McLaughlin JF, 1998, DEV MED CHILD NEUROL, V40, P220; MUNRO D, 1952, NEW ENGL J MED, V246, P161, DOI 10.1056/NEJM195201312460501; Oki A, 2010, J NEUROSURG-PEDIATR, V6, P353, DOI 10.3171/2010.7.PEDS09318; Park T S, 2000, Clin Neurosurg, V47, P422; PEACOCK WJ, 1987, PEDIATR NEUROSCI, V13, P61, DOI 10.1159/000120302; PRIVAT JM, 1976, ACTA NEUROCHIR, V35, P181, DOI 10.1007/BF01405946; Sacco DJ, 2000, PEDIATR NEUROSURG, V32, P114, DOI 10.1159/000028914; Salame K, 2003, ISRAEL MED ASSOC J, V5, P543; SCHIJMAN E, 1993, CHILD NERV SYST, V9, P474, DOI 10.1007/BF00393554; Sherrington C S, 1898, J Physiol, V22, P319; SIDDIQUE N, 2003, TXB CLIN NEUROLOGY, P759; SINDOU M, 1982, APPL NEUROPHYSIOL, V45, P335; Steinbok P, 1997, DEV MED CHILD NEUROL, V39, P178; Steinbok P, 2007, CHILD NERV SYST, V23, P981, DOI 10.1007/s00381-007-0379-5; Tubbs RS, 2007, J NEUROSURG, V106, P407, DOI 10.3171/ped.2007.106.5.407; van Schie PEM, 2011, J NEUROSURG-PEDIATR, V7, P557, DOI 10.3171/2011.2.PEDS10452; Wright FV, 1998, DEV MED CHILD NEUROL, V40, P239; Yang TF, 2002, AM J PHYS MED REHAB, V81, P467, DOI 10.1097/00002060-200206000-00013	38	19	20	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2013	35	5							E6	10.3171/2013.8.FOCUS13294			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	247EB	WOS:000326596900006	24175866	Bronze			2022-02-06	
J	Hamasaki, T; Yamada, K; Kuratsu, J				Hamasaki, Tadashi; Yamada, Kazumichi; Kuratsu, Jun-ichi			Seizures as a presenting symptom in neurosurgical patients: A retrospective single-institution analysis	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Epilepsy; Incidence; Organic lesion; Seizure	TRAUMATIC BRAIN-INJURY; EPILEPSY; MENINGIOMAS; POPULATION; TUMORS; GANGLIOGLIOMA; PROPHYLAXIS; PHENYTOIN; RESECTION; OUTCOMES	Background: In patients with brain lesions, the appropriate management of epileptic seizures is important because recurrent seizures have a negative effect on the clinical course and quality of life. Acute symptomatic seizures are known to be one of the risk factors to develop epilepsy that cause recurrent unprovoked seizures in the later stage. To obtain background information, we performed a retrospective study in which we investigated the incidence of seizures as one of the presenting symptoms in neurosurgical patients admitted to our department during the past 43 years. Methods: We extracted 4537 consecutive patients from 11,675 records in our inpatient database to calculate the seizure incidence in patients with 19 most common diagnoses. We also studied whether the location of cortical lesions have relation to the seizure incidence. Results: Among 2342 patients with brain tumors, 9 of 18 (50%) ganglioglioma-, 40 of 87 (46%) oligodendroglioma-, 69 of 207(33%) low-grade astrocytoma-, 172 of 804(21%) high-grade astrocytoma- or anaplastic oligodendroglioma-, 84 of 598(14%) meningioma-, 38 of 313 (12%) metastatic brain tumor-, 7 of 67 (10%) malignant meningioma-, 7 of 79 (9%) ependymoma-, and 11 of 169(7%) malignant lymphoma patients suffered seizures. There were 1626 patients with vascular lesions, 20 of 80 (25%) with cavernous malformation, 61 of 281 (22%) with arteriovenous malformation, 50 of 666(8%) with subarachnoid hemorrhage, 26 of 457 (6%) with brain infarcts, and 5 of 142 (4%) with hypertensive brain hemorrhage had seizures. Of the 569 patients with traumatic brain injury, 33 of 168 (20%) with traumatic intracranial hemorrhage, 6 of 31 (19%) with brain concussion, 18 of 96 (19%) with brain contusion, 15 of 244 (6%) with chronic subdural hematoma, and 1 of 30 (3%) with minor head injury suffered seizures. We found that these seizure incidences were significantly higher when the cortical lesion was located in the frontal lobe (p < 0.01, chi square test) but not in parietal, occipital, nor temporal lobes. Conclusion: We investigated the prevalence rate of seizures at the time of admission in a large number of patients who had been treated in our institution. Our results suggest that seizures are a common feature in patients with slow-growing and frontal intra-parenchymal lesions. (C) 2013 Elsevier B.V. All rights reserved.	[Hamasaki, Tadashi; Yamada, Kazumichi; Kuratsu, Jun-ichi] Kumamoto Univ Hosp, Dept Neurosurg, Chuo Ku, Kumamoto 8608556, Japan		Hamasaki, T (corresponding author), Kumamoto Univ, Sch Med, Dept Neurosurg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	thamasaki-nsu@umin.ac.jp			Department of Neurosurgery, Kumamoto University Medical School	This research was supported by Department of Neurosurgery, Kumamoto University Medical School.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; Chang EF, 2008, J NEUROSURG, V108, P227, DOI 10.3171/JNS/2008/108/2/0227; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Compton JJ, 2012, J NEUROSURG, V117, P825, DOI 10.3171/2012.7.JNS111260; Forsyth PA, 2003, CAN J NEUROL SCI, V30, P106, DOI 10.1017/S0317167100053361; FRANCESCHETTI S, 1990, ACTA NEUROCHIR, V103, P47, DOI 10.1007/BF01420191; Glantz MJ, 1996, NEUROLOGY, V46, P985, DOI 10.1212/WNL.46.4.985; Glantz MJ, 2000, NEUROLOGY, V54, P1886, DOI 10.1212/WNL.54.10.1886; Grobelny BT, 2009, J NEUROSURG, V111, P1257, DOI 10.3171/2009.6.JNS0928; Gross BA, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1165; Hamasaki T, 2012, ACTA NEUROCHIR, V154, P2241, DOI 10.1007/s00701-012-1511-1; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hu WH, 2012, ACTA NEUROCHIR, V154, P855, DOI 10.1007/s00701-011-1259-z; Kawaguchi T, 1996, NEUROL MED CHIR TOKY, V36, P573; Kawaguchi Tadashi, 1996, Neurologia Medico-Chirurgica, V36, P568, DOI 10.2176/nmc.36.568; Kuratsu Jun-ichi, 2001, International Journal of Clinical Oncology, V6, P183; Lanzino G, 2011, NEUROCRIT CARE, V15, P247, DOI 10.1007/s12028-011-9584-x; Lieu AS, 2000, EPILEPSY RES, V38, P45; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Makino K, 2010, CHILD NERV SYST, V26, P1029, DOI 10.1007/s00381-010-1126-x; Menon B, 2009, EPILEPSY RES, V87, P1, DOI 10.1016/j.eplepsyres.2009.08.007; Myint PK, 2006, POSTGRAD MED J, V82, P568, DOI 10.1136/pgmj.2005.041426; Nakamura H, 2011, INT J CLIN ONCOL, V16, P314, DOI 10.1007/s10147-010-0178-y; NORTH JB, 1983, J NEUROSURG, V58, P672, DOI 10.3171/jns.1983.58.5.0672; OHNO K, 1993, J NEUROL NEUROSUR PS, V56, P1231, DOI 10.1136/jnnp.56.11.1231; Olsen T S, 2001, Curr Atheroscler Rep, V3, P340, DOI 10.1007/s11883-001-0029-4; Pohlmann-Eden B, 2002, ARCH NEUROL-CHICAGO, V59, P1831, DOI 10.1001/archneur.59.11.1831; Rothoerl RD, 2003, NEUROSURG REV, V26, P108, DOI 10.1007/s10143-002-0240-y; RUBIN G, 1993, ACTA NEUROCHIR, V123, P39, DOI 10.1007/BF01476283; SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7; SHERWIN A, 1988, NEUROLOGY, V38, P920, DOI 10.1212/WNL.38.6.920; Southwell DG, 2012, NEUROSURGERY, V70, P1406, DOI 10.1227/NEU.0b013e3182500a4c; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; Villemure JG, 1996, CURR OPIN NEUROL, V9, P424, DOI 10.1097/00019052-199612000-00005; von der Brelie C, 2011, ACTA NEUROCHIR, V153, P249, DOI 10.1007/s00701-010-0915-z; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; Yano S, 2006, J NEUROSURG, V105, P538, DOI 10.3171/jns.2006.105.4.538	44	19	20	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2013	115	11					2336	2340		10.1016/j.clineuro.2013.08.016			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	264TX	WOS:000327905000005	24011499				2022-02-06	
J	Miller, T; Bhattacharya, S; Zamula, W; Lezotte, D; Kowalske, K; Herndon, D; Fauerbach, J; Engrav, L				Miller, Ted; Bhattacharya, Soma; Zamula, William; Lezotte, Dennis; Kowalske, Karen; Herndon, David; Fauerbach, James; Engrav, Loren			Quality-of-life loss of people admitted to burn centers, United States	QUALITY OF LIFE RESEARCH			English	Article						Burn; QALY; Systematic review of scorings; SF-12; EQ-5d	NATIONALLY REPRESENTATIVE SAMPLE; GENERAL-POPULATION; HEALTH-STATUS; EQ-5D INDEX; US SAMPLE; SF-12; VALIDITY; QUESTIONNAIRE; HETEROGENEITY; UTILITIES	To estimate quality-of-life loss per serious burn survivor in a large U.S. cohort. Longitudinal functional assessments of all 1,587 people receiving primary treatment in 5 burn centers between 2000 and 2009 included pre-burn (retrospective), at time of discharge, and 6, 12, and 24 months post-injury. We assessed adults with RAND Short Form (SF) 12 and children with SF-10 or Child Health Questionnaire, the child surveys scored using standard norms-based scoring. A literature review identified 20 quality-adjusted life year utility scorings for SF-12 and 27 scorings for EQ-5d response distributions predicted from SF-12 scores. We computed composite scores for each patient and time period by applying 32 scorings that met quality/non-duplication criteria. Mean quality-of-life scores were 0.805 4 weeks pre-burn, 0.562 at discharge, rebounded through 1 year, and stabilized at 0.735 (0.750 for TBSA burned below 25 %, 0.722 for TBSA burned of 25-50 %, and 0.695 for larger burns). As a percentage of initial levels, burns reduced short-term quality of life by 30 %. Long-term loss averaged 11 %, ranging from 9 % for TBSA burned below 25-13 % for TBSA burned above 50 %. Children recovered faster and more fully. Burns cause substantial losses in quality of life, with long-term losses comparable to traumatic brain injury.	[Miller, Ted; Bhattacharya, Soma] Pacific Inst Res & Evaluat, Calverton, MD USA; [Zamula, William] US Consumer Prod Safety Commiss, Bethesda, MD USA; [Lezotte, Dennis] Univ Colorado, Hlth Sci Ctr, Lakeland, CO USA; [Kowalske, Karen] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Herndon, David] Univ Texas Med Branch, Galveston, TX 77555 USA; [Herndon, David] Shriners Hosp Crippled Children, Galveston, TX USA; [Fauerbach, James] Johns Hopkins Univ, Baltimore, MD USA; [Engrav, Loren] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA		Miller, T (corresponding author), Pacific Inst Res & Evaluat, Calverton, MD USA.	miller@pire.org	Herndon, David/AAC-3354-2020	Miller, Ted/0000-0002-0958-2639	U.S. Consumer Product Safety Commission (CPSC); U.S. Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR)US Department of Education; BMS Centers; BMS National Data and Statistical Center	This study was funded by a contract with the U.S. Consumer Product Safety Commission (CPSC). This journal article was prepared in part by CPSC staff but has not been reviewed or approved by, and may not necessarily reflect the views of, the Commission. The deidentified data used for this study were obtained from the Burn Model Systems Centers Database which is supported by the U.S. Department of Education, National Institute on Disability and Rehabilitation Research (NIDRR) in collaboration with the BMS Centers and the BMS National Data and Statistical Center. However, these contents may not reflect the opinions or views of the BMS Centers, NIDRR, or the U.S. Department of Education.	Sanchez JLA, 2007, ARCH SURG-CHICAGO, V142, P50, DOI 10.1001/archsurg.142.1.50; [Anonymous], 2008, CHILD HLTH QUEST SCO; Badia X, 1998, QUAL LIFE RES, V7, P311, DOI 10.1023/A:1024933913698; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Bult JR, 1996, MED DECIS MAKING, V16, P226, DOI 10.1177/0272989X9601600306; Bult JR, 1998, MED CARE, V36, P523, DOI 10.1097/00005650-199804000-00008; Cleemput I, 2004, VALUE HEALTH, V7, P499, DOI 10.1111/j.1524-4733.2004.74013.x; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Drummond MF, 2015, METHODS EC EVALUATIO; Econsys, 2008, STUD COMP PAYM SERV, VIII; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Farivar Sepideh S, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P515, DOI 10.1586/14737167.4.5.515; Franks P, 2004, MED DECIS MAKING, V24, P247, DOI 10.1177/0272989X04265477; Franks P, 2003, MED CARE, V41, P1277, DOI 10.1097/01.MLR.0000093480.58308.D8; Fryback DG, 1997, MED DECIS MAKING, V17, P1, DOI 10.1177/0272989X9701700101; Gray AM, 2006, MED DECIS MAKING, V26, P18, DOI 10.1177/0272989X05284108; Greene W., 2008, ECONOMETRIC ANAL, V6; Grenier W., 2003, EUR J HEALTH ECON, V4, P222; Hakim Z, 1999, HEALTH ECON, V8, P103; Jelsma Jennifer, 2003, Popul Health Metr, V1, P11, DOI 10.1186/1478-7954-1-11; Johnson JA, 1998, QUAL LIFE RES, V7, P155, DOI 10.1023/A:1008809610703; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Lawrence WF, 2004, MED DECIS MAKING, V24, P160, DOI 10.1177/0272989X04264015; Lundberg L, 1999, MED DECIS MAKING, V19, P128, DOI 10.1177/0272989X9901900203; MCHORNEY CA, 1992, MED CARE S, V30, P253; Mortimer D, 2008, MED DECIS MAKING, V28, P66, DOI 10.1177/0272989X07309642; Nichol MB, 2001, MED DECIS MAKING, V21, P105, DOI 10.1177/02729890122062352; Oster C, 2009, BURNS, V35, P723, DOI 10.1016/j.burns.2008.11.007; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Schofield M J, 1998, J Health Psychol, V3, P259, DOI 10.1177/135910539800300209; Sengupta N, 2004, MED CARE, V42, P927, DOI 10.1097/01.mlr.0000135812.52570.42; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Shmueli A, 2004, MED DECIS MAKING, V24, P61, DOI 10.1177/0272989X03261562; Shmueli A, 1999, MED DECIS MAKING, V19, P122, DOI 10.1177/0272989X9901900202; Stratmann-Schoene D, 2006, HEALTH ECON, V15, P553, DOI 10.1002/hec.1082; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; The EuroQol Group, 2007, EQ 5D VALUE SETS INV; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Turner-Bowker D. M., 2003, SF 10 CHILDREN USERS; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Ware J.E., 2002, SCORE VERSION 2 SF 1; Whitehead SJ, 2010, BRIT MED BULL, V96, P5, DOI 10.1093/bmb/ldq033; Wittrup-Jensen K. U., 2008, ESTIMATION PREFERENC	43	19	19	0	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	NOV	2013	22	9					2293	2305		10.1007/s11136-012-0321-5			13	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	268ZB	WOS:000328208300004	23224665				2022-02-06	
J	Clark, IA; Vissel, B				Clark, Ian A.; Vissel, Bryce			Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease	BIOCHEMICAL PHARMACOLOGY			English	Article						Alzheimer's disease; Parkinson's disease, alpha-Synuclein; DNA hypomethylation; TNF; Insulin resistance	NECROSIS-FACTOR-ALPHA; AMYLOID PRECURSOR PROTEIN; ONSET ALZHEIMERS-DISEASE; CENTRAL-NERVOUS-SYSTEM; CHIMERIC MONOCLONAL-ANTIBODY; APOLIPOPROTEIN-E SUPPRESSES; COLLAGEN-INDUCED ARTHRITIS; TRAUMATIC BRAIN-INJURY; HUMAN PERIPHERAL-BLOOD; AD MOUSE MODELS	The disappointments of a series of large anti-amyloid trials have brought home the point that until the driving force behind Alzheimer's disease, and the way it causes harm, are firmly established and accepted, researchers will remain ill-equipped to find a way to treat patients successfully. The origin of inflammation in neurodegenerative diseases is still an open question. We champion and expand the argument that a shift in intracellular location of et-synuclein, thereby moving a key methylation enzyme from the nucleus, provides global hypomethylation of patients' cerebral DNA that, through being sensed by TLR9, initiates production of the cytokines that drive these cerebral inflammatory states. After providing a background on the relevant inflammatory cytokines, this commentary then discusses many of the known alternatives to the primary amyloid argument of the pathogenesis of Alzheimer's disease, and the treatment approaches they provide. A key point to appreciate is the weight of evidence that inflammatory cytokines, largely through increasing insulin resistance and thereby reducing the strength of the ubiquitously important signaling mediated by insulin, bring together most of these treatments under development for neurodegenerative disease under the one roof. Moreover, the principles involved apply to a wide range of inflammatory diseases on both sides of the blood brain barrier. (c) 2013 Elsevier Inc. All rights reserved.	[Clark, Ian A.; Vissel, Bryce] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Vissel, Bryce] Garvan Inst, Neurodegenerat Res Grp, Sydney, NSW, Australia		Clark, IA (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia.	ian.clark@anu.edu.au		Vissel, Bryce/0000-0001-8860-8050			Adjou KT, 2007, J COMP PATHOL, V137, P78, DOI 10.1016/j.jcpa.2007.03.007; Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Ahern T, 2013, J EUROPEAN IN PRESS; Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43; Alkam T, 2008, BEHAV BRAIN RES, V189, P100, DOI 10.1016/j.bbr.2007.12.014; Alvarez-Erviti L, 2011, NEUROSCI RES, V69, P337, DOI 10.1016/j.neures.2010.12.020; Amaral PP, 2013, BRIEF FUNCT GENOMICS, V12, P254, DOI 10.1093/bfgp/elt016; Atamaniuk J, 2012, NEPHROL DIAL TRANSPL, V27, P902, DOI 10.1093/ndt/gfr695; Aucan C, 2004, J MED GENET, V41, P21, DOI 10.1136/jmg.2003.011981; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Bakulski KM, 2012, J ALZHEIMERS DIS, V29, P571, DOI 10.3233/JAD-2012-111223; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Benson JM, 2011, NAT BIOTECHNOL, V29, P615, DOI 10.1038/nbt.1903; Bihaqi SW, 2012, CURR ALZHEIMER RES, V9, P574; Bihaqi SW, 2011, J ALZHEIMERS DIS, V27, P819, DOI 10.3233/JAD-2011-111013; BROOKES AJ, 1994, TRENDS NEUROSCI, V17, P404, DOI 10.1016/0166-2236(94)90013-2; BRUGG B, 1995, P NATL ACAD SCI USA, V92, P3032, DOI 10.1073/pnas.92.7.3032; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Butchi NB, 2010, GLIA, V58, P650, DOI 10.1002/glia.20952; Canellada A, 2006, MOL CELL NEUROSCI, V31, P692, DOI 10.1016/j.mcn.2005.12.008; Castellani RJ, 2004, ACTA NEUROBIOL EXP, V64, P11; CAYOTA A, 1992, CLIN EXP IMMUNOL, V88, P478, DOI 10.1111/j.1365-2249.1992.tb06475.x; Chang YH, 2012, INT J OBESITY, V36, P993, DOI 10.1038/ijo.2011.168; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen TH, 2012, IMMUNOPHARM IMMUNOT, V34, P484, DOI 10.3109/08923973.2011.630398; Cheng YJ, 2006, ENVIRON HEALTH PERSP, V114, P507, DOI 10.1289/ehp.8550; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Clark I, 2012, PHARMACOL REV, V64, P1004, DOI 10.1124/pr.112.005850; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Clarke AW, 2010, MABS-AUSTIN, V2, P539, DOI 10.4161/mabs.2.5.13081; Corder EH, 1998, NAT MED, V4, P1182, DOI 10.1038/2677; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Craft S, 1999, ARCH GEN PSYCHIAT, V56, P1135, DOI 10.1001/archpsyc.56.12.1135; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Crouch PJ, 2011, J NEUROCHEM, V119, P220, DOI 10.1111/j.1471-4159.2011.07402.x; Darsalia V, 2012, CLIN SCI, V122, P473, DOI 10.1042/CS20110374; Das K, 2011, NEURODEGENER DIS, V8, P345, DOI 10.1159/000323797; de Bont N, 1999, J LIPID RES, V40, P680; Deng GM, 2001, J IMMUNOL, V167, P4616, DOI 10.4049/jimmunol.167.8.4616; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Desplats P, 2011, J BIOL CHEM, V286, P9031, DOI 10.1074/jbc.C110.212589; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; DONNELLY RJ, 1990, CELL MOL NEUROBIOL, V10, P485, DOI 10.1007/BF00712843; Dore GA, 2009, DIABETOLOGIA, V52, P2551, DOI 10.1007/s00125-009-1497-2; Egecioglu E, 2013, PSYCHONEUROENDOCRINO, V38, P1259, DOI 10.1016/j.psyneuen.2012.11.009; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; Gilman CP, 2003, J NEUROCHEM, V87, P1137, DOI 10.1046/j.1471-4159.2003.02073.x; Goedert M, 1997, NATURE, V388, P232, DOI 10.1038/40767; GOLDFELD AE, 1994, J EXP MED, V180, P763, DOI 10.1084/jem.180.2.763; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; Greig NH, 2004, ACTA NEUROBIOL EXP, V64, P1; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Guan QD, 2009, VACCINE, V27, P7096, DOI 10.1016/j.vaccine.2009.09.058; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo TL, 1996, J LEUKOCYTE BIOL, V59, P932, DOI 10.1002/jlb.59.6.932; Gupta VB, 2011, NEUROLOGY, V76, P1091, DOI 10.1212/WNL.0b013e318211c352; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; HARDARDOTTIR I, 1994, J CLIN INVEST, V94, P1304, DOI 10.1172/JCI117449; Harms AS, 2011, MOL THER, V19, P46, DOI 10.1038/mt.2010.217; HART PH, 1991, IMMUNOLOGY, V72, P344; Hayashita-Kinoh H, 2006, BIOCHEM BIOPH RES CO, V341, P1088, DOI 10.1016/j.bbrc.2006.01.057; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holst JJ, 2011, CURR MED RES OPIN, V27, P547, DOI 10.1185/03007995.2010.549466; Hoyer S, 1994, J Neural Transm Suppl, V44, P259; Iraola-Guzman S, 2011, CLIN GENET, V80, P1, DOI 10.1111/j.1399-0004.2011.01673.x; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Jang H, 2009, BBA-MOL BASIS DIS, V1792, P714, DOI 10.1016/j.bbadis.2008.08.001; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kaul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037767; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Kipnis J, 2008, TRENDS IMMUNOL, V29, P455, DOI 10.1016/j.it.2008.07.007; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kiyota T, 2010, FASEB J, V24, P3093, DOI 10.1096/fj.10-155317; Konoeda F, 2010, BIOCHEM BIOPH RES CO, V402, P500, DOI 10.1016/j.bbrc.2010.10.058; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Laufer BI, 2013, DIS MODEL MECH, V6, P977, DOI 10.1242/dmm.010975; Laurin D, 2009, NEUROBIOL AGING, V30, P1724, DOI 10.1016/j.neurobiolaging.2008.01.008; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lukiw WJ, 2012, NEUROREPORT, V23, P621, DOI [10.1097/WNR.0b013e32835542b0, 10.1097/00001756-201207110-00009]; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mao X, 2013, DRUG ALCOHO IN PRESS; Margulis L, 1998, TRENDS MICROBIOL, V6, P342, DOI 10.1016/S0966-842X(98)01325-0; MARHAUG G, 1994, BAILLIERE CLIN RHEUM, V8, P553, DOI 10.1016/S0950-3579(05)80115-3; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Mastroeni D, 2011, NEUROBIOL AGING, V32, P1161, DOI 10.1016/j.neurobiolaging.2010.08.017; Mastroeni D, 2010, NEUROBIOL AGING, V31, P2025, DOI 10.1016/j.neurobiolaging.2008.12.005; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; McGonagle D, 2007, SEMIN IMMUNOPATHOL, V29, P303, DOI 10.1007/s00281-007-0084-1; MONK M, 1987, DEVELOPMENT, V99, P371; Moravan MJ, 2011, RADIAT RES, V176, P459, DOI 10.1667/RR2587.1; Mori A, 2012, EUR J IMMUNOL, V42, P2709, DOI 10.1002/eji.201242372; Nolan Y, 2005, J BIOL CHEM, V280, P9354, DOI 10.1074/jbc.M412170200; O'Connor JJ, 2013, IRISH J MED SCI, V182, P157, DOI 10.1007/s11845-013-0911-4; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Ozbay LA, 2012, BRIT J CLIN PHARMACO, V73, P536, DOI 10.1111/j.1365-2125.2011.04118.x; Pardridge William M, 2010, Bioeng Bugs, V1, P231, DOI 10.4161/bbug.1.4.12105; Park JL, 2012, ONCOL LETT, V3, P921, DOI 10.3892/ol.2012.592; Parthsarathy V, 2013, EUR J PHARMACOL, V700, P42, DOI 10.1016/j.ejphar.2012.12.012; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.immunol.5.1.429; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Pottier C, 2013, J ALZHEIMERS DIS, V35, P45, DOI 10.3233/JAD-122311; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; PURI RK, 1993, BIOCHEM BIOPH RES CO, V197, P1424, DOI 10.1006/bbrc.1993.2636; Rachmany L, 2013, AGE DORDR IN PRESS; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sarkar S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2838; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Schuitemaker A, 2009, NEUROBIOL AGING, V30, P1885, DOI 10.1016/j.neurobiolaging.2008.01.014; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Shapshak P, 2013, BIOINFORMATION, V9, P222, DOI 10.6026/97320630009222; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Shin EC, 2000, MOL CELLS, V10, P65, DOI 10.1007/s10059-000-0065-x; Shirazi RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061965; SIPE JD, 1979, J EXP MED, V150, P597, DOI 10.1084/jem.150.3.597; Sommer G, 2009, J CELL BIOCHEM, V108, P1418, DOI 10.1002/jcb.22382; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tauber SC, 2009, J NEUROPATH EXP NEUR, V68, P1116, DOI 10.1097/NEN.0b013e3181b7fde5; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Tobinick Edward, 2006, MedGenMed, V8, P25; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036; Tukhovskaya EA, 2009, J NEUROSCI RES, V87, P677, DOI 10.1002/jnr.21874; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Vitek MP, 2012, NEURODEGENER DIS, V31, P359; Vom Berg J, 2012, NATURE MED; Wang CSM, 2009, J NEUROL NEUROSUR PS, V80, P562, DOI 10.1136/jnnp.2008.151654; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784; Wilson CM, 2009, INT J RADIAT ONCOL, V74, P934, DOI 10.1016/j.ijrobp.2009.02.035; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhang JB, 2012, INT J BIOL SCI, V8, P935, DOI 10.7150/ijbs.4499; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150; Zhao JY, 2012, DIABETES, V61, P542, DOI 10.2337/db11-1048; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zuckerkandl E, 2002, GENETICA, V115, P105, DOI 10.1023/A:1016080316076; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	182	19	21	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	OCT 1	2013	86	7					862	871		10.1016/j.bcp.2013.07.030			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	225QH	WOS:000324976900003	23939185				2022-02-06	
J	Harman-Smith, YE; Mathias, JL; Bowden, SC; Rosenfeld, JV; Bigler, ED				Harman-Smith, Yasmin E.; Mathias, Jane L.; Bowden, Stephen C.; Rosenfeld, Jeffrey V.; Bigler, Erin D.			Wechsler Adult Intelligence Scale-Third Edition profiles and their relationship to self-reported outcome following traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Cognitive tests; Cluster analysis; Cognitive symptoms; Functional recovery; Outcomes; Wechsler Adult Intelligence Scale-Third Edition	INDEX SCORE PATTERNS; NEUROPSYCHOLOGICAL OUTCOMES; HEAD-INJURY; EPIDEMIOLOGY; SYMPTOMS; MODERATE	Neuropsychological assessments of outcome after traumatic brain injury (TBI) are often unrelated to self-reported problems after TBI. The current study cluster-analyzed the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) subtest scores from mild, moderate, and severe TBI (n = 220) and orthopedic injury control (n = 95) groups, to determine whether specific cognitive profiles are related to people's perceived outcomes after TBI. A two-stage cluster analysis produced 4- and 6-cluster solutions, with the 6-cluster solution better capturing subtle variations in cognitive functioning. The 6 clusters differed in the levels and profiles of cognitive performance, self-reported recovery, and education and injury severity. The findings suggest that subtle cognitive impairments after TBI should be interpreted in conjunction with patient's self-reported problems.	[Harman-Smith, Yasmin E.; Mathias, Jane L.] Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia; [Bowden, Stephen C.] Univ Melbourne, Sch Psychol Sci, Dept Psychol, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol & Neurosci, Salt Lake City, UT USA		Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia.	jane.mathias@adelaide.edu.au	Mathias, J L/L-6295-2013; Rosenfeld, Jeffrey V/B-7249-2011	Harman-Smith, Yasmin/0000-0002-9227-8530; Mathias, Jane/0000-0001-8957-8594			Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Babor T. F., 1989, AUDIT ALCOHOL DISORD; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bardenhagen FJ, 1999, NEUROCASE, V5, P325; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blashfield R.K., 1984, CLUSTER ANAL; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Callahan CD, 1997, ARCH CLIN NEUROPSYCH, V12, P133, DOI 10.1016/S0887-6177(96)00029-7; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2001, ASSESSMENT, V8, P193, DOI 10.1177/107319110100800207; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Goldstein G, 2010, BRAIN INJURY, V24, P625, DOI 10.3109/02699051003670882; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Schinka J A, 1997, J Int Neuropsychol Soc, V3, P120; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; WechslerD, 2001, WECHSLER TEST ADULT; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE	40	19	20	1	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT 1	2013	35	8					785	798		10.1080/13803395.2013.824554			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	226TQ	WOS:000325059300001	23947758				2022-02-06	
J	Kramer, AH; Zygun, DA				Kramer, Andreas H.; Zygun, David A.			Declining mortality in neurocritical care patients: a cohort study in Southern Alberta over eleven years	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; HOSPITAL CARDIAC-ARREST; COLLABORATIVE STUDY-GROUP; LIFE-SUSTAINING THERAPY; CASE-FATALITY RATES; INTRACEREBRAL HEMORRHAGE; MECHANICAL VENTILATION; PROGNOSTIC-FACTORS; STROKE	Few interventions have been proven to improve outcomes in neurocritical care patients. It is unknown whether outcomes in Canada have changed over time. We performed a cohort study in Southern Alberta to determine whether survival and discharge disposition have improved. Using prospectively collected data, we identified patients admitted to regional intensive care units (ICUs) over a more than 11-year period with traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), intracerebral hemorrhage, anoxic encephalopathy, central nervous system infection, or status epilepticus. Four sequential time periods of 2.8 years were compared, as were periods before and after various practice modifications were introduced. Logistic regression was used to adjust for patient age, Glasgow Coma Scale score, and case mix. A total of 4,097 patients were assessed. The odds of death were lowest in the most recent time quartile (odds ratio [OR] 0.70, 95% confidence interval [CI] 0.56 to 0.88, P < 0.01). The odds of being discharged home without the need for support services increased over time (OR 1.45, 95% CI 1.38 to 1.85, P = 0.003). Improvements were not the same for all diagnostic subgroups. They were statistically significant for patients with TBI and SAH. Neurocritical care consultative services, evidence-based protocols, and clustering of patients within a multidisciplinary ICU were associated with improved outcomes. Length of stay in an ICU increased among hospital survivors (4.6 vs 3.8 days, P < 0.01). Mortality and discharge disposition of neurocritical care patients in Southern Alberta have improved over time. Practice modifications in the region were associated with positive outcome trends. Longer ICU length of stay may imply that intensivists are increasingly delaying decisions about withdrawing life-sustaining interventions.	[Kramer, Andreas H.] Univ Calgary, Hotchkiss Brain Inst, Foothills Med Ctr, Dept Crit Care Med, Calgary, AB T2N 2T9, Canada; [Kramer, Andreas H.] Univ Calgary, Hotchkiss Brain Inst, Foothills Med Ctr, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada; [Zygun, David A.] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada		Kramer, AH (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Foothills Med Ctr, Dept Crit Care Med, 3134 Hosp Dr NW, Calgary, AB T2N 2T9, Canada.	Andreas.Kramer@AlbertaHealthServices.ca					Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Berthiaume LR, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.07.004; Braga LHP, 2012, CAN J SURG, V55, P132, DOI 10.1503/cjs.036311; Broessner G, 2007, CRIT CARE MED, V35, P2025, DOI 10.1097/01.ccm.0000281449.07719.2b; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caulfield AF, 2010, NEUROLOGY, V74, P1096, DOI 10.1212/WNL.0b013e3181d8197f; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Christensen MC, 2009, STROKE, V40, P1677, DOI 10.1161/STROKEAHA.108.538967; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; de Keizer NF, 2000, INTENS CARE MED, V26, P577, DOI 10.1007/s001340051207; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Groenwold RHH, 2013, CAN MED ASSOC J, V185, P401, DOI 10.1503/cmaj.120592; Gujjar AR, 1998, NEUROLOGY, V51, P447, DOI 10.1212/WNL.51.2.447; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Hemphill JC, 2009, NEUROLOGY, V73, P1088, DOI 10.1212/WNL.0b013e3181b8b332; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Kramer AH, 2012, CAN J NEUROL SCI, V39, P328, DOI 10.1017/S0317167100013469; Kramer AH, 2011, NEUROCRIT CARE, V14, P329, DOI 10.1007/s12028-011-9530-y; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Mateen FJ, 2011, NEUROLOGY, V77, P1438, DOI 10.1212/WNL.0b013e318232ab33; Mayo NE, 1996, STROKE, V27, P1215, DOI 10.1161/01.STR.27.7.1215; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Ostbye T, 1997, STROKE, V28, P793, DOI 10.1161/01.STR.28.4.793; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Racine E, 2009, NEUROCRIT CARE, V11, P345, DOI 10.1007/s12028-009-9225-9; Redpath C, 2010, AM HEART J, V159, P577, DOI 10.1016/j.ahj.2009.12.030; Rocker G, 2004, CRIT CARE MED, V32, P1149, DOI 10.1097/01.CCM.0000126402.51524.52; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sandvei MS, 2011, NEUROLOGY, V77, P1833, DOI 10.1212/WNL.0b013e3182377de3; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vaillancourt C, 2004, CAN J CARDIOL, V20, P1081; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Varelas PN, 2004, CRIT CARE MED, V32, P2191, DOI 10.1097/01.CCM.0000146131.03578.21; Wright WL, 2012, CURR NEUROL NEUROSCI, V12, P466, DOI 10.1007/s11910-012-0284-5; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	70	19	19	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	OCT	2013	60	10					966	975		10.1007/s12630-013-0001-0			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	221DC	WOS:000324636700003	23877315	Bronze			2022-02-06	
J	Nakase-Richardson, R; Tran, J; Cifu, D; Barnett, SD; Horn, LJ; Greenwald, BD; Brunner, RC; Whyte, J; Hammond, FM; Yablon, SA; Giacino, JT				Nakase-Richardson, Risa; Tran, Johanna; Cifu, David; Barnett, Scott D.; Horn, Lawrence J.; Greenwald, Brian D.; Brunner, Robert C.; Whyte, John; Hammond, Flora M.; Yablon, Stuart A.; Giacino, Joseph T.			Do Rehospitalization Rates Differ Among Injury Severity Levels in the NIDRR Traumatic Brain Injury Model Systems Program?	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Consciousness disorders; Rehabilitation; Traumatic brain injuries	PERSISTENT VEGETATIVE STATE; EARLY INTENSIVE NEUROREHABILITATION; PROLONGED UNCONSCIOUS STATE; POSTTRAUMATIC SEIZURES; MULTICENTER ANALYSIS; YOUNG-ADULTS; CHILDREN; TBI	Objective: To compare the rate and nature of rehospitalization in a cohort of patients enrolled in the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems (TBIMS) who have disorders of consciousness (DOC) at the time of rehabilitation admission with those in persons with moderate or severe traumatic brain injury (TBI) but without DOC at rehabilitation admission. Design: Prospective observational study. Setting: Inpatient rehabilitation within TBIMS with annual follow-up. Participants: Of 9028 persons enrolled from 1988 to 2009 (N=9028), 366 from 20 centers met criteria for DOC at rehabilitation admission and follow-up data, and another 5132 individuals met criteria for moderate (n=769) or severe TBI (n=4363). Interventions: Not applicable. Main Outcome Measures: Participants and/or their family members completed follow-up data collection including questions about frequency and nature of rehospitalizations at 1 year postinjury. For the subset of participants with DOC, additional follow-up was conducted at 2 and 5 years postinjury. Results: The DOC group demonstrated an overall 2-fold increase in rehospitalization in the first year postinjury relative to those with moderate or severe TBI without DOC. Persons with DOC at rehabilitation admission have a higher rate of rehospitalization across several categories than persons with moderate or severe TBI. Conclusions: Although the specific details of rehospitalization are unknown, greater injury severity resulting in DOC status on rehabilitation admission has long-term implications. Data highlight the need for a longitudinal approach to patient management. (c) 2013 by the American Congress of Rehabilitation Medicine	[Nakase-Richardson, Risa] James A Haley Vet Hosp, Div MHBS, Tampa, FL 33612 USA; [Tran, Johanna; Barnett, Scott D.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Nakase-Richardson, Risa; Barnett, Scott D.] Ctr Excellence Maximizing Rehabil Outcomes, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Tran, Johanna] Univ S Florida, Dept Med, Tampa, FL USA; [Cifu, David] Hunter Holmes McGuire VA Hosp, Div PMRS, Richmond, VA USA; [Cifu, David] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Horn, Lawrence J.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Greenwald, Brian D.; Giacino, Joseph T.] Robert Wood Johnson Med Sch, JFK Johnson Rehabil Inst, Ctr Head Injuries, Edison, NJ USA; [Greenwald, Brian D.] Robert Wood Johnson Med Sch, Dept Phys Med & Rehabil, Edison, NJ USA; [Brunner, Robert C.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Yablon, Stuart A.] Glenrose Rehabil Hosp, Edmonton, AB, Canada; [Yablon, Stuart A.] Univ Alberta, Div Phys Med & Rehabil, Edmonton, AB, Canada; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Rehabil Neuropsychololgy, Boston, MA USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd 116-B, Tampa, FL 33612 USA.	Risa.Richardson@va.gov	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Tran, Johanna/0000-0001-6231-5620; Cifu, David/0000-0003-1600-9387; Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [H133A060038, H133A070036, H133A-080044, H133A070083, H133A070039, H133A070040, H133A070042, H133A070027, H133A120085]; Health Services Research and Development/Rehabilitation Research and Development Center of Excellence for Maximizing Rehabilitation Outcomes [COE - HFP 09-156]	Supported by the National Institute on Disability and Rehabilitation Research, United States Department of Education (grant nos. H133A060038 [TBI Model System National Data and Statistical Center], H133A070036 [Virginia Commonwealth TBI Model System], H133A-080044 [Southeastern Michigan TBI System], H133A070083 [Mount Sinai School of Medicine], H133A070039 [University of Alabama TBIMS], H133A070040 [Moss TBI Model System], H133A070042 [Carolinas Traumatic Brain Injury Rehabilitation and Research System], H133A070027 [North Texas TBI Model System], H133A120085 [Spaulding-Harvard TBI Model System]). The contents of the article do not necessarily represent the policy of the Department of Education, and endorsement by the Federal Govemment should not be assumed. Statistical support provided by the Health Services Research and Development/Rehabilitation Research and Development Center of Excellence for Maximizing Rehabilitation Outcomes (grant no. COE - HFP 09-156).	BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; FIELDS AI, 1993, CRIT CARE MED, V21, P1890, DOI 10.1097/00003246-199312000-00016; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983	20	19	19	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2013	94	10					1884	1890		10.1016/j.apmr.2012.11.054			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	231TU	WOS:000325442100006	23770278				2022-02-06	
J	Ansari, MA; Roberts, KN; Scheff, SW				Ansari, Mubeen A.; Roberts, Kelly N.; Scheff, Stephen W.			Dose- and Time-Dependent Neuroprotective Effects of Pycnogenol (R) following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						bioflavonoids; natural compounds; neurotrauma; oxidative stress; pycnogenol; synaptic proteins; traumatic brain injury	OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; AKT PHOSPHORYLATION; CORTICAL CONTUSION; SIGNALING PATHWAYS; SYNAPTIC PROTEINS; GENE-EXPRESSION; MOUSE MODEL; FLAVONOIDS; NEURONS	After traumatic brain injury (TBI), both primary and secondary injury cascades are initiated, leading to neuronal death and cognitive dysfunction. We have previously shown that the combinational bioflavonoid, Pycnogenol (R) (PYC), alters some secondary injury cascades and protects synaptic proteins when administered immediately following trauma. The purpose of the present study was to explore further the beneficial effects of PYC and to test whether it can be used in a more clinically relevant fashion. Young adult male Sprague-Dawley rats were subjected to a unilateral moderate/severe cortical contusion. Subjects received a single intravenous (i.v.) injection of PYC (1, 5, or 10 mg/kg) or vehicle, with treatment initiated at 15 min, 2 h, or 4 h post injury. All rats were killed at 96 h post TBI. Both the cortex and hippocampus ipsilateral and contralateral to the injury were evaluated for possible changes in oxidative stress (thiobarbituric acid reactive species; TBARS) and both pre- and post-synaptic proteins (synapsin-I, synaptophysin, drebrin, post synaptic density protein-95, and synapse associated protein-97). Following TBI, TBARS were significantly increased in both the injured cortex and ipsilateral hippocampus. Regardless of the dose and delay in treatment, PYC treatment significantly lowered TBARS. PYC treatment significantly protected both the cortex and hippocampus from injury-related declines in pre- and post-synaptic proteins. These results demonstrate that a single i.v. treatment of PYC is neuroprotective after TBI with a therapeutic window of at least 4 h post trauma. The natural bioflavonoid PYC may provide a possible therapeutic intervention in neurotrauma.	[Ansari, Mubeen A.; Roberts, Kelly N.; Scheff, Stephen W.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Scheff, SW (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging 101, Lexington, KY 40536 USA.	sscheff@email.uky.edu		Ansari, Mubeen Ahmad/0000-0002-1132-5965	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS66117]; Kentucky Spinal Cord Brain Injury Trust [12-16A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS066117] Funding Source: NIH RePORTER	This work was supported by National Institute of Health Grant R21NS66117 and Kentucky Spinal Cord Brain Injury Trust 12-16A. Pycnogenol (R) was a very generous gift from Horphag Research Inc., Hoboken, NJ.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P1510, DOI 10.1016/j.freeradbiomed.2008.08.025; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Azevedo MF, 2010, PHYTOTHER RES, V24, pS220, DOI 10.1002/ptr.3118; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Cayabyab FS, 2000, EUR J NEUROSCI, V12, P1949, DOI 10.1046/j.1460-9568.2000.00083.x; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cho KJ, 2001, ANN NY ACAD SCI, V928, P141; de la Monte SM, 2000, CELL MOL LIFE SCI, V57, P1471, DOI 10.1007/PL00000630; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Faul M, 2010, TRAUMATIC BRAIN INJU; Gamet-Payrastre L, 1999, GEN PHARMACOL-VASC S, V32, P279, DOI 10.1016/S0306-3623(98)00220-1; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hu LY, 2010, NEUROSCIENCE, V169, P1046, DOI 10.1016/j.neuroscience.2010.05.046; Ince I, 2009, PHYTOMEDICINE, V16, P1101, DOI 10.1016/j.phymed.2009.05.004; Itoh T, 2011, NEUROMOL MED, V13, P300, DOI 10.1007/s12017-011-8162-x; Johnson JL, 2011, J MED FOOD, V14, P325, DOI 10.1089/jmf.2010.0310; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kotulska K, 2006, J NEUROSCI RES, V84, P1091, DOI 10.1002/jnr.21000; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McIntosh TK, 1996, LAB INVEST, V74, P315; Mercer LD, 2005, BIOCHEM PHARMACOL, V69, P339, DOI 10.1016/j.bcp.2004.09.018; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Parajuli P, 2011, J NEURO-ONCOL, V101, P15, DOI 10.1007/s11060-010-0221-x; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; Ryan J, 2008, J PSYCHOPHARMACOL, V22, P553, DOI 10.1177/0269881108091584; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schroeter H, 2001, BIOCHEM J, V358, P547, DOI 10.1042/0264-6021:3580547; Schultke E, 2005, J NEUROTRAUM, V22, P1475, DOI 10.1089/neu.2005.22.1475; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z; Tunon MJ, 2009, CURR DRUG METAB, V10, P256, DOI 10.2174/138920009787846369; Vauzour D, 2007, J NEUROCHEM, V103, P1355, DOI 10.1111/j.1471-4159.2007.04841.x; de la Torre AV, 2012, PHARMACOL RES, V65, P66, DOI 10.1016/j.phrs.2011.08.006; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yen TL, 2012, J AGR FOOD CHEM, V60, P1937, DOI 10.1021/jf204909p	62	19	19	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2013	30	17					1542	1549		10.1089/neu.2013.2910			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	202HX	WOS:000323205800010	23557184	Green Published			2022-02-06	
J	Cartagena, CM; Phillips, KL; Williams, GL; Konopko, M; Tortella, FC; Dave, JR; Schmid, KE				Cartagena, Casandra M.; Phillips, Katie L.; Williams, Garry L.; Konopko, Melissa; Tortella, Frank C.; Dave, Jitendra R.; Schmid, Kara E.			Mechanism of Action for NNZ-2566 Anti-inflammatory Effects Following PBBI Involves Upregulation of Immunomodulator ATF3	NEUROMOLECULAR MEDICINE			English	Article						NNZ-2566; Penetrating ballistic-like brain injury; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; NATURAL-KILLER-CELLS; GLY-PRO-GLU; RAT MODEL; IN-VIVO; GLYPROMATE ANALOG; NERVOUS-SYSTEM; EXPRESSION; ASTROCYTES; ENCEPHALOMYELITIS	The tripeptide glycine-proline-glutamate analogue NNZ-2566 (Neuren Pharmaceuticals) demonstrates neuroprotective efficacy in models of traumatic brain injury. In penetrating ballistic-like brain injury (PBBI), it significantly decreases injury-induced upregulation of inflammatory cytokines including TNF-alpha, IFN-gamma, and IL-6. However, the mechanism by which NNZ-2566 acts has yet to be determined. The activating transcription factor-3 (ATF3) is known to repress expression of these inflammatory cytokines and was increased at the mRNA and protein level 24-h post-PBBI. This study investigated whether 12 h of NNZ-2566 treatment following PBBI alters atf3 expression. PBBI alone significantly increased atf3 mRNA levels by 13-fold at 12 h and these levels were increased by an additional fourfold with NNZ-2566 treatment. To confirm that changes in mRNA translated to changes in protein expression, ATF3 expression levels were determined in vivo in microglia/macrophages, T cells, natural killer cells (NKCs), astrocytes, and neurons. PBBI alone significantly increased ATF3 in microglia/macrophages (820 %), NKCs (58 %), and astrocytes (51 %), but decreased levels in T cells (48 %). NNZ-2566 treatment further increased ATF3 protein expression in microglia/macrophages (102 %), NKCs (308 %), and astrocytes (13 %), while reversing ATF3 decreases in T cells. Finally, PBBI increased ATF3 levels by 55 % in neurons and NNZ-2566 treatment further increased these levels an additional 33 %. Since increased ATF3 may be an innate protective mechanism to limit inflammation following injury, these results demonstrating that the anti-inflammatory and neuroprotective drug NNZ-2566 increase both mRNA and protein levels of ATF3 in multiple cell types provide a cellular mechanism for NNZ-2566 modulation of neuroinflammation following PBBI.	[Cartagena, Casandra M.; Phillips, Katie L.; Williams, Garry L.; Konopko, Melissa; Tortella, Frank C.; Dave, Jitendra R.; Schmid, Kara E.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Cartagena, CM (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	casandra.cartagena@us.army.mil; katie.phillips1@us.army.mil; garryleejr@hotmail.com; melissa.konopko@gmail.com; frank.c.tortella@us.army.mil; jitendra.ramanlal.dave@us.army.mil; kara.schmid@us.army.mil	Dave, Jitendra R/A-8940-2011	Konopko, Melissa/0000-0001-9515-398X	Neuren Pharmaceuticals Ltd. [W81XWH-05-0074]	We would like to thank Matthew Bombard and Weihong Yang for their excellent assistance with surgical procedures. These studies were supported in part by a cooperative research and development agreement with Neuren Pharmaceuticals Ltd. (W81XWH-05-0074). This material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official, or reflecting true views of the Department of the Army or the Department of Defense.	Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Bickerdike MJ, 2009, J NEUROL SCI, V278, P85, DOI 10.1016/j.jns.2008.12.003; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Byram SC, 2003, BRAIN BEHAV IMMUN, V17, P417, DOI 10.1016/S0889-1591(03)00089-8; Cartagena CM, 2008, J NEUROTRAUM, V25, P1087, DOI 10.1089/neu.2007.0444; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Francis JS, 2004, MOL BRAIN RES, V124, P199, DOI 10.1016/j.molbrainres.2003.10.027; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hammarberg H, 2000, J NEUROSCI, V20, P5283, DOI 10.1523/JNEUROSCI.20-14-05283.2000; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Massi L, 2012, J NEUROSCI, V32, P16496, DOI 10.1523/JNEUROSCI.3475-12.2012; Matsumoto Y, 1998, EUR J IMMUNOL, V28, P1681, DOI 10.1002/(SICI)1521-4141(199805)28:05<1681::AID-IMMU1681>3.0.CO;2-T; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Perussia Bice, 1996, Methods (Orlando), V9, P370, DOI 10.1006/meth.1996.0042; Raivich G, 1998, J NEUROSCI, V18, P5804; Rosenberger CM, 2008, P NATL ACAD SCI USA, V105, P2544, DOI 10.1073/pnas.0712182105; Saura J, 1999, NEUROREPORT, V10, P161, DOI 10.1097/00001756-199901180-00031; Schousboe A, 2005, NEUROTOX RES, V8, P221, DOI 10.1007/BF03033975; Schroeter M, 2005, NEUROMOL MED, V7, P183, DOI 10.1385/NMM:7:3:183; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Vianney-Rodrigues P, 2011, EUR J NEUROSCI, V33, P119, DOI 10.1111/j.1460-9568.2010.07487.x; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011	43	19	19	0	12	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084			NEUROMOL MED	Neuromol. Med.	SEP	2013	15	3					504	514		10.1007/s12017-013-8236-z			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	195RW	WOS:000322722300006	23765588	Green Submitted			2022-02-06	
J	Holley, MAB; Petteys, S; Mitchell, JD; Holley, PR; Collen, JF				Holley, Maj (P) Aaron B.; Petteys, Sarah; Mitchell, Joshua D.; Holley, Paul R.; Collen, Jacob F.			Thromboprophylaxis and VTE Rates in Soldiers Wounded in Operation Enduring Freedom and Operation Iraqi Freedom	CHEST			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP VENOUS THROMBOSIS; TRAUMATIC BRAIN-INJURY; THROMBOEMBOLISM PROPHYLAXIS; PULMONARY-EMBOLISM; VEIN THROMBOSIS; MAJOR TRAUMA; PHARMACOLOGICAL PROPHYLAXIS; INTRACRANIAL HEMORRHAGE; UNFRACTIONATED HEPARIN	Objectives: US soldiers suffer catastrophic injuries during combat. We sought to define risk factors and rates for VTE in this population. Methods: We gathered data each hospital day on all patients injured in Afghanistan or Iraq who were admitted to the Walter Reed Army Medical Center (WRAMC). We analyzed prophylaxis rates and efficacy and identified risk factors for VTE. Results: We recorded data on 506 combat casualties directly admitted to WRAMC after medical air evacuation. The average injury severity score for the group was 18.4 +/- 11.7, and the most common reason for air evacuation was injury by improvised explosive device (65%). As part of the initial resuscitation, patients received 4.7 +/- 9.0 and 4.00 +/- 7.8 units of packed RBCs and fresh frozen plasma, respectively, and 42 patients received factor VIIa. Forty-six patients (9.1%) were given a diagnosis of VTE prior to discharge, 18 (3.6%) during air evacuation, and 28 (5.5%) during the hospital stay. In Cox regression analysis, administration of 1 unit of packed RBCs was associated with a hazard ratio (HR) of 1.04 (95% CI, 1.02-1.07; P = .002), and enoxaparin, 30 mg bid, administered subcutaneously for the majority of hospital days was associated with a HR of 0.31 (95% CI, 0.11-0.86; P = .02) for VTE during the hospitalization. Conclusions: Patients who suffer traumatic injuries in combat overseas are at high risk for VTE during evacuation and recovery. Those with large resuscitations are at particularly high risk, and low-molecular-weight heparin is associated with a decrease in VTE.	[Holley, Maj (P) Aaron B.; Collen, Jacob F.] Walter Reed Natl Mil Med Ctr, Dept Pulm Crit Care & Sleep Med, Bethesda, MD 20889 USA; [Petteys, Sarah; Mitchell, Joshua D.] Walter Reed Natl Mil Med Ctr, Dept Internal Med, Bethesda, MD 20889 USA; [Holley, Paul R.] US Army Med Res Inst Infect Dis, Dept Informat, Frederick, MD USA		Holley, MAB (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Pulm Crit Care & Sleep Med, 8901 Rockville Pike, Bethesda, MD 20889 USA.	aholley9@gmail.com	Mitchell, Joshua/AAY-8104-2020	Mitchell, Joshua/0000-0001-7371-5742			Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; [Anonymous], 2008, JTTS CLIN PRACT GUID; [Anonymous], 2010, JOINT THEAT TRAUM SY; [Anonymous], 2007, JOINT THEAT TRAUM SY; Arnold JD, 2010, AM SURGEON, V76, P563; Carrier M, 2010, J THROMB HAEMOST, V8, P1716, DOI 10.1111/j.1538-7836.2010.03938.x; Chung KK, 2008, J TRAUMA, V65, P19, DOI 10.1097/TA.0b013e3181271b8a; Cohn SM, 1999, VASCULAR SURG, V33, P219, DOI 10.1177/153857449903300219; Cook D, 2005, CRIT CARE MED, V33, P1565, DOI 10.1097/01.CCM.0000171207.95319.B2; Depew AJ, 2008, AM SURGEON, V74, P906; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gillern SM, 2011, J TRAUMA, V71, P607, DOI 10.1097/TA.0b013e3182282574; Ginzburg E, 2003, BRIT J SURG, V90, P1338, DOI 10.1002/bjs.4309; Gould MK, 2012, CHEST S, V141, pe227S; GREEN D, 1990, ANN INTERN MED, V113, P571, DOI 10.7326/0003-4819-113-8-571; Greenfield LJ, 1997, J TRAUMA, V42, P100, DOI 10.1097/00005373-199701000-00017; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; Horlocker TT, 2003, REGION ANESTH PAIN M, V28, P172, DOI 10.1053/rapm.2003.50046; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Malinoski D, 2010, J TRAUMA, V68, P874, DOI 10.1097/TA.0b013e3181d32271; Menaker J, 2009, J TRAUMA, V67, P1244, DOI 10.1097/TA.0b013e31818c173a; Moser, 1988, J INTENSIVE CARE MED, V3, P87, DOI DOI 10.1177/088506668800300205; Murray CK, 2008, J TRAUMA, V64, pS232, DOI 10.1097/TA.0b013e318163c3f5; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Netto FS, 2012, INJURY, V43, P1502, DOI 10.1016/j.injury.2010.12.028; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; SEVITT S, 1961, BRIT J SURG, V48, P475, DOI 10.1002/bjs.18004821103; Stannard JP, 2006, J BONE JOINT SURG AM, V88A, P261, DOI 10.2106/JBJS.D.02932; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3; Velmahos GC, 2006, AM SURGEON, V72, P757; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; White RH, 2010, THROMB RES, V126, P61, DOI 10.1016/j.thromres.2010.03.009	41	19	21	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-3692			CHEST	Chest	SEP	2013	144	3					966	973		10.1378/chest.12-2879			8	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	241JC	WOS:000326161700035	23539197				2022-02-06	
J	Khaksari, M; Keshavarzi, Z; Gholamhoseinian, A; Bibak, B				Khaksari, Mohammad; Keshavarzi, Zakieh; Gholamhoseinian, Ahmad; Bibak, Bahram			The effect of female sexual hormones on the intestinal and serum cytokine response after traumatic brain injury: different roles for estrogen receptor subtypes	CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Article						proinflammatory cytokines; gut; brain injury; estrogen receptors	NF-KAPPA-B; GASTRIC-ACID; INFLAMMATORY CYTOKINES; STEROID-HORMONES; BARRIER FUNCTION; DOWN-REGULATION; UP-REGULATION; NITRIC-OXIDE; TNF-ALPHA; PROGESTERONE	The purpose of this study was to evaluate the effect of female sexual hormones on intestinal and serum cytokines following traumatic brain injury (TBI). Adult female rats were ovariectomized and distributed among the following 9 groups: (i) sham trauma, (ii) TBI (Marmarou's method), (iii) vehicle (dimethylsulfoxide) treated, (iv) estrogen (E2) treated, (v) progesterone (P) treated, (vi) treated with E2+P, (vii) propylpyrazole triol (PPT) treated, (viii) diarylpropionitrile (DPN) treated, and (ix) control. PPT and DPN are estrogen receptor alpha and beta agonists, respectively. Serum and intestinal levels of interleukin (IL)-1 beta were increased by TBI (P < 0.001). The level of intestinal IL-1 beta was increased in the group treated with E2 (P < 0.001). There was a reduction in serum IL-1 beta (P < 0.01) and an increase in intestinal IL-1 beta level (P < 0.001) in the PPT-treated group compared with the vehicle-treated group. TBI reduced serum IL-6 (P < 0.01) and increased intestinal IL-6 (P < 0.001). Serum IL-6 was increased in the group treated with E2 (P < 0.001), P (P < 0.001), E2+P (P < 0.01), and DPN (P < 0.001) after TBI; however, intestinal IL-6 was higher in the E2-treated group compared with the vehicle-treated group (P < 0.01). Intestinal tumor necrosis factor alpha (TNF-alpha) was increased by TBI (P < 0.001). Progesterone decreased serum TNF-alpha (P < 0.01). Intestinal TNF-alpha in the E2 (P < 0.01), E2+P (P < 0.001), and PPT (P < 0.001) treatment groups was less than in the vehicle-treated group. In conclusion, estrogen influences the intestinal levels of proinflammatory cytokines, in particular TNF-alpha, mediated through estrogen receptor alpha	[Khaksari, Mohammad] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman 76175113, Iran; [Keshavarzi, Zakieh] Kerman Univ Med Sci, Physiol Res Ctr, Kerman 76175113, Iran; [Gholamhoseinian, Ahmad] Kerman Univ Med Sci, Fac Med, Kerman 76175113, Iran; [Bibak, Bahram] Bojnurd Univ Med Sci, Bojnurd, Iran		Keshavarzi, Z (corresponding author), Kerman Univ Med Sci, Physiol Res Ctr, Kerman 76175113, Iran.	zakieh_keshavarzi@yahoo.com	Haddad, Mohammad Khaksari/AAB-9025-2019; Najar, Ahmad Gholamhoseinian/AAD-1367-2021; Keshavarzi, Zakieh/ABG-4268-2020	Haddad, Mohammad Khaksari/0000-0003-0770-4281; Najar, Ahmad Gholamhoseinian/0000-0003-3550-6290; 			ARJANDI BH, 1993, BONE MINER, V21, P63; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; BARTON BE, 1993, INFECT IMMUN, V61, P1496, DOI 10.1128/IAI.61.4.1496-1499.1993; Brzozowski T, 2000, EUR J PHARMACOL, V398, P147, DOI 10.1016/S0014-2999(00)00287-9; Castillo L, 1999, REV MED CHILE, V127, P639; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Chen JG, 2008, AM J PHYSIOL-GASTR L, V295, pG1131, DOI 10.1152/ajpgi.90443.2008; Colucci M, 2008, PHARMACOL RES, V57, P419, DOI 10.1016/j.phrs.2008.04.004; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; Deitch EA, 2008, SHOCK, V29, P78, DOI 10.1097/shk.0b013e318063e98a; Doucet D., 2010, PLOS ONE, V5, pe9422, DOI [10.1371/journal.pone.0009421, DOI 10.1371/J0URNAL.P0NE.0009421.PMID:20195535]; FRANKS AK, 1991, INFECT IMMUN, V59, P2609, DOI 10.1128/IAI.59.8.2609-2614.1991; FURNER SE, 1989, CANCER RES, V49, P4936; GIROUD M, 1991, INT J EPIDEMIOL, V20, P892, DOI 10.1093/ije/20.4.892; Gunel O, 2003, INFLAMMATION, V27, P351; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Harnish DC, 2006, CURR OPIN INVESTIG D, V7, P997; Hildebrand F, 2005, UNFALLCHIRURG, V108, P793, DOI 10.1007/s00113-005-1005-1; HOGABOAM CM, 1993, J IMMUNOL, V151, P3767; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Kawano N, 2004, HISTOCHEM CELL BIOL, V121, P399, DOI 10.1007/s00418-004-0644-6; Keck C, 1998, EXP CLIN ENDOCR DIAB, V106, P334, DOI 10.1055/s-0029-1211994; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Knoferl MW, 2000, ARCH SURG-CHICAGO, V135, P425, DOI 10.1001/archsurg.135.4.425; Lan L, 1999, MOL CELL ENDOCRINOL, V155, P123, DOI 10.1016/S0303-7207(99)00066-0; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Loftus EV, 2002, GASTROENTEROL CLIN N, V31, P1, DOI 10.1016/S0889-8553(01)00002-4; Malisorn N, 2010, AFR J PHARM PHARMACO, V4, P806; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin GR, 2006, EXP BIOL MED, V231, P130; Mazzon E, 2006, SHOCK, V25, P515, DOI 10.1097/01.shk.0000209556.31457.e7; Mizushima Y, 2000, ANN SURG, V232, P673, DOI 10.1097/00000658-200011000-00009; OLSON ME, 1986, CAN VET J, V27, P523; PALMER RMJ, 1993, BIOCHEM BIOPH RES CO, V193, P398, DOI 10.1006/bbrc.1993.1637; Partrick DA, 1997, J TRAUMA, V43, P297, DOI 10.1097/00005373-199708000-00015; Picotto G, 1999, BIOCHEM J, V339, P71, DOI 10.1042/0264-6021:3390071; Pioli PA, 2007, J IMMUNOL, V179, P6284, DOI 10.4049/jimmunol.179.9.6284; Playford RJ, 2005, J PATHOL, V205, P417, DOI 10.1002/path.1722; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; SAPERAS ES, 1990, GASTROENTEROLOGY, V99, P1599, DOI 10.1016/0016-5085(90)90463-B; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; SEKUT L, 1995, CLIN EXP IMMUNOL, V99, P461; Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; SHIBASAKI T, 1991, LIFE SCI, V48, P2267, DOI 10.1016/0024-3205(91)90342-9; Smith A, 2008, ENDOCRINOLOGY, V149, P4554, DOI 10.1210/en.2007-1597; Stadnyk AW, 2002, CAN J GASTROENTEROL, V16, P241, DOI 10.1155/2002/941087; Stice JP, 2008, MOL MED, V14, P517, DOI 10.2119/2008-00026.Stice; Telleria CM, 1998, ENDOCRINOLOGY, V139, P3597, DOI 10.1210/en.139.8.3597; THOMAS ML, 1993, ENDOCRINOLOGY, V132, P426, DOI 10.1210/en.132.1.426; UEHARA A, 1989, BIOCHEM BIOPH RES CO, V162, P1578, DOI 10.1016/0006-291X(89)90855-3; Vural P, 2006, PHARMACOL RES, V54, P298, DOI 10.1016/j.phrs.2006.06.006; WALLACE JL, 1991, AM J PHYSIOL, V261, pG559, DOI 10.1152/ajpgi.1991.261.4.G559; WALLACE JL, 1992, GASTROENTEROLOGY, V102, P1176; WALLACE JL, 1990, EUR J PHARMACOL, V186, P279, DOI 10.1016/0014-2999(90)90444-B; Won CK, 2006, J VET MED SCI, V68, P277, DOI 10.1292/jvms.68.277; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; WU KK, 1991, P NATL ACAD SCI USA, V88, P2384, DOI 10.1073/pnas.88.6.2384; Yang Xia, 2006, Shengli Xuebao, V58, P275; Yu HP, 2007, J LEUKOCYTE BIOL, V82, P774, DOI 10.1189/jlb.0307182; Yu HP, 2009, SHOCK, V31, P227, DOI 10.1097/SHK.0b013e31818347e7; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596	68	19	19	0	11	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4212	1205-7541		CAN J PHYSIOL PHARM	Can. J. Physiol. Pharmacol.	SEP	2013	91	9					700	707		10.1139/cjpp-2012-0359			8	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	208VS	WOS:000323710300007	23984641				2022-02-06	
J	Leon-Carrion, J; Machuca-Murga, F; Solis-Marcos, I; Leon-Dominguez, U; Dominguez-Morales, MD				Leon-Carrion, Jose; Machuca-Murga, Fernando; Solis-Marcos, Ignacio; Leon-Dominguez, Umberto; del Rosario Dominguez-Morales, Maria			The sooner patients begin neurorehabilitation, the better their functional outcome	BRAIN INJURY			English	Article						Early treatment; FAM; functional outcome; FIM; neurorehabilitation programmes; traumatic brain injury	TRAUMATIC BRAIN-INJURY; REHABILITATION	Primary objective: To determine whether early neurorehabilitation improves a patient's functional recovery. Research design: A retrospective study was carried out on patients with severe traumatic brain injury (TBI) who underwent a minimum of 4 months of integral and multidisciplinary neurorehabilitation. Methods and procedures: Fifty-eight patients with severe TBI were assessed at admission and at discharge using the FIM+FAM scale. Two groups were formed based on time elapsed from brain injury to onset of rehabilitation. The early treatment group (ET) included patients who began rehabilitation within the first 9 months post-trauma; the late treatment group (LT) began after the 9-month cut-off date. Intra-and between-group analysis of FIM+FAM scores were carried out at admission and discharge. Multiple linear regression was used to determine the best predictors for functional rehabilitation. Main outcomes and results: After neurorehabilitation, all subjects showed significant improvement in cognitive, motor, communication and psychosocial functioning. Moreover, the ET group showed better global functional outcome at discharge than patients who began later treatment. The best predictors for functional neurorehabilitation were months since injury, age, GCS score and months of treatment. Conclusions: It is concluded that the sooner patients begin neurorehabilitation, the better their functional outcome.	[Leon-Carrion, Jose; Machuca-Murga, Fernando; Solis-Marcos, Ignacio] Univ Seville, Dept Expt Psychol, Sch Psychol, Human Neuropsychol Lab, Seville 41005, Spain; [Leon-Dominguez, Umberto; del Rosario Dominguez-Morales, Maria] Ctr Brain Injury Rehabil CRECER, Seville, Spain		Leon-Carrion, J (corresponding author), Univ Seville, C Camilo Jose Cela S-N, Seville 41005, Spain.	leoncarrion@us.es	Marcos, Ignacio Solis/AAE-9161-2019	Marcos, Ignacio Solis/0000-0001-9309-5552; Leon-Dominguez, Umberto/0000-0001-5170-2553			Calzavacca P, 2008, INTENS CARE MED, V34, P2112, DOI 10.1007/s00134-008-1229-y; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Cope DN, 2004, TXB TRAUMATIC BRAIN, P559; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Leon Carrion J., 2001, REV ESPANOLA NEUROPS, V3, P58; Leon Carrion J, 1997, NEUROPSYCHOLOGICAL R; Leon-Carrion J, 2006, BRAIN INJURY TREATME; Leon-Carrion J, 2012, J REHABIL MED, V44, P505, DOI 10.2340/16501977-0982; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Pistarini C, 1997, ADV NEUROTRAUMA RES, P114; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa	20	19	20	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2013	27	10					1119	1123		10.3109/02699052.2013.804204			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	204KW	WOS:000323365200003	23895589				2022-02-06	
J	Mrazik, M; Naidu, D; Lebrun, C; Game, A; Matthews-White, J				Mrazik, Martin; Naidu, Dhiren; Lebrun, Constance; Game, Alex; Matthews-White, Joan			Does an Individual's Fitness Level Affect Baseline Concussion Symptoms?	JOURNAL OF ATHLETIC TRAINING			English	Article						sports; traumatic brain injuries; assessment; self-report symptoms	SHUTTLE RUN TEST; VALIDITY; SCALE	Context: Variables that may influence baseline concussion symptoms should be investigated. Objective: To evaluate the effect of physical fitness on self-report of baseline concussion symptoms in collegiate athletes and students. Design: Controlled laboratory study. Patients or Other Participants: A total of 125 undergraduates, including 95 collegiate athletes and 30 recreational athletes (83 males, 42 females). Intervention(s): Participants completed the Standardized Concussion Assessment Tool 2 (SCAT2; symptom report) at baseline, within 10 minutes of completing the Leger test, and within 24 hours of the initial baseline test. The Leger (beep) test is a shuttle-run field test used to predict maximal aerobic power. Main Outcome Measure(s): The total symptom score on the SCAT2 was calculated and analyzed with a repeated-measures analysis of variance. A linear regression analysis was used to determine if 3 variables (sport type, sex, or fitness level) accounted for a significant amount of the variance in the baseline symptom report. Results: Participants reported more symptoms postactivity but fewer symptoms at 24 hours compared with baseline, representing a time effect in our model (F-2,F-234 = 47.738, P < .001). No interactions were seen among the independent variables. We also found an effect for fitness level, with fitter individuals reporting fewer symptoms at all 3 time intervals. The regression analysis revealed that fitness level accounted for a significant amount of the variance in SCAT2 symptoms at baseline (R-2 = 0.22, F-3,F-121 = 11.44, P < .01). Conclusions: Fitness level affected the baseline concussion symptom report. Exercise seems to induce concussion symptom reporting, and symptom severity may be a function of an athlete's level of conditioning. Sports medicine professionals should consider an athlete's level of fitness when conducting baseline concussion symptom assessments.	[Mrazik, Martin; Naidu, Dhiren; Lebrun, Constance; Game, Alex; Matthews-White, Joan] Univ Alberta, Edmonton, AB T6G 2G5, Canada		Mrazik, M (corresponding author), Univ Alberta, 6-135 Educ North, Edmonton, AB T6G 2G5, Canada.	mrazik@ualberta.ca					Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; American College of Sports Medicine, 2010, ACSMS GUID EX TEST P; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Ferrara Michael S., 2001, J Athl Train, V36, P145; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; LEGER L, 1989, CAN J SPORT SCI, V14, P21; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McCrory Paul, 2009, Scand J Med Sci Sports, V19, P452, DOI 10.1111/j.1600-0838.2009.00978.x; Mihalik JP, 2009, J SCI MED SPORT, V12, P383, DOI 10.1016/j.jsams.2008.05.003; Patel AV, 2007, J ATHL TRAINING, V42, P66; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Stickland MK, 2003, CAN J APPL PHYSIOL, V28, P272, DOI 10.1139/h03-021	17	19	19	0	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2013	48	5					654	658		10.4085/1062-6050-48.3.19			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	268AR	WOS:000328140600009	23725489	Green Published, Bronze			2022-02-06	
J	Rosario, ER; Aqeel, R; Brown, MA; Sanchez, G; Moore, C; Patterson, D				Rosario, Emily R.; Aqeel, Rubina; Brown, Meghan A.; Sanchez, Gabriel; Moore, Colleen; Patterson, David			Hypothalamic-Pituitary Dysfunction Following Traumatic Brain Injury Affects Functional Improvement During Acute Inpatient Rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						functional independence measure (FIM); growth hormone; hypogonadism; hypopituitarism; IGF-1; rehabilitation; testosterone	GROWTH-HORMONE DEFICIENCY; QUALITY-OF-LIFE; PROSTATE-CANCER; LONG-TERM; HYPOPITUITARISM; TESTOSTERONE; ADULTS; HYPOGONADISM; PREVALENCE; INSUFFICIENCY	Objective: To evaluate the occurrence of hypothalamic-pituitary dysfunction following a traumatic brain injury (TBI) and to determine its effect on functional improvement in acute inpatient rehabilitation. Methods: A retrospective chart review identified male patients with a primary diagnosis of TBI with or without a skull fracture, an onset date within 6 months prior to admission, and were 16 years of age or older. The percentage of individuals in this population with abnormal hormone levels was determined on the basis of the established normal reference range for each hormone assay. The functional independence measure, which assesses functional outcomes in acute inpatient rehabilitation, was used to examine the relationship between hormone levels and functional improvement. Results: Hypothalamic-pituitary dysfunction was identified in nearly 70% of men following TBI. Hypogonadism, or low testosterone levels, was observed in 66% of the patients, followed by low levels of free T-4 in 46% and low levels of insulin growth factor-1 in 26% of patients. Hypopituitarism associated with impaired functional recovery. Specifically, the functional independence measure change per day was significantly lower in patients with low levels of testosterone and insulin growth factor-1. Conclusions: These findings suggest the importance of testosterone and insulin growth factor-1 activity in the early stages of physical and cognitive rehabilitation.	[Rosario, Emily R.; Aqeel, Rubina; Brown, Meghan A.; Sanchez, Gabriel; Moore, Colleen; Patterson, David] Casa Colina Hosp Rehabil Med, Pomona, CA 91769 USA		Rosario, ER (corresponding author), Casa Colina Hosp Rehabil Med, 255 E Bonita Ave, Pomona, CA 91769 USA.	erosario@casacolina.org	Brown, Meghan/AAM-4944-2020		Casa Colina Centers for Rehabilitation Foundation	The authors thank the Casa Colina Centers for Rehabilitation Foundation for supporting this research.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aimaretti G, 2005, THESCIENTIFICWORLDJO, V5, P777, DOI 10.1100/tsw.2005.100; Arwert LI, 2005, FRONT HORM RES, V33, P196, DOI 10.1159/000088425; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bassil Nazem, 2009, Ther Clin Risk Manag, V5, P427; Bassil N, 2010, CLIN GERIATR MED, V26, P197, DOI 10.1016/j.cger.2010.02.003; Bassil N, 2010, CLIN GERIATR MED, V26, P57, DOI 10.1016/j.cger.2009.12.004; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Chu LW, 2008, J AM GERIATR SOC, V56, P1286, DOI 10.1111/j.1532-5415.2008.01746.x; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Creyghton Wouter M, 2004, Semin Vasc Med, V4, P167, DOI 10.1055/s-2004-835375; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Dusick JR, 2008, PITUITARY, V4, P23; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P541, DOI 10.1097/00001199-200311000-00008; Faul M, 2010, TRAUMATIC BRAIN INJU; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; GOLDENBERG SL, 1995, UROLOGY, V45, P839; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; High WM, 2010, J NEUROTRAUMA; Hohl A, 2009, ARQ BRAS ENDOCRINOL, V53, P1012, DOI 10.1590/S0004-27302009000800016; Janowsky JS, 2000, J COGNITIVE NEUROSCI, V12, P407, DOI 10.1162/089892900562228; Jeong JH, 2010, J NEUROSURG, V113, P532, DOI 10.3171/2009.10.JNS091152; KAUFMAN JM, 2005, ENDOCR REV; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lamberts SWJ, 1998, LANCET, V352, P127; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; MacLusky NJ, 2006, NEUROSCIENCE, V138, P957, DOI 10.1016/j.neuroscience.2005.12.054; Maruff P, 2005, HORM RES, V64, P100, DOI 10.1159/000089325; Mauras N, 1998, J CLIN ENDOCR METAB, V83, P1886, DOI 10.1210/jc.83.6.1886; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Mukherjee A, 2004, HORM RES, V62, P35, DOI 10.1159/000080497; Murray RD, 2004, J CLIN ENDOCR METAB, V89, P1586, DOI 10.1210/jc.2003-030761; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Raynaud JP, 2006, J STEROID BIOCHEM, V102, P261, DOI 10.1016/j.jsbmb.2006.09.032; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shalet SM, 1998, ENDOCR REV, V19, P203, DOI 10.1210/er.19.2.203; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; van Dam PS, 2005, HORM RES, V64, P109, DOI 10.1159/000089326; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; WOOLF PD, 1985, J CLIN ENDOCR METAB, V60, P444, DOI 10.1210/jcem-60-3-444; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; Young TP, 2007, BRAIN INJURY, V21, P645, DOI 10.1080/02699050701210426	63	19	19	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					390	396		10.1097/HTR.0b013e318250eac6			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600086	22613945				2022-02-06	
J	Xiong, N; Yang, HC; Liu, L; Xiong, L; Zhang, ZW; Zhang, XW; Jia, M; Huang, JS; Zhang, ZT; Mohamed, AA; Lin, ZC; Wang, T				Xiong, Nian; Yang, Hecheng; Liu, Ling; Xiong, Ling; Zhang, Zhaowen; Zhang, Xiaowei; Jia, Min; Huang, Jinsha; Zhang, Zhentao; Mohamed, Asrah A.; Lin, Zhicheng; Wang, Tao			bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease	ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY			English	Article						Human bone marrow mesenchymal stem cells; Parkinson's disease; Basic fibroblast growth factor; Dopaminergic neurons; Multipotency; Rotenone	FIBROBLAST-GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; STROMAL CELLS; DOPAMINERGIC PHENOTYPE; IN-VITRO; TRANSPLANTATION; PROLIFERATION; RATS; NEUROGENESIS; EXPRESSION	Previous studies have shown that bone marrow mesenchymal stem cells (BMSCs) engraftment could alleviate motor dysfunction in parkinsonian animal models, but with limited efficacy and few engrafted cells surviving. On the other side, basic fibroblast growth factor (bFGF) reportedly displays many effects including neuroprotection and promoting multipotent cells to expand and differentiate. In this study, we assessed whether a combination of bFGF and human BMSCs (HBMSCs) therapy could enhance the treatment effectiveness in Parkinson's disease (PD) rat models. Specifically, bFGF promoted HBMSCs to transdifferentiate toward neural-like lineages in vitro. In addition, HBMSCs transplantation alleviated the motor functional asymmetry, as well as prevented dopaminergic neuron loss in a PD model, while bFGF administration enhances its neurodifferentiation capacity and therapeutic effect. In conclusion, optimizing culture condition like supplementation of bFGF could significantly improve the output of HBMSCs in vitro, and HBMSCs transplantation with bFGF might represent an improved transplantation approach for PD. (C) 2013 Elsevier B.V. All rights reserved.	[Xiong, Nian; Yang, Hecheng; Liu, Ling; Xiong, Ling; Zhang, Zhaowen; Zhang, Xiaowei; Jia, Min; Huang, Jinsha; Zhang, Zhentao; Mohamed, Asrah A.; Wang, Tao] Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Zhang, Zhentao] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan 430060, Peoples R China; [Lin, Zhicheng] Harvard Univ, Dept Psychiat, Sch Med, Cambridge, MA 02138 USA; [Lin, Zhicheng] McLean Hosp, Div Alcohol & Drug Abuse, Belmont, MA 02478 USA; [Lin, Zhicheng] McLean Hosp, Mailman Neurosci Res Ctr, Belmont, MA 02478 USA; [Lin, Zhicheng] Harvard NeuroDiscovery Ctr, Boston, MA 02114 USA		Wang, T (corresponding author), Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, 1277 Jiefang Rd, Wuhan 430022, Hubei, Peoples R China.	wangtaowh@yahoo.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870866, 81071021, 31171211, 81200983, 81100958]; China Medical FoundationChina Medical University [2012B09]; Wuhan Science and Technology Bureau, China [20066002100]	This work was supported by grants 30870866, 81071021 and 31171211 from the National Natural Science Foundation of China (to TW), grant 81200983 from the National Natural Science Foundation of China (to NX), grant 81100958 from the National Natural Science Foundation of China (to ZTZ), grant 2012B09 from China Medical Foundation (to NX) and grant 20066002100 from the Wuhan Science and Technology Bureau, China (to TW).	Akino K, 2003, WOUND REPAIR REGEN, V11, P354, DOI 10.1046/j.1524-475X.2003.11507.x; Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Barzilay R, 2009, STEM CELLS DEV, V18, P591, DOI 10.1089/scd.2008.0138; Bhang SH, 2007, BIOCHEM BIOPH RES CO, V359, P40, DOI 10.1016/j.bbrc.2007.05.046; Deierborg T, 2008, PROG NEUROBIOL, V85, P407, DOI 10.1016/j.pneurobio.2008.05.001; Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Hori Y, 2004, TISSUE ENG, V10, P995, DOI 10.1089/1076327041887790; Jiang JJ, 2010, NEUROSCI RES, V66, P46, DOI 10.1016/j.neures.2009.09.1711; Jiang XW, 2010, BONE, V46, P1156, DOI 10.1016/j.bone.2009.12.017; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin GZ, 2008, CELL BIOL INT, V32, P1433, DOI 10.1016/j.cellbi.2008.08.014; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Laskowski A, 2005, BRAIN RES, V1037, P78, DOI 10.1016/j.brainres.2004.12.035; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Lindvall Olle, 2002, Neurosurg Focus, V13, pe2; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Neubauer M, 2004, FEBS LETT, V577, P277, DOI 10.1016/j.febslet.2004.10.020; Ramirez JJ, 1999, NEUROREPORT, V10, P1201, DOI 10.1097/00001756-199904260-00008; Sadan O, 2009, STEM CELLS DEV, V18, P1179, DOI 10.1089/scd.2008.0411; Tatard VM, 2004, CELL TRANSPLANT, V13, P573, DOI 10.3727/000000004783983675; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Wang K, 2004, NEUROSCI LETT, V364, P154, DOI 10.1016/j.neulet.2004.04.086; Xiong N, 2011, GENE THER, V18, P394, DOI 10.1038/gt.2010.152; Xiong NA, 2010, BIOL BLOOD MARROW TR, V16, P1519, DOI 10.1016/j.bbmt.2010.06.004; Xiong NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007878; Xue XJ, 2010, MOL CELL NEUROSCI, V45, P26, DOI 10.1016/j.mcn.2010.05.006; Ye M, 2007, PARKINSONISM RELAT D, V13, P44, DOI 10.1016/j.parkreldis.2006.07.013; Yedjou CG, 2008, J BIOCHEM MOL TOXIC, V22, P85, DOI 10.1002/jbt.20223; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zanini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028175	33	19	24	0	27	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1382-6689			ENVIRON TOXICOL PHAR	Environ. Toxicol. Pharmacol.	SEP	2013	36	2					411	422		10.1016/j.etap.2013.05.005			12	Environmental Sciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Pharmacology & Pharmacy; Toxicology	213TK	WOS:000324082900020	23770451				2022-02-06	
J	Olson, DM; Lewis, LS; Bader, MK; Bautista, C; Malloy, R; Riemen, KE; McNett, MM				Olson, DaiWai M.; Lewis, Lisa S.; Bader, Mary Kay; Bautista, Cynthia; Malloy, Rachel; Riemen, Kristina E.; McNett, Molly M.			Significant Practice Pattern Variations Associated With Intracranial Pressure Monitoring	JOURNAL OF NEUROSCIENCE NURSING			English	Article						intracranial pressure; nursing; nursing interventions; nursing practice	TRAUMATIC BRAIN-INJURY; PATIENT; MEDICINE; SAFETY	Purpose: The purpose of this study was to describe nursing practice in the care of patients with intracranial pressure monitoring. Although standards for care of such patients have been established, there continue to be variations in the nursing practice. Methods: This was an observational study in which data were collected from 28 nurse-patient dyads at 16 different hospitals across the United States. Each dyad was observed for 2 hours; nursing actions and patient responses including intracranial pressure readings were documented. Results: Differences in the care of patients with intracranial pressure monitoring were prevalent. Variations in practice were prompted by healthcare provider prescriptions as well as nursing decisions. Prescriptions and interventions were often not supported by the available scientific evidence. Video Abstract: For more insights from the authors, see Supplemental Digital Content 1, at http://links.lww.com/JNN/A7.	[Olson, DaiWai M.] Univ Texas Southwestern, Dallas, TX USA; [Lewis, Lisa S.] Watts Sch Nursing, Durham, NC USA; [Bader, Mary Kay] Mission Hosp, Mission Viejo, CA USA; [Bautista, Cynthia] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Malloy, Rachel] Integra Lifesci, Plainsboro, NJ USA; [Riemen, Kristina E.] Duke Univ, Durham, NC USA; [McNett, Molly M.] Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA		Olson, DM (corresponding author), Univ Texas Southwestern, Dallas, TX USA.	DaiWai.Olson@UTsouthwestern.edu	Olson, DaiWai/I-5932-2019; Malloy, Rachel/J-5917-2019	Olson, DaiWai/0000-0002-9280-078X; Lewis, Lisa/0000-0001-5330-9747			ALLAN D, 1989, J ADV NURS, V14, P127, DOI 10.1111/j.1365-2648.1989.tb00910.x; *AM ASS NEUR NURS, 2004, AANN COR CURR NEUR N; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Bartels Jean E, 2005, Nurs Health Sci, V7, P221, DOI 10.1111/j.1442-2018.2005.00249.x; Benner P., 1984, NOVICE EXPERT; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Given B, 2009, CANCER NURS, V32, P89, DOI 10.1097/NCC.0b013e31819ac87f; Greenberg MS., 2010, HDB NEUROSURGERY, V7th; Grenvik A, 2009, CRIT CARE CLIN, V25, P239, DOI 10.1016/j.ccc.2008.11.001; Hickey JV, 2009, CLIN PRACTICE NEUROL, P270; Kerr ME, 1997, NURS RES, V46, P195, DOI 10.1097/00006199-199707000-00003; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; March K, 1990, J Neurosci Nurs, V22, P375; Marshall AP, 2011, WORLDV EVID-BASED NU, V8, P224, DOI 10.1111/j.1741-6787.2011.00221.x; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; McIlvoy L., 2011, AANN CLIN PRACTICE G; McNett M, 2010, AM J CRIT CARE, V19, P250, DOI 10.4037/ajcc2009293; McNett MM, 2010, J NEUROSCI NURS, V42, P71, DOI 10.1097/JNN.0b013e3181ce5b8a; Miller CM, 2012, CURR NEUROL NEUROSCI, V12, P474, DOI 10.1007/s11910-012-0274-7; MITCHELL PH, 1981, NURS RES, V30, P212; MITCHELL PH, 1978, NURS RES, V27, P4; Olson DM, 2010, J NEUROSCI NURS, V42, P119, DOI 10.1097/JNN.0b013e3181d4a3aa; Olson DM, 2005, AACN ADV CRIT CARE, V16, P441, DOI 10.1097/00044067-200510000-00003; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Rising C J, 1993, J Neurosci Nurs, V25, P302; SNYDER M, 1983, J ADV NURS, V8, P273; Wolfe TJ, 2009, CURR NEUROL NEUROSCI, V9, P477, DOI 10.1007/s11910-009-0070-1	29	19	20	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	AUG	2013	45	4					186	193		10.1097/JNN.0b013e3182986400			8	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	183XC	WOS:000321849600005	23812048				2022-02-06	
J	Pistoia, F; Sacco, S; Carolei, A; Sara, M				Pistoia, Francesca; Sacco, Simona; Carolei, Antonio; Sara, Marco			Corticomotor Facilitation in Vegetative State: Results of a Pilot Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Minimally conscious state; Rehabilitation; Transcranial magnetic stimulation; Vegetative state	TRAUMATIC BRAIN-INJURY; REVISED CRS-R; ITALIAN VERSION; HAND ACTIONS; CONSCIOUSNESS; DISORDERS; RECOVERY; MODULATION; IMITATION; AWARENESS	Objective: To investigate whether corticomotor facilitation induced by transcranial magnetic stimulation (TMS-CF) could evoke a simple purposeful motor behavior in patients with a diagnosis of vegetative state. Design: Cross-sectional survey. Setting: Post-coma and rehabilitation care unit. Participants: Patients (N=6) with a diagnosis of vegetative state. Interventions: A cascade of consecutive motor-evoked potentials (MEPs) was elicited under 3 different conditions: in the first condition, patients were at rest (Rest); in the second, they were asked to open and close the right hand (Execution); in the third, the examiner modeled a movement of abduction of the thumb in front of the patient who was encouraged in advance to imitate the action (Observation to Imitate). Main Outcome Measures: Changes in MEP values from the abductor pollicis brevis muscle and improvement in scores on the Coma Recovery Scale-Revised. Results: TMS-CF alone or combined with verbal instructions did not yield any change; only the combination with imitation caused changes in MEPs (shorter latency and increased amplitude) associated with behavioral improvement in 4 patients. Conclusions: Encouraging observation to imitate may favor the transformation of some perceived actions into motor images and performances, probably depending on the activation of mirror motor neurons. In our opinion, combining visual input with TMS-CF might have reinforced the coupling between movement planning and execution, promoting the recovery of elementary motor activities in some patients. The proposed protocol may contribute to unmasking signs of preserved consciousness in patients with latent capacities for recovery. (c) 2013 by the American Congress of Rehabilitation Medicine	[Pistoia, Francesca; Sacco, Simona; Carolei, Antonio] Univ Aquila, Dept Neurol, I-67100 Laquila, Italy; [Pistoia, Francesca; Sara, Marco] Hosp San Raffaele, Post Coma & Rehabil Care Unit, I-03043 Cassino, FR, Italy		Sara, M (corresponding author), Hosp San Raffaele, Via Gaetano Biasio 1, I-03043 Cassino, FR, Italy.	marco.sara@sanraffaele.it	Pistoia, Francesca/AAC-1027-2019; Sara, Marco/AAB-3651-2019; Sacco, Simona/I-5253-2012	Sacco, Simona/0000-0003-0651-1939; PISTOIA, Francesca/0000-0003-0790-4240	Italian Ministry of HealthMinistry of Health, Italy [RF2008 n.31]	Supported in part by the Italian Ministry of Health (grant no. RF2008 n.31).	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2012, CLIN NEUROPHYSIOL, V123, P1937, DOI 10.1016/j.clinph.2012.03.014; BAUER G, 1979, J NEUROL, V221, P77, DOI 10.1007/BF00313105; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Clark S, 2004, NEUROPSYCHOLOGIA, V42, P105, DOI 10.1016/S0028-3932(03)00144-1; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Conson M, 2009, EXP BRAIN RES, V199, P71, DOI 10.1007/s00221-009-1974-3; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Formisano R, 2011, BRAIN INJURY, V25, P638, DOI 10.3109/02699052.2011.572948; Garrison KA, 2010, NEUROREHAB NEURAL RE, V24, P404, DOI 10.1177/1545968309354536; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Leonard G, 2007, EXP BRAIN RES, V177, P167, DOI 10.1007/s00221-006-0657-6; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Pistoia F, 2012, J NEUROTRAUM, V29, P2328, DOI 10.1089/neu.2009.1257; Pistoia F, 2010, CNS DRUGS, V24, P625, DOI 10.2165/11535940-000000000-00000; Sacco S, 2011, BRAIN INJURY, V25, P488, DOI 10.3109/02699052.2011.558043; Sara M, 2008, BRAIN INJURY, V22, P33, DOI 10.1080/02699050701810670; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Sara M, 2011, NEUROREHAB NEURAL RE, V25, P35, DOI 10.1177/1545968310378508; Sara M, 2010, NONLIN DYNAM PSYCHOL, V14, P1; Sara M, 2010, J NEUROTRAUM, V27, P771, DOI [10.1089/neu.2008.0804, 10.1089/neu.2008-0804]; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Trojano L, 2012, J NEUROL, V259, P1888, DOI 10.1007/s00415-012-6435-4	27	19	25	1	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2013	94	8					1599	1606		10.1016/j.apmr.2013.01.019			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	196TZ	WOS:000322801600024	23385107				2022-02-06	
J	Sarsfield, MJ; Morley, EJ; Callahan, JM; Grant, WD; Wojcik, SM				Sarsfield, Matthew J.; Morley, Eric J.; Callahan, James M.; Grant, William D.; Wojcik, Susan M.			Evaluation of Emergency Medicine Discharge Instructions in Pediatric Head Injury	PEDIATRIC EMERGENCY CARE			English	Article						mild traumatic brain injury; discharge instructions; return to play; concussion; head injury	TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; CONCUSSION; MANAGEMENT; STATEMENT; SPORTS; CHILDREN	Objectives: Pediatric head trauma is a common occurrence. There is mounting evidence that even patients with minor head injury require limits on school activities and/or removal from sports and play to help speed recovery and limit morbidity. The objective of this study was to determine whether discharge instructions given to children who had sustained head injuries included information regarding activity restrictions, activity time constraints, and/or specifics of follow-up care. Methods: This was a retrospective chart review of patients aged 2 to 18 years evaluated and treated for head injury during a 4-month period at a level I trauma center (volume similar to 23,000 pediatric patients per year). Included were those children seen, evaluated, and diagnosed with any of the following: mild head injury, concussion, minor head trauma, or mild traumatic brain injury (mTBI). Subjects were excluded if there was a positive acute head injury computed tomography finding (other than findings of a simple linear skull fracture) or if the subject required admission. Results: Among the 204 patients meeting eligibility, 95.1% received instruction to follow up with a physician, 82.8% received anticipatory guidance regarding expected symptoms, 15.2% received specific restriction time from sports, and 21.5% were removed from sports. Of these patients, 113 patients were determined "likely" to have sustained an mTBI. Patients with sports-related mTBI received return-to-sports restrictions (chi(2) = 11.225, P < 0.008) and to remove the child from play (chi(2) = 9.781, P < 0.004) as discharge instructions significantly more than did patients with motor vehicle accident or other mechanisms of injury. Conclusions: Children sustaining head injury were inadequately instructed to restrict athletic activities upon discharge. This is particularly true for patients who sustain an mTBI from non-sports-related activity.	[Sarsfield, Matthew J.; Grant, William D.; Wojcik, Susan M.] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY 13202 USA; [Morley, Eric J.] SUNY Downstate Med Univ, Dept Emergency Med, Brooklyn, NY USA; [Callahan, James M.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA		Sarsfield, MJ (corresponding author), SUNY Upstate Med Univ, Dept Emergency Med, 550 E Genesee St, Syracuse, NY 13202 USA.	sarsfiem@upstate.edu					Adams J, 2001, J PEDIATR SURG, V36, P119, DOI 10.1053/jpsu.2001.20026; Adirim TA, 2007, CLIN PEDIATR EMERG M, V8, P2, DOI 10.1016/j.cpem.2007.02.002; [Anonymous], TRAUMATIC BRAIN INJU; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlas D, 1999, ANN EMERG MED, V34, P610, DOI 10.1016/S0196-0644(99)70163-0; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bowen Anne Phelan, 2003, J Emerg Nurs, V29, P287, DOI 10.1067/men.2003.90; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; Harmon KG, 1999, AM FAM PHYSICIAN, V60, P887; Kamerling SN, 2003, PEDIATR EMERG CARE, V19, P431, DOI 10.1097/01.pec.0000092590.40174.1f; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Poirier MP, 2000, PEDIATR EMERG CARE, V16, P278, DOI 10.1097/00006565-200008000-00018; Poirier MP, 2003, CLIN PEDIATR EMERG M, V4, P179, DOI DOI 10.1016/S1522-8401(03)00061-2; Scarfone RJ, 1996, ARCH PEDIAT ADOL MED, V150, P948, DOI 10.1001/archpedi.1996.02170340062012; Wang NE, 2003, ACAD EMERG MED, V10, P1278, DOI 10.1197/S1069-6563(03)00499-8	22	19	20	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	AUG	2013	29	8					884	887		10.1097/PEC.0b013e31829ec0d9			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	300NL	WOS:000330470500002	23903674				2022-02-06	
J	Allen, AR; Eilertson, K; Sharma, S; Schneider, D; Baure, J; Allen, B; Rosi, S; Raber, J; Fike, JR				Allen, Antino R.; Eilertson, Kirsten; Sharma, Sourabh; Schneider, Danielle; Baure, Jennifer; Allen, Barrett; Rosi, Susanna; Raber, Jacob; Fike, John R.			Effects of Radiation Combined Injury on Hippocampal Function are Modulated in Mice Deficient in Chemokine Receptor 2 (CCR2)	RADIATION RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; MONOCYTE CHEMOATTRACTANT PROTEIN-1; COGNITIVE IMPAIRMENTS; CRANIAL IRRADIATION; ADULT NEUROGENESIS; IONIZING-RADIATION; EXPRESSION; CELLS; PATHOPHYSIOLOGY; MACROPHAGES	Chemokines and their receptors play a crucial role in normal brain function as well as in pathological conditions such as injury and disease-associated neuroinflammation. Chemokine receptor-2 (CCR2), which mediates the recruitment of infiltrating and resident microglia to sites of central nervous system (CNS) inflammation, is upregulated by ionizing irradiation and traumatic brain injury. Our objective was to determine if a deficiency in CCR2 and subsequent effects on brain microglia affect neurogenesis and cognitive function after radiation combined injury (RCI). CCR2 knock-out (-/-) and wild-type (WT) mice received 4 Gy of whole body Cs-137 irradiation. Immediately after irradiation, unilateral traumatic brain injury was induced using a controlled cortical impact system. Forty-four days postirradiation, animals were tested for hippocampus-dependent cognitive performance in the Morris water-maze. After cognitive testing, animals were euthanized and their brains snap frozen for immunohistochemical assessment of neuroinflammation (activated microglia) and neurogenesis in the hippocampal dentate gyrus. All animals were able to locate the visible and hidden platform locations in the water maze; however, treatment effects were seen when spatial memory retention was assessed in the probe trials (no platform). In WT animals that received combined injury, a significant impairment in spatial memory retention was observed in the probe trial after the first day of hidden platform training (first probe trial). This impairment was associated with increased neurogenesis in the ipsilateral hemisphere of the dentate gyrus. In contrast, CCR2(-/-) mice, independent of insult showed significant memory retention in the first probe trial and there were no differences in the numbers of newly born neurons in the animals receiving irradiation, trauma or combined injury. Although the mechanisms involved are not clear, our data suggests that CCR2 deficiency can exert a protective effect preventing the impairment of cognitive function after combined injury. (C) 2013 by Radiation Research Society	[Allen, Antino R.; Sharma, Sourabh; Schneider, Danielle; Baure, Jennifer; Allen, Barrett; Rosi, Susanna; Fike, John R.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Rosi, Susanna] Univ Calif San Francisco, San Francisco, CA 94110 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94110 USA; [Eilertson, Kirsten] Gladstone Inst San Francisco, Bioinformat Core, San Francisco, CA 94158 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Neurol, Div Neurosci, Portland, OR 97239 USA		Fike, JR (corresponding author), San Francisco Gen Hosp, Brain & Spinal Injury Ctr, Bldg 1 Rm 101,1001 Potrero Ave, San Francisco, CA 94140 USA.	john.fike@ucsf.edu		Eilertson, Kirsten/0000-0003-4850-1210	National Institute of General Medical Sciences/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM081266]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R33 AI080531]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R33AI080531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM081266] Funding Source: NIH RePORTER	The research described was supported by award number K12GM081266 from the National Institute of General Medical Sciences/National Institutes of Health and National Institutes of Health (NIH) grant R33 AI080531.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Bennett LD, 2011, IMMUNOLOGY, V134, P246, DOI 10.1111/j.1365-2567.2011.03485.x; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chao NJ, 2007, EXP HEMATOL, V35, P24, DOI 10.1016/j.exphem.2007.01.008; Chin F. K. C., 2007, SMJ Singapore Medical Journal, V48, P950; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dzenko KA, 2005, MICROVASC RES, V70, P53, DOI 10.1016/j.mvr.2005.04.005; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goser S, 2005, CIRCULATION, V112, P3400, DOI 10.1161/CIRCULATIONAHA.105.572396; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Jacob A, 2010, MOL MED, V16, P137, DOI 10.2119/molmed.2009.00154; Jaerve A, 2012, CELL TISSUE RES, V349, P229, DOI 10.1007/s00441-012-1427-3; Joo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025936; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Ma MH, 2002, J NEUROSCI RES, V68, P691, DOI 10.1002/jnr.10269; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Manthous CA, 2007, CRIT CARE MED, V35, P716, DOI 10.1097/01.CCM.0000257328.31668.22; Marazziti D, 2012, CURR MED CHEM, V19, P1864, DOI 10.2174/092986712800099776; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Naert G, 2011, J NEUROSCI, V31, P6208, DOI 10.1523/JNEUROSCI.0299-11.2011; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raber J, 2011, HIPPOCAMPUS, V21, P72, DOI 10.1002/hipo.20724; Raber J, 2010, TOXICOL PATHOL, V38, P198, DOI 10.1177/0192623309352003; Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1; Rola R, 2004, RADIAT RES, V162, P442, DOI 10.1667/RR3234; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rosi S, 2012, HIPPOCAMPUS, V22, P544, DOI 10.1002/hipo.20920; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shi L, 2006, RADIAT RES, V166, P892, DOI 10.1667/RR0588.1; Smits HA, 2002, J NEUROIMMUNOL, V127, P160, DOI 10.1016/S0165-5728(02)00112-1; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tofilon PJ, 2000, RADIAT RES, V153, P357, DOI 10.1667/0033-7587(2000)153[0357:TROTCN]2.0.CO;2; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Villasana L, 2006, RADIAT RES, V166, P883, DOI 10.1667/RR0642.1; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	64	19	22	0	6	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	JUL	2013	180	1					78	88		10.1667/RR3344.1			11	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	AA3JD	WOS:000330987800009	23772926	Green Accepted			2022-02-06	
J	Bianchetti, E; Mladinic, M; Nistri, A				Bianchetti, E.; Mladinic, M.; Nistri, A.			Mechanisms underlying cell death in ischemia-like damage to the rat spinal cord in vitro	CELL DEATH & DISEASE			English	Article						magnesium; PAR; AIF; parthanatos; TRPM2; TRPM7	APOPTOSIS-INDUCING FACTOR; TRAUMATIC BRAIN-INJURY; POLY(ADP-RIBOSE) PAR POLYMER; RANDOMIZED CONTROLLED-TRIAL; NEONATAL-RAT; NEURONAL DEATH; LOCOMOTOR NETWORKS; MAGNESIUM-SULFATE; OXIDATIVE STRESS; MG2+ HOMEOSTASIS	New spinal cord injury (SCI) cases are frequently due to non-traumatic causes, including vascular disorders. To develop mechanism-based neuroprotective strategies for acute SCI requires full understanding of the early pathophysiological changes to prevent disability and paralysis. The aim of our study was to identify the molecular and cellular mechanisms of cell death triggered by a pathological medium (PM) mimicking ischemia in the rat spinal cord in vitro. We previously showed that extracellular Mg2+ (1 mM) worsened PM-induced damage and inhibited locomotor function. The present study indicated that 1 h of PM+Mg2+ application induced delayed pyknosis chiefly in the spinal white matter via overactivation of poly (ADP-ribose) polymerase 1 (PARP1), suggesting cell death mediated by the process of parthanatos that was largely suppressed by pharmacological block of PARP-1. Gray matter damage was less intense and concentrated in dorsal horn neurons and motoneurons that became immunoreactive for the mitochondrial apoptosis-inducing factor (the intracellular effector of parthanatos) translocated into the nucleus to induce chromatin condensation and DNA fragmentation. Immunoreactivity to TRPM ion channels believed to be involved in ischemic brain damage was also investigated. TRPM2 channel expression was enhanced 24 h later in dorsal horn and motoneurons, whereas TRPM7 channel expression concomitantly decreased. Conversely, TRPM7 expression was found earlier (3 h) in white matter cells, whereas TRPM2 remained undetectable. Simulating acute ischemic-like damage in vitro in the presence of Mg2+ showed how, during the first 24 h, this divalent cation unveiled differential vulnerability of white matter cells and motoneurons, with distinct changes in their TRPM expression.	[Bianchetti, E.; Mladinic, M.; Nistri, A.] Int Sch Adv Studies SISSA, Dept Neurosci, I-34136 Trieste, Italy; [Mladinic, M.; Nistri, A.] Ist Med Fis & Riabilitaz, SPINAL, Udine, Italy; [Mladinic, M.] Univ Rijeka, Dept Biotechnol, Rijeka, Croatia		Nistri, A (corresponding author), Int Sch Adv Studies SISSA, Dept Neurosci, Via Bonomea 265, I-34136 Trieste, Italy.	nistri@sissa.it	Pejatovic, Miranda/V-3554-2019; Mladinic, Miranda/A-8288-2015	Mladinic, Miranda/0000-0002-3985-6629; bianchetti, elena/0000-0002-6432-6558	government of the Friuli Venezia Giulia Region (SPINAL project)	We thank our colleague Dr. A Kuzhandaivel for her help with the ELISA assay, Dr. Micaela Grandolfo for support with quantitative image analysis and Dr. Andrea Tomicich for software support. This work was supported by a grant from the government of the Friuli Venezia Giulia Region (SPINAL project).	Aarts MM, 2005, PFLUG ARCH EUR J PHY, V451, P243, DOI 10.1007/s00424-005-1439-x; Abdelkarim GE, 2001, INT J MOL MED, V7, P255; Aldskogius H., 2013, ANIMAL MODELS SPINAL, P39, DOI [10.1007/978-1-62703-197-4_3, DOI 10.1007/978-1-62703-197-4_3]; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; Belrose JC, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-11; Burgoyne LA, 1999, EXP CELL RES, V248, P214, DOI 10.1006/excr.1999.4406; Carrascal L, 2005, BRAIN RES REV, V49, P377, DOI 10.1016/j.brainresrev.2005.02.003; CARRIEDO SG, 1995, NEUROREPORT, V6, P945, DOI 10.1097/00001756-199504190-00030; Chen HC, 2012, BIOCHEM J, V445, P441, DOI 10.1042/BJ20120248; Cifra A, 2012, DEV NEUROBIOL, V72, P1140, DOI 10.1002/dneu.20991; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cook NL, 2009, MAGNESIUM RES, V22, P225, DOI 10.1684/mrh.2009.0189; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Dent MAR, 2010, FEBS LETT, V584, P2767, DOI 10.1016/j.febslet.2010.04.073; Everaerts W, 2010, AM J PHYSIOL-RENAL, V298, pF692, DOI 10.1152/ajprenal.00599.2009; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Kuhn FJP, 2005, PFLUG ARCH EUR J PHY, V451, P212, DOI 10.1007/s00424-005-1446-y; Kuzhandaivel A, 2010, NEUROSCIENCE, V169, P325, DOI 10.1016/j.neuroscience.2010.05.011; Kuzhandaivel Anujaianthi, 2011, Front Cell Neurosci, V5, P9, DOI 10.3389/fncel.2011.00009; Kuzhandaivel A, 2010, CELL MOL NEUROBIOL, V30, P1001, DOI 10.1007/s10571-010-9531-y; Lee IH, 2005, J COMP NEUROL, V489, P1, DOI 10.1002/cne.20567; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Lin MC, 2004, J AM COLL NUTR, V23, p561S, DOI 10.1080/07315724.2004.10719404; Maas AI, 2007, LANCET NEUROL, V6, P20, DOI 10.1016/S1474-4422(06)70668-8; Margaryan G, 2009, NEUROSCIENCE, V163, P669, DOI 10.1016/j.neuroscience.2009.07.005; McNulty S, 2005, PFLUG ARCH EUR J PHY, V451, P235, DOI 10.1007/s00424-005-1440-4; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Nasrabady SE, 2011, EUR J NEUROSCI, V33, P2216, DOI 10.1111/j.1460-9568.2011.07714.x; Nasrabady SE, 2011, CELL MOL NEUROBIOL, V31, P503, DOI 10.1007/s10571-011-9661-x; Nicotera P, 2003, CELL, V115, P768, DOI 10.1016/S0092-8674(03)01019-5; Oh YK, 2006, NEUROSCI LETT, V406, P205, DOI 10.1016/j.neulet.2006.07.044; Palacios-Prado N, 2013, J NEUROSCI, V33, P4741, DOI 10.1523/JNEUROSCI.2825-12.2013; Penas C, 2009, J NEUROTRAUM, V26, P763, DOI [10.1089/neu.2008.0661, 10.1089/neu.2008-0661]; Penner R., 2007, V179, P313; Perlman JM, 2006, CLIN THER, V28, P1353, DOI 10.1016/j.clinthera.2006.09.005; Plesca D, 2008, METHOD ENZYMOL, V446, P107, DOI 10.1016/S0076-6879(08)01606-6; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Saeki H, 2004, ANESTH ANALG, V99, P1805, DOI 10.1213/01.ANE.0000138039.04548.3D; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Scharenberg AM, 2005, PFLUG ARCH EUR J PHY, V451, P220, DOI 10.1007/s00424-005-1444-0; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Taccola G, 2008, NEUROSCIENCE, V155, P538, DOI 10.1016/j.neuroscience.2008.06.008; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tresch MC, 2002, J NEUROSCI, V22, P9997; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Xie Yu-Feng, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P95; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x	60	19	20	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JUL	2013	4								e707	10.1038/cddis.2013.237			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	192US	WOS:000322512100008	23828570	Green Published, gold			2022-02-06	
J	DiFazio, J; Fletcher, DJ				DiFazio, Jillian; Fletcher, Daniel J.			Updates in the Management of the Small Animal Patient with Neurologic Trauma	VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE			English	Article						Neurotrauma; Traumatic brain injury; Head trauma; Acute spinal cord injury; Resuscitation; Dog; Cat; Cerebral ischemia	SPINAL-CORD-INJURY; INTERVERTEBRAL-DISK DISEASE; 7.5-PERCENT SODIUM-CHLORIDE; CEREBRAL PERFUSION-PRESSURE; PLACEBO-CONTROLLED TRIAL; URINARY-TRACT-INFECTION; SEVERE HEAD-INJURY; BRAIN-INJURY; INTRACRANIAL-PRESSURE; HYPERTONIC SALINE	Neurologic trauma, encompassing traumatic brain injury (TBI) and acute spinal cord injury (SCI), is a cause of significant morbidity and mortality in veterinary patients. Acute SCIs occurring secondary to trauma are also common. Essential to the management of TBI and SCI is a thorough understanding of the pathophysiology of the primary and secondary injury that occurs following trauma. This article reviews the pathophysiology of this primary and secondary injury, as well as recommendations regarding clinical assessment, diagnostics, pharmacologic and nonpharmacologic therapy, and prognosis.	[DiFazio, Jillian] Cornell Univ Hosp Anim, Sect Emergency & Crit Care, Ithaca, NY 14853 USA; [Fletcher, Daniel J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA		Fletcher, DJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, DCS Box 31, Ithaca, NY 14853 USA.	djf42@cornell.edu					Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Armitage-Chan EA, 2007, J VET EMERG CRIT CAR, V17, P5, DOI 10.1111/j.1476-4431.2006.00194.x; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Baltzer WI, 2008, SPINE, V33, P1397, DOI 10.1097/BRS.0b013e3181753c37; Barone G, 2002, J AM VET MED ASSOC, V220, P1499, DOI 10.2460/javma.2002.220.1499; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Boysen SR, 2004, JAVMA-J AM VET MED A, V225, P1198, DOI 10.2460/javma.2004.225.1198; BRACKEN MB, 1985, J NEUROSURG, V63, P704, DOI 10.3171/jns.1985.63.5.0704; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brain Trauma Foundation T National Association of State EMS Officials T National Association of EMTs, 2007, PREHOSP EMERG CARE S, V12, P1; Brisson BA, 2010, VET CLIN N AM-SMALL, V40, P829, DOI 10.1016/j.cvsm.2010.06.001; Bubenik L, 2008, VET SURG, V37, P791, DOI 10.1111/j.1532-950X.2008.00452.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caswell JL, 2003, CAN VET J, V44, P137; Cerda-Gonzalez S, 2006, JAVMA-J AM VET MED A, V228, P230, DOI 10.2460/javma.228.2.230; Chan PH, 2000, STROKE, V31, P1952; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; Cherrone KL, 2004, J AM ANIM HOSP ASSOC, V40, P316, DOI 10.5326/0400316; COATES JR, 1995, VET SURG, V24, P128, DOI 10.1111/j.1532-950X.1995.tb01307.x; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Croce MA, 2001, ANN SURG, V233, P851, DOI 10.1097/00000658-200106000-00016; da Silva JC, 2010, NEUROL RES, V32, P139, DOI 10.1179/174313209X405119; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; DENIS F, 1984, CLIN ORTHOP RELAT R, P65; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; Dewey C, 2008, PRACTICAL GUIDE CANI, P221; Dewey C., 2003, PRACTICAL GUIDE CANI, P419; Dewey CW, 2000, VET CLIN N AM-SMALL, V30, P207, DOI 10.1016/S0195-5616(00)50010-2; Dewey CW, 2008, PRACTICAL GUIDE CANI, P323; Dewey CW, 2008, PRACTICAL GUIDE CANI, P323; Dooney Neil, 2011, Int J Crit Illn Inj Sci, V1, P36, DOI 10.4103/2229-5151.79280; Edwards P, 2005, LANCET, V365, P1957; Eminaga S, 2011, J FELINE MED SURG, V13, P850, DOI 10.1016/j.jfms.2011.09.006; Fehlings MG, 2006, SPINE, V31, pS28, DOI 10.1097/01.brs.0000217973.11402.7f; FELTS JF, 1983, J AM ANIM HOSP ASSOC, V19, P755; Fink Matthew E, 2012, Continuum (Minneap Minn), V18, P640, DOI 10.1212/01.CON.0000415432.84147.1e; Fletcher D.J., 2009, SMALL ANIMAL CRITICA, P658; Fluehmann G, 2006, J SMALL ANIM PRACT, V47, P582, DOI 10.1111/j.1748-5827.2006.00106.x; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; GAGE ED, 1968, J AM VET MED ASSOC, V152, P351; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gill PJ, 1996, J AM ANIM HOSP ASSOC, V32, P77, DOI 10.5326/15473317-32-1-77; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Griffin J, 2009, COMPEND CONTIN ED PR, V31, pE1; Hains BC, 2004, EXP NEUROL, V188, P365, DOI 10.1016/j.expneurol.2004.04.001; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; HALL ED, 1986, J NEUROSURG, V64, P951, DOI 10.3171/jns.1986.64.6.0951; Hansen B, 2000, VET CLIN N AM-SMALL, V30, P899, DOI 10.1016/S0195-5616(08)70014-7; Hawthorne JC, 1999, J AM ANIM HOSP ASSOC, V35, P135, DOI 10.5326/15473317-35-2-135; Hayes GM, 2009, J VET EMERG CRIT CAR, V19, P629, DOI 10.1111/j.1476-4431.2009.00478.x; Hillman RB, 2009, J AM ANIM HOSP ASSOC, V45, P155, DOI 10.5326/0450155; Hopkins AL, 1996, VET CLIN N AM-SMALL, V26, P875, DOI 10.1016/S0195-5616(96)50110-5; Hopper K, 2009, SMALL ANIMAL CRITICA, P900; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Israel SK, 2009, VET RADIOL ULTRASOUN, V50, P247, DOI 10.1111/j.1740-8261.2009.01528.x; Jeffery ND, 2005, J NEUROTRAUM, V22, P1282, DOI 10.1089/neu.2005.22.1282; Jeffery ND, 2010, VET CLIN N AM-SMALL, V40, P809, DOI 10.1016/j.cvsm.2010.05.004; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Johnson K, 2009, SMALL ANIMAL CRITICA, P419; Johnson P, 2012, VET RADIOL ULTRASOUN, V53, P552, DOI 10.1111/j.1740-8261.2012.01959.x; Kaptanoglu E, 2005, ACTA NEUROCHIR, V147, P405, DOI 10.1007/s00701-004-0447-5; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KEEGAN RD, 1995, AM J VET RES, V56, P193; Kent M, 2010, J AM ANIM HOSP ASSOC, V46, P132, DOI 10.5326/0460132; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kinns J, 2006, VET RADIOL ULTRASOUN, V47, P563, DOI 10.1111/j.1740-8261.2006.00186.x; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; La Rosa G, 2004, SPINAL CORD, V42, P503, DOI 10.1038/sj.sc.3101627; Lamb CR, 2002, VET RADIOL ULTRASOUN, V43, P222, DOI 10.1111/j.1740-8261.2002.tb00994.x; Lauer KK, 1997, CAN J ANAESTH, V44, P929, DOI 10.1007/BF03011963; Leonard SE, 2002, J VET EMERG CRIT CAR, V12, P17, DOI 10.1046/j.1534-6935.2002.00003.x; Levine GJ, 2009, PREV VET MED, V89, P121, DOI 10.1016/j.prevetmed.2009.02.016; Levine JM, 2008, JAVMA-J AM VET MED A, V232, P411, DOI 10.2460/javma.232.3.411; Levine JM, 2007, VET SURG, V36, P482, DOI 10.1111/j.1532-950X.2007.00295.x; LEWIS DD, 1992, J AM VET MED ASSOC, V200, P1381; Ling Geoffrey S F, 2010, Continuum (Minneap Minn), V16, P27, DOI 10.1212/01.CON.0000391451.30299.bc; Lisciandro GR, 2011, J VET EMERG CRIT CAR, V21, P104, DOI 10.1111/j.1476-4431.2011.00626.x; Marioni-Henry K, 2004, J VET INTERN MED, V18, P851, DOI 10.1892/0891-6640(2004)18&lt;851:PODOTS&gt;2.0.CO;2; Mazzaferro E, 2009, SMALL ANIMAL CRITICA, P78, DOI DOI 10.1016/B978-1-4160-2591-7.10019-0; McCarthy P, 2012, PATHOPHYSIOLOGY, P735; McCartney W, 2007, J SMALL ANIM PRACT, V48, P498, DOI 10.1111/j.1748-5827.2006.00309.x; McManus ML, 1998, ANESTHESIOLOGY, V88, P1586, DOI 10.1097/00000542-199806000-00023; McMichael M, 2004, J VET EMERG CRIT CAR, V14, P231, DOI 10.1111/j.1476-4431.2004.04004.x; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Musulin SE, 2011, J VET PHARMACOL THER, V34, P17, DOI 10.1111/j.1365-2885.2010.01186.x; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Nishida H, 2012, VET SURG, V41, P437, DOI 10.1111/j.1532-950X.2011.00959.x; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Olby N, 2003, J AM VET MED ASSOC, V222, P762, DOI 10.2460/javma.2003.222.762; Olby N, 2010, VET CLIN N AM-SMALL, V40, P791, DOI 10.1016/j.cvsm.2010.05.007; Olby NJ, 2001, AM J VET RES, V62, P1624, DOI 10.2460/ajvr.2001.62.1624; OLBY NJ, 1994, J SMALL ANIM PRACT, V35, P345, DOI 10.1111/j.1748-5827.1994.tb01713.x; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Park EH, 2012, J VET EMERG CRIT CAR, V22, P160, DOI 10.1111/j.1476-4431.2012.00723.x; PARKER AJ, 1976, RES VET SCI, V21, P246, DOI 10.1016/S0034-5288(18)33383-6; Pascoe PJ, 2000, VET CLIN N AM-SMALL, V30, P757, DOI 10.1016/S0195-5616(08)70005-6; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Proulx J, 1998, COMP CONT EDUC PRACT, V20, P897; Rabinowitz RS, 2008, SPINE, V33, P2260, DOI 10.1097/BRS.0b013e31818786db; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Roberts I, 2004, LANCET, V364, P9442; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Rozanski EA, 2002, VET CLIN N AM-SMALL, V32, P1073, DOI 10.1016/S0195-5616(02)00039-6; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Schierhout G, 2012, COCHRANE DB SYST REV; Schwartz G, 2002, PROG BRAIN RES, V137, P177; SEIM HB, 1982, J AM ANIM HOSP ASSOC, V18, P233; Shores A., 1983, CURRENT VET THERAPY, P847; Simpson SA, 2009, J VET EMERG CRIT CAR, V19, P588, DOI 10.1111/j.1476-4431.2009.00468.x; Smarick SD, 2004, JAVMA-J AM VET MED A, V224, P1936, DOI 10.2460/javma.2004.224.1936; Smith PM, 2005, J VET INTERN MED, V19, P788, DOI 10.1892/0891-6640(2005)19[788:SSAACR]2.0.CO;2; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; Sturges B, 2009, SMALL ANIMAL CRITICA, P423; Syring RS, 2001, J AM VET MED ASSOC, V218, P1124, DOI 10.2460/javma.2001.218.1124; Tadie M., 1999, Society for Neuroscience Abstracts, V25, P1090; Tanaka H, 2005, J VET MED SCI, V67, P679, DOI 10.1292/jvms.67.679; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tidwell AS, 2002, VET RADIOL ULTRASOUN, V43, P319, DOI 10.1111/j.1740-8261.2002.tb01011.x; Todd MM, 2006, ANESTHESIOLOGY, V105, P1176, DOI 10.1097/00000542-200612000-00017; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Tsang KKT, 2012, BRIT J ORAL MAX SURG, V50, P298, DOI 10.1016/j.bjoms.2011.03.004; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vitale C, 2007, COMPENDIUM STANDARDS, V9, P1; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Walters MR, 2005, CEREBROVASC DIS, V20, P304, DOI 10.1159/000087929; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; Wijayatilake DS, 2012, CURR OPIN ANESTHESIO, V25, P540, DOI 10.1097/ACO.0b013e328357960a; Zeng HK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-153; ZHUANG J, 1995, CRIT CARE MED, V23, P140, DOI 10.1097/00003246-199501000-00023	143	19	19	2	46	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0195-5616	1878-1306		VET CLIN N AM-SMALL	Vet. Clin. N. Am.-Small Anim. Pract.	JUL	2013	43	4					915	+		10.1016/j.cvsm.2013.03.002			27	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	180KI	WOS:000321593700012	23747266				2022-02-06	
J	Leitgeb, J; Mauritz, W; Brazinova, A; Majdan, M; Janciak, I; Wilbacher, I; Rusnak, M				Leitgeb, J.; Mauritz, W.; Brazinova, A.; Majdan, M.; Janciak, I.; Wilbacher, I.; Rusnak, M.			Glasgow Coma Scale score at intensive care unit discharge predicts the 1-year outcome of patients with severe traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Severe; Glasgow Coma Scale score; Glasgow Outcome Scale score; Long-term outcomes	ADMISSION CHARACTERISTICS; PROGNOSTIC VALUE; EPIDEMIOLOGY; MANAGEMENT; VALIDATION; IMPACT	To analyse the association between the Glasgow Coma Scale (GCS) score at intensive care unit (ICU) discharge and the 1-year outcome of patients with severe traumatic brain injury (TBI). Retrospective analysis of prospectively collected observational data. Between 01/2001 and 12/2005, 13 European centres enrolled 1,172 patients with severe TBI. Data on accident, treatment and outcomes were collected. According to the GCS score at ICU discharge, survivors were classified into four groups: GCS scores 3-6, 7-9, 10-12 and 13-15. Using the Glasgow Outcome Scale (GOS), 1-year outcomes were classified as "favourable" (scores 5, 4) or "unfavourable" (scores < 4). Factors that may have contributed to outcomes were compared between groups and for favourable versus unfavourable outcomes within each group. Of the 538 patients analysed, 308 (57 %) had GCS scores 13-15, 101 (19 %) had scores 10-12, 46 (9 %) had scores 7-9 and 83 (15 %) had scores 3-6 at ICU discharge. Factors significantly associated with these GCS scores included age, severity of trauma, neurological status (GCS, pupils) at admission and patency of the basal cisterns on the first computed tomography (CT) scan. Favourable outcome was achieved in 74 % of all patients; the rates were significantly different between GCS groups (93, 83, 37 and 10 %, respectively). Within each of the GCS groups, significant differences regarding age and trauma severity were found between patients with favourable versus unfavourable outcomes; neurological status at admission and CT findings were not relevant. The GCS score at ICU discharge is a good predictor of 1-year outcome. Patients with a GCS score < 10 at ICU discharge have a poor chance of favourable outcome.	[Leitgeb, J.] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria; [Mauritz, W.] Trauma Hosp Lorenz Boehler, Vienna, Austria; [Mauritz, W.; Brazinova, A.; Janciak, I.; Wilbacher, I.; Rusnak, M.] INRO, Vienna, Austria; [Brazinova, A.; Majdan, M.; Rusnak, M.] Trnava Univ, Fac Hlth & Social Serv, Dept Publ Hlth, Trnava, Slovakia		Leitgeb, J (corresponding author), Med Univ Vienna, Dept Traumatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	johannes.leitgeb@meduniwien.ac.at	Rusnak, Martin/K-9349-2016; Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Rusnak, Martin/0000-0003-3321-1042; Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X	European UnionEuropean Commission [ICA2-CT-2002-100]; Austrian Worker's Compensation Board (AUVA) [FK 33/2003]; Austrian National Bank [8987]	The data used for this study were collected for a project funded by a European Union grant (Project "Research-Treat-TBI''; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries 1998-2002; contract number: ICA2-CT-2002-100) and for another project funded by the Austrian Worker's Compensation Board (AUVA; contract number FK 33/2003) and by the "Jubilee Fund'' of the Austrian National Bank (project number 8987). The International Neurotrauma Research Organization (INRO) is supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham, and by donations from various sources.	Berardino M, 2004, ACTA NEUROCHIR, V146, P453, DOI 10.1007/s00701-003-0176-1; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1975, LANCET, V1, P480; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	20	19	20	0	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933			EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2013	39	3					285	292		10.1007/s00068-013-0269-3			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	159MR	WOS:000320050000010	23762202	hybrid, Green Published			2022-02-06	
J	Stein, DM; Brenner, M; Hu, PF; Yang, S; Hall, EC; Stansbury, LG; Menaker, J; Scalea, TM				Stein, Deborah M.; Brenner, Megan; Hu, Peter F.; Yang, Shiming; Hall, Erin C.; Stansbury, Lynn G.; Menaker, Jay; Scalea, Thomas M.			Timing of Intracranial Hypertension Following Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article; Proceedings Paper	PROMMTT Symposium held at the 71st Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 12-15, 2012	HI	Amer Assoc Surg Trauma		Traumatic brain injury; Intracranial pressure; Intracranial hypertension; Functional outcome	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; EDEMA; ICP; DEXANABINOL; DIAGNOSIS	We asked whether continuous intracranial pressure (ICP) monitoring data could provide objective measures of the degree and timing of intracranial hypertension (ICH) in the first week of neurotrauma critical care and whether such data could be linked to outcome. We enrolled adult (> 17 years old) patients admitted to our Level I trauma center within 6 h of severe TBI. ICP data were automatically captured and ICP 5-minute means were grouped into 12-hour time periods from admission (hour 0) to > 7 days (hour 180). Means, maximum, percent time (% time), and pressure-times-time dose (PTD, mmHg h) of ICP > 20 mmHg and > 30 mmHg were calculated for each time period. From 2008 to 2010, we enrolled 191 patients. Only 2.1 % had no episodes of ICH. The timing of maximum PTD20 was relatively equally distributed across the 15 time periods. Median ICP, PTD20, %time(20), and %time(30) were all significantly higher in the 84-180 h time period than the 0-84 h time period. Stratified by functional outcome, those with poor functional outcome had significantly more ICH in hours 84-180. Multivariate analysis revealed that, after 84 h of monitoring, every 5 % increase in PTD20 was independently associated with 21 % higher odds of having a poor functional outcome (adjusted odds ratio = 1.21, 95 % CI 1.02-1.42, p = 0.03). Although early elevations in ICP occur, ICPs are the highest later in the hospital course than previously understood, and temporal patterns of ICP elevation are associated with functional outcome. Understanding this temporal nature of secondary insults has significant implications for management.	[Stein, Deborah M.; Brenner, Megan; Hall, Erin C.; Menaker, Jay; Scalea, Thomas M.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Program Trauma,Div Crit Care, Baltimore, MD 21201 USA; [Stein, Deborah M.; Brenner, Megan; Hu, Peter F.; Yang, Shiming; Stansbury, Lynn G.; Menaker, Jay; Scalea, Thomas M.] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA		Stein, DM (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Program Trauma,Div Crit Care, Baltimore, MD 21201 USA.	dstein@umm.edu; mbrenner@umm.edu; phu@umm.edu; syang@umm.edu; erincarlylehall@gmail.com; lynn.stansbury@gmail.com; jmenaker@umm.edu; tscalea@umm.edu	Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Stein, Deborah/0000-0003-3683-3963			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BUXTON RL, 1970, LANCET, V2, P498; Carter BG, 2008, CHILD NERV SYST, V24, P245, DOI 10.1007/s00381-007-0461-z; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; TEASDALE G, 1974, LANCET, V2, P81; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	38	19	20	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2013	18	3					332	340		10.1007/s12028-013-9832-3			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	147II	WOS:000319159600007	23494545				2022-02-06	
J	Jang, SH; Kim, SH; Kim, OR; Byun, WM; Kim, MS; Seo, JP; Chang, MC				Jang, Sung Ho; Kim, Seong Ho; Kim, Oh Ryong; Byun, Woo Mok; Kim, Min-Su; Seo, Jeong Pyo; Chang, Min Cheol			Cingulum injury in patients with diffuse axonal injury: A diffusion tensor imaging study	NEUROSCIENCE LETTERS			English	Article						Diffusion tensor imaging; Diffusion tensor tractography; Diffuse axonal injury; Head trauma; Cingulum	TRAUMATIC BRAIN-INJURY; FORNIX INJURY; CORTEX	Accurate assessment of the cingulum is difficult, because it is a long neural tract that extends from the orbitofrontal cortex to the medial temporal lobe. We divided the cingulum into five parts and investigated changes caused by injury in these regions in patients with diffuse axonal injury (DAI) using diffusion tensor tractography (DTT). Twenty-one patients with DAI and 21 control subjects were recruited. The cingulum was divided into; the anterior, superior (the anterior and posterior portions), posterior, and inferior regions. Fractional anisotropy (FA), apparent diffusion coefficient (ADC), and tract number were measured in each region. FA values and tract numbers in the patient group were lower in the anterior superior cingulum than in controls (p<0.05); whereas the ADC values in the patient group were higher in the anterior and posterior superior cingulum than in controls (p<0.05). In the superior cingulum, increases in the ADC values of the anterior portion (Delta 8.1%) were higher than those of the posterior portion (Delta 5.5%). We found that the superior cingulum was injured in patients with DAI, and that the anterior portion of the superior cingulum was more injured than the posterior portion. Consequently, the superior cingulum appears to be a vulnerable area and the anterior superior cingulum appears more vulnerable than the posterior superior cingulum in DAI. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Jang, Sung Ho; Seo, Jeong Pyo; Chang, Min Cheol] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kim, Seong Ho; Kim, Oh Ryong; Kim, Min-Su] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea; [Byun, Woo Mok] Yeungnam Univ, Coll Med, Dept Radiol, Taegu 705717, South Korea		Chang, MC (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	wheel633@hanmail.net			Ministry of Education, Science and Technology of KoreaMinistry of Education, Science and Technology, Republic of Korea [13-BD-0401]	This research was supported by the DGIST R&D Program of the Ministry of Education, Science and Technology of Korea (13-BD-0401).	Afifi A.K., FUNCTIONAL NEUROANAT; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; Concha L, 2005, AM J NEURORADIOL, V26, P2267; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Jang SH, 2009, ARCH NEUROL-CHICAGO, V66, P1424, DOI 10.1001/archneurol.2009.242; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kwak SY, 2010, EUR NEUROL, V63, P149, DOI 10.1159/000281108; LONG CJ, 1978, J NEUROSURG, V49, P264, DOI 10.3171/jns.1978.49.2.0264; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Nielson KA, 2005, NEUROBIOL LEARN MEM, V84, P42, DOI 10.1016/j.nlm.2005.03.004; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wechsler, 1997, WECHSLER ADULT INTEL; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	26	19	19	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 24	2013	543						47	51		10.1016/j.neulet.2013.02.058			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154BH	WOS:000319646000010	23562507				2022-02-06	
J	Megha, M; Harpreet, S; Nayeem, Z				Megha, M.; Harpreet, S.; Nayeem, Z.			Effect of frequency of multimodal coma stimulation on the consciousness levels of traumatic brain injury comatose patients	BRAIN INJURY			English	Article						Brain Injury; Western Neuro Sensory Stimulation Profile; Glasgow Coma Scale	SEVERE HEAD-INJURY; VEGETATIVE STATE; SENSORY STIMULATION; REHABILITATION; INDIVIDUALS; DYSFUNCTION; PARAMETERS; RECOVERY; ONSET	Objectives: To evaluate the effectiveness of multimodal coma stimulation on the conscious levels of head injury comatose patients and to find out which of the two protocols of coma stimulation, i.e. administrating twice a day or 5-times a day is more beneficial. Methods: Thirty comatose patients with traumatic head injury (GCS<8) were selected and were divided into three groups randomly. Group A (n=10) received multimodal coma stimulation 5-times a day (20 minutes each session), Group B (n=10) received stimulation twice a day (50 minutes each session) and Group C (n=10) received conventional physiotherapy twice daily. Subjects in all the three groups received treatment for 2 weeks. Results and conclusion: The results showed a significant difference (p<0.01) for Glasgow Coma Scale as well as Western Neuro Sensory Stimulation Profile scores between Groups A & C and B & C, i.e. multimodal coma stimulation is effective as compared to the control group. The results also revealed a significant difference (p<0.01) between Groups A, B and C on the Western Neuro Sensory Stimulation Profile but a non-significant difference (p>0.01) on the Glasgow coma scale. This indicates that short sessions of high frequency can be more beneficial.	[Megha, M.; Nayeem, Z.] Hamdard Univ, MPT Neurol, New Delhi, India; [Harpreet, S.] AIIMS, MPT Neurol, New Delhi, India		Nayeem, Z (corresponding author), Hamdard Univ, Dept Rehabil Sci, New Delhi, India.	naya_bpt@yahoo.co.in					Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Belayev A, 2003, BRAIN RES, V964, P121, DOI 10.1016/S0006-8993(02)04089-1; Brimioulle S, 1997, PHYS THER, V77, P1682, DOI 10.1093/ptj/77.12.1682; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Dettmers C, 2005, ARCH PHYS MED REHAB, V86, P204, DOI 10.1016/j.apmr.2004.05.007; Duff D L, 1997, J Neurosci Nurs, V29, P305; Gerber CS, 2005, CRIT CARE NURS Q, V28, P94, DOI 10.1097/00002727-200504000-00002; Gruner ML, 2000, BRAIN INJURY, V14, P585; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; JOHNSON DA, 1993, BRAIN INJURY, V7, P491, DOI 10.3109/02699059309008176; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; Karma D, 2006, INDIAN PEDIATR, V43, P856; Kater K M, 1989, West J Nurs Res, V11, P20, DOI 10.1177/019394598901100103; Keller I, 2007, FUNCT NEUROL, V22, P159; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); LEWINN EB, 1978, LANCET, V2, P156; LEWINN EB, 1980, ROY SOC HEALTH J, V100, P19, DOI 10.1177/146642408010000107; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; MALKMUS D, 1983, PHYS THER, V63, P1952, DOI 10.1093/ptj/63.12.1952; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; Moulton CAE, 2006, ANN SURG, V244, P400, DOI 10.1097/01.sla.0000234808.85789.6a; Oh H, 2003, J CLIN NURS, V12, P394, DOI 10.1046/j.1365-2702.2003.00750.x; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; PIERCE J P, 1990, Brain Injury, V4, P191, DOI 10.3109/02699059009026165; Rader M A, 1989, Brain Inj, V3, P141, DOI 10.3109/02699058909004545; Seabrook R, 2005, APPL COGNITIVE PSYCH, V19, P107, DOI 10.1002/acp.1066; Sullivan TE, 1998, J CLIN EXP NEUROPSYC, V20, P227, DOI 10.1076/jcen.20.2.227.1175; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; Wilson SL, 1996, BRAIN INJURY, V10, P509, DOI 10.1080/026990596124223; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113	36	19	20	2	33	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2013	27	5					570	577		10.3109/02699052.2013.767937			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	124UK	WOS:000317493000007	23473238				2022-02-06	
J	Robertson, CS; Garcia, R; Gaddam, SSK; Grill, RJ; Hand, CC; Tian, TS; Hannay, HJ				Robertson, Claudia S.; Garcia, Robert; Gaddam, Samson Sujit Kumar; Grill, Raymond J.; Hand, Carla Cerami; Tian, Tian Siva; Hannay, H. Julia			Treatment of Mild Traumatic Brain Injury with an Erythropoietin-Mimetic Peptide	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; traumatic brain injury; treatment strategies for traumatic brain injury	RECOMBINANT-HUMAN-ERYTHROPOIETIN; LATERAL FLUID PERCUSSION; ENHANCES NEUROGENESIS; BEHAVIORAL DEFICITS; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; 3D STRUCTURE; RATS; MODEL; NEUROPROTECTION	Mild traumatic brain injury (mTBI) results in an estimated 75-90% of the 1.7 million TBI-related emergency room visits each year. Post-concussion symptoms, which can include impaired memory problems, may persist for prolonged periods of time in a fraction of these cases. The purpose of this study was to determine if an erythropoietin-mimetic peptide, pyroglutamate helix B surface peptide (pHBSP), would improve neurological outcomes following mTBI. Sixty-four rats were randomly assigned to pHBSP or control (inactive peptide) 30 mu g/kg IP every 12 h for 3 days, starting at either 1 hour (early treatment) or 24 h (delayed treatment), after mTBI (cortical impact injury 3 m/sec, 2.5mm deformation). Treatment with pHBSP resulted in significantly improved performance on the Morris water maze task. Rats that received pHBSP required 22.3 +/- 1.3 sec to find the platform, compared to 26.3 +/- 1.3 sec in control rats (p = 0.022). The rats that received pHBSP also traveled a significantly shorter distance to get to the platform, 5.0 +/- 0.3 meters, compared to 6.1 +/- 0.3 meters in control rats (p = 0.019). Motor tasks were only transiently impaired in this mTBI model, and no treatment effect on motor performance was observed with pHBSP. Despite the minimal tissue injury with this mTBI model, there was significant activation of inflammatory cells identified by labeling with CD68, which was reduced in the pHBSP-treated animals. The results suggest that pHBSP may improve cognitive function following mTBI.	[Robertson, Claudia S.; Garcia, Robert; Gaddam, Samson Sujit Kumar] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Grill, Raymond J.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA; [Hand, Carla Cerami] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Tian, Tian Siva; Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX USA		Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.edu		Hannay, H. Julia/0000-0001-7023-912X; Cerami, Carla/0000-0002-7634-0955	U.S. Army Award [W81XWH-08-2-0132, W81XWH-08-2-0150]	This work was funded by U.S. Army Award numbers W81XWH-08-2-0132 (C.S.R.) and W81XWH-08-2-0150 (R.J.G.).	Ahmet I, 2011, MOL MED, V17, P194, DOI 10.2119/molmed.2010.00235; Atalay B, 2007, BRIT J NEUROSURG, V21, P281, DOI 10.1080/02688690701364781; Atalay B, 2008, TURK NEUROSURG, V18, P356; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Cohen J., 2013, STAT POWER ANAL BEHA; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Drude S, 2011, LAB ANIMAL, V40, P119, DOI 10.1038/laban0411-119; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lieutaud T, 2008, J NEUROTRAUM, V25, P1179, DOI 10.1089/neu.2008.0591; Livingstone SA, 2007, BEHAV BRAIN RES, V185, P21, DOI 10.1016/j.bbr.2007.07.015; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Marti HH, 2000, NEWS PHYSIOL SCI, V15, P225; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Miskowiak K, 2008, EXP BRAIN RES, V184, P313, DOI 10.1007/s00221-007-1102-1; Miskowiak K, 2007, J NEUROSCI, V27, P2788, DOI 10.1523/JNEUROSCI.5013-06.2007; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Patel NSA, 2011, MOL MED, V17, P883, DOI 10.2119/molmed.2011.00053; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pickett JL, 1999, AM J KIDNEY DIS, V33, P1122, DOI 10.1016/S0272-6386(99)70150-2; Ray B, 2011, NEUROSCIENCE, V184, P139, DOI 10.1016/j.neuroscience.2011.03.067; Robertson CS, 2012, J NEUROTRAUM, V29, P1156, DOI 10.1089/neu.2011.1827; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Seeger N, 2011, EPILEPSIA, V52, P2333, DOI 10.1111/j.1528-1167.2011.03302.x; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Szabo Z, 2010, BRAIN RES, V1341, P25, DOI 10.1016/j.brainres.2009.01.035; Ueba H, 2010, P NATL ACAD SCI USA, V107, P14357, DOI 10.1073/pnas.1003019107; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zellinger C, 2011, EPILEPSY RES, V96, P241, DOI 10.1016/j.eplepsyres.2011.06.009; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	50	19	20	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2013	30	9			SI		765	774		10.1089/neu.2012.2431			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	145BJ	WOS:000318987600008	22827443	Green Submitted, Green Published			2022-02-06	
J	Stolwyk, RJ; Downing, MG; Taffe, J; Kreutzer, JS; Zasler, ND; Ponsford, JL				Stolwyk, Renerus J.; Downing, Marina G.; Taffe, John; Kreutzer, Jeffrey S.; Zasler, Nathan D.; Ponsford, Jennie L.			Assessment of Sexuality Following Traumatic Brain Injury: Validation of the Brain Injury Questionnaire of Sexuality	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; reliability; sexual function; sexual well-being; sexuality; traumatic brain injury; validity		Background: The importance of effectively identifying and managing sexuality issues following acquired brain injury is being increasingly recognized within clinical and research domains. However, a tool specifically developed to measure sexuality following brain injury is yet to be validated. Objectives: In this study, the reliability and validity of the Brain Injury Questionnaire of Sexuality (BIQS) was evaluated. Method: Eight hundred and sixty-five people who had sustained traumatic brain injury participated in this study. All participants completed the BIQS, and a subsample also completed the Derogatis Interview for Sexual Functioning-Self-Report version (DISF-SR). Results: Exploratory factor analysis supported a 3-subscale structure of the BIQS, which aligns with contemporary conceptual models of sexuality in chronic disease. All subscales of the BIQS demonstrated very good internal consistency. Convergent and divergent validity of all BIQS subscales was also demonstrated. Conclusions: Results from the study support the reliability and validity of the BIQS, which shows promise as a measurement tool for future traumatic brain injury sexuality research. Further validation work including evaluation for potential clinical applications is encouraged.	[Stolwyk, Renerus J.; Downing, Marina G.; Taffe, John; Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia; [Downing, Marina G.; Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA		Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol & Psychiat, Bldg 17,Clayton Campus, Melbourne, Vic 3800, Australia.	rene.stolwyk@monash.edu	Downing, Marina/AAX-2380-2020	Downing, Marina/0000-0002-3126-6632	Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research	This project was funded by the Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research.	Althof SE, 2005, J SEX MARITAL THER, V31, P153, DOI 10.1080/00926230590909989; Basson R, 2007, LANCET, V369, P409, DOI 10.1016/S0140-6736(07)60197-4; Clayton A, 2008, ADV PSYCHOSOM MED, V29, P70, DOI 10.1159/000126625; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DeRogatis L. R., 1996, DEROGATIS INTERVIEW; Derogatis LR, 1997, J SEX MARITAL THER, V23, P291; DeVellis RF., 2012, SCALE DEV THEORY APP, V34; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gosling J, 1999, BRAIN INJURY, V13, P785; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Jennett B, 1981, MANAGEMENT HEAD INJU; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rust J, 1986, GOLOMBOK RUST INVENT; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; SANDEL ME, 2007, BRAIN INJURY MED PRI, P673; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; SCHAEFER MT, 1981, J MARITAL FAM THER, V7, P47, DOI 10.1111/j.1752-0606.1981.tb01351.x; Verschuren JEA, 2010, J SEX RES, V47, P153, DOI 10.1080/00224491003658227	24	19	19	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2013	28	3					164	170		10.1097/HTR.0b013e31828197d1			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	149PS	WOS:000319334000002	23474881				2022-02-06	
J	Fedor, A; Gunstad, J				Fedor, Andrew; Gunstad, John			Higher BMI Is Associated with Reduced Cognitive Performance in Division I Athletes	OBESITY FACTS			English	Article						Body mass index; Physical activity; Risk factors; Weight status	CARDIOVASCULAR FITNESS; PHYSICAL-ACTIVITY; OBESITY; OVERWEIGHT; RISK; VARIABILITY; SENSITIVITY; IMPAIRMENT; EXERCISE; DECLINE	Objective: Poor cardiovascular fitness has been implicated as a possible mechanism for obesity-related cognitive decline, though no study has examined whether BMI is associated with poorer cognitive function in persons with excellent fitness levels. The current study examined the relationship between BMI and cognitive function by the Immediate Post Concussion and Cognitive Test (ImPACT) in Division I collegiate athletes. Methods: Participants had an average age of 20.14 +/- 1.78 years, were 31.3% female, and 53.9% football players. BMI ranged from 19.04 to 41.14 and averaged 26.72 +/- 4.62. Results: Regression analyses revealed that BMI incrementally predicted performance on visual memory (R-2 change = 0.015, p = 0.026) beyond control variables. Follow-up partial correlation analyses revealed small but significant negative correlations between BMI and verbal memory (r = -0.17), visual memory (r = -0.16), and visual motor speed (r = -0.12). Conclusions: These results suggest that higher BMI is associated with reduced cognitive function, even in a sample expected to have excellent levels of cardiovascular fitness. Further work is needed to better understand mechanisms for these associations. Copyright (C) 2013 S. Karger GmbH, Freiburg	[Fedor, Andrew; Gunstad, John] Kent State Univ, Dept Psychol, Kent, OH 44242 USA		Gunstad, J (corresponding author), Kent State Univ, Dept Psychol, 221 Kent Hall, Kent, OH 44242 USA.	jgunstad@kent.edu					Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; [Anonymous], 2008, SPSS VERS 16; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; de la Monte SM, 2010, J ALZHEIMERS DIS, V21, P967, DOI 10.3233/JAD-2010-091726; Fergenbaum JH, 2009, OBESITY, V17, P1957, DOI 10.1038/oby.2009.161; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Gonzales MM, 2010, OBESITY, V18, P2131, DOI 10.1038/oby.2010.183; Gunstad J, 2006, Eat Weight Disord, V11, pe15; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gunstad J, 2010, NEUROEPIDEMIOLOGY, V34, P222, DOI 10.1159/000297742; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Haennel RG, 2002, CAN FAM PHYSICIAN, V48, P65; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hassenstab JJ, 2010, DEMENT GERIATR COGN, V29, P356, DOI 10.1159/000296071; Huizinga MM, 2008, OBESITY, V16, P1966, DOI 10.1038/oby.2008.294; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Kakos Lynn S, 2010, Prev Cardiol, V13, P100, DOI 10.1111/j.1751-7141.2009.00065.x; Kohrt WM, 1998, CORONARY ARTERY DIS, V9, P489, DOI 10.1097/00019501-199809080-00004; Lovell MR, 2007, IMPACT VERSION 6 0 C; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nilsson LG, 2009, SCAND J PSYCHOL, V50, P660, DOI 10.1111/j.1467-9450.2009.00777.x; Okonkwo OC, 2011, J CARDIOPULM REHABIL, V31, P290, DOI 10.1097/HCR.0b013e318220a817; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sellbom KS, 2012, J ALZHEIMERS DIS, V30, pS89, DOI 10.3233/JAD-2011-111073; Sherry B., 2010, Morbidity and Mortality Weekly Report, V59, P951; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Smith PJ, 2010, HYPERTENSION, V55, P1331, DOI 10.1161/HYPERTENSIONAHA.109.146795; Stanek KM, 2010, OBESITY, V19, P500; Stephan BC, 2010, HYPERTENSION, V55, P1331; STEVENSON JS, 1990, RES NURS HEALTH, V13, P209, DOI 10.1002/nur.4770130403; STUNKARD A, 1958, PSYCHOSOM MED, V20, P366, DOI 10.1097/00006842-195809000-00004; Taylor VH, 2007, OBES REV, V8, P409, DOI 10.1111/j.1467-789X.2007.00401.x; Wilkerson GB, 2010, J ATHL TRAINING, V45, P67, DOI 10.4085/1062-6050-45.1.67; Willeumier KC, 2011, OBESITY SILVER SPRIN, V16, P1; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16; World Health Organization, 2011, OB OV	42	19	20	0	12	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1662-4025	1662-4033		OBESITY FACTS	Obes. Facts	APR	2013	6	2					185	192		10.1159/000351138			8	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	137ZT	WOS:000318478500009	23594505	gold, Green Published			2022-02-06	
J	Roberson, CJ; Boone, KB; Goldberg, H; Miora, D; Cottingham, M; Victor, T; Ziegler, E; Zeller, M; Wright, M				Roberson, Cedria J.; Boone, Kyle Brauer; Goldberg, Hope; Miora, Deborah; Cottingham, Maria; Victor, Tara; Ziegler, Elizabeth; Zeller, Michelle; Wright, Matthew			Cross Validation of the b Test in a Large Known Groups Sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						b Test; Malingering; Cognitive symptom validity	SUSPECT EFFORT; RECOGNITION TRIAL; RESPONSE BIAS; SENSITIVITY; SPECIFICITY; SCORES; PERFORMANCE	The b Test (Boone, Lu, & Herzberg, 2002a) is a measure of cognitive performance validity originally validated on 91 non-credible participants and 7 credible clinical comparison groups (total n=161). The purpose of the current study was to provide cross-validation data for the b Test on a known groups sample of non-credible participants (n=212) and credible heterogeneous neuropsychological clinic patients (n=103). The new data showed that while the original E-score cut-off of 155 achieved excellent specificity (99%), it was associated with relatively poor sensitivity (41%). However, the cut-off could be substantially lowered to 82, while still maintaining adequate specificity (90%) and raising sensitivity to 68%. Examination of non-credible subgroups revealed that b Test sensitivity in feigned mild traumatic brain injury (mTBI) was 58%, whereas in non-credible patients claiming depression and psychosis, cut-off sensitivity was 76% and 67%, respectively. These data suggest that the b Test may have a particular role in detection of non-credible cognitive symptoms associated with feigned psychiatric symptoms, and that fabricated deficits in processing speed and vigilance/visual scanning, detected by the b Test, are more prominent in feigned psychiatric presentations than in feigned mTBI. Further, b Test failures in patients with somatoform disorders were common, indicating that the b Test may have a specific use in detection of non-consciously created cognitive dysfunction associated with somatoform conditions.	[Roberson, Cedria J.; Boone, Kyle Brauer; Miora, Deborah] Alliant Int Univ, Calif Sch Forens Studies, Torrance, CA USA; [Goldberg, Hope] Olive View UCLA Med Ctr, Dept Psychiat, Sylmar, CA 91342 USA; [Cottingham, Maria] Henry M Jackson Fdn Adv Mil Med, Def & Vet Brain Injury Ctr, Camp Pendleton, CA USA; [Victor, Tara] Calif State Univ Dominguez Hills, Dept Psychol, Carson, CA 90747 USA; [Ziegler, Elizabeth] Spokane Vet Adm, Spokane, WA USA; [Zeller, Michelle] West Los Angeles Vet Adm, Los Angeles, CA USA; [Wright, Matthew] Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA; [Wright, Matthew] Los Angeles Biomed Inst, Torrance, CA USA		Roberson, CJ (corresponding author), Alliant Int Univ, Calif Sch Forens Studies, 1000 S Fremont, Alhambra, CA 91803 USA.	croberson@alliant.edu	Victor, Tara/K-6581-2019				Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Back C., 1996, ASSESSMENT, V3, P449, DOI [https://doi.org/10.1177/107319119600300411, DOI 10.1177/107319119600300411]; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P461, DOI 10.1076/clin.15.4.461.1890; Boone K., 2002, B TEST MANUAL; Boone K. B., 2002, DOT COUNTING TEST MA; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Jasinski LJ, 2011, CLIN NEUROPSYCHOL, V25, P1415, DOI 10.1080/13854046.2011.630024; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; Shandera AL, 2010, PSYCHOL ASSESSMENT, V22, P50, DOI 10.1037/a0016585; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T. N., 1997, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Vilar-Lopez R, 2008, J CLIN EXP NEUROPSYC, V30, P710, DOI 10.1080/13803390701684562; Vilar-Lopez R, 2007, ARCH CLIN NEUROPSYCH, V22, P379, DOI 10.1016/j.acn.2007.01.012	24	19	19	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	APR 1	2013	27	3					495	508		10.1080/13854046.2012.737027			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	129JK	WOS:000317835100012	23157695				2022-02-06	
J	Yuhasz, JE				Yuhasz, James E.			Misconceptions About Traumatic Brain Injury Among Correctional Health Care Professionals	JOURNAL OF CORRECTIONAL HEALTH CARE			English	Article						traumatic brain injury; inmates; correctional health care professionals	HEAD-INJURIES; EPIDEMIOLOGY	This study explored the prevalence of misconceptions of traumatic brain injury (TBI) among a sample of correctional health care professionals. Prior research has identified a high prevalence of TBI among criminal offenders, and misconceptions about TBI exist among laypersons and nonexpert professionals. Participants (N = 155) completed a 25-item survey about the sequelae of TBI. Results were compared with previous studies. This sample performed significantly better than laypersons and commensurable to other nonexpert professionals. Misconceptions were higher on items related to loss of consciousness, memory, and recovery. Gender, prior familiarity to someone with a history of TBI, and prior training in TBI accounted for statistically fewer misconceptions. The findings support the need for continued training and increased awareness about TBI among inmates.	[Yuhasz, James E.] Univ Med & Dent New Jersey, Annandale, NJ 08801 USA		Yuhasz, JE (corresponding author), Univ Med & Dent New Jersey, Dept Psychol, 31 Petticoat Lane, Annandale, NJ 08801 USA.	dryuhasz@hotmail.com					Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Finkelstein E., 2006, INCIDENCE EC BURDEN; GLAZE LE, 2008, PROBATION PAROLE US; Gouvier D. W., 1988, ARCH CLIN NEUROPSYCH, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; Shah MN, 2004, BRAIN INJURY, V18, P765, DOI 10.1080/02699050410001671801; Shiroma E. J., 2009, J CORRECT HEALTH CAR, V16, P147; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P	15	19	19	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1078-3458	1940-5200		J CORRECT HEALTH CAR	J. Correct. Health Care	APR	2013	19	2					135	143		10.1177/1078345812474644			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AK3QU	WOS:000338340600006	23446874				2022-02-06	
J	Brush, LN; Monagle, PT; Mackay, MT; Gordon, AL				Brush, Lauren N.; Monagle, Paul T.; Mackay, Mark T.; Gordon, Anne L.			Hypertension at time of diagnosis and long-term outcome after childhood ischemic stroke	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; HIGH BLOOD-PRESSURE; RISK-FACTORS; CEREBRAL-PALSY; HEAD-INJURY; CHILDREN; SCALE; CLASSIFICATION; ASSOCIATION; RELIABILITY	Objective: To determine the prevalence of hypertension (HPT) in the acute phase after ischemic stroke (IS) and explore its relationship to outcome. Methods: We performed a retrospective review of children aged 1 month to 18 years with first IS admitted to a tertiary hospital between 2003 and 2008. Blood pressure readings recorded over the first 72 hours after diagnosis and morbidity or mortality at 12 months were documented. HPT was defined as 2 consecutive readings of systolic blood pressure >= 95th percentile for age. Results: Ninety children were identified (median age 3.8 years). Fifty-three of 84 patients (63%) who had blood pressure readings available had at least 1 episode of HPT and 19 (22%) had HPT on 3 consecutive days. HPT was more prevalent at both ends of the age spectrum. The relative risk of 12-month mortality was 4.5 times higher (95% confidence interval = 0.6-34.5, p = 0.096) and relative risk of death in the hospital was 1.7 times higher (95% confidence interval = 1.4-2.0, p = 0.05) if the patient experienced HPT. There was no association between HPT and vascular territory, etiology, or neurologic disability. Conclusions: HPT is prevalent in children with IS in the first 3 days after diagnosis and is associated with increased risk of death. Larger prospective studies involving systematic recording of blood pressure are required to delineate the impact of HPT on risk of death or disability. Neurology (R) 2013;80:1225-1230	[Brush, Lauren N.] Univ Melbourne, Sch Med, Melbourne, Vic, Australia; [Monagle, Paul T.; Mackay, Mark T.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Monagle, Paul T.] Royal Childrens Hosp, Dept Haematol, Melbourne, Vic, Australia; [Mackay, Mark T.] Royal Childrens Hosp, Dept Neurol, Melbourne, Vic, Australia; [Monagle, Paul T.; Mackay, Mark T.; Gordon, Anne L.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Guys & St Thomas Hosp NHS Fdn Trust, Evelina Childrens Hosp, London, England		Gordon, AL (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	anne.gordon@gstt.nhs.uk		Monagle, Paul/0000-0002-3970-8984; Mackay, Mark/0000-0002-3787-1112	Murdoch Children's Research Institute; Brain Foundation; National Stroke Foundation; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Brockoff Foundation; Royal Children's Hospital Foundation Melbourne; University of MelbourneUniversity of Melbourne; BayerBayer AG; Stago	L. Brush reports no disclosures. M. Mackay received research funding from the Murdoch Children's Research Institute, the Brain Foundation, and the National Stroke Foundation. P. Monagle received research funding from the National Health and Medical Research Council of Australia, the Brockoff Foundation, Royal Children's Hospital Foundation Melbourne, University of Melbourne, Murdoch Children's Research Institute, and Bayer. He is a member of the steering committee of the Bayer-sponsored trial of rivaroxaban in children, and has given talks at a Stago-sponsored symposium. He gave evidence as an expert witness in the trial Waller v James. A. Gordon received research funding from the Murdoch Children's Research Institute. Go to Neurology.org for full disclosures.	Agrawal N, 2009, STROKE, V40, P3415, DOI 10.1161/STROKEAHA.109.564633; Amlie-Lefond C, 2008, LANCET NEUROL, V7, P425, DOI 10.1016/S1474-4422(08)70086-3; [Anonymous], 1987, PEDIATRICS, V79, P1; Bath P, 2004, CEREBROVASC DIS, V17, P51, DOI 10.1159/000074795; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; DESWIET M, 1980, PEDIATRICS, V65, P1028; deVeber G, 2003, ANN NEUROL, V53, P149, DOI 10.1002/ana.10461; deVeber G, 2000, Semin Pediatr Neurol, V7, P309, DOI 10.1053/spen.2000.20074; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; Dickinson CJ, 2003, CURR OPIN NEPHROL HY, V12, P91, DOI 10.1097/00041552-200301000-00015; Dickinson CJ, 2001, J HYPERTENS, V19, P1515, DOI 10.1097/00004872-200109000-00001; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Fullerton HJ, 2007, PEDIATRICS, V119, P495, DOI 10.1542/peds.2006-2791; Ganesan V, 2003, ANN NEUROL, V53, P167, DOI 10.1002/ana.10423; Ganesan V, 2006, CIRCULATION, V114, P2170, DOI 10.1161/CIRCULATIONAHA.105.583690; Gordon AL, 2002, J CHILD NEUROL, V17, P429, DOI 10.1177/088307380201700606; Hutchison James S, 2004, Semin Pediatr Neurol, V11, P139, DOI 10.1016/j.spen.2004.04.004; Jordan LC, 2006, NEUROLOGIST, V12, P94, DOI 10.1097/01.nrl.0000195826.72179.0b; KANTER RK, 1985, CLIN PEDIATR, V24, P320, DOI 10.1177/000992288502400603; Keezer MR, 2008, CEREBROVASC DIS, V25, P202, DOI 10.1159/000113857; Kirkham FJ, 2003, CURR OPIN PEDIATR, V15, P547, DOI 10.1097/00008480-200312000-00002; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; Mackay MT, 2007, AUST FAM PHYSICIAN, V36, P896; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Molofsky WJ, 2006, PEDIATR ANN, V35, P379, DOI 10.3928/0090-4481-20060501-10; Murphy S L, 2000, Natl Vital Stat Rep, V48, P1; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; OCONNELL JE, 1994, BMJ-BRIT MED J, V308, P1523, DOI 10.1136/bmj.308.6943.1523; Paget SP, 2012, DEV NEUROREHABIL, V15, P171, DOI 10.3109/17518423.2012.671381; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pavlakis SG, 2009, STROKE, V40, pS79, DOI 10.1161/STROKEAHA.108.531749; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Strater R, 2002, LANCET, V360, P1540, DOI 10.1016/S0140-6736(02)11520-0; Tikhonoff V, 2009, LANCET NEUROL, V8, P938, DOI 10.1016/S1474-4422(09)70184-X; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; WALLACE JD, 1981, JAMA-J AM MED ASSOC, V246, P2177, DOI 10.1001/jama.246.19.2177; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35; World Health Organization, INT STAT CLASS DIS R; Wraige E, 2005, DEV MED CHILD NEUROL, V47, P252, DOI 10.1017/S0012162205000484	41	19	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR	2013	80	13					1225	1230		10.1212/WNL.0b013e3182896ffb			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113OF	WOS:000316676700019	23468545				2022-02-06	
J	Pavawalla, SP; Salazar, R; Cimino, C; Belanger, HG; Vanderploeg, RD				Pavawalla, Shital P.; Salazar, Robert; Cimino, Cynthia; Belanger, Heather G.; Vanderploeg, Rodney D.			An Exploration of Diagnosis Threat and Group Identification Following Concussion Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Head injury; Memory; Expectations; Stereotype threat; Neuropsychological tests; Gender	STEREOTYPE THREAT; COGNITIVE PERFORMANCE; SYMPTOMS; MATH	Cognitive performance can be impacted by many non-neurological factors, including preexisting expectations. The phenomenon of stereotype threat, or reduced cognitive performance due to preexisting beliefs, can apply to individuals following neurological injury (i.e., "diagnosis threat''). We examined the effect of diagnosis threat on cognitive performance and symptom reporting following concussions while accounting for group identification (i.e., extent to which one's identity is tied to being concussed). We also examined gender stereotype threat (i.e., women and math ability) to understand how these two related threat effects compare. Participants with a history of concussion were randomly assigned to one of three instructional sets emphasizing concussion history or gender, or neutral instructions. Individuals without a history of concussion served as a comparison group. Results revealed an effect of diagnosis threat on cognitive performance after group identification was taken into account, but only in male participants. In contrast, an underlying gender stereotype threat was observed in females across conditions, which was counteracted in the gender stereotype condition (i.e., stereotype reactance effect) due to the type of threat cues used. Also, controls exhibited greater symptom reporting than individuals with a concussion. Our findings highlight the importance of considering non-neurological factors impacting cognitive performance. (JINS, 2013, 19, 305-313)	[Pavawalla, Shital P.] George Washington Med Fac Associates, Adventist Med Grp, Washington, DC USA; [Pavawalla, Shital P.; Belanger, Heather G.; Vanderploeg, Rodney D.] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Salazar, Robert; Cimino, Cynthia; Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Salazar, Robert] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Cimino, Cynthia] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA		Pavawalla, SP (corresponding author), Adventist Rehabil Hosp, 9909 Med Ctr Dr, Rockville, MD 20850 USA.	spavawal@adventisthealthcare.com			Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Health Administration (VHA)US Department of Veterans Affairs; Tampa VA Medical Center	This research received no specific grant from any funding agency, commercial or not-for-profit sectors. No financial relationships exist that could be interpreted as a conflict of interest affecting this manuscript. The research was supported by the Department of Veterans Affairs and Veterans Health Administration (VHA). Further support was provided by the Tampa VA Medical Center. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. We gratefully acknowledge the contributions of London Butterfield and Samantha Oliveira for their support in data collection. Unless otherwise indicated, the information in this manuscript and the manuscript itself is new and original, is not currently under review by any other publication, and has never been published either electronically or in print.	Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; KATZ I, 1965, J PERS SOC PSYCHOL, V2, P53, DOI 10.1037/h0022080; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keller J, 2003, PERS SOC PSYCHOL B, V29, P371, DOI 10.1177/0146167202250218; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; McKay PF, 2002, J APPL SOC PSYCHOL, V32, P767, DOI 10.1111/j.1559-1816.2002.tb00241.x; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nguyen HHD, 2008, J APPL PSYCHOL, V93, P1314, DOI 10.1037/a0012702; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Schmader T, 2002, J EXP SOC PSYCHOL, V38, P194, DOI 10.1006/jesp.2001.1500; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Wechsler D., 2008, WECHSLER ADULT INTEL	22	19	19	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2013	19	3					305	313		10.1017/S135561771200135X			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	107DV	WOS:000316195900008	23298459				2022-02-06	
J	Schneider, JC; Gerrard, P; Goldstein, R; Divita, MA; Niewczyk, P; Ryan, CM; Kowalske, K; Zafonte, R				Schneider, Jeffrey C.; Gerrard, Paul; Goldstein, Richard; Divita, Margaret A.; Niewczyk, Paulette; Ryan, Colleen M.; Kowalske, Karen; Zafonte, Ross			The Impact of Comorbidities and Complications on Burn Injury Inpatient Rehabilitation Outcomes	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; LENGTH-OF-STAY; RISK-FACTORS; ACUTE-CARE; MORTALITY; PERFORMANCE; ELIXHAUSER; PREDICTION; RECOVERY	Objective: To examine the impact of comorbidities and complications on burn inpatient rehabilitation facilities (IRE) outcomes. Design: A retrospective cross-sectional study. Setting: Inpatient rehabilitation hospitals. Patients: A total of 4572 patients with a primary diagnosis of burn injury from the Uniform Data System for Medical Rehabilitation database from 2002 to 2010. Methods or Interventions: Regression analyses were used to determine whether 3 different comorbidity measures (Charlson Comorbidity Index, Elixhauser Comoribidity Index, Centers for Medicare and Medicaid Services Comorbidity Tiers) and 1 complication measure improved the predictive model (c-statistic) for each outcome measure. Main Outcome Measurements: Community discharge, Functional Independence Measure (FIM) gain, length of stay efficiency, transfer to acute care within the first 3 days of IRE stay, and transfer to acute care for all time periods. Results: For all outcomes, there was no difference between the Standard Model and the models that include the comorbidity and complication variables as measured by the c-statistic confidence intervals. Conclusions: Comorbidities and complications did not significantly affect burn IRE outcomes. Future research is needed to examine the impact of comorbidities and complications on outcomes of other IRE populations to better understand the implications for current and future health care policy. PM R2013;5:114-121	[Schneider, Jeffrey C.; Gerrard, Paul; Goldstein, Richard; Zafonte, Ross] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02114 USA; [Divita, Margaret A.; Niewczyk, Paulette] Uniform Data Syst Med Rehabilitat, Amherst, NY USA; [Niewczyk, Paulette] Daemen Coll, Hlth Care Studies Dept, Amherst, NY USA; [Ryan, Colleen M.] Shriners Hosp Children Boston, Dept Surg, Boston, MA USA; [Ryan, Colleen M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Sumner Redstone Burn Ctr,Surg Serv, Boston, MA 02114 USA; [Kowalske, Karen] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA		Schneider, JC (corresponding author), Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, 125 Nashua St, Boston, MA 02114 USA.	jcschneider@partners.org	Schneider, Jeffrey/AAO-2126-2020	DiVita, Margaret/0000-0002-4878-2959; Gerrard, Paul/0000-0003-0654-5354; Ryan, Colleen/0000-0002-6455-936X	Department of DefenseUnited States Department of Defense	grant, Department of Defense	Alam E, 2008, ARCH PHYS MED REHAB, V89, P1284, DOI 10.1016/j.apmr.2008.01.014; Baldwin LM, 2006, MED CARE, V44, P745, DOI 10.1097/01.mlr.0000223475.70440.07; Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; CARTER GM, 2002, EXECUTIVE SUMMARY AN; Carter GM, 2002, ANAL INITIAL IMPLEME, P99; Carter GM, 2002, ANAL INITIAL IMPLEME; Centers for Medicare and Medicaid Services, 2011, FED REGISTER, V76, P24214; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P47836; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CMS, 2001, FED REGISTER, V66, P41316; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1046/j.1525-1497.1997.012004203.x; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Gerrard P, 2011, PM&R, V3, pS259; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Gomez M, 2008, J BURN CARE RES, V29, P130, DOI [1097/BCR.0b013e31815f6efd, 10.1097/BCR.0b013e31815f6efd]; GRANGER CV, 1992, STROKE, V23, P978, DOI 10.1161/01.STR.23.7.978; GREENFIELD S, 1988, JAMA-J AM MED ASSOC, V260, P2253, DOI 10.1001/jama.260.15.2253; GREENFIELD S, 1993, MED CARE, V31, P141, DOI 10.1097/00005650-199302000-00005; Guo Y, 2008, AM J PHYS MED REHAB, V87, P647, DOI 10.1097/PHM.0b013e31817fb94e; Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2; Hurria A, 2011, J CLIN ONCOL, V29, P4217, DOI 10.1200/JCO.2011.37.5717; IEZZONI LI, 1992, JAMA-J AM MED ASSOC, V267, P2197, DOI 10.1001/jama.267.16.2197; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Lo A, 2012, INT J STROKE, V7, P118, DOI 10.1111/j.1747-4949.2011.00694.x; MALEC J, 1983, ARCH PHYS MED REHAB, V64, P359; NORRISBAKER C, 1981, ARCH PHYS MED REHAB, V62, P602; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Post MWM, 1998, ARCH PHYS MED REHAB, V79, P395, DOI 10.1016/S0003-9993(98)90139-3; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Schneider J, 2010, AM J PHYS MED REHABI, V89, pS36; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Stillman G, 2009, PM&R, V1, P234, DOI 10.1016/j.pmrj.2008.10.014; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P712, DOI 10.1016/S0003-9993(03)04850-5; Stukenborg GJ, 2001, MED CARE, V39, P727, DOI 10.1097/00005650-200107000-00009; Tan WH, 2012, J BURN CARE RES, V33, P110, DOI 10.1097/BCR.0b013e318234d91a; Thombs BD, 2007, ANN SURG, V245, P629, DOI 10.1097/01.sla.0000250422.36168.67; Uniform Data System for Medical Rehabilitation, ALPHAFIMADVANTAGE; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Wright RE, 1996, ARCH PHYS MED REHAB, V77, P1049, DOI 10.1016/S0003-9993(96)90067-2	46	19	19	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	FEB	2013	5	2					114	121		10.1016/j.pmrj.2012.07.014			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	095VP	WOS:000315363400005	22981003				2022-02-06	
J	Wood, RL; McHugh, L				Wood, Rodger Ll.; McHugh, Louise			Decision Making after Traumatic Brain Injury: A Temporal Discounting Paradigm	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; TBI; Impulsive behavior; Neuropsychological tests; Executive function; Decision making	VENTROMEDIAL PREFRONTAL CORTEX; BARRATT IMPULSIVENESS SCALE; WORKING-MEMORY; SELF-CONTROL; RISK-TAKING; BEHAVIOR; CHOICE; DELAY; INTELLIGENCE; AMYGDALA	A temporal discounting paradigm was used to examine decision making for hypothetical monetary reward following traumatic brain injury (TBI). A case-control design compared individuals following moderate or severe TBI with a healthy control group matched for age and gender. The impact of intelligence, impulsivity, and mood on temporal discounting performance was examined. A within-subjects design for the TBI group determined the influence of a range of neuropsychological tests on temporal discounting performance. Both patients and controls demonstrated temporal discounting. However, the TBI group discounted more than controls, suggesting that their decision making was more impulsive, consistent with ratings on the impulsiveness questionnaire. Discounting performance was independent of neuropsychological measures of intelligence, memory, and executive function. There was no relationship between temporal discounting and ratings of everyday executive function made by patients' relatives. Low mood did not account for discounting performance. The results of this study suggest that temporal discounting may be a useful neuropsychological paradigm to assess decision making linked to monetary reward following TBI. Performance was relatively independent of intelligence, memory and standard tests of executive ability and may therefore assist when assessing a patient's mental capacity to manage their financial affairs. (JINS, 2013, 19, 181-188)	[Wood, Rodger Ll.] Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales; [McHugh, Louise] Univ Coll Dublin, Sch Psychol, Dublin 2, Ireland		Wood, RL (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Brain Injury Res Grp, Dept Psychol, Swansea SA2 8PP, W Glam, Wales.	r.l.wood@swansea.ac.uk		McHugh, Louise/0000-0002-2526-4649			Ainslie G., 2001, BREAKDOWN WILL; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Burgess P.W., 1997, HAYLING BRIXTON TEST; Carpenter PA, 2000, CURR OPIN NEUROBIOL, V10, P195, DOI 10.1016/S0959-4388(00)00074-X; Christ SE, 2003, NEUROPSYCHOLOGY, V17, P171, DOI 10.1037/0894-4105.17.1.171; Cicerone K.D., 1997, ARCH CLIN NEUROPSYCH, V12, P175; Crean JP, 2000, EXP CLIN PSYCHOPHARM, V8, P155, DOI 10.1037/1064-1297.8.2.155; Critchfield TS, 2001, J APPL BEHAV ANAL, V34, P101, DOI 10.1901/jaba.2001.34-101; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; GREEN L, 1993, BEHAV PHILOS, V21, P37; Greve KW, 2001, BRAIN INJURY, V15, P255; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Klapproth F, 2011, KRONOSCOPE, V11, P41, DOI 10.1163/156852411X595251; Marsh DM, 2002, PERS INDIV DIFFER, V33, P1291, DOI 10.1016/S0191-8869(02)00014-4; MCALLISTER TW, 2007, BRAIN INJURY MED PRI, P835; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MILLER LA, 1992, NEUROPSYCHOLOGIA, V30, P69, DOI 10.1016/0028-3932(92)90015-E; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Oddy M, 2008, J CLIN EXP NEUROPSYC, V30, P568, DOI 10.1080/13803390701555598; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pfister HR, 2008, JUDGM DECIS MAK, V3, P5; RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15; Reed DD, 2011, J APPL BEHAV ANAL, V44, P1, DOI 10.1901/jaba.2011.44-1; Richards JB, 1999, J EXP ANAL BEHAV, V71, P121, DOI 10.1901/jeab.1999.71-121; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Steadman H.J., 1994, VIOLENCE MENTAL DISO, P61; TEASDALE G, 1974, LANCET, V2, P81; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Walsh K. W., 1985, UNDERSTANDING BRAIN; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Willner P, 2010, AJIDD-AM J INTELLECT, V115, P157, DOI 10.1352/1944-7558-115.2.157; Wilson B.A., 1997, NEUROPSYCHOL REHABIL, V5, P662; Yuen KSL, 2003, J AFFECT DISORDERS, V75, P11, DOI 10.1016/S0165-0327(02)00022-8; Zeelenberg M, 2008, JUDGM DECIS MAK, V3, P18	42	19	19	1	22	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	FEB	2013	19	2					181	188		10.1017/S135561771200118X			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	085WV	WOS:000314645900008	23298735				2022-02-06	
J	Kanbak, G; Kartkaya, K; Ozcelik, E; Guvenal, AB; Kabay, SC; Arslan, G; Durmaz, R				Kanbak, Gungor; Kartkaya, Kazim; Ozcelik, Eda; Guvenal, Ahmet Burak; Kabay, Sibel Canbaz; Arslan, Gul; Durmaz, Ramazan			The neuroprotective effect of acute moderate alcohol consumption on caspase-3 mediated neuroapoptosis in traumatic brain injury: The role of lysosomal cathepsin L and nitric oxide	GENE			English	Article						Alcohol; Apoptosis; Caspase-3; Cathepsin L; Nitric oxide; Traumatic brain injury	ACUTE ETHANOL INTOXICATION; NEURONAL DEATH; INHIBITION; APOPTOSIS; PROTEASE; SYNTHASE; MODEL	Our aim in this study was to investigate the effect of moderate acute alcohol administration on cysteine protease mediated neuronal apoptosis and nitric oxide production in the traumatic brain injury. A total of 29 adult Sprague-Dawley male rats weighing 250-300 g were used. The rats were allocated into four groups. The first group was the control (sham-operated) group in which only a craniotomy was performed, the others were alcohol, trauma and trauma + alcohol groups. Caspase-3 enzyme activity in the trauma group increased significantly in comparison with the control group. The alcohol given group showed a decreased caspase-3 enzyme activity compared to the trauma group. The level of caspase-3 enzyme activity in the alcohol + trauma group decreased in comparison to the trauma group. SF/EEL ratio of cathepsin-L enzyme activity in the trauma group was significantly higher than in the control group. Our results indicate that moderate alcohol consumption may have protective effects on apoptotic cell death after traumatic brain injury. Protective effects of moderate ethanol consumption might be related to inhibition of lysosomal protease release and nitric oxide production. Published by Elsevier B.V.	[Kanbak, Gungor; Kartkaya, Kazim; Ozcelik, Eda] Eskisehir Osmangazi Univ, Sch Med, Dept Biochem, Eskisehir, Turkey; [Guvenal, Ahmet Burak; Durmaz, Ramazan] Eskisehir Osmangazi Univ, Sch Med, Dept Neurosurg, Eskisehir, Turkey; [Kabay, Sibel Canbaz] Kutahya Dumlupinar Univ, Sch Med, Dept Neurol, Kutahya, Turkey; [Arslan, Gul] Eskisehir Osmangazi Univ, Vocat High Sch Hlth Serv, Eskisehir, Turkey		Ozcelik, E (corresponding author), Eskisehir Osmangazi Univ, Sch Med, Dept Biochem, Eskisehir, Turkey.	eda_ozcelik@yahoo.com	Dokumacioglu, Eda/AAL-5167-2021	Dokumacioglu, Eda/0000-0001-6779-3082; canbaz kabay, sibel/0000-0003-4808-2191			CHANDLER LJ, 1994, J PHARMACOL EXP THER, V271, P67; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Costa ET, 2003, NEUROSCI LETT, V343, P41, DOI 10.1016/S0304-3940(03)00330-6; Davis RL, 2005, BRAIN RES REV, V49, P494, DOI 10.1016/j.brainresrev.2005.01.008; Durmaz R, 2008, NEUROCHEM RES, V33, P1683, DOI 10.1007/s11064-008-9605-0; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Gray J, 2001, J BIOL CHEM, V276, P32750, DOI 10.1074/jbc.M103150200; ICHIHARA K, 1987, J PHARMACOL EXP THER, V242, P1109; Is M, 2005, NEUROSURG QUART, V15, P60, DOI 10.1097/01.wnq.0000152407.39871.c7; Islekel H, 1999, BRAIN RES, V843, P18, DOI 10.1016/S0006-8993(99)01845-4; Jang MH, 2002, EUR J PHARMACOL, V449, P39, DOI 10.1016/S0014-2999(02)01973-8; Kavitha G, 2008, ALCOHOL, V42, P47, DOI 10.1016/j.alcohol.2007.10.006; Kim PKM, 2001, INT IMMUNOPHARMACOL, V1, P1421, DOI 10.1016/S1567-5769(01)00088-1; KIRSCHKE H, 1983, BIOCHEM J, V214, P871, DOI 10.1042/bj2140871; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Lu J, 2003, NEUROSCI LETT, V339, P147, DOI 10.1016/S0304-3940(03)00003-X; Marklund N., 1997, NEUROREPORT, V717, P109; Nabeshima T., 1996, EUR NEUROPSYCHOPHARM, V6, P156; Robertson GS, 2000, BRAIN PATHOL, V10, P283, DOI 10.1111/j.1750-3639.2000.tb00262.x; Savas HA, 2006, WORLD J BIOL PSYCHIA, V7, P51, DOI 10.1080/15622970510029993; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; Vancompernolle K, 1998, FEBS LETT, V438, P150, DOI 10.1016/S0014-5793(98)01275-7; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Zhang Yan-bo, 2006, Fa Yi Xue Za Zhi, V22, P404; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7; Zink BJ, 2001, ALCOHOL CLIN EXP RES, V25, P916; Zovein A, 2004, AM J PHYSIOL-REG I, V286, pR273, DOI 10.1152/ajpregu.00160.2003	29	19	19	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	JAN 10	2013	512	2					492	495		10.1016/j.gene.2012.10.012			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073UP	WOS:000313768900050	23099040				2022-02-06	
J	Agirbasli, M; Undar, A				Agirbasli, Mehmet; Uendar, Akif			Monitoring Biomarkers After Pediatric Heart Surgery: A New Paradigm on the Horizon	ARTIFICIAL ORGANS			English	Article; Proceedings Paper	8th International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Perfusion	JUN 13-16, 2012	Istanbul, TURKEY			Pediatric heart surgery; Biomarkers; Cardiopulmonary bypass; Outcomes; Congenital heart disease	FIBRILLARY ACIDIC PROTEIN; ACUTE CORONARY SYNDROMES; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; PLASMA-PROTEIN; SERUM; MARKERS; DISEASE; FEASIBILITY	Until recently, risk scoring systems for adult patients consisted of only clinical criteria. Currently, we are experiencing an abundant surge of literature integrating a wide range of biomarker arrays to clinical criteria in assessing the risk in an adult. In fact, novel risk scoring systems such as Reynolds criteria have emerged by combining the validated biomarkers to the traditional risk factors. Novel biomarkers potentially improve clinical management of cardiovascular disease, but there are gaps in understanding their role during childhood. The reason might be related to relatively lower prevalence of cardiovascular disease in children compared to the adult population. One exceptional group is the children with congenital heart disease. Recent studies indicate that novel biomarkers can alert the clinician in a timely manner about neurological and myocardial injury and their inflammatory consequences. Current technologies enable us to measure several biomarkers using only a few microliters of plasma. The preliminary studies show that novel biomarkers in addition to the traditionally studied biomarkers can help the clinician to identify children at high risk following pediatric heart surgery. Future studies are needed to confirm the role of biomarkers in monitoring children after cardiopulmonary bypass.	[Agirbasli, Mehmet] Marmara Univ, Dept Cardiol, Istanbul, Turkey; [Uendar, Akif] Penn State Hershey Childrens Hosp, Penn State Hershey Coll Med, Penn State Hershey Pediat Cardiovasc Res Ctr, Dept Pediat,Penn State Milton S Hershey Med Ctr, Hershey, PA USA; [Uendar, Akif] Penn State Hershey Childrens Hosp, Penn State Hershey Coll Med, Penn State Milton S Hershey Med Ctr, Dept Surg & Bioengn, Hershey, PA USA		Undar, A (corresponding author), Penn State Hershey Coll Med, Dept Pediat, H085,500 Univ Dr,POB 850, Hershey, PA 17033 USA.	aundar@psu.edu	Wang, Shigang/B-1215-2013	Wang, Shigang/0000-0002-5229-3330			ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; Adams JE, 1999, CLIN CHIM ACTA, V284, P127, DOI 10.1016/S0009-8981(99)00074-1; ADAMS JE, 1993, CIRCULATION, V88, P750, DOI 10.1161/01.CIR.88.2.750; Agirbasli M, 2005, INT J CLIN PRACT, V59, P102, DOI 10.1111/j.1742-1241.2005.00379.x; Agirbasli M, 2010, ARTIF ORGANS, V34, P987, DOI 10.1111/j.1525-1594.2010.01133.x; Akcevin A, 2010, ARTIF ORGANS, V34, P879, DOI 10.1111/j.1525-1594.2010.01159.x; Andropoulos DB, 2010, J THORAC CARDIOV SUR, V139, P543, DOI 10.1016/j.jtcvs.2009.08.022; Aran K, 2011, LAB CHIP, V11, P2858, DOI 10.1039/c1lc20080a; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; CHANDLER WL, 1990, BLOOD, V76, P930; Creighton DE, 2007, PEDIATRICS, V120, pE478, DOI 10.1542/peds.2006-3250; Domico M, 2011, PEDIATR CRIT CARE ME, V12, pS33, DOI 10.1097/PCC.0b013e318221178d; Furukawa T, 2012, PEDIATR CARDIOL, V33, P264, DOI 10.1007/s00246-011-0135-1; Hasegawa T, 2004, J THORAC CARDIOV SUR, V127, P1697, DOI 10.1016/j.jtcvs.2004.02.006; Jenkins Kathy J, 2004, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V7, P180, DOI 10.1053/j.pcsu.2004.02.009; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V124, P97, DOI 10.1067/mtc.2002.122311; JONAS RA, 1993, ANN THORAC SURG, V56, P1467, DOI 10.1016/0003-4975(93)90732-W; Knottnerus ILH, 2010, STROKE, V41, P1617, DOI 10.1161/STROKEAHA.109.576223; Lardner D, 2004, PEDIATR ANESTH, V14, P495, DOI 10.1111/j.1460-9592.2004.01230.x; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Lund J, 2010, CLIN CHEM, V56, P1158, DOI 10.1373/clinchem.2009.136960; Maar SP, 2008, PEDIATR EMERG CARE, V24, P883, DOI 10.1097/PEC.0b013e31819112b7; Majnemer A, 2006, J PEDIATR-US, V148, P72, DOI 10.1016/j.jpeds.2005.08.036; Moller JH, 1998, PERS PED C, V6, P19; O'Connor RE, 2010, CIRCULATION, V122, pS787, DOI 10.1161/CIRCULATIONAHA.110.971028; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pinto N, 2011, CURR DRUG METAB, V12, P487, DOI 10.2174/138920011795495321; Ramaswamy V, 2009, PEDIATR NEUROL, V40, P215, DOI 10.1016/j.pediatrneurol.2008.09.026; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Rizzo G, 2011, J MATERN-FETAL NEO M, V24, P253, DOI 10.3109/14767058.2010.482627; Sasso LA, 2010, MICROFLUID NANOFLUID, V9, P253, DOI 10.1007/s10404-009-0543-1; Savage WJ, 2011, AM J HEMATOL, V86, P427, DOI 10.1002/ajh.21995; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Schmitt B, 1998, BRAIN DEV-JPN, V20, P536, DOI 10.1016/S0387-7604(98)00046-1; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Su XWW, 2010, ARTIF ORGANS, V34, pE91, DOI 10.1111/j.1525-1594.2009.00963.x; Umstead TM, 2012, ARTIF ORGANS, V36, pE1, DOI 10.1111/j.1525-1594.2011.01412.x; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; Williams RG, 2006, J AM COLL CARDIOL, V47, P701, DOI 10.1016/j.jacc.2005.08.074	40	19	20	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	JAN	2013	37	1					10	15		10.1111/j.1525-1594.2012.01573.x			6	Engineering, Biomedical; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Engineering; Transplantation	072XG	WOS:000313706400004	24329546				2022-02-06	
J	Barfield, JP; Malone, LA				Barfield, J. P.; Malone, Laurie A.			Perceived exercise benefits and barriers among power wheelchair soccer players	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						disability sport; environmental barriers; multiple sclerosis; physical disability; rehabilitation; social barriers; social cognitive theory; spinal cord injury; therapeutic exercise; traumatic brain injury	SPINAL-CORD-INJURY; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; DISABILITIES; PARTICIPATION; FACILITATORS; ADULTS; GAMES; BASKETBALL; VETERANS	Lack of exercise is a major risk factor for secondary conditions among persons dependent upon motorized wheelchairs. Power wheelchair soccer is a unique exercise opportunity for this population, and understanding factors that influence exercise decision-making is necessary for clinicians to help those in motorized chairs reduce their secondary risk. Therefore, this study examined differences in perceived benefits and barriers to exercise among power wheelchair soccer players using a mixed-methods analysis. The most common perceived benefit to exercise was "Exercising lets me have contact with friends and persons I enjoy." Post hoc comparisons of quantitative data indicated that persons with muscular dystrophy perceived exercise to be significantly less important than did other disability groups (p < 0.05). "Exercise is hard work for me," "Exercise tires me," and "There are too few places for me to exercise" were the most common perceived barriers. These findings can assist with development of exercise opportunities for power wheelchair users.	[Barfield, J. P.] Tennessee Technol Univ, Dept Exercise Sci Phys Educ & Wellness, Cookeville, TN USA; [Malone, Laurie A.] Lakeshore Fdn, Birmingham, AL USA		Barfield, JP (corresponding author), Endicott Coll, Sch Sport Sci, 376 Hale St, Beverly, MA 01945 USA.	barfield@endicott.edu		Barfield, J.P./0000-0003-1692-9650; Malone, Laurie/0000-0001-9426-6325			Abel T, 2008, SPINAL CORD, V46, P785, DOI 10.1038/sc.2008.54; Anneken V, 2010, SPINAL CORD, V48, P393, DOI 10.1038/sc.2009.137; Barfield JP, 2010, J SPORT SCI, V28, P389, DOI 10.1080/02640410903508839; Barfield JP, 2005, MED SCI SPORT EXER, V37, P718, DOI 10.1249/01.MSS.0000161807.77552.8B; Bodde AE, 2009, DISABIL HEALTH J, V2, P57, DOI 10.1016/j.dhjo.2008.11.004; Brown Debra J, 2005, Policy Polit Nurs Pract, V6, P331, DOI 10.1177/1527154405283380; Buffart LM, 2009, J REHABIL MED, V41, P881, DOI 10.2340/16501977-0420; Cardinal BJ, 2004, MED SCI SPORT EXER, V36, P868, DOI 10.1249/01.MSS.0000126568.63402.22; Croft L, 2010, INT J SPORT PHYSIOL, V5, P301, DOI 10.1123/ijspp.5.3.301; Di Russo F, 2010, J NEUROTRAUM, V27, P2309, DOI 10.1089/neu.2010.1501; Disability and Health-Healthy People 2020, 2012, DIS HLTH HLTH PEOPL; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Furmaniuk L, 2010, J REHABIL MED, V42, P688, DOI 10.2340/16501977-0580; FURST DM, 1993, PSYCHOL REP, V72, P403, DOI 10.2466/pr0.1993.72.2.403; Giacobbi PR, 2008, ADAPT PHYS ACT Q, V25, P189, DOI 10.1123/apaq.25.3.189; Gil-Agudo Angel, 2010, Phys Med Rehabil Clin N Am, V21, P141, DOI 10.1016/j.pmr.2009.07.002; Ginis KAM, 2008, SPINAL CORD, V46, P216, DOI 10.1038/sj.sc.3102103; Goosey-Tolfrey V, 2006, BRIT J SPORT MED, V40, P684, DOI 10.1136/bjsm.2006.026815; Johnson CC, 2009, AM J HEALTH PROMOT, V23, P157, DOI 10.4278/ajhp.070930103; Karmarkar AM, 2009, J REHABIL RES DEV, V46, P567, DOI 10.1682/JRRD.2008.08.0102; Kehn M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-168; Kerstin W, 2006, DISABIL REHABIL, V28, P481, DOI 10.1080/09638280500211932; Kinne S, 1999, DISABIL REHABIL, V21, P15, DOI 10.1080/096382899298052; Kumar A, 2012, J REHABIL RES DEV, V49, P75, DOI 10.1682/JRRD.2010.09.0191; Levins SM, 2004, PHYS THER, V84, P496, DOI 10.1093/ptj/84.6.496; Malone LA, 2012, DISABIL HEALTH J, V5, P254, DOI 10.1016/j.dhjo.2012.05.004; Martin JJ, 2008, ADAPT PHYS ACT Q, V25, P275, DOI 10.1123/apaq.25.4.275; McVeigh SA, 2009, J SPINAL CORD MED, V32, P115, DOI 10.1080/10790268.2009.11760762; MORGULEC N., 2006, RES YB STUDIES PHYS, V12, P195; National Disability Sports Alliance, 2009, PALAESTRA, V24, P17; Odette Fran, 2003, Health Care Women Int, V24, P125, DOI 10.1080/07399330390170105; Rimmer J. H., 2007, Morbidity and Mortality Weekly Report, V56, P1021; Rimmer JH, 2010, AM J PHYS MED REHAB, V89, P249, DOI 10.1097/PHM.0b013e3181c9fa9d; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Rimmer JH, 2000, ARCH PHYS MED REHAB, V81, P182; Roy JLP, 2006, J STRENGTH COND RES, V20, P665; Scelza WM, 2005, AM J PHYS MED REHAB, V84, P576, DOI 10.1097/01.phm.0000171172.96290.67; SECHRIST KR, 1987, RES NURS HEALTH, V10, P357, DOI 10.1002/nur.4770100603; Shiba S, 2010, ARCH PHYS MED REHAB, V91, P1262, DOI 10.1016/j.apmr.2010.04.024; Sporner ML, 2009, PROSTHET ORTHOT INT, V33, P210, DOI 10.1080/03093640903051816; Sporner ML, 2009, DISABIL REHABIL, V31, P410, DOI 10.1080/09638280802030923; US Department of Health and Human Services OoDPaHP, 2000, HLTH PEOPL 2010 UND; van Langeveld SA, 2011, DISABIL REHABIL, V33, P412, DOI 10.3109/09638288.2010.498548; Vissers M, 2008, J REHABIL MED, V40, P461, DOI 10.2340/16501977-0191; Vlak T, 2009, CROAT MED J, V50, P527, DOI 10.3325/cmj.2009.50.527; Williams Bernadette R, 2006, J Geriatr Phys Ther, V29, P43	46	19	19	0	35	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	2					231	238		10.1682/JRRD.2011.12.0234			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149FF	WOS:000319303700012	23761004	Bronze			2022-02-06	
J	Brandner, S; Thaler, C; Lewczuk, P; Lelental, N; Buchfelder, M; Kleindienst, A				Brandner, Sebastian; Thaler, Christian; Lewczuk, Piotr; Lelental, Natalia; Buchfelder, Michael; Kleindienst, Andrea			Neuroprotein Dynamics in the Cerebrospinal Fluid: Intraindividual Concomitant Ventricular and Lumbar Measurements	EUROPEAN NEUROLOGY			English	Article						Biomarker; S100B; Neuron-specific enolase; beta-Trace; Neurotrauma; Neuroproteins; Cerebrospinal fluid; Ventricular drain	NEURON-SPECIFIC ENOLASE; BETA-TRACE PROTEIN; S-100 PROTEIN; S100B; SERUM; MARKER; CSF; RELEASE; DAMAGE; BLOOD	Objective:The measurement of neuromarker/neuroproteins in the cerebrospinal fluid (CSF) is gaining increased popularity. However, insufficient information is available on the rostrocaudal distribution of neuroproteins in the CSF to guarantee an appropriate interpretation of ventricular versus lumbar concentrations. Methods: In 10 patients treated with both an external ventricular and a lumbar CSF drain, we collected concomitant CSF samples. We measured CSF concentrations of the glial S100B protein, the neuron-specific enolase (Cobas e411 (R); Roche Diagnostics), the leptomeningeal beta-trace protein (BN Pro Spec (R); Dade Behring/Siemens), and the blood-derived albumin (Immage; Beckman Coulter). Statistical analysis was performed with a paired Wilcoxon signed ranks test. Results: In patients with a free CSF circulation without any recent neurosurgical procedure, S100B and neuron-specific enolase concentrations did not differ between the ventricular and lumbar CSF while beta-trace and albumin levels were significantly higher in the lumbar than in the ventricular CSF (p = 0.008 and p = 0.005). Following posterior fossa tumor surgery, all proteins accumulate in the lumbar CSF. Conclusion: For brain-derived proteins, we could not confirm a rostrocaudal CSF gradient while lepto-meningeal and blood-derived proteins accumulate in the lumbar CSF. We conclude that for the interpretation of protein CSF concentrations, the source of the sample is of crucial importance. Copyright (C) 2013 S. Karger AG, Basel	[Brandner, Sebastian; Thaler, Christian; Buchfelder, Michael; Kleindienst, Andrea] Univ Erlangen Nurnberg, Dept Neurosurg, DE-91054 Erlangen, Germany; [Lewczuk, Piotr; Lelental, Natalia] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, DE-91054 Erlangen, Germany		Kleindienst, A (corresponding author), Univ Erlangen Nurnberg, Dept Neurosurg, Schwabachanlage 6, DE-91054 Erlangen, Germany.	andrea.kleindienst@uk-erlangen.de	Kleindienst, Andrea/F-1674-2014; Brandner, Sebastian/AAU-2615-2021; Brandner, Sebastian/J-4562-2014	Kleindienst, Andrea/0000-0003-4758-0324; Brandner, Sebastian/0000-0002-8635-7195; Brandner, Sebastian/0000-0002-9821-0342	ZNS - Hannelore Kohl Stiftung	This work was supported by a grant of the ZNS - Hannelore Kohl Stiftung to A.K.	Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Brandner S, 2013, J NEUROTRAUM, V30, P1205, DOI 10.1089/neu.2012.2621; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; JACOBI C, 1988, CLIN CHIM ACTA, V177, P49, DOI 10.1016/0009-8981(88)90306-3; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Kleindienst Andrea, 2010, Cardiovasc Psychiatry Neurol, V2010, P801295, DOI 10.1155/2010/801295; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Nygaard O, 1997, CLIN CHEM, V43, P541; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; PERSSON L, 1988, ACTA NEUROCHIR, V93, P116, DOI 10.1007/BF01402892; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Reiber H, 2003, ACTA NEUROL SCAND, V108, P359, DOI 10.1034/j.1600-0404.2003.00173.x; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Staykov D, 2009, STROKE, V40, P3275, DOI 10.1161/STROKEAHA.109.551945; TAKAYASU M, 1985, J NEUROSURG, V63, P417, DOI 10.3171/jns.1985.63.3.0417; Tarnaris A, 2011, NEUROCHEM RES, V36, P528, DOI 10.1007/s11064-010-0374-1; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Woertgen C, 2004, NEUROSURG REV, V27, P178, DOI 10.1007/s10143-004-0341-x	25	19	19	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022	1421-9913		EUR NEUROL	Eur. Neurol.		2013	70	3-4					189	194		10.1159/000352032			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	240ZF	WOS:000326135500015	23969528	Green Published			2022-02-06	
J	Chen, X; Zhao, ZL; Chai, Y; Luo, LL; Jiang, RC; Dong, JF; Zhang, JN				Chen, Xin; Zhao, Zilong; Chai, Yan; Luo, Lanlan; Jiang, Rongcai; Dong, Jingfei; Zhang, Jianning			Stress-dose hydrocortisone reduces critical illness-related corticosteroid insufficiency associated with severe traumatic brain injury in rats	CRITICAL CARE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SEPTIC SHOCK; RECEPTOR ACTIVATION; CRITICAL-CARE; CELL-DEATH; BARRIER; EXPRESSION; APOPTOSIS; GLUCOCORTICOIDS; THERAPY	Introduction: The spectrum of critical illness-related corticosteroid insufficiency (CIRCI) in severe traumatic brain injury (TBI) is not fully defined and no effective treatments for TBI-induced CIRCI are available to date. Despite growing interest in the use of stress-dose hydrocortisone as a potential therapy for CIRCI, there remains a paucity of data regarding its benefits following severe TBI. This study was designed to investigate the effects of stress-dose hydrocortisone on CIRCI development and neurological outcomes in a rat model of severe traumatic brain injury. Methods: Rats were subjected to lateral fluid percussion injury of 3.2-3.5 atmosphere. These rats were then treated with either a stress-dose hydrocortisone (HC, 3 mg/kg/d for 5 days, 1.5 mg/kg on day 6, and 0.75 mg on day 7), a low-dose methylprednisolone (MP, 1 mg/kg/d for 5 days, 0.5 mg/kg on day 6, and 0.25 mg on day 7) or control saline solution intraperitoneally daily for 7 days after injury. Results: We investigated the effects of stress-dose HC on the mortality, CIRCI occurrence, and neurological deficits using an electrical stimulation test to assess corticosteroid response and modified neurological severity score (mNSS). We also studied pathological changes in the hypothalamus, especially in the paraventricular nuclei (PVN), after stress-dose HC or a low dose of MP was administered, including apoptosis detected by a TUNEL assay, blood-brain barrier (BBB) permeability assessed by brain water content and Evans Blue extravasation into the cerebral parenchyma, and BBB integrity evaluated by CD31 and claudin-5 expression. We made the following observations. First, 70% injured rats developed CIRCI, with a peak incidence on post-injury day 7. The TBI-associated CIRCI was closely correlated with an increased mortality and delayed neurological recovery. Second, post-injury administration of stress-dose HC, but not MP or saline increased corticosteroid response, prevented CIRCI, reduced mortality, and improved neurological function during the first 14 days post injury dosing. Thirdly, these beneficial effects were closely related to improved vascular function by the preservation of tight junctions in surviving endothelial cells, and reduced neural apoptosis in the PVN of hypothalamus. Conclusions: Our findings indicate that post-injury administration of stress-dose HC, but not MP reduces CIRCI and improves neurological recovery. These improvements are associated with reducing the damage to the tight junction of vascular endothelial cells and blocking neuronal apoptosis in the PVN of the hypothalamus.	[Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Luo, Lanlan] Tianjin Huanhu Hosp, Dept Psychol, Tianjin 300060, Peoples R China; [Dong, Jingfei] Univ Washington, Dept Med, Puget Sound Blood Res Inst JD, Div Hematol, Seattle, WA 98104 USA		Chen, X (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China.	xinchentianjin@me.com; jianningzhang@hotmail.com	Zhao, Zilong/AAZ-2196-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000533]; Project of Tianjin Applied Basic and Cutting-edge Technological Research [13JCQNJC10500]	This work was supported by grants from the National Natural Science Foundation of China (grant no. 81000533), and the Project of Tianjin Applied Basic and Cutting-edge Technological Research (13JCQNJC10500).	Annane D, 2008, EUR RESPIR J, V31, P1150, DOI 10.1183/09031936.00040908; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; Asehnoune K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-228; Aziz MH, 2012, J BIOL CHEM, V287, P29825, DOI 10.1074/jbc.M112.393256; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Chantong B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-260; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen X, 2011, BRAIN RES, V1382, P298, DOI 10.1016/j.brainres.2011.01.045; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gomes JA, 2005, CRIT CARE MED, V33, P1214, DOI 10.1097/01.CCM.0000166389.85273.38; Gursoy-Ozdemir Y, 2012, J NEUROCHEM, V123, P2, DOI 10.1111/j.1471-4159.2012.07938.x; JAATTELA M, 1991, ENDOCRINOLOGY, V128, P623; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jung B, 2012, CRIT CARE, V16, DOI 10.1186/cc11871; Knollmann BC, 2011, GOODMAN GILMANS PHAR, V12th, P1209; Krugers HJ, 2010, NAT REV NEUROSCI, V11, P675, DOI 10.1038/nrn2913; Kwon YS, 2010, INTENS CARE MED, V36, P1845, DOI 10.1007/s00134-010-1971-9; Laurer H.L., 2002, ENCY HUMAN BRAIN, P93; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; Levin H, 2013, LANCET NEUROL, V12, P15, DOI 10.1016/S1474-4422(12)70300-9; Ma B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056580; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; Martinho A, 2013, MOL CELL BIOCHEM, V376, P41, DOI 10.1007/s11010-012-1547-9; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Miyauchi T, 2009, J ANESTH, V23, P266, DOI 10.1007/s00540-008-0725-0; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Oberleithner H, 2006, J CELL SCI, V119, P1926, DOI 10.1242/jcs.02886; Peng YS, 2009, CRIT CARE, V13, DOI 10.1186/cc7978; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Polito A, 2011, CRIT CARE MED, V39, P597, DOI 10.1097/CCM.0b013e31820b7426; Ramirez SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055972; RINK A, 1995, AM J PATHOL, V147, P1575; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schoknecht K, 2012, EPILEPSIA, V53, P7, DOI 10.1111/j.1528-1167.2012.03697.x; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Triantos CK, 2011, CLIN GASTROENTEROL H, V9, P595, DOI 10.1016/j.cgh.2011.03.033; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794; Wajanaponsan N, 2007, CRIT CARE, V11, DOI 10.1186/cc5954; Walker ML, 2011, AM SURGEON, V77, P579; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao YD, 2001, WORLD J SURG, V25, P1202	57	19	21	2	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2013	17	5							R241	10.1186/cc13067			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1HA	WOS:000331540900057	24131855	gold, Green Published			2022-02-06	
J	Galloway, RV; Granger, CV; Karmarkar, AM; Graham, JE; Deutsch, A; Niewczyk, P; DiVita, MA; Ottenbacher, KJ				Galloway, Rebecca V.; Granger, Carl V.; Karmarkar, Amol M.; Graham, James E.; Deutsch, Anne; Niewczyk, Paulette; DiVita, Margaret A.; Ottenbacher, Kenneth J.			The Uniform Data System for Medical Rehabilitation Report of Patients with Debility Discharged from Inpatient Rehabilitation Programs in 2000-2010	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Rehabilitation Outcome; Activities of Daily Living; Benchmarking; Muscle Weakness	FUNCTIONAL INDEPENDENCE MEASURE; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; OLDER-ADULTS; ASSESSMENT SCALES; HIP FRACTURE; OUTCOMES; RELIABILITY; PAYMENT; STROKE	Galloway RV, Granger CV, Karmarkar AM, Graham JE, Deutsch A, Niewczyk P, DiVita MA, Ottenbacher KJ: The Uniform Data System for Medical Rehabilitation: Report of patients with debility discharged from inpatient rehabilitation programs in 2000-2010. Am J Phys Med Rehabil 2013;92:14-27. Objective: Benchmark data are provided for a national sample of patients who received inpatient rehabilitation for debility. Design: Patients with debility from 830 inpatient rehabilitation facilities in the United States contributing to the Uniform Data System for Medical Rehabilitation from 2000 to 2010 were examined. Demographic information (age, marital status, sex, race/ethnicity, prehospital living setting, and discharge setting), hospital information (length of stay, program interruptions, payer, and codes for admitting diagnosis), and functional status (Functional Independence Measure [FIM] instrument ratings at admission and discharge, FIM change, and FIM efficiency) were analyzed. Results: Data from 2000 to 2010 (N = 260,373) revealed a decrease in mean (SD) FIM total admission ratings from 73.9 (16.2) to 62.5 (15.8). The FIM total discharge ratings decreased from 95.0 (19.7) to 88.2 (19.8). Mean (SD) length of stay decreased from 14.3 (9.1) to 12.1 (6.2) days. The FIM efficiency (change/day) increased from 1.9 (1.7) to 2.4 (1.9). Discharge to community decreased from 80% to 75%. Acute care discharges accounted for 12% of the cases. Policy changes affecting classification, reimbursement, and/or documentation processes may have influenced the results. Conclusions: National data indicate that the number of debility cases is increasing with diverse composition of etiologic diagnoses. A high proportion of these patients is discharged to acute care compared with other impairment groups.	[Karmarkar, Amol M.; Graham, James E.; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Galloway, Rebecca V.] Univ Texas Med Branch, Dept Phys Therapy, Galveston, TX 77555 USA; [Granger, Carl V.; Niewczyk, Paulette; DiVita, Margaret A.] UB Fdn Act Inc, Uniform Data Syst Med Rehabil, Buffalo, NY USA; [Deutsch, Anne] Northwestern Univ, Rehabil Inst Chicago, Feinberg Sch Med, Chicago, IL 60611 USA; [Deutsch, Anne] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Deutsch, Anne] Northwestern Univ, Inst Healthcare Studies, Feinberg Sch Med, Chicago, IL 60611 USA		Ottenbacher, KJ (corresponding author), Univ Texas Med Branch, Div Rehabil Sci, 301 Univ Blvd, Galveston, TX 77555 USA.		Deutsch, Anne/B-7530-2017; Karmarkar, Amol/E-6030-2011	Deutsch, Anne/0000-0003-2290-7757; Karmarkar, Amol/0000-0001-8355-1585; Galloway, Rebecca/0000-0002-8013-7781; Ottenbacher, Kenneth/0000-0001-5990-3982; DiVita, Margaret/0000-0002-4878-2959	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24 HD065702]; National Institute on Disability and Rehabilitation Research [H133G080163]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024832] Funding Source: NIH RePORTER	Supported, in part, by grants from the National Institutes of Health (R24 HD065702) and the National Institute on Disability and Rehabilitation Research (H133G080163).	Carter GM, 2003, HEALTH CARE FINANC R, V24, P25; CARTER GM, 2002, EXECUTIVE SUMMARY AN; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Deutsch A, 2002, AM J PHYS MED REHAB, V81, P133, DOI 10.1097/00002060-200202000-00010; Deutsch A, 2008, ARCH PHYS MED REHAB, V89, P2274, DOI 10.1016/j.apmr.2008.06.014; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Federal Register, 2005, FED REG, V70, P47880; Granger CV, 2007, AM J PHYS MED REHAB, V86, P883, DOI 10.1097/PHM.0b013e318152058a; Granger CV, 2012, AM J PHYS MED REHAB, V91, P289, DOI 10.1097/PHM.0b013e31824ad2fd; Granger CV, 2011, AM J PHYS MED REHAB, V90, P177, DOI 10.1097/PHM.0b013e31820b18d7; Granger CV, 2010, AM J PHYS MED REHAB, V89, P781, DOI 10.1097/PHM.0b013e3181f1c83a; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181c1ec38, 10.1097/PHM.0b013e3181clec38]; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Haley R, 2011, AM J PHYS MED REHAB, V90, P791, DOI 10.1097/PHM.0b013e31822deaf4; Hamilton BB, 1999, ARCH PHYS MED REHAB, V80, P385, DOI 10.1016/S0003-9993(99)90274-5; Kortebein P, 2008, AM J PHYS MED REHAB, V87, P118, DOI 10.1097/PHM.0b013e3181588429; Kortebein P, 2009, ARCH PHYS MED REHAB, V90, P934, DOI 10.1016/j.apmr.2008.12.010; Medicare Payment Advisory Commission, 2012, REPORT C MED PAYM PO; National Center for Health Statistics Centers for Disease Control and Prevention, 2010, INT CLASS DIS 9 REV; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; UB Foundation Activities, 2002, INP REH FAC PAT ASS; UB Foundation Activities, 2004, INP REH FAC PAT ASS; 2003, FED REG, V68, P45674	28	19	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JAN	2013	92	1					14	27		10.1097/PHM.0b013e31827441bc			14	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	057DO	WOS:000312542500002	23117268	Green Accepted			2022-02-06	
J	Huang, YH; Yang, TM; Lee, TC; Chen, WF; Yang, KY				Huang, Yu-Hua; Yang, Tzu-Ming; Lee, Tao-Chen; Chen, Wu-Fu; Yang, Ka-Yen			Acute autologous bone flap infection after cranioplasty for postinjury decompressive craniectomy	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Cranioplasty; Bone flap infection; Traumatic brain injury; Decompressive craniectomy; Risk factor	DELAYED CRANIOPLASTY; GRAFT INFECTION; FROZEN	Background: Acute bone flap infection is a devastating complication after cranioplasty for postinjury decompressive craniectomy. We aim to identify the risk factors of autologous bone flap infection. Methods: We enrolled 151 patients undergoing 153 cranioplasties in the 4-year retrospective study. Autologous bones stored at -75 degrees C were used in the cranioplasties. Acute bone flap infection was defined as the onset of infection <= 14 days after cranioplasty. The epidemiological data of patients and details of the cranioplasty procedure were recorded. Results: Acute bone flap infection was identified in five of the 153 cranioplasties, accounting for 3.3% of all episodes. Three of the 5 infected patients and five of 143 uninfected patients presented with dysfunction of subgaleal drainage comparatively, which was significantly different (p = 0.001). Statistical analysis of the cranioplasty procedures and subsequent results of the two patient groups revealed the following significant findings: the duration of operation (p = 0.03) and the length of hospital stay after cranioplasty (p < 0.001). Conclusions: Dysfunction of subgaleal drainage and long operative duration of cranioplasty are risk factors of acute autologous bone flap infection. Regarding the prolonged hospital stay in complicated patients, better surgical techniques should be implemented in order to eliminate the risks of infection. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.	[Huang, Yu-Hua; Yang, Tzu-Ming; Lee, Tao-Chen; Chen, Wu-Fu; Yang, Ka-Yen] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Hsien, Taiwan		Yang, KY (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, 123 Ta Pei Rd, Kaohsiung, Hsien, Taiwan.	newlupin2002@yahoo.com.tw					ABBOTT KH, 1953, J NEUROSURG, V10, P380, DOI 10.3171/jns.1953.10.4.0380; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Crotti F M, 1979, J Neurosurg Sci, V23, P289; ELLIOTT H, 1951, BRIT J SURG, V39, P31, DOI 10.1002/bjs.18003915305; Fry D.E., 2003, SURG SITE INFECT PAT; HAUPTLI J, 1980, HELV CHIR ACTA, V47, P121; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Nagayama K, 2002, NEUROL SURG TOKYO, V30, P165; ODOM GL, 1952, J NEUROSURG, V9, P606, DOI 10.3171/jns.1952.9.6.0606; OSAWA M, 1990, ACTA NEUROCHIR, V102, P38, DOI 10.1007/BF01402184; PROLO DJ, 1979, NEUROSURGERY, V4, P18, DOI 10.1227/00006123-197901000-00005; Zingale A, 2003, J Neurosurg Sci, V47, P137	13	19	23	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JAN	2013	44	1					44	47		10.1016/j.injury.2011.11.005			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	051MZ	WOS:000312132700008	22154044				2022-02-06	
J	Jonsson, CA; Catroppa, C; Godfrey, C; Smedler, AC; Anderson, V				Jonsson, Catherine Aaro; Catroppa, Cathy; Godfrey, Celia; Smedler, Ann-Charlotte; Anderson, Vicki			Cognitive Recovery and Development after Traumatic Brain Injury in Childhood: A Person-Oriented, Longitudinal Study	JOURNAL OF NEUROTRAUMA			English	Article						childhood; cognition; cluster analysis; follow-up studies; TBI	CHILDREN; PLASTICITY; MEMORY; TERM; PROFILES; OUTCOMES	Influence of childhood traumatic brain injury (TBI) on cognitive recovery and subsequent development is poorly understood. In this longitudinal study we used cluster analysis to explore acute stage individual profiles of injury age and cognition in 118 children with traumatic brain injury. Repeated measures of cognitive function were conducted at 30 months, indicating recovery, and 10 years post-injury, indicating development. Nine clusters were identified. Recovery was evident in three clusters, two of them with low functioning profiles. Developmental gains occurred for three clusters and an acute profile of higher freedom from distractibility (FFD) and lower processing speed (PS) was related to positive differences. One cluster, average low functioning and especially low verbal comprehension, demonstrated a slower development than peers. This suggests that developmental change after TBI in childhood takes place on a continuum, with both chance of long-term catching up, and risk of poor development. An acute profile of higher FFD and lower PS seemed to reflect injury consequences and were followed by developmental gains. These results challenge previous findings, and warrant further investigation.	[Jonsson, Catherine Aaro; Catroppa, Cathy; Godfrey, Celia; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Smedler, Ann-Charlotte] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden		Jonsson, CA (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	catherine.aaro.jonsson@jll.se	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Swedish Council for Working Life and Social ResearchSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte) [2010-1390]; Victorian Government; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This article was supported by grants of Swedish Council for Working Life and Social Research (C.A.J., grant number 2010-1390), the Victorian Government's Operational Infrastructure Support Program, and the Australian National Health and Medical Research Council.	Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bergman L. R., 2003, STUDYING INDIVIDUAL; Bergman L.R., 2006, DEV PSYCHOPATHOL, VVol. 2, P850; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Cohen J., 2013, STAT POWER ANAL BEHA; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; Kamphaus R.W., 2005, CHILD ADOLESCENT INT; Lehnung M, 2003, BRAIN INJURY, V17, P855, DOI 10.1080/0269905031000089369; Lehnung M, 2001, CHILD NEUROPSYCHOL, V7, P59, DOI 10.1076/chin.7.2.59.3129; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Schneider W., 1997, MEMORY DEV 2 20; Spencer-Smith M, 2009, DEV NEUROREHABIL, V12, P279, DOI 10.3109/17518420903090701; TEASDALE G, 1974, LANCET, V2, P81; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; von Eye A, 2006, J ADOLESCENCE, V29, P981, DOI 10.1016/j.adolescence.2006.06.007; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wechsler D., 1989, MANUAL PRESCHOOL PRI; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; [No title captured]	40	19	20	1	21	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2013	30	2					76	83		10.1089/neu.2012.2592			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	069NT	WOS:000313444000002	23025803	Green Published			2022-02-06	
J	Kozlowski, DA; Leasure, JL; Schallert, T				Kozlowski, Dorothy A.; Leasure, J. Leigh; Schallert, Timothy			The Control of Movement Following Traumatic Brain Injury	COMPREHENSIVE PHYSIOLOGY			English	Article							CONSTRAINT-INDUCED MOVEMENT; UNILATERAL SENSORIMOTOR CORTEX; LESS-AFFECTED FORELIMB; USE-DEPENDENT EXAGGERATION; CORTICAL CONTUSION INJURY; ENVIRONMENTAL ENRICHMENT; VOLUNTARY EXERCISE; MOTOR CORTEX; NEUROTROPHIC FACTOR; ADULT-RATS	Traumatic brain injury (TBI) results in a variety of impairments in cognition, mood, sensation, and movement, depending upon the location and severity of injury. Although not as extensively studied as cognitive impairments, motor impairments are common, especially in moderately to severely injured patients. The recovery of these deficits is not usually complete; however, extensive effort is put into the rehabilitation of motor skills to enhance independence and quality of life. Understanding the motor recovery process and how it can be influenced by rehabilitation has been extensively studied in animal models of stroke and focal lesions, albeit to a lesser extent following animal models of TBI. Injury-induced neural plasticity is intricately involved in motor recovery and influenced by behavioral compensation and rehabilitation following stroke and focal lesions. New studies in animal models of TBI indicate that neural plasticity and the processes of motor recovery and rehabilitation following brain injury may not mirror those processes shown to occur following stroke. Further examination of motor recovery, rehabilitation, and plasticity in animal models of TBI as well as in individuals with TBI will be necessary to fully understand the control of movement following brain injury. (C) 2013 American Physiological Society. Compr Physiol 3:121-139, 2013.	[Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Leasure, J. Leigh] Univ Houston, Dept Psychol, Houston, TX USA; [Leasure, J. Leigh] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Schallert, Timothy] Univ Texas Austin, Inst Neurosci, Dept Psychol, Austin, TX 78712 USA		Kozlowski, DA (corresponding author), Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA.	dkozlows@depaul.edu		Leasure, J. Leigh/0000-0002-9014-2525			Adkins DL, 2004, NEUROSCIENCE, V128, P473, DOI 10.1016/j.neuroscience.2004.07.019; Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Alessio HM, 2005, PHYSIOL BEHAV, V84, P65, DOI 10.1016/j.physbeh.2004.10.010; Allred RP, 2008, EXP NEUROL, V210, P172, DOI 10.1016/j.expneurol.2007.10.010; Allred RP, 2010, BEHAV NEUROSCI, V124, P124, DOI 10.1037/a0018457; Allred RP, 2005, RESTOR NEUROL NEUROS, V23, P297; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Bell K, 2007, BRAIN INJURY MED, P605; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Bland ST, 1999, NEUROSCI LETT, V277, P119, DOI 10.1016/S0304-3940(99)00855-1; Brene S, 2007, PHYSIOL BEHAV, V92, P136, DOI 10.1016/j.physbeh.2007.05.015; Brooks V, 1981, NERVOUS SYSTEM MOT 1, P1480; Brooks VB, 1981, NERVOUS SYSTEM MOT 2; Bury SD, 2000, NEUROPHARMACOLOGY, V39, P743, DOI 10.1016/S0028-3908(99)00272-5; Bury SD, 2002, J NEUROSCI, V22, P8597; Bury SD, 2000, NEUROSCI LETT, V287, P85, DOI 10.1016/S0304-3940(00)01138-1; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; Devine JM, 2009, PM&R, V1, P560, DOI 10.1016/j.pmrj.2009.03.015; Di Russo F, 2005, J NEUROTRAUM, V22, P297; Dixon CE, 1996, NEUROTRAUMA, P1337; DOD, 2007, POL GUID TRAUM BRAIN; Dromerick AW, 2009, NEUROLOGY, V73, P195, DOI 10.1212/WNL.0b013e3181ab2b27; DVBIC, 2010, TBI NUMB; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P483, DOI 10.1053/apmr.2002.31203; Fang PC, 2010, STROKE, V41, P544, DOI 10.1161/STROKEAHA.109.572073; Faul M, 2010, TRAUMATIC BRAIN INJU, P74; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feeney DM, 1997, ADV NEUROL, V73, P383; Ferguson L, 2010, NAT NEUR SOC M; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Goldstein Larry B, 2006, NeuroRx, V3, P451, DOI 10.1016/j.nurx.2006.07.010; Goldstein Larry B, 2003, Phys Med Rehabil Clin N Am, V14, pS125, DOI 10.1016/S1047-9651(02)00060-8; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Greenwald BND, 2009, MT SINAI J MED, V76, P182, DOI 10.1002/msj.20103; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hansson AC, 2006, J NEUROENDOCRINOL, V18, P104, DOI 10.1111/j.1365-2826.2005.01390.x; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Hoffman JM, PM R, V2, P911; Hsu JE, 2006, EXP NEUROL, V201, P479, DOI 10.1016/j.expneurol.2006.05.003; Hsu JE, 2005, EUR J NEUROSCI, V22, P2069, DOI 10.1111/j.1460-9568.2005.04370.x; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; Jang SH, 2011, NEUROREHABILITATION, V29, P339, DOI 10.3233/NRE-2011-0710; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Jones TA, 1999, J NEUROSCI, V19, P10153; Jones TA, 1999, J COMP NEUROL, V414, P57; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Jones TA, 2003, ILAR J, V44, P144, DOI 10.1093/ilar.44.2.144; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Jones TA, 2011, DEV PSYCHOBIOL, V53, P466, DOI 10.1002/dev.20557; KAAS JH, 1983, ANNU REV NEUROSCI, V6, P325, DOI 10.1146/annurev.ne.06.030183.001545; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Kozlowski DA, 2004, J NEUROTRAUM, V21, P513, DOI 10.1089/089771504774129856; KOZLOWSKI DA, 1994, RESTOR NEUROL NEUROS, V7, P119, DOI 10.3233/RNN-1994-7207; Kozlowski DA, 1996, ABSTR SOC NEUR; Kozlowski DA, 1997, ABSTR SOC NEUR; KRAUSS J, 2007, BRAIN INJURY MED PRI, P469; Krauss JK, 1996, NEUROLOGY, V47, P1488, DOI 10.1212/WNL.47.6.1488; Krauss JK, 1997, MOVEMENT DISORD, V12, P428, DOI 10.1002/mds.870120326; KRAUSS JK, 1995, NEUROL RES, V17, P409, DOI 10.1080/01616412.1995.11740353; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Leasure JL, 2004, BEHAV BRAIN RES, V150, P83, DOI 10.1016/S0166-4328(03)00254-7; Leunissen I, 2012, HUM BRAIN MAPP; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lotze M, 2006, NEUROREHAB NEURAL RE, V20, P14, DOI 10.1177/1545968305282919; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Luke LM, 2004, SYNAPSE, V54, P187, DOI 10.1002/syn.20080; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mark VW, 2004, RESTOR NEUROL NEUROS, V22, P317; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; Mayer NH, 2007, BRAIN INJURY MED, P615; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Mohammed AH, 2002, PROG BRAIN RES, V138, P109, DOI 10.1016/S0079-6123(02)38074-9; Mumford N, 2012, BRAIN INJURY, V26, P166, DOI 10.3109/02699052.2011.648706; NATIV A, 1991, PHYS THER, V71, P48, DOI 10.1093/ptj/71.1.48; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Nudo RJ, 2010, BRAIN INJURY MED PRI, P913; Oostra KM, 2012, ARCH PHYS MED REHAB, V93, P828, DOI 10.1016/j.apmr.2011.11.018; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Phillips JP, 2003, J HEAD TRAUMA REHAB, V18, P342, DOI 10.1097/00001199-200307000-00005; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Povlishock JT, 1996, NEUROTRAUMA; Purves D, 2008, NEUROSCIENCE, P857; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Quinn B, 2000, BRAIN INJURY, V14, P1063; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Risedal A, 1999, J CEREBR BLOOD F MET, V19, P997, DOI 10.1097/00004647-199909000-00007; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sacco K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00146; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; SCHALLERT T, 1993, J NEURAL TRANSP PLAS, V4, P193, DOI 10.1155/NP.1993.193; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHALLERT T, 1983, BEHAV NEUROSCI, V97, P159, DOI 10.1037/0735-7044.97.1.159; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Shaw SE, 2005, J REHABIL RES DEV, V42, P769, DOI 10.1682/JRRD.2005.06.0094; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stevens MC, 2012, BRAIN IMAGING BEHAV; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Taub E, 2006, NEUROREHABILITATION, V21, P93; TEITELBA.P, 1969, J COMP PHYSIOL PSYCH, V67, P430, DOI 10.1037/h0027288; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Voorhies AC, 2002, BEHAV BRAIN RES, V133, P237, DOI 10.1016/S0166-4328(02)00029-3; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Whishaw IQ, 2004, J NEUROTRAUM, V21, P1584, DOI 10.1089/neu.2004.21.1584; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	160	19	19	0	41	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2040-4603			COMPR PHYSIOL	Compr. Physiol.	JAN	2013	3	1					121	139		10.1002/cphy.c110005			19	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	086AH	WOS:000314654900003	23720282				2022-02-06	
J	Larson, EB; Kondiles, BR; Starr, CR; Zollman, FS				Larson, Eric B.; Kondiles, Bethany R.; Starr, Christine R.; Zollman, Felise S.			Postconcussive Complaints, Cognition, Symptom Attribution and Effort among Veterans	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Postconcussion syndrome; Brain concussion - diagnosis; Brain concussion - complications; Neuropsychological tests methods; Diagnosis threat; Symptom attribution	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; POST-CONCUSSION SYNDROME; ILLNESS PERCEPTIONS; REPEATABLE BATTERY; IDENTIFICATION; PERFORMANCE; TBI	The etiology of postconcussive symptoms is not clearly understood. Development of etiological models of those symptoms will be helpful for accurate diagnosis and for planning effective treatment. Such a model should characterize the role of subject characteristics (education, premorbid intelligence), social psychological factors and symptom validity. Toward that end, the present study examined the association of postconcussive complaints and cognitive performance with symptom attribution and level of effort on testing. In a sample of 155 veterans, attribution to concussion was associated with endorsement of more severe postconcussive complaints, after controlling for the effects of other factors such as subject characteristics. Similarly, effort was associated with cognitive performance after controlling for the effects of these other factors. The present findings are consistent with previous reports that illness perception and effort on testing are associated with postconcussive complaints. This supports previous recommendations to routinely educate all concussion patients immediately after injury to reduce distorted perceptions and related persistent complaints. Finally, these findings highlight a need for routine assessment of patients' perception of their injury to identify cases that may require psychotherapy to address any misattributions that develop. (JINS, 2013, 19, 88-95)	[Larson, Eric B.; Kondiles, Bethany R.; Starr, Christine R.] Rehabil Inst Chicago, Brain Injury Med & Rehabil Program, Chicago, IL 60611 USA; [Larson, Eric B.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Zollman, Felise S.] NorthShore Univ Hlth Syst, Dept Neurol, Glenview, IL USA		Larson, EB (corresponding author), Rehabil Inst Chicago, Brain Injury Med & Rehabil Program, 345 E Super St, Chicago, IL 60611 USA.	elarson@ric.org	Larson, Eric/AAD-9567-2021	Starr, Christine/0000-0002-8662-0387	Robert M. McCormick Tribune Foundation; Julius N. Frankel Foundation; Joseph G. Nicholas Foundation; Barker Welfare Foundation	This study was funded by grants from the Robert M. McCormick Tribune Foundation, the Julius N. Frankel Foundation, the Joseph G. Nicholas Foundation and the Barker Welfare Foundation. All of the authors report they have no conflicts of interest.	American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; Barker MD, 2010, CLIN NEUROPSYCHOL, V24, P1064, DOI 10.1080/13854046.2010.486009; Chan RCK, 2005, BRAIN INJURY, V19, P1117, DOI 10.1080/026990500150088; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverson G, 2007, BRAIN INJURY MED PRI; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Larson E., 2011, MEMORY POSTCONCUSSIO; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Nelson NW, 2011, CLIN NEUROPSYCHOL, V25, P716, DOI 10.1080/13854046.2011.579174; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Randolph C., 1998, REPEATABLE BATTERY A; Resnick PJ, 1997, CLIN ASSESSMENT MALI, P130; Rief W, 2007, CLIN PSYCHOL REV, V27, P821, DOI 10.1016/j.cpr.2007.07.005; Santa Maria MP, 2001, ARCH CLIN NEUROPSYCH, V16, P133; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; WechslerD, 2001, WECHSLER TEST ADULT; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; World Health Organization, 1992, ICD 10 CLASSIFICATIO	36	19	19	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2013	19	1					88	95		10.1017/S1355617712000999			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	063NB	WOS:000313005400009	23146625				2022-02-06	
J	Ragan, DK; McKinstry, R; Benzinger, T; Leonard, JR; Pineda, JA				Ragan, Dustin K.; McKinstry, Robert; Benzinger, Tammie; Leonard, Jeffrey R.; Pineda, Jose A.			Alterations in cerebral oxygen metabolism after traumatic brain injury in children	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain imaging; brain trauma; cerebral blood flow	POSITRON-EMISSION-TOMOGRAPHY; BLOOD-FLOW MEASUREMENTS; QUANTITATIVE-EVALUATION; PERFUSION; MR; ISCHEMIA; CONSUMPTION; EXTRACTION; HUMANS; RAT	Traumatic brain injury (TBI) is the most common cause of acquired disability in children. Metabolic defects, and in particular mitochondrial dysfunction, are important contributors to brain injury after TBI. Studies of metabolic dysfunction are limited, but magnetic resonance methods suitable for use in children are overcoming this limitation. We performed noninvasive measurements of cerebral blood flow and oxygen metabolic index (ON) to assess metabolic dysfunction in children with severe TBI. Cerebral blood flow is variable after TBI but hypoperfusion and low OMI are predominant, supporting metabolic dysfunction. This finding is consistent with preclinical and adult clinical studies of brain metabolism and mitochondrial dysfunction after TBI. Journal of Cerebral Blood Flow & Metabolism (2013) 33, 48-52; doi:10.1038/jcbfm.2012.130; published online 12 September 2012	[Ragan, Dustin K.; Pineda, Jose A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [McKinstry, Robert; Benzinger, Tammie] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Leonard, Jeffrey R.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA		Pineda, JA (corresponding author), Washington Univ, Sch Med, Dept Pediat & Neurol, Div Crit Care Med, Campus Box 8116,1 Childrens Pl,NWT-10, St Louis, MO 63110 USA.	pineda_j@kids.wustl.edu	Pineda, Jose/W-2806-2019; Benzinger, Tammie/L-6104-2013; Benzinger, Tammie L. S./ABA-8534-2020	Benzinger, Tammie L. S./0000-0002-8114-0552	Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); American Heart AssociationAmerican Heart Association; Washington University Institute of Clinical and Translational Sciences [KL2 RRO24994, 12POST8860002, UL1 RR024992]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024994, UL1RR024992] Funding Source: NIH RePORTER	Financial support was received from the Robert Wood Johnson Foundation, the American Heart Association and from the Washington University Institute of Clinical and Translational Sciences (KL2 RRO24994, 12POST8860002, and UL1 RR024992).	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Aliefendioglu D, 2007, J PEDIAT HEMATOL ONC, V29, P747, DOI 10.1097/MPH.0b013e318157fd85; An HY, 2009, STROKE, V40, P2165, DOI 10.1161/STROKEAHA.108.540864; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BUCHWEITZ E, 1980, SCIENCE, V209, P499, DOI 10.1126/science.7394515; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Detre JA, 1999, EUR J RADIOL, V30, P115, DOI 10.1016/S0720-048X(99)00050-9; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Faul M., 2010, CTR DIS CONTROL PREV; Fernandez-Seara MA, 2006, MAGN RESON MED, V55, P967, DOI 10.1002/mrm.20892; Fujima N, 2011, NEUROIMAGE, V54, P344, DOI 10.1016/j.neuroimage.2010.08.020; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; HARPER AM, 1966, J NEUROL NEUROSUR PS, V29, P398, DOI 10.1136/jnnp.29.5.398; Henriksen OM, 2012, J MAGN RESON IMAGING, V35, P1290, DOI 10.1002/jmri.23579; HOFFMAN WE, 1986, ANESTH ANALG, V65, P729; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Jain V, 2012, RADIOLOGY, V263, P527, DOI 10.1148/radiol.12111509; Jain V, 2011, J CEREBR BLOOD F MET, V31, P1504, DOI 10.1038/jcbfm.2011.34; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kissack CM, 2005, J CEREBR BLOOD F MET, V25, P545, DOI 10.1038/sj.jcbfm.9600046; LEBRUNGRANDIE P, 1983, ARCH NEUROL-CHICAGO, V40, P230, DOI 10.1001/archneur.1983.04050040060010; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lu HZ, 2008, MAGN RESON MED, V60, P357, DOI 10.1002/mrm.21627; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MICHENFELDER JD, 1971, BRIT J ANAESTH, V43, P630, DOI 10.1093/bja/43.7.630; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Poncelet BP, 1999, MAGN RESON MED, V41, P510, DOI 10.1002/(SICI)1522-2594(199903)41:3<510::AID-MRM13>3.0.CO;2-G; Qiu ML, 2010, MAGN RESON MED, V63, P374, DOI 10.1002/mrm.22218; Ragan DK, 2012, PEDIATR RES, V71, P199, DOI 10.1038/pr.2011.31; Raynaud JS, 2001, MAGN RESON MED, V46, P305, DOI 10.1002/mrm.1192; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Taki Y, 2011, HUM BRAIN MAPP, V32, P1973, DOI 10.1002/hbm.21163; TENJIN H, 1990, NEUROSURGERY, V26, P971, DOI 10.1227/00006123-199006000-00009; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Ye FQ, 2000, MAGNET RESON MED, V44, P450, DOI 10.1002/1522-2594(200009)44:3<450::AID-MRM16>3.3.CO;2-S; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	54	19	19	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2013	33	1					48	52		10.1038/jcbfm.2012.130			5	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	066MJ	WOS:000313224600006	22968318	Bronze, Green Published			2022-02-06	
J	Taylor, MK				Taylor, Marcus K.			Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate: Anabolic, Neuroprotective, and Neuroexcitatory Properties in Military Men	MILITARY MEDICINE			English	Article							SALIVARY ALPHA-AMYLASE; TRAUMATIC BRAIN-INJURY; ADRENERGIC ACTIVITY; STRESS; RECEPTOR; CORTICOSTERONE; DHEA; HIPPOCAMPAL; RAT; METABOLITES	Evidence links dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) to crucial military health issues, including operational stress, resilience, and traumatic brain injury. This study evaluated the anabolic, neuroprotective, and neuroexcitatory properties of DHEA(S) in healthy military men. A salivary sample was obtained from 42 men and assayed for DHEA(S), testosterone, nerve growth factor (NGF; which supports nerve cell proliferation), and salivary alpha amylase (sAA; a proxy of sympathetic nervous system function). Separate regression analyses were conducted with DHEA and DHEAS as independent variables, and testosterone, NGF, and sAA as dependent variables, respectively. The models explained 23.4% of variance in testosterone (p < 0.01), 17.2% of variance in NGF (p < 0.01), and 7.4% of variance in sAA (p = 0.09). Standardized beta coefficients revealed that DHEA independently influenced testosterone (beta = 0.40, p < 0.01), whereas DHEAS independently influenced NGF (beta = 0.48, p < 0.01) and sAA (beta = 0.36, p < 0.05). DHEA demonstrated anabolic properties, whereas DHEAS demonstrated neuroprotective and neuroexcitatory properties in military men. This area of study has broad implications for stress inoculation, traumatic brain injury rehabilitation, and regenerative medicine in military personnel.	Naval Hlth Res Ctr, Dept Behav Sci & Epidemiol, Behav Sci Lab, San Diego, CA 92106 USA		Taylor, MK (corresponding author), Naval Hlth Res Ctr, Dept Behav Sci & Epidemiol, Behav Sci Lab, San Diego, CA 92106 USA.				Office of Naval ResearchOffice of Naval Research [PB401]	The author would like to thank Michelle LeWark for her editorial expertise. This work was supported by the Office of Naval Research, under Work Unit No. PB401.	Bastianetto S, 1999, MOL BRAIN RES, V66, P35, DOI 10.1016/S0169-328X(99)00002-9; Baulieu EE, 1998, P NATL ACAD SCI USA, V95, P4089, DOI 10.1073/pnas.95.8.4089; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Compagnone NA, 1998, P NATL ACAD SCI USA, V95, P4678, DOI 10.1073/pnas.95.8.4678; Dazzi L, 2011, BRAIN RES, V1386, P41, DOI 10.1016/j.brainres.2011.02.065; Gartside SE, 2010, J PSYCHOPHARMACOL, V24, P1717, DOI 10.1177/0269881109105836; Giordano R, 2003, CLIN ENDOCRINOL, V59, P314, DOI 10.1046/j.1365-2265.2003.01847.x; Granger DA, 2007, PHYSIOL BEHAV, V92, P583, DOI 10.1016/j.physbeh.2007.05.004; Gubba EM, 2004, MOL BRAIN RES, V127, P48, DOI 10.1016/j.molbrainres.2004.05.004; Hoffman SW, 2003, J NEUROTRAUM, V20, P859, DOI 10.1089/089771503322385791; Hu Y, 2000, BIOCHEM PHARMACOL, V59, P753, DOI 10.1016/S0006-2952(99)00385-8; Hulin MW, ADV PHARM SCI, DOI [10.1155/2011/926361, DOI 10.1155/2011/926361]; Imamura M, 1998, BIOCHEM BIOPH RES CO, V243, P771, DOI 10.1006/bbrc.1998.8177; Karishma KK, 2002, EUR J NEUROSCI, V16, P445, DOI 10.1046/j.1460-9568.2002.02099.x; Kimonides VG, 1999, NEUROSCIENCE, V89, P429, DOI 10.1016/S0306-4522(98)00347-9; Lazaridis I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001051; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Morgan CA, 2009, BIOL PSYCHIAT, V66, P334, DOI 10.1016/j.biopsych.2009.04.004; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Newman AEM, 2010, J COMP NEUROL, V518, P3662, DOI 10.1002/cne.22395; Park-Chung M, 1999, BRAIN RES, V830, P72, DOI 10.1016/S0006-8993(99)01381-5; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Schulte-Herbruggen O, 2007, J REPROD IMMUNOL, V74, P170, DOI 10.1016/j.jri.2006.10.003; Smith KS, 2012, NEUROPHARMACOLOGY, V62, P54, DOI 10.1016/j.neuropharm.2011.07.026; Steiner PM, 2010, PSYCHOL METHODS, V15, P250, DOI 10.1037/a0018719; Stuart-Hamilton I., 2007, DICT PSYCHOL TESTING; Tanaka M, 2012, NEUROPHARMACOLOGY, V62, P2373, DOI 10.1016/j.neuropharm.2012.02.007; Taylor MK, 2012, STRESS, V15, P85, DOI 10.3109/10253890.2011.585189; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; Xu YX, 2012, HIPPOCAMPUS, V22, P707, DOI 10.1002/hipo.20932	33	19	20	0	4	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN	2013	178	1					100	106		10.7205/MILMED-D-12-00296			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7TV	WOS:000340804800022	23356127				2022-02-06	
J	Copin, JC; Rebetez, MML; Turck, N; Robin, X; Sanchez, JC; Schaller, K; Gasche, Y; Walder, B				Copin, Jean-Christophe; Rebetez, Marie My Lien; Turck, Natacha; Robin, Xavier; Sanchez, Jean-Charles; Schaller, Karl; Gasche, Yvan; Walder, Bernhard			Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Head injury; Prediction; Outcome; Plasmatic biomarker	MATRIX METALLOPROTEINASES; BARRIER BREAKDOWN; PROTEIN-LEVELS; BLOOD; SERUM; MORTALITY; MODERATE; MODELS; S100B; EPIDEMIOLOGY	Background: The relationship between severe traumatic brain injury (TBI) and blood levels of matrix metalloproteinase-9 (MMP-9) or cellular fibronectin (c-Fn) has never been reported. In this study, we aimed to assess whether plasma concentrations of MMP-9 and c-Fn could have predictive values for the composite endpoint of intensive care unit (ICU) length of stay (LOS) of survivors and mortality after severe TBI. Secondary outcomes were the state of consciousness measured with the Glasgow Coma Scale (GCS) of survivors at 14 days and Glasgow Outcome Scale Extended (GOSE) at 3 months. Methods: Forty-nine patients with abbreviated injury scores of the head region >= 4 were included. Blood was sampled at 6, 12, 24 and 48 hours after injury. MMP-9 and c-Fn concentrations were measured by ELISA. The values of MMP-9 and c-Fn, and, for comparison, the value of the GCS on the field of the accident (fGCS), as predictors of the composite outcome of ICU LOS and death were assessed by logistic regression. Results: There was a linear relationship between maximal MMP-9 concentration, measured during the 6-12-hour period, and maximal c-Fn concentration, measured during the 24-48-hour period. The risk of staying longer than 9 days in the ICU or of dying was increased in patients with a maximal early MMP-9 concentration >= 21.6 ng/ml (OR = 5.0; 95% CI: 1.3 to 18.6; p = 0.02) or with a maximal late c-Fn concentration >= 7.7 mu g/ml (OR = 5.4; 95% CI: 1.4 to 20.8; p = 0.01). A similar risk association was observed with fGCS = 8 (OR, 4.4; 95% CI, 1.2-15.8; p = 0.02). No relationship was observed between MMP-9, c-Fn concentrations or fGCS and the GCS at 14 days of survivors and GOSE at 3 months. Conclusions: Plasma MMP-9 and c-Fn concentrations in the first 48 hours after injury are predictive for the composite endpoint of ICU LOS and death after severe TBI but not for consciousness at 14 days and outcome at 3 months.	[Copin, Jean-Christophe; Gasche, Yvan] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland; [Copin, Jean-Christophe; Gasche, Yvan] Univ Hosp Geneva, Div Intens Care, Geneva, Switzerland; [Copin, Jean-Christophe] Univ Hosp Geneva, Div Neurosurg, Geneva, Switzerland; [Rebetez, Marie My Lien; Walder, Bernhard] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland; [Turck, Natacha; Robin, Xavier; Sanchez, Jean-Charles; Schaller, Karl] Univ Geneva, Med Ctr, Biomed Prote Res Grp, Dept Human Prot Sci, CH-1211 Geneva, Switzerland; [Copin, Jean-Christophe] Ctr Med Univ Geneva, CH-1211 Geneva 4, Switzerland		Copin, JC (corresponding author), Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland.	jean-christophe.copin@unige.ch	Robin, Xavier/A-1680-2009	Robin, Xavier/0000-0002-6813-3200	SUVA Foundation; Bangerter-Rhyner Foundation; Geneva University Hospital Research & Development fund; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B-116774]	This study was supported by the SUVA Foundation (BW), the Bangerter-Rhyner Foundation (BW), the Geneva University Hospital Research & Development fund (YG) and the Swiss National Science Foundation grant #32003B-116774 (YG).	American Association for Automotive Medicine, 1998, ABBR INJ SCAL 1990 V; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; Castellanos M, 2007, STROKE, V38, P1855, DOI 10.1161/STROKEAHA.106.481556; Copin JC, 2008, EXP NEUROL, V213, P196, DOI 10.1016/j.expneurol.2008.05.022; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Gasche Y, 2006, FRONT BIOSCI-LANDMRK, V11, P1289, DOI 10.2741/1883; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Lescot T, 2010, J NEUROTRAUM, V27, P1069, DOI 10.1089/neu.2009.1188; Lin ZX, 2011, CLIN CHIM ACTA, V412, P1678, DOI 10.1016/j.cca.2011.05.031; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Peters JH, 2003, J LAB CLIN MED, V141, P401, DOI 10.1016/S0022-2143(03)00042-8; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI [10.1089/neu.2009-0959, 10.1089/neu.2009.0959]; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	47	19	21	0	15	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	DEC 18	2012	20								83	10.1186/1757-7241-20-83			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	088KP	WOS:000314833400002	23249478	Green Published, gold			2022-02-06	
J	Friedenberg, SG; Butler, AL; Wei, L; Moore, SA; Cooper, ES				Friedenberg, Steven G.; Butler, Amy L.; Wei, Lai; Moore, Sarah A.; Cooper, Edward S.			Seizures following head trauma in dogs: 259 cases (1999-2009)	JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC EPILEPSY; BRAIN-INJURY; RESPONSE RATES; EPIDEMIOLOGY; RISK	Objective To determine whether dogs with head trauma have a greater incidence of seizures than the general canine patient population. Design Retrospective case series. Animals-259 client-owned dogs. Procedures Medical records of dogs evaluated for head trauma at The Ohio State University Veterinary Medical Center from 1999 to 2009 were reviewed. Data were collected regarding the cause of the head trauma, physical examination and neurologic examination findings, comorbidities, and the development of seizures during hospitalization. A telephone survey was conducted to question owners regarding the development of seizures after discharge. Relationships between the nature of the head trauma and the development of seizures were then examined. Results-3.5% of dogs with head trauma developed in-hospital seizures, and 6.8% of dogs with head trauma for which follow-up information was available developed seizures after hospital discharge, compared with an epilepsy rate of 1.4% in our hospital. Dogs that developed in-hospital seizures were significantly more likely to have been hit by a car or experienced acceleration-deceleration injury. Additionally, 10% of dogs with traumatic brain injury had in-hospital seizures. No visit or patient characteristics were significantly associated with the development of out-of-hospital seizures. Conclusions and Clinical Relevance Dogs with head trauma may develop seizures at a greater rate than dogs in the general canine patient population. Particularly in the immediate to early posttraumatic period, clinicians should remain vigilant for the development of posttraumatic seizures and treat patients accordingly. (J Am Vet Med Assoc 2012;241:1479-1483)	[Friedenberg, Steven G.; Butler, Amy L.; Moore, Sarah A.; Cooper, Edward S.] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Wei, Lai] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA		Friedenberg, SG (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA.	friedenberg.4@osu.edu	Friedenberg, Steven/L-2681-2019; Moore, Sarah/D-2682-2012	Friedenberg, Steven/0000-0002-7510-2322; Moore, Sarah/0000-0002-4311-6199			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hocking JS, 2006, J CLIN EPIDEMIOL, V59, P521, DOI 10.1016/j.jclinepi.2005.10.009; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; O'Toole J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-71; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Platt SR, 2002, VET REC, V151, P243, DOI 10.1136/vr.151.8.243; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Platt SR, 2007, J VET INT MED, V21, P1145; PODELL M, 1995, J AM VET MED ASSOC, V206, P1721; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Zimmermann R, 2009, J VET INTERN MED, V23, P970, DOI 10.1111/j.1939-1676.2009.0368.x	23	19	19	0	28	AMER VETERINARY MEDICAL ASSOC	SCHAUMBURG	1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA	0003-1488	1943-569X		JAVMA-J AM VET MED A	JAVMA-J. Am. Vet. Med. Assoc.	DEC 1	2012	241	11					1479	1483		10.2460/javma.241.11.1479			5	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	044XB	WOS:000311657400013	23176240				2022-02-06	
J	Mattei, TA; Bond, BJ; Goulart, CR; Sloffer, CA; Morris, MJ; Lin, JJ				Mattei, Tobias A.; Bond, Brandon J.; Goulart, Carlos R.; Sloffer, Chris A.; Morris, Martin J.; Lin, Julian J.			Performance analysis of the protective effects of bicycle helmets during impact and crush tests in pediatric skull models Laboratory investigation	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						crushing traumatic brain injury; pediatric traumatic brain injury; cadaver skull; bicycle helmet; performance analysis; trauma	TRAUMATIC BRAIN-INJURY; HEAD-INJURIES; DECOMPRESSIVE CRANIECTOMY; UNITED-STATES; CHILDREN; FOOTBALL; LEGISLATION; SEVERITY; OUTCOMES	Object. Bicycle accidents are a very important cause of clinically important traumatic brain injury (TB!) in children. One factor that has been shown to mitigate the severity of lesions associated with TBI in such scenarios is the proper use of a helmet. The object of this study was to test and evaluate the protection afforded by a children's bicycle helmet to human cadaver skulls with a child's anthropometry in both "impact" and "crushing" situations. Methods. The authors tested human skulls with and without bicycle helmets in drop tests in a monorail-guided free-fall impact apparatus from heights of 6 to 48 in onto a flat steel anvil. Unhelmeted skulls were dropped at 6 in, with progressive height increases until failure (fracture). The maximum resultant acceleration rates experienced by helmeted and unhelmeted skulls on impact were recorded by an accelerometer attached to the skulls. In addition, compressive forces were applied to both helmeted and unhelmeted skulls in progressive amounts. The tolerance in each circumstance was recorded and compared between the two groups. Results. Helmets conferred up to an 87% reduction in so-called mean maximum resultant acceleration over unhelmeted skulls. In compression testing, helmeted skulls were unable to be crushed in the compression fixture up to 470 pound-force (approximately 230 kgf), whereas both skull and helmet alone failed in testing. Conclusions. Children's bicycle helmets provide measurable protection in terms of attenuating the acceleration experienced by a skull on the introduction of an impact force. Moreover, such helmets have the durability to mitigate the effects of a more rare but catastrophic direct compressive force. Therefore, the use of bicycle helmets is an important preventive tool to reduce the incidence of severe associated TBI in children as well as to minimize the morbidity of its neurological consequences. (http://thejns.org/doi/abs/10.3171/2012.8.PEDS12116)	[Mattei, Tobias A.; Lin, Julian J.] Univ Illinois, Dept Neurosurg, Coll Med, Illinois Neurol Inst, Peoria, IL 61637 USA; [Sloffer, Chris A.; Morris, Martin J.] Bradley Univ, Dept Mech Engn, Peoria, IL 61625 USA; [Goulart, Carlos R.] Evangel Univ Parana, Curitiba, Parana, Brazil		Mattei, TA (corresponding author), Univ Illinois, Dept Neurosurg, Coll Med, Illinois Neurol Inst, 530 NE Glen Oak,7430, Peoria, IL 61637 USA.	tobiasmattei@yahoo.com	Goulart, Carlos/AAB-3827-2019; Mattei, Tobias A./U-7166-2019				American National Standards Institute, 1984, AM NAT STAND PROT HE; American Society of Testing and Materials Committee on Standards, 1993, STAND SPEC PROT HEAD; Appelboom G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11177; Asiminei AG, 2008, P 2008 FIN EL WORKSH, V1, P13; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; BENZ G, 1993, EUR J PEDIATR SURG, V3, P259, DOI 10.1055/s-2008-1063555; Chaze B, 2008, NEUROL CLIN, V26, P325, DOI 10.1016/j.ncl.2007.11.009; CODY BE, 2004, HEADED INJURY OBSERV; COTE TR, 1992, PEDIATRICS, V89, P1216; CPSC, 1998, FED REGISTER, V63, P11711; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; DeRosia J, 2000, FRONTIERS WHIPLASH T, P265; DIGUISEPPI CG, 1989, JAMA-J AM MED ASSOC, V262, P2256, DOI 10.1001/jama.262.16.2256; DORSCH MM, 1987, ACCIDENT ANAL PREV, V19, P183, DOI 10.1016/0001-4575(87)90002-9; FRIEDE AM, 1985, PEDIATR CLIN N AM, V32, P141; Higgins M, 2007, J ATHL TRAINING, V42, P5; Hoshizaki B, 2012, J NEUROSURG-PEDIATR, V9, P133, DOI 10.3171/2011.11.PEDS11299; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P76, DOI 10.2105/AJPH.77.1.76; Levy S, 1999, NEUROSURGERY, V45, P696; Macpherson A, 2008, COCHRANE DB SYST REV, V16; Meaney DF, 1998, BIOM HLTH R, V21, P169; Mehan TJ, 2009, CLIN PEDIATR, V48, P166, DOI 10.1177/0009922808324952; Mills N J, 1990, Br J Sports Med, V24, P55; MORRIS BAP, 1991, CAN J PUBLIC HEALTH, V82, P92; Niess C, 2002, ACTA NEUROPATHOL, V104, P79, DOI 10.1007/s00401-002-0525-9; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Ommaya AK, 1967, 11 STAPP CAR CRASH C, P73; PARKIN PC, 1993, PEDIATRICS, V91, P772; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; RIVARA FP, 1994, PEDIATRICS, V93, P567; RODGERS GB, 1995, ACCIDENT ANAL PREV, V27, P43, DOI 10.1016/0001-4575(94)00044-M; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; SELBST SM, 1987, AM J DIS CHILD, V141, P140, DOI 10.1001/archpedi.1987.04460020030021; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Snell Memorial Foundation, 1990, 1990 STAND PROT HEAD; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; TORG JS, 1990, AM J SPORT MED, V18, P50, DOI 10.1177/036354659001800109; WASSERMAN RC, 1988, AM J PUBLIC HEALTH, V78, P1220, DOI 10.2105/AJPH.78.9.1220; WASSERMAN RC, 1990, AM J SPORT MED, V18, P96, DOI 10.1177/036354659001800116; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; YOGANANDAN N, 1987, CRIT REV BIOMED ENG, V15, P29	46	19	19	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2012	10	6					490	497		10.3171/2012.8.PEDS12116			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	042IE	WOS:000311464100008	23030382	Bronze			2022-02-06	
J	Tuominen, R; Joelsson, P; Tenovuo, O				Tuominen, Risto; Joelsson, Petteri; Tenovuo, Olli			Treatment costs and productivity losses caused by traumatic brain injuries	BRAIN INJURY			English	Article						traumatic brain injury; treatment costs; productivity losses	ECONOMIC BURDEN; HEAD-INJURIES; EPIDEMIOLOGY; EUROPE; TRENDS	Objective: To estimate the magnitude and relative importance of hospital treatment costs and productivity losses caused by traumatic brain injuries (TBIs). Patients: A total of 155 patients with new TBI diagnoses admitted to Turku University Hospital were systematically sampled. Methods: Hospital costs were determined by collecting detailed data from patient records and applying the actual cost from the hospital administration. For estimating the productivity losses, the age of retirement was adjusted according to the age- and sex-specific retirement probability. Results: Median treatment costs per TBI patient were (sic)5429, surgery (sic)1600 and other costs (sic)3651. Overall treatment costs for severe brain injuries were significantly (p < 0.01) higher than for less severe cases. Median production losses due to early retirement were estimated to be (sic)1.19 million per TBI patient, significantly (p < 0.03) lower among less severe than among the severe cases. Age, sex and severity of TBI could explain only 9% of the variation in treatment costs, but explained 73% of the variation in production losses. Conclusions: Indirect productivity losses form the great majority of the overall economic burden of TBI to society. The direct treatment costs in tertiary level hospitals also impose a considerable burden on the healthcare sector.	[Tuominen, Risto; Joelsson, Petteri] Univ Turku, Dept Publ Hlth, SF-20014 Turku, Finland; [Tuominen, Risto] Turku Univ Hosp, Primary Hlth Care Unit, Turku, Finland; [Joelsson, Petteri; Tenovuo, Olli] Univ Turku, Dept Neurol, SF-20014 Turku, Finland		Tuominen, R (corresponding author), Univ Turku, Dept Publ Hlth, Lemminkaisenkatu 1, SF-20014 Turku, Finland.	risto.tuominen@utu.fi			Hospital District of Southwest Finland	The authors report no conflicts of interest. The Hospital District of Southwest Finland supported this study.	Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Berg Jenny, 2004, Eur J Health Econ, V5 Suppl 1, pS84, DOI 10.1007/s10198-005-0293-2; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Hashimoto K, 2006, J REHABIL MED, V38, P141, DOI 10.1080/16501970500441690; Heidi Nyman and Statistical Group, 2010, STAT YB PENS FINL 20, P42; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Statistics Board, 2010, POP STRUCT 2009; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson K, 2001, N C Med J, V62, P376; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	28	19	19	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1697	1701		10.3109/02699052.2012.722256			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700015	23163250				2022-02-06	
J	Chen, J; Weng, JF; Hong, WC; Luo, LF; Yu, W; Luo, SD				Chen, Jun; Weng, Jian-Feng; Hong, Wei-Cong; Luo, Li-Feng; Yu, Wei; Luo, Shi-Da			Change in plasma visfatin level after severe traumatic brain injury	PEPTIDES			English	Article						Visfatin; Traumatic brain injury; Prognosis	COLONY-ENHANCING FACTOR; EXPRESSION; CANCER	Higher plasma visfatin concentration has been associated with ischemic stroke. Thus, we sought to investigate change in plasma visfatin level after traumatic brain injury and to evaluate its relation with disease outcome. Seventy-six healthy controls and 98 patients with acute severe traumatic brain injury were recruited. Twenty-seven patients (27.6%) died and 48 patients (49.0%) suffered from unfavorable outcome (Glasgow outcome scale score of 1-3) in 6 months. On admission, plasma visfatin level was increased in patients than in healthy controls and was highly correlated with Glasgow Coma Scale score. A multivariate analysis identified plasma visfatin level as an independent predictor for 6-month mortality and unfavorable outcome. According to receiver operating characteristic curve analysis, the predictive value of the plasma visfatin concentration was similar to Glasgow Coma Scale score's. In a combined logistic-regression model, visfatin did not improve the predictive value of Glasgow Coma Scale score. Thus, increased plasma visfatin level is associated with 6-month clinical outcomes after severe traumatic brain injury. (C) 2012 Elsevier Inc. All rights reserved.	[Chen, Jun; Weng, Jian-Feng; Hong, Wei-Cong; Luo, Li-Feng; Yu, Wei; Luo, Shi-Da] Second Peoples Hosp Cixi City, Dept Neurosurg, Cixi 315315, Peoples R China		Weng, JF (corresponding author), Second Peoples Hosp Cixi City, Dept Neurosurg, 77 Datong Rd, Cixi 315315, Peoples R China.	cxeycjwjf@163.com			Ningbo Municipal Natural Science Foundation of China [2011A610045]	This work is financially supported by Ningbo Municipal Natural Science Foundation of China (Grant No. 2011A610045).	Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Bi J, 2012, J NEUROCHEM, V120, P334, DOI 10.1111/j.1471-4159.2011.07566.x; Carrero JJ, 2010, NEPHROL DIAL TRANSPL, V25, P901, DOI 10.1093/ndt/gfp587; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; JENNETT B, 1975, LANCET, V1, P480; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI 10.1172/JCI19930; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kang YS, 2011, NEUROSCI LETT, V504, P121, DOI 10.1016/j.neulet.2011.09.014; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lee YC, 2011, CANCER EPIDEM BIOMAR, V20, P1892, DOI 10.1158/1055-9965.EPI-11-0399; Liu P, 2009, J BIOL CHEM, V284, P27344, DOI 10.1074/jbc.M109.002519; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Lu LF, 2009, J STROKE CEREBROVASC, V18, P354, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.003; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mercader J, 2008, HORM METAB RES, V40, P467, DOI 10.1055/s-2008-1065324; Nakajima TE, 2009, J GASTROENTEROL, V44, P685, DOI 10.1007/s00535-009-0063-5; Ognjanovic S, 2001, J MOL ENDOCRINOL, V26, P107, DOI 10.1677/jme.0.0260107; Ognjanovic S, 2003, AM J OBSTET GYNECOL, V189, P1187, DOI 10.1067/S0002-9378(03)00591-X; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Xie H, 2007, CALCIFIED TISSUE INT, V80, P201, DOI 10.1007/s00223-006-0155-7; Zhang WP, 2010, J CEREBR BLOOD F MET, V30, P1962, DOI 10.1038/jcbfm.2010.71	23	19	21	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0196-9781	1873-5169		PEPTIDES	Peptides	NOV	2012	38	1					8	12		10.1016/j.peptides.2012.08.016			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	073WL	WOS:000313773700002	22960047				2022-02-06	
J	DiLeonardi, AM; Huh, JW; Raghupathi, R				DiLeonardi, Ann Mae; Huh, Jimmy W.; Raghupathi, Ramesh			Differential Effects of FK506 on Structural and Functional Axonal Deficits After Diffuse Brain Injury in the Immature Rat	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Axonal injury; Calcineurin; Compound action potential; FK506; Immature rat; Neurofilament; Traumatic brain injury	FLUID PERCUSSION INJURY; SPINAL-CORD-INJURY; CORPUS-CALLOSUM; STRETCH INJURY; CYCLOSPORINE-A; NEUROFILAMENT COMPACTION; UNMYELINATED AXONS; WHITE-MATTER; HEAD-INJURY; AXOLEMMAL PERMEABILITY	Diffuse axonal injury is a major component of traumatic brain injury in children and correlates with long-term cognitive impairment. Traumatic brain injury in adult rodents has been linked to a decrease in compound action potential (CAP) in the corpus callosum, but information on trauma-associated diffuse axonal injury in immature rodents is limited. We investigated the effects of closed head injury on CAP in the corpus callosum of 17-day-old rats. The injury resulted in CAP deficits of both myelinated and unmyelinated fibers in the corpus callosum between 1 and 14 days postinjury (dpi). These deficits were accompanied by intra-axonal dephosphorylation of the 200-kDa neurofilament subunit (NF200) at 1 and 3 dpi, a decrease in total NF200 at 3 dpi and axonal degeneration at 3 and 7 dpi. Although total phosphatase activity decreased at 1 dpi, calcineurin activity was unchanged. The calcineurin inhibitor, FK506, significantly attenuated the injury-induced NF200 dephosphorylation of NF200 at 3 dpi and axonal degeneration at 3 and 7 dpi but did not affect the decrease in NF200 protein levels or impaired axonal transport. FK506 had no effect on CAP deficits at 3 dpi but exacerbated the deficit in only the myelinated fibers at 7 dpi. Thus, in contrast to adult animals, FK506 treatment did not improve axonal function in brain-injured immature animals, suggesting that calcineurin may not contribute to impaired axonal function.	[Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; [DiLeonardi, Ann Mae; Raghupathi, Ramesh] Drexel Univ, Coll Med, Program Neurosci, Philadelphia, PA 19129 USA; [Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA		Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA.	rramesh@drexelmed.edu	Raghupathi, Ramesh/AAX-5538-2021	DiLeonardi, Ann Mae/0000-0002-1476-7726	 [R01-HD061963];  [K08-NS053651]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS053651] Funding Source: NIH RePORTER	These studies are supported in part by R01-HD061963 and K08-NS053651.	Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Ai JL, 2007, EXP BRAIN RES, V177, P95, DOI 10.1007/s00221-006-0654-9; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Bales JW, 2010, BRAIN RES, V1358, P211, DOI 10.1016/j.brainres.2010.08.029; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; EYER J, 1988, BIOCHEM J, V252, P655, DOI 10.1042/bj2520655; FERN R, 1995, J NEUROPHYSIOL, V74, P369, DOI 10.1152/jn.1995.74.1.369; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GUANDALINI P, 1989, EXP BRAIN RES, V74, P453; HALL GF, 1995, J COMP NEUROL, V353, P38, DOI 10.1002/cne.903530106; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Nottingham S, 2002, EXP NEUROL, V177, P242, DOI 10.1006/exnr.2002.7975; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Setkowicz Z, 2004, EPILEPSY RES, V61, P63, DOI 10.1016/j.eplepsyres.2004.06.001; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; STYS PK, 1990, P NATL ACAD SCI USA, V87, P4212, DOI 10.1073/pnas.87.11.4212; TANAKA T, 1993, METHOD FIND EXP CLIN, V15, P77; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wakita H, 1998, BRAIN RES, V792, P105, DOI 10.1016/S0006-8993(98)00126-7	61	19	19	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	NOV	2012	71	11					959	972		10.1097/NEN.0b013e31826f5876			14	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	030CF	WOS:000310544800003	23095847	Green Accepted, Bronze			2022-02-06	
J	Ettenhofer, ML; Melrose, RJ; Delawalla, Z; Castellon, SA; Okonek, A				Ettenhofer, Mark L.; Melrose, Rebecca J.; Delawalla, Zainab; Castellon, Steven A.; Okonek, Anna			Correlates of Functional Status Among OEF/OIF Veterans With a History of Traumatic Brain Injury	MILITARY MEDICINE			English	Article								This study was conducted to identify factors related to functional status within a clinical sample of Veterans of Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OFF) with a history of traumatic brain injury (TBI). Medical chart review was conducted for a consecutive group of OEF/OIF Veterans who were referred for neuropsychological evaluation within a Veterans Affairs Medical Center Polytrauma Program related to history of TBI (n = 57). Level of involvement in occupational and academic activity, presence or absence of housing insecurity, and clinician ratings of overall functioning served as indicators of functional status. Reduced functional status was most strongly related to poorer cognitive function, particularly motor function, processing speed, and executive function. Lower levels of functioning were also related to increased severity of postconcussive symptoms, lower levels of education, and ongoing medication treatment for sleep or psychiatric symptoms. Comprehensive evaluation of cognitive, affective, and behavioral functioning among OEF/OIF Veterans with a history of TBI is likely to provide valuable information to inform rehabilitation strategies and identify potential warning signs for poor postdeployment reintegration. Increased awareness of these factors may aid clinicians in identifying patients at risk for poor outcomes and in more effectively targeting symptoms for intervention.	[Ettenhofer, Mark L.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA; [Melrose, Rebecca J.; Delawalla, Zainab; Castellon, Steven A.; Okonek, Anna] VA Greater Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Melrose, Rebecca J.; Castellon, Steven A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Okonek, Anna] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA		Ettenhofer, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.		Ettenhofer, Mark L./J-7171-2019	Ettenhofer, Mark L./0000-0001-9381-7578	VA Greater Los Angeles Healthcare SystemUS Department of Veterans Affairs; Uniformed Services University of the Health Sciences; Department of Veterans AffairsUS Department of Veterans Affairs	Financial support was provided by VA Greater Los Angeles Healthcare System, the Uniformed Services University of the Health Sciences, and the Department of Veterans Affairs (Career Development Award to R. Melrose; Office of Academic Affiliations, Special Fellowship Program in Advanced Geriatrics).	Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Delis D.C., 2000, CALIFORNIA VERBAL LE; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heaton R., 2000, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jaycox, 2008, INVISIBLE WOUNDS WAR; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Larrabee GJ, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P327; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Meyers JE., 1995, REY COMPLEX FIGURE T; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; Royall DR, 2005, J INT NEUROPSYCH SOC, V11, P899, DOI 10.1017/S135561770505109X; Ruff R. M, 1996, RUFF FIGURAL FLUENCY; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	49	19	19	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2012	177	11					1272	1278		10.7205/MILMED-D-12-00095			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V33OF	WOS:000209027400007	23198501	Bronze			2022-02-06	
J	Fogelman, D; Zafonte, R				Fogelman, David; Zafonte, Ross			Exercise to Enhance Neurocognitive Function After Traumatic Brain Injury	PM&R			English	Article							PLASTICITY-RELATED PROTEINS; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC PLASTICITY; VOLUNTARY EXERCISE; PHYSICAL-ACTIVITY; UP-REGULATION; BED REST; CONCUSSION; SPORTS; PATHOPHYSIOLOGY	Vigorous exercise has long been associated with improved health in many domains. Results of clinical observation have suggested that neurocognitive performance also is improved by vigorous exercise. Data derived from animal model based research have been emerging that show molecular and neuroanatomic mechanisms that may explain how exercise improves cognition, particularly after traumatic brain injury. This article will summarize the current state of the basic science and clinical literature regarding exercise as an intervention, both independently and in conjunction with other modalities, for brain injury rehabilitation. A key principle is the factor of timing of the initiation of exercise after mild traumatic brain injury, balancing potentially favorable and detrimental effects on recovery. PM R 2012;4:908-913	[Zafonte, Ross] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Massachusetts Gen Hosp,Dept Phys Med & Rehabil, Cambridge, MA 02138 USA		Fogelman, D (corresponding author), 125 Nashua St, Boston, MA 02114 USA.	rzafonte@partners.org					ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Devine JM, 2009, PM&R, V1, P560, DOI 10.1016/j.pmrj.2009.03.015; Ding QX, 2006, EUR J NEUROSCI, V24, P1265, DOI 10.1111/j.1460-9568.2006.05026.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Iverson G, 2007, BRAIN INJURY MED PRI; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marlatt MW, 2010, BRAIN RES, V1341, P93, DOI 10.1016/j.brainres.2010.03.086; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Moser RS, 2012, J PEDIAT; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Richards M, 2003, SOC SCI MED, V56, P785, DOI 10.1016/S0277-9536(02)00075-8; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Silverberg ND, 2012, J HEAD TRAUMA REHABI; Solomon GS, 2007, J NEUROPSYCH CLIN N, V19, P195, DOI 10.1176/appi.neuropsych.19.2.195; vanBoxtel MPJ, 1997, MED SCI SPORT EXER, V29, P1357, DOI 10.1097/00005768-199710000-00013; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Williamson GM, 2000, HEALTH PSYCHOL, V19, P339, DOI 10.1037//0278-6133.19.4.339; Winkelman C, 2009, AACN ADV CRIT CARE, V20, P254, DOI 10.1097/NCI.0b013e3181ac838d	39	19	19	0	36	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	NOV	2012	4	11					908	913		10.1016/j.pmrj.2012.09.028			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	048AU	WOS:000311883400019	23174558				2022-02-06	
J	Schneider, EB; Hirani, SA; Hambridge, HL; Haut, ER; Carlini, AR; Castillo, RC; Efron, DT; Haider, AH				Schneider, Eric B.; Hirani, Salman A.; Hambridge, Hali L.; Haut, Elliott R.; Carlini, Anthony R.; Castillo, Renan C.; Efron, David T.; Haider, Adil H.			Beating the weekend trend: Increased mortality in older adult traumatic brain injury (TBI) patients admitted on weekends	JOURNAL OF SURGICAL RESEARCH			English	Article						Weekend admission; Weekday admission; Head trauma; Traumatic brain injury; Older adults; Nationwide Inpatient Sample	HOSPITAL ADMISSION; WEEKDAY ADMISSION; STROKE; CARE	Background: Weekend admission is associated with mortality in cardiovascular emergencies and stroke but the effect of weekend admission for trauma is not well defined. We sought to determine whether differences in mortality outcomes existed for older adults with substantial head trauma admitted on a weekday versus over the weekend. Methods: Data from the 2006, 2007, and 2008 Nationwide Inpatient Sample were combined and head trauma admissions were isolated. Abbreviated injury scale (AIS) scores were calculated using ICDMAP-90 Software. Individuals aged 65 to 89 y with head AIS equal to 3 or 4 and no other region score <3 were included. Individual Charlson comorbidity scores were calculated and individuals with missing mortality, sex, or insurance data were excluded. Wilcoxon rank sum andStudent t-tests compared demographics, length of stay, and total charges for week day versus weekend admissions. The chi(2) tests compared sex and head injury severity. Logistic regression modeled mortality adjusting for age, sex, injury severity, comorbidity, and insurance status. Results: Of the 38,675 patients meeting criteria, 9937 (25.6%) were admitted on weekends. Mean age was similar (78.4 versus 78.4, P = 0.796) but more weekend admissions were female (51.6% versus 50.2%, P = 0.022). Weekend patients demonstrated slightly lower comorbidity (mean Charlson = 1.07 versus 1.14, P < 0.001) and head injury severity (58.3% versus 60.8% AIS = 4, P < 0.001). Median weekend length of stay was shorter (4 versus 5 d, P < 0.001). Weekend and weekday median total charges did not differ ($27,128 versus $27,703, respectively, P = 0.667). Proportional mortality was higher among weekend patients (9.3% versus 8.4%, P = 0.008). After adjustment, weekend patients demonstrated 14% increased odds of mortality (OR 1.14, 95% CI 1.05-1.23). Conclusion: Older adults with substantial head trauma admitted on weekends are less severely injured, carry less comorbidity, and generate similar total charges compared with those admitted on weekdays. However, after accounting for known risk confounders, weekend patients demonstrated 14% greater odds of mortality. Mechanisms behind this disparity must be determined and eliminated. (C) 2012 Elsevier Inc. All rights reserved.	[Schneider, Eric B.] Johns Hopkins Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, Baltimore, MD 21287 USA; [Hambridge, Hali L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Carlini, Anthony R.; Castillo, Renan C.; Haider, Adil H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA		Schneider, EB (corresponding author), Johns Hopkins Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, 600 N Wolfe St,Harvey 616, Baltimore, MD 21287 USA.	eschnei1@jhmi.edu	Haut, Elliott R./J-3948-2019; Carlini, Anthony/AAN-1153-2020	Carlini, Anthony/0000-0003-1419-4515; Haut, Elliott/0000-0001-7075-771X			Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Carr BG, 2011, ARCH SURG-CHICAGO, V146, P810, DOI 10.1001/archsurg.2011.60; Carr BG, 2010, J TRAUMA, V69, P1042, DOI 10.1097/TA.0b013e3181f6f958; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Crowley RW, 2009, J NEUROSURG, V111, P60, DOI 10.3171/2008.11.JNS081038; Faul M, 2010, TRAUMATIC BRAIN INJU; Haut ER, 2006, J TRAUMA, V61, P272, DOI 10.1097/01.ta.0000222939.51147.1c; HCUP Nationwide Inpatient Sample (NIS), 2008, HCUP NAT INP SAMPL N; Heros RC, 2009, J NEUROSURG, V111, P57, DOI 10.3171/2008.11.JNS081550; Horwich TB, 2009, AM HEART J, V158, P451, DOI 10.1016/j.ahj.2009.06.025; James MT, 2010, J AM SOC NEPHROL, V21, P845, DOI 10.1681/ASN.2009070682; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McKinney JS, 2011, STROKE, V42, P2403, DOI 10.1161/STROKEAHA.110.612317; Meretoja A, 2010, STROKE, V41, P1102, DOI 10.1161/STROKEAHA.109.577718; O'Brien EC, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/383012; Zhan C, 2003, QUAL SAF HEALTH CARE, V12, pII58, DOI 10.1136/qhc.12.suppl_2.ii58	19	19	19	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2012	177	2					295	300		10.1016/j.jss.2012.06.022			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	004VD	WOS:000308708400025	22795343				2022-02-06	
J	Steuer, J; Wanhainen, A; Thelin, S; Nyman, R; Eriksson, MO; Bjorck, M				Steuer, Johnny; Wanhainen, Anders; Thelin, Stefan; Nyman, Rickard; Eriksson, Mats-Ola; Bjorck, Martin			Outcome of endovascular treatment of traumatic aortic transection	JOURNAL OF VASCULAR SURGERY			English	Article							SURGERY-OF-TRAUMA; MULTICENTER TRIAL; SWEDVASC REGISTRY; OPERATIVE REPAIR; STENT GRAFT; INJURY; ASSOCIATION; MANAGEMENT; EXPERIENCE; HEART	Objective: The purpose of this study was to analyze our experience of thoracic endovascular aortic repair (TEVAR) in patients with traumatic aortic transection. Methods: This was a single-center consecutive case series that was conducted at the Uppsala University Hospital, Tertiary Referral Center. There were a total of 17 consecutive patients undergoing TEVAR for traumatic thoracic aortic transection. All patients undergoing TEVAR for aortic transection were registered prospectively and their medical records were reviewed regarding technical details, mechanism of injury, and concomitant injuries. Long-term outcome was analyzed with respect to need for reintervention and survival. Results: Between 2001 and 2010, 17 patients underwent TEVAR for traumatic aortic injury. Median age was 42 years (range, 18-77 years), and 15 of 17 patients (88%) were men. Fourteen patients had been involved in motor vehicle accidents, two had fallen from heights, and one fell off a bicycle on a slope. In all cases, the aortic injury was located in the proximity of the origin of the left subclavian artery. All patients had concomitant injuries. In all patients, a single stent graft was sufficient to exclude the injured part of the aorta. The median cover length was 120 mm (range, 100-200 mm). In-hospital mortality was 24% (4 of 17 patients). One patient died perioperatively and three postoperatively, two from brain injuries and one from multiorgan failure. After a median follow-up of 36 months (range, 10-98 months), three patients underwent reintervention (18%), each patient only once; one for a type I endoleak, and two for pseudocoarctation secondary to stent graft infolding. Two were treated endovascularly, and one had a stent graft explantation. Conclusions: Endovascular repair allows rapid and minimally invasive therapy in patients with traumatic aortic injury with good technical results. The outcome is highly dependent on the severity of other concurrent injuries. (J Vasc Surg 2012;56:973-8.)	[Steuer, Johnny; Wanhainen, Anders; Thelin, Stefan; Bjorck, Martin] Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden; [Nyman, Rickard; Eriksson, Mats-Ola] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden		Steuer, J (corresponding author), Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden.	joste@me.com					Acosta S, 2011, BRIT J SURG, V98, P735, DOI 10.1002/bjs.7383; Alsac JM, 2008, J VASC SURG, V48, P1369, DOI 10.1016/j.jvs.2008.07.019; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bent CL, 2007, J VASC SURG, V46, P920, DOI 10.1016/j.jvs.2007.07.032; Bjorck M, 2008, EUR J VASC ENDOVASC, V35, P129, DOI 10.1016/j.ejvs.2007.09.010; Botta L, 2008, J THORAC CARDIOV SUR, V136, P1558, DOI 10.1016/j.jtcvs.2008.07.040; Clancy TV, 2001, J TRAUMA, V51, P346, DOI 10.1097/00005373-200108000-00021; Coady MA, 2010, CIRCULATION, V121, P2780, DOI 10.1161/CIR.0b013e3181e4d033; Demetriades D, 2008, J TRAUMA, V64, P561, DOI 10.1097/TA.0b013e3181641bb3; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Jonker FHW, 2010, J ENDOVASC THER, V17, P725, DOI 10.1583/10-3130.1; Jonker FHW, 2010, J VASC SURG, V52, P39, DOI 10.1016/j.jvs.2010.02.256; Jonker FHW, 2010, J VASC SURG, V51, P565, DOI 10.1016/j.jvs.2009.10.046; Lam RC, 2007, J VASC SURG, V45, P875, DOI 10.1016/j.jvs.2006.12.059; Lee WA, 2011, J VASC SURG, V53, P187, DOI 10.1016/j.jvs.2010.08.027; Madhwal S, 2008, J INVASIVE CARDIOL, V20, P200; Mattox KL, 2008, J TRAUMA, V64, P570; Meredith W, 1997, J TRAUMA, V42, P380; Mitchell RS, 2002, J ENDOVASC THER, V9, P98; Mosquera VX, 2011, J THORAC CARDIOV SUR, V142, P614, DOI 10.1016/j.jtcvs.2010.10.044; Neschis DG, 2009, ANN SURG, V250, P377, DOI 10.1097/SLA.0b013e3181b3b5c9; Pretre R, 1997, NEW ENGL J MED, V336, P626, DOI 10.1056/NEJM199702273360906; Rahimi SA, 2010, J VASC SURG, V52, P891, DOI 10.1016/j.jvs.2010.05.014; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Rotondo MF, 1993, J TRAUMA, V35, P382; Steuer J, 2011, EUR J VASC ENDOVASC, V41, P318, DOI 10.1016/j.ejvs.2010.11.024; Troeng T, 2008, EUR J VASC ENDOVASC, V36, P705, DOI 10.1016/j.ejvs.2008.08.017; Xenos ES, 2008, J VASC SURG, V48, P1343, DOI 10.1016/j.jvs.2008.04.060	28	19	19	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	OCT	2012	56	4					973	978		10.1016/j.jvs.2012.03.259			6	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	016IV	WOS:000309512300012	22608791	Bronze			2022-02-06	
J	Viscomi, MT; D'Amelio, M				Viscomi, Maria Teresa; D'Amelio, Marcello			The "Janus-Faced Role" of Autophagy in Neuronal Sickness: Focus on Neurodegeneration	MOLECULAR NEUROBIOLOGY			English	Article						Autophagosomes; Autophagic flux; Cell death; Acute brain damage; Neuronal recovery	TRAUMATIC BRAIN-INJURY; CHAPERONE-MEDIATED AUTOPHAGY; NEONATAL HYPOXIA-ISCHEMIA; FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; CELL-DEATH; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MUTANT HUNTINGTIN	The mature brain is a highly dynamic organ that constantly changes its organization by destroying and forming new connections. Collectively, these changes are referred to as brain plasticity and are associated with functional changes, such as memory, addiction, and recovery of function after brain damage. Neuronal plasticity is sustained by the fine regulation of protein synthesis and organelle biogenesis and their degradation to ensure efficient turnover. Thus, autophagy, as quality control mechanism of proteins and organelles in neurons, is essential to their physiology and pathology. Here, we review recent several findings proving that defects in autophagy affect neuronal function and impair functional recovery after brain insults, contributing to neurodegeneration, in chronic and acute neurological disorders. Thus, an understanding of the molecular mechanisms by which the autophagy machinery is finely regulated might accelerate the development of therapeutic interventions in many neurological disorders for which no cure is available.	[Viscomi, Maria Teresa; D'Amelio, Marcello] IRCCS S Lucia Fdn, Dept Expt Neurosci, I-00143 Rome, Italy; [D'Amelio, Marcello] Univ Campus Biomed, I-00128 Rome, Italy		Viscomi, MT (corresponding author), IRCCS S Lucia Fdn, Dept Expt Neurosci, Via Fosso di Fiorano 65, I-00143 Rome, Italy.	mt.viscomi@hsantalucia.it; m.damelio@hsantalucia.it	Viscomi, Maria Teresa/G-4173-2011; Viscomi, Maria Teresa/AAL-6625-2021; Viscomi, Maria Teresa/AAB-9412-2022	Viscomi, Maria Teresa/0000-0002-9096-4967; Viscomi, Maria Teresa/0000-0002-9096-4967; D'Amelio, Marcello/0000-0001-6526-1832	Wings for Life Spinal Cord Research Foundation [WFL1-2011]; Projects for Research of National Interest (PRIN); Alzheimer's AssociationAlzheimer's Association [NIRG-11-204588]	This work was supported by Wings for Life Spinal Cord Research Foundation (WFL1-2011) (M. T. V.), by Projects for Research of National Interest (PRIN 2009), and by grant from the Alzheimer's Association (NIRG-11-204588) (M.DA). We thank Prof. M. Molinari and Prof. G. Bernardi for their continuous support and encouragement. The professional editorial work of Blue Pencil Science is also acknowledged.	Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Carloni S, 2012, NEUROSCIENCE, V203, P160, DOI 10.1016/j.neuroscience.2011.12.021; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Puyal J, 2012, NEUROSCIENTIST, V18, P224, DOI 10.1177/1073858411404948; Puyal J, 2009, AUTOPHAGY, V5, P1060, DOI 10.4161/auto.5.7.9728; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Rami A, 2008, AUTOPHAGY, V4, P227, DOI 10.4161/auto.5339; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008; Thomas B, 2009, ANTIOXID REDOX SIGN, V11, P2077, DOI 10.1089/ars.2009.2697; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Viscomi MT, 2009, CEREBELLUM, V8, P184, DOI 10.1007/s12311-009-0107-7; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu M, 2011, ACTA PHARMACOL SIN, V32, P1089, DOI 10.1038/aps.2011.50; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	76	19	19	0	11	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	OCT	2012	46	2					513	521		10.1007/s12035-012-8296-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013YF	WOS:000309341500019	22773113				2022-02-06	
J	Elbin, RJ; Covassin, T; Hakun, J; Kontos, AP; Berger, K; Pfeiffer, K; Ravizza, S				Elbin, R. J.; Covassin, Tracey; Hakun, Jonathan; Kontos, Anthony P.; Berger, Kevin; Pfeiffer, Karin; Ravizza, Susan			Do brain activation changes persist in athletes with a history of multiple concussions who are asymptomatic?	BRAIN INJURY			English	Article						Concussion; functional MRI; neuropsychological	PARIETAL CORTEX; PERFORMANCE; SYMPTOMS; INJURY	Primary objective: To evaluate brain activation patterns of asymptomatic athletes with a history of two or more concussions. Research design: A paired case-control design was used to evaluate brain activation patterns during cognitive performance in 14 athletes with a history of two or more concussions and 14 age-and sex-matched controls with no previous concussion. Methods and procedures: Percentage Blood-Oxygen-Level-Dependent (BOLD) change during an N-back working memory task was assessed in all participants. Performance on the Trail-Making Test Form A and B, Symbol-Digit Modalities Test and the Immediate Post-concussion Assessment and Cognitive Test (ImPACT) was also compared between groups. Main results: As expected, brain regions activated during the performance of the N-back were equivalent between groups. The groups performed similarly on the neurocognitive measures. The history of concussion group was less accurate than controls on the 1-, 2- and 3-back conditions of the N-back. Conclusions: Following the complete resolution of symptoms, a history of two or more concussions is not associated with changes in regional brain activation during the performance of working memory task. Compensatory brain activation may only persist during the typically brief time athletes experience symptoms following concussion.	[Elbin, R. J.; Kontos, Anthony P.] Univ Pittsburgh, Sch Med, UPMC Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; [Covassin, Tracey; Pfeiffer, Karin] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Hakun, Jonathan; Ravizza, Susan] Michigan State Univ, Dept Psychol, Cognit Control Lab, E Lansing, MI 48824 USA; [Berger, Kevin] Michigan State Univ, Dept Radiol, Cognit Imaging Res Ctr, E Lansing, MI 48824 USA		Elbin, RJ (corresponding author), Univ Pittsburgh, Sch Med, UPMC Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA.	rje13@pitt.edu	Pfeiffer, Karin A/D-5252-2018	Pfeiffer, Karin A/0000-0001-6280-9495; Kontos, Anthony/0000-0002-3749-4310	Blue Cross Blue Shield of Michigan Foundation Student-Award Program; Radiology Department and College of Education at Michigan State University	None of the authors declare any financial interests related to this study. The authors would like to acknowledge The Blue Cross Blue Shield of Michigan Foundation Student-Award Program and the Radiology Department and College of Education at Michigan State University for their financial support of this study.	Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jonides J, 1998, J NEUROSCI, V18, P5026; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell M.R., 2006, IMPACT 2006 5 0 CLIN; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2007, IMPACT VERSION 6 0 C; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Reitan R, 1993, HALSTAD REITAN NEURO; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smith A., 1968, SYMBOL DIGIT MODALIT; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Wagenmakers EJ, 2008, PSYCHON B REV, V15, P1229, DOI 10.3758/PBR.15.6.1229; Wechsler D., 1955, MANUAL WECHSLER ADUL	35	19	19	2	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2012	26	10					1217	1225		10.3109/02699052.2012.672788			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	984GR	WOS:000307178600007	22616764				2022-02-06	
J	Malec, JF; Hammond, FM; Giacino, JT; Whyte, J; Wright, J				Malec, James F.; Hammond, Flora M.; Giacino, Joseph T.; Whyte, John; Wright, Jerry			Structured Interview to Improve the Reliability and Psychometric Integrity of the Disability Rating Scale	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Outcomes assessment; Rehabilitation	TRAUMATIC BRAIN-INJURY; GLASGOW OUTCOME SCALE; FUNCTIONAL INDEPENDENCE MEASURE; COMMUNITY	Malec JF, Hammond FM, Giacino JT, Whyte J, Wright J. Structured interview to improve the reliability and psychometric integrity of the Disability Rating Scale. Arch Phys Med Rehabil 2012;93: 1603-8. Objectives: To (1) develop a standardized interview for telephone administration, (2) assess the psychometric properties of this interview format (Disability Rating Scale-Postacute Interview [DRS-PI]), and (3) identify additional items to reduce skew. Design: Prospective cohort assessment study. Setting: Not applicable. Participants: Participants (N=406; 287 individuals with traumatic brain injury [TBI], 1.19 caregivers) in the U.S. TBI Model Systems national database during 1- to 20-year telephone follow-up. Interventions: Not applicable. Main Outcome Measures: Original Disability Rating Scale (DRS) and DRS-PI variations. DRS-PI questions were developed by consensus of the study investigators; item scores were derived from responses to questions by algorithm. Unnecessary questions were pruned. Results: The DRS-PI correlated highly with the original DRS (intraclass correlation, .91) and demonstrated satisfactory construct validity and internal consistency (person separation/reliability, 2.51/.86; item separation/reliability, 16.72/1.00; Cronbach alpha=.83). Both versions showed substantial skew. For the original DRS, 42% of scores were 0 or 1; for DRS-PI, 44%. Adding several items to the DRS-PI including actual employment status further improved its psychometric properties (person separation/reliability, 3.10/.91; item separation/reliability, 21.42/1.00; Cronbach alpha=.92) and reduced skew. For the Expanded DRS-PI, 18% of scores were 0 or 1. Conclusions: The DRS-PI provides an efficient method to ensure standardized administration of, and correlates highly with, the original DRS. The addition of several new items including actual employment status mitigates skew in postacute samples.	[Malec, James F.] IUSM, Dept Phys Med & Rehabil, PM&R, Indianapolis, IN 46254 USA; [Malec, James F.; Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN 46254 USA; [Hammond, Flora M.] Carolinas HealthCare Syst, Carolinas Rehabil, Charlotte, NC USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Boston, MA USA; [Whyte, John] Moss Rehabil Res Inst, Philadelphia, PA USA; [Wright, Jerry] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA		Malec, JF (corresponding author), IUSM, Dept Phys Med & Rehabil, PM&R, 4141 Shore Dr, Indianapolis, IN 46254 USA.	jmalec@rhin.com	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research [H133A070042]	Supported by a TBI Model System supplemental grant (no. H133A070042) from the National Institute on Disability and Rehabilitation Research.	CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Graves DE, 2011, ARCH PHYS MED REHA S, V92, pSI; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	12	19	19	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2012	93	9					1603	1608		10.1016/j.apmr.2012.04.003			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	001IL	WOS:000308453800013	22510680				2022-02-06	
J	Ooi, YC; Dagi, TF; Maltenfort, M; Rincon, F; Vibbert, M; Jabbour, P; Gonzalez, LF; Rosenwasser, R; Jallo, J				Ooi, Yinn Cher; Dagi, T. Forcht; Maltenfort, Mitchell; Rincon, Fred; Vibbert, Matthew; Jabbour, Pascal; Gonzalez, L. Fernando; Rosenwasser, Robert; Jallo, Jack			Tight Glycemic Control Reduces Infection and Improves Neurological Outcome in Critically Ill Neurosurgical and Neurological Patients	NEUROSURGERY			English	Article						Hyperglycemia; Intensive insulin therapy; Tight glycemic control	INTENSIVE INSULIN THERAPY; TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CARDIAC SURGICAL-PROCEDURES; BLOOD-GLUCOSE CONCENTRATION; STERNAL WOUND-INFECTION; DIABETES-MELLITUS; ISCHEMIC-STROKE; MEDICAL ICU; HEAD-INJURY	BACKGROUND: Tight glycemic control (TGC) may improve outcomes in hyperglycemic neurosurgical patients. The adoption of TGC has been limited by a lack of adequate data on optimal insulin delivery protocols and serum glucose concentration and by concerns about the risks of hypoglycemia. OBJECTIVE: This study was designed as a meta-analysis of outcomes to compare intensive insulin therapy and TGC with conventional insulin therapy and conventional glucose control. The secondary objective was to determine retrospectively whether a particular glucose range correlates with better outcomes. METHODS: Using electronic databases, we retrieved all English language studies published between January 1997 and December 2010 reporting outcomes in neurological and neurosurgical patients as a function of glucose levels and insulin protocols. We conducted a meta-analysis around 4 outcome measures: infection, neurological outcome, hypoglycemia, and mortality. Effect sizes in each study were individually correlated with target intensive insulin therapy glucose levels. Individual studies were assessed for quality by use of the Jadad scale. RESULTS: Nine studies reporting on 1459 patients met the inclusion criteria. Five were restricted to neurosurgical patients. Four included neurological patients. Compared with conventional glucose control, TGC lowered infection rates (odds ratio, 0.59; 95% confidence interval, 0.47-0.76; P < .001) and yielded better neurological outcomes (odds ratio, 1.72; 95% confidence interval, 1.36-2.16; P < .001). Beneficial effects increased as glucose limits tightened and study quality improved (R-2 > 0.9 for both). TGC resulted in a higher rate of hypoglycemic events (odds ratio, 8.04; 95% confidence interval, 4.85-13.31; P < .001). Mortality was not affected. CONCLUSION: TGC reduced infection risk and improved neurological outcome despite increased rates of hypoglycemic events. An optimal target for serum glucose concentrations could not be determined.	[Ooi, Yinn Cher] Univ Calif Los Angeles, Dept Neurol Surg, Los Angeles, CA USA; [Maltenfort, Mitchell; Rincon, Fred; Vibbert, Matthew; Jabbour, Pascal; Gonzalez, L. Fernando; Rosenwasser, Robert; Jallo, Jack] Thomas Jefferson Univ Hosp, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Dagi, T. Forcht] Harvard MIT Program Hlth Sci & Technol, Div Hlth Sci & Technol, Boston, MA USA		Jallo, J (corresponding author), 909 Walnut St, Philadelphia, PA 19107 USA.	jack.jallo@jefferson.edu	ROSENWASSER, ROBERT H/L-2482-2014	Rincon, Fred/0000-0002-8510-118X; Jallo, Jack/0000-0002-5512-1729	Nuvasive	Dr Jallo receives research support in the form of a grant from Nuvasive. The other authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Anderson RE, 1999, STROKE, V30, P160, DOI 10.1161/01.STR.30.1.160; Bhalla A, 2003, EUR J NEUROL, V10, P25, DOI 10.1046/j.1468-1331.2003.00504.x; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Culliford AT, 1999, ANN THORAC SURG, V67, P360; DECOURTENMYERS GM, 1994, J CEREBR BLOOD F MET, V14, P227, DOI 10.1038/jcbfm.1994.29; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; Gale SC, 2007, AM SURGEON, V73, P454; Grey Neil J, 2004, Endocr Pract, V10 Suppl 2, P46; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JENNETT B, 1975, LANCET, V1, P480; Kimura K, 2007, J NEUROL SCI, V255, P90, DOI 10.1016/j.jns.2007.02.005; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Latorre JGS, 2009, STROKE, V40, P1644, DOI 10.1161/STROKEAHA.108.535534; LI PA, 1994, NEUROSCI LETT, V177, P63, DOI 10.1016/0304-3940(94)90045-0; Lukins MB, 2005, ANESTH ANALG, V100, P1129, DOI 10.1213/01.ANE.0000146943.45445.55; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Mebis L, 2007, CURR OPIN CRIT CARE, V13, P392, DOI 10.1097/MCC.0b013e3281c1c9c8; Mechanick JI, 2007, CURR OPIN CLIN NUTR, V10, P193, DOI 10.1097/MCO.0b013e32802b7016; Moghissie ES, ACP HOSP S; Parsons MW, 2002, ANN NEUROL, V52, P20, DOI 10.1002/ana.10241; Pasternak JJ, 2004, J NEUROSURG ANESTH, V16, P122, DOI 10.1097/00008506-200404000-00003; Pittas AG, 2004, ARCH INTERN MED, V164, P2005, DOI 10.1001/archinte.164.18.2005; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; RANKIN J, 1957, Scott Med J, V2, P200; Schlenk F, 2009, NEUROCRIT CARE, V11, P56, DOI 10.1007/s12028-009-9222-z; Schlenk F, 2008, CRIT CARE, V12, DOI 10.1186/cc6776; Scott JF, 1999, STROKE, V30, P793, DOI 10.1161/01.STR.30.4.793; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Thomas G, 2007, NEPHROL DIAL TRANSPL, V22, P2849, DOI 10.1093/ndt/gfm401; Timmer JR, 2004, AM HEART J, V148, P399, DOI 10.1016/j.ahj.2004.04.007; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2008, CRIT CARE, V12, DOI 10.1186/cc6986; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0; Wass CT, 1996, MAYO CLIN PROC, V71, P801; WIDOM B, 1990, ANN INTERN MED, V112, P904, DOI 10.7326/0003-4819-112-12-904; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yamada K, 2007, CRIT CARE, V11, DOI 10.1186/cc5953; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	52	19	19	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	SEP	2012	71	3					692	702		10.1227/NEU.0b013e3182631eb4			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	996HB	WOS:000308074400038	22688953				2022-02-06	
J	Yellowlees, PM; Holloway, KM; Parish, MB				Yellowlees, Peter M.; Holloway, Kevin M.; Parish, Michelle Burke			Therapy in Virtual Environments-Clinical and Ethical Issues	TELEMEDICINE AND E-HEALTH			English	Article						virtual environment; virtual reality; post-traumatic stress disorder treatment; traumatic brain injury treatment; ethical and legal guidelines for virtual reality	REALITY EXPOSURE THERAPY; ANXIETY DISORDERS; BRAIN-INJURY; VIETNAM VETERANS; MENTAL-HEALTH; REHABILITATION; PSYCHOTHERAPY; SIMULATION; AVATARS; PHOBIA	Background: As virtual reality and computer-assisted therapy strategies are increasingly implemented for the treatment of psychological disorders, ethical standards and guidelines must be considered. This study determined a set of ethical and legal guidelines for treatment of post-traumatic stress disorder (PTSD)/traumatic brain injury (TBI) in a virtual environment incorporating the rights of an individual who is represented by an avatar. Materials and Methods: A comprehensive literature review was undertaken. An example of a case study of therapy in Second Life (a popular online virtual world developed by Linden Labs) was described. Results: Ethical and legal considerations regarding psychiatric treatment of PTSD/TBI in a virtual environment were examined. The following issues were described and discussed: authentication of providers and patients, informed consent, patient confidentiality, patient well-being, clinician competence (licensing and credentialing), training of providers, insurance for providers, the therapeutic environment, and emergencies. Ethical and legal guidelines relevant to these issues in a virtual environment were proposed. Conclusions: Ethical and legal issues in virtual environments are similar to those that occur in the in-person world. Individuals represented by an avatar have the rights equivalent to the individual and should be treated as such.	[Yellowlees, Peter M.] Univ Calif Davis, Dept Psychiat, Sacramento, CA 95817 USA; [Holloway, Kevin M.] Natl Ctr Telehlth & Technol, Tacoma, WA USA; [Parish, Michelle Burke] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA		Yellowlees, PM (corresponding author), Univ Calif Davis, Dept Psychiat, 2450 48th St,Suite 2856, Sacramento, CA 95817 USA.	pmyellowlees@ucdavis.edu					Anderson P, 2003, COGN BEHAV PRACT, V10, P240, DOI 10.1016/S1077-7229(03)80036-6; [Anonymous], 2010, PRACTICING MED TELEM; Bart O, 2011, DISABIL REHABIL, V33, P1579, DOI 10.3109/09638288.2010.540291; Bell MD, 2011, SCHIZOPHRENIA BULL, V37, pS91, DOI 10.1093/schbul/sbr061; Botella C, 2000, BEHAV THER, V31, P583, DOI 10.1016/S0005-7894(00)80032-5; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Cobb SVG, 1999, PRESENCE-TELEOP VIRT, V8, P169, DOI 10.1162/105474699566152; Coodin S, 2001, PSYCHIATR REHABIL J, V24, P299, DOI 10.1037/h0095082; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Ferrer-Garcia M, 2010, STUD HEALTH TECHNOL, V154, P44, DOI 10.3233/978-1-60750-561-7-44; Ferrer-Garcia M, 2009, BEHAV MODIF, V33, P830, DOI 10.1177/0145445509348056; Flaherty JH, 2002, ACAD MED, V77, P336, DOI 10.1097/00001888-200204000-00017; Garcia-Palacios A, 2002, BEHAV RES THER, V40, P983, DOI 10.1016/S0005-7967(01)00068-7; Gorini A, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1029; Gorrindo T, 2009, ACAD PSYCHIATR, V33, P413, DOI 10.1176/appi.ap.33.5.413; Gourlay D, 2000, INT J MED INFORM, V60, P255, DOI 10.1016/S1386-5056(00)00100-3; Graber MA, 2011, MED HUMANIT, V37, P9, DOI 10.1136/jmh.2010.005637; Graber MA, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1299; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Gregg L, 2007, SOC PSYCH PSYCH EPID, V42, P343, DOI 10.1007/s00127-007-0173-4; Hodges LF, 2001, IEEE COMPUT GRAPH, V21, P25, DOI 10.1109/38.963458; Hoffman HG, 2004, SCI AM, V291, P58, DOI 10.1038/scientificamerican0804-58; Hoffman HG, 2011, ANN BEHAV MED, V41, P183, DOI 10.1007/s12160-010-9248-7; Hsiung R., 2002, E THERAPY CASE STUDI; Hsiung RC, 2001, TELEMED J E-HEALTH, V7, P39, DOI 10.1089/153056201300093895; Klinger E, 2005, CYBERPSYCHOL BEHAV, V8, P76, DOI 10.1089/cpb.2005.8.76; Kramer TL, 2010, PSYCHIAT SERV, V61, P1153, DOI 10.1176/ps.2010.61.11.1153; Krijn M, 2004, CLIN PSYCHOL REV, V24, P259, DOI 10.1016/j.cpr.2004.04.001; Meyerbroker K, 2011, STUD COMPUT INTELL, V337, P47; Meyerbroker K, 2010, DEPRESS ANXIETY, V27, P933, DOI 10.1002/da.20734; Nagel DM, 2009, TELEHEALTH WORLD, P1; Nichols S, 2002, APPL ERGON, V33, P251, DOI 10.1016/S0003-6870(02)00020-0; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Perpina C, 2003, EUR EAT DISORD REV, V11, P261, DOI 10.1002/erv.520; Reger GM, 2011, J TRAUMA STRESS, V24, P93, DOI 10.1002/jts.20574; Repetto C, 2011, NEUROPSYCHIATRY-LOND, V1, P31, DOI 10.2217/NPY.11.5; Riva G, 2005, CYBERPSYCHOL BEHAV, V8, P220, DOI 10.1089/cpb.2005.8.220; Riva Giuseppe, 2011, J Diabetes Sci Technol, V5, P283; Riva G, 2009, BRIT J GUID COUNS, V37, P337, DOI 10.1080/03069880902957056; Rizzo A, 2011, J CLIN PSYCHOL MED S, V18, P176, DOI 10.1007/s10880-011-9247-2; Rizzo AS, 2002, STUD NEUROPSYCHOL DE, P243; Rothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617, DOI 10.4088/JCP.v62n0808; Rothbaum BO, 1999, J TRAUMA STRESS, V12, P263, DOI 10.1023/A:1024772308758; Rothbaum BO, 2010, CORSINI ENCY PSYCHOL; Salo R, 2002, PSYCHIAT RES, V111, P65, DOI 10.1016/S0165-1781(02)00111-7; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Schmitt YS, 2011, BURNS, V37, P61, DOI 10.1016/j.burns.2010.07.007; Schneider S M, 1999, Cyberpsychol Behav, V2, P125, DOI 10.1089/cpb.1999.2.125; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Taylor CB, 2003, CURR DIR PSYCHOL SCI, V12, P18, DOI 10.1111/1467-8721.01214; Wilson J, 2010, USE TECHNOLOGY MENTA, P104; Wood DP, 2010, CYBERPSYCH BEH SOC N, V13, P3, DOI 10.1089/cyber.2009.0396; Wootton R, 2003, TELEPSYCHIATRY E MEN; Wright J H, 1997, J Psychother Pract Res, V6, P315; Yellowlees P, 2010, TELEMED J E-HEALTH, V16, P1074, DOI 10.1089/tmj.2010.0148; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	56	19	20	3	57	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	SEP	2012	18	7					558	564		10.1089/tmj.2011.0195			7	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	004TF	WOS:000308703300013	22823138				2022-02-06	
J	Tran, MD; Furones-Alonso, O; Sanchez-Molano, J; Bramlett, HM				Minh Dinh Tran; Furones-Alonso, Ofelia; Sanchez-Molano, Juliana; Bramlett, Helen Marie			Trauma-induced expression of astrocytic thrombospondin-1 is regulated by P2 receptors coupled to protein kinase cascades	NEUROREPORT			English	Article						astrocytes; protein kinase signaling; purinergic receptors; thrombospondin; traumatic brain injury	EXTRACELLULAR ATP; CULTURED ASTROCYTES; DNA-SYNTHESIS; INJURY; CELLS; SYNAPTOGENESIS; ACTIVATION; ERK1/2; P2Y(2); CNS	Thrombospondin-1 (TSP-1) is an extracellular matrix protein produced by astrocytes, which can promote synaptogenesis. The regulation of astrocytic TSP-1 involves extracellular ATP through the activation of P2Y receptors coupled to various protein kinase signaling pathways. However, not much is known about the mechanisms regulating TSP-1 expression in primary cortical astrocytes after a traumatic brain injury. Using an in-vitro model of central nervous system trauma that stimulates the release of ATP, we found that trauma-induced expression and release of TSP-1 involved purinergic signaling as both expression and release were significantly attenuated by pyridoxalphosphate-6-azophenyl-2'-4'-disulfonic acid, a P2 receptor antagonist Further antagonist studies with reactive blue 2 point to a role for P2Y4, as reactive blue 2 is a potent antagonist for rat P2Y4 receptors. In addition, the injury-induced expression of TSP-1 was significantly attenuated by the inhibition of extracellular signal-regulated kinase and p38/mitogen-activated protein kinase, whereas injury-induced release of TSP-1 was significantly blocked by the inhibition of extracellular signal-regulated kinase and Akt Using an in-vivo model of a moderate parasagittal fluid-percussion brain injury, we found that TSP-1 levels were increased when compared with those in sham animals in the cortex, thalamus, and hippocampus. We conclude that TSP-1 expression after injury can be regulated by the activation of P2 receptors coupled with protein kinase signaling pathways and suggest that purinergic signaling, by regulating TSP expression, may play an important role in cell-matrix and cell-cell interactions such as those occurring during central nervous system repair. NeuroReport 23:721-726 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Minh Dinh Tran; Bramlett, Helen Marie] Miami VA Healthcare Syst, Res Serv, Miami, FL 33125 USA; [Furones-Alonso, Ofelia; Sanchez-Molano, Juliana; Bramlett, Helen Marie] Lois Pope LIFE Ctr, Miami Project Cure Paralysis, Miami, FL USA; [Bramlett, Helen Marie] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA		Tran, MD (corresponding author), Miami VA Healthcare Syst, Res Serv, 1201 NW 16th St, Miami, FL 33125 USA.	minh.tran@va.gov			Department of Veterans AffairsUS Department of Veterans Affairs	This work was supported by the Department of Veterans Affairs (to H.M.B.). We are grateful to Joseph T Neary, PhD, for valuable discussions.	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Bussolati B, 2006, J MOL MED-JMM, V84, P852, DOI 10.1007/s00109-006-0075-z; Chen JK, 2011, J CELL BIOCHEM, V112, P59, DOI 10.1002/jcb.22732; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; El Btaouri H, 2011, BBA-MOL CELL RES, V1813, P695, DOI 10.1016/j.bbamcr.2011.02.004; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Kim MS, 2006, PHOTOCHEM PHOTOBIOL, V82, P645, DOI 10.1562/2005-09-29-RA-702; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Lo FS, 2011, J NEUROPHYSIOL, V106, P2876, DOI 10.1152/jn.00312.2011; Moon Y, 2008, LIFE SCI, V82, P591, DOI 10.1016/j.lfs.2007.11.030; Nakagawa T, 2005, J AM SOC NEPHROL, V16, P899, DOI 10.1681/ASN.2004080689; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; NEARY JT, 1994, J NEUROCHEM, V63, P490; NEARY JT, 1994, ACTA NEUROPATHOL, V87, P8; ScottDrew S, 1997, J NEUROSCI RES, V50, P202, DOI 10.1002/(SICI)1097-4547(19971015)50:2<202::AID-JNR9>3.0.CO;2-J; Shreiber DI, 1995, INCIDENCE CEREBRAL C, P233; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Wang M, 2005, J NEUROCHEM, V95, P630, DOI 10.1111/j.1471-4159.2005.03408.x; Wang XH, 2009, J CLIN NEUROSCI, V16, P818, DOI 10.1016/j.jocn.2008.09.014; Wildman SS, 2003, BRIT J PHARMACOL, V140, P1177, DOI 10.1038/sj.bjp.0705544; Yonezawa T, 2010, GLIA, V58, P755, DOI 10.1002/glia.20959; Yu KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002470	25	19	20	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 22	2012	23	12					721	726		10.1097/WNR.0b013e32835688fe			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	980HV	WOS:000306885100006	22776902				2022-02-06	
J	Moojen, VKM; Damiani-Neves, M; Bavaresco, DV; Pescador, BB; Comim, CM; Quevedo, J; Boeck, CR				Moojen, Vania K. M.; Damiani-Neves, Marcela; Bavaresco, Daniela V.; Pescador, Bruna B.; Comim, Clarissa M.; Quevedo, Joao; Boeck, Carina R.			NMDA preconditioning prevents object recognition memory impairment and increases brain viability in mice exposed to traumatic brain injury	BRAIN RESEARCH			English	Article						NMDA preconditioning; Memory; Cellular viability; Traumatic brain injury	METHYL-D-ASPARTATE; CEREBELLAR GRANULE CELLS; GLUTAMATE NEUROTOXICITY; SIGNALING PATHWAYS; QUINOLINIC ACID; HIPPOCAMPUS; NEURONS; RAT; RECEPTORS; ACTIVATION	Recent studies have focused on the role of N-methyl-D-aspartate (NMDA) in brain injury. The present study is aimed at verifying memory, anxiety/depression parameters, and cellular viability in the brain of mice preconditioned with NMDA and subjected to the model of mild traumatic brain injury. For this purpose, male albino CF-1 mice were pre-treated with NMDA (75 mg/kg) and subjected to brain trauma, and after 24 h submitted to memory tasks and anxiety and depression-like behavioral tests. The memory tests were evaluated at 1.5 h, 24 h, and 7 days after the training. In addition, the cellular viability was evaluated in the cerebral cortex and hippocampus 96 h after the trauma. It was observed that the cellular viability was reduced in the hippocampus of the mice subjected to trauma and the preconditioning with NMDA was able to protect this damage. All mice learnt the task in the habituation test, but in the object recognition task the mice preconditioned with NMDA were protected against impairment induced by TBI in both short and long-term memory. On the other hand, in the step-down inhibitory avoidance test, only the mice treated with NMDA showed impairment of long-term memory (7 days after training session). The evaluation of anxiety/depression behavior showed no changes after TBI. In conclusion, NMDA preconditioning induced impairment of the long-term memory; however, it was able to protect against the novel recognition memory impairment and increase the cellular survival in the hippocampus of mice exposed to traumatic brain injury. (c) 2012 Elsevier B.V. All rights reserved.	[Comim, Clarissa M.; Quevedo, Joao; Boeck, Carina R.] Univ Extremo S Catarinense UNESC, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Neurociencias,INCT TM, BR-88806000 Criciuma, SC, Brazil; [Moojen, Vania K. M.; Damiani-Neves, Marcela; Bavaresco, Daniela V.; Pescador, Bruna B.; Boeck, Carina R.] Univ Extremo S Catarinense UNESC, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Biol Celular & Mol,INCT TM, BR-88806000 Criciuma, SC, Brazil		Boeck, CR (corresponding author), Univ Extremo S Catarinense, UNASAU, PPGCS, Lab Neurociencias, BR-88806000 Criciuma, SC, Brazil.	cariboeck@hotmail.com	Comim, Clarissa M/S-9007-2019; de Quevedo, Joao Luciano/N-1407-2019; Comim, Clarissa M/C-4365-2014; de Quevedo, Joao Luciano/E-5491-2013; Boeck, Carina Rodrigues/E-9472-2011; Bavaresco, Daniela/I-4136-2018	Comim, Clarissa M/0000-0003-4991-042X; de Quevedo, Joao Luciano/0000-0003-3114-6611; de Quevedo, Joao Luciano/0000-0003-3114-6611; Boeck, Carina Rodrigues/0000-0002-6828-5634; Bavaresco, Daniela/0000-0002-5533-8848	Brazilian National Council Research: CNPq grants [484193/2010-4]; UNESC	This work was supported by funds from the Brazilian National Council Research: CNPq grants no. 484193/2010-4 and UNESC.	Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Boeck CR, 2005, NEUROPHARMACOLOGY, V49, P17, DOI 10.1016/j.neuropharm.2005.01.024; Boeck CR, 2004, EPILEPSIA, V45, P745, DOI 10.1111/j.0013-9580.2004.65203.x; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHUANG DM, 1992, MOL PHARMACOL, V42, P210; Conti AC, 1998, J NEUROSCI, V18, P5663; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; DAMSCHRODERWILLIAMS P, 1995, J NEUROCHEM, V65, P1069; Dickie BGM, 1996, NEUROSCIENCE, V72, P731, DOI 10.1016/0306-4522(95)00611-7; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Gidday JM, 2010, TRANSL STROKE RES, V1, P19, DOI 10.1007/s12975-010-0011-y; GIMENEZLLORT L, 1995, EUR J PHARMACOL, V275, P171, DOI 10.1016/0014-2999(94)00768-3; GOLD PE, 1986, BEHAV NEURAL BIOL, V46, P87, DOI 10.1016/S0163-1047(86)90927-1; Herculano BD, 2011, BEHAV BRAIN RES, V219, P92, DOI 10.1016/j.bbr.2010.12.025; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.0.CO;2-5; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Levin ED, 1998, BEHAV GENET, V28, P381, DOI 10.1023/A:1021673703129; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Love S, 1999, BRAIN PATHOL, V9, P119; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Ogita K, 2005, NEUROPHARMACOLOGY, V48, P810, DOI 10.1016/j.neuropharm.2004.12.018; Ogita K, 2003, J NEUROCHEM, V85, P1336, DOI 10.1046/j.1471-4159.2003.01778.x; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Sandhu R, 1996, CIRC RES, V78, P137, DOI 10.1161/01.RES.78.1.137; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tauskela JS, 1999, BRAIN RES, V827, P143, DOI 10.1016/S0006-8993(99)01322-0; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Willis C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003986.PUB2; Xiong J, 2011, CHINESE MED J-PEKING, V124, P2209, DOI 10.3760/cma.j.issn.0366-6999.2011.14.023; Youssef FF, 2006, BRAIN RES, V1073, P183, DOI 10.1016/j.brainres.2005.12.008	55	19	19	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 23	2012	1466						82	90		10.1016/j.brainres.2012.05.041			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989ZH	WOS:000307600300008	22652305	hybrid			2022-02-06	
J	Cernich, AN; Chandler, L; Scherdell, T; Kurtz, S				Cernich, Alison N.; Chandler, Lauren; Scherdell, Traci; Kurtz, Shira			Assessment of Co-Occurring Disorders in Veterans Diagnosed With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adult; brain injuries/complications; Iraq war; mental disorders/diagnosis; veterans/psychology	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; MILITARY SERVICE MEMBERS; OIF/OEF VETERANS; CHRONIC PAIN; POLYTRAUMA; DEPRESSION; SEQUELAE; IRAQ; REHABILITATION	Aims: The co-occurrence of psychiatric disorders and other somatic disorders poses a significant challenge for the individual clinician working with veterans who report a history of mild traumatic brain injury (mTBI). In this article, common co-occurring symptoms and disorders will be described in relation to the population of veterans with mTBI, using a retrospective analysis of data from initial screening and secondary level evaluation for traumatic brain injury (TBI) in an urban Veteran's Affairs Medical Center. Participants: Four hundred two veterans of the recent conflicts who received secondary level evaluation for TBI following positive TBI screening. Outcomes: Significant differences were detected in symptom reporting between those who screened positive and those who screened negative on psychiatric screening. Those with positive posttraumatic stress disorder and depression screens endorsed more cognitive and affective symptoms; individuals screening positive for alcohol abuse did not report significantly more symptoms. Individuals without positive psychiatric screens reported fewer symptoms than those with positive screens. Consideration of these data in the context of a clinical case will be used to elucidate the challenge this presents to the clinical team. Conclusion: The presence of co-occurring disorders should be considered in the etiology of a veteran's continued symptomatic complaints following TBI.	[Cernich, Alison N.] Dept Vet Affairs, Off Rehabil Serv, Washington, DC USA; [Cernich, Alison N.] Def Ctr Excellence Psychol Hlth & Traumat Brain I, Silver Spring, MD USA; [Cernich, Alison N.; Chandler, Lauren; Scherdell, Traci; Kurtz, Shira] VA Maryland Hlth Care Syst, Baltimore, MD USA; [Cernich, Alison N.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA		Cernich, AN (corresponding author), Def Ctr Excellence, 9th Floor,1355 East West Highway, Silver Spring, MD 20910 USA.	Alison.Cernich@va.gov					Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Ryan PB, 2011, BRAIN INJURY, V25, P1019, DOI 10.3109/02699052.2011.597044; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Weathers F.W., 1993, 9 ANN C ISTSS; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271	34	19	19	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2012	27	4					253	260		10.1097/HTR.0b013e3182585cd5			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	975PJ	WOS:000306523000003	22767073				2022-02-06	
J	Kaneko, Y; Tajiri, N; Yu, S; Hayashi, T; Stahl, CE; Bae, E; Mestre, H; Franzese, N; Rodrigues, A; Rodrigues, MC; Ishikawa, H; Shinozuka, K; Hethorn, W; Weinbren, N; Glover, LE; Tan, J; Achyuta, AH; Van Loveren, H; Sanberg, PR; Shivsankar, S; Borlongan, CV				Kaneko, Yuji; Tajiri, Naoki; Yu, SeongJin; Hayashi, Takuro; Stahl, Christine E.; Bae, Eunkyung; Mestre, Humberto; Franzese, Nicholas; Rodrigues, Antonio, Jr.; Rodrigues, Maria C.; Ishikawa, Hiroto; Shinozuka, Kazutaka; Hethorn, Whitney; Weinbren, Nathan; Glover, Loren E.; Tan, Jun; Achyuta, Anilkumar Harapanahalli; Van Loveren, Harry; Sanberg, Paul R.; Shivsankar, Sundaram; Borlongan, Cesar V.			Nestin Overexpression Precedes Caspase-3 Upregulation in Rats Exposed to Controlled Cortical Impact Traumatic Brain Injury	CELL MEDICINE			English	Article						Cell proliferation; Neurogenesis; Apoptosis; Head trauma; Nestin; Caspase-3		Our understanding of biological mechanisms and treatment options for traumatic brain injury (TBI) is limited. Here, we employed quantitative real-time PCR (QRT-PCR) and immunohistochemical analyses to determine the dynamic expression of cell proliferation and apoptosis in an effort to provide insights into the therapeutic window for developing regenerative strategies for TBI. For this purpose, young adult Sprague-Dawley rats were subjected to experimental TBI using a controlled cortical impactor and then euthanized 1-48 h after TBI for QRT-PCR and immunohistochemistry. QRT-PCR revealed that brains from TBI-exposed rats initially displayed nestin mRNA expression that modestly increased as early as 1 h post-TBI, then significantly peaked at 8 h, but thereafter reverted to pre-TBI levels. On the other hand, caspase-3 mRNA expression was slightly elevated at 8 h post-TBI, which did not become significantly upregulated until 48 h. Immunofluorescent microscopy revealed a significant surge in nestin-immunoreactive cells in the cortex, corpus callosum, and subventricular zone at 24 h post-TBI, whereas a significant increase in the number of active caspase-3-immunoreactive cells was only found in the cortex and not until 48 h. These results suggest that the injured brain attempts to repair itself via cell proliferation immediately after TBI but this endogenous regenerative mechanism is not sufficient to abrogate the secondary apoptotic cell death. Treatment strategies designed to amplify cell proliferation and to prevent apoptosis are likely to exert maximal benefits when initiated at the acute phase of TBI.	[Kaneko, Yuji; Tajiri, Naoki; Yu, SeongJin; Hayashi, Takuro; Bae, Eunkyung; Mestre, Humberto; Franzese, Nicholas; Rodrigues, Antonio, Jr.; Rodrigues, Maria C.; Ishikawa, Hiroto; Shinozuka, Kazutaka; Hethorn, Whitney; Weinbren, Nathan; Glover, Loren E.; Van Loveren, Harry; Sanberg, Paul R.; Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA; [Stahl, Christine E.] MacDill Air Force Base, Dept Aerosp Med, Tampa, FL USA; [Tan, Jun] James A Haley Vet Adm Hosp, Tampa, FL USA; [Tan, Jun] Univ S Florida, Rashid Lab Dev Neurobiol, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Achyuta, Anilkumar Harapanahalli; Shivsankar, Sundaram] Draper Lab, Bioengn Ctr, Tampa, FL USA		Borlongan, CV (corresponding author), Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Rodrigues, Antonio A/B-8646-2012; Mestre, Humberto/AAO-5848-2020; Rodrigues, Maria Carolina Oliveira/A-2302-2012	Rodrigues, Antonio A/0000-0002-3908-5836; Mestre, Humberto/0000-0001-5876-5397; Rodrigues, Maria Carolina Oliveira/0000-0003-0691-2222; Shinozuka, Kazutaka/0000-0002-6435-4460; Ishikawa, Hiroto/0000-0003-0760-7203	Draper Laboratory; University of South Florida Department of Neurosurgery and Brain Repair funds; James and Esther King Biomedical Research Foundation [1KG01-33966]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5U01NS055914-04, 1R01NS071956-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956] Funding Source: NIH RePORTER	Financial support for this study was partially through the Draper Laboratory and the University of South Florida Department of Neurosurgery and Brain Repair funds. CVB is funded by the James and Esther King Biomedical Research Foundation 1KG01-33966, NIH 5U01NS055914-04, and NIH 1R01NS071956-01A1. The authors declare no conflict of interest.	Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Chuck Y, 2008, MILD TRAUMATIC BRAIN; CLARKE SR, 1994, NEUROREPORT, V5, P1885, DOI 10.1097/00001756-199410000-00011; Conti AC, 1998, J NEUROSCI, V18, P5663; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Hung HS, 2009, CELL TRANSPLANT, V18, P1003, DOI 10.3727/096368909X12483162196683; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kern DS, 2011, CELL TRANSPLANT, V20, P371, DOI 10.3727/096368910X528085; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Lieutaud T, 2008, J NEUROTRAUM, V25, P1179, DOI 10.1089/neu.2008.0591; Lin SZ, 2011, CELL TRANSPLANT, V20, P1, DOI 10.3727/096368910X532873; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Moreels M, 2008, NEUROPATH APPL NEURO, V34, P532, DOI 10.1111/j.1365-2990.2007.00910.x; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Sanberg PR, 2011, CELL TRANSPLANT, V20, P85, DOI 10.3727/096368910X532855; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Schmidt-Kastner R, 2002, INT J DEV NEUROSCI, V20, P29, DOI 10.1016/S0736-5748(02)00003-5; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sheibani N, 2004, CRIT CARE MED, V32, P2274, DOI 10.1097/01.CCM.0000145998.11686.ED; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	49	19	19	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2155-1790			CELL MED	Cell Med.	JUL	2012	4	2					55	63		10.3727/215517912X639306			9	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	VC4TS	WOS:000433780100001	23101029	Green Published, Green Accepted			2022-02-06	
J	McNamee, S; Howe, L; Nakase-Richardson, R; Peterson, M				McNamee, Shane; Howe, Laura; Nakase-Richardson, Risa; Peterson, Michelle			Treatment of Disorders of Consciousness in the Veterans Health Administration Polytrauma Centers	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; disorders of consciousness; rehabilitation	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; SENSORY STIMULATION; AMANTADINE; METHYLPHENIDATE; MANAGEMENT; AWAKENINGS; CHILDREN; RECOVERY; FAMILY	This article describes the evolution of the emerging consciousness programs and the approach to care for veterans and active duty service members with disorders of consciousness (DOC) at the 4 polytrauma rehabilitation centers of the Veterans Health Administration. Compared to traditional rehabilitation patients, DOC patients have unique recovery patterns and rehabilitative needs, and they require an intensive medical and nursing support structure. This requires closely integrated rehabilitation and acute medical care to ensure the highest level of outcomes. Unfortunately, little information exists in the literature to establish best practices for the rehabilitation of this population. It is the authors' intentions to bridge the literature gap in regard to programmatic structure, treatment approaches for those with DOC, and support of their caregivers. This article includes descriptions of medical care protocols, review of stimulation approaches (environmental and pharmacologic) caregiver support, and monitoring of recovery patterns.	[McNamee, Shane] Hunter Holmes McGuire VA Hosp, Phys Med & Rehabil Serv, Richmond, VA USA; [McNamee, Shane] Virginia Commonwealth Univ, Dept PM&R, Richmond, VA 23284 USA; [Howe, Laura] VA Palo Alto Hlth Care Syst, Psychol Serv, Palo Alto, CA USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, Phys Med & Rehabil Serv, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Ctr Excellence Maximizing Rehabil Outcomes, Tampa, FL USA; [Peterson, Michelle] Minneapolis VA Hlth Care Syst, Phys Med & Rehabil Serv, Minneapolis, VA USA		McNamee, S (corresponding author), Hunter Holmes McGuire Med Ctr, Dept Vet Affairs, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	Shane.McNamee@va.gov					Abbasi M, 2011, J MAGN RESON IMAGING, V34, P429; Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; [Anonymous], FAM CAR MAP POL SYST; [Anonymous], 2008, EM CONSC PROGR VHA P; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Ashwal S, 2003, BRAIN DEV-JPN, V25, P535, DOI 10.1016/S0387-7604(03)00095-0; Berube J, 2006, MOHONK REPORT REPORT; Blatow M, 2011, J MAGN RESON IMAGING, V34, P429, DOI 10.1002/jmri.22629; Boss P.G., 2006, LOSS TRAUMA RESILIEN; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cotman CW, 1978, NEURONAL PLASTICITY; DeMarchi R, 2005, CAN J NEUROL SCI, V32, P4, DOI 10.1017/S0317167100016826; Duff Diane, 2006, Axone, V27, P9; Eickhoff SB, 2008, EXP NEUROL, V214, P240, DOI 10.1016/j.expneurol.2008.08.007; Ferraro L, 1999, NEUROPSYCHOPHARMACOL, V20, P346, DOI 10.1016/S0893-133X(98)00085-2; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; Giacino JT, 2005, REHABILITATION TRAUM, P305; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; Haler EM, 2010, PHYS MED REHABILITAT, P1249; Han L, 2001, ARCH INTERN MED, V161, P1099, DOI 10.1001/archinte.161.8.1099; JACKSON RD, 1989, AM J PHYS MED REHAB, V68, P18, DOI 10.1097/00002060-198902000-00006; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; Magnuson B, 2011, NUTR CLIN PRACT, V26, P253, DOI 10.1177/0884533611405673; Marks Jean P, 2006, J Neurosci Nurs, V38, P84; Martin RT, 2007, AM J PHYS MED REHAB, V86, P613, DOI 10.1097/PHM.0b013e3181154a84; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; McMahon MA, 2009, AM J PHYS MED REHAB, V88, P525, DOI 10.1097/PHM.0b013e3181a5ade3; Nakase-Richardson R, 2010, AM C REH MED ANN C M; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Oliveira L, 2011, BRAIN INJURY, V25, P315, DOI 10.3109/02699052.2011.556103; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Pistoia F, 2010, CNS DRUGS, V24, P625, DOI 10.2165/11535940-000000000-00000; Polytrauma Emerging Consciousness Program Scope of Services, 2007, EM CONSC PROGR VHA P; Polytrauma/TBI System of Care, FAM CAR SUPP TRAIN E; RAISMAN G, 1969, BRAIN RES, V14, P25, DOI 10.1016/0006-8993(69)90029-8; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Spellman N., 2000, TXB MILITARY MED, P741; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Thaxton L, 2002, J HEAD TRAUMA REHAB, V17, P335, DOI 10.1097/00001199-200208000-00007; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; VALACH J, 1950, Slov Lek, V12, P380; Walker WC, 1999, BRAIN INJURY, V10, P65; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113; Worzniak M, 1997, J FAM PRACTICE, V44, P495; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zhu JH, 2009, J NEUROTRAUM, V26, P677, DOI 10.1089/neu.2008.0691	62	19	19	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2012	27	4					244	252		10.1097/HTR.0b013e31825e12c8			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	975PJ	WOS:000306523000002	22767072				2022-02-06	
J	Mulligan, I; Boland, M; Payette, J				Mulligan, Ivan; Boland, Mark; Payette, Justin			Prevalence of Neurocognitive and Balance Deficits in Collegiate Football Players Without Clinically Diagnosed Concussion	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						BESS; ImPACT; test battery; traumatic brain injury	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; NEUROPSYCHOLOGICAL ASSESSMENT; POSTURAL STABILITY; MANAGEMENT; PERFORMANCE; STATEMENT; IMPACT; INJURY; RECOMMENDATIONS	STUDY DESIGN: Prospective cohort. OBJECTIVES: To identify the prevalence of neurocognitive and balance deficits in collegiate football players 48 hours following competition. BACKGROUND: Neurocognitive testing, balance assessments, and subjective report of symptoms are a test battery commonly used to examine athletes suspected of having sustained a concussion. Previous literature suggests that many concussions go unreported. Little research exists examining the prevalence of neurocognitive or balance deficits in athletes who do not report concussion-like symptoms to a healthcare provider. METHODS: Forty-five Division IA collegiate football players participated in this study. Preseason baseline scores using the Balance Error Scoring System, the Immediate Post-Concussion Assessment and Cognitive Testing, and the Postconcussion Symptom Scale were compared to posttest results obtained 48 hours following a game. Prevalence of symptoms was analyzed and reported. RESULTS: Thirty-two (71%) of the 45 athletes tested demonstrated at least 1 deficit in either the Postconcussion Symptom Scale, Balance Error Scoring System, or at least 1 composite score of the Immediate Post-Concussion Assessment and Cognitive Testing. Nineteen of the 32 subjects demonstrated a change in 2 or more categories of neurocognitive and balance function. CONCLUSION: In a cohort of football players tested 48 hours following their last game of the season, who did not seek medical attention related to a concussion, a significant number demonstrated limitations in neurocognitive and balance performance, suggesting that further research may need to be performed to improve recognition of an athlete's deficits and to improve the ability to assess concussion.	[Mulligan, Ivan; Boland, Mark; Payette, Justin] St Francis Univ, DiSepio Inst Rural Hlth & Wellness, Loretto, PA 15940 USA; [Mulligan, Ivan] St Francis Univ, Phys Therapy Dept, Loretto, PA 15940 USA		Mulligan, I (corresponding author), St Francis Univ, DiSepio Inst Rural Hlth & Wellness, 108 Franciscan Way, Loretto, PA 15940 USA.	imulligan@francis.edu					Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Brown CN, 2007, J ATHL TRAINING, V42, P515; Centers for Disease Control and Prevention, 2009, HEADS FACTS PHYS MIL; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Collins Michael W, 2002, Curr Sports Med Rep, V1, P12; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2006, J ATHL TRAINING, V41, P137; Lovell MR, 2007, TECHNICAL MANUAL PSY; Lovell MR, 2006, J ATHL TRAINING, V41, P138; Makdissi M, 2010, AUST FAM PHYSICIAN, V39, P12; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Randolph C, 2001, J ATHL TRAINING, V36, P288; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Runkle D, 2010, CONCUSSION MANAGEMEN; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shuttleworth-Edwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P479, DOI 10.1016/j.acn.2008.07.002; Talavage T, J NEUROTRAUMA; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	42	19	19	0	23	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	JUL	2012	42	7					625	632		10.2519/jospt.2012.3798			8	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	969YG	WOS:000306094700005	22531476				2022-02-06	
J	Peiniger, S; Nienaber, U; Lefering, R; Braun, M; Wafaisade, A; Borgman, MA; Spinella, PC; Maegele, M				Peiniger, Sigune; Nienaber, Ulrike; Lefering, Rolf; Braun, Maximilian; Wafaisade, Arasch; Borgman, Matthew A.; Spinella, Philip C.; Maegele, Marc		Trauma Registry Deutsch Gesell Unf	Glasgow Coma Scale as a predictor for hemocoagulative disorders after blunt pediatric traumatic brain injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; Glasgow Coma Scale; hemocoagulative disorders; traumatic brain injury	SEVERE HEAD-INJURY; MASSIVE TRANSFUSION; RETROSPECTIVE ANALYSIS; PROGNOSTIC FACTORS; MULTIPLE INJURY; CHILDREN; COAGULOPATHY; COAGULATION; MODERATE; RESUSCITATION	Objective: Coagulopathy is a complication of traumatic brain injury and its presence after injury has been identified as a risk factor for prognosis. It was our aim to determine whether neurologic findings reflected by Glasgow Coma Scale at initial resuscitation can predict hemocoagulative disorders resulting from traumatic brain injury that may aggravate clinical sequelae and outcome in children. Design: A retrospective analysis of 200 datasets from children with blunt, isolated traumatic brain injury documented in the Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie was conducted. Inclusion criteria were primary admission, age <14 yrs, and sustained isolated blunt traumatic brain injury. Setting: Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie-affiliated trauma centers in Germany. Patients: Two hundred datasets of children (age <14 yrs) with blunt isolated traumatic brain injury were analyzed: children were subdivided into two groups according to Glasgow Coma Scale at the scene (Glasgow Coma Scale <= 8 vs. Glasgow Coma Scale >8) and reviewed for coagulation abnormalities upon emergency room admission and outcome. Measurement and Main Results: Fifty-one percent (n = 102 of 200) of children had Glasgow Coma Scale >8 and 49% (n = 98 of 200) had Glasgow Coma Scale <= 8 at the scene. The incidence of coagulopathy at admission was higher in children with Glasgow Coma Scale <= 8 compared to children with Glasgow Coma Scale >8: 44% (n = 31 of 71) vs. 14% (n = 11 of 79) (p < .001). Multivariate logistic regression revealed that Glasgow Coma Scale <= 8 at scene was associated with coagulopathy at admission (odds ratio 3.378, p = .009) and stepwise regression identified Glasgow Coma Scale <= 8 as an independent risk factor for coagulopathy. Mortality in children with Glasgow Coma Scale <= 8 at scene was substantially higher with the presence of coagulation abnormalities at admission compared to children in which coagulopathy was absent (51.6%, n = 16 of 31 vs. 5% n = 2 of 40). Conclusions: Glasgow Coma Scale <= 8 at scene in children with isolated traumatic brain injury is associated with increased risk for coagulopathy and mortality. These results may guide laboratory testing, management, and blood bank resources in acute pediatric trauma care. (Pediatr Crit Care Med 2012; 13:455-460)	[Peiniger, Sigune; Braun, Maximilian; Wafaisade, Arasch; Maegele, Marc] Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Trauma & Orthoped Surg, Cologne, Germany; [Peiniger, Sigune; Nienaber, Ulrike; Braun, Maximilian; Wafaisade, Arasch; Maegele, Marc] Univ Witten Herdecke, Cologne Merheim Med Ctr, Inst Res Operat Med, Cologne, Germany; [Borgman, Matthew A.] Brooke Army Med Ctr, Houston, TX USA; [Spinella, Philip C.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Spinella, Philip C.] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA		Maegele, M (corresponding author), Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Trauma & Orthoped Surg, Cologne, Germany.	Marc.Maegele@t.online.de	Borgman, Matthew A/L-9477-2015	Borgman, Matthew A/0000-0002-2008-7380			Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Becker S, 1999, EUR J PEDIATR, V158, pS197, DOI 10.1007/PL00014355; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chiaretti A, 2002, CHILD NERV SYST, V18, P54, DOI 10.1007/s00381-001-0533-4; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Duchesne JC, 2009, BRIT J HOSP MED, V70, P22, DOI 10.12968/hmed.2009.70.1.37690; GOODNIGHT SH, 1974, ANN NY ACAD SCI, V230, P271, DOI 10.1111/j.1749-6632.1974.tb14459.x; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Kapapa T, 2010, J CHILD NEUROL, V25, P409, DOI 10.1177/0883073809340697; Keller M S, 2001, Semin Pediatr Surg, V10, P12, DOI 10.1053/spsu.2001.19381; Maegele M, 2008, VOX SANG, V95, P112, DOI 10.1111/j.1423-0410.2008.01074.x; Maegele M, 2011, VOX SANG, V100, P231, DOI 10.1111/j.1423-0410.2010.01387.x; Maegele M, 2009, VOX SANG, V97, P39, DOI 10.1111/j.1423-0410.2009.01179.x; Maegele M, 2009, TRANSFUSION MED, V19, P117, DOI 10.1111/j.1365-3148.2009.00920.x; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; May AK, 1997, AM SURGEON, V63, P233; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Morenski JD, 2003, J NEUROSURG, V98, P611, DOI 10.3171/jns.2003.98.3.0611; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pathak A, 2005, Neurol India, V53, P178; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; PFENNINGER J, 1982, Z KINDERCHIR, V37, P53; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; PFENNINGER J, 1984, Z KINDERCHIR, V39, P223; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TEASDALE G, 1974, LANCET, V2, P81; Thomas L, 2000, LABOR DIAGNOSE INDIK; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; WAGNER C, 2000, LABOR DIAGNOSE, P613; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; Zehtahchi S, 2008, J TRAUMA, V65, P1571, DOI 10.1097/TA.0b013e31818c9c33	41	19	24	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2012	13	4					455	460		10.1097/PCC.0b013e31823893c5			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	970FU	WOS:000306114300023	22422166				2022-02-06	
J	Rao, V; Mielke, M; Xu, X; Smith, GS; McCann, UD; Bergey, A; Doshi, V; Pham, DL; Yousem, D; Mori, S				Rao, Vani; Mielke, Michelle; Xu, Xin; Smith, Gwenn S.; McCann, Una D.; Bergey, Alyssa; Doshi, Vishal; Pham, Dzung L.; Yousem, David; Mori, Susumi			Diffusion Tensor Imaging Atlas-Based Analyses in Major Depression After Mild Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							MRI; ABNORMALITIES; SEQUELAE	There are currently no known early neuroanatomical markers predictive of the development of major depression or depressive symptoms after mild traumatic brain injury (mTBI). The authors conducted a 1-year longitudinal pilot study to determine whether diffusion tensor imaging (DTI) measures collected within 1 month of mTBI could predict incident depression. Of the 14 subjects who met study inclusion criteria, 4 (28.6%) developed major depression over the follow-up period. Compared with the nondepressed group, those who developed depression had white-matter abnormalities in the fronto-temporal regions measured by DTI. These preliminary results highlight the need for additional studies, including studies using a larger sample and appropriate controls. (The Journal of Neuropsychiatry and Clinical Neurosciences 2012; 24:309-315)	[Rao, Vani; Smith, Gwenn S.; McCann, Una D.; Bergey, Alyssa; Doshi, Vishal] Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21218 USA; [Mielke, Michelle] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA; [Xu, Xin; Yousem, David; Mori, Susumi] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Xu, Xin; Yousem, David; Mori, Susumi] Sch Med, Baltimore, MD USA; [Pham, Dzung L.] NIH, Image Proc Core, Ctr Neurosci & Regenerat Med, USUHS, Bethesda, MD 20892 USA		Rao, V (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21218 USA.	vrao@jhmi.edu	Pham, Dzung/AAR-8263-2020	Mielke, Michelle/0000-0001-7177-1185	National Alliance for Research on Schizophrenia and Depression (NARSAD)French National Research Agency (ANR)NARSAD; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Forest; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH086881] Funding Source: NIH RePORTER	This study was fully supported by grant from National Alliance for Research on Schizophrenia and Depression (NARSAD) and partially supported by the Department of Defense in the Center for Neuroscience and Regenerative Medicine.; Dr. Rao has a grant from Forest to conduct a clinical trial in post-TBI depression.	Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Diggle P., 2002, ANAL LONGITUDINAL DA; Faria AV, 2011, NEUROIMAGE, V54, P1854, DOI 10.1016/j.neuroimage.2010.09.061; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Miller MI, 2005, P NATL ACAD SCI USA, V102, P9685, DOI 10.1073/pnas.0503892102; Morys Joanna M, 2003, Folia Morphol (Warsz), V62, P347; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Takahashi T, 2010, PROG NEURO-PSYCHOPH, V34, P98, DOI 10.1016/j.pnpbp.2009.10.005	25	19	20	0	5	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2012	24	3					309	315		10.1176/appi.neuropsych.11080188			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	057VS	WOS:000312592800040	23037644	Green Accepted			2022-02-06	
J	Strutt, AM; Scott, BM; Lozano, VJ; Tieu, PG; Peery, S				Strutt, Adriana M.; Scott, Bonnie M.; Lozano, Veronica J.; Tieu, Phoebe G.; Peery, Shelley			Assessing sub-optimal performance with the Test of Memory Malingering in Spanish speaking patients with TBI	BRAIN INJURY			English	Article						Spanish speakers; suspect effort/motivation; traumatic brain injury; symptom validity testing; TOMM	SYMPTOM VALIDITY TESTS; SUSPECT EFFORT; BASE RATES; TOMM; POPULATION; SCORES; SAMPLE	Primary objectives: To examine the clinical utility of the Test of Memory Malingering (TOMM) with US Spanish speaking patients diagnosed with traumatic brain injury (TBI). Research design: The demographic characteristics and neuropsychological functioning of Spanish speaking patients with TBI with valid vs suboptimal performance were compared. Methods and procedures: Demographic and neuropsychological data were retrospectively collected from charts of patients who underwent neurocognitive evaluations for clinical, med-legal and workmen's compensation purposes. Slick et al. criteria for malingered neurocognitive dysfunction were employed for clinical determination of the validity of participants' neuropsychological profiles, resulting in 16 valid and four suboptimal performers. Main outcomes and results: Valid performers obtained significantly greater scores than suboptimal performers on all trials of the TOMM and generally demonstrated less impairment across neuropsychological domains. The traditional cut-off score for the TOMM misclassified 18.8% of participants not suspected of malingering and lower levels of education appeared to reduce performance on this measure within the valid group. Conclusions: The current findings generally support the use of the TOMM with US primarily Spanish speaking patients diagnosed with TBI. However, caution is recommended when utilizing this measure with individuals having minimal levels of education. Future research with a larger sample and a non-neurological age-and education-matched sample should investigate lower cut-off scores for use with such patients.	[Strutt, Adriana M.; Scott, Bonnie M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Lozano, Veronica J.] TIRR Mem Hermann, Dept Psychol Neupsychol, Houston, TX USA		Strutt, AM (corresponding author), 6550 Fannin,Suite 1801, Houston, TX 77030 USA.	adrianam@bcm.edu	Peery, Shelley/AAA-8090-2019	Scott, Bonnie/0000-0002-4868-6238			Acevedo A, 2007, J CLIN EXP NEUROPSYC, V29, P530, DOI 10.1080/13803390600814740; [Anonymous], 2003, HDB REY OST COMPL FI; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Ardila A, 2003, HDB REY OSTERRIETH C; Artiola i Fortuny L, 1999, MANUAL NORMAS PROCED; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT, 1993, BECK ANXIETY INVENTO; Benedict, 2001, HOPKINS VERBAL LEARN; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Bureau. USC, 2006, AM COMM SURV DEM HOU; Bureau. USC, 2009, AM COMM SURV DEM HOU; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Duncan A, 2005, ASSESSMENT, V12, P123, DOI 10.1177/1073191105275512; Ediciones T, 2004, WMS 3 ESCALA MEMORIA; Ediciones T, 2001, WAIS 3 ESCALA INTELI; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moderno EEM, 2003, WAIS 3 ESCALA WECHSL; Ostrosky-Solis F, 2003, NEUROPSY ATENCION ME; Ostrosky-Solis F, 1997, NEUROPSI EVALUACION; Ramirez RM, 2004, REV NEUROLOGIA, V38, P28, DOI 10.33588/rn.3801.2003533; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reyes B, 2009, DISS ABSTR INT A, V70, P1; Schmidt M., 1996, REY AUDITORY VERBAL; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P109, DOI 10.1076/clin.16.2.109.13237; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vilar-Lopez R, 2008, J CLIN EXP NEUROPSYC, V30, P710, DOI 10.1080/13803390701684562; Vilar-Lopez R, 2008, ARCH CLIN NEUROPSYCH, V23, P365, DOI 10.1016/j.acn.2008.01.007; Vilar-Lopez R, 2007, ARCH CLIN NEUROPSYCH, V22, P379, DOI 10.1016/j.acn.2007.01.012	41	19	19	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2012	26	6					853	863		10.3109/02699052.2012.655366			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500007	22583176				2022-02-06	
J	Wu, XM; Jin, W; Liu, XJ; Fu, HR; Gong, PP; Xu, J; Cui, G; Ni, YH; Ke, KF; Gao, ZW; Gao, YL				Wu, Xinmin; Jin, Wei; Liu, Xiaojuan; Fu, Hongran; Gong, Peipei; Xu, Jian; Cui, Gang; Ni, Yaohui; Ke, Kaifu; Gao, Zhiwei; Gao, Yilu			Cyclic AMP Response Element Modulator-1 (CREM-1) Involves in Neuronal Apoptosis after Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						CREM-1; Traumatic brain injury; Apoptosis; Rat; CREB	TRANSCRIPTION FACTORS; BCL-2 EXPRESSION; GENE-EXPRESSION; CELL-DEATH; IN-VITRO; CREB; PROTEINS; BINDING; RAT; PROLIFERATION	The cyclic AMP response element-binding protein (CREB) family can regulate biological functions of various types of cells by forming homo- or heterodimers to bind the target DNA sequences; it plays an essential role in individual neuronal function and entire neuronal circuits. One attractive activity of the CREB family is regulating the transcription of apoptosis-suppressor gene bcl-2. Cyclic AMP response element modulator-1 (CREM-1) is one member of the family with limited acquaintance. To investigate whether CREM-1 is involved in central nervous system injury and repair, we performed an acute traumatic brain injury (TBI) model in adult rats. Western blot analysis and immunohistochemistry showed a significant upregulation of CREM-1 in ipsilateral peritrauma cortex. Immunofluorescent labeling indicated that CREM-1 was localized mainly in the nuclei of neurons; co-localization of CREM-1 and active-caspase-3 in the ipsilateral cortex suggested that CREM-1 might participate in neuronal apoptosis. To further investigate the function of CREM-1, a neuronal cell line PC12 was employed to establish an apoptosis model. We analyzed the association of CREM-1 with p-CREB on PC12 cells by Western blot, immunofluorescent labeling, and co-immunoprecipitation. The result implied that the association of CREM-1 with p-CREB was enhanced in apoptotic cells. Additionally, knocking CREM-1 down with siRNA demonstrated the probable pro-apoptotic role played by CREM-1 in neuronal apoptosis. Together with our data, we hypothesized that CREM-1 might play an important role in regulating neuronal death after TBI by interacting with CREB.	[Wu, Xinmin; Jin, Wei; Fu, Hongran; Gong, Peipei; Cui, Gang; Ni, Yaohui; Ke, Kaifu; Gao, Zhiwei] Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China; [Liu, Xiaojuan] Nantong Univ, Dept Immunol, Coll Med, Nantong 226001, Jiangsu, Peoples R China; [Xu, Jian] Nantong Univ, Dept Psychiat, Peoples Hosp 4, Nantong 226001, Jiangsu, Peoples R China; [Gao, Yilu] Nantong Univ, Dept Neurosurg, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China		Gao, ZW (corresponding author), Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.	gzw1956@163.com; yilugao@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070992]; Nantong University	This study was supported by the National Natural Science Foundation of China (No. 81070992) and funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Nantong University graduate scientific and technological innovation projects.	Allagnat F, 2005, J CELL SCI, V118, P5335, DOI 10.1242/jcs.02600; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Balasubramanian G, 2000, TOXICOL APPL PHARM, V169, P142, DOI 10.1006/taap.2000.9061; Barco A, 2011, MOL NEUROBIOL, V44, P330, DOI 10.1007/s12035-011-8209-x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Dey S, 2007, NEUROSCIENCE, V144, P509, DOI 10.1016/j.neuroscience.2006.09.047; Engel T, 2011, J CEREBR BLOOD F MET, V31, P1196, DOI 10.1038/jcbfm.2011.26; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Guo Z, 1998, J NEUROSCI, V18, P8163; Haddad JJ, 2007, PROTEIN PEPTIDE LETT, V14, P361, DOI 10.2174/092986607780363925; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Jaworski J, 2003, J NEUROSCI, V23, P4519; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LOGAN A, 1992, J NEUROSCI, V12, P3828; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; RINK A, 1995, AM J PATHOL, V147, P1575; Saggioro D, 2011, VIRUSES-BASEL, V3, P1001, DOI 10.3390/v3071001; Sawka-Verhelle D, 2004, J BIOL CHEM, V279, P17772, DOI 10.1074/jbc.M311991200; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Shankar E, 2010, INT J ONCOL, V36, P883, DOI 10.3892/ijo_00000566; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131	38	19	20	1	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696			J MOL NEUROSCI	J. Mol. Neurosci.	JUN	2012	47	2					357	367		10.1007/s12031-012-9761-1			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	949HQ	WOS:000304567700015					2022-02-06	
J	Diringer, MN; Scalfani, MT; Zazulia, AR; Videen, TO; Dhar, R; Powers, WJ				Diringer, Michael N.; Scalfani, Michael T.; Zazulia, Allyson R.; Videen, Tom O.; Dhar, Rajat; Powers, William J.			Effect of Mannitol on Cerebral Blood Volume in Patients With Head Injury	NEUROSURGERY			English	Article						Cerebral blood flow; Cerebral blood volume; Mannitol; Osmotic	POSITRON EMISSION TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; INTRAVENOUS (H2O)-O-15; O-15 RADIOTRACERS; WATER-CONTENT; HYPERVENTILATION; FLOW; MANAGEMENT	BACKGROUND: Mannitol has traditionally been the mainstay of medical therapy for intracranial hypertension in patients with head injury. We previously demonstrated that mannitol reduces brain volume in patients with cerebral edema, although whether this occurs because of a reduction in brain water, blood volume, or both remains poorly understood. OBJECTIVE: To test the hypothesis that mannitol acts by lowering blood viscosity leading to reflex vasoconstriction and a fall in cerebral blood volume (CBV). METHODS: We used O-15 positron emission tomography to study 6 patients with traumatic brain injuries requiring treatment for intracranial hypertension. Cerebral blood flow (CBF), CBV, and cerebral metabolic rate for oxygen (CMRO2) were measured before and 1 hour after administration of 1.0 g/kg 20% mannitol. RESULTS: CBV rose from 4.1 +/- 0.4 to 4.2 +/- 0.2 mL/100 g (P = .3), while intracranial pressure fell from 21.5 +/- 4.9 to 13.7 +/- 5.1 mm Hg (P < .003) after mannitol. Blood pressure, PaCO2, oxygen content, CBF, and CMRO2 did not change. CONCLUSION: A single bolus of 1 g/kg of 20% mannitol does not acutely lower CBV. Another mechanism, such as a reduction in brain water, may better explain mannitol's ability to lower intracranial pressure and reduce mass effect.	[Diringer, Michael N.; Scalfani, Michael T.; Zazulia, Allyson R.; Videen, Tom O.; Dhar, Rajat] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Diringer, Michael N.; Scalfani, Michael T.; Zazulia, Allyson R.; Videen, Tom O.; Dhar, Rajat] Washington Univ, Sch Med, Dept Neurol Surg, Neurol Neurosurg Intens Care Unit, St Louis, MO 63110 USA; [Zazulia, Allyson R.; Videen, Tom O.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Powers, William J.] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USA		Diringer, MN (corresponding author), Washington Univ, Sch Med, Dept Neurol, Campus Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	diringerm@wustl.edu	Diringer, Michael N/C-1165-2008	Diringer, Michael N/0000-0003-2337-5537; Dhar, Rajat/0000-0002-5167-5097	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS035966]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS035966, P01NS035966] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grant NS035966. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; CASCINO T, 1983, NEUROLOGY, V33, P898, DOI 10.1212/WNL.33.7.898; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; DONATO T, 1994, ANESTH ANALG, V78, P58; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; INAO S, 1990, ACT NEUR S, V51, P401; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; Lin WL, 1997, MAGNET RESON MED, V38, P420, DOI 10.1002/mrm.1910380311; Manno EM, 1999, NEUROLOGY, V52, P583, DOI 10.1212/WNL.52.3.583; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARTIN WRW, 1987, J CEREBR BLOOD F MET, V7, P421, DOI 10.1038/jcbfm.1987.85; MCGRAW CP, 1978, SURG NEUROL, V10, P127; MINTUN MA, 1984, J NUCL MED, V25, P177; Monro A., 1783, OBSERVATIONS STRUCTU; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; NATH F, 1986, J NEUROSURG, V65, P41, DOI 10.3171/jns.1986.65.1.0041; RAICHLE ME, 1983, J NUCL MED, V24, P790; RAVUSSIN P, 1985, CAN ANAESTH SOC J, V32, P506, DOI 10.1007/BF03010801; ROBERTS PA, 1987, J NEUROSURG, V66, P440, DOI 10.3171/jns.1987.66.3.0440; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; ROSNER MJ, 1995, NEUROSURG CLIN N AM, V6, P761; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Videen TO, 2001, NEUROLOGY, V57, P2120, DOI 10.1212/WNL.57.11.2120; VIDEEN TO, 1987, J CEREBR BLOOD F MET, V7, P513, DOI 10.1038/jcbfm.1987.97	26	19	20	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	2012	70	5					1215	1218		10.1227/NEU.0b013e3182417bc2			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	933VA	WOS:000303390400044	22089753	Bronze, Green Accepted			2022-02-06	
J	Kosty, J; Macyszyn, L; Lai, K; McCroskery, J; Park, HR; Stein, SC				Kosty, Jennifer; Macyszyn, Luke; Lai, Kevin; McCroskery, James; Park, Hae-Ran; Stein, Sherman C.			Relating Quality of Life to Glasgow Outcome Scale Health States	JOURNAL OF NEUROTRAUMA			English	Article						comparative effectiveness research; decision analysis; Glasgow Outcome Scale; standard gamble; quality of life	TRAUMATIC BRAIN-INJURY; 1ST 5 YEARS; HEAD-INJURY; QOLIBRI; UTILITY; SATISFACTION; DISABILITY; INTERVIEWS; MANAGEMENT; MORTALITY	There has recently been a call for the adoption of comparative effectiveness research (CER) and related research approaches for studying traumatic brain injury (TBI). These methods allow researchers to compare the effectiveness of different therapies in producing patient-oriented outcomes of interest. Heretofore, the only measures by which to compare such therapies have been mortality and rate of poor outcome. Better comparisons can be made if parametric, preference-based quality-of-life (QOL) values are available for intermediate outcomes, such as those described by the Glasgow Outcome Scale Extended (GOSE). Our objective was therefore to determine QOL for the health states described by the GOSE. We interviewed community members at least 18 years of age using the standard gamble method to assess QOL for descriptions of GOSE scores of 2-7 derived from the structured interview. Linear regression analysis was also performed to assess the effect of age, gender, and years of education on QOL. One hundred and one participants between the ages of 18 and 83 were interviewed (mean age 40 +/- 19 years), including 55 men and 46 women. Functional impairment and QOL showed a strong inverse relationship, as assessed by both linear regression and the Spearman rank order coefficient. No consistent effect or age, gender, or years of education was seen. As expected, QOL decreased with functional outcome as described by the GOSE. The results of this study will provide the groundwork for future groups seeking to apply CER methods to clinical studies of TBI.	[Kosty, Jennifer; Macyszyn, Luke; Lai, Kevin; McCroskery, James; Park, Hae-Ran; Stein, Sherman C.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Stein, SC (corresponding author), Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.	sherman.stein@uphs.upenn.edu					Aoki N, 1998, MED DECIS MAKING, V18, P357, DOI 10.1177/0272989X9801800401; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Drummond J., 2000, METHODS EC EVALUATIO; Faul M, 2010, TRAUMATIC BRAIN INJU; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Finkelstein E., 2006, INCIDENCE EC BURDEN; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; Gold M., 1996, COST EFFECTIVENESS H; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hallan S, 1999, J INTERN MED, V246, P309, DOI 10.1046/j.1365-2796.1999.00531.x; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hillier SL, 1997, BRAIN INJURY, V11, P661; HOFFMANN KJ, 1984, EUR J DRUG METAB PH, V9, P215, DOI 10.1007/BF03189644; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kinsella G, 1989, Int Disabil Stud, V11, P9; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lu J, 2005, ACT NEUR S, V95, P281; Maas A., 2011, J NEUROTRAUM, V28, P1; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Post PN, 2001, STROKE, V32, P1425, DOI 10.1161/01.STR.32.6.1425; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; RICHARDSON J, 1994, SOC SCI MED, V39, P7, DOI 10.1016/0277-9536(94)90162-7; Rosen AB, 2003, MED DECIS MAKING, V23, P511, DOI 10.1177/0272989X03258431; ROSSER R, 1978, INT J EPIDEMIOL, V7, P347, DOI 10.1093/ije/7.4.347; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; Sox HC, 2007, MED DECISION MAKING; Stein S. C., 1996, NEUROTRAUMA, P31; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; TEMKIN N, 1988, J CLIN EPIDEMIOL, V41, P47, DOI 10.1016/0895-4356(88)90008-X; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Truelle JL, 2008, ACTA NEUROCHIR SUPPL, V101, P125; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Van Wijck EEE, 1998, MED DECIS MAKING, V18, P400, DOI 10.1177/0272989X9801800407; von Neumann J., 1953, THEORY GAMES EC BEHA; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	54	19	21	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1322	1327		10.1089/neu.2011.2222			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600005	22339668				2022-02-06	
J	Schmidt, AT; Hanten, GR; Li, XQ; Vasquez, AC; Wilde, EA; Chapman, SB; Levin, HS				Schmidt, Adam T.; Hanten, Gerri R.; Li, Xiaoqi; Vasquez, Ana C.; Wilde, Elisabeth A.; Chapman, Sandra B.; Levin, Harvey S.			Decision making after pediatric traumatic brain injury: trajectory of recovery and relationship to age and gender	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Child; TBI; Adolescent risk; Gambling task; Decision making	VENTROMEDIAL PREFRONTAL CORTEX; IOWA GAMBLING TASK; CHILDHOOD HEAD-INJURY; WORKING-MEMORY; SHORT-TERM; CHILDREN; PERFORMANCE; ADOLESCENTS; PERSONALITY; SEVERITY	The aim of the study was to examine longitudinal patterns of decision making based on risk and reward using a modified version of the Iowa Gambling Task (IGT) in children who had sustained traumatic brain injury (TBI) and children with orthopedic injury (01). Participants were 135 children and adolescents with TB! (n = 71) or 01 (n = 64) who were 7-17 years at the time of injury were enrolled and assessed prospectively at baseline and at follow-up intervals of 3, 12, 18, and 24 months after injury. Groups were similar in age, socioeconomic status, and gender. Participants chose from four decks of cards with the aim of maximizing earnings across 100 trials. Two of the decks offered relatively small rewards and relatively small losses, but were advantageous over the course of the experiment. The other two decks offered large rewards, but also introduced occasional large losses, and were considered disadvantageous over the course of the experiment. The variable of interest was the proportion of advantageous decks chosen across trials. Longitudinal analysis of the pattern of change across 2 years revealed a three-way interaction among injury group, age, and the quadratic term of interval-since-injury. In this interaction, the effect of age weakened in the TBI group across time, as compared to the 01 group, which showed stronger quadratic patterns across the recovery intervals that differed by age. The 01 group generally outperformed the TBI group. In addition, analyses revealed a three-way interaction among group, gender and the cubic term of post-injury interval, such that overall, males improved a great deal with time, but females showed small gains, regardless of injury group. (C) 2011 ISDN. Published by Elsevier Ltd. All rights reserved.	[Schmidt, Adam T.; Hanten, Gerri R.; Li, Xiaoqi; Vasquez, Ana C.; Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Hanten, Gerri R.] Rice Univ, Houston, TX 77251 USA; [Chapman, Sandra B.] Univ Texas Dallas, Ctr BrainHlth, Richardson, TX 75083 USA		Hanten, GR (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	ghanten@bcm.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This research was supported by Grant Number R01NS021889 from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health.	Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Crone EA, 2005, CHILD NEUROPSYCHOL, V11, P245, DOI 10.1080/092970490911261; Crone EA, 2004, DEV NEUROPSYCHOL, V25, P251, DOI 10.1207/s15326942dn2503_2; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Garon N, 2004, BRAIN COGNITION, V55, P158, DOI 10.1016/s0278-2626(03)00272-0; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hanten G, 2006, NEUROCASE, V12, P247, DOI 10.1080/13554790600910490; Hooper CJ, 2008, PERS INDIV DIFFER, V44, P598, DOI 10.1016/j.paid.2007.09.021; Hooper CJ, 2004, DEV PSYCHOL, V40, P1148, DOI 10.1037/0012-1649.40.6.1148; Huizenga HM, 2007, DEVELOPMENTAL SCI, V10, P814, DOI 10.1111/j.1467-7687.2007.00621.x; Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6; Kim YT, 2006, ALCOHOL CLIN EXP RES, V30, P466, DOI 10.1111/j.1530-0277.2006.00051.x; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Krueger RF, 2011, ARCH GEN PSYCHIAT, V68, P10, DOI 10.1001/archgenpsychiatry.2010.188; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levin IP, 2003, J BEHAV DECIS MAKING, V16, P397, DOI 10.1002/bdm.453; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Romer D, 2009, NEUROPSYCHOLOGIA, V47, P2916, DOI 10.1016/j.neuropsychologia.2009.06.019; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Suhr JA, 2007, PERS INDIV DIFFER, V43, P27, DOI 10.1016/j.paid.2006.11.004; TEASDALE G, 1974, LANCET, V2, P81; Van Leijenhorst L, 2008, DEV NEUROPSYCHOL, V33, P179, DOI 10.1080/87565640701884287; van Leijenhorst L, 2006, NEUROPSYCHOLOGIA, V44, P2158, DOI 10.1016/j.neuropsychologia.2006.02.002; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	40	19	20	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748			INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	MAY	2012	30	3			SI		225	230		10.1016/j.ijdevneu.2011.11.003			6	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Developmental Biology; Neurosciences & Neurology	936XH	WOS:000303622800008	22138008	Green Accepted			2022-02-06	
J	Teranishi, K; Scultetus, A; Haque, A; Stern, S; Philbin, N; Rice, J; Johnson, T; Auker, C; McCarron, R; Freilich, D; Arnaud, F				Teranishi, Kohsuke; Scultetus, Anke; Haque, Ashraful; Stern, Susan; Philbin, Nora; Rice, Jennifer; Johnson, Todd; Auker, Charles; McCarron, Richard; Freilich, Daniel; Arnaud, Francoise			Traumatic brain injury and severe uncontrolled haemorrhage with short delay pre-hospital resuscitation in a swine model	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Haemoglobin-based oxygen carrier; Polytrauma; Haemorrhagic shock; Traumatic brain injury; Resuscitation	CEREBRAL BLOOD-FLOW; POLYMERIZED HEMOGLOBIN HBOC-201; CARRYING SOLUTION HBOC-201; LOW-VOLUME RESUSCITATION; INTRACRANIAL-PRESSURE; OXYGEN CARRIER; FLUID RESUSCITATION; PORCINE MODEL; HEAD-INJURY; SHOCK	Introduction: Unavailability of blood (and oxygen delivery) for pre-hospital resuscitation in haemorrhagic shock patients are major problems, supporting the importance for novel resuscitation strategies. In a combined polytrauma model of uncontrolled haemorrhage and traumatic brain injury (TBI) in swine, we investigated if pre-hospital administration of the haemoglobin based oxygen carrier HBOC-201 will improve tissue oxygenation and physiologic parameters compared to Lactated Ringer's (LR) solution. Materials and methods: Anaesthetised Yorkshire swine underwent fluid-percussion TBI and Grade III liver laceration. During a 30-min pre-hospital phase, the animals were resuscitated with a single infusion of HBOC-201, LR solution, or nothing (NON). Upon hospital arrival, the animals were given blood or normal saline as needed. Surviving animals were euthanised 6 h post-injury. Cerebral blood flow was measured by microsphere injection, and pathology was assessed by gross observation and immunohistochemical analysis. Results: Mean TBI force (2.4 +/- 0.1 atm) (means +/- standard error of the mean) and blood loss (22.5 +/- 1.7 mL/kg) were similar between groups. Survival at the 6 h endpoint was similar in all groups (similar to 50%). Cerebral perfusion pressure (CPP) and brain tissue oxygen tension were significantly greater in HBOC-201 as compared with LR animals (p < 0.005). Mean arterial pressure (MAP) and mean pulmonary artery pressure (MPAP) were not significantly different amongst groups. Blood transfusion requirements were delayed in HBOC-201 animals. Animals treated with HBOC-201 or LR showed no immunohistopathological differences in glial fibrillary acidic protein (GFAP) and microtubule-associated protein 2 (MAP-2). Severity of subarachnoid and intraparenchymal haemorrhages were similar for HBOC and LR groups. Conclusion: In this polytrauma swine model of uncontrolled haemorrhage and TBI with a 30-min delay to hospital arrival, pre-hospital resuscitation with one bolus of HBOC-201 indicated short term benefits in systemic and cerebrovascular physiological parameters. True clinical benefits of this strategy need to be confirmed on TBI and haemorrhagic shock patients. (C) 2010 Elsevier Ltd. All rights reserved.	[Arnaud, Francoise] USN, Med Res Ctr, Operat & Undersea Med Directorate, NeuroTrauma Dept, Silver Spring, MD 20910 USA; [Teranishi, Kohsuke] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan; [Scultetus, Anke; McCarron, Richard; Freilich, Daniel; Arnaud, Francoise] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Stern, Susan] Univ Washington, Dept Emergency, Seattle, WA 98195 USA; [Johnson, Todd] Walter Reed Army Inst Res, Dept Pathol, Silver Spring, MD USA		Arnaud, F (corresponding author), USN, Med Res Ctr, Operat & Undersea Med Directorate, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Francoise.Arnaud@med.navy.mil			Naval Medical Research Center, Silver Spring, MD; DoD Work Unit [604771N.9737.001.A0315]	This work was performed at Naval Medical Research Center, Silver Spring, MD and was supported by funding from DoD Work Unit No. 604771N.9737.001.A0315. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U. S. Government.	Arnaud F, 2007, TRANSFUSION, V47, P2098, DOI 10.1111/j.1537-2995.2007.01435.x; Asano Y, 1998, AM J PHYSIOL-HEART C, V275, pH1313, DOI 10.1152/ajpheart.1998.275.4.H1313; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GUNNAR W, 1988, SURGERY, V103, P398; Gurney J, 2004, J TRAUMA, V57, P726, DOI 10.1097/01.TA.0000147520.84792.B4; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Katz LM, 2002, RESUSCITATION, V54, P77, DOI 10.1016/S0300-9572(02)00053-9; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee SK, 2002, ACAD EMERG MED, V9, P969; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ortegon DP, 2002, J TRAUMA, V53, P1068, DOI 10.1097/00005373-200212000-00007; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Rebel A, 2002, AM J PHYSIOL-HEART C, V282, pH832, DOI 10.1152/ajpheart.00880.2001; Rice J, 2008, J TRAUMA, V64, P1240, DOI 10.1097/TA.0b013e318058245e; Rice J, 2006, J TRAUMA, V61, P1085, DOI 10.1097/01.ta.0000236640.62893.fa; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Sampson JB, 2003, J TRAUMA, V55, P747, DOI 10.1097/01.TA.0000084519.47163.77; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Stern S, 2008, SHOCK; STERN S, 1996, ACAD EMERG MED, V3, P545; STERN SA, 1995, ACAD EMERG MED, V2, P89, DOI 10.1111/j.1553-2712.1995.tb03167.x; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Talmor D, 1999, ANESTH ANALG, V89, P950, DOI 10.1097/00000539-199910000-00024; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; York GB, 2003, J TRAUMA, V55, P873, DOI 10.1097/01.TA.0000092681.17874.6F; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; [No title captured]	38	19	20	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2012	43	5					585	593		10.1016/j.injury.2010.09.042			9	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	918RC	WOS:000302267100008	21036354				2022-02-06	
J	Courtney, AC; Andrusiv, LP; Courtney, MW				Courtney, Amy C.; Andrusiv, Lubov P.; Courtney, Michael W.			Oxy-acetylene driven laboratory scale shock tubes for studying blast wave effects	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article							TRAUMATIC BRAIN-INJURY; MODEL	This paper describes the development and characterization of modular, oxy-acetylene driven laboratory scale shock tubes. Such tools are needed to produce realistic blast waves in a laboratory setting. The pressure-time profiles measured at 1 MHz using high-speed piezoelectric pressure sensors have relevant durations and show a true shock front and exponential decay characteristic of free-field blast waves. Descriptions are included for shock tube diameters of 27-79 mm. A range of peak pressures from 204 kPa to 1187 kPa (with 0.5-5.6% standard error of the mean) were produced by selection of the driver section diameter and distance from the shock tube opening. The peak pressures varied predictably with distance from the shock tube opening while maintaining both a true blast wave profile and relevant pulse duration for distances up to about one diameter from the shock tube opening. This shock tube design provides a more realistic blast profile than current compression-driven shock tubes, and it does not have a large jet effect. In addition, operation does not require specialized personnel or facilities like most blast-driven shock tubes, which reduces operating costs and effort and permits greater throughput and accessibility. It is expected to be useful in assessing the response of various sensors to shock wave loading; assessing the reflection, transmission, and absorption properties of candidate armor materials; assessing material properties at high rates of loading; assessing the response of biological materials to shock wave exposure; and providing a means to validate numerical models of the interaction of shock waves with structures. All of these activities have been difficult to pursue in a laboratory setting due in part to lack of appropriate means to produce a realistic blast loading profile. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.3702803]	[Courtney, Amy C.] Force Protect Ind Inc, R&D, Ladson, SC 29456 USA; [Andrusiv, Lubov P.; Courtney, Michael W.] USAF Acad, Colorado Springs, CO 80840 USA		Courtney, AC (corresponding author), Force Protect Ind Inc, R&D, 9801 Highway 78, Ladson, SC 29456 USA.	amy_courtney@post.harvard.edu		Courtney, Amy/0000-0002-1925-8736	BTG Research	This work was supported in part by BTG Research, www.btgresearch.org.	Alley M., 2009, THESIS PURDUE U W LA; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Courtney MW, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3518970; DUFF RE, 1966, REV SCI INSTRUM, V37, P579, DOI 10.1063/1.1720256; Henshall B. D., 1957, AERONAUTICAL RES COU, V3044; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Richmond D. R., 1966, 1854 DASA; Risling Marten, 2010, Front Neurol, V1, P1, DOI 10.3389/fneur.2010.00001; Segars R. A., 2008, NATICKTR09010 US ARM; Snyder A, 1965, AFAPLTR6593; Wang ZG, 1998, CHINESE MED J-PEKING, V111, P109	17	19	21	0	15	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0034-6748			REV SCI INSTRUM	Rev. Sci. Instrum.	APR	2012	83	4							045111	10.1063/1.3702803			7	Instruments & Instrumentation; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Instruments & Instrumentation; Physics	934BO	WOS:000303415300073	22559580	Green Submitted			2022-02-06	
J	Helton, WS; Head, J				Helton, William S.; Head, James			Earthquakes on the Mind: Implications of Disasters for Human Performance	HUMAN FACTORS			English	Article						attention; disaster; earthquake; response inhibition; stress; sustained attention; vigilance	TRAUMATIC BRAIN-INJURY; SUSTAINED ATTENTION; TARGET DETECTION; TASK; VIGILANCE; DEPRESSION; DISORDER; FAILURES; VALIDITY; STIMULI	Objective: The present study explored the impact a natural disaster has on human performance. Background: Previous research indicates that traffic accidents increase after disasters. A plausible explanation for this finding is that disasters induce cognitive disruption and this disruption negatively affects performance (e.g., driving quality). Method: A total of 16 participants (7 men and 9 women) performed a sustained-attention-to-response task before and after a 7.1-magnitude earthquake. Performance (errors of omission, errors of commission, and reaction time) was compared before and after the earthquake. Results: Errors of omission increased after the earthquake. Changes in errors of commission and reaction times were, however, dependent on individual differences in stress response to the earthquake. Conclusion: The results indicate that natural disasters may have a negative impact on performance. Application: Communities need to be aware of the increased risk of accidents following disasters and develop countermeasures, including individualized assessment tools.	[Helton, William S.] Univ Canterbury, Dept Psychol, Christchurch 8140, New Zealand		Helton, WS (corresponding author), Univ Canterbury, Dept Psychol, Private Bag 4800, Christchurch 8140, New Zealand.	Deak.Helton@canterbury.ac.nz					Bergiannaki JD, 2003, ACTA PSYCHIAT SCAND, V107, P18, DOI 10.1034/j.1600-0447.2003.01467.x; CARDENA E, 1993, AM J PSYCHIAT, V150, P474; Chan RCK, 2001, BRAIN INJURY, V15, P819, DOI 10.1080/02699050110034325; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; COLQUHOUN WP, 1970, HUM FACTORS, V12, P537, DOI 10.1177/001872087001200603; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Gigerenzer G, 2004, PSYCHOL SCI, V15, P286, DOI 10.1111/j.0956-7976.2004.00668.x; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Helton WS, 2008, ACTA PSYCHOL, V129, P18, DOI 10.1016/j.actpsy.2008.04.002; Helton WS, 2011, HUM FACTORS, V53, P132, DOI 10.1177/0018720811401385; Helton WS, 2011, EXP BRAIN RES, V209, P401, DOI 10.1007/s00221-011-2563-9; Helton WS, 2010, BRAIN COGNITION, V74, P75, DOI 10.1016/j.bandc.2010.06.008; Helton WS, 2010, CONSCIOUS COGN, V19, P77, DOI 10.1016/j.concog.2010.01.006; Helton WS, 2009, CONSCIOUS COGN, V18, P600, DOI 10.1016/j.concog.2009.06.002; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P630, DOI 10.1016/j.neuropsychologia.2006.03.034; Kemp S., AUSTR J DIS IN PRESS; Mcvay JC, 2010, PSYCHOL BULL, V136, P188, DOI 10.1037/a0018298; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Ossowski U, 2011, CONSCIOUS COGN, V20, P1649, DOI 10.1016/j.concog.2011.08.015; PARASURAMAN R, 1991, PSYCHOL AGING, V6, P155, DOI 10.1037/0882-7974.6.2.155; Peebles D, 2004, PROCEEDINGS OF THE SIXTH INTERNATIONAL CONFERENCE ON COGNITIVE MODELING, P231; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2010, PSYCHOL BULL, V136, P202, DOI 10.1037/a0018673; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Stecklov G, 2004, P NATL ACAD SCI USA, V101, P14551, DOI 10.1073/pnas.0402483101; Su JC, 2009, PSYCHOL SCI, V20, P59, DOI 10.1111/j.1467-9280.2008.02257.x; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012	37	19	19	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0018-7208	1547-8181		HUM FACTORS	Hum. Factors	APR	2012	54	2					189	194		10.1177/0018720811430503			6	Behavioral Sciences; Engineering, Industrial; Ergonomics; Psychology, Applied; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Engineering; Psychology	915FJ	WOS:000302009200003	22624286				2022-02-06	
J	Kim, HB; Kim, DK; Kwak, YH; Shin, SD; Song, KJ; Lee, SC; Park, JO; Jang, HY; Kim, SC				Kim, Hahn Bom; Kim, Do Kyun; Kwak, Young Ho; Shin, Sang Do; Song, Kyoung Jun; Lee, Seung Chul; Park, Ju Ok; Jang, Hye Young; Kim, Seong Chun			Epidemiology of Traumatic Head Injury in Korean Children	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Epidemiology; Head Trauma; Pediatrics	BRAIN-INJURY; UNITED-STATES; COMPUTED-TOMOGRAPHY; AGE	The aim of this study was to elucidate the epidemiology of traumatic head injury (THI) among Korean children. A prospective, in-depth trauma survey was conducted in five teaching hospitals. Data from all of the children who attended the emergency department (ED) were analyzed. From June 2008 to May 2009, 2,856 children with THI visited the 5 EDs. The average age of the subjects was 5.6 (SD +/- 4.9) yr old, and 1,585 (55.5%) were 0-4 yr old. The male-to-female ratio was 2.3 to 1 (1,979 vs 877). Consciousness levels of the subjects were classified according to the Glasgow Coma Scale (GCS), and 99.1%, 0.6%, and 0.4% were determined as mild, moderate, or severe injury, respectively, according to the GCS categorization. Most injuries occurred at home (51.3%), and the most common mechanism of injury was collision (43.2%). With regard to outcome, 2,682 (93.9%) patients were sent home, and 35 (1.2%) were transferred to another hospital. A total of 133 (4.7%) patients were hospitalized, and 38 (1.3%) underwent surgery. The incidence and characteristics of pediatric THI in Korea are affected by sex, location and injury mechanism.	[Kim, Do Kyun; Kwak, Young Ho; Shin, Sang Do] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul 110744, South Korea; [Kim, Hahn Bom; Song, Kyoung Jun] Seoul Natl Univ, Boramae Med Ctr, Dept Emergency Med, Seoul 110744, South Korea; [Lee, Seung Chul] Dongguk Univ, Coll Med, Dept Emergency Med, Goyang, South Korea; [Park, Ju Ok] Cheju Natl Univ, Sch Med, Dept Emergency Med, Cheju, South Korea; [Jang, Hye Young] Soonchunhyang Univ, Seoul Hosp, Dept Emergency Med, Seoul, South Korea; [Kim, Seong Chun] Gyeongsang Natl Univ, Sch Med, Dept Emergency Med, Jinju, South Korea		Kim, DK (corresponding author), Seoul Natl Univ, Coll Med, Dept Emergency Med, 101 Daehak Ro, Seoul 110744, South Korea.	birdbeak@snuh.org	KIM, KYUN/Q-3070-2018; Shin, Sang/J-5523-2012; Kwak, Young Ho/J-5373-2012	KIM, KYUN/0000-0002-6144-302X; Kwak, Young Ho/0000-0003-2062-7575			Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; BERNEY J, 1994, CHILD NERV SYST, V10, P509, DOI 10.1007/BF00335073; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Hawkins ER, 2007, PEDIATR EMERG CARE, V23, P790, DOI 10.1097/PEC.0b013e318159ffd9; Kim JK, 1998, J KOREAN NEUROSURG S, V27, P625; Korean Statistical Information Service, 2009, ANN REP CAUS DEATH S; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee KW, 1999, J KOREAN NEUROSURG S, V28, P42; Nagaraja J, 2005, PEDIATRICS, V116, P454, DOI 10.1542/peds.2004-1415; National Center for Health Statistics; National Vital Statistics Reports, NAT VIT STAT REP; National Center for Injury Prevention and Control, TRAUM BRAIN INJ US E; National Center for Injury Prevention and Control, TRAUM BRAIN INJ US A; National Center for Injury Prevention and Control Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Park HS, CONSTRUCTION NATL SY; Ryu MS, 2006, J KOREAN CHILD NEURO, V14, P87; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; UNICEF, LEAG TABL CHILD DEAT; WHO-ICECI Coordination and Maintenance Group, 2004, TEST ICECI REV FIL T; Youn S, 2004, KOREAN J PEDIAT, V47, P1198	30	19	20	0	2	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934			J KOREAN MED SCI	J. Korean Med. Sci.	APR	2012	27	4					437	442		10.3346/jkms.2012.27.4.437			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922ZX	WOS:000302588800016	22468109	Green Published, gold			2022-02-06	
J	Matsushima, K; Peng, M; Velasco, C; Schaefer, E; Diaz-Arrastia, R; Frankel, H				Matsushima, Kazuhide; Peng, Monica; Velasco, Carlos; Schaefer, Eric; Diaz-Arrastia, Ramon; Frankel, Heidi			Glucose variability negatively impacts long-term functional outcome in patients with traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Glucose variability; Traumatic brain injury; Long-term functional outcome	INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; FASTING PLASMA-GLUCOSE; BLOOD-GLUCOSE; INDEPENDENT PREDICTOR; INCREASED MORTALITY; CARE-UNIT; HYPERGLYCEMIA; MANAGEMENT	Purpose: Significant glycemic excursions (so-called glucose variability) affect the outcome of generic critically ill patients but has not been well studied in patients with traumatic brain injury (TBI). The purpose of this study was to evaluate the impact of glucose variability on long-term functional outcome of patients with TBI. Material and Methods: A noncomputerized tight glucose control protocol was used in our intensivist model surgical intensive care unit. The relationship between the glucose variability and long-term (a median of 6 months after injury) functional outcome defined by extended Glasgow Outcome Scale (GOSE) was analyzed using ordinal logistic regression models. Glucose variability was defined by SD and percentage of excursion (POE) from the preset range glucose level. Results: A total of 109 patients with TBI under tight glucose control had long-term GOSE evaluated. In univariable analysis, there was a significant association between lower GOSE score and higher mean glucose, higher SD, POE more than 60, POE 80 to 150, and single episode of glucose less than 60 mg/dL but not POE 80 to 110. After adjusting for possible confounding variables in multivariable ordinal logistic regression models, higher SD, POE more than 60, POE 80 to 150, and single episode of glucose less than 60 mg/dL were significantly associated with lower GOSE score. Conclusions: Glucose variability was significantly associated with poorer long-term functional outcome in patients with TBI as measured by the GOSE score. Well-designed protocols to minimize glucose variability may be key in improving long-term functional outcome. (C) 2012 Elsevier Inc. All rights reserved.	[Matsushima, Kazuhide] Penn State Milton S Hershey Med Ctr, Dept Surg, Div Trauma Acute Care & Crit Care Surg, Hershey, PA 17036 USA; [Peng, Monica; Velasco, Carlos] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Schaefer, Eric] Penn State Milton S Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA 17036 USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Frankel, Heidi] R Adams CowleyUniv Maryland, Sch Med, Baltimore, MD 21201 USA		Matsushima, K (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Surg, Div Trauma Acute Care & Crit Care Surg, Hershey, PA 17036 USA.	kmatsushima@hmc.psu.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594			Ali NA, 2008, CRIT CARE MED, V36, P2316, DOI 10.1097/CCM.0b013e3181810378; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; ATKINSON EJ, 1997, TECHNICAL REPORT SER, V61; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cavalcanti AB, 2009, J CRIT CARE, V24, P371, DOI 10.1016/j.jcrc.2009.05.005; Egi M, 2008, CRIT CARE MED, V36, P2249, DOI 10.1097/CCM.0b013e318181039a; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gale SC, 2007, AM SURGEON, V73, P454; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9; Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401; Holzinger U, 2010, DIABETES CARE, V33, P467, DOI 10.2337/dc09-1352; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Kreutziger J, 2009, J TRAUMA, V67, P704, DOI 10.1097/TA.0b013e3181b22e37; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Monnier Louis, 2008, J Diabetes Sci Technol, V2, P1094; Muggeo M, 2000, DIABETES CARE, V23, P45, DOI 10.2337/diacare.23.1.45; Muggeo M, 1997, CIRCULATION, V96, P1750, DOI 10.1161/01.CIR.96.6.1750; Paddle JJ, 2011, ANAESTHESIA, V66, P92, DOI 10.1111/j.1365-2044.2010.06603.x; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Salim A, 2009, AM SURGEON, V75, P25; Suarez JI, 2009, J NEUROSURG ANESTH, V21, P52, DOI 10.1097/01.ana.0000343199.62838.02; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wahl WL, 2008, J TRAUMA, V65, P42, DOI 10.1097/TA.0b013e318176c54e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yoder J, 2009, J NEUROSURG ANESTH, V21, P55, DOI 10.1097/01.ana.0000343200.93263.a4	39	19	24	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2012	27	2					125	131		10.1016/j.jcrc.2011.08.012			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	918ZV	WOS:000302291300004	22033047				2022-02-06	
J	Olivecrona, Z; Koskinen, LOD				Olivecrona, Zandra; Koskinen, Lars-Owe D.			The release of S-100B and NSE in severe traumatic head injury is associated with APOE epsilon 4	ACTA NEUROCHIRURGICA			English	Article						Severe traumatic brain injury; APOE epsilon 4; S-100B; NSE	APOLIPOPROTEIN-E POLYMORPHISM; CEREBRAL AMYLOID ANGIOPATHY; BRAIN-INJURY; ALZHEIMERS-DISEASE; E GENOTYPE; SUBARACHNOID HEMORRHAGE; S-100-BETA; PATHOLOGY; ALLELES	In this article we tested the hypothesis that the level of two biochemical markers of brain injury may be associated with the apolipoprotein E (APOE) epsilon 4 allele. In this prospective consecutive study patients with sTBI were included (n = 48). Inclusion criteria were Glasgow Coma Scale (GCS) score a parts per thousand currency signaEuro parts per thousand 8 at the time of intubation and sedation, patient age between 15 and 70 years, an initial cerebral perfusion pressure > 10 mmHg, and arrival to our level-one trauma university hospital within 24 h after trauma. Blood samples for neuron-specific enolase (NSE) and S-100B were collected as soon as possibly after arrival, and then twice daily (12-h intervals) for 5 consecutive days. Venous blood was used for APOE genotype determination. Clinical outcome at 3 months after injury was assessed with the Extended Glasgow Outcome Scale (GOSE). Significantly higher levels of the maximal S-100B (S-100B(max)) and area under the curve (S-100B(AUC)) were found in subjects with the APOE epsilon 4 allele compared to those with non-epsilon 4. A similar tendency was observed for NSEmax and NSEAUC, though not statistically significant. Our data indicate that there might be a gene-induced susceptibility to severe traumatic brain injury and that patients with the APOE epsilon 4 allele may be more predisposed to brain cellular damage measured as S-100B and NSE. Thus, it seems to be of importance to consider the APOE genotype in interpreting the levels of the biomarkers.	[Olivecrona, Zandra; Koskinen, Lars-Owe D.] Umea Univ, Dept Pharmacol & Clin Neurosci, Sect Neurosurg, SE-90185 Umea, Sweden		Olivecrona, Z (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Sect Neurosurg, SE-90185 Umea, Sweden.	zandra.olivecrona@gmail.com; lars-owe.koskinen@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502	Department of Pharmacology and Clinical Neuroscience, Umea University; Tore Nilsson Foundation; Kempe Foundation; Capio Research Foundation	We acknowledge the staff at the intensive care unit and neurosurgical department, our research nurses Kristin Nyman and Anna-Lena Ostlund, and our colleagues Drs. Magnus Olivecrona, Silvana Naredi and Marie Rodling-Wahlstrom. Special thanks to Ann-Margret Kallberg at Sangtech Medical for assistance with the analysis of the biomarkers. Financial support from the Department of Pharmacology and Clinical Neuroscience, Umea University, the Tore Nilsson Foundation, Kempe Foundation and Capio Research Foundation is acknowledged.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Alfieri A, 2008, J NEUROSURG, V109, P1019, DOI 10.3171/JNS.2008.109.12.1019; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Juvela S, 2009, J NEUROSURG, V110, P989, DOI 10.3171/2008.11.JNS081266; Kalaria RN, 1996, ANN NY ACAD SCI, V777, P266, DOI 10.1111/j.1749-6632.1996.tb34430.x; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Kofke WA, 2004, ANESTH ANALG, V99, P1323, DOI 10.1213/01.ANE.0000135345.03635.6A; Leclercq PD, 2005, J NEUROL NEUROSUR PS, V76, P229, DOI 10.1136/jnnp.2003.025528; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Marshall, 1991, J NEUROSURG S, V75, pS14; McDonagh DL, 2010, ANESTHESIOLOGY, V112, P852, DOI 10.1097/ALN.0b013e3181d31fd7; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Miller MA, 2010, BRAIN INJURY, V24, P1468, DOI 10.3109/02699052.2010.520299; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Olivecrona M, 2010, J NEUROSURG, V112, P1113, DOI 10.3171/2009.8.JNS09636; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Premkumar DRD, 1996, AM J PATHOL, V148, P2083; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Quinn TJ, 2004, NEUROPATH APPL NEURO, V30, P569, DOI 10.1111/j.1365-2990.2004.00581.x; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91; Ytrebo LM, 2000, SCAND J GASTROENTERO, V35, P546	28	19	23	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	APR	2012	154	4					675	680		10.1007/s00701-012-1292-6			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	912IA	WOS:000301788900017	22322856				2022-02-06	
J	Arazpour, M; Chitsazan, A; Hutchins, SW; Ghomshe, FT; Mousavi, ME; Takamjani, EE; Aminian, G; Rahgozar, M; Bani, MA				Arazpour, Mokhtar; Chitsazan, Ahmad; Hutchins, Stephen W.; Ghomshe, Farhad Tabatabai; Mousavi, Mohammad Ebrahim; Takamjani, Esmaeil Ebrahimi; Aminian, Gholamreza; Rahgozar, Mehdi; Bani, Monireh Ahmadi			Design and simulation of a new powered gait orthosis for paraplegic patients	PROSTHETICS AND ORTHOTICS INTERNATIONAL			English	Article						Fabrication techniques; lower limb orthotics; paraplegia	FUNCTIONAL ELECTRICAL-STIMULATION; CONTROL WBC ORTHOSIS; SPINAL-CORD-INJURY; ENERGY-EXPENDITURE; WALKING; HIP; AMBULATION; PERFORMANCE; SYSTEM; JOINT	Background and Aim: This article describes the development and testing of a new powered gait orthosis to potentially assist spinal cord injury patients to walk by producing synchronized hip and knee joint movements. Technique: The first evaluation of the orthosis was performed without users, and was followed by evaluation of the orthosis performance using three healthy subjects to test the structure under weight-bearing conditions. The orthosis was primarily evaluated to ascertain its ability to generate appropriate hip and knee motion during walking. The walking experiments replicated the flexion and extension of both the hip and knee produced by the actuators which had previously been demonstrated during the initial computer simulations. Discussion: The results suggest that this new orthosis could be used to assist paraplegic subjects who have adequate ranges of motion and also with weakness or reduced tone to ambulate, and may also be suitable for other subjects with impaired lower limb function (e.g. stroke, poliomyelitis, myelomeningocele and traumatic brain injury provided they do not have increased tone or movement disorders.	[Arazpour, Mokhtar; Ghomshe, Farhad Tabatabai; Mousavi, Mohammad Ebrahim; Aminian, Gholamreza; Rahgozar, Mehdi; Bani, Monireh Ahmadi] Univ Social Welf & Rehabil Sci, Tehran, Iran; [Chitsazan, Ahmad] Amirkabir Univ Technol, Tehran, Iran; [Hutchins, Stephen W.] Univ Salford, Fac Hlth & Social Care, IHSCR, Salford M5 4WT, Lancs, England; [Takamjani, Esmaeil Ebrahimi] Univ Tehran Med Sci, Tehran, Iran		Arazpour, M (corresponding author), Univ Social Welf & Rehabil Sci, Tehran, Iran.	M.Arazpour@uswr.ac.ir	Bani, Monireh Ahmadi/D-9121-2017; aminian, gholamreza/D-9106-2017; rahgozar, mehdi/P-4913-2017; arazpour, Mokhtar/D-9132-2017; Ebrahimi-Takamjani, Ismail/P-3602-2018	ebrahimi, ismail/0000-0003-1784-0244; Ebrahimi-Takamjani, Ismail/0000-0002-5855-8432; Tabatabai Ghomsheh, Farhad/0000-0002-0754-0814			Audu ML, 2010, IEEE T NEUR SYS REH, V18, P610, DOI 10.1109/TNSRE.2010.2047594; BERNARDI M, 1995, PARAPLEGIA, V33, P409, DOI 10.1038/sc.1995.91; Dall PM, 1999, PROSTHET ORTHOT INT, V23, P152; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Franceschini M, 1997, ARCH PHYS MED REHAB, V78, P582, DOI 10.1016/S0003-9993(97)90422-6; GELLMAN H, 1988, J BONE JOINT SURG AM, V70A, P517, DOI 10.2106/00004623-198870040-00006; Genda E, 2004, PROSTHET ORTHOT INT, V28, P69; Harvey LA, 1998, ARCH PHYS MED REHAB, V79, P945, DOI 10.1016/S0003-9993(98)90092-2; HIROKAWA S, 1990, ARCH PHYS MED REHAB, V71, P687; Jaspers P, 1997, SPINAL CORD, V35, P585, DOI 10.1038/sj.sc.3100462; Kang S, 2007, IFMBE PROC, V14, P2889; Kawashima N, 2003, SPINAL CORD, V41, P506, DOI 10.1038/sj.sc.3101494; Kirtley C, 1992, 7 WORLD C INT SOC PR; Leung A, 2009, PROSTHET ORTHOT INT, V33, P61, DOI 10.1080/03093640802562368; Lissons M, 1992, 7 WORLD C INT SOC PR; Massucci M, 1998, SPINAL CORD, V36, P223, DOI 10.1038/sj.sc.3100564; Motlock WM, 1992, P 7 WORLD C INT SOC, P28; NENE AV, 1990, ARCH PHYS MED REHAB, V71, P116; Ohta Y, 2007, P I MECH ENG H, V221, P629, DOI 10.1243/09544119JEIM55; PHILLIPS CA, 1991, PARAPLEGIA, V29, P268, DOI 10.1038/sc.1991.38; Ruthenberg BJ, 1997, J REHABIL RES DEV, V34, P203; Saitoh E, 1996, AM J PHYS MED REHAB, V75, P198, DOI 10.1097/00002060-199605000-00010; Solomonow M, 1988, IEEE ENG MED BIOL SO, V10, P1672; SYKES L, 1995, ARCH PHYS MED REHAB, V76, P779, DOI 10.1016/S0003-9993(95)80534-6; TASHMAN S, 1995, J BIOMECH ENG-T ASME, V117, P300, DOI 10.1115/1.2794185; WINCHESTER PK, 1993, PROSTHET ORTHOT INT, V17, P101; Yakimovich T, 2009, J REHABIL RES DEV, V46, P257, DOI 10.1682/JRRD.2008.02.0024; Yang L, 1996, J BIOMECH, V29, P217, DOI 10.1016/0021-9290(95)00018-6; Yang L, 1997, ARTIF ORGANS, V21, P183, DOI 10.1111/j.1525-1594.1997.tb04648.x; Yano H, 1997, PROSTHET ORTHOT INT, V21, P222	30	19	19	2	20	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0309-3646	1746-1553		PROSTHET ORTHOT INT	Prosthet. Orthot. Int.	MAR	2012	36	1					125	130		10.1177/0309364611431481			6	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	962TQ	WOS:000305568400016	22235109	Bronze			2022-02-06	
J	Bramley, H; Kroft, C; Polk, D; Newberry, T; Silvis, M				Bramley, Harry; Kroft, Christopher; Polk, David; Newberry, Ty; Silvis, Matthew			Do Youth Hockey Coaches Allow Players With a Known Concussion to Participate in a Game?	CLINICAL PEDIATRICS			English	Article						concussion; traumatic brain injury; head injuries; pediatrics; hockey	SPORT-RELATED CONCUSSION; CLINICAL VIGNETTES; PHYSICIAN PRACTICE; UNITED-STATES; BRAIN-INJURY; QUALITY; IMPACT; RISK	Ice hockey is a high-risk sport for concussion. It is important that coaches have an understanding of concussion, although previous studies have demonstrated poor knowledge of concussion recognition and management by youth coaches. A cross-sectional survey with 7 case scenarios was completed by 314 youth hockey coaches. Each case scenario described a player with a concussion during a game, and scores reflected how the coach would respond to each scenario. Although most coaches would not allow a player to continue participating in a game after suffering a concussion, there was a small percentage that would. Statistical analysis found an inverse relationship between the coaches' age and consideration of continued participation. This places athletes at significant risk for further injury and is not consistent with current concussion guidelines. USA Hockey should provide additional concussion training for their coaches as well as mandatory health care clearance following a concussion.	[Bramley, Harry] Penn State Milton S Hershey Med Ctr, Dept Pediat, Hershey, PA 17033 USA; [Kroft, Christopher; Polk, David] York Coll Penn, York, PA USA; [Newberry, Ty] USA Hockey, Washington, DC USA		Bramley, H (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Pediat, Mail Code H085,500 Univ Dr, Hershey, PA 17033 USA.	hbramley@hmc.psu.edu					*BOST U CTR STUD T, CAS STUD; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; *HOCKEYCANADA, HOCK CAN ANN REP 200; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; National Federation of State High School Association, CONC SPORT WHAT YOU; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Pham T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-128; Pittsburgh Amateur Hockey League, RUL REG 2010 2011 SE; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Sosin DM, 1996, BRAIN INJURY, V10, P47; US Department of Health and Human Services Centers for Disease Control and Prevention, 2005, HEADS TOOLK; USA Hockey, USA HOCK BOARD DIR A; USAHockey, 2009, USA HOCK ANN C REG R; *WA STAT DEP HLTH, CONC MAN SCH SPORTS	23	19	19	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228			CLIN PEDIATR	Clin. Pediatr.	MAR	2012	51	3					283	287		10.1177/0009922811422434			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	899AB	WOS:000300782400014	21937746				2022-02-06	
J	Foley, CM; Wang, DH				Foley, Cassidy M.; Wang, David H.			Central Diabetes Insipidus Following a Sports-Related Concussion: A Case Report	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; diabetes insipidus; hypopituitarism; mild traumatic brain injury; sport		A 24-year-old female swimmer presented to a sports medicine clinic with complaints of frequent urination and increased thirst. The patient admitted to progressive worsening of her symptoms over a 4-year period since suffering a concussion. A water deprivation test, antidiuretic hormone level, and diamino-8-D-arginine vasopressin challenge were completed, and the patient was diagnosed with persistent central diabetes insipidus. As concussion awareness increases, health care professionals will be faced with treatment of post-concussive patients more often. The aim of this case report is to increase awareness of possible pituitary dysfunction-specifically, central diabetes insipidus-following a concussion.	[Foley, Cassidy M.; Wang, David H.] Connecticut Childrens Med Ctr, Farmington, CT USA		Foley, CM (corresponding author), Connecticut Childrens Med Ctr, Elite Sports Med, 399 Farmington Ave,3rd Floor, Farmington, CT 06034 USA.	Tbeaulieu@ccmckids.org		Foley Davelaar, Cassidy/0000-0002-6559-5071			Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Boughey JC, 2004, AM SURGEON, V70, P500; Chou YC, 2009, BRAIN INJURY, V23, P1095, DOI 10.3109/02699050903379396; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Su DH, 2005, J FORMOS MED ASSOC, V104, P463; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476	11	19	19	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR-APR	2012	4	2					139	141		10.1177/1941738111434275			3	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V19WW	WOS:000214850100007	23016080	Green Published			2022-02-06	
J	Han, HS; Park, J; Kim, JH; Suk, K				Han, Hyung Soo; Park, Jaechan; Kim, Jong-Heon; Suk, Kyoungho			Molecular and Cellular Pathways as a Target of Therapeutic Hypothermia: Pharmacological Aspect	CURRENT NEUROPHARMACOLOGY			English	Article						Hypothermia; pharmacotherapy; drug target; signal pathway; neuroinflammation	NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; GLOBAL CEREBRAL-ISCHEMIA; TRANSIENT FOREBRAIN ISCHEMIA; TO-MODERATE HYPOTHERMIA; NITRIC-OXIDE SYNTHASE; MILD HYPOTHERMIA; POSTISCHEMIC HYPOTHERMIA; EXPERIMENTAL STROKE	Induced therapeutic hypothermia is the one of the most effective tools against brain injury and inflammation. Even though its beneficial effects are well known, there are a lot of pitfalls to overcome, since the potential adverse effects of systemic hypothermia are still troublesome. Without the knowledge of the precise mechanisms of hypothermia, it will be difficult to tackle the application of hypothermia in clinical fields. Better understanding of the characteristics and modes of hypothermic actions may further extend the usage of hypothermia by developing novel drugs based on the hypothermic mechanisms or by combining hypothermia with other therapeutic modalities such as neuroprotective drugs. In this review, we describe the potential therapeutic targets for the development of new drugs, with a focus on signal pathways, gene expression, and structural changes of cells. Theapeutic hypothermia has been shown to attenuate neuroinflammation by reducing the production of reactive oxygen species and proinflammatory mediators in the central nervous system. Along with the mechanism-based drug targets, applications of therapeutic hypothermia in combination with drug treatment will also be discussed in this review.	[Kim, Jong-Heon; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Brain Sci & Engn Inst, Taegu 700422, South Korea; [Park, Jaechan] Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Brain Sci & Engn Inst, Taegu 700422, South Korea; [Han, Hyung Soo] Kyungpook Natl Univ, Sch Med, Dept Physiol, Brain Sci & Engn Inst, Taegu 700422, South Korea		Suk, K (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Brain Sci & Engn Inst, 101 Dongin 2 Ga, Taegu 700422, South Korea.	ksuk@knu.ac.kr		Park, Jaechan/0000-0001-7572-3260	Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [A100870]; Industrial Strategic Technology Development Program [10035197]; Ministry of Knowledge Economy (MKE, Korea)Ministry of Knowledge Economy, Republic of Korea	This work was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A100870), and by a grant of the Industrial Strategic Technology Development Program (10035197) funded by the Ministry of Knowledge Economy (MKE, Korea).	Akaji K, 2003, BRAIN RES, V975, P149, DOI 10.1016/S0006-8993(03)02622-2; Ali SS, 2010, J BIOL CHEM, V285, P32522, DOI 10.1074/jbc.M110.155432; Arai Takahiro, 2008, Allergol Int, V57, P331, DOI 10.2332/allergolint.O-08-532; Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Bartrons M, 2004, CRYOBIOLOGY, V49, P190, DOI 10.1016/j.cryobiol.2004.06.004; Baumann E, 2009, BRAIN RES, V1269, P185, DOI 10.1016/j.brainres.2009.02.062; Belanger M, 2005, J HEPATOL, V42, P694, DOI 10.1016/j.jhep.2004.12.029; Burattini S, 2010, CURR PHARM DESIGN, V16, P1376, DOI 10.2174/138161210791033941; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Capani F, 2009, EXP NEUROL, V219, P404, DOI 10.1016/j.expneurol.2009.06.007; CARDELL M, 1991, J NEUROCHEM, V57, P1814, DOI 10.1111/j.1471-4159.1991.tb06387.x; Cavaglia M, 2004, ANN THORAC SURG, V78, P1418, DOI 10.1016/j.athoracsur.2004.04.036; Chan EYW, 1999, J CLIN INVEST, V103, P1337, DOI 10.1172/JCI5474; Chen J, 2009, MED HYPOTHESES, V72, P62, DOI 10.1016/j.mehy.2008.07.056; Choi DK, 2010, EXPERT OPIN THER PAT, V20, P1531, DOI 10.1517/13543776.2010.525220; Choi J.S., 2011, STROKE RES IN PRESS; D'Cruz BJ, 2005, BRAIN RES, V1064, P108, DOI 10.1016/j.brainres.2005.09.052; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; Dai Da-wei, 2006, Zhonghua Yi Xue Za Zhi, V86, P906; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Diestel A, 2010, EUR J NEUROSCI, V31, P779, DOI 10.1111/j.1460-9568.2010.07128.x; Diestel A, 2009, VASC PHARMACOL, V51, P246, DOI 10.1016/j.vph.2009.06.006; Diestel A, 2008, CRYOBIOLOGY, V57, P216, DOI 10.1016/j.cryobiol.2008.08.005; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dietrichs ES, 2010, ULTRASTRUCT PATHOL, V34, P82, DOI 10.3109/01913120903398753; Duz B, 2007, CRYOBIOLOGY, V55, P279, DOI 10.1016/j.cryobiol.2007.08.009; Fairchild KD, 2005, AM J PHYSIOL-CELL PH, V289, pC1114, DOI 10.1152/ajpcell.00152.2005; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Fang D, 2009, NEUROCHEM INT, V55, P181, DOI 10.1016/j.neuint.2008.12.009; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Florian B, 2008, NEUROSCI LETT, V438, P180, DOI 10.1016/j.neulet.2008.04.020; Fosgerau K, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-51; Gibas M, 2004, MED SCI MONITOR, V10, pBR109; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Gisselsson LL, 2005, J CEREBR BLOOD F MET, V25, P1346, DOI 10.1038/sj.jcbfm.9600131; Gordan ML, 2010, PERFUSION-UK, V25, P349, DOI 10.1177/0267659110377946; Haddix TL, 1996, J SURG RES, V64, P176, DOI 10.1006/jsre.1996.0325; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Horiguchi T, 2003, J NEUROTRAUM, V20, P511, DOI 10.1089/089771503765355577; Horiuchi T, 2009, ANESTH ANALG, V109, P559, DOI 10.1213/ane.0b013e3181aa96a1; HU BR, 1995, NEUROSCIENCE, V68, P1003, DOI 10.1016/0306-4522(95)00213-3; Hu WW, 2008, HIPPOCAMPUS, V18, P386, DOI 10.1002/hipo.20402; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Imada S, 2010, J NEUROSCI RES, V88, P3457, DOI 10.1002/jnr.22520; Jang J.H., 2009, VASC NEUROL, V1, P53; Ji XM, 2007, FRONT BIOSCI, V12, P1737, DOI 10.2741/2185; Jin JS, 2006, NEUROL MED-CHIR, V46, P321, DOI 10.2176/nmc.46.321; Jin KL, 2000, ANN NEUROL, V48, P257, DOI 10.1002/1531-8249(200008)48:2<257::AID-ANA18>3.3.CO;2-G; KAMME F, 1995, EUR J NEUROSCI, V7, P2007, DOI 10.1111/j.1460-9568.1995.tb00623.x; Kellermann K, 2009, PERFUSION-UK, V24, P429, DOI 10.1177/0267659109358655; Kim OS, 2002, J BIOL CHEM, V277, P40594, DOI 10.1074/jbc.M203885200; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Kiyatkin EA, 2009, NEUROSCIENCE, V161, P926, DOI 10.1016/j.neuroscience.2009.04.004; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kobayashi MS, 2008, BRAIN RES REV, V58, P171, DOI 10.1016/j.brainresrev.2008.03.001; Kolomiytseva IK, 2009, DOKL BIOCHEM BIOPHYS, V427, P225, DOI 10.1134/S1607672909040152; Kolomiytseva IK, 2008, COMP BIOCHEM PHYS B, V151, P386, DOI 10.1016/j.cbpb.2008.08.001; Kuboki S, 2007, AM J PHYSIOL-GASTR L, V292, pG201, DOI 10.1152/ajpgi.00186.2006; Lee JE, 2005, J NEUROSURG, V103, P289, DOI 10.3171/jns.2005.103.2.0289; Lee KM, 2009, GENES GENOM, V31, P89, DOI 10.1007/BF03191142; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Leker RR, 2003, STROKE, V34, P2000, DOI 10.1161/01.STR.0000079817.68944.1E; Lin H.W., 2011, ANTIOXID REDOX SIGNA; Lopez-Hernandez FJ, 2006, APOPTOSIS, V11, P1339, DOI 10.1007/s10495-006-7689-z; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Matsuda T, 1999, J Anesth, V13, P99, DOI 10.1007/s005400050034; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Mueller-Burke D, 2008, INT J DEV NEUROSCI, V26, P67, DOI 10.1016/j.ijdevneu.2007.08.015; Nagel S, 2008, BRAIN RES, V1188, P198, DOI 10.1016/j.brainres.2007.10.052; Ning XH, 2002, J APPL PHYSIOL, V92, P2200, DOI 10.1152/japplphysiol.01035.2001; Oda Y., 2010, J CEREB BLOOD FLOW M; Pabello NG, 2005, BRAIN RES, V1038, P11, DOI 10.1016/j.brainres.2004.12.047; Park WS, 2001, NEUROCHEM RES, V26, P369, DOI 10.1023/A:1010947030587; Parkinson EJ, 2004, J PEDIATR SURG, V39, P696, DOI 10.1016/j.jpedsurg.2004.01.025; Pedersen Trine Funder, 2007, Tidsskr Nor Laegeforen, V127, P163; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Popov VI, 2007, NEUROSCIENCE, V149, P549, DOI 10.1016/j.neuroscience.2007.07.059; Qing M, 2003, CRIT CARE MED, V31, P2769, DOI 10.1097/01.CCM.0000098858.64868.9C; Qing M, 2006, CRIT CARE, V10, DOI 10.1186/cc4886; Rawls SM, 2004, PHARMACOL BIOCHEM BE, V78, P83, DOI 10.1016/j.pbb.2004.02.006; Rawls SM, 2002, J PHARMACOL EXP THER, V301, P963, DOI 10.1124/jpet.301.3.963; Roberts JR, 2002, CRYOBIOLOGY, V44, P161, DOI 10.1016/S0011-2240(02)00018-4; Roelandse M, 2004, J NEUROSCI, V24, P7843, DOI 10.1523/JNEUROSCI.2872-04.2004; Roszer T, 2010, CELL TISSUE RES, V342, P191, DOI 10.1007/s00441-010-1063-8; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; Sawe N, 2008, J NEUROSCI RES, V86, P1659, DOI 10.1002/jnr.21604; Schmitt KRL, 2007, NEUROSCI RES, V59, P68, DOI 10.1016/j.neures.2007.05.011; Schmitt KRL, 2006, NEUROSCI LETT, V404, P309, DOI 10.1016/j.neulet.2006.05.064; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Schmitt KRL, 2007, J NEUROIMMUNOL, V189, P7, DOI 10.1016/j.jneuroim.2007.06.010; Shao ZH, 2010, AM J PHYSIOL-HEART C, V298, pH2164, DOI 10.1152/ajpheart.00994.2009; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; SHAY J, 1973, AM J PATHOL, V72, P369; Shuja F, 2009, J AM COLL SURGEONS, V209, P89, DOI 10.1016/j.jamcollsurg.2009.03.010; Smart F, 2007, J NEUROCHEM, V101, P1367, DOI 10.1111/j.1471-4159.2007.04521.x; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Suh S.J., 2009, VASC NEUROL, V1, P46; Tanaka T, 2010, AM J PHYSIOL-REG I, V298, pR661, DOI 10.1152/ajpregu.00732.2009; Terao Y, 2009, NEUROSCI RES, V64, P75, DOI 10.1016/j.neures.2009.01.017; Todani M, 2010, FREE RADICAL RES, V44, P462, DOI 10.3109/10715761003610752; Tomimatsu T, 2001, NEUROSCI LETT, V312, P21, DOI 10.1016/S0304-3940(01)02178-4; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Vallerand AL, 1999, AVIAT SPACE ENVIR MD, V70, P42; van den Broek MPH, 2010, CLIN PHARMACOKINET, V49, P277, DOI 10.2165/11319360-000000000-00000; Vexler ZS, 2009, DEV NEUROSCI-BASEL, V31, P378, DOI 10.1159/000232556; Viscomi MT, 2010, EXP NEUROL, V224, P56, DOI 10.1016/j.expneurol.2010.03.023; Vosler PS, 2005, MOL BRAIN RES, V135, P21, DOI 10.1016/j.molbrainres.2004.11.006; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Xiong M, 2009, BRAIN RES BULL, V79, P351, DOI 10.1016/j.brainresbull.2009.03.011; Yang D, 2010, CELL PHYSIOL BIOCHEM, V25, P605, DOI 10.1159/000315079; Yang D, 2010, CARDIOVASC RES, V85, P520, DOI 10.1093/cvr/cvp323; Yang D, 2009, FEBS LETT, V583, P2500, DOI 10.1016/j.febslet.2009.07.006; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Zhang F, 2007, NEUROBIOL DIS, V25, P45, DOI 10.1016/j.nbd.2006.08.007; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	121	19	19	0	4	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1570-159X	1875-6190		CURR NEUROPHARMACOL	Curr. Neuropharmacol.	MAR	2012	10	1					80	87					8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	897HA	WOS:000300637600008	22942881	Green Submitted, Green Published			2022-02-06	
J	Rayan, N; Barnes, S; Fleming, N; Kudyakov, R; Ballard, D; Gentilello, LM; Shafi, S				Rayan, Nadine; Barnes, Sunni; Fleming, Neil; Kudyakov, Rustam; Ballard, David; Gentilello, Larry M.; Shafi, Shahid			Barriers to compliance with evidence-based care in trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Quality improvement; practice guidelines; innovation diffusion	QUALITY; MORTALITY; SYSTEMS	BACKGROUND: We have preciously demonstrated that trauma patients receive less than two-thirds of the care recommended by evidence-based medicine. The purpose of this study was to identify patients least likely to receive optimal care. METHODS: Records of a random sample of 774 patients admitted to a Level I trauma center (2006-2008) with moderate to severe injuries (Abbreviated Injury Scale score >= 3) were reviewed for compliance with 25 trauma-specific processes of care (T-POC) endorsed by Advanced Trauma Life Support, Eastern Association for the Surgery of Trauma, the Brain Trauma Foundation, Surgical Care Improvement Project, and the Glue Grant Consortium based on evidence or consensus. These encompassed all aspects of trauma care, including initial evaluation, resuscitation, operative care, critical care, rehabilitation, and injury prevention. Multivariate logistic regression was used to identify patients likely to receive recommended care. RESULTS: Study patients were eligible for a total of 2,603 T-POC, of which only 1,515 (58%) were provided to the patient. Compliance was highest for T-POC involving resuscitation (83%) and was lowest for neurosurgical interventions (17%). Increasing severity of head injuries was associated with lower compliance, while intensive care unit stay was associated with higher compliance. There was no relationship between compliance and patient demographics, socioeconomic status, overall injury severity, or daily volume of trauma admissions. CONCLUSION: Little over half of recommended care was delivered to trauma patients with moderate to severe injuries. Patients with increasing severity of traumatic brain injuries were least likely to receive optimal care. However, differences among patient subgroups are small in relation to the overall gap between observed and recommended care. (J Trauma. 2012; 72: 585-593. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Rayan, Nadine; Barnes, Sunni; Fleming, Neil; Kudyakov, Rustam; Ballard, David; Shafi, Shahid] Baylor Hlth Care Syst, Inst Hlth Care Res & Improvement, Dallas, TX USA; [Gentilello, Larry M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA		Shafi, S (corresponding author), Baylor Hlth Care Syst, 1600 W Coll St,Suite LL 10, Grapevine, TX 76051 USA.	shahid.shafi@baylorhealth.edu			Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1R01HS017718-01A1]; Seeger Foundation of the Baylor University Medical Center, Dallas, TX; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS017718] Funding Source: NIH RePORTER	Supported in part by Agency for Healthcare Research and Quality (AHRQ grant #1R01HS017718-01A1) and the Seeger Foundation of the Baylor University Medical Center, Dallas, TX.	American College of Surgeons, 2008, ATLS DOCT STUD MAN; Balas E A, 2000, Yearb Med Inform, P65; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; BROOS PLO, 1993, INJURY, V24, P365, DOI 10.1016/0020-1383(93)90096-O; Centers for Disease Control and Prevention, INJ PREV CONTR DAT S; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Gurses AP, 2008, QUAL SAF HEALTH CARE, V17, P351, DOI 10.1136/qshc.2006.021709; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Ingraham AM, 2010, ANN SURG, V252, P358, DOI 10.1097/SLA.0b013e3181e623bf; Kalhan R, 2006, CRIT CARE MED, V34, P300, DOI 10.1097/01.CCM.0000198328.83571.4A; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Nathens AB, 2008, J TRAUMA, V65, P628, DOI 10.1097/TA.0b013e3181837994; QualityNet, SCIP PROJ INF; Scott IA, 2005, MED J AUSTRALIA, V182, P325, DOI 10.5694/j.1326-5377.2005.tb06729.x; Shafi S, J TRAUMA IN PRESS; Shafi S, 2008, J TRAUMA, V64, P599, DOI 10.1097/TA.0b013e31816533f9; Shafi S, 2010, J TRAUMA, V68, P771, DOI 10.1097/TA.0b013e3181d03a20; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Shafi S, 2008, ARCH SURG-CHICAGO, V143, P1057, DOI 10.1001/archsurg.143.11.1057; Vogeli C, 2009, MED CARE, V47, P591, DOI 10.1097/MLR.0b013e31819432cd	21	19	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2012	72	3					585	592		10.1097/TA.0b013e318243da4d			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	906TR	WOS:000301371100014	22491540				2022-02-06	
J	Honeybul, S; Ho, K; Hanlon, SO				Honeybul, Stephen; Ho, Kwok; Hanlon, Susan O'			Access to Reliable Information about Long-Term Prognosis Influences Clinical Opinion on Use of Lifesaving Intervention	PLOS ONE			English	Article							CEREBRAL-ARTERY INFARCTION; TRAUMATIC BRAIN-INJURY; OF-LIFE DECISIONS; DECOMPRESSIVE CRANIECTOMY; SURGICAL DECOMPRESSION; HEMICRANIECTOMY; ATTITUDES; CARE; MULTICENTER; NEUROTRAUMA	Background: Decompressive craniectomy has been traditionally used as a lifesaving rescue treatment in severe traumatic brain injury (TBI). This study assessed whether objective information on long-term prognosis would influence healthcare workers' opinion about using decompressive craniectomy as a lifesaving procedure for patients with severe TBI. Method: A two-part structured interview was used to assess the participants' opinion to perform decompressive craniectomy for three patients who had very severe TBI. Their opinion was assessed before and after knowing the predicted and observed risks of an unfavourable long-term neurological outcome in various scenarios. Results: Five hundred healthcare workers with a wide variety of clinical backgrounds participated. The participants were significantly more likely to recommend decompressive craniectomy for their patients than for themselves (mean difference in visual analogue scale [VAS] -1.5, 95% confidence interval -1.3 to -1.6), especially when the next of kin of the patients requested intervention. Patients' preferences were more similar to patients who had advance directives. The participants' preferences to perform the procedure for themselves and their patients both significantly reduced after knowing the predicted risks of unfavourable outcomes, and the changes in attitude were consistent across different specialties, amount of experience in caring for similar patients, religious backgrounds, and positions in the specialty of the participants. Conclusions: Access to objective information on risk of an unfavourable long-term outcome influenced healthcare workers' decision to recommend decompressive craniectomy, considered as a lifesaving procedure, for patients with very severe TBI.	[Honeybul, Stephen; Hanlon, Susan O'] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Ho, Kwok] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia; [Ho, Kwok] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Azoulay E, 2009, AM J RESP CRIT CARE, V180, P853, DOI 10.1164/rccm.200810-1614OC; Barbour KA, 2006, CHEST, V129, P1367, DOI 10.1378/chest.129.5.1367; Burns JP, 2001, CRIT CARE MED, V29, P658, DOI 10.1097/00003246-200103000-00036; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Granja C, 2001, INTENS CARE MED, V27, P555, DOI 10.1007/s001340100852; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Ho KM, 2005, INTENS CARE MED, V31, P668, DOI 10.1007/s00134-005-2613-5; Ho KM, 2004, ANAESTH INTENS CARE, V32, P781, DOI 10.1177/0310057X0403200609; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Honeybul S, 2011, J MED ETHICS, V37, P707, DOI 10.1136/medethics-2011-100081; Honeybul S, 2011, ACTA NEUROCHIR, V153, P1105, DOI 10.1007/s00701-011-0974-9; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kelly AG, 2010, NEUROLOGY, V75, P682, DOI 10.1212/WNL.0b013e3181eee273; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Koh MS, 2000, SURG NEUROL, V53, P225, DOI 10.1016/S0090-3019(00)00163-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pugh EJ, 2009, PALLIATIVE MED, V23, P158, DOI 10.1177/0269216308100248; Pusic A, 2007, OTOLARYNG HEAD NECK, V136, P525, DOI 10.1016/j.otohns.2006.12.006; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sanoff HK, 2007, CLIN COLORECTAL CANC, V6, P700, DOI 10.3816/CCC.2007.n.039; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235	36	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e32375	10.1371/journal.pone.0032375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	WOS:000302916100075	22384231	Green Published, Green Submitted, gold			2022-02-06	
J	Boselli, M; Aquilani, R; Baiardi, P; Dioguardi, FS; Guarnaschelli, C; Achilli, MP; Arrigoni, N; Iadarola, P; Verri, M; Viglio, S; Barbieri, A; Boschi, F				Boselli, Mirella; Aquilani, Roberto; Baiardi, Paola; Dioguardi, Francesco Saverio; Guarnaschelli, Caterina; Achilli, Maria Pia; Arrigoni, Nadia; Iadarola, Paolo; Verri, Manuela; Viglio, Simona; Barbieri, Annalisa; Boschi, Federica			Supplementation of Essential Amino Acids May Reduce the Occurrence of Infections in Rehabilitation Patients With Brain Injury	NUTRITION IN CLINICAL PRACTICE			English	Article						amino acids; essential; infection; brain injuries	C-REACTIVE PROTEIN; SUBARACHNOID HEMORRHAGE; ISCHEMIC-STROKE; MEDICAL COMPLICATIONS; COGNITIVE RECOVERY; RESPONSE SYNDROME; BODY-COMPOSITION; RISK-FACTOR; MUSCLE; IMMUNE	Background: To investigate whether supplementation with oral essential amino acids (EAAs) may reduce the occurrence of nosocomial infection among patients with brain injury (BI: stroke, trauma, anoxic coma). Methods: Patients (n = 125; 77 men, 48 women; mean age 63 +/- 15 years) with stroke (68.8%), subarachnoid hemorrhage (17.6%), traumatic BI (7.2%), and anoxic BI (6.4%) 88 +/- 15days after the index event. Patients were randomly assigned to 2 months of oral EAAs (n = 63; 8 g/d) or placebo (n = 62). Results: Over the first month of rehabilitation, there were 60 infections in the whole population of 125 patients (48%); however, the rate was 23.2% lower in the EAA group (23 episodes/63 patients; 36.5%) than in the placebo group (37 episodes/62 patients; 59.7%) (P < .01). The types of infection were similarly distributed between the 2 groups. Serum levels of prealbumin < 20 mg/dL and C-reactive protein (CRP) > 0.3 mg/dL were the best predictors of future infection (prealbumin: odds ratio [OR] = 4.17, confidence interval [CI] 1.84-9.45, P < .001; CRP: OR = 3.8, CI 1.71-8.44, P < .001). Conclusion: Supplementary EAAs may reduce the occurrence of nosocomial infections in rehabilitation patients with BI. Prealbumin and CRP are the best predictors of future infections. (Nutr Clin Pract. 2012; 27: 99-114)	[Barbieri, Annalisa; Boschi, Federica] Univ Pavia, Dipartimento Sci Farmaco, I-27100 Pavia, Italy; [Boselli, Mirella; Guarnaschelli, Caterina; Achilli, Maria Pia; Arrigoni, Nadia] Ist Sci Montescano, IRCCS, Fdn S Maugeri,Unita Riabilitaz Neuromotoria, Unita Gravi Cerebrolesioni Acquisite, Pavia, Italy; [Aquilani, Roberto] Ist Sci Montescano, IRCCS, Fdn S Maugeri, Serv Fisiopatol Metab Nutr & Nutr Clin, Pavia, Italy; [Baiardi, Paola] Univ Pavia, Fdn S Maugeri, Consorzio Valutaz Biol & Farmacol, I-27100 Pavia, Italy; [Dioguardi, Francesco Saverio] Univ Milan, Dipartimento Med Interna, Milan, Italy; [Iadarola, Paolo; Viglio, Simona] Univ Pavia, Dipartimento Biochim A Castellani, I-27100 Pavia, Italy; [Verri, Manuela] Univ Pavia, Dipartimento Med Legale Sci Forensi & Farmacotoss, Sez Sci Farmacol & Tossicol, I-27100 Pavia, Italy		Boschi, F (corresponding author), Univ Pavia, Dipartimento Sci Farmaco, Viale Taramelli 12, I-27100 Pavia, Italy.	federica.boschi@unipv.it	Baiardi, Paola/AAB-9060-2020; Saverio, Francesco/B-4422-2017; Barbieri, Annalisa/ABE-6328-2021; Achilli, Maria Pia/AAE-1142-2021	Baiardi, Paola/0000-0002-1622-8400; Saverio, Francesco/0000-0003-0445-3106; Barbieri, Annalisa/0000-0003-2947-0084; Achilli, Maria Pia/0000-0003-1918-2388; Viglio, Simona/0000-0001-5020-478X; Boselli, Mirella/0000-0003-4545-5271			Alpers D. H., 1988, MANUAL NUTR THERAPEU; Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 1999, EUR HEART J, V20, P1020, DOI 10.1053/euhj.1999.1402; Aquilani R, 2008, ARCH PHYS MED REHAB, V89, P1642, DOI 10.1016/j.apmr.2008.02.023; Aquilani R, 2011, ARCH GERONTOL GERIAT, V52, pE123, DOI 10.1016/j.archger.2010.09.005; Aquilani R, 2010, NUTR NEUROSCI, V13, P129, DOI 10.1179/147683010X12611460764002; Aquilani R, 2009, NUTR NEUROSCI, V12, P219, DOI 10.1179/147683009X423445; Aquilani R, 2008, NUTR NEUROSCI, V11, P235, DOI 10.1179/147683008X301586; Aquilani R, 2008, CLIN REHABIL, V22, P1042, DOI 10.1177/0269215508094244; Arenillas JF, 2003, STROKE, V34, P2463, DOI 10.1161/01.STR.0000089920.93927.A7; Badjatia N, 2010, JPEN-PARENTER ENTER, V34, P64, DOI 10.1177/0148607109348797; Belayev L, 2005, STROKE, V36, P118, DOI 10.1161/01.STR.0000149620.74770.2e; Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Calder PC, 2007, BRIT J NUTR, V98, pS133, DOI 10.1017/S0007114507832909; Chandra RK, 2002, EUR J CLIN NUTR, V56, pS73, DOI 10.1038/sj.ejcn.1601492; CHUMLEA WC, 1985, J AM GERIATR SOC, V33, P116, DOI 10.1111/j.1532-5415.1985.tb02276.x; de Maat MPM, 2004, CURR OPIN LIPIDOL, V15, P651, DOI 10.1097/00041433-200412000-00005; Dhar R, 2008, NEUROCRIT CARE, V8, P404, DOI 10.1007/s12028-008-9054-2; Droge W, 2002, EXP GERONTOL, V37, P1333, DOI 10.1016/S0531-5565(02)00175-4; Esper DH, 2006, JPEN-PARENTER ENTER, V30, P71, DOI 10.1177/014860710603000271; Fafournoux P, 2000, BIOCHEM J, V351, P1, DOI 10.1042/0264-6021:3510001; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1102, DOI 10.1111/j.1532-5415.2000.tb04787.x; Frontera JA, 2008, NEUROSURGERY, V62, P80, DOI 10.1227/01.NEU.0000311064.18368.EA; FUGAZZA G, 1998, EUROPA MEDICOPHYSICA, V34, P125; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gussekloo J, 2000, ARTERIOSCL THROM VAS, V20, P1047, DOI 10.1161/01.ATV.20.4.1047; HERSIO K, 1990, ACTA NEUROCHIR, V106, P13, DOI 10.1007/BF01809327; Hill AG, 1998, BRIT J SURG, V85, P884; Hugonnet S, 2004, EMERG INFECT DIS, V10, P76, DOI 10.3201/eid1001.030407; *I SUP NAZ NUTR, 1989, TAB COMP AL; KALRA L, 1995, STROKE, V26, P990, DOI 10.1161/01.STR.26.6.990; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Kuptniratsaikul V, 2009, AM J PHYS MED REHAB, V88, P92, DOI 10.1097/PHM.0b013e3181909d5f; Laviano A, 2011, NEUROCRIT CARE, V14, P44, DOI 10.1007/s12028-010-9461-z; LESOURD B, 1995, NUTR REV, V53, pS86; Lesourd B, 1995, NUTR REV, V53, pS92; Liong MT, 2006, J DAIRY SCI, V89, P1390, DOI 10.3168/jds.S0022-0302(06)72207-X; Liu ZQ, 2006, J NUTR, V136, p212S, DOI 10.1093/jn/136.1.212S; Lombardo A, 2004, CIRCULATION, V109, P3158, DOI 10.1161/01.CIR.0000130786.28008.56; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE503, DOI 10.1152/ajpendo.00084.2002; Martindale RG, 2005, JPEN-PARENTER ENTER, V29, pS53, DOI 10.1177/01486071050290S1S53; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Mendez Christian M, 2005, Nutr Clin Pract, V20, P314, DOI 10.1177/0115426505020003314; Mermel LA, 2000, ANN INTERN MED, V133, P395; Mokart D, 2002, BRIT J SURG, V89, P1450, DOI 10.1046/j.1365-2168.2002.02218.x; Molls RR, 2005, J NUTR, V135, P2644, DOI 10.1093/jn/135.11.2644; Mylotte JM, 2001, INFECT CONT HOSP EP, V22, P83, DOI 10.1086/501868; NIELSEN HJ, 1995, BRIT J SURG, V82, P582, DOI 10.1002/bjs.1800820505; Olano-Martin E, 2000, BRIT J NUTR, V83, P247, DOI 10.1017/S0007114500000325; Rello J, 2001, CHEST, V120, P955, DOI 10.1378/chest.120.3.955; Rennie MJ, 2006, J NUTR, V136, p264S, DOI 10.1093/jn/136.1.264S; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Roth E, 2007, CLIN NUTR, V26, P535, DOI 10.1016/j.clnu.2007.05.007; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; Selim MH, 2004, AGEING RES REV, V3, P345, DOI 10.1016/j.arr.2004.04.001; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Sorbello D, 2009, CEREBROVASC DIS, V28, P378, DOI 10.1159/000230712; TOUHO H, 1990, J NEUROSURG, V72, P710, DOI 10.3171/jns.1990.72.5.0710; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Visser M, 2005, AM J CLIN NUTR, V82, P531; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Wichienchot S., 2006, Current Issues in Intestinal Microbiology, V7, P7; Winbeck K, 2002, STROKE, V33, P2459, DOI 10.1161/01.STR.0000029828.51413.82; Wu AW, 2000, J AM GERIATR SOC, V48, pS6, DOI 10.1111/j.1532-5415.2000.tb03142.x; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646; Zuliani G, 2001, J GERONTOL A-BIOL, V56, pM212, DOI 10.1093/gerona/56.4.M212	71	19	19	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0884-5336			NUTR CLIN PRACT	Nutr. Clin. Pract.	FEB	2012	27	1					99	113		10.1177/0884533611431068			15	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	886IU	WOS:000299848900012	22307494				2022-02-06	
J	Dreer, LE; DeVivo, MJ; Novack, TA; Marson, DC				Dreer, Laura E.; DeVivo, Michael J.; Novack, Thomas A.; Marson, Daniel C.			Financial Capacity Following Traumatic Brain Injury: A Six-Month Longitudinal Study	REHABILITATION PSYCHOLOGY			English	Article						financial capacity; financial decision making; competency; traumatic brain injury; head injury	DECISION-MAKING CAPACITY; SPINAL-CORD-INJURY; ALZHEIMER-DISEASE; MODERATE; IMPAIRMENT; COMPETENCE; BANKRUPTCY; ABILITIES; RECOVERY; MILD	Objective: To longitudinally investigate financial capacity (FC) following traumatic brain injury (TBI). Design: Longitudinal study comparing FC in cognitively healthy adults and persons with moderate to severe TBI at time of acute hospitalization (Time 1) and at 6 months postinjury (Time 2). Setting: Inpatient brain injury rehabilitation unit. Participants: Twenty healthy adult controls and 24 adult persons with moderate to severe TBI. Main Outcome Measures: Participants were administered the Financial Capacity Instrument (FCI-9), a standardized instrument that measures performance on 18 financial tasks, 9 domains, and 2 global scores. Between- and within-group differences were examined for each FCI-9 domain and global scores. Using control group referenced cut scores, participants with TBI were also assigned an impairment rating (intact, marginal, or impaired) on each domain and global score. Results: At Time I, participants with TBI performed significantly below controls on the majority of financial variables tested. At Time 2, participants with TBI demonstrated within group improvement on both simple and complex financial domains, but continued to perform below adult controls on complex financial domains and both global scores. Group by time interactions were significant for four domains and both global scores. At Time I, high percentages of participants with TBI were assigned either "marginal" or "impaired" ratings on the domains and global scores, with significant percentage increases of "intact" ratings at Time 2. Conclusions: Immediately following acute injury, persons with moderate to severe TBI show global impairment of FC. Findings indicate improvement of both simple and complex financial skills over a 6-month period, but continued impairment on more complex financial skills. Future studies should examine loss and recovery of FC following TBI over longer time periods and a wider range of injury severity.	[Marson, Daniel C.] Univ Alabama, Dept Neurol, Sparks Ctr 650K, Birmingham, AL 35233 USA; [Dreer, Laura E.] Univ Alabama, Dept Ophthalmol, Birmingham, AL 35233 USA; [DeVivo, Michael J.; Novack, Thomas A.] Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL 35233 USA; [Marson, Daniel C.] Univ Alabama, Alzheimers Dis Ctr, Birmingham, AL 35233 USA		Marson, DC (corresponding author), Univ Alabama, Dept Neurol, Sparks Ctr 650K, 1530 3rd Ave S, Birmingham, AL 35233 USA.	dmarson@uab.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074, T32HD007420] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23EY017327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG031054, R01AG021927] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23 EY017327-04, K23 EY017327] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG021927, P30AG031054, 2R01AG02192, P30 AG031054] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074, T32 HD007420, R01 HD053074, T32HD07420] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A980010] Funding Source: Medline		Anderson TP, 1989, J HEAD TRAUMA REHAB, V4, P57, DOI DOI 10.1097/00001199-198903000-00008; Crowe K. M., 2005, PSYCHIAT PSYCHOL LAW, V12, P56, DOI [10.1375/pplt.2005.12.1.56, DOI 10.1375/PPLT.2005.12.1.56, http://dx.doi.org/10.1375/pplt.2005.12.1.56]; Crowe SF, 2004, ARCH CLIN NEUROPSYCH, V19, P673, DOI 10.1016/j.acn.2003.09.002; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; Fisk GD, 1998, BRAIN INJURY, V12, P683; Fong K., 2010, NEUROREHABILITATION, V7, P19; Gaudette M, 2002, BRAIN INJURY, V16, P133, DOI 10.1080/02699050110102068; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Griffith HR, 2003, NEUROLOGY, V60, P449, DOI 10.1212/WNL.60.3.449; HAFFEY WJ, 1989, J HEAD TRAUMA REHAB, V4, P43, DOI DOI 10.1097/00001199-198903000-00007; Hollingworth W, 2007, MED CARE, V45, P702, DOI 10.1097/MLR.0b013e318041f765; Kane RA., 1981, ASSESSING ELDERLY PR; Lundqvist A, 2001, BRAIN INJURY, V15, P981, DOI 10.1080/02699050110065637; Marson D., 2001, INT J LAW PSYCHIAT, V8, P109; Marson D., 2007, CLIN DIAGNOSIS MANAG, P323; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; Martin RC, 2003, ARCH NEUROL-CHICAGO, V60, P1585, DOI 10.1001/archneur.60.11.1585; Mukherjee D, 2001, REHABIL PSYCHOL, V46, P82, DOI 10.1037/0090-5550.46.1.82; Pressman Helaine Tobey, 2007, Phys Med Rehabil Clin N Am, V18, P165, DOI 10.1016/j.pmr.2006.11.006; Reid-Proctor GM, 2001, BRAIN INJURY, V15, P377, DOI 10.1080/02699050010005977; Relyea-Chew A, 2009, ARCH PHYS MED REHAB, V90, P413, DOI 10.1016/j.apmr.2008.07.031; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; TEASDALE G, 1974, LANCET, V2, P81	25	19	20	2	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2012	57	1					5	12		10.1037/a0025818			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	901JX	WOS:000300964300002	22369113	Green Accepted			2022-02-06	
J	Zhu, J; Aja, S; Kim, EK; Park, MJ; Ramamurthy, S; Jia, JL; Hu, XY; Geng, P; Ronnett, GV				Zhu, Jing; Aja, Susan; Kim, Eun-Kyoung; Park, Min Jung; Ramamurthy, Santosh; Jia, Junling; Hu, Xueying; Geng, Ping; Ronnett, Gabriele V.			Physiological Oxygen Level Is Critical for Modeling Neuronal Metabolism In Vitro	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						neuron; culture; oxygen; AMPK; metabolism	ACTIVATED PROTEIN-KINASE; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; OXIDATIVE STRESS; ENERGY-METABOLISM; CORTICAL-NEURONS; NORMOBARIC HYPEROXIA; CEREBRAL-ISCHEMIA; REDOX STATUS; HYPOXIA	In vitro models are important tools for studying the mechanisms that govern neuronal responses to injury. Most neuronal culture methods employ nonphysiological conditions with regard to metabolic parameters. Standard neuronal cell culture is performed at ambient (21%) oxygen levels, whereas actual tissue oxygen levels in the mammalian brain range from 1% to 5%. In this study, we examined the consequences of oxygen level on the viability and metabolism of primary cultures of cortical neurons. Our results indicate that physiological oxygen level (5% O-2) has a beneficial effect on cortical neuronal survival and mitochondrial function in vitro. Moreover, oxygen level affects metabolic fluxes: glucose uptake and glycolysis was enhanced at physiological oxygen level, whereas glucose oxidation and fatty acid oxidation were reduced. Adenosine monophosphate-activated protein kinase (AMPK) was more activated in 5% O-2 and appears to play a role in these metabolic effects. Inhibiting AMPK activity with compound C decreased glucose uptake, intracellular ATP level, and viability in neurons cultured in 5% O-2. These data indicate that oxygen level is an important parameter to consider when modeling neuronal responses to stress in vitro. (C) 2011 Wiley Periodicals, Inc.	[Zhu, Jing; Aja, Susan; Park, Min Jung; Ramamurthy, Santosh; Hu, Xueying; Geng, Ping; Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Kim, Eun-Kyoung; Ronnett, Gabriele V.] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain Sci, Taegu, South Korea; [Jia, Junling] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Embryol,Carnegie Inst Sci, Baltimore, MD 21205 USA; [Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ronnett, Gabriele V.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA		Ronnett, GV (corresponding author), Johns Hopkins Sch Med, Dept Neurosci, 725 N Wolfe St,Rangos 480, Baltimore, MD 21205 USA.	gronnett@jhmi.edu		Park, Min Jung/0000-0001-5644-9585	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS041079]; Daegu-Gyeongbuk Institute of Science and Technology (DGIST) Convergence Science Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS041079] Funding Source: NIH RePORTER	Contract grant sponsor: NINDS; Contract grant number: R01 NS041079 (to G.V.R.); Contract grant sponsor: Research Collaboration Agreement with the Daegu-Gyeongbuk Institute of Science and Technology (DGIST) Convergence Science Center (to S.A.).	Abbud W, 2000, ARCH BIOCHEM BIOPHYS, V380, P347, DOI 10.1006/abbi.2000.1935; AHDABBARMADA M, 1980, PEDIATRICS, V66, P840; Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Bickford PC, 1999, FREE RADICAL BIO MED, V26, P817, DOI 10.1016/S0891-5849(98)00260-3; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Burgers HF, 2008, EXP BRAIN RES, V188, P33, DOI 10.1007/s00221-008-1336-6; Carrier RL, 2006, J NEUROSCI METH, V154, P239, DOI 10.1016/j.jneumeth.2005.12.030; Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Chen PS, 2001, WORLD J GASTROENTERO, V7, P647; COLTON CA, 1995, EXP NEUROL, V132, P54, DOI 10.1016/0014-4886(95)90058-6; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Dean JB, 2004, J APPL PHYSIOL, V96, P784, DOI 10.1152/japplphysiol.00892.2003; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Genetos DC, 2010, J MOL NEUROSCI, V40, P360, DOI 10.1007/s12031-009-9326-0; Grote J, 1996, J AUTONOM NERV SYST, V57, P168, DOI 10.1016/0165-1838(95)00096-8; Hazelton JL, 2010, J NEUROTRAUM, V27, P753, DOI 10.1089/neu.2009.1186; Hermann Martin, 2008, Cell Commun Signal, V6, P4, DOI 10.1186/1478-811X-6-4; Hinkelbein J, 2010, MOL CELL BIOCHEM, V339, P9, DOI 10.1007/s11010-009-0365-1; Horie N, 2008, CELL MOL NEUROBIOL, V28, P833, DOI 10.1007/s10571-007-9237-y; KAPLAN FS, 1986, BRAIN RES, V384, P199, DOI 10.1016/0006-8993(86)91240-0; Kleman AM, 2008, J NEUROSCI METH, V167, P292, DOI 10.1016/j.jneumeth.2007.08.028; Kumaria A, 2009, BRIT J NEUROSURG, V23, P1; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; La Noce A, 2000, ACTA RADIOL, V41, P394, DOI 10.1034/j.1600-0455.2000.041004394.x; Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; Levin BE, 2001, NAT NEUROSCI, V4, P459, DOI 10.1038/87405; LIU KJ, 1995, BRAIN RES, V685, P91, DOI 10.1016/0006-8993(95)00413-K; Macri MA, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-14; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mander P, 2004, BIOCHEM SOC T, V32, P1068, DOI 10.1042/BST0321068; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; METZGER H, 1977, PFLUG ARCH EUR J PHY, V370, P201, DOI 10.1007/BF00581695; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Morgenthaler FD, 2006, NEUROSCIENCE, V141, P157, DOI 10.1016/j.neuroscience.2006.03.065; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; NAIR P, 1975, MICROVASC RES, V9, P158, DOI 10.1016/0026-2862(75)90077-1; Potier E, 2008, J TISSUE ENG REGEN M, V2, P272, DOI 10.1002/term.92; Pouzaud F, 2006, COMP BIOCHEM PHYS C, V143, P232, DOI 10.1016/j.cbpc.2006.02.006; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Putnam KP, 2002, TOXICOL IN VITRO, V16, P599, DOI 10.1016/S0887-2333(02)00050-4; Ramamurthy S, 2006, J PHYSIOL-LONDON, V574, P85, DOI 10.1113/jphysiol.2006.110122; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sana TR, 2008, J CHROMATOGR B, V871, P314, DOI 10.1016/j.jchromb.2008.04.030; Schechter M, 2009, ADV EXP MED BIOL, V645, P293, DOI 10.1007/978-0-387-85998-9_44; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Severinghaus J W, 1986, J Clin Monit, V2, P174, DOI 10.1007/BF01620550; Shi HL, 2006, NEUROSCI LETT, V410, P57, DOI 10.1016/j.neulet.2006.09.066; SHIBATA M, 1991, BRAIN RES BULL, V26, P467, DOI 10.1016/0361-9230(91)90026-G; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11; SMITH RH, 1977, MICROVASC RES, V13, P233, DOI 10.1016/0026-2862(77)90088-7; Studer L, 2000, J NEUROSCI, V20, P7377; Tachtsidis I, 2009, ADV EXP MED BIOL, V645, P315, DOI 10.1007/978-0-387-85998-9_47; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Tolias CM, 2009, J NEUROSURG, V110, P607, DOI 10.3171/JNS.2009.110.3.0607a; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; WERNER JC, 1989, AM J PHYSIOL, V256, pE315, DOI 10.1152/ajpendo.1989.256.2.E315; White RJ, 1996, J NEUROSCI, V16, P5688; WILSON DF, 1991, J APPL PHYSIOL, V70, P2691, DOI 10.1152/jappl.1991.70.6.2691; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zhu LL, 2005, MOL NEUROBIOL, V31, P231, DOI 10.1385/MN:31:1-3:231	73	19	19	0	17	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	FEB	2012	90	2					422	434		10.1002/jnr.22765			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	875YN	WOS:000299072300009	22002503				2022-02-06	
J	Valiyaveettil, M; Alamneh, Y; Oguntayo, S; Wei, YL; Wang, Y; Arun, P; Nambiar, MP				Valiyaveettil, Manojkumar; Alamneh, Yonas; Oguntayo, Samuel; Wei, Yanling; Wang, Ying; Arun, Peethambaran; Nambiar, Madhusoodana P.			Regional specific alterations in brain acetylcholinesterase activity after repeated blast exposures in mice	NEUROSCIENCE LETTERS			English	Article						Blast injury; Acetylcholinesterase; Cholinergic pathway; Traumatic brain injury; Repeated blast exposure	REDUCED EVOKED RELEASE; CLOSED-HEAD INJURY; CHOLINERGIC DYSFUNCTION; COGNITIVE IMPAIRMENT; STRESS; RATS; MODEL; DEFICITS; BLOOD; OVERPRESSURE	Acetylcholinesterase (AChE) which catalyzes the hydrolysis of the neurotransmitter acetylcholine has been recognized as one of the major regulators of stress responses after traumatic brain injury (TBI). Repeated blast exposure induces TBI (blast TBI) with a variable neuropathology at different brain regions. Since AChE inhibitors are being used as a line of treatment for TBI, we sought to determine the time course of AChE activity in the blood and different brain regions after repeated blast exposures using modified Ellman assay. Our data showed that repeated blast exposures significantly reduced AChE activity in the whole-blood and erythrocytes by 3-6 h, while plasma AChE activity was significantly increased by 3 h post-blast. In the brain, significant increase in AChE activity was observed at 6 h in the frontal cortex, while hind cortex and hippocampus showed a significant decrease at 6 h post-blast, which returned to normal levels by 7 days. AChE activity in the cerebellum and mid brain showed a decrease at 6 h, followed by significant increase at 3 days and that was decreased significantly at 14 days post-blast. Medulla region showed decreased AChE activity at 24 h post-blast, which was significantly increased at 14 days. These results suggest that there are brain regional and time-related changes in AChE activity after tightly coupled repeated blast exposures in mice. In summary, acute and chronic regional specific changes in the AChE activity after repeated blast exposures warrant systematic evaluation of the possibility of AChE inhibitor therapeutics against blast TBI. Published by Elsevier Ireland Ltd.	[Valiyaveettil, Manojkumar; Alamneh, Yonas; Oguntayo, Samuel; Wei, Yanling; Wang, Ying; Arun, Peethambaran; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA		Valiyaveettil, M (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA.	m.valiyaveettil@amedd.army.mil; madhusoodana.nambiar@amedd.army.mil					Arciniegas DB, 2011, J HEAD TRAUMA REHAB, V26, P319, DOI 10.1097/HTR.0b013e31821ebfb3; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; AUGUSTINSSON KB, 1978, CLIN CHIM ACTA, V89, P239, DOI 10.1016/0009-8981(78)90322-4; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; DONOVAN DA, 1994, J WILDLIFE DIS, V30, P234, DOI 10.7589/0090-3558-30.2.234; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Shaked I, 2008, ANN NY ACAD SCI, V1148, P269, DOI 10.1196/annals.1410.001; Shohami E, 2000, J MOL MED-JMM, V78, P228, DOI 10.1007/s001090000104; Sklan EH, 2006, BIOL PSYCHIAT, V60, P741, DOI 10.1016/j.biopsych.2006.03.080; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tomkins O, 2001, CELL MOL NEUROBIOL, V21, P675, DOI 10.1023/A:1015147920283; Wang LS, 2002, BRAIN RES, V949, P162, DOI 10.1016/S0006-8993(02)02977-3; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362	40	19	19	1	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JAN 6	2012	506	1					141	145		10.1016/j.neulet.2011.10.067			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	891GK	WOS:000300205000029	22079491				2022-02-06	
J	Alway, Y; McKay, A; Ponsford, J; Schonberger, M				Alway, Yvette; McKay, Adam; Ponsford, Jennie; Schoenberger, Michael			Expressed emotion and its relationship to anxiety and depression after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Expressed emotion; Traumatic brain injury; Attributions	ILLNESS PERCEPTION QUESTIONNAIRE; PSYCHIATRIC-DISORDERS; 1ST-EPISODE PSYCHOSIS; CAUSAL ATTRIBUTIONS; OVER-INVOLVEMENT; EATING-DISORDERS; HOSPITAL ANXIETY; SELF-REPORT; IPQ-R; RELATIVES	Levels of expressed emotion (EE) within the family, particularly criticism and emotional over-involvement, are associated with a patient's psychological outcome in a range of psychiatric and medical conditions. This study aimed to examine the relationship between levels of family EE and anxiety and depression in patients who have sustained a traumatic brain injury (TBI). A further aim was to examine whether family members' levels of psychological distress and attributions of patient symptom controllability, were related to their levels of patient-directed EE. Participants were 43 patients who had sustained a complicated mild to severe TBI three months to five years previously, and their nominated family members. Results indicated that family members' criticism and emotional over-involvement were associated with patients' levels of anxiety and depression. Moreover, family members' levels of anxiety and depression were associated with their levels of patient-directed criticism and emotional over-involvement, whilst their attributions of patient symptom control were not. These findings suggest that levels of EE within the family are associated with psychological adjustment following TBI. Consequently, interventions targeting EE in family members may help to reduce psychiatric difficulties following TBI.	[Alway, Yvette; McKay, Adam; Ponsford, Jennie; Schoenberger, Michael] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia; [Alway, Yvette; McKay, Adam; Ponsford, Jennie; Schoenberger, Michael] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Freiburg, Germany		Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton Campus,Wellington Rd,Bldg 17, Melbourne, Vic 3800, Australia.	jennie.ponsford@monash.edu	McKay, Adam JD/M-6003-2017	McKay, Adam JD/0000-0002-0479-7681			Alvarez-Jimenez M, 2010, PSYCHOL MED, V40, P63, DOI 10.1017/S0033291708004765; Barrowclough C, 2003, CLIN PSYCHOL REV, V23, P849, DOI 10.1016/S0272-7358(03)00075-8; Barrowclough C, 2001, BRIT J CLIN PSYCHOL, V40, P371, DOI 10.1348/014466501163869; Barrowclough C, 2008, BEHAV RES THER, V46, P207, DOI 10.1016/j.brat.2007.11.005; Bentsen H, 1996, BRIT J PSYCHIAT, V169, P622, DOI 10.1192/bjp.169.5.622; Breitborde NJK, 2009, SOC PSYCH PSYCH EPID, V44, P716, DOI 10.1007/s00127-008-0492-0; Bressi C, 2007, SEIZURE-EUR J EPILEP, V16, P417, DOI 10.1016/j.seizure.2007.02.015; Bressi C, 2009, J CARDIOVASC MED, V10, P752, DOI 10.2459/JCM.0b013e32832cae71; BREWIN CR, 1991, J ABNORM PSYCHOL, V100, P546, DOI 10.1037/0021-843X.100.4.546; BROWN GW, 1958, LANCET, V2, P685; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Cohen J., 2013, STAT POWER ANAL BEHA; Cutting LP, 2006, SCHIZOPHRENIA BULL, V32, P743, DOI 10.1093/schbul/sbl001; de Vellis RF, 2003, SCALE DEV THEORY APP, V2nd; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fichter MM, 1997, FAM PROCESS, V36, P203, DOI 10.1111/j.1545-5300.1997.00203.x; Flanagan DAJ, 1998, BRIT J CLIN PSYCHOL, V37, P431, DOI 10.1111/j.2044-8260.1998.tb01400.x; Fogler JM, 2007, BEHAV RES THER, V45, P235, DOI 10.1016/j.brat.2006.03.002; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Grice SJ, 2009, BEHAV RES THER, V47, P783, DOI 10.1016/j.brat.2009.06.004; Hooley J. M, 1987, NATURE ORIGINS EXPRE; Hooley JM, 2007, ANNU REV CLIN PSYCHO, V3, P329, DOI 10.1146/annurev.clinpsy.2.022305.095236; HOOLEY JM, 1985, CLIN PSYCHOL REV, V5, P119, DOI 10.1016/0272-7358(85)90018-2; Hooley JM, 2002, PSYCHOL MED, V32, P1091, DOI 10.1017/S0033291702005779; Hooley JM, 1997, J ABNORM PSYCHOL, V106, P298, DOI 10.1037/0021-843X.106.2.298; Jan Shah A, 2010, BR J MED PRACT, V3, P327; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KUIPERS L, 1988, PSYCHOL MED, V18, P893, DOI 10.1017/S0033291700009831; Kyriacou O, 2008, INT J EAT DISORDER, V41, P37, DOI 10.1002/eat.20469; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; McMurrich SL, 2009, BEHAV THER, V40, P315, DOI 10.1016/j.beth.2008.09.003; McNab C, 2007, PSYCHIAT RES, V151, P97, DOI 10.1016/j.psychres.2006.08.004; Miklowitz DJ, 2004, DEV PSYCHOPATHOL, V16, P667, DOI 10.1017/S0954579404004729; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pharoah F, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000088.pub2, 10.1002/14651858.CD000088.pub3]; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Renshaw KD, 2006, BEHAV THER, V37, P159, DOI 10.1016/j.beth.2005.11.001; Rogosch FA, 2004, DEV PSYCHOPATHOL, V16, P689, DOI 10.1017/S0954579404004730; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Sterba KR, 2009, PSYCHOL HEALTH, V24, P473, DOI 10.1080/08870440701867788; Tarrier N, 2002, J ABNORM PSYCHOL, V111, P340, DOI 10.1037//0021-843X.111.2.340; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Wearden AJ, 2000, J PSYCHOSOM RES, V49, P125, DOI 10.1016/S0022-3999(00)00141-0; Wearden AJ, 2000, CLIN PSYCHOL REV, V20, P633, DOI 10.1016/S0272-7358(99)00008-2; WEDDELL RA, 1987, SCAND J REHABIL MED, V19, P93; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Wiedemann G, 2002, PSYCHIAT RES, V109, P265, DOI 10.1016/S0165-1781(02)00023-9; Zabala MJ, 2009, EUR EAT DISORD REV, V17, P338, DOI 10.1002/erv.925; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	19	19	0	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2012	22	3					374	390		10.1080/09602011.2011.648757			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	936BV	WOS:000303566800003	22292905				2022-02-06	
J	Bakar, AM; Park, SW; Kim, M; Lee, HT				Bakar, Adnan M.; Park, Sang Won; Kim, Mihwa; Lee, H. Thomas			Isoflurane Protects Against Human Endothelial Cell Apoptosis by Inducing Sphingosine Kinase-1 via ERK MAPK	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						EA.hy926; sphingosine kinase; extracellular signal-regulated kinase; necrosis; volatile anesthetic	ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL INFARCT SIZE; TRAUMATIC BRAIN-INJURY; PROXIMAL TUBULE CELLS; SMOOTH-MUSCLE-CELLS; VOLATILE ANESTHETICS; 1-PHOSPHATE; RATS; PRETREATMENT; KIDNEY	Endothelial dysfunction is a major clinical problem affecting virtually every patient requiring critical care. Volatile anesthetics are frequently used during the perioperative period and protect the heart and kidney against ischemia and reperfusion injury. We aimed to determine whether isoflurane, the most commonly used volatile anesthetic in the USA, protects against endothelial apoptosis and necrosis and the mechanisms involved in this protection. Human endothelial EA.hy926 cells were pretreated with isoflurane or carrier gas (95% room air + 5% CO2) then subjected to apoptosis with tumor necrosis factor-alpha or to necrosis with hydrogen peroxide. DNA laddering and in situ Terminal Deoxynucleotidyl Transferase Biotin-dUTP Nick-End Labeling (TUNEL) staining determined EA.hy926 cell apoptosis and percent LDH released determined necrosis. We also determined whether isoflurane modulates the expression and activity of sphingosine kinase-1 (SK1) and induces the phosphorylation of extracellular signal regulated kinase (ERK MAPK) as both enzymes are known to protect against cell death. Isoflurane pretreatment significantly decreased apoptosis in EA. hy926 cells as evidenced by reduced TUNEL staining and DNA laddering without affecting necrosis. Mechanistically, isoflurane induces the phosphorylation of ERK MAPK and increased SK1 expression and activity in EA.hy926 cells. Finally, selective blockade of SK1 (with SKI-II) or S1P(1) receptor (with W146) abolished the anti-apoptotic effects of isoflurane. Taken together, we demonstrate that isoflurane, in addition to its potent analgesic and anesthetic properties, protects against endothelial apoptosis most likely via SK1 and ERK MAPK activation. Our findings have significant clinical implication for protection of endothelial cells during the perioperative period and patients requiring critical care.	[Bakar, Adnan M.; Park, Sang Won; Kim, Mihwa; Lee, H. Thomas] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY 10032 USA; [Bakar, Adnan M.] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA		Lee, HT (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, P&S Box 46,PH 5,630 W 168th St, New York, NY 10032 USA.	amb9045@nyp.org; swp2109@columbia.edu; mk2767@columbia.edu; TL128@columbia.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 DK-058547, 01 GM-067081]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK058547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM067081] Funding Source: NIH RePORTER	This work was supported by National Institute of Health Grants R01 DK-058547 and 01 GM-067081.	Ait-Oufella H, 2010, INTENS CARE MED, V36, P1286, DOI 10.1007/s00134-010-1893-6; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF1516, DOI 10.1152/ajprenal.00311.2005; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Cason BA, 1997, ANESTHESIOLOGY, V87, P1182, DOI 10.1097/00000542-199711000-00023; Chi OZ, 2010, ANESTH ANALG, V110, P1412, DOI 10.1213/ANE.0b013e3181d6c0ae; de Klaver MJM, 2003, ANESTHESIOLOGY, V99, P896, DOI 10.1097/00000542-200310000-00023; de Klaver MJM, 2002, ANESTHESIOLOGY, V97, P24, DOI 10.1097/00000542-200207000-00005; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jo SK, 2008, KIDNEY INT, V73, P1220, DOI 10.1038/ki.2008.34; Johnson ME, 1996, ANESTHESIOLOGY, V84, P103, DOI 10.1097/00000542-199601000-00013; Kersten JR, 1997, ANESTHESIOLOGY, V87, P361, DOI 10.1097/00000542-199708000-00024; Kim M, 2011, ANN SURG IN PRESS; Kim M, 2010, AM J NEPHROL, V31, P353, DOI 10.1159/000298339; Kim M, 2007, AM J PHYSIOL-RENAL, V293, pF1827, DOI 10.1152/ajprenal.00290.2007; Kimura T, 2001, J BIOL CHEM, V276, P31780, DOI 10.1074/jbc.M104353200; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; Kon SP, 1997, ANESTHESIOLOGY, V86, P128, DOI 10.1097/00000542-199701000-00017; Lee HT, 2006, AM J PHYSIOL-RENAL, V291, pF67, DOI 10.1152/ajprenal.00412.2005; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Lee HT, 2002, AM J PHYSIOL-RENAL, V282, pF844, DOI 10.1152/ajprenal.00195.2001; Lemkuil BP, 2011, ANESTHESIOLOGY, V114, P49, DOI 10.1097/ALN.0b013e318201dcb3; LEVIN ED, 1991, NEUROTOXICOL TERATOL, V13, P461, DOI 10.1016/0892-0362(91)90096-F; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; Lochhead KM, 1998, KIDNEY INT, V54, P373, DOI 10.1046/j.1523-1755.1998.00022.x; Min JK, 2002, ANAL BIOCHEM, V303, P167, DOI 10.1006/abio.2002.5579; Moriue T, 2008, BIOCHEM BIOPH RES CO, V368, P852, DOI 10.1016/j.bbrc.2008.01.155; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Preckel B, 2005, BEST PRACT RES-CLIN, V19, P331, DOI 10.1016/j.bpa.2005.01.003; SHAYEVITZ JR, 1995, SHOCK, V4, P61, DOI 10.1097/00024382-199507000-00010; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stefanec T, 2000, CHEST, V117, P841, DOI 10.1378/chest.117.3.841; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Vessey DA, 2005, ANAL BIOCHEM, V337, P136, DOI 10.1016/j.ab.2004.10.032; Vessey DA, 2006, MED SCI MONITOR, V12, pBR318; Weber NC, 2008, ANESTHESIOLOGY, V108, P199, DOI 10.1097/01.anes.0000299441.32091.ed; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757	45	19	20	0	22	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1661-6596			INT J MOL SCI	Int. J. Mol. Sci.	JAN	2012	13	1					977	993		10.3390/ijms13010977			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	890ZE	WOS:000300184800064	22312298	Green Published, Green Submitted, gold			2022-02-06	
J	Brown, SB; Colantonio, A; Kim, H				Brown, Stephanie B.; Colantonio, Angela; Kim, Hwan			Gender Differences in Discharge Destination Among Older Adults Following Traumatic Brain Injury	HEALTH CARE FOR WOMEN INTERNATIONAL			English	Article							SEVERITY SCORE; OUTCOMES; EPIDEMIOLOGY; CARE; TBI; SEX	Traumatic brain injury (TBI) is a leading cause of death and disability, and the highest in-patient admission rates are among older adults. We identified that gender independently influences discharge destination following TBI in older adults. In this cross-sectional study, we examined discharge destinations of patients admitted to acute care over a 4-year period, as captured by the Ontario Trauma Registry (n = 3,480). Following TBI, women were significantly more likely than men to be sent to long term care facilities rather than home settings (p < .05), controlling for age, injury severity, mechanism of injury, and comorbidities.	[Colantonio, Angela; Kim, Hwan] Toronto Rehabil Inst UHN, Toronto, ON M5G 1V7, Canada; [Brown, Stephanie B.] Univ Toronto, Fac Dent, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Colantonio, A (corresponding author), Toronto Rehabil Inst UHN, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [200603MOP] Funding Source: Medline		Aras MD, 2004, INT J REHABIL RES, V27, P257, DOI 10.1097/00004356-200412000-00001; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Colantonio A., 2003, ONT NEUR FDN IN PROV; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; COOKE RS, 1995, INJURY, V26, P399, DOI 10.1016/0020-1383(95)00064-G; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Holroyd-Leduc JM, 2000, STROKE, V31, P1833, DOI 10.1161/01.STR.31.8.1833; Kim H, 2006, CAN J NEUROL SCI, V33, P48, DOI 10.1017/S0317167100004686; Neale Rachel, 2003, Emerg Med (Fremantle), V15, P38, DOI 10.1046/j.1442-2026.2003.00406.x; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Sorensen EA, 2009, HEART LUNG, V38, P306, DOI 10.1016/j.hrtlng.2008.10.009; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662	20	19	19	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	0739-9332			HEALTH CARE WOMEN IN	Health Care Women Int.		2012	33	10					896	904		10.1080/07399332.2012.673654			9	Public, Environmental & Occupational Health; Women's Studies	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Women's Studies	001FD	WOS:000308444900003	22946592	Green Submitted			2022-02-06	
J	Budinich, CS; Chen, HZ; Lowe, D; Rosenberger, JG; Bernstock, JD; McCabe, JT				Budinich, Craig S.; Chen, HuaZhen; Lowe, Dennell; Rosenberger, John G.; Bernstock, Joshua D.; McCabe, Joseph T.			Mouse Brain PSA-NCAM Levels Are Altered by Graded-Controlled Cortical Impact Injury	NEURAL PLASTICITY			English	Article							CELL-ADHESION MOLECULE; CENTRAL-NERVOUS-SYSTEM; FOCAL CEREBRAL-ISCHEMIA; POLYSIALIC ACID; STRUCTURAL BIOLOGY; PROGENITOR CELLS; ADULT-RAT; IN-VITRO; EXPRESSION; NEUROGENESIS	Traumatic brain injury (TBI) is a worldwide endemic that results in unacceptably high morbidity and mortality. Secondary injury processes following primary injury are composed of intricate interactions between assorted molecules that ultimately dictate the degree of longer-term neurological deficits. One comparatively unexplored molecule that may contribute to exacerbation of injury or enhancement of recovery is the posttranslationally modified polysialic acid form of neural cell adhesion molecule, PSA-NCAM. This molecule is a critical modulator of central nervous system plasticity and reorganization after injury. In this study, we used controlled cortical impact (CCI) to produce moderate or severe TBI in the mouse. Immunoblotting and immunohistochemical analysis were used to track the early (2, 24, and 48 hour) and late (1 and 3 week) time course and location of changes in the levels of PSA-NCAM after TBI. Variable and heterogeneous short-and long-term increases or decreases in expression were found. In general, alterations in PSA-NCAM levels were seen in the cerebral cortex immediately after injury, and these reductions persisted in brain regions distal to the primary injury site, especially after severe injury. This information provides a starting point to dissect the role of PSA-NCAM in TBI-related pathology and recovery.	[Budinich, Craig S.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, FE Hebert Sch Med, Bethesda, MD 20814 USA; [Chen, HuaZhen; Lowe, Dennell; Rosenberger, John G.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, FE Hebert Sch Med, Bethesda, MD 20814 USA; [Bernstock, Joshua D.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Grad Program Mol & Cell Biol, FE Hebert Sch Med, Bethesda, MD 20814 USA; [McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, FE Hebert Sch Med, Bethesda, MD 20814 USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, FE Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	jmccabe@usuhs.mil	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Bernstock, Joshua/0000-0002-7814-3867	TriService Nursing Research Program [N10-P09]; US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-2-0147]; USUHS Concept Award [RO704B]	This work was supported by TriService Nursing Research Program Grant N10-P09 to C. S. Budinich and US Army Medical Research and Materiel Command grant W81XWH-09-2-0147 and a USUHS Concept Award RO704B to J. T. MCabe. The experiments were conducted according to the principles set forth in the Guide for Care and Use of Laboratory Animals, ILAR, National Research Council, DHEW Publication no. (NIH) 73-23. The opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the US Army, Department of Defense, the US government, or the Uniformed Services University of the Health Sciences. The use of trade names does not constitute an official endorsement or approval of the use of such reagents or commercial hardware or software. This paper may not be cited for purposes of advertisement. The investigators appreciated utilization of the preclinical core facilities of the Center for Neuroscience and Regenerative Medicine, USUHS. The authors thank Mr. Eric Prager for assistance with the construction of Figure 7.	Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Asher R A, 2001, Prog Brain Res, V132, P611; Bachelin C, 2010, BRAIN, V133, P406, DOI 10.1093/brain/awp256; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; BONFANTI L, 1992, NEUROSCIENCE, V49, P419, DOI 10.1016/0306-4522(92)90107-D; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown S, 2011, BRAIN INJURY, V25, P453, DOI 10.3109/02699052.2011.556581; Cassens C, 2010, J BIOL CHEM, V285, P28959, DOI 10.1074/jbc.M110.114835; *CDC, 2011, INJ PREV CONTR TRAUM; CHUONG CM, 1984, J NEUROSCI, V4, P2354; Cox ET, 2009, NEUROSCIENCE, V162, P96, DOI 10.1016/j.neuroscience.2009.04.037; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Dominguez MI, 2003, BRAIN RES, V966, P206, DOI 10.1016/S0006-8993(02)04164-1; Duveau V, 2007, NEUROBIOL DIS, V26, P385, DOI 10.1016/j.nbd.2007.01.007; Duveau V, 2010, EUR J NEUROSCI, V32, P89, DOI 10.1111/j.1460-9568.2010.07272.x; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; El Maarouf A, 2010, ADV EXP MED BIOL, V663, P137, DOI 10.1007/978-1-4419-1170-4_9; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gascon E, 2007, DEVELOPMENT, V134, P1181, DOI 10.1242/dev.02808; Gascon E, 2010, ADV EXP MED BIOL, V663, P127, DOI 10.1007/978-1-4419-1170-4_8; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; Hampton T, 2011, JAMA-J AM MED ASSOC, V306, P477, DOI 10.1001/jama.2011.1092; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kiselyov VV, 2010, ADV EXP MED BIOL, V663, P67, DOI 10.1007/978-1-4419-1170-4_4; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Lavdas AA, 2006, GLIA, V53, P868, DOI 10.1002/glia.20340; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Morel MP, 2002, J NEUROCYTOL, V31, P633, DOI 10.1023/A:1025739511646; Nacher J, 2002, BRAIN RES, V927, P111, DOI 10.1016/S0006-8993(01)03241-3; Nielsen J, 2010, ADV EXP MED BIOL, V663, P23, DOI 10.1007/978-1-4419-1170-4_2; NOBLE M, 1985, NATURE, V316, P725, DOI 10.1038/316725a0; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Petridis AK, 2004, DEV DYNAM, V230, P675, DOI 10.1002/dvdy.20094; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Prosser RA, 2003, J NEUROSCI, V23, P652, DOI 10.1523/JNEUROSCI.23-02-00652.2003; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; RUTISHAUSER U, 1976, P NATL ACAD SCI USA, V73, P577, DOI 10.1073/pnas.73.2.577; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Seidenfaden R, 2006, NEUROCHEM INT, V49, P1, DOI 10.1016/j.neuint.2005.12.011; Soares S, 2000, J NEUROSCI, V20, P2551; Soroka V, 2010, ADV EXP MED BIOL, V663, P3, DOI 10.1007/978-1-4419-1170-4_1; Spijker S, 2011, NEUROMETHODS, V57, P13, DOI 10.1007/978-1-61779-111-6_2; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Vutskits L, 2006, NEUROCHEM RES, V31, P215, DOI 10.1007/s11064-005-9021-7; Vutskits L, 2003, EUR J NEUROSCI, V17, P2119, DOI 10.1046/j.1460-9568.2003.02660.x; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Zhang Y, 2007, EUR J NEUROSCI, V25, P351, DOI 10.1111/j.1460-9568.2007.05311.x; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	56	19	19	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2012	2012								378307	10.1155/2012/378307			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989UN	WOS:000307586400001	22848850	Green Published, gold, Green Submitted			2022-02-06	
J	Davis, JJ; Millis, SR; Axelrod, BN				Davis, Jeremy J.; Millis, Scott R.; Axelrod, Bradley N.			Derivation of an Embedded Rey Auditory Verbal Learning Test Performance Validity Indicator	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity; Effort assessment; Forensic neuropsychology; Rey Auditory Verbal Learning Test	INCOMPLETE EFFORT; MODEL SELECTION; RESPONSE BIAS; HEAD-INJURY; DIGIT SPAN; SPECIFICITY; SENSITIVITY; SCORES; NEUROPSYCHOLOGISTS; NAN	This study derived an embedded performance validity indicator for the Rey Auditory Verbal Learning Test (AVLT) using an archival dataset. Participants aged 20 to 65 (N = 167) who reported traumatic brain injury and completed at least two performance validity tests were included. The group who passed all performance validity measures (n = 68) demonstrated higher scores on all AVLT trials than the group who failed two or more validity indicators (n = 62). Bayesian model averaging was used to identify the optimal combination of AVLT variables for group discrimination; Total Learning and Recognition raw scores were selected. Logistic regression using these variables showed excellent discrimination with an area under the curve of .85. The resulting AVLT performance validity index demonstrated sensitivity of .55 with specificity of .91. Further study of this index is warranted and cross-validation is recommended prior to clinical use.	[Davis, Jeremy J.] Univ Utah, Sch Med, Div Phys Med & Rehabil, Salt Lake City, UT 84132 USA; [Millis, Scott R.] Wayne State Univ, Sch Med, Detroit, MI USA; [Axelrod, Bradley N.] Dept Vet Affairs Med Ctr, Detroit, MI USA		Davis, JJ (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, 30 North 1900 East,1R55, Salt Lake City, UT 84132 USA.	jeremy.davis@hsc.utah.edu					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Green P., 2002, GREENS WORD MEMORY T; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; Harrell FE Jr, 2017, REGRESSION MODELING; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MADIGAN D, 1994, J AM STAT ASSOC, V89, P1535, DOI 10.2307/2291017; Meyers J E, 2001, Appl Neuropsychol, V8, P234, DOI 10.1207/09084280152829084; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Millis S. R., 2002, J FORENSIC NEUROPSYC, V2, P147; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; R Development Core Team,, 2012, R LANG ENV STAT COMP; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Raftery A, 2012, BMA BAYESIAN MODEL A; Schutte C., 2012, MILD TRAUMATIC BRAIN; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976; Wang DL, 2004, STAT MED, V23, P3451, DOI 10.1002/sim.1930; Wasserman L, 2000, J MATH PSYCHOL, V44, P92, DOI 10.1006/jmps.1999.1278; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	44	19	19	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	8					1397	1408		10.1080/13854046.2012.728627			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	045LG	WOS:000311696700009	23075400				2022-02-06	
J	Henry, JA; Zaugg, TL; Myers, PJ; Schmidt, CJ; Griest, S; Legro, MW; Kaelin, C; Thielman, EJ; Storzbach, DM; McMillan, GP; Carlson, KF				Henry, James A.; Zaugg, Tara L.; Myers, Paula J.; Schmidt, Caroline J.; Griest, Susan; Legro, Marcia W.; Kaelin, Christine; Thielman, Emily J.; Storzbach, Daniel M.; McMillan, Garnett P.; Carlson, Kathleen F.			Pilot study to develop telehealth tinnitus management for persons with and without traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast injury; clinical trial; cognitive-behavioral therapy; education; hearing disorders; military Veterans; rehabilitation; telehealth; tinnitus; traumatic brain injury	TELEPHONE PSYCHOTHERAPY; HOSPITAL ANXIETY; WAR VETERANS; DEPRESSION; HEALTH; PREVALENCE; MODERATE; BLAST; IRAQ; CARE	Tinnitus, or "ringing in the ears," affects 10%-15% of adults; cases can be problematic and require lifelong management. Many people who have experienced traumatic brain injury (TBI) also experience tinnitus. We developed Progressive Tinnitus Management (PTM), which uses education and counseling to help patients learn how to self-manage their reactions to tinnitus. We adapted PTM by delivering the intervention via telephone and by adding cognitive-behavioral therapy. A pilot study was conducted to evaluate the feasibility and potential efficacy of this approach for individuals with and without TBI. Participants with clinically significant tinnitus were recruited into three groups: probable symptomatic mild TBI (n = 15), moderate to severe TBI (n = 9), and no symptomatic TBI (72 = 12). Participants received telephone counseling (six sessions over 6 months) by an audiologist and a psychologist. Questionnaires were completed at baseline, 12 weeks, and 24 weeks. All groups showed trends reflecting improvement in self-perceived functional limitations due to tinnitus. A follow-up randomized clinical study is underway.	[Henry, James A.; Zaugg, Tara L.; Griest, Susan; Legro, Marcia W.; Kaelin, Christine; Thielman, Emily J.; McMillan, Garnett P.] VA Med Ctr, Dept Vet Affairs VA Rehabil Res & Dev Natl Ctr Re, Portland, OR USA; [Henry, James A.; Griest, Susan] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Myers, Paula J.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Schmidt, Caroline J.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Schmidt, Caroline J.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Storzbach, Daniel M.] VA Med Ctr, Neuropsychol Clin, Portland, OR USA; [Storzbach, Daniel M.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Storzbach, Daniel M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Carlson, Kathleen F.] VA Med Ctr, VA Hlth Serv Res & Dev Portland Ctr Study Chron C, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA		Henry, JA (corresponding author), VA Med Ctr NCRAR, POB 1034, Portland, OR 97207 USA.	james.henry@va.gov			VA, VHA, Rehabilitation Research and Development Service [C6770R, F7070S, C2659C]; VA, VHA, Health Services Research and Development Career Development Award Program [08-025]	This material was based on work supported by the VA, VHA, Rehabilitation Research and Development Service (grants C6770R, F7070S, C2659C). Dr. Carlson's efforts were supported by the VA, VHA, Health Services Research and Development Career Development Award Program (grant 08-025).	Andersson G, 2002, CLIN PSYCHOL REV, V22, P977, DOI 10.1016/S0272-7358(01)00124-6; Beck J.S., 1995, COGNITIVE THERAPY BA; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Chandler D W, 1997, J Am Acad Audiol, V8, P81; Cohen J., 2013, STAT POWER ANAL BEHA; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; DelliFraine JL, 2008, J TELEMED TELECARE, V14, P62, DOI 10.1258/jtt.2007.070709; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Godleski L, 2008, BEHAV SCI LAW, V26, P271, DOI 10.1002/bsl.811; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Henry J, 1998, TINNITUS TREATMENT R, P99; Henry J. A., 2010, MANAGE YOUR TINNITUS; HENRY JA, PROGR TINNITUS MANAG, P44760; Henry JA, 2010, PROGR TINNITUS MANAG; HENRY JA, 2008, MANAGE YOUR TINNITUS; HENRY JA, 2009, MANAGE YOUR TINNITUS, P44760; Henry JA, 2007, J REHABIL RES DEV, V44, P21, DOI 10.1682/JRRD.2006.02.0018; Henry JA, 2010, J FAM PRACTICE, V59, P389; Henry JA, 2009, NOISE HEALTH, V11, P33, DOI 10.4103/1463-1741.45311; Henry James A, 2008, Trends Amplif, V12, P170, DOI 10.1177/1084713808319941; Hersh WR, 2006, AHRQ PUBLICATION; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverson G.L., 2006, BRAIN INJURY MED PRI, P333; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KRUMM M, 2008, AUDIOLOGY TODAY, V20, P36; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lipsey M., 1990, DESIGN SENSITIVITY S; Martinez Devesa P., 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD005233.PUB2; McCrea M., 2008, MILD TRAUMATIC BRAIN; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; MYERS P, 2003, WRITTEN MAT RESOURCE, P44760; Newman C W, 1998, J Am Acad Audiol, V9, P153; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Newman CW, 2004, TINNITUS THEORY MANA, P237; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Simon GE, 2009, ARCH GEN PSYCHIAT, V66, P1081, DOI 10.1001/archgenpsychiatry.2009.123; Snow J, 2004, TINNITUS THEORY MANA, P16; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Stetler CB, 2006, J GEN INTERN MED, V21, pS1, DOI [10.1007/s11606-006-0267-9, 10.1111/j.1525-1497.2006.00355.x]; Sweetow R., 2000, TINNITUS HDB, P297; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TELEHEALTH WBJ, 2001, J GERONTOL NURS, V27, P9; Tuerk PW, 2010, TELEMED J E-HEALTH, V16, P115, DOI 10.1089/tmj.2009.0144; Tutty S, 2005, GEN HOSP PSYCHIAT, V27, P400, DOI 10.1016/j.genhosppsych.2005.06.009; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WILKINSON MJB, 1988, J ROY COLL GEN PRACT, V38, P311; ZAUGG TL, 2003, P 7 INT TINN SEM 200, P226; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zoger S, 2001, AUDIOLOGY, V40, P133	61	19	21	1	18	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1025	1042		10.1682/JRRD.2010.07.0125			18	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149EZ	WOS:000319303100007	23341277	Bronze			2022-02-06	
J	Hsieh, MY; Ponsford, J; Wong, D; McKay, A				Hsieh, Ming-Yun; Ponsford, Jennie; Wong, Dana; McKay, Adam			Exploring variables associated with change in cognitive behaviour therapy (CBT) for anxiety following traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						anxiety; cognitive behaviour therapy; traumatic brain injury	WORKING ALLIANCE; PANIC DISORDER; REHABILITATION; DEPRESSION; DEFICITS; METAANALYSIS; VALIDATION; PREDICTORS; EXPECTANCY; RETENTION	Purpose: In a pilot randomized controlled trial, we investigated the effectiveness of a 12-weekly anxiety treatment programme adapted for individuals with moderate-severe TBI, based on cognitive behaviour therapy (CBT) and Motivational Interviewing (MI). The current study explored the variables associated with treatment response and group differences in change expectancy and working alliance. Methods: Twenty-seven participants recruited from a brain injury rehabilitation hospital were randomly assigned to MI + CBT, non-directive counselling (NDC) + CBT and treatment-as-usual and assessors were blinded to treatment conditions. Correlation and multiple regression were used to examine the association between reduction in anxiety ratings and a number of clinical, injury and cognitive variables. Random effects regression was used to examine group difference in changes in working alliance and expectancy. Results: There was a trend suggesting that greater injury severity may be predictive of poorer response to CBT and injury severity was significantly related to memory functioning. Participants receiving MI pre-treatment showed a greater increase in change expectancy at the end of CBT and at follow-up, but not at the end of MI. Conclusions: There is a need to further investigate the effectiveness of treatment for individuals with different injury severity and to explore the relationship between change expectancy and treatment outcome.	[Hsieh, Ming-Yun; Ponsford, Jennie; Wong, Dana; McKay, Adam] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Hsieh, Ming-Yun; Ponsford, Jennie; McKay, Adam] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Hsieh, Ming-Yun] Victorian Rehabil Ctr, Melbourne, Vic, Australia		Hsieh, MY (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	ming-yun.hsieh@monash.edu	McKay, Adam JD/M-6003-2017; Wong, Dana/AAD-3410-2020	McKay, Adam JD/0000-0002-0479-7681; Wong, Dana/0000-0001-9619-1929	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Monash UniversityMonash University; Victorian Brain Injury Recovery Association (Australia)	This study was supported in part by grants from the National Health and Medical Research Council and Monash University, and a scholarship from the Victorian Brain Injury Recovery Association (Australia). The funding sources had no role in study design and analysis of data. The authors alone were responsible for the content and writing of the paper.	Aharonovich E, 2006, DRUG ALCOHOL DEPEN, V81, P313, DOI 10.1016/j.drugalcdep.2005.08.003; Aharonovich E, 2003, DRUG ALCOHOL DEPEN, V71, P207, DOI 10.1016/S0376-8716(03)00092-9; Aharonovich E, 2008, DRUG ALCOHOL DEPEN, V95, P279, DOI 10.1016/j.drugalcdep.2008.01.009; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Boardman T, 2006, J SUBST ABUSE TREAT, V31, P329, DOI 10.1016/j.jsat.2006.05.006; Brabban A, 2009, SCHIZOPHRENIA BULL, V35, P859, DOI 10.1093/schbul/sbp065; Burgess P.W., 1997, HAYLING BRIXTON TEST; Coughlin A, 2007, MEMORY INFORM PROCES; Craighead WE, 2005, CLIN PSYCHOL-SCI PR, V12, P189, DOI 10.1093/clipsy/bpi024; Dow MGT, 2007, PSYCHOL MED, V37, P1493, DOI 10.1017/S0033291707000670; Dozois DJA, 2005, BEHAV RES THER, V43, P1655, DOI 10.1016/j.brat.2004.12.001; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Field A., 2017, DISCOVERING STAT USI, V5th; First M, 2007, STRUCTURED CLIN INTE; Fleming JM, 1996, BRAIN INJURY, V10, P1; Haby MM, 2006, AUST NZ J PSYCHIAT, V40, P9, DOI 10.1080/j.1440-1614.2006.01736.x; Hatcher RL, 2006, PSYCHOTHER RES, V16, P12, DOI 10.1080/10503300500352500; Hox J.J., 2010, QUANTITATIVE METHODO, V2; Hsieh M-Y, 2010, MOTIVATIONA IN PRESS; Jumisko E, 2007, DISABIL REHABIL, V29, P1535, DOI 10.1080/09638280601055816; Kazantzis N, 2007, COGN BEHAV PRACT, V14, P317, DOI 10.1016/j.cbpra.2006.08.003; Kazantzis N, 2010, CLIN PSYCHOL-SCI PR, V17, P144, DOI 10.1111/j.1468-2850.2010.01204.x; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Miller W.R., 2002, MOTIVATIONAL INTERVI; Mohlman J, 2005, BEHAV RES THER, V43, P447, DOI 10.1016/j.brat.2004.03.007; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Renison B, 2010, CONCURRENT ECOLOGICA; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; SHADISH WR, 1991, J CONSULT CLIN PSYCH, V59, P883, DOI 10.1037/0022-006X.59.6.883; Soo C, 2007, COCHRANE DATABASE SY, P3; StatCorp, 2009, STAT STAT SOFTW REL; Westra HA, 2007, MOTIVATIONAL INTERVI, P26; Westra HA, 2007, J CONSULT CLIN PSYCH, V75, P363, DOI 10.1037/0022-006X.75.3.363; Westra HA, 2006, COGNITIVE THER RES, V30, P481, DOI 10.1007/s10608-006-9016-y; Wood Angela M, 2004, Clin Trials, V1, P368; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	19	19	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2012	34	5					408	415		10.3109/09638288.2011.607219			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	876CV	WOS:000299085700005	22087644				2022-02-06	
S	Ono, T; Galanopoulou, AS		Ahmad, SI		Ono, Tomonori; Galanopoulou, Aristea S.			EPILEPSY AND EPILEPTIC SYNDROME	NEURODEGENERATIVE DISEASES	Advances in Experimental Medicine and Biology		English	Article; Book Chapter							TEMPORAL-LOBE EPILEPSY; ELECTRICAL STATUS EPILEPTICUS; TUBEROUS SCLEROSIS COMPLEX; MAGNETIC-RESONANCE-SPECTROSCOPY; MULTICENTER RANDOMIZED-TRIAL; REDUCES SPONTANEOUS SEIZURES; LITHIUM-PILOCARPINE MODEL; PROGRESSIVE NEURONAL LOSS; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SCLEROSIS	Epilepsy is one of the most common neurological disorders. In most patients with epilepsy, seizures respond to available medications. However, a significant number of patients, especially in the setting of medically-intractable epilepsies, may experience different degrees of memory or cognitive impairment, behavioral abnormalities or psychiatric symptoms, which may limit their daily functioning. As a result, in many patients, epilepsy may resemble a neurodegenerative disease. Epileptic seizures and their potential impact on brain development, the progressive nature of epileptogenesis that may functionally alter brain regions involved in cognitive processing, neurodegenerative processes that relate to the underlying etiology, comorbid conditions or epigenetic factors, such as stress, medications, social factors, may all contribute to the progessive nature of epilepsy. Clinical and experimental studies have addressed the pathogenetic mechanisms underlying epileptogenesis and neurodegeneration. We will primarily focus on the findings derived from studies on one of the most common causes of focal onset epilepsy, the temporal lobe epilepsy, which indicate that both processes are progressive and utilize common or interacting pathways. In this chapter we will discuss some of these studies, the potential candidate targets for neuroprotective therapies as well as the attempts to identify early biomarkers of progression and epileptogenesis, so as to implement therapies with early-onset disease-modifying effects.	[Ono, Tomonori; Galanopoulou, Aristea S.] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10467 USA; [Galanopoulou, Aristea S.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA		Galanopoulou, AS (corresponding author), Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10467 USA.	aristea.galanopoulou@einstein.yu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS62947, NS20253, K02 NS062947] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS020253, R01NS020253, K02NS062947] Funding Source: NIH RePORTER		Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; ALBALA BJ, 1984, DEV BRAIN RES, V13, P139, DOI 10.1016/0165-3806(84)90085-3; Andersson-Roswall L, 2010, NEUROLOGY, V74, P1977, DOI 10.1212/WNL.0b013e3181e39684; Andre VM, 2010, EPILEPSIA, V51, P166, DOI 10.1111/j.1528-1167.2010.02634.x; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Badawy RAB, 2009, J CLIN NEUROSCI, V16, P485, DOI 10.1016/j.jocn.2008.10.001; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berg AT, 2001, NEUROLOGY, V56, P1445, DOI 10.1212/WNL.56.11.1445; Berg AT, 2010, OPTN SRTR ANN REP, P9; Beume LA, 2010, NEUROPEDIATRICS, V41, P135, DOI 10.1055/s-0030-1263155; Bittigau P, 2003, ANN NY ACAD SCI, V993, P103, DOI 10.1111/j.1749-6632.2003.tb07517.x; Blumcke I, 1999, J COMP NEUROL, V414, P437, DOI 10.1002/(SICI)1096-9861(19991129)414:4<437::AID-CNE2>3.0.CO;2-3; Blumenfeld H, 2008, EPILEPSIA, V49, P400, DOI 10.1111/j.1528-1167.2007.01458.x; Boyett JM, 2001, HIPPOCAMPUS, V11, P418, DOI 10.1002/hipo.1056; Brodie MJ, 2005, ACTA NEUROL SCAND, V112, P36, DOI 10.1111/j.1600-0404.2005.00507.x; Brooks-Kayal AR, 2009, NEUROTHERAPEUTICS, V6, P312, DOI 10.1016/j.nurt.2009.01.019; Buckmaster PS, 1999, J NEUROPHYSIOL, V81, P712, DOI 10.1152/jn.1999.81.2.712; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; CAVAZOS JE, 1990, BRAIN RES, V527, P1, DOI 10.1016/0006-8993(90)91054-K; CAVAZOS JE, 1994, J NEUROSCI, V14, P3106; Cavazos JE, 2006, EPILEPSY BEHAV, V8, P483, DOI 10.1016/j.yebeh.2006.01.011; CENDES F, 1993, ANN NEUROL, V34, P795, DOI 10.1002/ana.410340607; Cepeda C, 2010, EPILEPSIA, V51, P160, DOI 10.1111/j.1528-1167.2010.02633.x; Chen CM, 2008, J NEUROSCI RES, V86, P2696, DOI 10.1002/jnr.21706; Connelly A, 1998, NEUROLOGY, V51, P61, DOI 10.1212/WNL.51.1.61; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; Darke K, 2010, ARCH DIS CHILD, V95, P382, DOI 10.1136/adc.2009.160606; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; Dhanushkodi A, 2008, NEUROSCI BIOBEHAV R, V32, P657, DOI 10.1016/j.neubiorev.2007.10.004; Dube C, 2004, ANN NEUROL, V56, P709, DOI 10.1002/ana.20266; Elliott-Hunt CR, 2002, J NEUROCHEM, V80, P416, DOI 10.1046/j.0022-3042.2001.00712.x; Elsharkawy AE, 2009, EPILEPSY RES, V86, P191, DOI 10.1016/j.eplepsyres.2009.06.008; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Engel J, 2005, ADV BEHAV BIOL, V55, P371; Engel J, 2010, EPILEPSIA, V51, P2363, DOI 10.1111/j.1528-1167.2010.02701.x; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Galanopoulou AS, 2008, CURR NEUROPHARMACOL, V6, P1, DOI 10.2174/157015908783769653; Galanopoulou AS, 2008, J NEUROSCI, V28, P1557, DOI 10.1523/JNEUROSCI.5180-07.2008; Galanopoulou AS, 2009, EPILEPSIA, V50, P37, DOI 10.1111/j.1528-1167.2009.02217.x; Galanopoulou AS, 2002, DEV NEUROSCI-BASEL, V24, P355, DOI 10.1159/000069047; Galanopoulou AS, 2003, NEUROSCI LETT, V342, P201, DOI 10.1016/S0304-3940(03)00282-9; Galanopoulou AS, 2000, BRAIN DEV-JPN, V22, P279, DOI 10.1016/S0387-7604(00)00127-3; Giblin KA, 2010, NEUROSCIENTIST, V16, P253, DOI 10.1177/1073858409354385; Gleissner U, 2005, BRAIN, V128, P2822, DOI 10.1093/brain/awh597; Goffin K, 2009, EXP NEUROL, V217, P205, DOI 10.1016/j.expneurol.2009.02.008; Gomes WA, 2007, MAGN RESON MED, V58, P230, DOI 10.1002/mrm.21310; Guo X, 2001, EUR J NEUROSCI, V13, P1683, DOI 10.1046/j.0953-816x.2001.01542.x; Guo Y, 2009, NEUROSCIENCE, V162, P972, DOI 10.1016/j.neuroscience.2009.05.041; Hamed SA, 2010, RESTOR NEUROL NEUROS, V28, P323, DOI 10.3233/RNN-2010-0537; Hermann B, 2002, EPILEPSIA, V43, P1062, DOI 10.1046/j.1528-1157.2002.49901.x; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Holmes GL, 2007, EPILEPSIA, V48, P617, DOI 10.1111/j.1528-1167.2007.01035.x; Hrachovy RA, 2003, J CLIN NEUROPHYSIOL, V20, P408, DOI 10.1097/00004691-200311000-00004; Isaeva E, 2006, EUR J NEUROSCI, V23, P1559, DOI 10.1111/j.1460-9568.2006.04693.x; JAMBAQUE I, 1993, NEUROPSYCHOLOGIA, V31, P1321, DOI 10.1016/0028-3932(93)90101-5; Jonas R, 2004, NEUROLOGY, V62, P1712, DOI 10.1212/01.WNL.0000127109.14569.C3; Jupp B, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2007.01245.x; Kabuto H, 1998, EPILEPSIA, V39, P237, DOI 10.1111/j.1528-1157.1998.tb01367.x; Kalviainen R, 1998, NEUROLOGY, V50, P1377, DOI 10.1212/WNL.50.5.1377; Kamida T, 2009, SEIZURE-EUR J EPILEP, V18, P71, DOI 10.1016/j.seizure.2008.06.012; Kim CH, 2010, EPILEPSY RES, V90, P21, DOI 10.1016/j.eplepsyres.2010.03.002; Kivity S, 2004, EPILEPSIA, V45, P255, DOI 10.1111/j.0013-9580.2004.30503.x; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Komatsu M, 2000, EPILEPSIA, V41, P1091, DOI 10.1111/j.1528-1157.2000.tb00312.x; KOO B, 1993, NEUROLOGY, V43, P2322, DOI 10.1212/WNL.43.11.2322; Kotloski R, 2002, PROG BRAIN RES, V135, P95; Kuster GW, 2007, ARQ NEURO-PSIQUIAT, V65, P1101, DOI 10.1590/S0004-282X2007000700002; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2001, LANCET, V357, P216, DOI 10.1016/S0140-6736(00)03600-X; Larner AJ, 2010, NEUROMOL MED, V12, P71, DOI 10.1007/s12017-009-8076-z; Liacu D, 2010, NEUROPHYSIOL CLIN, V40, P151, DOI 10.1016/j.neucli.2010.01.003; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; LOMBROSO CT, 1983, EPILEPSIA, V24, P135, DOI 10.1111/j.1528-1157.1983.tb04874.x; Lopantsev V, 2009, EUR J NEUROSCI, V29, P1153, DOI 10.1111/j.1460-9568.2009.06663.x; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Lux AL, 2005, LANCET NEUROL, V4, P712, DOI 10.1016/S1474-4422(05)70199-X; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Mathern GW, 1997, HIPPOCAMPAL SCLEROSI, P133; McVicar KA, 2004, MENT RETARD DEV D R, V10, P144, DOI 10.1002/mrdd.20028; Mendez MF, 2003, DRUG AGING, V20, P791, DOI 10.2165/00002512-200320110-00001; Meyerhoff JL, 2004, BRAIN RES, V1016, P139, DOI 10.1016/j.brainres.2004.03.019; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mirrione MM, 2006, SYNAPSE, V59, P119, DOI 10.1002/syn.20216; Miyamoto R, 2008, BRAIN RES, V1209, P85, DOI 10.1016/j.brainres.2008.02.064; Moldrich RX, 2003, EUR J PHARMACOL, V476, P3, DOI 10.1016/S0014-2999(03)02149-6; Mori A, 2004, ACTA MED OKAYAMA, V58, P111; Motamedi G, 2003, EPILEPSY BEHAV, V4, pS25, DOI 10.1016/j.yebeh.2003.07.004; Muller-Schwarze AB, 1999, NEUROREPORT, V10, P1517, DOI 10.1097/00001756-199905140-00023; Naegele JR, 2007, EPILEPSIA, V48, P107, DOI 10.1111/j.1528-1167.2007.01071.x; Naegele JR, 2010, NEUROPHARMACOLOGY, V58, P855, DOI 10.1016/j.neuropharm.2010.01.019; Nairismagi J, 2004, EPILEPSIA, V45, P1024, DOI 10.1111/j.0013-9580.2004.08904.x; Napolioni V, 2009, BRAIN DEV-JPN, V31, P104, DOI 10.1016/j.braindev.2008.09.013; Noe F, 2007, PEPTIDES, V28, P377, DOI 10.1016/j.peptides.2006.07.025; Nordli DR, 2010, BRAIN DEV-JPN, V32, P37, DOI 10.1016/j.braindev.2009.09.015; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; OLEARY DS, 1983, J NERV MENT DIS, V171, P624, DOI 10.1097/00005053-198310000-00006; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Paradiso B, 2009, P NATL ACAD SCI USA, V106, P7191, DOI 10.1073/pnas.0810710106; Partikian A, 2010, J CHILD NEUROL, V25, P423, DOI 10.1177/0883073809341664; Pellock JM, 2010, EPILEPSIA, V51, P2175, DOI 10.1111/j.1528-1167.2010.02657.x; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2004, EXPERT OPIN PHARMACO, V5, P777, DOI 10.1517/eoph.5.4.777.30162; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Pitkanen A, 2010, EPILEPSIA, V51, P2, DOI 10.1111/j.1528-1167.2010.02602.x; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Pretel S, 1997, ACTA HISTOCHEM, V99, P71, DOI 10.1016/S0065-1281(97)80010-4; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Raol YSH, 2003, ANN NEUROL, V53, P503, DOI 10.1002/ana.10490; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Rener-Primec Z, 2006, EPILEPSIA, V47, P2202, DOI 10.1111/j.1528-1167.2006.00888.x; Riikonen RS, 2010, EUR J PAEDIATR NEURO, V14, P13, DOI 10.1016/j.ejpn.2009.03.004; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Roch C, 2002, EPILEPSIA, V43, P1129, DOI 10.1046/j.1528-1157.2002.17802.x; Roch C, 2002, EPILEPSIA, V43, P325, DOI 10.1046/j.1528-1157.2002.11301.x; Rugg-Gunn FJ, 2001, BRAIN, V124, P627, DOI 10.1093/brain/124.3.627; Salmenpera T, 2001, EPILEPSY RES, V46, P69, DOI 10.1016/S0920-1211(01)00258-3; Sanchez RM, 2001, J NEUROSCI, V21, P8154, DOI 10.1523/JNEUROSCI.21-20-08154.2001; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Sharma V, 2007, SEIZURE-EUR J EPILEP, V16, P680, DOI 10.1016/j.seizure.2007.05.012; Shen J, 2009, J INT MED RES, V37, P1211, DOI 10.1177/147323000903700428; Shih JJ, 2004, EPILEPSIA, V45, P223, DOI 10.1111/j.0013-9580.2004.13503.x; Shinnar S, 2008, NEUROLOGY, V71, P170, DOI 10.1212/01.wnl.0000310774.01185.97; SHINNAR S, 1994, EPILEPSIA, V35, P471, DOI 10.1111/j.1528-1157.1994.tb02464.x; Shinnar S, 1996, PEDIATRICS, V98, P216; Shon YM, 2010, EPILEPSIA, V51, P529, DOI 10.1111/j.1528-1167.2009.02327.x; Spanaki MV, 2000, EPILEPSIA, V41, P1227, DOI 10.1111/j.1528-1157.2000.tb00330.x; Spooner CG, 2006, NEUROLOGY, V67, P2147, DOI 10.1212/01.wnl.0000248189.93630.4f; STAFSTROM CE, 1992, DEV BRAIN RES, V65, P227, DOI 10.1016/0165-3806(92)90184-X; SUTULA T, 1992, J NEUROSCI, V12, P4173; Sutula Thomas, 2002, Epilepsy Curr, V2, P86, DOI 10.1046/j.1535-7597.2002.00032.x; Sutula TP, 2003, CURR OPIN NEUROL, V16, P189, DOI 10.1097/00019052-200304000-00012; Swann JW, 2007, DEV NEUROSCI-BASEL, V29, P168, DOI 10.1159/000096221; Tasch E, 1999, ANN NEUROL, V45, P568, DOI 10.1002/1531-8249(199905)45:5<568::AID-ANA4>3.0.CO;2-P; TASSINARI CA, 1992, EPILEPSY RES, P111; Tassinari CA, 2006, EPILEPSIA, V47, P40, DOI 10.1111/j.1528-1167.2006.00686.x; Theodore WH, 1999, NEUROLOGY, V52, P132, DOI 10.1212/WNL.52.1.132; Thom M, 2002, J NEUROPATH EXP NEUR, V61, P510, DOI 10.1093/jnen/61.6.510; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tokumitsu T, 1997, BRAIN RES, V744, P57, DOI 10.1016/S0006-8993(96)01071-2; Tubbs RS, 2005, CHILD NERV SYST, V21, P461, DOI 10.1007/s00381-005-1136-2; VanLandingham KE, 1998, ANN NEUROL, V43, P413, DOI 10.1002/ana.410430403; Veliskova J, 2001, ANN NEUROL, V50, P596, DOI 10.1002/ana.1248; Vezzani A, 2008, EPILEPSIA, V49, P24, DOI 10.1111/j.1528-1167.2008.01490.x; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Wang YY, 2010, BRAIN PATHOL, V20, P1, DOI 10.1111/j.1750-3639.2008.00254.x; WHO, 2009, EP FACT SHEET 2009; Wieshmann UC, 1997, EPILEPSIA, V38, P1238, DOI 10.1111/j.1528-1157.1997.tb01222.x; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; Woermann FG, 1999, ANN NEUROL, V45, P369, DOI 10.1002/1531-8249(199903)45:3<369::AID-ANA13>3.0.CO;2-Q; Wong M, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2007.01270.x; Yan HD, 2005, EPILEPSIA, V46, P1170, DOI 10.1111/j.1528-1167.2005.35204.x; Yang TH, 2010, J NEUROL SCI, V296, P1, DOI 10.1016/j.jns.2010.06.002; YOKOI I, 1995, FREE RADICAL BIO MED, V19, P473, DOI 10.1016/0891-5849(95)00050-8; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang G, 2004, NEUROSCIENCE, V125, P299, DOI 10.1016/j.neuroscience.2004.01.040	165	19	20	1	10	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	0065-2598	2214-8019	978-1-4614-0652-5; 978-1-4614-0653-2	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2012	724						99	113			10.1007/978-1-4614-0653-2		15	Medicine, Research & Experimental; Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	BA2XJ	WOS:000333978900010	22411237				2022-02-06	
J	Stalnacke, BM				Stalnacke, Britt Marie			Postconcussion Symptoms in Patients with Injury-Related Chronic Pain	REHABILITATION RESEARCH AND PRACTICE			English	Article							POST-CONCUSSION SYMPTOMS; TRAUMATIC BRAIN-INJURY; CEREBRAL SYMPTOMS; HEAD-INJURY; QUESTIONNAIRE; COMPLAINTS; SCALE	Background. Postconcussion symptoms (PCSs)-such as fatigue, headache, irritability, dizziness, and impaired memory-are commonly reported in patients who have mild traumatic brain injuries (MTBIs). Evaluation of PCS after MTBI is proposed to have a diagnostic value although it is unclear whether PCS are specific to MTBI. After whiplash injuries, patients most often complain of headaches and neck pain; the other PCS are not as closely evaluated. In patients with chronic pain because of other injuries, the presence of PCS is unclear. This study aimed to describe the frequency of PCS in patients with injury-related pain and to examine the relationships between PCS, pain, and psychological factors. Methods. This study collected data using questionnaires addressing PCS (Rivermead Postconcussion Questionnaire, RPQ), pain intensity (Visual Analogue Scale), depression, anxiety (Hospital, Anxiety, and Depression Scale), and posttraumatic stress (Impact of Event Scale). Results. Fatigue (90.7%), sleep disturbance (84.9%), headache (73.5%), poor concentration (88.2%), and poor memory (67.1%) were some of the most commonly reported PCS. Significant relationships were found between PCS and posttraumatic stress, depression, and anxiety. Conclusion. To optimize treatment, it is important to assess each patient's PCS, the mechanism of injury, and factors such as posttraumatic stress and depression.	[Stalnacke, Britt Marie] Umea Univ, Umea Univ Hosp, Dept Community Med & Rehabil, Bldg 9A, S-90185 Umea, Sweden		Stalnacke, BM (corresponding author), Umea Univ, Umea Univ Hosp, Dept Community Med & Rehabil, Bldg 9A, S-90185 Umea, Sweden.	brittmarie.stalnacke@rehabmed.umu.se					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 1979, Pain, V6, P249; BARNSLEY L, 1994, PAIN, V58, P283, DOI 10.1016/0304-3959(94)90123-6; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Valenza MC, 2011, J BODYW MOV THER, V15, P262, DOI 10.1016/j.jbmt.2010.07.009; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; KISCHKA U, 1991, EUR NEUROL, V31, P136, DOI 10.1159/000116663; KRAUS JF, 1989, MILD MODERATE HEAD I, P9; Kyhlback M, 2002, INT J REHABIL RES, V25, P181, DOI 10.1097/00004356-200209000-00003; Merrick Daniel, 2010, BMC Res Notes, V3, P190, DOI 10.1186/1756-0500-3-190; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Scrimshaw SV, 2001, J MANIP PHYSIOL THER, V24, P501, DOI 10.1067/mmt.2001.118208; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; *WHO, 1997, ICD 10 INT STAT CLAS; Williamson E, 2008, PAIN, V135, P20, DOI 10.1016/j.pain.2007.04.035; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	19	19	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2867	2090-2875		REHABIL RES PRACT	Rehabil. Res. Pract.		2012	2012								528265	10.1155/2012/528265			5	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V18NK	WOS:000214757900020	22685666	gold, Green Submitted, Green Published			2022-02-06	
J	Valiyaveettil, M; Alamneh, Y; Miller, SA; Hammamieh, R; Wang, Y; Arun, P; Wei, YL; Oguntayo, S; Nambiar, MP				Valiyaveettil, Manojkumar; Alamneh, Yonas; Miller, Stacy-Ann; Hammamieh, Rasha; Wang, Ying; Arun, Peethambaran; Wei, Yanling; Oguntayo, Samuel; Nambiar, Madhusoodana P.			Preliminary studies on differential expression of auditory functional genes in the brain after repeated blast exposures	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						auditory functional genes; auditory process; blast injury; cadherin; hearing loss; neurotrauma; otoancorin; otoferlin; protocadherin; tinnitus	INDUCED HEARING-LOSS; CU/ZN-SUPEROXIDE-DISMUTASE; GATED CALCIUM-CHANNEL; HEAT-SHOCK PROTEINS; HAIR-CELLS; INNER-EAR; NOISE OVERSTIMULATION; MOUSE COCHLEA; TIP LINK; INJURY	The mechanisms of central auditory processing involved in auditory/vestibular injuries and subsequent tinnitus and hearing loss in Active Duty servicemembers exposed to blast are not currently known. We analyzed the expression of hearing-related genes in different regions of the brain 6 h after repeated blast exposures in mice. Preliminary data showed that the expression of the deafness-related genes otoferlin and otoancorin was significantly changed in the hippocampus after blast exposures. Differential expression of cadherin and protocadherin genes, which are involved in hearing impairment, was observed in the hippocampus, cerebellum, frontal cortex, and midbrain after repeated blasts. A series of calcium-signaling genes that are known to be involved in auditory signal processing were also found to be significantly altered after repeated blast exposures. The hippocampus and midbrain showed significant increase in the gene expression of hearing loss-related antioxidant enzymes. Histopathology of the auditory cortex showed more significant injury in the inner layer compared to the outer layer. In summary, mice exposed to repeated blasts showed injury to the auditory cortex and significant alterations in multiple genes in the brain known to be involved in age- or noise-induced hearing impairment.	[Valiyaveettil, Manojkumar; Alamneh, Yonas; Wang, Ying; Arun, Peethambaran; Wei, Yanling; Oguntayo, Samuel; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Miller, Stacy-Ann; Hammamieh, Rasha] USA, Ctr Environm Hlth Res, Med Res & Mat Command, Ft Detrick, MD USA		Valiyaveettil, M (corresponding author), Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	m.valiyaveettil@amedd.army.mil; madhusoodana.nambiar@amedd.army.mil					Abaamrane L, 2011, EUR ARCH OTO-RHINO-L, V268, P987, DOI 10.1007/s00405-011-1487-0; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Elgoyhen AB, 2009, BIOCHEM PHARMACOL, V78, P712, DOI 10.1016/j.bcp.2009.05.023; Beurg M, 2010, J NEUROSCI, V30, P13281, DOI 10.1523/JNEUROSCI.2528-10.2010; Bolz Hanno, 2004, Hum Mutat, V24, P274, DOI 10.1002/humu.9272; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Choi BY, 2009, CLIN GENET, V75, P237, DOI 10.1111/j.1399-0004.2008.01128.x; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; ELSAMMAA M, 1986, AM J OTOL, V7, P241; Fairfield DA, 2005, J NEUROSCI RES, V81, P589, DOI 10.1002/jnr.20417; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fetoni AR, 2009, ACTA OTORHINOLARYNGO, V29, P70; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gong TW, 2012, JARO-J ASSOC RES OTO, V13, P29, DOI 10.1007/s10162-011-0289-9; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Jovine L, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-28; Kathiresan T, 2009, MOL CELL PROTEOMICS, V8, P1972, DOI 10.1074/mcp.M800495-MCP200; Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009; Kelley A., 2010, 201016 US ARM AER RE; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Le T, 2007, HEARING RES, V226, P194, DOI 10.1016/j.heares.2006.04.003; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; McFadden Sandra L., 2001, Noise Health, V3, P49; Momiyama J, 2006, TOHOKU J EXP MED, V209, P89, DOI 10.1620/tjem.209.89; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Mrena R, 2002, AUDIOL NEURO-OTOL, V7, P122, DOI 10.1159/000057660; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Ohlemiller KK, 2006, BRAIN RES, V1091, P89, DOI 10.1016/j.brainres.2006.03.017; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; Ohlemiller KK, 2000, HEARING RES, V149, P239, DOI 10.1016/S0378-5955(00)00191-X; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P219, DOI 10.1159/000013845; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Pangrsic T, 2010, NAT NEUROSCI, V13, P869, DOI 10.1038/nn.2578; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P3227, DOI 10.1074/jbc.M806177200; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; Reisinger E, 2011, J NEUROSCI, V31, P4886, DOI 10.1523/JNEUROSCI.5122-10.2011; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Scherer EQ, 2002, STROKE, V33, P2965, DOI 10.1161/01.STR.0000043673.22993.FD; Schug N, 2006, EUR J NEUROSCI, V24, P3372, DOI 10.1111/j.1460-9568.2006.05225.x; Shen HY, 2011, HEARING RES, V277, P184, DOI 10.1016/j.heares.2011.01.009; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Spencer RF, 2002, HEARING RES, V171, P129, DOI 10.1016/S0378-5955(02)00494-X; Uemaetomari I, 2009, TOHOKU J EXP MED, V218, P41, DOI 10.1620/tjem.218.41; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Zheng QY, 2005, HUM MOL GENET, V14, P103, DOI 10.1093/hmg/ddi010; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999	54	19	21	1	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1153	1162		10.1682/JRRD.2011.09.0182			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149EZ	WOS:000319303100016	23341286	Bronze			2022-02-06	
J	Viano, DC; Withnall, C; Wonnacott, M				Viano, David C.; Withnall, Chris; Wonnacott, Michael			Effect of Mouthguards on Head Responses and Mandible Forces in Football Helmet Impacts	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Protective headgear; Recreation and sport; Concussion; Helmets; Sport equipment	PROFESSIONAL FOOTBALL; PROTECTIVE EQUIPMENT; DENTAL INJURIES; CONCUSSION; PREVENTION; PLAYERS; SPORTS	The potential for mouthguards to change the risk of concussion was studied in football helmet impacts. The Hybrid III head was modified with an articulating mandible, dentition, and compliant temporomandibular joints (TMJ). It was instrumented for triaxial head acceleration and triaxial force at the TMJs and upper dentition. Mandible force and displacement were validated against cadaver impacts to the chin. In phase 1, one of five mouthguards significantly lowered HIC in 6.7 m/s impacts (p = 0.025) from the no mouthguard condition but not in 9.5 m/s tests. In phase 2, eight mouthguards increased HIC from +1 to +17% in facemask impacts that loaded the chinstraps and mandible; one was statistically higher (p = 0.018). Peak head acceleration was +1 to +15% higher with six mouthguards and 2-3% lower with two others. The differences were not statistically significant. Five of eight mouthguards significantly reduced forces on the upper dentition by 40.8-63.9%. Mouthguards tested in this study with the Hybrid III articulating mandible lowered forces on the dentition and TMJ, but generally did not influence HIC or concussion risks.	[Viano, David C.] ProBiomechanics LLC, Bloomfield Hills, MI 48304 USA; [Withnall, Chris; Wonnacott, Michael] Biokinet & Associates Ltd, Ottawa, ON K1H 1E1, Canada		Viano, DC (corresponding author), ProBiomechanics LLC, 265 Warrington Rd, Bloomfield Hills, MI 48304 USA.	dviano@comcast.net			National Football League	The testing at Biokinetics and Associates Ltd. was funded by the National Football League. Their support of the research on the effects of mouthguards on head responses is appreciated. The opinions presented here are those of the authors and not necessarily those of the NFL. The development of the articulating mandible for the Hybrid III,<SUP>8,41</SUP> cadaver testing and development of biofidelity corridors for impacts to the chin<SUP>6,7,9</SUP> and the series of helmet testing reported here were completed while the lead author was a member of the NFL's MTBI Committee and oversaw the research.	Backaitis S. H., 1994, HYBRID; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Beachy G, 2004, J ATHL TRAINING, V39, P310; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Chou CC, 1974, SAE T, P398; Craig M., 2006, AM SOC MECH ENG 2006; Craig M. J., 2009, 2009010388 SAE; Craig M. J., 2007, THESIS WAYNE STATE U; Craig M, 2008, J BIOMECH, V41, P2972, DOI 10.1016/j.jbiomech.2008.07.020; Dalley AF., 1999, CLIN ORIENTED ANATOM; DIPIETRO GJ, 1976, J PROSTHET DENT, V36, P624, DOI 10.1016/0022-3913(76)90026-3; Dragulescu D., 2002, 10 C MECH VIBR INT P; Echlin PS, 2005, BRIT J SPORT MED, V39, P254, DOI 10.1136/bjsm.2004.013128; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Goodson J. M., 1975, MONOGRAPHS ORAL SCI, V5; Halstead P. D, 2011, COMPEND CONTIN ED DE, V30, P18; Hubbard R., 1994, HYBRID; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; KOOLSTRA JH, 1995, J DENT RES, V74, P1564, DOI 10.1177/00220345950740091001; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lacrosse U. S, 2003, US POS STAT US MOUTH; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; MERTZ HJ, 1989, 890756 SAE; Mertz HJ, 2001, 45 STAPP CAR CRASH C; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Moore K, 1992, CLIN ORIENTED ANATOM; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Raaii F, 2011, CLIN J SPORT MED, V21, P320, DOI 10.1097/JSM.0b013e31821f5cd7; Roberson T. M., 2001, STURDEVANTS ART SCI; Robin S, 2001, HUMOS HUMAN MODEL SA; Rowson Steven, 2008, Biomed Sci Instrum, V44, P195; SAE (Society of Automotive Engineers), 1995, J2111 SAE; Society of Automotive Engineer (SAE), 1994, J1733 SAE; STEDMAN TL, 1995, STEDMANS MED DICT; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Warnet L, 2001, BRIT J SPORT MED, V35, P257, DOI 10.1136/bjsm.35.4.257; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Wonnacott M., 2010, 2010010136 SAE; Zawawi Khalid H, 2003, J Can Dent Assoc, V69, P737; Zhang FT, 2002, J BIOMECH, V35, P975, DOI 10.1016/S0021-9290(02)00057-X	43	19	19	1	25	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		47	69		10.1007/s10439-011-0399-x			23	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	895HJ	WOS:000300486700005	21994059				2022-02-06	
J	Warren, DE; Duff, MC; Magnotta, V; Capizzano, AA; Cassell, MD; Tranel, D				Warren, David E.; Duff, Melissa C.; Magnotta, Vincent; Capizzano, Aristides A.; Cassell, Martin D.; Tranel, Daniel			Long-Term Neuropsychological, Neuroanatomical, and Life Outcome in Hippocampal Amnesia	CLINICAL NEUROPSYCHOLOGIST			English	Article						Amnesia; Hippocampus; Memory; Medial temporal lobe; Anoxia	MEDIAL TEMPORAL-LOBE; TRAUMATIC BRAIN-INJURY; ENDURING MEMORY IMPAIRMENT; DELAYED NEURONAL DEATH; HIGH-RESOLUTION MRI; RETROGRADE-AMNESIA; STATUS EPILEPTICUS; RELATIONAL MEMORY; FOLLOW-UP; DECLARATIVE MEMORY	Focal bilateral hippocampal damage typically causes severe and selective amnesia for new declarative information (facts and events), a cognitive deficit that greatly impacts the ability to live a normal, fully independent life. We describe the case of 1846, a 48-year-old woman with profound hippocampal amnesia following status epilepticus and an associated anoxic episode at age 30. Patient 1846 has undergone extensive neuropsychological testing on many occasions over the 18 years since her injury, and we present data indicating that her memory impairment has remained severe and stable during that time. New, high-resolution, structural MRI studies of 1846's brain reveal substantial bilateral hippocampal atrophy resembling that of other well-known amnesic patients. In spite of severe amnesia 1846 lives a full and mostly independent adult life, facilitated by an extensive social support network of family and friends. Her case provides an example of a rare and unlikely positive outcome in the face of severe memory problems.	[Warren, David E.; Duff, Melissa C.; Tranel, Daniel] Univ Iowa, Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Duff, Melissa C.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Magnotta, Vincent; Capizzano, Aristides A.] Univ Iowa, Coll Med, Dept Radiol, Iowa City, IA 52242 USA; [Cassell, Martin D.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Tranel, Daniel] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA		Warren, DE (corresponding author), Univ Iowa, Coll Med, Dept Neurol, 200 Hawkins Dr,2192 RCP, Iowa City, IA 52242 USA.	davideugenewarren@gmail.com	Capizzano, Aristides A./AAC-5963-2019	Magnotta, Vincent/0000-0001-8639-5354; Warren, David/0000-0003-0539-2587; Capizzano, Aristides/0000-0003-1950-8499; Tranel, Daniel/0000-0002-1338-1389	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS19632]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS019632] Funding Source: NIH RePORTER	This work was supported by the following funding sources: NINDS P50 NS19632 (DT). The authors would like to express their gratitude to 1846, her husband, and her parents for consenting to participate in our research and for the interviews that informed this case report. The authors would also like to thank Dr. Steven W. Anderson, Dr. Sara Cavaco, Kenneth Manzel, and Joel Bruss for their contributions to this report.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; ALBERT MS, 1981, ARCH NEUROL-CHICAGO, V38, P495, DOI 10.1001/archneur.1981.00510080057008; ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; Allen JS, 2006, J CLIN EXP NEUROPSYC, V28, P457, DOI 10.1080/13803390590949287; Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Auer RN, 2002, GREENFIELDS NEUROPAT, V7th, P233; BARR WB, 1990, NEUROPSYCHOLOGIA, V28, P243, DOI 10.1016/0028-3932(90)90018-J; Barrash J., 1997, J INT NEUROPSYCH SOC, V3, P27; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BENTON A, 1994, BENTON LAB TESTS; Benton AL, 1994, MULTILINGUAL APHASIA; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; BRIERLEY JB, 1973, ARCH NEUROL-CHICAGO, V29, P367, DOI 10.1001/archneur.1973.00490300029003; Bright P, 2006, LEARN MEMORY, V13, P545, DOI 10.1101/lm.265906; BROOKS DN, 1976, NEUROPSYCHOLOGIA, V14, P111, DOI 10.1016/0028-3932(76)90012-9; Buchanan TW, 2009, HORM BEHAV, V56, P44, DOI 10.1016/j.yhbeh.2009.02.011; Buchanan TW, 2005, J NEUROSCI, V25, P3151, DOI 10.1523/JNEUROSCI.4735-04.2005; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Cavaco S, 2004, BRAIN, V127, P1853, DOI 10.1093/brain/awh208; Clark E, 2009, ISSUES DIVERS CLIN N, P69, DOI 10.1007/978-0-387-76908-0_4; Cohen, 2001, CONDITIONING CONSCIO; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Cohen NJ., 1993, MEMORY AMNESIA HIPPO; Corkin S, 1997, J NEUROSCI, V17, P3964; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CORSELLIS JAN, 1983, STATUS EPILEPTICUS M, P129; Damasio A. R., 1989, HDB NEUROPSYCHOLOGY; DAMASIO AR, 1985, ARCH NEUROL-CHICAGO, V42, P252, DOI 10.1001/archneur.1985.04060030070012; Davachi L, 2008, CURR DIR PSYCHOL SCI, V17, P112, DOI 10.1111/j.1467-8721.2008.00559.x; DeFilippis N., 1997, BOOKLET CATEGORY TES, V2nd; DEGIORGIO CM, 1992, EPILEPSIA, V33, P23, DOI 10.1111/j.1528-1157.1992.tb02278.x; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dietl T, 2004, EPILEPSY BEHAV, V5, P394, DOI 10.1016/j.yebeh.2004.01.004; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Duff MC, 2006, NAT NEUROSCI, V9, P140, DOI 10.1038/nn1601; Duff MC, 2008, J CLIN EXP NEUROPSYC, V30, P931, DOI 10.1080/13803390801894681; Duff MC, 2008, APHASIOLOGY, V22, P866, DOI 10.1080/02687030701844196; Duff MC, 2007, APHASIOLOGY, V21, P702, DOI 10.1080/02687030701192265; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Feinstein JS, 2010, P NATL ACAD SCI USA, V107, P7674, DOI 10.1073/pnas.0914054107; Feinstein JS, 2010, J CLIN EXP NEUROPSYC, V32, P88, DOI 10.1080/13803390903066873; Fujikawa DG, 2005, EPILEPSY BEHAV, V7, pS3, DOI 10.1016/j.yebeh.2005.08.003; Fujikawa DG, 1996, BRAIN RES, V725, P11, DOI 10.1016/0006-8993(96)00203-X; GilNagel A, 1997, BRAIN, V120, P183, DOI 10.1093/brain/120.1.183; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; Golden CJ, 1978, STROOP COLOR WORD TE; Goodglass H., 1972, ASSESSMENT APHASIA R; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; Graham KS, 2010, NEUROPSYCHOLOGIA, V48, P831, DOI 10.1016/j.neuropsychologia.2010.01.001; Grant D. A., 1993, WISCONSIN CARD SORTI; Grubb NR, 2000, STROKE, V31, P1509, DOI 10.1161/01.STR.31.7.1509; Guerreiro CAM, 2001, EPILEPSY BEHAV, V2, P224, DOI 10.1006/ebeh.2001.0167; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; Holdstock JS, 2000, NEUROPSYCHOLOGIA, V38, P410, DOI 10.1016/S0028-3932(99)00099-8; Hooper H., 1958, HOOPER VISUAL ORG TE; Horstmann A, 2010, NEUROLOGY, V74, P306, DOI 10.1212/WNL.0b013e3181cbcd6f; Jones RD, 1998, NEUROCASE, V4, P471, DOI 10.1080/13554799808410640; Kaplan E, 1983, BOSTON NAMING TEST; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Knake S, 2009, EPILEPSY BEHAV, V15, P10, DOI 10.1016/j.yebeh.2009.02.027; Konkel A, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.015.2008; KRUMHOLZ A, 1995, NEUROLOGY, V45, P1499, DOI 10.1212/WNL.45.8.1499; Lin JJ, 2007, CEREB CORTEX, V17, P2007, DOI 10.1093/cercor/bhl109; LUCAS E, 1881, RECREATIONS MATH; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Matthews CG., 1964, INSTRUCTION MANUAL A; Mayes AR, 2002, HIPPOCAMPUS, V12, P325, DOI 10.1002/hipo.1111; Mayes AR, 2001, COGNITIVE NEUROPSYCH, V18, P97, DOI 10.1080/02643290125897; McCarthy RA, 2005, NEUROPSYCHOLOGIA, V43, P356, DOI 10.1016/j.neuropsychologia.2004.06.024; McKinley JC, 1944, J APPL PSYCHOL, V28, P153, DOI 10.1037/h0059245; Meldrum B. S., 1997, NEUROPATHOL APPL NEU, V23, P201; Meldrum BS, 1997, NEUROPATH APPL NEURO, V23, P185, DOI 10.1111/j.1365-2990.1997.tb01201.x; MEYER A, 1955, J NEUROL NEUROSUR PS, V18, P24, DOI 10.1136/jnnp.18.1.24; Milner B., 1962, PSYCHOL HIPPOCAMPE, P272; Moscovitch M, 1998, CURR OPIN NEUROBIOL, V8, P297, DOI 10.1016/S0959-4388(98)80155-4; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Mueller SG, 2007, NEUROBIOL AGING, V28, P719, DOI 10.1016/j.neurobiolaging.2006.03.007; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; NEVANDER G, 1985, ANN NEUROL, V18, P281, DOI 10.1002/ana.410180303; NG T, 1989, ACTA NEUROPATHOL, V78, P438, DOI 10.1007/BF00688181; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Oxbury S, 1997, NEUROPSYCHOLOGIA, V35, P975, DOI 10.1016/S0028-3932(97)00025-0; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Radovsky A, 1997, TOXICOL PATHOL, V25, P500, DOI 10.1177/019262339702500512; Ranganath C, 2010, HIPPOCAMPUS, V20, P1263, DOI 10.1002/hipo.20852; Reitan R, 1985, HALSTEAD REITAN NEUR; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ribot, 1881, MALADIES MEMOIRE; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Salat DH, 2006, HIPPOCAMPUS, V16, P936, DOI 10.1002/hipo.20222; SANDERS HI, 1971, BRAIN, V94, P661, DOI 10.1093/brain/94.4.661; SCOVILLE WB, 1954, J NEUROSURG, V11, P64, DOI 10.3171/jns.1954.11.1.0064; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sivan AB., 1992, BENTON VISUAL RETENT; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SQUIRE LR, 1989, EXP NEUROL, V105, P23, DOI 10.1016/0014-4886(89)90168-4; SQUIRE LR, 1989, J NEUROSCI, V9, P828; Stark SM, 2010, LEARN MEMORY, V17, P284, DOI 10.1101/lm.1768110; Stefanacci L, 2000, J NEUROSCI, V20, P7024, DOI 10.1523/JNEUROSCI.20-18-07024.2000; Suhr J, 1999, NEUROPSYCHOL REHABIL, V9, P31, DOI 10.1080/713755590; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Tate R., 2004, ESSENTIAL HDB MEMORY, P329; Teasdale TW, 2005, BRAIN INJURY, V19, P1049, DOI 10.1080/02699050500110421; Tranel D, 2006, J CLIN EXP NEUROPSYC, V28, P43, DOI 10.1080/13803390490919344; Tranel D, 2006, NEUROPSYCHOLOGY, V20, P1, DOI 10.1037/0894-4105.20.1.1; Tranel D, 2005, J CLIN EXP NEUROPSYC, V27, P102, DOI 10.1080/138033990513663; VOLPE BT, 1985, NEUROLOGY, V35, P1793, DOI 10.1212/WNL.35.12.1793; Voss JL, 2011, P NATL ACAD SCI USA, V108, pE402, DOI 10.1073/pnas.1100225108; Walker M., 2007, HIPPOCAMPUS BOOK, P769; Warren DE, 2012, HIPPOCAMPUS, V22, P1577, DOI 10.1002/hipo.21000; Warren DE, 2011, J COGNITIVE NEUROSCI, V23, P3862, DOI 10.1162/jocn_a_00089; Warren DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00035; Warrington E, 1984, RECOGNITION MEMORY T, V1; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1987, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wieshmann UC, 1999, J ANAT, V195, P131, DOI 10.1046/j.1469-7580.1999.19510131.x; Wilkinson, 1984, WIDE RANGE ACHIEVEME; Wilson B. A., 1999, CASE STUDIES NEUROPS, P43; Wilson BA, 1996, BRAIN INJURY, V10, P863, DOI 10.1080/026990596123846; WILSON BA, 1995, BROKEN MEMORIES CASE, P14; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	135	19	19	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	2					335	369		10.1080/13854046.2012.655781			35	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	936EO	WOS:000303573900011	22401298	Green Accepted			2022-02-06	
J	Webb, JW; Batchelor, J; Meares, S; Taylor, A; Marsh, NV				Webb, James W.; Batchelor, Jennifer; Meares, Susanne; Taylor, Alan; Marsh, Nigel V.			Effort Test Failure: Toward a Predictive Model	CLINICAL NEUROPSYCHOLOGIST			English	Article						Symptom validity testing; Malingering; Effort; Depression; Psychosis; Illness behavior	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TESTS; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; DISABILITY PENSION; CLASSIFICATION ACCURACY; MEMORY PERFORMANCE; CROSS-VALIDATION; POOR EFFORT; TEST-SCORES; SICK-LEAVE	Predictors of effort test failure were examined in an archival sample of 555 traumatically brain-injured (TBI) adults. Logistic regression models were used to examine whether compensation-seeking, injury-related, psychological, demographic, and cultural factors predicted effort test failure (ETF). ETF was significantly associated with compensation-seeking (OR = 3.51, 95% CI [1.25, 9.79]), low education (OR: .83 [. 74, .94]), self-reported mood disorder (OR: 5.53 [3.10, 9.85]), exaggerated displays of behavior (OR: 5.84 [2.15, 15.84]), psychotic illness (OR: 12.86 [3.21, 51.44]), being foreign-born (OR: 5.10 [2.35, 11.06]), having sustained a workplace accident (OR: 4.60 [2.40, 8.81]), and mild traumatic brain injury severity compared with very severe traumatic brain injury severity (OR: 0.37 [0.13, 0.995]). ETF was associated with a broader range of statistical predictors than has previously been identified and the relative importance of psychological and behavioral predictors of ETF was evident in the logistic regression model. Variables that might potentially extend the model of ETF are identified for future research efforts.	[Webb, James W.; Batchelor, Jennifer; Meares, Susanne; Taylor, Alan] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Marsh, Nigel V.] James Cook Univ, Dept Psychol, Singapore, Singapore		Webb, JW (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.	james.webb@xtra.co.nz	Marsh, Nigel V./F-5433-2019; Marsh, Nigel/ABA-3609-2021	Marsh, Nigel V./0000-0002-4060-6432; Marsh, Nigel/0000-0002-4060-6432; Batchelor, Jennifer/0000-0003-4438-4993; Meares, Susanne/0000-0002-3859-9974; Taylor, Alan/0000-0003-1137-0691			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; Belsley DA., 1980, REGRESSION DIAGNOSTI, DOI 10.1002/0471725153; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bierley RA, 2001, BRAIN INJURY, V15, P697, DOI 10.1080/02699050010013671; Boone KB, 1999, CLIN NEUROPSYCHOL, V13, P414; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bruusgaard D, 2010, SCAND J PUBLIC HEALT, V38, P686, DOI 10.1177/1403494810378916; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chafetz M, 2011, APPL NEUROPSYCHOL, V18, P143, DOI 10.1080/09084282.2011.570619; Dandachi-FitzGerald B, 2011, CLIN NEUROPSYCHOL, V25, P812, DOI 10.1080/13854046.2011.583280; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Dragano N, 2011, REHABILITATION, V50, P28, DOI 10.1055/s-0030-1270431; Ekman P, 2006, BEHAV SCI LAW, V24, P673, DOI 10.1002/bsl.729; Faul M, 2010, TRAUMATIC BRAIN INJU; Flach PA, 2008, SCAND J PUBLIC HEALT, V36, P713, DOI 10.1177/1403494808092251; Goldberg H.E., 2007, ASSESSMENT FEIGNED C, P281; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P, 2001, CLIN NEUROPSYCHOL, V15, P492, DOI 10.1076/clin.15.4.492.1887; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2009, NEUROPSYCHOLOGY MALI, P132; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Hardin J. W., 1995, STATA TECHNICAL B; Harrell FE Jr, 2017, REGRESSION MODELING; Henry GK, 2011, APPL NEUROPSYCHOL, V18, P47, DOI 10.1080/09084282.2010.523385; Hoffman E, 1996, AM ECON REV, V86, P653; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Jones A, 2011, CLIN NEUROPSYCHOL, V25, P1207, DOI 10.1080/13854046.2011.600726; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Killeen PR, 2009, PSYCHOL REV, V116, P602, DOI 10.1037/a0016414; Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183; Kuoppala J, 2011, J OCCUP ENVIRON MED, V53, P633, DOI 10.1097/JOM.0b013e31821aa48c; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 2007, ASSESSMENT MALINGERE, P3; Lemeshow S, 2000, APPL LOGISTIC REGRES; Mahdavi ME, 2011, ARCH IRAN MED, V14, P58, DOI 011141/AIM.0013; Mason S, 2002, J TRAUMA, V53, P98, DOI 10.1097/00005373-200207000-00019; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLER H, 1972, LANCET, V1, P580; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; OLEARY A, 1985, BEHAV RES THER, V23, P437, DOI 10.1016/0005-7967(85)90172-X; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ruocco AC, 2005, ARCH CLIN NEUROPSYCH, V20, P883; Salazar X.F., 2007, ASSESSMENT FEIGNED C, P405; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Statacorp, 2011, STAT REL 12 STAT SOF; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr J. A., 2007, ASSESSMENT MALINGERE, P334; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sumanti M, 2006, CLIN NEUROPSYCHOL, V20, P754, DOI 10.1080/13854040500428467; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Torres X, 2009, GEN HOSP PSYCHIAT, V31, P137, DOI 10.1016/j.genhosppsych.2008.12.001; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Wenzel M, 2004, J ECON PSYCHOL, V25, P213, DOI 10.1016/S0167-4870(02)00168-X; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	92	19	19	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	8					1377	1396		10.1080/13854046.2012.728248			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	045LG	WOS:000311696700008	23061431				2022-02-06	
J	Huang, APH; Lee, CW; Hsieh, HJ; Yang, CC; Tsai, YH; Tsuang, FY; Kuo, LT; Chen, YS; Tu, YK; Huang, SJ; Liu, HM; Tsai, JC				Huang, Abel Po-Hao; Lee, Chung-Wei; Hsieh, Hong-Jen; Yang, Chi-Cheng; Tsai, Yi-Hsin; Tsuang, Fon-Yih; Kuo, Lu-Ting; Chen, Yuan-Shen; Tu, Yong-Kwang; Huang, Sheng-Jean; Liu, Hon-Man; Tsai, Jui-Chang			Early Parenchymal Contrast Extravasation Predicts Subsequent Hemorrhage Progression, Clinical Deterioration, and Need for Surgery in Patients With Traumatic Cerebral Contusion	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head trauma; Contrast extravasation; Perfusion; Computed tomography; Contusion; Blood-brain barrier	ACUTE ISCHEMIC-STROKE; SPOT SIGN SCORE; INTRACEREBRAL HEMORRHAGE; BRAIN-INJURY; IDENTIFIES PATIENTS; HIGHEST RISK; HEAD TRAUMA; BLOOD-FLOW; TRANSFORMATION; PERMEABILITY	Background: This study aimed to identify early radiologic signs that are predictive of hemorrhage progression and clinical deterioration in patients with traumatic cerebral contusion. We hypothesized that contrast extravasation (CE) and blood-brain barrier disruption might be associated with hemorrhage progression, brain edema, and clinical deterioration in these patients. Methods: Twenty-two patients with traumatic cerebral contusion (diagnosed on initial noncontrast head computed tomography [CT]) who initially did not require surgical intervention were enrolled in this study. Contrast-enhanced and perfusion CT scans were performed within 6 hours of injury, and follow-up noncontrast CT scans were performed at 24 hours and 72 hours. Results: In each noncontrast CT scan, the volumes of the contusion hemorrhage and edema were calculated using computerized planimetric techniques. The initial Glasgow Coma Scale, hemorrhage progression, clinical deterioration, and the need for subsequent surgery were recorded. The early radiologic findings were compared with these parameters and functional outcome at 6 months to identify predictive radiologic signs. CE was present in 9 of 22 patients (41%) and was highly associated with hemorrhage progression (p < 0.05), clinical deterioration (p < 0.01), and need for subsequent surgery (p < 0.01). In addition, patients with CE had a greater volume of edema at 24 hours (p < 0.01) and 72 hours (p < 0.01) than those who did not have CE. However, CE was not found to be associated with poor outcome. Conclusions: Early parenchymal CE is associated with hemorrhage progression, cerebral edema, clinical deterioration, and need for subsequent surgery. These patients should be monitored closely, and early surgery may be needed if deterioration occurs. Further elucidation of the pathophysiology is needed to formulate effective treatment for these high-risk patients.	[Huang, Abel Po-Hao; Tsai, Yi-Hsin; Tsuang, Fon-Yih; Kuo, Lu-Ting; Chen, Yuan-Shen; Tu, Yong-Kwang; Huang, Sheng-Jean; Tsai, Jui-Chang] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Tsai, Yi-Hsin; Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Lee, Chung-Wei; Liu, Hon-Man] Natl Taiwan Univ Hosp, Dept Radiol, Taipei, Taiwan; [Huang, Abel Po-Hao; Kuo, Lu-Ting; Chen, Yuan-Shen; Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Dept Surg, Yun Lin Branch, Yunlin, Taiwan; [Hsieh, Hong-Jen] Natl Taiwan Univ Hosp, Dept Radiol, Yun Lin Branch, Yunlin, Taiwan; [Tsai, Jui-Chang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei, Taiwan; [Yang, Chi-Cheng] Chang Gung Univ, Grad Inst Clin Behav Sci, Tao Yuan, Taiwan; [Yang, Chi-Cheng] Chang Gung Univ, Dept Occupat Therapy, Tao Yuan, Taiwan		Tsai, JC (corresponding author), 7 Chung Shan S Rd, Taipei 100, Taiwan.	jctsai@ntu.edu.tw	Liu, Hon-Man/B-1352-2012; Kuo, Lu-Ting/AAU-3205-2021	Tsuang, Fon-Yih/0000-0001-5797-1885; TSAI, JUI-CHANG/0000-0003-2723-6841; Tu, Yong-kwang/0000-0003-2113-1176; LIU, HON-MAN/0000-0001-6715-6366; Kuo, Lu-Ting/0000-0002-1405-8700; LEE, CHUNG-WEI/0000-0002-3573-2506; HUANG, ABEL PO-HAO/0000-0002-5689-6761			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Almandoz JED, 2010, STROKE, V41, P54, DOI 10.1161/STROKEAHA.109.565382; Almandoz JED, 2009, STROKE, V40, P2994, DOI 10.1161/STROKEAHA.109.554667; Chakraborty S, 2010, BRIT J RADIOL, V83, pE216, DOI 10.1259/bjr/74416385; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Hallevi H, 2010, CEREBROVASC DIS, V29, P217, DOI 10.1159/000267842; Hom J, 2011, AM J NEURORADIOL, V32, P41, DOI 10.3174/ajnr.A2244; Jander S, 2007, STROKE, V38, P642, DOI 10.1161/01.STR.0000250048.42916.ad; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Powers WJ, 2010, STROKE, V41, pS107, DOI 10.1161/STROKEAHA.110.595058; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Vo KD, 2003, AM J NEURORADIOL, V24, P674; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Zaharchuk G, 2007, AM J NEURORADIOL, V28, P1850, DOI 10.3174/ajnr.A0831	23	19	21	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1593	1599		10.1097/TA.0b013e31822c8865			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	869RT	WOS:000298616400026	22182869				2022-02-06	
J	Wei, XE; Wang, D; Li, MH; Zhang, YZ; Li, YH; Li, WB				Wei, Xiao-Er; Wang, Dan; Li, Ming-Hua; Zhang, Yu-Zhen; Li, Yue-Hua; Li, Wen-Bin			A Useful Tool for the Initial Assessment of Blood-Brain Barrier Permeability After Traumatic Brain Injury in Rabbits: Dynamic Contrast-Enhanced Magnetic Resonance Imaging	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Dynamic contrast-enhanced MRI; T2-weighted imaging; Blood-brain barrier; Traumatic brain injury; Rabbit	CLOSED-HEAD INJURY; T-1-WEIGHTED MRI; LESION VOLUME; ACUTE STROKE; IN-VIVO; DISRUPTION; RAT; DYSFUNCTION; DISEASE; MODELS	Objective: The aim of this study was to evaluate the role of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and its quantitative coefficient (K(trans)) in the assessment of the extent of traumatic brain injury (TBI) in a rabbit model. Methods: A weight-drop device (height, 20 cm) was used with varying impact force, 30-, 60-, or 90-g weight, to induce mild, moderate, or severe TBI, respectively. DCE-MRI and T2-weighted MRI was used to examine the injured groups and a sham group 1 day after TBI. We analyzed the relationship between K(trans) and the lesion volume on the basis of T2-weighted images in each group. Results: The lesion volumes in both the severe and the moderate injury groups were greater than those observed in the mild injury group (p < 0.01). Furthermore, the lesion volumes in the severe injury group tended to be greater than those seen in the moderate injury group (p = 0.053). The K(trans) values in all injury groups were greater than those observed in the sham group (p < 0.01). In addition, the K(trans) values in the severe and moderate injury groups were greater than those of the mild injury group (p < 0.01), and the values seen in the severe injury group tended to be greater than those of the moderate injury group (p = 0.08). Moreover, we observed a correlation between the K(trans) value and lesion volume in all injury groups (mild injury group: r = 0.766, p = 0.01; moderate injury group: r = 0.731, p = 0.04; and severe injury group: r = 0.886, p = 0.019). Conclusions: DCE-MRI and its quantitative coefficient, K(trans), have the potential to accurately assess the blood-brain barrier and the extent of injury in an in vivo model of TBI.	[Wei, Xiao-Er; Wang, Dan; Li, Ming-Hua; Zhang, Yu-Zhen; Li, Yue-Hua; Li, Wen-Bin] Shanghai Jiao Tong Univ, Dept Intervent & Diagnost Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China		Li, WB (corresponding author), 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin@sh163.net			Science and Technology Commission of Shanghai Municipality, ShanghaiScience & Technology Commission of Shanghai Municipality (STCSM) [08411951200]	Supported by a grant part from Science and Technology Commission of Shanghai Municipality, Shanghai (Grant No. 08411951200).	Abo-Ramadan U, 2009, EXP NEUROL, V219, P328, DOI 10.1016/j.expneurol.2009.06.002; Adelson PD, 1998, ACT NEUR S, V71, P104; Armitage PA, 2011, MAGN RESON IMAGING, V29, P305, DOI 10.1016/j.mri.2010.09.002; Barrett KM, 2009, STROKE, V40, P2422, DOI 10.1161/STROKEAHA.109.548933; Bartels AL, 2008, J NEURAL TRANSM, V115, P1001, DOI 10.1007/s00702-008-0030-y; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bowman GL, 2007, NEUROLOGY, V68, P1809, DOI 10.1212/01.wnl.0000262031.18018.1a; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Darling WG, 2009, EXP NEUROL, V220, P90, DOI 10.1016/j.expneurol.2009.07.034; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Larsson HBW, 2009, MAGN RESON MED, V62, P1270, DOI 10.1002/mrm.22136; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lemasson B, 2010, RADIOLOGY, V257, P342, DOI 10.1148/radiol.10092343; Lorberboym M, 2003, J NUCL MED, V44, P1898; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Noworolski SM, 2008, MAGN RESON IMAGING, V26, P1071, DOI 10.1016/j.mri.2008.01.033; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P295, DOI 10.1196/annals.1403.022; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Song SK, 2011, NEUROBIOL AGING, V32, P2183, DOI 10.1016/j.neurobiolaging.2009.12.017; Thijs VN, 2000, STROKE, V31, P2597, DOI 10.1161/01.STR.31.11.2597; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Turkbey B, 2010, DIAGN INTERV RADIOL, V16, P186, DOI 10.4261/1305-3825.DIR.2537-08.1; Vidarsson L, 2009, MAGN RESON IMAGING, V27, P1216, DOI 10.1016/j.mri.2009.01.019; Wang GM, 2009, BRAIN RES, V1294, P183, DOI 10.1016/j.brainres.2009.07.070; Wang HL, 2006, J MAGN RESON IMAGING, V24, P695, DOI 10.1002/jmri.20669; Wuerfel E, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-70; Yang FY, 2010, J MAGN RESON IMAGING, V32, P593, DOI 10.1002/jmri.22297; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	41	19	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1645	1650		10.1097/TA.0b013e31823498eb			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	869RT	WOS:000298616400037	22182873				2022-02-06	
J	Cameron, RP; Mona, LR; Syme, ML; Cordes, CC; Fraley, SS; Chen, SS; Klein, LS; Welsh, E; Smith, K; Lemos, L				Cameron, Rebecca P.; Mona, Linda R.; Syme, Maggie L.; Cordes, Colleen Clemency; Fraley, Sarah S.; Chen, Suzie S.; Klein, Leslie S.; Welsh, Elizabeth; Smith, Kimberly; Lemos, Larry			Sexuality Among Wounded Veterans of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND): Implications for Rehabilitation Psychologists	REHABILITATION PSYCHOLOGY			English	Article						sex; veterans; disability; PTSD; TBI	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COGNITIVE-PROCESSING THERAPY; COMBAT VETERANS; MILITARY SERVICE; HEALTH; WOMEN; SCALE; PEOPLE; DYSFUNCTION	Objective: The sexual lives of returning Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) veterans have only been discussed minimally in the psychological literature. Given the nature of military social and cultural contexts, the potential for exposure to combat-related stressors that may lead to posttraumatic stress disorder (PTSD), and the risk of traumatic brain injury secondary to physical injury, the potential for significant psychological and relational ramifications exists. This article focuses on the intimate relationships and sexuality of returning OIF/OEF/OND veterans within the context of their personal cultural variables and the diverse experience of being a part of military life. Conclusions: Culturally competent assessment and evidenced-based treatment approaches are highlighted to offer clinicians initial strategies to begin treatment of sexuality issues within the returning Veteran population. These clinical tools are discussed within a positive psychology approach that emphasizes healthy sexuality as a part of overall satisfactory quality of life.	[Cameron, Rebecca P.] Calif State Univ Sacramento, Dept Psychol, Sacramento, CA 95819 USA; [Fraley, Sarah S.] VA Long Beach Healthcare Syst, Behav Hlth, Long Beach, CA USA; [Syme, Maggie L.] SDSU UCSD Canc Ctr Comprehens Partnership, San Diego, CA USA; [Cordes, Colleen Clemency] Arizona State Univ, Nicholas A Cummings Behav Hlth Program, Tempe, AZ 85287 USA; [Chen, Suzie S.] VA Long Beach Healthcare Syst, Spinal Cord Injury Disorders Serv, Long Beach, CA USA; [Klein, Leslie S.] Gallaudet Univ, Dept Psychol, Washington, DC 20002 USA; [Welsh, Elizabeth] VA Los Angeles Ambulatory Care Ctr, Los Angeles, CA USA; [Smith, Kimberly] Pepperdine Univ, Grad Sch Educ & Psychol, Malibu, CA USA; [Lemos, Larry] VA Long Beach Healthcare Syst, Geriatr & Extended Care, Long Beach, CA USA		Cameron, RP (corresponding author), Calif State Univ Sacramento, Dept Psychol, 6000 J St, Sacramento, CA 95819 USA.	Cameron@csus.edu		Brindle, Sarah/0000-0002-7529-394X; Syme, Maggie/0000-0003-3260-5568			Allen ES, 2010, J FAM PSYCHOL, V24, P280, DOI 10.1037/a0019405; Aloni R., 2003, SEXUAL DIFFICULTIES; Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; BAGATELL CJ, 1994, J CLIN ENDOCR METAB, V78, P711, DOI 10.1210/jc.78.3.711; BARLOW DH, 1986, J CONSULT CLIN PSYCH, V54, P140, DOI 10.1037/0022-006X.54.2.140; Becker CB, 2001, COGN BEHAV PRACT, V8, P107, DOI 10.1016/S1077-7229(01)80017-1; Belfield T, 2007, J ROY SOC MED, V100, P499, DOI 10.1258/jrsm.100.11.499; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Bormann JE, 2008, J HOLIST NURS, V26, P109, DOI 10.1177/0898010107311276; Bowling KL, 2005, ARMED FORCES SOC, V31, P411, DOI 10.1177/0095327X0503100305; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brown D., 2008, BAN SEX SOLDIERS AFG; Calhoun PS, 2002, J TRAUMA STRESS, V15, P205, DOI 10.1023/A:1015251210928; Chambless DL, 2001, ANNU REV PSYCHOL, V52, P685, DOI 10.1146/annurev.psych.52.1.685; Chance RS, 2002, J PSYCHOL THEOL, V30, P195, DOI 10.1177/009164710203000303; Cook JM, 2004, J FAM PSYCHOL, V18, P36, DOI 10.1037/0893-3200.18.1.36; Cooper TV, 2008, AM J HEALTH PROMOT, V22, P164, DOI 10.4278/ajhp.22.3.164; Cosgrove DJ, 2002, UROLOGY, V60, P881, DOI 10.1016/S0090-4295(02)01899-X; Csoka A, 2008, J SEX MED, V5, P2977, DOI 10.1111/j.1743-6109.2008.01073.x; Cukor J, 2009, CLIN PSYCHOL REV, V29, P715, DOI 10.1016/j.cpr.2009.09.001; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; Davis L., 1990, COURAGE HEAL WORKBOO; Department of Veterans Affairs, 2004, IR WAR CLIN GUID; Department of Veterans Affairs, 2009, MIL HLTH HIST POCK C; DeRogatis L, 2008, J SEX MED, V5, P357, DOI 10.1111/j.1743-6109.2007.00672.x; Dialmy A, 2010, EUR J CONTRACEP REPR, V15, P160, DOI 10.3109/13625181003793339; Duke MR, 2008, QUAL HEALTH RES, V18, P244, DOI 10.1177/1049732307312305; Erbes CR, 2008, J CLIN PSYCHOL, V64, P972, DOI 10.1002/jclp.20521; Ferguson Cynthia T, 2008, J Forensic Nurs, V4, P190; Fraley S. S., 2007, SEXUALITY RES SOCIAL, V4, P15, DOI [10.1525/srsp.2007.4.1.15, DOI 10.1525/SRSP.2007.4.1.15]; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Gates G., 2010, LESBIAN GAY BISEXUAL; Gates R. M., 2010, MEMORANDUM COMMANDER; Gill C. J., 1991, RES URBAN PLANNING A; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gosling J, 1999, BRAIN INJURY, V13, P785; Guldin A, 2000, SEX DISABIL, V18, P233, DOI 10.1023/A:1005690009575; Hanna W. J., 1991, DISABILITY HANDICAP, V6, P49, DOI DOI 10.1080/02674649166780041; Harrington Ellen F, 2006, Cultur Divers Ethnic Minor Psychol, V12, P212, DOI 10.1037/1099-9809.12.2.212; Harrison D, 2006, SOCIOL REV, V54, P546, DOI 10.1111/j.1467-954X.2006.00629.x; Hays P. A., 2008, ADDRESSING CULTURAL, V2nd, DOI [10.1037/11650-000, DOI 10.1037/11650-000]; Henry N, 2004, AGGRESS VIOLENT BEH, V9, P535, DOI 10.1016/S1359-1789(03)00048-X; Hepburn C., 1988, ALIVE WELL; Hibbard Buffington AL, 1996, J APPL REHABILITATIO, V27, P45; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Howard MD, 2007, SEX ADDICT COMPULS, V14, P77, DOI 10.1080/10720160701310443; Hoyt T, 2011, J TRAUMA DISSOCIATIO, V12, P244, DOI 10.1080/15299732.2011.542612; HUDSON WW, 1981, J SEX RES, V17, P157, DOI 10.1080/00224498109551110; Hunter C.L., 2009, INTEGRATED BEHAV HLT, DOI [10.1037/11871-000, DOI 10.1037/11871-000]; Hutchinson JW, 2008, MIL MED, V173, P1164, DOI 10.7205/MILMED.173.12.1164; Hyun JK., 2009, PTSD RES Q, V20, P1; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Kane T., 2006, WHO ARE RECRUITS DEM; Kang H, 2005, ANN EPIDEMIOL, V15, P191, DOI 10.1016/j.annepidem.2004.05.009; Kennedy CH, 2011, LIVING AND SURVIVING IN HARMS WAY: A PSYCHOLOGICAL TREATMENT HANDBOOK FOR PRE- AND POST-DEPLOYMENT OF MILITARY PERSONNEL, P67; Kimerling R, 2010, AM J PUBLIC HEALTH, V100, P1409, DOI 10.2105/AJPH.2009.171793; Knapp DE, 2008, EMPLOY RESPONSIB RIG, V20, P227, DOI 10.1007/s10672-008-9089-8; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Lessing J., 1984, LESBIAN SEX, P151; Letourneau EJ, 1997, J TRAUMA STRESS, V10, P125, DOI 10.1002/jts.2490100112; Linehan MM., 1993, COGNITIVE BEHAV TREA; Litz BT, 2002, AUST NZ J PSYCHIAT, V36, P198, DOI 10.1046/j.1440-1614.2002.01002.x; Maguen S, 2005, COGN BEHAV PRACT, V12, P479, DOI 10.1016/S1077-7229(05)80075-6; Martin L, 2000, BEHAV MED, V26, P23, DOI 10.1080/08964280009595750; McFarlane AC., 2001, SEX RELATSH THER, V16, P261, DOI [10.1080/14681990124457, DOI 10.1080/14681990124457]; McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623; Mercer B, 2008, J CLIN NURS, V17, P341, DOI 10.1111/j.1365-2702.2008.02582.x; Meyers S. L., 2009, NY TIMES; Military Acceptance Project, FREQ ASK QUEST; Miller W. R., 1979, J SEX MARITAL THER, P5282; Mohamed S, 2008, J CLIN PSYCHIAT, V69, P959, DOI 10.4088/JCP.v69n0611; Mona L. R., 2011, IMPLEMENTING CBT OLD, P263; Mona LR, 2010, HANDBOOK OF ASSESSMENT IN CLINICAL GERONTOLOGY, 2ND EDITION, P331, DOI 10.1016/B978-0-12-374961-1.10013-2; Mona LR, 2003, WOMEN THER, V26, P211, DOI 10.1300/J015v26n03_03; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Monson CM, 2009, CLIN PSYCHOL REV, V29, P707, DOI 10.1016/j.cpr.2009.09.002; Moradi B, 2009, MIL PSYCHOL, V21, P513, DOI 10.1080/08995600903206453; Murdoch M, 2009, MIL MED, V174, P1100, DOI 10.7205/MILMED-D-04-2308; National Center for Posttraumatic Stress Disorder, 2007, TRAUM BRAIN INJ PTSD; National Defense Research Institute, 2010, SEX OR US MIL PERS P; National Institute of Disability and Rehabilitation Research, 1999, NIDRR LONG RANG PLAN; Nunnink SE, 2010, MIL MED, V175, P424, DOI 10.7205/MILMED-D-09-00085; O'Brien C, 2008, J NERV MENT DIS, V196, P252, DOI 10.1097/NMD.0b013e318166397d; Oddy M, 2001, SEX RELATSH THER, V16, P247, DOI [10.1080/14681990125256, DOI 10.1080/14681990125256]; Odette, 2003, ULTIMATE GUIDE SEX D; Olkin R., 1999, WHAT PSYCHOTHERAPIST; Orsillo SM, 2005, BEHAV MODIF, V29, P95, DOI 10.1177/0145445504270876; Price J. L., 2007, PARTNERS VETERANS PT; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rowe EL, 2009, MIL PSYCHOL, V21, P387, DOI 10.1080/08995600902914768; Rubio-Aurioles E, 2009, J SEX MED, V6, P2255, DOI 10.1111/j.1743-6109.2009.01348.x; Santelli J, 2006, J ADOLESCENT HEALTH, V38, P72, DOI 10.1016/j.jadohealth.2005.10.006; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schnurr PP, 2010, EPIDEMIOLOGY PTSD; Schnurr PP, 2008, PTSD RES QTLY, V19, P1; Shafer MA, 2002, MIL MED, V167, P496, DOI 10.1093/milmed/167.6.496; Shawver L., 1995, FLAG WAS STILL THERE; Sherman MD, 2005, PROF PSYCHOL-RES PR, V36, P626, DOI 10.1037/0735-7028.36.6.626; Sinclair GD, 2009, J HOMOSEXUAL, V56, P701, DOI 10.1080/00918360903054137; Solomon Z, 2008, J FAM PSYCHOL, V22, P659, DOI 10.1037/a0013596; Spivak B, 2003, NEUROPSYCHOBIOLOGY, V47, P57, DOI 10.1159/000070009; Street AE, 2008, J REHABIL RES DEV, V45, P409, DOI 10.1682/JRRD.2007.06.0088; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tsimtsiou Z, 2006, J SEX MED, V3, P583, DOI 10.1111/j.1743-6109.2006.00271.x; Turchik JA, 2010, AGGRESS VIOLENT BEH, V15, P267, DOI 10.1016/j.avb.2010.01.005; Turna B, 2005, INT J IMPOT RES, V17, P148, DOI 10.1038/sj.ijir.3901294; Turnbull G., 2004, SEX RELATSH THER, V19, P265, DOI [DOI 10.1080/14681990410001715418, https://doi.org/10.1080/14681990410001715418]; United States Census, 2010, STAT ABSTR US 2010; Uomoto JM, 2009, REHABIL PSYCHOL, V54, P259, DOI 10.1037/a0016907; VA/DoD Clinical Practice Guideline Working Group, 2010, MAN POSTTR STRESS; VA/DoD Management of Concussion/mTBI Working Group, 2009, MAN CONC MILD TRAUM; von Sadovszky V, 2008, WOMEN HEALTH ISS, V18, P174, DOI 10.1016/j.whi.2008.01.004; von Sadovszky V, 2007, JOGNN-J OBST GYN NEO, V36, P348, DOI 10.1111/J.1552-6909.2007.00153.x; Weber J. P., 2000, MIL MED, V165, P297; Weber JP, 2000, MIL MED, V165, pIII, DOI 10.1093/milmed/165.4.iiia; Whitehead T. L., 1993, Journal of Burn Care and Rehabilitation, V14, P221, DOI 10.1097/00004630-199303000-00018; Yaeger D, 2006, J GEN INTERN MED, V21, pS65, DOI 10.1111/j.1525-1497.2006.00377.x; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004; Zeiss A. M., 1999, HDB ASSESSMENT CLIN, P270	126	19	19	0	21	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2011	56	4					289	301		10.1037/a0025513			13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	862AQ	WOS:000298062600003	22121937				2022-02-06	
J	Meares, S; Shores, EA; Taylor, AJ; Lammel, A; Batchelor, J				Meares, Susanne; Shores, E. Arthur; Taylor, Alan J.; Lammel, Andrea; Batchelor, Jennifer			Validation of the Abbreviated Westmead Post-traumatic Amnesia Scale: A brief measure to identify acute cognitive impairment in mild traumatic brain injury	BRAIN INJURY			English	Article						Glasgow Coma Scale; mild traumatic brain injury; post-traumatic amnesia; PTA; Westmead Post-Traumatic Amnesia Scale	GLASGOW COMA SCALE; HEAD-INJURY; EMERGENCY-DEPARTMENT; UNITED-STATES; PTA SCALE; MEMORY; ANALGESIA; ACCURACY; RECOVERY	Objective: To validate the use of the Abbreviated Westmead Post-traumatic Amnesia Scale (A-WPTAS) in the assessment of acute cognitive impairment in mild traumatic brain injury (mTBI). Methods: Data previously collected from 82 mTBI and 88 control participants using the Revised Westmead Post-traumatic Amnesia Scale (R-WPTAS) was converted to A-WPTAS scores and pass/fail classifications were calculated for both scales. Results: The proportion of failures on the R-WPTAS and the A-WPTAS did not differ and a similar number of mTBIs were classified on each. For mTBIs the relationship between the independent memory test and a pass/fail classification was the same for both scales. Bivariate logistic regressions revealed that mTBIs, relative to controls, were around 8 times more likely to fail the assessment (R-WPTAS: 95%% CI: 3.70-18.87; A-WPTAS: 95%% CI: 3.70-20.14). As verbal learning improved the likelihood of failure was reduced. Greater education was associated with a decreased likelihood of failure. The relationship between education and a fail performance was not sustained when education was adjusted for the effect of age, prior mTBI, blood alcohol level, injury status, verbal learning, and morphine administration. Conclusions: The A-WPTAS is a valid measure. The A-WPTAS may reduce the risk of failing to classify patients with mTBI by identifying and documenting acute cognitive impairment.	[Meares, Susanne; Shores, E. Arthur; Taylor, Alan J.; Lammel, Andrea; Batchelor, Jennifer] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia		Shores, EA (corresponding author), Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia.	arthur.shores@mq.edu.au		Meares, Susanne/0000-0002-3859-9974; Batchelor, Jennifer/0000-0003-4438-4993; Shores, Edwin A/0000-0003-1553-5131; Taylor, Alan/0000-0003-1137-0691	Motor Accidents Authority of New South Wales [04/239]; Macquarie University, Sydney, Australia [A006079]	This study was funded by the Motor Accidents Authority of New South Wales (Grant Ref: 04/239) and a Collaborative Research Grant from Macquarie University, Sydney, Australia (Grant Ref: A006079).	Andriessen TMJC, 2009, BRAIN INJURY, V23, P345, DOI 10.1080/02699050902791414; Bazarian J, 2000, BRAIN INJURY, V14, P285; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dawson KS, 2007, BRAIN INJURY, V21, P943, DOI 10.1080/02699050701553171; De Guise E, BRAIN INJURY, V19, P1087; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Faul M, 2010, TRAUMATIC BRAIN INJU; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kemp S, 2010, J NEUROPSYCHOL, V4, P231, DOI 10.1348/174866409X482614; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; McCarter RJ, 2007, BRAIN INJURY, V21, P1393, DOI 10.1080/02699050701793793; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Reed D, 2007, ADULT TRAUMA CLIN PR; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Shores EA, 2008, GLASGOW COMA SCALE G; Sosin DM, 1996, BRAIN INJURY, V10, P47; Symonds CP, 1943, LANCET, V1, P7; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198	40	19	19	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2011	25	12					1198	1205		10.3109/02699052.2011.608213			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WF	WOS:000295615200006	21902551				2022-02-06	
J	Ross, KA; McMillan, T; Kelly, T; Sumpter, R; Dorris, L				Ross, Kimberley A.; McMillan, Tom; Kelly, Tom; Sumpter, Ruth; Dorris, Liam			Friendship, loneliness and psychosocial functioning in children with traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; paediatric; social; friendship	CLOSED-HEAD-INJURY; DIFFICULTIES QUESTIONNAIRE; ADOLESCENTS; STRENGTHS; QUALITY	Objective: This study compares friendship quality, rates of loneliness and general psychosocial functioning in children who have sustained a traumatic brain injury (TBI) with non-injured controls. Methods: A between-subjects design with 14 participants in the TBI group and 14 in the non-injured control group, aged between 7-13 years and matched for age, gender, receptive vocabulary and socio-economic status. Children completed measures of receptive vocabulary (BPVS II), friendship quality (FQQ-R) and loneliness (LSDS). The main caregiver was asked to assess social skills and social withdrawal (PIC-2) and general psychosocial and behavioural functioning (SDQ). Results: Significant differences were not found on measures completed by children or on the PIC-2. On the SDQ, total difficulties were rated as much greater by caregivers in the TBI group (z == -2.6, p == 0.009) and these were mainly associated with sub-scales relating to emotional problems and hyperactivity. Conclusions: Whilst evidence for friendship problems was not found in children with TBI, evidence for emotional and behavioural difficulties that may lead to social vulnerabilities later in life were found. This indicates a need for prospective longitudinal research to explore the complex relationship between TBI and poorer social outcomes that may not become evident until adolescence.	[Dorris, Liam] Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Glasgow G3 8SJ, Lanark, Scotland; [Ross, Kimberley A.; McMillan, Tom; Sumpter, Ruth; Dorris, Liam] Univ Glasgow, Acad Unit Mental Hlth & Wellbeing, Gartnavel Royal Hosp, Glasgow, Lanark, Scotland; [Kelly, Tom] Royal Victoria Infirm, Dept Neuropsychol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England		Dorris, L (corresponding author), Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Glasgow G3 8SJ, Lanark, Scotland.	liamdorris@gmail.com	Dorris, Liam/AAK-2273-2021	Dorris, Liam/0000-0002-9502-3154	NHS Education Scotland	This research was part funded by NHS Education Scotland.	ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Asher S. R., 1990, PEER REJECTION CHILD; ASHER SR, 1985, J CONSULT CLIN PSYCH, V53, P500, DOI 10.1037/0022-006X.53.4.500; Biggs BK, 2010, ANXIETY STRESS COPIN, V23, P431, DOI 10.1080/10615800903406543; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Burley, 1997, BRIT PICTURE VOCABUL; Communities and Local Government, 2007, IND DEPR; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FONAGY P, 1997, BRIT J DEV PSYCHOL, V15, P56; Gauvin-Lepage J, 2010, BRAIN INJURY, V24, P1087, DOI 10.3109/02699052.2010.494593; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1111/1469-7610.00494; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; HAPPE F, 1995, CHILD DEV, V60, P843; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; LACHAR D, 2004, INSTRUMENTS CHILDREN, V2, P141; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1111/1469-7610.00708; PARKER JG, 1993, DEV PSYCHOL, V29, P611, DOI 10.1037/0012-1649.29.4.611; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rosenthal R., 1991, METAANALYTIC PROCEDU, DOI 10.4135/9781412984997; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; *SCOTT EX NAT STAT, 2009, SCOTT IND MULT DEPR; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Wirt RD, 1990, MULTIDIMENSIONAL DES; [No title captured]	34	19	19	0	15	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2011	25	12					1206	1211		10.3109/02699052.2011.609519			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WF	WOS:000295615200007	21961568				2022-02-06	
J	Yu, GX; Dymond, M; Yuan, LS; Chaturvedi, LS; Shiratsuchi, H; Durairaj, S; Marsh, HM; Basson, MD				Yu, Guangxiang; Dymond, Michael; Yuan, Lisi; Chaturvedi, Lakshmi S.; Shiratsuchi, Hiroe; Durairaj, Srinivasan; Marsh, H. Michael; Basson, Marc D.			Propofol's effects on phagocytosis, proliferation, nitrate production, and cytokine secretion in pressure-stimulated microglial cells	SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; INTESTINAL EPITHELIAL-CELLS; SEVERE HEAD-INJURY; EXTRACELLULAR PRESSURE; MACROPHAGE PHAGOCYTOSIS; REPETITIVE DEFORMATION; INTRACRANIAL-PRESSURE; NERVOUS-SYSTEM; NITRIC-OXIDE; RAT-BRAIN	Background. Intracranial hypertension complicates severe traumatic brain injury frequently and might be associated with poor outcomes. Traumatic brain injury induces a neuroinflammatory response by microglial activation and upregulation of proinflammatory cytokines, such as interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6. To elucidate the effect of increased intracranial pressure on microglial function, we studied the effects of increased extracellular pressure on primary human. microglial cell phagocytosis, proliferation, cytokine secretion, and total nitrate production. In addition, because many patients receive propofol during anesthesia or intensive care unit sedation, we evaluated whether propofol alters the effects of pressure. Methods. Human microglial cells were pretreated with (2.5-20 mu g/mL) propofol or Intralipid as a vehicle control were incubated at ambient atmospheric pressure or at 15 or 30 mm fig increased pressure far 2 h for phagocytosis assays or 24 h for proliferation, cytokine secretion, and total nitrate production studies. Phagocytosis was determined by incorporation of intracellular fluorescent latex beads. Tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 were assayed by sandwich enzyme-linked immunosorbent assay and total nitrate by Greiss reagent. Results. Increased extracellular pressure stimulated phagocytosis versus untreated microglial cells or cells treated with an Intralipid vehicle control. Propofol also stimulated microglial phagocytosis at ambient pressure. Increased pressure, however; decreased phagocytosis in the presence of propofol. Pressure also increased microglial tumor necrosis factor-alpha and interleukin-1 beta secretion and propofol pretreatment blocked the pressure-stimulated effect. Interleukin-6 production was not altered either by pressure or by propofol. Pressure also induced total nitrate secretion, and propofol pretreatment decreased basal as well as pressure-induced microglial nitrate production. Conclusion. Extracellular pressures consistent with increased intracranial pressure after a head injury activate inflammatory signals in human primary microglial cells in vitro, stimulating phagocytosis, proliferation, tumor necrosis factor-alpha, interleukin-1 beta, and total nitrate secretion but not affecting interleukin-6. Such inflammatory) events may contribute to the worsened prognosis of traumatic brain injury after increased intracranial pressure. Because propofol alleviated these potentially proinflammatory effects, these results suggest that the inflammatory cascade activated by intracranial pressure might be targeted by propofol in patients with increased intracranial pressure after traumatic brain injury. (Surgery 2011;150:887-96.)	[Basson, Marc D.] Michigan State Univ, Coll Human Med, Dept Surg, Lansing, MI 48912 USA; [Yu, Guangxiang; Dymond, Michael; Chaturvedi, Lakshmi S.; Marsh, H. Michael; Basson, Marc D.] Wayne State Univ, Dept Anesthesiol, Detroit, MI USA; [Dymond, Michael; Chaturvedi, Lakshmi S.; Shiratsuchi, Hiroe; Marsh, H. Michael; Basson, Marc D.] John D Dingell VA Med Ctr, Detroit, MI USA		Basson, MD (corresponding author), Michigan State Univ, Coll Human Med, Dept Surg, 1200 E Michigan Ave,Suite 655, Lansing, MI 48912 USA.	marc.basson@hc.msu.edu	/AAL-3363-2020; Yuan, Lisi/G-1615-2013		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK060771] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01 DK060771-09, R01 DK060771] Funding Source: Medline		Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Basson MD, 2000, J CELL BIOCHEM, V78, P47, DOI 10.1002/(SICI)1097-4644(20000701)78:1<47::AID-JCB5>3.0.CO;2-M; Bhalla S, 2009, AM J SURG, V198, P611, DOI 10.1016/j.amjsurg.2009.07.006; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Chen RM, 2005, ANN NY ACAD SCI, V1042, P262, DOI 10.1196/annals.1338.030; Chen RM, 2003, ANESTHESIOLOGY, V98, P1178, DOI 10.1097/00000542-200305000-00021; Chiu WT, 2009, CHEM-BIOL INTERACT, V181, P430, DOI 10.1016/j.cbi.2009.06.011; Craig DH, 2008, CELL MOL BIOL LETT, V13, P260, DOI 10.2478/s11658-007-0054-6; Craig DH, 2007, AM J SURG, V194, P618, DOI 10.1016/j.amjsurg.2007.08.001; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Diestel A, 2003, J EXP MED, V198, P1729, DOI 10.1084/jem.20030975; Engdahl O, 1998, BRIT J ANAESTH, V81, P957, DOI 10.1093/bja/81.6.957; Farber K, 2006, PFLUG ARCH EUR J PHY, V452, P615, DOI 10.1007/s00424-006-0064-7; Flanigan TL, 2008, AM J SURG, V196, P683, DOI 10.1016/j.amjsurg.2008.07.016; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; GEHRMANN J, 1993, BRAIN PATHOL, V3, P11, DOI 10.1111/j.1750-3639.1993.tb00720.x; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Hall NG, 2006, AM J RESP CELL MOL, V34, P719, DOI 10.1165/rcmb.2005-0463OC; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Honsho S, 2009, CIRC RES, V105, P1149, DOI 10.1161/CIRCRESAHA.109.208199; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Koshinaga M, 2007, HISTOL HISTOPATHOL, V22, P129, DOI 10.14670/HH-22.129; Lee CJ, 2010, SHOCK, V33, P93, DOI 10.1097/SHK.0b013e3181a6eaf5; Luo D, 2009, BIOCH BIOPH IN PRESS; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mattana J, 1996, PATHOBIOLOGY, V64, P40, DOI 10.1159/000164004; Mikawa K, 1998, ANESTH ANALG, V87, P695, DOI 10.1097/00000539-199809000-00039; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nagai A, 2001, NEUROBIOL DIS, V8, P1057, DOI 10.1006/nbdi.2001.0437; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Shiratsuch H, 2005, AM J SURG, V190, P757, DOI 10.1016/j.amjsurg.2005.07.016; Shiratsuchi H, 2005, AM J PHYSIOL-CELL PH, V288, pC1083, DOI 10.1152/ajpcell.00543.2004; Shiratsuchi H, 2004, AM J PHYSIOL-CELL PH, V286, pC1358, DOI 10.1152/ajpcell.00553.2003; Shiratsuchi H, 2007, J CELL BIOCHEM, V102, P353, DOI 10.1002/jcb.21295; Shiratsuchi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1400, DOI 10.1152/ajpcell.00345.2008; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; SHYR MH, 1995, NEUROSCI LETT, V184, P212, DOI 10.1016/0304-3940(94)11209-2; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Thamilselvan V, 2004, GASTROENTEROLOGY, V126, P8, DOI 10.1053/j.gastro.2003.10.078; Tomkins O, 2011, CARDIOVASC PSYCHIAT, V2011; VASS K, 1993, LAB INVEST, V69, P275; Vouyouka AG, 2004, SURGERY, V136, P282, DOI 10.1016/j.surg.2004.04.033; Walsh MF, 2004, CELL PROLIFERAT, V37, P427, DOI 10.1111/j.1365-2184.2004.00324.x; WHITTEMORE ER, 1993, BRAIN RES, V621, P59, DOI 10.1016/0006-8993(93)90297-Z; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Wu GJ, 2009, CHEM-BIOL INTERACT, V180, P465, DOI 10.1016/j.cbi.2009.05.003	60	19	20	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	NOV	2011	150	5					887	896		10.1016/j.surg.2011.04.002			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	845NC	WOS:000296828600002	21676422	Green Accepted			2022-02-06	
J	Zhou, ND; Windmiller, JR; Valdes-Ramirez, G; Zhou, M; Halamek, J; Katz, E; Wang, J				Zhou, Nandi; Windmiller, Joshua R.; Valdes-Ramirez, Gabriela; Zhou, Ming; Halamek, Jan; Katz, Evgeny; Wang, Joseph			Enzyme-based NAND gate for rapid electrochemical screening of traumatic brain injury in serum	ANALYTICA CHIMICA ACTA			English	Article						Glutamate; Lactate dehydrogenase; Traumatic brain injury; Assay; Electrochemical sensor; Amperometry	EXCITATORY AMINO-ACIDS; CEREBROSPINAL-FLUID; GLUTAMATE; HUMANS	We report on the development of a rapid enzyme logic gate-based electrochemical assay for the assessment of traumatic brain injury (TBI). The concept harnesses a biocatalytic cascade that emulates the functionality of a Boolean NAND gate in order to process relevant physiological parameters in the biochemical domain. The enzymatic backbone ensures that a high-fidelity diagnosis of traumatic brain injury can be tendered in a rapid fashion when the concentrations of key serum-based biomarkers reach pathological levels. The excitatory neurotransmitter glutamate and the enzyme lactate dehydrogenase were used here as clinically-relevant input TBI biomarkers, in connection to the low-potential detection of the NADH product in the presence of methylene green at a glassy carbon electrode. A systematic optimization of the gate and the entire protocol has resulted in the effective discrimination between the physiological and pathological logic levels. Owing to its robust design, the enzyme-based logic gate mitigates potential interferences from both physiological and electroactive sources and is able to perform direct measurements in human serum samples. Granted further detailed clinical validation, this proof-of-concept study demonstrates the potential of the electrochemical assay to aid in the rapid and decentralized diagnosis of TBI. (C) 2011 Elsevier B.V. All rights reserved.	[Zhou, Nandi; Windmiller, Joshua R.; Valdes-Ramirez, Gabriela; Zhou, Ming; Wang, Joseph] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Halamek, Jan; Katz, Evgeny] Clarkson Univ, Dept Chem & Biomol Sci, Potsdam, NY 13699 USA		Katz, E (corresponding author), Clarkson Univ, Dept Chem & Biomol Sci, Potsdam, NY 13699 USA.	ekatz@clarkson.edu; josephwang@ucsd.edu	Valdes-Ramirez, Gabriela/D-2053-2012; Zhou, Ming/B-7451-2009; Wang, Joseph/C-6175-2011; Zhou, Nandi/C-5111-2011	Zhou, Ming/0000-0003-2239-9342; Zhou, Nandi/0000-0002-2906-7781; Valdes Ramirez, Gabriela/0000-0002-9566-930X	Office of Naval Research (ONR)Office of Naval Research [N00014-08-1-1202]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [20805020]; Chinese Ministry of EducationMinistry of Education, China [109079]; CONACyT from the Mexican government	This work was supported by the Office of Naval Research (ONR Award #N00014-08-1-1202). N.Z. acknowledges support from the National Natural Science Foundation of China (Award no. 20805020) and the Key Project of the Chinese Ministry of Education (Award no. 109079). G.V.R. acknowledges a CONACyT post-doctoral fellowship from the Mexican government.	BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BERGMEYER HU, 1978, CLIN CHEM, V24, P58; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Choi D. W, 1990, BRAIN METAB REV, V2, P105; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; GAY RJ, 1968, CLIN CHEM, V14, P740; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; GRIFFITHS T, 1984, J NEUROTRAUM, V15, P253; Halamek J, 2010, MOL BIOSYST, V6, P2554, DOI 10.1039/c0mb00153h; Halamek J, 2010, ANALYST, V135, P2249, DOI 10.1039/c0an00270d; Hara I, 1997, Int J Urol, V4, P202, DOI 10.1111/j.1442-2042.1997.tb00171.x; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Melnikov D, 2010, J PHYS CHEM B, V114, P12166, DOI 10.1021/jp105912e; Opitz T, 1994, NEUROPSYCHOPHARMACOL, V11, P278; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Sammour T, 2009, INJURY, V40, P104, DOI 10.1016/j.injury.2008.07.032; Suzuki M, 2002, J NEUROTRAUM, V19, P285, DOI 10.1089/08977150252807027; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wang J, 2010, ANAL BIOANAL CHEM, V398, P1591, DOI 10.1007/s00216-010-3746-0; Windmiller JR, 2011, SENSOR ACTUAT B-CHEM, V155, P206, DOI 10.1016/j.snb.2010.11.048; Windmiller JR, 2010, SENSOR ACTUAT B-CHEM, V150, P285, DOI 10.1016/j.snb.2010.07.001; YAO T, 1990, ANAL CHIM ACTA, V231, P121, DOI 10.1016/S0003-2670(00)86405-3; Zhou JA, 2011, TALANTA, V83, P955, DOI 10.1016/j.talanta.2010.10.057	26	19	19	1	32	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670			ANAL CHIM ACTA	Anal. Chim. Acta	OCT 3	2011	703	1					94	100		10.1016/j.aca.2011.07.023			7	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	829EP	WOS:000295561700012	21843680				2022-02-06	
J	Wu, DY; Cai, G; Zorowitz, RD; Yuan, Y; Wang, J; Song, WQ				Wu, Dong-yu; Cai, Gui; Zorowitz, Richard D.; Yuan, Ying; Wang, Jie; Song, Wei-qun			Measuring interconnection of the residual cortical functional islands in persistent vegetative state and minimal conscious state with EEG nonlinear analysis	CLINICAL NEUROPHYSIOLOGY			English	Article						Electroencephalography; Nonlinear dynamics; Unconsciousness; Traumatic brain injury; Stroke	PATIENTS OWN NAME; APPROXIMATE ENTROPY; MISMATCH NEGATIVITY; EVOKED-POTENTIALS; CHRONIC DISORDERS; BISPECTRAL INDEX; SPECTRAL ENTROPY; BRAIN; ACTIVATION; PROPOFOL	Objectives: The aim of the study is to investigate the cortical response to painful and auditory stimuli for subjects in persistent vegetative state (PVS) and minimal conscious state (MCS), and measure the interconnection of the residual cortical functional islands with electroencephalographic (EEG) nonlinear dynamic analysis (NDA). Methods: Thirty PVS subjects, 20 MCS subjects and 30 subjects in normal conscious state (NCS) were involved in the study. EEG was recorded under three conditions: eyes closed, auditory stimuli and painful stimuli. EEG nonlinear index of cross-approximate entropy (C-ApEn) was calculated for all subjects. Results: Interconnection of local and distant cortical networks of patients in PVS was generally suppressed, and painful or auditory stimulation could hardly cause any activation of associative cortices. Instead, interconnection of local cortical networks of patients in MCS improved significantly. The only significant difference with the NCS existed in the unaffected distant cortical networks. Conclusions: Interconnection of local and distant cortical networks in MCS is superior to that of PVS. NDA could measure interconnection of the residual cortical functional islands with associative cortices in the unconscious patients. Significance: NDA can characterise the interconnection of cortical networks for the unconscious state and provide some information of unconsciousness at the awareness level. (C) 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Wu, Dong-yu; Yuan, Ying; Wang, Jie; Song, Wei-qun] Capital Med Univ, Xuanwu Hosp, Dept Rehabil, Beijing 100053, Peoples R China; [Cai, Gui] China Astronaut Res & Training Ctr, Beijing, Peoples R China; [Zorowitz, Richard D.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA		Wu, DY (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Rehabil, 45 Changchun St,POB 100053, Beijing 100053, Peoples R China.	wudongyu73@yahoo.com.cn	Wu, Dongyu/AAW-6037-2020	Zorowitz, Richard/0000-0001-8938-786X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30600186]; National Basic Research Program of ChinaNational Basic Research Program of China [2011CB711000]	This study was supported by the grants from National Natural Science Foundation of China (Grant No. 30600186) and National Basic Research Program of China (Grant No. 2011CB711000).	Anderson RE, 2004, ANAESTHESIA, V59, P52, DOI 10.1111/j.1365-2044.2004.03523.x; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Bruhn J, 2003, ANESTHESIOLOGY, V98, P621, DOI 10.1097/00000542-200303000-00008; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GRILLON C, 1986, ELECTROEN CLIN NEURO, V63, P42, DOI 10.1016/0013-4694(86)90061-1; Hans P, 2005, BRIT J ANAESTH, V94, P336, DOI 10.1093/bja/aei047; Hudetz AG, 2002, BRAIN RES, V954, P123, DOI 10.1016/S0006-8993(02)03358-9; Jelles B, 1999, ACTA NEUROL SCAND, V100, P360; Kassubek J, 2003, J NEUROL SCI, V212, P85, DOI 10.1016/S0022-510X(03)00106-0; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, NEUROREHABILITATION, V19, P335; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Niedermeyer E, 2004, ELECTROENCEPHALOGRAP; Owen AM, 2008, ANN NY ACAD SCI, V1129, P130, DOI 10.1196/annals.1417.018; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Owen AM, 2007, CURR OPIN NEUROL, V20, P632, DOI 10.1097/WCO.0b013e3282f15669; Owen AM, 2005, NEUROPSYCHOL REHABIL, V15, P290, DOI 10.1080/09602010443000579; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Pincus S, 1996, P NATL ACAD SCI USA, V93, P2083, DOI 10.1073/pnas.93.5.2083; Pincus SM, 2006, BIPOLAR DISORD, V8, P430, DOI 10.1111/j.1399-5618.2006.00375.x; PRITCHARD WS, 1995, BRAIN COGNITION, V27, P353, DOI 10.1006/brcg.1995.1027; Qin PM, 2008, NEUROSCI LETT, V448, P24, DOI 10.1016/j.neulet.2008.10.029; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Sleigh J. W., 2001, P 5 INT C MEM AW CON; Vakkuri A, 2004, ACTA ANAESTH SCAND, V48, P145, DOI 10.1111/j.0001-5172.2004.00323.x; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	41	19	25	1	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2011	122	10					1956	1966		10.1016/j.clinph.2011.03.018			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	814WZ	WOS:000294489200009	21530389				2022-02-06	
J	Higgins, AZ; Cullen, DK; LaPlaca, MC; Karlsson, JOM				Higgins, Adam Z.; Cullen, D. Kacy; LaPlaca, Michelle C.; Karlsson, Jens O. M.			Effects of freezing profile parameters on the survival of cryopreserved rat embryonic neural cells	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Cryopreservation; Controlled-rate freezing; Intracellular ice formation; Solutions effects; Optimization	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; DOPAMINE NEURONS; FETAL-BRAIN; HIPPOCAMPAL-NEURONS; TISSUE-CULTURE; TRANSPLANTATION; GRAFTS; MATURATION; VIABILITY	The ability to successfully cryopreserve neural cells would represent an important advance with benefits to neural tissue engineering, neural transplantation, and neuroscience research. We have examined key factors responsible for damage to rat embryonic neural cells during cryopreservation using a two-step temperature profile, with an emphasis on the effects of cooling rate and plunge temperature. Our results indicate that the initial addition of 8% dimethyl sulfoxide (DMSO) and seeding of extracellular ice do not significantly decrease viable cell yield. However, subsequent freezing resulted in significant cell losses for all profile parameter combinations examined. A maximum post-thaw survival of 56% (compared to unfrozen controls) was observed after cooling at 2 degrees C/min to -80 degrees C followed by direct immersion in liquid nitrogen. Single-step removal of DMSO after thawing was associated with an additional 40-70% loss of viable cells, and the number of viable cells was further reduced by approximately 70% after 2 days of cell culture (resulting in a net viable cell yield of 9.6 +/- 0.4%). Nonetheless, the cryopreserved neurons that did survive displayed a normal morphology, including formation of neurites. Trends in neuronal viability conformed with predictions of existing theoretical models of cell freezing, with reduced survival for rapid cooling rates or high plunge temperatures (attributable to intracellular ice formation), and decreasing viability with increasing profile duration (consistent with the known effects of cell dehydration at suboptimal cooling rates). These observations suggest that neural cells are good candidates for further refinement of freezing profile design using a physics-based approach to parameter optimization. (C) 2011 Elsevier B.V. All rights reserved.	[Higgins, Adam Z.; Cullen, D. Kacy; LaPlaca, Michelle C.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Karlsson, Jens O. M.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA		Karlsson, JOM (corresponding author), Villanova Univ, Dept Mech Engn, 800 Lancaster Ave, Villanova, PA 19085 USA.	karlsson@alum.mit.edu			National Science Foundation (NSF)National Science Foundation (NSF); Howard Hughes Medical InstituteHoward Hughes Medical Institute; Medtronic Foundation; George Family Foundation; Georgia Tech/Emory Center for the Engineering of Living Tissues; NSF Engineering Research CenterNational Science Foundation (NSF) [EEC-9731643]	Fellowship support (for AZH) was provided by the National Science Foundation (NSF), the Howard Hughes Medical Institute, the Medtronic Foundation and the George Family Foundation. The work was performed using facilities that were funded in part by the Georgia Tech/Emory Center for the Engineering of Living Tissues, an NSF Engineering Research Center (EEC-9731643).	ARCHER DR, 1994, EXP NEUROL, V125, P268, DOI 10.1006/exnr.1994.1029; Baust JM, 2000, IN VITRO CELL DEV-AN, V36, P262; Ben-Hur T, 2005, CURR DRUG TARGETS, V6, P3, DOI 10.2174/1389450053345000; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; BOND NW, 1989, BIOL PSYCHOL, V28, P67, DOI 10.1016/0301-0511(89)90111-7; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Cameron DF, 1997, CELL TRANSPLANT, V6, P185, DOI 10.1016/S0963-6897(97)00022-5; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; COLLIER TJ, 1987, BRAIN RES, V436, P363, DOI 10.1016/0006-8993(87)91680-5; COLLIER TJ, 1993, BRAIN RES, V623, P249, DOI 10.1016/0006-8993(93)91435-U; COLLIER TJ, 1988, PROG BRAIN RES, V78, P631; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; DAS GD, 1983, J NEUROSCI METH, V8, P1, DOI 10.1016/0165-0270(83)90047-X; Decherchi P, 1997, CRYOBIOLOGY, V34, P214, DOI 10.1006/cryo.1997.2003; Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007; DILLER KR, 1975, CRYOBIOLOGY, V12, P480, DOI 10.1016/0011-2240(75)90029-2; Dinsmore J H, 1998, Expert Opin Investig Drugs, V7, P527, DOI 10.1517/13543784.7.4.527; DONG JF, 1993, BRAIN RES, V621, P242, DOI 10.1016/0006-8993(93)90112-Z; Inden M, 2005, NEUROSCI LETT, V387, P151, DOI 10.1016/j.neulet.2005.06.029; JENSEN S, 1984, J COMP NEUROL, V227, P558, DOI 10.1002/cne.902270407; JUN F, 1992, CRYOBIOLOGY, V29, P267, DOI 10.1016/0011-2240(92)90025-W; Karlsson JOM, 2010, CRYOBIOLOGY, V60, P43, DOI 10.1016/j.cryobiol.2009.07.004; Karlsson JOM, 2009, MOL REPROD DEV, V76, P321, DOI 10.1002/mrd.20956; Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1; Karlsson JOM, 2001, CRYOBIOLOGY, V42, P154, DOI 10.1006/cryo.2001.2318; Karlsson JOM, 1996, HUM REPROD, V11, P1296; KARLSSON JOM, 1993, BIOPHYS J, V65, P2524, DOI 10.1016/S0006-3495(93)81319-5; Karlsson JOM, 2000, PRINCIPLES TISSUE EN, V2, P293, DOI [10.1007/11749219, DOI 10.1007/11749219]; KAWAMOTO JC, 1986, BRAIN RES, V384, P84, DOI 10.1016/0006-8993(86)91222-9; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lindvall Olle, 2004, NeuroRx, V1, P379, DOI 10.1007/BF03206624; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; MATTSON MP, 1990, BRAIN RES, V522, P204, DOI 10.1016/0006-8993(90)91462-P; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; Muir JK, 1999, J NEUROTRAUM, V16, P403, DOI 10.1089/neu.1999.16.403; Negishi T, 2002, EXP ANIM TOKYO, V51, P383, DOI 10.1538/expanim.51.383; Oliveira Alcyr A. Jr, 2005, Current Alzheimer Research, V2, P79, DOI 10.2174/1567205052772759; Otto F, 2003, J NEUROSCI METH, V128, P173, DOI 10.1016/S0165-0270(03)00186-9; Paynter SJ, 2009, CRYOBIOLOGY, V58, P308, DOI 10.1016/j.cryobiol.2009.02.008; Paynter SJ, 2008, BRAIN RES BULL, V75, P1, DOI 10.1016/j.brainresbull.2007.08.004; SAUER H, 1992, EXP BRAIN RES, V90, P54, DOI 10.1007/BF00229256; Sautter J, 1996, J NEUROSCI METH, V64, P173, DOI 10.1016/0165-0270(95)00130-1; Sautter J, 2000, EXP NEUROL, V164, P121, DOI 10.1006/exnr.2000.7410; Seggio AM, 2008, J NEUROSCI METH, V173, P67, DOI 10.1016/j.jneumeth.2008.05.017; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; SORENSEN T, 1986, J COMP NEUROL, V252, P468, DOI 10.1002/cne.902520404; Steinschneider R, 1996, DEV BRAIN RES, V95, P15, DOI 10.1016/0165-3806(96)00052-1; SWETT JW, 1994, EXP NEUROL, V129, P330, DOI 10.1006/exnr.1994.1175; TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670; Totoiu MO, 2004, EXP NEUROL, V187, P254, DOI 10.1016/j.expneurol.2004.01.028; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Watts C, 2000, CELL TRANSPLANT, V9, P223, DOI 10.1177/096368970000900208; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105	56	19	19	1	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2011	201	1					9	16		10.1016/j.jneumeth.2011.06.033			8	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	828LY	WOS:000295503700002	21816171				2022-02-06	
J	Norazit, A; Nguyen, MN; Dickson, CGM; Tuxworth, G; Goss, B; Mackay-Sim, A; Meedeniya, ACB				Norazit, A.; Nguyen, M. N.; Dickson, C. G. M.; Tuxworth, G.; Goss, B.; Mackay-Sim, A.; Meedeniya, A. C. B.			VASCULAR ENDOTHELIAL GROWTH FACTOR AND PLATELET DERIVED GROWTH FACTOR MODULATES THE GLIAL RESPONSE TO A CORTICAL STAB INJURY	NEUROSCIENCE			English	Article						vascular endothelial growth factor; platelet derived growth factor; astrogliosis; microglial response; brain injury	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SLICE CULTURES; RESTING MICROGLIAL CELLS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; NEUROTROPHIC FACTOR; DOPAMINERGIC-NEURONS; REACTIVE ASTROCYTES; IN-VITRO; PARKINSONS-DISEASE	Traumatic injury to the brain initiates an increase in astrocyte and microglial infiltration as part of an inflammatory response to injury. Increased astrogliosis around the injury impedes regeneration of axons through the injury, while activated microglia release inflammatory mediators. The persistent inflammatory response can lead to local progressive cell death. Modulating the astrocyte and microglial response to traumatic injury therefore has potential therapeutic benefit in brain repair. We examine the modulatory effect of a single bolus of vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) in combination on astrocytes and microglia to acute cerebral injury. A combination of VEGF and PDGF (20 pg) was injected into the striatum of adult male Sprague-Dawley rats. The effects of treatment were assessed by quantitative immunofluorescence microscopy analyzing astrocytes and microglia across the stab injury over time. Treatment delayed the onset of astrogliosis in the centre and edge of the stab injury up to day 5; however, increased astrogliosis at areas remote to the stab injury up to day 5 was observed. A persistent astrocytic response was observed in the centre and edge of the stab injury up to day 60. Treatment altered microglia cell morphology and numbers across the stab injury, with a decrease in ramified microglia, but an increase in activated and phagocytic microglia up to day 5 after stab injury. The increased microglial response from 10 until day 60 was comprised of the ramified morphology. Thus, VEGF and PDGF applied at the same time as a stab injury to the brain initially delayed the inflammatory response up to day 5 but evoked a persistent astrogliosis and microglial response up to 60 days. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.	[Norazit, A.; Nguyen, M. N.; Dickson, C. G. M.; Tuxworth, G.; Mackay-Sim, A.; Meedeniya, A. C. B.] Griffith Univ, Natl Ctr Adult Stern Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Norazit, A.] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia; [Tuxworth, G.] Griffith Univ, Sch Informat & Commun Technol, Gold Coast, Qld 4222, Australia; [Goss, B.] Queensland Univ Technol, Brisbane Spine Reference Ctr, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia		Meedeniya, ACB (corresponding author), Griffith Univ, Natl Ctr Adult Stern Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia.	A.Meedeniya@griffith.edu.au	Mackay-Sim, Alan/C-3431-2008; NORAZIT, ANWAR/B-5263-2010; Goss, Ben/F-1867-2010	Mackay-Sim, Alan/0000-0003-4446-5371; Goss, Ben/0000-0003-0518-1229; Tuxworth, Gervase/0000-0002-9278-4695	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Australian Department of Health and AgeingAustralian GovernmentDepartment of Health & Ageing	We would like to thank Brenton Cavanagh, Joseph Kan, Will Young, and Cameron Lutton for their technical support. This work was funded by a grant from the National Health and Medical Research Council and the Australian Department of Health and Ageing to A.M.S.	BARRES BA, 1991, J NEUROSCI, V11, P3685; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Batchelor PE, 2008, J NEUROTRAUM, V25, P1217, DOI 10.1089/neu.2007.0308; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 1999, J NEUROSCI, V19, P8182; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Hailer NP, 1997, EUR J NEUROSCI, V9, P863, DOI 10.1111/j.1460-9568.1997.tb01436.x; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; HUTCHINS JB, 1993, MOL CELL NEUROSCI, V4, P250, DOI 10.1006/mcne.1993.1032; Kanazawa H, 2002, J BIOL CHEM, V277, P20026, DOI 10.1074/jbc.M109218200; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kettenmann H, 2004, NEUROGLIA; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Kolker S, 2001, EUR J NEUROSCI, V13, P2115, DOI 10.1046/j.0953-816x.2001.01595.x; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Krum JM, 2002, NEUROSCIENCE, V110, P589, DOI 10.1016/S0306-4522(01)00615-7; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; LEVINE JM, 1989, NEURON, V3, P103, DOI 10.1016/0896-6273(89)90119-0; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Mizuta I, 2001, NEUROSCI LETT, V310, P117, DOI 10.1016/S0304-3940(01)02098-5; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NGUYEN MN, 2010, TISSUE PROCESSING EP; Nicholas RS, 2001, EUR J NEUROSCI, V13, P959, DOI 10.1046/j.0953-816x.2001.01470.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Norazit A, 2010, BRAIN RES, V1360, P119, DOI 10.1016/j.brainres.2010.08.070; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Peterson DA, 1999, METHODS, V18, P493, DOI 10.1006/meth.1999.0818; Pietz K, 1996, NEUROSCI LETT, V204, P101, DOI 10.1016/0304-3940(96)12326-0; Pitzer MR, 2003, EXP NEUROL, V182, P435, DOI 10.1016/S0014-4886(03)00100-6; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Rezaie P, 2002, EXP CELL RES, V274, P68, DOI 10.1006/excr.2001.5431; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; SCHWARTZ JP, 1994, BRAIN RES BULL, V35, P403, DOI 10.1016/0361-9230(94)90151-1; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Szczepanik AM, 1996, NEUROSCIENCE, V70, P57, DOI 10.1016/0306-4522(95)00296-U; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wang K, 2004, BRAIN RES, V1024, P193, DOI 10.1016/j.brainres.2004.07.086; WOLSWIJK G, 1991, GLIA, V4, P495, DOI 10.1002/glia.440040509; Yasuhara T, 2005, BRAIN RES, V1038, P1, DOI 10.1016/j.brainres.2004.12.055	54	19	19	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	SEP 29	2011	192						652	660		10.1016/j.neuroscience.2011.06.035			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	829DB	WOS:000295555100062	21704679	Green Published			2022-02-06	
J	Holschneider, DP; Guo, YM; Roch, M; Norman, KM; Scremin, OU				Holschneider, Daniel P.; Guo, Yumei; Roch, Margareth; Norman, Keith M.; Scremin, Oscar U.			Acetylcholinesterase Inhibition and Locomotor Function after Motor-Sensory Cortex Impact Injury	JOURNAL OF NEUROTRAUMA			English	Article						acetylcholinesterase; cholinergic; motor function; neurorehabilitation; TBI	TRAUMATIC BRAIN-INJURY; ORAL PHYSOSTIGMINE; MEMORY DEFICITS; WORKING MEMORY; HEAD-INJURY; LONG-TERM; RECOVERY; RATS; RIVASTIGMINE; DONEPEZIL	Traumatic brain injury (TBI) induces transient or persistent dysfunction of gait and balance. Enhancement of cholinergic transmission has been reported to accelerate recovery of cognitive function after TBI, but the effects of this intervention on locomotor activity remain largely unexplored. The hypothesis that enhancement of cholinergic function by inhibition of acetylcholinesterase (AChE) improves locomotion following TBI was tested in Sprague-Dawley male rats after a unilateral controlled cortical impact (CCI) injury of the motor-sensory cortex. Locomotion was tested by time to fall on the constant speed and accelerating Rotarod, placement errors and time to cross while walking through a horizontal ladder, activity monitoring in the home cages, and rearing behavior. Assessments were performed the 1st and 2nd day and the 1st, 2nd, and 3rd week after TBI. The AChE inhibitor physostigmine hemisulfate (PHY) was administered continuously via osmotic minipumps implanted subcutaneously at the rates of 1.6-12.8 mu mol/kg/day. All measures of locomotion were impaired by TBI and recovered to initial levels between 1 and 3 weeks post-TBI, with the exception of the maximum speed achievable on the accelerating Rotarod, as well as rearing in the open field. PHY improved performance in the accelerating Rotarod at 1.6 and 3.2 mu mol/kg/day (AChE activity 95 and 78% of control, respectively), however, higher doses induced progressive deterioration. No effect or worsening of outcomes was observed at all PHY doses for home cage activity, rearing, and horizontal ladder walking. Potential benefits of cholinesterase inhibition on locomotor function have to be weighed against the evidence of the narrow range of useful doses.	[Holschneider, Daniel P.; Guo, Yumei] Univ So Calif, USC Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, USC Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, USC Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.; Roch, Margareth; Norman, Keith M.; Scremin, Oscar U.] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA; [Scremin, Oscar U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA		Holschneider, DP (corresponding author), Univ So Calif, USC Keck Sch Med, Dept Psychiat & Behav Sci, 1333 San Pablo St,BMT 403,MC9112, Los Angeles, CA 90033 USA.	holschne@usc.edu			Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VA RRD) [B5089R]	This work was supported by a Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VA RR&D) #B5089R and a VA RR&D Research Career Scientist award (O.U.S).	Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; ARCINIEGAS DB, 2004, PHYS MED REH CLIN N, V50, pR8; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; CHROBAK JJ, 1988, BRAIN RES, V463, P107, DOI 10.1016/0006-8993(88)90532-X; DAWSON GR, 1991, PHARMACOL BIOCHEM BE, V39, P865, DOI 10.1016/0091-3057(91)90045-4; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FIBIGER HC, 1971, PSYCHOPHARMACOLOGIA, V20, P366, DOI 10.1007/BF00403568; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2002, PHYSIOL BEHAV, V76, P271, DOI 10.1016/S0031-9384(02)00714-X; Holschneider DP, 2003, J CEREBR BLOOD F MET, V23, P925, DOI 10.1097/01.WCB.0000072797.66873.6A; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; JANOWSKY DS, 1972, LANCET, V2, P632; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; LUINE V, 1990, BRAIN RES, V523, P321, DOI 10.1016/0006-8993(90)91507-D; MACCIOCCHI SN, 1993, CURR OPIN NEUROL, V6, P773, DOI 10.1097/00019052-199310000-00016; MUIR JL, 1995, PSYCHOPHARMACOLOGY, V118, P82; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; SASAKI M, 1987, Brain and Nerve (Tokyo), V39, P983; Scremin OU, 2007, BRAIN RES, V1141, P235, DOI 10.1016/j.brainres.2007.01.006; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; SCREMIN OU, 1990, J NEUROSCI RES, V26, P188, DOI 10.1002/jnr.490260208; Scremin OU, 1997, J NEUROTRAUM, V14, P573, DOI 10.1089/neu.1997.14.573; Sharma HS, 2006, ACTA NEUROCHIR SUPPL, V96, P288; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; STERN Y, 1987, ANN NEUROL, V22, P306, DOI 10.1002/ana.410220305; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Wright LKM, 2010, NEUROTOXICOL TERATOL, V32, P329, DOI 10.1016/j.ntt.2009.12.006; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	42	19	19	1	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2011	28	9					1909	1919		10.1089/neu.2011.1978			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821AK	WOS:000294947000020	21787180				2022-02-06	
J	Purcell, L; LeBlanc, CMA; McCambridge, TM; Brenner, JS; Benjamin, HJ; Cappetta, CT; Demorest, RA; Halstead, ME; Koutures, CG; LaBella, CR; Labotz, M; Loud, K; Martin, SS; Weiss-Kelly, A				Purcell, Laura; LeBlanc, Claire M. A.; McCambridge, Teri M.; Brenner, Joel S.; Benjamin, Holly J.; Cappetta, Charles T.; Demorest, Rebecca A.; Halstead, Mark E.; Koutures, Chris G.; LaBella, Cynthia R.; Labotz, Michele; Loud, Keith; Martin, Stephanie S.; Weiss-Kelly, Amanda			Policy Statement-Boxing Participation by Children and Adolescents	PEDIATRICS			English	Article						boxing; youth; children and adolescents; head injuries; concussion	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; AMATEUR BOXERS; RECOVERY; ADULTS	Thousands of boys and girls younger than 19 years participate in boxing in North America. Although boxing provides benefits for participants, including exercise, self-discipline, and self-confidence, the sport of boxing encourages and rewards deliberate blows to the head and face. Participants in boxing are at risk of head, face, and neck injuries, including chronic and even fatal neurologic injuries. Concussions are one of the most common injuries that occur with boxing. Because of the risk of head and facial injuries, the American Academy of Pediatrics and the Canadian Paediatric Society oppose boxing as a sport for children and adolescents. These organizations recommend that physicians vigorously oppose boxing in youth and encourage patients to participate in alternative sports in which intentional head blows are not central to the sport. Pediatrics 2011; 128: 617-623						Houghton, Kristin/0000-0001-7174-1007			[American Academy of Pediatrics Committee on Sports Medicine and Fitness], 2006, PEDIATRICS, V117, P1467; American Medical Association, H 470 963 BOX INJ; Australian Medical Association, BOX 1997 REAFF 2007; Bianco M, 2005, BRIT J SPORT MED, V39, P532, DOI 10.1136/bjsm.2004.014365; Bianco M, 2005, BRIT J SPORT MED, V39, P70, DOI 10.1136/bjsm.2003.006643; British Medical Association, BOX BMAS POS; [Canadian Medical Association Office for Public Health], BOX; Canadian Pediatric Society, 2006, PAEDIAT CHILD HLTH, V11, P420; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gambrell Robert C, 2007, Curr Sports Med Rep, V6, P317; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HEILBRONNER RL, 1991, AM J SPORT MED, V19, P376, DOI 10.1177/036354659101900409; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Matser EJT, 2000, PHYSICIAN SPORTSMED, V28, P87, DOI 10.3810/psm.2000.01.645; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Pearn J, 1998, J PAEDIATR CHILD H, V34, P311, DOI 10.1046/j.1440-1754.1998.00231.x; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; [Public Health Agency of Canada Health Surveillance and Epidemiology Division], 2008, INJ ASS FORM BOX CAN; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Risser WL, 1997, PEDIATRICS, V99, P134; Ryan AJ, 1998, CLIN SPORT MED, V17, P155, DOI 10.1016/S0278-5919(05)70070-3; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Sokol DK, 2004, J MED ETHICS, V30, P513, DOI 10.1136/jme.2003.004952; Toth C, 2005, SPORTS MED, V35, P685, DOI 10.2165/00007256-200535080-00003; US Consumer Product Safety Commission, 2007, NEISS DAT HIGHL 2007; USA Boxing, 2008 US BOX RUL; USA Boxing, BOX BAS; Washington RL, 2005, PEDIATRICS, V116, P1557, DOI 10.1542/peds.2005-2314; World Medical Association, WMA STAT BOX; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zazryn TR, 2008, NEUROL CLIN, V26, P257, DOI 10.1016/j.ncl.2007.11.004; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	43	19	20	1	9	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2011	128	3					617	623		10.1542/peds.2011-1165			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	827DB	WOS:000295406100061	21873697	Bronze			2022-02-06	
J	Prieto, R; Tavazzi, B; Taya, K; Barrios, L; Amorini, AM; Di Pietro, V; Pascual, JM; Marmarou, A; Marmarou, CR				Prieto, Ruth; Tavazzi, Barbara; Taya, Keisuke; Barrios, Laura; Amorini, Angela M.; Di Pietro, Valentina; Pascual, Jose M.; Marmarou, Anthony; Marmarou, Christina R.			Brain energy depletion in a rodent model of diffuse traumatic brain injury is not prevented with administration of sodium lactate	BRAIN RESEARCH			English	Article						ATP; Brain trauma; Energy metabolism; Lactate; Mitochondria; Cerebral metabolism	TRICARBOXYLIC-ACID CYCLE; MITOCHONDRIAL DYSFUNCTION; MAGNETIC-RESONANCE; NAD(+) DEPLETION; PERMEABILITY TRANSITION; COGNITIVE DEFICITS; OXIDATIVE STRESS; RAT; METABOLISM; ASTROCYTES	Lactate has been identified as an alternative fuel for the brain in situations of increased energy demand, as following a traumatic brain injury (TBI). This study investigates the effect of treatment with sodium lactate (NaLac) on the changes in brain energy state induced by a severe diffuse TBI. Rats were assigned to one of the eight groups (n=10 per group): 1 sham, normal saline; 2 TBI, normal saline; 3 TBI, hypertonic saline; 4 TBI, 100 mM NaLac, 5 TB!, 500 mM NaLac; 6 TBI, 1280 mM NaLac; 7 TBI, 2000 mM NaLac and 8-TBI-500 mM NaLac+magnesium sulfate. Cerebrums were removed 6 h after trauma. Metabolites representative of the energy state (ATP, ATP-catabolites), N-acetylaspartate (NAA), antioxidant defenses (ascorbic acid, glutathione), markers of oxidative stress (malondialdehyde, ADP-ribose) and nicotinic coenzymes (NAD(+)) were measured by HPLC. TBI induced a marked decrease in the cerebral levels of ATP, NAA, ascorbic acid, glutathione and NAD(+) and a significant rise in the content of ATP-catabolites, malondialdehyde and ADP-ribose. These alterations were not ameliorated with NaLac infusion. We observed a significant reduction in cerebral NAD(+), an essential co-enzyme for mitochondrial lactate-dehydrogenase that converts lactate into pyruvate and thus replenishes the tricarboxylic acid cycle. These results suggest that the metabolic pathway necessary to consume lactate may be compromised following a severe diffuse TBI in rats. (C) 2011 Elsevier B.V. All rights reserved.	[Prieto, Ruth] Clin San Carlos Univ Hosp, Dept Neurosurg, Madrid 28040, Spain; [Prieto, Ruth; Taya, Keisuke; Marmarou, Anthony; Marmarou, Christina R.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Tavazzi, Barbara; Amorini, Angela M.; Di Pietro, Valentina] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Rome, Italy; [Taya, Keisuke] Jikei Univ Hosp, Dept Neurosurg, Tokyo, Japan; [Barrios, Laura] CSIC, Dept Stat, Comp Tech Ctr, Madrid, Spain; [Pascual, Jose M.] La Princesa Univ Hosp, Dept Neurosurg, Madrid, Spain		Prieto, R (corresponding author), Clin San Carlos Univ Hosp, Dept Neurosurg, Prof Martin Lagos S-N, Madrid 28040, Spain.	rprieto29@hotmail.com; btavazzi@rm.unicatt.it; K_taya2004@yahoo.co.jp; laura@cti.csic.es; amorini@unict.it; valentina.dipietro@rm.unicatt.it; jmpasncj@hotmail.com; crmarmar@vcu.edu	Pascual, Jose Maria/AAA-6111-2022; TAVAZZI, BARBARA/AAB-9830-2019	Pascual, Jose Maria/0000-0002-3114-0474; TAVAZZI, BARBARA/0000-0001-8743-0895; Di Pietro, Valentina/0000-0001-9430-4723; AMORINI, Angela Maria/0000-0003-3525-9955	National Institutes of Health, BethesdaUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS12587, RO1 NS19235]; Johnson & Johnson Medical Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, R01NS019235] Funding Source: NIH RePORTER	This research was supported by grants RO1 NS12587 and RO1 NS19235 from the National Institutes of Health, Bethesda and by the scholarship provided to R.P. by Johnson & Johnson Medical Company. The contents are the sole responsibility of the authors and do not necessarily represent the official views of the Fund or the Advisory Board.	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Ang BT, 2003, J NEUROSURG, V99, P125, DOI 10.3171/jns.2003.99.1.0125; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Fink EL, 2008, J CEREBR BLOOD F MET, V28, P1523, DOI 10.1038/jcbfm.2008.52; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Ide K, 2000, J PHYSIOL-LONDON, V522, P159, DOI 10.1111/j.1469-7793.2000.t01-2-00159.xm; IZUMI Y, 1994, NEUROREPORT, V5, P617, DOI 10.1097/00001756-199401000-00021; KOWALCHUK JM, 1988, J APPL PHYSIOL, V65, P2080, DOI 10.1152/jappl.1988.65.5.2080; Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x; Lazzarino G, 2003, ANAL BIOCHEM, V322, P51, DOI 10.1016/j.ab.2003.07.013; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; MARAN A, 1994, LANCET, V343, P16, DOI 10.1016/S0140-6736(94)90876-1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Schuck Otto, 2005, Biomedical Papers (Olomouc), V149, P69; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002	40	19	20	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 2	2011	1404						39	49		10.1016/j.brainres.2011.06.006			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	802DP	WOS:000293489800005	21723535	Green Accepted			2022-02-06	
J	Salehpour, F; Bazzazi, AM; Porhomayon, J; Nader, ND				Salehpour, Firooz; Bazzazi, Amir Mohammad; Porhomayon, Jahan; Nader, Nader D.			Correlation between coagulopathy and outcome in severe head trauma in neurointensive care and trauma units	JOURNAL OF CRITICAL CARE			English	Article						Coagulopathy; Severe head trauma; Glasgow coma scale; Glasgow outcome scale	DISSEMINATED INTRAVASCULAR COAGULATION; PROGRESSIVE BRAIN INJURY; SEVERE CEREBRAL TRAUMA; POSTTRAUMA COAGULATION; HEMOSTATIC ACTIVATION; CHILDREN; DISORDERS; DISTURBANCES; FIBRINOLYSIS; MARKERS	Background: Abnormal blood coagulation after traumatic brain injury is a common finding. Some studies have proposed these changes as useful predictors of outcome in patients with head trauma. This study aimed at evaluating the association of the routine tests of blood coagulation within the first hours after severe head trauma with prognosis of patients with severe head trauma. Materials and Methods: A total of 52 patients with severe head trauma (Glasgow Coma Scale [GCS], <= 8) were admitted at Tabriz University Hospital for 1 year. Patients with major accompanying trauma were excluded. On admission, serum levels of hemoglobin and hematocrit as well as the platelet count, prothrombin time (PT), partial thromboplastin time (PTT), and international normalized ratio (INR) were documented. The relation between these parameters with final outcome and also with GCS at admission, 24 hours, 48 hours, and 1 week after admission and discharge time and Glasgow Outcome Scale (GOS) were studied. Results: Thirty three patients were discharged, and 19 died. There were significant negative correlations between PT, PTT, and INR with all GCS and GOS scores. These correlations were significant and positive between the platelet count and all GCS and GOS scores. Median PT, PTT, and INR were significantly higher in nonsurvivors. Median serum platelets count was significantly lower in nonsurvivors. Conclusion: On-admission PT, PTT, INR and platelet count may be used as predictors of outcome and prognosis of patients with severe head trauma. Published by Elsevier Inc.	[Nader, Nader D.] SUNY Buffalo, Div Cardiothorac Anesthesia & Pain Med, VA Western New York Healthcare Syst, Sch Med & Biomed Sci,Dept Anesthesiol, Buffalo, NY 14215 USA; [Salehpour, Firooz] Tabriz Univ Med Sci, Dept Neurosurg, Tabriz, Iran; [Bazzazi, Amir Mohammad] Urmia Univ Med Sci, Dept Neurosurg, Orumiyeh, Iran; [Porhomayon, Jahan] SUNY Buffalo, Div Crit Care & Pain Med, VA Western New York Healthcare Syst, Sch Med & Biomed Sci,Dept Anesthesiol, Buffalo, NY 14215 USA		Nader, ND (corresponding author), SUNY Buffalo, Div Cardiothorac Anesthesia & Pain Med, VA Western New York Healthcare Syst, Sch Med & Biomed Sci,Dept Anesthesiol, Buffalo, NY 14215 USA.	nnader@buffalo.edu	Nader, Nader/AAO-9442-2020; salehpour, firooz/L-8833-2017	Nader, Nader/0000-0002-5744-7319; salehpour, firooz/0000-0003-0693-6400; porhomayon,, jahan/0000-0001-7096-1825			AUER L, 1978, ACTA NEUROCHIR, V43, P51, DOI 10.1007/BF01809225; AUER LM, 1979, ACTA NEUROCHIR, V49, P219, DOI 10.1007/BF01808961; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Becker S, 1999, EUR J PEDIATR, V158, pS197, DOI 10.1007/PL00014355; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; COPES WS, 1993, P 33 ANN M ASS ADV A, P205; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; GANDO S, 1995, CRIT CARE MED, V23, P1835, DOI 10.1097/00003246-199511000-00009; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Goodnight S H Jr, 1977, Compr Ther, V3, P25; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; LUSTENBERGER T, 2010, INJURY; May AK, 1997, AM SURGEON, V63, P233; MAY AK, 1997, AM SURGEON, V63, P236; Murshid WR, 2002, BRIT J NEUROSURG, V16, P362, DOI 10.1080/0268869021000007597; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PENICK G D, 1960, Int Rec Med, V173, P491; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pondaag W, 1979, Acta Neurochir Suppl (Wien), V28, P98; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; SORENSEN JV, 1993, SCAND J CLIN LAB INV, V53, P659, DOI 10.3109/00365519309092568; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	37	19	20	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441			J CRIT CARE	J. Crit. Care	AUG	2011	26	4					352	356		10.1016/j.jcrc.2010.12.005			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816NG	WOS:000294608400005	21273031				2022-02-06	
J	Kim, YJ				Kim, Young Ju			THE IMPACT OF TIME FROM ED ARRIVAL TO SURGERY ON MORTALITY AND HOSPITAL LENGTH OF STAY IN PATIENTS WITH TRAUMATIC BRAIN INJURY	JOURNAL OF EMERGENCY NURSING			English	Article						Time to surgery; Traumatic brain injury; Mortality; Length of stay	HEAD-INJURY; LEVEL-I; OUTCOMES; CENTERS; TRIAGE	Introduction: The previous studies examining the benefits of timely surgery in patients with traumatic brain injury (TBI) have yielded inconsistent conclusions. This study examined how time from ED arrival to surgery in patients with TBI influenced two patient outcomes: hospital mortality and length of hospital stay. Methods: Using a multivariate and cross-sectional research design, the study sample included 493 patients from the 17 level I and II trauma centers that met inclusion criteria in the National Trauma Data Bank 4.0. The patient characteristics (eg, age, Glasgow Coma Scale score, Injury Severity score, and ED arrival time) and trauma center characteristics (eg, ownership, designation type, and center level) were examined. Student t test, chi(2) test, analysis of variance, and multilevel regression models were used to analyze data. Results: Patients who underwent craniotomy or drainage of hematoma within 4 hours of arrival had half the likelihood of mortality when compared with those who underwent surgery more than 4 hours after ED arrival (odds ratio = .49; 95% confidence interval = .24 to .99). When patients had surgery within 4 hours of arrival, they had a significantly shorter length of hospital stay than did patients who had surgery more than 4 hours after arrival in the emergency department (Estimate = -.10, 95% confidence interval = -.19 to -.01). Discussion: Based on the results of this study using a large sample from multiple centers and advanced statistics, benefits of early clinical assessment and quick access to neurosurgical surgery are substantiated in patients with TBI.	Sungshin Womens Univ, Coll Nursing, Seoul 136742, South Korea		Kim, YJ (corresponding author), Sungshin Womens Univ, Coll Nursing, 249-1 Dongseon Dong 3 Ga, Seoul 136742, South Korea.	yjkim727@sungshin.ac.kr			Sungshin Women's University	This work was supported by the Sungshin Women's University Research Grant.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Clancy TV, 2001, J TRAUMA, V51, P346, DOI 10.1097/00005373-200108000-00021; *COMM TRAUM, 2006, RES OPT CAR INJ PAT; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Karni A, 2001, AM SURGEON, V67, P1098; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Meagher R J, 2000, Clin Neurosurg, V46, P127; Sawauchi S, 2002, ACT NEUR S, V81, P243; Wolf L, 2006, J EMERG NURS, V32, P357, DOI 10.1016/j.jen.2006.04.019	14	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0099-1767	1527-2966		J EMERG NURS	J. Emerg. Nurs.	JUL	2011	37	4					328	333		10.1016/j.jen.2010.04.017			6	Emergency Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Nursing	795ZX	WOS:000293020200011	21741566				2022-02-06	
J	Zehr, EP				Zehr, E. Paul			Evidence-based risk assessment and recommendations for physical activity clearance: stroke and spinal cord injury	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM			English	Article						rehabilitation; physical therapy; neurotrauma; functional capacity; safety	BODY-WEIGHT SUPPORT; CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; HEMIPARETIC STROKE; EXERCISE RECOMMENDATIONS; CEREBROVASCULAR-DISEASE; POSTSTROKE HEMIPLEGIA; SCIENTIFIC STATEMENT; AEROBIC EXERCISE; IMPROVES WALKING	Physical activity (PA) has potential benefits after stroke or spinal cord injury (SCI), especially in improving efficiency and functional capacity in activities of daily living. Currently, many who could benefit from PA may be routinely excluded from participation because of myths related to functional capacity and the concern for harm. The purpose of this review was to evaluate the literature for reports of adverse events during exercise after stroke or SCI, and to provide recommendations regarding exercise participation in supervised and unsupervised environments. Studies were evaluated for quality, and the summary level and quality of evidence were evaluated using the AGREE rubric, modified to address the main outcome measure of adverse events. Levels of exercise stress were evaluated for aerobic activities, using an established rubric. Included in the current analysis were 32 studies for stroke and 4 for SCI. In aggregate, this yielded a total of 730 experimental participants with stroke and 143 with SCI. It should be noted that almost all studies were not designed to examine naturally occurring adverse events from PA. Significant contraindications to unsupervised exercise include manifestation of autonomic dysreflexia in SCI and cardiovascular comorbidity after stroke. There are clear benefits of exercise training on physiological outcomes in stroke and SCI, but the relation between outcomes and safety remains unclear. However, taken on balance, the risk-to-benefit ratio favors the recommendation of exercise. This recommendation is based on studies in which participants were almost universally screened for participation in supervised environments. Thus, the grading of evidence for finding adverse events to support this conclusion is inadequate.	[Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC V8W 3P1, Canada; [Zehr, E. Paul] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada; [Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC V8W 3P1, Canada; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC V8W 3P1, Canada; [Zehr, E. Paul] Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Victoria, BC V8W 3P1, Canada		Zehr, EP (corresponding author), Univ Victoria, Rehabil Neurosci Lab, POB 3015 STN CSC, Victoria, BC V8W 3P1, Canada.	pzehr@uvic.ca					Ada L, 2003, ARCH PHYS MED REHAB, V84, P1486, DOI 10.1016/S0003-9993(03)00349-6; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Adams RJ, 2003, CIRCULATION, V108, P1278, DOI 10.1161/01.CIR.0000090444.87006.CF; American Spinal Injury Association, 2002, INT STAND NEUR CLASS; [Anonymous], 1993, Schweiz Z Sportmed, V41, P127; Badics E, 2002, NEUROREHABILITATION, V17, P211; Barzi Y, 2008, CLIN NEUROPHYSIOL, V119, P1443, DOI 10.1016/j.clinph.2008.02.016; Bourbonnais D, 2002, AM J PHYS MED REHAB, V81, P890, DOI 10.1097/00002060-200212000-00002; Brosseau L, 2006, TOP STROKE REHABIL, V13, P1, DOI 10.1310/3TKX-7XEC-2DTG-XQKH; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Corcoran P J, 1970, Arch Phys Med Rehabil, V51, P69; CUVIELLOPALMER ED, 1988, THESIS TEXAS WOMENS; da Cunha IT, 2002, ARCH PHYS MED REHAB, V83, P1258, DOI 10.1053/apmr.2002.34267; Dean CM, 2000, ARCH PHYS MED REHAB, V81, P409, DOI 10.1053/mr.2000.3839; Dobkin B, 2006, NEUROLOGY, V66, P484, DOI 10.1212/01.wnl.0000202600.72018.39; Dobrovolny CL, 2003, ARCH PHYS MED REHAB, V84, P1308, DOI 10.1016/S0003-9993(03)00150-3; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duncan P, 1998, STROKE, V29, P2055, DOI 10.1161/01.STR.29.10.2055; Eich HJ, 2004, CLIN REHABIL, V18, P640, DOI 10.1191/0269215504cr779oa; ENGARDT M, 1995, ARCH PHYS MED REHAB, V76, P419, DOI 10.1016/S0003-9993(95)80570-2; Farry, 2010, INCIDENCE PREVALENCE; Farry A., 2010, SPINAL CORD INJURY C; Field-Fote Edelle C, 2005, J Neurol Phys Ther, V29, P127; Figoni S.F., 2002, ACSMS RESOURCES CLIN, P48; GERSTEN J W, 1971, Scandinavian Journal of Rehabilitation Medicine, V3, P85; Giuliani CA, 1992, P FORUM STROKE REHAB, P49; GLASSER L, 1986, PHYS THER, V66, P673, DOI 10.1093/ptj/66.5.673; Gordon NF, 2004, CIRCULATION, V109, P2031, DOI 10.1161/01.CIR.0000126280.65777.A4; Heart and Stroke Foundation, 2010, STROK STAT; HERTZER NR, 1985, ARCH INTERN MED, V145, P849, DOI 10.1001/archinte.145.5.849; Inaba M, 1973, Phys Ther, V53, P28; Ivey F M, 2005, Top Stroke Rehabil, V12, P1; Ivey FM, 2008, J CARDIOPULM REHABIL, V28, P2, DOI 10.1097/01.HCR.0000311501.57022.a8; Ivey Frederick M, 2006, NeuroRx, V3, P439, DOI 10.1016/j.nurx.2006.07.011; Jacobs PL, 2004, SPORTS MED, V34, P727, DOI 10.2165/00007256-200434110-00003; Jaffe DL, 2004, J REHABIL RES DEV, V41, P283, DOI 10.1682/JRRD.2004.03.0283; Karimi H., THESIS QUEENS U KING; Kelly Brian M, 2007, Phys Med Rehabil Clin N Am, V18, P631, DOI 10.1016/j.pmr.2007.07.006; Kim C M, 2001, J Stroke Cerebrovasc Dis, V10, P265, DOI 10.1053/jscd.2001.123775; Kosak MC, 2000, NEUROREHAB NEURAL RE, V14, P13, DOI 10.1177/154596830001400102; Krassioukov A, 2009, ARCH PHYS MED REHAB, V90, P682, DOI 10.1016/j.apmr.2008.10.017; Lau DCW, 2007, CAN MED ASSOC J, V176, P1103, DOI 10.1503/cmaj.070306; Laufer Y, 2001, J REHABIL RES DEV, V38, P69; Liston R, 2000, AGE AGEING, V29, P311, DOI 10.1093/ageing/29.4.311; Macko R.F., 2008, ARCH PHYS M IN PRESS; Macko RF, 1997, STROKE, V28, P988, DOI 10.1161/01.STR.28.5.988; Meek C, 2003, CLIN REHABIL, V17, P6, DOI 10.1191/0269215503cr579oa; Mehrholz J., 2008, COCHRANE DB SYST REV, V10; Morris SL, 2004, CLIN REHABIL, V18, P27, DOI 10.1191/0269215504cr699oa; Moseley AM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.cd002840.pub2; Myers J, 2007, AM J PHYS MED REHAB, V86, P142, DOI 10.1097/PHM.0b013e31802f0247; NAKAJIMA A, 1988, PARAPLEGIA, V26, P165, DOI 10.1038/sc.1988.27; Nilsson L, 2001, CLIN REHABIL, V15, P515, DOI 10.1191/026921501680425234; Ouellette MM, 2004, STROKE, V35, P1404, DOI 10.1161/01.STR.0000127785.73065.34; Patten C, 2004, J REHABIL RES DEV, V41, P293, DOI 10.1682/JRRD.2004.03.0293; Pohl M, 2002, STROKE, V33, P553, DOI 10.1161/hs0202.102365; Postans NJ, 2004, ARCH PHYS MED REHAB, V85, P604, DOI 10.1016/j.apmr.2003.08.083; Potempa K, 1996, SPORTS MED, V21, P337, DOI 10.2165/00007256-199621050-00003; POTEMPA K, 1995, STROKE, V26, P101, DOI 10.1161/01.STR.26.1.101; Ramas J, 2007, Ann Readapt Med Phys, V50, P438, DOI 10.1016/j.annrmp.2007.04.005; RICHARDS CL, 1993, ARCH PHYS MED REHAB, V74, P612, DOI 10.1016/0003-9993(93)90159-8; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; ROTH EJ, 1993, ARCH PHYS MED REHAB, V74, P752, DOI 10.1016/0003-9993(93)90038-C; Saunders DH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub3; Scheidtmann K, 1999, NEUROL REHABIL, V5, P198; Sharp SA, 1997, ARCH PHYS MED REHAB, V78, P1231, DOI 10.1016/S0003-9993(97)90337-3; Teixeira-Salmela LF, 1999, ARCH PHYS MED REHAB, V80, P1211, DOI 10.1016/S0003-9993(99)90018-7; The AGREE Collaboration, 2001, APPR GUID RES EV AGR; van de Port IGL, 2007, AM J PHYS MED REHAB, V86, P935, DOI 10.1097/PHM.0b013e31802ee464; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; Warburton Darren E R, 2007, Top Spinal Cord Inj Rehabil, V13, P98, DOI 10.1310/sci1301-98; Warburton DER, 2006, CAN MED ASSOC J, V174, P961, DOI 10.1503/cmaj.1040750; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Weiss A, 2000, AM J PHYS MED REHAB, V79, P369, DOI 10.1097/00002060-200007000-00009; Werner C, 2002, EUR J NEUROL, V9, P639, DOI 10.1046/j.1468-1331.2002.00492.x; Winstein CJ, 2004, ARCH PHYS MED REHAB, V85, P620, DOI 10.1016/j.apmr.2003.06.027; Zehr E.P., CLIN NEUROP IN PRESS	78	19	20	0	15	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1715-5312	1715-5320		APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	JUL	2011	36			1			S214	S231		10.1139/H11-055			18	Nutrition & Dietetics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nutrition & Dietetics; Physiology; Sport Sciences	885JM	WOS:000299775200011	21800943				2022-02-06	
J	Pan, Y; Zhang, HB; Acharya, AB; Cruz-Flores, S; Panneton, WM				Pan, Yi; Zhang, Haibo; Acharya, Aninda B.; Cruz-Flores, Salvador; Panneton, W. Michael			The effect of heliox treatment in a rat model of focal transient cerebral ischemia	NEUROSCIENCE LETTERS			English	Article						Helium; Heliox; Acute stroke; Transient focal ischemia; Rat model	MITOCHONDRIAL PERMEABILITY TRANSITION; TRAUMATIC BRAIN-INJURY; NORMOBARIC HYPEROXIA; IN-VIVO; ARTERY OCCLUSION; INFARCT VOLUME; STROKE; CARDIOPROTECTION; NEUROPROTECTION; THERAPY	Manipulation of inhaled gases during ischemia/reperfusion is a potential novel therapy for acute stroke. We previously found that treatment with a mixture of 70%/30% helium/oxygen (heliox) or 100% oxygen protects the brain against acute focal ischemia-reperfusion injury. This study evaluates the potential neuro-protective effects of delayed heliox treatment and its dose response effects in a rat transient focal cerebral ischemia model. Adult male rats were subjected to 2-h middle cerebral artery occlusion and then assigned to 1 of 4 inhaled gas exposure groups: I: 70%/30% nitrogen/oxygen (control); II: 70%/30% helium/oxygen administered immediately after occlusion; III: 70%/30% helium/oxygen administered after a 30-60 min delay; or, IV: 40%/30%/30% nitrogen/helium/oxygen administered immediately after occlusion. Outcome measurements included infarct size and neurological deficit score. Mean infarct sizes from groups I to IV were 228, 35, 109, and 124 mm(3) respectively (p = 0.012). Only group II had significantly smaller infarct size compared to the control group (p = 0.008). In addition, only Group II had a significantly lower neurological deficit score at 24h post ischemia when compared to the control group (p < 0.001). Since heliox reduced infarct size and improved neurological deficit scores if initiated immediately after onset of ischemia, it may be a useful adjuvant to other stroke therapies. (C) 2011 Elsevier Ireland Ltd. All rights reserved.	[Pan, Yi; Zhang, Haibo; Acharya, Aninda B.; Cruz-Flores, Salvador] St Louis Univ, Dept Neurol & Psychiat, St Louis, MO 63104 USA; [Panneton, W. Michael] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA		Pan, Y (corresponding author), St Louis Univ, Dept Neurol & Psychiat, 1438 S Grand Blvd, St Louis, MO 63104 USA.	pany@slu.edu	Cruz-Flores, Salvador/AAR-1233-2020	Cruz-Flores, Salvador/0000-0003-4998-1471	Department of Neurology & Psychiatry, School of Medicine, Saint Louis University; Souers Stroke Institute	The Souers Stroke Institute, Department of Neurology & Psychiatry, School of Medicine, Saint Louis University provided support for this study.	Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; David HN, 2009, J CEREBR BLOOD F MET, V29, P1159, DOI 10.1038/jcbfm.2009.40; Fujiwara N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-79; Goldlust EJ, 1996, STROKE, V27, P1657, DOI 10.1161/01.STR.27.9.1657; Heinen A, 2008, ANESTHESIOLOGY, V109, P830, DOI 10.1097/ALN.0b013e3181895aa0; Henninger N, 2007, J CEREBR BLOOD F MET, V27, P1632, DOI 10.1038/sj.jcbfm.9600463; Henninger N, 2009, J CEREBR BLOOD F MET, V29, P119, DOI 10.1038/jcbfm.2008.104; Hess DR, 2006, RESPIR CARE, V51, P608; Huhn R, 2009, BRIT J ANAESTH, V102, P614, DOI 10.1093/bja/aep042; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Kim HY, 2005, ANN NEUROL, V57, P571, DOI 10.1002/ana.20430; Liu SM, 2006, J CEREBR BLOOD F MET, V26, P1274, DOI 10.1038/sj.jcbfm.9600277; Liu WL, 2009, J NEUROCHEM, V108, P811, DOI 10.1111/j.1471-4159.2008.05821.x; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lucchinetti E, 2009, ANESTH ANALG, V109, P101, DOI 10.1213/ane.0b013e3181a27e4b; Pagel PS, 2008, ANESTH ANALG, V107, P762, DOI 10.1213/ane.0b013e3181815995; Pagel PS, 2008, ANESTH ANALG, V107, P769, DOI 10.1213/ane.0b013e3181815b84; Pagel PS, 2008, J CARDIOTHOR VASC AN, V22, P554, DOI 10.1053/j.jvca.2008.04.005; Pagel PS, 2007, ANESTH ANALG, V105, P562, DOI 10.1213/01.ane.0000278083.31991.36; Pagel PS, 2009, J CARDIOTHOR VASC AN, V23, P619, DOI 10.1053/j.jvca.2008.12.020; Pagel PS, 2009, ANESTH ANALG, V108, P1076, DOI 10.1213/ane.0b013e318193e934; Pan Y, 2007, EXP NEUROL, V205, P587, DOI 10.1016/j.expneurol.2007.03.023; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; VanDeripe DR, 2004, MED HYPOTHESES, V62, P294, DOI 10.1016/S0306-9877(03)00304-9; Yamamoto H, 2003, EXP NEUROL, V182, P261, DOI 10.1016/S0014-4886(03)00116-X	28	19	19	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 22	2011	497	2					144	147		10.1016/j.neulet.2011.04.048			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	787VI	WOS:000292404400015	21539894				2022-02-06	
J	Wu, N; Wang, WH; Tian, Y; Zou, XT; Maffeo, M; Niezrecki, C; Chen, JL; Wang, XW				Wu, Nan; Wang, Wenhui; Tian, Ye; Zou, Xiaotian; Maffeo, Michael; Niezrecki, Christopher; Chen, Julie; Wang, Xingwei			Low-cost rapid miniature optical pressure sensors for blast wave measurements	OPTICS EXPRESS			English	Article							TRAUMATIC BRAIN-INJURY; SHOCK	This paper presents an optical pressure sensor based on a Fabry-Perot (FP) interferometer formed by a 45 degrees angle polished single mode fiber and an external silicon nitride diaphragm. The sensor is comprised of two V-shape grooves with different widths on a silicon chip, a silicon nitride diaphragm released on the surface of the wider V-groove, and a 45 degrees angle polished single mode fiber. The sensor is especially suitable for blast wave measurements: its compact structure ensures a high spatial resolution; its thin diaphragm based design and the optical demodulation scheme allow a fast response to the rapid changing signals experienced during blast events. The sensor shows linearity with the correlation coefficient of 0.9999 as well as a hysteresis of less than 0.3%. The shock tube test demonstrated that the sensor has a rise time of less than 2 mu s from 0 kPa to 140 kPa. (C) 2011 Optical Society of America	[Wu, Nan; Wang, Wenhui; Tian, Ye; Zou, Xiaotian; Wang, Xingwei] Univ Massachusetts Lowell, Dept Elect & Comp Engn, Lowell, MA 01854 USA; [Maffeo, Michael] USA, Natick Soldier Res Dev & Engn Ctr, Natick, MA 01760 USA; [Niezrecki, Christopher; Chen, Julie] Univ Massachusetts Lowell, Dept Mech Engn, Lowell, MA 01854 USA		Wu, N (corresponding author), Univ Massachusetts Lowell, Dept Elect & Comp Engn, 1 Univ Ave, Lowell, MA 01854 USA.	xingwei_wang@uml.edu	Zou, Xiaotian/J-8657-2013; Tian, Ye/C-4662-2013; Tian, Ye/A-1090-2014	Tian, Ye/0000-0002-0785-1145; Tian, Ye/0000-0002-0785-1145	Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-07-2-0081]	The authors are grateful for the collaboration with Natick Soldier Research, Development, and Engineering Center for sharing the shock tube and the reference pressure sensors. The authors also appreciate the Army Research Laboratory for sponsoring this work (Nanomanufacturing of Multifunctional Sensors Ref. Award Number: W911NF-07-2-0081).	Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; MacPherson WN, 2000, MEAS SCI TECHNOL, V11, P95, DOI 10.1088/0957-0233/11/2/302; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parkes W, 2007, J MICROMECH MICROENG, V17, P1334, DOI 10.1088/0960-1317/17/7/016; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; TOHYAMA O, 1997, SOLID STATE SENSORS, V1482, P1489; Wang WH, 2010, OPT EXPRESS, V18, P9006, DOI 10.1364/OE.18.009006; Wang WH, 2009, OPT EXPRESS, V17, P16613, DOI 10.1364/OE.17.016613; Watson S, 2006, MEAS SCI TECHNOL, V17, P1337, DOI 10.1088/0957-0233/17/6/008; Xu JC, 2005, IEEE PHOTONIC TECH L, V17, P870, DOI 10.1109/LPT.2005.844013	12	19	21	3	17	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1094-4087			OPT EXPRESS	Opt. Express	MAY 23	2011	19	11					10797	10804		10.1364/OE.19.010797			8	Optics	Science Citation Index Expanded (SCI-EXPANDED)	Optics	767JN	WOS:000290852800076	21643336	gold			2022-02-06	
J	Batchelor, PE; Kerr, NF; Gatt, AM; Cox, SF; Ghasem-Zadeh, A; Wills, TE; Sidon, TK; Howells, DW				Batchelor, Peter E.; Kerr, Nicole F.; Gatt, Amy M.; Cox, Susan F.; Ghasem-Zadeh, Ali; Wills, Taryn E.; Sidon, Tara K.; Howells, David W.			Intracanal Pressure in Compressive Spinal Cord Injury: Reduction with Hypothermia	JOURNAL OF NEUROTRAUMA			English	Article						decompression; hypothermia; intracanal pressure; neuroprotection; spinal cord injury	SEVERE HEAD-INJURY; HOSPITAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; 4-DEGREES-C NORMAL SALINE; INTRACRANIAL-PRESSURE; CERVICAL-SPINE; POSTTRAUMATIC HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; COMATOSE SURVIVORS; CRANICAL PRESSURE	Most cases of human spinal cord injury (SCI) are accompanied by continuing cord compression. Experimentally, compression results in rapid neurological decline over hours, suggesting a rise in intracanal pressure local to the site of injury. The aim of this study was to measure the rise in local intracanal pressure accompanying progressive canal occlusion and to determine the relationship between raised intracanal pressure and neurological outcome. We also aimed to establish whether hypothermia was able to reduce raised intracanal pressure. We demonstrate that, following SCI in F344 rats, local intracanal pressure remains near normal until canal occlusion exceeds 30% of diameter, whereupon a rapid increase in pressure occurs. Intracanal pressure appears to be an important determinant of neurological recovery, with poor long-term behavioural and histological outcomes in animals subject to 8 h of 45% canal occlusion, in which intracanal pressure is significantly elevated. In contrast, good neurological recovery occurs in animals with near normal intracanal pressure (animals undergoing 8 h of 30% canal occlusion or those undergoing immediate decompression). We further demonstrate that hypothermia is an effective therapy to control raised intracanal pressure, rapidly reducing elevated intracanal pressure accompanying critical (45%) canal occlusion to near normal. Overall these data indicate that following SCI only limited canal narrowing is tolerated before local intracanal pressure rapidly rises, inducing a sharp decline in neurological outcome. Raised intracanal pressure can be controlled with hypothermia, which may be a useful therapy to emergently decompress the spinal cord prior to surgical decompression.	[Batchelor, Peter E.; Kerr, Nicole F.; Gatt, Amy M.; Cox, Susan F.; Wills, Taryn E.; Sidon, Tara K.; Howells, David W.] Natl Stroke Res Inst, Dept Med, Heidelberg, Vic, Australia; [Ghasem-Zadeh, Ali] Natl Stroke Res Inst, Endocrinol Ctr Excellence, Heidelberg, Vic, Australia; Univ Melbourne, Austin Hlth, Heidelberg, Vic, Australia		Batchelor, PE (corresponding author), Austin Hlth, Dept Med, Studley Rd, Heidelberg, Vic 3084, Australia.	batch@bigpond.net.au		Howells, David/0000-0002-2512-7724	National Stroke Research Institute	This study was supported by the National Stroke Research Institute.	ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; Anderson RE, 2003, J TRAUMA, V54, P550, DOI 10.1097/01.TA.0000047049.64695.69; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Batchelor PE, 2010, J NEUROTRAUM, V27, P1357, DOI 10.1089/neu.2010.1360; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2010, CIRCULATION, V122, P737, DOI 10.1161/CIRCULATIONAHA.109.906859; Botel U, 1997, SPINAL CORD, V35, P420, DOI 10.1038/sj.sc.3100407; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Carlson GD, 1997, SPINE, V22, P1285, DOI 10.1097/00007632-199706150-00002; Carlson GD, 2003, J BONE JOINT SURG AM, V85A, P86, DOI 10.2106/00004623-200301000-00014; Carlson GD, 2000, SPINE, V25, P1218, DOI 10.1097/00007632-200005150-00004; Dahlqvist Mats B, 2010, J Med Case Rep, V4, P297, DOI 10.1186/1752-1947-4-297; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; Dimar JR, 1999, SPINE, V24, P1623, DOI 10.1097/00007632-199908150-00002; DOWNEY JA, 1969, J APPL PHYSIOL, V27, P209, DOI 10.1152/jappl.1969.27.2.209; DOWNEY JA, 1967, J APPL PHYSIOL, V22, P91, DOI 10.1152/jappl.1967.22.1.91; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FEHLINGS M, 2009, CAN J SURG S, V52, P10; Fehlings MG, 1999, SPINE, V24, P605, DOI 10.1097/00007632-199903150-00023; Fraidakis M, 1998, EXP NEUROL, V153, P299, DOI 10.1006/exnr.1998.6897; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HERZOG RJ, 1991, SPINE, V16, pS178, DOI 10.1097/00007632-199106001-00001; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Kakulas BA, 1992, HDB CLIN NEUROLOGY, P21; Khan S, 2007, J SPINAL CORD MED, V30, P27, DOI 10.1080/10790268.2007.11753910; Kim F, 2005, CIRCULATION, V112, P715, DOI 10.1161/CIRCULATIONAHA.105.544528; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; LEECH P, 1974, J NEUROL NEUROSUR PS, V37, P1093, DOI 10.1136/jnnp.37.10.1093; Levi AD, 2010, NEUROSURGERY, V66, P670, DOI 10.1227/01.NEU.0000367557.77973.5F; Levi AD, 2009, J NEUROTRAUM, V26, P407, DOI 10.1089/neu.2008.0745; LEVI L, 1991, NEUROSURGERY, V29, P216, DOI 10.1227/00006123-199108000-00008; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P575; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Morishita Y, 2009, EUR SPINE J, V18, P877, DOI 10.1007/s00586-009-0968-y; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Ng W. P., 1999, NEUROSURG FOCUS, V6, pe3; Norman G, 2008, BIOSTATISTICS BARE E, P46; Papadopoulos SM, 2002, J TRAUMA, V52, P323, DOI 10.1097/00005373-200202000-00019; Pointillart V, 2000, SPINAL CORD, V38, P71, DOI 10.1038/sj.sc.3100962; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Prasad SS, 2003, SPINE, V28, P1263, DOI 10.1097/00007632-200306150-00009; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Rabinowitz RS, 2008, SPINE, V33, P2260, DOI 10.1097/BRS.0b013e31818786db; Rajek A, 2000, ANESTHESIOLOGY, V93, P629, DOI 10.1097/00000542-200009000-00010; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; SCHMIDT KD, 1992, MAYO CLIN PROC, V67, P469, DOI 10.1016/S0025-6196(12)60394-2; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Shields CB, 2005, J NEUROSURG-SPINE, V3, P302, DOI 10.3171/spi.2005.3.4.0302; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Tator CH, 1999, J NEUROSURG, V91, P12, DOI 10.3171/spi.1999.91.1.0012; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vroemen M, 2006, AM J NEURORADIOL, V27, P598; Wolfla CE, 1996, J NEUROSURG, V84, P642, DOI 10.3171/jns.1996.84.4.0642; Yu WR, 1999, ACTA NEUROPATHOL, V98, P15, DOI 10.1007/s004010051046	67	19	20	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2011	28	5					809	820		10.1089/neu.2010.1622			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	762JI	WOS:000290472100281	21250916				2022-02-06	
J	Zhao, J; Redell, JB; Moore, AN; Dash, PK				Zhao, Jing; Redell, John B.; Moore, Anthony N.; Dash, Pramod K.			A novel strategy to activate cytoprotective genes in the injured brain	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Blood-brain barrier; Cytoprotective genes; Keap1; Nrf2; Peptide-based therapy; TBI	CORTICAL IMPACT MODEL; INDUCED AXONAL INJURY; CLOSED-HEAD INJURY; MU-CALPAIN; PROTEOLYSIS; PROTECTS; NRF2; RAT; EXPRESSION; INDUCTION	The transcription factor nuclear factor E2-related factor 2 (Nrf2) regulates the expression of multiple cytoprotective genes that have been shown to offer protection in response to a number of insults. The present study describes a novel strategy to increase expression of Nrf2-responsive genes in brain injured mice. Under normal conditions, the adapter protein Kelch-like ECH-associated protein 1 (Keap1) binds to Nrf2 and promotes its proteosomal degradation in the cytoplasm. The amino acid sequence DEETGE, located at amino acid 77-82 of Nrf2, is critical for Nr12-Keap1 interaction, and synthetic peptides containing this sequence can be used to disrupt the complex in vitro. We observed that intracerebroventricular (i.c.v.) infusion of a peptide containing the DEETGE sequence along with the cell transduction domain of the HIV-TAT protein (TAT-DEETGE) into brain-injured mice did not increase the mRNA levels for Nrf2-driven genes. However, when a calpain cleavage sequence was introduced between the TAT sequence and the DEETGE sequence, the new peptide (TAT-CAL-DEETGE) increased the mRNA levels of these genes. Increased gene expression was not observed when the TAT-CAL-DEETGE peptide was injected into uninjured animals. Furthermore, injection of TAT-CAL-DEETGE peptides before or after brain injury reduced blood-brain barrier compromise, a prominent secondary pathology that negatively influences outcome. The present strategy to increase Nrf2-responsive gene expression can be adapted to treat other insults or diseases based on their underlying mechanism(s) of cellular damage. (C) 2011 Elsevier Inc. All rights reserved.	[Zhao, Jing; Redell, John B.; Moore, Anthony N.; Dash, Pramod K.] Univ Texas Med Sch, Dept Neurobiol & Anat, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Med Sch, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	Jing.Zhao@uth.tmc.edu; John.B.Redell@uth.tmc.edu; Anthony.N.Moore@uth.tmc.edu; p.dash@uth.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS049160, NS053588, MH072933]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH072933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049160, R01NS053588] Funding Source: NIH RePORTER	The authors thank the members of the Dash Laboratory for their insightful comments, suggestions and critical reading of the manuscript. This work was supported by research grants (NS049160, NS053588 and MH072933) from the National Institutes of Health. The sponsors had no role in the study design, in the collection, analysis or interpretation of data, nor did they have any influence on the decision to submit our findings for publication.	Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ho A, 2001, CANCER RES, V61, P474; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Ping Z, 2010, BRAIN RES, V1343, P178, DOI 10.1016/j.brainres.2010.04.036; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Redell JB, 2003, EXP BIOL MED, V228, P261, DOI 10.1177/153537020322800304; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Son TG, 2010, J NEUROCHEM, V112, P1316, DOI 10.1111/j.1471-4159.2009.06552.x; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	24	19	19	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	APR 15	2011	407	3					501	506		10.1016/j.bbrc.2011.03.046			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	755TB	WOS:000289958500011	21414291	Green Accepted			2022-02-06	
J	Malmivaara, K; Kivisaari, R; Hernesniemi, J; Siironen, J				Malmivaara, K.; Kivisaari, R.; Hernesniemi, J.; Siironen, J.			Cost-effectiveness of decompressive craniectomy in traumatic brain injuries	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						cost-effectiveness; decompressive craniectomy; health-related quality of life; quality-adjusted life year; traumatic brain injury	SEVERE HEAD-INJURY; MANAGEMENT	Background and purpose: Decompressive craniectomy (DC) is used regularly in traumatic brain injury (TBI). There are, however, no cost-effectiveness studies of the procedure. Methods: We evaluated the outcomes and treatment costs of all decompressive craniectomies performed between the 2000 and 2006 in a single institution to lower intractable intracranial pressure after TBI. The health-related quality of life was evaluated on the Euroqol (EQ-5D) questionnaire and on the visual-analogue scale (VAS), and cost of a quality-adjusted life year (QALY) was calculated. Results: In this study of 54 patients, the median follow-up time was 5.6 years. Overall mortality rate was 41%. Of the 22 non-survivors, 73% died within 30 days. For 32 survivors, the median EQ-5D index value was 0.85, which is equal to the normal population. The median VAS value was 73, whilst normal population's value is 80. Of the survivors, 81% (26/32) were able to live at home and 31% (10/32) returned to work. The cost of neurosurgical treatment for one QALY was 2400euro. Estimation for all medical costs, including rehabilitation and anticipated future costs, resulted cost of a QALY 17 900 euro. Conclusion Mortality after severe TBI leading to DC was high, but amongst the survivors, the health-related quality of life was equal to normal population. Most survivors were able to live at home and were almost as satisfied with their health as in general people are. Cost of neurosurgical treatment was low, and also including all evaluated costs, cost of a QALY gained was acceptable.	[Kivisaari, R.; Hernesniemi, J.; Siironen, J.] Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland; [Malmivaara, K.] Paijat Hame Cent Hosp, Dept Pediat, Lahti, Finland		Malmivaara, K (corresponding author), Dept Neurosurg, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland.	malmivaara@helsinki.fi			Maire Taponen Foundation; Paijat-Hame Central hospital	The research was supported by the Maire Taponen Foundation (KM, JS) and Paijat-Hame Central hospital research grant (KM).	Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Lemcke J, 2010, ACTA NEUROCHIR SUPPL, V106, P231, DOI 10.1007/978-3-211-98811-4_43; MALMIVAARA K, 2010, EUR J NEUROL, DOI DOI 10.1111/J.1468-1331-2010.03162.X; Malmivaara K, 2009, NEUROSURGERY, V65, P530, DOI 10.1227/01.NEU.0000350861.97585.CE; Meier U, 2008, ACTA NEUROCHIR SUPPL, V102, P29, DOI 10.1007/978-3-211-85578-2_6; Meier U, 2000, ACTA NEUROCHIR SUPPL, V76, P475; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; PICKARD JD, 1990, BRIT MED J, V301, P629, DOI 10.1136/bmj.301.6753.629; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Weinstein MC, 2009, VALUE HEALTH, V12, pS5, DOI 10.1111/j.1524-4733.2009.00515.x; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4	27	19	21	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	APR	2011	18	4					656	662		10.1111/j.1468-1331.2010.03294.x			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	736OI	WOS:000288503600023	21175999				2022-02-06	
J	Kim, J; Woo, J; Park, YG; Chae, S; Jo, S; Choi, JW; Jun, HY; Young, YI; Park, SH; Kim, KH; Shin, HS; Kim, D				Kim, Jeongjin; Woo, Jeonghoon; Park, Young-Gyun; Chae, Sujin; Jo, Seonmi; Choi, Jeong Woo; Jun, Hong Young; Yeom, Young Il; Park, Seong Hoon; Kim, Kyung Hwan; Shin, Hee-Sup; Kim, Daesoo			Thalamic T-Type Ca2+ Channels Mediate Frontal Lobe Dysfunctions Caused by a Hypoxia-Like Damage in the Prefrontal Cortex	JOURNAL OF NEUROSCIENCE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CORTICALLY GENERATED SEIZURES; TRAUMATIC BRAIN INJURY; SPIKE-WAVE COMPLEXES; THALAMOCORTICAL RELAY; CALCIUM-CHANNELS; ABSENCE SEIZURES; FAST COMPONENTS; EARLY-CHILDHOOD	Hypoxic damage to the prefrontal cortex (PFC) has been implicated in the frontal lobe dysfunction found in various neuropsychiatric disorders. The underlying subcortical mechanisms, however, have not been well explored. In this study, we induced a PFC-specific hypoxia-like damage by cobalt-wire implantation to demonstrate that the role of the mediodorsal thalamus (MD) is critical for the development of frontal lobe dysfunction, including frontal lobe-specific seizures and abnormal hyperactivity. Before the onset of these abnormalities, the cross talk between the MD and PFC nuclei at theta frequencies was enhanced. During the theta frequency interactions, burst spikes, known to depend on T-type Ca2+ channels, were increased in MD neurons. In vivo knockout or knockdown of the T-type Ca2+ channel gene (Ca(V)3.1) in the MD substantially reduced the theta frequency MD-PFC cross talk, frontal lobe-specific seizures, and locomotor hyperactivity in this model. These results suggest a two-step model of prefrontal dysfunction in which the response to a hypoxic lesion in the PFC results in abnormal thalamocortical feedback driven by thalamic T-type Ca2+ channels, which, in turn, leads to the onset of neurological and behavioral abnormalities. This study provides valuable insights into preventing the development of neuropsychiatric disorders arising from irreversible PFC damage.	[Kim, Jeongjin; Woo, Jeonghoon; Park, Young-Gyun; Jo, Seonmi; Kim, Daesoo] Korea Adv Inst Sci & Technol, Taejon 305701, South Korea; [Chae, Sujin; Yeom, Young Il] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea; [Choi, Jeong Woo; Kim, Kyung Hwan] Yonsei Univ, Wonju 220710, South Korea; [Shin, Hee-Sup] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea; [Jun, Hong Young; Park, Seong Hoon] Wonkwang Univ, Sch Med, Dept Radiol, Iksan 570749, Chonbuk, South Korea; [Jun, Hong Young; Park, Seong Hoon] Wonkwang Univ, Sch Med, Inst Radiol Imaging Sci, Iksan 570749, Chonbuk, South Korea		Kim, D (corresponding author), Korea Adv Inst Sci & Technol, Taejon 305701, South Korea.	daesoo@kaist.ac.kr	Kim, Daesoo/C-1625-2011; Park, Young-Gyun/AAS-5614-2021	Kim, Daesoo/0000-0001-9915-1463; Kim, Kyung Hwan/0000-0001-9044-0437; Choi, Jeong Woo/0000-0001-5824-8859	Korea governmentKorean Government [2010000002, 20100000032]; Korea Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2010k000814]	This work was supported by the National Honor Scientist Program of Korea (Grant 2010000002, to H.-S.S.), the Mid-Career Researcher Program of the National Research Foundation of Korea funded by the Korea government (Grant 20100000032, to D. K.), and by the 21st Century Frontier R&D Programs of the Korea Ministry of Education, Science and Technology (Grant 2010k000814, to D. K.). We thank H. S. Choi and S. B. Park for their useful comments and help with data analysis. We are grateful to S. Y. Bahk for her assistance with manuscript preparation.	Adachi N, 2000, SEIZURE-EUR J EPILEP, V9, P328, DOI 10.1053/seiz.2000.0413; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Beleza P, 2009, EPILEPSIA, V50, P550, DOI 10.1111/j.1528-1167.2008.01780.x; BENSON DF, 1991, J CHILD NEUROL, V6, pS9, DOI 10.1177/0883073891006001S02; CHOI DW, 1990, J NEUROSCI, V10, P2493; Chua C. K, 2007, C P IEEE ENG MED BIO, P6496, DOI 10.1109/IEMBS.2007.4353847; COULTER DA, 1989, ANN NEUROL, V25, P582, DOI 10.1002/ana.410250610; Cox CL, 1997, P NATL ACAD SCI USA, V94, P8854, DOI 10.1073/pnas.94.16.8854; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; CRUNELLI V, 1989, J PHYSIOL-LONDON, V413, P543, DOI 10.1113/jphysiol.1989.sp017668; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Daffner KR, 2000, J NEUROL NEUROSUR PS, V68, P18, DOI 10.1136/jnnp.68.1.18; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Davids E, 2003, BRAIN RES REV, V42, P1, DOI 10.1016/S0165-0173(02)00274-6; Destexhe A, 1999, NEUROSCIENCE, V92, P427, DOI 10.1016/S0306-4522(99)00024-X; ELBERT T, 1992, BIOL PSYCHIAT, V32, P595, DOI 10.1016/0006-3223(92)90072-8; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ernst WL, 2009, J NEUROSCI, V29, P1615, DOI 10.1523/JNEUROSCI.2081-08.2009; Frampton JE, 2005, CNS DRUGS, V19, P347, DOI 10.2165/00023210-200519040-00010; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; GEDYE A, 1991, MED HYPOTHESES, V34, P174, DOI 10.1016/0306-9877(91)90189-6; Gilby KL, 2008, EPILEPSIA, V49, P108, DOI 10.1111/j.1528-1167.2008.01851.x; Gonzalez-Heydrich J, 2007, EPILEPSY BEHAV, V10, P384, DOI 10.1016/j.yebeh.2007.01.010; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; Gucuyener K, 2003, J CHILD NEUROL, V18, P109, DOI 10.1177/08830738030180020601; GUIDO W, 1992, J NEUROPHYSIOL, V68, P2199, DOI 10.1152/jn.1992.68.6.2199; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321, DOI 10.1152/jn.1982.48.6.1321; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Helmstaedter C, 2001, EPILEPSY BEHAV, V2, P384, DOI 10.1006/ebeh.2001.0259; Hermann B, 2007, BRAIN, V130, P3135, DOI 10.1093/brain/awm227; HERNANDEZ MT, 2001, ADV BEHAV BIOL, V50, P103; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.ph.58.030196.001553; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Ito U, 2006, STROKE, V37, P2134, DOI 10.1161/01.STR.0000231875.96714.b1; Jeanmonod D., 2001, Thalamus & Related Systems, V1, P245, DOI 10.1017/S1472928801000267; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093/brain/119.2.363; Jensen FE, 1998, J NEUROPHYSIOL, V79, P73, DOI 10.1152/jn.1998.79.1.73; Jobst BC, 2005, PSYCHIAT CLIN N AM, V28, P635, DOI 10.1016/j.psc.2005.05.012; Kates WR, 2005, PEDIATR NEUROL, V32, P109, DOI 10.1016/j.pediatrneurol.2004.09.005; Kellinghaus C, 2004, EPILEPTIC DISORD, V6, P223; Kim D, 2003, SCIENCE, V302, P117, DOI 10.1126/science.1088886; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; KURODA M, 1993, BRAIN RES, V612, P339, DOI 10.1016/0006-8993(93)91683-J; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; LEVIN S, 1984, J PSYCHIAT RES, V18, P57, DOI 10.1016/0022-3956(84)90047-5; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; LUHMANN HJ, 1992, J NEUROPHYSIOL, V67, P798, DOI 10.1152/jn.1992.67.4.798; LURIA AR, 1964, NEUROPSYCHOLOGIA, V2, P257, DOI 10.1016/0028-3932(64)90034-X; Macmillan Malcolm, 2002, ODD KIND FAME STORIE; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; Max JE, 2005, J AM ACAD CHILD PSY, V44, P443, DOI 10.1097/01.chi.0000156661.38576.0f; MCALLISTER TW, 1987, COMPR PSYCHIAT, V28, P14, DOI 10.1016/0010-440X(87)90039-3; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; MCGUIRE TL, 1987, J LEARN DISABIL, V20, P590, DOI 10.1177/002221948702001004; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Millichap JG, 2008, PEDIATRICS, V121, pE358, DOI 10.1542/peds.2007-1332; Neckelmann D, 1998, J NEUROPHYSIOL, V80, P1480, DOI 10.1152/jn.1998.80.3.1480; Niedermeyer E, 1998, CLIN ELECTROENCEPHAL, V29, P79, DOI 10.1177/155005949802900206; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; OWEN AM, 1993, BRAIN, V116, P1159, DOI 10.1093/brain/116.5.1159; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; Patrikelis P, 2009, EPILEPSY BEHAV, V14, P19, DOI 10.1016/j.yebeh.2008.09.013; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; SCHEFFER IE, 1995, BRAIN, V118, P61, DOI 10.1093/brain/118.1.61; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; SHUE KL, 1992, BRAIN COGNITION, V20, P104, DOI 10.1016/0278-2626(92)90064-S; Sitnikova E, 2008, J NEUROSCI METH, V170, P245, DOI 10.1016/j.jneumeth.2008.01.017; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1995, J NEUROSCI, V15, P623; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STORES G, 1991, DEV MED CHILD NEUROL, V33, P998; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tan M, 2005, ARCH DIS CHILD, V90, P57, DOI 10.1136/adc.2003.048504; WALTON NY, 1988, EPILEPSY RES, V2, P79, DOI 10.1016/0920-1211(88)90023-X; Wienbruch C, 2003, CLIN NEUROPHYSIOL, V114, P2052, DOI 10.1016/S1388-2457(03)00210-4; Yoon JH, 2008, AM J PSYCHIAT, V165, P1006, DOI 10.1176/appi.ajp.2008.07060945; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006; [No title captured]	94	19	24	0	6	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 16	2011	31	11					4063	4073		10.1523/JNEUROSCI.4493-10.2011			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	735YC	WOS:000288455700015	21411648	Bronze, Green Published			2022-02-06	
J	Larson, EB; Ramaiya, M; Zollman, FS; Pacini, S; Hsu, N; Patton, JL; Dvorkin, AY				Larson, Eric B.; Ramaiya, Milan; Zollman, Felise S.; Pacini, Sonia; Hsu, Nancy; Patton, James L.; Dvorkin, Assaf Y.			Tolerance of a virtual reality intervention for attention remediation in persons with severe TBI	BRAIN INJURY			English	Article						Brain injury; attention; rehabilitation	TRAUMATIC BRAIN-INJURY; REHABILITATION; EFFICACY; DEFICITS; SCALE	Objective: To evaluate the feasibility of applying virtual reality and robotics technology to improve attention in patients with severe traumatic brain injury (TBI) in the early stages of recovery. Methods: A sample of TBI patients (n = 18, aged 19-73) who were receiving acute inpatient rehabilitation completed three-dimensional cancellation exercises over two consecutive days in an interactive virtual environment that minimized distractions and that integrated both visual and haptic (tactile) stimuli. Observations of behaviour during the intervention and of the instructions needed to encourage compliance were recorded. Performance data were compiled to assess improvement across three different treatment conditions. Outcomes: Fifteen of the 18 patients demonstrated tolerance of the virtual environment by completing the entire treatment protocol. Within-subjects comparisons of target acquisition time during treatment showed that a treatment condition that included haptic cues produced improved performance compared to a condition in which such cues were not provided. Separating out participants who were in post-traumatic amnesia showed that this group also demonstrated improvement in performance across trials despite their memory impairment. Conclusions: It is proposed that attention exercises using virtual environments are well-tolerated and engaging and that they could be beneficial for inpatients with severe TBI.	[Larson, Eric B.; Zollman, Felise S.; Pacini, Sonia; Hsu, Nancy] Rehabil Inst Chicago, Brain Injury Rehabil & Med Program, Chicago, IL 60611 USA; [Larson, Eric B.; Zollman, Felise S.; Dvorkin, Assaf Y.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Ramaiya, Milan; Patton, James L.] Univ Illinois, Dept Biomed Engn, Chicago, IL USA; [Ramaiya, Milan; Patton, James L.; Dvorkin, Assaf Y.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Patton, James L.] Northwestern Univ, Dept Biomed & Mech Engn, Chicago, IL 60611 USA		Larson, EB (corresponding author), Rehabil Inst Chicago, Brain Injury Rehabil & Med Program, 345 E Super St, Chicago, IL 60611 USA.	elarson@ric.org	Larson, Eric/AAD-9567-2021		US Department of Education, National Institute on Disability and Rehabilitation Research Midwest Regional Traumatic Brain Injury Model SystemUS Department of Education [H133A080045A]	Supported by the US Department of Education, National Institute on Disability and Rehabilitation Research (Grant # H133A080045A) through the Midwest Regional Traumatic Brain Injury Model System: Innovative Approaches to Improve Cognition, Function, and Community Living.	Chib VS, 2006, J NEUROPHYSIOL, V95, P1068, DOI 10.1152/jn.00610.2005; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Dvorkin Assaf Y, 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P962, DOI 10.1109/ICORR.2009.5209629; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Gray J M, 1989, Brain Inj, V3, P163, DOI 10.3109/02699058909004548; Hagen C, 1979, REHABILITATION HEAD; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Huang FC, 2007, J MOTOR BEHAV, V39, P179, DOI 10.3200/JMBR.39.3.179-193; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lloyd J, 2009, NEUROPSYCHOL REHABIL, V19, P98, DOI 10.1080/09602010802117392; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; Novack TA, 1996, J HEAD TRAUMA REHAB, V11, P52, DOI 10.1097/00001199-199606000-00008; Patton J, 2006, ASSIST TECHNOL, V18, P181, DOI 10.1080/10400435.2006.10131917; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; ROZARIO SV, 2009, EMBC 2009 ANN INT C, P1151; RUFF R, 1994, BRAIN INJURY, V8, P3, DOI 10.3109/02699059409150954; Sohlberg M.M., 1986, ATTENTION PROCESS TR; Sweeney S, 2010, NEUROPSYCHOL REHABIL, V20, P239, DOI 10.1080/09602010903080531; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; YOUNG JJ, 2003, P 11 S HAPT INT VIRT; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	24	19	25	1	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2011	25	3					274	281		10.3109/02699052.2010.551648			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	734UP	WOS:000288365400003	21299370				2022-02-06	
J	Ostberg, A; Virta, J; Rinne, JO; Oikonen, V; Luoto, P; Nagren, K; Arponen, E; Tenovuo, O				Ostberg, A.; Virta, J.; Rinne, J. O.; Oikonen, V.; Luoto, P.; Nagren, K.; Arponen, E.; Tenovuo, O.			Cholinergic dysfunction after traumatic brain injury Preliminary findings from a PET study	NEUROLOGY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HEAD-INJURY; ACETYLCHOLINESTERASE ACTIVITY; ALZHEIMERS-DISEASE; BASAL FOREBRAIN; IN-VIVO; RIVASTIGMINE; DONEPEZIL; IMPAIRMENT; PROPIONATE	Objective: There is evidence that the cholinergic system is frequently involved in the cognitive consequences of traumatic brain injury (TBI). We studied whether the brain cholinergic function is altered after TBI in vivo using PET. Methods: Cholinergic function was assessed with [methyl-C-11]N-methylpiperidyl-4-acetate, which reflects the acetylcholinesterase (AChE) activity, in 17 subjects more than 1 year after a TBI and in 12 healthy controls. All subjects had been without any centrally acting drugs for at least 4 weeks. Results: The AChE activity was significantly lower in subjects with TBI compared to controls in several areas of the neocortex (-5.9% to -10.8%, p = 0.053 to 0.004). Conclusions: Patients with chronic cognitive symptoms after TBI show widely lowered AChE activity across the neocortex. Neurology (R) 2011;76:1046-1050	[Ostberg, A.; Tenovuo, O.] Univ Turku, Dept Neurol, FIN-20251 Turku, Finland; [Virta, J.; Rinne, J. O.; Oikonen, V.; Luoto, P.; Nagren, K.; Arponen, E.] Univ Turku, Turku Positron Emiss Tomog Ctr, FIN-20251 Turku, Finland; Turku Univ, Cent Hosp, Turku, Finland		Tenovuo, O (corresponding author), Univ Turku, Dept Neurol, POB 52, FIN-20251 Turku, Finland.	olli.tenovuo@tyks.fi	Nagren, Kjell/AAE-7039-2019	Nagren, Kjell/0000-0001-5182-8199; Oikonen, Vesa/0000-0002-1947-0219	Hospital District of Southwest Finland; NovartisNovartis; Turku Imanet Oy (subsidiary of GE Healthcare); Orion Corporation; Bayer Schering PharmaBayer AG; Turku University Foundation	Supported by Hospital District of Southwest Finland Research grant from the hospital's research funding resources.; Dr. Ostberg reports no disclosures. Dr. Virta has received funding for travel from Novartis and received research support from Turku Imanet Oy (subsidiary of GE Healthcare), Orion Corporation, and Bayer Schering Pharma. Dr. Rinne serves on scientific advisory boards for Lundbeck Inc. and Boehringer Ingelheim; serves as an Associate Editor for Journal of Alzheimer's Disease; and receives research support from GE Healthcare and its subsidiary Turku Imanet Oy, Bristol-Myers Squibb, Roche, Wyeth, AC Immune SA, the Academy of Finland, and the Sigrid Juselius Foundation. Dr. Oikonen, P. Luoto, Dr. Nagren, and E. Arponen report no disclosures. Dr. Tenovuo receives research support from Turku University Foundation.	[Anonymous], 2003, J NEUROPSYCH CLIN N, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Bentley P, 2003, NEUROIMAGE, V20, P58, DOI 10.1016/S1053-8119(03)00302-1; Bohnen NI, 2005, NEUROSCI LETT, V380, P127, DOI 10.1016/j.neulet.2005.01.031; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; DEKKER AJAM, 1991, NEUROSCI BIOBEHAV R, V15, P299, DOI 10.1016/S0149-7634(05)80008-9; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; Kaasinen V, 2002, J CLIN PSYCHOPHARM, V22, P615, DOI 10.1097/00004714-200212000-00012; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kilbourn MR, 1996, SYNAPSE, V22, P123, DOI 10.1002/(SICI)1098-2396(199602)22:2<123::AID-SYN5>3.0.CO;2-F; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; Kuhl DE, 2002, J CLIN PSYCHOPHARM, V22, P615; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Meyer JH, 1999, NEUROIMAGE, V9, P545, DOI 10.1006/nimg.1999.0431; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Nagatsuka S, 2001, J CEREBR BLOOD F MET, V21, P1354, DOI 10.1097/00004647-200111000-00011; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sato K, 2004, J CEREBR BLOOD F MET, V24, P600, DOI 10.1097/01.WCB.0000117689.98763.6A; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Semba K, 2000, BEHAV BRAIN RES, V115, P115, DOI 10.1016/S0166-4328(00)00253-9; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Snyder SE, 2001, J CEREBR BLOOD F MET, V21, P132, DOI 10.1097/00004647-200102000-00004; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Tenovuo OS, 2006, CURR DRUG THER, V1, P187, DOI 10.2174/157488506776930932; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	37	19	21	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR	2011	76	12					1046	1050		10.1212/WNL.0b013e318211c1c4			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741GW	WOS:000288853200008	21422456				2022-02-06	
J	Lammert, A; Bode, H; Hammes, HP; Birck, R; Fatar, M; Zohsel, K; Braun, J; Schmieder, K; Diepers, M; Schubert, GA; Barth, M; Thome, C; Seiz, M				Lammert, A.; Bode, H.; Hammes, H. -P.; Birck, R.; Fatar, M.; Zohsel, K.; Braun, J.; Schmieder, K.; Diepers, M.; Schubert, G. A.; Barth, M.; Thome, C.; Seiz, M.			Neuro-Endocrine and Neuropsychological Outcome After Aneurysmal Subarachnoid Hemorrhage (aSAH): A Prospective Cohort Study	EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES			English	Article						hypopituitarism; aneurysmal subarachnoid hemorrhage; neuropsychological deficit	TRAUMATIC BRAIN-INJURY; HYPOPITUITARISM; DYSFUNCTION	Objective: Neuropsychological sequelae are common after aneurysmal subarachnoid hemorrhage (aSAH) and may be associated with or caused by supposed hypothalamic-pituitary dysfunction. We evaluated the incidence of neuroendocrine and neuropsychological deficits after aSAH and their interrelations in a standardized manner. Methods: 26 patients (20 females) were prospectively screened for neuro-endocrine and neuropsychological deficits 3 and 6 months after aSAH. We measured GH, IGF-1, prolactin, LH, FSH, estradiol, TSH, fT4, total T3, testosterone, ACTH as well as cortisol before and after ACTH-stimulation. Neuropsychological analysis covered verbal comprehension, short term and working memory, visuospatial construction, figural memory, psychomotor speed, attention, and concentration. Results: After 3 months central hypogonadism was observed in 2 patients accompanied by central hypothyroidism in 1 male subject. Central hypogonadism resolved spontaneously after 6 months in both. After 3 months, neuropsychological deficits were detected in 57% of the examined patients (44% attention deficits, 38% memory impairment, 12% psychomotor deficits). Neuropsychological deficits were still present in 53% after 6 months. Conclusion: We found a low prevalence of neuro-endocrine and a high prevalence of neuropsychological deficits in patients 3 and 6 months after aSAH. Thus, the absent co-incidence of central hormonal and psychological dysfunction leaves a causal association questionable.	[Lammert, A.; Bode, H.; Hammes, H. -P.; Birck, R.] Univ Med Ctr Mannheim, Dept Med 5, D-68167 Mannheim, Germany; [Fatar, M.; Zohsel, K.] Univ Med Ctr Mannheim, Dept Neurol, D-68167 Mannheim, Germany; [Braun, J.; Schmieder, K.; Schubert, G. A.; Barth, M.; Thome, C.; Seiz, M.] Univ Med Ctr Mannheim, Dept Neurosurg, D-68167 Mannheim, Germany; [Diepers, M.] Univ Med Ctr Mannheim, Dept Neuroradiol, D-68167 Mannheim, Germany; [Thome, C.; Seiz, M.] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria		Lammert, A (corresponding author), Univ Med Ctr Mannheim, Dept Med 5, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	alexander.lammert@umm.de	Fatar, Marc/E-6892-2015; Schubert, Gerrit Alexander/Q-9192-2017; Barth, Martin/E-8265-2014; Hammes, Hans-Peter/S-3719-2019	Schubert, Gerrit Alexander/0000-0001-9135-6042; 			Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Anderson SW, 2006, ANN NEUROL, V60, P518, DOI 10.1002/ana.21018; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bellebaum C, 2004, J CLIN EXP NEUROPSYC, V26, P1081, DOI 10.1080/13803390490515342; Berry E, 1997, BRIT J NEUROSURG, V11, P378; Brabant G, 2007, J CLIN ENDOCR METAB, V92, P2604, DOI 10.1210/jc.2007-0153; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; KOKSHOORN N, 2009, EUR J ENDOCRINOL; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; LINDHOLM J, 1987, CLIN ENDOCRINOL, V26, P53, DOI 10.1111/j.1365-2265.1987.tb03638.x; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SIEVERS C, 2009, CLIN ENDOCRINOL OXF; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001; Van den Berghe G, 2001, J CLIN ENDOCR METAB, V86, P3217, DOI 10.1210/jc.86.7.3217	18	19	19	0	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0947-7349	1439-3646		EXP CLIN ENDOCR DIAB	Exp. Clin. Endocrinol. Diabet.	FEB	2011	119	2					111	116		10.1055/s-0030-1262815			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	742CX	WOS:000288918100008	20690074				2022-02-06	
J	Winkler, D; Farnworth, L; Sloan, S; Brown, T				Winkler, Dianne; Farnworth, Louise; Sloan, Sue; Brown, Ted			Moving from aged care facilities to community-based accommodation: Outcomes and environmental factors	BRAIN INJURY			English	Article						Acquired brain injury; young adults; aged care	TRAUMATIC BRAIN-INJURY; SUPPORT NEEDS; INTEGRATION; PEOPLE; INCONTINENCE; SATISFACTION; ABI	Objective: Nearly 3500 people under 60 years of age are living in residential aged care in Australia, a situation which is generally recognized as incompatible with optimum quality of life. The objective of the current study is to explore the transition experiences of young people with acquired brain injury who have lived in aged care facilities and moved into community-based settings. Research design: Grounded theory, qualitative design. Methods and procedures: Semi-structured interviews were conducted with seven individuals with very severe ABI, seven family caregivers and two disability support workers. Each interview was recorded and transcribed verbatim. Results: Participants identified a range of positive outcomes that resulted from the transition from aged care settings to community living environments including increased independence in everyday activities, improved well-being and a greater degree of social inclusion. Participants also identified environmental factors that they deemed as crucial to facilitating positive outcomes. Conclusions: People with very severe ABI have the potential to increase their level of independence in community-based accommodation settings; a potential that is not fostered in most aged care environments. The findings inform the outcome variables and environmental factors that should be measured in studies of transition from aged care to the community.	[Winkler, Dianne] Summer Fdn Ltd, Blackburn 3130, Lancs, England; [Farnworth, Louise; Brown, Ted] Monash Univ, Dept Occupat Therapy, Frankston, Vic, Australia; [Sloan, Sue] Osborn Sloan & Associates, Occupat Therapist & Neuropsychol, Melbourne, Vic, Australia		Winkler, D (corresponding author), Summer Fdn Ltd, POB 208, Blackburn 3130, Lancs, England.	di.winkler@summerfoundation.org.au		Winkler, Di/0000-0003-3899-6248; Brown, Ted/0000-0001-9403-5877			ABELLO D, 2008, QUALITY LIFE OUTCOME; *ACIL TASM PTY LTD, 2003, FF WORKF STRUCT AUST; *ACT GOV DEP DIS H, 2006, ACQ BRAIN INJ PROJ R; *AG CAR PRIC REV T, 2004, REV PRIC ARR RES AG; *AUSTR GOV DEP FAM, 2008, YOUNG PEOPL DIS RES; *AUSTR GOV DEP FAM, YOUNG PEOPL DIS RES; *AUSTR I HLTH WELF, 2007, TABL 30 JUN 2006 STA; Australian Institute of Health & Welfare, 2006, RES AG CAR AUSTR 200; Ball Kathleen, 2001, LINK MAGAZINE, V10, P14; Barreca S, 2003, BRAIN INJURY, V17, P1065, DOI 10.1080/0269905031000110535; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; CALLAWAY L, 2005, AUSTR OCCUPATIONAL T, V52, P262; Cameron C, 2001, AUST NZ J PUBL HEAL, V25, P261, DOI 10.1111/j.1467-842X.2001.tb00574.x; Chou SC, 2003, GERONTOLOGIST, V43, P459, DOI 10.1093/geront/43.4.459; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; *CONT FDN AUSTR, FUND SCH CONT PROD; Cummins R., 1997, COMPREHENSIVE QUALIT; Cummins RA., 2005, PERSONAL WELLBEING I; Department of Human Services, 2005, CREAT NEW OPP RESP N; Department of Human Services Victoria, 2001, ACQ BRAIN INJ STRAT; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Felce D., 1996, DEINSTITUTIONALISATI, P81; Fleminger S, 2005, PSYCHIATR BULL, V29, P53, DOI 10.1192/pb.29.2.53; Foxx-Orenstein A, 2003, ARCH PHYS MED REHAB, V84, P231, DOI 10.1053/apmr.2003.50095; Fyffe C, 2003, YOUNG PEOPLE ABI LES; GALLOP J, 2001, BOARD INQUIRY DISA 1; Glaser B, 1965, AWARENESS DYING; Goffman E., 1961, ASYLUMS; Jones G, 1999, YOUNG PEOPLE NURSING; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kelly G, 2007, BRAIN IMPAIR, V8, P262, DOI DOI 10.1375/BRIM.8.3.262; Lanno E., 2008, BRAIN INJURY S1, V22, P49; Mansell J., 1996, DEINSTITUTIONALISATI, P242; Martin B., 2008, WHO CARES OLDER AUST; MASON T, 2008, J PSYCHIATR MENT HLT, V3, P303; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; MCKNIGHT J, 1995, CARELESS SOC COMMUNI; McMillan TM, 2004, CLIN REHABIL, V18, P132, DOI 10.1191/0269215504cr712oa; *MIN HLTH LONG TER, 2005, REP STUD REV LEV SER; Moylan M, 1995, NATL RES PROJECT EXA; OAKLEY F, 1986, OCCUP THER J RES, V6, P157, DOI 10.1177/153944928600600303; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PAPASTRAT LA, 1992, J HEAD TRAUMA REHAB, V7, P11; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; *QSR INT PTY LTD, 2002, NVIVO 2 0; Regnier V, 2009, NEUROREHABILITATION, V25, P169, DOI 10.3233/NRE-2009-0514; Richards L., 2005, HANDLING QUALITATIVE; Roberts K, 1998, NURSING RES PROCESSE; SCHOFIELD M, 2004, RES METHODS NURSING; Senate Community Affairs References Committee, 2005, COMM AFF REF COMM QU; Shimada H, 2009, AM J PHYS MED REHAB, V88, P823, DOI 10.1097/PHM.0b013e3181b71ec2; SHORTEN B, 2008, PARLIAMENTARY SECRET; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; Sloan S, 2008, ACQUIRED BRAIN INJUR; Sloan S, 2009, BRAIN IMPAIR, V10, P282, DOI 10.1375/brim.10.3.282; Sloan S, 2009, BRAIN IMPAIR, V10, P295, DOI 10.1375/brim.10.3.295; Soulsby G, 2008, BRAIN INJURY, V22, P155; Strettles B, 2005, ACCOMMODATION NSW AD; Stringer K, 1999, STUDY ACCOMMODATION; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; TATE RL, 2003, FROM HOSP TO WHERE, P12; UDS Data Management Service, 1990, GUID US UN DAT SET M; VicHealth, 2005, SOC INCL DET MENT HL; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P11; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler D., 2007, YOUNGER PEOPLE RESID; WINKLER D, 2008, YOUNG PEOPLE RESIDEN; Winkler Dianne, 2006, Aust Health Rev, V30, P100; World Health Organization, 2007, INT CLASS FUNCT DIS; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408; [No title captured]	71	19	19	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2011	25	2					153	168		10.3109/02699052.2010.541403			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JJ	WOS:000288101800003	21219088				2022-02-06	
J	Davies, SR; Field, ARJ; Andersen, T; Pestell, C				Davies, Simon R.; Field, Alan R. J.; Andersen, Thorvald; Pestell, Carmela			The ecological validity of the Rey-Osterrieth Complex Figure: Predicting everyday problems in children with neuropsychological disorders	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Rey-Osterrieth Complex Figure; Ecological validity; Child neuropsychological disorders; Parent rating questionnaires; Behavioral executive dysfunction	BEHAVIOR RATING INVENTORY; ACUTE LYMPHOBLASTIC-LEUKEMIA; QUALITATIVE SCORING SYSTEM; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; ORGANIZATIONAL APPROACH; PERFORMANCE; CHILDHOOD; MEMORY; ADOLESCENTS	Despite its extensive use, the validity of the Rey Complex Figure in predicting everyday behavioral executive dysfunction displayed by children with various neuropsychological disorders is unknown. The copied figures of 263 children aged 6 to 17 years were rescored using an accuracy approach that measured visuospatial ability and three process approaches developed to measure executive functioning. Controlling for age and IQ, partial correlations between scores derived by all scoring methods and the parent ratings on an executive function inventory were zero. In contrast, all four scoring approaches were associated with parent ratings on questionnaires that indexed children's academic achievement, developmental status, and adaptive ability. The findings suggest that the ecological validity of the Rey Complex Figure for children with various central nervous system disorders is more associated with visual-motor integration skills than executive functioning.	[Davies, Simon R.] N Metropolitan Area Mental Hlth Serv, Neurosci Unit, Graylands Selby Lemnos Serv, Claremont, WA 6190, Australia; [Davies, Simon R.; Field, Alan R. J.; Andersen, Thorvald] Murdoch Univ, Dept Psychol, Murdoch, WA 6150, Australia; [Pestell, Carmela] CAHDS, Joondalup, WA, Australia; [Davies, Simon R.] N Metropolitan Area Mental Hlth Serv, Neurosci Unit, Special Care Hlth Serv, Claremont, WA 6190, Australia		Davies, SR (corresponding author), N Metropolitan Area Mental Hlth Serv, Neurosci Unit, Graylands Selby Lemnos Serv, Private Bag 1, Claremont, WA 6190, Australia.	simon.davies@health.wa.gov.au		Pestell, Carmela/0000-0002-1737-7774			AKSHOOMOFF NA, 1995, NEUROPSYCHOLOGY, V9, P364, DOI 10.1037/0894-4105.9.3.364; Anderson P, 2001, CLIN NEUROPSYCHOL, V15, P81, DOI 10.1076/clin.15.1.81.1905; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Bart O, 2007, INFANT CHILD DEV, V16, P597, DOI 10.1002/icd.514; Beebe DW, 2004, APPL NEUROPSYCHOL, V11, P91, DOI 10.1207/s15324826an1102_4; BEERY K, 1989, DEV TEST VISUAL MOTO; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; BERNSTEIN JH, 1996, DEV SCORING SYSTEM R; Bodnar LE, 2007, CHILD NEUROPSYCHOL, V13, P345, DOI 10.1080/09297040600899867; Boone KB, 2000, J CLIN EXP NEUROPSYC, V22, P430; Cahn DA, 1996, CLIN NEUROPSYCHOL, V10, P397, DOI 10.1080/13854049608406700; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Deckersbach T, 2000, J CLIN EXP NEUROPSYC, V22, P640, DOI 10.1076/1380-3395(200010)22:5;1-9;FT640; Demsky Y, 2000, PERCEPT MOTOR SKILL, V91, P311, DOI 10.2466/PMS.91.5.311-321; Denckla MB, 2002, CHILD NEUROPSYCHOL, V8, P304, DOI 10.1076/chin.8.4.304.13512; DUFFEY JB, 1976, PERCEPT MOTOR SKILL, V43, P543, DOI 10.2466/pms.1976.43.2.543; Elliot CD., 1990, DIFFERENTIAL ABILITY; Emslie H, 2003, CHILD NEUROPSYCHOL, V13, P539; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Frisk V, 2005, CHILD NEUROPSYCHOL, V11, P135, DOI 10.1080/092970490911289; Garth J, 1997, Pediatr Rehabil, V1, P99; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goulden LG, 1997, ARCH CLIN NEUROPSYCH, V12, P326, DOI 10.1093/arclin/12.4.326; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Harris N. S., 1999, J INT NEUROPSYCH SOC, V5, P119; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; Kirk U, 1985, HEMISPHERIC FUNCTION, P193; Kirkwood MW, 2001, CLIN NEUROPSYCHOL, V15, P345, DOI 10.1076/clin.15.3.345.10268; KLICPERA C, 1983, ACTA PAEDOPSYCHIATR, V49, P73; Knight JA, 2003, HDB REY OSTERRIETH C; LACHAR D, 2004, COMPREHENSIVE HDB PS, V2, P192; LACHAR D, 2001, PERSONALITY INVENTOR; Lawrence Vivienne, 2004, J Atten Disord, V7, P137, DOI 10.1177/108705470400700302; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Long, 1996, ECOLOGICAL VALIDITY, P15; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P52, DOI 10.1076/chin.8.1.52.8719; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Mayes S. D., 2009, LEARN INDIVID DIFFER, V19, P239; MCHALE K, 1992, AM J OCCUP THER, V46, P898, DOI 10.5014/ajot.46.10.898; Molho CE, 1997, ARCH CLIN NEUROPSYCH, V12, P370, DOI 10.1093/arclin/12.4.370a; Nakano K, 2006, BRAIN DEV-JPN, V28, P641, DOI 10.1016/j.braindev.2006.04.011; Osterrieth P, 1944, ARCH PSYCHOL, V20, P206; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; POULTON RG, 1995, ARCH CLIN NEUROPSYCH, V10, P47, DOI 10.1016/0887-6177(93)E0003-T; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Savage CR, 1999, BIOL PSYCHIAT, V45, P905, DOI 10.1016/S0006-3223(98)00278-9; Sbordone R. J., 1996, ECOLOGICAL VALIDITY, P1; Seidman LJ, 1995, J CHILD PSYCHOL PSYC, V36, P1459, DOI 10.1111/j.1469-7610.1995.tb01675.x; Seidman LJ, 1997, J CONSULT CLIN PSYCH, V65, P150, DOI 10.1037/0022-006X.65.1.150; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Smith SR, 2006, CHILD NEUROPSYCHOL, V12, P383, DOI 10.1080/09297040500350953; Stern R., 1999, BOSTON QUALITATIVE S; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Taylor E., 1959, PSYCHOL APPRAISAL CH; Tupper D. E., 1991, NEUROPSYCHOLOGY EVER, P1; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; WABER DP, 1992, DEV NEUROPSYCHOL, V8, P1, DOI 10.1080/87565649209540512; WABER DP, 1994, DEV NEUROPSYCHOL, V10, P349, DOI 10.1080/87565649409540589; WABER DP, 1995, DEV NEUROPSYCHOL, V11, P237, DOI 10.1080/87565649509540616; WABER DP, 1985, J CLIN EXP NEUROPSYC, V7, P264, DOI 10.1080/01688638508401259; Watanabe K, 2005, BRAIN DEV-JPN, V27, P564, DOI 10.1016/j.braindev.2005.02.007; Wechsler D, 2003, WECHSLER INTELLIGENC; World Health Organization, 2016, INT STAT CLASS DIS R	71	19	19	0	27	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	7					820	831		10.1080/13803395.2011.574608			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882HE	WOS:000299553600009	21957867				2022-02-06	
B	Garcia, P		Rosen, J; Hannaford, B; Satava, RM		Garcia, Pablo			Telemedicine for the Battlefield: Present and Future Technologies	SURGICAL ROBOTICS: SYSTEMS APPLICATIONS AND VISIONS			English	Article; Book Chapter							SURGERY; ROBOTICS	Providing medical care in the field is very challenging because of the limited availability of medical resources. The current practice in military operations is to stabilize patients far forward and evacuate them to better equipped medical facilities, such as combat field hospital: This strategy has proven very successful in recent conflicts. However, it is possible to save more lives and ameliorate the consequences of long term injuries by providing an accurate diagnosis earlier, specialized surgical care faster and more sophisticated intensive care during transport. This chapter focuses on technologies that allow augmenting the diagnostics and treatment capabilities of medical teams in the field. The decisions made by the first responders are critical for the patient chances of survival and they are done with very little information on the real status of the patient. For example, recognizing an internal head injury or abdominal bleeding is critical to determine where the patient should be evacuated but this information is currently not available. Once a patient is evacuated to a medical facility it is impossible to provide all specialties required to treat complex injuries (it is not uncommon for general trauma surgeons to conduct head procedures because they do not have a neurosurgeon in the staff). Finally, once patients are stable enough to transport them outside the country they are taken on long transcontinental flights with a small team of nurses and doctors who have limited means to react to adverse conditions in patients. Technology can be used to force multiply the capabilities of the medical personnel in the field by allowing them to perform more sophisticated diagnosis and treatments closed to the point of injury. Figure 3.1 illustrates the different layers of technology which can be used to treat patients in the field. Each additional layer adds a level of sophistication to the one below but is applicable to a smaller pool of patients.	SRI Int, Menlo Pk, CA 94025 USA		Garcia, P (corresponding author), SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	pablo.garcia@sri.com					AMIR Y, 2004, IEEE T PARALLEL DIST, V15; Ballantyne GH, 2002, SURG LAPARO ENDO PER, V12, P1, DOI 10.1097/00129689-200202000-00001; Blum AL, 1997, ARTIF INTELL, V90, P281, DOI 10.1016/S0004-3702(96)00047-1; Buess GF, 2000, ARCH SURG-CHICAGO, V135, P229, DOI 10.1001/archsurg.135.2.229; Cleary K, 2001, Comput Aided Surg, V6, P312, DOI 10.3109/10929080109146301; GREEN PS, 1995, IEEE ENG MED BIOL, V14, P324, DOI 10.1109/51.391769; HARDEN T, 2005, P ASME 2005 DES ENG; Howe RD, 1999, ANNU REV BIOMED ENG, V1, P211, DOI 10.1146/annurev.bioeng.1.1.211; KAPOOR C, 1998, P 12 CSIM IFTOMM S T; KAPOOR C, 2006, IND ROBOT INT J, V33; Nau D, 2005, IEEE INTELL SYST, V20, P34, DOI 10.1109/MIS.2005.20; PHOLSIRI C, 2005, P ASME 2005 DES ENG; Rosen J, 2006, IEEE SPECTRUM, V43, P34, DOI 10.1109/MSPEC.2006.1705774; Satava RM, 2003, SURG ENDOSC, V17, P104, DOI 10.1007/s00464-002-0018-x; Speich J., 2004, ENCY BIOMATERIALS BI, P983, DOI DOI 10.1081/E-EBBE-120024154; TAYLOR RH, 1999, HDB IND ROBOTICS, P1213	16	19	19	0	1	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY			978-1-4419-1125-4				2011							33	68		10.1007/978-1-4419-1126-1_3	10.1007/978-1-4419-1126-1		36	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Robotics; Surgery	Book Citation Index – Science (BKCI-S)	Computer Science; Engineering; Robotics; Surgery	BSX98	WOS:000286092400003					2022-02-06	
J	McFadden, KL; Healy, KM; Dettmann, ML; Kaye, JT; Ito, TA; Hernandez, TD				McFadden, Kristina L.; Healy, Kyle M.; Dettmann, Miranda L.; Kaye, Jesse T.; Ito, Tiffany A.; Hernandez, Theresa D.			Acupressure as a Non-Pharmacological Intervention for Traumatic Brain Injury (TBI)	JOURNAL OF NEUROTRAUMA			English	Article						ERPs; neuropsychological assessment; oddball task; placebo-controlled; Stroop task	MILD HEAD-INJURY; UNITED-STATES; TRANSCENDENTAL-MEDITATION; COGNITIVE FUNCTION; SYMPTOMS; POTENTIALS; SEQUELAE; OPTIMISM; SMOKING; STRESS	Acupressure is a complementary and alternative medicine (CAM) treatment using fingertips to stimulate acupoints on the skin. Although suggested to improve cognitive function, acupressure has not been previously investigated with a controlled design in traumatic brain injury (TBI) survivors, who could particularly benefit from a non-pharmacological intervention for cognitive impairment. A randomized, placebo-controlled, single-blind design assessed the effects of acupressure (eight treatments over 4 weeks) on cognitive impairment and state of being following TBI, including assessment of event-related potentials (ERPs) during Stroop and auditory oddball tasks. It was hypothesized that active acupressure treatments would confer greater cognitive improvement than placebo treatments, perhaps because of enhanced relaxation response induction and resulting stress reduction. Significant treatment effects were found comparing pre- to post-treatment change between groups. During the Stroop task, the active-treatment group showed greater reduction in both P300 latency (p = 0.010, partial eta(2)=0.26) and amplitude (p=0.011, partial eta(2)=0.26), as well as a reduced Stroop effect on accuracy (p = 0.008, partial eta(2)=0.21) than did the placebo group. Additionally, the active-treatment group improved more than did the placebo group on the digit span test (p = 0.043, Cohen's d = 0.68). Together, these results suggest an enhancement in working memory function associated with active treatments. Because acupressure emphasizes self-care and can be taught to novice individuals, it warrants further study as an adjunct treatment for TBI.	[McFadden, Kristina L.; Healy, Kyle M.; Dettmann, Miranda L.; Kaye, Jesse T.; Ito, Tiffany A.; Hernandez, Theresa D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA		Hernandez, TD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, 1905 Colorado Ave, Boulder, CO 80309 USA.	Theresa.Hernandez@colorado.edu	Kaye, Jesse T./H-6042-2019; Legget, Kristina/AAU-8563-2020	Kaye, Jesse T./0000-0001-6350-4247; Legget, Kristina/0000-0002-2948-506X	Colorado Traumatic Brain Injury Trust	We thank Jin Shin (acupressure) practitioners Christine Palafox, B.A., C.M.T., N.C.T.M.B. and Tara Dempsey, B.A., and all study participants. We also thank professional research assistant Kate Hoversten, B.A. for help with data collection; undergraduate research assistants D. Frank Distel and Samantha Kile for help with data acquisition/entry; undergraduate research assistant Nathan Faes for help with data entry; and professional research assistant Jessica Sannan, B.S. and departmental information technology specialist Jon Roberts, M.A. for technical support. This work was supported by funding from the Colorado Traumatic Brain Injury Trust Fund.	Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BENSON H, 1974, PSYCHIATRY, V37, P37, DOI 10.1080/00332747.1974.11023785; BLAIR SN, 1985, AM J EPIDEMIOL, V122, P794, DOI 10.1093/oxfordjournals.aje.a114163; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; BURMEISTER AJ, 1997, JIN SHIN IYUTSU TOUC; Canter PH, 2003, WIEN KLIN WOCHENSCHR, V115, P758, DOI 10.1007/BF03040500; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; CLANCY D, 1996, ALTERNATIVE COMPLEME, V2, P173; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ernst M, 2001, NEUROPSYCHOPHARMACOL, V25, P313, DOI 10.1016/S0893-133X(01)00257-3; Esch Tobias, 2003, Med Sci Monit, V9, pRA23; Eslinger PJ, 2007, BRAIN INJURY MED PRI, P779; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Felhendler D, 1999, Complement Ther Med, V7, P231, DOI 10.1016/S0965-2299(99)80007-7; GILSON BS, 1975, AM J PUBLIC HEALTH, V65, P1304, DOI 10.2105/AJPH.65.12.1304; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Harris RE, 2005, J ALTERN COMPLEM MED, V11, P673, DOI 10.1089/acm.2005.11.673; HERNANDEZ TD, 2003, SOC AC RES ABSTR, V43; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Hruby T, 2003, ACTA NEUROBIOL EXP, V63, P55; Ilan AB, 2001, INT J PSYCHOPHYSIOL, V40, P109, DOI 10.1016/S0167-8760(00)00156-2; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1017/S0048577298961479; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; KREBS C, 1998, REVOLUTIONARY WAY TH; Kubota JT, 2007, J EXP SOC PSYCHOL, V43, P738, DOI 10.1016/j.jesp.2006.10.023; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; Lesak M. D., 2004, NEUROPSYCHOLOGICAL A; MARSH NV, 1995, BRAIN INJURY, V9, P553, DOI 10.3109/02699059509008214; McCrea M., 2008, MILD TRAUMATIC BRAIN; McFadden KL, 2010, EXPLORE-NY, V6, P380, DOI 10.1016/j.explore.2010.08.004; McFadden KL, 2010, COMPLEMENT THER MED, V18, P42, DOI 10.1016/j.ctim.2010.01.001; MINES S, 2003, WE ARE ALL SHOCK OVE; Mines S, 1982, WELLSPRING, V11, P16; Myers SS, 2008, J GEN INTERN MED, V23, P148, DOI 10.1007/s11606-007-0460-5; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newberg AB, 2010, J ALZHEIMERS DIS, V20, P517, DOI 10.3233/JAD-2010-1391; Oken BS, 2006, ALTERN THER HEALTH M, V12, P40; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Potter DD, 1999, J PSYCHOPHYSIOL, V13, P173, DOI 10.1027//0269-8803.13.3.173; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitan R, 1969, MANUAL ADM NEUROPSYC; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHEIER MF, 1992, COGNITIVE THER RES, V16, P201, DOI 10.1007/BF01173489; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SHAPIRO DA, 1981, BRIT J CLIN PSYCHOL, V20, P111, DOI 10.1111/j.2044-8260.1981.tb00504.x; Sivak S, 2008, BRAIN INJURY, V22, P193, DOI 10.1080/02699050801895431; So KT, 2001, INTELLIGENCE, V29, P419, DOI 10.1016/S0160-2896(01)00070-8; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spielberger CD., 1970, STATE TRAIT ANXIETY; Spikman JM, 2004, J INT NEUROPSYCH SOC, V10, P851, DOI 10.1017/S1355617704106061; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Subramanya P, 2009, BIOPSYCHOSOC MED, V3, DOI 10.1186/1751-0759-3-8; Sugiura Toshifumi, 2007, Journal of Physiological Anthropology, V26, P257, DOI 10.2114/jpa2.26.257; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; Tosevski DL, 2010, CURR OPIN PSYCHIATR, V23, P48, DOI 10.1097/YCO.0b013e328333d625; Tsay SL, 2004, INT J NURS STUD, V41, P99, DOI 10.1016/S0020-7489(03)00079-8; Vanderhasselt MA, 2009, BIOL PSYCHOL, V81, P169, DOI 10.1016/j.biopsycho.2009.03.009; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Wang MC, 2007, J TRAUMA, V62, P1250, DOI 10.1097/01.ta.0000215581.50234.56; Wechsler, 1997, WECHSLER ADULT INTEL	84	19	19	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2011	28	1					21	34		10.1089/neu.2010.1515			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	710DT	WOS:000286491800003	20979460				2022-02-06	
J	Sundin, J; Forbes, H; Fear, NT; Dandeker, C; Wessely, S				Sundin, Josefin; Forbes, Harriet; Fear, Nicola T.; Dandeker, Christopher; Wessely, Simon			The impact of the conflicts of Iraq and Afghanistan: A UK perspective	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							MENTAL-HEALTH PROBLEMS; POSTTRAUMATIC-STRESS-DISORDER; ARMED-FORCES PERSONNEL; TRAUMATIC BRAIN-INJURY; MILITARY PERSONNEL; DEPLOYMENT LENGTH; RISK-FACTORS; WAR; SOLDIERS; SYMPTOMS	Concerns about the mental health of military personnel deployed to Iraq and Afghanistan has led to a new generation of research. This review is an examination of the UK literature on the mental health consequences of deployment of armed forces personnel to Iraq and Afghanistan. As yet, deployment to Iraq or Afghanistan has not been associated with a general increase in mental health problems for the UK Armed Forces. However, research has highlighted certain problems that continue to need to be addressed. Whilst, the rate of post-traumatic stress disorder (PTSD) is low in the UK Armed Forces (1.6-6%), deployment to Iraq or Afghanistan is associated with an increased risk of PTSD for reserve personnel. In contrast to PTSD, the rate of alcohol misuse is high in the UK Armed Forces (between 16-20%), and has been associated with deployment to Iraq or Afghanistan for regular personnel. As the UK military engagement in Afghanistan continues and more personnel are deployed, the demand for help from military health services, the NHS and the service charities will increase.	[Sundin, Josefin] Kings Coll London, Acad Ctr Def Mental Hlth, Weston Educ Ctr, London SE5 9RJ, England; [Forbes, Harriet; Dandeker, Christopher; Wessely, Simon] Kings Coll London, Kings Ctr Mil Hlth Res, London SE5 9RJ, England		Sundin, J (corresponding author), Kings Coll London, Acad Ctr Def Mental Hlth, Weston Educ Ctr, 10 Cutcombe Rd, London SE5 9RJ, England.	Josefin.sundin@kcl.ac.uk	Fear, Nicola/A-1917-2012; Wessely, Simon C/A-8713-2008; Sundin, Josefin/B-9666-2012	Fear, Nicola/0000-0002-5792-2925; Forbes, Harriet/0000-0001-6888-2212; Sundin, Josefin/0000-0002-0609-586X; Wessely, Simon Charles/0000-0002-6743-9929			Adler AB, 2005, J OCCUP HEALTH PSYCH, V10, P121, DOI 10.1037/1076-8998.10.2.121; Basoglu M, 2005, JAMA-J AM MED ASSOC, V294, P580, DOI 10.1001/jama.294.5.580; Browne T, 2008, OCCUP ENVIRON MED, V65, P628, DOI 10.1136/oem.2007.036830; Browne T, 2007, BRIT J PSYCHIAT, V190, P484, DOI 10.1192/bjp.bp.106.030544; Buckman JEJ, 2011, OCCUP ENVIRON MED, V68, P69, DOI 10.1136/oem.2009.054692; Burbeck R, 2002, EMERG MED J, V19, P234, DOI 10.1136/emj.19.3.234; Collins PA, 2003, OCCUP MED-OXFORD, V53, P256, DOI 10.1093/occmed/kqg061; Dandeker C, 2010, ARMED FORCES SOC, V36, P264, DOI 10.1177/0095327X09344068; *DASA, 2010, UK ARM FORC PSYCH MO; *DASA, 2009, UK ARM FORC PSYCH MO; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; Dikel TN, 2005, J TRAUMA STRESS, V18, P69, DOI 10.1002/jts.20002; *DIR RES FORC CAD, 2005, FUT US UK RES FORC; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Fear NT, 2007, ADDICTION, V102, P1749, DOI 10.1111/j.1360-0443.2007.01978.x; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Fear NT, 2009, INT J OCCUP ENV HEAL, V15, P291; Gould M, 2010, J ROY SOC MED, V103, P148, DOI 10.1258/jrsm.2010.090426; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; *HC DEF COMM, 2004, 3 HOUS COMM DEF COMM; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Horn O, 2006, LANCET, V367, P1742, DOI 10.1016/S0140-6736(06)68661-3; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Hughes JH, 2005, BRIT J PSYCHIAT, V186, P536, DOI 10.1192/bjp.186.6.536; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Langston V, 2007, MIL MED, V172, P931, DOI 10.7205/MILMED.172.9.931; Langston V, 2010, J MENT HEALTH, V19, P8, DOI 10.3109/09638230802522999; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mulligan K, 2010, BRIT J PSYCHIAT, V197, P405, DOI 10.1192/bjp.bp.110.077263; National Audit Office, 2006, 16331 HC NAT AUD OFF, P2005; *NCCMH NICE, 2005, 26 NCCMHNICE ROYAL C; Perrin MA, 2007, AM J PSYCHIAT, V164, P1385, DOI 10.1176/appi.ajp.2007.06101645; Rona RJ, 2007, BRIT MED J, V335, P603, DOI 10.1136/bmj.39274.585752.BE; Rona RJ, 2006, BMJ-BRIT MED J, V333, P991, DOI 10.1136/BMJ.38985.610949.55; Rona RJ, 2009, J TRAUMA STRESS, V22, P11, DOI 10.1002/jts.20383; Sundin J, 2010, OCCUP MED-OXFORD, V60, P552, DOI 10.1093/occmed/kqq129; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Sundin J, 2010, INT ARCH OCC ENV HEA, V83, P653, DOI 10.1007/s00420-009-0504-8; SWEENEY M, 2007, GUARDIAN        0405; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Turner MA, 2005, BRIT J PSYCHIAT, V186, P476, DOI 10.1192/bjp.186.6.476; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; 2010, DEFENCE POLICY BUSIN	50	19	19	0	11	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0954-0261			INT REV PSYCHIATR	Int. Rev. Psych.		2011	23	2					153	159		10.3109/09540261.2011.561303			7	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	755PO	WOS:000289946800005	21521084				2022-02-06	
J	Zakzanis, KK; McDonald, K; Troyer, AK				Zakzanis, Konstantine K.; McDonald, Krysta; Troyer, Angela K.			Component analysis of verbal fluency in patients with mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Verbal fluency; Component analysis scores	HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; LONGITUDINAL ANALYSIS; WORKING-MEMORY; BASE RATES; MODERATE; PERFORMANCE; DYSFUNCTION; FATIGUE; MRI	We set out to examine the sensitivity of switching and clustering component scores of verbal fluency in patients with mild traumatic brain injury (mTBI). Clustering and switching scores were compared between patients with mTBI and healthy normal controls as well as those with moderate TBI and severe TBI. Fifty-four healthy controls along with 20 mild TBI, 8 moderate TBI, and 12 severe TBI patients were included in the study. Our findings demonstrate that component score effect sizes were larger than those of total words generated for both phonemic and semantic fluency. This pattern of finding held true regardless of comparison group. In addition, semantic fluency component scores were found to correspond to larger component score effect sizes than did phonemic fluency component scores. Our findings demonstrate that component scores derived from the Controlled Oral Word Association Test may be sufficient to reliably capture the effects of unremitting injury (i.e., more than 3 months post status) to the frontal and temporal brain as evinced in cases of unremitting mTBI. This differential pattern of performance provides preliminary evidence for the potential usefulness of switching and clustering in the assessment of mTBI. Given the small sample sizes employed in our study, however, future studies are needed to determine whether component measures of verbal fluency have discriminative ability.	[Zakzanis, Konstantine K.; McDonald, Krysta] Univ Toronto Scarborough, Dept Psychol, Toronto, ON M1C 1A4, Canada; [Troyer, Angela K.] Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON, Canada		Zakzanis, KK (corresponding author), Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	zakzanis@utsc.utoronto.ca		Troyer, Angela K./0000-0001-5660-4127			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cohen J., 2013, STAT POWER ANAL BEHA; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Ho AK, 2002, NEUROPSYCHOLOGIA, V40, P1277, DOI 10.1016/S0028-3932(01)00217-2; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange R. T., 2010, J CLIN EXPT NEUROPSY, V30, P1; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Moore DJ, 2006, SCHIZOPHR RES, V87, P254, DOI 10.1016/j.schres.2006.06.005; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rich JB, 1999, NEUROPSYCHOLOGY, V13, P525, DOI 10.1037/0894-4105.13.4.525; Robert PH, 1998, J INT NEUROPSYCH SOC, V4, P539, DOI 10.1017/S1355617798466025; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wrightson P, 1999, MILD HEAD INJURY GUI; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; Zakzanis KK, 1998, J CLIN EXP NEUROPSYC, V20, P419, DOI 10.1076/jcen.20.3.419.821; Zakzanis KK, 2000, NEUROPSY NEUROPSY BE, V13, P239; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	64	19	20	0	16	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	7					785	792		10.1080/13803395.2011.558496			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882HE	WOS:000299553600006	21480023				2022-02-06	
J	Baralic, I; Savic, S; Alempijevic, DM; Jecmenica, DS; Sbutega-Milosevic, G; Obradovic, M				Baralic, Ivanka; Savic, Slobodan; Alempijevic, Djordje M.; Jecmenica, Dragan S.; Sbutega-Milosevic, Gorica; Obradovic, Miroljub			Child homicide on the territory of Belgrade	CHILD ABUSE & NEGLECT			English	Article						Children; Homicide; Neonaticide; Fatal child abuse; Forensic pathology	INFANTICIDE; WALES; FILICIDE; ENGLAND; DEATHS	Objective: This study examines the incidence and other epidemiological and medico-legal characteristics of child homicide in the territory of Belgrade, Republic of Serbia. Methods: We performed a retrospective analysis of all autopsies carried out at the Institute of Forensic Medicine in Belgrade during a 15 year period between 1991 and 2005, focusing on homicide cases of victims aged 0-14 years. These were then analyzed in terms of number of deaths, mortality rates, age, and sex of the victim, relation to the perpetrator, and cause of death and injury. Results: Forty-six homicides were identified where the victims were aged 0-14 years. These included 24 girls and 22 boys. In 32 cases (69.6%) the perpetrator was one of the child's birth parents, more frequently the mother. Blunt head trauma was the most frequent cause of death, followed by exsanguination. In 9 cases (19.5%) there was evidence of physical abuse; 16 children died in the setting of multiple homicide and/or murder/suicide. In 4 cases (8.7%) there was evidence of neglect which contributed to the fatal outcome. There were 10 cases of neonaticide within the 46 homicides. There were, however, 49 further cases where bodies of newborn infants were discovered after having been disposed of in suspicious circumstances. Conclusions: Proportionally, the largest number of victims fell within the 1-4 years age group, with a slight preponderance of females, most of them killed at home by a close family member, usually the mother. Blunt head trauma was the single most frequent cause of death. Injury patterns consistent with child abuse were identified among 20% of the study group. (C) 2010 Elsevier Ltd. All rights reserved.	[Baralic, Ivanka; Savic, Slobodan; Alempijevic, Djordje M.; Jecmenica, Dragan S.; Obradovic, Miroljub] Univ Belgrade, Inst Forens Med, Sch Med, Belgrade 11000, Serbia; [Sbutega-Milosevic, Gorica] Univ Belgrade, Inst Hyg & Med Ecol, Sch Med, Belgrade 11000, Serbia		Alempijevic, DM (corresponding author), Univ Belgrade, Inst Forens Med, Sch Med, Deligradska 31A, Belgrade 11000, Serbia.		Alempijevic, Djordje/H-1128-2014	Alempijevic, Djordje/0000-0002-0810-9559			Alempijevic Djordje, 2006, Srp Arh Celok Lek, V134 Suppl 2, P135; Bohnert M, 2005, INT J LEGAL MED, V119, P31, DOI 10.1007/s00414-004-0458-z; Bourget D, 2002, J AM ACAD PSYCHIATRY, V30, P345; Brookman F, 2006, J INTERPERS VIOLENCE, V21, P869, DOI 10.1177/0886260506288935; BYARD WR, 2004, FORENSIC PATHOLOGY R, V1, P171; *CDCP, 1997, JAMA-J AM MED ASSOC, V277, P704; Cordner S M, 2001, Leg Med (Tokyo), V3, P95, DOI 10.1016/S1344-6223(01)00016-5; DICKEMANN M, 2008, INFANTICIDE COMP EVO, P427; DiMaio V., 2001, FORENSIC PATHOLOGY; Dix J, 1998, AM J FOREN MED PATH, V19, P321, DOI 10.1097/00000433-199812000-00005; Flynn SM, 2007, J CLIN PSYCHIAT, V68, P1501, DOI 10.4088/JCP.v68n1005; Friedman SH, 2005, AM J PSYCHIAT, V162, P1578, DOI 10.1176/appi.ajp.162.9.1578; Goldfrank LR, 1998, GOLDFRANKS TOXICOLOG; Hadareanu V, 2007, ROM J LEG MED, V15, P278; Karakus M, 2003, CROAT MED J, V44, P592; KASIM MS, 1995, CHILD ABUSE NEGLECT, V19, P847, DOI 10.1016/0145-2134(95)00046-B; KEELING WJ, 2009, PAEDIAT FORENSIC MED, P180; Knight B., 1996, FORENSIC PATHOLOGY; LAZIN D, 2006, KRIVICNI ZAKONIK OBR; Lucas DR, 2002, CHILD ABUSE NEGLECT, V26, P167, DOI 10.1016/S0145-2134(01)00315-5; Lyman JM, 2003, CHILD ABUSE NEGLECT, V27, P1063, DOI 10.1016/S0145-2134(03)00166-2; Marcikic M, 2006, COLLEGIUM ANTROPOL, V30, P437; MARKS MN, 1993, MED SCI LAW, V33, P329, DOI 10.1177/002580249303300411; Meadow R, 1999, ARCH DIS CHILD, V80, P7, DOI 10.1136/adc.80.1.7; Moniruzzaman S, 2005, SCAND J PUBLIC HEALT, V33, P464, DOI 10.1080/14034940510006021; Mujkic A, 2008, ARCH PEDIAT ADOL MED, V162, P140, DOI 10.1001/archpediatrics.2007.31; Nielssen OB, 2009, MED J AUSTRALIA, V190, P7, DOI 10.5694/j.1326-5377.2009.tb02252.x; PATTON SB, 2003, TOPICS ADV PRACTICE, V3; Pearson J, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-26; Romain N, 2003, MED SCI LAW, V43, P203, DOI 10.1258/rsmmsl.43.3.203; Rouge-Maillart C, 2005, AM J FOREN MED PATH, V26, P320, DOI 10.1097/01.paf.0000188085.11961.b2; *ROYAL COLL PAED C, 2004, SUDD UNEXP DEATH INF; *STAT ANN BELGR, 2008, BELGR BUR INF STAT; WEEKESSHACKELFO.VA, 2004, METHODS, V19, P75; [No title captured]	35	19	19	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134			CHILD ABUSE NEGLECT	Child Abuse Negl.	DEC	2010	34	12					935	942		10.1016/j.chiabu.2010.06.003			8	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	704FX	WOS:000286037600005	21030080				2022-02-06	
J	Chevignard, MP; Brooks, N; Truelle, JL				Chevignard, Mathilde P.; Brooks, Neil; Truelle, Jean-Luc			Community integration following severe childhood traumatic brain injury	CURRENT OPINION IN NEUROLOGY			English	Article						childhood traumatic brain injury; community integration; intervention; outcome; quality of life	QUALITY-OF-LIFE; PEDIATRIC TBI; FAMILY INTERVENTION; FUNCTIONAL RECOVERY; EXECUTIVE FUNCTIONS; COGNITIVE SEQUELAE; YOUNG-CHILDREN; OUTCOMES; TERM; REHABILITATION	Purpose of review Severe childhood traumatic brain injury (TBI) is the leading cause of death and acquired disability in children, causing impairments in children's sensory-motor, cognitive and behavioural functioning, with devastating consequences on community integration. Community integration is the ultimate goal of rehabilitation; it is a complex outcome, with many variables contributing to it. Recent findings Community integration and quality of life (QOL) are lower in children who sustained severe TBI at a younger age. Further, a wide range of injury-related, demographic and postinjury factors influence outcomes, and should serve as targets for specific interventions. An increasing number of interventions targeting cognitive, behavioural or family-related issues have been developed, with promising results. Summary Children should benefit from early integrated patient and family-centred specific care, and receive long-term follow-up until early adulthood, with regular assessments, enabling detection and treatment of any emerging problem, and to ensure the acquisition of independent living skills and stable vocational outcome when this is possible. So far, few well conducted intervention studies are available, but their number is increasing with positive results on the trained skills. Well designed studies using large samples and looking at generalization of the skills in everyday life are needed.	[Chevignard, Mathilde P.] Hop Natl St Maurice, Rehabil Dept Children Acquired Brain Injury, St Maurice, France; [Chevignard, Mathilde P.] Univ Paris 06, Paris, France; [Brooks, Neil] Rehab Walls, Milton Keynes, Bucks, England; [Truelle, Jean-Luc] Univ Hosp, Neurorehabil Dept, Garches, France		Chevignard, MP (corresponding author), Hop Natl St Maurice, INR A, 14 Rue Val dOsne, F-94410 St Maurice, France.	m.chevignard@hopital-saint-maurice.fr			Hopital National de Saint Maurice; France Traumatisme Cranien - SOFMER; 'Societe Francophone d'Etudes et de Recherche sur les Handicaps de l'Enfance' (SFERHE)	Research from the author as described in the study has been supported by the Hopital National de Saint Maurice, as well as by grants from 'France Traumatisme Cranien - SOFMER' and the 'Societe Francophone d'Etudes et de Recherche sur les Handicaps de l'Enfance' (SFERHE). We thank Associate Professor Cathy Catroppa, Professor Pascale Pradat-Diehl, Doctor Anne Laurent-Vannier and Frederique Poncet for their helpful advice about the article and for the English corrections.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Badge H, 2010, CHILD CARE HLTH DEV, V36, P54, DOI 10.1111/j.1365-2214.2009.01005.x; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Carney J, 2009, DEV DISABIL RES REV, V15, P152, DOI 10.1002/ddrr.57; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Chevignard MP, 2010, BRAIN IMPAIR, V11, P125, DOI 10.1375/brim.11.2.125; Chevignard MP, 2009, DEV NEUROREHABIL, V12, P76, DOI 10.1080/17518420902777019; Cole WR, 2009, DEV DISABIL RES REV, V15, P159, DOI 10.1002/ddrr.58; Davis AS, 2010, APPL NEUROPSYCHOL, V17, P104, DOI 10.1080/09084281003708951; Dise-Lewis JE, 2009, J HEAD TRAUMA REHAB, V24, P166, DOI 10.1097/HTR.0b013e3181a7ecb0; Dooley JJ, 2010, BRAIN IMPAIR, V11, P152, DOI 10.1375/brim.11.2.152; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gale SD, 2010, J HEAD TRAUMA REHAB, V25, P15, DOI 10.1097/HTR.0b013e3181c39960; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Horton AM, 2010, APPL NEUROPSYCHOL, V17, P99, DOI 10.1080/09084281003708944; Javouhey E, 2006, EUR J PEDIATR, V165, P519, DOI 10.1007/s00431-006-0118-z; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kapapa T, 2010, J CHILD NEUROL, V25, P409, DOI 10.1177/0883073809340697; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kumar R, 2009, CHILD NERV SYST, V25, P813, DOI 10.1007/s00381-009-0820-z; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Laurent-Vannier A, 2009, Ann Phys Rehabil Med, V52, P436, DOI 10.1016/j.rehab.2009.03.001; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Martin C, 2008, CURR OPIN PEDIATR, V20, P294, DOI 10.1097/MOP.0b013e3282ff0dfa; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P110, DOI 10.1080/09084281003708977; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Nybo T, 1999, BRAIN INJURY, V13, P759; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Sharples PM, 1998, INJURY YOUNG, V263-299; Slifer KJ, 2009, DEV DISABIL RES REV, V15, P144, DOI 10.1002/ddrr.60; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Stipanicic A, 2008, CHILD ABUSE NEGLECT, V32, P415, DOI 10.1016/j.chiabu.2007.07.008; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Winthrop AL, 2010, CURR OPIN PEDIATR, V22, P346, DOI 10.1097/MOP.0b013e3283394351; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	59	19	19	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2010	23	6					695	700		10.1097/WCO.0b013e328340296f			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	675SJ	WOS:000283852400023	20962640				2022-02-06	
J	Kubota, M; Kasahara, T; Iwamoto, K; Komori, A; Ishiwata, M; Miyauchi, T; Kato, T				Kubota, Mie; Kasahara, Takaoki; Iwamoto, Kazuya; Komori, Atsuko; Ishiwata, Mizuho; Miyauchi, Taeko; Kato, Tadafumi			Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						Bipolar disorder; cyclophilin D; DNA microarray; mtDNA; NIM811	MITOCHONDRIAL PERMEABILITY TRANSITION; MAGNETIC-RESONANCE-SPECTROSCOPY; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CELL-DEATH; CYCLOSPORINE-A; DNA MUTATIONS; GENE-EXPRESSION; MOOD STABILIZER; SPLICING FACTOR	We previously reported that neuron-specific mutant Polg1 (mitochondrial DNA polymerase) transgenic (Tg) mice exhibited bipolar disorder (BD)-like phenotypes such as periodic activity change and altered circadian rhythm. In this study, we re-evaluated two datasets resulting from DNA microarray analysis to estimate a biological pathway associated with the disorder. The gene lists were derived from the comparison between post-mortem brains of BD patients and control subjects, and from the comparison between the brains of Tg and wild-type mice. Gene ontology analysis showed that 16 categories overlapped in the altered gene expression profiles of BD patients and the mouse model. In the brains of Tg mice, 33 genes showed similar changes in the frontal cortex and hippocampus compared to wild-type mice. Among the 33 genes, SFPQ and PPIF were differentially expressed in post-mortem brains of BD patients compared to control subjects. The only gene consistently down-regulated in both patients and the mouse model was PPIF, which encodes cyclophilin D (CypD), a component of the mitochondrial permeability transition pore. A blood-brain barrier-permeable CypD inhibitor significantly improved the abnormal behaviour of Tg mice at 40 mg/kg.d. These findings collectively suggest that CypD is a promising target for a new drug for BD.	[Kubota, Mie; Kasahara, Takaoki; Iwamoto, Kazuya; Komori, Atsuko; Ishiwata, Mizuho; Miyauchi, Taeko; Kato, Tadafumi] RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan		Kato, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kato@brain.riken.jp	Kato, Tadafumi/J-3583-2014; Kasahara, Takaoki/AAJ-5367-2020	Kato, Tadafumi/0000-0001-7856-3952; Kasahara, Takaoki/0000-0002-0953-5146	RIKEN BSI; Japanese Ministry of Health and Labor; Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	Post-mortem brains were donated by the Stanley Foundation Brain Collection, courtesy of Drs Michael B. Knable, E. Fuller Torrey, Maree J. Webster, and Robert H. Yolken. We are grateful to staff members of the BSI Research Resource Center for technical assistance and for microarray analysis. We also thank BoldFace Editors, Inc., for language editing of the manuscript. This work was supported by grants to the Laboratory for Molecular Dynamics of Mental Disorders, RIKEN BSI, a Grant-in-Aid from the Japanese Ministry of Health and Labor, and Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology. NIM 811 was provided by Novartis Pharma.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Billups B, 2002, J NEUROSCI, V22, P5840; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Chanas-Sacre G, 1999, J NEUROSCI RES, V57, P62, DOI 10.1002/(SICI)1097-4547(19990701)57:1<62::AID-JNR7>3.0.CO;2-Y; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Corson TW, 2004, EUR NEUROPSYCHOPHARM, V14, P143, DOI 10.1016/S0924-977X(03)00102-0; Dager SR, 2004, ARCH GEN PSYCHIAT, V61, P450, DOI 10.1001/archpsyc.61.5.450; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Glatt S. J., 2009, Current Pharmacogenomics & Personalized Medicine, V7, P164; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; Hiroi T, 2005, PHARMACOGENOMICS J, V5, P102, DOI 10.1038/sj.tpj.6500296; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iacobazzi V, 2005, BIOCHEM J, V391, P613, DOI 10.1042/BJ20050776; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jeong MR, 2003, FEBS LETT, V542, P74, DOI 10.1016/S0014-5793(03)00350-8; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824; KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3; KATO T, 1993, J AFFECT DISORDERS, V27, P53, DOI 10.1016/0165-0327(93)90097-4; Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x; Kato T, 2008, TRENDS NEUROSCI, V31, P495, DOI 10.1016/j.tins.2008.07.007; Kato T, 2007, CNS DRUGS, V21, P1, DOI 10.2165/00023210-200721010-00001; Kim MH, 2005, J NEUROSCI, V25, P6057, DOI 10.1523/JNEUROSCI.0454-05.2005; Kitraki E, 1999, NEUROENDOCRINOLOGY, V69, P331, DOI 10.1159/000054435; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kubota M, 2006, J NEUROSCI, V26, P12314, DOI 10.1523/JNEUROSCI.3933-06.2006; Le-Niculescu H, 2008, AM J MED GENET B, V147B, P134, DOI 10.1002/ajmg.b.30707; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132; Luvisetto S, 2008, NEUROSCIENCE, V155, P585, DOI 10.1016/j.neuroscience.2008.06.030; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Mott JL, 2004, BIOCHEM BIOPH RES CO, V319, P1210, DOI 10.1016/j.bbrc.2004.05.104; Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7; Mott JL, 2006, BBA-BIOENERGETICS, V1757, P596, DOI 10.1016/j.bbabio.2006.04.014; Mouri A, 2010, HIPPOCAMPUS, V20, P293, DOI 10.1002/hipo.20625; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126; Qing H, 2003, EUR J NEUROSCI, V17, P1563, DOI 10.1046/j.1460-9568.2003.02590.x; Rasmussen A, 1996, TRANSPLANTATION, V62, P1031, DOI 10.1097/00007890-199610150-00026; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Regenold WT, 2009, BIOL PSYCHIAT, V65, P489, DOI 10.1016/j.biopsych.2008.11.010; SAKATA A, 1994, BIOCHEM PHARMACOL, V48, P1989, DOI 10.1016/0006-2952(94)90601-7; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Watanuki T, 2008, J AFFECT DISORDERS, V110, P62, DOI 10.1016/j.jad.2008.01.003; Zhang DX, 2005, AM J PHYSIOL-HEART C, V288, pH302, DOI 10.1152/ajpheart.00661.2004	61	19	20	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1461-1457			INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	NOV	2010	13	10					1355	1368		10.1017/S1461145710000362			14	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	674WH	WOS:000283780600006	20392297	Green Submitted, hybrid			2022-02-06	
J	Lee, JHT; Roy, J; Sohn, HM; Cheong, MA; Liu, J; Stammers, AT; Tetzlaff, W; Kwon, BK				Lee, Jae H. T.; Roy, Josee; Sohn, Hong Moon; Cheong, Mi Ae; Liu, Jie; Stammers, Anthea T.; Tetzlaff, Wolfram; Kwon, Brian K.			Magnesium in a Polyethylene Glycol Formulation Provides Neuroprotection After Unilateral Cervical Spinal Cord Injury	SPINE			English	Article						cervical spinal cord injury; magnesium chloride; polyethylene glycol; neuroprotection	INTRACELLULAR FREE MAGNESIUM; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; SULFATE TREATMENT; ACUTE STROKE; RAT; FORELIMB; RECOVERY; THERAPY; PLASTICITY	Study Design. Experimental animal study. Objective. To investigate the neuroprotective efficacy of this magnesium in polyethylene glycol (PEG) formulation in a contusive model of cervical spinal cord injury (SCI). Summary of Background Data. Intravenously administered magnesium has been extensively investigated as a neuroprotective agent in animal models of SCI, stroke, and traumatic brain injuries, and has been evaluated in large scale clinical trials for the latter 2 indications. We have developed a novel formulation of magnesium chloride (MgCl(2)) within PEG, and have previously demonstrated the neuroprotective benefit of this formulation in animal models of thoracic SCI. Methods. Twenty-two Sprague Dawley rats underwent a unilateral cervical hemicontusion at C4-C5 and were randomized 2 hours later to either the MgCl(2) in PEG formulation, or normal saline. Each treatment was administered in 5 intravenous infusions spaced 6 hours apart. Behavioral recovery was assessed over 6 weeks, after which the cord was analyzed to measure the extent of gray matter and white matter sparing through the injury site. Results. In the horizontal ladder test, the percentage of forelimb errors made by the animals treated with MgCl(2) in PEG formulation was significantly lower than the saline-treated controls. Histologic analysis also revealed a significantly higher cumulative white matter sparing through the injury site in the MgCl(2) in PEG group. Conclusion. MgCl(2) in a PEG formulation reduced secondary damage and improved behavioral recovery when administered 2 hours after a unilateral cervical hemicontusion injury. These findings are consistent with the neurologic benefit observed when administering this magnesium formulation in contusive and compressive models of thoracic SCI. Demonstrating the robustness of this neuroprotective effect in multiple injury models (and in the cervical injury model in particular) is important when considering the applicability of such a therapy for human SCIs.	[Lee, Jae H. T.; Liu, Jie; Stammers, Anthea T.; Tetzlaff, Wolfram; Kwon, Brian K.] Univ British Columbia, ICORD, Vancouver, BC V5Z 1M9, Canada; [Roy, Josee] Medtronic, Memphis, TN USA; [Sohn, Hong Moon] Chosun Univ, Chosun Univ Hosp, Dept Orthopaed, Kwangju, South Korea; [Cheong, Mi Ae] Hanyang Univ, Dept Anesthesiol, Seoul 133791, South Korea; [Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada		Kwon, BK (corresponding author), VGH, Blusson Spinal Cord Ctr, 6th Floor,818 W 10th Ave, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@vch.ca	Tetzlaff, Wolfram/AAY-4430-2020				Anderson KD, 2005, EXP NEUROL, V194, P161, DOI 10.1016/j.expneurol.2005.02.006; Aronow Wilbert S, 2007, Heart Fail Clin, V3, P465, DOI 10.1016/j.hfc.2007.07.010; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P265, DOI 10.1097/00002826-200109000-00003; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Gok B, 2007, CHINESE J PHYSIOL, V50, P93; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Jain A, 2008, CRIT REV THER DRUG, V25, P403, DOI 10.1615/CritRevTherDrugCarrierSyst.v25.i5.10; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Kaptanoglu E, 2003, NEUROSURG REV, V26, P283, DOI 10.1007/s10143-003-0272-y; Kaptanoglu E, 2003, J CLIN NEUROSCI, V10, P329, DOI 10.1016/S0967-5868(03)00031-6; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Kwon Brian K, 2002, Mol Interv, V2, P244, DOI 10.1124/mi.2.4.244; Kwon BK, 2009, J NEUROTRAUM, V26, P1379, DOI [10.1089/neu.2009.0884, 10.1089/neu.2009-0884]; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Liu Y, 1999, J NEUROSCI, V19, P4370; McKenna JE, 2000, J COMP NEUROL, V419, P286, DOI 10.1002/(SICI)1096-9861(20000410)419:3<286::AID-CNE2>3.0.CO;2-3; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; *NAT SPIN CORD INJ, 2008, J SPINAL CORD MED, V31, P357; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; Nurko S, 2008, J PEDIATR, V153, P254, DOI 10.1016/j.jpeds.2008.01.039; Ozdemir M, 2005, MAGNESIUM RES, V18, P170; PENCE S, 2002, BASIC CLIN PHYSL PHA, V13, P41; Poschel KA, 2000, KIDNEY INT, V58, P2478, DOI 10.1046/j.1523-1755.2000.00431.x; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Soblosky JS, 1997, J NEUROSCI METH, V78, P75, DOI 10.1016/S0165-0270(97)00131-3; Soblosky JS, 2001, BEHAV BRAIN RES, V119, P1, DOI 10.1016/S0166-4328(00)00328-4; Solaroglu I, 2005, SURG NEUROL, V64, P17, DOI 10.1016/j.surneu.2005.07.058; Stackhouse SK, 2008, J NEUROTRAUM, V25, P1039, DOI 10.1089/neu.2007.0419; Suzer T, 1999, SPINAL CORD, V37, P480, DOI 10.1038/sj.sc.3100874; Tang AC, 2002, BEHAV BRAIN RES, V131, P1, DOI 10.1016/S0166-4328(01)00330-8; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; VINK R, 1989, BRAIN RES, V490, P144, DOI 10.1016/0006-8993(89)90440-X; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; VINK R, 1988, J BIOL CHEM, V263, P757; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	47	19	19	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-2436			SPINE	SPINE	NOV 1	2010	35	23					2041	2048		10.1097/BRS.0b013e3181d2d6c5			8	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	671GX	WOS:000283490100022	20938394				2022-02-06	
J	Ritz, MF; Graumann, U; Gutierrez, B; Hausmann, O				Ritz, Marie-Francoise; Graumann, Ursula; Gutierrez, Bertha; Hausmann, Oliver			Traumatic Spinal Cord Injury Alters Angiogenic Factors and TGF-Beta1 that may Affect Vascular Recovery	CURRENT NEUROVASCULAR RESEARCH			English	Article						Angiogenic factors; gene expression; rat model; revascularization; spinal cord injury; vessel regression	ENDOTHELIAL GROWTH-FACTOR; BLOOD-BRAIN-BARRIER; VON-WILLEBRAND-FACTOR; CCN FAMILY; FACTOR-B; FUNCTIONAL RECOVERY; COMPRESSION INJURY; CEREBRAL-ISCHEMIA; CONTUSION INJURY; NERVOUS-SYSTEM	Traumatic spinal cord injury (SCI) disrupts the blood-spinal cord barrier and reduces the blood supply caused by microvascular changes. Vessel regression and neovascularization have been observed in the course of secondary injury contributing to microvascular remodeling after trauma. Spatio-temporal distribution of blood vessels and modulation of gene expression of several angiogenic factors have been investigated in rats after spinal cord compression injury. Rarefaction of vessels was detectable at the injury site 2 days after SCI before they disappeared in the developing cavity after 2 and 4 weeks, whereas no changes were observed in the penumbra. Investigation of the temporal expression of angiogenic genes using quantitative RT-PCR disclosed a constant down-regulation of the vascular endothelial growth factor (VEGF), and transient decreases of angiopoietin-1 (Ang-1), platelet-derived growth factor-BB (PDGF-BB), as well as placental growth factor (PlGF), with the lowest values obtained 3 days after injury, when compared to the expression levels obtained in sham-operated rats. Hepatocyte growth factor (HGF) was the only angiogenic factor with a constant increased gene expression when compared with controls, starting at day 3 post-SCI. mRNA levels of transforming growth factor-beta 1 (TGF-beta 1) were elevated at every time point following SCI, whereas those encoding for the cysteine-rich protein CCN1/CYR61 were upregulated after 2 h, 6 h, and 1 week only. Our data provide an overview of the temporal modulated expression of the major angiogenic factors, hampering revascularization in the lesion during the phase of secondary injury. These findings should be considered in order to improve therapeutic interventions.	[Ritz, Marie-Francoise] Pharmactr, Dept Biomed, CH-4056 Basel, Switzerland; [Graumann, Ursula; Gutierrez, Bertha; Hausmann, Oliver] Spinal Injury Res, Swiss Parapleg Res, CH-6207 Nottwil, Switzerland; [Hausmann, Oliver] Neuro & Spine Ctr Hirslanden Clin St Anna, CH-6006 Luzern, Switzerland		Ritz, MF (corresponding author), Pharmactr, Dept Biomed, Klingelbergstr 50, CH-4056 Basel, Switzerland.	marie-francoise.ritz@unibas.ch			Swiss Paraplegic Foundation, Nottwil, Switzerland; Swiss Neuro Institute, Hirslanden, Zurich, Switzerland	This work was supported by the Swiss Paraplegic Foundation, Nottwil, Switzerland, and by the Swiss Neuro Institute, Hirslanden, Zurich, Switzerland.	Aigner L, 2008, CELL TISSUE RES, V331, P225, DOI 10.1007/s00441-007-0466-7; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bai T, 2010, J IMMUNOL, V184, P3223, DOI 10.4049/jimmunol.0902792; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Beck H, 2002, J NEUROPATH EXP NEUR, V61, P339, DOI 10.1093/jnen/61.4.339; Benton RL, 2009, CURR NEUROVASC RES, V6, P124, DOI 10.2174/156720209788185678; Benton RL, 2003, NEUROCHEM RES, V28, P1693, DOI 10.1023/A:1026013106016; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; BLIGHT AR, 1991, J NEUROL SCI, V106, P158, DOI 10.1016/0022-510X(91)90253-4; Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I; Buss A, 2008, SPINAL CORD, V46, P364, DOI 10.1038/sj.sc.3102148; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Chen XH, 2007, J CARD FAIL, V13, P874, DOI 10.1016/j.cardfail.2007.07.004; Chow J, 2001, DEV BRAIN RES, V130, P123, DOI 10.1016/S0165-3806(01)00220-6; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Paula EV, 2009, TRANSL RES, V153, P232, DOI 10.1016/j.trsl.2009.02.002; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Fataccioli V, 2002, HUM GENE THER, V13, P1461, DOI 10.1089/10430340260185094; Goodwin CR, 2010, CANCER RES, V70, P2932, DOI 10.1158/0008-5472.CAN-09-3570; Graumann U, 2010, CURR NEUROVASC RES, V7, P144, DOI 10.2174/156720210791184907; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; Higgins Stephen P, 2009, Cell Commun Insights, V2, P1; Hughes JM, 2007, DIABETOLOGIA, V50, P1089, DOI 10.1007/s00125-007-0621-4; Ieda Y, 2007, J MOL CELL CARDIOL, V42, P540, DOI 10.1016/j.yjmcc.2006.11.015; IIHARA K, 1994, J CEREBR BLOOD F MET, V14, P818, DOI 10.1038/jcbfm.1994.102; ImperatoKalmar EL, 1997, EXP NEUROL, V145, P322, DOI 10.1006/exnr.1997.6449; Jaeger CB, 1997, EXP NEUROL, V144, P381, DOI 10.1006/exnr.1996.6405; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kaneko M, 1998, ACTA NEUROPATHOL, V95, P471, DOI 10.1007/s004010050827; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Lagord C, 2002, MOL CELL NEUROSCI, V20, P69, DOI 10.1006/mcne.2002.1121; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li J, 2010, MICROVASC RES, V80, P10, DOI 10.1016/j.mvr.2009.12.002; Li W, 1996, DIABETOLOGIA, V39, P537; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Ma H, 2002, ATHEROSCLEROSIS, V164, P79, DOI 10.1016/S0021-9150(02)00062-X; Meyuhas R, 2008, MOL CANCER RES, V6, P1397, DOI 10.1158/1541-7786.MCR-07-2086; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; Mueller CA, 2007, J NEUROSURG-SPINE, V7, P205, DOI 10.3171/SPI-07/08/205; Nakagawa T, 2004, KIDNEY INT, V66, P605, DOI 10.1111/j.1523-1755.2004.00780.x; Nesic-Taylor O, 2005, J NEUROSCI RES, V79, P628, DOI 10.1002/jnr.20400; Niimi H, 2003, CLIN HEMORHEOL MICRO, V29, P149; Noubade R, 2008, AM J PATHOL, V173, P892, DOI 10.2353/ajpath.2008.080001; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; Renner O, 2003, MOL BRAIN RES, V113, P44, DOI 10.1016/S0169-328X(03)00085-8; Risau W, 1998, PATHOL BIOL, V46, P171; Roncal C, 2008, J PATHOL, V216, P236, DOI 10.1002/path.2408; ROSS R, 1990, SCIENCE, V248, P1009, DOI 10.1126/science.2343305; Ruggeri ZM, 2003, CURR OPIN HEMATOL, V10, P142, DOI 10.1097/00062752-200303000-00008; Sennino B, 2007, CANCER RES, V67, P7358, DOI 10.1158/0008-5472.CAN-07-0293; Shimamura M, 2007, BRAIN RES, V1151, P188, DOI 10.1016/j.brainres.2007.03.022; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Van Belle E, 1998, CIRCULATION, V97, P381; Vincent L, 2004, CANCER CELL, V6, P307, DOI 10.1016/j.ccr.2004.09.024; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Xiyang YB, 2009, J NEUROTRAUM, V26, P275, DOI 10.1089/neu.2007.0374; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; You JJ, 2009, INVEST OPHTH VIS SCI, V50, P3447, DOI 10.1167/iovs.08-2603; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zhang ZC, 2010, ACTA CRYSTALLOGR C, V66, pI9, DOI 10.1107/S0108270109054316; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	84	19	22	0	9	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026			CURR NEUROVASC RES	Curr. Neurovasc. Res.	NOV	2010	7	4					301	310		10.2174/156720210793180756			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	685IY	WOS:000284623600004	20860549				2022-02-06	
J	Iselin, G; Le Brocque, R; Kenardy, J; Anderson, V; McKinlay, L				Iselin, Greg; Le Brocque, Robyne; Kenardy, Justin; Anderson, Vicki; McKinlay, Lynne			Which method of posttraumatic stress disorder classification best predicts psychosocial function in children with traumatic brain injury?	JOURNAL OF ANXIETY DISORDERS			English	Article						PTSD; Diagnostic criteria; Classification; Pediatrics; Traumatic brain injury	HEAD-INJURY; PTSD; SYMPTOMS; DIAGNOSIS; QUESTIONNAIRE; VALIDITY; CRITERIA	Controversy surrounds the classification of posttraumatic stress disorder (PTSD), particularly in children and adolescents with traumatic brain injury (TBI). In these populations, it is difficult to differentiate TBI-related organic memory loss from dissociative amnesia. Several alternative PTSD classification algorithms have been proposed for use with children. This paper investigates DSM-IV-TR and alternative PTSD classification algorithms, including and excluding the dissociative amnesia item, in terms of their ability to predict psychosocial function following pediatric TBI. A sample of 184 children aged 6-14 years were recruited following emergency department presentation and/or hospital admission for TBI. PTSD was assessed via semi-structured clinical interview (CAPS-CA) with the child at 3 months post-injury. Psychosocial function was assessed using the parent report CHQ-PF50. Two alternative classification algorithms, the PTSD-AA and 2 of 3 algorithms, reached statistical significance. While the inclusion of the dissociative amnesia item increased prevalence rates across algorithms, it generally resulted in weaker associations with psychosocial function. The PTSD-AA algorithm appears to have the strongest association with psychosocial function following TBI in children and adolescents. Removing the dissociative amnesia item from the diagnostic algorithm generally results in improved validity. (C) 2010 Elsevier Ltd. All rights reserved.	[Iselin, Greg; Le Brocque, Robyne; Kenardy, Justin] Univ Queensland, Sch Med, Ctr Natl Res Disabil & Rehabil Med CONROD, Herston, Qld 4006, Australia; [Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [McKinlay, Lynne] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Herston, Qld 4006, Australia		Kenardy, J (corresponding author), Univ Queensland, Sch Med, Ctr Natl Res Disabil & Rehabil Med CONROD, Herston Rd, Herston, Qld 4006, Australia.	j.kenardy@uq.edu.au	Le Brocque, Robyne/F-4848-2010; Kenardy, Justin A/H-6603-2014; Kenardy, Justin/F-2085-2010	Le Brocque, Robyne/0000-0002-4574-1254; Kenardy, Justin A/0000-0001-9475-8450; McKinlay, Lynne/0000-0002-6677-0628			Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bedard-Gilligan M, 2008, BEHAV RES THER, V46, P1062, DOI 10.1016/j.brat.2008.06.009; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Carrion VG, 2002, J AM ACAD CHILD PSY, V41, P166, DOI 10.1097/00004583-200202000-00010; Chalton LD, 2009, BRAIN INJURY, V23, P77, DOI 10.1080/02699050802635273; Cohen JA, 1998, J AM ACAD CHILD PSY, V37, p4S, DOI 10.1097/00004583-199810001-00002; Cohen Judith A, 2009, Dialogues Clin Neurosci, V11, P91; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Kassam-Adams N, 2004, J AM ACAD CHILD PSY, V43, P403, DOI 10.1097/00004583-200404000-00006; Kenardy J, 2007, J ANXIETY DISORD, V21, P456, DOI 10.1016/j.janxdis.2006.05.007; KILPATRICK DG, 1998, DSM IV SOURCEBOOK, V0004, P00803; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; KING NS, 2008, PSYCHOL APPROACHES R, P294; Landgraf JM, 1996, CHILD HLTH QUESTIONN; Langeland W, 2008, NEUROSCI BIOBEHAV R, V32, P161, DOI 10.1016/j.neubiorev.2007.07.002; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; McKinnon AC, 2008, BEHAV RES THER, V46, P766, DOI 10.1016/j.brat.2008.02.008; McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050118030; Meiser-Stedman R, 2008, AM J PSYCHIAT, V165, P1326, DOI 10.1176/appi.ajp.2008.07081282; Nader K., 1996, CLIN ADM PTSD SCALE; Orr SP, 1997, ANN NY ACAD SCI, V821, P114, DOI 10.1111/j.1749-6632.1997.tb48273.x; Salmon K, 2002, CLIN PSYCHOL REV, V22, P163, DOI 10.1016/S0272-7358(01)00086-1; Scheeringa M, 2003, J AM ACAD CHILD PSY, V42, P561, DOI 10.1097/01.CHI.0000046822.95464.14; Scheeringa MS, 2006, AM J PSYCHIAT, V163, P644, DOI 10.1176/appi.ajp.163.4.644; Scheeringa MS, 2005, J AM ACAD CHILD PSY, V44, P899, DOI 10.1097/01.chi.0000169013.81536.71; Scheeringa MS, 1995, INF MENTAL HLTH J, V16, P259, DOI 10.1002/1097-0355(199524)16:4<259::AID-IMHJ2280160403>3.0.CO;2-T; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; Stallard P, 2007, J CHILD PSYCHOL PSYC, V48, P194, DOI 10.1111/j.1469-7610.2006.01692.x; Stallard P, 2003, BEHAV COGN PSYCHOTH, V31, P337, DOI 10.1017/S1352465803003084; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Waters E, 2000, AUST NZ J PUBL HEAL, V24, P207, DOI 10.1111/j.1467-842X.2000.tb00145.x; Winston FK, 2003, JAMA-J AM MED ASSOC, V290, P643, DOI 10.1001/jama.290.5.643; *ZER 3, 1994, DIAGN CLASS MENT HLT	40	19	19	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6185	1873-7897		J ANXIETY DISORD	J. Anxiety Disord.	OCT	2010	24	7					774	779		10.1016/j.janxdis.2010.05.011			6	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	643UT	WOS:000281325600017	20541906				2022-02-06	
J	Wei, G; Lu, XCM; Yang, XF; Tortella, FC				Wei, Guo; Lu, Xi-Chun M.; Yang, Xiaofang; Tortella, Frank C.			Intracranial Pressure following Penetrating Ballistic-Like Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						cerebral perfusion pressure; intracranial pressure; mean arterial blood pressure; penetrating ballistic-like brain injury; rat	TRAUMATIC BRAIN; GUNSHOT WOUNDS; HEAD-INJURY; ISCHEMIA; NNZ-2566; ANALOG; EDEMA; MODEL	Penetrating ballistic brain injury involves a leading shockwave producing a temporary cavity causing substantial secondary injury. In response to the prevalence of this type of brain trauma in the military, a rat model of penetrating ballistic-like brain injury (PBBI) was established. This study focuses on cerebral physiological responses resulting from a PBBI, specifically the immediate and delayed changes in intracranial pressure (ICP) and cerebral perfusion pressure (CPP). ICP/CPP was measured continuously in rats subjected to PBBI, probe insertion alone, or sham injury. Immediately following the PBBI, a transient (<0.1 sec) and dramatic elevation of ICP reaching 280.0 +/- 86.0 mm Hg occurred, accompanied by a profound decrease in CPP to -180.2 +/- 90.1 mm Hg. This emergent ICP/CPP response resolved spontaneously within seconds, but was followed by a slowly-developing and sustained secondary phase, which peaked at 24 h post-injury, reaching 37.2 +/- 10.4 mm Hg, and remained elevated until 72 h post-injury. The measured decrease in CPP reached 85.3 +/- 17.2 mm Hg at 3 h post-injury. By comparison, probe insertion alone did not produce the immediate ICP crisis (28.6 +/- 9.1 mm Hg), and only a mild and sustained increase in ICP (13.5 +/- 2.1 mm Hg) was observed in the following 3 h post-injury. Injury severity, as measured by lesion volume, brain swelling, and neurological deficits at 1, 3, and 7 days post-injury, also reflected the distinctive differences between the dynamics of the PBBI versus controls. These results not only reinforced the severe nature of this model in mimicking the ballistic effect of PBBI, but also established cerebral pathophysiological targets for neuroprotective therapies.	[Wei, Guo; Lu, Xi-Chun M.; Yang, Xiaofang; Tortella, Frank C.] Walter Reed Army Inst Res, Dept Appl Neurobiol, Silver Spring, MD 20910 USA		Wei, G (corresponding author), Walter Reed Army Inst Res, Dept Appl Neurobiol, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Guo.Wei@US.ARMY.MIL					Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; BARACH E, 1986, J TRAUMA, V26, P225, DOI 10.1097/00005373-198603000-00003; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Koszyca B, 1998, J NEUROTRAUM, V15, P675, DOI 10.1089/neu.1998.15.675; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Pintar F A, 2001, Biomed Sci Instrum, V37, P429; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Shear DA, 2009, PHARMACOL BIOCHEM BE, V94, P56, DOI 10.1016/j.pbb.2009.07.006; SOBLOSKY JS, 1992, J NEUROSURG, V76, P119, DOI 10.3171/jns.1992.76.1.0119; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; Volgas DA, 2005, INJURY, V36, P380, DOI 10.1016/j.injury.2004.08.038; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Williams AJ, 2005, PHARMACOL BIOCHEM BE, V81, P182, DOI 10.1016/j.pbb.2005.03.011; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Yoganandan N, 1997, J TRAUMA, V42, P266, DOI 10.1097/00005373-199702000-00014; Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021; Zhang JY, 2005, J NEUROTRAUM, V22, P1335, DOI 10.1089/neu.2005.22.1335	26	19	19	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2010	27	9					1635	1641		10.1089/neu.2010.1378			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	649TJ	WOS:000281796500010	20568960				2022-02-06	
J	Colley, BS; Phillips, LL; Reeves, TM				Colley, Beverly S.; Phillips, Linda L.; Reeves, Thomas M.			The effects of cyclosporin-A on axonal conduction deficits following traumatic brain injury in adult rats	EXPERIMENTAL NEUROLOGY			English	Article						Cyclosporin-A; Compound action potentials; Traumatic brain injury; Neuroprotection; Corpus callosum; Rat	FLUID PERCUSSION INJURY; CORD WHITE-MATTER; ACUTE MITOCHONDRIAL DYSFUNCTION; TRANSIENT FOREBRAIN ISCHEMIA; VISUAL CALLOSAL AXONS; CORPUS-CALLOSUM; SPINAL-CORD; NEUROFILAMENT COMPACTION; UNMYELINATED AXONS; TACROLIMUS FK506	Immunophilin ligands, including cyclosporin-A (CsA), have been shown to be neuroprotective in experimental models of traumatic brain injury (TBI) and to attenuate the severity of traumatic axonal injury. Prior studies have documented CsA treatment to reduce essential components of posttraumatic axonal pathology, including impaired axoplasmic transport, spectrin proteolysis, and axonal swelling. However, the effects of CsA administration on axonal function, following TBI, have not been evaluated. The present study assessed the effects of CsA treatment on compound action potentials (CAPs) evoked in corpus callosum of adult rats following midline fluid percussion injury. Rats received a 20 mg/kg bolus of CsA, or cremaphor vehicle, at either 15 min or 1 h postinjury, and at 24 h postinjury CAP recording was conducted in coronal brain slices. To elucidate how injury and CsA treatments affect specific populations of axons, CAP waveforms generated largely by myelinated axons (N1) were analyzed separately from the CAP signal, which predominantly reflects activity in unmyelinated axons (N2). CsA administration at 15 min postinjury resulted in significant protection of CAP area, and this effect was more pronounced in N1, than in the N2, CAP component. This treatment also significantly protected against TBI-induced reductions in high-frequency responding of the N1 CAP signal. In contrast, CsA treatment at 1 h did not significantly protect CAPs but was associated with atypical waveforms in N1 CAPs, including decreased CAP duration and reduced refractoriness. The present findings also support growing evidence that myelinated and unmyelinated axons respond differentially to injury and neuroprotective compounds. (C) 2010 Elsevier Inc. All rights reserved.	[Colley, Beverly S.; Phillips, Linda L.; Reeves, Thomas M.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Sch Med, Med Ctr, Richmond, VA 23298 USA		Reeves, TM (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Sch Med, Med Ctr, 1217 E Marshall St,Room 740,MCV Campus Box 980709, Richmond, VA 23298 USA.	tmreeves@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-057758, NS-056247]; Virginia Commonwealth Neurotrauma Initiative [07-302F]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056247, R01NS057758] Funding Source: NIH RePORTER	The authors gratefully acknowledge the expert technical assistance of Nancy Lee and Terry Smith. This study was supported by NIH research grants NS-057758 (T.M.R.) and NS-056247 (L.L.P.) and by a Virginia Commonwealth Neurotrauma Initiative Award 07-302F (T.M.R.).	Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; BEMENT SL, 1969, EXP NEUROL, V24, P147, DOI 10.1016/0014-4886(69)90012-0; BLACK JA, 1982, BRAIN RES, V250, P1, DOI 10.1016/0006-8993(82)90948-9; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FAMIGLIO L, 1989, TRANSPLANTATION, V48, P316, DOI 10.1097/00007890-198908000-00025; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Mobley Lloyd W 3rd, 2003, Spine J, V3, P11, DOI 10.1016/S1529-9430(02)00442-4; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Partadiredja G, 2003, J NEUROCYTOL, V32, P1165, DOI 10.1023/B:NEUR.0000021910.65920.41; Peasley MA, 2002, AM J PHYSIOL-CELL PH, V283, pC980, DOI 10.1152/ajpcell.00591.2001; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Pryor J, 2006, SPINAL CORD, V44, P653, DOI 10.1038/sj.sc.3101901; Pyrzynska B, 2001, NEUROCHEM INT, V38, P409, DOI 10.1016/S0197-0186(00)00105-4; RACUSEN LC, 1990, LIFE SCI, V46, P1021, DOI 10.1016/0024-3205(90)90026-N; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Setkowicz Z, 2007, ACTA NEUROBIOL EXP, V67, P399; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Stover JF, 2001, J NEUROSURG, V94, P782, DOI 10.3171/jns.2001.94.5.0782; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; SWADLOW HA, 1976, EXP NEUROL, V53, P128, DOI 10.1016/0014-4886(76)90288-0; Swanson TH, 1998, BRAIN RES, V784, P188, DOI 10.1016/S0006-8993(97)01323-1; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; WALKER RW, 1988, NEUROL CLIN, V6, P261, DOI 10.1016/S0733-8619(18)30869-7; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; WAXMAN SG, 1976, EXP NEUROL, V53, P115, DOI 10.1016/0014-4886(76)90287-9; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610; Zawadzka M, 2003, MOL CELL NEUROSCI, V22, P202, DOI 10.1016/S1044-7431(03)00036-8	60	19	19	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2010	224	1			SI		241	251		10.1016/j.expneurol.2010.03.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615IO	WOS:000279128400027	20362574	Green Accepted			2022-02-06	
J	Hoenig, H; Lee, J; Stineman, M				Hoenig, Helen; Lee, Jeanne; Stineman, Margaret			Conceptual Overview of Frameworks for Measuring Quality in Rehabilitation	TOPICS IN STROKE REHABILITATION			English	Article						outcome and process assessment; quality of care; rehabilitation	SKILLED NURSING FACILITIES; TRAUMATIC BRAIN-INJURY; OF-THE-SCIENCE; STROKE REHABILITATION; RANDOMIZED-TRIAL; INPATIENT REHABILITATION; GERIATRIC EVALUATION; OUTCOMES RESEARCH; PATIENT OUTCOMES; POSTACUTE CARE	This article reviews theories and conceptual models that may be helpful in evaluating quality of care in rehabilitation, with a focus on the seminal Donabedian model of structure, process, and outcomes. In addition, this article reviews a variety of new theories and conceptual models that have been developed to expand the Donabedian model in areas specific to rehabilitation (eg, the multidisciplinary team, assistive technology), and it covers new approaches developed to help with implementing changes to improve quality. Directions for future research and development are identified, including the need for consensus and consistent use of terminology and measures and the need for quality measures with greater breadth, depth, and granularity that capture the complex interactions between the structure and processes of care unique to rehabilitation of physical disability.	[Hoenig, Helen; Lee, Jeanne] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hoenig, Helen] Durham VA Med Ctr, Phys Med & Rehabil Serv, Durham, NC USA; [Stineman, Margaret] Univ Penn, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA		Hoenig, H (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.				Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness of Alternative Levels of Stroke RehabilitationUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1-R01 HS018540-01]; Veterans Health Administration Rehabilitation Research and Development (RRD) [042251]; National Institute on Disability and Rehabilitation Research of the US Department of Education [H133E080003]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS018540] Funding Source: NIH RePORTER	M. Stineman was supported in part through the Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness of Alternative Levels of Stroke Rehabilitation grant 1-R01 HS018540-01.; H. Hoenig received support from the Veterans Health Administration Rehabilitation Research and Development (RR&D) grant 042251 and by the Mobility Rehabilitation and Engineering Research Center, which is funded by the National Institute on Disability and Rehabilitation Research of the US Department of Education under grant H133E080003. The views of the authors do not necessarily reflect the views of the funding agencies.	*ACRM TAX TASK FOR, 2005, RES AG DEV REH TAX; *AG HEALTHC RES QU, 2006, INTR AHRQ QUAL IND; [Anonymous], 2017, CONC MOD; *ASKOXFORD, COMP OXF ENGL DICT P; Berlowitz DR, 2010, TOP STROKE REHABIL, V17, P252, DOI 10.1310/tsr1704-252; Bettger JAP, 2007, ARCH PHYS MED REHAB, V88, P1526, DOI 10.1016/j.apmr.2007.06.768; *BUS EXC, TOT QUAL MAN TOOLS B; CHIODO LK, 1992, PHYS THER, V72, P168, DOI 10.1093/ptj/72.3.168; CHIODO LK, 1992, PHYS THER, V72, P174, DOI 10.1093/ptj/72.3.174; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; Crawford VLS, 2009, STROKE, V40, P2143, DOI 10.1161/STROKEAHA.108.545376; Daugherty EL, 2009, CRIT CARE MED, V37, P1210, DOI [10.1097/CCM.0b013e31819d67b5, 10.1097/CCM.0b013e3181b6fa29]; DEANE JP, 2004, THESIS U FLORIDA GAI; DeJong G, 2005, ARCH PHYS MED REHAB, V86, pS1, DOI 10.1016/j.apmr.2005.09.003; DeJong G, 2004, ARCH PHYS MED REHAB, V85, P678, DOI 10.1016/j.apmr.2003.06.033; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Duncan PW, 2002, STROKE, V33, P167, DOI 10.1161/hs0102.101014; FUHRER MJ, 1987, OVERVIEW OUTCOME ANA, P1; Gage B, 2007, ARCH PHYS MED REHAB, V88, P1737, DOI 10.1016/j.apmr.2007.09.025; Goldstein LB, 2003, NEUROLOGY, V61, P792, DOI 10.1212/01.WNL.0000082724.77447.3A; Hoenig H, 2005, J AM GERIATR SOC, V53, P1712, DOI 10.1111/j.1532-5415.2005.53502.x; Hoenig H, 2002, MED CARE, V40, P1036, DOI 10.1097/00005650-200211000-00005; Hoenig H, 2001, HEALTH SERV RES, V35, P1293; Hoenig H, 1999, J REHABIL RES DEV, V36, P19; Hoenig H, 2000, ARCH PHYS MED REHAB, V81, P853, DOI 10.1053/apmr.2000.5569; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; HUGHES SL, 1990, MED CARE, V28, P135, DOI 10.1097/00005650-199002000-00004; Jette DU, 2005, ARCH PHYS MED REHAB, V86, P373, DOI 10.1016/j.apmr.2004.10.018; Kirschner KL, 2009, PM&R, V1, P957, DOI 10.1016/j.pmrj.2009.09.001; Lemieux-Charles L, 2006, MED CARE RES REV, V63, P263, DOI 10.1177/1077558706287003; Lenker JA, 2003, ASSIST TECHNOL, V15, P1, DOI 10.1080/10400435.2003.10131885; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2004, PSYCHOL HEALTH, V19, P29, DOI 10.1080/0887044031000141199; Needham DM, 2010, TOP STROKE REHABIL, V17, P271, DOI 10.1310/tsr1704-271; *OFF QUAL PERF DEP, PERF MEAS; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Phibbs CS, 2006, MED CARE, V44, P91, DOI 10.1097/01.mlr.0000188981.06522.e0; Pound P, 1999, AGE AGEING, V28, P433, DOI 10.1093/ageing/28.5.433; Pound P, 2000, SOC SCI MED, V51, P1437, DOI 10.1016/S0277-9536(00)00040-X; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Reker DM, 2000, J REHABIL RES DEV, V37, P483; Reker DM, 2002, ARCH PHYS MED REHAB, V83, P750, DOI 10.1053/apmr.2002.99736; Rodkey GV, 2009, AM J SURG, V198, pS3, DOI 10.1016/j.amjsurg.2009.08.004; ROSE SS, 2003, THESIS U ARIZONA TUC; Rubenstein LZ, 2007, J AM GERIATR SOC, V55, P166, DOI 10.1111/j.1532-5415.2007.01044.x; RUBENSTEIN LZ, 1988, J CLIN EPIDEMIOL, V41, P441, DOI 10.1016/0895-4356(88)90045-5; RUBENSTEIN LZ, 1995, AGING-CLIN EXP RES, V7, P212, DOI 10.1007/BF03324318; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Shoemaker LL, 2009, AM J PHYS MED REHAB, V88, P1020, DOI 10.1097/PHM.0b013e3181bc0d55; SIVENIUS J, 1985, STROKE, V16, P928, DOI 10.1161/01.STR.16.6.928; Stineman M G, 2001, Top Stroke Rehabil, V8, P34; Stineman MG, 2008, ARCH PHYS MED REHAB, V89, P1863, DOI 10.1016/j.apmr.2008.03.013; Stineman MG, 2007, DISABIL REHABIL, V29, P1165, DOI 10.1080/09638280600976145; Stineman MG, 2010, TOP STROKE REHABIL, V17, P262, DOI 10.1310/tsr1704-262; Stineman MG, 2010, PM&R, V2, P232, DOI 10.1016/j.pmrj.2010.01.012; Stineman MG, 1997, MED CARE, V35, pJS90, DOI 10.1097/00005650-199706001-00018; Stineman MG, 1997, MED CARE, V35, pJS106; Strasser DC, 2008, ARCH PHYS MED REHAB, V89, P10, DOI 10.1016/j.apmr.2007.08.127; Strasser DC, 2010, TOP STROKE REHABIL, V17, P225, DOI 10.1310/tsr1704-225; Strasser DC, 2005, ARCH PHYS MED REHAB, V86, P403, DOI 10.1016/j.apmr.2004.04.046; Van Craen K, 2010, J AM GERIATR SOC, V58, P83, DOI 10.1111/j.1532-5415.2009.02621.x; *VET HLTH ADM, QUERI IMPL GUID; Walsh K, 2002, POSTGRAD MED J, V78, P322, DOI 10.1136/pmj.78.920.322; Wang YC, 2008, J REHABIL RES DEV, V45, P1065, DOI 10.1682/JRRD.2007.12.0211; WIELAND D, 1986, JAMA-J AM MED ASSOC, V255, P2622, DOI 10.1001/jama.255.19.2622; WINKLER SLH, J REHABIL RES UNPUB; World Health Organization, 2007, INT CLASS FUNCT DIS; Yagura H, 2005, CEREBROVASC DIS, V20, P258, DOI 10.1159/000087708	70	19	21	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1074-9357	1945-5119		TOP STROKE REHABIL	Top. Stroke Rehabil.	JUL-AUG	2010	17	4					239	251		10.1310/tsr1704-239			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	654FD	WOS:000282153000003	20826412				2022-02-06	
J	Mandell, SP; Kaufman, R; Mack, CD; Bulger, EM				Mandell, Samuel P.; Kaufman, Robert; Mack, Christopher D.; Bulger, Eileen M.			Mortality and injury patterns associated with roof crush in rollover crashes	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Rollover; Roof crush; Roof intrusion; Occupant safety	OCCUPANT	Background: In the United States, a significant number of spine injuries, traumatic brain injuries (TBI), and deaths result from motor vehicle rollover crashes each year though they make up a small percentage of total crashes. We sought to explore the relationship between these injuries and the degree of roof crush. Methods: We searched the NASS CDS database for belted, adult (>= 16), non-middle seat passengers involved in rollover crashes from 1993 to 2006. We also searched the CIREN database for illustrative cases. Logistic regression was used to evaluate the relationship between different levels of roof crush and mortality, severe injury (AIS >= 3) to the spine, spinal cord, and head injury. Results: The risk of mortality, TBI, and spine injury all increased as the degree of roof crush increased. For mortality increased risk occurred at >15 cm [15-30 cm: OR 2.089 (95% CI: 1.461-2.987); >30 cm: OR 6.301 (95% CI: 4.369-9.087)]. For TBI, increased risk was seen above 15 cm crush [15-30cm: OR 1.52(95% CI: 1.045-2.21); >30 cm: OR 3.672 (95% CI: 2.456-5.490)]. For spine injury increased risk was seen above 8 cm crush [8-15 cm: OR 1.968(95% CI 1.273-3.043); 15-30 cm: OR 2.530 (95% CI 1.634-3.917); >= 30 cm OR 2.682 (95% CI 1.474, 4.877). Results were similar across the different statistical models. Conclusion: There is an association between the degree of roof crush and mortality, spine injury, and head injury in rollover crashes. (C) 2010 Elsevier Ltd. All rights reserved.	[Mandell, Samuel P.; Bulger, Eileen M.] Univ Washington, Harborview Med Ctr, Dept Trauma Surg, Seattle, WA 98104 USA; [Kaufman, Robert; Mack, Christopher D.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA		Mandell, SP (corresponding author), Univ Washington, Harborview Med Ctr, Dept Trauma Surg, 325 9th Ave, Seattle, WA 98104 USA.	mandells@u.washington.edu	Mandell, Samuel/AAM-4647-2021				BAHLING GS, 1995, J TRAUMA, V38, P557, DOI 10.1097/00005373-199504000-00015; Bidez MW, 2007, ANN BIOMED ENG, V35, P1973, DOI 10.1007/s10439-007-9355-1; Brumbelow M., 2008, ROOF STRENGTH INJURY; BURNS SP, INJURY PREVENT UNPUB; BURNS SP, J SPINAL CORD UNPUB; FDA, 2009, FED REG; FRIEDMAN D, 2005, 050417 CTR INJ RES; Grzebieta R. H., 2007, P AUSTR ROAD SAF RES; GRZEBIETA RH, 2007, ROLLOVER CRASHES DIV; Hu Jingwen, 2005, Annu Proc Assoc Adv Automot Med, V49, P119; Jehle D, 2007, ACAD EMERG MED, V14, P899, DOI 10.1197/j.aem.2007.06.029; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Moffatt E.A, 2005, 2005010942 SAE; MOFFATT EA, 1975, 19 C AM ASS AUT MED; NHTSA, 2005, 810631 NHTSA DOT HS; Revell M, 2003, TRAUMA, V5, P61, DOI [10.1191/1460408603ta268oa, DOI 10.1191/1460408603TA268OA]; RIDELLA S, 2008, INT IRCOBI C BIM INJ, P33; STRASHNY A, 2007, ROLE VERTICAL ROOF I, V216; Viano David C, 2007, Traffic Inj Prev, V8, P382, DOI 10.1080/15389580701583379; VIANO DC, 2006, ANAL REPORTS LIT HEA; Young D, 2007, INT J CRASHWORTHINES, V12, P609, DOI 10.1080/13588260701497946; YOUNG DGR, 2008, ACCIDENT RECONSTRUCT, V10; 2005, AAAM ABBREVIATED INJ	23	19	20	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUL	2010	42	4					1326	1331		10.1016/j.aap.2010.02.013			6	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	607LD	WOS:000278504700046	20441849				2022-02-06	
J	Nichol, AD; Bailey, M; Cooper, DJ				Nichol, A. D.; Bailey, M.; Cooper, D. J.		POLAR Investigator; EPO Investigators	Challenging issues in randomised controlled trials	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article; Proceedings Paper	Annual Trauma Research Methods Workshop	NOV 19, 2009	Monash Univ, Melbourne, AUSTRALIA	Australian Natl Trauma Res Inst	Monash Univ	Randomised controlled trial; Intensive care; Research; Education	TRAUMATIC BRAIN-INJURY; CONSORT STATEMENT; QUALITY; RESUSCITATION; SALINE; SIZE	What this topic is about: Randomised controlled trials (RCTs) are the most rigorous way of determining whether a cause-effect relation exists between treatment and outcome and are an integral component in the hierarchy of evidence which guide current clinical practice. Whether ensuring the success of a RCT or interpreting the medical literature, it is important to understand the key components of RCT design to assess their quality and therefore the weight which should be attributed to its findings. This article will highlight some of these key components by using a number of ongoing trauma studies being coordinated by the Australian and New Zealand Intensive Care Research Centre, Monash University. Common problems and challenges: The quality of many RCTs could be improved by avoiding some common pitfalls, such as (i) unclear hypotheses and multiple objectives, (ii) poor selection of endpoints, (iii) inappropriate subject selection criteria, (iv) non-clinically relevant or feasible treatment/intervention regimens, (v) inadequate randomisation, stratification, blinding, (vi) lack of stratification in small RCTs (vii) inadequate blinding of trials, (viii) insufficient sample size/power, (ix) failure to use intention to treat analysis and (x) failure to anticipate common practical problems encountered during the conduct of a RCT. Tips for researchers: The RCTs most likely to be funded and/or be of high quality always address these issues. (C) 2010 Elsevier Ltd. All rights reserved.	[Nichol, A. D.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Nichol, A. D.; Cooper, D. J.] Alfred Hosp, Melbourne, Vic 3004, Australia		Nichol, AD (corresponding author), Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Alfred Hosp Campus,89 Commercial Rd, Melbourne, Vic 3004, Australia.	alistair.nichol@med.monash.edu.au	Bailey, Michael J/A-4499-2012; Cooper, D. James/G-7961-2013	Bailey, Michael J/0000-0002-5551-1401; Cooper, D. James/0000-0002-5872-9051; Nichol, Alistair/0000-0002-4689-1238; Nichol, Alistair Dualta/0000-0002-4771-5615			Altman DG, 1996, BRIT MED J, V313, P570; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; *BRAIN TRAUM FDN, 2007, J NEUROTRAUM, P24; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; Jadad AR, 1998, JAMA-J AM MED ASSOC, V279, P319, DOI 10.1001/jama.279.4.319; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Stolberg HO, 2004, AM J ROENTGENOL, V183, P1539, DOI 10.2214/ajr.183.6.01831539; Thornley B, 1998, BRIT MED J, V317, P1181, DOI 10.1136/bmj.317.7167.1181; 1992, JAMA, V268, P2420	17	19	19	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JUL	2010	41			1			20	23		10.1016/j.injury.2010.03.033			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	617ZV	WOS:000279321600007	20413119				2022-02-06	
J	Cao, Y; He, W				Cao, Yu; He, Wei			Synthesis and Characterization of Glucocorticoid Functionalized Poly(N-vinyl pyrrolidone): A Versatile Prodrug for Neural Interface	BIOMACROMOLECULES			English	Article							SILICON MICROELECTRODE ARRAYS; ALTERNATING MULTILAYER FILM; TRAUMATIC BRAIN-INJURY; DRUG-DELIVERY; IN-VIVO; TISSUE-RESPONSE; NERVOUS-SYSTEM; POLYMER-FILMS; PH; DEVICES	A poly(N-vinyl pyrrolidone)-based glucocorticoid prodrug was synthesized via a hydrazone linkage and characterized by H-1 NMR and UV-vis spectroscopy. pH sensitivity of drug release from the prodrug was observed under conditions mimicking inflammation-induced tissue acidosis. Multi layers of poly(acrylic acid)/prodrug were successfully deposited onto silicon substrates via hydrogen bond-driven layer-by-layer (LBL) assembly. The layers were destructible when incubated in physiological pH, which could be beneficial for biosensors such as neural electrodes. Bioactivity of the prodrug and its released free drug were studied with RAW264.7 macrophages in vitro, where inhibition of nitric oxide production was observed, suggesting the desired anti-inflammatory effect. Neural culture showed that both the prodrug and its precursor polymer were nontoxic to neurons and did not alter the ability of neurons to maintain neurite extensions, reassuring further application of this prodrug to mitigate inflammation at the neural interface. This system allows localized pharmacological interventions that deliver anti-inflammatory drugs based on the extent of inflammation without interfering with the electrical properties of Me neural electrodes.	[Cao, Yu; He, Wei] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [He, Wei] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA		He, W (corresponding author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.	whe5@utk.edu	He, Wei/K-7218-2013	He, Wei/0000-0002-6638-9691	University of Tennessee	The research was supported by the startup fund from the University of Tennessee. We thank Dr. Tim Sparer (Department of Microbiology, the University of Tennessee) for kindly providing macrophages, Dr. Bin Zhao's group (Department of Chemistry, the University of Tennessee) for use of the ellipsometer and GPC, and Dr. Fang Cheng (Department of Bioengineering, University of Washington) for helpful suggestions. We also appreciate Zheng Cao and Jonathan Page for their help with cell culture and insightful discussions.	Abidian MR, 2008, BIOMATERIALS, V29, P1273, DOI 10.1016/j.biomaterials.2007.11.022; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Basu A, 2006, BIOCONJUGATE CHEM, V17, P618, DOI 10.1021/bc050322y; Bencini M, 2005, MACROMOLECULES, V38, P8211, DOI 10.1021/ma050422z; Bencini M, 2006, MACROMOL RAPID COMM, V27, P1060, DOI 10.1002/marc.200600194; Berna M, 2006, BIOMACROMOLECULES, V7, P146, DOI 10.1021/bm050480s; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026; Buhler V., 2005, POLYVINYLPYRROLIDONE; Buttgereit F, 1998, ARTHRITIS RHEUM, V41, P761, DOI 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M; Capadona JR, 2008, SCIENCE, V319, P1370, DOI 10.1126/science.1153307; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Coessens V, 1996, J CONTROL RELEASE, V38, P141, DOI 10.1016/0168-3659(95)00111-5; D'Souza AJM, 2004, J PHARM SCI-US, V93, P1962, DOI 10.1002/jps.20096; Engstrom JUA, 2006, MACROMOL CHEM PHYS, V207, P536, DOI 10.1002/macp.200500479; Frunder H., 1949, PHARMAZIE, V4, P345; Gao ZG, 2005, J DRUG TARGET, V13, P391, DOI 10.1080/10611860500376741; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Halthur TJ, 2004, LANGMUIR, V20, P1739, DOI 10.1021/la035475t; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; HANSON GR, 1982, DEV BRAIN RES, V3, P529, DOI 10.1016/0165-3806(82)90052-9; He W, 2003, BIOMACROMOLECULES, V4, P75, DOI 10.1021/bm0256505; He W, 2007, ADV MATER, V19, P3529, DOI 10.1002/adma.200700943; He W, 2006, J NEURAL ENG, V3, P316, DOI 10.1088/1741-2560/3/4/009; He XH, 1999, LIFE SCI, V65, P355, DOI 10.1016/S0024-3205(99)00257-X; HENSON PM, 1971, J IMMUNOL, V107, P1547; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Hickey T, 2002, J BIOMED MATER RES, V61, P180, DOI 10.1002/jbm.10016; Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.0.CO;2-M; Ihre HR, 2002, BIOCONJUGATE CHEM, V13, P443, DOI 10.1021/bc010102u; Johnson MD, 2007, J NEUROSCI METH, V160, P276, DOI 10.1016/j.jneumeth.2006.09.023; Kaal ECA, 2004, CURR OPIN ONCOL, V16, P593, DOI 10.1097/01.cco.0000142076.52721.b3; KENNEDY PR, 1989, J NEUROSCI METH, V29, P181, DOI 10.1016/0165-0270(89)90142-8; Kharlampieva E, 2006, POLYM REV, V46, P377, DOI 10.1080/15583720600945386; Kipke DR, 2003, IEEE T NEUR SYS REH, V11, P151, DOI 10.1109/TNSRE.2003.814443; KIRSH YE, 1998, WATER SOLUBLE POLYNV; KOEHLER PJ, 1995, ANTI-CANCER DRUG, V6, P19, DOI 10.1097/00001813-199502000-00002; Lakard S, 2004, BIOELECTROCHEMISTRY, V62, P19, DOI 10.1016/j.bioelechem.2003.09.009; Lee ES, 2007, J CONTROL RELEASE, V123, P19, DOI 10.1016/j.jconrel.2007.08.006; Lee HY, 2007, MACROMOL RES, V15, P547, DOI 10.1007/BF03218829; Lu DX, 2009, J BIOMED MATER RES B, V89B, P177, DOI 10.1002/jbm.b.31203; Maynard EM, 2000, J NEUROSCI METH, V97, P93, DOI 10.1016/S0165-0270(00)00159-X; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Park KK, 2006, STEROIDS, V71, P183, DOI 10.1016/j.steroids.2005.10.003; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Quinn JF, 2007, CHEM SOC REV, V36, P707, DOI 10.1039/b610778h; Ransom B., 1998, PH BRAIN FUNCTION; Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800; Shain W, 2003, IEEE T NEUR SYS REH, V11, P186, DOI 10.1109/TNSRE.2003.814800; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; Singh A, 2003, BIOMATERIALS, V24, P5083, DOI 10.1016/S0142-9612(03)00424-1; Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037; Spireas S, 1998, INT J PHARM, V166, P177, DOI 10.1016/S0378-5173(98)00046-5; STEENBERGEN C, 1977, CIRC RES, V41, P849, DOI 10.1161/01.RES.41.6.849; Stockton WB, 1997, MACROMOLECULES, V30, P2717, DOI 10.1021/ma9700486; Sukhishvili SA, 2000, J AM CHEM SOC, V122, P9550, DOI 10.1021/ja002410t; Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113; Thierry B, 2005, J AM CHEM SOC, V127, P1626, DOI 10.1021/ja045077s; Thomas M, 2005, PHARM RES-DORDR, V22, P373, DOI 10.1007/s11095-004-1874-y; TWYCROSS R, 1994, DRUG SAFETY, V11, P163, DOI 10.2165/00002018-199411030-00003; Vleggeert-Lankamp CLAM, 2004, BIOMATERIALS, V25, P2741, DOI 10.1016/j.biomaterials.2003.09.067; Wang D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2106; Wang LY, 1997, MACROMOL RAPID COMM, V18, P509, DOI 10.1002/marc.1997.030180609; Wang LY, 1999, LANGMUIR, V15, P1360, DOI 10.1021/la981181+; Wuts P. G. M., 2007, GREENES PROTECTIVE G, V4th; YAMAOKA T, 1995, J PHARM SCI, V84, P349, DOI 10.1002/jps.2600840316; Yang JY, 2004, SENSOR ACTUAT A-PHYS, V113, P204, DOI 10.1016/j.sna.2004.02.029; Yang SG, 2006, LANGMUIR, V22, P338, DOI 10.1021/la051581e; Yoon JJ, 2003, BIOMATERIALS, V24, P2323, DOI 10.1016/S0142-9612(03)00024-3; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024	74	19	20	0	27	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	MAY	2010	11	5					1298	1307		10.1021/bm100095t			10	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry; Polymer Science	592DO	WOS:000277355800022	20411929				2022-02-06	
J	Johnson, CL; Resch, JA; Elliott, TR; Villarreal, V; Kwok, OM; Berry, JW; Underhill, AT				Johnson, Caitlin L.; Resch, J. Aaron; Elliott, Timothy R.; Villarreal, Victor; Kwok, Oi-Man; Berry, Jack W.; Underhill, Andrea T.			Family Satisfaction Predicts Life Satisfaction Trajectories Over the First 5 Years After Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; family satisfaction; life satisfaction; modeling	SET-POINT MODEL; QUALITY-OF-LIFE; SELF-EFFICACY; SPINAL-CORD; RELIABILITY; ADAPTATION; HAPPINESS; INDIVIDUALS; DISABILITY; ADJUSTMENT	Objectives: Examined the influence of functional impairment, stable marital status, and family satisfaction on life satisfaction trajectories for 609 individuals (435 men, 174 women) over the first 5 years after traumatic brain injury (TB!). Measures: Participants completed the Family Satisfaction Scale (FSS), Functional Independence Measure (FIM), and the Life Satisfaction Index (LSI) at years I. 2, 4, and 5 after sustaining a TBI. Results: Trajectory modeling revealed that higher family satisfaction was associated with increases in life satisfaction for individuals with less functional impairment. Stable marital status was not significantly associated with life satisfaction trajectories. Implications: Family satisfaction appears to have pronounced beneficial effects on life satisfaction for persons with less functional impairment after TBI regardless of marital status. In contrast, a stable marriage appears to have no apparent benefits to self-reported life satisfaction over the first 5 years post-TBI. Theoretical and clinical implications of these results are discussed.	[Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77845 USA; [Berry, Jack W.] Samford Univ, Homewood, AL USA; [Underhill, Andrea T.] Univ Alabama Birmingham, Birmingham, AL USA		Elliott, TR (corresponding author), Texas A&M Univ, Dept Educ Psychol, 4225 TAMU, College Stn, TX 77845 USA.	telliott@tamu.edu	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714; Kwok, Oiman/0000-0002-4617-4562	NCIPC CDC HHS [R49-CE000191] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000191] Funding Source: NIH RePORTER		ADAMS DL, 1969, J GERONTOL, V24, P470, DOI 10.1093/geronj/24.4.470; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Bond T, 2001, APPL RASCH MODEL FUN; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cumsille P.E., 1994, J FAM PSYCHOL, V8, P202, DOI [10.1037/0893-3200.8.2.202., DOI 10.1037/0893-3200.8.2.202]; Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dunn D.S., 2009, OXFORD HDB POSITIVE, P650, DOI [DOI 10.1093/OXFORDHB/9780195187243.013.0062, 10.1093/oxfordhb/9780195187243.013.0062]; Dunn DS, 2008, REHABIL PSYCHOL, V53, P413, DOI 10.1037/a0013749; ELLIOTT TR, 2007, PSYCHOL MANAGEMENT P, P16; ELLIOTT TR, 2002, HDB POSITIVE PSYCHOL, P00687; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fisher G. H., 1976, ADV PSYCHOL ED MEASU, P97; Frederick S., 1999, WELL BEING FDN HEDON, P302; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Kaplan RM, 2005, ANNU REV CLIN PSYCHO, V1, P525, DOI 10.1146/annurev.clinpsy.1.102803.144118; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kosciulek JF, 1996, J REHABIL, V62, P49; Kosciulek JF, 1999, BRAIN INJURY, V13, P245, DOI 10.1080/026990599121610; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lightsey OR, 2008, FAM J, V16, P212, DOI 10.1177/1066480708317503; Lobello SG, 2004, BRAIN INJURY, V18, P1127, DOI 10.1080/02699050410001672378; Lucas RE, 2003, J PERS SOC PSYCHOL, V84, P527, DOI 10.1037/0022-3514.84.3.527; Lucas RE, 2007, J PERS SOC PSYCHOL, V92, P717, DOI 10.1037/0022-3514.92.4.717; Lucas RE, 2007, CURR DIR PSYCHOL SCI, V16, P75, DOI 10.1111/j.1467-8721.2007.00479.x; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Olson D. H., 1983, CIRCUMPLEX MODEL SYS; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; RAO VN, 1982, INT J AGING HUM DEV, V14, P55, DOI 10.2190/DWM4-E05K-CNTD-XNAA; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Underhill AT, 2004, J REHABIL RES DEV, V41, P603, DOI 10.1682/JRRD.2003.06.0094; Wallace KA, 2002, EDUC PSYCHOL MEAS, V62, P674, DOI 10.1177/001316402128775085; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wilson, 1982, FAMILY INVENTORIES I, P25; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; [No title captured]	57	19	19	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2010	55	2					180	187		10.1037/a0019480			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	604KX	WOS:000278279000008	20496972				2022-02-06	
J	Kinoshita, Y; Kamitani, H; Mamun, MH; Wasita, B; Kazuki, Y; Hiratsuka, M; Oshimura, M; Watanabe, T				Kinoshita, Yusuke; Kamitani, Hideki; Mamun, Mahabub Hasan; Wasita, Brian; Kazuki, Yasuhiro; Hiratsuka, Masaharu; Oshimura, Mitsuo; Watanabe, Takashi			A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells	NEUROLOGICAL RESEARCH			English	Article						Mesenchymal stem cell; human artificial chromosome vector; migration; herpes simplex virus thymidine kinase gene; gene delivery system; glioblastoma	TRAUMATIC BRAIN-INJURY; THERAPY; GLIOMA; TUMOR; MODEL; DIFFERENTIATION; EXPRESSION; TROPISM; MSC	Mesenchymal stem cells (MSCs) have been expected to become useful gene delivery vehicles against human malignant gliomas when coupled with an appropriate vector system, because they migrate towards the lesion. Human artificial chromosomes (HACs) are non-integrating vectors with several advantages for gene therapy, namely, no limitations on the size and number of genes that can be inserted. We investigated the migration of human immortalized MSCs bearing a HAC vector containing the herpes simplex virus thymidine kinase gene (HAC-tk-hiMSCs) towards malignant gliomas in vivo. Red fluorescence protein-labeled human glioblastoma HTB14 cells were implanted into a subcortical region in nude mice. Four days later, green fluorescence protein-labeled HAC-tk-hiMSCs were injected into a contralateral subcortical region (the HTB14/HAC-tk-hiMSC injection model). Tropism to the glioma mass and the route of migration were visualized by fluorescence microscopy and immunohistochemical staining. HAC-tk-hiMSCs began to migrate toward the HTB14 glioma area via the corpus callosum on day 4, and gathered around the HTB14 glioma mass on day 7. To test whether the delivered gene could effectively treat glioblastoma in vivo, HTB14/HAC-tk-hiMSC injected mice were treated with ganciclovir (GCV) or PBS. The HTB14 glioma mass was significantly reduced by GCV treatment in mice injected with HAC-tk-hiMSCs. It was confirmed that gene delivery by our HAC-hiMSC system was effective after migration of MSCs to the glioma mass in vivo. Therefore, MSCs containing HACs carrying an anticancer gene or genes may provide a new tool for the treatment of malignant gliomas and possibly of other tumor types.	[Kinoshita, Yusuke; Kamitani, Hideki; Mamun, Mahabub Hasan; Wasita, Brian; Watanabe, Takashi] Tottori Univ, Fac Med, Dept Neurosurg, Tottori 6838504, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Tottori 6838504, Japan; [Hiratsuka, Masaharu] Tottori Univ, Sch Life Sci, Dept Mol & Cellular Biol, Tottori 6838504, Japan		Kinoshita, Y (corresponding author), Tottori Univ, Fac Med, Dept Neurosurg, 36-1 Nishi Cho, Tottori 6838504, Japan.	yuusuke.kinoshita@hospital.tottori.tottori.jp		Wasita, Brian/0000-0002-5501-3541			Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Buhring HJ, 2007, ANN NY ACAD SCI, V1106, P262, DOI 10.1196/annals.1392.000; Ehtesham M, 2004, NEOPLASIA, V6, P287, DOI 10.1593/neo.03427; Ehtesham M, 2002, CANCER RES, V62, P5657; Hamada H, 2005, CANCER SCI, V96, P149, DOI 10.1111/j.1349-7006.2005.00032.x; Katoh M, 2004, BIOCHEM BIOPH RES CO, V321, P280, DOI 10.1016/j.bbrc.2004.06.145; Kazuki Y, 2008, GENE THER, V15, P617, DOI 10.1038/sj.gt.3303091; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Li SY, 2005, CANCER GENE THER, V12, P600, DOI 10.1038/sj.cgt.7700826; Mageed AS, 2007, TRANSPLANTATION, V83, P1019, DOI 10.1097/01.tp.0000259752.13304.0b; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Namba H, 1998, HUM GENE THER, V9, P5, DOI 10.1089/hum.1998.9.1-5; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499; Ren XY, 2006, STEM CELL REV, V2, P43, DOI 10.1007/s12015-006-0008-9; Ren XY, 2005, STEM CELLS, V23, P1608, DOI 10.1634/stemcells.2005-0021; Satake K, 2004, SPINE, V29, P1971, DOI 10.1097/01.brs.0000138273.02820.0a; Schmidt NO, 2005, NEOPLASIA, V7, P623, DOI 10.1593/neo.04781; Shah K, 2005, ANN NEUROL, V57, P34, DOI 10.1002/ana.20306; Shitara S, 2008, BIOCHEM BIOPH RES CO, V369, P807, DOI 10.1016/j.bbrc.2008.02.119; Soling Ariane, 2004, Genet Vaccines Ther, V2, P7, DOI 10.1186/1479-0556-2-7; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088	24	19	20	0	10	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	MAY	2010	32	4					429	437		10.1179/174313209X455718			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	593IJ	WOS:000277446600017	19589205	Green Submitted			2022-02-06	
J	Luccichenti, G; Giugni, E; Peran, P; Cherubini, A; Barba, C; Bivona, U; Formisano, R; Sabatini, U				Luccichenti, Giacomo; Giugni, Elisabetta; Peran, Patrice; Cherubini, Andrea; Barba, Carmen; Bivona, Umberto; Formisano, Rita; Sabatini, Umberto			3 Tesla is twice as sensitive as 1.5 Tesla magnetic resonance imaging in the assessment of diffuse axonal injury in traumatic brain injury patients	FUNCTIONAL NEUROLOGY			English	Article						diffuse axonal injury; gradient echo sequences; high-field magnetic resonance; traumatic brain injury	MILD HEAD-INJURY; PRACTICAL SCALE; SEQUELAE; ECHO; LESIONS; COMA; MICROBLEEDS; TECHNOLOGY; SEQUENCES; DAMAGE	Diffuse axonal injury (DAI), associated with deafferentation and functional rearrangement, probably plays a role in the chronic phase of traumatic brain injury (TBI). DAI with a haemorrhagic component can be quantified using magnetic resonance imaging (MRI) thanks to the iron-based susceptibility effect of haemosiderin, which increases with magnetic field strength. The aim of this work was to compare conventional 1.5 Tesla and 3 Tesla MRI in the assessment of DAI in TBI patients. Eighteen TBI patients were submitted, in random order, to a 1.5T and a 3T MRI examination using standard gradient echo sequences. Both scans were always performed on the same day. DAI lesions with a haemorrhagic component were manually segmented and classified by anatomical location. The Wilcoxon and ANOVA tests were used for statistical analysis, significance being set at p<0.05. The results of this study showed that 3T MRI is almost twice as sensitive as 1.5T MRI in assessing DAI in terms of lesion number and volume. Differences between the two scanners were not significant in the posterior cranial fossa. High-field MRI enhances the assessment of DAI and may help to increase understanding of the mechanisms underlying subacute and chronic clinical, cognitive and behavioural changes in TBI patients.	[Luccichenti, Giacomo] IRCCS Fdn Santa Lucia, Dept Radiol, I-00179 Rome, Italy		Luccichenti, G (corresponding author), IRCCS Fdn Santa Lucia, Dept Radiol, Via Ardeatina 306, I-00179 Rome, Italy.	g.luccichenti@yahoo.it	Vapiwala, Neha/ABG-4062-2021; barba, carmen/K-4942-2016; Peran, Patrice/N-7561-2015; Barba, Carmen/AAB-7162-2022; Cherubini, Andrea/D-1327-2009; SABATINI, Umberto/K-4659-2016	barba, carmen/0000-0001-5445-5842; Peran, Patrice/0000-0001-7200-0139; Cherubini, Andrea/0000-0002-5946-4390; SABATINI, Umberto/0000-0001-5321-8626			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Allkemper T, 2004, EUR RADIOL, V14, P1000, DOI 10.1007/s00330-004-2241-4; Bastianello S, 2009, FUNCT NEUROL, V24, P69; Caltagirone C, 2008, FUNCT NEUROL, V23, P195; Cherubini A, 2007, NEUROIMAGE, V34, P1331, DOI 10.1016/j.neuroimage.2006.11.024; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; JENNETT B, 1975, LANCET, V1, P480; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; TEASDALE G, 1974, LANCET, V2, P81; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013	26	19	19	0	6	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264			FUNCT NEUROL	Funct. Neurol.	APR-JUN	2010	25	2					109	114					6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726ZM	WOS:000287766900008	20923609				2022-02-06	
J	Cartagena, CM; Burns, MP; Rebeck, GW				Cartagena, Casandra M.; Burns, Mark P.; Rebeck, G. William			24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury	BRAIN RESEARCH			English	Article						Cyp46; 24S-hydroxycholesterol; Lipid metabolism; Traumatic brain injury	LIVER-X-RECEPTOR; CENTRAL-NERVOUS-SYSTEM; STEROL-REGULATED TRANSPORT; EVANS BLUE EXTRAVASATION; FATTY-ACID SYNTHESIS; CHOLESTEROL HOMEOSTASIS; CEREBROSPINAL-FLUID; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL EXPRESSION; ENDOPLASMIC-RETICULUM	Membrane damage during traumatic brain injury (TBI) alters the brain homeostasis of cholesterol and other lipids. Cholesterol 24S-hydroxylase (Cyp46) is a cholesterol metabolic enzyme that is increased after TBI. Here, we systematically examined the effects of the enzymatic product of Cyp46, 24S-hydroxycholesterol, on the cholesterol regulatory genes, SREBP-1 and 2, their posttranslational regulation, and their effects on gene transcription. 24S-hydroxycholesterol increased levels of SREBP-1 mRNA and full-length protein but did not change levels of cleaved SREBP-1, consistent with the role of 24-hydroxycholesterol as an LXR agonist. In contrast, 24S-hydroxycholesterol decreased levels of LXR-independent SREBP-2 mRNA, full-length protein, and SREBP-2 active cleavage product. We examined the downstream effects of changes to these lipid regulatory factors by studying cholesterol and fatty acid synthesis genes. In neuroblastoma cells, 24S-hydroxycholesterol decreased mRNA levels of the cholesterol synthesis genes HMG CoA reductase, squalene synthase, and FPP synthase but did not alter levels of the mRNA of fatty acid synthesis genes acetyl CoA carboxylase or fatty acid synthase. After TB!, as after 24S-hydroxycholesterol treatment in vitro, SREBP-1 mRNA levels were increased while SREBP-2 mRNA levels were decreased. Also similar to the in vitro results with 24S-hydroxycholesterol, HMG CoA reductase and squalene synthase mRNA levels were significantly decreased. Fatty acid synthase mRNA levels were not altered but acetyl CoA carboxylase mRNA levels were significantly decreased. Thus, changes to transcription of cholesterol synthesis genes after TBI were consistent with increases in Cyp46 activity, but changes to fatty acid synthesis genes must be regulated by other mechanisms. (C) 2010 Elsevier B.V. All rights reserved.	[Cartagena, Casandra M.; Burns, Mark P.; Rebeck, G. William] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA		Rebeck, GW (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	casandra.cartagena@us.army.mil; mpb37@georgetown.edu; gwr2@georgetown.edu	Rebeck, George William/J-2192-2012	Rebeck, George William/0000-0001-6276-248X; Burns, Mark P/0000-0003-4750-2000	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-AG14473, F31-AG025676]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG014473, F31AG025676, P01AG030128] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health (R01-AG14473, F31-AG025676).	Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Bogdanovica N, 2001, NEUROSCI LETT, V314, P45, DOI 10.1016/S0304-3940(01)02277-7; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brun T, 1997, DIABETES, V46, P393, DOI 10.2337/diabetes.46.3.393; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Cartagena CM, 2008, J NEUROTRAUM, V25, P1087, DOI 10.1089/neu.2007.0444; Costet P, 2000, J BIOL CHEM, V275, P28240; Dhillon HS, 1999, J NEUROTRAUM, V16, P455, DOI 10.1089/neu.1999.16.455; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Du XM, 2004, J BIOL CHEM, V279, P47010, DOI 10.1074/jbc.M408690200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fagan AM, 1998, EXP NEUROL, V151, P314, DOI 10.1006/exnr.1998.6818; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Fujiyoshi M, 2007, J NEUROCHEM, V100, P968, DOI 10.1111/j.1471-4159.2006.04240.x; Fukumoto H, 2002, J BIOL CHEM, V277, P48508, DOI 10.1074/jbc.M209085200; Gasparovic C, 2001, NEUROSCI LETT, V301, P87, DOI 10.1016/S0304-3940(01)01616-0; Gilardi F, 2009, NEUROSCIENCE, V164, P530, DOI 10.1016/j.neuroscience.2009.08.003; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; Gimpl G, 2002, TRENDS BIOCHEM SCI, V27, P596, DOI 10.1016/S0968-0004(02)02224-7; He X, 2006, J NEUROPATH EXP NEUR, V65, P652, DOI 10.1097/01.jnen.0000225906.82428.69; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Huang ZH, 2001, ARTERIOSCL THROM VAS, V21, P2019, DOI 10.1161/hq1201.100242; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Kamada H, 2003, NEUROSCI RES, V45, P91, DOI 10.1016/S0168-0102(02)00203-1; Karu K, 2007, J LIPID RES, V48, P976, DOI 10.1194/jlr.M600497-JLR200; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; Liang Y, 2004, J NEUROCHEM, V88, P623, DOI 10.1111/j.1471-4159.2004.02183.x; LUND E, 1993, BIOCHIM BIOPHYS ACTA, V1166, P177, DOI 10.1016/0005-2760(93)90094-P; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Mak PA, 2002, J BIOL CHEM, V277, P31900, DOI 10.1074/jbc.M202993200; Meir K, 2002, J BIOL CHEM, V277, P34036, DOI 10.1074/jbc.M201122200; Natali F, 2007, J LIPID RES, V48, P1966, DOI 10.1194/jlr.M700051-JLR200; NIKAWA J, 1979, FEBS LETT, V102, P223, DOI 10.1016/0014-5793(79)80005-8; Ohyama Y, 2006, J BIOL CHEM, V281, P3810, DOI 10.1074/jbc.M505179200; Olkkonen VM, 2009, MOL ASPECTS MED, V30, P123, DOI 10.1016/j.mam.2009.02.004; Papassotiropoulos A, 2002, J PSYCHIAT RES, V36, P27, DOI 10.1016/S0022-3956(01)00050-4; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; PITAS RE, 1987, J BIOL CHEM, V262, P14352; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Rebeck GW, 2004, J MOL NEUROSCI, V23, P219, DOI 10.1385/JMN:23:3:219; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Rubink DS, 2005, J APPL PHYSIOL, V98, P1221, DOI 10.1152/japplphysiol.00621.2004; Sabol SL, 2005, J LIPID RES, V46, P2151, DOI 10.1194/jlr.M500080-JLR200; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; SAUCIER SE, 1989, J BIOL CHEM, V264, P6863; Shafaati M, 2007, NEUROSCI LETT, V425, P78, DOI 10.1016/j.neulet.2007.08.014; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Teunissen CE, 2007, J NEUROSCI RES, V85, P1499, DOI 10.1002/jnr.21266; Thewke DP, 1998, J BIOL CHEM, V273, P21402, DOI 10.1074/jbc.273.33.21402; Turley SD, 1996, J LIPID RES, V37, P1953; Turley SD, 1998, AM J PHYSIOL-ENDOC M, V274, pE1099, DOI 10.1152/ajpendo.1998.274.6.E1099; Vaya J, 2007, J NEUROCHEM, V102, P1727, DOI 10.1111/j.1471-4159.2007.04689.x; Wang YQ, 2008, J PROTEOME RES, V7, P1606, DOI 10.1021/pr7006076; Whitney KD, 2002, MOL ENDOCRINOL, V16, P1378, DOI 10.1210/me.16.6.1378; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200	78	19	20	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 10	2010	1319						1	12		10.1016/j.brainres.2009.12.080			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569TI	WOS:000275624100001	20053345	Green Accepted			2022-02-06	
J	James, SE; Dunham, M; Carrion-Jones, M; Murashov, A; Lu, Q				James, Sarah E.; Dunham, Mayisha; Carrion-Jones, Monica; Murashov, Alexander; Lu, Qun			Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin	NEUROTOXICOLOGY			English	Article						Cisplatin; Peripheral neuropathy; Regeneration; Rho GTPases; Y-27632	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; DORSAL-ROOT GANGLIA; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; TESTICULAR CANCER; ACTIVATION; GTPASES; NEUROTOXICITY; DNA	Chemotherapy drugs have neurotoxicity associated with treatment, which can become a dose-limiting problem when clinical presentation is severe. However, there is no effective therapy to circumvent the neurotoxicity of anti-cancer drug treatment. In this study, we utilized a newly designed mouse model of cisplatin-induced peripheral neuropathy to determine both the severity of neurotoxicity induced by drug treatment and the effectiveness of the Rho kinase inhibitor Y-27632 in post-treatment recovery. Sensory nerve conduction studies revealed a significant increase in mean distal (peak) latency with cisplatin treatment, indicating a deterioration of sensory nerve function. Also, hind paw touch sensitivity decreased steadily with increasing cumulative dose of cisplatin. Histological and immunohistochemical analyses of the sural nerve using neuronal marker protein gene product 9.5 (PGP 9.5) demonstrated abnormal nerve fiber morphology in cisplatin-treated mice. Remarkably, post-treatment with Y-27632 improved the sural nerve distal (peak) latency and sensory threshold to return to pre-treatment levels. Sural nerve histology worsened in the absence of Y-27632 during recovery. These studies suggest that Rho kinase inhibitor Y-27632 can initiate regeneration of damaged nerves following cisplatin treatment. (C) 2010 Elsevier Inc. All rights reserved.	[James, Sarah E.; Lu, Qun] E Carolina Univ, Dept Anat & Cell Biol, Leo Jenkins Canc Ctr, Brody Sch Med, Greenville, NC 27834 USA; [Lu, Qun] E Carolina Univ, Dept Med, Brody Sch Med, Greenville, NC 27834 USA; [Dunham, Mayisha; Carrion-Jones, Monica] E Carolina Univ, Dept Phys Med & Rehabil, Brody Sch Med, Greenville, NC 27834 USA; [Murashov, Alexander] E Carolina Univ, Dept Physiol, Brody Sch Med, Greenville, NC 27834 USA		Lu, Q (corresponding author), E Carolina Univ, Dept Anat & Cell Biol, Leo Jenkins Canc Ctr, Brody Sch Med, 7N84 Brody Sci Bldg,600 Moye Blvd, Greenville, NC 27834 USA.	luq@ecu.edu	Murashov, Alexander K/F-2241-2011; Murashov, Alexander/ABB-2151-2020	Murashov, Alexander K/0000-0002-8912-5891; Murashov, Alexander/0000-0002-8912-5891	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG026630]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA111891]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA111891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG026630] Funding Source: NIH RePORTER	The authors wish to thank Melissa Clark and Joani Zary for technical assistance and Dr. Teresa Lever for helpful discussions. This study was supported in part by grants from National Institute on Aging AG026630 and National Cancer Institute CA111891 (Q.L.).	Akahori H, 2004, DIABETES RES CLIN PR, V64, P153, DOI 10.1016/j.diabres.2003.10.012; Alaedini A, 2008, EXP NEUROL, V210, P368, DOI 10.1016/j.expneurol.2007.11.018; Aquino JB, 2006, BRAIN RES, V1117, P80, DOI 10.1016/j.brainres.2006.02.045; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Dergham P, 2002, J NEUROSCI, V22, P6570; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Dunham MW, 2009, AM J PHYS MED REHAB, V88, P542, DOI 10.1097/PHM.0b013e31819c575b; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Ellezam B, 2002, PROG BRAIN RES, V137, P371; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Gnad R, 2001, EXP CELL RES, V264, P244, DOI 10.1006/excr.2001.5165; James SE, 2008, NEUROTOXICOLOGY, V29, P605, DOI 10.1016/j.neuro.2008.04.008; Jones SB, 2004, J NEUROSCI, V24, P8510, DOI 10.1523/JNEUROSCI.1264-04.2004; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Madura T, 2004, EMBO REP, V5, P412, DOI 10.1038/sj.embor.7400117; McDonald ES, 2005, NEUROBIOL DIS, V18, P305, DOI 10.1016/j.nbd.2004.09.013; Meijer C, 1999, NEUROTOXICOLOGY, V20, P883; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; Negishi M, 2005, NEUROSCIENTIST, V11, P187, DOI 10.1177/1073858404268768; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Sung JK, 2003, BRAIN RES, V959, P29, DOI 10.1016/S0006-8993(02)03717-4; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Wilder-Smith EP, 2007, HISTOPATHOLOGY, V51, P674, DOI 10.1111/j.1365-2559.2007.02851.x; Yuan Z, 2009, CANCER CHEMOTH PHARM, V65, P13, DOI 10.1007/s00280-009-0998-5	31	19	20	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	MAR	2010	31	2					188	194		10.1016/j.neuro.2009.12.010			7	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	574KF	WOS:000275987300003	20060419	Green Accepted			2022-02-06	
J	Kean, S				Kean, Susanne			The experience of ambiguous loss in families of brain injured ICU patients	NURSING IN CRITICAL CARE			English	Article						Family care in critical care; Family-centred care; Family nursing; Interview/focus group techniques; Qualitative research		Background: Advances in medical technology have led to increased survival rates for critically ill patients, resulting in the survival of patients with serious traumatic brain injury. These patients may suffer some permanent brain damage leading to an ambiguous loss in families. Ambiguous loss has two dimensions: (1) a loss that relates to the physical absence but psychological presence of the family member and (2) a loss that refers to the psychological absence but physical presence of the family member. Aim: The overall study aimed at exploring families' experiences with critical illness in intensive care and nurses' perception of families. This article presents findings of one specific aspect, namely, families who experienced an ambiguous loss following the patient's brain injury which resulted in permanent brain damage. Design and method: Constructivist grounded theory that used focus groups as the method of choice. Reported data originate from nine family interviews (12 adults, 12 children/young people). Data analysis: Interviews were recorded, transcribed verbatim and imported into NVivo for data management and analysis. The principle approach in grounded theory, the constant comparative method, was followed. Results: The findings suggest that 'the emergence of ambiguous loss' reflects the families' experiences with the second type of ambiguous loss, namely a loss that relates to a family member who was physically present but psychologically absent. 'Mapping the future' is a further dimension of this theme which underlines the impact of an ambiguous loss on everyday family life. Conclusion: Families where the patient had suffered permanent brain damage experience an ambiguous loss. In this situation a caring scenario emerged which had a fundamental impact on the family's future. The dimension of 'mapping the future' draws out these implications for different family members. Relevance to clinical practice: Nurses need to be aware of the implications an ambiguous loss can have on families.	Univ Edinburgh, Sch Med, Sch Hlth Social Sci, Edinburgh EH8 9AG, Midlothian, Scotland		Kean, S (corresponding author), Univ Edinburgh, Sch Med, Sch Hlth Social Sci, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	susanne.kean@ed.ac.uk		Kean, Susanne/0000-0002-3717-9740	Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/F029179/1] Funding Source: researchfish; ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/F029179/1] Funding Source: UKRI		ALLMOND B, 1999, FAMILY IS PATIENT; Anspach R.R., 1997, DECIDING WHO LIVES F; Bernardes, 1997, FAMILY STUDIES INTRO; Bloor M., 2001, FOCUS GROUPS SOCIAL; Bosk, 1979, FORGIVE REMEMBER MAN; Boss P, 2002, LANCET, V360, pS39, DOI 10.1016/S0140-6736(02)11815-0; Boss P., 1999, AMBIGUOUS LOSS LEARN; Boss P.G., 2006, LOSS TRAUMA RESILIEN; Boss PG, 2002, FAM PROCESS, V41, P14, DOI 10.1111/j.1545-5300.2002.40102000014.x; Carey M., 1994, CRITICAL ISSUES QUAL; Cavallo MM, 2005, TXB TRAUMATIC BRAIN; Charmaz, 1991, GOOD DAYS BAD DAYS S; CHARMAZ K, 1990, SOC SCI MED, V30, P1161, DOI 10.1016/0277-9536(90)90256-R; Charmaz K, 2002, HDB INTERVIEW RES CO; Charmaz K., 2014, BROKERAGE CLOSURE IN; Charmaz K., 2000, GROUNDED THEORY OBJE; Chesla C A, 1996, Image J Nurs Sch, V28, P199, DOI 10.1111/j.1547-5069.1996.tb00352.x; DALE BJ, 2006, HDB FAMILIES HEALTH; DAVIS F, 1960, AM J SOCIOL, V66, P41, DOI 10.1086/222821; DAVIS F, 1963, PASSAGE CRISIS POLIO; DeYoung R, 2003, OMEGA-J DEATH DYING, V47, P343, DOI 10.2190/QYTT-GC1X-MNLX-6WLU; Glaser B., 1967, DISCOVERY GROUNDED T; Glaser B. G., 1992, EMERGENCE VS FORCING; Glaser B.G., 1978, THEORETICAL SENSITIV; Greenstein Theodore, 2006, METHODS FAMILY RES; Gubrium Jaber F., 1990, WHAT IS FAMILY; Hess R. D., 1959, FAMILY WORLDS PSYCHO; Jones D.W, 2002, MYTHS MADNESS FAMILY; KEAN S, 2008, THESIS U EDINBURGH E; Kean S, 2010, J CLIN NURS, V19, P266, DOI 10.1111/j.1365-2702.2009.02837.x; KEENAN S, 2004, SURVIVING INTENSIVE; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Leahey M., 2005, NURSES FAMILIES GUID; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; LEWISFRAVEL D, 1992, QUALITATIVE METHODS; Lindeke L L, 2000, J Pediatr Nurs, V15, P99, DOI 10.1053/jn.2000.5447; McGoldrick M., 2003, NORMAL FAMILY PROCES; McKie L, 2004, SOCIOLOGY, V38, P593, DOI 10.1177/0038038504043220; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; Morgan D., 1996, FAMILY CONNECTIONS I; Morgan D., 1997, FOCUS GROUPS QUALITA, V2nd; MUNCIE J, 1997, UNDERSTANDING FAMILY; Risman Barbara J., 1998, GENDER VERTIGO AM FA; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; TIMMERMANS S, 1999, SUDDEN DEATH MYTH CP; Vogler C, 1999, SOCIOLOGY FAMILY REA; Wasoff F., 2000, FAMILY POLICY; WILLIAMS J, 1991, HEAD INJURY FAMILY M; Zussman R., 1994, INTENSIVE CARE MED E; [No title captured]	51	19	20	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1362-1017	1478-5153		NURS CRIT CARE	Nurs. Crit. Care	MAR-APR	2010	15	2					66	75		10.1111/j.1478-5153.2010.00379.x			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	796QB	WOS:000293065600005	20236433				2022-02-06	
J	Kreipke, CW; Schafer, PC; Rossi, NF; Rafols, JA				Kreipke, Christian W.; Schafer, Patrick C.; Rossi, Noreen F.; Rafols, Jose A.			Differential effects of endothelin receptor A and B antagonism on cerebral hypoperfusion following traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Brain trauma; endothelin; vascular regulation	RESPONSES; ISCHEMIA; DAMAGE; MODEL; RATS	Objectives: Our laboratory has previously shown that endothelin 1 (ET-1), a powerful vasoconstrictor, and its receptors, A (ETrA) and B (ETrB), are up-regulated following trauma. This up-regulation coincides temporally with enhanced vasoreactivity in cerebral cortical microvessels, which leads to a state of chronic hypoperfusion for up to 48 hours following traumatic brain injury (TBI). However, the direct contribution of either receptor up-regulation to decreased cerebral blood flow (CBF) after closed head trauma has not been determined. Furthermore, how ET-1 blockade may affect histological outcome following TBI has not been explored. Therefore, the effects of ETrA and B antagonism on TBI induced hypoperfusion of CBF and cell injury in sensorimotor cortex (smCx) and hippocampus (Hipp) were assessed by arterial spin labeling magnetic resonance imaging and Fluoro-Jade staining, respectively. Methods: Adult male rats were given intracerebroventricular injections of ETrA (BQ123) or ETrB antagonist (BQ788) before being subjected to TBI using a closed head acceleration impact model. Following TBI, CBF was measured and histological examination of cell integrity was carried out. Results: ETrA blockade ameliorated TBI induced hypoperfusion in smCx and Hipp at 4 and 24 hours after TBI and caused a mild hyperemia in both centers by 48 hours after injury. Furthermore, ETrA antagonism reduced the extent of Fluoro-Jade labeled cells within smCx and Hipp as compared with TBI only. ETrB blockade had little effect on TBI induced hypoperfusion and did not change the extent of cell injury following TBI. Discussion: These results suggest that decreased CBF following TBI may be caused by ETrA, but not ETrB, up-regulation. Furthermore, these results suggest that TBI induced hypoperfusion may contribute to poor neurologic outcome following TBI. In this work, we provide a rationale for studying the clinical relevancy of use of ETrA antagonists following TBI.	[Kreipke, Christian W.; Schafer, Patrick C.; Rafols, Jose A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Rossi, Noreen F.] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA		Rafols, JA (corresponding author), Room 9312 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS039860]; International Conference on endothelin [ET-10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health (grant no. NS039860). A partial report of these findings was presented at the International Conference on endothelin (ET-10) in Bergamo, Italy.	Andersson KE, 2001, UROL CLIN N AM, V28, P233, DOI 10.1016/S0094-0143(05)70134-8; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; BEGNINI A, 2007, P ET 10 BERG IT; EHRENREICH H, 2005, SCIENCE, V309, P392; ISHIKAWA K, 1992, J MED CHEM, V35, P2139, DOI 10.1021/jm00089a028; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; Jacobs A, 2006, CURR MED RES OPIN, V22, P2567, DOI 10.1185/030079906X158020; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pollock DM, 2006, HYPERTENSION, V48, P211, DOI 10.1161/01.HYP.0000229908.62191.6e; Rafols JA, 2007, NEUROL RES, V29, P337, DOI 10.1179/016164107X204639; Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Siren AL, 2002, BRAIN RES, V945, P144, DOI 10.1016/S0006-8993(02)02911-6; Touzani O, 1997, J CEREBR BLOOD F MET, V17, P1157, DOI 10.1097/00004647-199711000-00004; Zhao P, 2007, ANESTHESIOLOGY, V107, P963, DOI 10.1097/01.anes.0000291447.21046.4d	18	19	20	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2010	32	2					209	214		10.1179/174313209X414515			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558XJ	WOS:000274781900017	19570328				2022-02-06	
J	Jacobs, B; Beems, T; van der Vliet, TM; Borm, GF; Vos, PE				Jacobs, Bram; Beems, Tjemme; van der Vliet, Ton M.; Borm, George F.; Vos, Pieter E.			The Status of the Fourth Ventricle and Ambient Cisterns Predict Outcome in Moderate and Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cisterns; computed tomography scan; head injury; outcome; severe traumatic brain injury; ventricles	SEVERE HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; PROGNOSTIC VALUE; BASAL CISTERNS; CT SCAN; VALIDATION; CLASSIFICATION; SURVIVAL; MODELS; IMPACT	Computed tomography (CT) of the head has become the diagnostic tool of choice, particularly for moderate and severe traumatic brain injury (TBI). Various CT characteristics are associated with outcome, and may therefore be used as outcome predictors. One of the most prominent predictors appears to be the status of the basal cisterns. This study describes the prognostic value of the appearance of individual cisterns and ventricles in relation to that of the basal cisterns. Further, we determine the interrater and intrarater reliability in the evaluation of the cisterns and ventricles. All consecutive moderate and severe adult TBI patients admitted to our hospital were included in this study as part of the prospective Radboud University Brain Injury Cohort Study (RUBICS). Outcome was assessed at 6 months post-trauma using the Glasgow Outcome Scale-Extended (GOS-E). The predictive value of cisterns and ventricles was determined using multivariate binary logistic regression analysis. We included 126 moderate and 574 severe TBI patients. Absence (complete obliteration), but also compression of the ambient cisterns and/or the fourth ventricle were strongly related to unfavorable outcome and death and emerged as the only significant outcome predictors after multivariate analysis. The assessment of the ambient cisterns and the fourth ventricle had a satisfactory inter-and intrarater reliability (kappa coefficients: 0.80-0.95). We conclude that, because obliteration of the ambient cisterns and the fourth ventricle both are better than the status of the basal cisterns as outcome predictors, they might be used in CT prediction models in cases of moderate and severe TBI.	[Jacobs, Bram; Vos, Pieter E.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Beems, Tjemme] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, NL-6500 HB Nijmegen, Netherlands; [van der Vliet, Ton M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6500 HB Nijmegen, Netherlands; [Borm, George F.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6500 HB Nijmegen, Netherlands		Vos, PE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dep Neurol 935, POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.vos@neuro.umcn.nl	Vos, Pieter/A-6043-2012				*AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P597; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Chen R, 2009, SURG RADIOL ANAT, V31, P129, DOI 10.1007/s00276-008-0417-3; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; COLQUHOUN IR, 1989, CLIN RADIOL, V40, P13, DOI 10.1016/S0009-9260(89)80006-6; COOPER PR, 1979, NEUROSURGERY, V5, P566, DOI 10.1227/00006123-197911000-00004; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Edwards P, 2005, LANCET, V365, P1957; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fearnside M, 1998, AUST NZ J SURG, V68, P58, DOI 10.1111/j.1445-2197.1998.tb04638.x; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JACOBS B, 2009, J NEUROTRAUMA; LANDIS JR, 1977, BIOMETRICS, V33, P174; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LIU HM, 1995, J TRAUMA, V38, P330, DOI 10.1097/00005373-199503000-00003; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	45	19	19	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2010	27	2					331	340		10.1089/neu.2009.1105			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	557JG	WOS:000274664800006	19852584	Green Submitted			2022-02-06	
J	Cooper, DB; Mercado-Couch, JM; Critchfield, E; Kennedy, J; Vanderploeg, RD; DeVillibis, C; Gaylord, KM				Cooper, Douglas B.; Mercado-Couch, Janyna M.; Critchfield, Edan; Kennedy, Jan; Vanderploeg, Rodney D.; DeVillibis, Carita; Gaylord, Kathryn M.			Factors influencing cognitive functioning following mild traumatic brain injury in OIF/OEF burn patients	NEUROREHABILITATION			English	Article						Mild traumatic brain injury; blast injury; cognitive dysfunction	POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL STATUS RBANS; REPEATABLE BATTERY; POSTCONCUSSIVE SYMPTOMS; BASE RATES; IRAQ; AFGHANISTAN; MECHANISMS; DIAGNOSIS; VALIDITY	Objective: To examine the relationship between mild traumatic brain injury (mTBI), psychiatric conditions, pain medications, and injury severity on cognitive functioning in service members admitted to a burn unit. We hypothesize that psychiatric co-morbidity and pain medications will have a stronger relationship with cognitive dysfunction than mTBI diagnosis in this population. Method: Retrospective review of clinical evaluations (n = 194) completed between September 2005-October 2007 on service members with burn injuries secondary to explosive munitions. Evaluations were completed during the acute stage of recovery (mean = 7.87 weeks). mTBI diagnosis (n = 50) was made through a clinical interview using ACRM criteria [1]. Exclusion criteria included duration of posttraumatic amnesia > 24 hours (n = 10); and inability to complete neurocognitive measures due to severe bimanual burns and/or amputations (n = 17). Cognitive functioning was evaluated using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Results: Subjects who sustained mTBI demonstrated significantly greater difficulty on the RBANS visuospatial and attention/processing speed indices. A hierarchical linear regression, using mTBI diagnosis, psychiatric diagnosis, time since injury, presence of pain medications, and measures of trauma severity as predictive factors, found that mTBI diagnosis had a significant, but small unique effect on cognitive functioning. Contrary to our hypothesis, psychiatric co-morbidity was not shown to have a significant effect on this population of acutely injured service members. Conclusions: While the relationship between severe TBI and cognitive functioning is well established, the relationship between mTBI and its effects on cognitive and behavioral abilities is less clear. The current study demonstrates that mTBI and analgesic medications have a small effect neurocognitive functioning in this population. Continued examination of this relationship is warranted.	[Cooper, Douglas B.] Brooke Army Med Ctr, Dept Orthoped, Traumat Brain Injury Serv, Ft Sam Houston, TX 78234 USA; [Cooper, Douglas B.] Brooke Army Med Ctr, Dept Rehabil, Traumat Brain Injury Serv, Ft Sam Houston, TX 78234 USA; [Mercado-Couch, Janyna M.; Critchfield, Edan] Brooke Army Med Ctr, Dept Behav Med, Ft Sam Houston, TX 78234 USA; [Kennedy, Jan; Vanderploeg, Rodney D.] DVBIC, Washington, DC USA; [Vanderploeg, Rodney D.] James A Haley Vet Adm Med Ctr, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.] Univ S Florida, Tampa, FL USA; [DeVillibis, Carita] USA, Res Lab, Adelphi, MD USA; [Gaylord, Kathryn M.] US Inst Surg Res USAISR, Ft Sam Houston, TX USA		Cooper, DB (corresponding author), MCHE DOR TBI, Dept Orthoped & Rehabil, Traumat Brain Injury Serv, 3851 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	douglas.cooper2@amedd.army.mil			NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG012300] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG P30-12300-10] Funding Source: Medline		American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Atiyeh BS, 2005, WORLD J SURG, V29, P131, DOI 10.1007/s00268-004-1082-2; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beatty WW, 2004, ARCH CLIN NEUROPSYCH, V19, P825, DOI 10.1016/j.acn.2003.12.001; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Freilich BM, 2007, PSYCHOL REP, V101, P119, DOI 10.2466/PR0.101.1.119-129; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2008, CLIN NEUROPSYCHOL, V22, P209, DOI 10.1080/13854040701290062; Lovell M, 2008, NEUROL CLIN, V26, P45, DOI 10.1016/j.ncl.2007.12.001; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Powell GE, 2008, J NEUROL NEUROSUR PS, V79, P237, DOI 10.1136/jnnp.2007.131722; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Randolph C., 1998, REPEATABLE BATTERY A; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schrimsher GW, 2008, J PSYCHOPATHOL BEHAV, V30, P146, DOI 10.1007/s10862-007-9054-0; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilde MC, 2006, CLIN NEUROPSYCHOL, V20, P702, DOI 10.1080/13854040500246901; Wilk CM, 2004, SCHIZOPHR RES, V70, P175, DOI 10.1016/j.schres.2003.10.009	28	19	19	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	26	3					233	238		10.3233/NRE-2010-0559			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	603OQ	WOS:000278218300007	20448313				2022-02-06	
J	Drake, AI; Meyer, KS; Cessante, LM; Cheung, CR; Cullen, MA; McDonald, EC; Holland, MC				Drake, Angela I.; Meyer, Kimberly S.; Cessante, Lynne M.; Cheung, Catherine R.; Cullen, Maren A.; McDonald, Eric C.; Holland, Martin C.			Routine TBI screening following combat deployments	NEUROREHABILITATION			English	Article						Blast; combat veteran; injury mechanism; Iraq; Afghanistan; Marines; military; post-deployment; prevalence; screening; traumatic brain injury	TRAUMATIC BRAIN-INJURY; WAR; IRAQ; VETERANS; CARE	A precise estimate of the rates of traumatic brain injury (TBI) in returning combat troops is difficult to establish given the challenges of screening large numbers of military personnel returning from combat deployments. The Brief Traumatic Brain Injury Screen (BTBIS) was implemented in the First Marine Expeditionary Force between 2004 and 2006. Nine percent of the 7909 marines who completed the BTBIS were considered having a positive screen; that is, they endorsed at least one injury mechanism and indicated a change in mental status at the time of injury. The majority of combat-related TBI's were due to multiple injury agents with the next largest group related to blast exposure only. Most importantly, of those who screened positive for TBI 70.5% (n = 500) were first identified by the screen. Service members who endorsed items on the BTBIS were contacted for follow-up assessment of persistent symptoms related to TBI and clinical referrals were made as needed. Given the rate of positive TBI screens in this non-referred sample of military personnel returning from a combat deployment, routine TBI screening appears valuable in screening individuals who might not be identified otherwise. Furthermore, this study appears to refute the contention that routine TBI screening will result in an over-identification of TBI in this population.	[Drake, Angela I.; Meyer, Kimberly S.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; [Cessante, Lynne M.; Cheung, Catherine R.; Cullen, Maren A.] USN, Def & Vet Brain Injury Ctr, Med Ctr, San Diego, CA 92152 USA		Drake, AI (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Bldg 1,Room B209,6900 Georgia Ave NW, Washington, DC 20307 USA.	adrake@dvbic.org	Meyer, Kimberly/L-5430-2019				Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Institute of Medicine, 2008, GULF WAR HLTH, V7; KENNEDY JE, 2010, NEUROREHABILITATION; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; SCHWAB KA, 2006, NEUROLOGY S2, V66; STAHURA B, 2005, YEAR VETERANS AFFAIR, P78; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; ENHANCED POSTDEPLOYM	17	19	21	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2010	26	3					183	189		10.3233/NRE-2010-0554			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	603OQ	WOS:000278218300002	20448308				2022-02-06	
J	Gale, SD; Prigatano, GP				Gale, Shawn D.; Prigatano, George P.			Deep White Matter Volume Loss and Social Reintegration After Traumatic Brain Injury in Children	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							VOXEL-BASED MORPHOMETRY; CHILDHOOD HEAD-INJURY; RECOVERY; OUTCOMES; PREDICTORS	Objective: To explore whether children judged by their parents as showing an "excellent" or "complete" social reintegration after pediatric traumatic brain injury have less white matter volume (WMV) loss and better neuropsychological test scores than children who do not achieve this same level of reintegration. Setting: Primary-care hospital/medical center. Participants: Twenty-eight children with post-acute traumatic brain injury evaluated as outpatients. Measures: Parental ratings of overall social reintegration, neuropsychological test performance, and voxel-based morphometry analysis of brain WMV loss. Results: In addition to showing worse neuropsychological test performance, children judged not to make a complete or excellent social reintegration had greater WNW loss, particularly within the corpus callosum. WMV loss in the corpus callosum correlated with the child's Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV) Full Scale IQ (rho = .677, P = .000) and parental ratings of level of social integration (rho = .415, P = .028). Admitting Glasgow Coma Scale scores, mother's level of education, WISC-IV Processing Speed Index scores, and WMV loss in the region of the corpus callosum significantly contributed to parental ratings of a child's level of social reintegration. Conclusions: Preliminary findings suggested that diffuse WMV loss, particularly in deep brain regions (eg, corpus callosum), may relate to the child's long-term psychosocial outcome as viewed from the parents' perspective.	[Gale, Shawn D.; Prigatano, George P.] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 222 W Thomas Rd,Ste 315, Phoenix, AZ 85013 USA.	gprigat@chw.edu	Gale, Shawn/M-3144-2013	Gale, Shawn/0000-0002-8989-0964	Barrow Neurological Foundation	Funding for the study was made possible by the Barrow Neurological Foundation.	Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bigler ED, 2005, TXB TRAUMATIC BRAIN; BIRCH HG, 1964, BRAIN DAMAGE CHILDRE; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Broman S. H., 1995, TRAUMATIC HEAD INJUR; Delis DC., 1994, CALIFORNIA VERBAL LE; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gennarelli TA, 2005, TXB TRAUMATIC BRAIN; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LEVIN HS, 1997, NEUROSURGERY, V40, P440; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Prigatano GP, 2008, J INT NEUROPSYCH SOC, V14, P143, DOI 10.1017/S1355617708080089; Prigatano GP, 2008, BRAIN INJURY, V22, P491, DOI 10.1080/02699050802084902; Prigatano GP, 2008, J HEAD TRAUMA REHAB, V23, P414, DOI 10.1097/01.HTR.0000341438.97745.ee; Prigatano GP, 2008, J HEAD TRAUMA REHAB, V23, P378, DOI 10.1097/01.HTR.0000341433.67251.01; Reitan R, 1985, HALSTEAD REITAN NEUR; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; Shaffer D, 1975, Ciba Found Symp, P191; SPSS, 2008, SPSS WIND REL 16 0 2; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Wechsler D, 2003, WECHSLER INTELLIGENC; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	37	19	20	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2010	25	1					15	22		10.1097/HTR.0b013e3181c39960			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	550XC	WOS:000274165800003	20051899				2022-02-06	
J	Klonoff, PS; Olson, KC; Talley, MC; Husk, KL; Myles, SM; Gehrels, JA; Dawson, LK				Klonoff, Pamela S.; Olson, Karen C.; Talley, Melanie C.; Husk, Kristi L.; Myles, Stephen M.; Gehrels, Jo-Ann; Dawson, Lauren K.			The relationship of cognitive retraining to neurological patients' driving status: The role of process variables and compensation training	BRAIN INJURY			English	Article						Driving; cognitive rehabilitation; community integration; outcome	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; CEREBRAL INJURY; REHABILITATION; NEUROREHABILITATION; OUTCOMES; FITNESS; STROKE; PERFORMANCE; PREDICTION	Primary objective: To explore the relationship of cognitive retraining performance to discharge driving status. Methods and procedures: One hundred and three brain-injured patients from a holistic milieu-oriented work/school re-entry programme. Experimental interventions: Initial, last, mean, and best cognitive retraining scores; Behavioural Checklist ratings; Working Alliance (WA) scores. Main outcomes and results: At the time of discharge, 50.5% of the sample were cleared to drive. Better performance on a cognitive retraining task addressing information processing and motor speed, focused attention, visual scanning and memory was associated with clearance to drive. Patients' behavioural approach to cognitive retraining tasks (use of compensations, organizational and procedural skills) and higher mean and discharge WA scores with staff were associated with driving clearance. Higher mean WA scores were also related to an enhanced behavioural approach to cognitive retraining tasks, including timeliness to sessions, compensation use, better communication pragmatics, decreased distractibility and the ability to apply the 'big picture' benefits of cognitive retraining to the 'real world'. Conclusions: Cognitive retraining exercises that incorporate skill remediation, 'process' variables and metacognitive skills, as well as a better WA with patients, positively related to clearance to drive at the time of discharge from a holistic milieu-oriented programme.	[Klonoff, Pamela S.; Husk, Kristi L.; Myles, Stephen M.; Gehrels, Jo-Ann] Barrow Neurol Inst, Ctr Transit NeuroRehabil, Phoenix, AZ 85013 USA; [Olson, Karen C.] Gentiva Rehab Walls, Phoenix, AZ USA; [Talley, Melanie C.] Moore Counseling Ctr, Moore, OK USA; [Dawson, Lauren K.] Private Practice, Honolulu, HI USA		Klonoff, PS (corresponding author), Barrow Neurol Inst, Ctr Transit NeuroRehabil, 222 W Thomas Rd,Suite 401, Phoenix, AZ 85013 USA.	pamela.klonoff@chw.edu	LUO, JINGJING/AAZ-6697-2021	LUO, JINGJING/0000-0002-3222-1276			Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Bordin E.S., 1994, WORKING ALLIANCE THE; Brenner LA, 2008, REHABIL PSYCHOL, V53, P18, DOI 10.1037/0090-5550.53.1.18; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Elkin-Frankston S, 2007, ARCH CLIN NEUROPSYCH, V22, P631, DOI 10.1016/j.acn.2007.04.004; Formisano R, 2005, BRAIN INJURY, V19, P159, DOI 10.1080/02699050400017163; Galski T, 2000, J HEAD TRAUMA REHAB, V15, P895, DOI 10.1097/00001199-200006000-00004; Galski T, 1997, AM J OCCUP THER, V51, P352, DOI 10.5014/ajot.51.5.352; GOUVIER WD, 1989, ARCH PHYS MED REHAB, V70, P745; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; HOPEWELL CA, 1990, NEUROPSYCHOLOGY EVER, P307; Klonoff PS, 2007, BRAIN INJURY, V21, P1097, DOI 10.1080/02699050701687342; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Klonoff PS, 1989, J HEAD TRAUMA REHAB, V4, P37; KLONOFF PS, 1996, THEORETICAL FDN CLIN, P219; Klonoff PS, 2000, INT HDB NEUROPSYCHOL, P195; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; LEGHSMITH J, 1986, J ROY SOC MED, V79, P200, DOI 10.1177/014107688607900404; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; Lundqvist A, 2001, BRAIN INJURY, V15, P981, DOI 10.1080/02699050110065637; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; McKenna P, 2004, BRIT J CLIN PSYCHOL, V43, P325, DOI 10.1348/0144665031752952; McKenna P, 2007, J NEUROPSYCHOL, V1, P85, DOI 10.1348/174866407X180837; PERNA RB, 2000, J COGNITIVE REHABILI, V7, P16; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; SCOTT CA, 2008, J CLIN EXPT NEUROPSY, V1, P1; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; Soderstrom ST, 2006, SCAND J PSYCHOL, V47, P419, DOI 10.1111/j.1467-9450.2006.00550.x; Spreen O, 1991, COMPENDIUM NEUROPSYC; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Yale Steven H, 2003, Clin Med Res, V1, P177	45	19	19	0	9	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	2					63	73		10.3109/02699050903512863			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	597BF	WOS:000277729500001	20085443				2022-02-06	
J	Leung, AWS; Cheng, SKW; Mak, AKY; Leung, KK; Li, LSW; Lee, TMC				Leung, Ada W. S.; Cheng, Stephen K. W.; Mak, Amanda K. Y.; Leung, Kwok-Keung; Li, Leonard S. W.; Lee, Tatia M. C.			Functional gain in hemorrhagic stroke patients is predicted by functional level and cognitive abilities measured at hospital admission	NEUROREHABILITATION			English	Article						Stroke; FIM; functional recovery; learning; memory	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL DEFICITS; SUBARACHNOID HEMORRHAGE; INDEPENDENCE MEASURE; ISCHEMIC-STROKE; RECOVERY; REHABILITATION; POSTSTROKE; MILD; SYMPTOMS	Background and purpose: Few studies have addressed factors that contribute to functional recovery in people with hemorrhagic stroke. We assessed the value of using pre-training functional level and cognitive abilities measured at admission in order to predict functional gain in a sample of stroke patients. Methods: The Functional Independence Measure (FIM) was administered to 85 hemorrhagic stroke patients. Three multiple regression models were constructed using total gain in FIM scores, gain in scores in the cognitive domain of FIM, and gain in scores in the motor domain of FIM as outcome variables. Predictor variables were age; scores on the Digit Span Forward Test (DSF), Digit Span Backward Test (DSB). and Chinese Auditory Verbal Learning Test (CAVLT); and the FIM scores measured at admission. Results: All regression models were significant, Ps < 0.001, and each explained over 73% of the variance in the FIM gains. Age and admission FIM scores were both significant predictors in each of the three models. The DSB span score was a significant predictor of the total FIM and the cognitive FIM gains. The CAVLT recognition score was also a significant predictor of the cognitive FIM gain. Conclusions: Functional improvement in patients with hemorrhagic stroke after in-patient rehabilitation was predicted by age, pre-training functional level, and cognitive abilities measured at admission.	[Leung, Ada W. S.; Mak, Amanda K. Y.; Leung, Kwok-Keung; Lee, Tatia M. C.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Cheng, Stephen K. W.] MacLehose Med Rehabil Ctr, Occupat Therapy Dept, Hong Kong, Hong Kong, Peoples R China; [Mak, Amanda K. Y.; Leung, Kwok-Keung; Li, Leonard S. W.; Lee, Tatia M. C.] MacLehose Med Rehabil Ctr, Inst Clin Neuropsychol, Hong Kong, Hong Kong, Peoples R China; [Li, Leonard S. W.] Tung Wah Hosp, Dept Rehabil Med, Hong Kong, Hong Kong, Peoples R China		Lee, TMC (corresponding author), Univ Hong Kong, Neuropsychol Lab, K610,Knowles Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	tmclee@hkusua.hku.hk					BIRKETT DP, 2008, PSYCHIAT STROKE, P5; BLACK FW, 1986, J CLIN PSYCHOL, V42, P770, DOI 10.1002/1097-4679(198609)42:5<770::AID-JCLP2270420516>3.0.CO;2-P; de Freitas GR, 2000, ARCH NEUROL-CHICAGO, V57, P513, DOI 10.1001/archneur.57.4.513; Denti L, 2008, EUR J PHYS REHAB MED, V44, P3; HUTTER BO, 1993, NEUROSURGERY, V33, P999; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Katrak PH, 2009, PM&R, V1, P427, DOI 10.1016/j.pmrj.2009.03.002; Kelly PJ, 2003, ARCH PHYS MED REHAB, V84, P968, DOI 10.1016/S0003-9993(03)00040-6; Kelly PJ, 2001, STROKE, V32, P530, DOI 10.1161/01.STR.32.2.530; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Lee TMC, 2004, INT J GERIATR PSYCH, V19, P216, DOI 10.1002/gps.1053; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Leskela M, 1999, EUR J NEUROL, V6, P653, DOI 10.1046/j.1468-1331.1999.660653.x; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lipson DM, 2005, INT J REHABIL RES, V28, P303, DOI 10.1097/00004356-200512000-00002; MORROW LA, 1992, NEUROPSYCHOLOGIA, V30, P911, DOI 10.1016/0028-3932(92)90035-K; Nedeltchev K, 2007, STROKE, V38, P2531, DOI 10.1161/STROKEAHA.107.482554; O'Dell MW, 2002, ARCH PHYS MED REHAB, V83, P678, DOI 10.1053/apmr.2002.32305; Ozdemir F, 2001, AM J PHYS MED REHAB, V80, P410, DOI 10.1097/00002060-200106000-00003; PULLICINO P, 1992, STROKE, V23, P919, DOI 10.1161/str.23.6.919a; Rey A., 1959, ARCH PSYCHOL, V37, P126; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; Schepers V, 2009, J REHABIL MED, V41, P930, DOI 10.2340/16501977-0446; Schepers VPM, 2008, J REHABIL MED, V40, P487, DOI 10.2340/16501977-0198; Schepers VP, 2006, ARCH PHYS MED REHAB, V87, P184, DOI 10.1016/j.apmr.2005.10.005; Schepers VP, 2005, ARCH PHYS MED REHAB, V86, P1472, DOI 10.1016/j.apmr.2004.11.039; Su CY, 2000, ARCH PHYS MED REHAB, V81, P706, DOI 10.1053/apmr.2000.4437; TIDSWELL P, 1995, NEUROLOGY, V45, P875; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004	30	19	21	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	27	4					351	358		10.3233/NRE-2010-0619			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	723XJ	WOS:000287540400008	21160125				2022-02-06	
J	Penna, S; Novack, TA; Carlson, N; Grote, M; Corrigan, JD; Hart, T				Penna, Suzanne; Novack, Thomas A.; Carlson, Nichole; Grote, Miranda; Corrigan, John D.; Hart, Tessa			Residence Following Traumatic Brain Injury: A Longitudinal Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						craniocerebral trauma; household composition; longitudinal study; traumatic brain injury	COMMUNITY; COMA; PREDICTORS; SCALE	Objective: To examine change in residence following traumatic brain injury (TBI) as a function of preinjury residential status, demographic factors, and injury-related characteristics. Design: Prospective, observational study. Setting: Inpatient, comprehensive rehabilitation programs for persons with TBI. Participants: A total of 7925 patients with moderate or severe TBI receiving acute rehabilitation, and enrolled in the TBI Model Systems National Database. Main Measures: Preinjury and discharge residential status determined during rehabilitation, and at 1, 2, and 5 years postinjury by telephone interview. Variables contributing to residential status included Injury severity, demographic information, and functional status. Results: There was significant change in residence across 5 years characterized by discharge to a less independent residence following injury, with a return to a more independent residence over time. The most significant transition took place in the first year after injury. Residence prior to injury was the strongest predictor of residence after injury. Age and race were significantly associated with residence following TBI, with increasing age related to more independent residence, and whites more likely to live independently than are African Americans. Severity of injury had little impact, although functional status at rehabilitation discharge was associated with residence, with higher functional status associated with a more independent residence. Conclusion: Among persons who received acute rehabilitation for TBI, 35.4% were discharged from rehabilitation to a setting different from the one in which they resided before injury. The degree of change varied on the basis of preinjury residence. Overall, the results indicate that while many patients are discharged to a different residential setting than prior to their injury, some patients recover to the point where they are able to return to their premorbid residential setting. The most substantial change was for those living alone at the time of injury, and within the first year of injury.	[Penna, Suzanne] Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA; [Novack, Thomas A.] Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL USA; [Carlson, Nichole; Grote, Miranda] Univ Colorado, Dept Biostat & Informat, Denver, CO 80202 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Hart, Tessa] Moss Rehabil Res Inst, Philadelphia, PA USA		Penna, S (corresponding author), Emory Univ, Dept Rehabil Med, 1441 Clifton Rd NE, Atlanta, GA 30322 USA.	suzanne.penna@emoryhealthcare.com	Corrigan, John D./E-2921-2011		National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A970032, H133AO7039]	This study was supported by The National Institute on Disability and Rehabilitation Research, US Department of Education (grants H133A970032 and H133AO7039).	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Blicher Jakob Udby, 2007, Ugeskr Laeger, V169, P228; Brzuzy S, 1996, J HEAD TRAUMA REHAB, V11, P74, DOI 10.1097/00001199-199606000-00011; COLE JR, 1985, ARCH PHYS MED REHAB, V66, P38; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KARPMAN T, 1985, J APPL REHABIL COUNS, V78, P1321; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kleinbaum DG, 1998, APPL REGRESSION ANAL, V3rd; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; McColl MA, 1999, BRAIN INJURY, V13, P311, DOI 10.1080/026990599121511; Molenberghs G., 2005, MODELS DISCRETE LONG; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; TEASDALE G, 1974, LANCET, V2, P81; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561	23	19	19	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2010	25	1					52	60		10.1097/HTR.0b013e3181c29952			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	550XC	WOS:000274165800007	20051896				2022-02-06	
J	Prieto, G; Delgado, AR; Perea, MV; Ladera, V				Prieto, Gerardo; Delgado, Ana R.; Perea, Maria V.; Ladera, Valentina			Scoring Neuropsychological Tests Using the Rasch Model: An Illustrative Example With the Rey-Osterrieth Complex Figure	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuropsychological testing; Rasch Rating Scale Model; ROCF		Parametric statistical methods are typically used for analyzing test scores, even though they are ordinal at best. The Meyers and Meyers' Rey-Osterrieth Complex Figure four-category scoring system has been evaluated with the Rasch Rating Scale Model, and disordered thresholds have been found. However, Rasch-modeling dichotomized data led to good fit for both normal (n = 219) and Traumatic Brain Injury (n = 54) samples and generalized validity for these groups, as well as for male and female groups. The logarithmic transformation of the item and person data performed by the model converts the ordinal data to yield interval scaled data. This is desirable not only from a scientific perspective, but also from the point of view of interpretability and communicability.	[Prieto, Gerardo; Delgado, Ana R.; Perea, Maria V.; Ladera, Valentina] Univ Salamanca, E-37008 Salamanca, Spain		Delgado, AR (corresponding author), Univ Salamanca, E-37008 Salamanca, Spain.	adelgado@usal.es	Prieto, Gerardo/F-3397-2012; Ladera, Valentina/Q-6132-2017; Delgado, Ana R./A-3846-2012; Perea, M. Victoria/B-2904-2018	Ladera, Valentina/0000-0003-4075-4483; Delgado, Ana R./0000-0003-0380-8999; Perea, M. Victoria/0000-0002-0258-8480; Prieto, Gerardo/0000-0001-8187-7784			ANDERSEN EB, 1970, J ROY STAT SOC B, V32, P283; ANDERSEN EB, 1973, PSYCHOMETRIKA, V38, P123, DOI 10.1007/BF02291180; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Bond T. G., 2007, APPL RASCH MODEL; Delgado AR, 2007, BEHAV RES METHODS, V39, P570, DOI 10.3758/BF03193027; Embretson SE, 2006, AM PSYCHOL, V61, P50, DOI 10.1037/0003-066X.61.1.50; Fernando K, 2003, NEW ZEAL J PSYCHOL, V32, P33; LEZAK K, 1995, NEUROPSYCHOLOGICAL A; Linacre J.M., 2006, USERS GUIDE WINSTEPS; Linacre John M, 2002, J Appl Meas, V3, P85; LUCE RD, 1964, J MATH PSYCHOL, V1, P1, DOI 10.1016/0022-2496(64)90015-X; Meyers J., 1995, REY COMPLEX FIGURE R; Michell J., 1999, MEASUREMENT PSYCHOL; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; PEREA V, 2000, PSICOTHEMA, V12, P353; Perez G, 1995, WSS NONLIN SCI SER B, V7, P105; PRIETO G, 2003, ENCY PSYCHOL ASSESSM, V2, P975; Rasch G., 1960, PROBABILISTIC MODELS; Rasch G., 1968, MATH THEORY OBJECTIV; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; STERN RA, 1994, CLIN NEUROPSYCHOL, V8, P309, DOI 10.1080/13854049408404137; Velicer, 2003, HDB PSYCHOL, P635, DOI 10.1002/0471264385.wei0225; WABER DP, 1985, J CLIN EXP NEUROPSYC, V7, P264, DOI 10.1080/01688638508401259; [No title captured]	25	19	22	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2010	24	1					45	56	PII 913604714	10.1080/13854040903074645			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	535MK	WOS:000272972300004	19658034				2022-02-06	
J	Siddiqui, MA; Sim, L; Koh, J; Fook-Chong, S; Tan, C; Sen Howe, T				Siddiqui, Mashfiqul A.; Sim, Lynette; Koh, Joyce; Fook-Chong, Stephanie; Tan, Carol; Sen Howe, Tet			Stress Levels amongst Caregivers of Patients with Osteoporotic Hip Fractures - A Prospective Cohort Study	ANNALS ACADEMY OF MEDICINE SINGAPORE			English	Article						Caregiver strain index; Hip fractures	TRAUMATIC BRAIN-INJURY; BURDEN; DEPRESSION; DEMENTIA; ANXIETY; PEOPLE; STROKE; CARE	Introduction: We evaluated if there was significant stress in caregivers of elderly patients with osteoporotic hip fractures and determine any contributory factors. Materials and Methods: A prospective cohort study was performed from June 2005 to June 2006 in a single tertiary hospital. Patients admitted during this period and their primary caregivers were interviewed on admission and at 6 months. Information on patient's demographics, comorbidities, functional and mental status, placement post-discharge and financial strain were noted. Caregiver stress was measured using the caregiver strain index (CSI). Relationships between key variables were analysed to derive possible correlations. Results: The study comprised caregivers of 76 patients with a mean age of 77 years (range, 50 to 95; SD, 11). Within I week of admission, 45 of the 76 caregivers (59.2%) were significantly stressed based on the CSI while at 6 months, 30 of the caregivers (50%) were significantly stressed. The mean CSI within I week of admission and at 6 months post-admission was 7.18 and 6.25 respectively (P = 0.042). The most significant contributory factor to stress was financial strain (P = 0.01) attributable to medical bills, rehabilitation costs and transport expenses. Conclusion: There is a significant amount of stress that is experienced by caregivers of elderly patients with hip fractures which commences from admission of the patient and it remains high at 6-months post-fracture. Financial strain has been found to be the only significant cause on both univariate and multivariate analysis. Adequate resources should be available to caregivers of patients with osteoporotic hip fractures.	[Siddiqui, Mashfiqul A.; Koh, Joyce; Sen Howe, Tet] Singapore Gen Hosp, Dept Orthopaed Surg, Singapore 169608, Singapore; [Sim, Lynette] OzWorks Therapy Pte Ltd, Singapore, Singapore; [Fook-Chong, Stephanie] Singapore Gen Hosp, Dept Clin Res, Singapore 169608, Singapore; [Tan, Carol] KK Womens & Childrens Hosp, Geriatr Serv, Singapore, Singapore		Siddiqui, MA (corresponding author), Singapore Gen Hosp, Dept Orthopaed Surg, Outram Rd, Singapore 169608, Singapore.	mohd.mashfiqul@gmail.com					Bandeira DR, 2007, AGING MENT HEALTH, V11, P14, DOI 10.1080/13607860600640814; Bond J, 1998, INT J GERIATR PSYCH, V13, P601, DOI 10.1002/(SICI)1099-1166(199809)13:9<601::AID-GPS827>3.3.CO;2-2; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Dorra HH, 2002, INT J PSYCHIAT MED, V32, P249, DOI 10.2190/6REK-NYYD-MAXF-TD34; Gruffydd Emma, 2006, Community Pract, V79, P15; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hirakawa Y, 2008, ARCH GERONTOL GERIAT, V46, P367, DOI 10.1016/j.archger.2007.05.011; JOHANSSON I, 1988, AGING, V10, P377; JONGJIT K, 2003, SE ASIAN J TROP MED, V34, P670; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mehta KK, 2005, J CROSS-CULT GERONTO, V20, P319, DOI 10.1007/s10823-006-9009-z; Onishi J, 2005, ARCH GERONTOL GERIAT, V41, P159, DOI 10.1016/j.archger.2005.01.004; Post MWM, 2005, SPINAL CORD, V43, P311, DOI 10.1038/sj.sc.3101704; Randell AG, 2000, OSTEOPOROSIS INT, V11, P460, DOI 10.1007/s001980070115; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHELBY J, 1992, Journal of Burn Care and Rehabilitation, V13, P58, DOI 10.1097/00004630-199201000-00013; SULLIVAN TM, MODIFIED CAREGIVER S	20	19	22	0	8	ACAD MEDICINE SINGAPORE	REPUBLIC SINGAPORE	142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE	0304-4602			ANN ACAD MED SINGAP	Ann. Acad. Med. Singap.	JAN	2010	39	1					38	42					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558ME	WOS:000274746200009	20126813				2022-02-06	
J	Svestkova, O; Angerova, Y; Sladkova, P; Bickenbach, JE; Raggi, A				Svestkova, Olga; Angerova, Yvona; Sladkova, Petra; Bickenbach, Jerome Edmond; Raggi, Alberto			Functioning and disability in traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; disability; ICF classification; ICF checklist; WHO-DAS II; FIM	LONG-TERM DISABILITY; UNITED-STATES; RATING-SCALE; FOLLOW-UP; ICF; EPIDEMIOLOGY; REHABILITATION; QUESTIONNAIRE; HEALTH	Purpose. To describe functioning and disability in patients with traumatic brain injury (TBI) according to the model endorsed by the International Classification of Functioning Disability and Health (ICF). Methods. Adult patients with acquired TBI were consecutively enrolled. The Functional Independence Measure (FIM), the WHO Disability Assessment Schedule II (WHO-DAS II) and the ICF checklist were administered in individual sessions. Descriptive analyses were performed to report on FIM and WHO-DAS II scores. ICF categories reported as a problem by more than 20% of patients were described in detail. Results. One hundred patients (66 males, mean age 36.1) were enrolled. Mean WHO-DAS II score was 16.8, mean FIM was 116.5 and 87 ICF categories were selected: 27 Body Functions (mainly mental and movement-related) and Structures, 43 Activities and Participation (mainly connected with mobility) and 17 Environmental Factors. Negligible difference between capacity and performance qualifiers was observed. Conclusions. The ICF can be successfully implemented in clinical and rehabilitation of patients with TBI, because it enables to describe the variety of problems they encounter: ICF-derived data provide a holistic view of disability and enable the impact of service interventions on functioning and participation, and enable clinicians to tailor intervention according to patient's actual needs.	[Svestkova, Olga; Angerova, Yvona; Sladkova, Petra] Charles Univ Prague, Dept Rehabil Med, Prague 12800, Czech Republic; [Bickenbach, Jerome Edmond] Swiss Parapleg Fdn, Notwill, Switzerland; [Raggi, Alberto] Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Sci Directorate, Milan, Italy		Svestkova, O (corresponding author), Charles Univ Prague, Dept Rehabil Med, Albertov 7, Prague 12800, Czech Republic.		Svetkova, Olga/O-1062-2017; Raggi, Alberto/K-5787-2016; Angerova, Yvona/AAL-8925-2021	Svetkova, Olga/0000-0002-4271-4795; Raggi, Alberto/0000-0002-7433-7779; 	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [SP-24-CT-2004-513708]	MHADIE project was funded by the European Commission, Sixth Framework Programme. Contract Number: SP-24-CT-2004-513708, thematic priority 'Scientific Support to Policies'.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, pVIII, DOI 10.1111/j.1468-1331.2005.01201.x; AYUSO JL, 2010, DISABIL REHABIL, V32, pS17; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Cieza Alarcos, 2006, BMC Med Res Methodol, V6, P36, DOI 10.1186/1471-2288-6-36; *CRAIG HOSP, TRAUM BRAIN INJ MOD; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Ewert T, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410015362; Francescutti C, 2009, DISABIL REHABIL, V31, pS46, DOI 10.3109/09638280903317757; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; Hamilton BB, 1987, REHABILITATION OUTCO; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Kuipers P, 2009, DISABIL REHABIL, V31, P144, DOI 10.1080/01674820701817938; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; O'Donovan MA, 2009, DISABIL REHABIL, V31, P2073, DOI 10.3109/09638280902918738; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Scarponi F, 2009, DISABIL REHABIL, V31, pS134, DOI 10.3109/09638280903317906; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Steiner WA, 2002, PHYS THER, V82, P1098, DOI 10.1093/ptj/82.11.1098; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tempest S, 2006, DISABIL REHABIL, V28, P663, DOI 10.1080/09638280500276992; Ustun T, 2010, MEASURING HLTH DISAB; von Holst H, 2009, NEUROEPIDEMIOLOGY, V33, P314; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; World Health Organization, 2007, INT CLASS FUNCT DIS; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	31	19	19	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2010	32			1			S68	S77		10.3109/09638288.2010.511690			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	671HR	WOS:000283492200009	20929314				2022-02-06	
J	Niven, DJ; Laupland, KB; Gregson, DB; Church, DL				Niven, Daniel J.; Laupland, Kevin B.; Gregson, Daniel B.; Church, Deirdre L.		S Aureus Screening Initiative Grp	Epidemiology of Staphylococcus aureus nasal colonization and influence on outcome in the critically ill	JOURNAL OF CRITICAL CARE			English	Article						Staphylococcus aureus; Nasal colonization; Critically ill	VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE UNIT; TRAUMATIC BRAIN-INJURY; MAJOR RISK-FACTOR; METHICILLIN-RESISTANT; NOSOCOMIAL INFECTIONS; CARRIAGE; BACTEREMIA; SURVEILLANCE; HOSPITALS	Purpose: To determine the rate of Staphylococcus aureus nasal colonization at admission to intensive care units (ICU) and assess its effect on the development of an ICU-acquired S aureus infection. Materials and Methods: We screened all ICU admissions for nasal colonization within the Calgary Health Region from October 2005 to September 2006 and followed up patients to hospital discharge or death or S aureus infection to 30 days. Results: One thousand three hundred eight patients were admitted to ICU for more than 48 hours and screened for nasal colonization. Fifty (4%) were methicillin-resistant S aureus (MRSA)-positive, 311 (24%) were methicillin-sensitive S aureus (MSSA)-positive, and 947 (72%) were nasal screen-negative. Overall, 5% (63/1239) of patients uninfected at ICU admission developed an ICU-acquired S aureus infection. The rate of ICU-acquired infection was 5% in MRSA colonized patients, 12% in MSSA colonized patients, and 3% in noncolonized patients. A positive nasal screen (odds ratio [OR], 4.7; 95% confidence interval [CI] 2.7-7.9), neuro/trauma patients (OR, 3.1; 95% CI, 1.8-5.2), and higher first Therapeutic Intervention Scoring System score (OR, 1.03 per point; 95% CI, 1.01-1.05) were independent predictors for developing an ICU-acquired S aureus infection. Conclusions: Nasal colonization with S aureus is a significant risk factor for ICU-acquired S aureus infections, and strategies to control these infections should target both MSSA and MRSA colonization. (C) 2009 Elsevier Inc. All rights reserved.	[Niven, Daniel J.; Laupland, Kevin B.; Gregson, Daniel B.; Church, Deirdre L.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Niven, Daniel J.; Laupland, Kevin B.; Gregson, Daniel B.; Church, Deirdre L.] Calgary Lab Serv, Calgary, AB, Canada; [Laupland, Kevin B.; Gregson, Daniel B.; Church, Deirdre L.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Laupland, Kevin B.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Laupland, Kevin B.] Univ Calgary, Ctr Antimicrobial Resistance, Calgary, AB, Canada		Laupland, KB (corresponding author), Foothills Med Ctr Calgary, Calgary, AB T2N 2T9, Canada.	kevin.laupland@calgaryhealthregion.ca	Laupland, kevin/AAJ-6339-2020; Laupland, Kevin/AAG-3656-2020; Viani, Rafael/V-1196-2018	Laupland, kevin/0000-0002-1205-5354; 	Department of Critical Care Medicine; Calgary Health Region	We thank all members and intensive care unit staff of the Department of Critical Care Medicine, Calgary Health Region, for their support of this initiative.	BRAWLEY RL, 1989, AM J EPIDEMIOL, V130, P769, DOI 10.1093/oxfordjournals.aje.a115398; BROWN RB, 1985, CRIT CARE MED, V13, P472, DOI 10.1097/00003246-198506000-00006; CHANDRASEKAR PH, 1986, CRIT CARE MED, V14, P508, DOI 10.1097/00003246-198605000-00017; Corbella X, 1997, EUR J CLIN MICROBIOL, V16, P351, DOI 10.1007/BF01726362; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Cullen D J, 1974, Crit Care Med, V2, P57, DOI 10.1097/00003246-197403000-00001; DONOWITZ LG, 1982, CRIT CARE MED, V10, P355, DOI 10.1097/00003246-198206000-00001; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Haddadin AS, 2002, POSTGRAD MED J, V78, P385, DOI 10.1136/pmj.78.921.385; Kalmeijer MD, 2000, INFECT CONT HOSP EP, V21, P319, DOI 10.1086/501763; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Laupland KB, 2006, J HOSP INFECT, V63, P124, DOI 10.1016/j.jhin.2005.12.016; Porter R, 2003, INTENS CARE MED, V29, P655, DOI 10.1007/s00134-003-1679-1; Pujol M, 1996, AM J MED, V100, P509, DOI 10.1016/S0002-9343(96)00014-9; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Shorr AF, 2006, CRIT CARE, V10, DOI 10.1186/cc4934; Simor AE, 2001, CAN MED ASSOC J, V165, P21; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Weber DJ, 1999, CHEST, V115, p34S, DOI 10.1378/chest.115.suppl_1.34S; WEINSTEIN HJ, 1959, NEW ENGL J MED, V260, P1303, DOI 10.1056/NEJM195906252602601; Wood GC, 2002, PHARMACOTHERAPY, V22, P972, DOI 10.1592/phco.22.12.972.33596; YU VL, 1986, NEW ENGL J MED, V315, P91, DOI 10.1056/NEJM198607103150204; Zygun D, 2006, CRIT CARE, V10, DOI 10.1186/cc5007; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	26	19	21	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2009	24	4					583	589		10.1016/j.jcrc.2008.10.004			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527XJ	WOS:000272404200018	19327313				2022-02-06	
J	Rousseau, P; Post, A; Hoshizaki, TB				Rousseau, P.; Post, A.; Hoshizaki, T. B.			The effects of impact management materials in ice hockey helmets on head injury criteria	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						hockey; helmet; mild traumatic brain injury; linear acceleration; angular acceleration; head injury criterion		The objective of this study was to compare the capacity of vinyl nitrile and expanded polypropylene, two materials commonly used in ice hockey helmets, to reduce the peak linear acceleration, peak angular acceleration, and head injury criterion values during a direct impact to a hybrid III headform. Six different ice hockey helmets were tested using a pneumatic linear impactor at velocities similar to those in hockey. The results showed that helmets using expanded polypropylene foam liners are significantly better at reducing linear acceleration; however, helmets using vinyl nitrile foam liners are significantly better at reducing angular acceleration. Furthermore, the impact location influenced the performance of the liner.	[Rousseau, P.; Post, A.; Hoshizaki, T. B.] Univ Ottawa, Dept Human Kinet, Neurotrauma Impact Sci Lab, Ottawa, ON K1N 6N5, Canada		Rousseau, P (corresponding author), Univ Ottawa, Dept Human Kinet, Neurotrauma Impact Sci Lab, 125 Univ St, Ottawa, ON K1N 6N5, Canada.	prous83@yahoo.ca		Post, Andrew/0000-0002-5960-5552	Xenith	The authors would like to thank Itech Mission, Nike Bauer, and Reebok CCM for kindly providing us with helmets. They would also like to thank Xenith for supporting in part the laboratory.	[Anonymous], 1997, CANCSAZ2621M90; [Anonymous], 2006, 83SC5N ISO TC; ASTM International, 2007, F104507 ASTM; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, P 16 STAPP CAR CRASH, P296; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; GURDJIAN ES, 1943, SURG GYNECOL OBSTET, V76, P623; Holbourn AHS, 1943, LANCET, V2, P438; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ono K, 1980, P 24 STAPP CAR CRASH, P103; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patrick L. M., 1965, P 7 STAPP CAR CRASH, P483; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	30	19	19	3	17	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	DEC	2009	223	P4					159	165		10.1243/17543371JSET36			7	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	V23QG	WOS:000208356700004					2022-02-06	
J	Yadon, CA; Bugg, JM; Kisley, MA; Davalos, DB				Yadon, Carly A.; Bugg, Julie M.; Kisley, Michael A.; Davalos, Deana B.			P50 sensory gating is related to performance on select tasks of cognitive inhibition	COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; EVOKED POTENTIAL P50; HIPPOCAMPAL VOLUME; PREFRONTAL CORTEX; ATTENTION-DEFICIT; VISUAL-ATTENTION; PERCEPTUAL LOAD; SCHIZOPHRENIA; INTERFERENCE; SUPPRESSION	P50 suppression deficits have been documented in clinical and nonclinical populations, but the behavioral correlates of impaired auditory sensory gating remain poorly understood. In the present study, we examined the relationship between P50 gating and healthy adults' performance on cognitive inhibition tasks. On the basis of load theory (Lavie, Hirst, de Fockert, & Viding, 2004), we predicted that a high perceptual load, a possible consequence of poor auditory P50 sensory gating, would have differential (i.e., positive vs. negative) effects on performance of cognitive inhibition tasks. A dissociation was observed such that P50 gating was negatively related to interference resolution on a Stroop task and positively related to response inhibition on a go/no-go task. Our findings support the idea that a high perceptual load may be beneficial to Stroop performance because of the reduced processing of distractors but detrimental to performance on the go/no-go task because of interference with stimulus discrimination.	[Yadon, Carly A.; Davalos, Deana B.] Colorado State Univ, Ft Collins, CO 80523 USA; [Bugg, Julie M.] Washington Univ, St Louis, MO USA; [Kisley, Michael A.] Univ Colorado, Colorado Springs, CO 80907 USA		Yadon, CA (corresponding author), Colorado State Univ, Ft Collins, CO 80523 USA.	cyadon@lamar.colostate.edu	Kisley, Michael/AAZ-3102-2020; Davalos, Deana/ABB-6630-2021		National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5T32AG00030]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000030] Funding Source: NIH RePORTER	The authors thank Aubrey Anthony, Kathleen Kelsey, Lauren Shirley, and Becky Tucker for assistance with data collection and analysis. J.M.B. was supported by National Institute on Aging Grant 5T32AG00030 during writing of the manuscript. Correspondence concerning this article should be addressed to C. A. Yadon, 1876 Campus Delivery, Department of Psychology, Colorado State University, Ft. Collins, CO 80521 (e-mail: cyadon@lamancolostate.edu).	ADLER LE, 1985, BIOL PSYCHIAT, V20, P1284, DOI 10.1016/0006-3223(85)90113-1; ADLER LE, 1992, BIOL PSYCHIAT, V32, P607, DOI 10.1016/0006-3223(92)90073-9; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Arnfred SM, 2001, PSYCHIAT RES, V101, P221, DOI 10.1016/S0165-1781(01)00226-8; Barch DM, 1999, SCHIZOPHRENIA BULL, V25, P749, DOI 10.1093/oxfordjournals.schbul.a033416; Barnhardt J, 2008, NEUROPSYCHOLOGIA, V46, P2071, DOI 10.1016/j.neuropsychologia.2008.02.007; BICKFORDWIMER PC, 1990, BIOL PSYCHIAT, V27, P183, DOI 10.1016/0006-3223(90)90648-L; Braver TS, 2007, VARIATION WORKING ME, V3, P106, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Brink JM, 1999, J GERONTOL B-PSYCHOL, V54, pP30, DOI 10.1093/geronb/54B.1.P30; Brumback CR, 2004, NEUROREPORT, V15, P373, DOI 10.1097/00001756-200402090-00032; Clementz BA, 1998, AM J PSYCHIAT, V155, P1691, DOI 10.1176/ajp.155.12.1691; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Croft RJ, 2001, BIOL PSYCHIAT, V50, P441, DOI 10.1016/S0006-3223(01)01082-4; CULLUM CM, 1993, SCHIZOPHR RES, V10, P131, DOI 10.1016/0920-9964(93)90048-N; Wilde OM, 2007, SCHIZOPHR RES, V97, P137, DOI 10.1016/j.schres.2007.04.028; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Donders FC, 1868, ATTENTION PERFORM, V2, P92; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Erwin RJ, 1998, SCHIZOPHR RES, V33, P157, DOI 10.1016/S0920-9964(98)00075-9; EVERETT J, 1989, J NERV MENT DIS, V177, P735, DOI 10.1097/00005053-198912000-00004; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Fuerst DR, 2007, PSYCHOPHYSIOLOGY, V44, P620, DOI 10.1111/j.1469-8986.2007.00524.x; Ghisolfi ES, 2006, J PSYCHIATR RES, V40, P535, DOI 10.1016/j.jpsychires.2006.02.006; Gooding DC, 2006, SCHIZOPHR RES, V88, P169, DOI 10.1016/j.schres.2006.07.009; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Grunwald T, 2003, BIOL PSYCHIAT, V53, P511, DOI 10.1016/S0006-3223(02)01673-6; GUTERMAN Y, 1994, INT J PSYCHOPHYSIOL, V18, P1, DOI 10.1016/0167-8760(84)90010-2; GUTERMAN Y, 1992, INT J PSYCHOPHYSIOL, V12, P197, DOI 10.1016/0167-8760(92)90011-Y; HEAL L, 1970, INT REV MENTAL RETAR, P107; Healey MK, 2008, PROG BRAIN RES, V169, P353, DOI 10.1016/S0079-6123(07)00022-2; JERGER K, 1992, BIOL PSYCHIAT, V31, P365, DOI 10.1016/0006-3223(92)90230-W; Jessen F, 2001, AM J PSYCHIAT, V158, P1319, DOI 10.1176/appi.ajp.158.8.1319; Kisley MA, 2004, PSYCHOPHYSIOLOGY, V41, P604, DOI 10.1111/j.1469-8986.2004.00191.x; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Korzyukov O, 2007, NEUROIMAGE, V35, P814, DOI 10.1016/j.neuroimage.2006.12.011; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Kurthen M, 2007, PSYCHIAT RES-NEUROIM, V155, P121, DOI 10.1016/j.pscychresns.2006.10.003; LADAVAS E, 1990, CORTEX, V26, P307, DOI 10.1016/S0010-9452(13)80083-4; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Luu P, 2005, DETERMINATION GEODES; MacLeod C.M., 2007, INHIBITION COGNITION, P145, DOI [10.1037/11587-008, DOI 10.1037/11587-008]; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P126, DOI 10.1037/0278-7393.14.1.126; MARLOWOCONNER MA, 2005, DISS ABSTR INT, V66, P3417; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; Nagamoto HT, 1996, BIOL PSYCHIAT, V40, P181, DOI 10.1016/0006-3223(95)00371-1; NAGAMOTO HT, 1991, SCHIZOPHR RES, V4, P31, DOI 10.1016/0920-9964(91)90007-E; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; NEILL WT, 1977, J EXP PSYCHOL HUMAN, V3, P444, DOI 10.1037/0096-1523.3.3.444; Olincy A, 2000, BIOL PSYCHIAT, V47, P969, DOI 10.1016/S0006-3223(00)00239-0; Patterson JV, 2008, PSYCHIAT RES, V158, P226, DOI 10.1016/j.psychres.2007.02.009; PERSONS JB, 1986, AM PSYCHOL, V41, P1252, DOI 10.1037/0003-066X.41.11.1252; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Potter D, 2006, SCHIZOPHRENIA BULL, V32, P692, DOI 10.1093/schbul/sbj050; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; SMITH DA, 1994, PSYCHOPHYSIOLOGY, V31, P495, DOI 10.1111/j.1469-8986.1994.tb01053.x; Steel C, 2001, NEUROREPORT, V12, P3619, DOI 10.1097/00001756-200111160-00049; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TALAYONGAN A, 2000, INT J DISABIL DEV ED, V47, P201, DOI DOI 10.1080/713671112; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Tregellas JR, 2007, SCHIZOPHR RES, V92, P262, DOI 10.1016/j.schres.2006.12.033; Uc EY, 2003, J NEUROL SCI, V212, P1, DOI 10.1016/S0022-510X(03)00082-0; VENABLES P H, 1964, Prog Exp Pers Res, V72, P1; WALDO MC, 1994, SCHIZOPHR RES, V12, P93, DOI 10.1016/0920-9964(94)90067-1; Weisbrod M, 2000, BIOL PSYCHIAT, V47, P51, DOI 10.1016/S0006-3223(99)00218-8; Weisser R, 2001, NEUROREPORT, V12, P3303, DOI 10.1097/00001756-200110290-00031; Wright CI, 2006, NEUROIMAGE, V30, P983, DOI 10.1016/j.neuroimage.2005.10.015	73	19	19	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1530-7026	1531-135X		COGN AFFECT BEHAV NE	Cogn. Affect. Behav. Neurosci.	DEC	2009	9	4					448	458		10.3758/CABN.9.4.448			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	525ZF	WOS:000272256100009	19897797	Green Accepted, Bronze			2022-02-06	
J	Katada, R; Nishitani, Y; Honmou, O; Okazaki, S; Houkin, K; Matsumoto, H				Katada, Ryuichi; Nishitani, Yoko; Honmou, Osamu; Okazaki, Shunichiro; Houkin, Kiyohiro; Matsumoto, Hiroshi			Prior Ethanol Injection Promotes Brain Edema after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						alcohol consumption; brain contusion; brain edema; oxidative stress; rats	TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVITY; OXIDATIVE STRESS; HEAD-INJURY; INFLAMMATORY CYTOKINES; CEREBRAL-ISCHEMIA; N-ACETYLCYSTEINE; FACTOR-ALPHA; RATS; PATHOPHYSIOLOGY	Alcohol consumption prior to traumatic brain injury (TBI) promotes morbidity and mortality although the mechanisms involved remain unclear. The morbidity and mortality caused by TBI, especially brain contusion, are known to be closely associated with brain edema. Here we examined the effects of ethanol pretreatment on brain edema, inflammatory responses, and oxidative stress after brain contusion. Male Wistar rats were given 3g/kg ethanol intraperitoneally and 1 h later were subjected to brain contusion. The ethanol-pretreated group had a significantly decreased survival rate. Magnetic resonance imaging showed ethanol pretreatment significantly augmented the volume of cytotoxic brain edema after contusion. In the ethanol-pretreated rat, the activities of NF-kappa B and AP-1 were reduced 6 h after contusion and COX-2 mRNA expression was increased 24 h after contusion. These findings suggest that ethanol augmented cerebral edema and mortality in rats with brain contusion, possibly through actions on cell survival pathways or COX-2 expression. In addition, antioxidant treatment at 3 h post-injury significantly attenuated some markers of oxidative stress, mortality, and volume of edema at 24 h after ethanol treatment and contusion.	[Matsumoto, Hiroshi] Sapporo Med Univ, Sch Med, Dept Legal Med & Mol Alcohol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Katada, Ryuichi; Honmou, Osamu; Houkin, Kiyohiro] Sapporo Med Univ, Sch Med, Dept Neurosurg, Sapporo, Hokkaido 0608556, Japan		Matsumoto, H (corresponding author), Sapporo Med Univ, Sch Med, Dept Legal Med & Mol Alcohol, Chuo Ku, S-1 W-17, Sapporo, Hokkaido 0608556, Japan.	hmatsumo@sapmed.ac.jp	Houkin, Kiyohiro/G-5364-2012	honmou, Osamu/0000-0001-8697-7530	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; Allansson L, 2001, J NEUROCHEM, V76, P472, DOI 10.1046/j.1471-4159.2001.00097.x; Aschner M, 2001, BRAIN RES, V900, P219, DOI 10.1016/S0006-8993(01)02314-9; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; El-Guindy NBD, 2007, ALCOHOL, V41, P335, DOI 10.1016/j.alcohol.2007.07.002; Emanuele N, 2005, ENDOCR RES, V31, P9, DOI 10.1080/07435800500228930; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fitzgerald DJ, 2007, ALCOHOL CLIN EXP RES, V31, P317, DOI 10.1111/j.1530-0277.2006.00307.x; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kelly G S, 1998, Altern Med Rev, V3, P114; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1994, ACTA NEUROCHIR, P421; Mascalchi M, 2005, RADIOL MED, V109, P155; Matsumoto H, 2000, ALCOHOL ALCOHOLISM, V35, P31, DOI 10.1093/alcalc/35.1.31; Matsumoto H, 2002, ALCOHOL CLIN EXP RES, V26, p6S, DOI 10.1097/01.ALC.0000026827.79925.C9; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Nishitani Y, 2006, FEBS LETT, V580, P9, DOI 10.1016/j.febslet.2005.11.030; Nordmann R, 1987, Alcohol Alcohol Suppl, V1, P75; Onda T, 2008, J CEREBR BLOOD F MET, V28, P329, DOI 10.1038/sj.jcbfm.9600527; RATAN RR, 1994, J NEUROSCI, V14, P4385; Ringel F, 2006, J NEUROTRAUM, V23, P1693, DOI 10.1089/neu.2006.23.1693; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; Shackford SR, 1997, J TRAUMA, V42, pS48, DOI 10.1097/00005373-199705001-00009; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055	44	19	24	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					2015	2025		10.1089/neu.2008.0552			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600016	19558208				2022-02-06	
J	Shields, BJ; Smith, GA				Shields, Brenda J.; Smith, Gary A.			Cheerleading-Related Injuries in the United States: A Prospective Surveillance Study	JOURNAL OF ATHLETIC TRAINING			English	Article						injury rates; injury epidemiology; trauma; accidents; athletes	WOMENS GYMNASTICS INJURIES; HIGH-SCHOOL; SPORTS INJURIES; YOUNG ATHLETE; EPIDEMIOLOGY; PREVENTION; ISSUES; RISKS; HEAD	Context: Cheerleading injuries are on the rise and are a significant source of injury to females. No published studies have described the epidemiology of cheerleading injuries by type of cheerleading team and event. Objective: To describe the epidemiology of cheerleading injuries and to calculate injury rates by type of cheerleading team and event. Design: Prospective injury surveillance study. Setting: Participant exposure and injury data were collected from US cheerleading teams via the Cheerleading RIO (Reporting Information Online) online surveillance tool. Patients or Other Participants: Athletes from enrolled cheerleading teams who participated in official, organized cheerleading practices, pep rallies, athletic events, or cheerleading competitions. Main Outcome Measure(s): The numbers and rates of cheerleading injuries during a 1-year period (2006-2007) are reported by team type and event type. Results: A cohort of 9022 cheerleaders on 412 US cheerleading teams participated in the study. During the 1-year period, 567 cheerleading injuries were reported; 83% (467/565) occurred during practice, 52% (296/565) occurred while the cheerleader was attempting a stunt, and 24% (132/563) occurred while the cheerleader was basing or spotting 1 or more cheerleaders. Lower extremity injuries (30%, 168/565) and strains and sprains (53%, 302/565) were most common. Collegiate cheerleaders were more likely to sustain a concussion (P = .01, rate ratio [RR] = 2.98, 95% confidence interval [CI] = 1.34, 6.59), and All Star cheerleaders were more likely to sustain a fracture or dislocation (P = .01, RR = 1.76, 95% CI = 1.16, 2.66) than were cheerleaders on other types of teams. Overall injury rates for practices, pep rallies, athletic events, and cheerleading competitions were 1.0, 0.6, 0.6, and 1.4 injuries per 1000 athlete-exposures, respectively. Conclusions: We are the first to report cheerleading injury rates based on actual exposure data by type of team and event. These injury rates are lower than those reported for other high school and collegiate sports; however, many cheerleading injuries are preventable.	[Shields, Brenda J.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Shields, BJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	brenda.shields@nationwidechildrens.org			Research Institute at Nationwide Children's HospitalOhio State University	Funding for this study was provided by The Research Institute at Nationwide Children's Hospital. We thank Jason Morrison for designing the Cheerleading RIO Web site, programming the exposure and injury report questionnaires, and maintaining the Web site and database throughout the study year. Terri Blecker used her outstanding artistic talent to design the certificates presented to study participants. Debbie Bracewell, Lisa Thompson, and Steve Wedge helped to categorize the cheerleading maneuvers. Gwen Holtsclaw provided the cheerleading photographs used on the Web site and on the certificates and was invaluable in offering advice, answering questions, and helping with issues that arose during the study year. We thank the cheerleading industry for assistance in identifying and contacting potential study participants and for donating incentives for the participants who completed the full study year.	Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; *AM ASS CHEERL COA, 2007 08 HIGH SCH SAF; *AM ASS CHEERL COA, 2007 2008 AACCA COLL; *AM SPORTS DAT INC, 2004, SUP SPORTS PART, V2, P14; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; GARRICK JG, 1980, AM J SPORT MED, V8, P261, DOI 10.1177/036354658000800409; Giannone L., 2006, AM ASS CHEERLEADING, P1; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hutchinson MR, 1997, PHYSICIAN SPORTSMED, V25, P83, DOI 10.3810/psm.1997.09.1508; Jacobson BH, 2004, J ORTHOP SPORT PHYS, V34, P261, DOI 10.2519/jospt.2004.34.5.261; KINGSBURY K, CHEERLEADINGS RISKY; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Knowles SB, 2006, AM J EPIDEMIOL, V164, P1209, DOI 10.1093/aje/kwj337; Lawrence JP, 2006, J AM ACAD ORTHOP SUR, V14, P726, DOI 10.5435/00124635-200612000-00004; Luckstead EF, 2002, PEDIATR CLIN N AM, V49, P753, DOI 10.1016/S0031-3955(02)00017-2; Luckstead EF, 2002, PEDIATR CLIN N AM, V49, P581, DOI 10.1016/S0031-3955(02)00006-8; Marshall SW, 2007, J ATHL TRAINING, V42, P234; Mueller FO, 1982, 25 NAT CTR CAT SPORT; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Thacker SB, 2004, MED SCI SPORT EXER, V36, P371, DOI 10.1249/01.MSS.0000117134.83018.F7; US Consumer Product Safety Commission, PUBL PLAYGR SAF HDB; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507	30	19	19	8	29	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2009	44	6					567	577		10.4085/1062-6050-44.6.567			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	522OU	WOS:000272008400002	19911082	Green Published, Bronze			2022-02-06	
J	Shields, BJ; Smith, GA				Shields, Brenda J.; Smith, Gary A.			The Potential for Brain Injury on Selected Surfaces Used by Cheerleaders	JOURNAL OF ATHLETIC TRAINING			English	Article						surface impact attenuation; Triax; critical height; Head Injury Criterion	COLLEGIATE FOOTBALL PLAYERS; RISK-FACTORS; PROFESSIONAL FOOTBALL; PLAYGROUND EQUIPMENT; OUTSTRETCHED HAND; ARM FRACTURE; CONCUSSION; FALLS; HEAD; IMPACTS	Context: Although playground surfaces have been investigated for fall impact attenuation, the surfaces that cheerleaders use have received little attention. Objective: To determine (1) the critical height for selected surfaces used by cheerleaders at or below which a serious head impact injury from a fall is unlikely to occur, (2) the critical heights for non-impact-absorbing surfaces for comparison purposes, and (3) the effect of soil moisture and grass height on g(max) (which is defined as the multiple of g [acceleration due to gravity at the earth's surface at sea level: ie, 32.2 feet.s(-1).s(-1)] that represents the maximum deceleration experienced during an impact) and the Head Injury Criterion (HIC) at the critical height for a dry grass surface. Design: Observational study. Settings: A local cheerleading gym, indoor locations within the authors' institution, and various outdoor locations. Main Outcome Measure(s): g(max), HIC, and critical height. Results: Critical heights for the surfaces tested ranged from 0.5 ft (0.15 m) for concrete and vinyl tile installed over concrete to more than 11 ft (3.35 m) for a spring floor. Increases in grass height and soil moisture resulted in an increase in the critical height for grass surfaces. Only spring floors and 4-in (0.10-m)-thick landing mats placed on traditional foam floors had critical heights greater than 10.5 ft (3.20 m), thus providing enough impact-absorbing capacity for performance of 2-level stunts. Conclusions: The potential for serious head impact injuries can be minimized by increasing the shock-absorbing capacity of the surface, decreasing the height from which the person falls, or both. Cheerleaders and cheerleading coaches should use the critical heights reported in this study to compare the relative impact-absorbing capacities of the various surfaces tested, with critical height as an indicator of the impact-absorption capacity of the surface. The findings of this study can be used to select the most appropriate surface for the type of maneuver to be performed, based on the maximum height expected to be achieved by the cheerleader(s) during execution of the maneuver. Cheerleaders should not perform maneuvers at heights that exceed the critical height for the surface on which they are performing.	[Shields, Brenda J.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Shields, BJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	brenda.shields@nationwidechildrens.org			Research Institute at Nationwide Children's HospitalOhio State University	Funding for this Study was provided by the Research Institute at Nationwide Children's Hospital. Randall Davis, Mandy Lucas, Jean Powers, Liz Rossetti, and Ashley Swert assisted in performing the Triax drop tests. Marcie Rehmar located testing sites and obtained permission to perform testing at the sites. Terri Bleeker took the photographs of the Triax 2000 and created Figure 1.	*AM ASS CHEERL COA, 2007 08 HIGH SCH SAF; *AM ASS CHEERL COA, 2007 2008 AACCA COLL; *ASTM, 1999, F129299 ASTM; ASTM, 2004, F129204 ASTM; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; *CBS BROADC INC, 2006, CHEERL INJ FALL COUR; Chalmers D J, 1996, Inj Prev, V2, P98, DOI 10.1136/ip.2.2.98; Chiu J, 1998, J BIOMECH, V31, P1169, DOI 10.1016/S0021-9290(98)00137-7; CHRISTIANSEN ML, 1995, POINTS PLAYGROUNDS, P157; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gunatilaka AH, 2004, INJURY PREV, V10, P174, DOI 10.1136/ip.2003.004010; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hutchinson MR, 1997, PHYSICIAN SPORTSMED, V25, P83, DOI 10.3810/psm.1997.09.1508; King AI, 2003, INT RES COUNC BIOM I; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; LEWIS LM, 1993, J TRAUMA, V35, P932, DOI 10.1097/00005373-199312000-00020; Macarthur C, 2000, ACCIDENT ANAL PREV, V32, P377, DOI 10.1016/S0001-4575(99)00079-2; Mchenry B.G., 2004, HEAD INJURY CRITERIO; Mott A, 1997, LANCET, V349, P1874, DOI 10.1016/S0140-6736(96)10343-3; Mowat D L, 1998, Inj Prev, V4, P39; MUELLER FO, 25 NAT CTR CAT SPORT; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Robinovitch SN, 1998, J ORTHOPAED RES, V16, P309, DOI 10.1002/jor.1100160306; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Sherker S, 2005, INJURY PREV, V11, P120, DOI 10.1136/ip.2004.007310; Sherker S, 2004, MED J AUSTRALIA, V180, P562, DOI 10.5694/j.1326-5377.2004.tb06092.x; Sherker S, 2003, INJURY PREV, V9, P279, DOI 10.1136/ip.9.3.279; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Vidair Charles, 2007, Int J Inj Contr Saf Promot, V14, P225, DOI 10.1080/17457300701584290; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	38	19	19	2	19	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2009	44	6					595	602		10.4085/1062-6050-44.6.595			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	522OU	WOS:000272008400005	19911085	Green Published, Bronze			2022-02-06	
J	Li, CY; Ahn, CH; Shutter, LA; Narayan, RK				Li, Chunyan; Ahn, Chong H.; Shutter, Lori A.; Narayan, Raj K.			Toward real-time continuous brain glucose and oxygen monitoring with a smart catheter	BIOSENSORS & BIOELECTRONICS			English	Article						Glucose sensor; Oxygen sensor; Traumatic brain injury; Lab-on-a-tube; Continuous monitoring	IN-VIVO; INJURY; BIOSENSORS; MICRODIALYSIS; CARE; FILM; NANOPARTICLES; PRESSURE; CHITOSAN	Oxygen and glucose biosensors have been designed, fabricated, characterized and optimized for real-time continuous monitoring on a new smart catheter for use in patients with traumatic brain injury (TBI). Oxygen sensors with three-electrode configuration were designed to achieve zero net oxygen consumption. Glucose sensors were based on the use of platinum nanoparticle-enhanced electrodes that were modified with polycation and glucose oxidase immobilized by chitosan matrix. An iridium oxide electrode was developed to work as a biocompatible reference electrode with enhanced durability and stability in the biological solutions. A study of the effect of temperature on oxygen sensor performance, and both temperature and oxygen effects on glucose sensor performance were accomplished to enhance their operative stability and provide useful information for in vivo applications. A new methodology for automatic correction of the temperature and oxygen dependence of biosensor outputs is demonstrated through programmed LabView (TM) software. In vitro experiments in both physiological and pathophysiological ranges (oxygen: 0-60 mmHg; glucose: 0.1-10 mM; temperature: 25-40 degrees C) with clinical samples of cerebrospinal fluid obtained from TBI patients have demonstrated stable measurements with enhanced accuracy, indicating the feasibility of the sensors for a real-time continuous in vivo monitoring. Published by Elsevier B.V.	[Li, Chunyan; Shutter, Lori A.; Narayan, Raj K.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45267 USA; [Li, Chunyan; Ahn, Chong H.] Univ Cincinnati, Dept Elect & Comp Engn, Cincinnati, OH 45221 USA		Li, CY (corresponding author), Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45267 USA.	lic2@ucmail.uc.edu	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628	Integra Lifesciences Foundation	The work was supported by the Integra Lifesciences Foundation. The authors wish to thank Mr. Ron Flenniken of the Nano/Micro Fabrication Engineering Research Center at the University of Cincinnati for his technical support with the e-beam deposition of Iridium, and also Mr. Michael Rust at the Microsystems and BioMEMS lab for his valuable discussions.	Anzai Y, 2004, AM J NEURORADIOL, V25, P274; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bott A. W., 1995, CURR SEP, V14, P64; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; EVANS ML, 2003, ELLENBERG RIFKINS DI, P117; FISHMAN RA, 2003, LUMBAR PUNCTURE, P953; Ges IA, 2005, BIOSENS BIOELECTRON, V21, P248, DOI 10.1016/j.bios.2004.09.021; JANKOWSKA L, 1979, AM J PHYSIOL, V236, pF220, DOI 10.1152/ajprenal.1979.236.3.F220; Kang XH, 2008, TALANTA, V74, P879, DOI 10.1016/j.talanta.2007.07.019; KARAGOUNIS V, 1986, IEEE T BIO-MED ENG, V33, P108, DOI 10.1109/TBME.1986.325884; Kim DH, 2006, NEUROCRIT CARE, V4, P83, DOI 10.1385/NCC:4:1:083; Koschwanez HE, 2007, BIOMATERIALS, V28, P3687, DOI 10.1016/j.biomaterials.2007.03.034; Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013; Lau C, 2007, BIOSENS BIOELECTRON, V22, P3014, DOI 10.1016/j.bios.2006.12.033; Laurinavicius V, 1999, ANAL LETT, V32, P299, DOI 10.1080/00032719908542822; Li CY, 2008, BIOMED MICRODEVICES, V10, P671, DOI 10.1007/s10544-008-9178-3; Li CY, 2009, LAB CHIP, V9, P1988, DOI 10.1039/b900651f; Li J, 2007, BIOSENS BIOELECTRON, V22, P2898, DOI 10.1016/j.bios.2006.12.004; Luo XL, 2006, ELECTROANAL, V18, P319, DOI 10.1002/elan.200503415; MEIXENSBERGER J, 1997, SEVERE HEAD INJURIES, P99; Miyashita M, 2009, BIOSENS BIOELECTRON, V24, P1336, DOI 10.1016/j.bios.2008.07.072; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Smith M, 2005, ANAESTHESIA, PAIN, INTENSIVE CARE AND EMERGENCY MEDICINE - APICE 19, P139, DOI 10.1007/88-470-0351-2_13; Stevens Wendy J, 2004, J Neurosci Nurs, V36, P332; SUELTER CH, 1990, EXPT ENZYMOLOGIE GRU; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wang J, 2008, TALANTA, V75, P636, DOI 10.1016/j.talanta.2007.10.023; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wright WL, 2007, J NEUROL SCI, V261, P10, DOI 10.1016/j.jns.2007.04.027; Yang MH, 2004, SENSOR ACTUAT B-CHEM, V101, P269, DOI 10.1016/j.snb.2004.01.003; Yang YX, 2004, PROG COMPUT FLUID DY, V4, P46, DOI 10.1504/PCFD.2004.003785; YEAGER E, 1984, ELECTROCHIM ACTA, V29, P1527, DOI 10.1016/0013-4686(84)85006-9; Zaharchuk G, 2005, MAGNET RESON MED, V54, P113, DOI 10.1002/mrm.20546	39	19	19	0	26	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663			BIOSENS BIOELECTRON	Biosens. Bioelectron.	SEP 15	2009	25	1					173	178		10.1016/j.bios.2009.06.032			6	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	503MM	WOS:000270538400028	19625179				2022-02-06	
J	Ball, CG; Rozycki, GS; Feliciano, DV				Ball, Chad G.; Rozycki, Grace S.; Feliciano, David V.			Upper Extremity Amputations After Motor Vehicle Rollovers	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Motor vehicle collision; Amputation; Rollover	MANAGEMENT; TRAUMA	Background: The upper extremity is vulnerable to injury during a rollover motor vehicle crash (MVC). There is some concern that positioning one's arm oil a vehicle door/window eliminates the benefit of maintaining containment within a protective structure. Mangled extremities with associated vascular injuries have an amputation rate exceeding 40%. The primary goal was to describe the care process and outcome of patients requiring an emergent upper extremity amputation after a rollover MVC. Methods: All patients requiring an upper extremity amputation after a rollover MVC (2000-2008) were included. Patient demographics, injuries, and outcomes were analyzed. Results: Seventeen patients required an upper extremity amputation after a rollover MVC (mean injury severity score = 23; hemodynamic instability at presentation 29%). Injuries occurred on the side ipsilateral to the occupant vehicle position in 88% of cases. Most (76%) amputations occurred between May I and August I of their respective years, with 11 (65%) in the past 24 months. All amputations except one (replantation attempt) were completed within 24 hours. Concurrent operative procedures were performed in six (35%) patients, including three diagnostic peritoneal lavages, two laparotomies (splenectomies), one craniotomy, and one thoracotomy (atrial rupture). Mortality (12%) was a direct result of traumatic brain injuries. Temporary intravascular shunts were used before amputation in four (24%) patients. The majority (65%) of amputations were above the elbow joint. Conclusions: Blunt mangled upper extremities requiring completion amputations are most often caused by MVC rollovers. The risk of this injury is strongly associated with summer days and seems to be increasing in frequency.	[Ball, Chad G.; Rozycki, Grace S.; Feliciano, David V.] Emory Univ, Dept Surg, Grady Mem Hosp, Atlanta, GA 30322 USA		Ball, CG (corresponding author), Dept Surg, Grady Mem Hosp Campus,Glenn Mem Bldg,Room 302,69, Atlanta, GA 30303 USA.	ball.chad@gmail.com					Chang James, 2004, Tech Hand Up Extrem Surg, V8, P161, DOI 10.1097/01.bth.0000134711.75677.3b; Chapman M W, 1982, Instr Course Lect, V31, P75; Dente CJ, 2004, AM SURGEON, V70, P1088; Durham RM, 1996, AM J SURG, V172, P569, DOI 10.1016/S0002-9610(96)00245-0; GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009; Hunt JP, 2008, TRAUMA, V17, P105; JOHANSEN K, 1990, J TRAUMA, V30, P568, DOI 10.1097/00005373-199005000-00007; PETERSON SL, 2008, TRAUMA, P871; Rozycki GS, 2003, J TRAUMA, V55, P814, DOI 10.1097/01.TA.0000087807.44105.AE; Sane AD, 2007, CHIR MAIN, V26, P221, DOI 10.1016/j.main.2007.08.001; VANWIJNGAARDEN M, 1993, SURG GYNECOL OBSTET, V1777, P41	11	19	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2009	67	2					410	412		10.1097/TA.0b013e3181adf4eb			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	482OL	WOS:000268898500040	19667899				2022-02-06	
J	Duncan, CC; Mirsky, AF; Lovelace, CT; Theodore, WH				Duncan, Connie C.; Mirsky, Allan F.; Lovelace, Christopher T.; Theodore, William H.			Assessment of the attention impairment in absence epilepsy: Comparison of visual and auditory P300	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article; Proceedings Paper	14th World Congress of Psychophysiology the Olympics of the Brain	SEP 08-13, 2008	St Petersburg, RUSSIA	Int Org Psychophysiol		Event-related potentials; P300; Absence epilepsy; Complex partial epilepsy; Attention; CPT	EVENT-RELATED POTENTIALS; JUVENILE MYOCLONIC EPILEPSY; CENTRENCEPHALIC EPILEPSY; TEMPORAL-LOBE; PERFORMANCE; INFORMATION; DEFICITS	We report an investigation of P300 measures of information processing in patients with generalized epilepsy of the absence type and those with complex partial epilepsy. Studies have demonstrated that absence patients perform more poorly than complex partial patients on behavioral tests of sustained attention (the Continuous Performance Test, or CPT). Duncan (Duncan, C.C., 1988. Application of event-related brain potentials to the analysis of interictal attention in absence epilepsy. In: Myslobodsky, M.S., Mirsky A.F. (Eds.), Elements of Petit Mal Epilepsy. Peter Lang, New York, pp. 341-364] reported that P300 was significantly reduced in a group of absence patients as compared with healthy controls. The present investigation was undertaken to compare the attention deficit in absence patients to that in complex partial seizure patients. Thus, ERPs were recorded while participants with absence seizure disorder, complex partial seizure disorder, and healthy controls performed auditory and visual versions of the CPT. A significant reduction in the amplitude of P300 on the visual CPT was observed in both groups of seizure patients as compared to controls. In contrast, P300 on the auditory CPT was reduced only in the group with absence seizures. These ERP data support and amplify previous behavioral findings of the impaired capacity of absence patients to mobilize and sustain attentional resources. Auditory sustained attention seems to be more affected by the pathophysiology of absence epilepsy than visual attention. Two possible factors may be involved: (a) There are separate visual and auditory attention systems in the brain, and the latter is more vulnerable than the former [Duncan, C.C., Kosmidis, M.H., Mirsky, A.F., 2005. Closed head injury-related information processing deficits: An event-related potential analysis. Int. J. Psychophysiol. 58, 133-157]; and (b) Auditory processing depends on intact mechanisms in the brainstem, which are dysfunctional in patients with absence seizures. (C) 2009 Elsevier B.V. All rights reserved.	[Duncan, Connie C.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Clin Psychophysiol & Psychopharmacol Lab, Bethesda, MD 20814 USA; [Mirsky, Allan F.] NIMH, NIH, Bethesda, MD 20892 USA; [Lovelace, Christopher T.] Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA; [Theodore, William H.] NINDS, Clin Epilepsy Sect, NIH, Bethesda, MD 20892 USA		Duncan, CC (corresponding author), USU, Dept Psychiat, CPPL, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	cduncan@usuhs.mil		Lovelace, Christopher/0000-0003-1741-0017	Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z01 NS002858-16] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002236, ZIANS002858] Funding Source: NIH RePORTER		BOCQUILLON P, 2008, HUM BRAIN MAPP  1125; Chayasirisobhon WV, 2007, CLIN EEG NEUROSCI, V38, P168, DOI 10.1177/155005940703800314; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Duncan CC, 1988, ELEMENTS PETIT MAL E, P341; DUNCAN CC, 2003, ANN M SOC PSYCH RES; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; FEDIO P, 1969, NEUROPSYCHOLOGIA, V7, P287, DOI 10.1016/0028-3932(69)90054-2; FUKAI M, 1990, ACTA NEUROL SCAND, V82, P197, DOI 10.1111/j.1600-0404.1990.tb04488.x; GLOOR P, 1988, ELEMENTS PETIT MAL E, P159; Kim SY, 2007, J CLIN NEUROL, V3, P86, DOI 10.3988/jcn.2007.3.2.86; LANSDELL H, 1964, EXP NEUROL, V9, P463, DOI 10.1016/0014-4886(64)90054-8; Levav M, 2002, J CLIN EXP NEUROPSYC, V24, P311, DOI 10.1076/jcen.24.3.311.985; Lindsley DB, 1960, HDB PHYSIOLOGY, P1553; MIRSKY AF, 1965, ELECTROEN CLIN NEURO, V18, P334, DOI 10.1016/0013-4694(65)90053-2; MIRSKY AF, 1986, J CLIN NEUROPHYSIOL, V3, P179; MIRSKY AF, 1960, EXP NEUROL, V2, P75, DOI 10.1016/0014-4886(60)90049-2; MIRSKY AF, 1988, ELEMENTS PETIT MAL E, P311; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; ORREN MM, 1974, THESIS BOSTON U BOST; ORREN MM, 1978, CONT CLIN NEUROPHY S, V34, P251; Penfield W, 1954, EPILEPSY FUNCTIONAL; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Schwab, 1939, J NERV MENT DIS, V89, P690; Sonmez F, 2004, EPILEPSY BEHAV, V5, P329, DOI 10.1016/j.yebeh.2004.01.007; Spitzer R.L., 1978, SCHEDULE AFFECTIVE D; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Zgorzalewicz M, 2000, Neurol Neurochir Pol, V34 Suppl 1, P109; Zgorzalewicz Malgorzata, 2006, Przegl Lek, V63 Suppl 1, P8	30	19	20	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	AUG	2009	73	2			SI		118	122		10.1016/j.ijpsycho.2009.03.005			5	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Neurosciences & Neurology; Physiology	478YW	WOS:000268625700010	19414047	Green Accepted			2022-02-06	
J	Majernicek, M; Dungl, P; Kolman, J; Malkus, T; Vaculik, J				Majernicek, M.; Dungl, P.; Kolman, J.; Malkus, T.; Vaculik, J.			Osteosynthesis of Intracapsular Femoral Neck Fractures by Dynamic Hip Screw (DHS) Fixation	ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA			Czech	Article						DHS; intra-capsular fracture of the femoral head	AVASCULAR NECROSIS; SUBCAPITAL FRACTURES; INTERNAL-FIXATION; RADIOGRAPHS; HEAD	PURPOSE OF THE STUDY The treatment of femoral neck fractures shows a relatively high number of poor outcomes, usually due to late complications, such as avascular necrosis of the femoral head or pseudoarthrosis. The latter may develop when the osteosynthesis of osteoporotic bone fails. The aim of this retrospective study was to evaluate a group of patients treated by osteosynthesis for intra-capsular femoral neck fractures at our department, and to verify indication criteria and identify the therapeutic procedures that are best suited to our conditions. MATERIAL In the 1997-2001 period, a total of 81 patients with intra-capsular femoral neck fractures were operated on. Of these, 64 treated by dynamic hip screw (DHS) fixation were followed up for at least 5 years. There were 33 women and 31 men; the average age was 21.5 years (range, 21 to 74 years). METHODS The Garden classification was used to evaluate the displacement of femoral neck fractures. Preferably, osteosynthesis was carried out by closed reduction; only exceptionally was an extension device for the operating table used. A 135-degree sliding hip screw, with a short thread, directed to the head centre and a two-hole side plate were used most often. The average follow-up was 6.9 years. Evaluated were: the occurrence of late complications in relation to the length of time between injury and surgery, quality of fracture reduction, use of an anti-rotation screw and necessity of repeat surgery. RESULTS Garden I or II fractures were diagnosed in 13 patients, 51 had Garden III or Garden IV fractures. Bone union without complications was achieved in 73.4% of the patients within 12 months of surgery. Late complications were found in 26.6%; of these, only one had Garden I fracture and the rest were Garden III and IV fractures. An anti-rotation screw was used in 39 patients (60.9%) and its use had no effect on the development of late complications. Of the seven patients who developed pseudoarthrosis, the screw was used in four (57.1%); out of the nine patients with avascular necrosis, it was used in six (66.7%). In the whole group, an unsatisfactory outcome of post-operative reduction was recorded in 29.7%. in the patients with late complications this was found in 52.9%, which was a statistically significant difference. Of the 17 patients with poor outcomes, 14 underwent total hip arthroplasty; in the patients with necrosis, arthroplasty was carried out at an average of 26 months post-operatively, in those with pseudoarthrosis it was at 7 months post-operatively. DISCUSSION For the treatment of intra-capsular fractures of the femoral neck, surgery is the most frequent approach, but there are controversial views on various relevant issues. An important factor affecting the treatment outcome is the patient's bone quality. CONCLUSIONS Our results show a direct relationship between the extent of fracture displacement and late complications, i.e., avascular necrosis and non-union. The quality of fracture reduction had a greater effect on fracture non-union than on the development of femoral head necrosis. The length of time between injury and surgery played a lesser role than it is believed. The use of an anti-rotation screw was not significantly related to the occurrence of late complications. The DHS method is economical and available, and provided sufficient results whose comparisons with the literature data show that this therapeutic approach is correct.	[Majernicek, M.; Dungl, P.; Kolman, J.; Malkus, T.; Vaculik, J.] FN Bulovce, IPVZ & LF UK 1, Ortoped Klin, Prague 18081, Czech Republic		Majernicek, M (corresponding author), FN Bulovce, IPVZ & LF UK 1, Ortoped Klin, Budinova 2, Prague 18081, Czech Republic.	m.majernicek@toscali.cz	Vacullik, Jan/J-3999-2017; Dungl, Pavel/J-4115-2017	Vacullik, Jan/0000-0003-4850-9490; Dungl, Pavel/0000-0001-6018-7362; Majernicek, Marek/0000-0003-4783-1488			ALBERTS KA, 1999, CLIN ORTHOP RELAT R, V257, P129; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; BECK M, 2004, CLIN ORTHOP RELAT R, V424, P149; Bonnaire FA, 2002, INJURY, V33, pS33; Bonnaire FA, 2002, INJURY, V33, pS24; Cho MR, 2007, J ORTHOP TRAUMA, V21, P158, DOI 10.1097/BOT.0b013e31803773ae; GARDEN RS, 1961, J BONE JOINT SURG BR, V43, P647, DOI 10.1302/0301-620X.43B4.647; GARDEN RS, 1964, J BONE JOINT SURG BR, V46, P630, DOI 10.1302/0301-620X.46B4.630; Heetveld MJ, 2005, ARCH ORTHOP TRAUM SU, V125, P160, DOI 10.1007/s00402-004-0780-4; Itadera Eichi, 2003, J Orthop Sci, V8, P155, DOI 10.1007/s007760300026; Jakob M, 1999, Swiss Surg, V5, P257, DOI 10.1024/1023-9332.5.6.257; Kunesova M, 2006, Acta Chir Orthop Traumatol Cech, V73, P380; Lee KBL, 2004, ANN ACAD MED SINGAP, V33, P248; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; Nikolopoulos KE, 2003, INJURY, V34, P525, DOI 10.1016/S0020-1383(02)00367-4; Parker MJ, 2007, CLIN ORTHOP RELAT R, P175, DOI 10.1097/BLO.0b013e3180325a42; Parker MJ, 2002, J BONE JOINT SURG BR, V84B, P1150, DOI 10.1302/0301-620X.84B8.13522; Perren SM, 2008, ACTA CHIR ORTHOP TR, V75, P241; RAAYMAKERS ELFB, 1991, J BONE JOINT SURG BR, V73, P950, DOI 10.1302/0301-620X.73B6.1955443; Raaymakers ELFB, 2002, INJURY, V33, pS8; Raaymakers Ernst L F B, 2006, Acta Chir Orthop Traumatol Cech, V73, P45; SINGH M, 1970, J BONE JOINT SURG AM, VA 52, P457, DOI 10.2106/00004623-197052030-00005; Skala-Rosenbaum J, 2005, Rozhl Chir, V84, P291; Toh EM, 2004, INJURY, V35, P125, DOI 10.1016/S0020-1383(02)00422-9; Totterman A, 2007, ARCH ORTHOP TRAUM SU, V127, P185, DOI 10.1007/s00402-006-0276-5; Visna P, 2007, ACTA CHIR ORTHOP TR, V74, P37; Watanabe Y, 2007, J ORTHOP TRAUMA, V21, P456, DOI 10.1097/BOT.0b013e318126bb56; Yih-Shiunn L, 2007, INT ORTHOP, V31, P677, DOI 10.1007/s00264-006-0243-3; Zofka P, 2007, ACTA CHIR ORTHOP TR, V74, P99	29	19	28	0	1	GALEN SRO	PRAGUE 5	NA BELIDLE 34, PRAGUE 5, 150 00, CZECH REPUBLIC	0001-5415			ACTA CHIR ORTHOP TR	Acta Chir. Orthop. Traumatol. Cechoslov.	AUG	2009	76	4					319	325					7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	492VV	WOS:000269691300009	19755057				2022-02-06	
J	Uomoto, JM; Williams, RM				Uomoto, Jay M.; Williams, Rhonda M.			Post-Acute Polytrauma Rehabilitation and Integrated Care of Returning Veterans: Toward a Holistic Approach	REHABILITATION PSYCHOLOGY			English	Article						Operation Enduring Freedom; Operation Iraqi Freedom; war; rehabilitation; brain injuries; stress disorders	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; OPERATION IRAQI FREEDOM; MENTAL-HEALTH PROBLEMS; MEDICALLY UNEXPLAINED SYMPTOMS; PEER SUPPORT; GULF-WAR; COGNITIVE REHABILITATION; PSYCHOLOGICAL SYMPTOMS; MARITAL SATISFACTION	Throughout the history of war, exposure to combat has been associated with clusters of physical and psychological symptoms labeled in various ways, from "hysteria" to "shell shock" in World War I to "polytrauma" in Operations Enduring Freedom (OEF) and Iraqi Freedom (OIF). Objective: To describe the historical conceptualizations of combat injury and the ways they are relevant to developing current rehabilitation strategies, discuss the symptom complex presented by OEF/OIF veterans, and describe key elements and principles of holistic, integrated care for post-acute OEF/OIF veterans. Conclusions: A conceptualization of rehabilitation recognizing a final common pathway of functional disability and suffering is proposed, and both systematic and treatment-specific aspects at the core of a veteran-centered holistic approach are discussed.	[Uomoto, Jay M.] VA Puget Sound Hlth Care Syst, VISN VHA Polytrauma Network Site 20, Ctr Polytrauma Care, Rehabil Care Serv, Seattle, WA USA; [Williams, Rhonda M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA		Uomoto, JM (corresponding author), VA Puget Sound Hlth Care Syst, VISN VHA Polytrauma Network Site 20, Ctr Polytrauma Care, Rehabil Care Serv, Seattle, WA USA.	jay.uomoto@va.gov	Uomoto, Jay/AAF-4809-2019				Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Anger WK, 1999, J INT NEUROPSYCH SOC, V5, P203, DOI 10.1017/S1355617799533031; Ashbury FD, 1998, PATIENT EDUC COUNS, V35, P89, DOI 10.1016/S0738-3991(98)00035-4; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brailey K, 2007, J TRAUMA STRESS, V20, P495, DOI 10.1002/jts.20234; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cassell EJ, 1999, ANN INTERN MED, V131, P531, DOI 10.7326/0003-4819-131-7-199910050-00009; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 2005, ARCH PHYS MED REHAB, V86, P1861; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Davison KP, 2000, AM PSYCHOL, V55, P205, DOI 10.1037/0003-066X.55.2.205; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; *DEP VET AFF, 2009, VET HLTH ADM DIR 200; Department of Veterans Affair, 2004, VA DOD CLIN PRACT GU; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2701; DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2708; Dunn J, 1999, J COMMUNITY APPL SOC, V9, P13, DOI 10.1002/(SICI)1099-1298(199901/02)9:1<13::AID-CASP488>3.0.CO;2-F; Dunn J, 2003, J PSYCHOSOC ONCOL, V21, P55, DOI 10.1300/J077v21n02_04; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Ehde DM, 2006, TRAUMA REHABILITATION, P245; Ford JD, 2001, PSYCHOSOM MED, V63, P842, DOI 10.1097/00006842-200109000-00019; FORDYCE WE, 1988, AM PSYCHOL, V43, P276, DOI 10.1037/0003-066X.43.4.276; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gibbs DA, 2007, JAMA-J AM MED ASSOC, V298, P528, DOI 10.1001/jama.298.5.528; Gosling J, 1999, BRAIN INJURY, V13, P785; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; Howorth PW, 2000, PSYCHIAT B, V24, P225, DOI DOI 10.1192/PB.24.6.225; Jones E, 2003, J TRAUMA STRESS, V16, P411, DOI 10.1023/A:1024426321072; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kipen HM, 2002, ENVIRON HEALTH PERSP, V110, P591, DOI 10.1289/ehp.02110s4591; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Levy BS, 2009, ANNU REV PUBL HEALTH, V30, P123, DOI 10.1146/annurev.publhealth.031308.100147; LOESER JD, 1980, PERSPECTIVES PAIN CL, P313; Loughran T, 2008, HIST PSYCHIATR, V19, P25, DOI 10.1177/0957154X07077749; Manguno-Mire G, 2007, J NERV MENT DIS, V195, P144, DOI 10.1097/01.nmd.0000254755.53549.69; Marshall AD, 2005, CLIN PSYCHOL REV, V25, P862, DOI 10.1016/j.cpr.2005.05.009; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Myers CS, 1915, LANCET, V1, P316; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ozakinci G, 2006, ENVIRON HEALTH PERSP, V114, P1553, DOI 10.1289/ehp.9251; Pasquina PF, 2008, J REHABIL RES DEV, V45, P953, DOI 10.1682/JRRD.2007.10.0163; Pols H, 2006, ENDEAVOUR, V30, P144, DOI 10.1016/j.endeavour.2006.10.002; Prigatano GP, 1985, NEUROPSYCHOLOGICAL R; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Renshaw KD, 2008, J FAM PSYCHOL, V22, P586, DOI 10.1037/0893-3200.22.3.586; Renshaw KD, 2009, ANXIETY STRESS COPIN, V22, P101, DOI 10.1080/10615800802354000; Rentz ED, 2006, TRAUMA VIOLENCE ABUS, V7, P93, DOI 10.1177/1524838005285916; ROMANO JM, 1985, PSYCHOL BULL, V97, P18, DOI 10.1037/0033-2909.97.1.18; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sharp D, 2006, LANCET, V368, P975, DOI 10.1016/S0140-6736(06)69395-1; Sherman MD, 2005, PSYCHIAT SERV, V56, P1150, DOI 10.1176/appi.ps.56.9.1150; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Smith RC, 2006, J GEN INTERN MED, V21, P671, DOI 10.1111/j.1525-1497.2006.00460.x; Soetekouw PMMB, 2000, EUR J CLIN INVEST, V30, P630; Sohlberg M., 2001, COGNITIVE REHABILITA; Taft CT, 2008, J CONSULT CLIN PSYCH, V76, P648, DOI 10.1037/a0012576; Toomey R, 2007, BRIT J PSYCHIAT, V190, P385, DOI 10.1192/bjp.bp.105.019539; UOMOTO JM, TRAUMATIC B IN PRESS; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling JJ, 2008, J REHABIL RES DEV, V45, P347, DOI 10.1682/JRRD.2007.05.0077; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Veith EM, 2006, REHABIL PSYCHOL, V51, P289, DOI 10.1037/0090-5550.51.4.289; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wells L M, 1993, Health Soc Work, V18, P221; Williams RM, 2002, J BURN CARE REHABIL, V23, P449, DOI 10.1097/00004630-200211000-00012; WILLIAMS RM, 2009, PEER VISITATION OIF; Wilson BA, 2002, NEUROREHAB NEURAL RE, V16, P207, DOI 10.1177/0888439002016002003; World Health Organization, 2007, INT CLASS FUNCT DIS	84	19	19	1	5	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2009	54	3					259	269		10.1037/a0016907			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	488SW	WOS:000269371100003	19702424				2022-02-06	
J	Chiang, HL; Lyu, RK; Tseng, MY; Chang, KH; Chang, HS; Hsu, WC; Kuo, HC; Chu, CC; Wu, YR; Ro, LS; Huang, CC; Chen, CM				Chiang, Han-Lin; Lyu, Rong-Kuo; Tseng, Mu-Yun; Chang, Kuo-Hsuan; Chang, Hong-Shiu; Hsu, Wen-Chuin; Kuo, Hung-Chou; Chu, Chun-Che; Wu, Yih-Ru; Ro, Long-Sun; Huang, Chin-Chang; Chen, Chiung-Mei			Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barre syndrome and other neurological disorders	CLINICA CHIMICA ACTA			English	Article						Transthyretin; Cerebrospinal fluid; Guillain-Barre syndrome	INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; PRE-ALBUMIN; IDIOPATHIC POLYNEURITIS; COMPARATIVE PROTEOMICS; DIAGNOSTIC-CRITERIA; APOLIPOPROTEIN-E; PROTEIN MARKERS	Background: Guillain-Barre syndrome (GBS) is an autoimmune inflammatory polyradiculoneuropathy that causes acute are flexic paralysis with a high risk of respiratory failure. Previously, using two-dimensional gel electrophoresis and mass spectrometry, we found that the transthyretin level was altered in the cerebrospinal fluid (CSF) of GBS patients when compared to that in CSF of control patients. Methods: We used enzyme-linked immunosorbent assay (ELISA) to measure the transthyretin levels in the CSF and serum from 22 GBS, 4 Miller-Fisher syndrome (MFS), 9 chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), 22 multiple sclerosis (MS), 10 Alzheimer's disease (AD), and 6 viral meningitis (VM) patients, and 18 controls. Results: The results show that CSF transthyretin concentration of the GBS patients is significantly higher than that of the control, MS, AD and VM patients (p < 0.05), although not significantly different from that of MFS and CIDP patients. Conclusion: The increased CSF transthyretin level may be explained by barrier dysfunction or decreased CSF flow in the GBS patients along with increased intrathecal synthesis of transthyretin that might be a protective response to nerve damage. (c) 2009 Elsevier B.V. All rights reserved.	[Chiang, Han-Lin; Lyu, Rong-Kuo; Tseng, Mu-Yun; Chang, Kuo-Hsuan; Chang, Hong-Shiu; Hsu, Wen-Chuin; Kuo, Hung-Chou; Chu, Chun-Che; Wu, Yih-Ru; Ro, Long-Sun; Huang, Chin-Chang; Chen, Chiung-Mei] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Neurol, Taipei, Taiwan		Chen, CM (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Neurol, 199 Tung Hwa N Rd, Taipei, Taiwan.	cmchen@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		Chang Gung Memorial Hospital, Taipei, TaiwanChang Gung Memorial Hospital [CMRPG 37056]; National Science Council, Executive Yuan, TaiwanMinistry of Science and Technology, Taiwan [96-2314-B-182A107-MY2]	This work was supported by grant CMRPG 37056 from Chang Gung Memorial Hospital, Taipei, Taiwan, and grant NSC 96-2314-B-182A107-MY2 from the National Science Council, Executive Yuan, Taiwan.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; BERLIT P, 1992, J CLIN NEURO-OPHTHAL, V12, P57; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Chang KH, 2007, PROTEOM CLIN APPL, V1, P467, DOI 10.1002/prca.200600949; Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0; Cosi V, 2006, NEUROL SCI, V27, pS47, DOI 10.1007/s10072-006-0548-4; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; DICKSON PW, 1982, EUR J BIOCHEM, V129, P289, DOI 10.1111/j.1432-1033.1982.tb07051.x; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; HERBERT J, 1986, NEUROLOGY, V36, P900, DOI 10.1212/WNL.36.7.900; Huang YC, 2009, J NEUROIMMUNOL, V206, P100, DOI 10.1016/j.jneuroim.2008.10.011; Hughes RAC, 2006, J PERIPHER NERV SYST, V11, P30, DOI 10.1111/j.1085-9489.2006.00061.x; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; Jin T, 2007, EUR J NEUROL, V14, P563, DOI 10.1111/j.1468-1331.2007.01761.x; Kassem NA, 2006, AM J PHYSIOL-REG I, V291, pR1310, DOI 10.1152/ajpregu.00789.2005; KRZALIC L, 1982, CLIN CHIM ACTA, V124, P339, DOI 10.1016/0009-8981(82)90427-2; Kunicki S, 1998, CLIN BIOCHEM, V31, P409, DOI 10.1016/S0009-9120(98)00027-7; LAMOUREUX G, 1975, NEUROLOGY, V25, P537, DOI 10.1212/WNL.25.6.537; LARSEN PD, 1987, NEUROLOGY, V37, P1262, DOI 10.1212/WNL.37.7.1262; Lehmensiek V, 2007, MULT SCLER, V13, P840, DOI 10.1177/1352458507076406; Lehmensiek V, 2007, J NEUROIMMUNOL, V185, P190, DOI 10.1016/j.jneuroim.2007.01.022; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Merched A, 1998, FEBS LETT, V425, P225, DOI 10.1016/S0014-5793(98)00234-8; Press R, 2003, J CLIN IMMUNOL, V23, P259, DOI 10.1023/A:1024532715775; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Reiber H, 1997, NEUROCHEMISTRY, P423; Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; ROSTENBERG I, 1979, J NATL CANCER I, V62, P299; Serot JM, 1997, J NEUROL NEUROSUR PS, V63, P506, DOI 10.1136/jnnp.63.4.506; SMITH FR, 1973, AM J CLIN NUTR, V26, P973, DOI 10.1093/ajcn/26.9.973; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Trojaborg W, 1998, ELECTROEN CLIN NEURO, V107, P303, DOI 10.1016/S0013-4694(98)00096-0; Van Den Bergh PYK, 2004, MUSCLE NERVE, V29, P565, DOI 10.1002/mus.20022; Yang YR, 2008, CELL MOL NEUROBIOL, V28, P737, DOI 10.1007/s10571-007-9257-7; Yu RK, 2006, INFECT IMMUN, V74, P6517, DOI 10.1128/IAI.00967-06; Zou LL, 1998, J NEUROCHEM, V71, P887	42	19	20	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JUL	2009	405	1-2					143	147		10.1016/j.cca.2009.04.022			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	463RA	WOS:000267448300026	19410571				2022-02-06	
J	Kochanek, PM; Tasker, RC				Kochanek, Patrick M.; Tasker, Robert C.			Pediatric Neurointensive Care: 2008 Update for the Rogers' Textbook of Pediatric Intensive Care	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; cardiac arrest; asphyxia; hypoxic ischemic encephalopathy; stroke; status epilepticus; children; infant; hypothermia	TRAUMATIC-BRAIN-INJURY; INTRACRANIAL-PRESSURE; MODERATE HYPOTHERMIA; STATUS EPILEPTICUS; INSULIN THERAPY; CLINICAL-TRIAL; HEAD-INJURY; CHILDREN; STROKE; HYPERGLYCEMIA	Objective: To review important articles, in the field of pediatric neurointensive care, that were published subsequent to the fourth edition of the Rogers' Textbook of Pediatric Intensive Care. Data Sources: The U.S. National Library of Medicine (http://www.ncbi.nlm.nih.gov/sites/entrezPubMed) was searched for the term pediatric and the following individual terms, cardiac arrest, asphyxia, traumatic brain injury, status epilepticus, stroke, cerebral ischemia, and cerebral hemorrhage, to generate abstracts of additional citations that were then screened for potential inclusion. The authors were also aware of a number of key recent articles in both pediatric and adult neurointensive care and these were also screened. Study Selection and Data Extraction: Promising articles were reviewed and the decision as to whether they were included was made at the discretion of the section editors. Data Synthesis: Articles in four categories were included based on selected chapters in the neurointensive care section of the textbook, using the specific chapter heading in the textbook, namely, head and spinal cord trauma, hypoxic-ischemic encephalopathy, status epilepticus, and cerebrovascular disease and stroke. Conclusion: Developments in the field and practice of pediatric neurocritical care continue with significant additions to the literature and practice recommendations concerning care following traumatic brain injury, cardiac arrest, status epilepticus, and cerebrovascular events. Importantly, the continued progression in knowledge raises the health services issue of whether, in certain settings of high clinical volume, it is time for specialized pediatric neurointensive care services or units. (Pediatr Crit Care Med 2009; 10:517-523)	[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Tasker, Robert C.] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Sch Clin, Cambridge CB2 2QQ, England		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.	kochanekpccm@anes.upmc.edu	Kochanek, Patrick M/D-2371-2015; Tasker, Robert C/R-5837-2019	Kochanek, Patrick M/0000-0002-2627-913X; Tasker, Robert/0000-0003-3647-8113	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38087, 3730318]; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); United States ArmyUnited States Department of Defense [PR-054755 W81, WH06-1-0247]; The Evelyn Trust, Cambridge, U.K.; Sparks, U.K.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038087] Funding Source: NIH RePORTER	Supported, in part, by grants from NINDS (NS38087, 3730318), the CDC (University of Pittsburgh Center for Injury Research and Control/CIRCL), DARPA, and the United States Army PR-054755 W81 x WH06-1-0247 (to PMK) and from The Evelyn Trust, Cambridge, U.K., and Sparks, U.K. (to RCT).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Appleton R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001905.pub2; Beardsall K, 2008, NEW ENGL J MED, V359, P1873, DOI 10.1056/NEJMoa0803725; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Burns CM, 2008, PEDIATRICS, V122, P65, DOI 10.1542/peds.2007-2822; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; DeVeber G, 2008, LANCET NEUROL, V7, P983, DOI 10.1016/S1474-4422(08)70231-X; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Forsyth RJ, 2008, PEDIATR CRIT CARE ME, V9, P8, DOI 10.1097/01.PCC.0000298759.78616.3A; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Hattori H, 2008, BRAIN DEV-JPN, V30, P504, DOI 10.1016/j.braindev.2007.12.016; Hickey RW, 2000, PEDIATRICS, V106, P118, DOI 10.1542/peds.106.1.118; Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401; Holzer M, 2002, NEW ENGL J MED, V346, P549; Huang SC, 2008, CRIT CARE MED, V36, P1607, DOI 10.1097/CCM.0b013e318170b82b; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Klein GW, 2008, J PEDIATR-US, V153, P379, DOI 10.1016/j.jpeds.2008.04.012; Kollmar R, 2009, NEUROCRIT CARE, V10, P173, DOI 10.1007/s12028-008-9162-z; Laptook A, 2008, PEDIATRICS, V122, P491, DOI 10.1542/peds.2007-1673; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Monagle P, 2008, CHEST, V133, p887S, DOI 10.1378/chest.08-0762; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Nenadovic V, 2008, J NEUROTRAUM, V25, P615, DOI 10.1089/neu.2007.0474; Polderman KH, 2002, NEW ENGL J MED, V347, P64; Preissig CM, 2008, PEDIATR CRIT CARE ME, V9, P581, DOI 10.1097/PCC.0b013e31818d36cb; Rafaat KT, 2008, PEDIATR CRIT CARE ME, V9, P567, DOI 10.1097/PCC.0b013e31818c8955; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; ROGERS MC, 2008, ROGERS TXB PEDIAT IN, P810; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; Schrader DV, 2009, EUR J PAEDIATR NEURO, V13, P10, DOI 10.1016/j.ejpn.2008.01.011; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shany E, 2007, J CHILD NEUROL, V22, P255, DOI 10.1177/0883073807299858; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Tobias JD, 2008, SOUTH MED J, V101, P268, DOI 10.1097/SMJ.0b013e318164e3f0; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Zamponi N, 2008, NEUROSURG REV, V31, P291, DOI 10.1007/s10143-008-0134-8	46	19	20	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2009	10	4					517	523		10.1097/PCC.0b013e3181ab88cd			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	468SI	WOS:000267840500014	19584637				2022-02-06	
J	Larson, MJ; Kaufman, DAS; Kellison, IL; Schmalfuss, IM; Perlstein, WM				Larson, Michael J.; Kaufman, David A. S.; Kellison, Ida L.; Schmalfuss, Ilona M.; Perlstein, William M.			Double Jeopardy! The Additive Consequences of Negative Affect on Performance-Monitoring Decrements Following Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						depression; anxiety; cognitive control; executive function; error monitoring	ANTERIOR CINGULATE CORTEX; ERROR-RELATED-NEGATIVITY; MAJOR DEPRESSIVE DISORDER; EVENT-RELATED POTENTIALS; CLOSED-HEAD INJURY; COGNITIVE CONTROL; SEVERE TBI; FUNCTIONAL-SIGNIFICANCE; ANTISACCADE TASK; MOOD DISORDERS	Survivors of severe traumatic brain injury (TBI) are at increased risk for emotional sequelae. The current study utilized the error-related negativity (ERN) and posterror positivity (Pe) components of the event-related potential (ERP) to test the hypothesis that negative affect disproportionately impairs performance-monitoring following severe TBI. High-density ERPs were acquired while 20 survivors of severe TBI and 20 demographically matched controls performed a single-trial Stroop task. Response-locked ERPs were separately averaged for correct and error trials. Negative affect was measured as the single latent factor of measures of depression and anxiety. Groups did not differ on overall level of negative affect. Control and TBI participants did not differ on error rates as a function of negative affect, but differed in response times. ERP results revealed disproportionately smaller ERN amplitudes in participants with TBI relative to controls as a function of negative affect. Pe amplitude did not differ between groups. Negative affect inversely correlated with ERN amplitude in TBI but not control participants. Overall, results support a "double jeopardy" hypothesis of disproportionate impairments in performance monitoring when negative affect is overlaid on severe TBI.	[Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Kaufman, David A. S.; Kellison, Ida L.; Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Schmalfuss, Ilona M.] N Florida S Georgia Vet Adm Hosp, Dept Radiol, Gainesville, FL USA; [Schmalfuss, Ilona M.] Univ Florida, Dept Med, Gainesville, FL 32611 USA; [Perlstein, William M.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Perlstein, William M.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA		Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA.	michael_larson@byu.edu	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 NS053335, K01 MH01857, R21 MH073076]; Evelyn F. McKnight Brain Research Grant Program; Florida Brain and Spinal Cord Injury Research Trust Fund; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH073076, K01MH001857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS053335] Funding Source: NIH RePORTER	This original research has not been published elsewhere and was supported by a predoctoral National Institute of Health (NIH) Fellowship F31 NS053335 to Michael J. Larson and grants front the Evelyn F. McKnight Brain Research Grant Program., the Florida Brain and Spinal Cord Injury Research Trust Fund, and NIH to William M. Perlstein (K01 MH01857; R21 MH073076). We extend our appreciation to Ashley Carroll, Cortney Mauer, Megan McIntyre, Drew Nagle, Floris Singletary, Allen Sirizi, and Raechel Steckicy for their assistance in participant recruitment and data collection.	Alain C, 2002, CEREB CORTEX, V12, P840, DOI 10.1093/cercor/12.8.840; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BURLE B, J COGNITIVE IN PRESS; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CACIOPPO JT, 1990, AM PSYCHOL, V45, P177; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chiu PH, 2007, AM J PSYCHIAT, V164, P608, DOI 10.1176/appi.ajp.164.4.608; CLARK DA, 1994, J ABNORM PSYCHOL, V103, P645, DOI 10.1037/0021-843X.103.4.645; Clark J, 1924, AM J PHYSL OPTICS; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Cohen J., 2013, STAT POWER ANAL BEHA; Compton RJ, 2007, BRAIN COGNITION, V64, P247, DOI 10.1016/j.bandc.2007.03.006; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Dux MC, 2008, J INT NEUROPSYCH SOC, V14, P327, DOI 10.1017/S1355617708080363; Emerson CS, 2005, ARCH CLIN NEUROPSYCH, V20, P539, DOI 10.1016/j.acn.2004.10.003; Emerson CS, 2001, NEUROPSY NEUROPSY BE, V14, P130; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Falkenstein M, 2005, J PSYCHOPHYSIOL, V19, P305, DOI 10.1027/0269-8803.19.4.305; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; FELDMAN LA, 1993, J CONSULT CLIN PSYCH, V61, P631, DOI 10.1037/0022-006X.61.4.631; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Hajcak G, 2004, BRAIN COGNITION, V56, P189, DOI 10.1016/j.bandc.2003.11.001; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hajcak G, 2003, BIOL PSYCHOL, V64, P77, DOI 10.1016/S0301-0511(03)00103-0; Hajcak G, 2002, PSYCHIAT RES, V110, P63, DOI 10.1016/S0165-1781(02)00034-3; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hirsh AT, 2006, J PAIN, V7, P592, DOI 10.1016/j.jpain.2006.02.006; Holroyd CB, 2005, J EXP PSYCHOL GEN, V134, P163, DOI 10.1037/0096-3445.134.2.163; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Larson MJ, 2006, NEUROREPORT, V17, P329, DOI 10.1097/01.wnr.0000199461.01542.db; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Luu P, 2000, J EXP PSYCHOL GEN, V129, P43, DOI [10.1037/0096-3445.129.1.43, 10.1037//0096-3445.129.1.43]; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; Mathalon DH, 2003, NEUROBIOL AGING, V24, P675, DOI 10.1016/S0197-4580(02)00154-9; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mialet JP, 1996, PSYCHOL MED, V26, P1009, DOI 10.1017/S0033291700035339; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miltner WHR, 2003, BIOL PSYCHOL, V64, P157, DOI 10.1016/S0301-0511(03)00107-8; Neter J., 1985, APPL LINEAR STAT MOD; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reza MF, 2007, NEUROPSYCHOL REHABIL, V17, P723, DOI 10.1080/09602010601082441; Robinson RG, 2005, TXB TRAUMATIC BRAIN, P201; Ruchsow M, 2006, J PSYCHIATR RES, V40, P37, DOI 10.1016/j.jpsychires.2005.02.002; Ruchsow M, 2004, PSYCHOPHYSIOLOGY, V41, P833, DOI 10.1111/j.1469-8986.2004.00237.x; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Shenal BV, 2003, NEUROPSYCHOL REV, V13, P33, DOI 10.1023/A:1022300622902; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; SPEILBERGER CD, 1983, MANUAL STATE TRAIT A; Sweeney JA, 2000, BIOL PSYCHIAT, V48, P674, DOI 10.1016/S0006-3223(00)00910-0; TEASDALE G, 1974, LANCET, V2, P81; TRICHARD C, 1995, PSYCHOL MED, V25, P79, DOI 10.1017/S0033291700028105; Tucker DM, 2003, J ABNORM PSYCHOL, V112, P667, DOI 10.1037/0021-843X.112.4.667; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; WETZLER S, 1989, J PSYCHIATR RES, V23, P1, DOI 10.1016/0022-3956(89)90013-7; Wilson RS, 2003, AM J EPIDEMIOL, V158, P827, DOI 10.1093/aje/kwg224; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x	91	19	20	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JUL	2009	23	4					433	444		10.1037/a0015723			12	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	472IA	WOS:000268122600003	19586208				2022-02-06	
J	de Leon, MB; Kirsch, NL; Maio, RF; Tan-Schriner, CU; Millis, SR; Frederiksen, S; Tanner, CL; Breer, L				de Leon, Marita B.; Kirsch, Ned L.; Maio, Ronald F.; Tan-Schriner, Cheribeth U.; Millis, Scott R.; Frederiksen, Shirley; Tanner, Clare L.; Breer, Lynn			Baseline Predictors of Fatigue 1 Year After Mild Head Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	James W Rae Scientific Day Conference 2008	MAY09, 2008	Univ Michigan, Dept Phys Med & Rehabilitat, Ann Arbor, MI		Univ Michigan, Dept Phys Med & Rehabilitat	Fatigue; Rehabilitation	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CONCUSSION SYMPTOMS; RECOVERY; ADULTS; PARTICIPATION; DISABILITY; SF-36; INDIVIDUALS; POPULATION	Objective: To compare reports of fatigue 12 months after minor trauma by participants with mild head injury (MHI) with those with other injury, and identify injury and baseline predictors of fatigue. Design: An inception cohort study of participants with MHI and other nonhead injuries recruited from and interviewed at the emergency department (ED), with a follow-up telephone interview at 12 months. Setting: Level II Community hospital ED. Participants: Participants (n=58) with MHI and loss of consciousness (LOC) of 30 minutes or less and/or posttraumatic amnesia (PTA) less than 24 hours, 173 with MHI but no PTA/LOC, and 128 with other mild nonhead injuries. Inclusion criteria: age 18 years or older. within 24 hours of injury, Glasgow Coma Scale score of 13 or higher, and discharge from the ED. Interventions: Not applicable. Main Outcome Measure: Medical Outcomes Study 36-Item Short-Form Health Survey Vitality subscale. Results: Significant predictors of fatigue severity at 12 months were baseline fatigue, having seen a Counselor for a mental health issue, medical disability, marital status, and in some stage of litigation. Injury type was not a significant predictor. Conclusions: Fatigue severity 12 months after injury is associated with baseline characteristics and not MHI. Clinicians should be cautious about attributing persisting fatigue to MHI without comprehensive consideration of other possible etiologic factors.	[de Leon, Marita B.; Kirsch, Ned L.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Maio, Ronald F.; Frederiksen, Shirley] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Maio, Ronald F.] Univ Michigan, Injury Res Ctr, Ann Arbor, MI 48109 USA; [Millis, Scott R.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Tan-Schriner, Cheribeth U.; Tanner, Clare L.; Breer, Lynn] Michigan Publ Hlth Inst, Okemos, MI USA		Kirsch, NL (corresponding author), Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, 355 Briarwood Circle, Ann Arbor, MI 48109 USA.	nlkirsch@umich.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5-T32-HD007422-17] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR523223-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007422] Funding Source: NIH RePORTER		Andersson AL, 1997, INJURY, V28, P539, DOI 10.1016/S0020-1383(97)00083-1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frenisy MC, 2006, J TRAUMA, V60, P1018, DOI 10.1097/01-ta.0000215977.00034.c2; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; O'Connor PJ, 2004, J PSYCHOSOM RES, V57, P435, DOI 10.1016/j.jpsychores.2003.12.006; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; van der Sluis CK, 1998, INJURY, V29, P277, DOI 10.1016/S0020-1383(97)00198-8; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Ware J., 2000, SCORE VERSION 2 SF 3; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	52	19	19	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2009	90	6					956	965		10.1016/j.apmr.2008.12.016			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	455SW	WOS:000266787000009	19480871				2022-02-06	
J	Hosalkar, HS; Greenbaum, JN; Flynn, JM; Cameron, DB; Dormans, JP; Drummond, DS				Hosalkar, H. S.; Greenbaum, J. N.; Flynn, J. M.; Cameron, D. B.; Dormans, J. P.; Drummond, D. S.			Fractures of the odontoid in children with an open basilar synchondrosis	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							CERVICAL-SPINE INJURIES; YOUNG-CHILDREN; DISLOCATIONS; ADOLESCENTS; AXIS	Fractures of the odontoid in children with an open basilar synchondrosis differ from those which occur in older children and adults. We have reviewed the morphology of these fractures and present a classification system for them. There were four distinct patterns of fracture (types IA to IC and type II) which were distinguished by the site of the fracture, the degree of displacement and the presence or absence of atlantoaxial dislocation. Children with a closed synchondrosis were classified using the system devised by Anderson and D'Alonzo. Those with an open synchondrosis had a comparatively lower incidence of traumatic brain injury, a higher rate of missed diagnosis and a shorter mean stay in hospital. Certain subtypes ( type IA and type II) are likely to be missed on plain radiographs and therefore more advanced imaging is recommended. We suggest staged treatment with initial stabilisation in a Halo body jacket and early fusion for those with unstable injuries, severe displacement or neurological involvement.	[Flynn, J. M.; Cameron, D. B.; Dormans, J. P.] Childrens Hosp Philadelphia, Dept Orthopaed Surg, Philadelphia, PA 19104 USA		Hosalkar, HS (corresponding author), Univ Penn, Sch Med, 2nd Floor Silverstein,3400 Spruce St, Philadelphia, PA 19104 USA.	Harish.hosalkar@uphs.upenn.edu					ALP MS, 1990, BMJ-BRIT MED J, V300, P319, DOI 10.1136/bmj.300.6720.319; AMYES EW, 1956, ARCH SURG-CHICAGO, V72, P377, DOI 10.1001/archsurg.1956.01270210007002; ANDERSON LD, 1974, J BONE JOINT SURG AM, VA 56, P1663, DOI 10.2106/00004623-197456080-00017; [Anonymous], INT CLASSIFICATION D; APPLE JS, 1987, PEDIATR RADIOL, V17, P45, DOI 10.1007/BF02386594; BOHN D, 1990, J TRAUMA, V30, P463, DOI 10.1097/00005373-199030040-00017; CONNOLLY B, 1995, PEDIATR RADIOL, V25, P129; Copley L A, 1998, J Am Acad Orthop Surg, V6, P204; EVANS DL, 1989, J PEDIATR ORTHOPED, V9, P563, DOI 10.1097/01241398-198909010-00011; FIELDING JW, 1974, J BONE JOINT SURG AM, VA 56, P187, DOI 10.2106/00004623-197456010-00023; FLYNN J, 2001, SPINE, V14, P249; FREIBERGER RH, 1965, J BONE JOINT SURG AM, VA 47, P1231, DOI 10.2106/00004623-196547060-00013; FUJII E, 1988, SPINE, V13, P604; Godard J, 1997, CHILD NERV SYST, V13, P105, DOI 10.1007/s003810050054; GRIFFITHS SC, 1972, J PEDIATR SURG, V7, P680, DOI 10.1016/0022-3468(72)90279-5; GROPPER P, 1975, J BONE JOINT SUR B S, V33, P434; Lui TN, 1996, J TRAUMA, V40, P408, DOI 10.1097/00005373-199603000-00014; MANDABACH M, 1993, PEDIATR NEUROSURG, V19, P225, DOI 10.1159/000120737; MAZUR JM, 2002, SPINE, V27, P197; MCGRORY BJ, 1994, J BONE JOINT SURG AM, V76A, P1606, DOI 10.2106/00004623-199411000-00003; Odent T, 1999, J PEDIATR ORTHOPED, V19, P51, DOI 10.1097/00004694-199901000-00012; Schippers N, 1996, ACTA NEUROCHIR, V138, P524, DOI 10.1007/BF01411172; SEIMON LP, 1977, J BONE JOINT SURG AM, V59, P943, DOI 10.2106/00004623-197759070-00019; SHERK HH, 1978, J BONE JOINT SURG AM, V60, P921, DOI 10.2106/00004623-197860070-00008; UEMARA K, 1996, NEUROL MED CHIR TOKY, V36, P175; VINING DJ, 1992, J NEUROSURG, V77, P795, DOI 10.3171/jns.1992.77.5.0795; GLASGOW COMA SCORE	27	19	23	0	1	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X			J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	JUN	2009	91B	6					789	796		10.1302/0301-620X.91B6.22173			8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	458PF	WOS:000267035300015	19483234	Bronze			2022-02-06	
J	Scott, LK; Green, R; McCarthy, PJ; Conrad, SA				Scott, L. Keith; Green, Rebecca; McCarthy, Paul J.; Conrad, Steven A.			Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; agitation; aggression; ziprasidone; Riker Sedation-Agitation Scale	ANTIPSYCHOTICS; ADOLESCENTS; EFFICACY; CHILDREN	Object. Agitation and aggression are common after traumatic brain injury (TBI) and can hamper recovery and rehabilitative efforts. To date. there is no consensus on pharmaceutical intervention for these conditions after TBI. Ziprasidone has been reported efficacious in this Population but the evidence is limited. The authors report their experience of using ziprasidone to treat posttraumatic brain injury agitation in 20 consecutive pediatric patients. A secondary objective of this case series was to attempt to establish an age-specific dosage and identify possible side effects of this medication. Methods. This case series Study was performed at a university hospital and pediatric trauma center. Over an 18-month period, all patients who presented to the pediatric intensive care unit with TBI and later developed agitation and/or aggression were treated with ziprasidone as the sole intervention. Pre- and posttreatment scored; on the Riker Scclation-A-itation Scale (SAS) were recorded along with demographic data. Results. Twenty children received ziprasidone for agitation and/or aggression during the immediate recovery period from TBI. The median patient age was 8 years (range 9 months-17 years). Children were stratified into 4 age groups: < 2 years old (Group 1). 2-6 years old (Group 2), 7-12 years old (Group 3), and >= 13 years old (Group 4). The SAS score, before and 24 hours after the initiation of ziprasidone, demonstrated a significant reduction after initiation of the medication (p < 0.001). The initial dose for Groups 1-4 was 1.7, 0.9, 0.7, and 0.6 mg/kg, respectively, with final doses of 1.8, 1.5, 1.7, and 0.07 mg/kg. respectively. The duration of therapy for Groups 1-4 was 5, 8 6, and 3 clays, respectively. All patients received continuous cardiac and blood-pressure monitoring. No adverse events were reported in any of the age groups. Conclusions. Based oil this limited patient series. ziprasidone appears to be safe and effective in pediatric patients with closed head injuries who develop agitation and/or aggression in the immediate postinjury period. Ziprasidone consistently lowered SAS scores and did so in all age groups. There were minimal dose adjustments and the duration of therapy was relatively brief. No adverse events were reported. A prospective trial of ziprasidone in this Population appears warranted. (DOI: 10.3171/2009.2.PEDS08292)	[Scott, L. Keith; McCarthy, Paul J.; Conrad, Steven A.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Shreveport, LA 71130 USA; [Scott, L. Keith; Green, Rebecca; Conrad, Steven A.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Shreveport, LA 71130 USA; [Scott, L. Keith; McCarthy, Paul J.; Conrad, Steven A.] Louisiana State Univ, Hlth Sci Ctr, Dept Neurosurg, Shreveport, LA 71130 USA		Scott, LK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Med, 1541 Kings Highway, Shreveport, LA 71130 USA.	lscott2@lsuhsc.edu	Conrad, Steven/F-3257-2015	Conrad, Steven/0000-0002-4014-969X			Biederman J, 2007, BIPOLAR DISORD, V9, P888, DOI 10.1111/j.1399-5618.2007.00450.x; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; FLEMINGER S, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003299; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Lescot T, 2007, NEUROCRIT CARE, V7, P124, DOI 10.1007/s12028-007-0051-7; Maryniak O, 2001, BRAIN INJURY, V15, P167, DOI 10.1080/026990501458399; Noe E, 2007, BEHAV NEUROL, V18, P7, DOI 10.1155/2007/529076; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Rosati DL, 2002, AM J PHYS MED REHAB, V81, P90, DOI 10.1097/00002060-200202000-00003; Sallee FR, 2003, J AM ACAD CHILD PSY, V42, P902, DOI 10.1097/01.CHI.0000046897.27264.46; Serretti A, 2004, CURR MED CHEM, V11, P343, DOI 10.2174/0929867043456043; Sprouse JS, 1999, NEUROPSYCHOPHARMACOL, V21, P622, DOI 10.1016/S0893-133X(99)00057-3; Teng CJ, 2001, BRAIN INJURY, V15, P463, DOI 10.1080/02699050010005931	17	19	19	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROS-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2009	3	6					484	487		10.3171/2009.2.PEDS08292			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	451HK	WOS:000266461100009	19485732				2022-02-06	
J	Kassner, SS; Kollmar, R; Bonaterra, GA; Hildebrandt, W; Schwab, S; Kinscherf, R				Kassner, S. S.; Kollmar, R.; Bonaterra, G. A.; Hildebrandt, W.; Schwab, S.; Kinscherf, R.			THE EARLY IMMUNOLOGICAL RESPONSE TO ACUTE ISCHEMIC STROKE: DIFFERENTIAL GENE EXPRESSION IN SUBPOPULATIONS OF MONONUCLEAR CELLS	NEUROSCIENCE			English	Article						lymphocytes; lymphopenia; macrophages; monocytes; oxLDL; PBMC	LOW-DENSITY-LIPOPROTEIN; TUMOR-NECROSIS-FACTOR; ACTIVATED PARENCHYMAL MICROGLIA/MACROPHAGES; MANGANESE SUPEROXIDE-DISMUTASE; HUMAN ENDOTHELIAL-CELLS; TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; PLASMA OXIDIZED LDL; CEREBRAL-ISCHEMIA; CD40 LIGAND	Peripheral blood mononuclear cells (PBMCs), i.e. lymphocytes, monocytes and macrophages are key players in the development of innate and adaptive immune responses. However, little is known about their properties in patients with acute stroke. Experimental procedures: We presently characterized the early time course of PBMC subpopulations in 19 patients with acute ischemic stroke and symptom onset below 6 h compared to 19 age-matched healthy subjects. Immediately after acute ischemic stroke, as well as 1 and 3 days thereafter, PBMC subpopulations (cluster of differentiation [CD]3+, CD14+, CD19+, CD68+) were isolated by magnetic bead system and the expression of proinflammatory (CD40, tumor necrosis factor-alpha [TNF alpha]), proapoptotic (caspase-3 [CPP32], poly(ADP-ribose) polymerase [PARP]) and adhesion relevant (CD38) genes was measured by quantitative polymerase chain reaction (PCR). Furthermore, besides routine parameters, plasma levels of oxidized low-density lipoproteins (oxLDL) were studied. Results: In comparison to healthy subjects, patients revealed (i) twofold elevated plasma oxLDL concentrations, (ii) decreased (15%) blood cholesterol levels, and (iii) a 40% decrease in total number of lymphocytes. Furthermore, the majority of PBMC subpopulations revealed an increased expression of proinflammatory, proapoptotic or adhesion-relevant genes. Significant positive correlations were observed between expression of most of these genes in PBMCs and individual plasma oxLDL concentrations. Conclusion: Elevated expression of proinflammatory, proapoptotic and adhesion genes in subsets of PBMCs after ischemic stroke may contribute to an immunodepressive syndrome, possibly due to increased plasma oxLDL levels. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.	[Bonaterra, G. A.; Kinscherf, R.] TRIDOMUS C, Ctr Biomed & Med Technol Mannheim, Sect Macroscop Anat, D-68167 Mannheim, Germany; [Kassner, S. S.] Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, D-68167 Mannheim, Germany; [Kollmar, R.; Schwab, S.] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Hildebrandt, W.] German Canc Res Ctr, D-69120 Heidelberg, Germany		Kinscherf, R (corresponding author), TRIDOMUS C, Ctr Biomed & Med Technol Mannheim, Sect Macroscop Anat, Ludolf Krehl Str 13-17, D-68167 Mannheim, Germany.	Ralf.Kinscherf@medma.uni-heidelberg.de	Kinscherf, Ralf/AAV-7164-2021				Berard M, 1999, IMMUNOLOGY, V98, P47; Berard R, 1999, J IMMUNOL, V163, P4655; Beschorner R, 2002, J NEUROIMMUNOL, V126, P107, DOI 10.1016/S0165-5728(02)00046-2; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Bonaterra GA, 2005, FREE RADICAL BIO MED, V38, P235, DOI 10.1016/j.freeradbiomed.2004.10.021; Bonaterra GA, 2007, J MOL MED, V85, P181, DOI 10.1007/s00109-006-0117-6; Braun JS, 2007, EXP NEUROL, V206, P183, DOI 10.1016/j.expneurol.2007.03.032; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523, DOI 10.1161/01.ATV.18.10.1523; Di Napoli M, 2002, STROKE, V33, P1763, DOI 10.1161/01.STR.0000019124.54361.08; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Du XL, 2006, GENOMICS, V87, P693, DOI 10.1016/j.ygeno.2006.02.003; Endres M, 2006, ATHEROSCLEROSIS SUPP, V7, P31, DOI 10.1016/j.atherosclerosissup.2006.01.005; Fujita E, 1998, CELL DEATH DIFFER, V5, P289, DOI 10.1038/sj.cdd.4400355; GARCIA JH, 1974, J NEUROPATH EXP NEUR, V33, P408, DOI 10.1097/00005072-197407000-00007; Garlichs CD, 2001, CIRCULATION, V104, P2395, DOI 10.1161/hc4501.099312; Greig NH, 2004, ANN NY ACAD SCI, V1035, P290, DOI 10.1196/annals.1332.018; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Hakkinen T, 2000, VIRCHOWS ARCH, V437, P396, DOI 10.1007/s004280000239; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; Holvoet P, 2006, CLIN CHEM, V52, P760, DOI 10.1373/clinchem.2005.064337; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Jeong YJ, 2005, BRIT J NUTR, V93, P581, DOI 10.1079/BJN20041397; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kinscherf R, 2003, FREE RADICAL BIO MED, V35, P1286, DOI 10.1016/j.freeradbiomed.2003.07.001; Kinscherf R, 1998, FASEB J, V12, P461, DOI 10.1096/fasebj.12.6.461; Kinscherf R, 1997, FASEB J, V11, P1317, DOI 10.1096/fasebj.11.14.9409551; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Krupinski J, 1996, FOLIA NEUROPATHOL, V34, P17; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Love S, 2000, NEUROREPORT, V11, P2495, DOI 10.1097/00001756-200008030-00030; Luo YK, 2004, J CARDIOVASC PHARM, V44, P381, DOI 10.1097/01.fjc.0000138164.88740.f8; Meier P, 2007, J AM SOC NEPHROL, V18, P331, DOI 10.1681/ASN.2006050514; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Omari KM, 2003, J NEUROIMMUNOL, V134, P166, DOI 10.1016/S0165-5728(02)00423-X; Pasceri V, 2001, CIRCULATION, V103, P2531; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prass K, 2006, STROKE, V37, P2607, DOI 10.1161/01.STR.0000240409.68739.2b; Qing Z, 2001, J NEUROPATH EXP NEUR, V60, P798, DOI 10.1093/jnen/60.8.798; Qizilbash N, 1995, LANCET, V346, P1647; Schlittenhardt D, 2005, CELL TISSUE RES, V322, P425, DOI 10.1007/s00441-005-0024-0; Schulte-Herbruggen O, 2006, NEUROIMMUNOMODULAT, V13, P13, DOI 10.1159/000092109; Schwab JM, 2001, J NEUROTRAUM, V18, P881, DOI 10.1089/089771501750451802; SILVESTRINI M, 1994, STROKE, V25, P1390, DOI 10.1161/01.STR.25.7.1390; SORNAS R, 1972, ARCH NEUROL-CHICAGO, V26, P489, DOI 10.1001/archneur.1972.00490120029002; Sotgiu S, 2006, EUR J NEUROL, V13, P505, DOI 10.1111/j.1468-1331.2006.01280.x; Tanne D, 2006, INT J CARDIOL, V107, P322, DOI 10.1016/j.ijcard.2005.03.051; Thienel U, 1999, CELL IMMUNOL, V198, P87, DOI 10.1006/cimm.1999.1583; Uno M, 2005, NEUROL RES, V27, P94, DOI 10.1179/016164105X18395; Uno M, 2003, J NEUROL NEUROSUR PS, V74, P312, DOI 10.1136/jnnp.74.3.312; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; Urra X, 2009, NEUROSCIENCE, V158, P1174, DOI 10.1016/j.neuroscience.2008.06.014; Virag Laszlo, 2005, Current Vascular Pharmacology, V3, P209, DOI 10.2174/1570161054368625; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Yin L, 2003, ACT NEUR S, V86, P93	59	19	20	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 5	2009	160	2					394	401		10.1016/j.neuroscience.2009.02.050			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436PQ	WOS:000265426700014	19258025				2022-02-06	
J	Fleming, J; Kennedy, S; Fisher, R; Gill, H; Gullo, M; Shum, D				Fleming, Jennifer; Kennedy, Sahra; Fisher, Rebecca; Gill, Hannah; Gullo, Matthew; Shum, David			Validity of the Comprehensive Assessment of Prospective Memory (CAPM) for Use With Adults With Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						neuropsychological assessment; psychosocial integration; self-report; test validity	HEAD-INJURY; QUESTIONNAIRE; REHABILITATION; PERFORMANCE; FAILURES	Objective: To expand upon the existing psychometric properties of the Comprehensive Assessment of Prospective Memory (CAPM) for use with adults with traumatic brain injury by examining concurrent and criterion validity. Method: Participants were 45 adults with a traumatic brain injury. Participants and their relatives completed Section A of the CAPM and a measure of psychosocial integration. Participants were also administered two neuropsychological tests of prospective memory, the Cambridge Prospective Memory Test (CAM-PROMPT) and the Memory Intentions Screening Test (MIST). Concurrent validity was measured by comparing scores on the CAPM with scores on the CAM-PROMPT and MIST. Criterion validity was examined by correlating CAPM scores with level of psychosocial integration. Results: Participant self-reports on the CAPM were not significantly correlated with the CAM-PROMPT or MIST, but were significantly correlated with level of psychosocial integration. Relative reports on the CAPM were correlated significantly with total score on the MIST and CAM-PROMPT and level of psychological integration. Conclusions: The findings indicate that the concurrent validity of the self-report version of CAPM is low suggesting that self-reports alone do not provide an objective measure for assessing prospective memory function. The relative report version however, demonstrated reasonable concurrent and criterion validity, suggesting that the relative report version of the Section A of the CAPM is a useful means of evaluating frequency of prospective memory failure in adults with traumatic brain injury.	[Fleming, Jennifer; Kennedy, Sahra; Fisher, Rebecca; Gill, Hannah] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Gill, Hannah; Gullo, Matthew; Shum, David] Griffith Univ, Griffith Inst Hlth & Med Res, Nathan, Qld 4111, Australia; [Gullo, Matthew; Shum, David] Griffith Univ, Sch Psychol, Nathan, Qld 4111, Australia		Fleming, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	j.fleming@uq.edu.au	Shum, David/A-3914-2008; Gullo, Matthew/C-3850-2008; Gullo, Hannah/C-5011-2008; Fleming, Jennifer M/B-4436-2011	Shum, David/0000-0002-4810-9262; Gullo, Matthew/0000-0003-3657-5191; GULLO, Hannah/0000-0003-4238-4033	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia;  [113 277002]	This research was funded by a National Health and Medical Research Council (NHMRC) Project grant (113 No. 277002).	Andrewes DG, 1998, NEUROPSYCHOL REHABIL, V8, P377, DOI 10.1080/713755582; BENNETTLEVY J, 1980, BRIT J SOC CLIN PSYC, V19, P177, DOI 10.1111/j.2044-8260.1980.tb00946.x; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Carey CL, 2006, J CLIN EXP NEUROPSYC, V28, P536, DOI 10.1080/13803390590949494; CHAU IT, 2007, NEUROPSYCHOL REHABIL, V5, P1; CICERONE KD, 1990, J CLIN EXP NEUROPSYC, V12, P92; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Fleming J, 2000, BRAIN IMPAIR, V1, P141, DOI DOI 10.1375/brim.1.2.141; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; GILWESKI MJ, 1988, PSYCHOPHARMACOLOGY B, V24, P665; GOLDSTEIN LH, 1992, BRIT J CLIN PSYCHOL, V31, P75, DOI 10.1111/j.2044-8260.1992.tb00969.x; Gravetter F. J., 2000, STAT BEHAV SCI; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; HERRMANN DJ, 1983, BRAIN IMPAIRMENT, V3, P1; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; MAYLOR EA, 2002, NEUROPSYCHOLOGY, V20, P144; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; RASKIN S, 2000, MEMORY INTENTI UNPUB; Raskin S, 2004, J INT NEUROPSYCHO S1, V10, P110, DOI DOI 10.1017/S1355617704040019; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Waugh N., 1999, THESIS GRIFFITH U BR; WEITEN W, 1998, PSYCHOL THEMES VARIA; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Winograd E., 1988, PRACTICAL ASPECTS ME, V1, P348	31	19	20	0	14	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	MAY	2009	10	1					34	44		10.1375/brim.10.1.34			11	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	443CQ	WOS:000265888200006		Green Published			2022-02-06	
J	Weireter, LJ; Collins, JN; Britt, RC; Reed, SF; Novosel, TJ; Britt, LD				Weireter, Leonard J., Jr.; Collins, J. N.; Britt, Rebecca C.; Reed, Scott F.; Novosel, T. J.; Britt, L. D.			Impact of a Monitored Program of Care on Incidence of Ventilator-Associated Pneumonia: Results of a Longterm Performance-Improvement Project	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	120th Annual Meeting of the Southern-Surgical-Association	DEC, 2008	Palm Beach, FL	SE Surg Assoc			SYSTEMS	BACKGROUND: Ventilator-associated Pneumonia (VAP) remains a major source of morbidity, mortality, and expense in the ICU despite therapies directed against it. STUDY DESIGN: A retrospective review of a prospectively developed performance-improvement project monitoring the incidence of VAP in two adjacent ICUs was conducted. In response to an excessive VAP rate, weekly multidisciplinary team meetings were instituted to review data, develop care protocols, and modify care routines. Protocol compliance was monitored daily and feedback provided weekly to the care teams. VAP rates were determined by the institutional Infection Control Committee and reviewed monthly with the ICU multidisciplinary team. Duration of the investigational period was 10 years. RESULTS: A standardized ventilator-weaning protocol was instituted with confirmed 95% use. Additional modifications of care, such as patient positioning, use of specific endotracheal tubes to minimize aspiration of supraglottic secretions, an oral-care regimen, and aggressive antibiotic stewardship were standardized, with a compliance rate >90%. VAP rates dropped from 12.8 per 1,000 patient-days in 1998 to 1.1 in 2007 in the burn trauma ICU and from 21.2 to <1 in the neurotrauma ICU in the same time frame. Also, mean ventilator length of stay decreased from 6 days to 4.2 and from 5.8 days to 4.75 simultaneously in the respective ICUs. Such performance improvement has been sustained since implementation of the program. CONCLUSION: A systematic, monitored program of standardized care protocols can markedly reduce VAP rate in the ICU. (J Am Coll Surg 2009;208:700-705. (C) 2009 by the American College of Surgeons)	[Weireter, Leonard J., Jr.; Collins, J. N.; Britt, Rebecca C.; Reed, Scott F.; Novosel, T. J.; Britt, L. D.] Eastern Virginia Med Sch, Dept Surg, Norfolk, VA 23507 USA		Weireter, LJ (corresponding author), Eastern Virginia Med Sch, Dept Surg, 825 Fairfax Ave,Ste 610, Norfolk, VA 23507 USA.	weiretlj@evms.edu					[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Berwick DM, 1998, ANN INTERN MED, V128, P289, DOI 10.7326/0003-4819-128-4-199802150-00008; Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; Kollef MH, 1999, NEW ENGL J MED, V340, P627, DOI 10.1056/NEJM199902253400807; Langley G., 1996, IMPROVEMENT GUIDE PR; Nolan TW, 1998, ANN INTERN MED, V128, P293, DOI 10.7326/0003-4819-128-4-199802150-00009; WEIRETER LJ, 1999, AM ASS SURG TRAUM AN	7	19	19	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	MAY	2009	208	5					700	704		10.1016/j.jamcollsurg.2009.01.041			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	441WP	WOS:000265801500010	19476819				2022-02-06	
J	Kochanek, PM; Fink, EL; Bell, MJ; Bayir, H; Clark, RSB				Kochanek, Patrick M.; Fink, Ericka L.; Bell, Michael J.; Bayir, Huelya; Clark, Robert S. B.			Therapeutic Hypothermia: Applications in Pediatric Cardiac Arrest	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	2nd International Brain Hypothermia Symposium	OCT, 2007	Miami Beach, FL			asphyxia; cooling; drowning; neonate; newborn; resuscitation	WHOLE-BODY HYPOTHERMIA; MILD SYSTEMIC HYPOTHERMIA; TRAUMATIC BRAIN-INJURY; PERINATAL ASPHYXIA; NEONATAL ENCEPHALOPATHY; CEREBRAL RESUSCITATION; RAT-BRAIN; CHILDREN; INFANTS; TEMPERATURE	There is a rich history for the use of therapeutic hypothermia after cardiac arrest in neonatology and pediatrics. Laboratory reports date back to 1824 in experimental perinatal asphyxia. Similarly, clinical reports in pediatric cold water drowning victims represented key initiating work in the field. The application of therapeutic hypothermia in pediatric drowning victims represented some of the seminal clinical use of this modality in modern neurointensive care. Uncontrolled application (too deep and too long) and unique facets of asphyxial cardiac arrest in children (a very difficult insult to affect any benefit) likely combined to result in abandonment of therapeutic hypothermia in the mid to late 1980s. Important studies in perinatal medicine have built upon the landmark clinical trials in adults, and are once again bringing therapeutic hypothermia into standard care for pediatrics. Although more work is needed, particularly in the use of mild therapeutic hypothermia in children, there is a strong possibility that this important therapy will ultimately have broad applications after cardiac arrest and central nervous system (CNS) insults in the pediatric arena.	[Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Sch Med, Pittsburgh, PA 15260 USA; [Clark, Robert S. B.] Dept Pediat, Pittsburgh, PA USA; [Bayir, Huelya] Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Bayir, Huelya] Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA USA; [Kochanek, Patrick M.; Fink, Ericka L.; Bell, Michael J.; Bayir, Huelya; Clark, Robert S. B.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Sch Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Fink, Ericka/AAU-9792-2021	Kochanek, Patrick M/0000-0002-2627-913X; Fink, Ericka/0000-0002-3683-4571	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD047349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038087, P20NS030318, P01NS030318, P50NS030318] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD047349-02, K12 HD047349, 5K12HD047349-02] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS030318-169003, R01 NS038087-01A1, P01 NS030318, R01 NS038087, NS30318, P01 NS030318-160010, NS38087, R01 NS038087-09] Funding Source: Medline		Atkins DL, 2006, PEDIATRICS, V117, pE1005, DOI 10.1542/peds.2006-0346; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; Battin MR, 2003, PEDIATRICS, V111, P244, DOI 10.1542/peds.111.2.244; Battin MR, 2001, PEDIATRICS, V107, P480, DOI 10.1542/peds.107.3.480; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; BIGGART MJ, 1990, J PEDIATR-US, V117, P179, DOI 10.1016/S0022-3476(05)80526-8; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CONN AW, 1979, PEDIATR CLIN N AM, V26, P691; CONN AW, 1979, CAN MED ASSOC J, V120, P397; DANIEL SS, 1966, J PEDIATR-US, V68, P45, DOI 10.1016/S0022-3476(66)80421-3; Debillon T, 2003, DEV MED CHILD NEUROL, V45, P17, DOI 10.1017/S0012162203000045; EDWARDS WF, 1824, INFLUENCE AGENTS PHY; Fink EL, 2005, DEV NEUROSCI-BASEL, V27, P191, DOI 10.1159/000085992; Fink EL, 2007, CRIT CARE MED, V35, pA97; FREWEN TC, 1982, J PEDIATR-US, V100, P663, DOI 10.1016/S0022-3476(82)80782-8; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Haque IU, 2006, PEDIATR CRIT CARE ME, V7, P7, DOI 10.1097/01.PCC.0000192322.45123.80; Higgins RD, 2006, J PEDIATR-US, V148, P170, DOI 10.1016/j.jpeds.2005.12.009; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; JENKINS LW, 2008, ROGERS TXB PEDIAT IN, P810; Johnston MV, 2005, BRAIN PATHOL, V15, P234; KOCHANEK PM, 1988, CRIT CARE CLIN, V4, P661; LANSKY LL, 1977, J PEDIATR-US, V90, P639, DOI 10.1016/S0022-3476(77)80390-9; LEVENE MI, 1986, LANCET, V1, P67, DOI 10.1016/S0140-6736(86)90718-X; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McDonald J W, 1993, NIDA Res Monogr, V133, P185; MCDONALD JW, 1991, NEUROSCI LETT, V126, P83, DOI 10.1016/0304-3940(91)90377-6; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Nehlig A, 1997, DIABETES METAB, V23, P18; Nishisaki A, 2007, PEDIATR CRIT CARE ME, V8, P10, DOI 10.1097/01.pcc.0000256621.63135.4b; NUSSBAUM E, 1988, PEDIATRICS, V81, P630; OATES RK, 1976, ARCH DIS CHILD, V51, P512, DOI 10.1136/adc.51.7.512; Ohmura A, 2005, BRAIN DEV-JPN, V27, P517, DOI 10.1016/j.braindev.2005.01.004; OROURKE PP, 1986, CRIT CARE MED, V14, P466, DOI 10.1097/00003246-198605000-00006; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Roelfsema V, 2004, J CEREBR BLOOD F MET, V24, P877, DOI 10.1097/01.WCB.0000123904.17746.92; Shankaran S, 2002, PEDIATRICS, V110, P377, DOI 10.1542/peds.110.2.377; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shimohama S, 2001, BIOCHEM BIOPH RES CO, V289, P1063, DOI 10.1006/bbrc.2001.6108; SIEBKE H, 1975, LANCET, V1, P1275; SILVERMAN WA, 1958, PEDIATRICS, V22, P876; Topjian AA, 2007, CIRCULATION, V116, P945; Vaagenes P, 1997, RESUSCITATION, V35, P41, DOI 10.1016/S0300-9572(97)01108-8; VANNUCCI RC, 1990, PEDIATRICS, V85, P961; Vannucci RC, 1997, PEDIATRICS, V100, P1004, DOI 10.1542/peds.100.6.1004; WESTIN B, 1962, ACTA PAEDIATR SCAND, V51, P5; YAGER J, 1993, PEDIATR RES, V34, P525, DOI 10.1203/00006450-199310000-00029; YASUDA T, 1995, J NEUROSCI RES, V40, P306, DOI 10.1002/jnr.490400304; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157	54	19	20	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2009	26	3					421	427		10.1089/neu.2008.0587			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	420ZO	WOS:000264327900017	19271968	Green Accepted, Green Published			2022-02-06	
J	Lasarzik, I; Winkelheide, U; Stallmann, S; Orth, C; Schneider, A; Tresch, A; Werner, C; Engelhard, K				Lasarzik, Irina; Winkelheide, Uta; Stallmann, Sonja; Orth, Christian; Schneider, Astrid; Tresch, Achim; Werner, Christian; Engelhard, Kristin			Assessment of Postischemic Neurogenesis in Rats with Cerebral Ischemia and Propofol Anesthesia	ANESTHESIOLOGY			English	Article; Proceedings Paper	Annual Meeting of the American-Society-of-Anesthesiologists	OCT 13-17, 2007	San Francisco, CA	Amer Soc Anesthesiologists			TRAUMATIC BRAIN-INJURY; FOREBRAIN ISCHEMIA; NEURONAL DIFFERENTIATION; ADULT NEUROGENESIS; MEMORY IMPAIRMENT; HIPPOCAMPUS; DAMAGE; CELLS; ISOFLURANE; STROKE	Background: Postischemic endogenous neurogenesis can be dose-dependently modulated by volatile anesthetics. The intravenous anesthetic propofol is used during operations with a risk of cerebral ischemia, such as neurosurgery, cardiac surgery, and vascular surgery. The effects of propofol on neurogenesis are unknown and, therefore, the object of this study. Methods: Eighty male Sprague-Dawley rats were randomly assigned to treatment groups with propofol administration for 3 h: 36 mg . kg(-1) . h(-1) propofol with or without cerebral ischemia and 72 mg . kg(-1) . h(-1) propofol with or without cerebral ischemia. In addition, 7 rats with propofol administration for 6 h and 14 treatment-naive rats were investigated. Forebrain ischemia was induced by bilateral carotid artery occlusion and hemorrhagic hypotension. Animals received 5-bromo-2-deoxyuridine for 7 days. 5-Bromo-2-deoxyuridine-positive neurons were counted in the dentate gyrus after 9 and 28 days. Spatial learning in the Barnes maze and histopathologic damage of the hippocampus were analyzed. Results: Propodol revealed no impact on basal neurogenesis. Cerebral ischemia increased the amount of new neurons. After 28 days, neurogenesis significantly increased in animals with low-dose propofol administered during cerebral ischemia compared with naive animals, whereas no significant difference was observed in animals with high-dose propofol during ischemia. Neuronal damage in the CA3 region was increased at 28 days with high-dose propofol. Postischemic deficits in spatial learning were not affected by propofol. Conclusions: Independent effects of propofol are difficult to ascertain. Peri-ischemic propofol administration may exert secondary effects on neurogenesis by modulating the severity of histopathologic	[Lasarzik, Irina; Winkelheide, Uta; Stallmann, Sonja; Orth, Christian; Werner, Christian; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Anasthesiol Klin, D-55131 Mainz, Germany		Lasarzik, I (corresponding author), Johannes Gutenberg Univ Mainz, Anasthesiol Klin, Langenbeckstr 1, D-55131 Mainz, Germany.	lasarzik@uni-mainz.de					ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bailey JM, 1997, ANESTH ANALG, V85, P681, DOI 10.1097/00000539-199709000-00036; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Cipolla MJ, 2002, STROKE, V33, P2094, DOI 10.1161/01.STR.0000020712.84444.8D; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Eberspacher E, 2006, ANESTH ANALG, V103, P1527, DOI 10.1213/01.ane.0000247803.30582.2d; Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016; Engelhard K, 2007, ANESTH ANALG, V104, P898, DOI 10.1213/01.ane.0000255730.73018.31; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Harburg GC, 2007, NEUROSCIENCE, V144, P77, DOI 10.1016/j.neuroscience.2006.09.018; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kawai T, 2004, J CEREBR BLOOD F MET, V24, P548, DOI 10.1097/00004647-200405000-00009; Liu SH, 2003, J NEUROSCI, V23, P732; Nasu I, 2006, ANESTH ANALG, V103, P413, DOI 10.1213/01.ane.0000223686.50202.38; Ng KP, 2006, ANESTH ANALG, V103, P1453, DOI 10.1213/01.ane.0000247732.33602.f5; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Sakai H, 2007, ANESTHESIOLOGY, V106, P92, DOI 10.1097/00000542-200701000-00017; Salazar-Colocho P, 2008, NEUROSCI RES, V61, P27, DOI 10.1016/j.neures.2008.01.008; Sharp FR, 2002, DEV BRAIN RES, V134, P23, DOI 10.1016/S0165-3806(01)00286-3; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Squire LR, 1996, HIPPOCAMPUS, V6, P546; Steckler T, 1998, PROG NEUROBIOL, V54, P313, DOI 10.1016/S0301-0082(97)00061-0; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taupin P, 2006, CR BIOL, V329, P465, DOI 10.1016/j.crvi.2006.04.001; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WARNER DS, 1990, BRAIN RES, V536, P176, DOI 10.1016/0006-8993(90)90023-5; Werner C, 1995, ANAESTHESIST, V44, pS566; ZOLAMORGAN S, 1992, J NEUROSCI, V12, P2582	35	19	22	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	MAR	2009	110	3					529	537		10.1097/ALN.0b013e318195b4fe			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	412OU	WOS:000263734900014	19212268	Bronze			2022-02-06	
J	Minardi, J; Crocco, TJ				Minardi, Joseph; Crocco, Todd J.			Management of Traumatic Brain Injury: First Link in Chain of Survival	MOUNT SINAI JOURNAL OF MEDICINE			English	Article						clinical management; prehospital; review; traumatic brain injury	7.5-PERCENT SODIUM-CHLORIDE; RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; HYPERTONIC SALINE; RESUSCITATION; IMPACT; MORTALITY; HYPOXIA; DEXTRAN; FIELD	Traumatic brain injury is a significant cause of morbidity and mortality. The prehospital care of the patients with a traumatic brain injury is critical to maximizing the chances for a good outcome. Prehospital management of the traumatic brain injury patient is directed toward preventing and limiting secondary brain injury while facilitating rapid transport to an appropriate facility capable of providing definitive neurocritical care. Key points in management include the assessment of oxygenation, blood pressure, and mental status (as measured with the Glasgow Coma Scale) and the pupillary examination. Treatment strategies are directed toward maintaining adequate oxygenation and perfusion and treating herniation. Judicious use of temporary hyperventilation and hypertonic saline are considerations. This review provides saline are considerations. This review provides the most recent evidence regarding the treatment of traumatic brain injury in the prehospital setting and introduces areas in need of future research. St. Sinai J Med. 76:138-144, 2009 (C) 2009 Mount Sinai School of Medicine	[Minardi, Joseph; Crocco, Todd J.] W Virginia Univ, Dept Emergency Med, Morgantown, WV 26506 USA		Crocco, TJ (corresponding author), W Virginia Univ, Dept Emergency Med, Morgantown, WV 26506 USA.	tcrocco@hsc.wvu.edu					Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Barton CW, 2005, ACAD EMERG MED, V12, P1, DOI 10.1197/j.aem.2004.08.043; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Davis DP, 2003, J TRAUMA, V55, P713, DOI 10.1097/01.TA.0000037428.65987.12; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Fakhry SM, 2006, J TRAUMA, V60, P997, DOI 10.1097/01.ta.0000217285.94057.5e; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P3204; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Lane Peter L, 2002, Prehosp Disaster Med, V17, P142; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Myburgh J, 2007, NEW ENGL J MED, V357, P874; *NAT CTR INJ PREV, TRAUM BRAIN INJ; Perel P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub3; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Silverboard H, 2005, J TRAUMA, V59, P717, DOI 10.1097/01.ta.0000174919.35240.21; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	32	19	20	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0027-2507	1931-7581		MT SINAI J MED	Mt. Sinai J. Med.	MAR-APR	2009	76	2					138	144		10.1002/msj.20105			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427OE	WOS:000264787800007	19306368				2022-02-06	
J	Arvanitidis, AP; Corbett, D; Colbourne, F				Arvanitidis, Anastasia P.; Corbett, Dale; Colbourne, Frederick			A high fat diet does not exacerbate CA1 injury and cognitive deficits following global ischemia in rats	BRAIN RESEARCH			English	Article						High fat western diet; Hippocampus; Morris water maze; Global ischemia; Stroke	NEUROTROPHIC FACTOR; BRAIN-DAMAGE; POSTISCHEMIC HYPOTHERMIA; FOREBRAIN ISCHEMIA; MEMORY IMPAIRMENT; RISK; STROKE; PLASTICITY; CHOLESTEROL; HIPPOCAMPUS	A diet high in saturated fat and similar in composition to western diets (WD) has been shown to exacerbate injury following traumatic brain injury. Thus, we investigated the effects of a WD on cell death and functional outcome following global ischemia. First we assessed the effects of a 60-day WD regimen on temperature, activity and glucose levels in normal rats (Experiment 1). Second, we evaluated the influence of a 60-day WD regimen on hippocampal CA1 injury and learning and memory impairments following global ischemia in rats (Experiment 2). Male Sprague-Dawley rats, obtained at similar to 50 g, were randomly assigned to either the WD or the low-fat control diet (CD). Animals were fed for 30 days, then subjected to surgery (body temperature probe implantation in experiment 1; forebrain ischemia in experiment 2), and then they stayed on the same diet for another 30 days. Two and 4 weeks following surgery, learning and memory were assessed using the Morris Water Maze. At 60 days, rats were killed and viable hippocampal CA1 cells were quantified. Results from experiment 1 revealed no differences in glucose or temperature profiles between animals fed the WD and CD; however, WD animals were significantly less active than CD animals. Eight minutes of ischemia in experiment 2 induced severe hippocampal CA1 cell loss (similar to 90%) and learning and memory impairments relative to non-ischemic controls. However, the WD did not exacerbate CA1 injury or behavioural deficits. These findings suggest that a 60-day WD regimen does not significantly influence recovery following global ischemia. (C) 2008 Elsevier B.V. All rights reserved.	[Arvanitidis, Anastasia P.; Colbourne, Frederick] Univ Alberta, Dept Psychol, Edmonton, AB T6G 2E9, Canada; [Corbett, Dale] Mem Univ Newfoundland, St John, NF, Canada; [Colbourne, Frederick] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2E9, Canada		Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, P217 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	fcolbour@ualberta.ca	Colbourne, Frederick/ABB-7774-2020; Corbett, Dale/D-6625-2011	Colbourne, Frederick/0000-0002-9567-2082; Corbett, Dale/0000-0003-0217-4576	Canadian Stroke Network (CSN); Alberta Heritage Foundation for Medical Research (AHFMR)Alberta Heritage Foundation for Medical Research	Research supported by a grant from the Canadian Stroke Network (CSN) to FC who is an Alberta Heritage Foundation for Medical Research (AHFMR) Senior Medical Scholar. APA is supported by the department of Psychology at the University of Alberta. The authors gratefully acknowledge M. Penner and L. Tong for their technical assistance.	Bobyn PJ, 2005, EXP NEUROL, V196, P308, DOI 10.1016/j.expneurol.2005.08.006; Brown RW, 2000, DEV PSYCHOBIOL, V37, P238, DOI 10.1002/1098-2302(2000)37:4<238::AID-DEV4>3.0.CO;2-J; COLBOURNE F, 1993, BRAIN RES, V602, P264, DOI 10.1016/0006-8993(93)90691-F; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; Ding EL, 2006, SEMIN NEUROL, V26, P11, DOI 10.1055/s-2006-933305; GERHARDT SC, 1988, BEHAV NEUROSCI, V102, P301, DOI 10.1037/0735-7044.102.2.301; Gillman MW, 1997, JAMA-J AM MED ASSOC, V278, P2145, DOI 10.1001/jama.278.24.2145; Greenwood CE, 1996, BEHAV NEUROSCI, V110, P451, DOI 10.1037/0735-7044.110.3.451; GREENWOOD CE, 1990, BEHAV NEURAL BIOL, V53, P74, DOI 10.1016/0163-1047(90)90831-P; He K, 2003, BRIT MED J, V327, P777, DOI 10.1136/bmj.327.7418.777; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Li PA, 1997, ACTA PHYSIOL SCAND, V161, P567, DOI 10.1046/j.1365-201X.1997.00264.x; MCGEE D, 1985, INT J EPIDEMIOL, V14, P97, DOI 10.1093/ije/14.1.97; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Morris MC, 2004, NEUROLOGY, V62, P1573, DOI 10.1212/01.WNL.0000123250.82849.B6; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Myers RE, 1979, ADV PERINATAL NEUROL, V1, P85; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; REED DM, 1988, STROKE, V19, P820, DOI 10.1161/01.STR.19.7.820; Sauvaget C, 2004, STROKE, V35, P1531, DOI 10.1161/01.STR.0000130426.52064.09; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; SIESJO BK, 1985, PROG BRAIN RES, V63, P121; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; WEBER KO, 1989, CEREBRAL ISCHEMIA CA, P79; WINOCUR G, 1993, PSYCHOBIOLOGY, V21, P286; Winocur G, 1999, BEHAV BRAIN RES, V101, P153, DOI 10.1016/S0166-4328(98)00147-8; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; [No title captured]	35	19	20	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 3	2009	1252						192	200		10.1016/j.brainres.2008.11.058			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	407WK	WOS:000263394800018	19071094				2022-02-06	
J	Grip, H; Jull, G; Treleaven, J				Grip, Helena; Jull, Gwendolen; Treleaven, Julia			HEAD EYE CO-ORDINATION USING SIMULTANEOUS MEASUREMENT OF EYE IN HEAD AND HEAD IN SPACE MOVEMENTS: POTENTIAL FOR USE IN SUBJECTS WITH A WHIPLASH INJURY	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						whiplash; head eye coordination; head movement; gaze stability; eye disturbances; monitoring		Objective. Describe reproducibility of a measurement method to investigate deficits in eye-head co-ordination. Methods. Combined recordings of head and eye rotation using wireless motion sensors and electrooculography (EOG) were used as an initial step towards a method to quantify eye-head co-ordination deficits. Head rotation to the side during gaze fixation and sequential head and eye movements were studied on 20 asymptomatic control subjects and six subjects with chronic whiplash disorders. All included whiplash subjects reported eye disturbances according to a vision symptom questionnaire. Results. The trial-to-trial reproducibility was moderate to high for 24 of 28 variables (Intraclass Correlation Coefficient 0.44 to 0.87). Velocity gain (ratio of eye and head velocities) was on average close to unity in both groups. Head stability was high in control subjects, while three of six whiplash subjects demonstrated head instability during eye movement. Whiplash subjects also demonstrated a decreased range of head movement during gaze fixation and lower head velocities as compared with the asymptomatics. Conclusions. The method of combined head and eye motion appears to give accurate, repeatable measurements. Case studies of whiplash subjects indicated deficits in head eye co-ordination. The method could be useful in further clinical research into eye and head movement in those with neck disorders.	[Grip, Helena; Treleaven, Julia] Umea Univ Hosp, Dept Biomed Engn & Informat, S-90185 Umea, Sweden; [Jull, Gwendolen] Univ Queensland, Whiplash Res Unit, Div Physiotherapy, Brisbane, Qld 4072, Australia		Grip, H (corresponding author), Umea Univ Hosp, Dept Biomed Engn & Informat, S-90185 Umea, Sweden.	helena.grip@vll.se	Treleaven, Julia/N-1379-2019; Treleaven, Julia M/F-8734-2010; Jull, Gwendolen/F-4233-2010	Treleaven, Julia/0000-0002-6258-3972; Treleaven, Julia M/0000-0002-6258-3972; Jull, Gwendolen/0000-0003-2670-1318; Grip, Helena/0000-0003-1635-122X			Allison RS, 1996, IEEE T BIO-MED ENG, V43, P1073, DOI 10.1109/10.541249; Brown M, 2006, DOC OPHTHALMOL, V113, P205, DOI 10.1007/s10633-006-9030-0; COLE GK, 1993, J BIOMECH ENG-T ASME, V115, P344, DOI 10.1115/1.2895496; Collewijn H, 2000, J NEUROPHYSIOL, V84, P376, DOI 10.1152/jn.2000.84.1.376; Corneil BD, 2002, J NEUROPHYSIOL, V88, P1980, DOI 10.1152/jn.2002.88.4.1980; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Grip H, 2003, IEEE T INF TECHNOL B, V7, P412, DOI 10.1109/TITB.2003.821322; Grip H, 2007, CLIN BIOMECH, V22, P865, DOI 10.1016/j.clinbiomech.2007.05.008; Hansson EE, 2006, J REHABIL MED, V38, P387, DOI 10.1080/16501970600768992; Hirvonen M, 2007, ARCH OTOLARYNGOL, V133, P157, DOI 10.1001/archotol.133.2.157; Hulse M, 2000, HNO, V48, P295, DOI 10.1007/s001060050569; Humphreys B, 2002, J WHIPLASH RELAT DIS, V1, P99, DOI [10.3109/J180v01n01_09, DOI 10.3109/J180V01N01_09, DOI 10.3109/J180V0LN01_09]; Jasiewicz JM, 2007, MANUAL THER, V12, P380, DOI 10.1016/j.math.2006.07.005; Joyce CA, 2002, PSYCHOPHYSIOLOGY, V39, P607, DOI 10.1017/S0048577202394113; Jull G, 2007, J ORTHOP RES, V25, P404, DOI 10.1002/jor.20220; JURGENS R, 1989, EXP BRAIN RES, V77, P381, DOI 10.1007/BF00274995; Kelders WPA, 2005, J NEUROTRAUM, V22, P133, DOI 10.1089/neu.2005.22.133; Kimpo RR, 2005, J NEUROPHYSIOL, V94, P3092, DOI 10.1152/jn.00048.2005; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Mergner T, 1998, EXP BRAIN RES, V120, P450, DOI 10.1007/s002210050418; Migliaccio AA, 2006, VISION RES, V46, P2475, DOI 10.1016/j.visres.2006.02.008; Montfoort I, 2006, INVEST OPHTH VIS SCI, V47, P2881, DOI 10.1167/iovs.05-1561; NORTH ALVIN W., 1965, INVEST OPHTHALMOL, V4, P343; Pereira MJ, 2008, ARCH PHYS MED REHAB, V89, P1097, DOI 10.1016/j.apmr.2007.10.044; Proudlock FA, 2003, INVEST OPHTH VIS SCI, V44, P2991, DOI 10.1167/iovs.02-1315; REVEL M, 1994, ARCH PHYS MED REHAB, V75, P895, DOI 10.1016/0003-9993(94)90115-5; Ronsse R, 2007, J NEUROSCI METH, V159, P158, DOI 10.1016/j.jneumeth.2006.06.016; SPITZER WO, 1995, SPINE, V20, pS1; Stahl JS, 2001, EXP BRAIN RES, V136, P200, DOI 10.1007/s002210000593; Storaci R, 2006, EUR SPINE J, V15, P1811, DOI 10.1007/s00586-006-0085-0; Tjell C, 1998, AM J OTOL, V19, P76; Treleaven J, 2005, J REHABIL MED, V37, P219, DOI 10.1080/16501970410024299; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; WERNER J, 1980, NEUROSCIENCE CLIN PE; Yakushin SB, 2005, J NEUROPHYSIOL, V93, P3693, DOI 10.1152/jn.01269.2004; YOUNG LR, 1975, AM PSYCHOL, V30, P315, DOI 10.1037/0003-066X.30.3.315	37	19	19	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307			J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	FEB	2009	23	1					31	40		10.1007/s10877-009-9160-5			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	V20OZ	WOS:000208150600004	19199060				2022-02-06	
J	Ellis, C; Peach, RK				Ellis, Charles; Peach, Richard K.			Sentence planning following traumatic brain injury	NEUROREHABILITATION			English	Article						Language; cognition; confusion; pauses; Rancho Levels; verbal initiation	DISCOURSE ABILITIES; ADULTS; DEFICITS; CHILDREN; MEMORY	Background: Current descriptions of the language problems following traumatic brain injury (TBI) generally emphasize evaluating discourse production and explaining the observed outcomes in terms of disruptions to executive processes. The notion of sentence production impairments at the sentence level has generally been ignored. To respond to this issue, we examined patterns of intrasentential pausing and sentence planning during sentences produced by normal and TBI speakers. Methods: Seven individuals with TBI functioning at Rancho Level V-VI and seven age-matched controls participated in this pilot experiment. Group performances were compared for pause time and verbal initiation time during the production of sentences varying in syntactic complexity under two conditions (reading and repetition). Results: Significant group differences were observed in pausing during both conditions. Pausing patterns of the participants with TBI were strongly correlated with the syntactic complexity of sentences. No significant group differences were observed on verbal initiation time of repeated sentences, although increased initiation times were present among the TBI participants. Conclusions: These findings of this pilot project suggest that the deficits in language production following TBI may include specific impairments to sentence planning. This evidence suggests that the language profile of TBI may be one of both microlinguistic and macrolinguistic impairments.	[Ellis, Charles] Med Univ S Carolina, Coll Hlth Profess, Dept Rehabil Sci, Charleston, SC 29425 USA; [Peach, Richard K.] Rush Univ, Med Ctr, Chicago, IL 60612 USA		Ellis, C (corresponding author), Med Univ S Carolina, Coll Hlth Profess, Dept Rehabil Sci, 151-B Rutledge Ave,POB 250965, Charleston, SC 29425 USA.	ellisc@musc.edu					Brown-Schmidt S, 2006, J MEM LANG, V54, P592, DOI 10.1016/j.jml.2005.12.008; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Caplan David, 1987, NEUROLINGUISTICS LIN; Caspari I, 2000, J NEUROLINGUIST, V13, P15, DOI 10.1016/S0911-6044(99)00009-3; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho C. A., 2007, BRAIN INJURY MED, P895; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); COELHO CA, 1994, DISCOURSE ANAL APPL; Copland DA, 2000, J MED SPEECH-LANG PA, V8, P1; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Ferreira F, 2002, J MEM LANG, V46, P57, DOI 10.1006/jmla.2001.2797; FERREIRA F, 1991, J MEM LANG, V30, P210, DOI 10.1016/0749-596X(91)90004-4; FORD M, 1978, COGNITION, V6, P35, DOI 10.1016/0010-0277(78)90008-2; GARRETT M, 1982, NORMALITY PATHOLOGY; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Goldman-Eisler F., 1968, PSYCHOLINGUISTICS EX; HAGEN C, 1984, LANGUAGE DISORDERS A; HAGEN C, 1979, ANN CONV AM SPEECH L; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Holmes V. M, 1988, LANG COGNITIVE PROC, V3, P323; HOLMES VM, 1984, LANG SPEECH, V27, P115, DOI 10.1177/002383098402700202; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Kertesz A., 1982, W APHASIA BATTERY; Kircher TTJ, 2004, NEUROIMAGE, V21, P84, DOI 10.1016/j.neuroimage.2003.09.041; KIRSNER K, 2002, P 9 INT SPEECH SCI T; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; MCDONALD S, 1999, COMMUNICATION DISORD; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Peach R. K., 1990, ANN CONV AM SPEECH L; Peach R. K., 1986, ANN CONV AM SPEECH L; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; *SIL INT, SPEECH TOOLS 2 0 SPE; Smith M, 1999, COGNITION, V73, P205, DOI 10.1016/S0010-0277(99)00053-0; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	44	19	19	1	16	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2009	24	3					255	266		10.3233/NRE-2009-0476			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	452ZR	WOS:000266580200008	19458433				2022-02-06	
J	Erkmen, N; Taskin, H; Kaplan, T; Sanioglu, A				Erkmen, Nurtekin; Taskin, Halil; Kaplan, Turgut; Sanioglu, Ahmet			The effect of fatiguing exercise on balance performance as measured by the balance error scoring system	ISOKINETICS AND EXERCISE SCIENCE			English	Article						Balance; BESS; exertion; fatigue; treadmill	UNILATERAL POSTURAL CONTROL; HEALTHY-SUBJECTS; MUSCLE FATIGUE; PERCEIVED EXERTION; STANDING BALANCE; SPONTANEOUS-SWAY; STABILITY; CONCUSSION; RELIABILITY; DEFICITS	The aim of the study was to investigate whether a fatiguing exercise on treadmill affects balance performance in recreationally active men and women. Nineteen subjects, aged 18-26 years, were assessed before and after a fatiguing exercise, using the Balance Error Scoring System (BESS). Fatiguing exercise was performed on treadmill using the Bruce protocol. A significant effect of fatigue was present in men ( P < 0.05) and women ( P < 0.05). Women performed at a significantly lower total BESS scores than men at both pretest ( P < 0.05) and posttest ( P < 0.05). The mean difference (posttest-pretest) between men and women was not significant ( P > 0.05). These findings suggest that a fatiguing exercise induced by means of treadmill increases postural sway in healthy subjects, and that this increase in postural sway is sex-independent.	[Erkmen, Nurtekin; Taskin, Halil; Kaplan, Turgut; Sanioglu, Ahmet] Selcuk Univ, Sch Phys Educ & Sport, TR-42079 Konya, Turkey		Taskin, H (corresponding author), Selcuk Univ, Sch Phys Educ & Sport, Alaaddin Keykubat Kampusu, TR-42079 Konya, Turkey.	htaskin@selcuk.edu.tr	Erkmen, Nurtekin/L-2341-2018	Erkmen, Nurtekin/0000-0002-5220-887X			Adlerton AK, 1996, SCAND J MED SCI SPOR, V6, P211; Arnold BL, 1998, J ATHL TRAINING, V33, P323; BALESTRA C, 1992, ELECTROEN CLIN NEURO, V85, P46, DOI 10.1016/0168-5597(92)90101-G; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BROOKS GA, 1996, EXERCISE PHYSL; Bruce RA, 1972, HDB PHYS; COLLEDGE NR, 1994, GERONTOLOGY, V40, P273, DOI 10.1159/000213596; Crowell DH, 2001, J ATHL TRAIN S2, V36, P33; Davidson BS, 2004, EUR J APPL PHYSIOL, V93, P183, DOI 10.1007/s00421-004-1195-1; EKDAHL C, 1989, SCAND J REHABIL MED, V21, P187; Era P, 1996, J GERONTOL A-BIOL, V51, pM53, DOI 10.1093/gerona/51A.2.M53; Erkmen N, 2007, SPORMETRE, VV, P115; Gioftsidou A, 2006, EUR J APPL PHYSIOL, V96, P659, DOI 10.1007/s00421-005-0123-3; Gribble PA, 2004, ARCH PHYS MED REHAB, V85, P589, DOI 10.1016/j.apmr.2003.06.031; Gribble PA, 2004, J ATHL TRAINING, V39, P321; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hansen MS, 2000, KNEE SURG SPORT TR A, V8, P180, DOI 10.1007/s001670050211; Hoffman M, 1998, J ATHL TRAINING, V33, P319; Kinzey SJ, 1998, J ORTHOP SPORT PHYS, V27, P356, DOI 10.2519/jospt.1998.27.5.356; Lee C T, 1998, SPUMS J, V28, P125; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; Levine D, 1996, J REHABIL RES DEV, V33, P36; LUNDIN TM, 1993, J APPL BIOMECH, V9, P191, DOI 10.1123/jab.9.3.191; Mahon AD, 1997, MED SCI SPORT EXER, V29, P1332, DOI 10.1097/00005768-199710000-00009; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Matheson AJ, 1999, J VESTIBUL RES-EQUIL, V9, P261; MCCOMAS AJ, 1996, FORM FUNCTION, P230; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mihalik JP, 2008, J SPORT REHABIL, V17, P38, DOI 10.1123/jsr.17.1.38; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; NASHNER LM, 1982, J NEUROSCI, V2, P536; Onate JA, 2007, J ATHL TRAINING, V42, P446; Palmieri RM, 2003, ARCH PHYS MED REHAB, V84, P1076, DOI 10.1016/S0003-9993(03)00129-1; PANZER VP, 1995, ARCH PHYS MED REHAB, V76, P151, DOI 10.1016/S0003-9993(95)80024-7; Perrin P, 2002, GAIT POSTURE, V15, P187, DOI 10.1016/S0966-6362(01)00149-7; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Robertson RJ, 2000, MED SCI SPORT EXER, V32, P2120, DOI 10.1097/00005768-200012000-00024; Rogind H, 2003, CLIN PHYSIOL FUNCT I, V23, P171, DOI 10.1046/j.1475-097X.2003.00492.x; Rowe A, 1999, J ORTHOP SPORT PHYS, V29, P455, DOI 10.2519/jospt.1999.29.8.455; Rozzi SL, 1999, J ATHL TRAINING, V34, P106; Surenkok O, 2006, ISOKINET EXERC SCI, V14, P301, DOI 10.3233/IES-2006-0238; Tripp BL, 2007, J ATHL TRAINING, V42, P90; Valovich TC, 2003, J ATHL TRAINING, V38, P51; WATSON JDG, 1984, BEHAV BRAIN RES, V13, P267, DOI 10.1016/0166-4328(84)90169-4; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Wilson EL, 2006, GAIT POSTURE, V23, P348, DOI 10.1016/j.gaitpost.2005.04.005; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	53	19	19	1	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0959-3020	1878-5913		ISOKINET EXERC SCI	Isokinetics Exerc. Sci.		2009	17	2					121	127		10.3233/IES-2009-0343			7	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	470CN	WOS:000267950800011					2022-02-06	
J	Kirk, D; Rainey, T; Vail, A; Childs, C				Kirk, Danielle; Rainey, Timothy; Vail, Andy; Childs, Charmaine			Infra-red thermometry: the reliability of tympanic and temporal artery readings for predicting brain temperature after severe traumatic brain injury	CRITICAL CARE			English	Article							CEREBRAL-BLOOD-FLOW; CARE; HYPERTHERMIA; SCORE	Introduction Temperature measurement is important during routine neurocritical care especially as differences between brain and systemic temperatures have been observed. The purpose of the study was to determine if infra-red temporal artery thermometry provides a better estimate of brain temperature than tympanic membrane temperature for patients with severe traumatic brain injury. Methods Brain parenchyma, tympanic membrane and temporal artery temperatures were recorded every 15-30 min for five hours during the first seven days after admission. Results Twenty patients aged 17-76 years were recruited. Brain and tympanic membrane temperature differences ranged from -0.8 degrees C to 2.5 degrees C (mean 0.9 degrees C). Brain and temporal artery temperature differences ranged from-0.7 degrees C to 1.5 degrees C (mean 0.3 degrees C). Tympanic membrane temperature differed from brain temperature by an average of 0.58 degrees C more than temporal artery temperature measurements (95% CI 0.31 degrees C to 0.85 degrees C, P < 0.0001). Conclusions At temperatures within the normal to febrile range, temporal artery temperature is closer to brain temperature than is tympanic membrane temperature.	[Kirk, Danielle; Rainey, Timothy; Childs, Charmaine] Univ Manchester, Salford Royal Fdn Trust, Brain Injury Res Grp, Sch Translat Med, Salford M6 8HD, Lancs, England; [Vail, Andy] Univ Manchester, Biostat Grp, Salford Royal Fdn Trust, Salford M6 8HD, Lancs, England		Childs, C (corresponding author), Univ Manchester, Salford Royal Fdn Trust, Brain Injury Res Grp, Sch Translat Med, Stott Lane, Salford M6 8HD, Lancs, England.	charmaine.childs@manchester.ac.uk	Childs, Charmaine/G-9928-2012	Vail, Andy/0000-0001-8274-2726	Salford Royal Foundation Trust	The authors would like to thank all the staff of the intensive care unit of the Salford Royal Foundation Trust for their support during the study.	Alyagari V, 2007, J NEUROL SCI, V261, P39, DOI 10.1016/j.jns.2007.04.030; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BERGERSEN TK, 1993, ACTA PHYSIOL SCAND, V147, P195, DOI 10.1111/j.1748-1716.1993.tb09489.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; BROGAN P, 1993, LANCET, V342, P1364, DOI 10.1016/0140-6736(93)92275-X; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs C, 1999, ARCH DIS CHILD, V80, P262, DOI 10.1136/adc.80.3.262; Childs C, 2008, BRIT J NEUROSURG, V22, P486, DOI 10.1080/02688690802245541; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; Craig JV, 2002, LANCET, V360, P603, DOI 10.1016/S0140-6736(02)09783-0; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; DUCHARME M, 1994, 6 INT C ENV ERG ERG, V2530, P146; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; HOOKER EA, 1993, SOUTHERN MED J, V86, P855, DOI 10.1097/00007611-199308000-00001; Johnston NJ, 2006, RESUSCITATION, V70, P254, DOI 10.1016/j.resuscitation.2006.02.010; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; POMPEI F, 2004, P SOC PHOTO-OPT INS, V5404, P61; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Suleman MI, 2002, ANESTH ANALG, V95, P67, DOI 10.1097/00000539-200207000-00012	26	19	20	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care		2009	13	3							R81	10.1186/cc7898			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487XN	WOS:000269311700020	19473522	gold, Green Published			2022-02-06	
J	Wahlstrom, MR; Olivecrona, M; Nystrom, F; Koskinen, LOD; Naredi, S				Wahlstrom, M. Rodling; Olivecrona, M.; Nystrom, F.; Koskinen, L. -O. D.; Naredi, S.			Fluid therapy and the use of albumin in the treatment of severe traumatic brain injury	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							RESPIRATORY-DISTRESS-SYNDROME; SEVERE HEAD-INJURY; ACUTE LUNG INJURY; INTRACRANIAL-PRESSURE; ONCOTIC THERAPY; ORGAN FAILURE; CARE; HYPERTENSION; METAANALYSIS; TRANSFUSION	Evidence-based guidelines for severe traumatic brain injury (TBI) do not include strategies for fluid administration. The protocol used in this study includes albumin administration to maintain normal colloid osmotic pressure and advocates a neutral to slightly negative fluid balance. The aim of this study was to analyze the occurrence of organ failure and the mortality in patients with severe TBI treated by a protocol that includes defined strategies for fluid therapy. Ninety-three patients with severe TBI and Glasgow Coma Score <= 8 were included during 1998-2001. Medical records of the first 10 days were retrieved. Organ dysfunction was evaluated with the Sequential Organ Failure Assessment (SOFA) score. Mortality was assessed after 10 and 28 days, 6 and 18 months. The total fluid balance was positive on days 1-3, and negative on days 4-10. The crystalloid balance was negative from day 2. The mean serum albumin was 38 +/- 6 g/l. Colloids constituted 40-60% of the total fluids given per day. Furosemide was administered to 94% of all patients. Severe organ failure defined as SOFA >= 3 was evident only for respiratory failure, which was observed in 29%. None developed renal failure. After 28 days, mortality was 11% and, after 18 months, it was 14%. A protocol including albumin administration in combination with a neutral to a slightly negative fluid balance was associated with low mortality in patients with severe TBI in spite of a relatively high frequency (29%) of respiratory failure, assessed with the SOFA score.	[Wahlstrom, M. Rodling; Nystrom, F.; Naredi, S.] Umea Univ Hosp, Dept Anesthesia & Intens Care, S-90185 Umea, Sweden; [Olivecrona, M.; Koskinen, L. -O. D.] Umea Univ Hosp, Dept Neurosurg, S-90185 Umea, Sweden		Wahlstrom, MR (corresponding author), Umea Univ Hosp, Dept Anesthesia & Intens Care, S-90185 Umea, Sweden.	marie.rodling@anestesi.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502; Olivecrona, Magnus/0000-0001-8457-4711; Naredi, Silvana/0000-0002-4409-6089	Faculty of Medicine; Umea University, Sweden; Vasterbotten Country Council, Sweden	This study was financially supported by the Faculty of Medicine, Umea University, Sweden, and the Vasterbotten Country Council, Sweden.	Abid O, 2000, CRIT CARE MED, V28, P947, DOI 10.1097/00003246-200004000-00006; ALBRIGHT AL, 1984, J NEUROSURG, V60, P481, DOI 10.3171/jns.1984.60.3.0481; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Drummond JC, 1998, ANESTHESIOLOGY, V88, P993, DOI 10.1097/00000542-199804000-00020; Dubois MJ, 2006, CRIT CARE MED, V34, P2536, DOI 10.1097/01.CCM.0000239119.57544.0C; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Grande PO, 2008, ACTA ANAESTH SCAND, V52, P738, DOI 10.1111/j.1399-6576.2008.01688.x; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hebert PC, 2007, CHEST, V131, P1583, DOI 10.1378/chest.06-1055; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Mangialardi RJ, 2000, CRIT CARE MED, V28, P3137, DOI 10.1097/00003246-200009000-00001; Martin GS, 2005, CRIT CARE MED, V33, P1681, DOI 10.1097/01.CCM.0000171539.47006.02; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; NAREDI S, 2001, ACTA ANAESTH SCAND, V45, P1; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Persson J, 2006, CRIT CARE MED, V34, P2456, DOI 10.1097/01.CCM.0000233876.87978.AB; Powers KA, 2003, CRIT CARE MED, V31, P2355, DOI 10.1097/01.CCM.0000084846.45830.AA; Rhee P, 2000, CRIT CARE MED, V28, P74, DOI 10.1097/00003246-200001000-00012; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; TOMITA H, 1994, ACTA NEUROCHIR, P547; Vincent JL, 2004, CRIT CARE MED, V32, P2029, DOI 10.1097/01.CCM.0000142574.00425.E9; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Wilkes MM, 2001, ANN INTERN MED, V135, P149, DOI 10.7326/0003-4819-135-3-200108070-00007; ZHUANG J, 1995, CRIT CARE MED, V23, P140, DOI 10.1097/00003246-199501000-00023; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	41	19	19	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	JAN	2009	53	1					18	25		10.1111/j.1399-6576.2008.01798.x			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	384YO	WOS:000261780300003	18945246	Green Published			2022-02-06	
J	Yanagawa, Y; Sakamoto, T; Takasu, A; Okada, Y				Yanagawa, Youchi; Sakamoto, Toshihisa; Takasu, Akira; Okada, Yoshiaki			Relationship Between Maximum Intracranial Pressure and Traumatic Lesions Detected by T2*-Weighted Imaging in Diffuse Axonal Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Intracranial pressure; T2*-weighted image; diffuse axonal injury	BRAIN-INJURY; HEAD-INJURY; NEUROPATHOLOGY; BIOMECHANICS; MECHANISMS; CHILDREN; IMPACT; MODEL; STATE; COMA	Background., We prospectively investigated whether the number of traumatic lesions detected by magnetic resonance imaging correlated with the level of intracranial pressure (ICP) and outcome among patients with diffuse axonal injury (DAI). Materials: We prospectively studied 19 patients with closed head injuries who were admitted to the Critical Care and Trauma Services at our medical center and who fulfilled the following criteria: did not recover to a Glasgow Coma Scale score greater than 8 after impact, without fixed dilated pupils, and with initial computed tomography findings compatible with DAI. All subjects (n = 19) underwent ICP monitoring for at least 4 days, and T2*-gradient echo imaging was performed within 4 weeks of the impact. Results: A significantly positive correlation was found between the number of lesions detected by magnetic resonance imaging and maximum ICP. The average Glasgow Coma Scale in the good outcome group (Glasgow Outcome Scale IV and V, n = 8) was significantly greater than that in the poor outcome group (Glasgow Outcome Scale I-III, n = 11). The average maximum ICP and the number of lesions in the good outcome group were significantly less than those in the poor outcome group. Conclusion: The number of lesions detected by T2*-gradient echo imaging correlates with the degree of intracranial hypertension and outcome in DAI.	[Yanagawa, Youchi; Sakamoto, Toshihisa; Takasu, Akira; Okada, Yoshiaki] Natl Def Med Coll, Dept Traumatol & Crit Care Med, Tokorozawa, Saitama 3598513, Japan		Yanagawa, Y (corresponding author), Natl Def Med Coll, Dept Traumatol & Crit Care Med, 3-2 Tokorozawa, Tokorozawa, Saitama 3598513, Japan.	yangawa@me.ndmc.ac.jp		Takasu, Akira/0000-0003-3430-0119			Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Marmarou A, 1990, Adv Neurol, V52, P233; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Reinert M, 2000, Neurosurg Focus, V8, pe10; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tomei G, 1991, J Neurosurg Sci, V35, P61; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Uzzell B P, 1990, Adv Neurol, V52, P269; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Woiciechowsky C, 2005, ACT NEUR S, V95, P373; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Yang Shu-Yuan, 2004, Chin J Traumatol, V7, P159	32	19	19	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2009	66	1					162	165		10.1097/TA.0b013e3181469857			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	395SJ	WOS:000262543500021	19131819				2022-02-06	
J	Jalali, R; Dutta, D; Kamble, R; Gupta, T; Munshi, A; Sarin, R; Dinshaw, K				Jalali, Rakesh; Dutta, Debnarayan; Kamble, Rashmi; Gupta, Tejpal; Munshi, Anusheel; Sarin, Rajiv; Dinshaw, Ketayun			Prospective assessment of activities of daily living using Modified Barthel's Index in children and young adults with low-grade gliomas treated with stereotactic conformal radiotherapy	JOURNAL OF NEURO-ONCOLOGY			English	Article						Modified Barthel's Index; Activities of daily living; Low-grade gliomas; Stereotactic conformal radiotherapy	TRAUMATIC BRAIN-INJURY; FUNCTIONAL ASSESSMENT; TUMORS; METASTASES; CHILDHOOD; BENIGN	Purpose To report prospective evaluations of activities of daily living (ADL) in young patients with low-grade gliomas treated with stereotactic conformal radiotherapy (SCRT). Materials and methods Between April 2001 and February 2008, 38 children and young adults (age 5-25 years, median 12.5 years) with low-grade gliomas with residual/progressive disease and treated with SCRT were accrued in a prospective protocol. Patients underwent baseline and follow-up ADL assessments by the modified Barthel's battery, which comprises domains of personal hygiene, bathing self, feeding, toilet, stair climbing, dressing, bowel control, bladder control, ambulation, and chair-bed transfer. Result The patient population consisted of 38 patients (male 29, female 9) with a diagnosis of residual or progressive low-grade glioma (pilocytic astrocytoma in 27, fibrillary astrocytoma in 5, ependymoma in 4, and oligodendroglioma and pleomorphic xanthoastrocytoma in 1 each). Three patients were visually handicapped. Mean of total modified Barthel's ADL score (Barthel' Index, BI) at baseline before staring SCRT was 94.5 (standard deviation 14.8, range 45-100). At 2-year and 3-year follow-up, mean BI was 97.1 and 99, respectively. At baseline pre-radiotherapy assessment, patients with impaired visual function and with low performance status (Karnofsky performance score, KPS < 70) had significantly lower BI than those with normal vision (P = 0.001) and with good performance status (P = 0.001). On follow-up, maximum improvement in individual BI was seen in the ambulation-related domain in patients with impaired visual function (P = 0.027), low KPS (P = 0.015), and age less than 13 years (P = 0.103). The mean pre-radiotherapy baseline BI of three patients, who eventually developed local recurrence, was only 64 (SD 32.1) as compared with a baseline score of 97.18 seen in patients whose tumor remained controlled at follow-up (P = 0.001). Conclusions Young patients with low-grade gliomas after surgical intervention had a lower than normal BI before starting radiotherapy, suggesting a decrease in ADL possibly due to tumor- and surgery-related factors. At 2-year and 3-year follow-up after SCRT, there was no further decrease in mean BI. A significant improvement in BI was seen in visually handicapped patients, patients with poor performance status, and younger patients. Patients who developed tumor recurrence at follow-up had a significantly lower BI at baseline than patients with controlled disease (P = 0.001).	[Jalali, Rakesh] Tata Mem Hosp Parel, Mumbai 400012, Maharashtra, India; [Jalali, Rakesh; Dutta, Debnarayan; Gupta, Tejpal; Munshi, Anusheel; Sarin, Rajiv; Dinshaw, Ketayun] Dept Radiat Oncol, Mumbai, Maharashtra, India; [Kamble, Rashmi] Dept Brain Tumor Fdn India, Mumbai, Maharashtra, India		Jalali, R (corresponding author), Tata Mem Hosp Parel, Radiat Oncol & NeuroOncol 125, Mumbai 400012, Maharashtra, India.	rjalali@tmc.gov.in		Sarin, Rajiv/0000-0002-6405-8282			Arthanat S, 2004, DISABIL REHABIL, V26, P235, DOI 10.1080/09638280310001644889; Brazil L, 1997, J NEURO-ONCOL, V34, P187, DOI 10.1023/A:1005710729748; Carpentieri SC, 2003, NEUROSURGERY, V52, P1348, DOI 10.1227/01.NEU.0000064804.00766.62; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chan KH, 2003, QJM-INT J MED, V96, P643, DOI 10.1093/qjmed/hcg108; DESIREE D, 2000, NEUROSURG FOCUS, V8, P1; Gerrard GE, 2003, CLIN ONCOL-UK, V15, P422, DOI 10.1016/S0936-6555(03)00148-1; Herman MA, 2003, AM J CLIN ONCOL-CANC, V26, P273, DOI 10.1097/00000421-200306000-00014; Jalali R, 2005, RADIOTHER ONCOL, V74, P37, DOI 10.1016/j.radonc.2004.09.014; Jalali R, 2007, PEDIATR BLOOD CANCER, V49, P430; Jalali R, 2006, INT J RADIAT ONCOL, V66, pS14, DOI 10.1016/j.ijrobp.2005.11.025; JANNOUN L, 1990, INT J RADIAT ONCOL, V18, P747, DOI 10.1016/0360-3016(90)90393-X; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; LEON J, 1989, FUNCTIONAL STATUS EL; Makris A, 1995, Clin Oncol (R Coll Radiol), V7, P82, DOI 10.1016/S0936-6555(05)80806-4; Marcinkevicius Egidijus, 2006, Medicina (Kaunas), V42, P130; Merchant TE, 2004, J CLIN ONCOL, V22, P3156, DOI 10.1200/JCO.2004.11.142; Nitta O., 2005, J PHYS THER SCI, V17, P103, DOI DOI 10.1589/JPTS.17.103; Pace A, 2003, ANN ONCOL, V14, P1722, DOI 10.1093/annonc/mdg502; Perks JR, 1999, INT J RADIAT ONCOL, V45, P507, DOI 10.1016/S0360-3016(99)00156-X; *ROYAL COLL PHYS B, 1992, STAND ASS SCAL ELD P; Sardell S, 2000, CLIN ONCOL-UK, V12, P36, DOI 10.1053/clon.2000.9108; SCAND J, 1990, CARING SCI, V4, P99; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SPECTOR WD, 1987, J CHRON DIS, V40, P481, DOI 10.1016/0021-9681(87)90004-X; Thomas R, 1995, Eur J Cancer Care (Engl), V4, P63, DOI 10.1111/j.1365-2354.1995.tb00077.x; Wade D, 1992, MEASUREMENT NEUROLOG	27	19	20	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X			J NEURO-ONCOL	J. Neuro-Oncol.	DEC	2008	90	3					321	328		10.1007/s11060-008-9666-6			8	Oncology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Neurosciences & Neurology	370NG	WOS:000260768300012	18704269				2022-02-06	
J	Salim, A; Hannon, M; Brown, C; Hadjizacharia, P; Backhus, L; Teixeira, PGR; Chan, LS; Ford, H				Salim, Ali; Hannon, Matthew; Brown, Carlos; Hadjizacharia, Pantelis; Backhus, Leah; Teixeira, Pedro G. R.; Chan, Linda S.; Ford, Henri			Intracranial Pressure Monitoring in Severe Isolated Pediatric Blunt Head Trauma	AMERICAN SURGEON			English	Article; Proceedings Paper	18th Annual Meeting of the Southern California Chapter of the American-College-of-Surgeons	JAN 19-21, 2007	Santa Barbara, CA	Amer Coll Surg, So Calif Chapter			BRAIN-INJURY; MANAGEMENT; CHILDREN	Very little research regarding standard treatments for pediatric traumatic brain injury (PTBI) exists. The objective of this study was to examine the use of intracranial pressure (ICP) monitoring devices in PTBI and to determine if its use was associated with any outcome benefit. Data were collected from the Trauma Registry over an 11-year period (1996-2006) on all blunt trauma pediatric patients (age < 14 years) with an initial Glasgow Coma Scale score <= 8. Data collected included: demographics, admission Glasgow Coma Scale score, mechanism of injury, Injury Severity Score, Abbreviated Injury Score, and use of an ICP monitor. Outcome measures included: mortality, complications, discharge location, and capacity. Thirty-three (25%) of 129 blunt PTBI patients had ICP monitors placed. Patients with monitors were more severely injured overall (Injury Severity Score: 25 vs 18, P = 0.001) and had more severe head injury (81% head Abbreviated Injury Score > 3 vs 55%, P = 0.01) than patients without monitors. However, there was no difference in mortality (28% vs 35%, P = 0.52), discharge location (P = 0.10), and discharge capacity (P = 0.84). After multivariable analysis to adjust for the differences between the two study groups, the use of ICP monitor provided no survival benefit (adjusted odds ratio: 1.1; 95% confidence interval [CI]: 0.3-4.1; adjusted P value = 0.85). The use of ICP monitor was, however, independently associated with a higher risk of developing extracranial complications (adjusted odds ratio: 4.3; 95% Cl: 1.2-16.4; adjusted P value = 0.025). In conclusion, the use of ICP monitors in pediatric patients with severe isolated head injury provided no survival benefit and was associated with an increased risk of complications.	[Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Hannon, Matthew; Hadjizacharia, Pantelis; Backhus, Leah; Teixeira, Pedro G. R.; Chan, Linda S.] Los Angeles Cty Univ So Calif, Med Ctr, Los Angeles, CA USA; [Brown, Carlos] Brackenridge Hosp, Div Trauma, Austin, TX USA; [Ford, Henri] Childrens Hosp Los Angeles, Dept Surg, Los Angeles, CA 90027 USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Teixeira, Pedro/H-2239-2011	Teixeira, Pedro/0000-0002-7258-7977; Hannon, Matthew/0000-0002-1631-232X			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; KUMAR R, 1991, CHILD NERV SYST, V7, P299, DOI 10.1007/BF00304824; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037	13	19	19	0	3	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	NOV	2008	74	11					1088	1093					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	373WX	WOS:000261005300010	19062667				2022-02-06	
J	Wertheimer, JC; Hanks, RA; Hasenau, DL				Wertheimer, Jeffrey C.; Hanks, Robin A.; Hasenau, Deborah L.			Comparing Functional Status and Community Integration in Severe Penetrating and Motor Vehicle-Related Brain Injuries	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries, penetrating; Health status; Rehabilitation; Wounds, gunshot	CIVILIAN GUNSHOT WOUNDS; GLASGOW-COMA-SCALE; OUTCOME PREDICTION; MODEL SYSTEMS; HEAD-INJURY; MANAGEMENT; PROGNOSIS; POPULATION	Objective: To examine the functional status of persons surviving a severe penetrating traumatic brain injury (TBI) resulting from a gunshot wound who require inpatient rehabilitation. Design: Data were collected prospectively at 4 different time periods: rehabilitation admission and discharge and year I and year 2 postinjury. Setting: Rehabilitation hospital within a Traumatic Brain Injury Model System. Participants: Forty-five persons with severe penetrating brain injury and 45 persons involved in a motor vehicle crash (MVC). Interventions: Not applicable. Main Outcome Measures: Disability Rating Scale (DRS), FIM instrument, and Community Integration Questionnaire (CIQ). Results: Results indicated functional improvements for both the penetrating and motor vehicle severe TBI groups on the DRS and the FIM from rehabilitation admission to discharge. Follow-up data at I and 2 years postinjury revealed continued improvements on the DRS and FIM measures for both groups, with the greatest improvement in recovery during the first year. In addition, improved community reintegration emerged between I and 2 years postinjury for both groups, as measured by the CIQ. There was a small significant difference on the outcome measures between the 2 groups in the course of their recovery. Conclusions: Persons who survive severe penetrating brain injuries and who require inpatient rehabilitation may show continuing improvement in functioning over time. For persons receiving inpatient rehabilitation services, initial improvement is most likely to occur during the hospital stay and continue postinjury, with the largest improvement in the first year after injury. Community reintegration can also be expected over time. One can expect similar outcomes for individuals who sustain a severe penetrating brain injury and a severe brain injury ensuing from an MVC.	[Wertheimer, Jeffrey C.] Brooks Rehabil Ctr, Dept Behav Med, Jacksonville, FL 32216 USA; [Wertheimer, Jeffrey C.; Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Wertheimer, Jeffrey C.; Hanks, Robin A.] Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Detroit, MI USA; [Hasenau, Deborah L.] William Beaumont Hosp, Dept Urol Res, Royal Oak, MI 48072 USA		Wertheimer, JC (corresponding author), Brooks Rehabil Ctr, Dept Behav Med, 3901 Univ Blvd S, Jacksonville, FL 32216 USA.	jeffrey.wertheimer@brookshealth.org			National Institute on Disability and Rehabilitation Research [H133A020515]	Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133A020515).	ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Ansari SA, 1998, BRIT J NEUROSURG, V12, P340; Aryan HE, 2005, BRAIN INJURY, V19, P505, DOI 10.1080/02699050400005143; Bakir A, 2005, NEUROL MED-CHIR, V45, P281, DOI 10.2176/nmc.45.281; BARLOW P, 1986, NEUROSURGERY, V19, P989, DOI 10.1227/00006123-198612000-00014; Beaman V, 2000, ANN EMERG MED, V35, P258, DOI 10.1016/S0196-0644(00)70077-1; Black KL, 2002, J HEAD TRAUMA REHAB, V17, P489, DOI 10.1097/00001199-200212000-00001; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Carey ME, 2000, NEUROSURG QUART, V10, P1; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; Kuhne CA, 2007, UNFALLCHIRURG, V110, P341, DOI 10.1007/s00113-007-1244-4; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; LINDGREN BR, 1993, PEDIATR PULM, V16, P336, DOI 10.1002/ppul.1950160603; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Minino AM, 2006, NATL VITAL STAT REP, V54, P1; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; TEASDALE G, 1974, LANCET, V2, P81; Tsuei Yuang-Seng, 2005, J Chin Med Assoc, V68, P126, DOI 10.1016/S1726-4901(09)70233-3; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Zafonte RD, 2001, NEUROL RES, V23, P219, DOI 10.1179/016164101101198370	32	19	19	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2008	89	10					1983	1990		10.1016/j.apmr.2008.04.010			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	366LY	WOS:000260484200019	18929027				2022-02-06	
J	Grandhi, R; Duane, TM; Dechert, T; Malhotra, AK; Aboutanos, MB; Wolfe, LG; Ivatury, RR				Grandhi, Ramesh; Duane, Therese M.; Dechert, Tracey; Malhotra, Ajai K.; Aboutanos, Michel B.; Wolfe, Luke G.; Ivatury, Rao R.			Anticoagulation and the elderly head trauma patient	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting and Postgraduate Course Program of the Southeastern-Surgical-Congress	FEB 09-12, 2008	Birmingham, AL	SE Surg Congress			PREINJURY WARFARIN USE; ATRIAL-FIBRILLATION; BRAIN-INJURY; BLEEDING COMPLICATIONS; ANTITHROMBOTIC THERAPY; RISK-FACTORS; MORTALITY; STROKE; AGE; SEVERITY	We sought to determine the effect of anticoagulation therapy on outcomes in elderly patients with closed head injury. We retrospectively reviewed elderly closed head injury patients (>= 65 years) comparing 52 patients on warfarin (AC) with 439 patients not on warfarin (NAC) with subsequent 1:3 propensity matching used to analyze comparable groups. The overall AC group had a higher head abbreviated injury score (AIS) (4.0 +/- 0.7 vs 3.8 +/- 0.7, P = 0.04) compared with the NAC group. After propensity matching, 49 AC patients were compared with 147 NAC patients who were similar for age, gender, injury severity score, and head AIS. Admission INR was higher in the AC group compared to the NAC group (2.5 +/- 1.3 vs 1.1 +/- 0.3, P < 0.0001) and the AC group had a higher mortality rate (38.8% AC (19/49) vs 23.1% NAC (34/147), P = 0.04). In the AC group, survivors and nonsurvivors had similar repeat International Normalized Ratio (INR) values (1.57 +/- 0.65 survivors vs 1.8 +/- 0.72 nonsurvivors, P = 0.31). The AC group experienced greater morbidity after trauma and had higher mortality rates than their NAC counterparts. Prevention of injury and more selective use of warfarin in this patient population are essential to decrease mortality.	[Grandhi, Ramesh; Duane, Therese M.; Dechert, Tracey; Malhotra, Ajai K.; Aboutanos, Michel B.; Wolfe, Luke G.; Ivatury, Rao R.] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA		Duane, TM (corresponding author), West Hosp, 1200 E Broad St,15th Floor,POB 980454, Richmond, VA 23298 USA.	tmduane@vcn.edu	Ivatury, Rao R./H-2922-2019	Dechert, Tracey/0000-0003-4712-883X			CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; Fleming B, 2001, CAN FAM PHYSICIAN, V47, P727; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; He W., 2005, US CENSUS BUREAU CUR, VP23-209, 65; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Karni A, 2001, AM SURGEON, V67, P1098; Kauder D.R., 2004, TRAUMA, P1041; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; OSLER T, 1988, AM J SURG, V156, P537, DOI 10.1016/S0002-9610(88)80548-8; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Schwab C.W., 1990, EARLY CARE INJURED P, P328; Stafford RS, 1996, ARCH INTERN MED, V156, P2537, DOI 10.1001/archinte.156.22.2537; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	27	19	20	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	SEP	2008	74	9					802	805					4	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	344NC	WOS:000258933400005	18807665				2022-02-06	
J	Klose, M; Feldt-Rasmussen, U				Klose, M.; Feldt-Rasmussen, U.			Does the type and severity of brain injury predict hypothalamo-pituitary dysfunction? Does post-traumatic hypopituitarism predict worse outcome?	PITUITARY			English	Article						hypopituitarism; traumatic brain injury; predictors; outcome	GROWTH-HORMONE DEFICIENCY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY INSUFFICIENCY; CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; LONG-TERM; CONSENSUS GUIDELINES; ANTIEPILEPTIC DRUGS; CORTISOL RESPONSE; CRITICAL ILLNESS	Several studies have reported a close association between traumatic brain injury (TBI) and pituitary dysfunction, and expert panels have recently proposed recommendations for hormone assessment and replacement for pituitary insufficiency after TBI. Given the high incidence of TBI, identification of reliable predictors is of utmost importance in order to secure a cost-effective screening strategy. It has not yet been possible to identify early hormone alterations as a useful tool for the prediction of long-term post-traumatic hypopituitarism, whereas indicators of increased trauma severity have been reported as predictive in an increasing number of studies. Outcome studies have moreover indicated that post-traumatic hypopituitarism is of clinical significance, which may justify introduction of neuroendocrine screening in TBI. Much larger cohorts are, however, still needed for further evaluation and confirmation of reliable screening markers, and future studies should be designed to ensure a high diagnostic robustness for proper identification of reliable predictors, as the results may be highly dependent on diagnostic pitfalls.	[Klose, M.; Feldt-Rasmussen, U.] Copenhagen Univ Hosp, Dept Med Endocrinol, Rigshosp, DK-2100 Copenhagen, Denmark		Feldt-Rasmussen, U (corresponding author), Copenhagen Univ Hosp, Dept Med Endocrinol, Rigshosp, PE2131,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	ulla.feldt-rasmussen@rh.regionh.dk					Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Benedetti MS, 2005, EUR J CLIN PHARMACOL, V61, P863, DOI 10.1007/s00228-005-0056-0; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; Bonnefont X, 2005, P NATL ACAD SCI USA, V102, P16880, DOI 10.1073/pnas.0508202102; Cansu A, 2006, EPILEPSIA, V47, P1855, DOI 10.1111/j.1528-1167.2006.00821.x; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Ceballos R, 1966, Ala J Med Sci, V3, P185; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Feldt-Rasmussen U, 2004, GROWTH HORM IGF RES, V14, pS51, DOI 10.1016/j.ghir.2004.03.013; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Herzog AG, 2005, CURR OPIN NEUROL, V18, P167, DOI 10.1097/01.wco.0000162859.42218.fd; HERZOG AG, 1986, ARCH NEUROL-CHICAGO, V43, P347, DOI 10.1001/archneur.1986.00520040035015; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Isojarvi JIT, 2005, CNS DRUGS, V19, P207, DOI 10.2165/00023210-200519030-00003; Isojarvi JIT, 2001, EPILEPSIA, V42, P930, DOI 10.1046/j.1528-1157.2001.042007930.x; Jochberger S, 2006, J CLIN ENDOCR METAB, V91, P4381, DOI 10.1210/jc.2005-2830; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Miller KK, 2005, J CLIN ENDOCR METAB, V90, P768, DOI 10.1210/jc.2004-0894; MOLIJN GJ, 1995, J CLIN ENDOCR METAB, V80, P1799, DOI 10.1210/jc.80.6.1799; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; RASMUSSEN MH, 1995, J CLIN ENDOCR METAB, V80, P1407, DOI 10.1210/jc.80.4.1407; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Vanhorebeek I, 2006, J CLIN ENDOCR METAB, V91, P3803, DOI 10.1210/jc.2005-2089	50	19	23	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	SEP	2008	11	3					255	261		10.1007/s11102-008-0102-x			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	322NN	WOS:000257382700003	18404391				2022-02-06	
J	Zhang, H; Zheng, XS; Yang, XF; Fang, SW; Shen, G; Zhao, CL; Tian, M				Zhang, Hong; Zheng, Xuesheng; Yang, Xiaofeng; Fang, Shengwei; Shen, Gang; Zhao, Chunlei; Tian, Mei			C-11-NMSP/F-18-FDG microPET to monitor neural stem cell transplantation in a rat model of traumatic brain injury	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						neural stem cell; transplantation; microPET; assessment	POSITRON-EMISSION-TOMOGRAPHY; REPORTER GENE-EXPRESSION; CENTRAL-NERVOUS-SYSTEM; DOPAMINE-RECEPTORS; LIVING ANIMALS; IN-VIVO; STROKE; REPLACEMENT; LIGAND; PET	Purpose To investigate whether C-11-N-methylspiperone (C-11-NMSP) microPET could be used for imaging neural stem cells (NSCs) transplantation in a rat model of traumatic brain injury. Methods NSCs were induced to express dopamine receptor type 2 (DRD2), then confirmed by RT-PCR, Western blotting and immunocytochemistry. Eighteen rats were subjected to focal traumatic brain injury in the right parietal lobe and then assigned randomly to the transplantation group and the control group. NSCs labeled with 5-bromo-2-deoxyuridine (BrdU) were transplanted into the cerebral lesion of the transplatation group. MicroPET scan using C-11-NMSP and F-18-FDG were performed to detect the DRD2 expression of transplanted NSCs and the regional glucose metabolism in the cerebral lesion, respectively. Behavioral neurological function of rats were also tested. Results Histological analysis identified viable NSCs. Western blotting and immunofluorescence showed high level of NSCs-induced DRD2 expression. Immunostaining demonstrated high levels of survived BrdU+ and DRD2+ donor cells in the cerebral lesion 2 weeks after transplantation. The lesion-to-normal contralateral ratio (L/N ratio) of C-11-NMSP in the cerebral lesion decreased significantly from 97% to 68% after injury and increased dramatically to 137% 1 day after the transplantation and then decreased gradually. Glucose metabolism showed a decrease of 35% in the cerebral lesion 1 day after injury and recovered to 87% 2 weeks after transplantation. The behavioral neurological function of the transplantation group was significantly improved compared with the control group. Conclusions This study verified that C-11-NMSP microPET can be used to assess the NSCs-induced DRD2 expression in rat model.	[Zhang, Hong; Fang, Shengwei; Zhao, Chunlei; Tian, Mei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Nucl Med, Hangzhou 310009, Zhejiang, Peoples R China; [Zhang, Hong; Zheng, Xuesheng; Fang, Shengwei; Zhao, Chunlei] Zhejiang Univ, Med PET Ctr, Hangzhou 310009, Zhejiang, Peoples R China; [Zhang, Hong; Fang, Shengwei; Zhao, Chunlei] Zhejiang Univ, Inst Nucl Med & Mol Imaging, Hangzhou 310009, Zhejiang, Peoples R China; [Zhang, Hong; Fang, Shengwei; Zhao, Chunlei] Key Lab Med Mol Imaging Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China		Tian, M (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Nucl Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	meitian@gmail.com	Tian, Mei/E-3751-2012		National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30672396]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [R205066]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2006DFB32940]	This study was supported by the grants from the National Science Foundation of China (NSFC) (No. 30672396), the Natural Science Foundation of Zhejiang Province (No. R205066), and a key project grant from the Ministry of Science and Technology of China (MOST; No. 2006DFB32940).	Arbab AS, 2006, EXPERT REV MED DEVIC, V3, P427, DOI 10.1586/17434440.3.4.427; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Blasberg Ronald G, 2002, Mol Imaging, V1, P280; DONALDBURNS H, 1984, J NUCI MED, V25, P1222; Findlay M, 1996, J CLIN ONCOL, V14, P700, DOI 10.1200/JCO.1996.14.3.700; Gambhir SS, 2000, NEOPLASIA, V2, P118, DOI 10.1038/sj.neo.7900083; Gambhir SS, 1999, NUCL MED BIOL, V26, P481, DOI 10.1016/S0969-8051(99)00021-9; Jacobs A, 2001, J NUCL MED, V42, P467; Liang Q, 2001, GENE THER, V8, P1490, DOI 10.1038/sj.gt.3301542; Liang QW, 2002, MOL THER, V6, P73, DOI 10.1006/mthe.2002.0626; Limke TL, 2003, DEV NEUROSCI-BASEL, V25, P257, DOI 10.1159/000072273; Luan Zuo, 2005, Zhonghua Er Ke Za Zhi, V43, P580; LYON RA, 1986, J NEUROSCI, V6, P2941; MacLaren DC, 1999, GENE THER, V6, P785, DOI 10.1038/sj.gt.3300877; MARTRES MP, 1985, SCIENCE, V228, P752, DOI 10.1126/science.3838821; Mayhall EA, 2004, CURR OPIN CELL BIOL, V16, P713, DOI 10.1016/j.ceb.2004.09.007; Modo M, 2004, NEUROIMAGE, V21, P311, DOI 10.1016/j.neuroimage.2003.08.030; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; Phelps ME, 2000, J NUCL MED, V41, P661; Price J, 2001, CURR OPIN NEUROBIOL, V11, P564, DOI 10.1016/S0959-4388(00)00250-6; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Su H, 2004, MOL IMAGING BIOL, V6, P139, DOI 10.1016/j.mibio.2004.02.001; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tian M, 2004, EUR J NUCL MED MOL I, V31, P5, DOI 10.1007/s00259-003-1316-9; Tonchev AB, 2003, MOL CELL NEUROSCI, V23, P292, DOI 10.1016/S1044-7431(03)00058-7; WAGNER H, 1986, SCIENCE, V221, P1264; Wu JC, 2002, CIRCULATION, V106, P180, DOI 10.1161/01.CIR.0000023620.59633.53; Zheng XS, 2007, BRAIN INJURY, V21, P275, DOI 10.1080/02699050701225754; Zheng XS, 2007, CANCER RES, V67, P3691, DOI 10.1158/0008-5472.CAN-06-3912; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	32	19	22	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	SEP	2008	35	9					1699	1708		10.1007/s00259-008-0835-9			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	340VT	WOS:000258673800016	18509630				2022-02-06	
J	Dalen, K; Bruaroy, S; Wentzel-Larsen, T; Laegreid, LM				Dalen, K.; Bruaroy, S.; Wentzel-Larsen, T.; Laegreid, L. M.			Intelligence in Children with Hydrocephalus, Aged 4-15 Years: A Population-based, Controlled Study	NEUROPEDIATRICS			English	Article						hydrocephalus; psychology; non-verbal communication; neuropsychological tests		The aim of this population-based study is to investigate IQ and IQ-related factors in children with hydrocephalus (HC). Psychometric intelligence was assessed in subjects below the age of 7.3 years (N = 52, F = 18, M = 34) with the Wechsler Preschool and. Primary Scale of Intelligence - Revised (WPPSI-R) and for children above the age of 7.3 years (N = 29, F = 6, M = 23) with the Wechsler Intelligence Scale for Children - Revised (WISC-R). The controls were matched according to age, gender, and geographic variables. All children were living in western Norway. 57 children had infantile HC (IH) and 24 had childhood HC (CH). Children with myelomeningocele (MMC), traumatic brain injury (TBI), or intracranial tumours were excluded. IQ levels were found to be significantly higher in the control group than in the HC groups. The Kaufman factors showed a similar pattern, with lowest values in IH, and CH intermediate between IH and NC. The results demonstrate that HC affects IQ. More specific cognitive profiles, such as nonverbal learning disabilities, are not detectable when using the Wechsler tests. For this purpose, other tests and models for analyses may be recommended.	[Dalen, K.] Univ Bergen, Dept Biol & Med Psychol, N-5009 Bergen, Norway; [Bruaroy, S.; Laegreid, L. M.] Haukeland Hosp, Dept Child Neurol, N-5021 Bergen, Norway; [Wentzel-Larsen, T.] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway		Dalen, K (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Jonas Liesvei 91, N-5009 Bergen, Norway.	knut.dalen@psych.uib.no					Dalen K, 2006, NEUROPEDIATRICS, V37, P1, DOI 10.1055/s-2006-923839; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DENNIS M, 1981, ARCH NEUROL-CHICAGO, V38, P607, DOI 10.1001/archneur.1981.00510100035004; HEIJ CPMOO, 1985, CLIN NEUROL NEUROSUR, V87, P247, DOI 10.1016/0303-8467(85)90131-3; Kaufman, 1979, INTELLIGENT TESTING; Korkman M, 1998, DEV NEUROPSYCHOLOGIC; *PSYCH CORP, 1989, WECHSL PRESCH PRIM S; RICHARDSON JTE, 1978, BRIT J SOC CLIN PSYC, V17, P261, DOI 10.1111/j.2044-8260.1978.tb00276.x; ROURKE BP, 1994, FRAMES REFERENCE ASS, P475; SHURTLEF.DB, 1973, AM J DIS CHILD, V125, P688, DOI 10.1001/archpedi.1973.04160050042008; YUDKIN PL, 1987, ARCH DIS CHILD, V62, P24, DOI 10.1136/adc.62.1.24; [No title captured]; ISI WEB KNOWLEDGE; 2007, STATA SE 9 2 WINDOWS; 2005, SPSS WINDOWS REL 14	15	19	19	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0174-304X	1439-1899		NEUROPEDIATRICS	Neuropediatrics	JUN	2008	39	3					146	150		10.1055/s-0028-1085463			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	375MJ	WOS:000261117700002	18991193				2022-02-06	
J	Catroppa, C; Anderson, V; Ditchfield, M; Coleman, L				Catroppa, Cathy; Anderson, Vicki; Ditchfield, Michael; Coleman, Lee			Using magnetic resonance imaging to predict new learning outcome at 5 years after childhood traumatic brain injury	JOURNAL OF CHILD NEUROLOGY			English	Article						traumatic brain injury; memory; magnetic resonance imaging	CLOSED-HEAD INJURY; WORKING-MEMORY; PREFRONTAL CORTEX; CHILDREN; RECOVERY	Memory and learning entail the recruitment of a number of neural areas, including the medial temporal lobes, temporal association areas, and prefrontal cortices. This study examined the effects of injury severity on long-term memory function in 55 children who sustained traumatic brain injury 5 years earlier and compared this with 17 healthy controls. It also investigated cortical damage and diffuse axonal injury and their association to memory and learning outcomes 5 years after traumatic brain injury Children were administered memory tests of increasing complexity. Results indicated that injury severity affected aspects of complex memory, with no significant influence on working memory; that focal cortical damage was not predictive of working or complex memory, whereas diffuse axonal injury predicted outcome on complex memory tasks. Findings suggest that the implementation of diffuse axonal injury as an index of injury may assist in predicting memory outcome after childhood traumatic brain injury.	Royal Childrens Hosp, Dept Psychol, Parkville, Vic 3052, Australia; [Catroppa, Cathy; Anderson, Vicki] Australian Ctr Child Neurospychol Studies, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Melbourne, Vic, Australia		Catroppa, C (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Amacher AL, 1988, PEDIAT HEAD INJURIES; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2001, BRAIN DAM B, P125; ANDERSON V, 1997, NEUROPSCHOLOGICAL AS; Anderson VA, 2000, BRAIN INJURY, V14, P679; ANDREWES D, 2001, NEUROPSYCHOLOGY FROM; Baddeley A.D., 1997, HUMAN MEMORY THEORY; BADDLEY A, 1990, HUIRTAN MEMORY THEOR; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; BROADBENT NJ, 2002, NEUROPSYCHOLOGY MEMO, P3; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Ciccetti D., 1984, VINELAND ADAPTIVE BE; COFFEY CE, 1991, AM PSYCHOP, P243; Cowan N., 1995, ATTENTION MEMORY INT; Cowan N., 1997, DEV MEMORY CHILDHOOD, P163; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; DANIEL A, 1983, PRIVILEGE PRESTIGE O; Farmer JE, 1999, DEV NEUROPSYCHOL, V15, P269, DOI 10.1080/87565649909540749; Fidell L.S., 2000, USING MULTIVARIATE S; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Garth J, 1997, Pediatr Rehabil, V1, P99; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Harris JR, 1996, J COMMUN DISORD, V29, P79, DOI 10.1016/0021-9924(94)00035-2; Johnson M. H., 1997, DEV COGNITIVE NEUROS; Johnson MH, 2003, BIOL PSYCHIAT, V54, P1312, DOI 10.1016/S0006-3223(03)00426-8; KOPLEMAN M, 2004, HDB MEMORY DISORDERS; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Miller EK, 1996, J NEUROSCI, V16, P5154; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; PETRIDES M, 1989, HDB NEUROPSYCHOLOGY, V3, P75; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; RYAN TV, 1996, PEDIAT ALEUROPSYCHOL, P17; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; TEASDALE G, 1974, LANCET, V2, P81; TEASEDALE G, 1984, CLOSED HEAD INJURY P; TRAVEL D, 2002, HDB MEMORY DISORDERS, P17; Tsujimoto S, 2004, CEREB CORTEX, V14, P703, DOI 10.1093/cercor/bhh030; Ward H, 2004, BRAIN INJURY, V18, P471, DOI 10.1080/02699050310001646107; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92	51	19	19	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	MAY	2008	23	5					486	496		10.1177/0883073807309773			11	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	292XO	WOS:000255299600003	18184933				2022-02-06	
J	Hartzfeld, P; Elisevich, K; Pace, M; Smith, B; Gutierrez, JA				Hartzfeld, P.; Elisevich, K.; Pace, M.; Smith, B.; Gutierrez, J. A.			Characteristics and surgical outcomes for medial temporal post-traumatic epilepsy	BRITISH JOURNAL OF NEUROSURGERY			English	Article						closed head injury; hippocampal sclerosis; magnetic resonance imaging; medial temporal epilepsy	TRAUMATIC BRAIN-INJURY; HUMAN HEAD-INJURY; HIPPOCAMPAL PATHOLOGY; ISCHEMIA; RECEPTOR; NEURONS; DAMAGE; RAT	A common post-traumatic location of epileptogenesis is the medial temporal lobe despite evidence of associated diffuse or remote cerebral injury. We undertook a review of post-traumatic medial temporal lobe epilepsy (MTLE) patients as part of an overall post-traumatic epilepsy population to assess the extent of cerebral injury sustained by this subpopulation and to establish whether surgical outcome differed from that of a non-traumatically-induced epilepsy population. A retrospective review of 57 patients operated for post-traumatic epilepsy (PTE) over a 10-year period (1993-2003) was undertaken with particular attention to those undergoing medial temporal resection. Preoperative magnetic resonance imaging (MRI) was assessed for the type and location of abnormalities. Postoperative outcomes were compared with those of patients with MTLE of non-traumatic origin operated by the same surgeon. Of the 57 patients operated, 30 cases underwent medial temporal lobe resection. The most common mechanism of injury was blunt trauma attributable to motor vehicle accidents with imaging abnormalities characterized by medial temporal sclerosis (MTS; 16 cases), T2/FLAIR hyperintensities (nine cases), periventricular gliosis (seven cases), diffuse cerebral atrophy (five cases) and focal encephalomalacia (three cases). Six patients had normal MRI studies. No significant differences in postoperative outcomes were found between post- and non-traumatic MTLE epilepsy groups. The presence of histopathological change in the medial temporal lobe varied greatly and provided no indication of a favourable postoperative outcome. Patients with post-traumatic medial temporal lobe epilepsy respond favourably to surgical treatment. In the case of medial temporal sclerosis, there is substantial variation of histopathological findings which correlate poorly with current imaging applications. The favourable outcomes obtained following surgery in this group attest to a commonality with other risk factors in the genesis of epilepsy in this location.	[Hartzfeld, P.; Elisevich, K.] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Pace, M.] Henry Ford Hlth Syst, Dept Radiol, Detroit, MI 48202 USA; [Smith, B.] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Gutierrez, J. A.] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI 48202 USA		Elisevich, K (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nskoe@neuro.hfh.edu	Elisevich, Kost/AAF-8260-2020	Elisevich, Kost/0000-0002-2695-7500			Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; de Jong EK, 2005, J NEUROSCI, V25, P7548, DOI 10.1523/JNEUROSCI.1019-05.2005; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; Gualtari CT, 1991, BRAIN INJURY, V5, P219; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Mitrasinovic OM, 2005, J NEUROSCI, V25, P4442, DOI 10.1523/JNEUROSCI.0514-05.2005; OLNEY J, 1987, EUR J PHARMACOL, V141, P357, DOI 10.1016/0014-2999(87)90552-8; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PAMPIGLIONE G, 1975, CIBA F SYMP, V34, P263; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SEISJO BK, 1988, ANN NY ACAD SCI, V522, P638; Soares HD, 1995, J NEUROSCI, V15, P8223; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	22	19	19	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	APR	2008	22	2					224	230		10.1080/02688690701818901			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	275KX	WOS:000254071400009	18348018				2022-02-06	
J	Spiotta, AM; Stiefel, MR; Heuer, GG; Bloom, S; Maloney-Wilensky, E; Yang, W; Grady, MS; Le Roux, PD				Spiotta, Alejandro M.; Stiefel, Michael R.; Heuer, Gregory G.; Bloom, Stephanie; Maloney-Wilensky, Eileen; Yang, Wei; Grady, M. Sean; Le Roux, Peter D.			Brain hyperthermia after traumatic brain injury does not reduce brain oxygen	NEUROSURGERY			English	Article						brain oxygen; hyperthermia; temperature; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; LENGTH-OF-STAY; INTRACRANIAL-PRESSURE; MODERATE HYPOTHERMIA; TISSUE OXYGENATION; BLOOD-FLOW; RECTAL TEMPERATURES; CARE; METABOLISM	OBJECTIVE: Hyperthermia can exacerbate outcome after traumatic brain injury (TBI). In this study, we examined the relationship between brain temperature (BT) and core body temperature and the relationship between BT and brain tissue oxygen (BtO(2)) to determine whether hyperthermia adversely affects BtO(2). METHODS: Seventy-two patients (mean age, 41 +/- 19 years) admitted to a Level I trauma center after TBI were retrospectively identified from a prospective observational database. Intracranial pressure (ICP), BT, and BtO(2) were recorded continuously. Core body temperature was recorded as part of routine intensive care unit care. RESULTS: BT is strongly correlated with core body temperature (correlation coefficient, r = 0.92) over a wide range. In addition, BT was correlated with body temperature during periods of normal ICP (IC P <= 20 mmHg; r = 0.87) and transiently elevated ICP (ICP range 21-63 mrnHg; r = 0.94). During periods of brain normothermia (BT < 38.1 degrees C), the average BtO(2) was 36.3 +/- 22.9 mmHg. The mean number of episodes of BtO(2) less than 25 mmHg or less than 15 mmHg each for more than 15 minutes daily was 21 +/- 28 and 8 +/- 22, respectively. The mean BtO(2) (37.2 +/- 16.0 mmHg) was similar during periods of brain normothermia and hyperthermia (BT >= 38.1 degrees C). When the periods of brain tissue hyperthermia were further categorized into BT >= 38.6 degrees C or BT >= 39.2 degrees C, mean daily BtO(2) was similar in all of the groups. When BT was 38.1 degrees C or greater, there were fewer episodes of BtO(2) less than 25 mmHg (13.5 +/- 24.6; P < 0.05) and of BtO(2) less than 15 mmHg (3.3 +/- 11.9; P < 0.05) than observed during brain normothermia. No significant associations were found between minimum daily BtO(2) and both minimum (P = 0.81) and maximum (P = 0.19) daily BT or between maximum daily BtO(2) and both minimum (P = 0.62) and maximum (P = 0.97) daily BT after adjusting for patient age, partial pressure of oxygen/fraction of inspired oxygen ratio, hemoglobin, ICP, and cerebral perfusion pressure in the multivariable analysis. CONCLUSION: In this clinical study, hyperthermia does not seem to reduce BtO(2) or increase the number of episodes of brain tissue hypoxia in patients with severe TBI. These results suggest that hyperthermia may worsen outcome after TBI through mechanisms that may be separate from compromised brain oxygen.	[Spiotta, Alejandro M.; Stiefel, Michael R.; Heuer, Gregory G.; Bloom, Stephanie; Maloney-Wilensky, Eileen; Yang, Wei; Grady, M. Sean; Le Roux, Peter D.] Univ Penn, Dept Neurosurg, Sch Med, Philadelphia, PA 19107 USA; [Yang, Wei] Univ Penn, Dept Biostat, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19107 USA		Le Roux, PD (corresponding author), Univ Penn, Dept Neurosurg, Sch Med, 330 S 9th St, Philadelphia, PA 19107 USA.	lerouxp@uphs.upenn.edu	Yang, Wei/A-9223-2009	Yang, Wei/0000-0001-8984-4389			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Alyagari V, 2007, J NEUROL SCI, V261, P39, DOI 10.1016/j.jns.2007.04.030; [Anonymous], 2000, MAN PROGN SEV TRAUM, P47; Axelrod YK, 2006, CRIT CARE CLIN, V22, P767, DOI 10.1016/j.ccc.2006.06.001; Bardt TF, 1998, ACT NEUR S, V71, P153; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clinchot DM, 1997, AM J PHYS MED REHAB, V76, P323, DOI 10.1097/00002060-199707000-00012; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Dings J, 1998, NEUROL RES, V20, pS71; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; HAGERDAL M, 1975, J NEUROCHEM, V24, P311, DOI 10.1111/j.1471-4159.1975.tb11881.x; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Huang WT, 2001, NEUROPHARMACOLOGY, V41, P811, DOI 10.1016/S0028-3908(01)00120-4; Jia Jun, 2005, Chin J Traumatol, V8, P138; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kinoshita K, 2003, ACTA NEUROCHIR SUPPL, V86, P377; MATTHEWS DSF, 1995, ARCH DIS CHILD, V72, P507, DOI 10.1136/adc.72.6.507; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MICHENFELDER JD, 1968, ANESTHESIOLOGY, V29, P1107, DOI 10.1097/00000542-196811000-00005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MURR R, 1995, NEUROL RES, V17, P329, DOI 10.1080/01616412.1995.11740338; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; ORITA T, 1995, NEUROL RES, V17, P443, DOI 10.1080/01616412.1995.11740360; Otawara Y, 2003, SURG NEUROL, V60, P549, DOI 10.1016/S0090-3019(03)00293-3; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, P5103; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Sakurai A, 2003, ACTA NEUROCHIR SUPPL, V86, P251; Salci Kontsantin, 2006, J Clin Monit Comput, V20, P25, DOI 10.1007/s10877-006-2864-x; SAPER CB, 1994, NEW ENGL J MED, V330, P1880; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P81; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Stubbe HD, 2004, J CEREBR BLOOD F MET, V24, P1400, DOI 10.1097/01.WCB.0000141516.61418.82; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Whalen MJ, 1997, ACT NEUR S, V70, P260; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278; Yamaguchi S, 2000, NEUROL RES, V22, P657; YOUNG B, 1996, NEUROTRAUMA, P345; Zhang Sai, 2002, Chin J Traumatol, V5, P43	73	19	19	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2008	62	4					864	872		10.1227/01.neu.0000316900.63124.ce			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	294TR	WOS:000255429300036	18414135				2022-02-06	
J	Casson, IR; Pellman, EJ; Viano, DC				Casson, Ira R.; Pellman, Elliot J.; Viano, David C.			Concussion in the national football league: an overview for neurologists	NEUROLOGIC CLINICS			English	Article							PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; GAME IMPACTS; INJURIES; BIOMECHANICS; PERFORMANCE; PLAYER	The authors' studies have yielded a great deal of data regarding the biomechanics of head injury and the clinical picture of mild traumatic brain injury (MTBI) in the National Football League (NFL). The research has demonstrated the link between the effects of biomechanical forces on the brain and the clinical symptomatology of the concussed players. New insights into the mechanisms of injury are leading to new ways of protecting football players from the effects of MTBI. The clinical data validate the effectiveness of the current NFL physician approach to the evaluation and treatment of the player who sustains MTBI. There are still many more questions to answer and much more knowledge to be gained from continuing research in this area.	[Viano, David C.] ProBiomech LLC, Bloomfield Hills, MI 48304 USA; [Casson, Ira R.; Pellman, Elliot J.; Viano, David C.] Natl Football League, Mild Traumat Brain Injury Comm, New York, NY 10017 USA; [Casson, Ira R.] Albert Einstein Coll Med, Long Isl Jewish Med Ctr, Dept Neurol, Bronx, NY 10467 USA; [Pellman, Elliot J.] LLP, ProHEALTH Care Associates, New Hyde Pk, NY 11042 USA; [Pellman, Elliot J.] Mt Sinai Hosp, Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Pellman, Elliot J.] Mt Sinai Hosp, Dept Orthopaed, New York, NY 10029 USA		Viano, DC (corresponding author), ProBiomech LLC, 265 Warrington Rd, Bloomfield Hills, MI 48304 USA.	dviano@comcast.net					*C NEUR SURG, 1996, CLIN NEUROSURG, V16, P386; CANTU RC, 2001, NEUROLOGICAL SPORTS, P25; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Casson Ira R, 2006, Neurosurgery, V59, pE1152; Casson Ira R, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEY.0000217313.15590.C5; *COL MED SOC, 1991, REP SPORTS MED COMM; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Kelly JP, 1997, NEUROLOGY, V48, P581; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; MORRISON RG, 1986, JAMA-J AM MED ASSOC, V255, P2475, DOI 10.1001/jama.255.18.2475; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C	30	19	19	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	FEB	2008	26	1					217	+		10.1016/j.ncl.2007.11.005			27	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281ID	WOS:000254489200013	18295092				2022-02-06	
J	Good, GE; Schopp, LH; Thomson, D; Hathaway, SL; Mazurek, MO; Sanford-Martens, TC				Good, Glenn E.; Schopp, Laura H.; Thomson, Doug; Hathaway, Stefani L.; Mazurek, Micah O.; Sanford-Martens, Tiffany C.			Men with serious injuries: Relations among masculinity, age, and alcohol use	REHABILITATION PSYCHOLOGY			English	Article						men; masculinity; alcohol abuse; traumatic brain injury; spinal cord injury	SPINAL-CORD-INJURY; GENDER-ROLE CONFLICT; TRAUMATIC BRAIN-INJURY; SUBSTANCE-ABUSE; SEXUAL ADJUSTMENT; HELP-SEEKING; PREDICTORS; DRINKING; REHABILITATION; STRESS	Objective: To increase understanding of masculine role attitudes and conflicts associated with alcohol use among men with serious injuries. Participants and Measures: Fifty-two Midwestern adult men with spinal cord injury or traumatic brain injury completed masculine role attitudes and conflicts and alcohol consumption instruments. Age and blood alcohol content at injury were obtained from records. Results: Younger men reported greater pursuit of status, drive for dominance, and risk taking but less self-reliance and overall masculine role conflict. Earlier age of injury was associated with greater pursuit of status and drive for dominance but less self-reliance, restrictive emotionality, and overall masculine role conflict. Endorsement of dominance correlated positively with number of alcoholic drinks per drinking episode (r(s) = .43) and binge drinking (r(s) = .47). Masculine role conflict associated with success, power, and competition correlated with number of drinks per drinking episode (r(s) = .46). Implications: Greater awareness and sensitivity to masculinity-related attitudes and conflicts may (a) reduce psychological barriers to accepting assistance, (b) promote active engagement in rehabilitation activities, (c) avoid counterproductive ambivalence and resistance, and (d) improve the therapeutic working alliance associated with favorable outcomes among men with serious injuries.	[Good, Glenn E.; Thomson, Doug; Hathaway, Stefani L.; Sanford-Martens, Tiffany C.] Univ Missouri, Dept Educ Sch & Counseling Psychol, Columbia, MO 65211 USA; [Schopp, Laura H.; Mazurek, Micah O.] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65211 USA		Good, GE (corresponding author), Univ Missouri, Dept Educ Sch & Counseling Psychol, 16 Hill Hall, Columbia, MO 65211 USA.	goodg@missouri.edu	Mazurek, Micah/ABE-8748-2020; Mazurek, Micah/AAR-6192-2020	Mazurek, Micah/0000-0001-7715-6538			ABREU JM, 2000, PSYCHOL MEN MASCULIN, V0001, P00075, DOI DOI 10.1037/1524-9220.1.2.75; Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Baumeister R. F., 1998, PSYCHOL BULL, V104, P3; Baumeister R.F., 1997, REV GEN PSYCHOL, V2, P145, DOI [10.1037/1089-2680.1.2.145, DOI 10.1037/1089-2680.1.2.145, 10.1037//1089-2680.1.2.145]; Berger JM, 2005, PSYCHOL MEN MASCULIN, V6, P73, DOI DOI 10.1037/1524-9220.6.1.73; Blazina C, 1996, J COUNS PSYCHOL, V43, P461, DOI 10.1037/0022-0167.43.4.461; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Bray RM, 1999, AM J DRUG ALCOHOL AB, V25, P239, DOI 10.1081/ADA-100101858; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Conroy L, 1999, SPINAL CORD, V37, P624, DOI 10.1038/sj.sc.3100904; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; COURNOYER RJ, 1995, J COUNS PSYCHOL, V42, P11, DOI 10.1037/0022-0167.42.1.11; Courtenay WH, 1998, J AM COLL HEALTH, V46, P279, DOI 10.1080/07448489809596004; Dawson DA, 2005, ALCOHOL ALCOHOLISM, V40, P453, DOI 10.1093/alcalc/agh176; GOOD GE, 1995, J COUNS PSYCHOL, V42, P3, DOI 10.1037/0022-0167.42.1.3; Good GE, 2006, PSYCHOL MEN MASCULIN, V7, P165, DOI DOI 10.1037/1524-9220.7.3.165; Grady Denise, 2006, N Y Times Web, pA30; HARRISON J, 1978, J SOC ISSUES, V34, P65, DOI 10.1111/j.1540-4560.1978.tb02541.x; HULL JG, 1983, J PERS SOC PSYCHOL, V44, P1097, DOI 10.1037/0022-3514.44.6.1097; ISENHART C, 2005, NEW HDB PSYCHOTHERAP, P134; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEMLE R, 1989, J SUBST ABUSE TREAT, V6, P213, DOI 10.1016/0740-5472(89)90045-7; LO CC, 1995, J DRUG ISSUES, V25, P817, DOI 10.1177/002204269502500411; Locke BD, 2005, J COUNS PSYCHOL, V52, P279, DOI 10.1037/0022-0167.52.3.279; Marini I. D., 2005, NEW HDB PSYCHOTHERAP, P88; MARLATT GA, 1988, ANNU REV PSYCHOL, V39, P223, DOI 10.1146/annurev.psych.39.1.223; McCreary DR, 1999, J COUNS PSYCHOL, V46, P109, DOI 10.1037/0022-0167.46.1.109; Middleton JW, 1998, ARCH PHYS MED REHAB, V79, P1428, DOI 10.1016/S0003-9993(98)90239-8; Miller W.R., 2002, MOTIVATIONAL INTERVI; *NAT SPIN CORD INJ, 2005, SPIN CORD INJ FACTS; Nolen-Hoeksema S, 2006, J GEN PSYCHOL, V133, P357, DOI 10.3200/GENP.133.4.357-374; O'Neil JM, 1995, NEW PSYCHOL MEN, P164; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; ONEIL JM, 1986, SEX ROLES, V14, P335; Phelps J, 2001, ARCH SEX BEHAV, V30, P591, DOI 10.1023/A:1011910900508; STILLSON RW, 1991, J COUNS PSYCHOL, V38, P458, DOI 10.1037/0022-0167.38.4.458; *SUBST AB MENT HLT, 2005, 2005 NATL SURV DRUG; Substance Abuse and Mental Health Services Administration OoAS, 2007, NSDUH REP GEND DIFF; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; Tokar DM, 2000, J COUNS PSYCHOL, V47, P380, DOI 10.1037//0022-0167.47.3.380; WATANABE ME, 2005, APPL NEUROLOGY, V1, P10; Williams RJ, 1999, J PSYCHOL, V133, P323, DOI 10.1080/00223989909599745; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; YOUNG ME, 1995, ARCH PHYS MED REHAB, V76, P525, DOI 10.1016/S0003-9993(95)80506-0; Zoroya G, 2005, US TODAY, pA1; [No title captured], DOI DOI 10.1037/1524-9220.4.1.3	51	19	19	0	11	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2008	53	1					39	45		10.1037/0090-5550.53.1.39			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	266JR	WOS:000253431900005					2022-02-06	
J	Lundblad, C; Grande, PO; Bentzer, P				Lundblad, Cornelia; Grande, Per-Olof; Bentzer, Peter			Increased cortical cell loss and prolonged hemodynamic depression after traumatic brain injury in mice lacking the IP receptor for prostacyclin	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain trauma; brain edema; microvascular permeability; microvascular perfusion; prostacyclin	LOW-DOSE PROSTACYCLIN; CEREBRAL BLOOD-FLOW; THROMBOXANE A(2); CAPILLARY PERFUSION; HEAD-INJURY; RAT; PERMEABILITY; INHIBITOR; ISCHEMIA; MOUSE	Prostacyclin is the major arachidonic acid metabolite of the vascular endothelium and is produced mainly via the cyclooxygenase-2 pathway. By acting on the prostacyclin (IP) receptor on platelets and vascular smooth muscle cells, prostacyclin exerts vasodilatory and antiaggregative/antiadhesive effects. Previous studies have shown that prostacyclin production increases after brain trauma, but the importance of prostacyclin for posttraumatic hemodynamic alterations and neuron survival has not been investigated. This study evaluated if endogenous prostacyclin plays a role in the pathophysiologic process in the brain after brain trauma. This was performed by comparing prostacyclin (IP) receptor-deficient (IP-/-) mice and mice with functional IP receptor (IP+/+) after a controlled cortical injury regarding contusion volume, cerebral blood flow ([C-14] iodoantipyrine autoradiography), number of perfused capillaries (fluorescein isothiocyanate-dextran fluorescence technique), the transfer constant (K-i) for [Cr-51] EDTA, and brain water content (wet vs dry weight) in the injured and contralateral cortex. Contusion volume was increased in IP-/- mice compared with IP+/+ mice. Three hours after trauma, cortical blood flow was decreased in the injured cortex of both groups and the reduction in blood flow in the cortex of the IP-/- mice persisted from 3 to 24 h, whereas blood flow approached normal values in the IP+/+ mice after 24 h. No differences could be detected between the two genotypes regarding other hemodynamic parameters. We conclude that the prostacyclin IP receptor is beneficial for neuron survival after brain trauma in mice, an effect that may be mediated by improved cortical perfusion.	[Lundblad, Cornelia; Grande, Per-Olof; Bentzer, Peter] Univ Lund Hosp, Dept Anesthesiol & Intens Care, Univ Lund, SE-22185 Lund, Sweden		Bentzer, P (corresponding author), Univ Lund Hosp, Dept Anesthesiol & Intens Care, Univ Lund, SE-22185 Lund, Sweden.	peter.bentzer@med.lu.se		Lundblad, Cornelia/0000-0001-9686-2112			Bentzer P, 2004, J TRAUMA, V56, P385, DOI 10.1097/01.TA.0000057238.75632.7F; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; ERLANSSON M, 1991, PROSTAGLANDINS, V41, P157, DOI 10.1016/0090-6980(91)90028-E; FENSTERMACHER JD, 1981, PHARMACOL THERAPEUT, V14, P217, DOI 10.1016/0163-7258(81)90062-0; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lundblad C, 2004, J NEUROTRAUM, V21, P741, DOI 10.1089/0897715041269614; Manganello JM, 1999, J BIOL CHEM, V274, P28003, DOI 10.1074/jbc.274.39.28003; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; MCCALDEN TA, 1984, LIFE SCI, V34, P1801, DOI 10.1016/0024-3205(84)90672-6; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; OIDA H, 1995, BRIT J PHARMACOL, V116, P2828, DOI 10.1111/j.1476-5381.1995.tb15933.x; Rudic RD, 2005, CIRC RES, V96, P1240, DOI 10.1161/01.RES.0000170888.11669.28; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; WANIEWSKI J, 1992, NEPHROL DIAL TRANSPL, V7, P50; WEISS HR, 1988, MICROVASC RES, V36, P172, DOI 10.1016/0026-2862(88)90017-9; WESTCOTT JY, 1987, PROSTAGLANDINS, V34, P877, DOI 10.1016/0090-6980(87)90068-2; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; [No title captured]	36	19	20	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2008	28	2					367	376		10.1038/sj.jcbfm.9600533			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	255MS	WOS:000252662700014	17713464	hybrid			2022-02-06	
J	Goslar, PW; Crawford, NR; Petersen, SR; Wilson, JR; Harrington, T				Goslar, Pamela W.; Crawford, Neil R.; Petersen, Scott R.; Wilson, Jeffrey R.; Harrington, Timothy			Helmet use and associated spinal fractures in motorcycle crash victims	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						motorcycle; helmets; spine fractures; statistics	FATAL INJURIES; NECK INJURIES; HEAD; SEVERITY; PATTERNS; ALCOHOL; TRAUMA; DRIVER; RIDERS; IMPACT	Background: The effect of helmet use on the incidence of cervical and thoracic fractures sustained in motorcycle crashes remains controversial. Methods: We retrospectively reviewed the incidence of these fractures in helmeted and nonhelmeted crash victims at a single Level I trauma hospital with a well-defined system for evaluating spinal fractures. Results: Of 422 motorcycle crash victims treated during 3 years, 190 had a traumatic brain injury (TBI) and 75 sustained some form of spinal fracture. Conclusions: Based on the statistical analysis, there was no relationship between helmet use and cervical or thoracic fractures, after controlling for speed of crash. The protective effect of helmet use in TBI was verified. These findings re-emphasize the need for a well-defined radiologic protocol for spinal injury at centers that evaluate crash victims.	[Wilson, Jeffrey R.] Arizona State Univ, WP Carey Sch Business, Tempe, AZ USA; [Petersen, Scott R.; Harrington, Timothy] St Josephs Hosp, Div Neurol Surg, Barrow Neurol Inst, Phoenix, AZ USA		Harrington, T (corresponding author), Barrow Neurol Inst, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	neuropub@chw.edu		Crawford, Neil/0000-0003-2919-2053			*AM COLL SURG, 2005, NAT TRAUM DAT BANK D; *AM COLL SURG, 2004, AM COLL SURG, V199, P260; Ankarath S, 2002, INJURY, V33, P473, DOI 10.1016/S0020-1383(02)00048-7; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BISHOP PJ, 1990, AM J SPORT MED, V18, P201, DOI 10.1177/036354659001800215; Bradbury A., 1993, Health Bulletin (Edinburgh), V51, P86; Branas CC, 2001, ACCIDENT ANAL PREV, V33, P641, DOI 10.1016/S0001-4575(00)00078-6; Camacho DLA, 2001, J BIOMECH ENG-T ASME, V123, P432, DOI 10.1115/1.1389086; CHENIER TC, 1987, ACCIDENT ANAL PREV, V19, P133, DOI 10.1016/0001-4575(87)90032-7; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; DAFFNER RH, 1987, SKELETAL RADIOL, V16, P280, DOI 10.1007/BF00361469; FANTUS RJ, 2005, B AM COL SURG, V90, P43; GOLDSTEIN JP, 1986, EVALUATION REV, V10, P355, DOI 10.1177/0193841X8601000306; GOLDSTEIN JP, 1988, REV HELMET HELMET LA; GOLDSTEIN SC, 1992, WESTERN J MED, V156, P210; *GOV OFF HIGHW SAF, 2005, TRANSP SAF PLAN STAT; Hitosugi M, 2004, AM J FOREN MED PATH, V25, P125, DOI 10.1097/01.paf.0000127397.67081.f5; Hitosugi M, 1999, AM J FOREN MED PATH, V20, P251, DOI 10.1097/00000433-199909000-00007; Hundley JC, 2004, J TRAUMA, V57, P944, DOI 10.1097/01.TA.0000149497.20065.F4; HUSTON RL, 1981, J BIOMECH ENG-T ASME, V103, P18, DOI 10.1115/1.3138238; IVERS RQ, 2004, EVIDENCE BASED HEALT, V8, P265; Kasantikul V, 2002, Annu Proc Assoc Adv Automot Med, V46, P125; KRANTZ KPG, 1985, INJURY, V16, P253; KUPFERSCHMID JP, 1989, J TRAUMA, V29, P593, DOI 10.1097/00005373-198905000-00009; Lin MR, 2004, NEUROEPIDEMIOLOGY, V23, P269, DOI 10.1159/000080091; Lin MR, 2003, ANN EMERG MED, V41, P783, DOI 10.1067/mem.2003.186; LIU B, 2004, COCHRANE DATABASE SY; Liu B., 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004333.PUB2, 10.1002/14651858.CD004333.pub2]; Lowenstein S, 1996, ANN EMERG MED, V27, P389; NELSON D, 1992, ANN EMERG MED, V21, P279, DOI 10.1016/S0196-0644(05)80888-1; Nightingale RW, 1996, J BONE JOINT SURG AM, V78A, P412, DOI 10.2106/00004623-199603000-00013; Nightingale RW, 1997, SPINE, V22, P2380, DOI 10.1097/00007632-199710150-00012; OFFNER PJ, 1992, J TRAUMA, V32, P636, DOI 10.1097/00005373-199205000-00016; Ooi S S, 2004, Med J Malaysia, V59, P146; ORSAY E, 1995, ANN EMERG MED, V26, P455, DOI 10.1016/S0196-0644(95)70114-1; ORSAY EM, 1994, ANN EMERG MED, V23, P802, DOI 10.1016/S0196-0644(94)70317-5; ORSAY EM, 1994, ANN EMERG MED, V24, P51, DOI 10.1016/S0196-0644(94)70162-8; PeekAsa C, 1996, J TRAUMA, V41, P989, DOI 10.1097/00005373-199612000-00008; Robertson A, 2002, SPINE, V27, P2825, DOI 10.1097/00007632-200212150-00019; Robertson A, 2002, J TRAUMA, V53, P5, DOI 10.1097/00005373-200207000-00002; RUTLEDGE R, 1993, ACCIDENT ANAL PREV, V25, P347, DOI 10.1016/0001-4575(93)90028-U; SARKAR S, 1995, J TRAUMA, V38, P242, DOI 10.1097/00005373-199502000-00017; SHROSBREE RD, 1978, PARAPLEGIA, V16, P102, DOI 10.1038/sc.1978.16; SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395; Stanislas MJC, 1998, INJURY, V29, P15, DOI 10.1016/S0020-1383(97)00109-5; TEASDALE G, 1974, LANCET, V2, P81; Van Camp L A, 1998, Eur J Emerg Med, V5, P207	47	19	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2008	64	1					190	196		10.1097/TA.0b013e3180f62eec			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	250UE	WOS:000252325700038	18188120				2022-02-06	
J	Jha, A; Lammertse, DP; Coll, JR; Charlifue, S; Coughlin, CT; Whiteneck, GG; Worley, G				Jha, Amitabh; Lammertse, Daniel P.; Coll, Joseph R.; Charlifue, Susan; Coughlin, Christopher T.; Whiteneck, Gale G.; Worley, Gordon			Apolipoprotein E epsilon-4 allele and outcomes of traumatic spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						apolipoprotein E; polymorphism; genotype; spinal cord injuries, cervical; tetraplegia; rehabilitation, physical	E POLYMORPHISM; BRAIN-INJURY; E GENOTYPE; CEREBROVASCULAR-DISEASE; APOE GENOTYPE; ASSOCIATION; EXPRESSION; RECOVERY; SURVIVAL	Background/Objective: To test the hypothesis that apolipoprotein E (APOE) polymorphisms are associated with outcomes after spinal cord injury (SCI). Methods: Retrospective cohort study, from rehabilitation admission to discharge. Participants: Convenience sample of 89 persons with cervical SCI (C3-C8) treated from 1995 through 2003. Median age was 30 years (range 14-70); 67 were male (75%) and 83 were white (93%). Main Outcome Measures: American Spinal Injury Association (ASIA) motor and sensory scores, ASIA Impairment Scale (AIS), time from injury to rehabilitation admission, and length of stay (LOS) in rehabilitation. Results: Subjects with an APOE epsilon 4 allele (n = 15; 17%) had significantly less motor recovery during rehabilitation than did individuals without an epsilon 4 allele (median 3.0 vs 5.5; P < 0.05) and a longer rehabilitation LOS (median 106 vs 89 days; P = 0.04), but better sensory-pin prick recovery (median 5.0 vs 2.0; P = 0.03). There were no significant differences by APOE epsilon 4 allele status in sensory-light touch recovery, likelihood of improving AIS Grade, or time from injury to rehabilitation admission. Conclusions: APOE epsilon 4 allele was associated with differences in neurological recovery and longer rehabilitation LOS. Genetic factors may be among the determinants of outcome after SCI and warrant further study.	[Jha, Amitabh] Univ Colorado, Craig Hosp, Res Dept, Englewood, CO 80113 USA; [Jha, Amitabh; Lammertse, Daniel P.; Coll, Joseph R.] Univ Colorado, Denver, CO 80202 USA; [Worley, Gordon] Duke Univ, Durham, NC USA		Jha, A (corresponding author), Univ Colorado, Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA.	ajha@craighospital.org	Coll, Joseph R/C-3165-2012				ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Cravchik A, 2001, ARCH NEUROL-CHICAGO, V58, P1772, DOI 10.1001/archneur.58.11.1772; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; HIXSON JE, 1990, J LIPID RES, V31, P545; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Marino RJ, 2003, J SPINAL CORD MED S1, V26, pS50; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; McCarron MO, 2000, ARCH NEUROL-CHICAGO, V57, P1480, DOI 10.1001/archneur.57.10.1480; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; Moretti EW, 2005, CRIT CARE MED, V33, P2521, DOI 10.1097/01.CCM.0000186368.96146.FB; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schiefermeier M, 2000, STROKE, V31, P2068, DOI 10.1161/01.STR.31.9.2068; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Tardiff BE, 1997, ANN THORAC SURG, V64, P715, DOI 10.1016/S0003-4975(97)00757-1; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3	28	19	19	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.		2008	31	2					171	176		10.1080/10790268.2008.11760708			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315KA	WOS:000256876200006	18581664	Green Published			2022-02-06	
J	McMahon, CG; Kenny, R; Bennett, K; Kirkman, E				McMahon, C. Geraldine; Kenny, RoseAnne; Bennett, Kathleen; Kirkman, Emrys			Modification of acute cardiovascular homeostatic responses to hemorrhage following mild to moderate traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						brain injuries; trauma; hemorrhagic shock; homeostasis	AFFERENT NERVE-STIMULATION; SEVERE HEAD-INJURY; BRADYCARDIA; MODELS; BAROREFLEX; SHOCK; RESUSCITATION; ISCHEMIA; SURVIVAL; MORPHINE	Objectives. The cardiovascular homeostatic responses to hemorrhage are coordinated in the central nervous system. Coincidental brain injury, which is present in 64% of trauma patients, could impair these responses. Our objective was to test the hypothesis that mild to moderate traumatic brain injury alters cardiovascular reflex responses to acute hemorrhage. Design: Experimental prospective, randomized study in terminally anesthetized rats. Setting: Experimental laboratory of university. Subjects. Twenty-four male Wistar rats weighing 240-260 g. Interventions., Brain injury was induced using the lateral fluid percussion injury model in anesthetized rats. The fluid percussion device delivered an applied cortical pressure of 1.2 atm and 1.8 atm, producing mild and moderate injury, respectively. Control animals underwent identical surgical procedures but with no applied cortical pressure. Hemorrhage was carried out 10 mins after brain injury, at a rate of 2% of blood volume per minute until 40% blood volume was withdrawn. Measurements and Main Results: The effects of acute traumatic brain injury on the biphasic heart rate and mean arterial blood pressure response to hemorrhage were studied. Traumatic brain injury attenuated the normal bradycardic response and delayed the hypotensive response to hemorrhage. This effect was graded according to the severity of brain injury. In mild injury, the depressor phase was delayed, but the biphasic pattern of heart rate response was maintained. No mortality was observed in this group. Following moderate brain injury, marked attenuation of the biphasic heart rate and mean arterial blood pressure response (p < .001 and p = .0007) was observed. Fifty percent of this group died within 90 mins of hemorrhage completion. Significant differences in the biphasic response were observed between survivors and nonsurvivors (p = .013, p = .001, respectively). In nonsurvivors, the biphasic response was abolished. Conclusions: Acute mild and moderate traumatic brain injury disrupts cardiovascular homeostatic responses to extracranial hemorrhage; this disruption is graded according to the severity of traumatic brain injury. Severe disruption is associated with an increase in early mortality.	[McMahon, C. Geraldine; Kenny, RoseAnne] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Bennett, Kathleen] Trinity Coll Dublin, Dept Pharmacol & Therapeut, Dublin, Ireland		McMahon, CG (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland.	gmcmahon@stjames.le	McMahon, C Geraldine/M-8684-2019	McMahon, C Geraldine/0000-0002-9870-3104			ANDERSON ID, 1990, BRIT J SURG, V77, P1338, DOI 10.1002/bjs.1800771207; ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; Atkinson JLD, 1998, J TRAUMA, V45, P941, DOI 10.1097/00005373-199811000-00016; Barcroft H, 1944, LANCET, V1, P489; Cushing H, 1902, AM J MED SCI, V124, P375, DOI 10.1097/00000441-190209000-00001; DRONEN SC, 1993, AM J EMERG MED, V11, P331, DOI 10.1016/0735-6757(93)90162-5; ELEBUTE EA, 1978, CLIN SCI MOL MED, V54, P431, DOI 10.1042/cs0540431; EVANS RG, 1992, CLIN EXP PHARMACOL P, V19, P657, DOI 10.1111/j.1440-1681.1992.tb00518.x; FEUERSTEIN G, 1986, CIRC SHOCK, V19, P293; Foex BA, 2004, CRIT CARE MED, V32, P740, DOI 10.1097/01.CCM.0000117320.69308.E5; GERMARELLI TA, 1983, ACTA NEUROCHIR SUPP, V32, P1; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Kongo M, 1999, EXP PHYSIOL, V84, P47, DOI 10.1111/j.1469-445X.1999.tb00071.x; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; LITTLE RA, 1989, Q J EXP PHYSIOL CMS, V74, P825, DOI 10.1113/expphysiol.1989.sp003352; LITTLE RA, 1984, Q J EXP PHYSIOL CMS, V69, P753, DOI 10.1113/expphysiol.1984.sp002866; Ludbrook J, 1996, AM J PHYSIOL-HEART C, V270, pH1538, DOI 10.1152/ajpheart.1996.270.5.H1538; Mackway-Jones K, 1999, J TRAUMA, V47, P481, DOI 10.1097/00005373-199909000-00008; Majde JA, 2003, J TRAUMA, V54, pS100, DOI 10.1097/01.TA.0000064503.24416.F4; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; OBERG B, 1970, Acta Physiologica Scandinavica, V80, P395, DOI 10.1111/j.1748-1716.1970.tb04803.x; Ohnishi M, 1997, BRAIN RES, V763, P39, DOI 10.1016/S0006-8993(97)00379-X; OVERMAN RR, 1947, AM J PHYSIOL, V148, P289, DOI 10.1152/ajplegacy.1947.148.2.289; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Ryan KL, 2006, RESUSCITATION, V70, P133, DOI 10.1016/j.resuscitation.2005.11.008; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SECHER NH, 1985, CLIN PHYSIOL, V5, P315, DOI 10.1111/j.1475-097X.1985.tb00752.x; SECHER NH, 1984, CIRC SHOCK, V14, P267; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TIMMS RJ, 1981, PFLUG ARCH EUR J PHY, V391, P49, DOI 10.1007/BF00580694; TOMLINSON BE, 1970, J CLIN PATH S4, V23, P178; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; TURNBULL AV, 1993, J PHYSIOL-LONDON, V468, P529, DOI 10.1113/jphysiol.1993.sp019786; *US NAT I HLTH, 1996, GUID CAR US LAB AN; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; YUAN XQ, 1992, SURG GYNECOL OBSTET, V174, P305; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7	43	19	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2008	36	1					216	224		10.1097/01.CCM.0000295425.41831.85			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YA	WOS:000255232100031	18090349				2022-02-06	
J	Ownsworth, TL; Turpin, M; Andrew, B; Fleming, J				Ownsworth, Tamara L.; Turpin, Merrill; Andrew, Brooke; Fleming, Jennifer			Participant perspectives on an individualised self-awareness intervention following stroke: A qualitative case study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; THALAMIC HEMORRHAGE; REHABILITATION; DEFICITS; PEOPLE; SCALE	Most research investigating the efficacy of neurorehabilitation has focused upon pre- versus post-intervention functioning, which is important for evidence-based practice but overlooks the therapeutic process. Therefore, this qualitative study aimed to investigate a participant's perspective of experiences in therapy throughout an awareness rehabilitation intervention. The participant (CP), a young male with awareness deficits following a right thalamic stroke, had repeatedly attempted to return to work and experienced recurrent periods of depression associated with his employment difficulties. Throughout a 12-session rehabilitation intervention, which targeted self-awareness and self-regulation skills, CP provided interview feedback concerning his experiences of different therapy exercises. The key themes emerging from the data regarding CP's perspectives included: understanding benchmarks and the value of feedback, learning through practical exercises, and individualising therapy. In collaboration with a disability employment support service, CP achieved paid durable employment. This study highlights the importance of considering participants' perspectives of the therapeutic process to assist in the design and evaluation of awareness rehabilitation interventions.	[Ownsworth, Tamara L.] Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia; [Ownsworth, Tamara L.] Griffith Univ, Appl Cognit Neurosci Res Ctr, Mt Gravatt, Qld 4122, Australia; [Turpin, Merrill; Andrew, Brooke; Fleming, Jennifer] Univ Queensland, Div Occupat Therapy, St Lucia, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia		Ownsworth, TL (corresponding author), Griffith Univ, Sch Psychol, Mt Gravatt Campus, Nathan, Qld 4111, Australia.	t.ownsworth@griffith.edu.au	Turpin, Merrill/F-8749-2010; Ownsworth, Tamara/ABB-6961-2021; Fleming, Jennifer M/B-4436-2011	Ownsworth, Tamara/0000-0003-1835-7094; Turpin, Merrill/0000-0001-7946-0883			BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BOGOUSSLAVSKY J, 1994, EUR NEUROL, V34, P306, DOI 10.1159/000117068; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming JM, 1996, BRAIN INJURY, V10, P1; GILCHRIST V, 1999, DOING QUALITATIVE RE; Kristensen OS, 2004, BRAIN INJURY, V18, P1049, DOI 10.1080/02699050410001672279; KUMRAL E, 1995, STROKE, V26, P964, DOI 10.1161/01.STR.26.6.964; Langer KG., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [DOI 10.1080/09602019208401395, 10.1080/09602019208401395]; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; Liebson E, 2000, J NEUROL NEUROSUR PS, V68, P107, DOI 10.1136/jnnp.68.1.107; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; McKenna K., 2006, CLIENT ED PARTNERSHI, P1; Morris RG, 2004, COGNITIVE NEUROPSYCH, P275; Myers P.S., 1999, RIGHT HEMISPHERE DAM; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; RUDDLE JA, 2005, J COGNITIVE REHABILI, V23, P12; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Snaith R., 1994, HOSP ANXIETY DEPRESS; Toglia J, 2000, NEUROREHABILITATION, V15, P57; TRZEPAC PT, 1993, PSYCHIAT MENTAL STAT; Wilson BA, 2000, INT HDB NEUROPSYCHOL, P231; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640; Yin RK, 2003, CASE STUDY RES DESIG	38	19	19	0	15	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2008	18	5-6					692	712		10.1080/09602010701595136			21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	360PQ	WOS:000260070200014	17926196				2022-02-06	
J	Salorio, CF; Slomine, BS; Guerguerian, AM; Christensen, JR; White, JRM; Natale, JE; Shaffner, DH; Grados, MA; Vasa, RA; Gerring, JP				Salorio, Cynthia F.; Slomine, Beth S.; Guerguerian, Anne-Marie; Christensen, James R.; White, Jeanette R. M.; Natale, JoAnne E.; Shaffner, Donald H.; Grados, Marco A.; Vasa, Roma A.; Gerring, Joan P.			Intensive care unit variables and outcome after pediatric traumatic brain injury: A retrospective study of survivors	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; critical care; outcome predictors; blood pressure; children	CEREBRAL PERFUSION-PRESSURE; DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; BLOOD-PRESSURE; AUTOREGULATION; CHILDREN; HYPOTENSION; PREDICTORS; COMA	Objective: Traumatic brain injury is a leading cause of death and disability in children. Hypotension has been associated with poor survival and outcome in children after traumatic brain injury, but the effect of acute hypertension is less certain. The objective was to obtain acute physiologic variables during the early hospitalization period in a cohort of children prospectively enrolled in another study. Design. Retrospective chart reviews. Setting: University-affiliated pediatric rehabilitation center. Patients. Fifty-seven survivors, 5-17 yrs of age, admitted for rehabilitation between 1992 and 1995 after sustaining a traumatic brain injury. Interventions: Standard of care. Measurements and Main Results. Outcomes were assessed at 1 yr postinjury through cognitive testing of the child and parent interview of the child's global functional skills. Cognitive outcome was measured using the Performance 10 from the Wechsler Intelligence Scale for Children, Third Edition. Overall functional outcome was assessed using the Disability Rating Scale. Conclusions. This study suggests that early markers of secondary injury after moderate to severe traumatic brain injury in children may be predictive of long-term outcome. This study reinforces the need for longer term, systematic, and more precise measurements of outcomes in children with traumatic brain injury and prospective studies to examine the predictive value of acute management variables on multiple types of outcomes after traumatic brain injury in children.	[Slomine, Beth S.] Kennedy Krieger Inst, Neuropsychol Rehabil Serv, Baltimore, MD 21205 USA; [Salorio, Cynthia F.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Christensen, James R.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA; [Christensen, James R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Grados, Marco A.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Guerguerian, Anne-Marie] Univ Toronto, Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Guerguerian, Anne-Marie] Univ Toronto, Res Inst, Toronto, ON, Canada; [White, Jeanette R. M.] Medicalliance, Sci Affairs, Columbia, MD USA; [Natale, JoAnne E.] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA; [Gerring, Joan P.] Johns Hopkins Bayview Med Ctr, Baltimore, MD USA		Salorio, CF (corresponding author), Kennedy Krieger Inst, Neuropsychol Rehabil Serv, Baltimore, MD 21205 USA.	salorio@kennedykrieger.org		SHAFFNER, DONALD/0000-0001-5530-0746; Grados, Marco/0000-0002-6189-6264	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5-T32-HD0741410] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007414] Funding Source: NIH RePORTER		ADELSON PD, 2004, PEDIATR CRIT CARE ME, V4, pS12; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; *BRAIN TRAUM FDN, 2003, GUID MAN SEV TRAUM B; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Fritz HG, 2004, J NEUROSURG ANESTH, V16, P43, DOI 10.1097/00008506-200401000-00009; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Heath D L, 1999, J Neurosci Nurs, V31, P97; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Immink RV, 2004, CIRCULATION, V110, P2241, DOI 10.1161/01.CIR.0000144472.08647.40; Jackson S, 2000, ACTA NEUROCHIR SUPPL, V76, P453; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jones PA, 2003, PHYSIOL MEAS, V24, P201, DOI 10.1088/0967-3334/24/1/315; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; TEASDALE G, 1974, LANCET, V2, P81; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; WILSON J T L, 1990, Brain Injury, V4, P349; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; [No title captured]	48	19	19	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2008	9	1					47	53		10.1097/01.PCC.0000298638.66240.0E			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	252QR	WOS:000252462200009	18477913				2022-02-06	
J	Yao, XL; Liu, J; McCabe, JT				Yao, Xianglan; Liu, Jiong; McCabe, Joseph T.			Ubiquitin and ubiquitin-conjugated protein expression in the rat cerebral cortex and hippocampus following traumatic brain injury (TBI)	BRAIN RESEARCH			English	Article						ubiquitin; free ubiquitin; ubiquitin-conjugated protein; cerebral cortex; hippocampus; protein degradation; Q-PCR; traumatic brain injury	GENE-EXPRESSION; MESSENGER-RNA; NUCLEOTIDE-SEQUENCE; RIBOSOMAL-PROTEINS; ISCHEMIA; IMMUNOREACTIVITY; NEURONS; FUSION; AGGREGATION; PROTEASOME	Regulation of protein turnover is essential to the survival of eukaryotic cells. This important cellular process is partly regulated by the ubiquitin-proteasome system through posttranslational modification by the conjugation of ubiquitin chains to proteins targeted for degradation by proteasomes. The present study examined ubiquitin mRNA and protein expression in the CNS of rats that sustained traumatic brain injury (TBI). Quantitative real-time polymerase chain reaction results indicated that mRNA levels of ubA52, ubB and ubC in the ipsilateral cerebral cortex were significantly decreased on Day I post-TBI, that UbC mRNA levels also were significantly lower than control on Day 3 post-TBI,but that by Day 7 post-TBI, ubA52, ubB and ubC mRNA levels had all returned to control levels. In the ipsilateral hippocampus, ubA52 mRNA levels were significantly lower on Days 1-7 post-TBI, while ubB and ubC mRNA levels were less only on Day I post-TBI. Western blotting found that free ubiquitin protein levels were significantly reduced in both ipsilateral cerebral cortex and hippocampus on Days 1-7 post-TBI, while there was markedly increased ubiquitin-conjugated protein in ipsilateral cerebral cortex on Day 7 and in hippocampus on Days 3-7 post-TBI. Our study suggests that altered ubiquitin system function in the CNS contributes to the pathological outcomes of TBI. (C) 2007 Elsevier B.V. All rights reserved.	[Yao, Xianglan; Liu, Jiong; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Yao, XL (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	XYao@usuhs.mil; JLiu@usuhs.mil; JMcCabe@usuhs.mil	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442			Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; BAKER RT, 1991, NUCLEIC ACIDS RES, V19, P1035, DOI 10.1093/nar/19.5.1035; BAKER RT, 1987, NUCLEIC ACIDS RES, V15, P443, DOI 10.1093/nar/15.2.443; Ceremuga TE, 2003, NEUROSCI RES, V45, P305, DOI 10.1016/S0168-0102(02)00228-6; Ceremuga TE, 2001, ENDOCR RES, V27, P433, DOI 10.1081/ERC-100107867; CHAN YL, 1995, BIOCHEM BIOPH RES CO, V215, P682, DOI 10.1006/bbrc.1995.2518; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groothuis TAM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-21; HAYASHI T, 1994, BBA-GENE STRUCT EXPR, V1218, P232, DOI 10.1016/0167-4781(94)90020-5; HAYASHI T, 1991, MOL CHEM NEUROPATHOL, V15, P75, DOI 10.1007/BF03161057; HAYASHI T, 1993, BRAIN RES, V620, P171, DOI 10.1016/0006-8993(93)90288-X; HAYASHI T, 1992, J NEUROSCI RES, V31, P561, DOI 10.1002/jnr.490310321; Hu BR, 2001, J CEREBR BLOOD F MET, V21, P865, DOI 10.1097/00004647-200107000-00012; Ide T, 1999, J CEREBR BLOOD F MET, V19, P750, DOI 10.1097/00004647-199907000-00004; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; KANAYAMA H, 1991, CANCER RES, V51, P6677; KAS K, 1992, BIOCHEM BIOPH RES CO, V187, P927, DOI 10.1016/0006-291X(92)91286-Y; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Liu C, 2005, NEUROSCIENCE, V134, P69, DOI 10.1016/j.neuroscience.2005.03.036; LUND PK, 1985, J BIOL CHEM, V260, P7609; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Mizukami K, 2002, ACTA NEUROPATHOL, V103, P453, DOI 10.1007/s00401-001-0489-1; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; MORI H, 1996, RECENT ADV GASTROENT, V1, P249; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Tan ZQ, 2001, MOL BRAIN RES, V91, P179, DOI 10.1016/S0169-328X(01)00117-6; Vannucci SJ, 1998, J CEREBR BLOOD F MET, V18, P376, DOI 10.1097/00004647-199804000-00005; Weih M, 2001, J CEREBR BLOOD F MET, V21, P1090, DOI 10.1097/00004647-200109000-00006; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; Yao XL, 2006, NEUROSCI LETT, V409, P65, DOI 10.1016/j.neulet.2006.09.015; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656	36	19	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 28	2007	1182						116	122		10.1016/j.brainres.2007.08.076			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	242CS	WOS:000251702700012	17936732				2022-02-06	
J	Halabchi, F; Ziaee, V; Lotfian, S				Halabchi, Farzin; Ziaee, Vahid; Lotfian, Sarah			Injury profile in women Shotokan karate championships in Iran (2004-2005)	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						karate; martial arts; athletic injuries; risk factors; safety; sports	MARTIAL ARTS; COMPETITIONS	The aims of this paper were to record injury rates among Iranian women competitive Shotokan karate athletes and propose possible predisposing factors. A prospective recording of the injuries resulting from all matches in 6 consecutive women national Shotokan Karate Championships in all age groups in Iran (season 2004-2005) was performed. Data recorded included demographic characteristics (Age and Weight), athletic background (rank, years of experience, time spent training and previous injuries), type, location and reason for the injury, and the result of the match. Results indicate 186 recorded injuries from a total of 1139 bouts involving 1019 athletes, therefore there were 0.163 injury per bout [C.I. 95%: 0.142-0.184] and 183 injuries per 1000 athletes [C.I. 95%: 159-205]. Injuries were most commonly located in the head and neck (55.4%) followed by the lower limb (21%), upper limb (12.9%) and trunk (10.8%). Punches (48.4%) were associated with more injuries than kicks (33.3%). The injuries consisted of muscle strain and contusion (81, 43.6%), hematoma and epistaxis (49, 26.3%), lacerations and abrasions (28, 15.1%), concussion (13, 7%), tooth avulsion or subluxation (3, 1.6%), joint dislocation (3, 1.6%) and fractures (3, 1.6%). In conclusion, as the majority of injuries are minor, and severe or longstanding injuries are uncommon, it can be argued that shotokan karate is a relatively safe for females, despite its image as a combat sport, where ostensibly the aim appears to injure your opponent. Further research is needed to evaluate the effective strategies to minimize the risk of injuries.	Univ Tehran Med Sci, Sports Med Res Ctr, Tehran, Iran		Ziaee, V (corresponding author), Univ Tehran Med Sci, Sports Med Res Ctr, POB 143950578, Tehran, Iran.	fhalabchi@sina.tums.ac.ir; ziaee@tums.ac.ir	Halabchi, Farzin/A-3191-2019; Ziaee, Vahid/E-2786-2014	Ziaee, Vahid/0000-0003-4648-3573			Arriaza R, 2005, KNEE SURG SPORT TR A, V13, P603, DOI 10.1007/s00167-004-0593-6; ARRIAZA R, 1990, Journal of Sports Traumatology and Related Research, V12, P255; BIRRER RB, 1988, AM J SPORT MED, V16, P408, DOI 10.1177/036354658801600418; BIRRER RB, 1996, AM J SPORTS MED, V24, P72; Buschbacher R M, 1999, Phys Med Rehabil Clin N Am, V10, P35; Critchley GR, 1999, BRIT J SPORT MED, V33, P174, DOI 10.1136/bjsm.33.3.174; Daniels K, 1992, Br J Sports Med, V26, P118; Daniels K, 1990, J SPORT SCI, V8, P95, DOI 10.1080/02640419008732137; Destombe C, 2006, JOINT BONE SPINE, V73, P182, DOI 10.1016/j.jbspin.2005.02.003; Fetto JF, 1994, SPORTS INJURIES MECH, P455; FREDERIC L, 1995, DICT MARTIAL ARTS; Johannsen H V, 1988, Br J Sports Med, V22, P113; KUJALA UM, 1995, BRIT MED J, V311, P1465, DOI 10.1136/bmj.311.7018.1465; LAYTON C, 1993, PERCEPT MOTOR SKILL, V76, P1001, DOI 10.2466/pms.1993.76.3.1001; Macan J, 2006, BRIT J SPORT MED, V40, P326, DOI 10.1136/bjsm.2005.022459; McLatchie G, 1981, Br J Sports Med, V15, P84; McLatchie G R, 1977, Br J Sports Med, V11, P78; MCLATCHIE GR, 1976, INJURY, V8, P132, DOI 10.1016/0020-1383(76)90049-8; Muller-Rath R, 2000, SPORTVERLETZ SPORTSC, V14, P20, DOI 10.1055/s-2000-3818; OLER M, 1991, J TRAUMA, V31, P251, DOI 10.1097/00005373-199131020-00017; Ortu M, 2006, BRIT J SPORT MED, V40, P730, DOI 10.1136/bjsm.2006.026500; Pieter W., 1994, Journal of Sports Traumatology and Related Research, V16, P49; Plancher KD, 1996, CLIN SPORT MED, V15, P207; STRICEVIC MV, 1983, AM J SPORT MED, V11, P320, DOI 10.1177/036354658301100507; TENVERGERT EM, 1992, J SPORT MED PHYS FIT, V32, P214; Tuominen Risto, 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P44; Violan MA, 1997, PEDIATR EXERC SCI, V9, P55, DOI 10.1123/pes.9.1.55; Zetaruk MN, 2005, BRIT J SPORT MED, V39, P29, DOI 10.1136/bjsm.2003.010322; Zetaruk MN, 2000, CLIN J SPORT MED, V10, P117, DOI 10.1097/00042752-200004000-00006; Zetaruk MN, 2000, ACCIDENT ANAL PREV, V32, P421, DOI 10.1016/S0001-4575(99)00120-7	30	19	19	0	5	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	OCT	2007	6				2		52	57					6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	215DS	WOS:000249789100010	24198704				2022-02-06	
J	Klonoff, PS; Talley, MC; Dawson, LK; Myles, SM; Watt, LM; Gehrels, JA; Henderson, SW				Klonoff, Pamela S.; Talley, Melanie C.; Dawson, Lauren K.; Myles, Stephen M.; Watt, Lisa M.; Gehrels, Jo-Ann; Henderson, Steven W.			The relationship of cognitive retraining to neurological patients' work and school status	BRAIN INJURY			English	Article						cognitive retraining; work; outcome; vocational rehabilitation; brain injury	TRAUMATIC BRAIN-INJURY; MILIEU-BASED NEUROREHABILITATION; 11 YEARS POSTDISCHARGE; REHABILITATION; OUTCOMES; AWARENESS; PROGRAM	Primary objective: To explore the relationship of cognitive retraining performance to discharge productivity status. Methods and procedures: One hundred and one brain-injured patients from a holistic milieu-oriented work/school re-entry programme. Experimental interventions: Initial, last, mean and best cognitive retraining scores; cognitive retraining behavioural checklist ratings; and working alliance scores. Main outcomes and results: Most (82.2%) of the sample returned to paid work or school. Better performance on two cognitive retraining tasks addressing information processing speed, visual scanning, visuospatial skills and memory were associated with return to the same level of work/school with and without modifications. Selected process variables related to the patients' behavioural approach to cognitive retraining tasks (e. g. their use of compensations, organizational and abstraction skills, procedural skills and unassisted task recall) were associated with better work/school outcomes. Patients' positive working alliance ratings related to their behavioural approach to cognitive retraining tasks. This highlights the importance of combining interventions targeting both the therapeutic interactive process and skill remediation to maximize work/ school reintegration. Conclusions: Cognitive Retraining exercises that incorporate both process variables and metacognitive skills, as well as a better working alliance with patients, positively related to return to work and school at the time of discharge from a holistic milieu-oriented programme.	Ctr Transit Neurorehabil, Barrow Neurol Inst, Phoenix, AZ USA		Klonoff, PS (corresponding author), St Josephs Hosp, Barrow Neurol Inst, CTN, 222 W Thomas Rd,Suite 401, Phoenix, AZ 85013 USA.	pamela.klonoff@chw.edu					Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Bordin E.S., 1994, WORKING ALLIANCE THE; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CHRISTENSEN AL, 1992, ACTA NEUROL SCAND, V85, P32; CHRISTENSEN AL, 1992, SCAND J REHABIL MED, P34; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; FRYER LJ, 1989, J HEAD TRAUMA REHAB, V4, P20; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; KLONOFF PS, 2005, CRITICAL TREATMENT I; Klonoff PS, 1989, J HEAD TRAUMA REHAB, V4, P37; KLONOFF PS, 1996, THEORETICAL FDN CLIN, P219; Klonoff PS, 2000, INT HDB NEUROPSYCHOL, P195; Malec J. F., 1992, NEURO REHABILITATION, V2, P1, DOI [10.3233/NRE-1992-2303, DOI 10.3233/NRE-1992-2303]; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; PERNA RB, 2000, J COGNITIVE REHABILI, V7, P18; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; SCHERZER BP, 1986, ARCH PHYS MED REHAB, V67, P366; Spreen O, 1991, COMPENDIUM NEUROPSYC; STERN JM, 1985, SCAND J REHABIL MED, P53; TEASDALE TW, 1993, BRAIN INJURY, V7, P535, DOI 10.3109/02699059309008181; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	31	19	19	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2007	21	11					1097	1107		10.1080/02699050701687342			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	222WX	WOS:000250329900001	17952711				2022-02-06	
J	Shah, MK; Carayannopoulos, AG; Burke, DT; Al-Adawi, S				Shah, Mrugeshkumar K.; Carayannopoulos, Alexios G.; Burke, David T.; Al-Adawi, Samir			A comparison of functional outcomes in hypoxia and traumatic brain injury: A pilot study	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	39th Annual Meeting of the Association-of-Academic-Physiatrists	MAR 26-30, 2003	Ft Lauderdale, FL	Assoc Acad Physiatrists		rehabilitation; anoxia; brain injury; traumatic brain injury; functional prognosis	CARDIAC-ARREST SURVIVORS; ANOXIC ENCEPHALOPATHY; NEUROLOGICAL REHABILITATION; INPATIENT REHABILITATION; CEREBRAL HYPOXIA; ADULT SURVIVORS; OLDER-ADULTS; FOLLOW-UP	We present our experience with 30 patients on functional outcomes of patients with anoxic brain injury (ABI, n=15) due to cardiac etiologies from freestanding inpatient rehabilitation hospital. A convenience sample of patient with traumatic brain injury (TBI, n=15) with similar demographic characteristic to ABI was used for comparison on indices of activity of daily living, cognition, mobility as well as other indices of functional prognosis such as hospital length of stay, cost and discharge predisposition. No statistical significant differences were found between the two groups on the presently employed outcome measures. This investigation supports the positive impact of inpatient rehabilitation for individuals with hypoxia of cardiac etiology. Future research comparing outcomes of ABI to TBI with larger, controlled trials is warranted. (C) 2007 Elsevier B.V. All rights reserved.	Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Behav Med, Al Khoud 123, Oman; Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Behav Med, Muscat, Oman		Al-Adawi, S (corresponding author), Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Behav Med, POB 35, Al Khoud 123, Oman.	adawi@squ.edu.om	Al-Adawi, Samir/A-9663-2016	Al-Adawi, Samir/0000-0002-9858-5582; Carayannopoulos, Alexios/0000-0001-5753-4810			Burke DT, 2005, BRAIN INJURY, V19, P675, DOI 10.1080/02699050400024953; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Campos JF, 2006, NEUROLOGIA, V21, P318; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Goldberg KB, 1997, BRAIN INJURY, V11, P743, DOI 10.1080/026990597123115; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; *I HLTH STUD, 1988, 9 REV CLIN MOD ANN E; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Najenson T, 1980, Int Rehabil Med, V2, P17; Pusswald G, 2000, RESUSCITATION, V47, P241, DOI 10.1016/S0300-9572(00)00240-9; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Wilson BA, 1996, BRAIN INJURY, V10, P863, DOI 10.1080/026990596123846; Wilson FC, 2003, NEUROREHABILITATION, V18, P291; 1995, GUIDE UNIFORM DATA S	20	19	19	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2007	260	1-2					95	99		10.1016/j.jns.2007.04.012			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	208JG	WOS:000249315000015	17537457				2022-02-06	
J	Kirchhoff, C; Stegmaier, J; Krotz, M; Muetzel, E; Mutschler, W; Kanz, KG; Heindl, B				Kirchhoff, Chlodwig; Stegmaier, Julia; Krotz, Michael; Muetzel, Elisabeth; Mutschler, Wolf; Kanz, Karl-Georg; Heindl, Bernhard			Celiac dissection after blunt abdominal trauma complicated by acute hepatic failure: Case report and review of literature	JOURNAL OF VASCULAR SURGERY			English	Article							SUPERIOR MESENTERIC-ARTERY; ROW CT ANGIOGRAPHY; SURGICAL-MANAGEMENT; COMPUTED-TOMOGRAPHY; MULTIDETECTOR CT; INJURY; AXIS; LIVER; AORTA; CIRCULATION	Injuries of the abdominal visceral vessels are uncommon but devastating entities resulting in extremely high rates of mortality. The most common cause of abdominal vascular injuries is penetrating trauma, accounting for 90% to 95% of these injuries. In contrast, blunt trauma accounts for 5% to 10% of all abdominal vascular lesions. Although traumatic injury to the celiac artery is among the rarest of all vascular injuries, mortality can be as high as 75%. We report a 66-year-old patient who sustained multiple injuries in a motor vehicle crash. The initial whole-body computed tomography (CT) scan revealed a combination of severe brain injury and bilateral thoracic lesions. On day 6 after the accident, the patient's clinical situation deteriorated rapidly. At this time, the abdominal arterial CT scan showed a dissection of the celiac artery. Therapeutic anticoagulation was not feasible because of the intracranial hemorrhage. Also the patient's clinical situation worsened so rapidly that interventional therapy, including surgical and endovascular treatment, could not be performed. Finally, the patient died of fulminant hepatic failure, therefore not surviving a potentially treatable injury. The diagnosis of celiac artery dissection in this patient was significantly delayed because the initial trauma CT protocol did not include an arterial phase of the abdominal vessels.	Univ Munich, Dept Traumat & Orthopaed Surg, D-80686 Munich, Germany; Univ Munich, Dept Clin Radiol, D-80686 Munich, Germany; Univ Munich, Dept Anesthesiol, D-80686 Munich, Germany; Univ Munich, Inst Forens Med, D-80686 Munich, Germany		Kirchhoff, C (corresponding author), Univ Munich, Dept Surg, Campus Innenstadt,Nussbaumstr 20, D-80686 Munich, Germany.	Chlodwig.Kirchhoff@med.uni-muenchen.de					Asensio JA, 2005, SOUTH MED J, V98, P462, DOI 10.1097/01.SMJ.0000136239.16913.C2; BENGMARK S, 1970, AM J SURG, V119, P620, DOI 10.1016/0002-9610(70)90228-X; Berthet JP, 2003, J VASC SURG, V38, P997, DOI 10.1016/S0741-5214(03)00613-X; Brofman N, 2006, RADIOGRAPHICS, V26, P1119, DOI 10.1148/rg.264055144; Brown DB, 1998, J VASC INTERV RADIOL, V9, P783, DOI 10.1016/S1051-0443(98)70392-6; BUSUTTIL RW, 1980, ANN SURG, V191, P641, DOI 10.1097/00000658-198005000-00017; Chaillou P, 1997, ANN VASC SURG, V11, P413, DOI 10.1007/s100169900070; CORBETTI F, 1989, J COMPUT ASSIST TOMO, V13, P965, DOI 10.1097/00004728-198911000-00006; Davis TP, 2001, AM SURGEON, V67, P565; Edwards MS, 2003, ANN VASC SURG, V17, P72, DOI 10.1007/s10016-001-0329-8; Francque S, 2004, EUR J GASTROEN HEPAT, V16, P411, DOI 10.1097/00042737-200404000-00008; Fujisawa Y, 2005, ANN VASC SURG, V19, P553, DOI 10.1007/s10016-005-5022-2; Graham DD, 1997, AM SURGEON, V63, P327; GUTHRIE W, 1972, J PATHOL, V108, P219, DOI 10.1002/path.1711080308; Hashimoto M, 1998, CLIN RADIOL, V53, P913, DOI 10.1016/S0009-9260(98)80220-1; HUET PM, 1986, SEMIN LIVER DIS, V6, P277, DOI 10.1055/s-2008-1040610; Johnson JW, 2002, J TRAUMA, V52, P1102, DOI 10.1097/00005373-200206000-00013; JURKOVICH GJ, 1995, J TRAUMA, V39, P426; Killeen KL, 2001, J TRAUMA, V51, P26, DOI 10.1097/00005373-200107000-00005; Kock MCJM, 2005, RADIOLOGY, V237, P727, DOI 10.1148/radiol.2372040616; Lalancette M, 2006, ANN VASC SURG, V20, P681, DOI 10.1007/s10016-006-9058-3; LINDNER HH, 1971, ARCH SURG-CHICAGO, V103, P600; Linsenmaier U, 2002, EUR RADIOL, V12, P1728, DOI 10.1007/s00330-001-1225-x; Linuma Y, 2006, J TRAUMA, V61, P451, DOI 10.1097/01.ta.0000229960.31334.ca; Martin ML, 2003, AM J ROENTGENOL, V180, P1085, DOI 10.2214/ajr.180.4.1801085; MILLER MA, 1989, J TRAUMA, V29, P1571, DOI 10.1097/00005373-198911000-00019; Peytel E, 2001, INTENS CARE MED, V27, P1756, DOI 10.1007/s00134-001-1119-z; PLENGVAN.U, 1972, ANN SURG, V175, P105, DOI 10.1097/00000658-197201000-00016; Poletti PA, 2004, J TRAUMA, V57, P1072, DOI 10.1097/01.TA.0000092680.73274.E1; Ray B, 2006, CARDIOVASC INTER RAD, V29, P886, DOI 10.1007/s00270-004-0113-6; Sachdev U, 2006, J VASC SURG, V44, P718, DOI 10.1016/j.jvs.2006.06.027; So YH, 2003, J VASC INTERV RADIOL, V14, P493, DOI 10.1097/01.RVI.0000064855.87207.C5; Starnes Benjamin W, 2006, Perspect Vasc Surg Endovasc Ther, V18, P114, DOI 10.1177/1531003506293418; STONEY RJ, 1966, ANN SURG, V164, P714, DOI 10.1097/00000658-196610000-00016; Tian JL, 2006, WORLD J GASTROENTERO, V12, P3265, DOI 10.3748/wjg.v12.i20.2000; Willmann JK, 2003, RADIOLOGY, V226, P798, DOI 10.1148/radiol.2271020014	36	19	20	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	SEP	2007	46	3					576	580		10.1016/j.jvs.2007.04.041			5	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	208JL	WOS:000249315500034	17826250	Bronze			2022-02-06	
J	Barrett, AM; Eslinger, PJ				Barrett, Anna M.; Eslinger, Paul J.			Amantadine for adynamic speech - Possible benefit for aphasia?	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						amantadine; aphasia; rehabilitation	TRAUMATIC BRAIN-INJURY; OPEN-LABEL TRIAL; NONFLUENT APHASIA; REHABILITATION; BROMOCRIPTINE	Objective: Dopaminergic agents may stimulate behavior and verbal expression after frontal lobe dysfunction. Although amantadine is used in neurorehabilitation of motivational disorders and head injury, it is not commonly prescribed to improve aphasia. This pilot study examined verbal fluency on and off amantadine for nonfluent speech. Design: Four participants undergoing inpatient rehabilitation, meeting criteria for transcortical motor aphasia had stroke (2), stroke postaneurysm surgery (1), or brain tumor resection (1). We administered 100 mg of amantadine twice a day in an open-label, on- off protocol, with multiple assessments per on-off period. Results: Off medication, subjects generated a mean 12.62 of words (abnormally few) on the Controlled Oral Word Association test. On medication, word generation significantly improved to 17.7 1 words (P = 0.04), although scores remained psychometrically in the abnormal range. Conclusions: Further research on amantadine, specifically for nonfluent speech and nonfluent aphasia, including effects on functional communication and control conditions, may be warranted.	Kessler Med Rehabilitat REs & Educ Cor, Stroke Rehabilitat Res Program, W Orange, NJ 07052 USA; Penn State Coll Med, Dept Neurol Neural & Behav Sci & Radiol, Hershey, PA USA		Barrett, AM (corresponding author), Kessler Med Rehabilitat REs & Educ Cor, Stroke Rehabilitat Res Program, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.		LUO, JINGJING/AAZ-6697-2021; Barrett, A.M./ABG-4475-2021	LUO, JINGJING/0000-0002-3222-1276; Barrett, A.M./0000-0002-0789-2887	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01 EB000454, EB00454] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS 002085, K02 NS047099, K02 NS047099-04, K02 NS047099-01, K08 NS002085-06, K02 NS 47099] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K02NS047099, K08NS002085] Funding Source: NIH RePORTER		Albert M. L., 1981, CLIN ASPECTS DYSPHAS; Arciniegas DB, 2004, BRAIN INJURY, V18, P1309, DOI 10.1080/02699050410001720130; BENSON DF, 1996, APHASIA CLIN PERSPEC, P15; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; DeMarchi R, 2005, CAN J NEUROL SCI, V32, P4, DOI 10.1017/S0317167100016826; DOTY L, 1990, GERONTOLOGIST, V30, P20; Drayton SJ, 2004, PSYCHOSOMATICS, V45, P205, DOI 10.1176/appi.psy.45.3.205; Gold M, 2000, BRAIN LANG, V74, P141, DOI 10.1006/brln.2000.2332; Greener J, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD000424]; Hamsher K., 1989, MULTILINGUAL APHASIA; HERRMANN M, 1989, APHASIOLOGY, V3, P513, DOI 10.1080/02687038908249019; Imamura T, 1994, No To Shinkei, V46, P556; Klein Reva B., 2004, Seminars in Speech and Language, V25, P193; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; KRUPP LB, 1995, NEUROLOGY, V45, P19956; MAZZONI M, 1995, APHASIOLOGY, V9, P553, DOI 10.1080/02687039508248714; MAZZONI M, 1992, APHASIOLOGY, V6, P387, DOI 10.1080/02687039208248609; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MILLET VM, 1982, ANTIMICROB AGENTS CH, V21, P1; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Patrick PD, 2003, BRAIN INJURY, V17, P497, DOI 10.1080/0269905031000070279; Pfeiffer RF, 1996, MOVEMENT DISORD, V11, P104, DOI 10.1002/mds.870110123; POSTMA JU, 1975, J AM GERIATR SOC, V23, P212, DOI 10.1111/j.1532-5415.1975.tb00187.x; Raymer AM, 2003, FRONT BIOSCI-LANDMRK, V8, pS845, DOI 10.2741/1142; Rothberg MB, 2003, ANN INTERN MED, V139, P321, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00007; SABE L, 1992, NEUROLOGY, V42, P1637, DOI 10.1212/WNL.42.8.1637; Sarno JE, 1998, ACQUIRED APHASIA, V569-94; Schneider WN, 1999, BRAIN INJURY, V13, P863; SILVER DE, 1972, NEUROLOGY, V22, P665, DOI 10.1212/WNL.22.7.665; TAUS C, 2003, COCHRANE DB SYST REV; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Zafonte RD, 1998, BRAIN INJURY, V12, P617; 2002, MOV DISORD S4, V17, pS13	33	19	20	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2007	86	8					605	612		10.1097/PHM.0b013e31811473b3			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	194ZX	WOS:000248383400002	17667190	Green Accepted			2022-02-06	
J	Slemmer, JE; Haasdijk, ED; Engel, DC; Plesnila, N; Weber, JT				Slemmer, Jennifer E.; Haasdijk, Elize D.; Engel, Doortje C.; Plesnila, Nikolaus; Weber, John T.			Aldolase C-positive cerebellar Purkinje cells are resistant to delayed death after cerebral trauma and AMPA-mediated excitotoxicity	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						cerebellum; controlled cortical impact; EAAT4; mouse; traumatic brain injury; zebrin II	CONTROLLED CORTICAL IMPACT; BRAIN-INJURY; GLUTAMATE TRANSPORTER; HIPPOCAMPAL CELLS; ZEBRIN-II; RECEPTORS; VULNERABILITY; SYNAPSES; ISCHEMIA; DAMAGE	The cerebellum has been shown to be vulnerable to global ischemic damage in tightly controlled zones of Purkinje cells (PCs) that lack aldolase C, an enzyme critical for glycolysis. Here, we investigated whether aldolase C-negative PCs were more likely to die after cerebral trauma in vivo, and whether this death was mediated by excitotoxic [alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)-mediated] means in vitro. Mice were subjected to controlled cortical impact, or remained uninjured, and were killed at 6 h, 24 h or 7 days after injury. Cerebellar sections (both ipsilateral and contralateral to the site of cerebral injury) were stained against aldolase C and calbindin (a marker of PCs). The number of viable, calbindin-positive PCs decreased significantly at 24 h and 7 days after injury, and the percentage of surviving, aldolase C-positive PCs significantly increased at those time-points. In addition, we subjected murine cerebellar cultures to AMPA (30 mu m, 20 min), which killed a significant number of PCs at 24 h post-treatment. A similar number of PCs was lost after transfection with aldolase C siRNA, and this effect was exacerbated in transfected cultures treated with AMPA. The results from the present study indicate that aldolase C provides marked neuroprotection to PCs after trauma and excitotoxicity.	Mem Univ Newfoundland, Sch Pharm, Hlth Sci Ctr, St John, NF A1B 3V6, Canada; Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; Univ Munich, Med Ctr, Lab Expt Neurosurg, D-80539 Munich, Germany		Weber, JT (corresponding author), Univ Prince Edward Isl, Dept Biol, Charlottetown, PE C1A 4P3, Canada.	jweber@mun.ca	Plesnila, Nikolaus/T-7522-2019				AHN AH, 1994, DEVELOPMENT, V120, P2081; Ai JL, 2004, PHARMACOLOGY, V71, P192, DOI 10.1159/000078085; Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Allen GV, 2001, NEUROSCIENCE, V102, P603, DOI 10.1016/S0306-4522(00)00519-4; Amino Y, 2001, NEUROSCI LETT, V309, P29, DOI 10.1016/S0304-3940(01)02018-3; BRASNJO G, 2004, P NATL ACAD SCI USA, V20, P6273; BRORSON JR, 1994, J NEUROSCI, V14, P187; Buono P, 2001, J NEUROCYTOL, V30, P957, DOI 10.1023/A:1021828421792; BURKE D, 2000, REHABILITATION PEOPL, P19; Donohoe PH, 2001, BRAIN RES, V917, P158, DOI 10.1016/S0006-8993(01)02849-9; Engel DC, 2005, NEUROPHARMACOLOGY, V49, P985, DOI 10.1016/j.neuropharm.2005.05.021; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAROOQUI AA, 1994, J NEUROSCI RES, V38, P6, DOI 10.1002/jnr.490380103; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; Lopez-Bayghen E, 2003, MOL BRAIN RES, V115, P1, DOI 10.1016/S0169-328X(03)00136-0; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nagao S, 1997, NEUROSCIENCE, V78, P929; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Park JY, 2004, BRAIN RES, V1026, P295, DOI 10.1016/j.brainres.2004.08.039; Rogido M, 2003, DEV BRAIN RES, V140, P287, DOI 10.1016/S0165-3806(02)00615-6; Sarna J, 2001, EUR J NEUROSCI, V13, P1873, DOI 10.1046/j.0953-816x.2001.01564.x; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; SASAKI K, 1977, EXP BRAIN RES, V29, P419; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Slemmer JE, 2005, PROG BRAIN RES, V148, P367, DOI 10.1016/S0079-6123(04)48029-7; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; Slemmer JE, 2004, NEUROBIOL DIS, V15, P563, DOI 10.1016/j.nbd.2003.11.027; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Stepanova T, 2003, J NEUROSCI, V23, P2655; Takayasu Y, 2005, J NEUROSCI, V25, P8788, DOI 10.1523/JNEUROSCI.1020-05.2005; Teasdale E, 2005, HEAD INJURY PATHOPHY, P169; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Voogd J, 1997, PROG BRAIN RES, V114, P21; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Welsh JP, 2002, ADV NEUROL, V89, P331; Yamada K, 1996, NEUROREPORT, V7, P2013, DOI 10.1097/00001756-199608120-00032; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	43	19	20	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2007	26	3					649	656		10.1111/j.1460-9568.2007.05708.x			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	197ZZ	WOS:000248598100012	17686042				2022-02-06	
J	Davis, DP; Douglas, DJ; Koenig, W; Carrison, D; Buono, C; Dunford, JV				Davis, Daniel P.; Douglas, Danielle J.; Koenig, William; Carrison, Dale; Buono, Colleen; Dunford, James V.			Hyperventilation following aero-medical rapid sequence intubation may be a deliberate response to hypoxemia	RESUSCITATION			English	Article						hyperventilation; aero-medical; hypoxemia	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; ENDOTRACHEAL INTUBATION; INTRAHOSPITAL TRANSPORT; BLOOD-GASES; HYPOXIA; HYPOTENSION; MODERATE; OUTCOMES; IMPACT	Background: Recent studies document a high incidence of hyperventilation by prehospital providers, with a potentially detrimental effect on outcome in traumatic brain injury (TBI). Purpose: To document the incidence of hyperventilation by aero-medical providers and explore a possible relationship between hyperventilation episodes and desaturations or impending hypoxemia. Methods: This was a prospective, descriptive study using TBI patients undergoing prehospital RSI by aero-medical crews. Continuous data regarding end-tidal CO2 (EtCO2), ventilatory rate, and oxygen saturation (SPO2) were downloaded from hand-held oximeter-capnometer devices. Two investigators independently assessed oximetry/capnometry data to identify the following occurrences: desaturation during RSI (SpO(2) < 90%), impending hypoxemia (SpO(2) decrease by >= 3% to a value <95%) following intubation, loss Of SpO(2) signal, hyperventilation (EtCO2 < 30 mmHg), and severe hyperventilation (EtCO2 < 25 mmHg). Covariate analysis was used to explore the possible association between hyperventilation episodes and either desaturation, impending hypoxemia, or loss of SpO(2) signal. Results: A total of 32 aero-medical patients were enrolled with a mean duration of ventilation monitoring of 14.8 min. The incidence of hyperventilation or severe hyperventitation was substantially tower than previously documented with ground paramedics. A total of 28 hyperventilation episodes were identified in 16 patients; 13 of these were associated with impending hypoxemia following intubation, five were associated with desaturation during RSI, and seven were associated with loss Of SpO(2) signal. The remaining three occurred immediately following intubation without desaturation during RSI. Desaturation was observed in 62% of patients; of note, desaturation was recorded on the quality improvement document in only 23% of these. Covariate analysis revealed an association between hyperventilation episodes and either desaturatios during RSI, impending hypoxemia following intubation, or toss of SpO(2) signal. Conclusions: The incidence of hyperventilation by aeromedical crews was lower than reported for ground paramedics and appears to occur in response to desaturation, impending hypoxemia, or toss of SpO(2) signal. (c) 2006 Elsevier Ireland Ltd. AR rights reserved.	Univ Calif San Diego, Med Ctr, Dept Emergency Med, San Diego, CA 92103 USA		Davis, DP (corresponding author), Univ Calif San Diego, Med Ctr, Dept Emergency Med, 200 W Arbor Dr,Mailcode 8676, San Diego, CA 92103 USA.	davismd@cox.net					Barton CW, 2005, ACAD EMERG MED, V12, P1, DOI 10.1197/j.aem.2004.08.043; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHUGANI HT, 1991, J CEREBR BLOOD F MET, V11, P35, DOI 10.1038/jcbfm.1991.4; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V59, P794; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DOBERSTEIN C, 1994, ACTA NEUROCHIR, P41; Douzinas EE, 2001, INTENS CARE MED, V27, P269, DOI 10.1007/s001340000796; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Falcone R E, 1996, Air Med J, V15, P163, DOI 10.1016/S1067-991X(96)90024-3; Feng ZC, 1998, RESUSCITATION, V37, P33, DOI 10.1016/S0300-9572(98)00031-8; GABIG TG, 1979, BLOOD, V53, P1133; GERVAIS HW, 1987, CRIT CARE MED, V15, P761, DOI 10.1097/00003246-198708000-00010; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; HEDGES JR, 1988, ANN EMERG MED, V17, P469, DOI 10.1016/S0196-0644(88)80238-5; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; HURST JM, 1989, J TRAUMA, V29, P1637, DOI 10.1097/00005373-198912000-00008; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Karch SB, 1996, AM J EMERG MED, V14, P617, DOI 10.1016/S0735-6757(96)90073-X; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Majima HJ, 1998, J BIOL CHEM, V273, P8217, DOI 10.1074/jbc.273.14.8217; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; OUYANG YB, 1994, BRAIN RES, V646, P65, DOI 10.1016/0006-8993(94)90058-2; Pace SA, 2000, ANN EMERG MED, V35, P568, DOI 10.1016/S0196-0644(00)70029-1; Pepe PE, 2003, J TRAUMA, V54, P1048, DOI 10.1097/01.TA.0000064280.05372.7C; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; Sing RF, 1998, AM J EMERG MED, V16, P598, DOI 10.1016/S0735-6757(98)90227-3; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; SYVERUD SA, 1988, ANN EMERG MED, V17, P236, DOI 10.1016/S0196-0644(88)80114-8; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Tobias JD, 1996, PEDIATR EMERG CARE, V12, P249, DOI 10.1097/00006565-199608000-00003; Vadeboncoeur TF, 2006, J EMERG MED, V30, P131, DOI 10.1016/j.jemermed.2005.04.019; Vilke Gary M., 1994, Journal of Emergency Medicine, V12, P217, DOI 10.1016/0736-4679(94)90702-1; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wayne M A, 1999, Prehosp Emerg Care, V3, P107, DOI 10.1080/10903129908958916	49	19	19	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	JUN	2007	73	3					354	361		10.1016/j.resuscitation.2006.09.015			8	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	180UW	WOS:000247392700006	17291673				2022-02-06	
J	Hamani, D; Charrueau, C; Butel, MJ; Besson, V; Belabed, L; Nicolis, I; Le Plenier, S; Marchand-Leromp, C; Chaumeil, JC; Cynober, L; Moinard, C				Hamani, Djamel; Charrueau, Christine; Butel, Marie-Jose; Besson, Valerie; Belabed, Linda; Nicolis, Ioannis; Le Plenier, Servane; Marchand-Leromp, Catherine; Chaumeil, Jean-Claude; Cynober, Luc; Moinard, Christophe			Effect of an immune-enhancing diet on lymphocyte in head-injured rats: What is the role of arginine?	INTENSIVE CARE MEDICINE			English	Article; Proceedings Paper	Clinical Nutrition Week 2005	JAN, 2005	Orlando, FL			arginine; head injury; immune-enhancing diet; dysimmunity; enteral nutrition; bacterial translocation	TRAUMATIC BRAIN-INJURY; ORNITHINE ALPHA-KETOGLUTARATE; CRITICALLY-ILL PATIENTS; BACTERIAL TRANSLOCATION; NITRIC-OXIDE; NOSOCOMIAL INFECTIONS; PROTEIN-METABOLISM; IN-VIVO; IMMUNONUTRITION; NUTRITION	Objective: The benefit of immune-enhancing diets (IEDs) in the intensive care unit remains controversial. Considering their complexity, the role of each component, in particular arginine (Arg), in their properties is largely unknown. The aim of this study was to determine the role of arginine in the immunomodulatory effects of an IED (Crucial(R)) in head-injured rats. Design: Thirty-four rats were randomized into five groups: AL (ad libitum), HI (head-injured), HI-STD (HI + standard enteral nutrition, EN), HI-STD-Arg (HI + standard EN + Arg in equimolar concentration to Arg in IED), and HI-IED (HI + IED). These isocaloric and isonitrogenous diets were administered over 4 days. After death, the thymus was removed and weighed. The density of CD25, CD4 and CD8 on lymphocytes from blood and from Peyer patches was evaluated. Mesenteric lymph nodes, liver and spleen were cultured for analysis of enterobacterial translocation and dissemination. Measurements and results: HI induced an atrophy of the thymus which was not corrected by the standard diet (HI 0.27 +/- 0.03, HI-STD 0.35 +/- 0.03 vs. AL 0.49 +/- 0.02 g; p < 0.05). However, the standard diet supplemented with arginine limited the thymic atrophy and the IED restored thymus weight. CD25 density and interleukin-2 production were increased only in the HI-STD-Arg and HI-IED groups (p < 0.05). Head injury induced enterobacterial translocation and dissemination which were blunted only in the HI-STD-Arg group (p < 0.05). Conclusions: In this rat HI model, arginine appears to be safe, contributes to a large extent to the immunomodulatory effects of the IED, and seems to limit enterobacterial translocation and dissemination more efficiently alone than in an IED.	Univ Paris 05, Fac Pharm, Lab Biol Nutr EA2498, F-75270 Paris 06, France; Univ Paris 05, Fac Pharm, Lab Pharm Galen EA2498, F-75270 Paris, France; Univ Paris 05, Fac Pharm, Microbiol Lab, F-75270 Paris 06, France; Univ Paris 05, Fac Pharm, Lab Pharmacol Circulat Cerebrale EA2510, F-75270 Paris 06, France; Univ Paris 05, Fac Pharm, Lab Biomath EA2498, F-75270 Paris 06, France; Hop Hotel Dieu, AP HP, Serv Biochim, Paris, France		Hamani, D (corresponding author), Univ Paris 05, Fac Pharm, Lab Biol Nutr EA2498, 4 Ave Observ, F-75270 Paris 06, France.	djamel.hamani@nutrition-paris5.org	BESSON, VALERIE/AAZ-9989-2020; Nicolis, Ioannis/C-3302-2012; MARCHAND-LEROUX, Catherine/L-7453-2017; Cynober, Luc/ABB-2368-2020; besson, valerie C/L-7388-2017	BESSON, VALERIE/0000-0002-1491-2380; Nicolis, Ioannis/0000-0001-7207-7689; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; besson, valerie C/0000-0002-1491-2380			BARBUL A, 1984, J SURG RES, V36, P620, DOI 10.1016/0022-4804(84)90149-5; Belabed L, 2006, CLIN NUTR, V25, P832, DOI 10.1016/j.clnu.2006.02.003; Besson VC, 2003, FREE RADICAL RES, V37, P1201, DOI 10.1080/10715760310001612568; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Breuille D, 1998, CLIN SCI, V94, P413, DOI 10.1042/cs0940413; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Calder PC., 2004, METABOLIC THERAPEUTI, V2nd ed, P305; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Correa L, 2000, J HOSP INFECT, V46, P89, DOI 10.1053/jhin.2000.0803; CYNOBER L, 1995, J NUTR BIOCHEM, V6, P402, DOI 10.1016/0955-2863(95)00066-9; Cynober L, 2003, CURR OPIN CLIN NUTR, V6, P189, DOI 10.1097/00075197-200303000-00007; ESTES RJ, 1995, INTENS CARE MED, V21, P365, DOI 10.1007/BF01705418; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Heard SO, 1998, CRIT CARE MED, V26, P748, DOI 10.1097/00003246-199804000-00027; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Ishikawa K, 2000, J TRAUMA, V49, P912, DOI 10.1097/00005373-200011000-00020; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; KANG W, 2005, J PARENTER ENTERAL N, V29, pS4; LeBoucher J, 1997, AM J PHYSIOL-ENDOC M, V273, pE557, DOI 10.1152/ajpendo.1997.273.3.E557; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Louin G, 2004, J NEUROSCI METH, V138, P73, DOI 10.1016/j.jneumeth.2004.03.010; MacFie J, 2006, BRIT J SURG, V93, P87, DOI 10.1002/bjs.5184; MAHONEY EJ, 2004, METABOLIC THERAPEUTI, P211; McCowen Karen C, 2002, Nutr Clin Pract, V17, P265, DOI 10.1177/0115426502017005265; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Moinard C, 2002, CLIN SCI, V102, P287, DOI 10.1042/CS20010162; Nitenberg Gerard, 2000, Curr Opin Crit Care, V6, P253, DOI 10.1097/00075198-200008000-00004; PRASAD AS, 1991, AM J CLIN NUTR, V53, P403, DOI 10.1093/ajcn/53.2.403; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; Radrizzani D, 2006, INTENS CARE MED, V32, P1191, DOI 10.1007/s00134-006-0238-y; Schneider SM, 2004, BRIT J NUTR, V92, P105, DOI 10.1079/BJN20041152; Singer P, 2005, NUTRITION, V21, P282, DOI 10.1016/j.nut.2004.10.001; Ulusoy H, 2003, J CLIN NEUROSCI, V10, P596, DOI 10.1016/S0967-5868(03)00142-5; VAUBOURDOLLE M, 1991, JPEN-PARENTER ENTER, V15, P517, DOI 10.1177/0148607191015005517; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Walrand S, 2004, AM J PHYSIOL-CELL PH, V286, pC1474, DOI 10.1152/ajpcell.00563.2002; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010; Zulfikaroglu B, 2003, CLIN NUTR, V22, P277, DOI 10.1016/S0261-5614(02)00211-X	42	19	19	0	5	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	JUN	2007	33	6					1076	1084		10.1007/s00134-007-0624-0			9	Critical Care Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177LV	WOS:000247155500023	17429607				2022-02-06	
J	Stanford, RE; Soden, R; Bartrop, R; Mikk, M; Taylor, TKF				Stanford, R. E.; Soden, R.; Bartrop, R.; Mikk, M.; Taylor, T. K. F.			Spinal cord and related injuries after attempted suicide: psychiatric diagnosis and long-term follow-up	SPINAL CORD			English	Article						acute spinal cord injury; fall from height; suicide; mental-illness; long-term outcome; drug abuse	TRAUMATIC BRAIN-INJURY; VERTICAL DECELERATION INJURIES; DRUG-USE; PSYCHOTIC DISORDERS; MENTAL-ILLNESS; RIVER BRIDGES; MORTALITY; SCHIZOPHRENIA; FALLS; AUTOKABALESIS	Study Design: Retrospective analysis of acute spinal cord injuries (ASCI). Objectives: Determine incidence of ASCI due to suicide attempt from 1970 to 2000. Describe demographics, injuries, mental illness, functional outcomes and nature of subsequent deaths. Setting: State spinal cord injury services, New South Wales, Australia. Methods: Retrospective record review and follow-up interview. Results: Of 2752 ASCI admissions, 56 were because of attempted suicide (55 falls, one gunshot wound). Thirty-six males and 20 females. Median age 30 years (15-74). Most common levels of vertebral injury were C5 and L1. Twenty-three had complete spinal cord injury. Thirty-two had an Injury Severity Score of > 415. Forty had more than one major injury. There was a significant rise in the incidence of ASCI following self-harm over time (Poisson regression, P = 0.004). There was a significant change in scene of injury away from hospitals over time (w 2 test, df = 1, P = 0.0001). Psychiatric diagnoses were personality disorder 27; schizophrenia 16; depression 14; chronic alcohol abuse 10; mood disorder 10; chronic substance abuse 10; other four. Follow-up was available in 47 cases (84%) at an average of 8 years. Four subsequent deaths were by suicide. Domiciliary arrangements were: home 28; hospital five; nursing home three; group home/hostel four. Conclusions: Community placement outcomes for survivors were good. Subsequent death by suicide was high. There was a significant rise in cases and a change in injury scene away from hospitals over time.	Prince Wales Hosp, Dept Orthopaed, Sydney, NSW, Australia; Univ New S Wales, Sydney, NSW, Australia; Univ Sydney, Sydney, NSW 2006, Australia; Royal N Shore Hosp, Dept Rehabil Med, Spinal Injuries Unit, Spinal Injuries Res Off, Sydney, NSW, Australia; Royal N Shore Hosp, Dept Psychol Med, Sydney, NSW, Australia; Prince Henry Hosp, Dept Rehabil Med, Spinal Cord Injury Unit, Sydney, NSW, Australia; Royal N Shore Hosp, Dept Traumat & Orthopaed Surg, Sydney, NSW, Australia; SpineCare Fdn, Parramatta, NSW, Australia		Stanford, RE (corresponding author), Prince Wales Hosp, Dept Orthopaed, Sydney, NSW, Australia.		Stanford, Ralph/AAV-2726-2020	Stanford, Ralph/0000-0002-4547-8927			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Babidge NC, 2001, ACTA PSYCHIAT SCAND, V103, P105, DOI 10.1034/j.1600-0447.2001.00192.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BIERINGSORENSEN F, 1992, PARAPLEGIA, V30, P139, DOI 10.1038/sc.1992.43; Bostman O M, 1987, Scand J Soc Med, V15, P119; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Burdekin B., 1993, HUMAN RIGHTS MENTAL; CANTOR CH, 1990, AUST NZ J PSYCHIAT, V24, P377, DOI 10.3109/00048679009077705; Cantor CH, 1999, MED J AUSTRALIA, V171, P137, DOI 10.5694/j.1326-5377.1999.tb123565.x; CANTOR CH, 1989, BRIT J PSYCHIAT, V155, P829, DOI 10.1192/bjp.155.6.829; Daigle MS, 2005, ACCIDENT ANAL PREV, V37, P625, DOI 10.1016/j.aap.2005.03.004; Degenhardt L, 2001, PSYCHOL MED, V31, P659, DOI 10.1017/S0033291701003865; Drake RE, 1998, RECENT DEV ALCOHOL, V14, P285, DOI 10.1007/0-306-47148-5_12; Gibb SJ, 2005, AUST NZ J PSYCHIAT, V39, P95, DOI 10.1111/j.1440-1614.2005.01514.x; GIRARD R, 1980, PARAPLEGIA, V18, P381, DOI 10.1038/sc.1980.66; Glass C A, 1992, J Am Paraplegia Soc, V15, P187; Hall W, 2004, DRUG ALCOHOL REV, V23, P433, DOI 10.1080/09595230412331324554; Hoff J, 1971, Proc Veterans Adm Spinal Cord Inj Conf, V18, P53; Hunt GE, 2002, SCHIZOPHR RES, V54, P253, DOI 10.1016/S0920-9964(01)00261-4; ISBISTER ES, 1992, INJURY, V23, P119, DOI 10.1016/0020-1383(92)90046-U; Jablensky A, 2000, AUST NZ J PSYCHIAT, V34, P221, DOI 10.1046/j.1440-1614.2000.00728.x; KATZ K, 1988, INJURY, V19, P371, DOI 10.1016/0020-1383(88)90124-6; Kavanagh DJ, 2004, SCHIZOPHR RES, V66, P115, DOI 10.1016/S0920-9964(03)00130-0; Kennedy P, 1999, SPINAL CORD, V37, P847, DOI 10.1038/sj.sc.3100932; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; KRAUSE JS, 1992, CURR OPIN NEUROL NEU, V5, P669; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Maxwell JC, 2003, DRUG ALCOHOL REV, V22, P347, DOI 10.1080/0959523031000154490; MCLENNAN W, 2000, SUICIDES AUSTR 1921; Montross Lori P, 2005, Ann Clin Psychiatry, V17, P173, DOI 10.1080/10401230591002156; Newton L, 2000, AUST NZ J PSYCHIAT, V34, P484, DOI 10.1080/j.1440-1614.2000.00733.x; Palmer DD, 1999, J CLIN PSYCHIAT, V60, P100; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Richter D, 1996, INJURY, V27, P655, DOI 10.1016/S0020-1383(96)00083-6; SCALEA T, 1986, J TRAUMA, V26, P706, DOI 10.1097/00005373-198608000-00005; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; SIMS A, 1979, MED SCI LAW, V19, P195, DOI 10.1177/002580247901900310; Soden RJ, 2000, SPINAL CORD, V38, P604, DOI 10.1038/sj.sc.3101080; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Wirbel RJ, 1998, EUR J SURG, V164, P109; Wyatt J P, 2000, J Clin Forensic Med, V7, P1, DOI 10.1054/jcfm.2000.0357; Yeo JD, 1998, SPINAL CORD, V36, P329, DOI 10.1038/sj.sc.3100628; [No title captured]	44	19	19	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	JUN	2007	45	6					437	443		10.1038/sj.sc.3102043			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	176JH	WOS:000247080500007	17339888	Bronze			2022-02-06	
J	Frumberg, DB; Fernando, MS; Lee, DE; Biegon, A; Schiffer, WK				Frumberg, David B.; Fernando, Marion S.; Lee, Dianne E.; Biegon, Anat; Schiffer, Wynne K.			Metabolic and behavioral deficits following a routine surgical procedure in rats	BRAIN RESEARCH			English	Article						glucose metabolism; brain injury; behavior; surgery; microdialysis; functional neuroimaging; parametric mapping	TRAUMATIC BRAIN-INJURY; CEREBRAL GLUCOSE-UTILIZATION; ONE-TRIAL TEST; COGNITIVE DEFICITS; SPATIAL NORMALIZATION; DYNAMIC CHANGES; MICROPET R4; CELL LOSS; MEMORY; CORTEX	To test the hypothesis that functional metabolic deficits observed following surgical brain injury are associated with changes in cognitive performance in rodents, we performed serial imaging studies in parallel with behavioral measures in control animals and in animals with surgical implants. Memory function was assessed using the novel object recognition (NOR) test, administered 3 days prior to and 3, 7, 14 and 56 days after surgery. At each time point, general locomotion was also measured. Metabolic imaging with F-18-fluorodeoxyglucose ([F-18]FDG) occurred 28 and 58 days after surgery. Animals with surgical implants performed significantly worse on tests of object recognition, while general locomotion was unaffected by the implant. There was a significant decrease in glucose uptake after surgery in most of the hemisphere ipsilateral to the implant relative to the contralateral hemisphere. At both time points, the most significant metabolic deficits occurred in the primary motor cortex (-25%; p<0.001), sensory cortex (-15%, p<0.001) and frontal cortex (-12%; p<0.001). Ipsilateral areas further from the site of insertion became progressively worse, including the sensory cortex, dorsal striatum and thalamus. These data was supported by a voxel-based analysis of the PET data, which revealed again a unilateral decrease in [F-18]FDG uptake that extended throughout the ipsilateral cortex and persisted for the duration of the 58-day study. Probe implantation in the striatum results in a widespread and long-lasting decline in cortical glucose metabolism together with a persistent, injury-related deficit in the performance of a cognitive (object recognition) task in rats. (c) 2007 Elsevier B.V. All rights reserved.	Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; Cornell Univ, Ithaca, NY 14853 USA		Schiffer, WK (corresponding author), Brookhaven Natl Lab, Dept Med, Bldg 555, Upton, NY 11973 USA.	wynne@bnl.gov			NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA015082, F31DA015874] Funding Source: NIH RePORTER; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA15082, F31 DA015874, F31 DA015874-02, R01 DA015082] Funding Source: Medline		Alexoff DL, 2003, J NUCL MED, V44, P815; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Broersen LM, 2000, PROG BRAIN RES, V126, P79; Chang Q, 2004, BEHAV NEUROSCI, V118, P383, DOI 10.1037/0735-7044.118.2.383; Chang Q, 2003, J NEUROSCI, V23, P3001; CHEN M, 1991, ANN NEUROL, V30, P62, DOI 10.1002/ana.410300112; COLLE LM, 1986, BRAIN RES, V397, P27, DOI 10.1016/0006-8993(86)91366-1; Courtiere A, 2005, EUR J NEUROSCI, V21, P1973, DOI 10.1111/j.1460-9568.2005.04015.x; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Engstad T, 2003, NEUROEPIDEMIOLOGY, V22, P326, DOI 10.1159/000072921; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; ENNACEUR A, 1992, BEHAV BRAIN RES, V51, P83, DOI 10.1016/S0166-4328(05)80315-8; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Funkiewiez A, 2004, J NEUROL NEUROSUR PS, V75, P834, DOI 10.1136/jnnp.2002.009803; GILMAN S, 1987, ANN NEUROL, V22, P370, DOI 10.1002/ana.410220314; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; Hauss-Wegrzyniak B, 2002, EXP NEUROL, V176, P336, DOI 10.1006/exnr.2002.7966; Hauss-Wegrzyniak B, 2000, NEUROREPORT, V11, P1759, DOI 10.1097/00001756-200006050-00032; Helmstaedter C, 2004, J NEUROL NEUROSUR PS, V75, P323; Hoofien D, 2001, BRAIN INJURY, V15, P189; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Knoess C, 2003, EUR J NUCL MED MOL I, V30, P737, DOI 10.1007/s00259-002-1052-6; Kossel AH, 1997, J NEUROSCI, V17, P9634; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Mostafa RM, 2002, PHYSIOL BEHAV, V76, P589, DOI 10.1016/S0031-9384(02)00730-8; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800; SANBERG PR, 1978, BRAIN RES, V149, P546, DOI 10.1016/0006-8993(78)90502-4; Schiffer WK, 2005, J NEUROSCI METH, V144, P25, DOI 10.1016/j.jneumeth.2004.10.016; Schiffer WK, 2000, LIFE SCI, V66, pPL169, DOI 10.1016/S0024-3205(00)00432-X; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; STENSAAS SS, 1976, ACTA NEUROPATHOL, V35, P187; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; TSABARI R, 2005, 95012 SOC NEUR; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; WAGNER KR, 1990, J CEREBR BLOOD F MET, V10, P417, DOI 10.1038/jcbfm.1990.72; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YUEN TGH, 1995, BIOMATERIALS, V16, P951, DOI 10.1016/0142-9612(95)93121-S; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	47	19	20	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 4	2007	1144						209	218		10.1016/j.brainres.2007.01.134			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	161RT	WOS:000246034100025	17346680	Green Accepted			2022-02-06	
J	Donohue, JT; Clark, DE; DeLorenzo, MA				Donohue, Joseph T.; Clark, David E.; DeLorenzo, Michael A.			Long-term survival of medicare patients with head injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	132nd Annual Meeting of the American-Public-Health-Association	NOV 06-10, 2004	Washington, DC	Amer Public Hlth Assoc		traumatic brain injury; survival; aged	GERIATRIC-PATIENTS; TRAUMA PATIENTS; MAJOR TRAUMA; BRAIN-INJURY; MORTALITY; VALIDATION; SEVERITY; DEATH; OLD	Background: An increasing number of older patients are being hospitalized with traumatic brain injury (TBI). Knowledge of their expected long-term survival may be useful in making clinical decisions. Methods: Patients age 65 or older admitted for the first time with head injury (ICD-9 800-804 or 850-854) during 1999 were identified in a complete national sample of fee-for-service Medicare hospitalization and denominator data. Cases were categorized by age, sex, maximum Abbreviated Injury Score (AISmax), and Charlson comorbidity score. Survival was determined at hospital discharge, and (using the denominator file) at 1, 6, 12, and 24 months after the initial hospital admission. Results: For all cases (n = 30,684), the hospital mortality was 14.3%, but was cumulatively 19.75%, 30.5%, 36.1%, and 44.9% at successive times up to 24 months. Long-term mortality was higher with increased age, comorbidity, or AISmax, and higher in men. These effects persisted with multivariate logistic regression analysis and were used to construct a simplified prediction score for clinical use. Conclusions: The mortality for older patients with TBI is much higher than for an uninjured control population. The relative risk for death remains elevated after hospital discharge and for at least 2 years. Awareness of the expected prognosis may help family members and health care providers make appropriate clinical decisions during acute hospitalization.	Maine Med Ctr, Portland, ME 04102 USA; Harvard Univ, Injury Control Res Ctr, Boston, MA 02115 USA		Clark, DE (corresponding author), 887 Congress St, Portland, ME 04102 USA.	clarkd@mmc.org			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR115279-04] Funding Source: Medline		ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; AMACHER AL, 1987, NEUROSURGERY, V20, P954; [Anonymous], 1971, JAMA-J AM MED ASSOC, V215, P277; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark DE, 2005, AM J PUBLIC HEALTH, V95, P273, DOI 10.2105/AJPH.2003.036871; Clark DE, 2004, J AM GERIATR SOC, V52, P2023, DOI 10.1111/j.1532-5415.2004.52560.x; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; FINELLI FC, 1989, J TRAUMA, V29, P541, DOI 10.1097/00005373-198905000-00001; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Gubler KD, 1997, ARCH SURG-CHICAGO, V132, P1010; Hannan EL, 2004, J TRAUMA, V56, P1297, DOI 10.1097/01.TA.0000075350.66739.53; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Nagurney JT, 1998, ACAD EMERG MED, V5, P678, DOI 10.1111/j.1553-2712.1998.tb02485.x; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; OSLER T, 1988, AM J SURG, V156, P537, DOI 10.1016/S0002-9610(88)80548-8; PELLICANE JV, 1992, J TRAUMA, V33, P440, DOI 10.1097/00005373-199209000-00018; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; SMITH DP, 1990, SOUTHERN MED J, V83, P171, DOI 10.1097/00007611-199002000-00010; VANAALST JA, 1991, J TRAUMA, V31, P1096; vanderSluis CK, 1996, J TRAUMA, V40, P78, DOI 10.1097/00005373-199601000-00015	26	19	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2007	62	2					419	423		10.1097/01.ta.0000219286.88179.18			5	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	137ZY	WOS:000244333300037	17297334				2022-02-06	
J	Ruocco, AC; Swirsky-Sacchetti, T				Ruocco, Anthony C.; Swirsky-Sacchetti, Thomas			Personality disorder symptomatology and neuropsychological functioning in closed head injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-DISORDERS; AXIS-I	Despite an emerging literature characterizing the neuropsychological profiles of borderline, antisocial, and schizotypal personality disorders, relations between personality disorder traits and neurocognitive domains remain unknown. The authors examined associations among Millon Clinical Multiaxial Inventory-III personality disorder scales and eight neuropsychological domains in 161 patients referred for neuropsychological evaluation following closed head injury. Most personality disorder scales were associated with some decrement in cognitive function, particularly speeded processing, executive function, and language, while histrionic and narcissistic scales had positive relations with neuropsychological functioning. Results suggest that many personality disorder traits are related to neurocognitive function, particularly those functions subserved by frontal and temporal regions.	Drexel Univ, Dept Psychol, Neuropsychol Program, Philadelphia, PA 19102 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Psychiat & Human Behav, Philadelphia, PA 19107 USA		Ruocco, AC (corresponding author), Drexel Univ, Dept Psychol, Neuropsychol Program, 245 N 15th St,Mail Stop 626, Philadelphia, PA 19102 USA.	acr32@drexel.edu	Ruocco, Anthony Charles/AAM-4794-2021; Ruocco, Anthony C./B-4915-2010	Ruocco, Anthony C./0000-0002-1942-7181			Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Burton LA, 1999, SEIZURE-EUR J EPILEP, V8, P116, DOI 10.1053/seiz.1999.0271; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Castano Monsalve B, 2005, Actas Esp Psiquiatr, V33, P96; Choca J, 1996, J PERS DISORD, V10, P377, DOI 10.1521/pedi.1996.10.4.377; Choca J.P., 2004, INTERPRETIVE GUIDE M, V3rd; COSTA PT, 1994, PERSONALITY DISORDER; Delis DC, 1987, CALIFORNIA VERBAL LE; Dickinson KA, 2003, J PERS DISORD, V17, P188, DOI 10.1521/pedi.17.3.188.22146; Golden CJ., 1978, STROOP COLOUR WORD T; GOLOMB M, 1995, AM J PSYCHIAT, V152, P579; GRAHAM JR, 1999, MMMP2 ASSESSING PERS; IRANI F, IN PRESS CLIN NEUROP; Kaplan E.F., 1978, BOSTON NAMING TEST; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Leyton M, 2001, AM J PSYCHIAT, V158, P775, DOI 10.1176/appi.ajp.158.5.775; Lysaker PH, 2004, SCHIZOPHR RES, V68, P87, DOI 10.1016/S0920-9964(03)00195-6; Mayberg H, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P177; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MILLON T, 1997, MCMI 3 MANUAL; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Narushima K, 2003, J NEUROPSYCH CLIN N, V15, P422, DOI 10.1176/appi.neuropsych.15.4.422; Ruocco AC, 2005, J CLIN PSYCHOL, V61, P1509, DOI 10.1002/jclp.20205; Ruocco AC, 2003, ARCH CLIN NEUROPSYCH, V18, P737; RUOCCO AC, IN PRESS PSYCHIAT RE; Sherry A, 2005, J PERS ASSESS, V84, P37, DOI 10.1207/s15327752jpa8401_09; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Skodol AE, 1999, DEPRESS ANXIETY, V10, P175, DOI 10.1002/(SICI)1520-6394(1999)10:4<175::AID-DA6>3.3.CO;2-U; Soloff PH, 2000, BIOL PSYCHIAT, V47, P540, DOI 10.1016/S0006-3223(99)00202-4; Spiers MV., 2001, PRINCIPLES NEUROPSYC; STONG C, 2004, NEUROL REV, P53; SWIRSKYSACCHETTI T, 1993, J CLIN PSYCHOL, V49, P385, DOI 10.1002/1097-4679(199305)49:3<385::AID-JCLP2270490313>3.0.CO;2-4; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TROBST KK, 1999, 4 ANN INTR SCI RETR; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Voglmaier MM, 2005, SCHIZOPHR RES, V74, P43, DOI 10.1016/j.schres.2004.09.013; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Yovel I, 2005, PSYCHOL SCI, V16, P123, DOI 10.1111/j.0956-7976.2005.00792.x	39	19	19	0	17	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FEB	2007	19	1					27	35		10.1176/appi.neuropsych.19.1.27			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	137KA	WOS:000244290300004	17308224				2022-02-06	
J	Coetzer, R				Coetzer, Rudi			Psychotherapy following traumatic brain injury: Integrating theory and practice	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						psychotherapy; traumatic brain injury	PERSONALITY PATHOLOGY; SELF-AWARENESS; REHABILITATION; INTERVENTIONS; DYSFUNCTION; DEPRESSION; DISTRESS; FEEDBACK; PEOPLE; MODEL	Psychotherapy is now an approach used within several models of neurorehabilitation. However, a core theoretical model to guide psychotherapeutic practice is lacking. This article attempts to illustrate how the Generic Model of Psychotherapy of Orlinsky and Howard, which emphasizes the common factors shared by many psychotherapies, can be applied in neurorehabilitation settings. A case report is presented to illustrate how this model can potentially inform psychotherapeutic practice. The use of a theoretical model to underpin psychotherapeutic interventions in neurorehabilitation settings has the potential to facilitate our understanding of the psychotherapeutic process following traumatic brain injury in this evolving area of professional practice.	Conwy & Denbighshire NHS Trust, Colwyn Bay Hosp, N Wales Brain Injury Serv, Colwyn Bay LL29 8AY, Wales; Univ Wales, Sch Psychol, Bangor, Gwynedd, Wales		Coetzer, R (corresponding author), Conwy & Denbighshire NHS Trust, Colwyn Bay Hosp, N Wales Brain Injury Serv, Hesketh Rd, Colwyn Bay LL29 8AY, Wales.	Rudi.Coetzer@cd-tr.wales.nhs.uk		Coetzer, Rudi/0000-0003-4505-7230			Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Ben-Yishay Y, 2000, INT HDB NEUROPSYCHOL, P127, DOI DOI 10.1007/978-1-4757-5569-5_8; Beutler LE, 2002, J CLIN PSYCHOL, V58, P1199, DOI 10.1002/jclp.10106; BRACY OL, 1994, J COGN REHAB, V12, P8; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; Caetano C., 1997, NEUROPSYCHOL REHABIL, P63; CHRISTENSEN AL, 1991, J HEAD TRAUMA REHAB, V6, P56; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Coetzer BR, 2001, J COGN REHABIL, V19, P8; COETZER BR, 2004, ILLNESS CRISIS LOSS, V12, P171, DOI DOI 10.1177/1054137303262216; Coetzer R., 2006, TRAUMATIC BRAIN INJU; Davis CG, 2001, AM BEHAV SCI, V44, P726, DOI 10.1177/0002764201044005003; Fischer, 2004, NEUROPSYCHOL ASSESSM; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Kolden G G, 1992, J Psychother Pract Res, V1, P225; Kolden GG, 2005, PSYCHOTHER RES, V15, P165, DOI 10.1080/10503300512331387825; Kolden GG, 1996, J PERS DISORD, V10, P107, DOI 10.1521/pedi.1996.10.2.107; Kolden GG, 2000, J CLIN PSYCHOL, V56, P1207, DOI 10.1002/1097-4679(200009)56:9<1207::AID-JCLP7>3.0.CO;2-Z; Kolden GG., 1991, PSYCHOTHER RES, V1, P62, DOI DOI 10.1080/10503309112331334071; Larry E, 2002, J CONTEMP PSYCHOTHER, V32, P25, DOI DOI 10.1023/A:1015579111666; Mateer C. A., 1997, NEUROPSYCHOL REHABIL, P285; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; McGrath J, 2004, CLIN REHABIL, V18, P767, DOI 10.1191/0269215504cr802oa; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Orlinsky D. E., 1995, COMPREHNSIVE TXB PSY, P3; Orlinsky D. E., 1986, HDB PSYCHOTHERAPY BE, P311; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; Prigatano G.P., 2000, BRIEF OVERVIEW 4 PRI, P115, DOI DOI 10.1007/978-1-4757-5569-5_7; Prigatano GP, 1997, J INT NEUROPSYCH SOC, V3, P497, DOI 10.1017/S1355617797004979; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P88, DOI 10.1097/00001199-199608000-00011; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schlund MW, 1999, BRAIN INJURY, V13, P889; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sprenkle DH, 2004, J MARITAL FAM THER, V30, P113, DOI 10.1111/j.1752-0606.2004.tb01228.x; TEASDALE T, 1997, NEUROPSYCHOL REHAB F, P469; Wallace CA, 2000, BRAIN INJURY, V14, P549; WAMPLOD BE, 2001, GREAT PSYHCOTHERAPY; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876	46	19	21	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2007	22	1					39	47		10.1097/00001199-200701000-00005			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	130SX	WOS:000243820400005	17235230				2022-02-06	
J	Gardner, HB				Gardner, Horace B.			A witnessed short fall mimicking presumed shaken baby syndrome (inflicted childhood neurotrauma)	PEDIATRIC NEUROSURGERY			English	Article						shaken baby syndrome; inflicted childhood neurotrauma; fall; trauma; subdural hematoma; retinal hemorrhage	ACUTE SUBDURAL-HEMATOMA	A witnessed fall backwards of an infant from a sitting position resulted in the subdural hematoma and retinal hemorrhages characteristic of presumed shaken baby syndrome. Violent shaking is not necessary to produce these findings. Copyright (c) 2007 S. Karger AG, Basel.			Gardner, HB (corresponding author), 318 Oklahoma Rd, Manitou Springs, CO 80829 USA.	horacebgardner@yahoo.com					AOKI N, 1984, J NEUROSURG, V61, P273, DOI 10.3171/jns.1984.61.2.0273; IKEDA A, 1987, CHILD NERV SYST, V3, P19, DOI 10.1007/BF00707188; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Piatt J H Jr, 1999, Neurosurg Focus, V7, pe4; Pittman T, 2003, PEDIATR NEUROSURG, V39, P57, DOI 10.1159/000071315; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001	6	19	19	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.		2007	43	5					433	435		10.1159/000106399			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	208FQ	WOS:000249305600019	17786015				2022-02-06	
J	Crespo, ART; Da Rocha, AB; Jotz, GP; Schneider, RF; Grivicich, I; Pinheiro, K; Zanoni, C; Regner, A				Proenca Crespo, Antonio Rogerio Tavares; Da Rocha, Adriana Brondani; Jotz, Geraldo Pereira; Schneider, Rogerio Fett; Grivicich, Ivana; Pinheiro, Kleiner; Zanoni, Caroline; Regner, Andrea			Increased serum sFas and TNF alpha following isolated severe head injury in males	BRAIN INJURY			English	Article						traumatic brain injury; sFas; TNF alpha; apoptosis; humans; biomarkers	TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; CORTICAL IMPACT INJURY; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; CELL-DEATH; ANTIINFLAMMATORY MEDIATORS; UP-REGULATION; FAS LIGAND; APOPTOSIS	Objectives: Severe traumatic brain injury ( TBI) is associated with a 30 - 70% mortality rate. Nevertheless, controversy has been raised concerning the prognostic value of biomarkers following severe TBI. Therefore, our aim was to determine whether sFas or TNF alpha serum levels correlate with primary outcome following isolated severe TBI. Methods: Seventeen consecutive male patients, victims of isolated severe TBI ( Glasgow Coma Scale score 3 - 8) and a control group consisting of 6 healthy male volunteers were enrolled in this prospective study. Clinical outcome variables of severe TBI comprised: survival, time for intensive care unit (ICU) discharge, and neurological assessment by Glasgow Outcome Scale at ICU discharge. Venous blood samples were taken at admission in the ICU. Serum sFas and TNF alpha concentrations were measured by ELISA assays. Results: At admission in the ICU ( mean time 10.2 h after injury), mean sFas and TNF alpha concentrations were significantly increased in the TBI ( 0.105 and 24.275 rho g/l, respectively) compared with the control group ( 0.047 and 15.475 rho g/l, respectively). However, no significant correlation was found between higher serum sFas or TNF alpha concentrations and fatal outcome. Conclusions: Increased serum sFas and TNF alpha levels following isolated severe TBI did not predict fatal outcome.	Univ Luterana Brasil, Ctr Pesquisa Ciencias Med, Lab Marcadores Estresse Celular, BR-92425900 Canoas, RS, Brazil; Hosp Municipal Pronto Socorro, SAMU, Porto Alegre, RS, Brazil; Hosp Municipal Pronto Socorro, Serv Cirurgia, Porto Alegre, RS, Brazil; Fdn Fac Fed Ciencias Med, Curso Med, Porto Alegre, RS, Brazil; Hosp Mae Deus, Serv Cirurgia Trauma, Porto Alegre, RS, Brazil		Regner, A (corresponding author), Univ Luterana Brasil, Ctr Pesquisa Ciencias Med, Lab Marcadores Estresse Celular, Ave Farroupilha 8001,Predio 22,5 Andar,Bairrao Sa, BR-92425900 Canoas, RS, Brazil.	regner@uol.com.br	Regner, Andrea/M-2596-2014; JOTZ, GERALDO P/G-2664-2014; Grivicich, Ivana/A-6777-2013	Regner, Andrea/0000-0002-6657-7991; JOTZ, GERALDO P/0000-0001-6289-7827; Grivicich, Ivana/0000-0001-9820-5730			ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; BEER R, 2000, J CEREBRAL BLOOD FLO, V20, P429; Bredesen DE, 2000, J NEUROTRAUM, V17, P801, DOI 10.1089/neu.2000.17.801; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; DUFF D, 2003, AXONE, V23, P18; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Felderhoff-Mueser U, 2000, BRAIN PATHOL, V10, P17; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jarrar D, 2000, AM J PHYSIOL-HEART C, V279, pH1015, DOI 10.1152/ajpheart.2000.279.3.H1015; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kanduc D, 2002, INT J ONCOL, V21, P165; Kraus J, 1996, NEUROTRAUMA, P13; Lai Y. C., 1998, Annals Academy of Medicine Singapore, V27, P326; Lambert C, 2003, APOPTOSIS, V8, P551, DOI 10.1023/A:1026113222478; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Maier B, 2005, J NEUROTRAUM, V22, P822, DOI 10.1089/neu.2005.22.822; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Martin-Villalba A, 2001, CELL DEATH DIFFER, V8, P679, DOI 10.1038/sj.cdd.4400882; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Qiu JH, 2002, J NEUROSCI, V22, P3504; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Raoul C, 2000, CURR OPIN NEUROBIOL, V10, P111, DOI 10.1016/S0959-4388(99)00055-0; Regner A, 2001, NEUROREPORT, V12, P691, DOI 10.1097/00001756-200103260-00015; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rosenbaum DM, 2000, J NEUROSCI RES, V61, P686, DOI 10.1002/1097-4547(20000915)61:6<686::AID-JNR12>3.0.CO;2-7; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje	59	19	22	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	4					441	447		10.1080/02699050701311125			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	168IY	WOS:000246518600010	17487642				2022-02-06	
J	Ulug, T; Ulubil, SA				Ulug, Tuncay; Ulubil, S. Arif			Contralateral labyrinthine concussion in temporal bone fractures	JOURNAL OF OTOLARYNGOLOGY			English	Article						hearing loss; labyrinthine concussion; temporal bone trauma	FACIAL-NERVE PARALYSIS	In this case presentation, three cases of labyrinthine concussion in the opposite ears of patients who had unilateral traumatic temporal bone fractures with facial paralysis are reported. The first patient was a 30-year-old male who had a right-sided longitudinal temporal bone fracture and labyrinthine concussion showing pure sensorineural hearing loss with a characteristic notch of 60 dB at 4000 Hz on the left side. The second patient was a 42-year-old male who had a right-sided traumatic facial paralysis owing to a mixed-type temporal bone fracture and labyrinthine concussion, demonstrating pure sensorineural hearing loss reaching its peak of 50 dB at 4000 Hz on the left. The third patient was a 19-year-old male who had a left-sided mixed-type temporal bone fracture and a right labyrinthine concussion exhibiting pure sensorineural hearing loss reaching 60 dB at 4000 Hz. For their facial paralyses, all three patients underwent middle cranial fossa or combined approach operations. The labyrinthine concussion in these patients was managed expectantly. At their 1-year follow-up, it was observed that the hearing loss owing to labyrinthine concussion persisted. Although labyrinthine concussion is not a rare complication of head injuries, it has rarely been reported in the medical literature. The main symptoms of labyrinthine concussion are hearing loss, tinnitus, and dizziness. The diagnosis mainly relies on audiometric tests, which reveal characteristic tracings reminiscent of acoustic trauma.	Univ Istanbul, Dept Otolaryngol, Fac Med, Istanbul, Turkey; Univ Miami, Dept Otolaryngol, Miami, FL 33152 USA		Ulug, T (corresponding author), Akdogan Sokak 30-11 Besiktas, Istanbul, Turkey.	tuncayu@superonline.com					AGUILAR EA, 1987, HEAD NECK-J SCI SPEC, V9, P162, DOI 10.1002/hed.2890090306; CANALIS RF, 1999, EAR COMPREHENSIVE OT, P795; CANNON CR, 1983, ARCH OTOLARYNGOL, V109, P285; GHORAYEB BY, 1992, LARYNGOSCOPE, V102, P129; KHAN AA, 1985, OTOLARYNG HEAD NECK, V93, P177, DOI 10.1177/019459988509300210; Lancaster JL, 1999, J ROY COLL SURG EDIN, V44, P87; Quaranta A, 2001, ACTA OTO-LARYNGOL, V121, P652, DOI 10.1080/000164801316878999; SCHUKNECHT HF, 1956, ARCHIV OTOLARYNGOL, V63, P513; Scott A M, 1999, Am J Audiol, V8, P101, DOI 10.1044/1059-0889(1999/020); Segal S, 2002, OTOL NEUROTOL, V23, P312, DOI 10.1097/00129492-200205000-00014; Ulrich K, 1926, ACTA OTO-LARYNGOL, V6, P1	11	19	20	0	4	B C DECKER INC	HAMILTON	50 KING STREET EAST, 2ND FLOOR, PO BOX 620, L C D 1, HAMILTON, ONTARIO L8N 3K7, CANADA	0381-6605			J OTOLARYNGOL	J. Otolaryngol.	DEC	2006	35	6					380	383		10.2310/7070.2006.0069			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	122TE	WOS:000243249000005	17380831				2022-02-06	
J	Ivashkova, Y; Svetnitsky, A; Mayzler, O; Pruneau, D; Benifla, M; Fuxman, Y; Cohen, A; Artru, AA; Shapira, Y				Ivashkova, Yulia; Svetnitsky, Albert; Mayzler, Olga; Pruneau, Didier; Benifla, Mony; Fuxman, Yulia; Cohen, Avi; Artru, Alan A.; Shapira, Yoram			Bradykinin B2 receptor antagonism with LF 18-1505T reduces brain edema and improves neurological outcome after closed head trauma in rats	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						bradykinin antagonist; brain edema; head injury; neurologic outcome; rat	NITRIC-OXIDE SYNTHASE; B-2 RECEPTOR; KININ RECEPTORS; GUINEA-PIG; INJURY; PERMEABILITY; INHIBITION; MODEL; RELAXATION; REDUCTION	Background: We evaluated the effect of LF 18-1505T, a novel nonpeptide bradykinin type-2 receptor antagonist, on brain edema and neurologic severity score (NSS) after closed head trauma (CHT). Methods: There were 132 rats anesthetized and assigned for sham or CHT; infusion of saline or LF 18-1505T (0.3, 1, 3, 10, or 30 mu g center dot kg(-1) center dot min(-1)); and determination of neurologic outcome (brain water content anti NSS) or physiologic variables (blood pressure, glucose concentration, etc.). Results: Post-CHT brain water content was less with LF 18-1505T doses of 3 and 10 mu g center dot kg(-1) center dot min(-1) (80.1 +/- 3.8 through 81.6 +/- 2.6%, mean +/- SD) than in the untreated group (84.6 +/- 1.9%, p < 0.01). Post-CHT NSS improved with doses of 3, 10, and 30 mu g center dot kg(-1) center dot min(-1) (median, 7; range, 0-12 through median, 10; range, 8-18) as compared with that in the untreated group (median, 17; range, 14-23; p < 0.05). LF 18-1505T with or without CHT did not significantly alter physiologic variables. Conclusions: LF 18-1505T decreased brain edema and improved neurologic status after CTH in rats without significantly altering physiologic. values.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Labs Fournier, Res Ctr, Daix, France; Barzilay Med Ctr, Dept Surg, Askelon, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol, Dept Surg, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Dept Neurol Surg, IL-84105 Beer Sheva, Israel		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA.	artruaa@u.washington.edu					Bastian S, 1997, BRIT J PHARMACOL, V122, P393, DOI 10.1038/sj.bjp.0701380; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Chabrier PE, 1999, P NATL ACAD SCI USA, V96, P10824, DOI 10.1073/pnas.96.19.10824; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Dixon CE, 1996, NEUROTRAUMA, P1337; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; ELLIS EF, 1990, NEW TRENDS LIPID MED, P129; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; FRANCEL PC, 1992, J NEUROTRAUMA S1, V9, P27; Gecse A, 1989, Adv Exp Med Biol, V247A, P249; Gorlach C, 2001, J NEUROTRAUM, V18, P833, DOI 10.1089/089771501316919193; Gorlach C, 1996, PEPTIDES, V17, P1373, DOI 10.1016/S0196-9781(96)00223-9; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Hsu CY, 1996, NEUROTRAUMA, P1433; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; JONES S, 1995, NEURON, V14, P399, DOI 10.1016/0896-6273(95)90295-3; Kaplanski J, 2003, RESUSCITATION, V56, P207, DOI 10.1016/S0300-9572(02)00371-4; Kaplanski J, 2002, J NEUROTRAUM, V19, P953, DOI 10.1089/089771502320317104; KATUSIC ZS, 1993, STROKE, V24, P392, DOI 10.1161/01.STR.24.3.392; Koyfman L, 2000, J NEUROSURG ANESTH, V12, P44, DOI 10.1097/00008506-200001000-00009; Lehmberg J, 2003, J CEREBR BLOOD F MET, V23, P441, DOI 10.1097/01.WCB.0000052280.23292.35; Marceau F, 1998, CLIN REV ALLERG IMMU, V16, P385, DOI 10.1007/BF02737658; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; MULLERESTERL W, 1989, THROMB HAEMOSTASIS, V61, P2; Narotam PK, 1998, ACTA NEUROCHIR, V140, P793, DOI 10.1007/s007010050181; Paquet JL, 1999, BRIT J PHARMACOL, V126, P1083, DOI 10.1038/sj.bjp.0702403; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; PEREZ M, 2001, J CLIN BASIC CARDIOL, V4, P39; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; Pruneau D, 1999, J NEUROTRAUM, V16, P1057, DOI 10.1089/neu.1999.16.1057; Pruneau D, 1999, FUND CLIN PHARMACOL, V13, P75, DOI 10.1111/j.1472-8206.1999.tb00323.x; Pruneau D, 1999, IMMUNOPHARMACOLOGY, V43, P187, DOI 10.1016/S0162-3109(99)00128-9; PRUNEAU D, 1995, BRIT J PHARMACOL, V116, P2106, DOI 10.1111/j.1476-5381.1995.tb16418.x; Raidoo DM, 1997, J NEUROIMMUNOL, V77, P39, DOI 10.1016/S0165-5728(97)00048-9; ROSENBLUM WI, 1987, CIRC RES, V61, P601, DOI 10.1161/01.RES.61.4.601; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P159; Sobey CG, 1997, STROKE, V28, P2290, DOI 10.1161/01.STR.28.11.2290; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; UNTERBERG A, 1984, J CEREBR BLOOD F MET, V4, P574, DOI 10.1038/jcbfm.1984.82; Wahl M, 1996, IMMUNOPHARMACOLOGY, V33, P257, DOI 10.1016/0162-3109(96)00068-9; WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A; Wang Q, 1997, J CELL PHYSIOL, V172, P171, DOI 10.1002/(SICI)1097-4652(199708)172:2<171::AID-JCP4>3.0.CO;2-L; WARD PE, 1991, BRADYKININ ANTAGONIS, P147; WHALLEY ET, 1983, N-S ARCH PHARMACOL, V323, P66, DOI 10.1007/BF00498830; Xing MZ, 1997, AM J PHYSIOL-CELL PH, V272, pC1380, DOI 10.1152/ajpcell.1997.272.4.C1380	54	19	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2006	61	4					879	885		10.1097/01.ta.0000234722.98537.01			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	096YU	WOS:000241413700022	17033555				2022-02-06	
J	Swann, IJ; Bauza-Rodriguez, B; Currans, R; Riley, J; Shukla, V				Swann, I. J.; Bauza-Rodriguez, B.; Currans, R.; Riley, J.; Shukla, V.			The significance of post-traumatic amnesia as a risk factor in the development of olfactory dysfunction following head injury	EMERGENCY MEDICINE JOURNAL			English	Article							RECOVERY	Objective: To test the following hypothesis in the assessment of head injury patients: only patients with 5 min or more of post-traumatic amnesia ( PTA) are at risk of acute olfactory dysfunction ( OD). Methods: This was a retrospective comparative study of olfactory status in head injury patients seen at a head injury clinic at Glasgow Royal Infirmary from 1985 to 2003. Of 828 clinic attenders, 101 had acute OD. These subjects were compared with a randomly selected control group of 102 patients with head injury but normal olfactory function. The main outcome measure was a significant likelihood of patients with PTA lasting for 5 or more minutes having acute OD compared with those with PTA of less than 5 min. Results: The likelihood of patients with a PTA of 5 min or more having acute OD compared to those with PTA of less than 5 min is clinically significant with an odds ratio of 9.6 ( p< 0.01). Conclusion: Examination of patients with 5 min or more of PTA should include a simple test of sense of smell. Patients with impaired smell sensation should be aware of their condition prior to discharge from hospital. In addition, the need for a CT brain scan and appropriate follow up should be considered.	Glasgow Royal Infirm, Dept Emergency Med, Glasgow G4 0SF, Lanark, Scotland; Greater Glasgow Hlth Board, N Glasgow Div, Glasgow, Lanark, Scotland; Glasgow Caledonian Univ, Div Math, Glasgow G4 0BA, Lanark, Scotland; Hull Royal Infirm, Kingston Upon Hull HU3 2JZ, N Humberside, England		Swann, IJ (corresponding author), Glasgow Royal Infirm, Dept Emergency Med, 84 Castle St, Glasgow G4 0SF, Lanark, Scotland.	Ian.Swann@northglasgow.scot.nhs.uk					Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Jackson JH, 1864, LOND HOSP REP, V1, P470; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; Mann Norman M, 2003, Conn Med, V67, P545; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; *SCOTT INT GUID NE, 2000, EARLY MAN PAT HEAD I; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; SWANN IJ, 1981, INJURY, V12, P274, DOI 10.1016/0020-1383(81)90200-X; Swann IJ, 2001, EMERG MED J, V18, P352, DOI 10.1136/emj.18.5.352; SWANN IJ, 1993, J NEUROTRAUM, V10, P176; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	15	19	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	AUG	2006	23	8					618	621		10.1136/emj.2005.029017			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	065NT	WOS:000239167300013	16858094	Green Published			2022-02-06	
J	Takeuchi, N; Ikoma, K; Chuma, T; Matsuo, Y				Takeuchi, Naoyuki; Ikoma, Katsunori; Chuma, Takayo; Matsuo, Yuichiro			Measurement of transcallosal inhibition in traumatic brain injury by transcranial magnetic stimulation	BRAIN INJURY			English	Article						traumatic brain injury; transcranial magnetic stimulation; corpus callosum; diffuse axonal injury	DIFFUSE AXONAL INJURY; HEAD-INJURY; CORPUS-CALLOSUM; MULTIPLE-SCLEROSIS; MOTOR CORTEX; HUMANS; FIBERS; COMA	Primary objective: To study whether transcallosal inhibition (TCI) can evaluate the severity of traumatic brain injury (TBI). Research design: Case-control study. Methods and procedures: Twenty patients with a chronic TBI and 20 control subjects were studied. The following transcranial magnetic stimulation parameters were checked; resting motor threshold, central motor latency times, onset latency of TCI, duration of TCI, transcallosal conduction times and amount of TCI. The severity of TBI was evaluated using the Glasgow Coma Scale (GCS). Main outcome and results: The amount of TCI was significantly lower in the patients than the control subjects (p < 0.001). The amount of TO was highly correlated with the GCS (r = 0.787, p < 0.001). Conclusion: An assessment of TCI was found to be a more sensitive and useful method for an evaluation of the severity of TBI.	Hokkaido Univ, Grad Sch Med, Dept Rehabil Med, Sapporo, Hokkaido 0600814, Japan		Takeuchi, N (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Rehabil Med, North 14 West 5, Sapporo, Hokkaido 0600814, Japan.	naoyuki@med.hokudai.ac.jp	Ikoma, Katsunori/D-8158-2012				Aranyi Z, 2002, EXP BRAIN RES, V145, P76, DOI 10.1007/s00221-002-1101-1; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; JANE JA, 1984, CLIN NEUROSURG, V29, P346; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Meyer BU, 1998, ANN NEUROL, V43, P360, DOI 10.1002/ana.410430314; Meyer BU, 1996, J PHYSIOL-LONDON, V497P, pP34; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moosavi SH, 1999, J NEUROL SCI, V164, P179, DOI 10.1016/S0022-510X(99)00065-9; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schmierer K, 2000, J NEUROL NEUROSUR PS, V68, P633, DOI 10.1136/jnnp.68.5.633; Schmierer K, 2002, NEUROLOGY, V59, P1218, DOI 10.1212/WNL.59.8.1218; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; WHYTE J, 1998, REHABILITATION MED P, P1191; Wolters A, 2004, MOVEMENT DISORD, V19, P518, DOI 10.1002/mds.20064	24	19	19	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2006	20	9					991	996		10.1080/02699050600909771			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	094ZN	WOS:000241278100011	17046801	Green Submitted			2022-02-06	
J	Sonna, LA; Kuhlmeier, MM; Carter, HC; Hasday, JD; Lilly, CM; Fairchild, KD				Sonna, Larry A.; Kuhlmeier, Matthew M.; Carter, Heather C.; Hasday, Jeffrey D.; Lilly, Craig M.; Fairchild, Karen D.			Effect of moderate hypothermia on gene expression by THP-1 cells: a DNA microarray study	PHYSIOLOGICAL GENOMICS			English	Article; Proceedings Paper	101st International Conference of the American-Thoracic-Society	MAY 20-25, 2005	San Diego, CA	Amer Thorac Soc, Fogarty AIDS Int Training & Res Program		cold stress; thermal stress; heat shock; mononuclear cells	TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; COLD STRESS; HEAT; DIFFERENTIATION; ADULTS	The mechanisms by which moderate hypothermia (32 C for 12-72 h) affect human cellular function are unclear. We tested the hypothesis that it produces broad changes in mRNA expression in vitro. Acute monocytic leukemia (THP-1) cells were incubated under control conditions (37 C) or moderate hypothermia (32 C) for 24 h. RNA was extracted, and the hypothermic response was confirmed by examining the expression of the cold-induced RNA-binding protein (CIRBP) gene by RT-PCR. Gene expression analysis was performed on seven sets of paired samples with Affymetrix U133A chips using established statistical methods. Sequences were considered affected by cold if they showed statistically significant changes in expression and also met published post hoc filter criteria (changes in geometric mean expression of >= 2-fold and expression calls of "present" or "marginal" in at least half of the experiments). Changes in the expression of selected sequences were further confirmed by PCR. Sixty-seven sequences met the criteria for increased expression ( including cold-inducible genes CIRBP and RNA binding motif 3), and 100 sequences showed decreased expression as a result of hypothermia. Functional categories affected by hypothermia included genes involved in immune responses; cell growth, proliferation, and differentiation; and metabolism and biosynthesis. Several heat shock proteins (HSPs) showed decreases in expression. Moderate hypothermia produces substantial changes in gene expression, in categories potentially of systemic importance. Cold exposure without rewarming decreased the expression of several HSPs. These in vitro findings suggest that prolonged hypothermia in vivo might be capable of producing physiologically relevant changes in gene expression by circulating leukocytes.	USA, Thermal & Mt Med Div, Res Inst Environm Med, Natick, MA USA; Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA USA; Univ Virginia Hosp, Div Neonatol, Charlottesville, VA USA		Sonna, LA (corresponding author), USA, Thermal & Mt Med Div, Res Inst Environm Med, 42 Kansas St, Natick, MA USA.	larry_sonna@yahoo.com					Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Castellani JW, 2002, MED SCI SPORT EXER, V34, P2013, DOI 10.1097/00005768-200212000-00023; Chen C, 2000, CANCER RES, V60, P4377; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; FARRELL RE, 1998, RNA METHODOLOGIES, P94; Hayden JM, 2002, J LIPID RES, V43, P26; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kaminski N, 2002, AM J RESP CELL MOL, V27, P125, DOI 10.1165/ajrcmb.27.2.f247; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Nishiyama H, 1997, GENE, V204, P115, DOI 10.1016/S0378-1119(97)00530-1; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sonna LA, 2004, J APPL PHYSIOL, V96, P1943, DOI 10.1152/japplphysiol.00886.2003; Sonna LA, 2003, PHYSIOL GENOMICS, V12, P195, DOI 10.1152/physiolgenomics.00104.2002; Sonna LA, 2002, J APPL PHYSIOL, V92, P2208, DOI 10.1152/japplphysiol.01002.2001; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Wood RJ, 2004, PHYSIOL GENOMICS, V17, P122, DOI 10.1152/physiolgenomics.00002.2003	22	19	19	0	5	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1094-8341			PHYSIOL GENOMICS	Physiol. Genomics	JUN 16	2006	26	1					91	98		10.1152/physiolgenomics.00296.2005			8	Cell Biology; Genetics & Heredity; Physiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Genetics & Heredity; Physiology	062AC	WOS:000238915500009	16595739				2022-02-06	
J	Ates, O; Yucel, N; Cayli, SR; Altinoz, E; Yologlu, S; Kocak, A; Cakir, CO; Turkoz, Y				Ates, Ozkan; Yucel, Neslihan; Cayli, Suleyman R.; Altinoz, Eyup; Yologlu, Sairn; Kocak, Ayhan; Cakir, Celal Ozbek; Turkoz, Yusuf			Neuroprotective effect of etomidate in the central nervous system of streptozotocin-induced diabetic rats	NEUROCHEMICAL RESEARCH			English	Article						central nervous system; diabetes mellitus; etomidate; malondialdehide; oxidative damage; streptozotocin	TRAUMATIC BRAIN-INJURY; INCOMPLETE FOREBRAIN ISCHEMIA; GLUTAMATE RELEASE INHIBITOR; NITRIC-OXIDE FORMATION; OXIDATIVE STRESS; XANTHINE-OXIDASE; ALZHEIMERS-DISEASE; RADICAL PRODUCTION; MELLITUS; NEURONS	It is well known that hyperglycaemia due to diabetes mellitus leads to oxidative stress in the central nervous system. Oxidative stress plays important role in the pathogenesis of neurodegenerative changes. In the present study we investigated the possible neuroprotective effect of etomidate against streptozotocin-induced (STZ-induced) hyperglycaemia in the rat brain and spinal cord. A total of 40 rats were used in this study. Rats were divided into four groups: sham-control, diabetic, diabetic-etomidate treated and vehicle for etomidate treatment group. Diabetes mellitus was induced by a single injection of streptozotocin (60 mg/kg body weight). Three days after streptoztocin injection, etomidate (2 mg/kg) was injected intraperitoneally for etomidate group and lipid emulsion (10%) for vehicle group was injected with corresponding amount intraperitoneally every day for 6 weeks. Six weeks after streptozotocin injection, seven rats from each group were killed and brain, brain stem and cervical spinal cord were removed. The hippocampus, cortex, cerebellum, brain stem and spinal cord were dissected for the biochemical analysis (the level of malondialdehyde [MDA], total nitrite, reduced glutathione [GSH], and xanthine oxidase [XO] activity). STZ-induced diabetes resulted in significantly elevation of MDA, XO and nitrite levels in the hippocampus, cortex, cerebellum,, brain stem and spinal cord of the rats (P < 0.05) while etomidate treatment provided significantly lower values (P < 0.05). This study demonstrated that etomidate have neuroprotective effect on the neuronal tissue against the diabetic oxidative damage.	Inonu Univ, Sch Med, Dept Neurosurg, Turgut Ozal Med Ctr, TR-44069 Malatya, Turkey; Inonu Univ, Sch Med, Dept Emergency Med, TR-44069 Malatya, Turkey; Inonu Univ, Sch Med, Dept Biochem, TR-44069 Malatya, Turkey; Inonu Univ, Sch Med, Dept Biostat, TR-44069 Malatya, Turkey		Ates, O (corresponding author), Inonu Univ, Sch Med, Dept Neurosurg, Turgut Ozal Med Ctr, TR-44069 Malatya, Turkey.	atesozkan@hotmail.com	Yucel, Neslihan/ABI-3412-2020; Yologlu, Saim/ABI-8014-2020; Turkoz, Yusuf/ABG-7931-2020	Yucel, Neslihan/0000-0001-5845-2614; Yologlu, Saim/0000-0002-9619-3462; Turkoz, Yusuf/0000-0001-5401-0720; Altinoz, Eyup/0000-0002-3991-9773			Asgary S, 1999, Pharm Acta Helv, V73, P223, DOI 10.1016/S0031-6865(98)00025-9; Baydas G, 2002, J PINEAL RES, V32, P225, DOI 10.1034/j.1600-079X.2002.01856.x; Baydas G, 2003, FREE RADICAL BIO MED, V35, P797, DOI 10.1016/S0891-5849(03)00408-8; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; BHATTACHARYYA A, 1992, J NEUROBIOL, V23, P451, DOI 10.1002/neu.480230410; BIESSELS GJ, 1994, DIABETOLOGIA, V37, P643, DOI 10.1007/BF00417687; Bonnefont-Rousselot D, 2000, DIABETES METAB, V26, P163; Bramwell KJ, 2006, PEDIATR EMERG CARE, V22, P90, DOI 10.1097/01.pec.0000199563.64264.3a; Cerutti SM, 2000, CELL BIOL INT, V24, P35, DOI 10.1006/cbir.1999.0451; DELLACOR.E, 1972, BIOCHEM J, V126, P739, DOI 10.1042/bj1260739; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Dincer Y, 2002, METABOLISM, V51, P1360, DOI 10.1053/meta.2002.35192; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ercel Ergul, 1999, Biomedical Research (Aligarh), V10, P95; Greene DA, 1999, EUR J PHARMACOL, V375, P217, DOI 10.1016/S0014-2999(99)00356-8; Guyot LL, 2000, BRAIN RES, V872, P29, DOI 10.1016/S0006-8993(00)02426-4; HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9; Hawkins CL, 2001, BBA-BIOENERGETICS, V1504, P196, DOI 10.1016/S0005-2728(00)00252-8; Hill R. A., 1995, COMPREHENSIVE ORGANI, V4; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Jungersten L, 1996, CLIN PHYSIOL, V16, P369, DOI 10.1111/j.1475-097X.1996.tb00726.x; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Karelson E, 2001, NEUROCHEM RES, V26, P353, DOI 10.1023/A:1010942929678; Kristal BS, 1997, FREE RADICAL BIO MED, V22, P813, DOI 10.1016/S0891-5849(96)00429-7; Low PA, 1997, DIABETES, V46, pS38, DOI 10.2337/diab.46.2.S38; Luxford C, 2000, CHEM RES TOXICOL, V13, P665, DOI 10.1021/tx000053u; LYSKO PG, 1994, STROKE, V25, P2476, DOI 10.1161/01.STR.25.12.2476; Malcangio M, 1998, PAIN, V76, P151, DOI 10.1016/S0304-3959(98)00037-2; MARSHAK DR, 1992, NEUROBIOL AGING, V13, P1, DOI 10.1016/0197-4580(92)90002-F; Matsumoto S, 2003, FREE RADICAL RES, V37, P767, DOI 10.1080/1071576031000107344; Mendez-Alvarez E, 2001, FREE RADICAL BIO MED, V31, P986, DOI 10.1016/S0891-5849(01)00679-7; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Moosmann B, 2002, EXPERT OPIN INV DRUG, V11, P1407, DOI 10.1517/13543784.11.10.1407; Mu XJ, 2000, BRAIN RES, V870, P66, DOI 10.1016/S0006-8993(00)02402-1; MULLARKEY CJ, 1990, BIOCHEM BIOPH RES CO, V173, P932, DOI 10.1016/S0006-291X(05)80875-7; Murugaiah KD, 1998, ANESTHESIOLOGY, V89, P919, DOI 10.1097/00000542-199810000-00017; Nakagawa T, 2005, J NUTR SCI VITAMINOL, V51, P278, DOI 10.3177/jnsv.51.278; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Ovtscharoff W, 2002, ACTA HISTOCHEM, V104, P23, DOI 10.1078/0065-1281-00634; Ozbek E, 2000, EUR UROL, V37, P172, DOI 10.1159/000020135; PARKS D, 1988, J APPL PHYSIOL, V254, P768; PATEL PM, 1995, ANESTH ANALG, V80, P933, DOI 10.1097/00000539-199505000-00013; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; PEUNOVA N, 1993, NATURE, V364, P450, DOI 10.1038/364450a0; PRAJDA N, 1975, FEBS LETT, V59, P245, DOI 10.1016/0014-5793(75)80385-1; PUIL E, 1994, NEUROSCI LETT, V176, P63, DOI 10.1016/0304-3940(94)90872-9; Revsin Y, 2005, BRAIN RES, V1038, P22, DOI 10.1016/j.brainres.2004.12.032; Sano T, 1998, DIABETOLOGIA, V41, P1355, DOI 10.1007/s001250051076; Schulz-Stubner S, 2005, CRIT CARE MED, V33, P2723, DOI 10.1097/01.CCM.0000187093.71107.A8; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; Somani SM, 1996, ALCOHOL, V13, P603, DOI 10.1016/S0741-8329(96)00075-4; Tachi Y, 2001, LIFE SCI, V69, P1039, DOI 10.1016/S0024-3205(01)01183-3; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; WATSON JC, 1992, NEUROSURGERY, V30, P540; ZEBALLOS GA, 1995, CIRCULATION, V91, P2982, DOI 10.1161/01.CIR.91.12.2982	60	19	24	0	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUN	2006	31	6					777	783		10.1007/s11064-006-9076-0			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	071VC	WOS:000239631000008	16794861				2022-02-06	
J	Morales, D; McIntosh, T; Conte, V; Fujimoto, S; Graham, D; Grady, MS; Stein, SC				Morales, Diego; McIntosh, Tracy; Conte, Valeria; Fujimoto, Scott; Graham, David; Grady, M. Sean; Stein, Sherman C.			Impaired fibrinolysis and traumatic brain injury in mice	JOURNAL OF NEUROTRAUMA			English	Article						fibrinolysis; mice; plasminogen; traumatic brain injury; uPA	TISSUE-PLASMINOGEN ACTIVATOR; CONTROLLED CORTICAL IMPACT; DISSEMINATED INTRAVASCULAR COAGULATION; CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; HIPPOCAMPAL CA3-REGION; MEMORY CONSOLIDATION; TRANSGENIC MOUSE; RATS; DEFICITS	Traumatic brain injury (TBI) has been associated with intravascular coagulation, which may be a result of thromboplastin released following brain injury. Clots thus formed are lysed by plasmin, which is activated by tissue-type and urokinase-type plasminogen activators (uPA). To evaluate the association between traumatic intravascular coagulation and post-traumatic outcome, uPA knockout (uPA -/-) transgenic mice (n = 12) or wild-type littermates (WT; n = 12) were anesthetized and subjected to controlled cortical impact (CCI) brain injury. A second group of uPA -/- (n = 12) and WT mice (n = 12) were subjected to sham injury. Motor function was assessed over 2 weeks using the composite neuroscore test and cognition (learning) was assessed with the Morris Water Maze (MWM) at 2 weeks post-injury, whereupon the animals were sacrificed for cortical lesion volume analysis. Motor function was significantly worse in the brain-injured uPA -/- mice when compared to brain-injured WT mice at 48 h (p < 0.05) and one week post-injury (p < 0.65). These differences resolved by 2 weeks post-injury. There was no significant difference in post-injury cognitive function between uPA -/- mice and WT mice. However, at 2 weeks post-injury, the brain-injured uPA -/- had a significantly larger volume of cortical tissue loss than their WT counterparts (P < 0.05). These results demonstrate that the absence of uPA in mice aggravates acute motor deficit and exacerbates cortical tissue loss following CCI brain injury, and suggests a neuroprotective role of the fibrinolytic process following TBI.	Univ Penn, Sch Med, Traumat Brain Injury Lab, Dept Neurosurg, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA USA; Osped Maggiore Policlin, Neurosurg Intens Care Unit, Dept Anesthesia & Crit Care Med, Fdn IRCCS, Milan, Italy; So Gen Hosp, Dept Neuropathol, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland		Stein, SC (corresponding author), 310 Spruce St, Philadelphia, PA 19106 USA.	sherman.stein@uphs.upenn.edu		Morales, Diego/0000-0001-6672-9046	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 008803, NS 40978] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040978, P50NS008803, P01NS008803] Funding Source: NIH RePORTER		Asakura H, 2001, CRIT CARE MED, V29, P1164, DOI 10.1097/00003246-200106000-00015; ASTRUP T, 1965, THROMB DIATH HAEMOST, V14, P401; AUER LM, 1979, ACTA NEUROCHIR, V49, P219, DOI 10.1007/BF01808961; Bdeir K, 2000, BLOOD, V96, P1820, DOI 10.1182/blood.V96.5.1820.h8001820_1820_1826; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eilertsen KE, 2004, BLOOD COAGUL FIBRIN, V15, P521, DOI 10.1097/00001721-200409000-00001; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FLECK RA, 1990, THROMB RES, V57, P765, DOI 10.1016/0049-3848(90)90034-A; Florian C, 2004, BEHAV BRAIN RES, V154, P365, DOI 10.1016/j.bbr.2004.03.003; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, MILD MODERATE HEAD I, P63; HAYES RL, 1989, MILD HEAD INJURY, P54; Hogan KA, 2002, THROMB HAEMOSTASIS, V87, P563, DOI 10.1055/s-0037-1613050; HOOTS WK, 1993, NEUROTRAUMA, P673; Hoover-Plow J, 2001, BRAIN RES, V898, P256, DOI 10.1016/S0006-8993(01)02191-6; Horwood JM, 2001, BEHAV PHARMACOL, V12, P487, DOI 10.1097/00008877-200111000-00010; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Kataoka K, 2000, BRAIN RES, V887, P187, DOI 10.1016/S0006-8993(00)03042-0; KATAYAMA Y, 1990, ACT NEUR S, V51, P271; KAUFMAN HH, 1985, CENTRAL NERVOUS SYST, P187; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levi M, 1999, THROMB HAEMOSTASIS, V82, P695; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; Ploplis VA, 2002, THROMB HAEMOSTASIS, V87, P22, DOI 10.1055/s-0037-1612938; Ripley TL, 2001, BEHAV BRAIN RES, V125, P215, DOI 10.1016/S0166-4328(01)00303-5; Rogove AD, 1999, J CELL SCI, V112, P4007; Seeds NW, 2003, J NEUROSCI, V23, P7368; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Stupien G, 2003, NEUROBIOL LEARN MEM, V80, P32, DOI 10.1016/S1074-7427(03)00022-4; Tsirka SE, 2002, BIOCHEM SOC T, V30, P222, DOI 10.1042/bst0300222; UEDA S, 1985, J NEUROL NEUROSUR PS, V48, P58, DOI 10.1136/jnnp.48.1.58; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; VINK R, 1987, SOC MAGNET RESON MED, V1, P525; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103	54	19	20	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2006	23	6					976	984		10.1089/neu.2006.23.976			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	056TW	WOS:000238549000013	16774481				2022-02-06	
J	Shin, YB; Kim, SJ; Kim, IJ; Kim, YK; Kim, DS; Park, JH; Yeom, SR				Shin, Yong Beom; Kim, Seong-Jang; Kim, In-Ju; Kim, Yong-Ki; Kim, Dong-Soo; Park, Jae Heung; Yeom, Seok-Ran			Voxel-based statistical analysis of cerebral blood flow using Tc-99m ECD brain SPECT in patients with traumatic brain injury: Group and individual analyses	BRAIN INJURY			English	Article						statistical parametric mapping; brain SPECT; traumatic brain injury	CLOSED-HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; LOBE EPILEPSY; MILD; CT; PERFORMANCE; MRI	Purpose: Statistical parametric mapping (SPM)was applied to brain perfusion single photon emission computed tomography ( SPECT) images in patients with traumatic brain injury ( TBI) to investigate regional cerebral abnormalities compared to age-matched normal controls. Method: Thirteen patients with TBI underwent brain perfusion SPECT were included in this study (10 males, three females, mean age 39.8 +/- 18.2, range 21 similar to 74). SPM2 software implemented in MATLAB 5.3 was used for spatial preprocessing and analysis and to determine the quantitative differences between TBI patients and age-matched normal controls. Results: Three large voxel clusters of significantly decreased cerebral blood perfusion were found in patients with TBI. The largest clusters were area including medial frontal gyrus ( voxel number 3642, peak Z-value 4.31, 4.27, p = 0.000) in both hemispheres. The second largest clusters were areas including cingulated gyrus and anterior cingulate gyrus of left hemisphere ( voxel number 381, peak Z-value = 3.67, 3.62, p = 0.000). Other clusters were parahippocampal gyrus ( voxel number 173, peak Z-value 3.40, p 0.000) and hippocampus ( voxel number 173, peak Z-value 3.23, p = 0.001) in the left hemisphere. The false discovery rate (FDR) was less than 0.04. Conclusion: From this study, group and individual analyses of SPM2 could clearly identify the perfusion abnormalities of brain SPECT in patients with TBI. Group analysis of SPM2 showed hypoperfusion pattern in the areas including medial frontal gyrus of both hemispheres, cingulate gyrus, anterior cingulate gyrus, parahippocampal gyrus and hippocampus in the left hemisphere compared to age-matched normal controls. Also, left parahippocampal gyrus and left hippocampus were additional hypoperfusion areas. However, these findings deserve further investigation on a larger number of patients to be performed to allow a better validation of objective SPM analysis in patients with TBI.	Pusan Natl Univ Hosp, Dept Nucl Med, Pusan 602739, South Korea; Pusan Natl Univ Hosp, Dept Rehabil Med, Pusan 602739, South Korea; Pusan Natl Univ Hosp, Dept Emergency Med, Pusan 602739, South Korea		Kim, SJ (corresponding author), Pusan Natl Univ Hosp, Dept Nucl Med, 1-10 Ami Dong, Pusan 602739, South Korea.	growthkim@daum.net		Shin, YongBeom/0000-0001-5026-1696			Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ahmadi J, 1989, Top Magn Reson Imaging, V2, P17; Davalos Deana B, 2002, Appl Neuropsychol, V9, P92, DOI 10.1207/S15324826AN0902_4; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; HADLEY DM, 1988, CLIN RADIOL, V39, P131; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; HUSSEIN MAD, 1998, CLIN NUCL MED, V23, P309; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kim SK, 2001, EPILEPSIA, V42, P1531, DOI 10.1046/j.1528-1157.2001.21901.x; Kim YK, 2002, J NUCL MED, V43, P1167; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Masdeu J C, 1994, J Neuroimaging, V4, P177; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Parker RS, 1996, NEUROPSYCHOL REV, V6, P135, DOI 10.1007/BF01874895; PRAYER L, 1993, ACTA RADIOL, V34, P593; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; Stamatakis EA, 2002, J NUCL MED, V43, P476; Talairach J, 1998, COPLANAR STEREOTAXIC; Umile EM, 1998, BRAIN INJURY, V12, P577; Van Laere KJ, 2002, J NUCL MED, V43, P458; YEALY D M, 1991, Emergency Medicine Clinics of North America, V9, P707	28	19	19	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2006	20	6					661	667		10.1080/02699050600677071			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	062LU	WOS:000238947100011	16754291				2022-02-06	
J	Chahine, LM; Chemali, Z				Chahine, L. M.; Chemali, Z.			Du rire aux larmes: Pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine	EPILEPSY & BEHAVIOR			English	Article						traumatic brain injury; pathological laughter and crying; lamotrigine	LAUGHTER	Pathologic laughter and crying (PLC) is the involuntary occurrence of laughter and crying in the absence of a corresponding change in affect. PLC resulting from structural brain damage in patients with traumatic brain injury can be the cause of substantial social dysfunction in these patients. The use of lamotrigine as an antiepileptic drug and mood stabilizer is well established; its use in PLC has been reported only once during treatment following a stroke. We present here four young patients with pathological laughter and/or pathological crying following traumatic brain injury who were successfully treated with lamotrigine. Data supporting the use of lamotrigine in the treatment of PLC following traumatic brain injury and the neuroanatomy of pathological laughing are briefly reviewed. (c) 2006 Elsevier Inc. All rights reserved.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cognit & Behav Neurol, Boston, MA 02115 USA; Amer Univ Beirut, Med Ctr, Dept Psychiat, Beirut, Lebanon; Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon		Chemali, Z (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cognit & Behav Neurol, Boston, MA 02115 USA.	zelchemali@partners.org		Chahine, Lana/0000-0003-2521-7196			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Blackburn-Munro G, 2005, CURR PHARM DESIGN, V11, P2961, DOI 10.2174/1381612054865000; CRAWFORD C, 1983, NEW ZEAL MED J, V96, P972; Derex L, 1997, STROKE, V28, P1464, DOI 10.1161/01.STR.28.7.1464; Gao KM, 2005, BIPOLAR DISORD, V7, P13, DOI 10.1111/j.1399-5618.2005.00250.x; Green B, 2003, CURR MED RES OPIN, V19, P272, DOI 10.1185/030079903125001703; Karceski S, 2005, EPILEPSY BEHAV, V7, pS1, DOI 10.1016/j.yebeh.2005.06.001; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; McCullagh S, 2000, J NEUROPSYCH CLIN N, V12, P100, DOI 10.1176/jnp.12.1.100; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Mild Traumatic Brain Injury Committee of the Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHABI, V8, P86; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Patsalos PN, 2005, EPILEPSIA, V46, P140, DOI 10.1111/j.1528-1167.2005.00326.x; Poeck K., 1969, HDB CLIN NEUROLOGY, P343; Ramasubbu R, 2003, CLIN NEUROPHARMACOL, V26, P233, DOI 10.1097/00002826-200309000-00006; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; Schlienger RG, 1998, NEUROLOGY, V51, P1172, DOI 10.1212/WNL.51.4.1172; SELIGER G M, 1992, Brain Injury, V6, P267, DOI 10.3109/02699059209029668; Southam E, 1998, EUR J PHARMACOL, V358, P19, DOI 10.1016/S0014-2999(98)00580-9; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tidwell A, 2003, AM J MANAG CARE, V9, P253; UDAKA F, 1984, ARCH NEUROL-CHICAGO, V41, P1095, DOI 10.1001/archneur.1984.04050210093023; VARDI J, 1994, BEHAV MED, V20, P44, DOI 10.1080/08964289.1994.9934615; Vinod KY, 2002, NEUROCHEM INT, V40, P315, DOI 10.1016/S0197-0186(01)00088-2; Wild B, 2003, BRAIN, V126, P2121, DOI 10.1093/brain/awg226; 1974, THOMSON MICROMEDEX H	28	19	20	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	MAY	2006	8	3					610	615		10.1016/j.yebeh.2006.01.017			6	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	045BD	WOS:000237716700022	16504590				2022-02-06	
J	Rogers, E; Wagner, AK				Rogers, Emily; Wagner, Amy K.			Gender, sex steroids, and neuroprotection following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL WOMEN; MEMORY; RATS; ALLOPREGNANOLONE; STROKE; TRIAL		Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Kaufmann Bldg,3471 5th Ave,Suite 201, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu					Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Duka T, 2000, PSYCHOPHARMACOLOGY, V149, P129, DOI 10.1007/s002139900324; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Mendelowitsch A, 2001, BRAIN RES, V901, P230, DOI 10.1016/S0006-8993(01)02359-9; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P485, DOI 10.1016/0306-4530(92)90007-T; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sherwin BB, 2005, HORM BEHAV, V47, P371, DOI 10.1016/j.yhbeh.2004.12.002; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Simpkins JW, 2005, CELL MOL LIFE SCI, V62, P271, DOI 10.1007/s00018-004-4382-2; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673	16	19	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2006	21	3					279	281		10.1097/00001199-200605000-00008			3	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	044YL	WOS:000237709600008	16717505				2022-02-06	
J	Beni, SM; Tsenter, J; Alexandrovich, AG; Galron-Krool, N; Barzilai, A; Kohen, R; Grigoriadis, N; Simeonidou, C; Shohami, E				Beni, SM; Tsenter, J; Alexandrovich, AG; Galron-Krool, N; Barzilai, A; Kohen, R; Grigoriadis, N; Simeonidou, C; Shohami, E			CuZn-SOD deficiency, rather than overexpression, is associated with enhanced recovery and attenuated activation of NF-kappa B after brain trauma in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						antioxidants; NF-kappa B; neuroprotection; oxidative stress; superoxide dismutase; traumatic brain injury	CLOSED-HEAD INJURY; CU/ZN-SUPEROXIDE-DISMUTASE; MITOCHONDRIAL CYTOCHROME-C; TRANSGENIC MICE; TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; LIPID-PEROXIDATION; GLOBAL-ISCHEMIA; INDUCED NEUROPROTECTION	Superoxide-dismutases (SOD) catalyze O-2(-) conversion to hydrogen peroxide (H2O2) and with other antioxidant enzymes and low molecular weight antioxidants (LMWA) constitute endogenous defense mechanisms. We first assessed the effects of SOD1 levels on outcome after closed head injury (CHI) and later, based on these results, the effects of SOD1 deficiency on cellular redox homeostasis. Superoxide-dismutase 1-deficient (SOD1(-/-)) and - overexpressing (transgenic (Tg)) mice and matched wild-type (WT) controls were subjected to CHI and outcome ( neurobehavioral and memory functions) was assessed during 14 days. Brain edema, LMWA, and SOD2 activity were measured along with histopathological analysis. Transactivation of nuclear factor-kappa B (NF-kappa B) was evaluated by electromobility shift assay. Mortality, motor, and cognitive outcome of Tg and WT mice were comparable. Mortality and edema were similar in SOD1(-/-) and WT mice, yet, unexpectedly, SOD1(-/-) displayed better neurobehavioral recovery (P<0.05) at 14 days after CHI. Basal LMWA were higher in the cortex and liver of SOD1(-/-) mice (P<0.05) and similar to WT in the cerebellum. Five minutes after CHI, cortical LMWA decreased only in SOD1(-/-) mice. One week after CHI, SOD2 activity decreased fourfold in WT cortex (P<0.001), but was preserved in the SOD1(-/-). Constitutive NF-kappa B transactivation was comparably low in SOD1(-/-) and WT; however, CHI induced a robust NF-kappa B activation that was absent in SOD1(-/-) cortices (P<0.005 versus WT). At the same time, immunohistochemical analysis of brain sections revealed that astrogliosis and neurodegeneration were of lesser severity in SOD1(-/-) mice. We suggest that SOD1 deficiency impairs H2O2-mediated activation of NF-kappa B, decreasing death-promoting signals, and leading to better outcome.	Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; Hadassah Med Ctr, Dept Phys Med & Rehabil, IL-91120 Jerusalem, Israel; Tel Aviv Univ, Dept Neurobiochem, IL-69978 Tel Aviv, Israel; Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel; AHEPA Univ Hosp, Dept Neurol, Thessaloniki, Greece; Aristotle Univ Thessaloniki, Fac Med, Dept Physiol, GR-54006 Thessaloniki, Greece; Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, IL-91905 Jerusalem, Israel		Shohami, E (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel.	esty@cc.huji.ac.il		Kohn, Ron/0000-0001-7268-9845			ANDERSON MT, 1994, P NATL ACAD SCI USA, V91, P11527, DOI 10.1073/pnas.91.24.11527; ASADA K, 1974, AGR BIOL CHEM TOKYO, V38, P471, DOI 10.1080/00021369.1974.10861178; BarPeled O, 1996, P NATL ACAD SCI USA, V93, P8530, DOI 10.1073/pnas.93.16.8530; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bernard D, 2002, ONCOGENE, V21, P4392, DOI 10.1038/sj.onc.1205536; Bethea JR, 1998, J NEUROSCI, V18, P3251; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Carballo M, 1999, J BIOL CHEM, V274, P93, DOI 10.1074/jbc.274.1.93; CEBALLOSPICOT I, 1992, MUTAT RES, V275, P281, DOI 10.1016/0921-8734(92)90032-K; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Clemens JA, 1998, STROKE, V29, P677, DOI 10.1161/01.STR.29.3.677; Combs CK, 2001, J NEUROSCI, V21, P1179; de Haan JB, 2003, REDOX REP, V8, P69, DOI 10.1179/135100003125001378; deHaan JB, 1996, HUM MOL GENET, V5, P283, DOI 10.1093/hmg/5.2.283; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Dopp JM, 2002, NEUROCHEM RES, V27, P1535, DOI 10.1023/A:1021608724117; ELROYSTEIN O, 1988, CELL, V52, P259, DOI 10.1016/0092-8674(88)90515-6; Ennaceur A, 2005, BEHAV BRAIN RES, V159, P247, DOI 10.1016/j.bbr.2004.11.006; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Fujimura M, 2001, BRAIN RES, V889, P208, DOI 10.1016/S0006-8993(00)03134-6; Fujimura M, 2000, J NEUROSCI, V20, P2817; Gahtan E, 1998, EUR J NEUROSCI, V10, P538, DOI 10.1046/j.1460-9568.1998.00058.x; Halliwell B., 1989, FREE RADICAL BIO MED, P160; Huang CY, 2001, J CEREBR BLOOD F MET, V21, P163, DOI 10.1097/00004647-200102000-00008; Huang TT, 1999, ANN NY ACAD SCI, V893, P95, DOI 10.1111/j.1749-6632.1999.tb07820.x; Kaltschmidt B, 1999, ANTIOXID REDOX SIGN, V1, P129, DOI 10.1089/ars.1999.1.2-129; Kamata H, 2002, FEBS LETT, V519, P231, DOI 10.1016/S0014-5793(02)02712-6; Kamata H, 2002, ANN NY ACAD SCI, V973, P419, DOI 10.1111/j.1749-6632.2002.tb04675.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawase M, 1999, STROKE, V30, P1962, DOI 10.1161/01.STR.30.9.1962; KELNER MJ, 1995, FREE RADICAL BIO MED, V18, P497, DOI 10.1016/0891-5849(94)00167-I; Khan JY, 2003, PEDIATR RES, V54, P77, DOI 10.1203/01.PDR.0000065736.69214.20; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; Kohen R, 1999, METHOD ENZYMOL, V300, P428; Kondo T, 1997, J NEUROSCI, V17, P4180; Lerner-Natoli M, 2000, EPILEPSY RES, V41, P141, DOI 10.1016/S0920-1211(00)00132-7; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Litchfield S, 2001, ACTA NEUROPATHOL, V101, P17; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Maehara K, 2000, J CELL BIOCHEM, V77, P474, DOI 10.1002/(SICI)1097-4644(20000601)77:3<474::AID-JCB12>3.0.CO;2-H; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; McDonald RPA, 1999, NEUROREPORT, V10, P1875, DOI 10.1097/00001756-199906230-00014; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; MIKAWA S, 1995, MOL BRAIN RES, V33, P288, DOI 10.1016/0169-328X(95)00146-J; Muller A, 2001, J MICROMECH MICROENG, V11, P301, DOI 10.1088/0960-1317/11/4/302; Murakami K, 1997, STROKE, V28, P1797, DOI 10.1161/01.STR.28.9.1797; Nishio S, 1997, ACT NEUR S, V70, P84; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; PeledKamar M, 1997, P NATL ACAD SCI USA, V94, P3883, DOI 10.1073/pnas.94.8.3883; PERKINS ND, 1992, P NATL ACAD SCI USA, V89, P1529, DOI 10.1073/pnas.89.5.1529; Rodriguez AM, 2000, FREE RADICAL BIO MED, V29, P801, DOI 10.1016/S0891-5849(00)00362-2; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cellbio.10.1.405; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vollgraf U, 1999, J NEUROCHEM, V73, P2501, DOI 10.1046/j.1471-4159.1999.0732501.x; XIE QW, 1994, J BIOL CHEM, V269, P4705; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; Yoshida T, 2000, CIRC RES, V86, P264, DOI 10.1161/01.RES.86.3.264	74	19	19	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	APR	2006	26	4					478	490		10.1038/sj.jcbfm.9600209			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	026LM	WOS:000236340400004	16094314	Bronze			2022-02-06	
J	Lotze, M; Grodd, W; Rodden, FA; Gut, E; Schonle, PW; Kardatzki, B; Cohen, LG				Lotze, M; Grodd, W; Rodden, FA; Gut, E; Schonle, PW; Kardatzki, B; Cohen, LG			Neuroimaging patterns associated with motor control in traumatic brain injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						TBI; fMRI; primary motor cortex; outcome	HEAD-INJURY; STROKE; RECOVERY; FMRI; METABOLISM; ACTIVATION; MODERATE; ARM	Objective. To determine if patients with traumatic brain injury (TBI) and motor deficits show differences in functional activation maps during repetitive hand movements relative to healthy controls. Are there predictors for motor Outcome in the functional maps of these patients? Methods. In an exploratory.. cross-sectional study, functional magnetic resonance imaging (fMRI) was used to study the blood-oxygenation-level-dependent (BOLD) response in cortical motor areas of 34 patients suffering from moderate motor deficits after TBI as they performed unilateral fist-clenching motions. Twelve of these patients with unilateral motor deficits were studied 3 months after TBI and a 2nd time approximately 4 months later. Results. Compared to age-matched, healthy controls performing the same task, TB patients showed diminished fMRI-signal change in the primary sensorimotor cortex contralateral to the moving hand (cSM1), the contralateral dorsal premotor cortex, and bilaterally in the supplementary motor areas (SMAs). Clinical impairment and the magnitude of the fMRI-signal change in cSM1 and SMA were negatively correlated. Patients with poor and good motor recovery showed comparable motor impairment at baseline. Only patients who evolved to "poor clinical outcome's had decreased fMRI-signal change in the cSM1 during baseline. Conclusions. These observations raise the hypothesis that the magnitude of the fMRI-signal change in the cSM1 region could have prognostic value in the evaluation of patients with TBI.	Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72074 Tubingen, Germany; Univ Tubingen, Dept Neuroradiol, CNS, Sect MR, D-7400 Tubingen, Germany; Univ Konstanz, Kliniken Schmieder, Lurija Inst Rehabil Sci & Hlth Res, Allenbach, Germany; NINDS, Human Cort Physiol Sect, NIH, Bethesda, MD 20892 USA		Lotze, M (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Gartenstr 29, D-72074 Tubingen, Germany.	martin.lotze@uni-tuebingen.de	Lotze, Martin/D-2964-2012	Lotze, Martin/0000-0003-4519-4956	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [Z01NS003030, ZIANS003030] Funding Source: NIH RePORTER		ADAMS RJ, 1987, STROKE, V18, P665, DOI 10.1161/01.STR.18.3.665; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Bobath B, 1977, Physiotherapy, V63, P310; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; JANDA V, 1993, MUSKELFUNKTIONSDIAGN; Kastrup A, 2002, NEUROIMAGE, V15, P74, DOI 10.1006/nimg.2001.0916; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Nelles G, 1999, ANN NEUROL, V46, P901, DOI 10.1002/1531-8249(199912)46:6<901::AID-ANA13>3.0.CO;2-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pariente J, 2001, ANN NEUROL, V50, P718, DOI 10.1002/ana.1257; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Shelton FDAP, 2001, STROKE, V32, P107, DOI 10.1161/01.STR.32.1.107; Talairach J., 1988, COPLANAR STEREOTAXIC; Turton A, 1996, ELECTROMYOGR MOTOR C, V101, P316, DOI 10.1016/0924-980X(96)95560-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Waldvogel D, 2000, NEUROREPORT, V11, P3843, DOI 10.1097/00001756-200011270-00048; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Weiller C, 1998, EXP BRAIN RES, V123, P13, DOI 10.1007/s002210050539; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; Wexler BE, 1997, MAGN RESON IMAGING, V15, P385, DOI 10.1016/S0730-725X(96)00232-9	27	19	19	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683			NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAR	2006	20	1					14	23		10.1177/1545968305282919			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	011PG	WOS:000235280000003	16467275				2022-02-06	
J	Trovato, M; Slomine, B; Pidcock, F; Christensen, J				Trovato, M; Slomine, B; Pidcock, F; Christensen, J			The efficacy of donepezil hydrochloride on memory functioning in three adolescents with severe traumatic brain injury	BRAIN INJURY			English	Article						brain injury; donepezil; adolescents; memory; cognition; drug therapy		Objective: To explore efficacy of donepezil on memory in adolescents with severe traumatic brain injury (TBI). Design: Single subject, unblinded, multiple baseline design. Methods and procedures: Memory functioning was examined in three adolescents with TBI on and off medication ( 5 and 10 mg) using the Selective Reminding Test. Four variables were examined: Total recall (TR) number of words total words recalled, Long Term Storage (LTS) words recalled on two trials in a row, Consistency of Long Term Retrieval (CLTR) words continuously recalled, Delay number of words recalled after delay. Results: On medication, three out of three participants demonstrated better memory. Two showed greatest improvement on 10 mg. All participants demonstrated improvement in TR and LTS. Two participants demonstrated improved CLTR. No participants displayed improvement in Delay. No adverse side effects were reported. Conclusions: Results suggests that donepezil may be effective in improving memory in adolescents with severe TBI and warrant further examination.	Kennedy Krieger Inst, Baltimore, MD 21205 USA		Trovato, M (corresponding author), Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA.	trovato@kennedykrieger.org					[Anonymous], 2003, J NEUROPSYCH CLIN N, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Bourgeois JA, 2002, J NEUROPSYCH CLIN N, V14, P463, DOI 10.1176/appi.neuropsych.14.4.463; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fisher RS, 2001, EPILEPSY BEHAV, V2, P330, DOI 10.1006/ebeh.2001.0221; Greene YM, 2000, J CLIN PSYCHOPHARM, V20, P350, DOI 10.1097/00004714-200006000-00010; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; HAYES RL, 1989, MILD HEAD INJURY, P69; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Taverni JP, 1998, BRAIN INJURY, V12, P77; THAL LJ, 1992, NEUROPSYCHOLOGY MEMO, P277; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	19	19	19	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2006	20	3					339	343		10.1080/02699050500487811			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	021GT	WOS:000235972400014	16537276				2022-02-06	
B	Dennis, M		Risberg, J; Grafman, J		Dennis, Maureen			Prefrontal cortex: typical and atypical development	FRONTAL LOBES: DEVELOPMENT, FUNCTION, AND PATHOLOGY	Series for the International Neuropsychological Society		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; DEFICIT HYPERACTIVITY DISORDER; HUMAN FRONTAL-CORTEX; AGE-RELATED-CHANGES; WORKING-MEMORY; COGNITIVE-DEVELOPMENT; INHIBITORY CONTROL; CEREBELLUM CONTRIBUTES; INTERFERENCE CONTROL		Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada		Dennis, M (corresponding author), Hosp Sick Children, Dept Psychol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.						ACKERLY SS, 1947, RES PUBL ASSOC RES N, V27, P479; Ackerly SS, 1964, FRONTAL GRANULAR COR, P192; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; APPOLLONIO IM, 1993, NEUROLOGY, V43, P1536, DOI 10.1212/WNL.43.8.1536; Band GPH, 2000, J EXP CHILD PSYCHOL, V75, P263, DOI 10.1006/jecp.1999.2538; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; BJORKLUND DF, 1990, DEV REV, V10, P48, DOI 10.1016/0273-2297(90)90004-N; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Broca P., 1877, SOC ANTHR PARIS, V2, P217; BUCK R, 1994, BIOL PSYCHOL, V38, P95, DOI 10.1016/0301-0511(94)90032-9; BUCK R, 1994, J PRAGMATICS, V22, P265, DOI 10.1016/0378-2166(94)90112-0; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CECI SJ, 1985, CHILD DEV, V56, P152, DOI 10.2307/1130182; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Cowan N., 1997, DEV MEMORY CHILDHOOD, P163; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crone EA, 2004, DEV NEUROPSYCHOL, V25, P251, DOI 10.1207/s15326942dn2503_2; Culhane-Shelburne K., 2002, J INT NEUROPSYCH SOC, V8, P623; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; DAVIDSON D, 1991, COGNITIVE DEV, V6, P77, DOI 10.1016/0885-2014(91)90007-Z; DEMETRE JD, 1992, BRIT J PSYCHOL, V83, P189, DOI 10.1111/j.2044-8295.1992.tb02434.x; DEMOREST A, 1984, CHILD DEV, V55, P1527, DOI 10.2307/1130022; Dempster F. N., 1993, EMERGING THEMES COGN, VI, P3, DOI DOI 10.1007/978-1-4613-9220-0_1; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M, 2005, NEUROPSYCHOLOGIA, V43, P976, DOI 10.1016/j.neuropsychologia.2004.08.012; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2004, BRAIN, V127, P1292, DOI 10.1093/brain/awh154; Dennis M, 1999, CHANGING NERVOUS SYSTEM, P172; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Dennis M., 2003, BEHAV NEUROLOGY NEUR, P783; Dennis M., 1977, LANGUAGE DEV NEUROLO, P93; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; DENNIS M, 2004, BRAIN SPINAL TUMORS, P213; Dennis M., 2006, THEORY MIND DE UNPUB; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; Diamond A, 1996, PHILOS T R SOC B, V351, P1483, DOI 10.1098/rstb.1996.0134; Diamond A, 1996, DEV PSYCHOBIOL, V29, P315, DOI 10.1002/(SICI)1098-2302(199605)29:4<315::AID-DEV2>3.0.CO;2-T; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; Dowsett SM, 2000, DEV PSYCHOBIOL, V36, P161, DOI 10.1002/(SICI)1098-2302(200003)36:2<161::AID-DEV7>3.0.CO;2-0; DUFRESNE A, 1989, J EXP CHILD PSYCHOL, V47, P274, DOI 10.1016/0022-0965(89)90033-7; Dum RP, 2003, J NEUROPHYSIOL, V89, P634, DOI 10.1152/jn.00626.2002; Durston S, 2002, DEVELOPMENTAL SCI, V5, pF9, DOI 10.1111/1467-7687.00235; Ekman P, 1978, MANUAL FACIAL ACTION; ENGLE RW, 1995, PSYCHOL SCI, V6, P122, DOI 10.1111/j.1467-9280.1995.tb00318.x; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; Fivush R., 1990, KNOWING REMEMBERING, P223; FLAVELL JH, 1985, DEV PSYCHOL, V21, P207, DOI 10.1037/0012-1649.21.2.207; Fletcher JM, 2005, J NEUROSURG, V102, P268, DOI 10.3171/ped.2005.102.3.0268; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Fodor J.A., 1983, MODULARITY MIND; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Frye D, 1995, COGNITIVE DEV, V10, P483, DOI 10.1016/0885-2014(95)90024-1; Fuster JM, 2000, PSYCHOBIOLOGY, V28, P125; GARRITY LI, 1975, DEV PSYCHOL, V11, P274, DOI 10.1037/h0076563; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldman-Rakic P. S., 2002, PRINCIPLES FRONTAL L, P31; Goldman-Rakic PS, 1997, DEV PREFRONTAL CORTE, P27; GRAFMAN J, 1992, NEUROLOGY, V42, P1493, DOI 10.1212/WNL.42.8.1493; Grafman J., 2002, PRINCIPLES FRONTAL L, P209; Grafman J., 1989, INTEGRATING THEORY P, P93; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; Hall W. S., 1986, MODELS MODULES STUDI, P26; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; Happaney K, 2003, DEVELOPMENTAL SCI, V6, P468, DOI 10.1111/1467-7687.00301; Happe F, 2001, NEUROPSYCHOLOGIA, V39, P83, DOI 10.1016/S0028-3932(00)00093-2; Harlow J.M., 1993, PUBLICATIONS MASSACH, V4, P274, DOI [DOI 10.1177/0957154X9300401407, https://doi.org/10.1177/0957154X9300401407]; Harnishfeger K. K., 1993, EMERGING THEMES COGN, DOI DOI 10.1007/978-1-4613-9220-0_; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; HAVERKATE H, 1990, J PRAGMATICS, V14, P77, DOI 10.1016/0378-2166(90)90065-L; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1207/s15516709cog0304_1; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; Heidolph K.E., 1970, PROGR LINGUISTICS, P143, DOI DOI 10.1515/9783111350219.143; Houghton George, 1994, P53; Hughes C, 2002, INFANT CHILD DEV, V11, P69, DOI 10.1002/icd.296; HULME C, 1995, J CHILD PSYCHOL PSYC, V36, P373, DOI 10.1111/j.1469-7610.1995.tb01297.x; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; KARTTUNEN L, 1971, LANGUAGE, V47, P340, DOI 10.2307/412084; Kates WR, 2002, PSYCHIAT RES-NEUROIM, V116, P63, DOI 10.1016/S0925-4927(02)00066-5; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennard MA, 1941, J NEUROPHYSIOL, V4, P512; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477, DOI 10.1152/jn.1938.1.6.477; KENNARD MA, 1942, MT SINAI J MED, V9, P594; Kerr A, 2004, BRAIN COGNITION, V55, P148, DOI 10.1016/s0278-2626(03)00275-6; KIM SG, 1994, SCIENCE, V265, P949, DOI 10.1126/science.8052851; Kirkham NZ, 2003, DEVELOPMENTAL SCI, V6, P474, DOI 10.1111/1467-7687.00303; Kochanska G, 1996, CHILD DEV, V67, P490, DOI 10.2307/1131828; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Kreutzer M. A., 1975, MEMORY OBSERVED REME, P343; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2001, NEUROPSYCHOLOGY, V15, P557, DOI 10.1037//0894-4105.15.4.557; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Levine B, 2004, BRAIN COGNITION, V55, P54, DOI 10.1016/s0278-2626(03)00280-x; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; LIVESEY DJ, 1991, AUST J PSYCHOL, V43, P133, DOI 10.1080/00049539108260137; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; Macmillan M, 2000, ODD KIND FAME STORIE; Manly T., 1999, TEST EVERYDAY ATTENT; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; Max J. E., 2005, J AM ACAD CHILD ADOL, V44, P435; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Mazzoni G, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, pIX; McCauley S. R., 2000, ANN M COGN NEUR SOC; McCauley S. R., 2001, 3 INT C MEM ICOM 3 V; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MIZE J, 1988, DEV PSYCHOL, V24, P782, DOI 10.1037/0012-1649.24.6.782; Montgomery J. W., 1995, J SPEECH HEAR RES, V33, P187; Moses LJ, 2001, CHILD DEV, V72, P688, DOI 10.1111/1467-8624.00306; O'Donnell S, 2005, NEUROIMAGE, V24, P948, DOI 10.1016/j.neuroimage.2004.10.014; Oberauer K, 2000, PSYCHON B REV, V7, P727, DOI 10.3758/BF03213013; Pascual-Leone J, 2001, BEHAV BRAIN SCI, V24, P136, DOI 10.1017/S0140525X01453921; Passolunghi MC, 1995, INT J BEHAV DEV, V18, P631, DOI 10.1177/016502549501800404; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Perner J, 2002, CHILD DEV, V73, P752, DOI 10.1111/1467-8624.00436; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Petrides M., 2002, PRINCIPLES FRONTAL L, V1, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Porteus S. D., 1959, PORTEUS MAZE TEST 50; Purvis K., 2001, J INT NEUROPSYCH SOC, V7, P165; RABINOWICZ T, 1979, HUMAN GROWTH, V3, P97; Rattermann MJ, 2001, COGNITIVE SCI, V25, P941, DOI 10.1207/s15516709cog2506_3; REIMAN EM, 1989, ARCH GEN PSYCHIAT, V46, P493; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Richards J. E., 2003, COGNITIVE NEUROSCIEN, P73; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Rogoff B., 1974, CHILD DEV, V44, P238; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Roncadin C., 2003, J INT NEUROPSYCH SOC, V9, P141; Rudolph KD, 1997, J APPL DEV PSYCHOL, V18, P107, DOI 10.1016/S0193-3973(97)90017-4; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Saarni C., 1999, DEV EMOTIONAL COMPET; Sadeh M, 2001, PEDIATR HEMAT ONCOL, V18, P423, DOI 10.1080/088800101750476005; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; SCHEIBEL RS, 1997, DEV PREFRONTAL CORTE, P241; SCHMAHMANN JD, 1995, NEUROSCI LETT, V199, P175, DOI 10.1016/0304-3940(95)12056-A; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 1997, J NEUROSCI, V17, P438, DOI 10.1523/JNEUROSCI.17-01-00438.1997; Schneider W, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P1; Segalowitz SJ, 2004, BRAIN COGNITION, V55, P116, DOI 10.1016/s0278-2626(03)00283-5; Seguin JR, 2004, BRAIN COGNITION, V55, P185, DOI 10.1016/s0278-2626(03)00273-2; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; Shum D., 2005, JOINT MID YEAR M INT; SILVERI MC, 1994, NEUROLOGY, V44, P2047, DOI 10.1212/WNL.44.11.2047; SOMERVILLE SC, 1983, J GENET PSYCHOL, V143, P87, DOI 10.1080/00221325.1983.10533537; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 1998, DEV NEUROPSYCHOL, V14, P599, DOI 10.1080/87565649809540731; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Tranel D., 2002, PRINCIPLES FRONTAL L, P338, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Tulving E, 2002, PRINCIPLES FRONTAL L, P311, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0020; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Warschausky S, 1997, Pediatr Rehabil, V1, P77; WICHMAN H, 1983, HUM FACTORS, V25, P583, DOI 10.1177/001872088302500512; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Winner E., 1988, POINT WORDS CHILDREN; Winner E., 1997, PROBLEM MEANING BEHA, V122, P377, DOI DOI 10.1016/S0166-4115(97)80142-2; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Yakovlev PI, 1967, REGIONAL DEV BRAIN E, P3; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; YEATES KO, 1990, CLIN PSYCHOL REV, V10, P567, DOI 10.1016/0272-7358(90)90097-T; [No title captured]; [No title captured]	199	19	19	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-521-67225-2	SER INT NEUROPSYCHOL			2006							128	162		10.1017/CBO9780511545917.007	10.1017/CBO9780511545917		35	Clinical Neurology; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BXN05	WOS:000296459600007					2022-02-06	
J	Lins, H; Wallesch, CW; Wunderlich, MT				Lins, H; Wallesch, CW; Wunderlich, MT			Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections	ACTA NEUROLOGICA SCANDINAVICA			English	Article						cerebrospinal fluid; serum; neurochemistry; central nervous system infection; protein S100B; neuron-specific enolase	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; MYELIN BASIC-PROTEIN; S-100 PROTEIN; PRACTICAL SCALE; INFARCTION; RELEASE; S100B; MENINGITIS	Objective - To elucidate the relation between release patterns and cerebrospinal fluid/serum concentrations of neurobiochemical markers of cerebral damage and their potential value as monitoring parameters in central nervous system infections. Methods - We investigated protein S-100B and neuron-specific enolase (NSE) in 102 sequential cerebrospinal fluid (CSF)-serum-pairs in patients with bacterial (n = 11) or viral (n = 13) meningitis/meningoencephalitis and neuroborreliosis (n = 8) in comparison with controls (n = 13). Results - Highest S-100B values in CSF and serum were found on admission and showed a significant decrease afterwards. Comparison between disease groups revealed significant differences between bacterial and viral meningitis and neuroborreliosis for S-100B and also when compared with controls. NSE was not significantly elevated. Conclusions - S-100B is altered in CNS infection but does not provide additional benefit in the differential diagnosis when compared with standard CSF parameters. Nevertheless, S-100B values might be used as an additional monitoring parameter especially when sequential lumbar punctures are contraindicated.	Univ Magdeburg, Dept Neurol, D-39120 Magdeburg, Germany		Wunderlich, MT (corresponding author), Univ Magdeburg, Dept Neurol, Leipziger Str 44, D-39120 Magdeburg, Germany.	michael.wunderlich@medizin.uni-magdeburg.de					Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P366, DOI 10.1177/000456329703400405; Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; Dotevall L, 1999, EUR J NEUROL, V6, P169, DOI 10.1111/j.1468-1331.1999.tb00010.x; Gazzolo D, 2004, CLIN CHEM, V50, P941, DOI 10.1373/clinchem.2003.021048; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Infante JR, 2000, TUMOR BIOL, V21, P38, DOI 10.1159/000030109; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; JENNETT B, 1975, LANCET, V1, P480; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; LAMERS KJB, 1995, ACTA NEUROL SCAND, V92, P247; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Nygaard O, 1997, CLIN CHEM, V43, P541; Oh SH, 2003, ARCH NEUROL-CHICAGO, V60, P37, DOI 10.1001/archneur.60.1.37; Otto M, 1998, BRIT MED J, V316, P577, DOI 10.1136/bmj.316.7131.577; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; TEASDALE G, 1974, LANCET, V2, P81; Unden J, 2004, SCAND J INFECT DIS, V36, P10, DOI 10.1080/00365540310017294; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wunderlich MT, 2004, J NEUROL SCI, V227, P49, DOI 10.1016/j.jns.2004.08.005	22	19	24	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	NOV	2005	112	5					303	308		10.1111/j.1600-0404.2005.00484.x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	972ZH	WOS:000232491900005	16218912				2022-02-06	
J	Nguyen, MP; Bittner, GD; Fishman, HM				Nguyen, MP; Bittner, GD; Fishman, HM			Critical interval of somal calcium transient after neurite transection determines B104 cell survival	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						plasmalemmal injury; calcium-initiated cell degeneration; injury-induced apoptosis; injured cell mortality; cell death prevention	EXCITOTOXIC NEURONAL DEATH; RETINAL GANGLION-CELLS; TRAUMATIC BRAIN-INJURY; SPINAL-CORD; NEUROBLASTOMA-CELLS; NITRIC-OXIDE; ADULT-RATS; IN-VIVO; APOPTOSIS; AXOTOMY	Nerve cells may survive or die after axohal or dendritic transection. After neurite transection near (< 50 mu m) the cell body of Fura-2-loaded B104 neuroblastoma (rat brain-derived) cells, the somal calcium concentration (SCC) undergoes a three-phase transient change: a rapid (0-0.15-min posttransection [PT]) rise phase, followed by an early (0.15-1.5-min PT) rapid decay phase, and succeeded by a late (1.5-60-min PT) slower decay phase that, restores SCC to preinjury levels. The SCC in a critical interval (1.5-12.5 min PT) of the third transient phase correlates with cell fate, i.e., most transected cells that exclude dye (restore a barrier) and die have a significantly higher (P < 0.005) SCC in this critical interval than do transected cells that exclude dye and survive at 24-hr PT Loading BAPTA (chelation of somal Ca2+) before, but not after, the critical interval increases the percentage of cells that survive compared to that of cells transected without BAPTA loading. Furthermore, most transected cells that die despite successful barrier restoration exhibit characteristics consistent with apoptosis initiated during the critical interval of the SCC, including caspase activation and plasmalemmal phosphaticlylserine translocation. These data suggest that decreased cell survival for injuries near the soma is due to Ca2+-initiated apoptosis during the critical interval of the third phase of the SCC transient. (c) 2005 Wiley-Liss, Inc.	Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; Univ Texas, Neurobiol Sect, Sch Biol Sci, Inst Neurosci, Austin, TX 78712 USA; Univ Texas, Coll Pharm, Austin, TX 78712 USA		Fishman, HM (corresponding author), Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	hfishman@utmb.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031256] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS031256, NS31256, R01 NS031256-12] Funding Source: Medline		Al-Abdulla NA, 1998, NEUROSCIENCE, V86, P191, DOI 10.1016/S0306-4522(98)00014-1; BALENTINE JD, 1982, LAB INVEST, V47, P286; BALENTINE JD, 1988, J NEUROPATH EXP NEUR, V47, P77, DOI 10.1097/00005072-198803000-00001; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chan YM, 2001, NEUROREPORT, V12, P541, DOI 10.1097/00001756-200103050-00022; Chaudhary P, 1999, MOL BRAIN RES, V67, P36, DOI 10.1016/S0169-328X(99)00032-7; CHEUNG JY, 1986, NEW ENGL J MED, V314, P1670; DibHajj SD, 1996, FEBS LETT, V384, P78, DOI 10.1016/0014-5793(96)00273-6; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Fishman HM, 2003, NEWS PHYSIOL SCI, V18, P115, DOI 10.1152/nips.01429.2002; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu XQ, 1996, BRAIN RES, V735, P50; HIMES BT, 1989, J COMP NEUROL, V284, P215, DOI 10.1002/cne.902840206; Hyrc K, 1997, J NEUROSCI, V17, P6669; INGOGLIA NA, 2001, AXONAL REGENERATION; Kermer P, 2000, MOL BRAIN RES, V85, P144, DOI 10.1016/S0169-328X(00)00256-4; Kermer P, 1998, J NEUROSCI, V18, P4656; Ko HW, 1998, J NEUROCHEM, V71, P1390; Leist M, 1997, MOL MED, V3, P750, DOI 10.1007/BF03401713; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lucas J H, 1985, Cent Nerv Syst Trauma, V2, P231; Luo J, 1999, J NEUROCHEM, V72, P2286, DOI 10.1046/j.1471-4159.1999.0722286.x; Luo J, 1997, BRAIN RES, V770, P139, DOI 10.1016/S0006-8993(97)00762-2; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Montgomery DC., 2001, DESIGN ANAL EXPT; Namura S, 1998, J NEUROSCI, V18, P3659; OCONNOR TM, 1974, J CELL BIOL, V60, P448, DOI 10.1083/jcb.60.2.448; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; SANNER CA, 1993, EXP NEUROL, V123, P81, DOI 10.1006/exnr.1993.1142; SCHUBERT D, 1975, NATURE, V254, P341, DOI 10.1038/254341a0; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Shi RY, 2000, J NEUROPHYSIOL, V84, P1763, DOI 10.1152/jn.2000.84.4.1763; SNIDER WD, 1989, J COMP NEUROL, V279, P489, DOI 10.1002/cne.902790312; STYS PK, 1990, MUSCLE NERVE, V13, P750, DOI 10.1002/mus.880130814; Tan ZY, 2003, NEUROSCI LETT, V340, P123, DOI 10.1016/S0304-3940(03)00094-6; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; TYMIANSKI M, 1994, J NEUROPHYSIOL, V72, P1973, DOI 10.1152/jn.1994.72.4.1973; TYNDALE RF, 1994, J NEUROSCI, V14, P5417; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Velier JJ, 1999, J NEUROSCI, V19, P5932, DOI 10.1523/JNEUROSCI.19-14-05932.1999; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Volbracht C, 2001, NEUROREPORT, V12, P3645, DOI 10.1097/00001756-200112040-00008; XIE XY, 1991, J NEUROSCI, V11, P3257; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yoo S, 2004, J NEUROBIOL, V60, P137, DOI 10.1002/neu.20005	53	19	20	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	SEP 15	2005	81	6					805	816		10.1002/jnr.20606			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	961BZ	WOS:000231638200006	16049977	Green Accepted			2022-02-06	
J	McCrory, P; Makdissi, M; Davis, G; Collie, A				McCrory, P; Makdissi, M; Davis, G; Collie, A			Value of neuropsychological testing after head injuries in football	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SPORT-RELATED CONCUSSION; COMPUTERIZED COGNITIVE ASSESSMENT; AUSTRALIAN RULES FOOTBALLERS; PROFESSIONAL SOCCER PLAYERS; TRAUMATIC BRAIN-INJURY; TEST-PERFORMANCE; TEST PROTOCOL; REACTION-TIME; IMPAIRMENT; RECOVERY	This paper reviews the pros and cons of the traditional paper and pencil and the newer computerised neuropsychological tests in the management of sports concussion. The differences between diagnosing concussion on the field and neuropsychological assessment at follow up and decision making with regard to return to play are described. The authors also discuss the issues involved in interpreting the results of neuropsychological testing (comparison with population norms versus player's own baseline test results) and potential problems of such testing in football. Finally, suggested recommendations for neuropsychological testing in football are given.	Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; Cabrini Med Ctr, Malvern, Vic, Australia; CogState Ltd, Melbourne, Vic, Australia		McCrory, P (corresponding author), Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia.	paulmccr@bigpond.net.au	McCrory, Paul/Q-8688-2019	makdissi, michael/0000-0003-0334-7133; Collie, Alex/0000-0003-2617-9339			Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barr WB, 2001, J ATHL TRAINING, V36, P297; Barth J T, 2000, Dent Clin North Am, V44, P67; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 2001, J ATHL TRAINING, V36, P253; Barth JT, 1989, MILD HEAD INJURY, P257; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BRUCE DA, 1984, PRIMARY CARE, V11, P175; Chan K M, 1984, Br J Sports Med, V18, P195; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; DAILEY SW, 1992, PHYSICIAN SPORTSMED, V20, P79, DOI 10.1080/00913847.1992.11947468; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; FAULKNER C, 1985, AUST J PHYSIOTHER, V31, P242; FIELDS KB, 1989, PHYSICIAN SPORTSMED, V17, P69, DOI 10.1080/00913847.1989.11709682; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1976, Proceedings of the Australian Association of Neurologists, V13, P143; Gronwall D, 1989, MILD HEAD INJURY, P153; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; *HLTH COUNC NETH, 2003, BRAIN DAM BOX SOCC P, P1; INKLAAR H, 1994, SPORTS MED, V18, P55, DOI 10.2165/00007256-199418010-00006; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Jordan BD, 1996, AM J SPORT MED, V24, P704, DOI 10.1177/036354659602400526; Jordan BD, 1998, PHYSICIAN SPORTSMED, V26, P25, DOI 10.3810/psm.1998.02.928; Juma A H, 1998, Indian J Med Sci, V52, P433; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; KUJALA UM, 1995, BRIT MED J, V311, P1465, DOI 10.1136/bmj.311.7018.1465; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; LURIA AR, 1962, HIGHER CONTROL FUNCT; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; MADDOCKS DL, 1995, AUST PSYCHOL, V30, P125, DOI 10.1080/00050069508258916; MADDOCKS DL, 1991, J CLIN EXP NEUROPSYC, V13, P439; Maddocks DL, 1993, INFORMATION PROCESSI, P1; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; MCGRATH A, 1997, HEADING INJURIES OUT; MCKEAG D, 1996, AM MED SOC SPORTS ME, P1; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SOCIETY CM, 1991, REPORT SPORTS MED CO; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Turner M., 1998, JOCK CLUB C HEAD INJ; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Walsh KW., 1991, UNDERSTANDING BRAIN; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	80	19	19	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	AUG	2005	39			1			I58	I63		10.1136/bjsm.2005.020776			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	954KI	WOS:000231153600008	16046357	Bronze, Green Published			2022-02-06	
J	Yidirim, E; Ozisik, K; Solaroglu, I; Kaptanoglu, E; Beskonakli, E; Sargon, MF; Kilinc, K; Sakinci, U				Yidirim, E; Ozisik, K; Solaroglu, I; Kaptanoglu, E; Beskonakli, E; Sargon, MF; Kilinc, K; Sakinci, U			Protective effect of erythropoietin on type II pneumocyte cells after traumatic brain injury in rats	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Tbi traumatic brain injury; lung; erythropoietin; ultrastructure	NEUROGENIC PULMONARY-EDEMA; CENTRAL-NERVOUS-SYSTEM; ACUTE LUNG INJURY; SPINAL-CORD-INJURY; LIPID-PEROXIDATION; NITRIC-OXIDE; GRANULOCYTE DEPLETION; ANTIOXIDANT; DAMAGE; METHYLPREDNISOLONE	Background: The main objective was to evaluate the protective effect of erythropoietin on lung ultrastructure against damage in rats after traumatic brain injury. Methods: We used forty Wistar-Albino female rats weighing 170-200 gr. The rats were allocated into five groups. The first group was the control and the second was the craniotomy without trauma. The third group was the trauma group. The fourth and fifth groups were erythropoietin (1000 IU/kg) and vehicle (0,4 mL/rat) groups, respectively. A weight-drop method was used for achieving head trauma. Samples were obtained from pulmonary lobes 24-hour post injury. Lipid peroxidation levels were determined and electron microscopic scoring model was used to reveal the ultrastructural changes. Results: Ultrastructural evaluation revealed pathologic changes in the trauma group compared with the control group (p < 0.05). Lipid peroxidation levels were found to be higher in the trauma group (p < 0.05). Erythropoietin significantly reduced both the ultrastructural pathologic changes and the lipid peroxidation levels in the treatment group (p < 0.05). Conclusions. Erythropoietin protects the ultrastructure of pneumocyte type II cells against damage after traumatic brain injury.	Ankara Numune Educ & Res Hosp, Dept Thorac Surg, Ankara, Turkey; Ankara Numune Educ & Res Hosp, Dept Neurosurg, Ankara, Turkey; Univ Hacettepe, Fac Med, Dept Anat, TR-06100 Ankara, Turkey; Univ Hacettepe, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey		Yidirim, E (corresponding author), Asagiovecler Mh 79 Sk 8-3, TR-06460 Ankara, Turkey.	erseyda@yahoo.com	Sargon, Mustafa F./AAZ-5470-2021; Solaroglu, Ihsan/ABF-7606-2020; Solaroglu, Ihsan/ABE-8816-2020	Sargon, Mustafa F./0000-0001-6360-6008; Solaroglu, Ihsan/0000-0002-9472-1735			Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Atkinson JLD, 1997, NEUROSURGERY, V41, P1214, DOI 10.1097/00006123-199711000-00052; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; BanyMohammed FM, 1996, PEDIATR RES, V40, P381, DOI 10.1203/00006450-199609000-00003; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BODENHAM A, 1989, BRIT MED J, V299, P1009, DOI 10.1136/bmj.299.6706.1009; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; BUERNI M, 2002, CLIN SCI, V103, P275; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Cecka J M, 1988, Clin Transpl, P399; Cerami A, 2001, SEMIN HEMATOL, V38, P33, DOI 10.1053/shem.2001.27484; CORMAN J, 1991, ANN CHIR, V45, P791; Deehan SC, 1996, INTENS CARE MED, V22, P672, DOI 10.1007/BF01709745; DETTBARN CL, 1989, HEART LUNG, V18, P583; EDMONDS HL, 1986, NEUROSURGERY, V19, P36, DOI 10.1227/00006123-198607000-00005; Eid Tore, 2002, Clin Breast Cancer, V3 Suppl 3, pS109, DOI 10.3816/CBC.2002.s.021; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Hall SRR, 2002, ANESTH ANALG, V94, P948; HEFLIN AC, 1981, J CLIN INVEST, V68, P1253, DOI 10.1172/JCI110371; HINSON JM, 1983, J APPL PHYSIOL, V55, P92, DOI 10.1152/jappl.1983.55.1.92; Hoffman SW, 1997, STROKE, V28, P844, DOI 10.1161/01.STR.28.4.844; Holt AW, 1999, MED J AUSTRALIA, V170, P479, DOI 10.5694/j.1326-5377.1999.tb127848.x; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; Kaptanoglu E, 2002, J NEUROSURG ANESTH, V14, P114, DOI 10.1097/00008506-200204000-00005; LEWIS JF, 1993, AM REV RESPIR DIS, V147, P218, DOI 10.1164/ajrccm/147.1.218; MARK L, 1999, AM J PHYSIOL, V276, P494; MARON MB, 1989, J APPL PHYSIOL, V67, P305, DOI 10.1152/jappl.1989.67.1.305; MARTIN N, 1997, HDB ORGANIC CONDUCTI, V1, P2; MIHARA M, 1981, YAKUGAKU ZASSHI, V101, P221, DOI 10.1248/yakushi1947.101.3_221; Piper IR, 1998, BRIT J ANAESTH, V80, P639, DOI 10.1093/bja/80.5.639; Pyeron A M, 2001, J Neurosci Nurs, V33, P203; RICHARD JN, 1996, ANN THORAC SURG, V62, P302; SAID SI, 1995, NEUROSCIENCE, V65, P943, DOI 10.1016/0306-4522(95)00021-A; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Schwarz S, 1997, NERVENARZT, V68, P956, DOI 10.1007/s001150050222; SHELLEY S, 1994, J FLA MED ASSOC, V8, P49; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; SINGBARTL G, 1989, ANAESTHESIST, V38, P360; Smith WS, 1997, CHEST, V111, P1326, DOI 10.1378/chest.111.5.1326; Solaroglu I, 2003, CHILD NERV SYST, V19, P19, DOI 10.1007/s00381-002-0680-2; WAUCHOB TD, 1984, ANAESTHESIA, V39, P529, DOI 10.1111/j.1365-2044.1984.tb07355.x; Yunoki M, 1997, J NEUROTRAUM, V14, P739, DOI 10.1089/neu.1997.14.739	47	19	21	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2005	58	6					1252	1258		10.1097/01.TA.0000169803.09482.F8			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	943EU	WOS:000230336100027	15995478				2022-02-06	
J	Krave, U; Hojer, S; Hansson, HA				Krave, U; Hojer, S; Hansson, HA			Transient, powerful pressures are generated in the brain by a rotational acceleration impulse to the head	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						DAI; diffuse brain injury; fibre optic pressure transducer; injury mechanism	MISSILE EXTREMITY IMPACT; NERVOUS-SYSTEM; WAVE INJURIES; BIOMECHANICS; MODEL; PIGS; TRAUMA; LIGHT; MILD; NECK	A rotational acceleration impulse to a head, as occurs at traffic accidents, sport injuries, assaults and falls, induces a diffuse brain damage that eventually could result in persistent neuropsychiatric deficits and neurodegeneration. Emphasis has been concentrated on the relative motion of the brain inside the skull during head impact, whereas less attention has been paid to whether intracranial pressure changes are generated and, if so, the implications thereof. In the present experimental study we investigated in an animal model system, based on rabbits, if a sagittal, anterior-posterior rotational acceleration of a head generated intracranial pressure changes, recorded by fibre optic pressure sensors, inserted ipsilaterally in the parieto-temporal and the occipital lobes. Two levels of rotational acceleration were used in the experiments; one higher, corresponding to the threshold limit for moderate diffuse brain injury, and one lower, close to being noninjurious. Several pressure recordings were performed in each rabbit at the two acceleration levels. The pressure recordings invariably revealed the same general characteristics of rapid, positive and negative pressures within the brain, with variations in amplitude and duration, lasting for up to 10 ms. A major finding was the generation of powerful negative pressures, as low as 0.3 bars in absolute pressure. The most prominent difference in amplitudes of the negative peak pressures between the two applied acceleration levels was demonstrated at the parieto-temporal location. The presented pressure recordings are the first to disclose the generation of transient, powerful intracerebral pressures at rotational acceleration of the head, which must be considered in studies of brain injury generation and distribution as well as prevention.	Gothenburg Univ, Inst Anat & Cell Biol, SE-40530 Gothenburg, Sweden; Chalmers Univ Technol, Dept Appl Mech, SE-41296 Gothenburg, Sweden; Samba Sensors AB, SE-41328 Gothenburg, Sweden		Hansson, HA (corresponding author), Gothenburg Univ, Inst Anat & Cell Biol, SE-40530 Gothenburg, Sweden.	hans-arne.hansson@anatcell.gu.se					CLAUSEN F, 2002, 20 ANN NAT NEUR SOC, P529; Eichberger A, 2000, ACCIDENT ANAL PREV, V32, P251, DOI 10.1016/S0001-4575(99)00097-4; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GOSCH HH, 1970, J TRAUM, V10, P370, DOI 10.1097/00005373-197005000-00002; Graham D I, 1993, Acta Neurochir Suppl (Wien), V57, P41; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; HANSSON HA, 2003, 21 ANN NAT NEUR SOC, P200; HARDY WN, 2001, 45 STAPP CAR CRASH C; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; KRAUS FJ, 1997, NEUROEPIDEMIOLOGY, V14, P435; MEANEY DF, 1993, ASME AMD, V169; NAHUM AM, 1977, 21 STAPP CAR CRASH; NUSHOLTZ GS, 1984, 28 STAPP CAR CRASH C; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ortengren T, 1996, J NEUROTRAUM, V13, P171, DOI 10.1089/neu.1996.13.171; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Reilly P, 1997, HEAD INJURY PATHOPHY; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Sosin DM, 1996, BRAIN INJURY, V10, P47; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007; SUNESON A, 1990, J TRAUMA, V30, P281, DOI 10.1097/00005373-199003000-00006; SVENSSON MY, 1993, 1993 INT IRCOBI C BI, P189; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Trosseille X, 1992, 36 STAPP CAR CRASH C; VALLFORS B, 1976, NEUROSURGICAL SUCTIO; Ward C., 1980, 24 STAPP CAR CRASH C; Wisniewski H. M, 1986, ATLAS RABBIT BRAIN S; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; [No title captured]	37	19	21	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	MAY	2005	21	10					2876	2882		10.1111/j.1460-9568.2005.04115.x			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929TQ	WOS:000229369700026	15926935				2022-02-06	
J	Marson, DC; Dreer, LE; Krzywanski, S; Huthwaite, JS; DeVivo, MJ; Novack, TA				Marson, DC; Dreer, LE; Krzywanski, S; Huthwaite, JS; DeVivo, MJ; Novack, TA			Impairment and partial recovery of medical decision-making capacity in traumatic brain injury: A 6-month longitudinal study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; decision making; mental competency; rehabilitation	MACARTHUR TREATMENT COMPETENCE; PHYSICIANS LEGAL STANDARD; MILD ALZHEIMERS-DISEASE; PROTOTYPE-INSTRUMENT; PERSONAL JUDGMENTS; COGNITIVE MODELS; CONSENT; ABILITIES; REHABILITATION; CONSISTENCY	Objective: To investigate empirically change in medical decision-making capacity (MDC) in patients with traumatic brain injury (TBI). Design: Longitudinal study comparing control and TBI groups at hospitalization and at 6 months postinjury. Setting: Inpatient brain injury rehabilitation unit. Participants: Twenty healthy controls and 24 patients with moderate to severe TBI. Interventions: Not applicable. Main Outcome Measures: MDC was measured by using the Capacity to Consent to Treatment Instrument (CCTI). The CCTI evaluates performance on a series of 4 accepted consent abilities, or standards: S1 (evidencing/communicating choice), S3 (appreciating consequences), S4 (reasoning about treatment), and S5 (understanding the treatment situation and choices), and I experimental standard [S2] (making the reasonable treatment choice when the alternative choice is unreasonable). In addition, TBI patients were assigned I of 3 capacity outcomes (capable, marginally capable, incapable) for each standard. Results: At hospitalization, TBI patients performed equivalently with controls on standards SI and [S2] but significantly below controls on S3 (P < .001), S4 (P < .02), and S5 (P < .001). At 6-month follow-up, TBI patients showed significant within-group improvement on these 3 standards (S3, S4, S5) but continued to fall significantly below controls on S3 (P < .006) and S5 (P < .001). A group by time interaction emerged on S5 (P < .02). The TBI group showed increasing proportions of capable outcomes on all standards over the 6 months. Conclusions: Patients with TBI showed initial impairment and subsequent partial recovery of MDC over a 6-month period. Complex consent abilities of appreciation, reasoning, and understanding were significantly impaired in hospitalized acute TBI patients. At follow-up, TBI patients showed substantial recovery of reasoning and partial recovery of appreciation and understanding consent abilities. The study suggests the importance in the rehabilitation setting of serial evaluations of MDC in patients with TBI.	Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Alzheimers Dis Res Ctr, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35233 USA		Marson, DC (corresponding author), Univ Alabama Birmingham, Dept Neurol, Rm JT1216, Birmingham, AL 35233 USA.	dmarson@uab.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG016582, U01AG010483] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1P50 AG16582-01, U01 AG 10483-12] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD07420] Funding Source: Medline		APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; BANJA JD, 1986, ARCH PHYS MED REHAB, V67, P790; Benson D.F., 1986, FRONTAL LOBES; *CDCP, 1997, MMWR-MORBID MORTAL W, V48, P8; CHRISTENSEN K, 1995, B AM ACAD PSYCH LAW, V18, P221; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1995, J INT NEUROPSYCH SOC, V1, P66; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dymek MP, 2001, NEUROLOGY, V56, P17, DOI 10.1212/WNL.56.1.17; Dymek MP, 1999, J FORENSIC NEUROPSYC, V1, P27, DOI DOI 10.1300/J151V01N01_; Earnst KS, 2000, J AM GERIATR SOC, V48, P919, DOI 10.1111/j.1532-5415.2000.tb06888.x; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; FITTEN LJ, 1990, ARCH INTERN MED, V150, P1717, DOI 10.1001/archinte.150.8.1717; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Griffith HR, 2003, NEUROLOGY, V60, P449, DOI 10.1212/WNL.60.3.449; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P149, DOI 10.1007/BF01499323; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P127, DOI 10.1007/BF01499322; GRISSO T, 1986, EVALUATINIG COMPETEN; Hillier SL, 1997, BRAIN INJURY, V11, P661; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; KAPP M, 1992, GERIATRICS LAW PATIE; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Levin H, 1979, J NERV MENT DIS, V20, P694; Marson D, 2001, ARCH CLIN NEUROPSYCH, V16, P754; Marson D., 2001, ALZHEIMERS DIS RELAT, P165; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Marson DC, 2000, J AM GERIATR SOC, V48, P911, DOI 10.1111/j.1532-5415.2000.tb06887.x; Marson DC, 1999, NEUROLOGY, V53, P1983, DOI 10.1212/WNL.53.9.1983; MARSON DC, 1994, ALZ DIS ASSOC DIS, V8, P5, DOI 10.1097/00002093-199424003-00002; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; Marson DC, 1997, J AM GERIATR SOC, V45, P458, DOI 10.1111/j.1532-5415.1997.tb05171.x; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P955, DOI 10.1001/archneur.1995.00540340035011; Marson DC, 1996, NEUROLOGY, V46, P666, DOI 10.1212/WNL.46.3.666; Marson DC, 1997, J AM GERIATR SOC, V45, P453, DOI 10.1111/j.1532-5415.1997.tb05170.x; MCNEMAR Q, 1975, PSYCHOLOGICAL STAT; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; ODDY M, 1984, CLOSED HEAD INJURY P, P108; Reid-Proctor GM, 2001, BRAIN INJURY, V15, P377, DOI 10.1080/02699050010005977; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; ROTH LH, 1977, AM J PSYCHIAT, V134, P279; Simon Robert I., 1994, P569; SPSS Inc, 2000, SPSS BAS 10 0 APPL G; TEASDALE G, 1974, LANCET, V2, P81; TEPPER AM, 1984, LAW HUMAN BEHAV, V8, P205, DOI 10.1007/BF01044693; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Wong JG, 1999, PSYCHOL MED, V29, P437, DOI 10.1017/S0033291798008113; WONG T, 1998, ETHICAL ISSUES EVALU, P187; Ylvisaker Mark, 1996, Seminars in Speech and Language, V17, P217, DOI 10.1055/s-2008-1064100	52	19	19	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2005	86	5					889	895		10.1016/j.apmr.2004.09.020			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	928NM	WOS:000229278500007	15895333				2022-02-06	
J	Gerber, CS				Gerber, Carolyn S.			Understanding and Managing Coma Stimulation Are We Doing Everything We Can?	CRITICAL CARE NURSING QUARTERLY			English	Article						coma; habituation; neuronal reorganization; reticular activating system (RAS); sensory regulation; structured coma stimulation; vigilance		The incidence of people surviving with traumatic brain injury is rising at a remarkable pace. Unfortunately, patients also experience some form of coma and significant deficits (ie, cognitive, functional, etc). The focus is shifting from saving these patients to trying to figure out what else can be done for them? In the past, patients were medically maintained, stabilized, and then sent to rehabilitation centers for coma stimulation, in the hope of waking up their reticular activating system. Today, healthcare professionals are being encouraged to research and explore the possibility of implementing structured coma stimulation programs as early as 72 hours postinjury in the intensive care unit. Starting early is of paramount importance to a patient's survival, quality of life, and overall long-term prognosis. The goal of this article is to educate healthcare professionals (in the hospital setting) about managing and implementing structured sensory stimulation sessions.	[Gerber, Carolyn S.] Scripps Mercy Hosp, Surg Intens Care Unit, 4077 Fifth Ave, San Diego, CA 92103 USA; [Gerber, Carolyn S.] Amer Assoc Neurosci Nurses, San Diego, CA USA		Gerber, CS (corresponding author), Scripps Mercy Hosp, Surg Intens Care Unit, 4077 Fifth Ave, San Diego, CA 92103 USA.	cgrnsdca@pacbell.net					Connell K, 1992, Nursing, V22, P44; Davis A E, 1995, Crit Care Nurs Clin North Am, V7, P351; Don Lehmkuhl L, 1993, NEUROLOGY REP, V17, P10; Giacino JT., 2003, COMA SEIZURES, V12, P11; Helwick L D, 1994, Crit Care Nurse, V14, P47; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Oh H, 2003, J CLIN NURS, V12, P394, DOI 10.1046/j.1365-2702.2003.00750.x; Sosnowski C, 1994, J Neurosci Nurs, V26, P336; Teasdale G, 1974, LANCET, V13, P4; Tolle Patrizia, 2003, Axone, V25, P20; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113	12	19	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0887-9303	1550-5111		CRIT CARE NURS Q	Crit. Care Nurs. Q.	APR-JUN	2005	28	2					94	108		10.1097/00002727-200504000-00002			15	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V1Y5O	WOS:000217351900003	15875441				2022-02-06	
J	Yang, JT; Lee, TH; Weng, HH; Chang, CN; Chen, WC; Cheng, WC; Wu, JH				Yang, JT; Lee, TH; Weng, HH; Chang, CN; Chen, WC; Cheng, WC; Wu, JH			Dexamethasone enhances NT-3 expression in rat hippocampus after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						dexamethasone; hippocampus; in situ hybridization; immunohistochemistry; neurotrophin-3; traumatic brain injury	MESSENGER-RNA EXPRESSION; SPINAL-CORD INJURY; NEUROTROPHIC FACTOR; HEAD-INJURY; GLUCOCORTICOIDS MODULATE; FOREBRAIN ISCHEMIA; NEURONS; RECEPTOR; BDNF; CA1	The cellular events in traumatic brain injury (TBI) are complicated, and the factors mediating neurotrophins to protect and repair the injured brain cells are only beginning to be identified. This study examined the effect of dexamethasone (DEX) on neurotrophin-3 (NT-3) expression following TBI. Levels of NT-3 mRNA and protein in rat hippocampus were measured using in situ hybridization and immunohistochemistry, respectively. After TBI, the NT-3 mRNA expression was down-regulated during the first 24 h. DEX reversed the post-traumatic reduction of NT-3 mRNA expression at 2, 4, 6, and 12 h in the hippocampus, and also decreased the cell death in hippocampal hilum and supraventricular cerebral cortex after 7 days. The NT-3 protein levels generally corresponded to the mRNA levels in the hippocampal region. DEX enhanced the NT-3 expression after TBI, indicating that post-traumatic neuroprotection in the hippocampus is at least partially mediated by NT-3 and thus can be modulated by DEX treatment. (c) 2005 Elsevier Inc. All rights reserved.	Chang Gung Univ, Coll Med, Mol Genet Lab 3, Tao Yuan 333, Taiwan; Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan; Chang Gung Mem Hosp, Dept Neurol, Taipei 10591, Taiwan; Chang Gung Mem Hosp, Dept Radiol, Chiayi, Taiwan; Chang Gung Mem Hosp, Dept Neurosurg, Taipei 10591, Taiwan; Chang Gung Mem Hosp, Dept Radiat Oncol, Chiayi, Taiwan; Tsu Ai Gen Hosp, Dept Neurosurg, Shi Luo, Taiwan		Wu, JH (corresponding author), Chang Gung Univ, Coll Med, Mol Genet Lab 3, 259 Wen Haw 1 Rd, Tao Yuan 333, Taiwan.	jhwu@mail.cgu.edu.tw	Yang, Jen-Tsung/C-3187-2011; Lee, Tsong Hai/C-1235-2011; Weng, Hsu-Huei/N-8329-2014	Weng, Hsu-Huei/0000-0002-2020-8912			BARBANY G, 1992, EUR J NEUROSCI, V4, P396, DOI 10.1111/j.1460-9568.1992.tb00888.x; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; DOI N, 1991, NEUROSCI LETT, V123, P99, DOI 10.1016/0304-3940(91)90167-R; DUPLESSIS JJ, 1992, BRIT J NEUROSURG, V6, P145, DOI 10.3109/02688699209002917; FANCONI S, 1988, INTENS CARE MED, V14, P163; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; Grundy PL, 2000, NEUROREPORT, V11, P3381, DOI 10.1097/00001756-200010200-00023; Grundy PL, 2004, MOL BRAIN RES, V120, P188, DOI 10.1016/j.molbrainres.2003.09.018; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; HALL ED, 1982, SURG NEUROL, V18, P320, DOI 10.1016/0090-3019(82)90140-9; Hansson AC, 2000, EUR J NEUROSCI, V12, P2918, DOI 10.1046/j.1460-9568.2000.00185.x; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Kostron H, 1990, Adv Neurol, V52, P289; Kraus JF, 1996, OCCUP MED, V11, P201; Lee TH, 2004, J NEUROSCI RES, V76, P705, DOI 10.1002/jnr.20097; LEE TH, 1995, J NEUROSCI RES, V41, P684, DOI 10.1002/jnr.490410515; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MEINIG G, 1990, ACT NEUR S, V51, P100; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SMITH A, 1977, COLOUR ATLAS HISTOLO; Yang JT, 2002, CRIT CARE MED, V30, P913, DOI 10.1097/00003246-200204000-00034; Yang JT, 1998, NEUROREPORT, V9, P3477, DOI 10.1097/00001756-199810260-00026	29	19	21	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2005	192	2					437	443		10.1016/j.expneurol.2004.12.023			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	908ZH	WOS:000227828200020	15755560				2022-02-06	
J	Unden, J; Bellner, J; Astrand, R; Romner, B				Unden, J; Bellner, J; Astrand, R; Romner, B			Serum S100B levels in patients with epidural haematomas	BRITISH JOURNAL OF NEUROSURGERY			English	Article						epidural/intracranial haematoma/haematoma; head/brain injury; S100B/S100/S-100	S-100B PROTEIN; BRAIN-DAMAGE; HEAD-INJURY; MANAGEMENT	Protein S100B is today the most promising biomarker for cerebral injury. A welcomed area for the use of such a marker is in the early stages of head trauma and diagnosis of brain injury, in particular epidural haematomas. We report five consecutive cases of epidural haematoma where serum samples for S100B were drawn at admission. Three of the patients showed low levels of S100B (<= 0.2 mu g/l). One patient with a large epidural haematoma with radiological signs of cerebral herniation displayed normal levels (0.14 mu g/l) of S100B 3.5 h after the initial head trauma. Normal S100B levels in serum do not predict normal intracranial findings. S100B may be unreliable as a marker for epidural haematomas after closed head injury.	Univ Lund Hosp, Dept Neurosurg, Neurointens care Unit NIVA, S-22185 Lund, Sweden		Romner, B (corresponding author), Univ Lund Hosp, Dept Neurosurg, Neurointens care Unit NIVA, S-22185 Lund, Sweden.	bertil.romner@skane.se					Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bottiger BW, 2001, CIRCULATION, V103, P2694; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; JENNETT B, 1996, J NEUROL NEUROSUR PS, V60, P101; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; KRAUS JF, 1993, HEAD INJURY; Raabe A, 1999, J NEUROSURG, V91, P875, DOI 10.3171/jns.1999.91.5.0875; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; Unden J, 2004, BRIT J NEUROSURG, V18, P277, DOI 10.1080/02688690410001732742; Unden J, 2004, SCAND J INFECT DIS, V36, P10, DOI 10.1080/00365540310017294; Wiesmann M, 1998, CLIN CHEM, V44, P1056	15	19	20	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2005	19	1					43	45		10.1080/02688690500089381			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	933IO	WOS:000229622300007	16147582				2022-02-06	
J	Marklund, N; Keck, C; Hoover, R; Soltesz, K; Millard, M; LeBold, D; Spangler, Z; Banning, A; Benson, J; McIntosh, TK				Marklund, N; Keck, C; Hoover, R; Soltesz, K; Millard, M; LeBold, D; Spangler, Z; Banning, A; Benson, J; McIntosh, TK			Administration of monoclonal antibodies neutralizing the inflammatory mediators tumor necrosis factor alpha and interleukin-6 does not attenuate acute behavioral deficits following experimental traumatic brain injury in the rat	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						traumatic brain injury; lateral fluid percussion; tumor necrosis factor (TNF)-alpha; interleukin (IL)-6; Morris water maze; neuroscore; rotating pole; cerebral edema; inflammation	CLOSED-HEAD INJURY; CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; PLATELET-ACTIVATING-FACTOR; GROWTH-FACTOR PRODUCTION; FOCAL CEREBRAL-ISCHEMIA; FLUID-PERCUSSION MODEL; NEURONAL CELL-DEATH; KAPPA-B ACTIVATION; TNF-ALPHA	Purpose: Although many previous studies have indicated that the acute inflammatory response following traumatic brain injury (TBI) is detrimental, inflammation may also positively influence outcome in the more chronic post-injury recovery period. We evaluated the effects of monoclonal antibodies (mAB), neutralizing either IL-6 (IL-6 mAB) or TNF-alpha (TNF mAB), administered intracerebroventricularly (i.c.v) on acute neurobehavioral outcome following TBI. Methods: Male Sprague-Dawley rats (n = 173) were anesthetized (sodium pentobarbital, 60 mg/kg) and subjected to lateral fluid percussion (FP) brain injury of moderate severity (n = 123) or sham injury (n = 50). Beginning 1 It post-injury, TNF mAB (n = 41, of which 25 were brain-injured) or IL-6 mAB (n = 42, of which 25 were brain-injured) at a concentration of 2 mg/mL was infused i.c.v ipsilateral to the injury for 48 hours. Vehicle-treated animals (control IgG; n = 43, of which 26 were brain-injured) served as controls. In Study 1, cognitive function was evaluated in the Morris Water Maze (MWM) followed by evaluation of regional cerebral edema at 48 h post-injury. In Study 2, animals were evaluated for neurological motor function and post-injury learning in the MWM at one week post-injury. Results: FP brain injury caused significant cognitive (p < 0.05) and neurological motor (p < 0.05) deficits and increased regional brain water content in the injured hemisphere. Treatment with either TNF- or IL-6-mAB had no effect on neurological motor, cognitive function or brain edema during the first post-injury week. Conclusions: Evaluation of anti-inflammatory mABs on more chronic behavioral deficits appears warranted.	Univ Penn, Dept Neurosurg, Traumat Brain Injury Labraty, Philadelphia, PA 19104 USA; Centocor Inc, Radnor, PA 19087 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA		McIntosh, TK (corresponding author), Univ Penn, Dept Neurosurg, Traumat Brain Injury Labraty, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	mcintosh@seas.upenn.edu		Marklund, Niklas/0000-0002-9797-5626	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS40978, NS08803] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, P01NS008803, R01NS040978] Funding Source: NIH RePORTER		Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Benveniste EN, 1998, CYTOKINE GROWTH F R, V9, P259, DOI 10.1016/S1359-6101(98)00015-X; Bjugstad KB, 2000, J NEUROVIROL, V6, P478, DOI 10.3109/13550280009091948; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Campbell IL, 1998, NEUROIMMUNOMODULAT, V5, P126, DOI 10.1159/000026329; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Carlson NG, 1999, J IMMUNOL, V163, P3963; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; CHENEY JA, 2001, J CEREB BLOOD FLOW M, V21, P403; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Farkas G, 1998, NEUROSCI LETT, V242, P147, DOI 10.1016/S0304-3940(98)00060-3; Fiedler M, 2002, PROTEIN ENG, V15, P931, DOI 10.1093/protein/15.11.931; GORDON HM, 1992, J IMMUNOL, V148, P4021; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Hans VHJ, 1999, NEUROREPORT, V10, P409; Hisahara S, 1997, J NEUROCHEM, V69, P10; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Ichiyama T, 2001, BRAIN RES, V911, P56, DOI 10.1016/S0006-8993(01)02672-5; KARKAR AM, 1998, J AM SOC NEPHROL, V9, P478; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; LaFleur M, 1996, J EXP MED, V184, P2311; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; MARKLUND N, 2004, 34 ANN M SAN DIEG CA; MATSUO Y, 1995, J CEREBR BLOOD F MET, V15, P941, DOI 10.1038/jcbfm.1995.119; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Probert L, 1997, J NEUROIMMUNOL, V72, P137, DOI 10.1016/S0165-5728(96)00184-1; Pulliam L, 1998, J NEUROSCI RES, V54, P530, DOI 10.1002/(SICI)1097-4547(19981115)54:4<530::AID-JNR10>3.0.CO;2-1; Qiu ZH, 1998, J NEUROSCI, V18, P10445; Rhodes JKJ, 2002, NEUROSCI LETT, V335, P1, DOI 10.1016/S0304-3940(02)00811-X; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sairanen T, 2001, STROKE, V32, P1750, DOI 10.1161/01.STR.32.8.1750; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; Spikes S E, 1996, Contemp Top Lab Anim Sci, V35, P53; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Sullivan PG, 1999, J NEUROSCI, V19, P6248; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TERADA LS, 1992, INFLAMMATION, V16, P13, DOI 10.1007/BF00917511; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Westmoreland SV, 1996, J NEUROVIROL, V2, P118, DOI 10.3109/13550289609146545; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; ZABEL P, 1989, LANCET, V2, P1474; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zou LL, 2002, J CEREBR BLOOD F MET, V22, P959, DOI 10.1097/00004647-200208000-00007	98	19	22	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2005	23	1					31	42					12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944HG	WOS:000230417200004	15846030				2022-02-06	
J	Mohr, JD; Bullock, LM				Mohr, J. Darrell; Bullock, Lyndal M.			Traumatic Brain Injury: Perspectives From Educational Professionals	PREVENTING SCHOOL FAILURE			English	Article						diverse needs; preparation; support; traumatic brain injury		This article reports the outcomes from 2 focus groups conducted to ascertain professional educators' perceptions regarding their (a) level of preparedness for working with students with traumatic brain injury (TBI), (b) ideas regarding ways to improve support to students and families, and (c) concerns about meeting the diverse needs of children with TBI.	[Mohr, J. Darrell; Bullock, Lyndal M.] Univ North Texas, Dept Special Educ, Denton, TX 76203 USA		Mohr, JD (corresponding author), Univ North Texas, Dept Special Educ, Denton, TX 76203 USA.						Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; Bullock LM, 2005, PREV SCH FAIL, V49, P6, DOI 10.3200/PSFL.49.4.6-10; Chapman J. K., 2000, RURAL SPECIAL ED Q, V19, P3; Clark E, 1999, SCHOOL PSYCHOL REV, V28, P242; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DEPOMPEI R, 1993, STAFF DEV CLIN INTER, P229; DePompei R., 1998, SPECIAL ED IEP CHECK; FARMER JE, 1995, SCHOOL PSYCHOL REV, V24, P230; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; HIBBARD M, 2001, STUDENTS TRAUMATIC B; Lash M., 2000, SIGNS STRATEGIES ED; Mayfield J, 2005, PREV SCH FAIL, V49, P17, DOI 10.3200/PSFL.49.4.17-22; MIRA MP, 1991, FOCUS EXCEPT CHILD, V23, P1; Savage R. C., 1988, ED MANUAL ED NEED ST; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; Savage RC, 2005, PREV SCH FAIL, V49, P43, DOI 10.3200/PSFL.49.4.43-52; SCHOENBRODT L, 2001, CHILDREN TRAUMATIC B; SEMRUDCLIKEMAN M, 2001, TRAUMATIC BRAIN INJU; Stavinoha PL, 2005, PREV SCH FAIL, V49, P11, DOI 10.3200/PSFL.49.4.11-16; Tyler J. S., 1999, TRAUMATIC BRAIN INJU; Ylvisaker M., 1998, COLLABORATIVE BRAIN	22	19	19	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1045-988X	1940-4387		PREV SCH FAIL	Prev. Sch. Fail.		2005	49	4					53	57		10.3200/PSFL.49.4.53-57			5	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V2Y9C	WOS:000218037100008					2022-02-06	
J	Tamimi, A; Abu-Elrub, M; Shudifat, A; Saleh, Q; Kharazi, K; Tamimi, I				Tamimi, A; Abu-Elrub, M; Shudifat, A; Saleh, Q; Kharazi, K; Tamimi, I			Superior sagittal sinus thrombosis associated with raised intracranial pressure in closed head injury with depressed skull fracture	PEDIATRIC NEUROSURGERY			English	Article						superior sagittal sinus; thrombosis; acetazolamide; lumbar puncture		A case of delayed signs of intracranial hypertension following closed head injury with a depressed cranial fracture and superior sagittal sinus thrombosis is reported. Conservative treatment of intracranial hypertension, including just repeated lumbar puncture and oral acetazolamide, was performed. Spontaneous recanalization of the superior sagittal sinus was observed. Pathogenesis and different modalities of treatment are discussed. Copyright (c) 2005 S. Karger AG, Basel.	Univ Jordan, Fac Med, Amman 11942, Jordan; Hosp Univ Jordan, Dept Neurosurg, Amman, Jordan		Tamimi, A (corresponding author), Univ Jordan, Fac Med, POB 13349, Amman 11942, Jordan.	aftamimi@hotmail.com	Alsabbagh, Qussay/ABB-8281-2020	Alsabbagh, Qussay/0000-0003-3981-6712; Tamimi Marino, Iskandar/0000-0003-4196-5151			BECKER DP, 1990, NEUROLOGICAL SURG, P2017; BELLER AJ, 1964, J NEUROL NEUROSUR PS, V27, P149, DOI 10.1136/jnnp.27.2.149; CARRIE AW, 1954, J NEUROSURG, V11, P173, DOI 10.3171/jns.1954.11.2.0173; D'Alise MD, 1998, SURG NEUROL, V49, P430, DOI 10.1016/S0090-3019(97)00182-1; DUPLESSIS JJ, 1993, J TRAUMA, V34, P290, DOI 10.1097/00005373-199302000-00021; GETTELFINGER DM, 1997, ARCH NEUROL-CHICAGO, V34, P2; Gudeman S. K., 1989, TXB HEAD INJURY, P138; KINAL ME, 1967, J NEUROSURG, V27, P142, DOI 10.3171/jns.1967.27.2.0142; KINAL ME, 1959, NEUROLOGICAL SURG, V2, P178; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; Kumar GSS, 2004, NEUROL INDIA, V52, P123; LeFeuvre D, 2004, SURG NEUROL, V62, P121, DOI 10.1016/j.surneu.2003.10.048; Muthukumar N, 2005, CHILD NERV SYST, V21, P86, DOI 10.1007/s00381-004-0926-2; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; Uzan M, 1998, J NEUROSURG, V88, P598, DOI 10.3171/jns.1998.88.3.0598; vandenBrink WA, 1996, NEUROSURGERY, V38, P1044, DOI 10.1097/00006123-199605000-00039; VANDENHEEVER CM, 1989, J NEUROSURG, V71, P186, DOI 10.3171/jns.1989.71.2.0186; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357	18	19	20	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2005	41	5					237	240		10.1159/000087480			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	970FN	WOS:000232290700003	16195674				2022-02-06	
J	Wittebole, X; Hantson, P; Laterre, PF; Galvez, R; Duprez, T; Dejonghe, D; Renkin, J; Gerber, BL; Brohet, CR				Wittebole, X; Hantson, P; Laterre, PF; Galvez, R; Duprez, T; Dejonghe, D; Renkin, J; Gerber, BL; Brohet, CR			Electrocardiographic changes after head trauma	JOURNAL OF ELECTROCARDIOLOGY			English	Article						head trauma; diffuse axonal injury; ECG changes	SUBARACHNOID HEMORRHAGE; INJURY	We report the case of a patient who developed, a few days after a closed head injury, marked electrocardiographic changes mimicking an acute coronary event, in the absence of actual cardiac damage. The electrocardiographic changes were fully reversible, paralleling the neurologic status. Neuro-imaging examinations excluded subarachnoid hemorrhage or space-occupying hematoma, but demonstrated diffuse axonal injury using susceptibility-weighted magnetic resonance techniques. This kind of traumatic brain injury thus may be responsible for a pseudo-acute myocardial ischemic syndrome. (C) 2005 Elsevier Inc. All rights reserved.	Catholic Univ Louvain, Hosp St Luc, Dept Intens Care, B-1200 Brussels, Belgium; Univ Catholique Louvain, Hosp St Luc, Dept Radiol & Med Imaging, B-1200 Brussels, Belgium; Catholic Univ Louvain, Hosp St Luc, Dept Internal Med, Div Cardiol, B-1200 Brussels, Belgium		Brohet, CR (corresponding author), Clin Univ St Luc, B-1200 Brussels, Belgium.	brohet@card.ucl.ac.be	Gerber, Bernhard L/H-5838-2011; Wittebole, Xavier/ABC-2036-2021	Duprez, Thierry/0000-0002-1579-0100; Gerber, Bernhard/0000-0003-1708-8558			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; CARRUTH JE, 1980, CHEST, V78, P886, DOI 10.1378/chest.78.6.886; DAVIS TP, 1993, PROG CARDIOVASC DIS, V36, P245, DOI 10.1016/0033-0620(93)90017-8; GREENSPAHN BR, 1978, CHEST, V74, P468, DOI 10.1378/chest.74.4.468; HERSCH C, 1961, CIRCULATION, V23, P853, DOI 10.1161/01.CIR.23.6.853; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; NATELSON BH, 1985, ARCH NEUROL-CHICAGO, V42, P178, DOI 10.1001/archneur.1985.04060020096022; REICHENBACH DD, 1968, ARCH PATHOL, V85, P189; Sakr YL, 2002, PROG CARDIOVASC DIS, V45, P67, DOI 10.1053/pcad.2002.124633; SCOTT I, 1988, MED J AUSTRALIA, V148, P94, DOI 10.5694/j.1326-5377.1988.tb104520.x; Sharkey SW, 1998, CHEST, V114, P98, DOI 10.1378/chest.114.1.98; SURAWICZ B, 2001, CHOUS ELECTROCARDIOG, P534; SURAWICZ B, 1989, COMPREHENSIVE ELECTR, P538	14	19	19	0	2	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0022-0736	1532-8430		J ELECTROCARDIOL	J. Electrocardiol.	JAN	2005	38	1					77	81		10.1016/j.jelectrocard.2004.09.004			5	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	896UE	WOS:000226958500013	15660352				2022-02-06	
J	Wongvatunyu, S; Porter, EJ				Wongvatunyu, S; Porter, EJ			Mothers' experience of helping young adults with traumatic brain injury	JOURNAL OF NURSING SCHOLARSHIP			English	Article						traumatic brain injury; maternal caregiving; phenomenology	HEAD-INJURY; FAMILY	Purpose: To describe mothers' experience of helping young adults with traumatic brain injury (TBI). Design: Descriptive. Methods: A convenience sample of participants from support groups for parents of young adults with TBI met the criteria of engaging in regular interaction or helping their children (aged 20 to 36 years). These young adults had suffered moderate or severe TBI from a motor vehicle collisions, sports-related injuries, or recreation-related injuries more than 6 months earlier. A descriptive phenomenological method was used. Three in-depth interviews were done with each mother over a 2-month period. Data were the mothers' perceptions, actions, and intentions pertaining to their experiences of helping the young adults. Findings: Five phenomena that were structures of the experience were discerned, discussed with participants to obtain their feedback, and compared to the relevant literature. The five phenomena of the mothers' experiences were: reconnecting my child's brain, considering my child's safety, making our lives as normal as possible, dealing with our biggest problem, and advocating for my child. Conclusions: The mothers continued rehabilitation efforts with the young adults, even when only minimal services were available to support their efforts. Mothers needed interventions to enhance their knowledge, and they and the young adults with TBI needed expanded community services.	Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65211 USA; Mahidol Univ, Ramathibodi Hosp, Fac Med, Ramathibodi Sch Nursing, Bangkok 10700, Thailand		Porter, EJ (corresponding author), Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65211 USA.	porterej@missouri.edu					*BRAIN INJ ASS MIS, 2000, BRAIN INJ BRIEF REV; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Carson P, 1993, J Neurosci Nurs, V25, P165; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; CRAFT MJ, 1992, NURS CLIN N AM, V27, P517; DEBOSKEY DS, 1991, ED FAMILIES HEAD INJ; *FAM CAR ALL, 1998, FACT SHEET TRAUM BRA; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; HAASE JE, 1987, ADV NURS SCI, V9, P64, DOI 10.1097/00012272-198701000-00010; Husserl E., 1913, IDEAS GEN INTRO PURE; Johnson B P, 1995, J Neurosci Nurs, V27, P113; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; KARPMAN T, 1985, J APPL REHABILITATIO, V0017, P00028; KOHAK E, 1978, IDEAS EXPERIENCE; Kosciulek J. F., 1994, REHABILITATION COUNS, V37, P245; KOSCIULEK JF, 1995, J APPL REHABILITATIO, V26, P13; KOSCIULEK JF, 1996, J APPL REHABILITATIO, V27, P8; Kramer BJ, 1997, GERONTOLOGIST, V37, P218, DOI 10.1093/geront/37.2.218; Kraus J, 2000, HEAD INJURY, P1; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; McCubin M. A., 1991, FAMILY ASSESSMENT IN, P3; Morse J., 1989, QUALITATIVE NURSING, P117; *NAT HEAD INJ FDN, 1984, NIH PUBL; Porter EJ, 1998, ADV NURS SCI, V21, P16, DOI 10.1097/00012272-199809000-00003; Raskin S. A., 2000, NEUROPSYCHOLOGICAL M, P93; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Smith J E, 2000, Care Manag J, V2, P27; Spiegelberg H., 1994, PHENOMENOLOGICAL MOV; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Willer B., 1990, CANADIAN J REHABILIT, V3, P167	30	19	19	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6546	1547-5069		J NURS SCHOLARSHIP	J. Nurs. Scholarsh.		2005	37	1					48	55		10.1111/j.1547-5069.2005.00015.x			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	900YM	WOS:000227250200012	15813587				2022-02-06	
J	Wiese, H; Stude, P; Nebel, K; Osenberg, D; Ischebeck, W; Stolke, D; Diener, HC; Keidel, M				Wiese, H; Stude, P; Nebel, K; Osenberg, D; Ischebeck, W; Stolke, D; Diener, HC; Keidel, M			Recovery of movement-related potentials in the temporal course after prefrontal traumatic brain injury: a follow-up study	CLINICAL NEUROPHYSIOLOGY			English	Article						traumatic brain injury; frontal lobe; EEG; Bereitschaftspotential; movement-related potential; recovery	SUPPLEMENTARY MOTOR AREA; EXTERNALLY TRIGGERED MOVEMENTS; VOLUNTARY MOVEMENT; FINGER MOVEMENTS; CEREBRAL-CORTEX; CORTICAL AREAS; ACTIVATION; READINESS; SCALP; CONNECTIONS	Objective: The movement-related potential (MRP) is an EEG measure related to self-initiated movements, consisting of the Bereitschaftspotential (BP), the negative slope, and the motor potential. Since in a former study the BP was reduced in acute prefrontal traumatic brain injury (TBI) patients, the present study examined the MRPs' course in follow-up examinations. Methods: Right index finger MRPs of 22 patients with contusions of the prefrontal cortex were recorded 12, 26, and 52 weeks after TBI and compared to controls. Results: Within the patient group, a significant increase of the BP in the temporal course after TBI was observed. MRPs 12 and 26 weeks after TBI did not differ significantly from the control group. One year after TBI, significantly enhanced BPs were found. Conclusions: In the temporal course after prefrontal TBI, a recovery of the initially reduced BP was observed. The enhanced BP areas 1 year after TBI might represent the need for increased cognitive resources during movement preparation, supporting a recovered, but less effective neuronal network. Significance: The present study represents the first longitudinal follow-up study of MRPs after prefrontal brain lesion. The observed changes reflect the plastic capacity of the brain, reorganizing the neuronal network function. (C) 2004 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	Univ Duisburg Essen, Dept Neurol, D-45122 Essen, Germany; Klin Holthausen, Hattingen, Germany; Univ Duisburg Essen, Dept Neurosurg, D-45122 Essen, Germany; Dist Hosp Bayeruth, Dept Neurol, Bayreuth, Germany; Dist Hosp Bayeruth, Dept Neurorehabil, Bayreuth, Germany		Wiese, H (corresponding author), Univ Duisburg Essen, Dept Neurol, Hufelandstr 55, D-45122 Essen, Germany.	holger.wiese@uni-essen.de	Wiese, Holger/M-5281-2014; Diener, Hans-Christoph/AAF-7275-2019	Wiese, Holger/0000-0003-4928-0771; 			Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; BARBAS H, 1987, J COMP NEUROL, V256, P211, DOI 10.1002/cne.902560203; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; BRUNIA CHM, 1980, BIOL PSYCHOL, V11, P181, DOI 10.1016/0301-0511(80)90054-X; BRUNIA CHM, 1981, BIOL PSYCHOL, V13, P261; Cui RQ, 1999, NEUROIMAGE, V9, P124, DOI 10.1006/nimg.1998.0388; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; DEECKE L, 1969, EXP BRAIN RES, V7, P158; DEECKE L, 1987, J NEUROL NEUROSUR PS, V50, P1430, DOI 10.1136/jnnp.50.11.1430; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; DICK JPR, 1987, ELECTROEN CLIN NEURO, V66, P263, DOI 10.1016/0013-4694(87)90075-7; Erdler M, 2000, NEUROIMAGE, V11, P697, DOI 10.1006/nimg.2000.0579; Fallgatter AJ, 2001, CLIN NEUROPHYSIOL, V112, P198, DOI 10.1016/S1388-2457(00)00505-8; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Green Joseph B, 2003, Top Stroke Rehabil, V10, P1; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; HOLM S, 1979, SCAND J STAT, V6, P65; Humberstone M, 1997, ANN NEUROL, V42, P632, DOI 10.1002/ana.410420414; IKEDA A, 1995, ELECTROEN CLIN NEURO, V95, P323, DOI 10.1016/0013-4694(95)00086-E; IKEDA A, 1992, BRAIN, V115, P1017, DOI 10.1093/brain/115.4.1017; IRLE E, 1987, BRAIN RES REV, V12, P307, DOI 10.1016/0165-0173(87)90003-8; Jahanshahi M, 2001, NEUROCASE, V7, P495, DOI 10.1093/neucas/7.6.495; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jahanshahi M., 2003, BEREITSCHAFTSPOTENTI, P1, DOI DOI 10.1007/978-1-4615-0189-3; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; Kahneman D., 1973, ATTENTION EFFORT; KELLER I, 1990, ELECTROEN CLIN NEURO, V76, P351, DOI 10.1016/0013-4694(90)90036-J; Knosche T, 1996, ELECTROEN CLIN NEURO, V99, P183, DOI 10.1016/0013-4694(96)95648-5; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kropp P, 2000, APPL PSYCHOPHYS BIOF, V25, P33, DOI 10.1023/A:1009533405695; Lee KM, 1999, NEUROIMAGE, V9, P117, DOI 10.1006/nimg.1998.0393; Loose R, 2003, HUM BRAIN MAPP, V18, P249, DOI 10.1002/hbm.10082; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MCCALLUM WC, 1993, NATO ADV SCI INST SE, V254, P1; NATIV A, 1991, PHYS THER, V71, P48, DOI 10.1093/ptj/71.1.48; NESHIGE R, 1988, BRAIN, V111, P719; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Pucak ML, 1996, J COMP NEUROL, V376, P614, DOI 10.1002/(SICI)1096-9861(19961223)376:4<614::AID-CNE9>3.0.CO;2-4; Rektor I, 2002, CLIN NEUROPHYSIOL, V113, P1998, DOI 10.1016/S1388-2457(02)00286-9; REMY P, 1994, ANN NEUROL, V36, P19, DOI 10.1002/ana.410360107; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; ROCKSTOHR B, 1989, SLOW CORTICAL POTENT; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; SINGH J, 1990, NEUROSCI LETT, V119, P27, DOI 10.1016/0304-3940(90)90747-W; SINGH J, 1990, BRAIN RES, V531, P45, DOI 10.1016/0006-8993(90)90756-2; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Toma K, 2003, BEREITSCHAFTSPOTENTI, P113; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Weeks RA, 2001, NEUROIMAGE, V14, P219, DOI 10.1006/nimg.2001.0780; Weilke F, 2001, J NEUROPHYSIOL, V85, P1858, DOI 10.1152/jn.2001.85.5.1858; Wessel K, 1997, J NEUROIMAGING, V7, P145, DOI 10.1111/jon199773145; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Wildgruber D, 1997, NEUROSCI LETT, V227, P161, DOI 10.1016/S0304-3940(97)00329-7; Zimmermann PFB., 1994, TESTBATTERIE AUFMERK	64	19	19	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	DEC	2004	115	12					2677	2692		10.1016/j.clinph.2004.06.015			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	877AQ	WOS:000225540600002	15546776				2022-02-06	
J	Curry, DJ; Wright, DA; Lee, RC; Kang, UL; Frim, DM				Curry, DJ; Wright, DA; Lee, RC; Kang, UL; Frim, DM			Poloxamer 188 volumetrically decreases neuronal loss in the rat in a time-dependent manner	NEUROSURGERY			English	Article						excitoxicity; Poloxamer 188; surfactant; time course	MITOCHONDRIAL PERMEABILITY TRANSITION; ACUTE MYOCARDIAL-INFARCTION; TRAUMATIC BRAIN-INJURY; D-ASPARTATE RECEPTOR; NERVE GROWTH-FACTOR; GLUTAMATE NEUROTOXICITY; CEREBRAL-ISCHEMIA; CELL-DEATH; APOPTOSIS; NECROSIS	OBJECTIVE: Excitotoxicity is a multistep process that results in either necrosis or apoptosis. It has been associated with neuronal death in trauma, ischemia, and neurodegeneration. The final step in necrotic cell death is the rupture of a cell's plasma membrane; repair of this membrane rupture is a potentially powerful technique of neuroprotection. Poloxamer 188 (P-188) is a synthetic surfactant that seals experimentally porated membranes. This study investigated the usefulness and time dependence of intrathecal P-188 in protecting neurons in an in vivo model of excitotoxicity in the rat. METHODS: Twenty-eight Sprague-Dawley rats underwent striatal infusion of quinolinic acid to produce a spherical excitotoxic lesion. Each animal then received either vehicle or P-188 at 10 minutes, 4 hours, or both time points after surgery by direct cisterna magna injection. Animals were killed at 1 week, and brains were stained immunohistochemically for the neuronal marker Neu-N. Volumes of neuronal loss were calculated and compared between groups by analysis of variance. RESULTS: All animals were found to have spherical, stereotyped lesions. The animals that received intrathecal poloxamer at the early injection time had statistically smaller lesions (8.16 +/- 6.12 mm(3); n = 5; P = 0.0015) than controls (18.25 +/- 11.42 mm(3); n = 11). Those animals that received poloxamer at both injection times also had statistically smaller lesions (10.57 +/- 9.00 mm(3); n = 7; P = 0.0095). The group that received poloxamer at the late injection time only did not have significantly decreased lesion size (14.86 +/- 7.95 mm(3); n = 5). CONCLUSION: Intrathecal P-188 reduces neuronal loss after excitotoxic injury in the rat only when delivered immediately after the toxin. This observation confirms the potential of surfactant molecules as neuroprotectants but predicts that their usefulness is best realized by early and potentially ongoing treatment.	Univ Chicago, Dept Surg, Chicago, IL 60637 USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA		Frim, DM (corresponding author), Univ Chicago Hosp, Sect Pediat Neurosurg, MC-4066,5841 S Maryland Ave, Chicago, IL 60637 USA.	dfrimn@peds.bsd.uchicago.edu	Wright, David/K-7898-2012	Wright, David/0000-0002-2785-0254; Kang, Un/0000-0002-5970-6839; Lee, Raphael C./0000-0002-6628-1867			AdamsGraves P, 1997, BLOOD, V90, P2041, DOI 10.1182/blood.V90.5.2041; Al-Abdulla NA, 1998, NEUROSCIENCE, V86, P191, DOI 10.1016/S0306-4522(98)00014-1; Almeida A, 2001, J NEUROCHEM, V77, P676, DOI 10.1046/j.1471-4159.2001.00276.x; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; ARMSTRONG JK, 1995, THROMB RES, V79, P437, DOI 10.1016/0049-3848(95)00134-D; *BASF WYAND CORP, 1975, PLUR POL TOX IRR STU; BATRAKOVA EV, 1999, PHARM RES, V16, P1317; BEATRICE MC, 1980, J BIOL CHEM, V255, P8663; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Borgens RB, 2001, NEUROSURGERY, V49, P370, DOI 10.1097/00006123-200108000-00021; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; COLBASSANI HJ, 1989, STROKE, V20, P1241, DOI 10.1161/01.STR.20.9.1241; Curry DJ, 2004, J NEUROSURG, V101, P91, DOI 10.3171/ped.2004.101.2.0091; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; FARBER JL, 1981, AM J PATHOL, V102, P271; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; FERRER I, 1995, ACTA NEUROPATHOL, V90, P504; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Frim DM, 2004, NEUROREPORT, V15, P171, DOI 10.1097/00001756-200401190-00033; HUNTER RL, 1995, ANTIMICROB AGENTS CH, V39, P435, DOI 10.1128/AAC.39.2.435; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; ITO U, 1975, ACTA NEUROPATHOL, V32, P209, DOI 10.1007/BF00696570; JACKSON GR, 1990, J NEUROSCI RES, V25, P360, DOI 10.1002/jnr.490250313; KNIZE DM, 1969, SURG GYNECOL OBSTETR, V129, P1019; Kowaltowski AJ, 1996, FEBS LETT, V378, P150, DOI 10.1016/0014-5793(95)01449-7; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Martin LJ, 1997, ANN NEUROL, V42, P335, DOI 10.1002/ana.410420310; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; MAY LE, 1958, J AM GERIATR SOC, V6, P814, DOI 10.1111/j.1532-5415.1958.tb00788.x; Maynard C, 1998, AM HEART J, V135, P797, DOI 10.1016/S0002-8703(98)70037-7; Mcintosh TK, 1999, TRAUMATIC BRAIN INJU, P39; MEZROW CK, 1992, J THORAC CARDIOV SUR, V103, P1143; Moghimi SM, 1996, J NATL CANCER I, V88, P766, DOI 10.1093/jnci/88.11.766; Moghimi SM, 2000, TRENDS BIOTECHNOL, V18, P412, DOI 10.1016/S0167-7799(00)01485-2; Nicholls DG, 1999, BIOCHEM SOC SYMP, V66, P55, DOI 10.1042/bss0660055; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; OKeefe JH, 1996, AM J CARDIOL, V78, P747, DOI 10.1016/S0002-9149(96)00414-6; Parnaud G, 2001, BRIT J CANCER, V84, P90, DOI 10.1054/bjoc.2000.1540; PATON BC, 1968, ORGAN PERFUSION PRES, P105; PELLEGRINIGIAMPIETRO DE, 1990, J NEUROSCI, V10, P1035, DOI 10.1523/jneurosci.10-03-01035.1990; PETITO CK, 1984, J NEUROPATH EXP NEUR, V43, P141, DOI 10.1097/00005072-198403000-00004; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; Rapoport N, 2000, ARCH BIOCHEM BIOPHYS, V384, P100, DOI 10.1006/abbi.2000.2104; RODEHEAVER GT, 1980, ANN EMERG MED, V9, P572, DOI 10.1016/S0196-0644(80)80228-9; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schinder AF, 1996, J NEUROSCI, V16, P6125; SCHUMACHER JM, 1991, NEUROSCIENCE, V45, P561, DOI 10.1016/0306-4522(91)90271-O; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; UHLER TA, 1994, NEUROSURGERY, V34, P122; Urushitani M, 2001, J NEUROSCI RES, V63, P377, DOI 10.1002/1097-4547(20010301)63:5<377::AID-JNR1032>3.0.CO;2-#; WADDELL WR, 1957, METABOLISM, V6, P815; Wang MY, 2001, NEUROSURGERY, V49, P962; Ward MW, 2000, J NEUROSCI, V20, P7208; WEATHERL.RC, 1969, SURGERY, V66, P208; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	64	19	20	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2004	55	4					943	948		10.1227/01.NEU.0000137890.29862.2C			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	860AI	WOS:000224309100048	15458603				2022-02-06	
J	Al-Adawi, S; Dorvlo, ASS; Burke, DT; Huynh, CC; Jacob, L; Knight, R; Shah, MK; Al-Hussaini, AA				Al-Adawi, S; Dorvlo, ASS; Burke, DT; Huynh, CC; Jacob, L; Knight, R; Shah, MK; Al-Hussaini, AA			Apathy and depression in cross-cultural survivors of traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							INTERNATIONAL DIAGNOSTIC INTERVIEW; CLOSED HEAD-INJURY; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; SCALE; OMAN; PREVALENCE; SYMPTOMS; MOOD; INDIVIDUALS	The disturbance of motivation and its relationship to depression continues to spark contradictory findings among European and North American populations. Could a cross-cultural study shed some light on the situation? This study aims to detect the prevalence of apathy and to test whether the Apathy Evaluation Scale (AES) can spot the presence or absence of depression in survivors of traumatic brain injury (TBI) in Oman. Eighty subjects who sustained a TBI were given an Arabic version of the AES and were also interviewed with the semistructured Composite International Diagnostic Interview (CIDI). The authors found that the incidence of apathy and depression among Omani people who sustained TBI is similar to that reported elsewhere. The AES has poor discriminatory power in identifying cases of depression. These findings emphasize the importance of developing assessment tools that are culturally sensitive hi light of the rising incidence of TBI in developing countries such as Oman.	Sultan Qaboos Univ, Coll Med, Dept Behav Med, Muscat, Oman; Harvard Univ, Sch Med, Spaulding Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; Sultan Qaboos Univ, Coll Sci, Dept Math & Stat, Muscat, Oman		Al-Adawi, S (corresponding author), Sultan Qaboos Univ, Coll Med, Dept Behav Med, POB 35,Al Khoudh 123, Muscat, Oman.	adawi@squ.edu.om	Al-Adawi, Samir/A-9663-2016	Al-Adawi, Samir/0000-0002-9858-5582			Abou-Saleh MT, 2001, SOC PSYCH PSYCH EPID, V36, P20, DOI 10.1007/s001270050286; Al-Adawi S, 2001, EPILEPSIA, V42, P1476, DOI 10.1046/j.1528-1157.2001.05599.x; Al-Adawi S, 2000, MED HYPOTHESES, V54, P523, DOI 10.1054/mehy.1999.0890; Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Al-Marshudi AS, 2001, WATER INT, V26, P259, DOI 10.1080/02508060108686912; ALADAWI S, 2001, SULTAN QABOOS U J SC, V3, P35; ALLAWATIA J, 2000, SULTAN QABOOS U J SC, V2, P105; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; COREY MR, 1987, COGNITIVE REHABILITA, V5, P28; Deen JL, 1999, B WORLD HEALTH ORGAN, V77, P518; Galynker I, 1997, J NERV MENT DIS, V185, P616, DOI 10.1097/00005053-199710000-00004; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; GRINSTEAD P, 1997, HOSP DOCTOR     0220, P36; Gualtari CT, 1991, BRAIN INJURY, V5, P219; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; *INF PUBL CTR, 2001, STAT YB SULT OM MIN; Isella V, 2002, MOVEMENT DISORD, V17, P366, DOI 10.1002/mds.10041; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jahanshahi M, 1998, COGN NEUROPSYCHOL, V15, P483, DOI 10.1080/026432998381005; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lampe IK, 2001, J GERIATR PSYCH NEUR, V14, P11, DOI 10.1177/089198870101400104; Landes AM, 2001, J AM GERIATR SOC, V49, P1700, DOI 10.1046/j.1532-5415.2001.49282.x; Lesser IM, 1997, J PSYCHOPATHOL BEHAV, V19, P149, DOI 10.1007/BF02229040; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; MARIN RS, 1994, J NERV MENT DIS, V182, P235, DOI 10.1097/00005053-199404000-00008; McPherson S, 2002, J INT NEUROPSYCH SOC, V8, P373, DOI 10.1017/S1355617702813182; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Okada K, 1997, STROKE, V28, P2437, DOI 10.1161/01.STR.28.12.2437; Pang FC, 2002, INT J GERIATR PSYCH, V17, P29, DOI 10.1002/gps.510; Patel V, 2001, BRIT MED BULL, V57, P33, DOI 10.1093/bmb/57.1.33; Ramirez SM, 2001, PSYCHOL REP, V88, P189, DOI 10.2466/PR0.88.1.189-200; Resnick B, 1998, Rehabil Nurs, V23, P141; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; SILVER JM, 1994, J HEAD TRAUMA REHAB, V9, P61, DOI 10.1097/00001199-199409000-00006; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; *SPSS, 1999, SPSS 9 0 WIND; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Starkstein SE, 2001, AM J PSYCHIAT, V158, P872, DOI 10.1176/appi.ajp.158.987.872; Sulaiman AJM, 2001, J TROP PEDIATRICS, V47, P1; TEASDALE G, 1974, LANCET, V2, P81; Thompson JC, 2002, J NEUROPSYCH CLIN N, V14, P37, DOI 10.1176/appi.neuropsych.14.1.37; USTUN TB, 2002, HDB PSYCHIAT CARE, P25; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Viguier D, 2001, BRAIN INJURY, V15, P263; WHO, 1993, COMP INT DIAGN INT C; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004; Zaidan ZAJ, 2002, TROP MED INT HEALTH, V7, P549, DOI 10.1046/j.1365-3156.2002.00887.x; [No title captured]	57	19	20	0	6	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2004	16	4					435	442		10.1176/appi.neuropsych.16.4.435			8	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	881VN	WOS:000225897600005	15616169				2022-02-06	
J	Kirsch, NL; Shenton, M; Spirl, E; Simpson, R; LoPresti, E; Schreckenghost, D				Kirsch, NL; Shenton, M; Spirl, E; Simpson, R; LoPresti, E; Schreckenghost, D			An assistive-technology intervention for verbose speech after traumatic brain injury - A single case study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assistive technology; cognition disorders; handheld computers; Internet; rehabilitation; traumatic brain injury	MEMORY AID; REHABILITATION; PARTICIPATION; INDIVIDUALS; IMPAIRMENTS; SYSTEMS; AMNESIA; NORMS; HOME	Objective: To assess an assistive-technology intervention for neurobehavioral change, coordinated with a Web-based data recording system. Participant: Male, mid-thirties, with a complex history, having verbose speech subsequent to traumatic brain injury. Design: BAB' single-case. Intervention and Measures: The intervention (B and B' trials) was a digital recording of the participant's voice, stating "be brief," delivered at fixed intervals by a personal digital assistant. Utterance start and stop times were monitored with a wireless, Web-enabled device and were recorded in a server-side database. Results: Utterance frequency did not change. However, the total utterance time was reduced during B trials, attributable to the reduced frequency of lengthier utterances. Conclusions: The target behavior was modified successfully. The participant adopted a specific cue-appropriate strategy. Since a variety of alternative response strategies may be required of a person, given a range of context-specific social practices and community settings, the importance of context-sensitive assistive technology cue repertoires is discussed.	Univ Michigan Hlth Syst, Div Rehabil Psychol & Neuropsychol, Ann Arbor, MI 48108 USA; Univ Michigan Hlth Syst, Adult Neurorehabil Day Program, Ann Arbor, MI 48108 USA; Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; AT Sci, Pittsburgh, PA USA; Metrica Inc, Houston, TX USA		Kirsch, NL (corresponding author), Univ Michigan Hlth Syst, Div Rehabil Psychol & Neuropsychol, Ann Arbor, MI 48108 USA.	nlkirsch@umich.edu	Shenton, Martha/V-8780-2019; Simpson, Richard/G-5683-2015	Simpson, Richard/0000-0002-6306-9393			Bergman M M, 2000, Appl Neuropsychol, V7, P76, DOI 10.1207/S15324826AN0702_2; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; BROWNTRIOLO D, 2001, ASSISTIVE TECHNOLOYG, P31; Buhler C, 2001, INT J HUM-COMPUT ST, V55, P645, DOI 10.1006/ijhc.2001.0489; CARMIENS, MAPS MEMORY AIDING P; Cole E, 1999, NEUROREHABILITATION, V12, P39; Cole E, 1994, NeuroRehabilitation, V4, P174, DOI 10.3233/NRE-1994-4308; Cole E., 1990, SIGCHI Bulletin, V22, P28; Cooper M, 1996, MED ENG PHYS, V18, P176, DOI 10.1016/1350-4533(95)00071-2; CROSSON B, 1998, J HEAD TRAUMA REHAB, V4, P46; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fastenau PS, 1998, J CLIN EXP NEUROPSYC, V20, P906, DOI 10.1076/jcen.20.6.906.1104; FLANNERY M, 1997, USING AVAILABLE TECH, P517; Flannery M A, 1997, Pediatr Rehabil, V1, P239; FORTA B, 2003, MACROMEDIA COLDFUSIO; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; GLISKY EL, 1992, J HEAD TRAUMA REHAB, V7, P1; Goldstein G, 1998, J REHABIL RES DEV, V35, P238; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton RK, 1999, J CLIN EXP NEUROPSYC, V21, P571, DOI 10.1076/jcen.21.4.572.882; Heaton RK, 1991, COMPREHENSIVE NORMS; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; HOMER A, 1997, INSTANT HTML; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; KIME S, 1995, BRAIN INJURY, V10, P17; Kirsch NL, 2004, REHABIL PSYCHOL, V49, P200, DOI 10.1037/0090-5550.49.3.200; KIRSCH NL, 1987, J HEAD TRAUMA REHAB, V2, P77; KIRSCH NL, 1992, J HEAD TRAUMA REHAB, V7, P13, DOI DOI 10.1097/00001199-199209000-00004; Kittel A, 2002, DISABIL REHABIL, V24, P106, DOI 10.1080/09638280110066785; Levinson R, 1997, J HEAD TRAUMA REHAB, V12, P85, DOI 10.1097/00001199-199704000-00010; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; LOPRESTI EF, 1997, ELECT VOCATIONAL PEO, P514; Maguire M, 2001, INT J HUM-COMPUT ST, V55, P587, DOI 10.1006/ijhc.2001.0503; MIHAILIDIS A, 2000, TECHNOLOGY DISABILIT, V12, P23; OSSORIO PG, 1997, ESSAYS CLIN TOPICS C, V2, P168; Pape TLB, 2002, DISABIL REHABIL, V24, P5, DOI 10.1080/09638280110066235; Phillips B, 1993, Assist Technol, V5, P36; Rialle V, 2002, TELEMED J E-HEALTH, V8, P395, DOI 10.1089/15305620260507530; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Scherer MJ, 1996, DISABIL REHABIL, V18, P439, DOI 10.3109/09638289609165907; Stickel MS, 2002, DISABIL REHABIL, V24, P115, DOI 10.1080/09638280110066794; Tang P, 2000, J TELEMED TELECARE, V6, P8, DOI 10.1258/1357633001933871; van den Broek MD, 2000, BRAIN INJURY, V14, P455; White GW, 2002, REHABIL PSYCHOL, V47, P438, DOI 10.1037//0090-5550.47.4.438; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; WILSON BA, 2002, REBABIL PSYCHOL, V44, P284; WILTIN P, 2000, BEGINNING JAVASCRIPT; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002	51	19	19	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2004	19	5					366	377		10.1097/00001199-200409000-00002			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858UB	WOS:000224216300002	15597028				2022-02-06	
J	Wingrave, JM; Sribnick, EA; Wilford, GG; Matzelle, DD; Mou, JA; Ray, SK; Hogan, EL; Banik, NL				Wingrave, JM; Sribnick, EA; Wilford, GG; Matzelle, DD; Mou, JA; Ray, SK; Hogan, EL; Banik, NL			Higher calpastatin levels correlate with resistance to calpain-mediated proteolysis and neuronal apoptosis in juvenile rats after spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						calpain; calpastatin; juvenile; neuronal apoptosis; secondary injury; spinal cord injury	ACTIVATED NEUTRAL PROTEINASE; TRAUMATIC BRAIN-INJURY; CELL-DEATH; NERVOUS-SYSTEM; LYMPHOID-CELLS; IMPACT TRAUMA; EXPRESSION; LESION; DISEASE; DEGRADATION	While the average age for patients admitted with spinal cord injury is 32 years, patients under the age of 16 account for 5% of spinal cord injured persons. For these younger patients, an increased mortality up to 24 h post-injury has been reported, however, survivors may regain more function than their adult counterparts, suggesting that age may play a role in injury tolerance. While the use of growth factors as a therapy for spinal cord injury is well researched, the response of the developing cord to secondary injury has not been thoroughly investigated. Following spinal cord injury, Ca2+ influx can activate enzymes such as calpain, a Ca2+ -dependent protease, which plays a role in the pathogenesis of spinal cord injury in rats. The present investigation revealed that following spinal cord injury, calpain upregulation was significantly less (15.3%) in the 21-day-old rats than in either 45-day-old (70%) or 90-day-old (99.6%) rats, as shown by Western blot and in situ immunofluorescent studies. Expression of the endogenous calpain inhibitor, calpastatin, was significantly higher in juvenile rats than adult rats. juvenile rats with spinal cord injury also showed a reduced Bax:Bcl-2 ratio (4:1 vs. 6:1), reduced caspase-3 staining, reduced myelin loss (3% vs. 18%), and less neuronal DNA damage, as compared to older rats. These results suggest that increased calpastatin levels found in juvenile rats muted calpain activity and neuronal apoptosis, following spinal cord injury.	Med Univ S Carolina, Dept Pathol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA		Banik, NL (corresponding author), 96 Jonathan Lucas St,Ste 309, Charleston, SC 29425 USA.	banikn1@musc.edu	Sribnick, Eric/AAH-6693-2020		NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA091460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045967, R01NS031622, R01NS041088, R01NS038146] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA 91460] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 08716] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 41088, NS 45967, NS 31622, NS 38146] Funding Source: Medline		Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; BALENTINE JD, 1978, LAB INVEST, V39, P236; Banik N L, 1984, Cent Nerv Syst Trauma, V1, P131; Bizat N, 2003, J NEUROSCI, V23, P5020; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; CHAKERES DW, 1987, AM J NEURORADIOL, V8, P5; CHAKRABARTI AK, 1988, J NEUROSCI RES, V20, P351, DOI 10.1002/jnr.490200309; CHAKRABARTI AK, 1993, DEV BRAIN RES, V71, P107, DOI 10.1016/0165-3806(93)90111-M; Cifu DX, 1999, J NEUROTRAUM, V16, P805, DOI 10.1089/neu.1999.16.805; Curt A, 1998, ARCH PHYS MED REHAB, V79, P81, DOI 10.1016/S0003-9993(98)90213-1; DESHPANDE RV, 1995, J NEUROSCI RES, V42, P259, DOI 10.1002/jnr.490420214; DESHPANDE RV, 1995, J BIOL CHEM, V270, P2497, DOI 10.1074/jbc.270.6.2497; DICKMAN CA, 1989, PEDIATR NEUROSCI, V15, P237, DOI 10.1159/000120476; DOHRMANN GJ, 1975, J TRAUMA, V15, P1003, DOI 10.1097/00005373-197511000-00011; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; EMORI Y, 1987, P NATL ACAD SCI USA, V84, P3590, DOI 10.1073/pnas.84.11.3590; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Falci S, 1997, J NEUROTRAUM, V14, P875, DOI 10.1089/neu.1997.14.875; Ghirnikar RS, 2000, J NEUROSCI RES, V59, P63, DOI 10.1002/(SICI)1097-4547(20000101)59:1<63::AID-JNR8>3.3.CO;2-N; Green JB, 1998, NEUROLOGY, V50, P1115, DOI 10.1212/WNL.50.4.1115; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HAJNAL JV, 1995, CLIN RADIOL, V50, P1, DOI 10.1016/S0009-9260(05)82956-3; Honda K, 2001, J NEUROSCI RES, V64, P466, DOI 10.1002/jnr.1098; HUBBARD DD, 1974, CLIN ORTHOP RELAT R, V100, P56; KALIL K, 1979, SCIENCE, V205, P1158, DOI 10.1126/science.472734; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kotlyar M, 2002, NEUROCHEM RES, V27, P1133, DOI 10.1023/A:1020969208033; LEMKE M, 1990, NEUROSCI LETT, V108, P201, DOI 10.1016/0304-3940(90)90731-N; LI ZH, 1995, BRAIN RES, V697, P112; Li ZH, 1996, NEUROCHEM RES, V21, P441, DOI 10.1007/BF02527708; Nakamura M, 2001, EXP NEUROL, V169, P407, DOI 10.1006/exnr.2001.7670; NELSON E, 1977, ARCH NEUROL-CHICAGO, V34, P332, DOI 10.1001/archneur.1977.00500180026005; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Newcomb JK, 1999, J NEUROTRAUM, V16, P1, DOI 10.1089/neu.1999.16.1; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; Park Il-Kwon, 2002, J Vet Sci, V3, P239; Pollard ME, 2003, SPINE, V28, P33, DOI 10.1097/00007632-200301010-00009; Ray SK, 2000, BRAIN RES PROTOC, V5, P305, DOI 10.1016/S1385-299X(00)00027-1; Ray SK, 1999, BRAIN RES, V816, P375, DOI 10.1016/S0006-8993(98)01128-7; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Ray SK, 2001, ANN NY ACAD SCI, V939, P436; Ruiz-Vela A, 1999, EMBO J, V18, P4988, DOI 10.1093/emboj/18.18.4988; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Sasaki S, 1978, Adv Neurol, V20, P423; SASAKI S, 1982, NEUROSURGERY, V10, P360, DOI 10.1227/00006123-198203000-00011; Schaecher K, 2002, J NEUROIMMUNOL, V129, P1, DOI 10.1016/S0165-5728(02)00142-X; Schellinger PD, 2001, SPINE, V26, P314, DOI 10.1097/00007632-200102010-00019; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Shields DC, 1999, P NATL ACAD SCI USA, V96, P11486, DOI 10.1073/pnas.96.20.11486; Shields DC, 2000, J NEUROSCI RES, V61, P146; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; vonEuler M, 1996, EXP NEUROL, V137, P242, DOI 10.1006/exnr.1996.0023; Wagner KR, 1996, STROKE, V27, P490, DOI 10.1161/01.STR.27.3.490; Wingrave JM, 2004, EXP NEUROL, V187, P529, DOI 10.1016/j.expneurol.2004.02.001; Yamakawa H, 2001, NEUROL RES, V23, P522, DOI 10.1179/016164101101198776; YOUNG W, 1980, J NEUROSURG, V52, P473, DOI 10.3171/jns.1980.52.4.0473; Zhang ZY, 1997, EXP NEUROL, V143, P141, DOI 10.1006/exnr.1996.6355	60	19	20	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2004	21	9					1240	1254		10.1089/0897715041953894			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	855HC	WOS:000223962900012	15453993				2022-02-06	
J	Adembri, C; Bechi, A; Meli, E; Gramigni, E; Venturi, L; Moroni, F; De Gaudio, AR; Pellegrini-Giampietro, DE				Adembri, C; Bechi, A; Meli, E; Gramigni, E; Venturi, L; Moroni, F; De Gaudio, AR; Pellegrini-Giampietro, DE			Erythropoietin attenuates post-traumatic injury in organotypic hippocampal slices	JOURNAL OF NEUROTRAUMA			English	Article						erythropoietin; neuroprotection; organotypic hippocampal slices; traumatic brain injury	RECOMBINANT-HUMAN-ERYTHROPOIETIN; IN-VITRO; CEREBRAL-ISCHEMIA; CORTICAL-NEURONS; NITRIC-OXIDE; CELL-DEATH; BRAIN; PROTECTS; CULTURES; RECEPTOR	Recent experimental evidence indicates that erythropoietin (Epo), in addition to its hormonal role in regulating red cell production, operates as a neuroprotective agent. So far, the neuroprotective effect of human recombinant Epo (rhEpo) has been mainly demonstrated in models of cerebral ischemia/hypoxia and in selected in vivo studies of traumatic neuronal injury. To further investigate the potential role of this multifunctional trophic factor in post-traumatic cell death, we examined the protective effects of rhEpo in a newly developed model of mechanical trauma in organotypic hippocampal slices. Organotypic rat hippocampal slices were subjected to traumatic injury by allowing a stylus to impact on the CA1 area with an energy of 6 muJ. Hippocampal damage was identified and measured 24 and 48 h later with the fluorescent dye propidium iodide (PI). In untreated slices, the impact induced a significant increase in the mean hippocampal PI fluorescence, co-localized with the area of impact at 24 h (primary post-traumatic injury) and progressively spread to the whole slice between 24 and 48 h (secondary post-traumatic injury). Addition of rhEpo (1-100 UI/mL) or of the NMDA antagonist MK-801 (30 muM) immediately after the traumatic injury reduced hippocampal damage by approximately 30% when observed 24 h later. At 48 h after trauma, the protective effect of rhEpo was greater (by about 47%) and significantly more pronounced than that of MK-801 (28%). Our results suggest that the neuroprotective activity of rhEpo is particularly effective against delayed, secondary post-traumatic damage. This well tolerated agent could provide a therapeutic benefit in pathologies involving post-traumatic neurodegeneration.	Univ Florence, Dipartimento Area Crit Med Chirurg, Sez Anestesiol & Terapia Intens, I-50134 Florence, Italy; Univ Florence, Dipartimento Farmacol Preclin & Clin, Florence, Italy		Adembri, C (corresponding author), Univ Florence, Dipartimento Area Crit Med Chirurg, Sez Anestesiol & Terapia Intens, Viale Morgagni,85, I-50134 Florence, Italy.	chiara.adembri@unifi.it		Pellegrini-Giampietro, Domenico E./0000-0002-3920-2297			AbdelHamid KM, 1997, J NEUROSCI, V17, P3538; Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Adembri C, 2002, CRIT CARE MED, V30, pA13, DOI 10.1097/00003246-200212001-00047; Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.0.CO;2-H; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Buemi M, 2002, CLIN SCI, V103, P275, DOI 10.1042/cs1030275; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Fisher JW, 2003, EXP BIOL MED, V228, P1; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Krassioukov AV, 2002, BRAIN RES PROTOC, V10, P60, DOI 10.1016/S1385-299X(02)00180-0; Lahtinen H, 2001, NEUROSCIENCE, V105, P131, DOI 10.1016/S0306-4522(01)00168-3; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Pellegrini-Giampietro DE, 1999, EUR J NEUROSCI, V11, P3637, DOI 10.1046/j.1460-9568.1999.00786.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sinor AD, 2000, NEUROSCI LETT, V290, P213, DOI 10.1016/S0304-3940(00)01361-6; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TASKER RC, 1992, J NEUROSCI, V12, P4298; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Yu XB, 2001, BLOOD, V98, P475, DOI 10.1182/blood.V98.2.475	39	19	21	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2004	21	8					1103	1112		10.1089/0897715041651079			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	846AK	WOS:000223286800012	15319009				2022-02-06	
J	Corbo, J; Tripathi, P				Corbo, J; Tripathi, P			Delayed presentation of diffuse axonal injury: A case report	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN INJURY; FAT-EMBOLISM SYNDROME; HEAD-INJURY; MR; CT	This report highlights a case of delayed onset of diffuse axonal Injury in the apparent absence of direct head trauma. This case questions the appropriate observation period for patients with signs of diffuse axonal injury presenting after a high-velocity crash.	Albert Einstein Coll Med, Dept Emergency Med, Jacobi Med Ctr, Bronx, NY 10462 USA		Corbo, J (corresponding author), Albert Einstein Coll Med, Dept Emergency Med, Jacobi Med Ctr, 1400 Pelham Pkwy S,Room 1W20, Bronx, NY 10462 USA.	jillcorbo@aol.com					Georgopoulos D, 2003, CHEST, V123, P982, DOI 10.1378/chest.123.4.982; Gieron MA, 1998, PEDIATR NEUROL, V19, P382, DOI 10.1016/S0887-8994(98)00072-1; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Johnson MJ, 1996, ORTHOPEDICS, V19, P41; KAMENAR E, 1980, STROKE, V11, P477, DOI 10.1161/01.STR.11.5.477; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Neumar RW, 2002, ANN EMERG MED, V39, P342, DOI 10.1067/mem.2002.122007; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	11	19	19	1	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUL	2004	44	1					57	60		10.1016/j.annemergmed.2003.11.010			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	835DO	WOS:000222460700008	15226709				2022-02-06	
J	Kozlowski, DA; Nahed, BV; Hovda, DA; Lee, SM				Kozlowski, DA; Nahed, BV; Hovda, DA; Lee, SM			Paradoxical effects of cortical impact injury on environmentally enriched rats	JOURNAL OF NEUROTRAUMA			English	Article						contusion; enriched environment; motor coordination; rats; traumatic brain injury	FACTOR MESSENGER-RNA; CEREBRAL-CORTEX; SPATIAL MEMORY; BRAIN-INJURY; LESIONS; HIPPOCAMPUS; COMPLEXITY; RECOVERY; EXPRESSION; INCREASES	Animals housed in an enriched environment develop thicker cortices, with increased numbers of dendrites, synapses, blood vessels, and glial cells. This study examines the responses of adult rats, developmentally reared in an enriched environment, to traumatic brain injury. Rats were placed in an enriched environment for 15 days, starting on postnatal day 21. Following enrichment, they were placed in standard vivarium conditions until adulthood. At 3 months of age, enriched and age-matched control rats received a mild unilateral controlled cortical impact and were allowed to recover for 41 days. During this time, they were examined for motor coordination deficits and for preferences in forelimb use. Results demonstrate that enriched animals had a larger contusion cavity and a greater initial deficit in forelimb use. However, this deficit quickly diminished in comparison to that seen in non-enriched injured rats. The deficit in motor coordination recovered more quickly in enriched rats, 1 week sooner than in controls. These data suggest that the response of enriched animals to brain injury results in more marked neurodegeneration and acute behavioral dysfunction, with a higher capacity for compensation and recovery.	Univ Calif Los Angeles, Sch Med, Brain Injury Res Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Surg Neurosurg, Los Angeles, CA USA		Kozlowski, DA (corresponding author), De Paul Univ, Dept Biol Sci, 2325 N Clifton, Chicago, IL 60614 USA.	dkozlows@depaul.edu	Nahed, Brian/E-4239-2014	Nahed, Brian/0000-0001-8537-106X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030308] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30308, NS37303] Funding Source: Medline		Belayev A, 2003, BRAIN RES, V964, P121, DOI 10.1016/S0006-8993(02)04089-1; DALRYMPLEALFORD JC, 1984, BEHAV NEUROSCI, V98, P23, DOI 10.1037/0735-7044.98.1.23; DIAMOND MC, 1967, J COMP NEUROL, V131, P357, DOI 10.1002/cne.901310305; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; FINGER S, 1978, DEV PSYCHOBIOL, V11, P5, DOI 10.1002/dev.420110105; Galani R, 1997, NEUROBIOL LEARN MEM, V67, P43, DOI 10.1006/nlme.1996.3745; GONZALEZLIMA F, 1994, DEV PSYCHOBIOL, V27, P343, DOI 10.1002/dev.420270603; Greenough W. T., 1992, Brain Dysfunction, V5, P129; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Hovda D.A., 1996, NEUROTRAUMA, P1459; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KRECH D, 1960, J COMP PHYSIOL PSYCH, V53, P509, DOI 10.1037/h0045402; Mattsson B, 1997, STROKE, V28, P1225, DOI 10.1161/01.STR.28.6.1225; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; STEIN DG, 1983, BEHAV NEURAL BIOL, V37, P185, DOI 10.1016/S0163-1047(83)91216-5; STUMMER W, 1995, STROKE, V26, P138; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; WILL B, 1992, ADV EXP MED BIOL, V325, P79; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zhao LR, 2000, NEUROSCIENCE, V97, P177, DOI 10.1016/S0306-4522(00)00023-3	28	19	20	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2004	21	5					513	519		10.1089/089771504774129856			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821LK	WOS:000221461900003	15165360				2022-02-06	
J	Phillips, VL; Greenspan, AI; Stringer, AY; Stroble, AK; Lehtonen, S				Phillips, VL; Greenspan, AI; Stringer, AY; Stroble, AK; Lehtonen, S			Severity of injury and service utilization following traumatic brain injury - The first 3 months	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						model systems; service utilization; TBI	REHABILITATION; CARE	Objective: To describe the madical and rehabilitation service use of model systems by brain injured participants 1 to 3 months postdischarge from inpatient rehabilitation. Design: Prospective follow-up study. Setting: Georgis Model Brain Injury System (GAMBIS). Participants: Seventy- three GAMBIS subjects consnting to participate in the utilization substudy. Main Outcome Measures: Receipt of services and intensity of service use. Analysis: Chi-square analysis of receipt of services by severity of injury. Results: The likelihood of service use did not vary with severity of injury. Data suggest that intensity of service use was a function of injury severity. Conclusions: Subjects with mild and moderate injuries were as likely to use a range of medical and rehabilitation services during the 3-month discharge period as those with severe injuries. Traditional rehabilitation services, such as physical therapy, were far more likely to be used, than nontradional services such as psychological counseling, in spite of the high level of cognitive and social disability associated with traumatic brain injury.	Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA		Phillips, VL (corresponding author), Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd, Atlanta, GA 30322 USA.	vpphiloi@sph.emory.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A 980028] Funding Source: Medline		Batavia AI, 2001, ARCH PHYS MED REHAB, V82, P546, DOI 10.1053/apmr.2001.20829; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; CHESTNUT RM, 1999, HEAD TRAUMA REHABIL, V14, P277; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Duan N., 1983, J BUS ECON STAT, V1, P115, DOI [DOI 10.2307/1391852, 10.2307/1391852]; Greenspan A I, 1989, Md Med J, V38, P239; Greenspan AI, 2000, BRAIN INJURY, V14, P417; HARRICK L, 1994, BRAIN INJURY, V8, P439, DOI 10.3109/02699059409150995; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Wheatley B, 1997, HEALTH CARE MANAGE R, V22, P25	17	19	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2004	19	3					217	225		10.1097/00001199-200405000-00003			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	826JB	WOS:000221824300003	15247844				2022-02-06	
J	Sawauchi, S; Marmarou, A; Beaumont, A; Signoretti, S; Fukui, S				Sawauchi, S; Marmarou, A; Beaumont, A; Signoretti, S; Fukui, S			Acute subdural hematoma associated with diffuse brain injury and hypoxemia in the rat: Effect of surgical evacuation of the hematoma	JOURNAL OF NEUROTRAUMA			English	Article						acute subdural hematoma; brain edema; cerebral blood flow; diffuse brain injury; hypoxemia; intracranial pressure; surgical evacuation	SEVERE HEAD-INJURY; COMATOSE PATIENTS; COMPUTERIZED-TOMOGRAPHY; MANAGEMENT; MORTALITY; VOLUME; MODEL	The aim of this study was to assess the effect of rapid or delayed surgical evacuation on the physiological consequence and brain edema formation in a rat model of acute subdural hematoma (SDH) coupled with either diffuse brain injury (DBI) or hypoxemia. The SDH was made by an autologous blood injection, while DBI was induced using the impact acceleration model (mild, 450 g/1 m; severe, 450 g/2 m). Physiological parameters measured included intracranial pressure (ICP), mean arterial blood pressure (MABP), cerebral blood flow (CBF), and brain tissue water content. At I h (rapid evacuation) or 4 h (delayed evacuation) after the SDH induction, surgical evacuation following a craniotomy was performed using saline irrigation and forceps. The study consisted of three different series, including 400 muL of SDH alone (Series 1), SDH400 + mild DBI (Series 2), and SDH300 + severe DBI + 20 min hypoxemia (Series 3). The hypoxemia was added in Group 3 to produce a steadily increasing ICP. In Series 1 and 2, all rats were randomized into the three following groups: non-, rapid, and delayed evacuation; Series 3 had two groups: non- and rapid evacuation. In Series 1, the surgical evacuation showed no beneficial effects on the brain edema formation assessed at 5 h post-injury. In Series 2, the rapid, but not delayed, evacuation significantly reduced both the increased ICP level and brain water content. The additional insult of hypoxemia (Series 3) resulted in a progressive ICP elevation, persistently depressed CBF, and severe brain swelling. Under this situation, the rapid evacuation exacerbated brain edema. These results have clinical implications for the management of severe traumatic SDH, especially its operative indication and timing.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA		Marmarou, A (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, POB 980508, Richmond, VA 23298 USA.	marmarou@abic.vcu.edu	Signoretti, stefano/AAL-5631-2020; Beaumont, Andrew/AAJ-7457-2020	Signoretti, stefano/0000-0002-8086-1622; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, R56NS019235, R01NS019235, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12587, NS-19235] Funding Source: Medline		CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CROCE MA, 1994, J TRAUMA, V36, P820, DOI 10.1097/00005373-199406000-00012; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; WONG CW, 1995, ACTA NEUROCHIR, V135, P38, DOI 10.1007/BF02307412	16	19	20	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2004	21	5					563	573		10.1089/089771504774129892			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821LK	WOS:000221461900007	15165364				2022-02-06	
J	Haug, E; Miner, J; Dannehy, M; Seigel, T; Biros, M				Haug, E; Miner, J; Dannehy, M; Seigel, T; Biros, M			Bispectral electroencephalographic analysis of head-injured patients in the emergency department	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	SAEM Annual Meeting	MAY, 2002	ST LOUIS, MO	SAEM		trauma; head injury; bispectral analysis; emergency department	BRAIN INJURY; SEDATION; PROPOFOL; INDEX; PREDICTION; ALFENTANIL; LEVEL	Objectives: Bispectral analysis of single-lead electroencephalographs (BIS) has proven valuable in assessing the level of awareness in sedated patients. In this study, the authors sought to determine if BIS values had a predictive value in patients with traumatic brain injuries (TBIs). Therefore, the objective was to determine in emergency department (ED) patients presenting with head trauma whether BIS and Glasgow Coma Scale score (GCS) prior to sedation would be sensitive and specific in predicting TBI. Methods: A convenience sample of patients with known or suspected head trauma presenting between June and August of both 2001 and 2002 were entered into the study by having a BIS monitor placed immediately on presentation to the ED. BIS and GCS scores were collected every 2 minutes. Head computed tomography (CT) results and discharge dictations were then evaluated to determine the presence of TBI. Results: Fifty-two patients were entered into the study; 13 were excluded due to receiving sedatives prior to enrollment. Of the remaining 39 patients, 14 had intracranial hemorrhage on initial head CT. Of these 14, two had BIS scores over 95. Both of these were neurologically intact at discharge. Eleven of the 12 remaining patients died or left the hospital neurologically impaired. Of the patients with no abnormalities on initial head CT, 19 of 25 had initial BIS scores >95 and all left the hospital neurologically intact. Of the patients with normal initial head CT and initial BIS scores <95, four of six died or were neurologically impaired at discharge. Twenty of 39 patients presented with an initial GCS of 15; four of 20 had an initial BIS score <95, three of whom were neurologically impaired at discharge. The 16 of 20 with BIS >95 left the hospital neurologically intact. All patients with a GCS of 14 had BIS scores >95 and left the hospital neurologically intact. All patients with a GCS of 13 had initial BIS scores <95 and were neurologically impaired at discharge. One patient with a GCS of 11 and a BIS score of 67 left the hospital neurologically intact; all other patients with a GCS <12 had a BIS <95 and left the hospital with a neurologic deficit. Conclusions: BIS scores obtained prior to sedative medicines in the face of trauma are predictive of TBI and neurologic outcome at discharge.	Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA		Miner, J (corresponding author), Hennepin Cty Med Ctr, Dept Emergency Med, 701 Pk Ave S, Minneapolis, MN 55415 USA.	jimminer@hotmail.com	Miner, James/AAI-4801-2020				AVRAMOV MN, 1995, CRIT CARE CLIN, V11, P803, DOI 10.1016/S0749-0704(18)30040-X; Bloom MJ, 1996, ANESTHESIOLOGY, V85, pA461; De Deyne C, 1998, INTENS CARE MED, V24, P1294, DOI 10.1007/s001340050765; Gill M, 2003, ACAD EMERG MED, V10, P175, DOI 10.1197/aemj.10.2.175; Glass PS, 1997, ANESTHESIOLOGY, V86, P836, DOI 10.1097/00000542-199704000-00014; Iselin-Chaves IA, 2000, ANESTHESIOLOGY, V92, P1300, DOI 10.1097/00000542-200005000-00018; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kearse LA, 1998, ANESTHESIOLOGY, V88, P25, DOI 10.1097/00000542-199801000-00007; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Miner JR, 2003, ACAD EMERG MED, V10, P638, DOI 10.1197/aemj.10.6.638; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; ROSOW C, 1998, ANESTHESIOL CLIN N A, V2, P89; Sandler N A, 2000, Anesth Prog, V47, P72	13	19	20	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	APR	2004	11	4					349	352		10.1197/j.aem.2003.12.015			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	809TO	WOS:000220659200005	15064207	Bronze			2022-02-06	
J	Kinuya, K; Kakuda, K; Nobata, K; Sakai, S; Yamamoto, K; Itoh, S; Kinuya, S				Kinuya, K; Kakuda, K; Nobata, K; Sakai, S; Yamamoto, K; Itoh, S; Kinuya, S			Role of brain perfusion single-photon emission tomography in traumatic head injury	NUCLEAR MEDICINE COMMUNICATIONS			English	Article						traumatic head injury; X-ray computerized tomography; single-photon emission tomography; magnetic resonance imaging; Tc-99-HMPAO	CEREBRAL-BLOOD-FLOW; TECHNETIUM-99M-HMPAO SPECT; MILD; CONSCIOUSNESS; CT	This investigation examined the role of brain perfusion single-photon emission tomography (SPET) in traumatic head injury in 35 patients. The results were compared with those of X-ray computerized tomography (CT) and magnetic resonance imaging (MRI). CT and MRI detected brain contusions in seven patients, subarachnoid haemorrhage in one patient and both in nine patients. In 16 of the 17 subjects (94%), SPET with technetium-99m-hexamethylpropyleneamine oxime (Tc-99m-HMPAO) revealed CT/MRI-negative abnormalities, such as hypoperfusion in the contre-coup region, frontal hypoperfusion related to personality change and cerebellar hypoperfusion associated with vertigo. In two patients presenting with diffuse axonal injury in the brainstem, hypoperfusion in the frontal cortex on the affected side was observed on SPET. SPET demonstrated hypoperfusion in the adjacent cortex, with no abnormality on either CT or MRI, in six of seven patients exhibiting acute epidural haematoma. SPET failed to provide additional information in two of five patients with acute subdural haematoma and in one of two patients displaying chronic subdural haematoma. In four of nine patients with post-traumatic amnesia, SPET detected hypoperfusion in the temporal lobe, with no abnormality on either CT or MRI. In five of eight patients with vertigo, SPET detected hypoperfusion in the morphologically normal cerebellum. In seven cases involving personality change, frontal hypoperfusion was observed in four; moreover, a markedly non-homogeneous pattern was evident in the remaining three. Overall, SPET afforded additional information in 26 patients (74%). CT possesses an advantage with respect to the detection of haemorrhagic lesions. MRI provides more precise information regarding contusions and axonal injury. Frequently, SPET may tie the only examination to reveal perfusion abnormalities which are related to symptoms in the absence of other objective findings, such as post-traumatic amnesia, vertigo or personality change. (C) 2004 Lippincott Williams Wilkins.	Tonami Gen Hosp, Dept Nucl Med, Tonami 9391395, Japan; Tonami Gen Hosp, Dept Radiol, Tonami 9391395, Japan; Tonami Gen Hosp, Dept Neurosurg, Tonami 9391395, Japan; Kanazawa Univ, Grad Sch Med Sci, Dept Biotracer Med, Kanazawa, Ishikawa 920, Japan		Kinuya, K (corresponding author), Tonami Gen Hosp, Dept Nucl Med, Shintomi Cho 1-61, Tonami 9391395, Japan.	dinky@dg.dion.ne.jp					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cantagallo A, 1999, BRAIN INJURY, V13, P219, DOI 10.1080/026990599121593; Castejon OJ, 1998, J SUBMICR CYTOL PATH, V30, P145; Chang CC, 1998, EUR J NUCL MED, V25, P1330, DOI 10.1007/s002590050303; DellaCorte F, 1997, ACTA NEUROCHIR, V139, P636; GOLDSTEIN J, 1991, MED CLIN N AM, V75, P641, DOI 10.1016/S0025-7125(16)30439-4; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; GRAY BG, 1992, J NUCL MED, V33, P52; ICHISE M, 1994, J NUCL MED, V35, P217; ISAKA Y, 1992, J NUCL MED, V33, P246; Kesler SR, 2000, BRAIN INJURY, V14, P851; MAESHIMA S, 1995, J NEUROL, V242, P613, DOI 10.1007/BF00866909; Mamelak M, 2000, NEUROPSY NEUROPSY BE, V13, P125; MATSUDA H, 1992, EUR J NUCL MED, V19, P195; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; PROVENZALE J, 1992, J NUCL MED, V33, P248; Shiina G, 1998, AM J NEURORADIOL, V19, P297; SILVERMAN IE, 1993, J NUCL MED, V34, P1447; TIKOFSKY RS, 1994, J NUCL MED, V35, P227; Venneri A, 1998, BRAIN INJURY, V12, P605, DOI 10.1080/026990598122368	22	19	20	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0143-3636	1473-5628		NUCL MED COMMUN	Nucl. Med. Commun.	APR	2004	25	4					333	337		10.1097/00006231-200404000-00004			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	815ZR	WOS:000221080700004	15097806				2022-02-06	
J	O'Neill, JH; Zuger, RR; Fields, A; Fraser, R; Pruce, T				O'Neill, JH; Zuger, RR; Fields, A; Fraser, R; Pruce, T			The program without walls: Innovative approach to state agency vocational rehabilitation of persons with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	State of the Science Conference	APR, 2002	Geroge Washington Univ, Washington, DC	Rehabilitat Res & Training Ctr, NIDRR	Geroge Washington Univ	brain injuries; community health services; rehabilitation; vocational	QUALITY-OF-LIFE; COMMUNITY; WORK	Objective: To describe the Program Without Walls (PWW), a person-centered, community-based approach for state rehabilitation counselors to provide vocational rehabilitation (VR) services to people with traumatic brain injury (TBI). Design: Nonrandomized posttest only matched control group design using existing state VR data. Setting: Community-based within 2 district offices of the state-federal VR program in New York State. Participants: VR consumers with TBI (N = 42); 21 received PWW services, and 21 matched controls received traditional VR services. Intervention: All participants experienced the initial VR process: eligibility determination and the development of an individualized employment plan. Participants receiving the traditional approach were referred to various organizations for services and monitored by their state VR counselor. Those receiving PWW services were never "handed off" to outside agencies. Instead, they received person-centered, community-based services from a team of freelance consultants who were recruited, trained, and supervised by the state VR counselor overseeing the PWW team. Main Outcome Measures: Data were gathered from VR central files for all consumers with a primary or secondary disability of TBI. Outcome variables were case status at closure, weekly earnings at closure, hours working at closure, and cost of case services. Results: The PWW successfully placed more consumers who worked a greater number of hours per week and earned more per week than those who received traditional VR services without increasing the cost of case services. Conclusions: The PWW showed promise as a systems change effort to improve VR services for people with TBI.	CUNY Hunter Coll, Dept Educ Fdn & Counseling Programs, New York, NY 10021 USA; Mt Sinai Sch Med, New York, NY USA; New York State Off Vocat & Educ Sci Individuals D, New York, NY USA; Univ Washington, Seattle, WA 98195 USA		O'Neill, JH (corresponding author), CUNY Hunter Coll, Dept Educ Fdn & Counseling Programs, 695 Pk Ave, New York, NY 10021 USA.	joneil@hunter.cuny.edu					BENNETT P, 1990, NAT HEAD INJ ASS 9 A; BERGMAN A, 2002, STAT OF THE SCI C CO; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; FRASER RT, 1994, NEUROL REHABIL, V5, P39; Gordon W. A., 2003, REH SERV ADM WORK GR; Hayward B., 2002, STAT OF THE SCI C CO; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	15	19	19	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2004	85	4		2			S68	S72		10.1016/j.apmr.2003.08.114			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	812FL	WOS:000220825300009	15083424				2022-02-06	
J	Wartenberg, KE; Patsalides, A; Yepes, MS				Wartenberg, KE; Patsalides, A; Yepes, MS			Is magnetic resonance spectroscopy superior to conventional diagnostic tools in hypoxic-ischemic encephalopathy?	JOURNAL OF NEUROIMAGING			English	Article						hypoxic-ischemic encephalopathy; MR spectroscopy; hypoxic brain injury; global ischemia; prognosis in hypoxic coma	PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; EVOKED-POTENTIALS; MEDICAL ASPECTS; COMA; MR; INVOLVEMENT; PREDICTION; MECHANISMS; LESIONS	Anoxic brain injury carries a poor prognosis. Therefore, a diagnostic tool sensitive enough to predict its outcome is needed. The authors describe the case of a 51-year-old woman who suffered cardiorespiratory arrest, Electroencephalography, somatosensory evoked potentials, and magnetic resonance imaging did not prove to be useful in establishing a definitive prognosis. Magnetic resonance spectroscopy demonstrated the presence of significant neuronal loss in the cortex and cerebellum and was the only diagnostic procedure closely associated with this patient's prognosis.	Georgetown Univ Hosp, Dept Neurol, Washington, DC 20007 USA; Georgetown Univ Hosp, Dept Neuroradiol, Washington, DC 20007 USA		Yepes, MS (corresponding author), Georgetown Univ, Dept Neurol, 3800 Reservoir Rd NW, Washington, DC 20007 USA.	yepesm@aol.com					Arbelaez A, 1999, AM J NEURORADIOL, V20, P999; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Baba Y, 1998, J COMPUT ASSIST TOMO, V22, P976, DOI 10.1097/00004728-199811000-00024; Centonze D, 2001, PROG NEUROBIOL, V63, P687, DOI 10.1016/S0301-0082(00)00037-X; Falini A, 1998, AM J NEURORADIOL, V19, P648; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Frucht S, 2000, MOVEMENT DISORD, V15, P1; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Genovese E, 2000, AM J NEURORADIOL, V21, P845; Guerit JM, 2000, ACTA NEUROL BELG, V100, P229; Hossmann KA, 1999, ADV EXP MED BIOL, V474, P155; Malisza KL, 1998, BIOCHEM CELL BIOL, V76, P487, DOI 10.1139/bcb-76-2-3-487; Neumar RW, 2000, ANN EMERG MED, V36, P483, DOI 10.1067/mem.2000.110995; Rothstein TL, 2000, J CLIN NEUROPHYSIOL, V17, P486, DOI 10.1097/00004691-200009000-00007; Rupright J, 1996, ARCH PHYS MED REHAB, V77, P1205, DOI 10.1016/S0003-9993(96)90150-1; SAFAR P, 1978, CRIT CARE MED, V6, P215, DOI 10.1097/00003246-197807000-00003; TAKAHASHI S, 1993, RADIOLOGY, V189, P449, DOI 10.1148/radiology.189.2.8210374; WEISSENBORN K, 1995, METAB BRAIN DIS, V10, P219, DOI 10.1007/BF02081027; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006; Zandbergen EGJ, 2000, J CLIN NEUROPHYSIOL, V17, P498, DOI 10.1097/00004691-200009000-00008; Zandbergen EGJ, 2001, INTENS CARE MED, V27, P1661, DOI 10.1007/s001340101076	22	19	19	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	APR	2004	14	2					180	186		10.1177/1051228403259514			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	876DA	WOS:000225474900016	15095566				2022-02-06	
J	Lee, CY; Yim, MB; Kim, IM; Son, EI; Kim, DW				Lee, CY; Yim, MB; Kim, IM; Son, EI; Kim, DW			Traumatic aneurysm of the supraclinoid internal carotid artery and an associated carotid-cavernous fistula: vascular reconstruction performed using intravascular implantation of stents and coils - Case report	JOURNAL OF NEUROSURGERY			English	Article						traumatic aneurysm; carotid-cavernous fistula; intravascular stent; coil embolization	TECHNICAL CASE-REPORT; INTRACRANIAL ANEURYSMS; FALSE ANEURYSM; SINUS FISTULA; EMBOLIZATION; OCCLUSION; REPAIR; PLACEMENT; EVOLUTION; GRAFTS	This report documents the treatment of a traumatic aneurysm of the supraclinoid internal carotid artery (ICA) that was associated with a carotid-cavernous fistula (CCF), which appeared following closed head trauma. This life-threatening lesion, which is very rare, required aggressive management achieved using intravascular stents and coils. A 19-year-old man presented with severe traumatic intracerebral and subarachnoid hematoma after he had suffered a severe closed head injury in a motor vehicle accident. Cerebral angiography performed 11 days after the injury demonstrated a traumatic aneurysm and severe narrowing of the right supraclinoid ICA, which was consistent with a dissection-induced stenosis associated with a direct CCF. Both lesions were successfully obliterated with preservation of the parent artery by using stents in conjunction with coils. Follow-up angiography obtained 7 months postoperatively revealed persistent obliteration of the aneurysm and CCF as well as patency of the parent artery. The patient remained asymptomatic during the clinical follow-up period of 14 months. Endovascular treatment involving the use of a stent combined with coils appears to be a feasible, minimally invasive option for treatment of this hard-to-treat lesion.	Keimyung Univ, Sch Med, Dept Neurosurg, Brain Res Inst, Jung Gu 700712, Daegu, South Korea		Yim, MB (corresponding author), Keimyung Univ, Sch Med, Dept Neurosurg, Brain Res Inst, 194 Dongsan Dong, Jung Gu 700712, Daegu, South Korea.	y760111@dsmc.or.kr					ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; Baskaya MK, 1996, NEUROL RES, V18, P135; Bendok BR, 1999, NEUROSURGERY, V45, P367, DOI 10.1097/00006123-199908000-00032; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BOUSQUET C, 1989, SURG NEUROL, V31, P319, DOI 10.1016/0090-3019(89)90059-1; DEBRUN GM, 1988, NEUROSURGERY, V22, P285, DOI 10.1227/00006123-198802000-00001; Dorros G, 1998, AM J NEURORADIOL, V19, P392; ENOMOTO H, 1984, NEUROSURGERY, V15, P700, DOI 10.1227/00006123-198411000-00011; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; Funahashi K, 1977, No Shinkei Geka, V5, P619; GEREMIA G, 1994, AM J NEURORADIOL, V15, P1223; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HALBACH VV, 1988, AM J NEURORADIOL, V9, P741; HANDA J., 1967, ACTA NEURO CHIR, V17, P161; Higashida RT, 1997, J NEUROSURG, V87, P944, DOI 10.3171/jns.1997.87.6.0944; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; KOMIYAMA M, 1991, SURG NEUROL, V36, P126, DOI 10.1016/0090-3019(91)90230-7; Lawton MT, 1996, NEUROSURGERY, V38, P83, DOI 10.1097/00006123-199601000-00020; Link J, 1996, RADIOLOGY, V200, P397, DOI 10.1148/radiology.200.2.8685332; LISTER JR, 1979, NEUROSURGERY, V5, P473; Lylyk P, 1998, NEUROSURGERY, V43, P385, DOI 10.1097/00006123-199808000-00132; MARIN ML, 1993, J VASC SURG, V18, P299, DOI 10.1016/0741-5214(93)90611-O; MASANA Y, 1992, J NEUROSURG, V76, P524, DOI 10.3171/jns.1992.76.3.0524; MASE M, 1995, NEUROSURGERY, V37, P832, DOI 10.1227/00006123-199510000-00032; MULLAN S, 1979, J NEUROSURG, V50, P131, DOI 10.3171/jns.1979.50.2.0131; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; PARKINSON D, 1973, J NEUROSURG, V38, P99, DOI 10.3171/jns.1973.38.1.0099; Parodi JC, 1996, WORLD J SURG, V20, P655, DOI 10.1007/s002689900100; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; PROLO DJ, 1971, J NEUROSURG, V35, P237, DOI 10.3171/jns.1971.35.2.0237; REDDY SVR, 1981, J NEUROSURG, V55, P813, DOI 10.3171/jns.1981.55.5.0813; Saito Kiyoshi, 1995, Neurologia Medico-Chirurgica, V35, P886, DOI 10.2176/nmc.35.886; Saito Ryoichi, 1992, Neurological Surgery, V20, P973; SALCMAN M, 1985, NEUROSURGERY, V16, P218; SALMON JH, 1968, J THORAC CARDIOV SUR, V56, P28, DOI 10.1016/S0022-5223(19)42868-7; Sekhar LN, 1999, NEUROSURGERY, V44, P1207, DOI 10.1097/00006123-199906000-00028; Siniluoto T, 1997, AM J NEURORADIOL, V18, P519; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; WAGA S, 1978, SURG NEUROL, V9, P367; Waga S, 1979, No Shinkei Geka, V7, P933; WAKHLOO A, 1996, CIRCULATION S, V94, P1; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	42	19	20	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2004	100	1					115	119		10.3171/jns.2004.100.1.0115			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	761YQ	WOS:000187943400018	14743921				2022-02-06	
J	Levine, NB; Tanaka, T; Jones, BV; Crone, KR				Levine, NB; Tanaka, T; Jones, BV; Crone, KR			Minimally invasive management of a traumatic artery aneurysm resulting from shaken baby syndrome	PEDIATRIC NEUROSURGERY			English	Article						traumatic aneurysms; pericallosal artery; posttraumatic obstructive hydrocephalus; third ventriculostomy; coiling	INTRACRANIAL ANEURYSMS; CHILDHOOD	Based on our review of the literature, we present the first use of coiling in an infant with a traumatic artery aneurysm that resulted from shaken baby syndrome. Computed tomography (CT) scans showed a skull fracture, hemorrhagic subdural collections, multiple parenchymal contusions, and intraventricular and subarachnoid hemorrhages in a 3-week-old infant who presented with lethargy, poor feeding, and seizure. These multiple injuries were consistent with shaken baby syndrome. After closed-head injury medical management, including subdural taps, the baby was discharged home. When increasing seizures and hydrocephalus developed 8 months later, CT angiographic scans showed a pseudoaneurysm of the anterior cerebral artery. We successfully occluded the aneurysm with pushable coils placed via a microcatheter and treated the obstructive hydrocephalus with endoscopic third ventriculostomy. We show that minimally invasive radiological and surgical techniques may be effective in managing the sequelae of trauma in children. Copyright (C) 2004 S. Karger AG, Basel.	Univ Cincinnati, Coll Med, Dept Neurosurg, Neurosci Inst,Editorial Off, Cincinnati, OH 45267 USA; Cincinnati Childrens Hosp Med Ctr, Dept Neurosurg, Cincinnati, OH USA		Crone, KR (corresponding author), Univ Cincinnati, Coll Med, Dept Neurosurg, Neurosci Inst,Editorial Off, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	editor@mayfieldclinic.com		Tanaka, Tomoko/0000-0003-0897-8217			BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; Jones BV, 2002, AM J NEURORADIOL, V23, P1145; Lam CH, 1996, NEUROSURGERY, V39, P1252, DOI 10.1097/00006123-199612000-00041; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294	6	19	19	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2004	40	3					128	131		10.1159/000079855			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	869XK	WOS:000225017700006	15367803				2022-02-06	
J	Statler, KD; Janesko, KL; Melick, JA; Clark, RSB; Jenkins, LW; Kochanek, PM				Statler, KD; Janesko, KL; Melick, JA; Clark, RSB; Jenkins, LW; Kochanek, PM			Hyperglycolysis is exacerbated after traumatic brain injury with fentanyl vs. isoflurane anesthesia in rats	BRAIN RESEARCH			English	Article						head injury; excitotoxicity; sedation; narcotics; metabolism	CEREBRAL BLOOD-FLOW; TOXICITY IN-VIVO; GLUCOSE-UTILIZATION; INTRACRANIAL-PRESSURE; PENTOBARBITAL REDUCE; AEROBIC GLYCOLYSIS; FOREBRAIN ISCHEMIA; INDUCED SEIZURES; AMINO-ACIDS; HIPPOCAMPAL	Despite common use of narcotics in the clinical management of severe traumatic brain injury (TBI), in experimental models rats treated with fentanyl have exhibited worse functional outcome and more CA1 hippocampal death than rats treated with standard isoflurane anesthesia. We hypothesized that greater post-traumatic excitotoxicity, reflected by cerebral glucose utilization (CMRglu), may account for detrimental effects of fentanyl vs. isoflurane. Rats were anesthetized with either isoflurane (1% by inhalation) or fentanyl (10 mcg/kg iv bolus then 50 mcg/kg/h infusion). C-14-deoxyglucose autoradiography was performed 45 min after controlled cortical impact (CCI) to left parietal cortex (n = 4 per anesthetic group) or in uninjured rats after 45 min of anesthesia (n = 3 per anesthetic group). Uninjured rats treated with fentanyl vs. isoflurane showed 35-45% higher CMRglu in all brain structures (p < 0.05) except CA3. After TBI in rats treated with isoflurane, CMRglu increased significantly only in ipsilateral CA1 and ipsilateral parietal cortex (p<0.05 vs. isoflurane uninjured). Conversely, after TBI in rats treated with fentanyl, CMRglu increased markedly and bilaterally in CA1 and CA3 (p < 0.05 vs. fentanyl uninjured), but not ipsilateral parietal cortex. In contralateral CA1, CMRglu was nearly two times greater after TBI in fentanyl vs. isoflurane treated rats (p < 0.05). Hyperglycolysis was exacerbated in CA1 and CA3 hippocampus after TBI in rats treated with fentanyl vs. isoflurane anesthesia. This post-traumatic hyperglycolysis suggests greater excitotoxicity and concurs with reports of worse functional outcome and more CA1 hippocampal death after TBI with fentanyl vs. isoflurane anesthesia. (C) 2003 Elsevier B.V. All rights reserved.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15260 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD40686] Funding Source: Medline		*AANS BRAIN TRAUM, 2000, J NEUROTRAUM, V17, P463; ARCHER DP, 1990, J CEREBR BLOOD F MET, V10, P624, DOI 10.1038/jcbfm.1990.114; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BICKLER PE, 1994, ANESTHESIOLOGY, V81, P1461, DOI 10.1097/00000542-199412000-00022; Boyeson MG, 1991, J NEUROTRAUM, V8, P205, DOI 10.1089/neu.1991.8.205; BRADLEY PB, 1984, BRIT J PHARMACOL, V83, P763, DOI 10.1111/j.1476-5381.1984.tb16231.x; Goren S, 2001, J NEUROSURG ANESTH, V13, P113, DOI 10.1097/00008506-200104000-00008; HANSEN TD, 1989, BRIT J ANAESTH, V63, P290, DOI 10.1093/bja/63.3.290; Harada H, 1999, ANESTH ANALG, V89, P1442, DOI 10.1097/00000539-199912000-00022; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; Izumi Y, 2002, J CLIN NEUROSCI, V9, P289, DOI 10.1054/jocn.2001.0966; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KEARSE LA, 1993, ELECTROEN CLIN NEURO, V87, P374, DOI 10.1016/0013-4694(93)90150-T; Kimbro JR, 2000, ANESTHESIOLOGY, V92, P806, DOI 10.1097/00000542-200003000-00024; KISSIN I, 1983, CAN ANAESTH SOC J, V30, P623, DOI 10.1007/BF03015233; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; MAEKAWA T, 1986, ANESTHESIOLOGY, V65, P144, DOI 10.1097/00000542-198608000-00003; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Miura Y, 1999, ANESTH ANALG, V88, P787, DOI 10.1097/00000539-199904000-00020; Miura Y, 1998, ANESTHESIOLOGY, V89, P391, DOI 10.1097/00000542-199808000-00016; Nellgard B, 2000, ANESTH ANALG, V91, P145, DOI 10.1097/00000539-200007000-00027; NEUMAIER JF, 1998, J PHARMACOL EXP THER, V244, P564; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PATEL PM, 1995, ANESTHESIOLOGY, V82, P996, DOI 10.1097/00000542-199504000-00024; Patel PM, 1998, ANESTH ANALG, V86, P773, DOI 10.1097/00000539-199804000-00018; Pellerin L, 1996, DEV NEUROSCI-BASEL, V18, P336, DOI 10.1159/000111426; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Popovic R, 2000, ANESTHESIOLOGY, V92, P1343, DOI 10.1097/00000542-200005000-00024; SAFO Y, 1985, ACTA ANAESTH SCAND, V29, P594, DOI 10.1111/j.1399-6576.1985.tb02261.x; Smolders I, 1997, EUR J PHARMACOL, V319, P21, DOI 10.1016/S0014-2999(96)00830-8; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Soonthon-Brant V, 1999, ANESTH ANALG, V88, P49, DOI 10.1097/00000539-199901000-00010; Statler KD, 2000, CRIT CARE MED, V28, pA53; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; TEMPELHOFF R, 1992, J NEUROSURG, V77, P201, DOI 10.3171/jns.1992.77.2.0201; TOMMASINO C, 1984, ANESTHESIOLOGY, V60, P283, DOI 10.1097/00000542-198404000-00003; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	41	19	19	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 19	2003	994	1					37	43		10.1016/j.brainres.2003.09.042			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	753UT	WOS:000187249500004	14642446				2022-02-06	
J	Bhambhani, Y; Rowland, G; Farag, M				Bhambhani, Y; Rowland, G; Farag, M			Reliability of peak cardiorespiratory responses in patients with moderate to severe traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	48th Annual Meeting of the American-College-of-Sports-Medicine	MAY-JUN -, 2001	BALTIMORE, MD	Amer Coll Sports Med		brain injuries; exercise; rehabilitation	EXERCISE; DEPRESSION; CAPACITY	Objective: To examine the test-retest reliability of acute physiologic responses in patients with traumatic brain injury (TBI). Design: Repeated measures within I week. Setting: Brain injury rehabilitation program and community rehabilitation hospital. Participants: Thirty-six inpatients or their legal guardians. Interventions: Each patient performed a symptom-limited incremental cycle ergometer test to voluntary fatigue on 2 separate occasions within I week. Main Outcome Measures: Peak values of power output and cardiorespiratory responses measured with a metabolic cart interfaced with an electrocardiogram. Results: Intraclass correlations between the 2 trials were as follows: power output, .96; absolute oxygen uptake,.98; relative oxygen uptake,.97; heart rate,.82; ventilation rate,.96; and respiratory exchange ratio,.81. Bland-Altman plots showed that all data points were within the 95% confidence limits of the mean value of the 2 trials for each variable. Conclusions: The reliability of the peak cardiorespiratory responses during non-weight-bearing exercise was high in patients with TBI in a controlled laboratory setting. Therefore, aerobic exercise programs can be accurately prescribed, and changes resulting from such interventions can be confidently evaluated in this population.	Univ Alberta, Fac Rehabil Med, Edmonton, AB T6G 2G4, Canada; Alberta Hosp Ponoka, Brain Injury Rehabil Prov Program, Ponoka, AB, Canada		Bhambhani, Y (corresponding author), Univ Alberta, Fac Rehabil Med, Rm 373,Corbett Hall, Edmonton, AB T6G 2G4, Canada.	yagesh.bhambhani@ualberta.ca					American College of Sports Medicine, 2001, GUID EX TEST PRESCR; [Anonymous], 1990, Med Sci Sports Exerc, V22, P265; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; BECKER E, 1978, SCAND J REHABIL MED, V10, P47; Bhambhani Y, 1985, Can J Appl Sport Sci, V10, P44; BHAMBHANI Y, 1994, CAN J APPL PHYSIOL, V19, P49, DOI 10.1139/h94-003; BHAMBHANI YN, 1991, ARCH PHYS MED REHAB, V72, P559; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; GOWLAND C, 1994, BRAIN INJURY REHABIL, P102; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Greenleaf J E, 1982, Exerc Sport Sci Rev, V10, P84; Hal KM, 1997, J REHABILITATION OUT, V1, P63; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Keller A, 2001, SPINE, V26, P771, DOI 10.1097/00007632-200104010-00017; Keppel G., 1973, DESIGN ANAL RES HDB; King ML, 1997, BRAIN INJURY, V11, P445; MCARDLE WD, 2001, EXERCISE PHYSIOLOGYE; MCLEAN KP, 2002, ACSM RESOURCES CLIN, P98; *NIH, 1998, NIH CONS STAT REH PE; NOVACK TA, 1988, REHABIL COUNS BULL, V31, P313; Puente-Maestu L, 2001, EUR J APPL PHYSIOL, V85, P434, DOI 10.1007/s004210100486; SALTIN B, 1968, CIRCULATION       S7, V38, P1, DOI DOI 10.1161/01.CIR.38.6.1104; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; *US DEP HHS, 1996, PHYS ACT HLTH REP SU, P15250; Vitale AE, 1996, BRAIN INJURY, V10, P367, DOI 10.1080/026990596124377; VITALE AE, 1995, PERCEPT MOTOR SKILL, V80, P57, DOI 10.2466/pms.1995.80.1.57; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; Wasserman K, 1994, PRINCIPLES EXERCISE; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Wiercisiewski DR, 1998, J HEAD TRAUMA REHAB, V13, P28, DOI 10.1097/00001199-199802000-00006	40	19	19	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2003	84	11					1629	1636		10.1053/S0003-9993(03)00343-5			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	741PR	WOS:000186466900009	14639562				2022-02-06	
J	Grados, MA				Grados, MA			Obsessive-compulsive disorder after traumatic brain injury	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							CLOSED-HEAD INJURY; POSTTRAUMATIC-STRESS-DISORDER; POSITRON-EMISSION-TOMOGRAPHY; PSYCHIATRIC-DISORDERS; FOLLOW-UP; ADOLESCENTS; CHILDREN; PHARMACOTHERAPY; PREVALENCE; DISABILITY	Traumatic brain injury (TBI) neuropsychiatric sequelae are a significant cause of morbidity in TBI victims. Among the recognized sequelae are anxiety, obsessions, compulsions and obsessive-compulsive disorder (OCD). This review addresses the emergence of OCD and OCD symptoms after TBI with an emphasis on neural circuits that underlie OCD symptom expression that may be affected by the injury. Current studies suggest that post-TBI emergent psychopathology, including OCD, is influenced by underlying sub-clinical diathesis, brain injury lesions sites, environmental stressors and the rehabilitation process. Pre-morbid status can be obtained by structured psychiatric interviews, and TBI brain lesions can be defined with advanced neuroimaging techniques. This information along with the management of family and environmental stressors and the enhanced clinical identification of symptoms of anxiety and OCD can be used in the rehabilitation process to improve prognosis after TBI.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA		Grados, MA (corresponding author), 3901 Greenspring Ave,2nd Floor, Baltimore, MD 21211 USA.			Grados, Marco/0000-0002-6189-6264	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23 MH066284-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH066284] Funding Source: NIH RePORTER		Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; DRUMMOND LM, 1988, BRIT J PSYCHIAT, V153, P839, DOI 10.1192/bjp.153.6.839; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FLAMENT MF, 1988, J AM ACAD CHILD PSY, V27, P764, DOI 10.1097/00004583-198811000-00018; Gamazo-Garran P, 2002, J CHILD ADOL PSYCHOP, V12, P259, DOI 10.1089/104454602760386950; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Grados M, 1999, CHILD ADOL PSYCH CL, V8, P617; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Heyman I, 2003, INT REV PSYCHIATR, V15, P178, DOI 10.1080/0954026021000046146; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; HILLBOM E, 1960, Acta Psychiatr Scand Suppl, V35, P1; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; HOLLINGSWORTH CE, 1980, J AM ACAD CHILD PSY, V19, P134, DOI 10.1016/S0002-7138(09)60658-0; INSEL TR, 1992, PSYCHIAT CLIN N AM, V15, P813; JENIKE M, 1984, J AFFECT DISORDERS, V2, P359; JOSEPH R, 1993, NAKED NEURON; Kant R, 1996, BRAIN INJURY, V10, P55; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Kim KW, 2002, J NEUROPSYCH CLIN N, V14, P88, DOI 10.1176/appi.neuropsych.14.1.88; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; LISHMAN WA, 1973, ORGANIC PSYCHIAT; Luria AR, 1969, HDB CLINICAL NEUROLO, P725; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P45, DOI 10.1097/00004583-199501000-00012; MCKEON J, 1984, BRIT J PSYCHIAT, V144, P190, DOI 10.1192/bjp.144.2.190; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Rosenberg DR, 1997, J PSYCHIATR NEUROSCI, V22, P29; Sachdev P, 2001, AUST NZ J PSYCHIAT, V35, P684, DOI 10.1080/0004867010060519; Sagan C., 1977, DRAGONS EDEN; SCHILDER P, 1938, AM J PSYCHIAT, V94, P1414; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Stein J, 2002, TXB ANXIETY DISORDER, P43; SWEDO SE, 1992, ARCH GEN PSYCHIAT, V49, P690; Szeszko PR, 1999, ARCH GEN PSYCHIAT, V56, P913, DOI 10.1001/archpsyc.56.10.913; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN PH, 1993, ACTA PSYCHIAT SCAND, V88, P212, DOI 10.1111/j.1600-0447.1993.tb03441.x; VALLENIBASILE LA, 1994, J AM ACAD CHILD PSY, V33, P782, DOI 10.1097/00004583-199407000-00002; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; ZOHAR AH, 1992, J AM ACAD CHILD PSY, V31, P1057, DOI 10.1097/00004583-199211000-00010	47	19	19	1	10	CARFAX PUBLISHING	BASINGSTOKE	RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND	0954-0261			INT REV PSYCHIATR	Int. Rev. Psych.	NOV	2003	15	4					350	358		10.1080/09540260310001606737			9	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	739UD	WOS:000186364100007	15276956				2022-02-06	
J	Kerr, ME; Kamboh, ML; Yookyung, K; Kraus, MF; Puccio, AM; DeKosky, ST; Marion, DW				Kerr, ME; Kamboh, ML; Yookyung, K; Kraus, MF; Puccio, AM; DeKosky, ST; Marion, DW			Relationship between apoE4 allele and excitatory amino acid levels after traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; excitatory amino acids; apolipoprotein; neuromonitoring; cerebrospinal fluid; cerebral ischemia; high-performance liquid chromatography	E-DEFICIENT MICE; CORTICAL EXTRACELLULAR LEVELS; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; HEAD-INJURY; CEREBRAL-ISCHEMIA; EPSILON-4 ALLELE; GLUTAMATE; RELEASE	Objective; Apolipoprotein E isoform (B) has been posited to affect outcomes after central nervous system injury. This project sought to determine the relationship between the apoE4 allele and the recovery of amino acid neurotransmitters (aspartate, glutamate, and lactate/pyruvate ratio [UP]) following a traumatic brain injury (TBI) after controlling for patient characteristics. Design: This prospective clinical study examined neurotransmitters and UP within the cerebrospinal fluid and compared the trends by apoE genotypes. Setting: Adults with TBI were recruited from a neurotraurna intensive care unit within a trauma 1 university medical center. Patients: Ninety-one patients were enrolled into the study after a severe TBI (Glasgow Coma Scale [GCS] score, less than or equal to8). Cerebrospinal fluid was serially sampled from a ventriculostomy every 4 hrs for the first 24 hrs and every 6 hrs for 25-120 hrs after injury. Measurements and Main Results: Hierarchical linear modeling analyses were used to compare the change of glutamate, aspartate, and UP over time by the presence or absence of the apoE4 allele, with GCS score, sex, race, and therapeutic hypothermias included as covariates. There was a significant apoE4 allele group effect on both the linear and quadratic slopes in aspartate. In glutamate, the rate of change in glutamate was statistically related to GCS score. There was no significant difference in the glutamate response over time by the presence of the apoE4 allele. There was a significant difference in the change in UP across time, with faster recovery when the apoE4 allele was absent. Conclusions: Recovery of aspartate and UP differed depending on the presence of the apoE4 allele. Patients with the allele had significant increased and sustained levels of aspartate and UP after TBI. Changes in glutamate were related to severity of illness and were independent of the presence of the apoE4 allele.	Univ Pittsburgh, Western Psychiat Inst & Clin, Med Ctr, Pittsburgh, PA 15213 USA		Kerr, ME (corresponding author), Univ Pittsburgh, Western Psychiat Inst & Clin, Med Ctr, 3811 Ohara St, Pittsburgh, PA 15213 USA.		Marion, Donald/AAR-5749-2021	DeKosky, Steven/0000-0003-3743-2758; Kamboh, M. Ilyas/0000-0002-3453-1438	NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR04301] Funding Source: Medline		[Anonymous], 2000, MODELING LONGITUDINA; ASSMANN G, 1984, CLIN CHEM, V30, P641; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Buttini M, 2000, NEUROSCIENCE, V97, P207, DOI 10.1016/S0306-4522(00)00069-5; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1990, J NEUROSCI, V10, P2493; De Sarno P, 1998, EXP NEUROL, V152, P123, DOI 10.1006/exnr.1998.6825; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Graham DI, 1996, ACT NEUR S, V66, P96; Gross R, 1997, JAMA-J AM MED ASSOC, V278, P2143, DOI 10.1001/jama.1997.03550240033025; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; HARTMANN H, 1994, BIOCHEM BIOPH RES CO, V200, P1185, DOI 10.1006/bbrc.1994.1576; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; KAMBOH MI, 1995, ATHEROSCLEROSIS, V112, P145, DOI 10.1016/0021-9150(94)05409-C; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kimelberg H K, 1987, Cent Nerv Syst Trauma, V4, P3; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; KIMELBERG HK, 1989, MOL CHEM NEUROPATHOL, V11, P1, DOI 10.1007/BF03160036; Klunk WE, 1998, NEUROBIOL AGING, V19, P511, DOI 10.1016/S0197-4580(98)00105-5; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Lendon CL, 2000, EUR J NEUROSCI, V12, P2235, DOI 10.1046/j.1460-9568.2000.00113.x; Mahley RW, 1996, ANN NY ACAD SCI, V777, P139, DOI 10.1111/j.1749-6632.1996.tb34412.x; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MessmerJoudrier S, 1996, EUR J NEUROSCI, V8, P2652, DOI 10.1111/j.1460-9568.1996.tb01560.x; MULLAN M, 1993, TRENDS NEUROSCI, V16, P398, DOI 10.1016/0166-2236(93)90007-9; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Overmyer M, 1999, DEMENT GERIATR COGN, V10, P252, DOI 10.1159/000017128; OYAMA F, 1995, MOL BRAIN RES, V29, P92, DOI 10.1016/0169-328X(94)00233-5; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Petegnief V, 2001, NEUROSCIENCE, V104, P223, DOI 10.1016/S0306-4522(01)00046-X; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Rao VLR, 1998, J NEUROCHEM, V70, P2020; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; SELKOE DJ, 1991, NATURE, V354, P432, DOI 10.1038/354432a0; SELKOE DJ, 1991, SCI AM, V265, P40, DOI 10.1038/scientificamerican1191-68; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; Shimokata H, 2000, J Epidemiol, V10, pS46; UTERMANN G, 1980, AM J HUM GENET, V32, P339; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; WARDELL MR, 1982, J LIPID RES, V23, P1174; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; YANKNER BA, 1991, NEW ENGL J MED, V325, P1849; [No title captured]	53	19	23	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2003	31	9					2371	2379		10.1097/01.CCM.0000080484.72004.C4			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721BL	WOS:000185297100016	14501969				2022-02-06	
J	Kim, CW; Smith, JM; Lee, A; Hoyt, DB; Kennedy, F; Newton, PO; Meyer, RS				Kim, CW; Smith, JM; Lee, A; Hoyt, DB; Kennedy, F; Newton, PO; Meyer, RS			Personal watercraft injuries: 62 patients admitted to the San Diego County trauma services	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						Jet Ski; waverunner; personal watercraft; boating; fractures; blunt trauma	HEALTH; JET	Objective: To determine the types and patterns of injuries seen in personal watercraft (PWC) accidents. Design: A retrospective review of medical records and imaging studies. Setting: Level 1 and 2 trauma centers in San Diego County, California. Patients/Participants: Trauma patients treated for PWC-related injuries between 1984 and 1997. Main Outcome Measurements: Evaluation of injury patterns via chart review and imaging studies. Intervention: None. Results: A total of 62 patients were identified. The average age was 23 years (range 2-59 years). There were 41 males and 21 females. A total of 35 injuries (56%) involved another PWC. Of patients, 24 had loss of consciousness, with 8 closed head injuries. There were 17 chest injuries, with 10 pneumothoraces, and 16 lower extremity fractures (9 femur, 3 hip, 3 tibia-fibula, and 1 patella). Conclusions: injuries related to PWC have increased dramatically over the past several years, becoming one of the leading causes of recreational water-sport injuries. This study supports a high level of awareness for significant blunt trauma to the chest and lower extremities in patients involved in PWC accidents.	Univ Calif San Diego, Med Ctr, Dept Orthopaed Surg, San Diego, CA 92103 USA; Univ Calif San Diego, Med Ctr, Div Trauma, San Diego, CA 92103 USA; Sharp Mem Hosp & Rehabil Ctr, Div Trauma, San Diego, CA 90034 USA; Childrens Hosp, San Diego, CA USA; Scripps Mem Hosp, San Diego, CA USA		Kim, CW (corresponding author), Univ Calif San Diego, Med Ctr, Dept Orthopaed, 350 Dickinson St, San Diego, CA 92103 USA.						Barach P, 1998, JAMA-J AM MED ASSOC, V279, P433, DOI 10.1001/jama.279.6.433-a; Bell W, 1998, CAN FAM PHYSICIAN, V44, P1775; Branche CM, 1997, JAMA-J AM MED ASSOC, V278, P663, DOI 10.1001/jama.278.8.663; DELPRINCIPE RF, 1997, CALIFORNIA BOATING A; Francis R A, 1994, Mo Med, V91, P241; Garri JI, 1999, PLAST RECONSTR SURG, V104, P922, DOI 10.1097/00006534-199909040-00005; HAMMAN BL, 1993, J PEDIATR SURG, V28, P920, DOI 10.1016/0022-3468(93)90697-J; Jeffery R S, 1991, Br J Sports Med, V25, P232; Jones C S, 1998, Inj Prev, V4, P61; Jones C S, 1999, J Ark Med Soc, V96, P97; Jones C S, 1997, J Ark Med Soc, V94, P111; Jones CS, 2000, ACCIDENT ANAL PREV, V32, P373, DOI 10.1016/S0001-4575(99)00091-3; Laraque D, 2000, PEDIATRICS, V105, P452, DOI 10.1542/peds.105.2.452; National Transportation Safety Board, 1998, PERS WAT SAF; Parsons DP, 1999, DIS COLON RECTUM, V42, P959, DOI 10.1007/BF02237110; Philpott JM, 1999, J TRAUMA, V47, P385, DOI 10.1097/00005373-199908000-00031; Shatz DV, 1998, J TRAUMA, V44, P198, DOI 10.1097/00005373-199801000-00029; Swinburn EEL, 1996, MED J AUSTRALIA, V165, P606, DOI 10.5694/j.1326-5377.1996.tb138662.x; Tyler B C, 1997, N C Med J, V58, P284; VERNBERG D, 1989, JAMA-J AM MED ASSOC, V261, P1883, DOI 10.1001/jama.1989.03420130045021; White MW, 1999, AM SURGEON, V65, P865	21	19	19	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	SEP	2003	17	8					571	573		10.1097/00005131-200309000-00005			3	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	724PL	WOS:000185495900005	14504578				2022-02-06	
J	Muellner, A; Benz, M; Kloss, CUA; Mautes, A; Burggraf, D; Hamann, GF				Muellner, A; Benz, M; Kloss, CUA; Mautes, A; Burggraf, D; Hamann, GF			Microvascular basal lamina antigen loss after traumatic brain injury in the rat	JOURNAL OF NEUROTRAUMA			English	Article						basal lamina; cerebral microvasculature; collagen type IV; fluid percussion injury; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; HEAD-INJURY; BARRIER DISRUPTION; CELLULAR EDEMA; BLOOD-FLOW; METABOLISM; MICROCIRCULATION; REPERFUSION; ACTIVATION; SEQUELAE	The loss of microvascular basal lamina antigen is known to be a consequence of cerebral ischemia, but little information is available on its role in traumatic brain injury (TBI). The aim of our study was (1) to test the hypothesis that there is damage to the basal lamina of brain microvasculature after TBI, (2) to localize microvascular damage, and (3) to compare this loss with that in ischemia. Rats (n = 14) were either sham operated (n = 5) or subjected to fluid percussion injury (n = 9; TBI = 1.5 atm) and killed after 0 (n = 5, sham), 12 (n = 4), or 24 h (n = 5). Collagen-type-IV immunoreactivity and a digital image-processing system were used to localize and quantify the number of stained vascular elements and the total collagen stained area. Western blot was used to compare collagen-type-IV content on the traumatic and nontraumatic brain side. The cortex of animals subjected to TBI and killed after 24 h showed a reduction in the area of stained collagen amounting to 19 +/- 4% (p < 0.009) and a reduction in the total number of microvessels identified by collagen stain (29 +/- 6 %; p < 0.02). The Western blot revealed a 31 +/- 6 % (p < 0.03) reduction of collagen, compared to the mirror cortical area after 24 h. No significant reduction was found in the group that survived 12 h or in basal ganglia in both groups. TBI causes microvascular basal lamina damage. Whereas TBI affected only cortical areas, cerebral ischemia also induced microvascular basal lamina damage in the basal ganglia. After 24 h, the extent of severe basal lamina damage due, to TBI was less severe than in ischemia.	Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany; Univ Saarland, Sch Med, Neurosurg Res Lab, D-66421 Homburg, Germany		Hamann, GF (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Neurol, Marchioninistr 15, D-81377 Munich, Germany.	hamann@brain.nefo.med.uni-muenchen.de	Hamann, Gerhard F./J-6300-2014				Armao D, 1997, BRAIN RES, V767, P259, DOI 10.1016/S0006-8993(97)00567-2; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Barzo P, 1997, ACT NEUR S, V70, P119; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; del Zoppo GJ, 1998, J NEUROL NEUROSUR PS, V65, P1, DOI 10.1136/jnnp.65.1.1; del Zoppo GJ, 2000, THROMB RES, V98, pV73; DELZOPPO GJ, 1994, CEREBROVAS BRAIN MET, V6, P47; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Franko J, 1999, LIFE SCI, V65, P1963, DOI 10.1016/S0024-3205(99)00456-7; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Grammas P, 2000, NEUROBIOL AGING, V21, P199, DOI 10.1016/S0197-4580(00)00102-0; Hamann Gerhard F., 1999, Thrombosis and Haemostasis, V82, P92; Hamann GF, 1996, J CEREBR BLOOD F MET, V16, P1373, DOI 10.1097/00004647-199611000-00036; HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120; Hamann GF, 2002, J CEREBR BLOOD F MET, V22, P526, DOI 10.1097/00004647-200205000-00004; HARPER SL, 1984, AM J PHYSIOL, V246, pH17, DOI 10.1152/ajpheart.1984.246.1.H17; JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9; Kloss CUA, 2002, NEUROL RES, V24, P713, DOI 10.1179/016164102101200636; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lijnen HR, 1997, PROG CARDIOVASC DIS, V39, P343, DOI 10.1016/S0033-0620(97)80032-1; Lijnen HR, 1999, THROMB HAEMOSTASIS, V81, P799; Lijnen HR, 1998, THROMB HAEMOSTASIS, V79, P1171; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; Mautes AEM, 2001, J MOL NEUROSCI, V16, P33, DOI 10.1385/JMN:16:1:33; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; MAXWELL WL, 1994, ACTA NEUROCHIR, P465; Nobles M, 1998, EUR J PHARMACOL, V361, P119, DOI 10.1016/S0014-2999(98)00671-2; Passineau MJ, 2000, AM J PHYSIOL-HEART C, V279, pH924, DOI 10.1152/ajpheart.2000.279.3.H924; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pettigrew LC, 1996, J CEREBR BLOOD F MET, V16, P1189, DOI 10.1097/00004647-199611000-00013; Pfefferkorn T, 2000, J CEREBR BLOOD F MET, V20, P337, DOI 10.1097/00004647-200002000-00015; PONTEN U, 1973, J NEUROCHEM, V21, P1127, DOI 10.1111/j.1471-4159.1973.tb07567.x; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; Risau W, 1998, PATHOL BIOL, V46, P171; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; Rosenberg GA, 1999, PROG CARDIOVASC DIS, V42, P209, DOI 10.1016/S0033-0620(99)70003-4; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; SAITO N, 1990, ACT NEUR S, V51, P186; Sharma HS, 1997, ACT NEUR S, V70, P269; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TOUZANI O, 1995, STROKE, V26, P2112, DOI 10.1161/01.STR.26.11.2112; Touzani O, 1997, BRAIN RES, V767, P17, DOI 10.1016/S0006-8993(97)00515-5; WANG W, 1996, AM J PHYSIOL, V271, P973; Weinzierl MR, 2002, J MOL NEUROSCI, V18, P247, DOI 10.1385/JMN:18:3:247; Wiedermann D, 2001, MAGN RESON MATER PHY, V13, P118, DOI 10.1007/BF02668160; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767	68	19	19	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2003	20	8					745	754		10.1089/089771503767869971			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	712BU	WOS:000184777000005	12965053				2022-02-06	
J	Cooper, MT; McGee, KM; Anderson, DG				Cooper, MT; McGee, KM; Anderson, DG			Epidemiology of athletic head and neck injuries	CLINICS IN SPORTS MEDICINE			English	Article							CERVICAL-SPINE INJURIES; TRAUMATIC BRAIN-INJURY; SOCCER INJURIES; SAFETY HELMETS; CORD-INJURY; ICE HOCKEY; CONCUSSION; SPORTS; PREVENTION; ACCIDENTS	In this article, we review the available data on sporting injuries to the head and neck and discuss sport-specific injury risk and prevention strategies, as well as the costs of head and neck injuries.	Univ Virginia, Sch Med, Dept Orthopaed Surg, Charlottesville, VA 22908 USA		Anderson, DG (corresponding author), Univ Virginia, Sch Med, Dept Orthopaed Surg, POB 800159, Charlottesville, VA 22908 USA.	dga3k@virginia.edu		Cooper, Minton/0000-0002-8860-2166			Albrand O W, 1975, Surg Neurol, V4, P461; ALBRIGHT JP, 1976, JAMA-J AM MED ASSOC, V236, P1243, DOI 10.1001/jama.236.11.1243; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; BIXBYHAMMETT D, 1990, SPORTS MED, V9, P36, DOI 10.2165/00007256-199009010-00004; Burt CW, 2001, ANN EMERG MED, V37, P301, DOI 10.1067/mem.2001.111707; *C NEUR SURG INC, 1966, CLIN NEUROSURG, V14, P424; CAINE D, 1989, AM J SPORT MED, V17, P811, DOI 10.1177/036354658901700616; Cantu RC, 2000, NEUROSURGERY, V47, P673, DOI 10.1097/00006123-200009000-00029; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; Cantu RC, 1997, MED SCI SPORT EXER, V29, pS233; Cantu RC, 2000, SEMIN NEUROL, V20, P173, DOI 10.1055/s-2000-9825; CANTU RC, 1995, CLIN SPORT MED, V14, P517; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; *CONS PROD SAF COM, 2001, TRAMPL SAF AL; *CONS PROD SAF COM, 1999, WHATS NEW BIC HELM; *CONS PROD SAF COM, 1996, CPSC URG BIC WEAR HE; *CONS PROD SAF COM, 1995, GUID MOV SOCC GOAL S; *CONS PROD SAF COM, 2001, PUB CPSC, V93; *CONS PROD SAF COM, 2002, PUB CPSC, V329; *CONS PROD SAF COM, 1990, 5044 CPSC; d'Hemecourt PA, 2000, CLIN SPORT MED, V19, P663, DOI 10.1016/S0278-5919(05)70231-3; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; Ferrera PC, 1999, AM J EMERG MED, V17, P575, DOI 10.1016/S0735-6757(99)90199-7; *FIFA, 2001, FIFA SURV APPR 250 M; Frankel HL, 1998, AM SURGEON, V64, P151; Furnival RA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.5.e57; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; GROSSMAN JAI, 1978, JAMA-J AM MED ASSOC, V240, P1881, DOI 10.1001/jama.240.17.1881; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hobbs Gregory D., 1994, Journal of Emergency Medicine, V12, P143, DOI 10.1016/0736-4679(94)90690-4; HOFF GL, 1986, AM J SPORT MED, V14, P231, DOI 10.1177/036354658601400309; Hunter RE, 1999, AM J SPORT MED, V27, P381, DOI 10.1177/03635465990270032101; Katoh S, 1996, SPINAL CORD, V34, P416, DOI 10.1038/sc.1996.74; Kelly J, 1997, JAMA-J AM MED ASSOC, V277, P1190; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Kuhlman GS, 1999, AM FAM PHYSICIAN, V60, P2035; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Marsan MA, 2000, J SYST ARCHITECT, V46, P105, DOI 10.1016/S1383-7621(98)00064-2; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; MORROW PL, 1988, J TRAUMA, V28, P95, DOI 10.1097/00005373-198801000-00014; Mueller F O, 2001, N C Med J, V62, P368; *NCCSIR, 2000, 18 ANN REP FALL 1982; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; Nilsson S, 1978, Am J Sports Med, V6, P358, DOI 10.1177/036354657800600608; *NSCISC, 2001, SPIN CORD INJ INF NE; PALEY D, 1986, AM J SPORT MED, V14, P92, DOI 10.1177/036354658601400117; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; PRALL JA, 1995, INJURY, V26, P539, DOI 10.1016/0020-1383(95)00085-N; Prall JA, 1995, J TRAUMA, V39, P1115, DOI 10.1097/00005373-199512000-00018; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; RODGERS GC, 2002, CONSUMER PRODUCT SAF; Rubin BD, 1999, CLIN SPORT MED, V18, P293, DOI 10.1016/S0278-5919(05)70145-9; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Schenke K, 1998, BRIT TELECOMMUN ENG, V17, P1; SCHER AT, 1991, AM J SPORT MED, V19, P485, DOI 10.1177/036354659101900511; Schmidt-Olsen S, 1985, Br J Sports Med, V19, P161; Schmitt H, 2001, CLIN J SPORT MED, V11, P17, DOI 10.1097/00042752-200101000-00004; TALL RL, 1993, CLIN SPORT MED, V12, P441; Tapper E M, 1978, Am J Sports Med, V6, P114, DOI 10.1177/036354657800600304; Tarazi F, 1999, AM J SPORT MED, V27, P177, DOI 10.1177/03635465990270021101; TATOR CH, 1993, PARAPLEGIA, V31, P700, DOI 10.1038/sc.1993.112; TATOR CH, 1984, CAN MED ASSOC J, V130, P875; Tator CH, 1998, CLIN SPORT MED, V17, P183, DOI 10.1016/S0278-5919(05)70072-7; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; TORG JS, 1985, MED SCI SPORT EXER, V17, P295; TORG JS, 1990, AM J SPORT MED, V18, P50, DOI 10.1177/036354659001800109; TOUGH SC, 1993, AM J FOREN MED PATH, V14, P12, DOI 10.1097/00000433-199303000-00003; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; WU WQ, 1985, SURG NEUROL, V23, P143, DOI 10.1016/0090-3019(85)90332-5	77	19	19	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JUL	2003	22	3					427	+		10.1016/S0278-5919(02)00110-2			18	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	692LT	WOS:000183663100003	12852678				2022-02-06	
J	Cross, KM; Serenelli, C				Cross, KM; Serenelli, C			Training and equipment to prevent athletic head and neck injuries	CLINICS IN SPORTS MEDICINE			English	Article							CERVICAL-SPINE; FOOTBALL; HYPEREXTENSION; MOUTHGUARDS; STRENGTH; FORCES	Due to the likelihood of poor outcomes from neurotraumas, it is very important that coaches and athletes comply with preventive measures. Strength training, sporting techniques, and equipment are the fundamental means of addressing this issue. Cervical spine injuries may be best addressed by cervical stabilization exercises and the use of proper sporting techniques. Concussions, however, are best addressed by proper use and fitting of sports equipment and sporting techniques.	Univ Virginia Sports Med, McCue Ctr, Charlottesville, VA 22904 USA		Cross, KM (corresponding author), Univ Virginia Sports Med, McCue Ctr, POB 400834,Emmet St & Massie Rd, Charlottesville, VA 22904 USA.	kmc7e@virginia.edu					ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; Andrish J T, 1977, Am J Sports Med, V5, P89, DOI 10.1177/036354657700500207; ARHEIM DD, 1997, PRINCIPLES ATHLETIC, P116; BAILES J, 1991, NEURO, V29; BLYTH C, 1978, AM FOOTB COACH ASS D; CANTU RC, 2000, NEUROLOGIC ATHLETIC, P1; CARTER DR, 1980, AM J SPORT MED, V8, P302, DOI 10.1177/036354658000800502; Caswell SV, 2002, J ATHL TRAINING, V37, P164; Clancy W G Jr, 1977, Am J Sports Med, V5, P209, DOI 10.1177/036354657700500508; Crisco JJ, 1997, MED SCI SPORT EXER, V29, P26, DOI 10.1097/00005768-199701000-00005; FISHER SV, 1978, ARCH PHYS MED REHAB, V59, P505; Grimmer K, 1994, Aust J Physiother, V40, P251, DOI 10.1016/S0004-9514(14)60461-X; Grimmer Karen, 1998, Aust J Physiother, V44, P201; HERTLING D, 1996, CERVICAL SPINE MANAG, P544; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; HOVIS WD, 1994, MED SCI SPORT EXER, V26, P872; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; KENDALL FP, 1993, MUSCLES TESTING FUNC, P334; Kettler A, 2002, J BIOMECH, V35, P339, DOI 10.1016/S0021-9290(01)00206-8; KISNER C, 1996, THERAPEUTIC EXERCISE, P551; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; MARKEY K, 1993, AM J SPORTS MED, V21, P1993; *NAT COLL ATHL ASS, 2001, SPORTS MED HDB NCAA; *NAT OP COMM STAND, 2000, NOCSAE MAN; Nightingale RW, 1996, J BONE JOINT SURG AM, V78A, P412, DOI 10.2106/00004623-199603000-00013; POLLOCK ML, 1993, ARCH PHYS MED REHAB, V74, P1080, DOI 10.1016/0003-9993(93)90065-I; ROAF R, 1960, J BONE JOINT SURG BR, V42, P810, DOI 10.1302/0301-620X.42B4.810; SALIBA E, 1996, ATHLETIC INJURIES RE, P899; SPEER KP, 1990, AM J SPORT MED, V18, P591, DOI 10.1177/036354659001800606; TORG JS, 1985, MED SCI SPORT EXER, V17, P295; TORG JS, 1990, AM J SPORT MED, V18, P50, DOI 10.1177/036354659001800109; Weinstein SM, 1998, CLIN SPORT MED, V17, P127, DOI 10.1016/S0278-5919(05)70067-3; Winkelstein BA, 1997, MED SCI SPORT EXER, V29, pS246, DOI 10.1097/00005768-199707001-00007; 2001, BR J SPORTS MED, V35, P81; 2002, NCCA NEWS FEATU 0805	35	19	19	0	26	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JUL	2003	22	3					639	+		10.1016/S0278-5919(02)00099-6			30	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	692LT	WOS:000183663100017	12852692				2022-02-06	
J	Edwards, MJ; McNeil, JE; Greenwood, RJ				Edwards, MJ; McNeil, JE; Greenwood, RJ			Process and outcome during early inpatient rehabilitation after brain injury	DISABILITY AND REHABILITATION			English	Article								Purpose: To describe aspects of process and outcome during early inpatient rehabilitation of younger adults after single incident brain injury. Method: Analysis of a database of 290 patients discharged from an inner-city hospital based inpatient unit for younger adults after single incident neurological events, over a 5-year period. Results: Analysis showed a stable case-mix of patients over the 5 years surveyed with a preponderance of young male patients after traumatic brain injury. Improvements in patients' disability and dependency, measured by the Barthel Index and Functional Independence Measure, were recorded in the majority of patients. The ethnic diversity of the patients, reflecting the multi-cultural nature of the catchment population, did not appear to affect rehabilitation outcome. Failure to record improvement in 15% of patients was related to the floor and ceiling effects of the instruments. A useful regression equation was produced relating length of stay to Barthel score on admission. Conclusions: These data demonstrate the changes that occur during early inpatient rehabilitation after single incident brain injury. They explore clinical indicators of dependency and outcome, and aspects of resource utilization that characterize our service. Publication of data of this sort, from this and other units, should encourage the development and improvement of current rehabilitation service delivery after brain injury.	Homerton Hosp, Reg Neurol Rehabil Unit, London, England		Greenwood, RJ (corresponding author), Homerton Hosp, Reg Neurol Rehabil Unit, London, England.	Richard.Greenwood@homerton.nhs.uk	Edwards, Mark J/F-1052-2012	Edwards, Mark J/0000-0002-8283-9015			ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; Clark Luther T., 1999, American Journal of Medicine, V107, p22S; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; CROMBIE IK, 1993, AUDIT HDB IMPROVING; Haigh R, 2001, J REHABIL MED, V33, P273; *INT WORK PART STR, 1999, NAT CLIN GUID STROK; King JT, 1997, NEUROIMAG CLIN N AM, V7, P659; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; MAHONEY F I, 1965, Md State Med J, V14, P61; McMillan T. M., 1993, CLIN REHABIL, V7, P346; McNeil JE, 1999, NEUROPSYCHOL REHABIL, V9, P321, DOI 10.1080/096020199389400; Mountney L, 2000, CLIN REHABIL, V14, P111; Novak S., 1996, CLIN REHABILITATION, V10, P128; RONDINELLI RD, 1991, ARCH PHYS MED REHAB, V72, P447; *ROYAL COLL SURG E, 1999, REP WORK PART MAN PA; SCHYVE PM, 1990, MEASURING OUTCOMES M; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SORYAL I, 1992, CLIN REHABIL, V6, P103; *STAT U NY BUFF, 1993, GUID UN DAT SYST MED; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; STINEMAN MG, 1998, CRIT REV PHYS REHABI, V10, P319; *STROK UN TRIAL CO, 1999, COCHR LIB; Tesio L, 1996, DISABIL REHABIL, V18, P502, DOI 10.3109/09638289609166036; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008	25	19	21	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	APR 22	2003	25	8					405	410		10.1080/0963828031000062642			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	683KN	WOS:000183147400005	12745950				2022-02-06	
J	Bleich, S; Wilhelm, J; Graesel, E; Degner, D; Sperling, W; Rossner, V; Javaheripour, K; Kornhuber, J				Bleich, S; Wilhelm, J; Graesel, E; Degner, D; Sperling, W; Rossner, V; Javaheripour, K; Kornhuber, J			Apolipoprotein E epsilon 4 is associated with hippocampal volume reduction in females with alcoholism	JOURNAL OF NEURAL TRANSMISSION			English	Article						alcoholism; apolipoprotein E epsilon 4 allele; hippocampal volume; brain shrinkage	TRAUMATIC BRAIN INJURY; ALZHEIMERS-DISEASE; E GENOTYPE; ALLELE DISTRIBUTION; CEREBRAL-CORTEX; E POLYMORPHISM; ATROPHY; NEURONS; SUSCEPTIBILITY; DEFICITS	There is evidence that a higher incidence of diverse neurodegenerative diseases is associated with the apolipoprotein E epsilon4 allele (ApoE4). Most recently it has been found that the ApoE4 allele is specifically related to an accelerated hippocampal atrophy in patients with Alzheimer's disease. Therefore, the aim of the present study was to investigate the association between ApoE4 genotypes and brain hippocampal volume reduction in alcoholics by using volumetric high-resolution MR imaging. In the present study, female alcoholics with the ApoE4 genotype were found to have significantly smaller hippocampal volumes than those not carrying an 84 allele (ANOVA, p < 0.05), whereas no differences in hippocampal volume were seen in male alcoholics. Since hippocampal volume reduction is lately discussed to be proportional to brain atrophy, we propose that the alcohol-related brain atrophy in patients suffering from chronic alcoholism, is more pronounced in female carriers of the apoE epsilon4 allele. These findings indicate a genetic disposition for alcohol related brain atrophy in female carrying the ApoE4 genotype, which may also explain why female alcoholics are more susceptible to alcohol-induced brain damage.	Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; Univ Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany; Univ Gottingen, Dept Neuroradiol, Gottingen, Germany		Kornhuber, J (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Schwabachanlage 6-10, D-91054 Erlangen, Germany.		Kornhuber, Johannes/B-9613-2014; Roessner, Veit/AAQ-8760-2020; Bleich, Stefan/ABC-1796-2020; Roessner, Veit/A-6876-2009	Kornhuber, Johannes/0000-0002-8096-3987; Roessner, Veit/0000-0002-1873-7081			Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; AMOUYEL P, 1994, LANCET, V344, P1315, DOI 10.1016/S0140-6736(94)90691-2; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Bleich S, 2000, ALCOHOL ALCOHOLISM, V35, P351, DOI 10.1093/alcalc/35.4.351; Bretsky PM, 1999, ALZ DIS ASSOC DIS, V13, P216, DOI 10.1097/00002093-199910000-00007; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DELAMONTE SM, 1988, ARCH NEUROL-CHICAGO, V45, P990, DOI 10.1001/archneur.1988.00520330076013; Durany N, 2000, PSYCHIAT GENET, V10, P73, DOI 10.1097/00041444-200010020-00003; Duvernoy HM., 1998, HUMAN HIPPOCAMPUS FU; FERRER I, 1984, NEUROPATH APPL NEURO, V10, P245, DOI 10.1111/j.1365-2990.1984.tb00357.x; FOX JH, 1976, JAMA-J AM MED ASSOC, V236, P365, DOI 10.1001/jama.236.4.365; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Graham DI, 1999, ACT NEUR S, V73, P89; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; HARPER C, 1987, BRIT MED J, V294, P534, DOI 10.1136/bmj.294.6571.534; HARPER C, 1989, J NEUROL SCI, V92, P81, DOI 10.1016/0022-510X(89)90177-9; HARPER CG, 1990, ALCOHOL ALCOHOLISM, V25, P207, DOI 10.1093/oxfordjournals.alcalc.a044994; Harrington CR, 1995, NEUROSCI LETT, V202, P101, DOI 10.1016/0304-3940(95)12218-4; JERNIGAN TL, 1991, ALCOHOL CLIN EXP RES, V15, P418, DOI 10.1111/j.1530-0277.1991.tb00540.x; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kalman J, 2000, NEUROBIOL AGING, V21, P555, DOI 10.1016/S0197-4580(00)00150-0; KORSAKOFF SS, 1887, VESTNIK PSICHIATRII, V4, P2; KRIL JJ, 1993, J NEUROPATH EXP NEUR, V52, P586, DOI 10.1097/00005072-199311000-00005; Laakso MP, 2000, BEHAV BRAIN RES, V109, P177, DOI 10.1016/S0166-4328(99)00172-2; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Mori E, 2002, ANN NEUROL, V51, P209, DOI 10.1002/ana.10093; Muramatsu T, 1997, J NEURAL TRANSM, V104, P913, DOI 10.1007/BF01285559; MURAMATSU T, 1994, ANN NEUROL, V36, P797, DOI 10.1002/ana.410360519; NOGUCHI S, 1993, LANCET, V342, P737, DOI 10.1016/0140-6736(93)91728-5; PAYAMI H, 1993, LANCET, V342, P738; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; RIIKONEN RS, 1994, PEDIATR NEUROL, V11, P332, DOI 10.1016/0887-8994(94)90012-4; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHNEIDER JA, 1995, ANN NEUROL, V38, P131, DOI 10.1002/ana.410380122; SULLIVAN EV, 1995, ALCOHOL CLIN EXP RES, V19, P110, DOI 10.1111/j.1530-0277.1995.tb01478.x; TORVIK A, 1982, J NEUROL SCI, V56, P233, DOI 10.1016/0022-510X(82)90145-9; TSAI GC, 1995, AM J PSYCHIAT, V152, P332; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wernicke C., 1881, LEHRBUCH GEHIRNKRANK	41	19	19	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0300-9564			J NEURAL TRANSM	J. Neural Transm.	APR	2003	110	4					401	411		10.1007/s00702-002-0789-1			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666NB	WOS:000182182400007	12658367				2022-02-06	
J	Bryant, RA; Harvey, AG				Bryant, RA; Harvey, AG			The influence of litigation on maintenance of posttraumatic stress disorder	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article							2-YEAR PROSPECTIVE EVALUATION; TRAUMATIC BRAIN INJURY; ACCIDENTS; INTERVIEW; PTSD		Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England		Bryant, RA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.		Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X			[Anonymous], 1990, ABBR INJ SCAL; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Blanchard EB, 1998, J TRAUMA STRESS, V11, P337, DOI 10.1023/A:1024407321677; BROOKS N, 1992, J TRAUMA STRESS, V5, P527, DOI 10.1007/BF00979222; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; BRYANT RA, 1995, BEHAV RES THER, V33, P631, DOI 10.1016/0005-7967(94)00093-Y; Bryant RA., 2000, ACUTE STRESS DISORDE; Fleiss J.L., 1981, STAT METHODS RATES P; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; Frueh BC, 1996, J TRAUMA STRESS, V9, P427, DOI 10.1007/BF02103656; GREEN RL, 1991, MMPI 2MMPI INTERPRET; Harvey AG, 1999, J CONSULT CLIN PSYCH, V67, P985, DOI 10.1037/0022-006X.67.6.985; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; KELLY R, 1981, J ROY SOC MED, V74, P275, DOI 10.1177/014107688107400407; MAYOU R, 1995, J PSYCHOSOM RES, V39, P789, DOI 10.1016/0022-3999(95)00031-D; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Napier M, 1991, Med Leg J, V59 ( Pt 3), P157; Peters L, 1996, INT J METHOD PSYCH, V6, P167, DOI 10.1002/(SICI)1234-988X(199610)6:3<167::AID-MPR159>3.3.CO;2-Z; SPIELBERGER CD, 1983, MANUAL STATE TRAIT A; Stone A A, 1993, Bull Am Acad Psychiatry Law, V21, P23; THOMPSON GN, 1965, AM J PSYCHIAT, V121, P1043, DOI 10.1176/ajp.121.11.1043	24	19	20	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	MAR	2003	191	3					191	193		10.1097/00005053-200303000-00009			3	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	655LD	WOS:000181553000008	12637846				2022-02-06	
J	Buhre, W; Heinzel, FR; Grund, S; Sonntag, H; Weyland, A				Buhre, W; Heinzel, FR; Grund, S; Sonntag, H; Weyland, A			Extrapolation to zero-flow pressure in cerebral arteries to estimate intracranial pressure	BRITISH JOURNAL OF ANAESTHESIA			English	Article						brain, blood flow; brain, intracranial pressure; head, injury	CRITICAL CLOSING PRESSURE; PERFUSION-PRESSURE; CIRCULATION; HYPERTENSION; VELOCITY; INJURY	Background. Cerebral perfusion pressure (CPP) is commonly calculated from the difference between arterial blood pressure (AP) and intracranial pressure (ICP). ICP can be considered the effective downstream pressure of the cerebral circulation. Consequently, cerebral circulatory arrest would occur when AP equals ICP. Estimation of AP for zero-flow pressure (ZFP) may thus allow estimation of ICP. We estimated ZFP from cerebral pressure-flow velocity relationships so that ICP could be measured by transcranial Doppler sonography. Methods. We studied 20 mechanically ventilated patients with severe head injury, in whom ICP was monitored by epidural pressure transducers. AP was measured with a radial artery cannula. Blood flow velocity in the middle cerebral artery (V-MCA) ipsilateral to the site of ICP measurement was measured with a 2 MHz transcranial Doppler probe. All data were recorded by a microcomputer from analogue-digital converters. ZFP was extrapolated by regression analysis of AP-V-MCA plots and compared with simultaneous measurements of ICP. Results. ZFP estimated from AP-V-MCA plots was linearly related to ICP over a wide range of values (r=0.93). There was no systematic difference between ZFP and ICP. Limit of agreement (2 sd) was 15.2 mm Hg. Short-term variations in ICP were closely followed by changes in ZFP. Conclusion. Extrapolation of cerebral ZFP from instantaneous AP-V-MCA relationships enables detection of severely elevated ICP and may be a useful and less invasive method for CPP monitoring than other methods.	Univ Klinikum RWTH Aachen, Anasthesiol Klin, D-52074 Aachen, Germany; Univ Essen Gesamthsch Klinikum, Inst Pathophysiol, D-4300 Essen, Germany; Univ Gottingen, Zentrum Anaesthesiol Rettungs & Intens Med, D-3400 Gottingen, Germany; Anasthesiol Klin, Oldenburg, Germany; Operat Intens Med Stadt Kliniken, Oldenburg, Germany		Buhre, W (corresponding author), Univ Klinikum RWTH Aachen, Anasthesiol Klin, Pauwelsstr 30, D-52074 Aachen, Germany.		Buhre, Wolfgang/X-9192-2018	Buhre, Wolfgang/0000-0002-8296-9426; Heinzel, Frank R./0000-0002-4529-5282			AASLID R, 1986, NEURORADIOLOGY, V28, P11, DOI 10.1007/BF00341759; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; DEWEY RC, 1976, AM J SURG, V131, P338, DOI 10.1016/0002-9610(76)90128-8; EARLY CB, 1974, J NEUROSURG, V41, P590, DOI 10.3171/jns.1974.41.5.0590; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KLOCKE FJ, 1985, CIRC RES, V56, P310, DOI 10.1161/01.RES.56.3.310; Lang E W, 1995, New Horiz, V3, P400; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; MELOT C, 1995, AM J PHYSIOL-HEART C, V268, pH817, DOI 10.1152/ajpheart.1995.268.2.H817; Nanto S, 1996, ANGIOLOGY, V47, P115, DOI 10.1177/000331979604700202; PANERAI RB, 1995, NEUROPEDIATRICS, V26, P168, DOI 10.1055/s-2007-979748; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Thees C, 2002, ANESTHESIOLOGY, V96, P595, DOI 10.1097/00000542-200203000-00014; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002; WEYLAND A, 1994, ANESTHESIOLOGY, V81, P1401, DOI 10.1097/00000542-199412000-00015	18	19	20	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-0912			BRIT J ANAESTH	Br. J. Anaesth.	MAR	2003	90	3					291	295		10.1093/bja/aeg073			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	652ZG	WOS:000181410300005	12594138	Bronze			2022-02-06	
J	Eames, P; Wood, RL				Eames, P; Wood, RL			Episodic disorders of behaviour and affect after acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							AGGRESSIVE-BEHAVIOR; DYSCONTROL; CARBAMAZEPINE; PROPRANOLOL; OUTBURSTS; EPILEPSY	Psychological disorders that follow traumatic brain injury are possibly more complex and diverse than those associated with other forms of "brain damage". These may include organic aggressive, or organic affective syndromes that are episodic in nature and therefore require a more specific diagnosis, a different classification, and a different approach to treatment. Consequently, it is necessary for clinicians to learn to distinguish between "primary" psychiatric illnesses and those disorders of behavioural control and mood that stem specifically from brain injury. There is relatively little in the clinical literature that explains the relationship between variable states of behaviour, mood or temperament, and clinical disorders that may have long-term implications for patient management. This concept paper therefore addresses abnormalities of mood and behaviour that are episodic in character and are not recognisably included in the DSM and ICD classifications of psychological or psychiatric disorders.	Univ Coll Swansea, Dept Psychol, Swansea SA2 8PP, W Glam, Wales; Beechwood House Brain Injury Rehabil Unit, Pontypool, Wales		Wood, RL (corresponding author), Univ Coll Swansea, Dept Psychol, Singleon Pk, Swansea SA2 8PP, W Glam, Wales.						ADAMEC RE, 1990, BIOL PSYCHIAT, V27, P249, DOI 10.1016/0006-3223(90)90001-I; ADAMEC RE, 1978, LIMBIC MECHANISMS CO, P405; ALDERMAN N, 2000, NEUROBEHAVIOURAL DIS; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANGST J, 1994, J CLIN PSYCHIAT, V55, P3; BACHYRITA G, 1971, AM J PSYCHIAT, V127, P1473, DOI 10.1176/ajp.127.11.1473; BACON C, 1982, BRIT J CLIN SOCIAL P, V2, P16; BLECK TP, 1990, CLIN NEUROPHARMACOL, V13, P121, DOI 10.1097/00002826-199004000-00002; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; BRODSKY L, 1978, 2 WORLD C BIOL PSYCH; CORRIGAN PW, 1993, HOSP COMMUNITY PSYCH, V44, P125; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; DEVINSKY O, 1984, AM J PSYCHIAT, V141, P651; Eames P. G., 1990, NEUROBEHAVIOURAL SEQ; ELLIOTT FA, 1982, J NERV MENT DIS, V170, P680, DOI 10.1097/00005053-198211000-00007; ELLIOTT FA, 1977, ANN NEUROL, V1, P489, DOI 10.1002/ana.410010516; Fava M, 1997, PSYCHIAT CLIN N AM, V20, P427, DOI 10.1016/S0193-953X(05)70321-X; FREDERIKSEN LW, 1981, VIOLENT BEHAV SOCIAL, P265; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; HARPER M, 1962, COMPR PSYCHIAT, V3, P129; Henry-Feugeas MC, 2000, BRAIN INJURY, V14, P597; HOOPER R S, 1945, J Ment Sci, V91, P458; KAPLAN K, 1899, P ROY SOC MED, V2, P458; KOCH G, 1987, ARCH NEUROL-CHICAGO, V44, P578, DOI 10.1001/archneur.1987.00520180004003; Kraepelin E., 1921, MANIC DEPRESSIVE INS; Letterman L, 1999, PHARMACOTHERAPY, V19, P565, DOI 10.1592/phco.19.8.565.31521; LEWIN J, 1992, BRIT J PSYCHIAT, V161, P261, DOI 10.1192/bjp.161.2.261; MAHCESTER D, 2000, NEUROBEHAVIOURAL DIS; MALETZKY BM, 1973, DIS NERV SYST, V34, P178; MATTES JA, 1986, J NERV MENT DIS, V174, P464, DOI 10.1097/00005053-198608000-00004; MATTES JA, 1984, PSYCHOPHARMACOL BULL, V20, P98; MONROE RR, 1989, COMPR PSYCHIAT, V30, P489, DOI 10.1016/0010-440X(89)90078-3; MONROE RR, 1982, J NERV MENT DIS, V170, P711, DOI 10.1097/00005053-198212000-00001; Monroe RR, 1970, EPISODIC BEHAV DISOR; MONROE RR, 1986, LIMBIC SYSTEM FUNCTI, P251; MONROE RR, 1978, BRAIN DYSFUNCTION AG, P105; Morikawa M, 2000, Nihon Shinkei Seishin Yakurigaku Zasshi, V20, P149; NOVACO RW, 1975, ANGER CONTROL DEV DE; ONEILL H, 1999, MANAGING ANGER; Penfield W., 1961, EPILEPSIA, V2, P109; PINEL JPJ, 1977, SCIENCE, V197, P1088, DOI 10.1126/science.560719; Pond DA., 1957, J INDIAN MED PROF, V3, P1421; POST RM, 1985, PSYCHIAT J U OTTAWA, V10, P205; SACHDEO RC, 1987, LANCET, V1, P1432; SILVER JM, 1987, PSYCHIAT ANN, V17, P367, DOI 10.3928/0048-5713-19870601-06; Silver Jonathan M., 1994, P313; STEIN G, 1992, BRIT J PSYCHIAT, V161, P167, DOI 10.1192/bjp.161.2.167; STONE JL, 1986, BIOL PSYCHIAT, V21, P208, DOI 10.1016/0006-3223(86)90148-4; Tariot PN, 1998, AM J PSYCHIAT, V155, P54, DOI 10.1176/ajp.155.1.54; Wood R, 2000, NEUROBEHAVIOURAL DIS; Wood R. L., 1987, BRAIN INJURY REHABIL; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Young J L, 1994, Bull Am Acad Psychiatry Law, V22, P53	54	19	19	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR-MAY	2003	13	1-2			SI		241	258		10.1080/09602010244000435			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	665EK	WOS:000182106500013	21854336				2022-02-06	
J	Woischneck, D; Klein, S; Reissberg, S; Peters, B; Avenarius, S; Gunther, G; Firsching, R				Woischneck, D; Klein, S; Reissberg, S; Peters, B; Avenarius, S; Gunther, G; Firsching, R			Prognosis of brain stem lesion in children with head injury	CHILDS NERVOUS SYSTEM			English	Article						head injury; children; magnetic resonance imaging; brain stem lesion	EVOKED-POTENTIALS	Introduction: Traumatic brain stem lesions (tBSL) in children are thought to be a rare phenomenon. This prospective study analyzed the frequency and significance of such lesions on early magnetic resonance imaging (MRI) after severe head injury, since CT fails to demonstrate these lesions. Methods: In 30 consecutive children comatose after head injuries, MRI was performed within 8 days of the injury. Results: The incidence of tBSL was 60%. When the lesion affected the pons or caudal portions of medulla oblongata bilaterally, mortality was 100%. The presence of tBSL significantly correlated with the duration of coma and the categories of outcome, as indicated by the Glasgow Outcome Score. The frequency and the distribution of tBSL in children were similar to adults. Conclusion: Magnetic resonance imaging appears to be of high predictive value after severe pediatric head injuries.	Otto Von Guericke Univ, Neurochirurg Klin, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Radiol Diagnost Klin, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Inst Biomed & Med Stat, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Klin Allgemeine Padiatrie & Neonatol, D-39120 Magdeburg, Germany		Woischneck, D (corresponding author), Otto Von Guericke Univ, Neurochirurg Klin, Leipziger Str 44, D-39120 Magdeburg, Germany.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; ALEXANDER E, 1982, SURG NEUROL, V17, P107, DOI 10.1016/S0090-3019(82)80031-1; BERNARDI B, 1993, TOP MAGN RESON IMAG, V5, P161; Carter BG, 1999, INTENS CARE MED, V25, P722, DOI 10.1007/s001340050936; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; FIRSCHING R, 1990, NEUROSURG REV, V13, P141, DOI 10.1007/BF00383655; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P1; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; JENNETT B, 1975, LANCET, V1, P81; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; Nieuwenhuys R., 1985, CHEMOARCHITECTURE BR; Stein H, 1996, ZBL CHIR, V121, P985; Wijdicks EFM, 1997, NEUROLOGY, V48, P1456, DOI 10.1212/WNL.48.5.1456	19	19	19	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	MAR	2003	19	3					174	178		10.1007/s00381-002-0703-z			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	670LV	WOS:000182410600008	12644869				2022-02-06	
J	Whyte, J; Hart, T; Bode, RK; Malec, JF				Whyte, J; Hart, T; Bode, RK; Malec, JF			The Moss Attention Rating Scale for traumatic brain injury: Initial psychometric assessment	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						attention; brain injuries; rehabilitation	HEAD-INJURY; WORKING-MEMORY; TASK; METHYLPHENIDATE; BEHAVIOR	Objective: To examine the psychometric properties of the Moss Attention Rating Scale (MARS), a new observational rating scale for attention-related behaviors in traumatic brain injury (TBI). Design: Prospective observational study. Setting: Eight acute inpatient rehabilitation facilities that are part of the Traumatic Brain Injury Model Systems program. Participants: Two hundred twenty-eight patients with TBI requiring acute inpatient rehabilitation treatment. Interventions: Not applicable. Main Outcome Measures: Rasch analysis on the 53-item MARS (45 attention items, 8 control items) as rated separately by the treating occupational therapist and physical therapist. Results: The MARS appeared to measure a single dimension and demonstrated good person separation (5.69) and reliability (.97). In post hoc assessment, misfitting attention items may not have required attention and control items that fit the dimension may have required at least rudimentary attention. Occupational therapists rated patients as slightly less attentive than did physical therapists. Overall, the scale was well targeted to an acute inpatient rehabilitation population. Conclusions: Our results provide: preliminary support for the viability of developing an observational attention rating scale for use in inpatient TBI rehabilitation. Further research will need to explore the existence of subdimensions and provide further validation with reference to other neuropsychologic measures of attention and knowledge of lesion severity and localization.	Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; Rehabil Inst Chicago, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Chicago, IL 60611 USA; Mayo Clin & Mayo Grad Sch Med, Rochester, MN USA		Whyte, J (corresponding author), Moss Rehabil Res Inst, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.	jwhyte@einstein.edu		Whyte, John/0000-0002-4381-1474			Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Burgess P, 1996, BEHAV ASSESSMENT DYS; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Doninger NA, 2000, J HEAD TRAUMA REHAB, V15, P683, DOI 10.1097/00001199-200002000-00007; Hinshaw SP, 1999, DIAGNOSTIC ASSESSMENT IN CHILD AND ADOLESCENT PSYCHOPATHOLOGY, P91; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; LINACRE JM, 2001, FACETS RASCH ANAL CO; Linacre JM., 1989, MANY FACET RASCH MEA; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Mehta MA, 2000, J NEUROSCI, V20; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Rasch Georg, 1980, PROBABILISTIC MODELS; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Whyte J, 1998, J INT NEUROPSYCH SOC, V4, P127, DOI 10.1017/S1355617798001271; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; WHYTE J, 1998, REHABILITATION MED P, P1191; WHYTE J, 1998, P 5 INT ASS STUD TRA, P154; Whyte J., 1997, PROMISE OUTCOMES RES, P43; WILLIAMS JM, 1987, COGNITIVE BEHAV RATI; Wright B, 1982, RATING SCALE ANAL RA; WRIGHT BD, 2001, WINSTEPS RASCH ANAL	29	19	19	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2003	84	2					268	276		10.1053/apmr.2003.50108			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	643QV	WOS:000180872700018	12601660				2022-02-06	
J	Ungerstedt, JS; Grenander, A; Bredbacka, S; Blomback, M				Ungerstedt, JS; Grenander, A; Bredbacka, S; Blomback, M			Clotting onset time may be a predictor of outcome in human brain injury: A pilot study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						brain injury; antithrombin; blood rheology; coagulation activation; bedside monitoring	ANTITHROMBIN-III; SOLUBLE FIBRIN; HEAD-INJURY; TRAUMA; ASSAY; PLASMA	In this study we assess the clotting onset time (COT) in samples from a population of traumatic brain injury patients. The patients were randomized to standard treatment plus high dose antithrombin (AT group) or standard treatment, alone (nonAT group), during the first 16 hours after hospital admission. Our aim was to study the two patient groups during the first 5 days after injury, to assess COT as a coagulation monitoring method compared to routine parameters (thrombin-antithrombin complex (TAT), b-dimer, and soluble fibrin), and to correlate COT to clinical parameters and outcome. Clotting onset time measurements are carried out using free oscillating rheometry, where the endpoint of coagulation onset is determined by a deviation from initial viscoelastic properties of an oscillating sample. Both patient groups initially showed hypercoagulation. In the AT group, a significant increase of COT (i.e., decrease in hypercoagulation), was already seen 16 hours after hospital admission, but not until day 3 in the non AT group. Routine coagulation tests were not able to discriminate AT patients from nonAT patients. Clotting onset time correlated significantly to soluble fibrin, D-dimer, TAT, and leukocyte count. Additionally, COT levels at hospital admission correlated to outcomes measured with the Glasgow Outcome Scale (GOS) after 3 months. These results indicate that COT may be a clinically relevant variable with prognostic value, able to monitor the degree of hypercoagulation over time.	Karolinska Sjukhuset, Div Blood Coagulat Res, S-17176 Stockholm, Sweden; Karolinska Sjukhuset, Karolinska Inst, Dept Surg Sci, Div Anesthesia & Intens Care, S-17176 Stockholm, Sweden		Ungerstedt, JS (corresponding author), Karolinska Sjukhuset, Div Blood Coagulat Res, Clin Chem Bldg L2-05, S-17176 Stockholm, Sweden.		Ungerstedt, Johanna/C-7004-2014				ABILDGAARD U, 1977, THROMB RES, V11, P549, DOI 10.1016/0049-3848(77)90208-0; BLAUHUT B, 1985, THROMB RES, V39, P81, DOI 10.1016/0049-3848(85)90123-9; BOHLIN L, 1994, INT PATENT COOPERATI; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; ELMS MJ, 1983, THROMB HAEMOSTASIS, V50, P591; ERIKSSON BI, 1995, THROMB HAEMOSTASIS, V73, P398; Grenander A, 2001, J NEUROSURG ANESTH, V13, P49, DOI 10.1097/00008506-200101000-00010; Hoots WK, 1997, SEMIN THROMB HEMOST, V23, P3; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; Okajima K, 1998, SEMIN THROMB HEMOST, V24, P27, DOI 10.1055/s-2007-995820; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PELZER H, 1988, THROMB HAEMOSTASIS, V59, P101; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; TEASDALE G, 1974, LANCET, V2, P81; Ungerstedt JS, 2002, SCAND J CLIN LAB INV, V62, P135; WIMAN B, 1986, THROMB HAEMOSTASIS, V55, P189	20	19	23	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2003	15	1					13	18		10.1097/00008506-200301000-00003			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	629UZ	WOS:000180070800003	12499977				2022-02-06	
J	Cato, MA; Brewster, J; Ryan, T; Giuliano, AJ				Cato, MA; Brewster, J; Ryan, T; Giuliano, AJ			Coaching and the ability to simulate mild traumatic brain injury symptoms	CLINICAL NEUROPSYCHOLOGIST			English	Article							FORCED-CHOICE METHOD; MEMORY IMPAIRMENT; BELIEVABLE DEFICITS; PERFORMANCE; TASK	This study assessed the ability of normal controls to simulate mild traumatic brain injury with or without the aid of general simulation strategies. An additional purpose was to evaluate the relative ability of four tests of performance motivation or malingering to discriminate among the five groups in this study. Twenty-one patients with documented mild traumatic brain injury (TBI) and 112 undergraduate students were administered the measures of symptom validity in randomized order with instructions either to perform to the best of their ability or to fake believable deficits. Students asked to malinger were either given instructions to do so with no guidance (No Strategies group or NS), a minimal level of guidance (Only Strategies group or OS) or a moderate level of guidance (Strategies and Example or SE). Students given simulation strategies (OS and SE groups) were able to match performance of the TBI group in only those instances when TBI performance was similar to the normal comparison group. When TBI performance fell considerably below the normal comparison group, naive simulators (NS group) best approximated TBI performance. The degree of variability in the classification success of the four tests underscored the necessity of combining detection methods, as well as the need to develop new tests more resistant to attempts to feign brain injury.	Univ Florida, Hlth Sci Ctr, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA; James Madison Univ, Sch Psychol, Harrisonburg, VA 22807 USA; Univ Virginia, Dept Psychiat Med, Charlottesville, VA USA; Univ Hartford, Dept Psychol, Hartford, CT USA		Cato, MA (corresponding author), Univ Florida, Hlth Sci Ctr, Dept Clin & Hlth Psychol, 1600 SW Archer Rd,Box 100165, Gainesville, FL 32610 USA.						BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; FAUST D, 1990, J CONSULT CLIN PSYCH, V58, P248, DOI 10.1037/0022-006X.58.2.248; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; Faust D, 1988, Arch Clin Neuropsychol, V3, P145, DOI 10.1016/0887-6177(88)90060-1; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Larrabee G. J., 1992, NEUROPSYCHOLOGY, V6, DOI https://doi.org/10.1037/0894-4105.6.1.23; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LORING DW, 1995, ANN M AM AC NEUR SEA; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; Pankratz L., 1997, CLIN ASSESSMENT MALI; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROGERS R, 1988, CLIN ASSESSMENT MALI; Warrington E, 1984, RECOGNITION MEMORY T, V1; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P1182; ZIELINSKI JJ, 1994, CLIN PSYCHOL-SCI PR, V1, P169, DOI 10.1111/j.1468-2850.1994.tb00018.x	23	19	19	0	4	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2002	16	4					524	535		10.1076/clin.16.4.524.13901			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	681AY	WOS:000183015300010	12822060				2022-02-06	
J	Gauggel, S; Hoop, M; Werner, K				Gauggel, S; Hoop, M; Werner, K			Assigned versus self-set goals and their impact on the performance of brain-damaged patients	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							FRONTAL-LOBE LESIONS; IMPAIRED AWARENESS; REACTION-TIME; INJURY; PARTICIPATION; ANOSOGNOSIA; VALIDITY; FLUENCY; DESIGN; TASK	The purpose of this study was to investigate the role played by goal difficulty and goal origin (i.e., self-set vs. assigned) on the performance of patients with brain injuries in a simple arithmetic task. Eighty-seven patients with either cerebral vascular accidents or traumatic brain injuries were investigated. Patients were randomly assigned to one of three conditions: (1) one in which a specific, high goal was assigned. (2) one in which a "do your best" goal was given. and (3) one in which a personal goal has to be stated. The results indicate that both goal difficulty and goal origin had an influence on performance. Assigned difficult goals lead to better performance than assigned easy goals. Self-setting a goal did not increase performance to the same level than the assignment of a difficult goal. This lower performance increase with self-set goals can he explained by the fact that participants selected goals which were not as difficult as the assigned difficult goal. Self-set goals were attained by most of the patients and only 1 patient showed a high discrepancy between self-set goal and actual performance. These findings suggest that goal origin and goal difficulty are important moderators in the goal setting process. Furthermore, patients with brain injuries do not necessarily set unrealistic high goals.	Univ Technol Chemnitz, Dept Psychol, D-09107 Chemnitz, Germany		Gauggel, S (corresponding author), Univ Technol Chemnitz, Dept Psychol, D-09107 Chemnitz, Germany.			Gauggel, Siegfried/0000-0002-2742-4917			Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Austin JT, 1996, PSYCHOL BULL, V120, P338, DOI 10.1037/0033-2909.120.3.338; Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L; Becker Edwin D., 1996, ENCY NUCL MAGNETIC R, V1, P1; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Bergquist Thomas F., 1993, Brain Injury, V7, P275, DOI 10.3109/02699059309029680; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; Brown T, 2001, AM POETRY REV, V30, P50; Cohen J., 2013, STAT POWER ANAL BEHA; EARLEY PC, 1985, ORGAN BEHAV HUM DEC, V36, P378, DOI 10.1016/0749-5978(85)90006-8; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gauggel S, 2000, J HEAD TRAUMA REHAB, V15, P710, DOI 10.1097/00001199-200002000-00009; Gauggel S, 2002, ARCH CLIN NEUROPSYCH, V17, P283, DOI 10.1016/S0887-6177(01)00113-5; Gauggel S, 2001, J CLIN EXP NEUROPSYC, V23, P351, DOI 10.1076/jcen.23.3.351.1178; Gauggel S, 2001, NEUROPSYCHOL REHABIL, V11, P33, DOI 10.1080/09602010042000150; Gauggel S, 2000, NEUROPSYCHOLOGY, V14, P125; GAUGGEL S, 1998, NEUROPSYCHOLOGISCHE; HINSZ VB, 1995, J APPL SOC PSYCHOL, V25, P965, DOI 10.1111/j.1559-1816.1995.tb02385.x; HINSZ VB, 1991, J APPL SOC PSYCHOL, V22, P1296; HOLLENBECK JR, 1987, ORGAN BEHAV HUM DEC, V40, P392, DOI 10.1016/0749-5978(87)90023-9; HOLLENBECK JR, 1989, J APPL PSYCHOL, V74, P951, DOI 10.1037/0021-9010.74.6.951; Horn W, 1983, LEISTUNGSPRUFSYSTEM; HSU LM, 1989, J CONSULT CLIN PSYCH, V57, P131, DOI 10.1037/0022-006X.57.1.131; HUCK SW, 1975, PSYCHOL BULL, V82, P511, DOI 10.1037/h0076767; LATHAM GP, 1982, PERS PSYCHOL, V35, P399, DOI 10.1111/j.1744-6570.1982.tb02204.x; LATHAM GP, 1988, J APPL PSYCHOL, V73, P753, DOI 10.1037/0021-9010.73.4.753; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Locke E.A., 1990, THEORY GOAL SETTING; LOCKE EA, 1991, ORGAN BEHAV HUM DEC, V50, P288, DOI 10.1016/0749-5978(91)90023-M; NAYLOR JC, 1984, RES ORGAN BEHAV, V6, P95; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schefft BK, 1997, CLIN NEUROPSYCHOLOGY, P237; Schwarzer, 1994, DIAGNOSTICA, V40, P105; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; STARKSTEIN SE, 1993, NEUROPSY NEUROPSY BE, V6, P93; STARKSTEIN SE, 1992, STROKE, V23, P1446, DOI 10.1161/01.STR.23.10.1446; STEVENS JP, 1990, INTERMEDIATE STAT; STRECHER VJ, 1995, HEALTH EDUC QUART, V22, P190, DOI 10.1177/109019819502200207; VILKKI J, 1994, NEUROPSYCHOLOGIA, V32, P1257, DOI 10.1016/0028-3932(94)90107-4; VILKKI J, 1991, CORTEX, V27, P203, DOI 10.1016/S0010-9452(13)80124-4; [No title captured]	44	19	19	0	9	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	DEC	2002	24	8					1070	1080		10.1076/jcen.24.8.1070.8377			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	642HA	WOS:000180797100008	12650232				2022-02-06	
J	Jako, P				Jako, P			Safety measures in amateur boxing	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CONCUSSION; SPORTS		Int Amateur Boxing Assoc, H-1053 Budapest, Hungary		Jako, P (corresponding author), Int Amateur Boxing Assoc, Veress Palne 33, H-1053 Budapest, Hungary.						Allanson-Winn R. G., 1897, BOXING; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; CANTU RC, 1995, BOXING MED, P11; JAKO P, 2000, HUNGARIAN REV SPORTS, V61, P173; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rodriguez G, 1998, ITAL J NEUROL SCI, V19, P367, DOI 10.1007/BF02341784	8	19	19	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	DEC	2002	36	6					394	395		10.1136/bjsm.36.6.394			2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	625BD	WOS:000179796200003	12453832	Green Published, Bronze			2022-02-06	
J	Luo, J; Li, N; Robinson, JP; Shi, R				Luo, J; Li, N; Robinson, JP; Shi, R			The increase of reactive oxygen species and their inhibition in an isolated guinea pig spinal cord compression model	SPINAL CORD			English	Article						spinal cord injury; reactive oxygen species (ROS); in vitro; ascorbic acid; hypothermia; flow cytometry	NERVOUS-SYSTEM TRAUMA; LIPID-PEROXIDATION; SUPEROXIDE PRODUCTION; MODERATE HYPOTHERMIA; POLYETHYLENE-GLYCOL; CEREBRAL-ISCHEMIA; ASCORBIC-ACID; CNS INJURY; DAMAGE; BRAIN	Study design: In vitro studies using isolated guinea pig spinal cord. Objectives: To develop an alternative model using isolated guinea pig spinal cord, which can be used to screen antioxidants for in vivo SCI treatment. Setting: Department of Basic Medical Sciences, Purdue University, West Lafayette, Indiana, USA. Methods: The compression injury was induced by a constant-displacement of 5-s compression of spinal cord using a modified forceps possessing a spacer. Reactive oxygen species (ROS) were evaluated using three distinct methods: fluorescence microscopy, lipid peroxidation assay, and flow cytometry. Results: The injury-mediated ROS increases are comparable with other in vivo studies and consistent with our previous observation using a similar injury model and measured with electrophysiological and anatomical technique. Further, ascorbic acid, hypothermia, or the combination of both significantly suppressed superoxide and lipid peroxidation. The combination treatment was the most effective when compared with ascorbic acid or hypothermia alone. Conclusion: This in vitro model has the advantage of replicating some of the in vivo conditions while gaining the ability to control the experimental conditions. This in vitro model is suitable to study the mechanisms of ROS generation and degradation and can also be used to critically evaluate the effective suppressor of ROS in the contents of spinal cord traumatic injury.	Purdue Univ, Sch Vet Med, Dept Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA; Purdue Univ, Cytometry Labs, W Lafayette, IN USA		Shi, R (corresponding author), Purdue Univ, Sch Vet Med, Dept Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA.		Robinson, Joseph/AAA-1001-2020; Robinson, Joseph P/K-8492-2012; Luo, Jian/B-8449-2014	Robinson, Joseph/0000-0001-8383-3240; Luo, Jian/0000-0002-2064-8467			Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; ASANO T, 1995, J NEUROTRAUM, V12, P993; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BLIGHT AR, 1991, J NEUROL SCI, V103, P156, DOI 10.1016/0022-510X(91)90159-5; BLIGHT AR, 1992, J NEUROTRAUMA, V9, P83; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; De Zwart LL, 1999, FREE RADICAL BIO MED, V26, P202, DOI 10.1016/S0891-5849(98)00196-8; Dietrich WD, 1996, ADV NEUROL, V71, P177; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1992, J NEUROTRAUM, V9, P169, DOI 10.1089/neu.1992.9.169; Farooque M, 1997, J NEUROTRAUM, V14, P63, DOI 10.1089/neu.1997.14.63; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GROGAN WM, 1990, GUIDE FLOW CYTOMETRY; HALL ED, 1989, CRIT CARE CLIN, V5, P793; Hall ED, 1995, J NEUROL SCI, V134, P79, DOI 10.1016/0022-510X(95)00211-J; IWASA K, 1989, FREE RADICAL BIO MED, V6, P599, DOI 10.1016/0891-5849(89)90067-1; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kaptanoglu E, 1999, J NEUROSURG, V91, P200, DOI 10.3171/spi.1999.91.2.0200; LAM DKC, 1986, Q J EXP PHYSIOL CMS, V71, P483, DOI 10.1113/expphysiol.1986.sp003007; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu DX, 1998, FREE RADICAL BIO MED, V25, P298, DOI 10.1016/S0891-5849(98)00055-0; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; MARTINEZARIZALA A, 1992, J NEUROTRAUM, V9, pS497; May JM, 1999, FASEB J, V13, P995, DOI 10.1096/fasebj.13.9.995; Mu XJ, 2000, BRAIN RES, V870, P66, DOI 10.1016/S0006-8993(00)02402-1; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Povlishock J T, 1992, Hum Cell, V5, P345; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; ROBINSON JP, 1993, HDB FLOW CYTOMETRY M; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Schmid-Elsaesser R, 1999, STROKE, V30, P1891, DOI 10.1161/01.STR.30.9.1891; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2000, NEUROSCIENCE, V98, P157, DOI 10.1016/S0306-4522(00)00096-8; Shi RY, 2000, J NEUROPHYSIOL, V84, P1763, DOI 10.1152/jn.2000.84.4.1763; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Springer JE, 1997, J NEUROCHEM, V68, P2469; Taoka Y, 1998, BRAIN RES, V799, P264, DOI 10.1016/S0006-8993(98)00459-4; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Tuzgen S, 1998, SPINAL CORD, V36, P654, DOI 10.1038/sj.sc.3100660	45	19	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	DEC	2002	40	12					656	665		10.1038/sj.sc.3101363			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	625QF	WOS:000179826600007	12483500	Bronze			2022-02-06	
J	MacKay, DG; James, LE				MacKay, DG; James, LE			Aging, retrograde amnesia, and the binding problem for phonology and orthography: A longitudinal study of "hippocampal amnesic" HM	AGING NEUROPSYCHOLOGY AND COGNITION			English	Article							CLOSED-HEAD-INJURY; OLDER ADULTS; TEMPORAL-LOBE; THEORETICAL IMPLICATIONS; LANGUAGE PRODUCTION; NEURONAL-ACTIVITY; EXPLICIT MEMORY; WORD RETRIEVAL; SYSTEM; AGE	This study develops and tests a theory of aging and long-term retrograde amnesia (RA) that extends to word retrieval, including the seemingly simple retrieval task of reading isolated words. Under the theory, transmission deficits due to aging, nonrecent use of connections, and infrequent use of connections over the lifespan cause mild and reversible RA in normals but severe and irreversible RA in amnesics who cannot readily form new connections to replace nonfunctioning ones. Consistent with this theory, "hippocampal amnesic" H.M. exhibited little or no retrieval deficit relative to memory-normal controls in reading short, moderately high frequency words at ages 60 or 71 but exhibited accelerated age-linked declines for low frequency words that were unrelated to cerebellar function, working memory capacity, practice effects, speed-accuracy trade-off, and sensory or attentional deficits.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA		MacKay, DG (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	mackay@psych.ucla.edu					ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; BALOTA DA, 1993, J MEM LANG, V32, P573, DOI 10.1006/jmla.1993.1029; Bock K, 1996, PSYCHON B REV, V3, P395, DOI 10.3758/BF03214545; Burke DM, 1997, PHILOS T R SOC B, V352, P1845, DOI 10.1098/rstb.1997.0170; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; CARPENTER GA, 1993, TRENDS NEUROSCI, V16, P131, DOI 10.1016/0166-2236(93)90118-6; Cohen NJ., 1993, MEMORY AMNESIA HIPPO; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Corkin S, 1997, J NEUROSCI, V17, P3964; CORKIN S, 1984, SEMIN NEUROL, V4, P249, DOI 10.1055/s-2008-1041556; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Francis W.N., 1982, FREQUENCY ANAL ENGLI; FREED DM, 1987, NEUROPSYCHOLOGIA, V25, P461, DOI 10.1016/0028-3932(87)90071-6; GABRIELI JDE, 1988, BRAIN COGNITION, V7, P157, DOI 10.1016/0278-2626(88)90027-9; Goodglass H., 1997, ANOMIA NEUROANATOMIC, P3; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; GRAFMAN J, 1996, BASIC APPL MEMORY TH, P259; Halgren E, 1991, Hippocampus, V1, P153, DOI 10.1002/hipo.450010204; Helmuth LI, 1997, LEARN MEMORY, V3, P456, DOI 10.1101/lm.3.6.456; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; James LE, 2001, PSYCHOL SCI, V12, P485, DOI 10.1111/1467-9280.00390; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; Kempermann G, 1998, NERVENARZT, V69, P851, DOI 10.1007/s001150050353; Kesner RP, 1998, PSYCHON B REV, V5, P585, DOI 10.3758/BF03208836; Kintsch W., 1998, COMPREHENSION PARADI; Kopelman MD, 1999, NEUROPSYCHOLOGIA, V37, P939, DOI 10.1016/S0028-3932(98)00143-2; LACKNER JR, 1974, NEUROPSYCHOLOGIA, V12, P199, DOI 10.1016/0028-3932(74)90005-0; LAVER GD, 1993, PSYCHOL AGING, V8, P34, DOI 10.1037/0882-7974.8.1.34; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; Loftus M, 2000, EXP NEUROL, V163, P180, DOI 10.1006/exnr.2000.7361; MacKay DG, 1998, J MEM LANG, V38, P28, DOI 10.1006/jmla.1997.2544; MACKAY DG, 1982, PSYCHOL REV, V89, P483, DOI 10.1037/0033-295X.89.5.483; MacKay DG, 1998, J COGNITIVE NEUROSCI, V10, P377, DOI 10.1162/089892998562807; MacKay DG, 1998, PSYCHOL AGING, V13, P647, DOI 10.1037/0882-7974.13.4.647; MacKay DG, 2001, BRAIN LANG, V78, P265, DOI 10.1006/brln.2001.2470; MacKay DG, 2001, LANG COGNITIVE PROC, V16, P419, DOI 10.1080/01690960042000102; MacKay DG, 1999, PSYCHOL AGING, V14, P3, DOI 10.1037/0882-7974.14.1.3; MACKAY DG, 1992, CONSCIOUS COGN, V1, P199, DOI 10.1016/1053-8100(92)90061-E; MacKay DG., 1990, RELATIONSHIPS PERCEP, P269, DOI [10.1007/978-3-642-75348-0_10, DOI 10.1007/978-3-642-75348-0_10]; MacKay DG., 1987, ORG PERCEPTION ACTIO; MACKAY DG, 1990, AGING COGNITION KNOW, P281, DOI DOI 10.1016/S0166-4115(08)60159-4; MACKAY DG, 2000, ANN M COGN NEUR SOC; Mackay Donald G., 1996, P251; MARSLENWILSON W, 1970, UNPUB BIOGRAPHICAL I, P1; MARSLENWILSON WD, 1975, NEUROPSYCHOLOGIA, V13, P353, DOI 10.1016/0028-3932(75)90013-5; MASSARO DW, 1978, VISIBLE LANG, V12, P3; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCCLELLAND JL, 1985, MEMORY DYSFUNCTIONS, V444, P1; METCALFE J, 1992, J COGNITIVE NEUROSCI, V4, P289, DOI 10.1162/jocn.1992.4.3.289; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Milner B, 1975, Adv Neurol, V8, P299; Morris RGM, 1999, CURR BIOL, V9, pR890; MULLER RU, 1987, J NEUROSCI, V9, P4101; Murre JMJ, 1996, HIPPOCAMPUS, V6, P675, DOI 10.1002/(SICI)1098-1063(1996)6:6<675::AID-HIPO10>3.0.CO;2-Y; Ogden J. A., 1991, MEMORY MECH TRIBUTE, P195; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; OMARA SM, 1994, J NEUROSCI, V14, P6511; PARKIN AJ, 1996, CLASSIC CASES NEUROP; PASHLER H, 1996, MEMORY, P4; Postle BR, 1998, NEUROPSYCHOLOGIA, V36, P421, DOI 10.1016/S0028-3932(97)00155-3; Rastle K, 2000, J MEM LANG, V42, P342, DOI 10.1006/jmla.1999.2687; RINGO JL, 1994, J NEUROPHYSIOL, V71, P1285, DOI 10.1152/jn.1994.71.3.1285; SAFFRAN E M, 1990, P137; Santiago J, 2000, LANG COGNITIVE PROC, V15, P1, DOI 10.1080/016909600386101; SCHACTER D L, 1990, P543; Shallice T., 1988, NEUROPSYCHOLOGY MENT; SHANKS D, 1996, COGNITIVE SCI INTRO, P276; Shiffrin R., 1968, PSYCHOL LEARNING MOT, P90, DOI [DOI 10.1016/S0079-7421(08)60422-3, 10.1016/S0079-7421(08)60422-3]; Squire LR., 1987, MEMORY BRAIN; STERNBERG RJ, 1985, HUMAN ABILITIES INFO; STRATTON RP, 1975, BEHAV RES METH INSTR, V7, P1, DOI 10.3758/BF03201278; Tulving E., 1983, ELEMENTS EPISODIC ME; White KK, 2002, PSYCHOL AGING, V17, P226, DOI 10.1037//0882-7974.17.2.226; WICKELGREN WA, 1979, PSYCHOL REV, V86, P44, DOI 10.1037/0033-295X.86.1.44; WICKELGREN WA, 1968, NEUROPSYCHOLOGIA, V6, P235, DOI 10.1016/0028-3932(68)90022-5; WICKELGREN WA, 1975, SHORT TERM MEMORY, P41; WILKINSON A, 1978, Age and Ageing, V7, P151, DOI 10.1093/ageing/7.3.151; WILSON FAW, 1990, BEHAV BRAIN RES, V40, P7, DOI 10.1016/0166-4328(90)90038-G; WILSON FAW, 1994, BEHAV BRAIN SCI, V17, P499, DOI 10.1017/S0140525X00035676; [No title captured]; 1949, WEBSTERS NEW COLL DI; [No title captured]	85	19	19	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1382-5585	1744-4128		AGING NEUROPSYCHOL C	Aging Neuropsychol. Cogn.	DEC	2002	9	4					298	333		10.1076/anec.9.4.298.8774			36	Psychology, Developmental; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	641XT	WOS:000180772900005					2022-02-06	
J	Ai, JL; Baker, A				Ai, JL; Baker, A			Presynaptic hyperexcitability at cerebellar synapses in traumatic injury rat	NEUROSCIENCE LETTERS			English	Article						cerebellum; neurotransmission; presynaptic; hyperexcitability; trauma brain injury	BRAIN INJURY; HIPPOCAMPUS; MOVEMENT	Neurotransmission in rat cerebellum following fluid percussion injury (FPI) was studied by extracellular recording method. An increased amplitude of population spikes from presynaptic mossy fibers was detected at 3 days after FPI. However, there were no differences at 1 h, 1 day, 1 week or 2 weeks after FPI compared to naive controls. An enhanced amplitude of the population spikes, as well as the after hyperpolarization component from presynaptic response of the parallel fibers, was seen in the groups at 3 days and 1 week post FPI, but not in other groups. These results indicate a presynaptic hyperexcitation was induced by FPI within a specific time window. This hyperexcitability may contribute to the reported loss of Purkinje cells after FPI. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Univ Toronto, St Michaels Hosp, Trauma Brain Injury Lab, Cara Phelan Ctr Trauma Res, Toronto, ON M5B 1W8, Canada		Ai, JL (corresponding author), Univ Toronto, St Michaels Hosp, Trauma Brain Injury Lab, Cara Phelan Ctr Trauma Res, Toronto, ON M5B 1W8, Canada.			AI, JINGLU/0000-0001-7414-0207			Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GILMAN S, 1994, ANN NEUROL, V35, P3, DOI 10.1002/ana.410350103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Thach WT, 1998, NEUROBIOL LEARN MEM, V70, P177, DOI 10.1006/nlme.1998.3846; Tian GF, 2000, J NEUROPHYSIOL, V83, P1830, DOI 10.1152/jn.2000.83.4.1830; vandenPol AN, 1996, J NEUROSCI, V16, P4283	17	19	20	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	NOV 8	2002	332	3					155	158	PII S0304-3940(02)00945-X	10.1016/S0304-3940(02)00945-X			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611JL	WOS:000179013300002	12399004				2022-02-06	
J	Heinius, G; Wladis, A; Hahn, RG; Kjellstrom, BT				Heinius, G; Wladis, A; Hahn, RG; Kjellstrom, BT			Induced hypothermia and rewarming after hemorrhagic shock	JOURNAL OF SURGICAL RESEARCH			English	Article						pig : shock; hypovolemia; temperature; coagulation.	TOTAL HIP-ARTHROPLASTY; BLOOD-LOSS; MILD HYPOTHERMIA; THROMBELASTOGRAPHY; COAGULATION; INJURY; TRAUMA; COAGULOPATHY	Background. Recent patient and animal studies have shown protective effects of hypothermia (HT) in traumatic brain injury and hemorrhagic shock. We have demonstrated a reduced stress level and a lack of additive hemodynamic effects of HT. The present work was undertaken to evaluate whether these effects persist during and after rewarming. Methods. Pigs were quickly exsanguinated of 40% of their individually calculated blood volume and randomized to HT (32.5degreesC) or normothermia (controls). After 30 min of HT, rewarming to baseline temperature was initiated. All animals were followed for 7 h. Thrombolelastography was used to evaluate blood coagulation. Results. HT did not aggravate the hemodynamic signs of hemorrhagic shock. HT decreased the oxygen uptake, however, which reduced the oxygen extraction ratio to the prehemorrhage level (P < 0.05). Serum levels of potassium were transiently stabilized by cooling. Coagulation was slower, but blood clot strength was normal. HT also delayed fibrinolysis (P < 0.05). Rewarming reversed all physiological changes induced by HT including those involving the coagulation system. Conclusion. HT produced few hemodynamic effects in the presence of hemorrhagic shock, but created a surplus of oxygen in the core circulation. Blood clotting was delayed by HT. (C) 2002 Elsevier Science (USA).	Karolinska Inst, Soder Hosp, Dept Surg, SE-11883 Stockholm, Sweden; Karolinska Inst, Soder Hosp, Dept Anesthesiol, SE-11883 Stockholm, Sweden; Swedish Def Res Agcy, Div Human Sci, Dept Expt Traumatol, Stockholm, Sweden		Heinius, G (corresponding author), Karolinska Inst, Soder Hosp, Dept Surg, SE-11883 Stockholm, Sweden.		Wladis, Andreas/AAJ-7844-2020	Wladis, Andreas/0000-0003-4377-0892; Heinius, Goran/0000-0002-4647-3773; Hahn, Robert/0000-0002-1528-3803			BERNABEI AF, 1992, J TRAUMA, V33, P835, DOI 10.1097/00005373-199212000-00007; DOUNING LK, 1995, ANESTH ANALG, V81, P608, DOI 10.1097/00000539-199509000-00033; HAHN RG, 1987, ACTA ANAESTH SCAND, V31, P572, DOI 10.1111/j.1399-6576.1987.tb02623.x; HANNON JP, 1985, AM J PHYSIOL, V248, pR293, DOI 10.1152/ajpregu.1985.248.3.R293; Johansson T, 1999, ACTA ANAESTH SCAND, V43, P1005, DOI 10.1034/j.1399-6576.1999.431006.x; Johnson KB, 1996, SHOCK, V6, P223, DOI 10.1097/00024382-199609010-00012; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kettner SC, 1998, BRIT J ANAESTH, V80, P313, DOI 10.1093/bja/80.3.313; MALLETT SV, 1992, BRIT J ANAESTH, V69, P307, DOI 10.1093/bja/69.3.307; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; OBrien PJ, 1997, LAB ANIM SCI, V47, P486; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Riddez L, 1999, Prehosp Disaster Med, V14, P87; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; TISHERMAN SA, 1998, TRAUMA MANUAL, P394; TUMAN KJ, 1987, ANESTH ANALG, V66, P856; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; WILSON RF, 1996, MANAGEMENT TRAUMA PI, P777; Wladis A, 2002, SHOCK, V17, P120, DOI 10.1097/00024382-200202000-00007; Wladis A, 2001, SHOCK, V15, P60, DOI 10.1097/00024382-200115010-00010; Yamakage M, 1998, CAN J ANAESTH, V45, P993, DOI 10.1007/BF03012308	22	19	21	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	NOV	2002	108	1					7	13		10.1006/jsre.2002.6470			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	620HM	WOS:000179528000002	12443709				2022-02-06	
J	Weber, JT; Rzigalinski, BA; Ellis, EF				Weber, JT; Rzigalinski, BA; Ellis, EF			Calcium responses to caffeine and muscarinic receptor agonists are altered in traumatically injured neurons	JOURNAL OF NEUROTRAUMA			English	Article						calcium imaging; calcium stores; cortical neurons; inositol (1,4,5)-trisphosphate; intracellular free calcium; in vitro; traumatic brain injury	EXPERIMENTAL BRAIN INJURY; STRETCH-INDUCED INJURY; CORTICAL-NEURONS; PHOSPHOLIPASE-C; STORES; CELLS; ASTROCYTES; RELEASE; RAT; TRISPHOSPHATE	A fundamental mechanism that is believed to contribute to neuronal injury and death following traumatic brain injury (TBI) is a disruption in cellular calcium homeostasis. Of primary importance to these homeostatic mechanisms are intracellular calcium stores located on the endoplasmic reticulum. These intracellular stores play an important role in maintaining normal levels of calcium and calcium-mediated signaling through these stores is critical to several physiological processes in neurons. Using an in vitro model of stretch-induced traumatic injury and fura-2 digital calcium imaging, we investigated alterations in calcium-induced calcium release (CICR) and inositol (1,4,5)trisphosphate (IP3)-linked signaling through intracellular calcium stores in populations of cultured rat cortical neurons. Caffeine, which stimulates CICR, produced a rapid elevation of intracellular free calcium ([Ca2+](i)) in 70% of uninjured neurons. Fifteen min after injury the population of caffeine-responsive neurons was reduced to 30%. The IP3-linked muscarinic acetylcholine receptor agonists, CDD-0097 HCl and McN-A-343, produced elevations in [Ca2+], in 91% and 70% of uninjured neurons, respectively. Following injury the population of responders was reduced to 19% and 26%, respectively. Differential responses to agonists were also noted after injury, in which the majority of neurons within a given culture well were unresponsive to agonists while others elicited a normal elevation of calcium. These results suggest disruptions in intracellular calcium store-mediated signaling and altered calcium signaling population dynamics following injury. These alterations could affect normal neurotransmission in the brain and may contribute to some of the pathology of TBI.	Erasmus Univ, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA		Weber, JT (corresponding author), Erasmus Univ, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-27214, NS-40490] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040490, R01NS027214] Funding Source: NIH RePORTER		Ahmed S. M., 2000, Journal of Neurotrauma, V17, P957; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; BRORSON JR, 1991, J NEUROSCI, V11, P4024; Choi S, 1996, J NEUROSCI, V16, P36; DELAHUNTY TM, 1995, NEUROCHEM RES, V20, P405; Dhillon HS, 1999, NEUROCHEM RES, V24, P751, DOI 10.1023/A:1020779413122; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Floyd CL, 2001, GLIA, V33, P12, DOI 10.1002/1098-1136(20010101)33:1<12::AID-GLIA1002>3.0.CO;2-V; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; IRVING AJ, 1992, J PHYSIOL-LONDON, V456, P667, DOI 10.1113/jphysiol.1992.sp019360; Kaftan EJ, 1997, J GEN PHYSIOL, V110, P529, DOI 10.1085/jgp.110.5.529; KOSTYUK P, 1994, NEUROSCIENCE, V63, P381, DOI 10.1016/0306-4522(94)90537-1; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Messer WS, 1997, J MED CHEM, V40, P1230, DOI 10.1021/jm960467d; MICHELETTI R, 1990, J PHARMACOL EXP THER, V253, P310; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Picard L, 1998, CELL CALCIUM, V23, P339, DOI 10.1016/S0143-4160(98)90029-X; POENIE M, 1990, CELL CALCIUM, V11, P85, DOI 10.1016/0143-4160(90)90062-Y; PRASAD MR, 1994, J NEUROCHEM, V63, P773; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0; Rzigalinski BA, 1999, J BIOL CHEM, V274, P175, DOI 10.1074/jbc.274.1.175; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Sanderson MJ, 1996, NEWS PHYSIOL SCI, V11, P262, DOI 10.1152/physiologyonline.1996.11.6.262; Schreiber D., 1995, P 1995 INT RES C BIO, P233; SHMIGOL A, 1994, PFLUG ARCH EUR J PHY, V426, P174, DOI 10.1007/BF00374686; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; TRUMP BF, 1996, SCI PRACTICE ACUTE M, V4, P139; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; WILLAN RL, 1990, MULTIPURPOSE TREE SP, V2, P11; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	40	19	19	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2002	19	11					1433	1443		10.1089/089771502320914660			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	620JD	WOS:000179529500004	12490008				2022-02-06	
J	Buczek, M; Alvarez, J; Azhar, J; Zhou, Y; Lust, WD; Selman, WR; Ratcheson, RA				Buczek, M; Alvarez, J; Azhar, J; Zhou, Y; Lust, WD; Selman, WR; Ratcheson, RA			Delayed changes in regional brain energy metabolism following cerebral concussion in rats	METABOLIC BRAIN DISEASE			English	Article						head injury; concussion; brain energy metabolism; glucose consumption	FLUID-PERCUSSION MODEL; CLOSED-HEAD INJURY; GLUCOSE-UTILIZATION; MAGNETIC-RESONANCE; BLOOD-FLOW; MECHANISMS; ISCHEMIA; EDEMA; EXPRESSION; OXIDASE	Traumatic brain injury (TBI) results in an acute altered metabolic profile of brain tissue which resolves within hours of initial insult and yet some of the functional deficits and cellular perturbations persist for days. It is hypothesized that a delayed change in energy status does occur and is a factor in the neural tissue's ability to survive and regain function. Regional metabolic profile and glucose consumption were determined at either 1 or 3 days following two different intensities of parasagittal fluid-percussion (F-P). A significant decrease in both 1CMR(g)luc and levels of ATP and P-creatine was evident in the hemisphere ipsilateral to the trauma at 1 day after the insult. The effect was greater in the cortical than the subcortical regions and was more pronounced at the higher trauma intensity. Normalization of glucose consumption and energy levels was essentially complete by 3 days. It would appear that the delayed metabolic changes at 1 day postinsult cannot be explained by a secondary ischemia since the changes in the metabolite profile do not elicit an increase in the consumption of glucose. These changes in energy metabolites may account for and contribute to the chronic neurological deficits following TBI.	Case Western Reserve Univ, Univ Hosp Cleveland, Res Inst, Lab Expt Neurol Surg,Dept Neurol Surg, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Cleveland, OH USA		Lust, WD (corresponding author), Case Western Reserve Univ, Univ Hosp Cleveland, Res Inst, Lab Expt Neurol Surg,Dept Neurol Surg, Biomed Res Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.						ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BUCZEK M, 1991, J CEREBR BLOOD F MET, V11, P845, DOI 10.1038/jcbfm.1991.144; DEMEDIUK P, 1988, Journal of Neurotrauma, V5, P105, DOI 10.1089/neu.1988.5.105; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GINSBERG MD, 1977, NEUROLOGY, V27, P1042, DOI 10.1212/WNL.27.11.1042; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; IKEDA Y, 1990, NEUROSURGERY, V27, P1; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Lowry OH., 1972, FLEXIBLE SYSTEM ENZY; LUST WD, 1981, ANAL BIOCHEM, V110, P258, DOI 10.1016/0003-2697(81)90144-5; LUST WD, IN PRESS METAB BRAIN; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCINTOSH TK, 1992, J NEUROTRAUMA S1, V9, P201; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; PONTEN U, 1973, J NEUROCHEM, V21, P1121, DOI 10.1111/j.1471-4159.1973.tb07566.x; PRASAD MR, 1994, J NEUROCHEM, V63, P1094; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Siesjo BK, 1999, ACTA NEUROCHIR SUPPL, V73, P7; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	46	19	19	0	4	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490			METAB BRAIN DIS	Metab. Brain Dis.	SEP	2002	17	3					153	167	UNSP 0885-7490/02/0900-0153/0	10.1023/A:1019973921217			15	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	587FM	WOS:000177629900005	12322786				2022-02-06	
J	Yunoki, M; Nishio, S; Ukita, N; Anzivino, MJ; Lee, KS				Yunoki, M; Nishio, S; Ukita, N; Anzivino, MJ; Lee, KS			Characteristics of hypothermic preconditioning influencing the induction of delayed ischemic tolerance	JOURNAL OF NEUROSURGERY			English	Article						hypothermia; neuronal tolerance; neuroprotection; preconditioning; rat	TRAUMATIC BRAIN-INJURY; GERBIL HIPPOCAMPUS; SPREADING DEPRESSION; CEREBRAL-ISCHEMIA; CORTICAL-NEURONS; GLOBAL-ISCHEMIA; NITRIC-OXIDE; DAMAGE; PRETREATMENT; NEUROPROTECTION	Object. A brief period of hypothermia has recently been shown to induce delayed tolerance to ischemic brain injury. This form of tolerance is initiated several hours after hypothermic preconditioning (HPC) and persists for a few days. Hypothermia-induced tolerance could provide a means for limiting cellular injury during predictable periods of ischemia, such as those that occur during many surgical procedures. The purpose of this study was to characterize the parameters of HPC that regulate the induction of delayed tolerance. Methods. The general design of the experiments was to perform HPC or a sham procedure on adult Sprague-Dawley rats. Twenty-four hours later, the animals were subjected to a transient period of ischemia induced by a 1-hour period of three-vessel occlusion. Infarct volume was assessed 24 hours postischemia. In the first series of experiments, the depth of global (that is, whole-body) HPC was set at 25.5, 28.5, or 31.5degreesC. and the duration of HPC was fixed at 20 minutes. In the second series of experiments, the duration of global HPC was set at 20, 60, 120, or 180 minutes. and the depth of HPC was set at 33 or 34.5degreesC. In the third series of experiments, focal HPC was administered by selectively cooling the head to achieve a cortical temperature of 28.5 or 31.5degreesC for 20 minutes, with the duration of HPC fixed at 20 minutes. The magnitude of tolerance induced by HPC was dependent on the depth and duration of the hypothermic stimulus. The parameters of hypothermia that are capable of inducing tolerance are similar to, or less severe than, those already in clinical use during intraoperative procedures. Focal cooling was as effective as global cooling for eliciting tolerance, indicating that it is possible to establish tolerance while limiting the potential complications of systemic hypothermia. Conclusions. The results of these experiments indicate that HPC may provide an effective and safe means for limiting cellular injury resulting from predictable periods of central nervous system ischemia.	Univ Virginia, Hlth Sci Ctr, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Sci Ctr, Dept Neurol Surg, Charlottesville, VA 22908 USA		Lee, KS (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Neurosci, Box 801392,MR4 Annex, Charlottesville, VA 22908 USA.	ksl3h@virginia.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038918] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38918] Funding Source: Medline		Caprioli J, 1996, INVEST OPHTH VIS SCI, V37, P2376; Centeno JM, 1999, BRAIN RES, V836, P62, DOI 10.1016/S0006-8993(99)01610-8; Chen J, 1997, NEUROLOGY, V48, P306, DOI 10.1212/WNL.48.2.306; CHOPP M, 1992, STROKE, V23, P104, DOI 10.1161/01.STR.23.1.104; CHOPP M, 1989, NEUROLOGY, V39, P1396, DOI 10.1212/WNL.39.10.1396; GIDDAY JM, 1994, NEUROSCI LETT, V168, P221, DOI 10.1016/0304-3940(94)90455-3; HEURTEAUX C, 1995, P NATL ACAD SCI USA, V92, P4666, DOI 10.1073/pnas.92.10.4666; Hiraide T, 2001, BRAIN RES, V910, P94, DOI 10.1016/S0006-8993(01)02647-6; HIRAMATSU K, 1993, ACTA NEUROCHIR, V120, P66, DOI 10.1007/BF02001472; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Kapinya K, 2000, BRAIN RES, V872, P282, DOI 10.1016/S0006-8993(00)02503-8; KATO H, 1992, BRAIN RES BULL, V29, P559, DOI 10.1016/0361-9230(92)90123-F; KATO H, 1995, NEUROSCI LETT, V189, P13, DOI 10.1016/0304-3940(95)11437-2; KATO H, 1991, BRAIN RES, V553, P238, DOI 10.1016/0006-8993(91)90831-F; KATO H, 1992, NEUROSCI LETT, V139, P118, DOI 10.1016/0304-3940(92)90871-4; KAWAHARA N, 1995, NEUROL RES, V17, P9, DOI 10.1080/01616412.1995.11740281; Kawahara N, 1997, NEUROSCI RES, V29, P37, DOI 10.1016/S0168-0102(97)00069-2; KIRINO T, 1991, J CEREBR BLOOD F MET, V11, P299, DOI 10.1038/jcbfm.1991.62; KITAGAWA K, 1991, BRAIN RES, V561, P203, DOI 10.1016/0006-8993(91)91596-S; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; KOBAYASHI S, 1995, J CEREBR BLOOD F MET, V15, P721, DOI 10.1038/jcbfm.1995.92; KULUZ JW, 1992, STROKE, V23, P1792, DOI 10.1161/01.STR.23.12.1792; Leben J, 1997, ANN NY ACAD SCI, V813, P807, DOI 10.1111/j.1749-6632.1997.tb51785.x; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MOURITZEN CV, 1966, J THORAC CARDIOV SUR, V51, P585, DOI 10.1016/S0022-5223(19)43326-6; NAKATA N, 1993, NEUROREPORT, V4, P695, DOI 10.1097/00001756-199306000-00023; Nandagopal K, 2001, J PHARMACOL EXP THER, V297, P474; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; NISHI S, 1993, BRAIN RES, V615, P281, DOI 10.1016/0006-8993(93)90039-P; Nishio S, 2000, J NEUROSURG, V93, P845, DOI 10.3171/jns.2000.93.5.0845; Nishio S, 1999, ANN NY ACAD SCI, V890, P26, DOI 10.1111/j.1749-6632.1999.tb07978.x; PerezPinzon MA, 1996, NEUROSCIENCE, V75, P687; Reshef A, 2000, NEUROREPORT, V11, P463, DOI 10.1097/00001756-200002280-00007; Riepe MW, 1997, MOL CELL BIOCHEM, V174, P249, DOI 10.1023/A:1006820927262; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; SCHUBERT A, 1997, J NEUROSURG ANESTHES, V7, P139; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; SHIMAZAKI K, 1994, NEUROSCI RES, V20, P95, DOI 10.1016/0168-0102(94)90026-4; SOMMER C, 1995, BRAIN PATHOL, V5, P135, DOI 10.1111/j.1750-3639.1995.tb00587.x; Sugino T, 2000, NEUROSCI LETT, V278, P101, DOI 10.1016/S0304-3940(99)00906-4; Tasaki K, 1997, BRAIN RES, V748, P267, DOI 10.1016/S0006-8993(96)01383-2; Tauskela JS, 1999, BRAIN RES, V827, P143, DOI 10.1016/S0006-8993(99)01322-0; Tomasevic G, 1999, MOL BRAIN RES, V70, P304, DOI 10.1016/S0169-328X(99)00146-1; Toyoda T, 1997, NEUROREPORT, V8, P847, DOI 10.1097/00001756-199703030-00008; Wada K, 1996, BRAIN RES, V740, P15; Wada S, 2000, MAR BIOTECHNOL, V2, P285, DOI 10.1007/s101260000006; Yanamoto H, 1998, BRAIN RES, V784, P239, DOI 10.1016/S0006-8993(97)01344-9; Yano S, 2001, J CEREBR BLOOD F MET, V21, P351, DOI 10.1097/00004647-200104000-00004	48	19	20	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2002	97	3					650	657		10.3171/jns.2002.97.3.0650			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	593JA	WOS:000177986400020	12296650				2022-02-06	
J	Brewer, TL; Metzger, BL; Therrien, B				Brewer, TL; Metzger, BL; Therrien, B			Trajectories of cognitive recovery following a minor brain injury	RESEARCH IN NURSING & HEALTH			English	Article						attention; minor brain injury; healing	CLOSED-HEAD INJURY; INTEGRATIVE SPATIAL ABILITY; PORTEUS MAZE TEST; PERFORMANCE; ATTENTION; SEQUELAE	Minor brain injury (MBI) is the most frequently diagnosed head trauma in the United States, with treatment costing more than $1.5 billion annually and many patients incapacitated for months following injury. The purpose of this study was to characterize the brain function disruptions associated with MBI and to determine the time trajectory of recovery, using a theoretical model of attention. Distractibility, impulsivity, irritability, and impaired executive functioning were demonstrated in all participants during the 24 hr after injury. Twenty percent of participants continued to complain of distractibility, impulsivity, and/or irritability throughout the 30-day study. Loss of consciousness was shown to confound participants' healing trajectories. These results suggest that standard emergency room treatment following MBI is inadequate and should include discharge directives to reduce cognitive demands for at least 48 hr at a minimum, for 30 days or longer for those with loss of consciousness. (C) 2002 Wiley Periodicals, Inc.	Univ Connecticut, Sch Nursing, Storrs, CT 06269 USA; Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA		Brewer, TL (corresponding author), Univ Connecticut, Sch Nursing, 231 Glenbrook Rd,U-26, Storrs, CT 06269 USA.				NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007074] Funding Source: NIH RePORTER; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32 NR07074] Funding Source: Medline		Allport, 1985, PSYCHOL BRIEFER COUR; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Benson D.F., 1986, FRONTAL LOBES; BERNDT DJ, 1981, J CLIN PSYCHOL, V37, P564, DOI 10.1002/1097-4679(198107)37:3<564::AID-JCLP2270370319>3.0.CO;2-2; BERNDT DJ, 1990, MULTISCORE DEPRESSIO; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BORNSTEIN RA, 1986, INT J CLIN NEUROPSYC, V8, P18; BORNSTEIN RA, 1993, NEUROPSYCHOLOGY, V7, P228, DOI DOI 10.1037/0894-4105.7.2.228; BREWER T, 1998, THESIS U MICHIGAN AN; CIMPRICH B, 1993, CANCER NURS, V16, P83; Cimprich B, 1990, THESIS U MICHIGAN AN; Conners C. K., 1995, CPT CONNERS CONTINUO; CURRY LM, 1997, PHILADELPHIA HEAD IN; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; GOW L, 1982, PERCEPT MOTOR SKILL, V54, P1043, DOI 10.2466/pms.1982.54.3c.1043; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kolb B., 1990, FUNDAMENTALS HUMAN N; KOZIOL LF, 1992, PERCEPT MOTOR SKILL, V75, P1187, DOI 10.2466/PMS.75.8.1187-1192; Levin H.S., 1989, MILD HEAD INJURY; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; MALCOLM CD, 1993, THESIS BOSTON U BOST; NORUSIS MJ, 1993, SPSS WINDOWS BASE SY; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; PENDLETON MG, 1982, J CLIN NEUROPSYCHOL, V4, P307, DOI 10.1080/01688638208401139; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Porteus S.D., 1965, PORTEUS MAZE TEST 50; ROBERTS AH, 1968, J ABNORM PSYCHOL, V73, P449, DOI 10.1037/h0026211; Salthouse T. A., 1996, J GERONTOL B-PSYCHOL, V51B, P317; SALTHOUSE TA, 1995, J GERONTOL B-PSYCHOL, V50, pP297, DOI 10.1093/geronb/50B.6.P297; SALTHOUSE TA, 1989, PSYCHOL AGING, V4, P18, DOI 10.1037/0882-7974.4.1.18; SALTHOUSE TA, 1987, PSYCHOL AGING, V2, P254, DOI 10.1037/0882-7974.2.3.254; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Spreen O, 1991, COMPENDIUM NEUROPSYC; TUPPER D, 1984, J CLIN PSYCHOL, V6, P411; UZZELL BP, 1988, ARCH NEUROL-CHICAGO, V45, P420, DOI 10.1001/archneur.1988.00520280066017; Wolfson, 1993, HALSTEAD REITAN NEUR	39	19	19	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-6891	1098-240X		RES NURS HEALTH	Res. Nurs. Health	AUG	2002	25	4					269	281		10.1002/nur.10045			13	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	580CU	WOS:000177217700004	12124721				2022-02-06	
J	Kulkarni, M; Armstead, WM				Kulkarni, M; Armstead, WM			Relationship between NOC/oFQ, dynorphin, and COX-2 activation in impaired NMDA cerebrovasodilation after brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral circulation; excitatory amino acids; newborn; opioids; oxygen free radicals	NOCICEPTIN/ORPHANIN FQ; CEREBRAL-CIRCULATION; HEAD-INJURY; ORPHANIN-FQ; CYCLOOXYGENASE-2; EXPRESSION; RELEASE; RAT; CONTRIBUTES; RECEPTOR	Previous studies have observed that the recently described endogenous opioid, nociceptin/orphanin FQ (NOC/oFQ), contributes to impairment of N-methyl-D-aspartate (NMDA)-induced cerebrovasodilation following fluid percussion brain injury (FPI) via a cyclooxygenase (COX)-dependent generation of superoxide anion (O-2(-)). This study was designed to investigate the relationship between NOC/oFQ, another opioid, dynorphin, and activation of the COX-2 isoform of the enzyme in such impaired dilation to NMDA after FPI in piglets equipped with a closed cranial window. Superoxide dismutase (SOD)-inhibitable nitroblue tetrazolium (NBT) reduction was determined as an index of O-2(-) generation. Under non-brain injury conditions, NOC/oFQ (10(-10) M), the CSF concentration observed after FPI, increased CSF dynorphin, while the NOC/oFQ antagonist [F/G] NOC/oFQ (1-13) NH2 attenuated the stimulated release of dynorphin following FPI (34 +/- 3 and 97 +/- 6 vs. 36 +/- 3 and 68 +/- 8 pg/mol for CSF dynorphin before and after FPI in untreated and NOC/oFQ antagonist-pretreated animals). FPI increased SOD-inhibitable NBT reduction, but pretreatment with norbinaltorphimine, a dynorphin antagonist, or NS398, a COX-2 inhibitor, blunted such reduction (1 +/- 1 vs. 19 +/- 3 vs. 4 +/- 1 vs. 4 +/- 1 pmol/mm(2) for control, FPI, FPI-norbinaltorphimine and FPI-NS398, respectively). Under non-brain injury conditions, dynorphin, in a concentration observed in CSF after FPI, also increased SOD-inhibitable NBT reduction, which was blunted by NS398. NMDA-induced pial artery dilation was reversed to vasoconstriction following FPI, but pretreatment with norbinaltorphimine or NS398 partially protected such responses (9 +/- 1 and 16 +/- 1, control; -8 +/- 1 and -13 +/- 2, FPI; 6 +/- 1 and 12 +/- 1% FPI-norbinaltorphimine for NMDA 10(-8), 10(-6) M, respectively). These data show that NOC/oFQ modulates the CSF release of dynorphin after FPI. These data also show that dynorphin contributes to O-2(-) generation after FPI via COX-2 activation. These data additionally indicate that dynorphin and COX-2 activation contribute to impairment of NMDA pial artery dilation after FPI. Finally, these data suggest that NOC/oFQ impairs NMDA dilation postinsult via the sequential release of dynorphin, activation of COX-2, and generation of O-2(-).	Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia, 3400 Spruce St, Philadelphia, PA 19104 USA.						Armstead WM, 2000, AM J PHYSIOL-HEART C, V279, pH2188, DOI 10.1152/ajpheart.2000.279.5.H2188; Armstead WM, 2000, J NEUROTRAUM, V17, P751, DOI 10.1089/neu.2000.17.751; ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; Armstead WM, 1997, P SOC EXP BIOL MED, V214, P210; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; FARACI FM, 1993, CIRC RES, V72, P476, DOI 10.1161/01.RES.72.2.476; FATAKI N, 1994, PROSTAGLANDINS, V47, P55; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Gintzler AR, 1997, EUR J PHARMACOL, V325, P29, DOI 10.1016/S0014-2999(97)00103-9; Gong C, 2001, BRAIN RES, V901, P38, DOI 10.1016/S0006-8993(01)02186-2; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kaufman AE, 1996, IEEE T VIS COMPUT GR, V2, P1; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kulkarni M, 2000, STROKE, V31, P1990, DOI 10.1161/01.STR.31.8.1990; Lapchak PA, 2001, STROKE, V32, P1220, DOI 10.1161/01.STR.32.5.1220; Leffler CW, 1993, REGULATION CEREBRAL, P297; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Resnick DK, 1998, J NEUROTRAUM, V15, P1005, DOI 10.1089/neu.1998.15.1005; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; Sairanen T, 1998, ANN NEUROL, V43, P738, DOI 10.1002/ana.410430608; Schwab JM, 2001, J NEUROTRAUM, V18, P881, DOI 10.1089/089771501750451802; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T	33	19	22	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2002	19	8					965	973		10.1089/089771502320317113			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	585JC	WOS:000177520800006	12225656				2022-02-06	
J	Andermahr, J; Greb, A; Hensler, T; Helling, HJ; Bouillon, B; Sauerland, S; Rehm, KE; Neugebauer, E				Andermahr, J; Greb, A; Hensler, T; Helling, HJ; Bouillon, B; Sauerland, S; Rehm, KE; Neugebauer, E			Pneumonia in multiple injured patients: a prospective controlled trial on early prediction using clinical and immunological parameters	INFLAMMATION RESEARCH			English	Article						pneumonia; multiple trauma; interleukin; TNF receptors; procalcitonin	RISK-FACTORS; INFLAMMATORY MEDIATORS; NOSOCOMIAL PNEUMONIA; ORGAN FAILURE; PLASMA-LEVELS; TRAUMA; SEPSIS; SEVERITY; PROCALCITONIN; INTERLEUKIN-10	Objective and design: In a prospective trial 266 multiple injured patients were included to evaluate clinical risk factors and immune parameters related to pneumonia. Methods: Clinical and humoral parameters were assessed and multivariate analysis performed. Results: The multivariate analysis (odds ratio with 95% confidence interval (Cl)) revealed male gender (3.65), traumatic brain injury (TBI) (2.52), thorax trauma (AIS(thorax) greater than or equal to 3) (2.05), antibiotic prophylaxis (1.30), injury severity score (ISS) (1.03 per ISS point) and the age (1.02 per year) as risk factors for pneumonia. The main pathogens were Acinetobacter Baumannii (40 %) and Staphylococcus aureus (25 %). A tendency towards higher Procalcitonin (PCT) and Interleukin (IL)-6 levels two days after trauma was observed for pneumonia patients. Conclusion: The immune parameters (PCT, IL-6, IL-10, soluble tumor necrosis factor p-55 and p-75) could not confirm the diagnosis of pneumonia earlier than the clinical parameters.	Univ Cologne, Clin Trauma Hand & Reconstruct Surg, DE-50924 Cologne, Germany; Univ Cologne, Dept Surg 2, Biochem & Expt Div, DE-51109 Cologne, Germany; Univ Cologne, Dept Surg 2, Surg Clin, DE-51109 Cologne, Germany		Andermahr, J (corresponding author), Univ Cologne, Clin Trauma Hand & Reconstruct Surg, Joseph Stelzmannstr 9, DE-50924 Cologne, Germany.	JAndermahr@t-online.de		Sauerland, Stefan/0000-0003-1048-796X			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ANTONELLI M, 1994, CHEST, V105, P224, DOI 10.1378/chest.105.1.224; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Aufmkolk M, 1998, UNFALLCHIRURG, V101, P433, DOI 10.1007/s001130050292; BILLIAU A, 1991, EUR J CLIN INVEST, V21, P559, DOI 10.1111/j.1365-2362.1991.tb01410.x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bone RC, 1996, CRIT CARE MED, V24, P163, DOI 10.1097/00003246-199601000-00026; BRUNBUISSON C, 1995, CURR OPIN CRIT CARE, V1, P341; Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711; CELIS R, 1988, CHEST, V93, P318, DOI 10.1378/chest.93.2.318; CHAMPION HR, 1983, WORLD J SURG, V7, P4, DOI 10.1007/BF01655906; CHEVRET S, 1993, INTENS CARE MED, V19, P256, DOI 10.1007/BF01690545; CRAIG CP, 1984, AM J INFECT CONTROL, V12, P233, DOI 10.1016/0196-6553(84)90114-7; DALISE MD, 1994, J TRAUMA, V37, P171, DOI 10.1097/00005373-199408000-00002; ERTEL W, 1995, J TRAUMA, V39, P879, DOI 10.1097/00005373-199511000-00011; FAIST E, 1992, SURGERY, V112, P562; Gendrel D, 1997, INFECTION, V25, P133, DOI 10.1007/BF02113598; HALEY RW, 1981, AM J MED, V70, P51, DOI 10.1016/0002-9343(81)90411-3; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; HOYT DB, 1993, J TRAUMA, V35, P524, DOI 10.1097/00005373-199310000-00005; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Kahlke V, 2000, CYTOKINE, V12, P69, DOI 10.1006/cyto.1999.0511; KRAGSBJERG P, 1995, EUR J SURG, V161, P17; KRAGSBJERG P, 1995, THORAX, V50, P1253, DOI 10.1136/thx.50.12.1253; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; RODRIGUEZ JL, 1991, J TRAUMA, V31, P907, DOI 10.1097/00005373-199107000-00005; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; Sherry RM, 1996, J TRAUMA, V40, P613, DOI 10.1097/00005373-199604000-00016; TOEWS GB, 1986, AM J MED SCI, V291, P355, DOI 10.1097/00000441-198605000-00013; TRINKLE JK, 1975, ANN THORAC SURG, V19, P355, DOI 10.1016/S0003-4975(10)64034-9; WALKER WE, 1985, ANN SURG, V201, P752, DOI 10.1097/00000658-198506000-00012; Wanner GA, 2000, CRIT CARE MED, V28, P950, DOI 10.1097/00003246-200004000-00007; WAYDHAS C, 1992, ARCH SURG-CHICAGO, V127, P460; Weber DJ, 1999, CHEST, V115, p34S, DOI 10.1378/chest.115.suppl_1.34S; Wichmann MW, 1996, CYTOKINE, V8, P853, DOI 10.1006/cyto.1996.0114	36	19	23	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	MAY	2002	51	5					265	272		10.1007/PL00000303			8	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	556BG	WOS:000175827100008	12056515				2022-02-06	
J	Hertel, M; Braun, S; Durka, S; Alzheimer, C; Werner, S				Hertel, M; Braun, S; Durka, S; Alzheimer, C; Werner, S			Upregulation and activation of the Nrf-1 transcription factor in the lesioned hippocampus	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						brain; heme oxygenase; kainic acid; reactive oxygen species	ANTIOXIDANT RESPONSIVE ELEMENTS; KAINATE-MEDIATED EXCITOTOXICITY; NMDA RECEPTOR ACTIVATION; HEME OXYGENASE-1; CELL-DEATH; IN-VIVO; EXPRESSION; INDUCTION; PROTEINS; BINDING	The Nrf-1 and Nrf-2 transcription factors play a pivotal role in the cellular defence against the toxic effects of reactive oxygen species (ROS). Although ROS are key effectors of neuronal death after ischaemic and traumatic brain injury, it is not known whether Nrf-1 and Nrf-2 are involved in neuroprotective signalling. Here, we analysed the temporal and spatial expression pattern of Nrf-1 and Nrf-2 after unilateral excitotoxic lesion of mouse hippocampus. In marked contrast to previous in vitro studies, where upregulation of these transcription factors on the mRNA level was never detected, we found a strong induction of Nrf-1 mRNA and protein expression in neurons of the lesioned hippocampus, accompanied by a weak elevation of Nrf-2 mRNA levels. Nrf-1 predominantly localized to the nucleus in the injured hippocampus. Furthermore, expression of the cytoprotective enzyme, heme oxygenase-1, a major target of Nrf-1 and Nrf-2 action, was coregulated with Nrf-1 in the same hippocampal neurons, suggesting that Nrf-1 is functionally active. Because Nrf-1 and Nrf-2 are potent inducers of various cytoprotective proteins, our data suggest a role of Nrf-1 and Nrf-2 in neuronal survival after acute brain injury.	Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; Univ Munich, Inst Physiol, D-80539 Munich, Germany		Werner, S (corresponding author), Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland.	Sabine.werner@cell.biol.ethz.ch		Werner, Sabine/0000-0001-7397-8710			ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BAST A, 1997, NEUROPROTECTION CNS, P147; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Boldyrev A, 2000, CELL MOL NEUROBIOL, V20, P433, DOI 10.1023/A:1007066913756; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Dong Z, 2000, AM J PATHOL, V156, P1485, DOI 10.1016/S0002-9440(10)65019-5; Elbirt KK, 1999, P ASSOC AM PHYSICIAN, V111, P438, DOI 10.1111/paa.1999.111.5.438; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GUNASEKAR PG, 1995, J NEUROCHEM, V65, P2016; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Matsuoka Y, 1998, NEUROSCIENCE, V85, P1223, DOI 10.1016/S0306-4522(97)00678-7; Nakaso K, 1999, BIOCHEM BIOPH RES CO, V259, P91, DOI 10.1006/bbrc.1999.0724; Nakaso K, 1999, MOL BRAIN RES, V69, P155, DOI 10.1016/S0169-328X(99)00093-5; Nakaso K, 2000, NEUROSCI LETT, V282, P57, DOI 10.1016/S0304-3940(00)00836-3; PRESKORN SH, 1995, PRINCIPLES PRACTICE, V1, P1; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Tretter YP, 1996, NEUROREPORT, V7, P1819, DOI 10.1097/00001756-199607290-00026; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896	25	19	20	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	MAY	2002	15	10					1707	1711		10.1046/j.1460-9568.2002.01992.x			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	561FB	WOS:000176128600015	12059978				2022-02-06	
J	Hatcher, JP; Virley, D; Hadingham, SJ; Roberts, J; Hunter, AJ; Parsons, AA				Hatcher, JP; Virley, D; Hadingham, SJ; Roberts, J; Hunter, AJ; Parsons, AA			The behavioural effect of middle cerebral artery occlusion on apolipoprotein-E deficient mice	BEHAVIOURAL BRAIN RESEARCH			English	Article						apolipoprotein-E; MCAO; behaviour; mouse	CLOSED-HEAD INJURY; COGNITIVE DEFICITS; GLOBAL-ISCHEMIA; PROTEIN; BRAINS; MOUSE	The behavioural effects of middle cerebral artery occlusion (MCAO) in apoliprotein-E deficient (Apo-E KO) mice were investigated using a modified SHIRPA protocol and compared with effects in wild type littermate controls. The MCA was permanently occluded by insertion of an intraluminal filament to its origin on the Circle of Willis and behavioural reponses were observed 24 It later. MCAO treatment caused a range or changes in the wild type mice whereas, few differences were observed in the Apo-E KO mice in the behavioural observation. In the rotarod task, MCAO operated wild type mice showed a significant reduction in performance compared with sham-operated and non-operated animals. In contrast, both sham and MCAO operated Apo-E KO mice showed significant impairment compared with non-operated controls. A significant reduction in performance was also observed in sham-operated Apo-E KO compared with sham-operated wild type mice. In locomotor activity tests, no significant reduction in activity was observed between non-operated and sham-operated wild type controls, whereas a significant reduction was found between sham operated and MCAO operated mice. In the Apo-E KO mice, both sham and MCAO-operated animals showed a reduction in locomotor activity compared with non-operated mice. Furthermore, Apo-E KO MCAO mice showed a worsened deficit in locomotor activity, which was significantly correlated with exacerbated cortical lesion volume, unlike wild-type MCAO mice. This study shows that Apo-E KO animals demonstrate an impaired functional recovery post surgery which may be further compounded by post experimental stroke and also demonstrates the utility of the SHIRPA test system for investigating behavioural changes in functional outcome post stroke. (C) 2002 Elsevier Science B.V. All rights reserved.	GlaxoSmithKline, Neurol CEDD, Harlow CM19 5AW, Essex, England		Hatcher, JP (corresponding author), GlaxoSmithKline, Neurol CEDD, New Frontiers Sci Pk,3rd Ave, Harlow CM19 5AW, Essex, England.						Ali SM, 1996, MOL BRAIN RES, V38, P37, DOI 10.1016/0169-328X(95)00301-8; Bart RD, 1998, NEUROREPORT, V9, P2615, DOI 10.1097/00001756-199808030-00035; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; FULLERTON SM, 1999, SOC NEUR ABSTR, V25, P542; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; Horsburgh K, 1996, NEUROPATH APPL NEURO, V22, P342, DOI 10.1111/j.1365-2990.1996.tb01113.x; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; Horsburgh K, 1999, NEUROREPORT, V10, P837, DOI 10.1097/00001756-199903170-00031; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KOIZUMI J, 1996, JPN J STROKE, V8, P1; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Matthews RT, 1996, BRAIN RES, V718, P181, DOI 10.1016/0006-8993(95)01576-0; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; OBRIEN MD, 1979, STROKE, V10, P623, DOI 10.1161/01.STR.10.6.623; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; SHORE VG, 1973, BIOCHEMISTRY-US, V12, P502, DOI 10.1021/bi00727a022; SLOOTER AJ, 1997, JAMA-J AM MED ASSOC, V227, P818; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhou Y, 1998, BRAIN RES, V788, P151, DOI 10.1016/S0006-8993(97)01533-3	28	19	22	2	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	APR 1	2002	131	1-2					139	149	PII S0166-4328(01)00377-1	10.1016/S0166-4328(01)00377-1			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	537UD	WOS:000174777200015	11844581				2022-02-06	
J	Krum, JM; Phillips, TM; Rosenstein, JM				Krum, JM; Phillips, TM; Rosenstein, JM			Changes in astroglial GLT-1 expression after neural transplantation or stab wounds	EXPERIMENTAL NEUROLOGY			English	Article						glutamate transporters; gliosis; neural grafting; nestin; GFAP; immunoaffinity chromatography	GLUTAMATE TRANSPORTER GLT-1; TRAUMATIC BRAIN INJURY; FIBRILLARY ACIDIC PROTEIN; FOCAL CEREBRAL-ISCHEMIA; EXCITATORY AMINO-ACIDS; INDUCED AXONAL INJURY; MOUSE SPINAL-CORD; NEOCORTICAL TRANSPLANTS; REACTIVE ASTROCYTES; NERVOUS-SYSTEM	Uncontrolled release of glutamate from damaged brain initiates events that result in excitotoxic neuronal death. Glutamate uptake by specialized astroglial transporters is essential for control of extracellular glutamate levels. Many studies have demonstrated a reduction in astrocytic GLT-1 expression after different forms of injury. Because extensive neuronal death does not occur after direct cortical stab wounds and viable developing neurons populate fetal CNS grafts, we hypothesized that reactive astroglia associated with these procedures might maintain or up-regulate GLT-1. We examined the temporal and spatial distribution of GLT-1, GFAP and nestin proteins by confocal double-label immunohistochemistry combined with a new methodology in which precise brain areas are microdissected and analyzed for protein content by immunoaffinity chromatography. In stab wounds, GLT-1 protein content did not change compared to normal cortex, as determined by direct protein measurements; GLT-1 colocalized with nestin- and GFAP(+) astroglia adjacent to the lesion. In contrast, host reactive astroglia adjacent to grafts significantly upregulated GLT-1 by 3 days postoperative. The GFAP protein analysis suggests that increased GLT-1 is not the result of greater numbers of activated astroglia around grafts, but that developing graft tissue influences adjacent host astroglia to upregulate GLT-1. GLT-1 protein within grafts was rapidly accelerated to mature levels by just three days, and was expressed by the nestin(+) cell population. These data, which demonstrate immunoexpression of GLT-1 protein combined with a new method for protein measurement in situ indicate that, in contrast to other injury models, astroglial GLT-1 is upregulated or maintained following invasive CNS procedures. (C) 2002 Elsevier Science (USA).	George Washington Univ, Med Ctr, Dept Anat & Cell Biol, Washington, DC 20037 USA		Krum, JM (corresponding author), George Washington Univ, Med Ctr, Dept Anat & Cell Biol, Washington, DC 20037 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38128, NS39282] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038128, R01NS039282] Funding Source: NIH RePORTER		Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; ANDERSON KJ, 1991, BRAIN RES, V562, P285, DOI 10.1016/0006-8993(91)90633-7; BABASHAK JV, 1988, J CHROMATOGR, V444, P21, DOI 10.1016/S0021-9673(01)94005-1; BarPeled O, 1997, J NEUROCHEM, V69, P2571; Bender AS, 1997, J NEUROCHEM, V69, pS241; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Chan H, 1999, NEUROCHEM RES, V24, P1397, DOI 10.1023/A:1022532623281; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; CHOI DW, 1994, PROG BRAIN RES, V100, P47; CHOI DW, 1987, J NEUROSCI, V7, P357; CLARKE SR, 1994, NEUROREPORT, V5, P1885, DOI 10.1097/00001756-199410000-00011; DAS GD, 1980, AM J ANAT, V158, P135, DOI 10.1002/aja.1001580204; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Eng DL, 1997, BRAIN RES, V778, P215, DOI 10.1016/S0006-8993(97)01093-7; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FONSECA M, 1988, EXP BRAIN RES, V69, P387; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Furuta A, 1997, J NEUROSCI, V17, P8363; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; GINSBERG SD, 1995, J NEUROCHEM, V65, P2800; Ginsberg SD, 1996, J NEUROCHEM, V67, P1208; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HOHMANN CF, 1988, BRAIN RES, V448, P53, DOI 10.1016/0006-8993(88)91101-8; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Knecht K, 1997, NEUROSCI LETT, V229, P201, DOI 10.1016/S0304-3940(97)00444-8; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; KRUM JM, 1989, EXP NEUROL, V103, P203, DOI 10.1016/0014-4886(89)90044-7; KRUM JM, 1988, J COMP NEUROL, V271, P331, DOI 10.1002/cne.902710304; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; LEVY LM, 1995, EUR J NEUROSCI, V7, P2036, DOI 10.1111/j.1460-9568.1995.tb00626.x; Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4; Lievens JC, 2000, J NEUROCHEM, V74, P909, DOI 10.1046/j.1471-4159.2000.0740909.x; McAdoo DJ, 2000, BRAIN RES, V865, P283, DOI 10.1016/S0006-8993(00)02296-4; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; Northington FJ, 1999, J NEUROBIOL, V39, P515; Ottersen OP, 1996, J CHEM NEUROANAT, V12, P1, DOI 10.1016/S0891-0618(96)00178-0; PHILLIPS TM, 1994, J CHROMATOGR B, V662, P307, DOI 10.1016/0378-4347(94)00190-1; PHILLIPS TM, 1994, J CHROMATOGR B, V656, P259, DOI 10.1016/0378-4347(94)00036-0; PHILLIPS TM, 1993, LC GC-MAG SEP SCI, V11, P36; Phillips TM, 1998, J CHROMATOGR B, V715, P55, DOI 10.1016/S0378-4347(97)00675-0; PHILLIPS TM, 1992, ANAL TECHNIQUES IMMU; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Reier P., 1983, SPINAL CORD RECONSTR, P163; Roettger V, 1996, NEUROSCIENCE, V75, P677, DOI 10.1016/0306-4522(96)00314-4; ROSEN GD, 1994, DEV BRAIN RES, V82, P127, DOI 10.1016/0165-3806(94)90155-4; ROSENBERG PA, 1990, NEUROSCI LETT, V116, P399; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; ROSENSTEIN JM, 1995, EXP NEUROL, V133, P1, DOI 10.1006/exnr.1995.1001; ROSENSTEIN JM, 1993, EXP NEUROL, V124, P208, DOI 10.1006/exnr.1993.1191; Rosenstein JM, 1996, CELL TRANSPLANT, V5, P233, DOI 10.1016/0963-6897(95)02031-4; ROSENSTEIN JM, 1995, CELL TRANSPLANT, V4, P83, DOI 10.1016/0963-6897(94)00041-H; ROSENSTEIN JM, 1989, BRAIN RES, V476, P110, DOI 10.1016/0006-8993(89)91542-4; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Schmitt A, 1996, NEUROSCIENCE, V71, P989, DOI 10.1016/0306-4522(95)00477-7; SCHULZ MK, 1993, EXP BRAIN RES, V96, P480; Shibata T, 1997, J NEUROSCI, V17, P9212; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Stover JF, 1999, J NEUROTRAUM, V16, P135, DOI 10.1089/neu.1999.16.135; SUGIYAMA K, 1989, NEUROSCIENCE, V32, P779, DOI 10.1016/0306-4522(89)90298-4; Sutherland ML, 1996, J NEUROSCI, V16, P2191; Swanson RA, 1997, J NEUROSCI, V17, P932; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; TORP R, 1995, EXP BRAIN RES, V103, P51; Velardo M. J., 1999, Society for Neuroscience Abstracts, V25, P524; Yamada K, 1998, J NEUROSCI, V18, P5706; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306	79	19	19	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	APR	2002	174	2					137	149		10.1006/exnr.2002.7867			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541PM	WOS:000174993000002	11922656				2022-02-06	
J	Wilson, DJ; Swaboda, JL				Wilson, DJ; Swaboda, JL			Partial weight-bearing gait retraining for persons following traumatic brain injury: preliminary report and proposed assessment scale	BRAIN INJURY			English	Article							COMMUNITY INTEGRATION QUESTIONNAIRE; NONAMBULATORY HEMIPARETIC PATIENTS; FUNCTIONAL ASSESSMENT MEASURE; REHABILITATION PROGRAM; SUPPORT; RELIABILITY; RECOVERY	The objectives of this investigation were to (1) document the recovery patterns of walking ability in two patients recovering from traumatic brain injury receiving partial weight-bearing gait retraining, and (2) introduce a new assessment scale of gait progress for patients receiving partial weight support therapy. The two patients were categorized as acute (< 6 months) and chronic (> 2 years) injury. Each patient received extensive in-patient rehabilitation, including physical therapy designed with twice-weekly partial body support gait training. The subjects made improvements in all measured indicators of gait ability (i.e. muscle strength, spasticity, standing balance). However, assessment of their improvement using standard assessment scales showed little progress. The newly devised Missouri Assisted Gait (MAG) scale, which includes developmental components of gait ability measured dramatic gains. This added precision of measurement was useful in communicating progress to both patients and providers.	SW Missouri State Univ, Dept Hlth Phys Educ & Recreat, Springfield, MO 65804 USA; Healthsouth, Howard A Rusk Rehabil Ctr, Columbia, MO USA		Wilson, DJ (corresponding author), SW Missouri State Univ, Dept Hlth Phys Educ & Recreat, 121C McDonald Arena,901 S Natl Ave, Springfield, MO 65804 USA.						Alcott D, 1997, DISABIL REHABIL, V19, P355, DOI 10.3109/09638289709166551; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; DOBKIN BH, 1993, WESTERN J MED, V159, P56; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; GRILLNER S, 1995, SCIENCE, V288, P143; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HESSE S, 1995, STROKE, V26, P976, DOI 10.1161/01.STR.26.6.976; HESSE S, 1994, ARCH PHYS MED REHAB, V75, P1087, DOI 10.1016/0003-9993(94)90083-3; HESSE SA, 1994, STROKE, V25, P1999, DOI 10.1161/01.STR.25.10.1999; KERRIGAN DC, 1994, AM J PHYS MED REHAB, V73, P421, DOI 10.1097/00002060-199411000-00007; LEMON R, 1988, TRENDS NEUROSCI, V11, P501, DOI 10.1016/0166-2236(88)90012-4; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MCPHERSON K, IN PRESS DISABILITY; NORMAN KE, 1995, ARCH PHYS MED REHAB, V76, P772, DOI 10.1016/S0003-9993(95)80533-8; RINEHART MA, 1990, REHABILITATION ADULT; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; SEEFELDT VS, 1972, M AM ASS HLTH PHYS E; SHIRLEY MM, 1931, 1 2 YEARS STUDY 22 B, V1; Wilson DJ, 1997, BRAIN INJURY, V11, P157, DOI 10.1080/026990597123610; [No title captured]	21	19	19	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK,, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2002	16	3					259	268		10.1080/02699050110103922			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	526HP	WOS:000174124800007	11874617				2022-02-06	
J	Choy, NL; Kuys, S; Richards, M; Isles, R				Choy, NL; Kuys, S; Richards, M; Isles, R			Measurement of functional ability following traumatic brain injury using the Clinical Outcomes Variable Scale: A reliability study	AUSTRALIAN JOURNAL OF PHYSIOTHERAPY			English	Article						brain injuries; outcome assessment (health care); rehabilitation; reproducibility of results	DISABILITY RATING-SCALE; MOTOR-ASSESSMENT SCALE; STROKE PATIENTS; INTERRATER RELIABILITY; REHABILITATION; COMMUNITY; VALIDITY	This study determined the inter-tester and intra-tester reliability of physiotherapists measuring functional motor ability of traumatic brain injury clients using the Clinical Outcomes Variable Scale (COVS). To test inter-tester reliability, 14 physiotherapists scored the ability of 16 videotaped patients to execute the items that comprise the COVS. Intra-tester reliability was determined by four physiotherapists repeating their assessments after one week, and three months later. The intra-class correlation coefficients (ICC) were very high for both inter-tester reliability (ICC > 0.97 for total COVS scores, ICC > 0.93 for individual COVS items) and intra-tester reliability (ICC > 0.97). This study demonstrates that physiotherapists are reliable in the administration of the COVS.	Univ Queensland, Dept Physiotherapy, Brisbane, Qld 4072, Australia		Choy, NL (corresponding author), Univ Queensland, Dept Physiotherapy, Brisbane, Qld 4072, Australia.		Kuys, Suzanne S/J-5530-2017; Kuys, Suzanne/S-8180-2019	Kuys, Suzanne S/0000-0002-6263-4223; Kuys, Suzanne/0000-0002-6263-4223			Ashley MJ, 1997, BRAIN INJURY, V11, P677; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Collen F M, 1990, Int Disabil Stud, V12, P6; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Dean C, 1992, Aust J Physiother, V38, P31, DOI 10.1016/S0004-9514(14)60548-1; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Fleming J, 1999, BRAIN INJURY, V13, P417; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; HUIJBREGTS M, 1996, PHYSIOTHER CAN, V48, P285; LENNON S, 1996, PHYSIOTHERAPY, V82, P655; Lincoln N, 1979, Physiotherapy, V65, P48; MAHER C, 1909, AUSTR J PHYSIOTHERAP, V39, P5; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Patrick L, 1996, AGING-CLIN EXP RES, V8, P328, DOI 10.1007/BF03339589; POOLE JL, 1988, ARCH PHYS MED REHAB, V69, P195; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SEABY L, 1989, Physiotherapy Canada, V41, P264; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420	22	19	21	0	3	AUSTRALIAN PHYSIOTHERAPY ASSOC	ST KILDA	LEVEL 3, 201  FITZROY ST, ST KILDA, 3182, AUSTRALIA	0004-9514			AUST J PHYSIOTHER	Aust. J. Physiother.		2002	48	1					35	39		10.1016/S0004-9514(14)60280-4			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	532AX	WOS:000174450400005	11869163	Bronze			2022-02-06	
J	Gallyas, F; Farkas, O; Mazlo, M				Gallyas, F; Farkas, O; Mazlo, M			Traumatic compaction of the axonal cytoskeleton induces argyrophilia: histological and theoretical importance	ACTA NEUROPATHOLOGICA			English	Article						head injury; axonal pathology; cytoskeletal compaction; silver staining; electron microscopy	LIGHT MICROSCOPIC RESPONSE; CONCUSSIVE HEAD-INJURY; NEURONAL SOMATA; DARK NEURONS; RAT; DENDRITES; TISSUE	It was earlier established that one of the primary morphopathological consequences of experimental traumatic brain injury is a dramatic reduction in the distances between the neurofilaments (cytoskeletal compaction) inside a number of axon segments that appear to be randomly distributed among normal axons in an otherwise undamaged parenchymal environment. The present results demonstrate that the cytoskeletal compaction instantly induces argyrophilia, thereby rendering possible selective visualisation of the affected axon segments for light microscopy through use of a special silver staining method. On combination of this method with electron microscopy, it was revealed that the cytoskeletal compaction is completed in much shorter times and extends to much longer axon segments than previously assumed.	Univ Pecs, Fac Med, Dept Neurosurg, H-7623 Pecs, Hungary; Univ Pecs, Fac Med, Cent Elect Microscop Lab, H-7623 Pecs, Hungary		Gallyas, F (corresponding author), Univ Pecs, Fac Med, Dept Neurosurg, Ret Utca 2, H-7623 Pecs, Hungary.		Gallyas, Ferenc/C-5450-2009				Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CAMMERMEYER JAN, 1961, ACTA NEUROPATHOL, V1, P245; GALLYAS F, 1993, J NEUROSCI METH, V50, P159, DOI 10.1016/0165-0270(93)90004-B; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P57; GALLYAS F, 1990, ACTA NEUROPATHOL, V79, P620, DOI 10.1007/BF00294239; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P394, DOI 10.1007/BF00713531; GALLYAS F, 1992, ACTA NEUROPATHOL, V83, P386, DOI 10.1007/BF00713530; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; HAYAT MA, 1981, FIXATION ELECT MICRO, P176; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Newman GR, 1998, J PATHOL, V186, P119; ONKOWO DO, 1999, NEUROREPORT, V10, P353; ONKOWO DO, 1998, BRAIN RES, V784, P1; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; PETTUS EH, 1996, BRAIN RES, V772, P1; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; VANDENPOL AN, 1990, J COMP NEUROL, V296, P654, DOI 10.1002/cne.902960410	21	19	20	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	JAN	2002	103	1					36	42		10.1007/s004010100424			7	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	510AY	WOS:000173187600005	11837745				2022-02-06	
J	Muller, SV; von Schweder, AJ; Frank, B; Dengler, R; Munte, TF; Johannes, S				Muller, SV; von Schweder, AJ; Frank, B; Dengler, R; Munte, TF; Johannes, S			The effects of proprioceptive stimulation on cognitive processes in patients after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; cognition; event-related potentials; P300; muscles; rehabilitation	MUSCLE VIBRATION; EVOKED-POTENTIALS; DISORDERS; CORTEX; INDEX	Objective: To investigate the hypothesis that proprioceptive stimulation may be effective in the treatment of brain injury, using neurophysiologic and neuropsychologic measures. Design: Cohort analytic study. Setting: Patients recovering from traumatic brain injury (TBI) in a neurologic rehabilitation hospital were examined. Participants: Eleven patients with TBI (Glasgow Coma Scale score > 3) and 11 healthy control subjects matched for age and education. Interventions: Subjects were examined with the event-related potential (ERP) technique during a computerized choice-reaction-time task, in which they had to discriminate between even and odd digits. There were experimental runs with and without vibratory stimuli applied to the left forearm serving a as proprioceptive stimulation. In addition, ERPs were recorded to vibratory stimuli without any additional task. Main Outcome Measures: Outcome measures included latencies and amplitudes of the P300 ERP component and of the late negative component. Results: In the passive vibration condition, both groups showed the same ERP distribution. In the choice-reaction-time task, latencies and amplitudes of the P300 differed between the 2 groups. The patient group showed longer P300 latencies, which were shortened by vibratory stimuli. In contrast, the control subjects were not affected by vibratory stimuli. Conclusion: Our findings support the hypothesis that pathologic cognitive processes after TBI can be improved by proprioceptive stimulation. Muscle vibration has positive effects on pathologically slowed cognitive processes but not in healthy subjects.	Otto Von Guericke Univ, Dept Neuropsychol, D-39016 Magdeburg, Germany; Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; Rehabil Hosp Leezen 3, Leezen, Germany		Muller, SV (corresponding author), Otto Von Guericke Univ, Dept Neuropsychol, Box 4120, D-39016 Magdeburg, Germany.	sandra.mueller@nat.uni-magdeburg.de	Munte, Thomas/C-2077-2014				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; COHEN LG, 1985, NEUROLOGY, V35, P691, DOI 10.1212/WNL.35.5.691; DINSE HR, 1997, ADV NEUROL, V73, P229; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; Elbert T, 1987, J PSYCHOPHYSIOL, V1, P317; ELEK JM, 1991, ELECTROEN CLIN NEURO, V81, P279, DOI 10.1016/0168-5597(91)90014-O; GOETZ CG, 1992, NEUROL CLIN, V10, P907, DOI 10.1016/S0733-8619(18)30187-7; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JENSEN AR, 1986, ACTA PSYCHOL, V25, P36; Kaipio ML, 1999, NEUROREPORT, V10, P2125, DOI 10.1097/00001756-199907130-00024; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; Karnath HO, 1996, EXP BRAIN RES, V109, P333; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; Khudados E, 1999, J NEUROL NEUROSUR PS, V67, P504, DOI 10.1136/jnnp.67.4.504; King JH, 1998, J CLIN EXP NEUROPSYC, V20, P603, DOI 10.1076/jcen.20.5.603.1124; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; Kossev A, 1999, MUSCLE NERVE, V22, P946, DOI 10.1002/(SICI)1097-4598(199907)22:7<946::AID-MUS22>3.0.CO;2-O; LEZAK MD, 1998, NEUROPSYCHOLOGICAL A; Maldjian JA, 1999, BRAIN RES, V824, P291, DOI 10.1016/S0006-8993(99)01126-9; MATTHEWS PBC, 1982, ANNU REV NEUROSCI, V5, P189, DOI 10.1146/annurev.ne.05.030182.001201; Moosavi SH, 1999, J NEUROL SCI, V164, P179, DOI 10.1016/S0022-510X(99)00065-9; Munte TF, 1996, NEUROSCI LETT, V216, P163, DOI 10.1016/0304-3940(96)13036-6; Munte TF, 1997, J COGNITIVE NEUROSCI, V9, P318, DOI 10.1162/jocn.1997.9.3.318; PECK EA, 1990, J CLIN EXP NEUROPSYC, V12, P34; RIXECKER H, 1980, J CLIN PSYCHOL, V36, P465, DOI 10.1002/jclp.6120360213; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; SCHOTT GD, 1996, LANCET, V348, P712; Siggelkow S, 1999, MUSCLE NERVE, V22, P1544, DOI 10.1002/(SICI)1097-4598(199911)22:11<1544::AID-MUS9>3.3.CO;2-#; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Strupp M, 1998, BRAIN, V121, P677, DOI 10.1093/brain/121.4.677; STURM W, 1984, THESIS U AACHEN AACH; SWARTZ JR, 1999, SCI PRACT NEUROPSYCH, P159; SWETS JA, 1973, SCIENCE, V182, P990, DOI 10.1126/science.182.4116.990; VALLAR G, 1995, NEUROPSYCHOLOGIA, V33, P73, DOI 10.1016/0028-3932(94)00088-7; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924; Zimmermann P., 1995, TESTBATTERIE AUFMERK	39	19	19	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2002	83	1					115	121		10.1053/apmr.2002.27472			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	509JU	WOS:000173145300018	11782841				2022-02-06	
J	Cazalis, F; Azouvi, P; Sirigu, A; Agar, N; Burnod, Y				Cazalis, F; Azouvi, P; Sirigu, A; Agar, N; Burnod, Y			Script knowledge after severe traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						script; executive functions; traumatic brain injury	CLOSED-HEAD-INJURY; DUAL-TASK PERFORMANCE; FRONTAL-LOBE; MENTAL REPRESENTATION; STRATEGY APPLICATION; WORKING-MEMORY; DAMAGE; LESIONS; IMPAIRMENTS; DEFICITS	Severe diffuse traumatic brain injury (TBI) may impair the performance of daily-life complex activities. The aim of the present study was to assess whether these difficulties are related to a representational impairment of action knowledge. Two tasks requiring the manipulation of scripts were used. The first (script reconstitution) required subjects to sort cards describing actions belonging to 4 different scripts, presented in a random order. The second (script generation) required subjects to generate actions belonging to a given script. The results showed that TBI patients had preserved access to goal representation and action knowledge. However, they demonstrated (1) significant impairments when they had to deal with simultaneous competing sources of information and (2) a lack of inhibitory control on routine overlearned skills. Patients' performance was significantly correlated with behavioral modifications in everyday life. These data suggest that action impairment in severe TBI patients cannot be attributed to an impairment of action knowledge per se. As previously suggested by Schwartz et al., a restriction of limited-capacity processing resources may account for the observed deficits.	Univ Paris 05, Hop Raymond Poincare, Dept Neurol Rehabil, Serv Reduc Neurol, F-92380 Garches, France; INSERM, U483, F-75654 Paris 13, France; CNRS, Inst Cognit Sci, Bron, France		Azouvi, P (corresponding author), Univ Paris 05, Hop Raymond Poincare, Dept Neurol Rehabil, Serv Reduc Neurol, F-92380 Garches, France.		Sirigu, Angela/L-4683-2017				Allain P, 1999, J CLIN EXP NEUROPSYC, V21, P643, DOI 10.1076/jcen.21.5.643.871; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; BOWER GH, 1979, COGNITIVE PSYCHOL, V11, P177, DOI 10.1016/0010-0285(79)90009-4; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; Davies DR., 1984, VARIETIES ATTENTION, P515; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Godbout L, 1995, NEUROPSYCHOLOGIA, V33, P1671, DOI 10.1016/0028-3932(95)00047-X; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schank R., 1982, DYNAMIC MEMORY THEOR; Schwartz MF, 1998, NEUROPSYCHOLOGY, V12, P13, DOI 10.1037/0894-4105.12.1.13; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Sirigu A, 1996, CORTEX, V32, P297, DOI 10.1016/S0010-9452(96)80052-9; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; WICKENS C. D., 1984, VARIETIES ATTENTION, P63; [No title captured]	39	19	22	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4221 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2001	7	7					795	804		10.1017/S1355617701777028			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	496YV	WOS:000172426700002	11771622	Green Published			2022-02-06	
J	Robertson, CL; Minamino, N; Ruppel, RA; Kangawa, K; Wisniewski, SR; Tsuji, T; Janesko, KL; Ohta, H; Adelson, PD; Marion, DW; Kochanek, PM				Robertson, CL; Minamino, N; Ruppel, RA; Kangawa, K; Wisniewski, SR; Tsuji, T; Janesko, KL; Ohta, H; Adelson, PD; Marion, DW; Kochanek, PM			Increased adrenomedullin in cerebrospinal fluid after traumatic brain injury in infants and children	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; head injury; pediatrics	CEREBRAL BLOOD-FLOW; PLASMA ADRENOMEDULLIN; HYPOTENSIVE PEPTIDE; HEAD-INJURIES; HYPERTENSION; METABOLISM; CELLS; RAT; CORRELATE; SECRETION	Adrenomedullin is a recently discovered 52-amino acid peptide that is a potent vasodilator and is produced in the brain in experimental models of cerebral ischemia. Infusion of adrenomedullin increases regional cerebral blood flow and reduces infarct volume after vascular occlusion in rats, and thus may represent an endogenous neuroprotectant. Disturbances in cerebral blood flow (CBF), including hypoperfusion and hyperemia, frequently occur after severe traumatic brain injury (TBI) in infants and children. We hypothesized that cerebrospinal fluid (CSF) adrenomedullin concentration would be increased after severe TBI in infants and children, and that increases in adrenomedullin would be associated with alterations in CBF. We also investigated whether posttraumatic CSF adrenomedullin concentration was associated with relevant clinical variables (CBF, age, Glasgow Coma Scale [GCS] score, mechanism of injury, and outcome). Total adrenomedullin concentration was measured using a radioimmunometric assay. Sixty-six samples of ventricular CSF from 21 pediatric patients were collected during the first 10 days after severe TBI (GCS score < 8). Control CSF was obtained from children (n = 10) undergoing lumbar puncture without TBI or meningitis. Patients received standard neurointensive care, including CSF drainage. CBF was measured using Xenon computed tomography (CT) in 11 of 21 patients. Adrenomedullin concentration was markedly increased in CSF of infants and children after severe TBI vs control (median 4.5 versus 1.0 fmol/mL, p < 0.05). Sixty-two of 66 CSF samples (93.9%) from head-injured infants and children had a total adrenomedullin concentration that was greater than the median value for controls. Increases in CSF adrenomedullin were most commonly observed early after TBI. CBF was positively correlated with CSF adrenomedullin concentration (p < 0.001), but this relationship was not significant when controlling for the effect of time. CSF adrenomedullin was not significantly associated with other selected clinical variables. We conclude adrenomedullin is markedly increased in the CSF of infants and children early after severe TBI. We speculate that adrenomedullin participates in the regulation of CBF after severe TBI.	Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Injury Control & Res, Pittsburgh, PA USA; Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; Shionogi & Co Ltd, Diagnost Sci Div, Osaka, Japan; Natl Cardiovasc Ctr, Res Inst, Osaka, Japan		Kochanek, PM (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@anes.upmce.edu	Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015; Marion, Donald/AAR-5749-2021	Kochanek, Patrick M/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, K08NS001809, P20NS030318, P50NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318, NS38081, NS01809] Funding Source: Medline		Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; BASKAYA MK, 1995, J CEREBR BLOOD F MET, V15, P827, DOI 10.1038/jcbfm.1995.103; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19, DOI 10.1097/00004647-199701000-00004; GUR D, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P68; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Inoue S, 1999, ANESTH ANALG, V88, P1030, DOI 10.1097/00000539-199905000-00011; ISHIMITSU T, 1994, J CLIN INVEST, V94, P2158, DOI 10.1172/JCI117573; JOUGASAKI M, 1995, CIRCULATION, V92, P286, DOI 10.1161/01.CIR.92.3.286; Kikumoto K, 1998, ANESTH ANALG, V87, P859, DOI 10.1097/00000539-199810000-00021; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V194, P720, DOI 10.1006/bbrc.1993.1881; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kuwasako K, 1997, INT ANGIOL, V16, P272; Lang MG, 1997, STROKE, V28, P181, DOI 10.1161/01.STR.28.1.181; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Miyao Y, 1998, HEART, V79, P39, DOI 10.1136/hrt.79.1.39; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Nagata N, 1998, EUR J ENDOCRINOL, V139, P611, DOI 10.1530/eje.0.1390611; Nishikimi T, 1997, HEART, V78, P390, DOI 10.1136/hrt.78.4.390; Nishio K, 1997, CRIT CARE MED, V25, P953, DOI 10.1097/00003246-199706000-00010; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Ohta H, 1999, CLIN CHIM ACTA, V287, P131, DOI 10.1016/S0009-8981(99)00128-X; Serrano J, 2000, BRAIN RES, V853, P245, DOI 10.1016/S0006-8993(99)02273-8; Shindo T, 2000, CIRCULATION, V101, P2309, DOI 10.1161/01.CIR.101.19.2309; Sone M, 1997, PEPTIDES, V18, P1125, DOI 10.1016/S0196-9781(97)00143-5; SUGO S, 1994, BIOCHEM BIOPH RES CO, V201, P1160, DOI 10.1006/bbrc.1994.1827; SUGO S, 1994, BIOCHEM BIOPH RES CO, V203, P719, DOI 10.1006/bbrc.1994.2241; Takahashi K, 1997, PEPTIDES, V18, P1051, DOI 10.1016/S0196-9781(97)00038-7; Takahashi K, 1997, J NEUROCHEM, V68, P726; Ueda S, 1999, AM J RESP CRIT CARE, V160, P132, DOI 10.1164/ajrccm.160.1.9810006; WANG XK, 1995, P NATL ACAD SCI USA, V92, P11480, DOI 10.1073/pnas.92.25.11480; WASHIMINE H, 1995, HISTOCHEM CELL BIOL, V103, P251, DOI 10.1007/BF01457408	36	19	19	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2001	18	9					861	868		10.1089/089771501750451785			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	471TP	WOS:000170945000002	11565598				2022-02-06	
J	Koestler, J; Keshavarz, R				Koestler, J; Keshavarz, R			Penetrating head injury in children: A case report and review of the literature	JOURNAL OF EMERGENCY MEDICINE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; TRAUMATIC BRAIN INJURY; POSTTRAUMATIC SEIZURES; CRANIOCEREBRAL INJURY; SUBARACHNOID HEMORRHAGE; EPIDEMIOLOGY; PREVENTION; CHILDHOOD; SCALE	Head trauma is exceedingly common in children, but rarely presents as a penetrating injury to the skull. Most of the recommendations on evaluation, management, and follow-up of Such injuries are based on the adult literature. We report a case of penetrating head injury from a tapered metal object in a 4-year old child. (C) 2001 Elsevier Science Inc.	Mt Sinai Sch Med, Dept Internal Med, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Emergency Med, New York, NY 10029 USA		Koestler, J (corresponding author), Mt Sinai Sch Med, Dept Internal Med, 1 Gustave L Levy Pl,Box 1512, New York, NY 10029 USA.						ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; Cushing H, 1918, Br Med J, V1, P221; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; DUFFY GP, 1969, BRIT J SURG, V56, P685, DOI 10.1002/bjs.1800560912; DUJOVNY M, 1975, J TRAUMA, V15, P981, DOI 10.1097/00005373-197511000-00007; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Geller E, 1997, PEDIATR RADIOL, V27, P790, DOI 10.1007/s002470050234; Glasier CM, 1997, CLIN NEUROSCI, V4, P153; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; James CA, 1997, CLIN NEUROSCI, V4, P137; JENNETT B, 1977, LANCET, V1, P878; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; KENNEDY CR, 1986, J HEAD TRAUMA REHAB, V1, P66; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KUHL DA, 1990, DICP ANN PHARMAC, V24, P277, DOI 10.1177/106002809002400314; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Mayberg MR, 1998, NEUROSURG CLIN N AM, V9, P615; MCKICKEN DB, 1986, ANN EMERG MED, V15, P274; MILLER CF, 1977, SURG NEUROL, V7, P95; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; REGEV E, 1990, INJURY, V21, P414, DOI 10.1016/0020-1383(90)90138-K; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; RIVERA F, 1987, PEDIATRICS, P579; RUGGIERI PM, 1992, CARDIOVASC INTER RAD, V15, P71, DOI 10.1007/BF02733902; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; SOTIROPOULOS SV, 1990, AM J DIS CHILD, V144, P980, DOI 10.1001/archpedi.1990.02150330040018; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; TAY JS, 1987, PEDIATRICS, V79, P261; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801	37	19	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	AUG	2001	21	2					145	150		10.1016/S0736-4679(01)00363-8			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	460UQ	WOS:000170327300007	11489404				2022-02-06	
J	Linan, E; O'Dell, MW; Pierce, JM				Linan, E; O'Dell, MW; Pierce, JM			Continuous passive motion in the management of heterotopic ossification in a brain injured patient	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						heterotopic ossification; continuous passive motion; traumatic brain injury; physical therapy	BONE-FORMATION	We report a man admitted to inpatient rehabilitation 6 wk after traumatic brain injury, who presented with bilateral knee heterotopic ossification. In addition to conventional physical therapy, we applied a continuous passive motion device during 4 wk increasing the range of motion of the knees. On the basis of the limited current literature and this case, we suggest that the use of continuous passive motion devices for heterotopic ossification may be effective and safe and should be the subject of further study.	Long Isl Jewish Med Ctr, Dept Phys Med & Rehabil, New Hyde Pk, NY 11040 USA; Southside Hosp, Reg Ctr Brain Injury Rehabil, Bay Shore, NY USA		Linan, E (corresponding author), Long Isl Jewish Med Ctr, Dept Phys Med & Rehabil, 270-05 76th Ave CH-005, New Hyde Pk, NY 11040 USA.						DELISA JA, 1998, REHABILITATION MED; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GARLAND DE, 1983, CLIN ORTHOP RELAT R, V176, P197; GOLDBERG MA, 1977, ARCH INTERN MED, V137, P619, DOI 10.1001/archinte.137.5.619; HAMMOND FM, 1997, PHYS MED REH CLIN N, V8, P667; JENSEN LL, 1987, AM J PHYS MED REHAB, V66, P351; Keenan MAE, 1996, J HEAD TRAUMA REHAB, V11, P8, DOI 10.1097/00001199-199608000-00004; MCINNES J, 1992, JAMA-J AM MED ASSOC, V268, P1423, DOI 10.1001/jama.268.11.1423; MICHELSSON JE, 1983, CLIN ORTHOP RELAT R, P265; NADLER SF, 1993, AM J PHYS MED REHAB, V72, P162, DOI 10.1097/00002060-199306000-00011; Norkin CC, 1995, MEASUREMENT JOINT MO; ROBERTS P H, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P70; Rogers R C, 1988, Brain Inj, V2, P169, DOI 10.3109/02699058809150941; Rusk H. A, 1971, REHABILITATION MED; Salter RB, 1996, HAND CLIN, V12, P1; SALTER RB, 1980, J BONE JOINT SURG AM, V62, P1232, DOI 10.2106/00004623-198062080-00002; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; vanSusante JLC, 1996, ACTA ORTHOP SCAND, V67, P450, DOI 10.3109/17453679608996666; VARGHESE G, 1992, PHYS MED REH CLIN N, V3, P410	22	19	22	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2001	80	8					614	617		10.1097/00002060-200108000-00013			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	454BR	WOS:000169953000011	11475483				2022-02-06	
J	[Anonymous]				[Anonymous]			Vascular complications of penetrating brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							CRANIOCEREBRAL GUNSHOT WOUNDS; MISSILE HEAD WOUNDS; TRAUMATIC ANEURYSMS; ANGIOGRAPHY; MANAGEMENT										AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; HADDAD FS, 1997, NEUROSURGERY, V28, P1; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; Kordestani RK, 1997, NEUROSURGERY, V41, P351, DOI 10.1097/00006123-199708000-00003; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3	10	19	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2001	51	2		S			S26	S28					3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	464LR	WOS:000170534500006	11505196				2022-02-06	
J	Cronin, AF				Cronin, AF			Traumatic brain injury in children: Issues in community function	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						child, exceptional; head injury occupational therapy; school based occupational therapy	HEAD-INJURIES; REHABILITATION; STUDENTS; SEQUELAE; INTERVENTION; ADOLESCENTS; TRANSITION; REENTRY; SCHOOL; MILD	The pathology and sequelae of pediatric traumatic brain injury (TBI) differ from those of the adult TBI population. In childhood TBI, cognitive impairment and secondary delays are often overlooked in the referral and intervention process. Although TBI is the leading cause of acquired dis ability in childhood, most children with TBI are discharged from acute care to home with little or no rehabilitation. This literature review provides current information germane to the occupational therapist on sequence and functional limitations that may exist or develop after TBI in children. Further, method by which these deficits can be addressed within the context of Individuals With Disabilities Education Act guidelines are described. Children with a history of TBI should be screened regularly because some cognitive problems emerge years after the injury as developmental demand on the child increase In this article school-based therapists are urged to look beyond a child's motor limitations to address the cognitive and neuropsychological problems typical of this population.	W Virginia Univ, Morgantown, WV 26505 USA		Cronin, AF (corresponding author), W Virginia Univ, Morgantown, WV 26505 USA.	acronin@hsc.wvu.edu					Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Berker E, 1996, INT J NEUROSCI, V85, P195, DOI 10.3109/00207459608986683; Blasier D, 1989, Orthop Rev, V18, P350; BLASKEY J, 1999, DECISION MAKING PEDI, P84; Blosser J, 1997, J HEAD TRAUMA REHAB, V12, P21, DOI 10.1097/00001199-199704000-00004; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bruce D A, 1990, Curr Probl Pediatr, V20, P61; CARNEY J, 1990, Pediatrician, V17, P222; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; DAmato RC, 1996, J LEARN DISABIL, V29, P670, DOI 10.1177/002221949602900611; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Heinemann AW, 1990, J NEUROL REHABIL, V4, P27; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; HUMPHRY R, 1996, OCCUPATIONAL THERAPY, P67; JENNETT B, 1975, LANCET, V1, P480; JOHNSTON MV, 1995, BRAIN DEV-JPN, V17, P301, DOI 10.1016/0387-7604(95)00079-Q; Kehle TJ, 1996, J LEARN DISABIL, V29, P633, DOI 10.1177/002221949602900607; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; LAZAR MF, 1995, J HEAD TRAUMA REHAB, V10, P55, DOI 10.1097/00001199-199510000-00007; LOWENTHAL B, 1998, INFANT TODDLER INTER, V8, P377; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MILLER L, 1991, COGNITIVE REHABILITA, V9, P16; Moseley AM, 1997, PHYS THER, V77, P240, DOI 10.1093/ptj/77.3.240; Nuismer BA, 1997, AM J OCCUP THER, V51, P538, DOI 10.5014/ajot.51.7.538; Pang D, 1985, HEAD INJURY REHABILI, P3; Parkin AE., 1996, AUSTR OCCUPATIONAL T, V43, P133; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PORR S, 1999, PEDIAT THERAPY SYSTE, P525; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Prosser R, 1996, J Hand Ther, V9, P378; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; Scott A.D., 1995, OCCUPATIONAL THERAPY, P705; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; SHURTLEFF HA, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199510000-00008; TEASDALE G, 1974, LANCET, V2, P81; VESSEY, 1997, PEDIAT NURSING, V23, P507; WALLECK C, 1994, NEUROSCIENCE NURSING, P324; WARREN M, 1991, OCCUPATIONAL THERAPY, P634; WESSON DE, 1992, J TRAUMA, V33, P252, DOI 10.1097/00005373-199208000-00015; WINKLER P, 1995, NEUROLOGICAL REHABIL, P421	50	19	20	0	7	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2001	55	4					377	384		10.5014/ajot.55.4.377			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	454BJ	WOS:000169952300003	11723981				2022-02-06	
J	Saleh, SS; Fuortes, L; Vaughn, T; Bauer, EP				Saleh, SS; Fuortes, L; Vaughn, T; Bauer, EP			Epidemiology of occupational injuries and illnesses in a university population: A focus on age and gender differences	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						occupational injuries; cause of injury; nature of injury; gender; age	WORKERS-COMPENSATION; UNITED-STATES; INDUSTRY; RATES; COSTS	Background Occupational injuries and illnesses are a major preventable public health problem. Methods This study evaluated the incidence, nature, and cause of awarded workers' compensation claims for a large state university and teaching hospital. Rates and types of injury weve compared across age and gender. Results Rates of injury varied over twofold with age, with those 16-25 having the lowest rates of injury and those 36-45 having the highest rates. Claims rates were 1.36-fold higher for women than men. Women had higher rates for injury resulting from lifting, falling noxious exposures, repetitive motion, and carpal tunnel syndrome. Similarly women had significantly higher rates of claims for pain, sprains, bruises, bums, concussion, and inhalation injury; with lower rates of cuts, ligament injury, and jammed joints. Conclusions These group differences suggest the need to examine age and gender job distributions and relevant ergonomic and environmental causative factors. Am. J. Ind. Med. 39:581-586, 2001. (C) 2001 Wiley-Liss, Inc.	Univ Iowa, Coll Publ Hlth, Dept Hlth Policy & Management, Iowa City, IA 52242 USA; Univ Iowa, Dept Prevent Med & Environm Hlth, Iowa City, IA 52242 USA		Saleh, SS (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Hlth Policy & Management, 2700 SB, Iowa City, IA 52242 USA.						BERNACKI EJ, 1996, J OCCUP ENVIRON MED, V38, P1019; CHEADLE A, 1994, AM J PUBLIC HEALTH, V84, P190, DOI 10.2105/AJPH.84.2.190; Choi BCK, 1996, J OCCUP ENVIRON MED, V38, P379, DOI 10.1097/00043764-199604000-00016; FUORTES LJ, 1990, AM J IND MED, V18, P211, DOI 10.1002/ajim.4700180213; Gluck JV, 1998, SPINE, V23, P1572, DOI 10.1097/00007632-199807150-00013; Goldsmith DF, 1998, OCCUP MED, V13, P389; Henry K, 1995, Minn Med, V78, P41; Khuder SA, 1999, J OCCUP ENVIRON MED, V41, P53, DOI 10.1097/00043764-199901000-00009; Kraus JF, 1997, AM J EPIDEMIOL, V146, P637; Leigh JP, 1997, ARCH INTERN MED, V157, P1557, DOI 10.1001/archinte.157.14.1557; MARKOWITZ S, 1992, ENV OCCUPATIONAL MED, P19; MCCURDY SA, 1989, AM J IND MED, V15, P499, DOI 10.1002/ajim.4700150503; Miller TR, 1995, ACCIDENT ANAL PREV, V27, P741, DOI 10.1016/0001-4575(95)00022-4; MITCHELL OS, 1988, MON LABOR REV, V111, P8; MONT D, 1999, WORKERS COMPENSATION; ROEGGE D, 1992, 29 ANN SUMM EMPL BEN, V1, P42; Vergara A E, 1998, Int J Occup Environ Health, V4, P199; WEBSTER S, 1993, SITES, V26, P2; ZWERLING C, 1993, AM J EPIDEMIOL, V138, P46, DOI 10.1093/oxfordjournals.aje.a116776	19	19	19	0	4	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0271-3586			AM J IND MED	Am. J. Ind. Med.	JUN	2001	39	6					581	586		10.1002/ajim.1057			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	438DF	WOS:000169037900006	11385642				2022-02-06	
J	Nakayama, Y; Aoki, Y; Niitsu, H				Nakayama, Y; Aoki, Y; Niitsu, H			Studies on the mechanisms responsible for the formation of focal swellings on neuronal processes using a novel in vitro model of axonal injury	JOURNAL OF NEUROTRAUMA			English	Article						axon reaction; cell culture; cytoskeleton; head injuries; closed; PC12 cells; transmission electron microscopy	PC12 CELLS; CYTOSKELETAL CHANGES; BRAIN INJURY; HEAD-INJURY; NEUROPATHOLOGY; PROTEOLYSIS; STRETCH	A novel in vitro model of axonal injury using PC12 cells was designed to introduce traumatic alterations on neuronal precesses and to identify mechanisms responsible for the formation of focal swellings by observation with phase-contrast and transmission electron microscopes. The injury on the processes was produced by one-dimensional, horizontal oscillation. The fluid shear stress applied by the oscillation did not exceed 380 dyne/cm(2). The injured processes showed two forms, One involved an increase in the terminal diameter of the processes and the other entailed beading along the injured portions, Long-term observation of cellular responses to the mechanical insult disclosed that the terminal swelling coincided with the detachment of growth cones from the culture plate. The finding suggests that the detachment of the growth cone destroys the cytoskeletal network, which determines and maintains the cell shape, resulting in spherical deformation of the processes. When the cytoskeletal destruction occurred at non-terminal sites along the processes, spherical deformations developed slowly, and these appeared as beads. The beading also caused the detachment of the growth cones, As the most proximal bead grew, they absorbed the distal segment and their growth cones were pulled proximally with the spreading cytoskeletal destruction. The processes with terminal swellings as well as the bead segments showed regeneration with time evidence of and growth cone formation.	Iwate Med Univ, Sch Med, Dept Legal Med, Morioka, Iwate 0208505, Japan		Nakayama, Y (corresponding author), Iwate Med Univ, Sch Med, Dept Legal Med, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	yumin@iwate-med.ac.jp					ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hotani H, 1990, Adv Biophys, V26, P135, DOI 10.1016/0065-227X(90)90010-Q; Jafari SS, 1998, J NEUROTRAUM, V15, P955, DOI 10.1089/neu.1998.15.955; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; LANGUI D, 1990, ACTA NEUROPATHOL, V80, P649, DOI 10.1007/BF00307634; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MITCHISON T, 1994, MOL BIOL CELL, P787; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; NAKAYAMA Y, 1998, 6 IND PAC C LEG MED, P991; NARUSE K, 1993, AM J PHYSIOL, V264, pC1037, DOI 10.1152/ajpcell.1993.264.4.C1037; Ochs S, 1996, NEUROSCIENCE, V70, P1081, DOI 10.1016/0306-4522(95)00390-8; OCHS S, 1994, NEUROSCIENCE, V61, P361, DOI 10.1016/0306-4522(94)90237-2; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; OKABE S, 1988, J CELL BIOL, V107, P651, DOI 10.1083/jcb.107.2.651; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Schweitzer ES, 1996, J NEUROSCI RES, V46, P519; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith DH, 1999, J NEUROSCI, V19, P4263; TAHIR SK, 1992, BIOCHEM CELL BIOL, V70, P1159, DOI 10.1139/o92-162	32	19	20	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2001	18	5					545	554		10.1089/089771501300227341			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	435CN	WOS:000168860000007	11393257				2022-02-06	
J	Guyot, LL; Kazmierczak, CD; Diaz, FG				Guyot, LL; Kazmierczak, CD; Diaz, FG			Vascular injury in neurotrauma	NEUROLOGICAL RESEARCH			English	Article						traumatic aneurysm; pseudoaneurysm; dissection; cavernous-carotid fistula	CAROTID-ARTERY DISSECTION; VERTEBRAL ARTERY; CAVERNOUS FISTULAS; TRAUMATIC ANEURYSMS; ANGIOGRAPHY; MANAGEMENT; DIAGNOSIS; HEAD; NECK; CLASSIFICATION	Traumatic vascular lesions can occur after severe or even the most mild of head and cervical trauma. The initial evaluation of the injured patient must be thorough and the clinical suspicion of vascular injury must be highly suspected based on the mechanism of injury. Traumatic vascular injuries can be broadly classified into traumatic aneurysms, dissections and occlusions and fistulae of the carotid or vertebral arteries. The current management and treatment options of each condition are discussed.	Wayne State Univ, Detroit Med Ctr, Dept Neurol Surg, Detroit, MI 48201 USA; Wayne State Univ, Detroit Med Ctr, Dept Radiol, Detroit, MI 48201 USA		Guyot, LL (corresponding author), Wayne State Univ, Dept Neurol Surg, 4201 St Antoine 6E-UHC, Detroit, MI 48201 USA.						AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; ACHTEREEKTE HAM, 1994, SURG NEUROL, V42, P240, DOI 10.1016/0090-3019(94)90270-4; Ahmadi J, 1996, NEUROSURGERY, VII, P2821; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Biousse V, 1998, ARCH NEUROL-CHICAGO, V55, P715, DOI 10.1001/archneur.55.5.715; BIOUSSE V, 1995, STROKE, V26, P235, DOI 10.1161/01.STR.26.2.235; Debehnke Daniel J., 1994, Journal of Emergency Medicine, V12, P27, DOI 10.1016/0736-4679(94)90008-6; DEBRUN G, 1981, J NEUROSURG, V55, P678, DOI 10.3171/jns.1981.55.5.0678; DEBRUN GM, 1988, NEUROSURGERY, V22, P285, DOI 10.1227/00006123-198802000-00001; DeOcampo J, 1997, J NEUROIMAGING, V7, P187, DOI 10.1111/jon199773187; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; Eachempati SR, 1998, J TRAUMA, V45, P997, DOI 10.1097/00005373-199812000-00004; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; FISHER CM, 1982, HEADACHE, V22, P60, DOI 10.1111/j.1526-4610.1982.hed2202060.x; Glauser Jonathan, 1994, Journal of Emergency Medicine, V12, P307, DOI 10.1016/0736-4679(94)90271-2; GOLUEKE P, 1987, J TRAUMA, V27, P856, DOI 10.1097/00005373-198708000-00003; GUGTOWSKI NJ, 1992, J NEUROL NEUROSUR PS, V55, P841; GUIBERT, 1895, ANN OCUL, V113, P314; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HALBACH VV, 1993, J NEUROSURG, V79, P183, DOI 10.3171/jns.1993.79.2.0183; HANUS SH, 1977, ARCH NEUROL-CHICAGO, V34, P574, DOI 10.1001/archneur.1977.00500210076015; HART RG, 1988, NEUROLOGY, V38, P987, DOI 10.1212/WNL.38.6.987; HERR RD, 1992, ANN EMERG MED, V21, P88, DOI 10.1016/S0196-0644(05)82248-6; HINSE P, 1991, J NEUROL NEUROSUR PS, V54, P863, DOI 10.1136/jnnp.54.10.863; HOFFMANN M, 1993, STROKE, V24, P815, DOI 10.1161/01.STR.24.6.815; Hong MK, 1997, AM J CARDIOL, V79, P538, DOI 10.1016/S0002-9149(96)00808-9; LEVY C, 1994, RADIOLOGY, V190, P97, DOI 10.1148/radiology.190.1.8259436; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; LEWIS AI, 1995, NEUROSURGERY, V36, P239, DOI 10.1227/00006123-199502000-00001; Liu AY, 1999, NEUROSURGERY, V45, P1368, DOI 10.1097/00006123-199912000-00022; Lucas C, 1998, STROKE, V29, P2646, DOI 10.1161/01.STR.29.12.2646; MAS JL, 1987, J NEUROL, V234, P237; Millman B, 1994, Ear Nose Throat J, V73, P408; PRABHU VC, 1994, SURG NEUROL, V42, P245, DOI 10.1016/0090-3019(94)90271-2; Sclafani AP, 1996, LARYNGOSCOPE, V106, P168, DOI 10.1097/00005537-199602000-00012; SERBINENKO FA, 1974, J NEUROSURG, V41, P125, DOI 10.3171/jns.1974.41.2.0125; STEINKE W, 1990, NEURORADIOLOGY, V32, P502, DOI 10.1007/BF02426464; STEINKE W, 1994, STROKE, V25, P998, DOI 10.1161/01.STR.25.5.998; TRAMO MJ, 1985, STROKE, V16, P1039, DOI 10.1161/01.STR.16.6.1039; TULYAPRONCHOTE R, 1994, NEUROLOGY, V44, P1379; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024; Wallick Kristin, 1997, Journal of Emergency Medicine, V15, P23, DOI 10.1016/S0736-4679(96)00239-9; Zetterling M, 2000, ACTA NEUROL SCAND, V101, P1, DOI 10.1034/j.1600-0404.2000.00001.x	45	19	20	1	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					291	296		10.1179/016164101101198442			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200022	11320609				2022-02-06	
J	Kemmeter, PR; Hoedema, RE; Foote, JA; Scholten, DJ				Kemmeter, PR; Hoedema, RE; Foote, JA; Scholten, DJ			Concomitant blunt enteric injuries with injuries of the liver and spleen: A dilemma for trauma surgeons	AMERICAN SURGEON			English	Article; Proceedings Paper	43rd Annual Meeting of the Midwest-Surgical-Association	AUG 13-16, 2000	MACKINAC ISL, MI	Midwest Surg Assoc			DIAGNOSTIC PERITONEAL-LAVAGE; SMALL-BOWEL INJURY; COMPUTED-TOMOGRAPHY; ABDOMINAL-TRAUMA; MORBIDITY; MORTALITY	Prompt identification of enteric injuries after blunt trauma remains problematic. With the increased utilization of nonoperative management of blunt abdominal trauma gastrointestinal disruptions may escape timely detection and repair, The purpose of this study was to evaluate blunt enteric injuries requiring operative repair in adult patients and the association of concomitant hepatic and/or splenic injuries, Over a 10-year period (January 1990 through December 1999) 1648 patients suffered blunt liver, spleen, and/or enteric injuries, with 87 (5.3%) of these requiring operative repairs of the enteric injury. These patients had enteric injury only (EI) (60.9%; 53 of 87), concomitant enteric/splenic injury (ESI) (10.3%; 9 of 87), concomitant enteric/hepatic injury (EHI) (13.8%; 12 of 87), and enteric/hepatic/splenic injury (EHSI) 14.9% (13 of 87). A delay in treatment of >8 hours from presentation of EI compared with either EHI or ESI was not significantly different between the two groups. EHSI had exploratory laparotomy more expeditiously related to hemodynamic instability. Mortality rates were higher with EHI related to hemorrhagic shock and/or severe traumatic brain injury. Morbidity was not related to a delay in diagnosis until the period of delay was greater than 24 hours. The nonoperative management of blunt solid organ injury does not delay the detection and treatment of concomitant bowel injuries compared with isolated blunt enteric injuries. Occult enteric injury with solid organ injury has a low incidence and represents a continuing challenge to the clinical acumen of the trauma surgeon.	Michigan State Univ, Spectrum Hlth, Grand Rapids, MI USA		Scholten, DJ (corresponding author), 1000 E Paris SE,Suite 150, Grand Rapids, MI 49546 USA.						Allen GS, 1998, J TRAUMA, V45, P69, DOI 10.1097/00005373-199807000-00014; Brownstein MR, 2000, J TRAUMA, V48, P402, DOI 10.1097/00005373-200003000-00006; BUCKMAN RF, 1988, J TRAUMA, V28, P1317, DOI 10.1097/00005373-198809000-00004; CARMONA RH, 1982, AM J SURG, V144, P88, DOI 10.1016/0002-9610(82)90607-9; DAUTERIVE AH, 1985, ANN SURG, V201, P198, DOI 10.1097/00000658-198502000-00011; Fakhry SM, 2000, J TRAUMA, V48, P408, DOI 10.1097/00005373-200003000-00007; FLAHERTY L, 1991, J TRAUMA, V31, P1618, DOI 10.1097/00005373-199112000-00009; HAGIWARA A, 1995, J TRAUMA, V38, P630, DOI 10.1097/00005373-199504000-00029; HUNTER RA, 1984, AUST NZ J SURG, V54, P129, DOI 10.1111/j.1445-2197.1984.tb06703.x; Kafie F, 1997, AM SURGEON, V63, P889; Kern SJ, 1997, AM SURGEON, V63, P669; McKenney MG, 1996, J TRAUMA, V40, P607, DOI 10.1097/00005373-199604000-00015; MEYER DM, 1989, J TRAUMA, V29, P1168, DOI 10.1097/00005373-198908000-00017; Otomo Y, 1998, J TRAUMA, V44, P991, DOI 10.1097/00005373-199806000-00010; Richards JR, 1999, RADIOLOGY, V211, P399, DOI 10.1148/radiology.211.2.r99ma54399; ROBBS JV, 1980, J TRAUMA, V20, P308; ROOT HD, 1967, ARCH SURG-CHICAGO, V95, P531; ROZYCKI GS, 1995, J TRAUMA, V39, P492; Sartorelli KH, 2000, J TRAUMA, V49, P56, DOI 10.1097/00005373-200007000-00008; SHERCK J, 1994, AM J SURG, V168, P670, DOI 10.1016/S0002-9610(05)80142-4; TRAUB AC, 1981, J TRAUMA, V21, P840, DOI 10.1097/00005373-198110000-00003	21	19	21	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	MAR	2001	67	3					221	225					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	409UE	WOS:000167403400006	11270878				2022-02-06	
J	Stibick, DL; Feeney, DM				Stibick, DL; Feeney, DM			Enduring vulnerability to transient reinstatement of hemiplegia by prazosin after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						alpha(1) noradrenergic receptors; brain injury; noradrenaline; prazosin; reinstatement; trauma	SENSORIMOTOR CORTEX CONTUSION; CORTICAL INJURY; RAT-BRAIN; AMPHETAMINE; RECOVERY; MOTOR; NEURONS; NOREPINEPHRINE; ORGANIZATION; RECEPTORS	A single dose of an alpha (1)-noradrenergic antagonist transiently reinstates hemiplegia after recovery from brain injury, which suggests that noradrenaline (NA) is required to maintain recovery. No systematic studies have determined the postinjury duration of this vulnerability. This study used a within-subject, dose-response design to determine whether prazosin (PRAZ), an alpha (1)-NA antagonist, or propranolol (PROP), a beta -NA antagonist, would continue to reinstate hemiplegia over time after recovery from weight-drop traumatic brain injury (TBI), PRAZ transiently reinstated hemiplegia as measured by beam walk (BW) score in a dose-dependent manner, with the same degree of symptom reinstatement at 1, 3, 6, and 12 months post-TBI, Between-animal variability in reinstatement of hemiplegia by PRAZ was predicted by severity of deficits in BW ability 24 h after TBI, In contrast, PRAZ did not reinstate tactile placing deficits at 1 month post-TBI suggesting a different mechanism of maintaining recovery for each task. Reinstatement of symptoms are not due to sedation. Only TBI rats receiving PRAZ, not high, sedating doses of PROP or saline (SAL), showed return of hemiplegia, These data indicate that vulnerability to transient reinstatement of hemiplegia on some tasks endures long after functional recovery from TBI.	Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA		Feeney, DM (corresponding author), Univ New Mexico, Dept Psychol, Logan Hall, Albuquerque, NM 87131 USA.	feeney@unm.edu					BOGEN J, 1975, J NEUROBIOL, V6, P125, DOI 10.1002/neu.480060115; BOYESON MG, 1993, RESTOR NEUROL NEUROS, V5, P283, DOI 10.3233/RNN-1993-5404; BOYESON MG, 1983, THESIS U NEW MEXICO; BRAILOWSKY S, 1987, NEUROBIOL AGING, V8, P441, DOI 10.1016/0197-4580(87)90039-X; BROWN AW, 1979, ANN NEUROL, V5, P127, DOI 10.1002/ana.410050206; COHEN Z, 1986, INT J COLOR DIS, V1, P2; DERYCK M, 1992, BRAIN RES, V573, P44; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1983, FED PROC, V42, P1157; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FEENEY DM, 1985, PHYSIOL PSYCHOL, V13, P197; FEENEY DM, 1983, PSYCHOPHARMACOLOGY, V79, P67, DOI 10.1007/BF00433018; FEENEY DM, 1989, J NEUROTRAUM, V6, P209; FEENEY DM, 1995, J NEUR ABSTR, V21, P495; FEENEY DM, 1998, CEREBROVASC DIS, P620; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; Goldstein LB, 1998, RESTORATIVE NEUROLOGY, P241; GOLDSTEIN LB, 1988, NEUROLOGY, V38, P1806, DOI 10.1212/WNL.38.11.1806; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HOFFMAN B B, 1990, P221; Hovda D.A., 1996, NEUROTRAUMA, P1459; HOVDA DA, 1983, SOC NEUR ABSTR, V9, P1002; KLUVER H, 1976, HISTOLOGICAL PROCESS, P39; KROBERT KA, 1994, J NEUROCHEM, V62, P2233; MEYER PM, 1963, J COMP PHYSIOL PSYCH, V56, P402, DOI 10.1037/h0049297; MINNEMAN KP, 1988, PHARMACOL REV, V40, P87; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; Queen SA, 1997, BRAIN RES, V777, P42, DOI 10.1016/S0006-8993(97)00717-8; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; RUTLEDGE CO, 1970, J PHARMACOL EXP THER, V171, P188; SAPORTA S, 1977, J COMP NEUROL, V174, P187, DOI 10.1002/cne.901740202; Schmanke T, 1997, J NEUROTRAUM, V14, P459, DOI 10.1089/neu.1997.14.459; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; SHENOY AK, 1979, LIFE SCI, V24, P255, DOI 10.1016/0024-3205(79)90227-3; STEWART J, 1987, CALCULUS, P440; STIBICK DL, 1998, P 5 INT WORLD C BIOM; SULZER D, 1990, NEURON, V5, P797, DOI 10.1016/0896-6273(90)90339-H; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; SUTTON RL, 1994, NEUROLOGICAL REHABIL, P469; SUTTON RL, 1995, CENTRAL NERVOUS SYST, P497; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TANIGUCHI T, 1988, LIFE SCI, V42, P2341, DOI 10.1016/0024-3205(88)90187-7; Tracey David J., 1995, P689; WEISEND M P, 1989, Society for Neuroscience Abstracts, V15, P69; WEISEND MP, 1994, J NEUROSURG, V80, P120, DOI 10.3171/jns.1994.80.1.0120; WILSON KM, 1991, J NEUROCHEM, V56, P953, DOI 10.1111/j.1471-4159.1991.tb02014.x; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	51	19	19	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2001	18	3					303	312		10.1089/08977150151070955			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	414EM	WOS:000167653000007	11284550				2022-02-06	
J	Allain, P; Etcharry-Bouyx, F; Le Gall, D				Allain, P; Etcharry-Bouyx, F; Le Gall, D			A case study of selective impairment of the central executive component of working memory after a focal frontal lobe damage	BRAIN AND COGNITION			English	Article; Proceedings Paper	19th Annual Mid-Year Meeting of the International-Neuropsychological-Society	JUN 19-22, 1996	VELDHOVEN, NETHERLANDS	Int Neuropsychol Soc			SORTING TEST-PERFORMANCE; UTILIZATION BEHAVIOR; PREFRONTAL CORTEX; SCRIPTS; LESIONS; TASKS; REPRESENTATION; DEMENTIA; DISEASE; SYSTEM	RC is a 36-year-old man who sustained a closed head injury with bilateral frontal lobe hypometabolism in 1978. In 1994, after a lobectomy of a large part of the left frontal lobe, he presented no behavioral disruption and normal performances on most of intelligence, longterm memory, and executive tests. However, he showed deficits in tasks that implicate short-term storage (i.e.. span tasks). These deficits in working memory were explored with regard to Baddeley's model using computerized tasks. On these tasks RC showed normal functioning of the articulatory loops and dysfunction of the central executive component in dual tasks. These results confirm those reported in another single case study by Van Der Linden, Coyette, and Seron (1993) and indicate that dual-task performance may assess one separable feature of executive functions. (C) 2001 Academic Press.	CHU Angers, Dept Neurol, Unite Neuropsychol, Psychol Lab, F-49033 Angers 01, France; Univ Angers, Psychol Lab, Angers, France		Allain, P (corresponding author), CHU Angers, Dept Neurol, Unite Neuropsychol, Psychol Lab, 4 Rue Larrey,EA 2646, F-49033 Angers 01, France.			ALLAIN, Philiooe/0000-0003-0668-0986			ABBOTT V, 1985, J MEM LANG, V24, P179, DOI 10.1016/0749-596X(85)90023-3; Agniel A, 1987, PROTOCOLE EVALUATION; Allain P, 1999, J CLIN EXP NEUROPSYC, V21, P643, DOI 10.1076/jcen.21.5.643.871; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Aubin G, 1997, REV NEUROPSYCHOL, V7, P411; AUBIN G, 1994, REV NEUROPSYCHOL, V4, P437; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley, 1990, HUMAN MEMORY THEORY; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P603, DOI 10.1080/14640748608401616; BADDELEY A, 1992, Q J EXP PSYCHOL-A, V44, P1, DOI 10.1080/14640749208401281; Baddeley A., 1974, PSYCHOL LEARNING MOT, V8; Baddeley A.D., 1986, WORKING MEMORY; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; BADDELEY AD, 1997, NEUROPSYCHOLOGY, V2, P187; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BELLEVILLE S, 1992, BRAIN LANG, V43, P713, DOI 10.1016/0093-934X(92)90092-S; Belleville S, 1992, BATTERIE EVALUATION; BRAZZELLI M, 1994, CORTEX, V30, P27, DOI 10.1016/S0010-9452(13)80323-1; Brooks DN, 1994, EVALUATION TRAUMATIS; Burgess P, 1996, BEHAV ASSESSMENT DYS; BURGESS PW, 1994, REV NEUROPSYCHOL, V4, P345; Cowey CM, 1996, MEMORY, V4, P19, DOI 10.1080/741940668; CREPEAU F, 1997, NEUROPSYCHOLOGICAL R, V2, P147; DALRYMPLEALFORD JC, 1994, J NEUROL NEUROSUR PS, V57, P360, DOI 10.1136/jnnp.57.3.360; Damasio H., 1989, LESION ANAL NEUROPSY; DeRenzi E, 1996, J NEUROL NEUROSUR PS, V61, P396, DOI 10.1136/jnnp.61.4.396; DEROUESNE C, 1994, REV NEUROPSYCHOL, V3, P273; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dubois B., 1994, NEUROPSYCHOLOGIE HUM, P453; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FASOTTI L, 1992, ARITHMETICAL WORD PR; FASOTTI L, 1999, NEUROPSYCHOLOGIE LOB, P255; Fasotti L., 1992, NEUROPSYCHOL REHABIL, V2, P3, DOI DOI 10.1080/09602019208401392; FASOTTI L, 1994, J CLIN EXPT NEUROPSY, V5, P723; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P121, DOI 10.1016/0028-3932(90)90095-6; Godbout L, 1995, NEUROPSYCHOLOGIA, V33, P1671, DOI 10.1016/0028-3932(95)00047-X; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; GRAFMAN J, 1990, PERCEPT MOTOR SKILL, V71, P1120, DOI 10.2466/PMS.71.7.1120-1122; Grafman J., 1989, INTEGRATING THEORY P, P93; GRAFMAN J, 1994, HDB NEUROPSYCHOLOGY, V9; GRAFMAN J, 1994, NEUROPSYCHOLOGY HDB, V15; HANLEY JR, 1991, Q J EXP PSYCHOL-A, V43, P101, DOI 10.1080/14640749108401001; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HECK ET, 1986, J CLIN EXP NEUROPSYC, V8, P313, DOI 10.1080/01688638608401321; JOANETTE Y, 1989, PENO PROTOCOLE EVALU; LEGALL D, 1993, REV NEUROPSYCHOL, V1, P87; LEGALL D, 1993, TETRALOGIQUES, V8, P64; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; LHERMITTE F, 1986, ANN NEUROL, V19, P335, DOI 10.1002/ana.410190405; LHERMITTE F, 1983, BRAIN, V106, P237, DOI 10.1093/brain/106.2.237; LHERMITTE F, 1972, REV NEUROL-FRANCE, V127, P415; Luria A.R., 1966, HIGHER CORTICAL FUNC; LURIA AR, 1967, TROUBLES RESOLUTION; MAZAUX JM, 1981, BOSTON DIAGNOSTIC AP; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; MORRIS RG, 1984, COGNITIVE NEUROPSYCH, V1, P143, DOI 10.1080/02643298408252019; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; RAVEN JC, 1982, PROGR MATRICES COU A; RAVEN JC, 1982, PROGR MATRICES COU C; RAVEN JC, 1982, PROGR MATRICES COU D; RAVEN JC, 1982, PROGR MATRICES COU B; RAVEN JC, 1982, PROGR MATRICES COU E; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; REY A, 1968, EPREUVES MNESIQUES A; Rey A, 1958, LEXAMEN CLINIQUE PSY; Salmon E, 1996, BRAIN, V119, P1617, DOI 10.1093/brain/119.5.1617; Schank R, 1977, SCRIPTS PLANS GOALS; Schwartz M. F., 1993, J HEAD TRAUMA REHAB, V8, P59, DOI [10.1097/00001199-199303000-00007, DOI 10.1097/00001199-199303000-00007]; SCHWARTZ MF, 1991, COGN NEUROPSYCHOL, V8, P381, DOI 10.1080/02643299108253379; Schwartz MF, 1995, COGNITIVE NEUROPSYCH, V12, P863, DOI 10.1080/02643299508251406; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; SHALLICE T, 1989, BRAIN, V112, P1587, DOI 10.1093/brain/112.6.1587; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Sirigu A, 1996, CORTEX, V32, P297, DOI 10.1016/S0010-9452(96)80052-9; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TRUELLE JL, 1995, NEUROPSY NEUROPSY BE, V8, P14; VALLAR G, 1984, J VERB LEARN VERB BE, V23, P151, DOI 10.1016/S0022-5371(84)90104-X; Vallar G, 1997, NEUROPSYCHOLOGIA, V35, P795, DOI 10.1016/S0028-3932(96)00127-3; VANDERLINDEN M, 1992, COGNITIVE NEUROPSYCH, V9, P301, DOI 10.1080/02643299208252063; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN; WATERS GS, 1991, COGNITIVE NEUROPSYCH, V8, P82; Wechsler D., 1991, ECHELLE CLIN MEMOIRE; Wechsler D., 1989, ECHELLE INTELLIGENCE; Wilson B.A., 1997, METHODOLOGY FRONTAL, P239; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; [No title captured]; [No title captured]; [No title captured]; [No title captured]	97	19	19	0	14	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	FEB	2001	45	1					21	43		10.1006/brcg.2000.1249			23	Neurosciences; Psychology, Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	403UF	WOS:000167060300003	11161360				2022-02-06	
J	Santa Maria, MP; Pinkston, JB; Miller, SR; Gouvier, WD				Santa Maria, MP; Pinkston, JB; Miller, SR; Gouvier, WD			Stability of postconcussion symptomatology differs between high and low responders and by gender but not by mild head injury status	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							SEX-DIFFERENCES; BASE RATES; SYMPTOMS; DEPRESSION; CONCUSSION; STRESS	A large sample of undergraduates (N = 2.326) was screened for general health. The screen discretely included items assessing postconcussion symptomatology and neurologic history. A subsample of experiment-blind participants whose self-reported postconcussion symptom levels were > 0.5 SD below the screening sample mean (low symptomatic; n = 45) or > 0.5 SD above the screening sample mean thigh symptomatic: n = 53) were re-evaluated for postconcussion symptomatology 3 to 90 days later. The sample included 50 participants who reported history of mild head injury (MHI) and 48 controls. MHI was defined as loss of consciousness of less than or equal to 20 minutes within the past 10 years, but no more recent than 3 months. Persons with history of > 1 head injury or with other neurologic history were not included in the study. The stability of postconcussion symptoms differed by high symptomatic versus low symptomatic presentation thigh symptomatic presentation was more variable) and by gender (females were more variable), but not by actual history of MHI. Sex differences in self-reported postconcussion symptomatology are consistent with gender-related differences in reporting of other physical and psychological symptoms. In addition to demonstrating differences in the stability of self-reported postconcussion symptomatology, the current study provides normative test-retest data for the Postconcussion Symptom Checklist for extreme responders by gender and MHI status. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA		Santa Maria, MP (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Neurol, 100 High St,D-6, Buffalo, NY 14203 USA.						BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Compas BE, 1997, J CONSULT CLIN PSYCH, V65, P617, DOI 10.1037/0022-006X.65.4.617; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; FRANK E, 1988, AM J PSYCHIAT, V145, P41; Frieze I. H., 1978, WOMEN SEX ROLES SOCI; Gater R, 1998, ARCH GEN PSYCHIAT, V55, P405, DOI 10.1001/archpsyc.55.5.405; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Goldberg D., 1972, DETECTION PSYCHIAT I; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; HannaPladdy B, 1997, ARCH CLIN NEUROPSYCH, V12, P329; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kibby M Y, 1997, Appl Neuropsychol, V4, P34, DOI 10.1207/s15324826an0401_4; KING DA, 1982, J PERS SOC PSYCHOL, V42, P963, DOI 10.1037/0022-3514.42.5.963; Kornstein SG, 1997, J CLIN PSYCHIAT, V58, P12; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; NOLENHOEKSEMA S, 1987, PSYCHOL BULL, V101, P259, DOI 10.1037/0033-2909.101.2.259; PHILLIPS DL, 1969, AM SOCIOL REV, V34, P58, DOI 10.2307/2092787; PINKSTON JB, 2000, IN PRESS BRAIN COGNI; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; WEISSMAN MM, 1977, ARCH GEN PSYCHIAT, V34, P98; WOOD F, 1984, INT J PSYCHIAT MED, V14, P277; YOUNG MA, 1990, J NERV MENT DIS, V178, P200, DOI 10.1097/00005053-199003000-00008	29	19	19	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2001	16	2					133	140					8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	415JB	WOS:000167716900002	14590181				2022-02-06	
J	Sinha, M; Kennedy, CS; Ramundo, ML				Sinha, M; Kennedy, CS; Ramundo, ML			Artificial neural network predicts CT scan abnormalities in pediatric patients with closed head injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	National Congress on Childhood Emergencies	MAR, 2000	BALTIMORE, MARYLAND			artificial neural networks; closed head injury; clinical prediction; predictive models	ACUTE MYOCARDIAL-INFARCTION; COMPUTED-TOMOGRAPHY; BRAIN INJURY; CHILDREN; TRAUMA; IDENTIFY	Background: Artificial neural networks (ANNs) use nonlinear statistical modeling techniques to explore relationships in complex clinical situations. This study compared predictive ability of a trained ANN model to that of physician prediction of cranial computed tomographic (CT) scan abnormalities in children with head injury, Methods: A prospective cohort of 351 patients who presented with head trauma and underwent CT scans were studied. All pertinent data on historical and demographic information, and clinical features were recorded, Emergency department physicians used clinical judgment to record pretest probability of abnormal CT scans for all patients prospectively, Similar data front a retrospective chart review of 382 patients with head injury in the immediate preceding year were collected and used to train the ANN, Data from the prospective study was used to validate the ANN, construct a logistic regression model, and compare physician prediction. Results: Forty-five (12.9%) of 351 patients had abnormal CT scans. In predicting CT scan abnormality, the ANN model was more sensitive (82.2%) compared with physician prediction (62.2%). Conclusion: ANNs may serve as a useful aid for decision support for emergency physicians in predicting intracranial abnormalities in closed head injury.	Childrens Hosp, Med Ctr, Div Pediat Emergency Med, Akron, OH 44308 USA		Sinha, M (corresponding author), 30 Chittaranjan Pk, New Delhi 110019, India.						BAXT WG, 1992, ANN EMERG MED, V21, P1439, DOI 10.1016/S0196-0644(05)80056-3; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Baxt WG, 1996, LANCET, V347, P12, DOI 10.1016/S0140-6736(96)91555-X; BLAKELEY DD, 1995, ANN INTERN MED, V122, P360, DOI 10.7326/0003-4819-122-5-199503010-00007; Bottaci L, 1997, LANCET, V350, P469, DOI 10.1016/S0140-6736(96)11196-X; CROSS SS, 1995, LANCET, V346, P1075, DOI 10.1016/S0140-6736(95)91746-2; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Heden B, 1997, CIRCULATION, V96, P1798, DOI 10.1161/01.CIR.96.6.1798; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; MASTERS SJ, 1980, AM J ROENTGENOL, V135, P539, DOI 10.2214/ajr.135.3.539; PATIL S, 1993, CHEST, V104, P1685, DOI 10.1378/chest.104.6.1685; RAMUNDO ML, 1995, PEDIATR EMERG CARE, V11, P1, DOI 10.1097/00006565-199502000-00001; RIVARA F, 1987, PEDIATRICS, V80, P579; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; THORNBURY JR, 1984, AM J ROENTGENOL, V143, P661	19	19	20	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2001	50	2					308	312		10.1097/00005373-200102000-00018			5	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	404WL	WOS:000167125000028	11242297				2022-02-06	
J	Solomon, NP; McKee, AS; Garcia-Barry, S				Solomon, NP; McKee, AS; Garcia-Barry, S			Intensive voice treatment and respiration treatment for hypokinetic-spastic dysarthria after traumatic brain injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	1998 Annual Convention of the American-Speech-Language-Hearing-Association	NOV, 1998	SAN ANTONIO, TX	Amer Speech Language Hearing Assoc		LSVT; TBI; dysarthria; breathing; voice; physical therapy; treatment efficacy	LARYNGEAL AIRWAY-RESISTANCE; PARKINSONS-DISEASE; PALLIDOTOMY SURGERY; SPEECH PRODUCTION; VOWEL PRODUCTION; CHEST WALL; RIB CAGE; ABDOMEN; AGE	The short-term efficacy of the Lee Silverman Voice Treatment (LSVT) and the short- and long-term efficacy of LSVT exercises combined with respiration treatment and physical therapy (Combination Treatment) were examined for a young man diagnosed with mixed hypokinetic-spastic dysarthria 20 months after sustaining a traumatic brain injury (TBI). The efficacy of the LSVT, an intensive 4-week program that focuses on increased vocal effort, is well documented for idiopathic Parkinson's disease. This is the first known published account of the use of LSVT with TBI. Breathing and speech function were assessed by spirometry, respiratory kinematics, intelligibility, and other selected acoustic and auditory-perceptual measures. Improvements generally were minor and inconsistent after LSVT, although sound pressure level (SPL) and loudness increased notably. After an additional 6 weeks of intensive Combination Treatment, gains were documented for resting and speech breathing. Moreover, SPL increased further and sentence intelligibility improved substantially. The gains were maintained to varying degrees after 10 weekly sessions of Combination Treatment. Although several measures returned to baseline 3 months after treatment ceased, some improvements in resting and speech breathing remained. Most important clinically, improvements in vocal SPL and sentence intelligibility persisted.	Univ Minnesota, Minneapolis, MN 55455 USA; Courage Ctr, Minneapolis, MN USA		Solomon, NP (corresponding author), Univ Minnesota, 115 Shevlin Hall,164 Pillsbury Dr SE, Minneapolis, MN 55455 USA.			Solomon, Nancy/0000-0002-5018-7569			Beukelman D.R., 1984, ASSESSMENT INTELLIGI; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; Burke D, 1988, Adv Neurol, V47, P401; Countryman S., 1993, J MED SPEECH-LANG PA, V1, P233; Countryman S, 1994, J MED SPEECH-LANG PA, V2, P211; Duffy JR., 2020, MOTOR SPEECH DISORDE; DWORKIN JP, 1991, MOTOR SPEECH DISORDE; Fairbanks G., 1960, VOICE ARTICULATION D; Hagen C, 1979, REHABILITATION HEAD; HIXON TJ, 1976, J SPEECH HEAR RES, V19, P297, DOI 10.1044/jshr.1902.297; HIXON TJ, 1973, J SPEECH HEAR RES, V16, P78, DOI 10.1044/jshr.1601.78; HOIT JD, 1987, J SPEECH HEAR RES, V30, P351, DOI 10.1044/jshr.3003.351; Johnson M.B., 1989, WOODCOCK JOHNSON PSY; McHenry MA, 1998, NEUROMOTOR SPEECH DISORDERS, P167; MELCON MC, 1989, J SPEECH HEAR DISORD, V54, P282, DOI 10.1044/jshd.5402.282; Ramig L. O., 1994, J MED SPEECH-LANG PA, V2, P191; Ramig LO, 1996, NEUROLOGY, V47, P1496, DOI 10.1212/WNL.47.6.1496; RAMIG LO, 1995, J SPEECH HEAR RES, V38, P1232, DOI 10.1044/jshr.3806.1232; Schulz GM, 1999, J SPEECH LANG HEAR R, V42, P1176, DOI 10.1044/jslhr.4205.1176; SMITHERAN JR, 1981, J SPEECH HEAR DISORD, V46, P138, DOI 10.1044/jshd.4602.138; TEASDALE G, 1974, LANCET, V2, P81; Theodoros DG, 1999, J MED SPEECH-LANG PA, V7, P157; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; VERDOLINI K, 1997, ASHA, V39, P34; Wilson BA, 1991, RIVERMEAD BEHAV MEMO; WILSON BA, 1995, HDB MEMORY DISORDERS, P451	26	19	19	2	15	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	FEB	2001	10	1					51	64		10.1044/1058-0360(2001/008)			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	405KF	WOS:000167158000009					2022-02-06	
J	Foster, M; Fleming, J; Tilse, C; Rosenman, L				Foster, M; Fleming, J; Tilse, C; Rosenman, L			Referral to post-acute care following traumatic brain injury (TBI) in the Australian context	BRAIN INJURY			English	Article							HEAD-INJURY; REHABILITATION; CHILDREN	The study aimed to describe the types of care allocated at the end of acute care to people diagnosed with TBI and to identify the factors associated with variations in referral to care. A retrospective analysis of medical records of 61 patients was conducted based on a sample from two hospitals. While 60.7% of the study sample were referred to formal rehabilitation care, this was primarily non-inpatient rehabilitation care (32.8%). Discriminant analysis was used to determine medical and non-medical predictors of referral. Results indicated that place of treatment and age contribute to group differences and were significant in separating the inpatient rehabilitation group from the non-inpatient and no rehabilitation groups. Review by a rehabilitation physician was associated with referral to inpatient rehabilitation but was not adequate to explain referral to non-inpatient rehabilitation. An in-depth exploration of post-acute referral is warranted to improve policy and practice in relation to continuity of care following TBI.	Univ Queensland, Sch Social Work & Social Policy, Brisbane, Qld 4072, Australia; Univ Queensland, Dept Occupat Therapy, Brisbane, Qld 4072, Australia; Univ Queensland, Fac Social & Behav Sci, Brisbane, Qld 4072, Australia		Foster, M (corresponding author), Univ Queensland, Sch Social Work & Social Policy, Brisbane, Qld 4072, Australia.		Fleming, Jennifer M/B-4436-2011; Tilse, Cheryl/AAH-2155-2019; Tilse, Cheryl/A-1266-2008	Tilse, Cheryl/0000-0001-5596-9132			ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; *AUSTR FAC REH MED, 1997, REH 21 CENT VIS VICT; CAPLAN A, 1987, HASTINGS CTR REP S, P1; CAREY RG, 1988, ARCH PHYS MED REHAB, V69, P337; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; COULTON CJ, 1988, SOC WORK HEALTH CARE, V13, P19, DOI 10.1300/J010v13n04_03; DEMBOVY M, 1996, BRAIN INJURY, V11, P305; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; Evans RW, 1992, J HEAD TRAUMA REHAB, V7, P24; FORTUNE N, 1999, 15 AIHW DIS; GILES GM, 1994, AM J OCCUP THER, V48, P199, DOI 10.5014/ajot.48.3.199; HAAS JF, 1988, ARCH PHYS MED REHAB, V69, P329; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Heinemann AW, 1990, J NEUROL REHABIL, V4, P27; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; Hoenig H, 1996, ARCH PHYS MED REHAB, V77, P58, DOI 10.1016/S0003-9993(96)90221-X; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Mooney GH, 1997, MED J AUSTRALIA, V166, P575, DOI 10.5694/j.1326-5377.1997.tb123266.x; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951; WRIGLEY JM, 1994, ARCH PHYS MED REHAB, V75, P149	23	19	20	0	2	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2000	14	12					1035	1045					11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	380YW	WOS:000165736100001	11147576				2022-02-06	
J	Hortobagyi, T; Hortobagyi, S; Gorlach, C; Harkany, T; Benbyo, Z; Gorogh, T; Nagel, W; Wahl, M				Hortobagyi, T; Hortobagyi, S; Gorlach, C; Harkany, T; Benbyo, Z; Gorogh, T; Nagel, W; Wahl, M			A novel brain trauma model in the mouse: effects of dexamethasone treatment	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						brain swelling; cold lesion; dexamethasone; mouse; oedema therapy	LATERAL FLUID-PERCUSSION; COLD-INJURY; CEREBRAL-CORTEX; EDEMA; MICE; RAT; BARRIER; NECROSIS; LESION	We describe a novel methodological approach for inducing cold lesion in the mouse as a model of human cortical contusion trauma. To validate its reproducibility and reliability, dexamethasone (Dxm) was repeatedly applied to demonstrate possible antioedematous drug effects. Following tho induction of anaesthesia with halothane, the dura was exposed via trephination. Using a micromanipulator a pre-cooled (-78 degreesC) copper cylinder, 3 mm in diameter, was pressed down to a depth of 1 mm onto the dura fur 30 s under microscopic control. The body temperature was held constant at 37 degreesC throughout the procedure. Blood pressure (BP), measured by a modified photosensor-monitored tail-cuff method, and acid-base status were not significantly different when analysed before and after cold lesion and prior to sacrifice. However, there was a marginal mixed respiratory and metabolic acidosis. The antioedematous action of Dxm was studied in four standard pre and post-treatment paradigms: 2x0.5 mg/kg (II), 2x12,5 mg/kg (III) and 4x6.25 mg/kg (IV: 3x pre-, 1x post-treatment; V: 1x pre-, 3x post-treatment). Physiological saline injections served as controls. High doses of Dxm (III-V) significantly attenuated the cold-lesion-induced loss of body mass. Dxm treatment also resulted in a reduction of brain water content (III; P<0.05), and brain swelling (IV; P<0.05) in the lesioned hemisphere, relative to controls. In conclusion, we have characterized a novel cold lesion model in the mouse to mimic traumatic brain injury and the beneficial effect of Dxm treatment on the extent of brain oedema.	Univ Munich, Dept Physiol, D-80336 Munich, Germany; Univ Groningen, Dept Anim Physiol, NL-9750 AA Haren, Netherlands; Semmelweis Univ, Inst Human Physiol & Clin Expt Res, H-1446 Budapest, Hungary; Univ Kiel, Dept Otorhinolaryngol Head & Neck Surg, Oncol Mol Lab, D-24105 Kiel, Germany		Hortobagyi, T (corresponding author), Univ Munich, Dept Physiol, Pettenkoferstr 12, D-80336 Munich, Germany.	hortobagyi@lrz.uni-muenchen.de	Benyo, Zoltan/C-9184-2009	Benyo, Zoltan/0000-0001-6015-0359			Abraham I, 1997, J NEUROENDOCRINOL, V9, P713, DOI 10.1046/j.1365-2826.1997.00634.x; Bertorelli R, 1998, NEUROSCI LETT, V246, P41, DOI 10.1016/S0304-3940(98)00221-3; Biros MH, 1996, AM J EMERG MED, V14, P27, DOI 10.1016/S0735-6757(96)90008-X; De Kloet ER, 1997, Stress, V2, P13; ERISKAT J, 1994, ACTA NEUROCHIR, P425; FOLGER S, 1991, P 25 INT S BIOL MOD, P9; HEDLEYWHYTE ET, 1986, ANN NEUROL, V19, P373, DOI 10.1002/ana.410190411; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; HORTOBAGYI T, 2000, PFLUGERS ARCH S, V439, pR437; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; KLATZO I, 1972, STEROIDS BRAIN EDEMA, P1; Kostron H, 1990, Adv Neurol, V52, P289; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meinig G, 1990, Adv Neurol, V52, P295; Michel C, 1999, PHYSIOL BEHAV, V68, P145, DOI 10.1016/S0031-9384(99)00159-6; Minet-Quinard R, 2000, JPEN-PARENTER ENTER, V24, P30, DOI 10.1177/014860710002400130; Morita-Fujimura Y, 1999, J CEREBR BLOOD F MET, V19, P634, DOI 10.1097/00004647-199906000-00006; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Nakata H, 1990, Adv Neurol, V52, P335; OLSON JJ, 1987, J NEUROPATH EXP NEUR, V46, P682, DOI 10.1097/00005072-198711000-00007; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; SCHILLING L, 1994, ACTA NEUROCHIR, P79; Steinbach JP, 1999, NEUROPATH APPL NEURO, V25, P468; Tajima A, 1990, Adv Neurol, V52, P343; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; VONANDRIANWERBU.U, 1992, THESIS U MUNICH; Wahl M., 1999, Acta Physiologica Hungarica, V86, P155	30	19	19	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	DEC	2000	441	2-3					409	415		10.1007/s004240000441			7	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	389BX	WOS:000166219700030	11211129				2022-02-06	
J	Alessandri, B; AL-Samsam, R; Corwin, F; Fatouros, P; Young, HF; Bullock, RM				Alessandri, B; AL-Samsam, R; Corwin, F; Fatouros, P; Young, HF; Bullock, RM			Acute and late changes in N-acetyl-aspartate following diffuse axonal injury in rats: An MRI spectroscopy and microdialysis study	NEUROLOGICAL RESEARCH			English	Article						proton nuclear magnetic resonance spectroscopy (H-1-NMR); microdialysis; N-acetyl-aspartate; traumatic brain injury; weight drop injury; neuronal death; rat; halothane anesthesia; brain	MAGNETIC-RESONANCE SPECTROSCOPY; TRAUMATIC BRAIN INJURY; CLOSED-HEAD INJURY; HYPOXIA-ISCHEMIA; ACETYLASPARTATE; LESIONS; DISEASE; MODEL; LOBE	N-acetyl-aspartate (NAA) measured by proton nuclear magnetic resonance spectroscopy (H-1-NMR) has been used as a marker of neuronal injury in many cerebral pathologies. Therefore, we evaluate the roles of microdialysis vs. H-1-NMR as techniques to assess NAA (NAA(d); NAA/Creatine ratio) in the living brain, and compare the results with whole brain NAA (NAA(w)) analyzed by HPLC after diffuse traumatic brain injury (TBI). Acute (4 h post-injury survival) and late (48 h survival) changes were studied in a sham-operated group (Sham, n = 4), and two injured groups (TBI/4h, n = 8; TBI/48h, n = 7). Baseline NAAd was 8.17 +/- 1 muM, and there was no significant difference between groups. There was only a small (twice of control), but transient increase in NAAd in the TBI/4 h group after trauma. Baseline NAA/Cr ratio was 1.35 +/- 0.2, which did not change significantly between baseline, 1, 2, 3, 4 and 48 h or between groups after TBI. Whole brain NAA, (baseline 8.5 +/- 0.5 mmol kg(-1) wet weight) did not differ significantly between groups before and after TBI. Diffuse TBI did not produce long-term changes in NAA, assessed by three different methods. These results may indicate that NAA is not a sensitive marker of the severity of diffuse axonal damage. However, further studies are needed to evaluate whether confounding factors such as microdialysis probe, voxel position and non-regional tissue homogenization might have influenced our data.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Div Pediat Crit Care, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Div Radiol, Richmond, VA 23298 USA		Bullock, RM (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, POB 980631,MCV Stn Box, Richmond, VA 23298 USA.	robulloc@hsc.vcu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline		Al-Samsam R, 1999, CRIT CARE MED, V27, pA104, DOI 10.1097/00003246-199901001-00265; ALSAMASAM R, 1998, J NEUROTRAUM, V15, pA9; ALSAMASAM R, 1999, IN PRESS J NEUROTRAU; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BERLINGUET L, 1996, CAN J BIOCHEM, V44, P783; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; CENDES F, 1994, ANN NEUROL, V35, P211, DOI 10.1002/ana.410350213; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; Condon B, 1998, J NEUROTRAUM, V15, P563, DOI 10.1089/neu.1998.15.563; Davie CA, 1997, J NEUROL NEUROSUR PS, V63, P736, DOI 10.1136/jnnp.63.6.736; DI X, 1999, 11 INT S BRAIN OED M, P65; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gallant PE, 1997, J NEUROTRAUM, V14, P811, DOI 10.1089/neu.1997.14.811; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; GIDEON P, 1992, STROKE, V23, P1566, DOI 10.1161/01.STR.23.11.1566; Harms L, 1997, J NEUROL NEUROSUR PS, V62, P27, DOI 10.1136/jnnp.62.1.27; KOLLER KJ, 1984, J NEUROCHEM, V43, P1136, DOI 10.1111/j.1471-4159.1984.tb12854.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MOATS RA, 1994, MAGNET RESON MED, V32, P110, DOI 10.1002/mrm.1910320115; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; PEDEN CJ, 1993, DEV MED CHILD NEUROL, V35, P502; Penrice J, 1996, PEDIATR RES, V40, P6, DOI 10.1203/00006450-199607000-00002; Penrice J, 1997, PEDIATR RES, V41, P443, DOI 10.1203/00006450-199703000-00024; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Rubin Y, 1997, J NEUROTRAUM, V14, P441, DOI 10.1089/neu.1997.14.441; Sager TN, 1999, J CEREBR BLOOD F MET, V19, P164, DOI 10.1097/00004647-199902000-00008; SAGER TN, 1995, J CEREBR BLOOD F MET, V15, P639, DOI 10.1038/jcbfm.1995.79; Sager TN, 1997, J NEUROCHEM, V68, P675; SHIINO A, 1993, SURG NEUROL, V39, P143, DOI 10.1016/0090-3019(93)90093-G; SIGNORETTI S, 1999, J NEUROTRAUM, V16, P990; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; TAYLOR DL, 1994, J NEUROCHEM, V62, P2349; TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M; TSUCHIDA E, 1999, IN PRESS J NEUROTRAU; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487	38	19	21	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	OCT	2000	22	7					705	712					8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	373LH	WOS:000165290600010	11091977				2022-02-06	
J	Feinstein, A; Hershkop, S; Jardine, A; Ouchterlony, D				Feinstein, A; Hershkop, S; Jardine, A; Ouchterlony, D			The prevalence and neuropsychiatric correlates of posttraumatic stress symptoms following mild traumatic brain injury	BRAIN AND COGNITION			English	Article							DISORDER; PREDICTORS	The prevalence of posttraumatic stress disorder (PTSD) symptomatology was investigated in 57 patients with mild traumatic brain injury (TBI) approximately one month after injury (mean = 44; SD = 26 days). Symptoms of varying severity were present in 84% of the sample. Patients with a premorbid psychiatric diagnosis, substance abuse, physical complaints, and those involved in litigation were more likely to endorse PTSD symptoms. A comparison of patients with and without PTSD symptoms demonstrated that the latter were significantly more anxious and depressed both on subjective and objective measures of pychopathology. The study demonstrates that PTSD symptoms are frequently present early in the recovery phase of mild TBI and are associated with significant psychiatric comorbidity. (C) 2000 Academic Press.	Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Toronto, ON, Canada		Feinstein, A (corresponding author), Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Toronto, ON, Canada.		Jardine, Alan/L-5770-2019				BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; FEINSTEIN A, 1991, PSYCHOL MED, V21, P85, DOI 10.1017/S0033291700014689; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106	5	19	19	0	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					78	82					5	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300020					2022-02-06	
J	Verma, A				Verma, A			Opportunities for neuroprotection in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						apoptosis; CNS trauma; inhibitory transmitters; neuroprotection	SPINAL-CORD INJURY; FOCAL CEREBRAL-ISCHEMIA; METHYL-D-ASPARTATE; POLY(ADP-RIBOSE) POLYMERASE; CYCLOSPORINE-A; IMPAIRED MITOCHONDRIAL; LIPID-PEROXIDATION; DENTATE GYRUS; NITRIC-OXIDE; HEAD-INJURY	Traumatic injury of the brain in man is normally followed by little or no recovery of function by the lesioned tissue. Neuroprotective strategies employed in the acute period after traumatic CNS injury attempt to use pharmacological tools to reduce the progressive secondary injury processes that follow after the initial lesion occurs to limit overall tissue damage. Results from experimental animal studies using a variety of drugs that modulate neurotransmitter function, scavenge free radicals, or interfere with cell death cascades point toward many new opportunities for pharmacological intervention in the acute and subacute period after traumatic brain injury.	Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA		Verma, A (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.						ABEL MS, 1992, J NEUROCHEM, V58, P740, DOI 10.1111/j.1471-4159.1992.tb09780.x; ALBERS GW, 1995, STROKE, V26, P254, DOI 10.1161/01.STR.26.2.254; ANDERSON DK, 1988, J NEUROSURG, V69, P562, DOI 10.3171/jns.1988.69.4.0562; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BRAUGHLER JM, 1982, J NEUROSURG, V56, P838, DOI 10.3171/jns.1982.56.6.0838; CHAN PH, 1994, BRAIN PATHOL, V4, P59; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Cookson MR, 1998, J NEUROCHEM, V70, P501; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; ENDERS M, 1997, J CEREB BLOOD FLOW M, V17, P1143; Faden A I, 1997, Adv Neurol, V72, P377; FAGG GE, 1983, NEUROSCIENCE, V9, P701, DOI 10.1016/0306-4522(83)90263-4; FAVIT A, 1999, SOC NEUR; FISHER M, 1995, EUR NEUROL, V35, P3, DOI 10.1159/000117082; Ford R W, 1985, Cent Nerv Syst Trauma, V2, P9; GERBER AM, 1980, NEUROSURGERY, V7, P472, DOI 10.1227/00006123-198011000-00009; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Haghighi SS, 1996, NEUROL RES, V18, P509; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; HARRISON NL, 1985, BRIT J PHARMACOL, V84, P381, DOI 10.1111/j.1476-5381.1985.tb12922.x; HSU CY, 1985, NEUROLOGY, V35, P1003, DOI 10.1212/WNL.35.7.1003; INGLIS FM, 1990, ACT NEUR S, V51, P277; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kass GEN, 1999, ENVIRON HEALTH PERSP, V107, P25, DOI 10.2307/3434469; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KIWAK KJ, 1985, J NEUROSURG, V62, P865, DOI 10.3171/jns.1985.62.6.0865; Koura SS, 1998, ACT NEUR S, V71, P244; Kuhn HG, 1996, J NEUROSCI, V16, P2027; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Lee KS, 1997, ANN NY ACAD SCI, V825, P95, DOI 10.1111/j.1749-6632.1997.tb48419.x; Liu SL, 1997, BRAIN RES, V756, P160, DOI 10.1016/S0006-8993(97)00137-6; Lyden PD, 1997, INT REV NEUROBIOL, V40, P233; Mao JR, 1997, PAIN, V72, P355, DOI 10.1016/S0304-3959(97)00063-8; MCDONALD JW, 1990, NEUROSCI LETT, V109, P234, DOI 10.1016/0304-3940(90)90569-U; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MUIR KW, 1995, STROKE, V26, P503, DOI 10.1161/01.STR.26.3.503; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; ONeill MJ, 1996, EUR J PHARMACOL, V310, P115, DOI 10.1016/0014-2999(96)00387-1; Peters Gary R., 1996, Stroke, V27, P195; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Rosenberg LJ, 1999, J NEUROSCI, V19, P464, DOI 10.1523/JNEUROSCI.19-01-00464.1999; Ross IB, 1991, J NEUROTRAUM, V8, P229, DOI 10.1089/neu.1991.8.229; Schubert P, 1997, ANN NY ACAD SCI, V825, P1, DOI 10.1111/j.1749-6632.1997.tb48409.x; SIMPSON JI, 1994, ANESTHESIOLOGY, V81, P1493, DOI 10.1097/00000542-199412000-00025; Stover JF, 1999, J NEUROTRAUM, V16, P135, DOI 10.1089/neu.1999.16.135; STRAND R, 1993, 7 NORD M CER DIS, P37; Strijbos PJLM, 1996, J NEUROSCI, V16, P5004; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; TSUDA T, 1991, NEUROSCIENCE, V44, P335, DOI 10.1016/0306-4522(91)90058-V; Urushitani M, 1998, ANN NEUROL, V44, P796, DOI 10.1002/ana.410440514; WAHLGREN NG, 1995, STROKE THERAPY, P315; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Winkler T, 1997, ACT NEUR S, V70, P216; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; XUE D, 1992, STROKE, V23, P894, DOI 10.1161/01.STR.23.6.894; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	63	19	20	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2000	15	5					1149	1161		10.1097/00001199-200010000-00008			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	359DT	WOS:000089596800008	10970935				2022-02-06	
J	Kowalske, K; Plenger, PM; Lusby, B; Hayden, ME				Kowalske, K; Plenger, PM; Lusby, B; Hayden, ME			Vocational reentry following TBI: An enablement model	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						ecological validity; employment; rehabilitation	TRAUMATIC BRAIN INJURY; INTEGRATION; PREDICTORS; WORK	Objective: To illustrate the importance of environmental factors for optimizing return to work following traumatic brain injury (TBI) using illustrative case examples. Design and Participants: Three case studies are presented that were selected from an overall sample of 57 TBI survivors. Setting: Postacute, outpatient TBI rehabilitation program. Main Outcome Measures: Outcome was essentially descriptive and focused on factors associated with successful return to work. Results and Conclusions: These case examples point out the necessity of specialized treatment that not only focuses on the specific strengths and weakness of the individual, but also on extant environmental factors, including degree of structure or distractions that either reinforce or preclude optimal performance.	Univ Texas, SW Med Ctr, Dallas, TX USA; Pate Rehabil, Vocat Programs, Dallas, TX USA		Kowalske, K (corresponding author), Univ Texas, SW Med Ctr, 5323 Harry Hines Blvd, Dallas, TX USA.						Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; HART T, 1986, CLIN NEUROPSYCHOLOGY; Hayden ME, 2000, J HEAD TRAUMA REHAB, V15, P1000, DOI 10.1097/00001199-200008000-00004; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; 1998, NATL I HLTH CONS DEV, V16, P1	12	19	19	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	2000	15	4					989	999		10.1097/00001199-200008000-00003			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	340DK	WOS:000088517700003	10876171				2022-02-06	
J	Schretlen, DJ				Schretlen, DJ			Do neurocognitive ability and personality traits account for different aspects of psychosocial outcome after traumatic brain injury?	REHABILITATION PSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; FOLLOW-UP; PREDICTORS; COMA; ADJUSTMENT; VALIDITY; SEQUELAE; SCALE	Objective: To examine the contributions of demographic, injury, cognitive, and personality characteristics to psychosocial outcome 8 years after traumatic brain injury (TBI). Design: Multiple regression analyses were used to estimate the variance explained by putative "predictors" of psychosocial outcome. Participants: Thirty-nine TBI survivors and 39 family member informants. On the basis of Glasgow Coma Scale scores and Accident Injury Severity (head) ratings, the patients' brain injuries ranged from mild to critical in severity. Main Outcome Measures: One self-report measure combined putative markers of social role engagement, such as marital status and earned income. Another, based on informant ratings using the Katz Adjustment Scale, was conceptualized as reflecting behavioral adjustment. Results: Whereas cognitive functioning explained significant unique variation in social role engagement, it did not account for variance in behavioral adjustment. Conversely, whereas 3 personality trait ratings explained significant incremental variance in behavioral stability, only 1 did the same with respect to social role engagement. Conclusions: Social role engagement and behavioral adjustment appear to represent 2 related but distinguishable aspects of TBI outcome that are associated with different patient characteristics.	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21218 USA		Schretlen, DJ (corresponding author), Johns Hopkins Hosp, 600 N Wolfe St,Meyer 218, Baltimore, MD 21287 USA.						*ASS ADV AUT MED, 1980, ABBR INJ SCAL 1980 R; BAYLESS JD, 1989, J CLIN EXP NEUROPSYC, V11, P913, DOI 10.1080/01688638908400944; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; DIAMOND R, 1988, INT J CLIN NEUROPSYC, V10, P35; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; FABIANO RJ, 1995, REHABIL PSYCHOL, V40, P223, DOI 10.1037/0090-5550.40.3.223; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Goran DA, 1997, ARCH CLIN NEUROPSYCH, V12, P691, DOI 10.1016/S0887-6177(97)00004-8; HAGEN C, 1982, COGNITIVE REHABILITA, P131; Hathaway S.R., 1989, MINNESOTA MULTIPHASI; Heaton RK, 1981, MANUAL WISCONSIN CAR; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; JENNETT B, 1975, LANCET, V1, P480; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KEYL PM, 2000, UNPUB CAN BRIEF NEUR; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; McCrae RR, 1985, PSYCHOL ASSESSMENT R; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Schretlen D, 2000, J ABNORM PSYCHOL, V109, P134, DOI 10.1037/0021-843X.109.1.134; Schretlen D., 1997, BRIEF TEST ATTENTION; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wechsler D., 1981, WAIS R MANUAL; Wong TM, 1999, ARCH CLIN NEUROPSYCH, V14, P728; Zachary R. A., 1986, SHIPLEY I LIVING SCA	40	19	19	0	6	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2000	45	3					260	273		10.1037/0090-5550.45.3.260			14	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	338BZ	WOS:000088399400003					2022-02-06	
J	Saternus, KS; Kernbach-Wighton, G; Oehmichen, M				Saternus, KS; Kernbach-Wighton, G; Oehmichen, M			The shaking trauma in infants - kinetic chains	FORENSIC SCIENCE INTERNATIONAL			English	Article						shaking trauma; kinetic chains; periosteal sign (bleeding); shoulder; cervical spine	CHILD-ABUSE; INJURIES	The findings in three children who died as a consequence of shaking and those in another child who survived are presented. In the three fatal cases, a combination of anatomical lesions were identified at autopsy which appear to indicate the sites where kinetic energy related to the shaking episodes had been applied thus enabling the sequence of events resulting in the fatal head injury to be elucidated. Such patterns of injuries involved the upper limb, the shoulder, the brachial nerve plexus and the muscles close to the scapula; hemorrhages were present at the insertions of the sternocleidomastoid muscles due to hyperextension trauma (the so-called periosteal sign) and in the transition zone between the cervical and thoracic spine and extradural hematomas. Characteristic lesions due to traction were also found in the legs. All three children with lethal shaking trauma died from a subdural hematoma only a few hours after the event. The surviving child had persistant hypoxic damage of the brain following on massive cerebral edema. All the children showed a discrepancy between the lack of identifiable external lesions and severe internal ones. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Univ Gottingen, Inst Legal Med, D-37073 Gottingen, Germany; Univ Lubeck, Inst Legal Med, D-23562 Lubeck, Germany		Saternus, KS (corresponding author), Univ Gottingen, Inst Legal Med, Windausweg 2, D-37073 Gottingen, Germany.						ADEBAHR G, 1982, AKT NEUROPAD, V4, P146; AMBERG R, 1993, ZBL RECHTSMED, V40, P229; AMBERG R, 1994, ZBL RECHTSMED, V42, P453; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1946, AJR, V56, P167; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Horisberger B, 1997, INT J LEGAL MED, V110, P73, DOI 10.1007/s004140050034; LOWENHIELM P, 1974, Z RECHTSMED, V75, P131, DOI 10.1007/BF02114709; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Oehmichen M, 1997, RES LEG MED, V17, P203; POUNDER DJ, 1997, AM J FOREN MED PATH, V18, P322; Saternus K.-S., 1992, PLOTZLICHE KINDSTOD, P11; SCHNEIDER V, 1979, MUNCHEN MED WOCHEN, V121, P171; Southall DP, 1997, PEDIATRICS, V100, P735, DOI 10.1542/peds.100.5.735; Thomsen TK, 1997, FORENSIC SCI INT, V90, P223, DOI 10.1016/S0379-0738(97)00166-7; UNTERHARNSCHEID.F, 1993, SPEZIELLE PATHOLOGIS, V13; UNTERHARNSCHEIDT F, 1969, ACTA NEUROPATHOL, V12, P200, DOI 10.1007/BF00692508; Voigt G E, 1968, Dtsch Z Gesamte Gerichtl Med, V64, P9, DOI 10.1007/BF00585127	20	19	20	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	APR 10	2000	109	3					203	213		10.1016/S0379-0738(00)00144-4			11	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	302FK	WOS:000086354900004	10725656				2022-02-06	
J	Denney, RL; Wynkoop, TF				Denney, RL; Wynkoop, TF			Clinical neuropsychology in the criminal forensic setting	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						competency; criminal; dangerousness; forensic; sanity; traumatic brain injury	CHRONIC COCAINE ABUSE; MENTAL DISORDER; VIOLENCE; MEMORY; PREDICTIONS; DEFICITS; HEALTH; MURDER	This article reviews the application of clinical neuropsychology to criminal court proceedings, a complex, underserved, yet growing area of neuropsychological practice. The authors write from the perspective that the audience is primarily neurorehabilitation clinicians with limited experience In criminal matters. Discussions on the theoretical differences between clinical and forensic work, the forensic evaluation process with conceptual model, historical and current perspectives on criminal competencies and responsibility, prediction of dangerousness, and professional and ethical issues often encountered in criminal neuropsychology are provided.	US Med Ctr Fed Prisoners, Springfield, MO 65807 USA; Bowling Green State Univ, Clin Affiliate Fac, Court Diagnost & Treatment Ctr, Toledo, OH USA; Forest Inst Profess Psychol, Springfield, MO 65807 USA		Denney, RL (corresponding author), US Med Ctr Fed Prisoners, 1900 W Sunshine, Springfield, MO 65807 USA.	rdenney@bop.gov					*AM PSYCH ASS, 1992, AM PSYCH, V0047, P01597, DOI DOI 10.1037/0003-066X.47.12.1597; [Anonymous], 1990, BLACKS LAW DICT, V6th; BENSON DF, 1997, BEHAV NEUROLOGY NEUR, P401; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BORUM R, 1995, PROF PSYCHOL-RES PR, V26, P465, DOI 10.1037/0735-7028.26.5.465; Brown L., 1982, TEST NONVERBAL INTEL; CERCY SP, 1997, CLIN ASSESSMENT MALI; CLARK CR, 1987, HDB FORENSIC PSYCHOL, P352; Denney R. L., 1999, J FORENSIC NEUROPSYC, V1, P29, DOI 10.1300/J151v01n02_04; Denney R. L., 1999, J FORENSIC NEUROPSYC, V1, P5; Denney RL, 1996, ARCH CLIN NEUROPSYCH, V11, P589, DOI 10.1016/0887-6177(95)00042-9; DENNEY RL, 1995, CLIN NEUROPSYCHOL, V9, P227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Everington C.T., 1992, COMPETENCE ASSESSMEN; Frederick R. I., 1997, VALIDITY INDICATOR P; FREDERICK RI, 1995, B AM ACAD PSYCH LAW, V23, P231; Frederick RI, 1998, CLIN NEUROPSYCHOL, V12, P193, DOI 10.1076/clin.12.2.193.2006; FREDERICK RI, IN PRESS ARCH CLIN N; FREDERICK RI, 1993, ANN CONV AM PSYCH AS; GIULIANO AJ, 1997, CRIT ISS NE, P1; GOLDING SL, 1991, LAW HUMAN BEHAV, V15, P655; GOLDING SL, 1990, INT J LAW PSYCHIAT, V13, P281, DOI 10.1016/0160-2527(90)90023-V; Gouvier WD, 1998, CRIT ISS NE, P55; GRISSO T, 1992, LAW HUMAN BEHAV, V16, P621, DOI 10.1007/BF01884019; GRISSO T, 1986, EVALUATING COMPETENC; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; HALL HV, 1988, INT J CLIN NEUROPSYC, V10, P113; HARTMAN DE, 1988, NEUROPSYCHOLOGICAL T; Haughton P M, 1979, Br J Audiol, V13, P135, DOI 10.3109/03005367909078888; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HEINRICHS RW, 1989, BIOL PSYCHIAT, V25, P174, DOI 10.1016/0006-3223(89)90161-3; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Hoge SK, 1997, LAW HUMAN BEHAV, V21, P141, DOI 10.1023/A:1024826312495; LEWIS DO, 1989, J AM ACAD CHILD PSY, V28, P431, DOI 10.1097/00004583-198905000-00022; LEWIS DO, 1985, AM J PSYCHIAT, V142, P1161; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MARTELL DA, 1992, J FORENSIC SCI, V37, P878; MARTELL DA, 1992, LAW HUMAN BEHAV, V16, P313, DOI 10.1007/BF01044772; McGarry A. L., 1973, COMPETENCY STAND TRI; MELTON GB, 1997, PSYCHOL EVALUATIONS; MILLS VM, 1997, NEUROLOGICAL REHABIL; MITTENBERG W, 1993, ARCH CLIN NEUROPSYCH, V8, P477, DOI 10.1016/0887-6177(93)90048-6; MONAHAN J, 1992, AM PSYCHOL, V47, P511, DOI 10.1037/0003-066X.47.4.511; Monahan J., 1994, VIOLENCE MENTAL DISO; MOSSMAN D, 1994, J CONSULT CLIN PSYCH, V62, P783, DOI 10.1037/0022-006X.62.4.783; MRAD D, 1996, ISS FOR ASS S FED BU; Nestor PG, 1997, J AM ACAD PSYCHIATRY, V25, P161; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; PANKRATZ L, 1979, J CONSULT CLIN PSYCH, V47, P409, DOI 10.1037/0022-006X.47.2.409; PARENTE R., 1996, RETRAINING COGNITION; PIACENTE GJ, 1986, PSYCHIAT CLIN N AM, V9, P329; Pirozzolo F. J., 1991, NEUROPSYCHOLOGY LAW, P1; Raine A, 1993, PSYCHOPATHOLOGY CRIM; REHKOPF DG, 1997, CRIT ISS NE, P135; Reisner R., 1990, LAW MENTAL HLTH SYST, V2nd ed.; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Reynolds CR, 1998, CRIT ISS NE, P261; Rogers R., 1992, STRUCTURED INTERVIEW; Rogers R, 1997, CLIN ASSESSMENT MALI, P373; SAKS MJ, 1990, LAW HUMAN BEHAV, V14, P291, DOI 10.1007/BF01068158; SCHREINER L, 1956, AM J PHYSIOL, V184, P486, DOI 10.1152/ajplegacy.1956.184.3.486; SCHRETLEN DJ, 1988, CLIN PSYCHOL REV, V8, P451, DOI 10.1016/0272-7358(88)90074-8; SHAPIRO DL, 1991, FORENSIC PSYCHOL ASS; Shapiro DL, 1999, CRIMINAL RESPONSIBIL; SOHLBERG MM, 1989, INTRO COGNITIVE BEHA; STEADMAN HJ, 1988, LAW HUMAN BEHAV, V12, P91, DOI 10.1007/BF01064276; STEADMAN HJ, 1993, HINCKLEY EVALUATING; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; THEODOR LH, 1973, J ABNORM PSYCHOL, V82, P552, DOI 10.1037/h0035362; TONKONOGY TM, 1991, J NEUROPSYCHIAT, V3, P189; VOLAVKA J, 1992, J FORENSIC SCI, V37, P237; WASHTON AM, 1984, PSYCHIAT ANN, V14, P733, DOI 10.3928/0048-5713-19841001-09; WILDMAN R, 1980, GEORGIA COURT COMPET; WONG MTH, 1994, ACTA PSYCHIAT SCAND, V90, P97, DOI 10.1111/j.1600-0447.1994.tb01562.x; Wynkoop TF, 1999, CLIN NEUROPSYCHOL, V13, P220; WYNKOOP TF, 1994, ADV MED PSYCHOTHER, V7, P181; Zachary R. A., 1986, SHIPLEY I LIVING SCA; 1982, TANAKH NEW TRANSLATI; [No title captured]	80	19	20	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	2000	15	2					804	828		10.1097/00001199-200004000-00005			25	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	305FY	WOS:000086529800005	10739969				2022-02-06	
J	Ricker, JH; Zafonte, RD				Ricker, JH; Zafonte, RD			Functional neuroimaging and quantitative electroencephalography in adult traumatic head injury: Clinical applications and interpretive cautions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; head injury; neuroimaging; positron emission tomography; single photon emission computed tomography	POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL BLOOD-FLOW; BRAIN INJURY; COMPUTED-TOMOGRAPHY; RETROGRADE-AMNESIA; SPECT; MILD; EEG; PERFUSION; METABOLISM	Functional neuroimaging and quantitative electroencephalographic procedures are being used increasingly in brain injury research and clinical care. These procedures are also seeing increased use in the context of forensic evaluations, particularly in cases of mild head trauma. This article provides an overview of the use of procedures such as positron emission tomography, single photon emission computed tomography, and quantitative electroencephalogram in adults. Also discussed are the clinical limitations of each procedure within the context of myriad interpretive confounds that can interfere with accurate differential diagnosis of mild head trauma.	Kessler Med Rehabil Res & Educ Corp, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Rehabil Inst Michigan, Detroit, MI USA; Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA		Ricker, JH (corresponding author), Kessler Med Rehabil Res & Educ Corp, Neuropsychol & Neurosci Lab, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.			Ricker, Joseph/0000-0003-3415-991X			ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Abu-Judeh HH, 1998, J NUCL MED, V39, P1357; ADAMS BL, 1993, J PSYCHIATR NEUROSCI, V18, P109; Altrocchi PH, 1996, NEUROLOGY, V46, P278; Amen D G, 1996, Ann Clin Psychiatry, V8, P129, DOI 10.3109/10401239609147750; [Anonymous], 1996, NEUROLOGY, V47, P592; BARON JC, 1995, REV NEUROL, V151, P511; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BRICOLO A, 1978, ELECTROEN CLIN NEURO, V45, P211, DOI 10.1016/0013-4694(78)90005-6; CHERTKOW H, 1994, LOCALIZATION NEUROIM, P151; DellaCorte F, 1997, ACTA NEUROCHIR, V139, P636; DUARA R, 1992, J CEREBR BLOOD F MET, V12, P927, DOI 10.1038/jcbfm.1992.129; Dupont RM, 1996, PSYCHIAT RES-NEUROIM, V67, P99, DOI 10.1016/0925-4927(96)02769-2; FONTAINE A, 1996, P AUST BRAIN INJ SOC, V1, P98; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Goncalves J M, 1992, Acta Neurochir Suppl (Wien), V55, P11; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; HARTHSONE M, 1994, FUNCTIONAL BRAIN IMA, P101; Herscovitch Peter, 1996, P89; HERTZMAN M, 1990, AM J PSYCHIAT, V147, P255; HOLMAN BL, 1992, J NUCL MED, V33, P1888; ICHISE M, 1994, J NUCL MED, V35, P217; IIDAKA T, 1995, CLIN PSYCHIATR, V37, P951; JACOBS A, 1994, J NUCL MED, V35, P942; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; JUNI JE, 1994, J NUCL MED, V35, P1891; KRYSTAL JH, 1995, AM J DRUG ALCOHOL AB, V21, P47, DOI 10.3109/00952999509095229; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LAZARUS A, 1989, J CLIN PSYCHIAT, V50, P475; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; LOUTFI ISSA, 1995, INVEST RADIOL, V30, P588, DOI 10.1097/00004424-199510000-00004; MAMPUNZA S, 1995, ACTA NEUROL BELG, V95, P164; MASDEU JC, 1995, J NEUROIMAGING, V5, pS14, DOI 10.1111/jon19955s1s14; Matousek M, 1996, ACTA ANAESTH SCAND, V40, P824, DOI 10.1111/j.1399-6576.1996.tb04540.x; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; MILLER S, 1992, S AFR J PHILOS, V11, P1; MODELL JG, 1995, J NEUROPSYCH CLIN N, V7, P15; Mozley PD, 1996, J NUCL MED, V37, P1965; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; PAULMAN RG, 1990, BIOL PSYCHIAT, V27, P377, DOI 10.1016/0006-3223(90)90549-H; RAO N, 1984, ARCH PHYS MED REHAB, V65, P780; READ SL, 1995, J AM GERIATR SOC, V43, P1243, DOI 10.1111/j.1532-5415.1995.tb07400.x; REID RH, 1990, CLIN NUCL MED, V15, P383, DOI 10.1097/00003072-199006000-00003; Ricker J, 1998, CLIN NEUROPSYCHOL, V12, P279; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; SACKEIM HA, 1990, ARCH GEN PSYCHIAT, V47, P60; SIRONI V, 1983, ADV NEUROTRAUMATOLOG, P329; TENJIN H, 1990, NEUROSURGERY, V26, P971, DOI 10.1227/00006123-199006000-00009; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Uchiyama Mayuki, 1997, Nippon Acta Radiologica, V57, P41; Umile EM, 1998, BRAIN INJURY, V12, P577; WOOD F, 1991, READ WRIT, V3, P379, DOI 10.1007/BF00354969; ZHANG JJ, 1994, CLIN NUCL MED, V19, P789, DOI 10.1097/00003072-199409000-00009	57	19	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	2000	15	2					859	868		10.1097/00001199-200004000-00007			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	305FY	WOS:000086529800007	10739971				2022-02-06	
J	Van den Heuvel, C; Blumbergs, P; Finnie, J; Manavis, J; Lewis, S; Jones, N; Reilly, P; Pereira, R				Van den Heuvel, C; Blumbergs, P; Finnie, J; Manavis, J; Lewis, S; Jones, N; Reilly, P; Pereira, R			Upregulation of amyloid precursor protein and its mRNA in an experimental model of paediatric head injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						amyloid precursor protein; paediatric head injury model; lambs; neuronal cell body; messenger RNA; immunocytochemistry; in-situ hybridisation	EXPERIMENTAL BRAIN INJURY; AXONAL INJURY; TRANSCRIPTIONAL ACTIVATION; ALZHEIMERS-DISEASE; IMPACT MODEL; RAT-BRAIN; GENE; NEURONS; EXPRESSION; IMMATURE	Amyloid precursor protein (APP), a membrane spanning glycoprotein which plays an important role in neuronal growth and synaptic plasticity, is increased after traumatic brain injury (TBI) and has been used as a sensitive marker of neuronal damage in an adult sheep head impact model. We hypothesised that APP expression would similarly be increased in lambs, suggesting that in the immature injured brain APP is also upregulated as an acute phase response to trauma. Ten anaesthetised and Ventilated 4-5 week old Merino lambs sustained a left temporal head impact from a humane stunner. At 2 h after impact, there was widespread and intense neuronal cell body APP immunoreactivity which was more widely distributed than axonal APP. APP messenger RNA (mRNA) expression was also markedly increased with a distribution similar to that of APP antigen. These results demonstrate that APP antigen and mRNA are sensitive early indicators of TBI in paediatric cases. (C) 2000 Harcourt Publishers Ltd.	Univ Adelaide, Dept Pathol, Adelaide, SA, Australia; Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA 5000, Australia; Inst Med & Vet Sci, Vet Div, Adelaide, SA 5000, Australia; Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia; Univ Adelaide, Dept Neurosurg, Adelaide, SA, Australia; Inst Med & Vet Sci, Infect Dis Lab, Adelaide, SA 5000, Australia		Van den Heuvel, C (corresponding author), Univ Adelaide, Dept Pathol, GPO Box 498, Adelaide, SA, Australia.			Reilly, Peter/0000-0003-3173-0666			AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ANDREWS EJ, 1993, J AM VET MED ASSOC, V202, P230; ARTHUR J, 1993, J GEN VIROL, V74, P1363, DOI 10.1099/0022-1317-74-7-1363; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; DEWJI NN, 1995, MOL BRAIN RES, V33, P245, DOI 10.1016/0169-328X(95)00131-B; Dewji NN, 1996, MOL BRAIN RES, V35, P325, DOI 10.1016/0169-328X(95)00214-D; DOBBING J, 1981, SCI FDN PAEDIAT, P747; Faden AI., 1994, NEUROBIOLOGY CENTRAL, P3; FARBER SA, 1995, J NEUROSCI, V15, P7442; FEARNSIDE MR, 1997, HEAD INJURY PATHOPHY, P3; Finnie J, 1999, J CLIN NEUROSCI, V6, P38, DOI 10.1016/S0967-5868(99)90601-X; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; HILBICH C, 1993, J BIOL CHEM, V268, P26571; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; PALACIOS G, 1992, MOL BRAIN RES, V15, P195, DOI 10.1016/0169-328X(92)90109-O; PEREIRA RA, 1994, J EXP MED, V180, P841, DOI 10.1084/jem.180.3.841; Pierce JES, 1996, J NEUROSCI, V16, P1083; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SANDBRINK R, 1994, J BIOL CHEM, V269, P1510; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SMITH ML, 1995, J NEUROTRAUM, V12, P143; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Ward JD, 1996, NEUROTRAUMA, P859; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N	42	19	19	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	MAR	2000	7	2					140	145					6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301LX	WOS:000086312600013	10844801				2022-02-06	
J	Dowler, RN; Bush, BA; Novack, TA; Jackson, WT				Dowler, RN; Bush, BA; Novack, TA; Jackson, WT			Cognitive orientation in rehabilitation and neuropsychological outcome after traumatic brain injury	BRAIN INJURY			English	Article							SCALE	This study evaluated the ability of the Orientation Log (O-Log) to predict cognitive outcome at rehabilitation discharge, as well as future neuropsychological outcome. The hypothesis was that patients who demonstrated better orientation upon admission would achieve superior functional cognitive outcome at discharge and on subsequent neuropsychological assessment. Sixty individuals receiving inpatient rehabilitation following a new-onset TBI participated Orientation data was collected using the O-Log during morning bedside rounds. Outcome data was collected at 6 and 12 months post-injury. Significant correlations were found between the O-log and measures of memory, executive functioning, basic verbal skills, and estimated intellectual ability. When compared to the other predictor variables, step-wise multiple regression analyses revealed that the minimum O-Log score was the primary significant predictor of performance on six neuropsychological and functional outcome measures. Results of this study suggest that evaluating orientation with the O-Log during acute rehabilitation may reflect level of injury severity and aid in predicting cognitive outcome.	Univ Alabama, Spain Rehabil Ctr, Dept Phys Med & Rehabil, Birmingham, AL 35233 USA		Novack, TA (corresponding author), Univ Alabama, Spain Rehabil Ctr, Dept Phys Med & Rehabil, 1717 6th Ave S, Birmingham, AL 35233 USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD07420] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [403641] Funding Source: Medline		Benton A.L., 1983, CONTRIBUTIONS NEUROP; DELIS D, 1987, CALIFORNIA VERBAL LE; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; KAPLAN E, 1983, BOSTON NAMING; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; *STAT U NEW YORK B, 1993, GUID UN SET MED REH; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1981, WAIS R MANUAL; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009	14	19	19	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2000	14	2					117	123		10.1080/026990500120781			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	281GW	WOS:000085151000002	10695568				2022-02-06	
J	Abraham, KE; Brewer, KL; McGinty, JF				Abraham, KE; Brewer, KL; McGinty, JF			Opioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injury	NEUROSCIENCE			English	Article						dynorphin; enkephalin; excitotoxicity; pain; quisqualic acid; spinal cord injury	DORSAL HORN NEURONS; TRAUMATIC INJURY; PERIPHERAL INFLAMMATION; INSITU HYBRIDIZATION; RADIOIMMUNOASSAY TECHNIQUE; INTRASPINAL INJECTIONS; CEREBRAL-CORTEX; QUISQUALIC ACID; RAT-BRAIN; DYNORPHIN	Spinal cord injury in rats is known to cause anatomical, physiological and molecular changes within the spinal cord. These changes may account for behavioral syndromes that appear following spinal cord injury, syndromes believed to be related to the clinical condition of chronic pain. Intraspinal injection of quisqualic acid produces an excitotoxic injury with pathological characteristics similar to those associated with ischemic and traumatic spinal cord injury. In addition, recent studies have demonstrated changes in blood flow, neuronal excitability and gene expression in the brain following excitotoxic injury, indicating that behavioral changes may result from modification of neuronal substrates at supraspinal levels of the neuraxis. Because changes in spinal opioid peptide expression have been demonstrated in models of traumatic spinal cord injury and chronic pain, the present study investigated messenger RNA expression of the opioid peptides, preproenkephalin and preprodynorphin, at spinal and supraspinal levels following excitotoxic spinal cord injury. Male, Long-Evans rats were given three intraspinal injections of quisqualic acid (total 1.2 mu l, 125 mM). After one, three, five, seven or 10 days, animals were killed and quantitative in situ hybridization performed on regions of the spinal cord surrounding the lesion site, as well as whole-brain sections through various levels of the thalamus. Preproenkephalin and preprodynorphin expression was increased in spinal cord areas adjacent to the site of quisqualic injection and in cortical regions associated with nociceptive function, preproenkephalin in the cingulate cortex and preprodynorphin in the parietal cortex, both ipsilaterally and contralaterally at various time-points following injury. These results further our knowledge of the secondary events that occur following spinal cord injury, specifically implicating supraspinal opioid systems in the CNS response to spinal cord injury. (C) 2000 IBRO. Published by Elsevier Science Ltd. All rights reserved.	E Carolina Univ, Sch Med, Dept Emergency Med, Greenville, NC 27858 USA; E Carolina Univ, Sch Med, Dept Anat & Cell Biol, Greenville, NC 27858 USA; Med Univ S Carolina, Dept Physiol & Neurosci, Charleston, SC 29425 USA		Brewer, KL (corresponding author), E Carolina Univ, Sch Med, Dept Emergency Med, Greenville, NC 27858 USA.	brewerk@mail.ecu.edu			NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA003982] Funding Source: NIH RePORTER; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA03982] Funding Source: Medline		ALVAREZBOLADO G, 1990, J COMP NEUROL, V300, P287, DOI 10.1002/cne.903000302; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bethea JR, 1998, J NEUROSCI, V18, P3251; Brewer K. L., 1997, Society for Neuroscience Abstracts, V23, P438; Christensen MD, 1996, PAIN, V68, P97, DOI 10.1016/S0304-3959(96)03224-1; DAVIDOFF G, 1987, PAIN, V29, P39, DOI 10.1016/0304-3959(87)90176-X; DRAISCI G, 1991, BRAIN RES, V560, P186, DOI 10.1016/0006-8993(91)91231-O; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; FADEN AI, 1985, ANN NEUROL, V17, P386, DOI 10.1002/ana.410170414; FADEN AI, 1985, REGUL PEPTIDES, V11, P35, DOI 10.1016/0167-0115(85)90029-1; Gabriel, 1993, NEUROBIOLOGY CINGULA, P313; GAUMANN DM, 1990, NEUROSCIENCE, V39, P761, DOI 10.1016/0306-4522(90)90259-7; HAO JX, 1991, PAIN, V45, P175, DOI 10.1016/0304-3959(91)90186-2; HARLAN RE, 1987, J COMP NEUROL, V258, P159, DOI 10.1002/cne.902580202; HELTON TE, 1993, MOL CELL NEUROSCI, V4, P319, DOI 10.1006/mcne.1993.1042; Hurd YL, 1996, NEUROSCIENCE, V72, P767, DOI 10.1016/0306-4522(96)00002-4; Kenshalo DR, 1991, CEREBRAL CORTEX, V9; KOSTERLITZ HW, 1985, PROC R SOC SER B-BIO, V225, P27, DOI 10.1098/rspb.1985.0048; LENZ FA, 1990, PAIN, V5, P493; LEVITT M, 1985, BRAIN RES REV, V10, P247, DOI 10.1016/0165-0173(85)90027-X; Liu SL, 1997, BRAIN RES, V756, P160, DOI 10.1016/S0006-8993(97)00137-6; LONG JB, 1989, BRAIN RES, V497, P155, DOI 10.1016/0006-8993(89)90982-7; MCGINTY JF, 1984, J NEUROSCI, V4, P1104; MELZACK R, 1968, P423; MELZACK R, 1978, PAIN, V4, P195, DOI 10.1016/0304-3959(77)90133-6; Morrow TJ, 2000, EXP NEUROL, V161, P220, DOI 10.1006/exnr.1999.7246; NOGUCHI K, 1992, NEUROSCIENCE, V46, P561, DOI 10.1016/0306-4522(92)90144-Q; NOGUCHI K, 1991, MOL BRAIN RES, V10, P227, DOI 10.1016/0169-328X(91)90065-6; Olsson Y, 1995, PROG BRAIN RES, V104, P381; PRZEWLOCKI R, 1988, MOL BRAIN RES, V4, P37, DOI 10.1016/0169-328X(88)90016-2; REEP RL, 1982, NEUROSCIENCE, V7, P1265, DOI 10.1016/0306-4522(82)91133-2; RUDA MA, 1988, P NATL ACAD SCI USA, V85, P622, DOI 10.1073/pnas.85.2.622; Ruda MA, 1995, PROG BRAIN RES, V104, P349; SHARMA HS, 1993, NEUROPHARMACOLOGY, V32, P711, DOI 10.1016/0028-3908(93)90085-H; SHARMA HS, 1992, NEUROSCI RES, V14, P195; SHARMA HS, 1994, REG PEPT S, V1, pS91; SIDDALL P, 1995, NEUROREPORT, V6, P1241, DOI 10.1097/00001756-199506090-00003; Siddall PJ, 1997, SPINAL CORD, V35, P69, DOI 10.1038/sj.sc.3100365; SMITH AP, 1988, ANNU REV PHARMACOL, V28, P123, DOI 10.1146/annurev.pa.28.040188.001011; SMITH DB, 1993, NUCLEIC ACIDS RES, V21, P359, DOI 10.1093/nar/21.2.359; Tachibana T, 1998, J NEUROTRAUM, V15, P485, DOI 10.1089/neu.1998.15.485; TASKER RR, 1991, SYMP PAIN R, P31; TUNKS E, 1986, MANAGEMENT SPINAL CO, P180; WANG JQ, 1995, J PHARMACOL EXP THER, V273, P909; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yezierski RP, 1996, PAIN, V68, P185, DOI 10.1016/S0304-3959(96)03178-8; Yezierski RP, 1998, PAIN, V75, P141, DOI 10.1016/S0304-3959(97)00216-9; YEZIERSKI RP, 1993, NEUROSCI LETT, V157, P115, DOI 10.1016/0304-3940(93)90656-6; YEZIERSKI RP, 1993, J NEUROTRAUM, V10, P445, DOI 10.1089/neu.1993.10.445; ZELTSER R, 1994, PROG PAIN RES MANAG, V3, P295	52	19	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2000	99	1					189	197		10.1016/S0306-4522(00)00150-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	343GA	WOS:000088692300018	10924963				2022-02-06	
J	Crimmins, DW; Palmer, JD				Crimmins, DW; Palmer, JD			Snapshot view of emergency neurosurgical head injury care in Great Britain and Ireland	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						head injury; transfer; intensive care unit; resources for healthcare	MANAGEMENT; GUIDELINES; RESUSCITATION; HEMATOMA	Objectives-To study the availability of neurosurgical intensive care for the traumatically brain injured in all 36 neurosurgical centres in the United Kingdom and Ireland receiving head injuries, the response times to referral, and the advice given to the referring hospitals. Methods-Telephone survey of receiving neurosurgeons regarding their bed status and their advice on three hypothetical case scenarios. Outcome measures included response times for an acute head injury to be accepted to a neurosurgical centre; the intensive care bed status; variations in advice given to the referring hospitals with regard to ventilation, use of mannitol, steroids, anticonvulsants, and antibiotics. Results-There were 43 neurosurgical intensive care beds available for an There were 1.8 beds available/million of the population for nonventilated patients, 0.64 beds available/million for ventilated patients, and 0.55 beds available/million for ventilated paediatric patients. London had a shortage of beds with 0.19 adult beds for ventilation/million north of the Thames and 0.14 adult beds for ventilation/million south of the Thames. The median response time for a patient with an extradural haematoma to be accepted for transfer was 6 minutes and 89% of such a referral was accepted within 30 minutes. Clinically significant delays in receiving referrals (over 30 minutes) occurred in four units. Practices regarding the use of hyperventilation, mannitol, anticonvulsants, and antibiotics showed little conformity and in some cases were against the available evidence and advice given by published guidelines. Conclusions-There is a severe shortage of available emergency neurosurgical beds especially in the south east of England. The lack of immediately available neurosurgical intensive care beds ventilated patients, 0.64 beds available England. The lack of immediately available neurosurgical intensive care beds results in delays of transfer that could adversely affect the outcome of surgery for traumatic intracranial haematoma. Advice given to the referring units by the receiving doctors is very variable.	Univ London, Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Neurosurg, London WC1N 3BG, England		Palmer, JD (corresponding author), Derriford Hosp, Dept Neurosurg, Plymouth PL6 8DH, Devon, England.						*AM COLL SURG COMM, 1993, ATLS COURS MAN; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; BRIGGS M, 1984, BRIT MED J, V288, P983; BROCKLEHURST G, 1987, BRIT MED J, V294, P345, DOI 10.1136/bmj.294.6568.345; BRYDEN JS, 1983, BRIT MED J, V286, P1791, DOI 10.1136/bmj.286.6380.1791; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock MR, 1996, J NEUROTRAUM, V13, P731; CAIRNS HWB, 1947, NOTES NEUROSURGICAL; DUNN LT, 1994, ANN ROY COLL SURG, V76, P353; GENTLEMAN D, 1993, BRIT MED J, V307, P547, DOI 10.1136/bmj.307.6903.547; GENTLEMAN D, 1990, INJURY, V21, P305, DOI 10.1016/0020-1383(90)90047-X; GENTLEMAN D, 1981, LANCET, V2, P853; JEFFREYS RV, 1981, LANCET, V2, P459; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kirkpatrick PJ, 1996, J NEUROL NEUROSUR PS, V60, P131, DOI 10.1136/jnnp.60.2.131; Kirkpatrick PJ, 1997, J NEUROL NEUROSUR PS, V62, P109, DOI 10.1136/jnnp.62.2.109; LAMBERT SM, 1993, INJURY, V24, P333, DOI 10.1016/0020-1383(93)90058-E; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marsh H, 1989, Br J Neurosurg, V3, P13, DOI 10.3109/02688698909001021; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; *POP EST UN OFF NA, 1994, POP VIT STAT UK; *ROYAL COLL SURG E, 1986, WORK PART HEAD INJ; *SOC BRIT NEUR SUR, 1993, SAF NEUR MAINT DEV H; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; *US BUR CENS, 1996, CENS POP IR 1996, V1; VYVYAN HAL, 1991, ANAESTHESIA, V46, P728, DOI 10.1111/j.1365-2044.1991.tb09766.x	28	19	19	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JAN	2000	68	1					8	13		10.1136/jnnp.68.1.8			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	270AL	WOS:000084513200005	10601392	Green Published, Bronze			2022-02-06	
J	Koyfman, L; Kaplanski, J; Artru, AA; Talmor, D; Rubin, M; Shapira, Y				Koyfman, L; Kaplanski, J; Artru, AA; Talmor, D; Rubin, M; Shapira, Y			Inhibition of cyclooxygenase 2 by nimesulide decreases prostaglandin E2 formation but does not alter brain edema or clinical recovery after closed head injury in rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						head injury; inflammatory reaction; prostaglandins; nimesulide; cyclooxygenase inhibitors; cerebral cortex	CEREBRAL-ISCHEMIA; GENE-EXPRESSION; NEURONS; TRAUMA; ACID; METHYLPREDNISOLONE; INDOMETHACIN; INDUCTION; TISSUE; DEATH	Recently, the enzyme cyclooxygenase (COX) has been recognized to exist as constitutive (COX-1) and inducible isoforms (COX-2). In previous studies, drugs chat were inhibitors of both COX-1 and COX-2 failed to decrease brain edema formation or improve Neurological Severity Score (NSS) after closed head trauma (CHT), although some did decrease prostaglandin-E2 (PGE2) formation. The present study examined whether or not a specific inhibitor of COX-2 (nimesulide) exerts a beneficial effect after CHT in rats. Halothane-anesthetized rats (n = 8 in each group) were randomly assigned to one of four groups: surgery, no CHT, no drug (group 1); surgery, no CHT, nimesulide 30 mg/kg intraperitoneally (IP) (group 2); surgery, CHT, no drug (group 3); and surgery, CHT, nimesulide 30 mg/kg IP (group 4). NSS was determined at 1 and 24 h, and brain tissue PGE2 concentration and water content were determined after killing at 24 h. Treatment with nimesulide did not improve NSS (NSS at 24 h = 11 +/- 6 [median +/- range] in group 3 and 12 +/- 4 in group 4) or edema formation (brain water content at 24 h = 84.3 +/- 1.8% [mean +/- SD] in group 3 and 83.8 +/- 1.9% in group 4). However, nimesulide did decrease cortical and hypothalamic PGE? formation by 41% and 47%, respectively during the first hour of incubation after brain tissue sampling. The authors conclude that although nimesulide does reduce tissue PGE2 formation, it does not exert a beneficial effect on brain tissue edema or functional activity after CHT in rats.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Ben Gurion Univ Negev, Soroka Med Ctr, Fac Hlth Sci, Div Anesthesiol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Fac Hlth Sci, Dept Clin Pharmacol, IL-84105 Beer Sheva, Israel		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Box 356540, Seattle, WA 98195 USA.						BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; CHAN PH, 1983, ANN NEUROL, V13, P625, DOI 10.1002/ana.410130608; DANON A, 1983, J PHARM PHARMACOL, V35, P576, DOI 10.1111/j.2042-7158.1983.tb04336.x; DAVIS R, 1994, DRUGS, V48, P431, DOI 10.2165/00003495-199448030-00008; Deininger MH, 1999, J NEUROIMMUNOL, V95, P202, DOI 10.1016/S0165-5728(98)00257-4; Dumont I, 1998, AM J PHYSIOL-REG I, V275, pR1812, DOI 10.1152/ajpregu.1998.275.6.R1812; Fiebich BL, 1998, J NEUROIMMUNOL, V92, P170, DOI 10.1016/S0165-5728(98)00201-X; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Hara K, 1998, NEUROSCI LETT, V256, P53, DOI 10.1016/S0304-3940(98)00755-1; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; Hirata T, 1997, LIFE SCI, V61, P1603, DOI 10.1016/S0024-3205(97)00739-X; Ho L, 1998, J NEUROIMMUNOL, V89, P142, DOI 10.1016/S0165-5728(98)00132-5; Iadecola C, 1997, ANN NY ACAD SCI, V835, P203, DOI 10.1111/j.1749-6632.1997.tb48631.x; IANNOTTI F, 1981, STROKE, V12, P301, DOI 10.1161/01.STR.12.3.301; KAPLANSKI J, 1992, SYMP PHARMA, V7, P33; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Knapp DJ, 1999, ALCOHOL CLIN EXP RES, V23, P633, DOI 10.1097/00000374-199904001-00010; Miettinen S, 1997, P NATL ACAD SCI USA, V94, P6500, DOI 10.1073/pnas.94.12.6500; MILDE LN, 1998, CLIN NEUROANAESTHESI, P177; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; Nogawa S, 1997, J NEUROSCI, V17, P2746; Nogawa S, 1998, P NATL ACAD SCI USA, V95, P10966, DOI 10.1073/pnas.95.18.10966; OBanion MK, 1996, J NEUROCHEM, V66, P2532; Sairanen T, 1998, ANN NEUROL, V43, P738, DOI 10.1002/ana.410430608; Saper CB, 1998, ANN NY ACAD SCI, V856, P90, DOI 10.1111/j.1749-6632.1998.tb08317.x; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1993, EUR J ANAESTH, V10, P155; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1989, PROSTAG LEUKOTR ESS, V36, P49, DOI 10.1016/0952-3278(89)90162-2; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; Shapira Y, 1998, J NEUROSURG ANESTH, V10, P94, DOI 10.1097/00008506-199804000-00005; Sharma Sangeeta, 1997, Indian Journal of Experimental Biology, V35, P1025; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; Sigthorsson G, 1998, SCAND J GASTROENTERO, V33, P728; Taniguchi Y, 1997, EUR J PHARMACOL, V330, P221, DOI 10.1016/S0014-2999(97)00183-0; Vellucci SV, 1998, NEUROPEPTIDES, V32, P439, DOI 10.1016/S0143-4179(98)90069-5; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X	42	19	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2000	12	1					44	50		10.1097/00008506-200001000-00009			7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	270PT	WOS:000084545200009	10636620				2022-02-06	
J	Ferstl, EC; Guthke, T; von Cramon, DY				Ferstl, EC; Guthke, T; von Cramon, DY			Change of perspective in discourse comprehension: Encoding and retrieval processes after brain injury	BRAIN AND LANGUAGE			English	Article							CLOSED HEAD-INJURY; FRONTAL-LOBE; INDIVIDUAL-DIFFERENCES; TEXT COMPREHENSION; WORKING-MEMORY; LANGUAGE; DEFICITS; BEHAVIOR; DAMAGE; ORGANIZATION	Damage to frontal areas has been associated with nonaphasic language disturbances in which word and sentence level processes remain largely intact but text level processes are impaired. Most studies providing evidence for these language deficits have concentrated on text production. To study text comprehension of nonaphasic patients, we adopted the paradigm of Anderson and Pichert (1978) that was developed to separate encoding from retrieval processes. Subjects read a story under one of two alternative perspectives and subsequently recalled it. After this first recall, they were instructed to now adopt the second perspective and to recall the story once more. Twenty-four brain injured patients participated. Each patient's lesion was evaluated with respect to the involvement of right- and/or left-frontal regions. Seven patients showed unilateral left-frontal lesions, five patients unilateral right-frontal lesions, four patients had bilateral frontal damage, and the lesions of the remaining eight patients did not involve frontal areas. The only factor predicting behavioral results was the presence of a left-frontal lesion. For patients without frontal lesions and patients with unilateral right-frontal lesions, we replicated previously reported results. Encoding relevant information was recalled better than other information. Furthermore, the switch of perspective aided recall of perspective relevant information during the second recall. In contrast, patients with left-frontal or bilateral frontal lesions could not make use of the perspective instructions. While they showed comparable recall performance, as well as sensitivity to the relative ease of information, neither the encoding instructions nor the switch instructions had an impact an the recall patterns. These results suggest that left-frontal damage leads to an impairment of goal directed text processing skills. (C) 1999 Academic Press.	Max Planck Inst Cognit Neurosci, D-04103 Leipzig, Germany; Univ Leipzig, D-7010 Leipzig, Germany		Ferstl, EC (corresponding author), Max Planck Inst Cognit Neurosci, Stephanstr 1 A, D-04103 Leipzig, Germany.	ferstl@cns.mpg.de					ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; ANDERSON RC, 1978, J VERB LEARN VERB BE, V17, P1, DOI 10.1016/S0022-5371(78)90485-1; Axelrod BN, 1996, J CLIN EXP NEUROPSYC, V18, P338, DOI 10.1080/01688639608408991; BAILLET SD, 1986, DISCOURSE PROCESS, V9, P247, DOI 10.1080/01638538609544643; Beeman M, 1998, RIGHT HEMISPHERE LAN; Benson D.F., 1986, FRONTAL LOBES; Bloom R. L., 1994, DISCOURSE ANAL APPL; BORLAND R, 1985, DISCOURSE PROCESS, V8, P305, DOI 10.1080/01638538509544619; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROOKSHIRE RH, 1984, BRAIN LANG, V21, P21, DOI 10.1016/0093-934X(84)90033-6; Brownell H., 1995, HDB NEUROLOGICAL SPE, P325; Burgess P, 1996, BEHAV ASSESSMENT DYS; Caplan D., 1992, LANGUAGE STRUCTURE P; CHAPMAN SB, 1995, HDB NEUROLOGICAL SPE, P387; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DELIS D, 1987, CALIFORNIA VERBAL LE; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; deZubicaray G, 1996, CLIN NEUROPSYCHOL, V10, P245, DOI 10.1080/13854049608406687; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; FUSTER JM, 1988, PREFRONTAL CORTEX; GERMANI MJ, 1992, BRAIN LANG, V42, P308, DOI 10.1016/0093-934X(92)90103-L; Glindemann R, 1995, SPRACHE-STIMME-GEHOR, V19, P1; Goldberg T E, 1990, J Neuropsychiatry Clin Neurosci, V2, P165; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; HAUT M W, 1990, Brain Injury, V4, P281, DOI 10.3109/02699059009026178; Hess T. M., 1992, J GERONTOL, V47, P52, DOI [10.1093/ geronj/ 47.1. P52, DOI 10.1093/GERONJ/47.1.P52]; Horn W, 1983, LEISTUNGSPRUFSYSTEM; HOUGH MS, 1990, BRAIN LANG, V38, P253, DOI 10.1016/0093-934X(90)90114-V; HUBER W, 1984, ADV NEUROLOGY, V42; JOANETTE Y, 1990, DISCOURSE ABILITY BR; Johnson-Laird P.N., 1983, MENTAL MODELS; Kaczmarek B. L. J., 1987, FRONTAL LOBES REVISI, P225; KACZMAREK BLJ, 1984, BRAIN LANG, V21, P52, DOI 10.1016/0093-934X(84)90035-X; KARDASH CAM, 1988, J EDUC PSYCHOL, V80, P324, DOI 10.1037/0022-0663.80.3.324; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; KINTSCH W, 1990, J MEM LANG, V29, P133, DOI 10.1016/0749-596X(90)90069-C; KINTSCH W, 1988, PSYCHOL REV, V95, P163, DOI 10.1037/0033-295X.95.2.163; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; KIRSHNER HS, 1995, HDB NEUROLOGICAL SPE; LEESAMMONS WH, 1991, J EXP PSYCHOL LEARN, V17, P1074, DOI 10.1037/0278-7393.17.6.1074; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; NEWSOME GL, 1986, J READING BEHAV, V18, P117, DOI 10.1080/10862968609547560; Nicholas L.E., 1995, AM J SPEECH LANGUAGE, V4, P69, DOI [DOI 10.1044/1058-0360.0403.69, 10.1044/1058-0360.0403.69]; NOVOA OP, 1987, BRAIN LANG, V30, P206, DOI 10.1016/0093-934X(87)90099-X; PICHERT JW, 1977, J EDUC PSYCHOL, V69, P309, DOI 10.1037/0022-0663.69.4.309; PIERCE RS, 1988, APHASIOLOGY, V2, P577, DOI 10.1080/02687038808248968; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; SAINTCYR JA, 1988, BRAIN, V111, P941, DOI 10.1093/brain/111.4.941; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Snow P, 1997, BRAIN INJURY, V11, P409; STACHOWIAK FJ, 1977, BRAIN LANG, V4, P177, DOI 10.1016/0093-934X(77)90016-5; Stemmer B, 1998, RIGHT HEMISPHERE LANGUAGE COMPREHENSION, P329; STUSS DT, 1987, FRONTAL LOBES REVIS; Ulatowska H. K., 1994, DISCOURSE ANAL APPL, P29; Van Dijk TA., 1983, STRATEGIES DISCOURSE; WALLESCH CW, 1983, ARCH PSYCHIAT NERVEN, V233, P279, DOI 10.1007/BF00345798; Wechsler D, 1987, MEMORY SCALE REVISED; Zimmermann P., 1992, TESTBATTERIE AUFMERK	64	19	20	0	5	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X			BRAIN LANG	Brain Lang.	DEC	1999	70	3					385	420		10.1006/brln.1999.2151			36	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	263YK	WOS:000084152700005	10600227				2022-02-06	
J	Kant, R; Coffey, CE; Bogyi, AM				Kant, R; Coffey, CE; Bogyi, AM			Safety and efficacy of ECT in patients with head injury: A case series	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							ELECTROCONVULSIVE-THERAPY; DISEASE; DEPRESSION; SCALE	Electroconvulsive therapy (ECT) is a safe and effective treatment for certain psychiatric disorders. Eleven patients who had sustained a closed head injury were treated with ECT for their psychiatric symptoms. Eight patients responded to an index course of ECT: 2 were partial responders and became responders during continuation ECT (cECT); 1 patient was 17 nonresponder. Post-ECT Neurobehavioral Cognitive Status Examination and Mini-Mental State Examination scores showed no significant decline (P>0.70 and P>0.89, respectively) from baseline. Eight patients received cECT, without any lasting cognitive side effects. These findings indicate that ECT can be used effectively in patients with a history of closed head injury without adverse effects on cognitive functioning.	Head Injury Clin, Pittsburgh, PA 15224 USA; Henry Ford Hosp, Dept Psychiat, Detroit, MI 48202 USA; St Elizabeth Hlth Ctr, Dept Psychiat, Youngstown, OH USA		Kant, R (corresponding author), Head Injury Clin, 4608 Penn Ave, Pittsburgh, PA 15224 USA.						American Psychiatric Association, 1990, PRACT ECT REC TREATM; CLARK AF, 1987, BRIT J PSYCHIAT, V150, P841, DOI 10.1192/bjp.150.6.841; COFFEY CE, 1995, BIOL PSYCHIAT, V37, P777, DOI 10.1016/0006-3223(95)00053-J; COFFEY CE, 1995, BIOL PSYCHIAT, V37, P713, DOI 10.1016/0006-3223(95)00262-F; DUBOVSKY SL, 1986, HOSP COMMUNITY PSYCH, V37, P819; Epstein Richard S., 1994, P285; FOLSTEIN MF, 1975, J PSYCHIAT RES, P189; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Hsiao John K., 1987, Convuls Ther, V3, P121; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; KANT R, 1995, CONVULSIVE THER, V11, P45; Kant R, 1996, BRAIN INJURY, V10, P55; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mulsant B H, 1991, J Geriatr Psychiatry Neurol, V4, P3, DOI 10.1177/089198879100400102; *NO CA NEUR GROUP, 1991, MAN NEUR COGN STAT E; OSHANICK GJ, 1988, PSYCHIATRY, P1; OSHANICK GJ, 1994, NEUROPSYCHIATRY TRAU, P163; PRICE TRP, 1989, CONVULSIVE THER, V5, P61; RANEN NG, 1994, J NEUROPSYCH CLIN N, V6, P154; RIMEL RW, 1981, NEUROSURGERY, V9, P274; RUEDRICH SL, 1983, AM J PSYCHIAT, V140, P928; SCHNUR DB, 1989, CONVULSIVE THER, V5, P353; SILVERMAN M, 1964, BRIT J PSYCHIAT, P648; STOUDEMIRE A, 1995, J NEUROPSYCH CLIN N, V7, P31; Taylor Craig A., 1994, P81; TEASDALE G, 1974, LANCET, V2, P81; ZWIL AS, 1994, INT J PSYCHIAT MED, V24, P1; ZWIL AS, 1992, CONVULSIVE THER, V8, P103	28	19	19	0	1	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	1999	11	1					32	37		10.1176/jnp.11.1.32			6	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	162PC	WOS:000078354800005	9990553				2022-02-06	
J	Hormuth, D; Cefali, D; Rouse, T; Cutshaw, J; Turner, W; Rodman, G				Hormuth, D; Cefali, D; Rouse, T; Cutshaw, J; Turner, W; Rodman, G			Traumatic disruption of the thoracic aorta in children	ARCHIVES OF SURGERY			English	Article; Proceedings Paper	106th Scientific Session of the Western-Surgical-Association	NOV 16-18, 1998	INDIANAPOLIS, IN	Western Surg Assoc			PRIMARY REPAIR; RUPTURE; DIAGNOSIS; INJURIES	Hypothesis: This study was undertaken to identify mechanisms of injury, diagnostic modalities, surgical management, and outcome in children with traumatic aortic disruptions. Design: Retrospective study. Setting: University-affiliated private hospital. Patients: All patients younger than 17 years listed in the trauma registry. Intervention: Operative repair of thoracic aortic injuries. Main Outcome Measures: There were 8 boys and 3 girls ranging in age from 12 to 17 years (mean, 14.8 years). Seven children were motor vehicle passengers; 3 were pedestrians struck by vehicles; and 1 was thrown from a bull. Aortic injuries were suspected on the basis of the mechanism of injury and abnormal chest x-ray films (mediastinal widening). Aortic injuries were confirmed in 9 patients by arch aortography and in 2 patients by computed tomography. The injuries involved the isthmus of the aorta in 9 patients (complete transections) and the aortic arch in 2 patients (avulsions of the great vessels). Isthmus injuries were repaired by means of left heart bypass with direct cannulation of the distal thoracic aorta in 8 patients and femoral venous to femoral arterial bypass in 1 patient. Arch injuries were repaired during hypothermic circulatory arrest. The injured aortic segments were replaced with interposition grafts. There were no direct complications of anticoagulation. Ten patients (91%) survived. The only death was caused by a severe closed head injury. There were no instances of paraplegia related to aortic repairs. Conclusion: Good outcomes resulted from early diagnosis based on mechanism of injury, prompt aortography, and computed tomography and operative management that included distal aortic perfusion with left heart bypass.	Clarian Methodist Hosp, Sect Cardiothorac Surg, Indianapolis, IN USA; Clarian Methodist Hosp, Pediat Surg Sect, Indianapolis, IN USA; Clarian Methodist Hosp, Sect Trauma Surg, Indianapolis, IN USA		Hormuth, D (corresponding author), 1801 N Senate Blvd,Suite 755, Indianapolis, IN 46202 USA.						ALI IS, 1992, J PEDIATR SURG, V27, P1281, DOI 10.1016/0022-3468(92)90274-B; Beaver B L, 1992, Semin Thorac Cardiovasc Surg, V4, P255; BERGMAN K, 1990, J TRAUMA, V30, P604, DOI 10.1097/00005373-199005000-00013; BORMAN KR, 1982, AM J SURG, V144, P728, DOI 10.1016/0002-9610(82)90559-1; BROOKS AP, 1989, CLIN RADIOL, V40, P133, DOI 10.1016/S0009-9260(89)80071-6; DART CH, 1976, ARCH SURG-CHICAGO, V111, P697; Defilippi Vincent J., 1995, P65; EDDY AC, 1990, J TRAUMA, V30, P989, DOI 10.1097/00005373-199008000-00007; HALLER JA, 1986, PEDIAT SURG, V1, P143; KIRSH MM, 1976, ANN SURG, V184, P308, DOI 10.1097/00000658-197609000-00008; MATTOX KL, 1989, ANN THORAC SURG, V48, P1, DOI 10.1016/0003-4975(89)90164-1; MCBRIDE LR, 1987, ANN THORAC SURG, V43, P65, DOI 10.1016/S0003-4975(10)60168-3; MELLER JL, 1984, PEDIATRICS, V74, P813; MILLER FB, 1989, SURGERY, V106, P596; MURE A J, 1990, Pediatric Emergency Care, V6, P104, DOI 10.1097/00006565-199006000-00008; NAKAYAMA DK, 1989, ANN SURG, V210, P770, DOI 10.1097/00000658-198912000-00013; ORRINGER MB, 1983, ANN THORAC SURG, V35, P672, DOI 10.1016/S0003-4975(10)61083-1; PARMLEY LF, 1958, CIRCULATION, V17, P1086, DOI 10.1161/01.CIR.17.6.1086; ROBERTS SR, 1995, MANAGEMENT PEDIAT TR, P248; SCHMIDT CA, 1989, J TRAUMA, V29, P248, DOI 10.1097/00005373-198902000-00020; SYMBAS PN, 1973, ANN SURG, V178, P6, DOI 10.1097/00000658-197307000-00002; Trachiotis GD, 1996, ANN THORAC SURG, V62, P724, DOI 10.1016/S0003-4975(96)00355-4; WOODRING J H, 1990, Journal of Emergency Medicine, V8, P467	23	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0004-0010	1538-3644		ARCH SURG-CHICAGO	Arch. Surg.	JUL	1999	134	7					759	763		10.1001/archsurg.134.7.759			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	212FF	WOS:000081206100025	10401829	Bronze			2022-02-06	
J	Kroppenstedt, SN; Stroop, R; Kern, M; Thomale, UW; Schneider, GH; Unterberg, AW				Kroppenstedt, SN; Stroop, R; Kern, M; Thomale, UW; Schneider, GH; Unterberg, AW			Lubeluzole following traumatic brain injury in the rat	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact injury; lubeluzole; neuroprotection; nitric oxide synthase pathway; traumatic brain injury	NITRIC-OXIDE SYNTHASE; FOCAL CEREBRAL-ISCHEMIA; CORTICAL IMPACT INJURY; SODIUM-CHANNEL BLOCKER; NEUROLOGICAL FUNCTION; STROKE; NEUROPROTECTION; PROTECTION; GLUTAMATE; MODEL	Lubeluzole, a novel nitric oxide synthase (NOS) pathway modulator, was shown to be neuroprotective in cerebral ischemia as studied in animal models and clinical trials. The present study investigated the effect of lubeluzole on contusion volume and brain edema following traumatic brain injury. Sprague-Dawley rats (n = 36) were subjected to cortical impact injury. Lubeluzole (0.8 mg/kg i.v.; n = 18) or a corresponding volume of vehicle (n = 18) was injected 15 and 75 minutes following trauma. Animals were sacrificed 24 hours following trauma. Contusion volume was measured planimetrically from coronal slices stained with hematoxylin and eosin. In this group, T-2-weighted magnetic resonance imaging (MRI) was also performed 90 minutes and 6 and 24 hours after trauma. Hemispheric swelling and water content were determined gravimetrically 24 hours after trauma. In this group, intracranial pressure (ICP), mean arterial blood pressure (MABP), and cerebral perfusion pressure (CPP) were monitored for 30 minutes before sacrifice. Lubeluzole did not reduce contusion volume, hemispheric swelling, or water content. ICP, MABP, and the resulting CPP did not differ between treated and untreated rats 24 hours after injury. T-2-weighted MRI revealed a higher volume of edema at 90 minutes after trauma in treated rats. However, at 6 and 24 hours after trauma, no significant difference was discernible. Under these experimental conditions, lubeluzole fails to exert beneficial effects following experimental traumatic brain injury (TBI).	Humboldt Univ, Charite, Dept Neurosurg, D-13353 Berlin, Germany		Kroppenstedt, SN (corresponding author), Humboldt Univ, Charite, Dept Neurosurg, Augustenburger Pl 1,Campus Virchow, D-13353 Berlin, Germany.			Schneider, Gerd-Helge/0000-0002-1301-2938			Aronowski J, 1996, STROKE, V27, P1571, DOI 10.1161/01.STR.27.9.1571; Ashton D, 1997, BRAIN RES, V745, P210, DOI 10.1016/S0006-8993(96)01094-3; Beaumont A, 1998, ACT NEUR S, V71, P149; BULLOCK R, 1996, NEUROTRAUMA, P375; Busse R, 1997, BRAIN PATHOL, V7, P1377; CARREAU A, 1994, EUR J PHARMACOL, V256, P241, DOI 10.1016/0014-2999(94)90549-5; CHOI DW, 1993, P NATL ACAD SCI USA, V90, P9741, DOI 10.1073/pnas.90.21.9741; DAWSON DA, 1994, CEREBROVAS BRAIN MET, V6, P299; DeRyck M, 1996, J PHARMACOL EXP THER, V279, P748; DeRyck M, 1997, CEREBROVASC DIS, V7, P18, DOI 10.1159/000108239; Di X, 1996, J NEUROTRAUM, V13, P497, DOI 10.1089/neu.1996.13.497; Diener HC, 1998, CEREBROVASC DIS, V8, P172, DOI 10.1159/000015847; Diener HC, 1996, STROKE, V27, P76, DOI 10.1161/01.STR.27.1.76; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; GROTTA J, 1997, STROKE, V12, P2338; Grotta JC, 1997, CEREBROVASC DIS, V7, P31, DOI 10.1159/000108240; Haseldonckx M, 1997, STROKE, V28, P428, DOI 10.1161/01.STR.28.2.428; IADECOLA C, 1994, J CEREBR BLOOD F MET, V14, P175, DOI 10.1038/jcbfm.1994.25; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LEE SM, 1997, J CEREB BLOOD FLOW S, V17, P592; Lesage A. S., 1994, Society for Neuroscience Abstracts, V20, P185; Lesage AS, 1996, J PHARMACOL EXP THER, V279, P759; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; Maiese K, 1997, J NEUROCHEM, V68, P710; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Mori T, 1998, ACT NEUR S, V71, P120; MURAMATSU H, 1996, CEREBROVASC DIS S2, V6, P49; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; RATZMANN IB, 1997, EUR J PHARMACOL, V320, P2; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Scheller DKA, 1997, EUR J PHARMACOL, V338, P243, DOI 10.1016/S0014-2999(97)81927-9; Stroop R, 1998, ACT NEUR S, V71, P303; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; THOMALE UW, 1997, ZENTRALBL NEUROCHI S, V55; Unterberg AW, 1997, ACT NEUR S, V70, P106; VANDERLINDEN A, 1996, P 4 SCI M SOC MAGN R, P503; VANREEMPTS J, 1996, P 10 INT BRAIN ED S; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Wallis RA, 1996, BRAIN RES, V710, P169, DOI 10.1016/0006-8993(95)01278-8; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	45	19	19	1	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	1999	16	7					629	637		10.1089/neu.1999.16.629			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	220EN	WOS:000081651700007	10447074				2022-02-06	
J	Swaine, BR; Pless, IB; Friedman, DS; Montes, JL				Swaine, BR; Pless, IB; Friedman, DS; Montes, JL			Using the measure of processes of care with parents of children hospitalized for head injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						head injury; rehabilitation; satisfaction	TRAUMATIC BRAIN INJURY; PATIENT SATISFACTION; MEDICAL-CARE; COMA; REHABILITATION; QUESTIONNAIRE; VALIDATION; FAMILIES; SYSTEM; SCALE	Despite recommendations that rehabilitation programs adopt family/patient satisfaction as an outcome measure, few studies have addressed satisfaction with services for children with head injury. This report describes our use of the Measure of Processes of Care (MPOC) to document the perceptions of care of parents whose children were hospitalized with a head injury and to compare parental perceptions of care with those of the service providers (n = 16). The MPOC is a self-administered questionnaire consisting of 56 items, each of which is included in one of five care-giving scales: (1) enabling and partnership; (2) providing general information; (3) providing specific information about the child; (4) coordinated and comprehensive care; (5) respectful and supportive care. The MPOC was mailed to parents of children with a head injury who were consecutively admitted to a pediatric trauma center during a 5-mo period. The results, based on the responses of 73 parents (response rate, 59.3%), revealed that the needs of these parents are being met to varying degrees. Mean scores for the five scales ranged from 4.6 to 6.4 and from 5.9 to 6.6 for parents and providers, respectively. Significant differences between the groups were found for two scales: providing general and specific information. Because of the low percentage of valid responses for three of the five scales, the MPOC appears to be an inappropriate tool for use with parents of children with mild head injury (89%) in the acute care setting. The MPOC, however, is applicable for parents of children who are more severely injured (e.g., average hospital stay, 9 days) and is informative for rehabilitation service providers.	Univ Montreal, Ecole Readaptat, Fac Med, Montreal, PQ H3T 1A8, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Biostat & Epidemiol, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3A 2T5, Canada; McGill Montreal Childrens Hosp, Res Inst, Montreal, PQ, Canada; Montreal Childrens Hosp, Neurotrauma Program, Montreal, PQ, Canada; Montreal Childrens Hosp, Dept Neurosurg, Montreal, PQ, Canada		Swaine, BR (corresponding author), Univ Montreal, Ecole Readaptat, Fac Med, 2375 Cote St Catherine Rd, Montreal, PQ H3T 1A8, Canada.						*AM AC FAM PHYS, 1994, AM FAM PHYSICIAN, V50, P807; American Speech and Hearing Association, 1995, ASHA S14, V37, P23; BRESLAU N, 1982, MED CARE, V20, P347, DOI 10.1097/00005650-198204000-00001; Cleary P D, 1989, QRB Qual Rev Bull, V15, P172; CLEARY PD, 1988, INQUIRY-J HEALTH CAR, V25, P25; Elliott-Burke TL., 1997, J REHABIL OUTCOMES M, V1, P18; *EM MED SERV CHILD, 1995, INF FAM POSS LONG TE; GADDIS GM, 1994, ANN EMERG MED, V23, P75, DOI 10.1016/S0196-0644(94)70012-5; GASTON L, 1992, EVAL PROGRAM PLANN, V15, P227, DOI 10.1016/0149-7189(92)90085-9; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Johnston MV, 1997, ARCH PHYS MED REHAB, V78, pS1, DOI 10.1016/S0003-9993(97)90148-9; King, 1995, MEASURE PROCESSES CA; King SM, 1996, DEV MED CHILD NEUROL, V38, P757, DOI 10.1111/j.1469-8749.1996.tb15110.x; Kosciulek JF, 1997, J REHABIL, V63, P5; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; LASH M, 1995, REHAB UPDATE     FAL; LASH M, 1996, REHAB UPDATE     WIN; LEWIS CC, 1986, MED CARE, V24, P209, DOI 10.1097/00005650-198603000-00003; Lucke JF, 1996, ANN EMERG MED, V28, P408, DOI 10.1016/S0196-0644(96)70006-9; MCCOMAS J, 1995, AM J OCCUP THER, V49, P980, DOI 10.5014/ajot.49.10.980; MCCORDIE WR, 1991, BRAIN INJURY, V5, P43; MERRITT KL, 1990, PSYCHOL REP, V67, P129, DOI 10.2466/PR0.67.5.129-130; MOSELEY A, 1995, BRAIN INJURY, V9, P355, DOI 10.3109/02699059509005775; MURPHY DL, 1991, BEACH CTR FAMILIES D; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Osberg JS, 1997, NEUROREHABILITATION, V9, P149, DOI 10.3233/NRE-1997-9206; Pascoe G C, 1983, Eval Program Plann, V6, P185, DOI 10.1016/0149-7189(83)90002-2; PETERS AV, 1994, B MED LIBR ASSOC, V82, P153; ROSENBAUM PL, 1992, DEV MED CHILD NEUROL, V34, P103; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rydman RJ, 1997, ANN EMERG MED, V29, P109, DOI 10.1016/S0196-0644(97)70316-0; Streiner D.L., 1989, HLTH MEASUREMENT SCA; TEASDALE G, 1974, LANCET, V2, P81; WAALAND PK, 1993, BRAIN INJURY, V7, P135, DOI 10.3109/02699059309008167; WARE JE, 1988, MED CARE, V26, P393, DOI 10.1097/00005650-198804000-00008; Zastowny T R, 1995, Qual Manag Health Care, V3, P50	36	19	19	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL-AUG	1999	78	4					323	329		10.1097/00002060-199907000-00006			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	216AP	WOS:000081418600005	10418837				2022-02-06	
J	Zasler, ND				Zasler, ND			Posttraumatic tension pneumocephalus	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; headache; pneumocephalus		This case presentation will review tension pneumocephalus as a rare etiology of delayed posttraumatic headache (PTHA). It demonstrates that clinicians must be aware of even the uncommon causes of PTHA if appropriate diagnostic assessment and treatment are to be rendered. The case involves a 26-year-old right-handed white male who was 4 years post severe traumatic brain injury with facial fractures and an initial Glasgow Coma Scale score of 5. The patient's main postinjury functional impairments were cognitive-behavioral dysfunction, dysmetria, left hemiparesis, and posttraumatic epilepsy. Approximately 3 years post injury, the patient started to have complaints of right unilateral frontal headache. This complaint was addressed conservatively by several treating physicians. Due to the progressive nature of the patient's complaints, a second opinion was obtained with the author. On assessment, the patient complained of unilateral right headache and described the pain as making him feel as if his head was going to "bust open." A computed tomography (CT) scan showed findings consistent with a tension pneumocephalus. The patient was referred to neurosurgery, at which time the tension pneumocephalus was evacuated and a dural leak, felt to be responsible for the condition, patched. The patient's headache complaints reserved postoperatively. Clinicians should be aware of uncommon conditions that may be present in patients presenting with late PTHA, particularly conditions such as tension pneumocephalus which may have a significant clinical morbidity.	Concuss Care Ctr Virginia, Glen Allen, VA 23060 USA; Tree Life, Glen Allen, VA USA		Zasler, ND (corresponding author), Concuss Care Ctr Virginia, 10120 W Broad St,Suite G, Glen Allen, VA 23060 USA.						Ferrante L, 1988, Br J Neurosurg, V2, P269, DOI 10.3109/02688698808992679; FLEMING M S, 1988, Journal of Computed Tomography, V12, P86, DOI 10.1016/0149-936X(88)90039-2; ISHIWATA Y, 1988, J NEUROSURG, V68, P58, DOI 10.3171/jns.1988.68.1.0058; KAWAKAMI Y, 1985, Neurological Surgery, V13, P833; LEWIN W, 1954, BRIT J SURG, V42, P1, DOI 10.1002/bjs.18004217102; MARKHAM JW, 1976, HDB CLIN NEUROLOGY I, P24; Marras LC, 1998, CAN J NEUROL SCI, V25, P79, DOI 10.1017/S0317167100033540; MATSUBA HM, 1986, AM J OTOL, V7, P208; MCCORMACK B, 1996, NEUROTRAUMA; NORTH JB, 1971, BRIT J SURG, V58, P826, DOI 10.1002/bjs.1800581106; RAM Z, 1992, CHILD NERV SYST, V8, P351, DOI 10.1007/BF00296568; STEUDEL WI, 1986, ACTA NEUROCHIR, V80, P93, DOI 10.1007/BF01812281	12	19	21	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1999	14	1					81	84		10.1097/00001199-199902000-00009			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	165LT	WOS:000078523100009	9949248				2022-02-06	
J	Parente, R; Stapleton, M				Parente, R; Stapleton, M			Development of a Cognitive strategies group for vocational training after traumatic brain injury	NEUROREHABILITATION			English	Article						cognitive rehabilitation; group therapy; memory training		This study evaluated the effectiveness of a group cognitive skills training model. Thirty-three clients with traumatic brain injury participated in the group over a one year period. Their vocational rehabilitation rate was compared to that of a baseline condition of 64 matched clients who receive similar services but who did not participate in the group. The results indicated a 76% rehabilitation rate for those clients who participated in the group. Fifty-eight percent of the baseline clients returned to work. A description of the group activities is presented that can be implemented by virtually any facility.	Towson State Univ, Dept Psychol, Towson, MD 21204 USA; Maryland Rehabil Ctr, Baltimore, MD 21218 USA		Parente, R (corresponding author), Towson State Univ, Dept Psychol, Townson, MD 21286 USA.		Parente, Frederick/W-2570-2019	Parente, Frederick/0000-0002-2784-3433			BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514; HART T, 1986, CLIN NEUROPSYCHOLOGY; Parente R, 1994, NeuroRehabilitation, V4, P25, DOI 10.3233/NRE-1994-4105; PARENTE R., 1996, RETRAINING COGNITION; PARENTE R, 1996, J VOCATIONAL REHABIL, V7, P181; PARENTE R, 1999, COGNITIVE TECHNOLOGY, V4, P57; PEPPING M, 1998, BRAIN INJURY SOURCE, V2; PRIGATANO G, 1996, NEUROPSYCHOLOGICAL R, P96; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P67; WILSON B, 1986, CLIN MANAGEMENT MEMO, P171	10	19	19	1	6	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		1999	13	1					13	20					8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	244UT	WOS:000083069700003					2022-02-06	
J	Slaughter, J; Bobo, W; Childers, MK				Slaughter, J; Bobo, W; Childers, MK			Selective serotonin reuptake inhibitor treatment of post-traumatic Kluver-Bucy syndrome	BRAIN INJURY			English	Article							DISORDERS; PATIENT	Two cases of Kluver-Bucy syndrome following severe traumatic brain injury (TBI), are described during the period of recovery from acute TBI. These patients posed significant management problems, until successfully managed with selective serotonin reuptake inhibitors (SSRIs). These cases support the benefit of SSRIs in treating associated Kluver-Bucy syndrome.	Univ Missouri, Dept Psychiat & Neurol, Columbia, MO 65212 USA; Univ Missouri, Sch Med, Columbia, MO 65212 USA		Slaughter, J (corresponding author), Univ Missouri, Dept Psychiat & Neurol, 1 Hosp Dr, Columbia, MO 65212 USA.			Childers, Martin/0000-0003-4754-0883			CLARKE DJ, 1990, BRIT J PSYCHIAT, V157, P439, DOI 10.1192/bjp.157.3.439; FORMISANO R, 1995, ACTA NEUROL SCAND, V91, P54; GERSTENBRAND F, 1983, NEUROSCI BIOBEHAV R, V7, P413, DOI 10.1016/0149-7634(83)90047-7; HOOSHMAND H, 1974, JAMA-J AM MED ASSOC, V229, P1782, DOI 10.1001/jama.229.13.1782; JACOME DE, 1991, AM J EEG TECHNOL, V31, P267; LILLY R, 1983, NEUROLOGY, V33, P1141, DOI 10.1212/WNL.33.9.1141; LOPEZ OL, 1995, NEUROPSY NEUROPSY BE, V8, P215; OTT BR, 1995, CLIN NEUROPHARMACOL, V18, P443, DOI 10.1097/00002826-199510000-00007; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; STEWART JT, 1985, J CLIN PSYCHIAT, V46, P496; VANPRAAG HM, 1987, BIOL PSYCHIAT, V22, P205, DOI 10.1016/0006-3223(87)90232-0	11	19	20	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1999	13	1					59	62		10.1080/026990599121890			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	158TA	WOS:000078131200008	9972444				2022-02-06	
J	Panizzon, KL; Shin, D; Frautschy, S; Wallis, RA				Panizzon, KL; Shin, D; Frautschy, S; Wallis, RA			Neuroprotection with Bcl-2(20-34) peptide against trauma	NEUROREPORT			English	Article						AMPA; apoptosis; Bcl-2; cerebral ischemia; hypoxia; nitric oxide; NMDA; slice; traumatic brain injury	ADP-RIBOSYLATION; NITRIC-OXIDE; BCL-2; ISCHEMIA; INJURY; APOPTOSIS; BAX; HIPPOCAMPUS; INHIBITORS; NEURONS	WE tested the neuroprotective potential of the Bcl-2(20-34) peptide sequence in hippocampal slices. Treatment with Bcl-2 after fluid percussion trauma significantly improved recovery of CA1 antidromic PS to a mean of 92% +/- 1 of initial amplitude, compared with only 16% +/- 2 in unmedicated slices. The EC50 for trauma protection was 84 mu M Bcl-2(20-34). Protection with Bcl-2(20-34) also extended to long-term potentiation. No protection was seen with the reverse sequence of Bcl-2(20-34). Treatment with Bcl-2(20-34) also protected against hypoxic damage, with treated slices recovering to 98% +/- 2, while unmedicated slices recovered to 14% +/- 2. Similar protection was seen against AMPA, NMDA and nitric oxide. These findings indicate that Bcl-2(20-34) provides specific neuroprotection against acute CA1 neuronal injury. (C) 1998 Lippincott Williams & Wilkins.	Sepulveda VAMC, Sepulveda, CA 91343 USA; Univ Calif Los Angeles, Sch Med, Neuronal Injury Lab, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Dept Geriatr, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Inst Brain Res, Los Angeles, CA 90024 USA		Wallis, RA (corresponding author), Sepulveda VAMC, 111-N1,16111 Plummer St, Sepulveda, CA 91343 USA.			Frautschy, Sally A./0000-0003-0194-0363			Bonfoco E, 1996, NEUROREPORT, V8, P273, DOI 10.1097/00001756-199612200-00054; Burek MJ, 1996, BRAIN PATHOL, V6, P427, DOI 10.1111/j.1750-3639.1996.tb00874.x; Chen J, 1996, J NEUROCHEM, V67, P64; Ellerby LM, 1996, J NEUROCHEM, V67, P1259; Frautschy SA, 1996, NEUROBIOL AGING, V17, P311, DOI 10.1016/0197-4580(95)02073-X; Gartshore G, 1997, EXP NEUROL, V147, P353, DOI 10.1006/exnr.1997.6635; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Hunter JJ, 1996, MOL CELL BIOL, V16, P877; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Long C J, 1983, Psychiatr Med, V1, P35; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; PERSSON L, 1976, ACTA NEUROPATHOL, V35, P333; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Wallis RA, 1996, BRAIN RES, V710, P169, DOI 10.1016/0006-8993(95)01278-8; WALLIS RA, 1993, NEUROREPORT, V5, P245; WALLIS RA, 1993, EUR J PHARMACOL, V238, P165, DOI 10.1016/0014-2999(93)90844-8; White MJ, 1997, ANN NEUROL, V42, P580, DOI 10.1002/ana.410420408; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440	25	19	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	DEC 21	1998	9	18					4131	4136		10.1097/00001756-199812210-00024			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	158QY	WOS:000078128400028	9926861				2022-02-06	
J	Barnfield, TV; Leathem, JM				Barnfield, TV; Leathem, JM			Neuropsychological outcomes of traumatic brain injury and substance abuse in a New Zealand prison population	BRAIN INJURY			English	Article							CHRONIC COCAINE ABUSERS; HEAD-INJURY; FOLLOW-UP; IMPAIRMENT; DEFICITS; INTOXICATION; PERFORMANCE; PERSONALITY; SEQUELAE; RECOVERY	Fifty subjects with a history of traumatic brain injury (TBI) and/or substance use, completed neuro psychological measures of shea and long term verbal and visual memory, information processing, motor speed and co-ordination, executive functioning, and malingering. AU subjects; performed below norms on tests of verbal memory and verbal abstract thinking, but overall no differences were found due to either severity of TBI or level of substance use. Maori subjects obtained the lowest scores on tests of verbal ability, but also reported higher rates of TBI and substance use, which is presumed to account for this result. In conclusion, prison populations seem to have disproportionately high rates of TBI, recurrent TBI, and substance use, compared to the general population. Further, there are a group of individuals who have experienced both TBI and substance abuse, with associated impairments in verbal memory and learning, abstract thinking, and who report problems with general memory and socialization. These difficulties may affect functioning both in prison and following release.	Massey Univ, Dept Psychol, Palmerston North, New Zealand; Hutt Valley Hlth, Adult Mental Hlth Serv, Lower Hutt, New Zealand		Leathem, JM (corresponding author), Massey Univ, Dept Psychol, POB 11-222, Palmerston North, New Zealand.						*ACC REH COMP INS, 1993, ACC INJ STAT 1992; ADAMS J, 1992, DRUG STAT 1992; ARDILA A, 1991, INT J NEUROSCI, V57, P73, DOI 10.3109/00207459109150348; BARNFIELD TV, BRAIN INJURY, V12, P455; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BENTON R, 1988, ROYAL COMMISSION S 2, V3; BERGMAN H, 1989, BRIT J ADDICT, V84, P547; BERRY J, 1993, DRUG ALCOHOL DEPEN, V32, P231, DOI 10.1016/0376-8716(93)90087-7; BLACK S, 1993, DRUGS NZ SURVEY; BOND MR, 1986, NEUROPSYCHOLOGICAL A; BOWDEN SC, 1994, NEUROPSYCHOLOGY CLIN; BRAYBROOK B, 1992, CENSUS PRISON INMATE; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; BROWNING MD, 1992, ALCOHOL HEALTH RES W, V16, P280; BRUN P, 1975, AM J PSYCHIAT, V132, P397; BURGESS PW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P110; CARLIN AS, 1991, FORENSIC NEUROPSYCHO, P99; CASSIDY JW, 1990, J HEAD TRAUMA REHAB, V5, P83; COSGROVE J, 1991, J CLIN PSYCHOL, V47, P159, DOI 10.1002/1097-4679(199101)47:1<159::AID-JCLP2270470125>3.0.CO;2-O; CROSSON B, 1987, CLIN NEUROPSYCHOLOGI, V1, P355; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; EAMES P, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P134; EDNA TH, 1982, ACTA CHIR SCAND, V148, P209; ELMER O, 1985, ACTA CHIR SCAND, V151, P305; Ennis J., 1987, TU TANGATA, V36, P21; Fishbein D. H., 1990, CRIME BIOL SOCIAL MO; FRANCESCHI M, 1984, J NEUROL NEUROSUR PS, V47, P1134, DOI 10.1136/jnnp.47.10.1134; GANDOSSY RP, 1980, DRUGS CRIME SURVEY A; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; GODFREY HPD, NZ J PSYCHOL, V16, P49; GRANT I, 1977, DRUG ALCOHOL DEPEN, V2, P91, DOI 10.1016/0376-8716(77)90010-2; GREER BG, 1986, J REHABILITATION JAN, P34; Gronwall Dorothy, 1990, HEAD INJURY FACTS GU; Gualtari CT, 1991, BRAIN INJURY, V5, P219; GUERRA D, 1987, DRUG ALCOHOL DEPEN, V20, P261, DOI 10.1016/0376-8716(87)90036-6; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; HARLOW CW, 1991, DRUGS JAIL INMATES 1; HASIN DS, 1987, COMPR PSYCHIAT, V28, P520, DOI 10.1016/0010-440X(87)90018-6; HORMES JT, 1986, NEUROLOGY, V36, P698, DOI 10.1212/WNL.36.5.698; JOHNSON DA, 1993, BRAIN INJURY, V7, P491, DOI 10.3109/02699059309008176; JONES GA, 1989, ALCOHOL HEALTH RES W, V13, P105; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; KAPLAN HI, 1991, SYNOPSIS PSYCHIAT BE; KOIB B, 1990, FUNDAMENTALS HUMAN N; LANGLEY M J, 1990, Brain Injury, V4, P77, DOI 10.3109/02699059009026151; LENINGER B, 1990, J NEUROL NEUROSUR PS, V53, P293; LEVIN HS, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P89; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LOBERG T, 1986, NEUROPSYCHOLOGICAL A; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; Massman, 1992, NEUROPSYCHOLOGY, V6, P43, DOI [10.1037/0894-4105.6.1.43, DOI 10.1037/0894-4105.6.1.43]; MEEK PS, 1989, J PSYCHOACTIVE DRUGS, V21, P153, DOI 10.1080/02791072.1989.10472155; MENDHIRATTA SS, 1988, BRIT J ADDICT, V83, P749; MILLER L, 1992, INT J LAW PSYCHIAT, V15, P303, DOI 10.1016/0160-2527(92)90005-L; Morse P, 1992, CLIN SYNDROMES ADULT, P85; NORRIS M, 1909, OFFENDING NZ TRENDS; NOVACK TA, 1988, REHABIL COUNS BULL, V31, P313; OMALLEY S, 1992, AM J DRUG ALCOHOL AB, V18, P131, DOI 10.3109/00952999208992826; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; PAGE JB, 1988, J PSYCHOACTIVE DRUGS, V20, P57, DOI 10.1080/02791072.1988.10524372; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1991, AWARENESS DEFICIT BR, P116; REY A, 1968, EPREUVES MNESIQUES A; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RICHARDS M, 1992, J SUBST ABUSE TREAT, V9, P371, DOI 10.1016/0740-5472(92)90033-K; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; SACHDEV PS, 1989, PSYCHOL MED, V19, P959, DOI 10.1017/S0033291700005687; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Schafer J, 1994, NEUROPSYCHOLOGY, V8, P100, DOI 10.1037/0894-4105.8.1.100; SELBY MJ, IN PRESS ARCH CLIN N, V10; SPICER P, 1993, CONVICTION SENTENCIN; Spreen O, 1991, COMPENDIUM NEUROPSYC; STAMBROOK M, 1993, ARCH CLIN NEUROPSYCH, V8, P95; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; SWEENEY JA, 1989, J CLIN PSYCHOL, V45, P346, DOI 10.1002/1097-4679(198903)45:2<346::AID-JCLP2270450227>3.0.CO;2-L; TARTER RE, 1986, ALCOHOL CLIN EXP RES, V10, P128, DOI 10.1111/j.1530-0277.1986.tb05059.x; TEASDALE G, 1974, LANCET, V2, P81; *US DEP JUST, 1983, BUR JUST STAT B; Waldegrave C., 1985, AUSTR NZ J FAMILY TH, V6, P197; Wechsler, 1997, WECHSLER ADULT INTEL; WYLLIE A, 1989, DRINKING NZ SURVEY 1; ZIELINSKI R, IN PRESS ARCH CLIN N; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	87	19	19	0	11	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	1998	12	11					951	962		10.1080/026990598122007			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	143NR	WOS:000077262300004	9839028				2022-02-06	
J	Klapdor, K; Van der Staay, FJ				Klapdor, K; Van der Staay, FJ			Repeated acquisition of a spatial navigation task in mice: Effects of spacing of trials and of unilateral middle cerebral artery occlusion	PHYSIOLOGY & BEHAVIOR			English	Article						repeated acquisition; Morris maze; working memory; spatial navigation; middle cerebral artery occlusion; MCA-O; C57BL mouse	TRAUMATIC BRAIN INJURY; WATER-ESCAPE BEHAVIOR; MEDIAL SEPTAL AREA; LEARNING-SET; RATS; MEMORY; MAZE; ISCHEMIA; AGE; PERFORMANCE	The working memory version of the Morris water escape task, the repeated acquisition task, consists of trial pairs in which an animal is started twice from the same start position. Animals have mastered this task when they need less time to find the platform in the second of the two trials. In this study, study, male C57BL mice were trained on this task with massed, spaced, or spaced delay trials in which there was a 90-min delay between the first and second trials of a pair. The mice trained with spaced trials learned the repeated acquisition task, whereas the mice trained with massed or spaced delay trials were not consistently able to do so. When the mice had reached a stable baseline performance, the middle cerebral artery (MCA) was occluded or the mice were sham-operated. Then, the effects of the MCA occlusion (MCA-O) on the performance in the repeated acquisition tasks were studied. MCA occlusion hardly affected the performance in this task, irrespective of the spacing condition of the trials, although surgery per se seemed to have a transient disruptive effect. (C) 1998 Elsevier Science Inc.	Bayer, CNS Res, D-51063 Cologne, Germany		Van der Staay, FJ (corresponding author), Bayer, CNS Res, Neurather Ring 1, D-51063 Cologne, Germany.			van der Staay, F. Josef/0000-0002-8704-3366			AITKEN DH, 1989, NEUROBIOL AGING, V10, P273, DOI 10.1016/0197-4580(89)90062-6; AUER RN, 1989, J NEUROSCI, V9, P1641; BARNES CA, 1988, TRENDS NEUROSCI, V11, P163, DOI 10.1016/0166-2236(88)90143-9; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; CHIAMULERA C, 1993, BRAIN RES, V606, P251, DOI 10.1016/0006-8993(93)90992-V; Cohn J, 1996, COGNITIVE BRAIN RES, V3, P183, DOI 10.1016/0926-6410(96)00005-5; DENENBERG VH, 1991, BRAIN RES, V562, P98, DOI 10.1016/0006-8993(91)91192-4; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; FRICK KM, 1995, NEUROBIOL AGING, V16, P149, DOI 10.1016/0197-4580(94)00155-3; GOTTI B, 1990, BRAIN RES, V522, P290, DOI 10.1016/0006-8993(90)91473-T; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HARA H, 1991, EUR J PHARMACOL, V197, P72; HIMORI N, 1990, J PHARMACOL METHOD, V23, P311; Klapdor K, 1996, PHYSIOL BEHAV, V60, P1247, DOI 10.1016/S0031-9384(96)00224-7; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; Kumon Y, 1996, NEUROSCI LETT, V206, P141; LAMBERTY Y, 1991, BEHAV NEURAL BIOL, V56, P89, DOI 10.1016/0163-1047(91)90315-H; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; MEMEZAWA H, 1993, THESIS U LUND SWEDEN; MHARZI M, 1987, PHYSIOL BEHAV, V40, P181, DOI 10.1016/0031-9384(87)90205-8; MORRIS RGM, 1984, J NEUROSCI METH, V1, P47; MUNDY WR, 1990, BRAIN RES, V512, P221, DOI 10.1016/0006-8993(90)90629-P; NAGAHARA AH, 1992, BRAIN RES, V591, P54, DOI 10.1016/0006-8993(92)90977-H; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; PARK CK, 1994, BRAIN RES, V645, P157; PAYLOR R, 1990, BEHAV BRAIN RES, V36, P79, DOI 10.1016/0166-4328(90)90162-8; Petrie BF, 1995, PSYCHOL REP, V77, P1339, DOI 10.2466/pr0.1995.77.3f.1339; PIERCE JES, 1993, BRAIN RES, V624, P199, DOI 10.1016/0006-8993(93)90078-2; PITSIKAS N, 1993, NEUROBIOL AGING, V14, P561, DOI 10.1016/0197-4580(93)90039-E; RashidyPour A, 1996, BRAIN RES, V709, P131, DOI 10.1016/0006-8993(95)01323-7; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Shinoda M, 1996, EUR J PHARMACOL, V305, P31, DOI 10.1016/0014-2999(96)00173-2; ShukittHale B, 1996, PHYSIOL BEHAV, V59, P867, DOI 10.1016/0031-9384(95)02107-8; SWEENEY JE, 1988, PHARMACOL BIOCHEM BE, V31, P141, DOI 10.1016/0091-3057(88)90325-5; TAMURA A, 1985, J CEREB BLOOD FLOW M, V5, P379; VANDERSTAAY FJ, 1993, BEHAV NEURAL BIOL, V60, P33, DOI 10.1016/0163-1047(93)90690-J; vanderStaay FJ, 1996, BRAIN RES, V715, P180, DOI 10.1016/0006-8993(95)01581-7; VANDERSTAAY FJ, 1992, NEUROSCI RES COMMUN, V11, P11; VINCENT GP, 1992, BRAIN RES, V597, P264, DOI 10.1016/0006-8993(92)91483-U; WEHNER JM, 1990, BRAIN RES, V523, P181, DOI 10.1016/0006-8993(90)91485-Y; WELSH FA, 1987, J NEUROCHEM, V49, P846, DOI 10.1111/j.1471-4159.1987.tb00971.x; WHISHAW IQ, 1995, PHYSIOL BEHAV, V58, P687, DOI 10.1016/0031-9384(95)00110-5; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P59, DOI 10.1016/0166-4328(87)90036-2; Winer B.J., 1971, STAT PRINCIPLES EXPT; YAMAMOTO M, 1991, EUR J PHARMACOL, V197, P117; YOUNGBLOOD BD, 1997, PHYSIOL BEHAV, V61, P239	47	19	19	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	MAR	1998	63	5					903	909		10.1016/S0031-9384(98)00003-1			7	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	ZN303	WOS:000073632400023	9618015				2022-02-06	
J	Popovich, PG; Whitacre, CC; Stokes, BT				Popovich, PG; Whitacre, CC; Stokes, BT			Is spinal cord injury an autoimmune disorder?	NEUROSCIENTIST			English	Article						T-lymphocyte; autoimmunity; CNS injury; microglia; demyelination; neuroimmunology	CENTRAL-NERVOUS-SYSTEM; BASIC-PROTEIN; MULTIPLE-SCLEROSIS; T-CELLS; LYMPHOCYTES; MYELIN; ENCEPHALOMYELITIS; REGENERATION; INHIBITION; DISEASE	Cross-talk between cells of the nervous and immune systems is an emerging concept in neurotrauma research. Previously, neuroimmunological approaches in brain and spinal cord injury have focused on the functional consequences of macrophage and microglial activation. These cells constitute the natural, or innate, branch of CNS immunity and respond to injury or infection in a nonspecific fashion. Recent evidence, however, has shown that T-lymphocytes may also play a significant role in spinal cord injury. Once activated, T-and B-lymphocytes orchestrate the complex functions of the inflammatory response. Acquired immunity is readily induced against "non-self," or foreign, antigens, although "self-reactive" lymphocytes are present in normal individuals, providing the potential for the onset of autoimmunity. Trauma to or infection in the CNS may release "self" antigens normally sequestered behind the blood-brain barrier that can trigger lymphocyte activation. This article addresses the potential pathological and physiological implications of lymphocyte activation induced by traumatic spinal cord injury.	Ohio State Univ, Coll Med & Publ Hlth, Dept Med Microbiol & Immunol, Columbus, OH 43210 USA; Ohio State Univ, Coll Med & Publ Hlth, Dept Physiol, Columbus, OH 43210 USA; Ohio State Univ, Coll Med & Publ Hlth, Spinal Cord Injury Res Ctr, Columbus, OH 43210 USA				Popovich, Phillip/C-9187-2009	Popovich, Phillip/0000-0003-1329-7395			APPEL SH, 1994, J NEUROL SCI, V124, P14, DOI 10.1016/0022-510X(94)90171-6; BERRY M, 1974, BRIT MED BULL, V30, P135, DOI 10.1093/oxfordjournals.bmb.a071183; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BRACKEN MB, 1985, J NEUROSURG, V63, P704, DOI 10.3171/jns.1985.63.5.0704; CROSS AH, 1990, LAB INVEST, V63, P162; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; Ehrlich P., 1900, P R SOC LOND, V66, P424, DOI DOI 10.1098/RSPL.1899.0121; Falcone M, 1997, J EXP MED, V185, P901, DOI 10.1084/jem.185.5.901; FERINGA ER, 1975, ARCH NEUROL-CHICAGO, V32, P676, DOI 10.1001/archneur.1975.00490520046007; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GUTH L, 1994, EXP NEUROL, V126, P76, DOI 10.1006/exnr.1994.1043; HARLINGBERG CJ, 1991, J NEUROIMMUNOL, V35, P45, DOI 10.1016/0165-5728(91)90160-9; HIRSCHBERG DL, 1994, J NEUROIMMUNOL, V50, P9, DOI 10.1016/0165-5728(94)90209-7; HORNER PJ, 1994, NEURAL TRANSPLANTATI, P119; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; LEHMANN PV, 1993, IMMUNOL TODAY, V14, P203, DOI 10.1016/0167-5699(93)90163-F; MARTIN R, 1995, CRIT REV CL LAB SCI, V32, P121, DOI 10.3109/10408369509084683; MILLER DJ, 1995, J NEUROSCI RES, V41, P291, DOI 10.1002/jnr.490410302; MIZRACHI Y, 1983, PARAPLEGIA, V21, P287, DOI 10.1038/sc.1983.48; NAPARSTEK Y, 1984, NATURE, V310, P241, DOI 10.1038/310241a0; OLSSON T, 1992, AUTOIMMUNITY, V13, P117, DOI 10.3109/08916939209001912; PALLADINI G, 1987, EXP NEUROL, V95, P639, DOI 10.1016/0014-4886(87)90305-0; PETTE M, 1990, NEUROLOGY, V40, P1770, DOI 10.1212/WNL.40.11.1770; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Prochazka M, 1971, Int Surg, V55, P322; RAINE CS, 1984, LAB INVEST, V50, P608; Ramirez F, 1996, J IMMUNOL, V156, P2406; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; SempleRowland SL, 1995, J NEUROTRAUM, V12, P1003, DOI 10.1089/neu.1995.12.1003; SHALIT F, 1995, CLIN IMMUNOL IMMUNOP, V75, P246, DOI 10.1006/clin.1995.1078; Stefan J, 1971, Int Surg, V55, P316; THEOFILOPOULOS AN, 1993, MOL PATHOLOGY AUTOIM, V1, P1; Whitacre CC, 1996, CLIN IMMUNOL IMMUNOP, V80, pS31, DOI 10.1006/clin.1996.0139; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P1031, DOI 10.1002/eji.1830220423; YAROM Y, 1983, NATURE, V303, P246, DOI 10.1038/303246a0	36	19	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	1073-8584			NEUROSCIENTIST	Neuroscientist	MAR	1998	4	2					71	76		10.1177/107385849800400203			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZC578	WOS:000072594700010					2022-02-06	
J	Hollander, JE; Singer, AJ; Valentine, S				Hollander, JE; Singer, AJ; Valentine, S			Comparison of wound care practices in pediatric and adult lacerations repaired in the emergency department	PEDIATRIC EMERGENCY CARE			English	Article						laceration; wound; irrigation; infection; cleansing	TERM COSMETIC APPEARANCE; URBAN CHILDREN; IRRIGATION; RATES; LEVEL	Objective: We compared emergency physician's wound care practices in young children (less than or equal to 5 years) and adults (greater than or equal to 18 years) and the effect of these different practices on infection rate and cosmetic appearance, Design: Cross sectional study, Setting: University hospital emergency department that rarely uses conscious sedation, Participants: Consecutive patients who presented with lacerations over a four-year period, Methods: Structured closed question data sheets that assessed 26 separate wound characteristics were prospectively completed at initial presentation and at suture removal, Infection and cosmetic appearance were assessed with previously validated scales, chi(2) tests were used for categorical variables, t tests for continuous variables, Results: We evaluated 3624 patients: 853 children and 2771 adults, Wounds in children were more likely to be on the head (86 vs 38%, P < 0.01); linear (88 vs 77%, P < 0.01); shorter (1.9 vs 3.0 cm, P < 0.01); less often contaminated (4 vs 11%, P < 0.01); and more commonly caused by blunt injury (69 vs 37%, P < 0.01), With respect to treatment, lacerations in children were less likely to receive irrigation (53 vs 77%; P < 0.001) but slightly more likely to be scrubbed (50 vs 45%, P = 0.01), The two groups received similar numbers of sutures per centimeter (2.6 vs 2.3), Using logistic regression, the differences in irrigation were not explained by the differences in laceration characteristics, Despite less frequent irrigation, children had lower wound infection rates (2.1 vs 4.1%; P = 0.004) and better cosmetic appearances (optimal score, 75 vs 64%, P = 0.0003), Conclusions: Emergency physicians at our institution are less likely to irrigate lacerations in children than adults; however, children had a lower infection rate and more favorable cosmetic outcome.	SUNY Stony Brook, Med Ctr, Dept Emergency Med, Stony Brook, NY 11794 USA		Singer, AJ (corresponding author), SUNY Stony Brook, Med Ctr, Dept Emergency Med, Stony Brook, NY 11794 USA.		Singer, Adam/ABG-4506-2021	Hollander, Judd/0000-0002-1318-2785			BAKER MD, 1990, ANN EMERG MED, V19, P1001; BAKER MD, 1990, AM J DIS CHILD, V144, P87, DOI 10.1001/archpedi.1990.02150250097042; BROWN LL, 1978, ANN SURG, V187, P170, DOI 10.1097/00000658-197802000-00013; CHENOWITH A, 1973, MATERNAL CHILD HLTH, P651; DIRE DJ, 1990, ANN EMERG MED, V19, P704, DOI 10.1016/S0196-0644(05)82484-9; DIRE DJ, 1995, ACAD EMERG MED, V2, P4, DOI 10.1111/j.1553-2712.1995.tb03070.x; EDLICH RF, 1969, AM J SURG, V118, P21, DOI 10.1016/0002-9610(69)90089-0; GOSNOLD JK, 1977, PRACTITIONER, V218, P584; GROSS A, 1972, AM J SURG, V124, P373, DOI 10.1016/0002-9610(72)90044-X; GROSS AG, 1971, J ORAL SURG, V29, P187; HOLLANDER JE, 1995, ACAD EMERG MED, V2, P983, DOI 10.1111/j.1553-2712.1995.tb03126.x; HOLLANDER JE, 1995, ANN EMERG MED, V25, P675, DOI 10.1016/S0196-0644(95)70183-4; IZANT RJ, 1966, J TRAUM, V6, P65, DOI 10.1097/00005373-196601000-00008; MANHEIMER DI, 1966, PUBLIC HLTH REP, V81, P529; Quinn JV, 1996, ACAD EMERG MED, V3, P298, DOI 10.1111/j.1553-2712.1996.tb03440.x; RIVARA FP, 1982, AM J DIS CHILD, V136, P502, DOI 10.1001/archpedi.1982.03970420026004; ROBSON MC, 1973, J SURG RES, V14, P426, DOI 10.1016/0022-4804(73)90049-8; RODEHEAVER GT, 1975, SURG GYNECOL OBSTET, V141, P357; Rosenberg N M, 1987, Pediatr Emerg Care, V3, P239, DOI 10.1097/00006565-198712000-00005; SINGER AJ, 1995, AM J EMERG MED, V13, P265, DOI 10.1016/0735-6757(95)90197-3; Singer AJ, 1997, ACAD EMERG MED, V4, P133, DOI 10.1111/j.1553-2712.1997.tb03720.x; Singer AJ, 1996, ACAD EMERG MED, V3, P378, DOI 10.1111/j.1553-2712.1996.tb03454.x; SINGER AJ, IN PRESS ACAD EMERG; Stevenson T R, 1976, JACEP, V5, P17, DOI 10.1016/S0361-1124(76)80160-8; SUSSMAN BJ, 1996, ADV DATA VIT HLTH ST, V275	25	19	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	FEB	1998	14	1					15	18		10.1097/00006565-199802000-00004			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	YY491	WOS:000072151900004	9516624				2022-02-06	
J	Jukkala-Partio, K; Partio, EK; Hirvensalo, E; Rokkanen, P				Jukkala-Partio, K; Partio, EK; Hirvensalo, E; Rokkanen, P			Absorbable fixation of femoral head fractures - A prospective study of six cases	ANNALES CHIRURGIAE ET GYNAECOLOGIAE			English	Article						bioabsorbable implants; fracture; femoral	DISLOCATION; HIP	Background and Aims: Fracture of the femoral head associated with a traumatic dislocation of the hip is a rare but severe injury. The methods of the recommended treatment have varied from primary closed or open reduction without fixation to excision of fragments or internal fixation. In our department we have treated other kinds of intra-articular fractures successfully with totally absorbable polyglycolide and poly-L-lactide implants. The aim of this study was to investigate the value of totally absorbable rods and screws in the fixation of the femoral head fractures. Material and Methods: Six femoral head fractures associated with a posterior traumatic dislocation of the hip were treated by open reduction and internal fixation using self-reinforced absorbable polyglycolide (SR-PGA) or poly-L-lactide (SR-PLLA) rods and screws. The follow-up time was 38 months in average (range 6 weeks to 77 months). Results: In three patients the end results were excellent and in one fair. One patient died six weeks after the accident from the consequences of the cerebral injury. In one 61-year-old patient an arthroplasty was performed one year after the primary osteosynthesis, because of avascular necrosis of the femoral head. Conclusions: Self-reinforced polyglycolide and polylactide implants can be used safely to fix femoral head fractures without the need of implant removal.	Univ Helsinki, Cent Hosp, Dept Orthopaed & Traumatol, FIN-00260 Helsinki, Finland		Jukkala-Partio, K (corresponding author), Univ Helsinki, Cent Hosp, Dept Orthopaed & Traumatol, Topeliuksenkatu 5, FIN-00260 Helsinki, Finland.						BOSTMAN O, 1987, J BONE JOINT SURG BR, V69, P615, DOI 10.1302/0301-620X.69B4.3611169; BUTLER JE, 1981, J BONE JOINT SURG AM, V63, P1292, DOI 10.2106/00004623-198163080-00011; EPSTEIN HC, 1973, CLIN ORTHOP RELAT R, P116; EPSTEIN HC, 1974, J BONE JOINT SURG AM, VA 56, P1103, DOI 10.2106/00004623-197456060-00001; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; GUIRAL J, 1992, INJURY, V23, P417, DOI 10.1016/0020-1383(92)90022-K; HIRVENSALO E, 1990, ARCH ORTHOP TRAUM SU, V109, P258, DOI 10.1007/BF00419939; HOUGAARD K, 1988, J BONE JOINT SURG AM, V70A, P233, DOI 10.2106/00004623-198870020-00011; HUANG X, 1995, CHINESE J ORTHOP, V15, P758; JAKOB JR, 1987, CLIN ORTHOPAEDICS, V214, P249; KELLY RP, 1971, J TRAUM, V11, P97, DOI 10.1097/00005373-197102000-00001; KUHN DA, 1987, J TRAUMA, V27, P442, DOI 10.1097/00005373-198704000-00019; LANGSTEVENSON A, 1987, INJURY, V18, P264, DOI 10.1016/0020-1383(87)90011-8; MOWERY C, 1986, J TRAUMA, V26, P1041, DOI 10.1097/00005373-198611000-00014; MURRAY P, 1988, INJURY, V19, P220, DOI 10.1016/0020-1383(88)90023-X; Partio E K, 1992, J Orthop Trauma, V6, P209, DOI 10.1097/00005131-199206000-00013; PIPKIN G, 1957, J BONE JOINT SURG AM, V39, P1027, DOI 10.2106/00004623-195739050-00004; ROEDER LF, 1980, CLIN ORTHOP RELAT R, P121; Ruf W, 1990, Unfallchirurgie, V16, P202, DOI 10.1007/BF02588776; SIMMERT JB, 1993, J ORTHOP TRAUMA, V7, P567, DOI 10.1097/00005131-199312000-00014; Swiontkowski M F, 1992, J Orthop Trauma, V6, P437, DOI 10.1097/00005131-199212000-00008; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; VERMEIREN JAM, 1991, J TRAUMA, V31, P579, DOI 10.1097/00005373-199104000-00020; Warren P J, 1991, J Orthop Trauma, V5, P504, DOI 10.1097/00005131-199112000-00020	24	19	20	0	0	FINNISH SURGICAL SOC	HELSINKI	MAKELANKATU 2, SF-00550 HELSINKI, FINLAND	0355-9521			ANN CHIR GYNAECOL FE	Ann. Chir. Gynaecol.		1998	87	1					44	48					5	Obstetrics & Gynecology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Surgery	ZL668	WOS:000073458500012	9598230				2022-02-06	
J	Urenjak, J; Obrenovitch, TP				Urenjak, J; Obrenovitch, TP			Neuroprotection - rationale for pharmacological modulation of Na+-channels	AMINO ACIDS			English	Article; Proceedings Paper	Satellite on Neurobiology at the 5th International Congress on Amino Acids	AUG 25-29, 1997	CHALKIDIKI, GREECE	Sandoz Res Inst Berne LTD, Berne, Switzerland, Lomberg Chem Fabrik Gmbh, Byk Gulden, Konstanz, Germany, Pfizer Ltd, Kent, England, Pharmacia & Upjohn Co, Kalamazoo, MI, Boehringer Ingelheim, Ingelheim am Rhein, Germany, Merz & Co, Frankfurt am Main, Germany, Astra Arcus AB, Sodertalje, Sweden		neuroprotection; Na+-channels; Na+-channel blockers; ischaemia; energy deprivation; traumatic brain injury	GLUTAMATE RELEASE INHIBITOR; DEPENDENT SODIUM-CHANNELS; GLOBAL CEREBRAL-ISCHEMIA; RAT HIPPOCAMPAL-NEURONS; EXCITATORY AMINO-ACIDS; CNS WHITE-MATTER; BRAIN INJURY; BLOCKER TETRODOTOXIN; ANTIEPILEPTIC DRUG; LOCAL-ANESTHETICS	The primary factor detrimental to neurons in neurological disorders associated with deficient oxygen supply or mitochondrial dysfunction is insufficient ATP production relative to their requirement. As a large part of the energy consumed by brain cells is used for maintenance of the Na+ gradient across the cellular membrane, reduction of energy demand by downmodulation of voltage-gated Na+-channels is a rational strategy for neuroprotection. In addition, preservation of the inward Na+ gradient may be beneficial because it is an essential driving force for vital ion exchanges and transport mechanisms such as Ca2+ homeostasis and neurotransmitter uptake.	Pfizer Cent Res, Discovery Biol, Sandwich, Kent, England; Inst Neurol, Dept Neurochem, London, England		Urenjak, J (corresponding author), Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England.						AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Ames Adelbert Iii, 1997, P17; Artru F, 1991, Agressologie, V32, P439; ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; BOENING JA, 1989, NEUROSCIENCE, V33, P263, DOI 10.1016/0306-4522(89)90205-4; CATTERALL WA, 1987, TRENDS PHARMACOL SCI, V8, P57, DOI 10.1016/0165-6147(87)90011-3; CHERUBINI E, 1989, J NEUROPHYSIOL, V62, P882, DOI 10.1152/jn.1989.62.4.882; CHEUNG H, 1992, EPILEPSY RES, V13, P107; CUMMINS TR, 1994, J NEUROPHYSIOL, V71, P1052, DOI 10.1152/jn.1994.71.3.1052; DARGENT B, 1990, P NATL ACAD SCI USA, V87, P5907, DOI 10.1073/pnas.87.15.5907; Douglas S. M., 1996, Society for Neuroscience Abstracts, V22, P230; EDWARDS RA, 1989, AM J PHYSIOL, V257, pR1354; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; EVANS DE, 1984, J NEUROSURG, V60, P257, DOI 10.3171/jns.1984.60.2.0257; FERN R, 1993, J PHARMACOL EXP THER, V266, P1549; FRIEDMAN JE, 1994, BRAIN RES, V641, P57, DOI 10.1016/0006-8993(94)91815-5; GILLAND E, 1994, DEV BRAIN RES, V83, P79, DOI 10.1016/0165-3806(94)90181-3; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; GRAHAM SH, 1994, J PHARMACOL EXP THER, V269, P854; GRAHAM SH, 1993, J CEREBR BLOOD F MET, V13, P88, DOI 10.1038/jcbfm.1993.11; HAKIM A M, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P115; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; HOEHN K, 1993, NEURON, V10, P543, DOI 10.1016/0896-6273(93)90341-N; KEMPSKI O, 1988, NEUROCHEM PATHOL, V9, P109; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; LANG DG, 1993, J PHARMACOL EXP THER, V266, P829; LEACH MJ, 1986, EPILEPSIA, V27, P490, DOI 10.1111/j.1528-1157.1986.tb03573.x; LEACH MJ, 1993, STROKE, V24, P1063, DOI 10.1161/01.STR.24.7.1063; LEES G, 1993, BRAIN RES, V612, P190, DOI 10.1016/0006-8993(93)91660-K; LEKIEFFRE D, 1993, NEUROSCIENCE, V56, P93, DOI 10.1016/0306-4522(93)90565-W; LUCAS LF, 1989, J NEUROSCI METH, V28, P47, DOI 10.1016/0165-0270(89)90008-3; Lysko P. G., 1993, Society for Neuroscience Abstracts, V19, P286; MELDRUM BS, 1992, BRAIN RES, V593, P1, DOI 10.1016/0006-8993(92)91254-C; MESSENHEIMER JA, 1995, EPILEPSIA, V36, pS87, DOI 10.1111/j.1528-1157.1995.tb06002.x; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; OBRENOVITCH TP, 1990, J NEUROPHYSIOL, V64, P1125, DOI 10.1152/jn.1990.64.4.1125; OBRENOVITCH TP, 1990, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1990, P97; OBRENOVITCH TP, 1997, REV CONTEMP PHARMACO, V8, P227; OBRENOVITCH TP, 1997, NEUROPROTECTIVE AGEN, P109; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; PEREZPINZON MA, 1992, AM J PHYSIOL, V262, pR712, DOI 10.1152/ajpregu.1992.262.4.R712; PRENEN GHM, 1988, EXP NEUROL, V99, P118, DOI 10.1016/0014-4886(88)90132-X; RASOOL N, 1990, STROKE, V21, P929, DOI 10.1161/01.STR.21.6.929; RATAUD J, 1994, NEUROSCI LETT, V172, P19, DOI 10.1016/0304-3940(94)90652-1; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; Schulz JB, 1996, NEUROSCIENCE, V71, P1043, DOI 10.1016/0306-4522(95)00527-7; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; SKILLING SR, 1988, J NEUROCHEM, V51, P127, DOI 10.1111/j.1471-4159.1988.tb04845.x; SMITH SE, 1995, STROKE, V26, P117, DOI 10.1161/01.STR.26.1.117; SMITH SE, 1993, NEUROREPORT, V4, P1339, DOI 10.1097/00001756-199309150-00013; SPETZLER R F, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P212; STYS PK, 1992, J NEUROSCI, V12, P430; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; TAYLOR CP, 1993, TRENDS NEUROSCI, V16, P455, DOI 10.1016/0166-2236(93)90077-Y; Urenjak J, 1996, PHARMACOL REV, V48, P21; URENJAK J, 1991, PHARMACOLOGY, V43, P26, DOI 10.1159/000138824; VORNOV JJ, 1994, STROKE, V25, P457, DOI 10.1161/01.STR.25.2.457; WAXMAN SG, 1994, BRAIN RES, V644, P197, DOI 10.1016/0006-8993(94)91680-2; WIARD RP, 1995, STROKE, V26, P466, DOI 10.1161/01.STR.26.3.466; XIA Y, 1994, J COMP NEUROL, V345, P279, DOI 10.1002/cne.903450209; XIA Y, 1993, J COMP NEUROL, V330, P363, DOI 10.1002/cne.903300307; Xie XM, 1996, NEUROSCIENCE, V73, P951, DOI 10.1016/0306-4522(96)00092-9; XIE XM, 1995, PFLUG ARCH EUR J PHY, V430, P437, DOI 10.1007/BF00373920; XIE YX, 1994, BRAIN RES, V652, P216, DOI 10.1016/0006-8993(94)90230-5; YAMASAKI Y, 1991, NEUROSCI LETT, V121, P251, DOI 10.1016/0304-3940(91)90697-R; YOUNG AMJ, 1990, J NEUROCHEM, V55, P1060, DOI 10.1111/j.1471-4159.1990.tb04597.x	67	19	19	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0939-4451			AMINO ACIDS	Amino Acids		1998	14	1-3					151	158		10.1007/BF01345256			8	Biochemistry & Molecular Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YU287	WOS:000071701500024	9871455				2022-02-06	
J	Casselman, JW; Bensimon, JL				Casselman, JW; Bensimon, JL			Imaging of the inner ear	RADIOLOGE			German	Article						inner ear; CT; MRT; malformation; trauma; tumor; inflammation	TEMPORAL BONE; HEARING-LOSS; SPIN-ECHO; MR; MALFORMATIONS; ENHANCEMENT; VERTIGO; CT	New computed tomography (CT) and magnetic resonance (MR) techniques allow more detailed anatomic studies of the inner ear. CT is still the best technique to study patients with fractures, congenital malformations and otodystrophies involving the inner ear. During recent years MR imaging has emerged as an excellent method to detect pathology in the internal auditory canal, membranous labyrinth and bony labyrinth and to characterize petrous apex lesions. MR has even proved its value in patients with fractures and congenital malformations making the diagnosis of, for instance, labyrinthine concussion and absence of the vestibulocochlear nerve possible. The diagnosis of acute/chronic labyrinthitis and intralabyrinthine tumors has also became possible. However, MR and CT are often complementary, as is the case in patients with mixed hearing loss, congenital malformations and petrous apex lesions.	AZ St Jan Brugge, Dept Radiol, B-8000 Brugge, Belgium; Imagerie ORL & Gen, Paris, France		Casselman, JW (corresponding author), AZ St Jan Brugge, Dept Radiol, Ruddershove 10, B-8000 Brugge, Belgium.						Brandt T, 1993, J Vestib Res, V3, P373; CASSELMAN JW, 1993, AM J NEURORADIOL, V14, P59; Casselman JW, 1996, NEURORADIOLOGY, V38, P278; Casselman JW, 1997, RADIOLOGY, V202, P773, DOI 10.1148/radiology.202.3.9051033; Casselman JW, 1996, NEUROIMAG CLIN N AM, V6, P265; CASSELMAN JW, 1993, AM J NEURORADIOL, V14, P47; CASSELMAN JW, 1994, AM J NEURORADIOL, V15, P131; HARNSBERGER HR, 1987, RADIOLOGY, V164, P53, DOI 10.1148/radiology.164.1.3108956; JACKLER RK, 1987, LARYNGOSCOPE, V97, P2; LO WWM, 1991, HEAD NECK IMAGING, P1046; Mafee M F, 1994, Neuroimaging Clin N Am, V4, P561; MARK AS, 1993, AM J NEURORADIOL, V14, P991; MARK AS, 1992, ANN OTO RHINOL LARYN, V101, P459, DOI 10.1177/000348949210100601; RAMSEY KL, 1993, AM J OTOL, V14, P605; SCHMALBROCK P, 1993, JMRI-J MAGN RESON IM, V3, P451, DOI 10.1002/jmri.1880030304; SCHUKNECHT HF, 1993, PATHOLOGY EAR, P105; SWARTZ JD, 1986, IMAGING TEMPORAL BON, P161; TANIOKA H, 1991, RADIOLOGY, V178, P141, DOI 10.1148/radiology.178.1.1984292; TIEN RD, 1992, AM J ROENTGENOL, V159, P395, DOI 10.2214/ajr.159.2.1632364; TIEN RD, 1993, MAGN RESON IMAGING, V11, P429, DOI 10.1016/0730-725X(93)90077-Q; TORIZUKA T, 1992, RADIOLOGY, V184, P109, DOI 10.1148/radiology.184.1.1609065	21	19	19	0	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0033-832X			RADIOLOGE	Radiologe	DEC	1997	37	12					954	963		10.1007/s001170050307			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	YP395	WOS:000071272600004	9498245				2022-02-06	
J	Soblosky, JS; Colgin, LL; Chorney-Lane, D; Davidson, JF; Carey, ME				Soblosky, JS; Colgin, LL; Chorney-Lane, D; Davidson, JF; Carey, ME			Some functional recovery and behavioral sparing occurs independent of task-specific practice after injury to the rat's sensorimotor cortex	BEHAVIOURAL BRAIN RESEARCH			English	Article						behavioral compensation; recovery; sensorimotor cortex; traumatic brain injury; forelimb deficit; task-specific practice; hindlimb deficit; rat	TRAUMATIC BRAIN INJURY; MOTOR CORTEX; ADULT-RATS; NEOCORTICAL DAMAGE; NEURONAL INJURY; LESIONS; AMPHETAMINE; MEMORY; ORGANIZATION; PLASTICITY	These experiments on rats evaluated whether recovery of competence in certain motor tests could be enhanced by practice begun soon after traumatic brain injury (TBI). Before TBI, rats were pre-trained to cross a flat and a pegged beam. Anesthetized animals received a right sensorimotor cortex TBI. One group began task-specific testing (flat and pegged beams) on day 1 after injury and repeated 13 times in 35 days by which time functional recovery occurred. Paw preference was evaluated eight times during the 35 day period, beginning the third day after injury. A second group of injured rats remained in their home cage without any testing for 35 days after injury. From day 35 they were tested 13 times over the next 35 days on both beam tests and eight times on the paw preference test. At day 35 those rats that remained in their home cage without testing (task-specific practice) performed as well on the flat beam as the rats that began testing 1 day after injury. By day 37, their third test day, the untested rats performed as well as the tested rats on the pegged beam. Paw preference was the same in both groups of rats. These results were compared to sham-operated controls. Post-injury performance as measured by these tests indicated that most of the recovery occurred without task-specific practice. However, task-specific practice was necessary to achieve optimum performance on both beam tests. This implies that neural reorganization occurred independent of any practice. Task specific practice served to 'fine tune' the rat's performance after 35 days. (C) 1997 Elsevier Science B.V.	Louisiana State Univ, Med Ctr, Dept Neurosurg, Neurotrauma Res Lab, New Orleans, LA 70112 USA		Soblosky, JS (corresponding author), Louisiana State Univ, Med Ctr, Dept Neurosurg, Neurotrauma Res Lab, 1542 Tulane Ave, New Orleans, LA 70112 USA.	JSOBLO@lsumc.edu		Colgin, Laura/0000-0002-4853-8913; Lane, Diane/0000-0001-7313-557X			BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CASTROALAMANCOS MA, 1992, EUR J NEUROSCI, V4, P853, DOI 10.1111/j.1460-9568.1992.tb00195.x; CASTROALAMANCOS MA, 1995, NEUROSCIENCE, V68, P793, DOI 10.1016/0306-4522(95)00178-L; CHEN S, 1990, BRAIN RES, V520, P103, DOI 10.1016/0006-8993(90)91695-D; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GENTILE AM, 1987, BEHAV NEURAL BIOL, V47, P321, DOI 10.1016/S0163-1047(87)90435-3; Goldstein L B, 1990, Restor Neurol Neurosci, V1, P311, DOI 10.3233/RNN-1990-1501; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; GOLDSTEIN LB, 1993, NEUROSCI PROTOCOLS, P1; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; PELLEGRINO I, 1979, STEREOTAXIC ATLAS RA; ROSE FD, 1993, BEHAV BRAIN RES, V56, P93, DOI 10.1016/0166-4328(93)90025-L; ROSE FD, 1987, BEHAV BRAIN RES, V24, P195, DOI 10.1016/0166-4328(87)90057-X; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; SOBLOSKY JS, UNPUB LADDER BEAM CA; STEPHENS J, 1986, Society for Neuroscience Abstracts, V12, P1285; STEPHENS J, 1987, PHYS THER, V67, P769; SZELE FG, 1995, J NEUROSCI, V15, P4429; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519	32	19	20	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	DEC	1997	89	1-2					51	59		10.1016/S0166-4328(97)00049-1			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	YT189	WOS:000071574400003	9475614				2022-02-06	
J	Brulot, MM; Strauss, E; Spellacy, F				Brulot, MM; Strauss, E; Spellacy, F			Validity of the Minnesota multiphasic personality inventory-2 correction factors for use with patients with suspected head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							TRAUMA PATIENTS; MMPI-2; PSYCHOPATHOLOGY; COMPLAINTS; SYMPTOMS; SEQUELAE; SCALES	The clinical scales of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) are thought to be artificially inflated in patients with closed head injury (CHI). Correction factors have been proposed (e.g,. Alfano, Paniak, & Finlayson, 1993; Artzy, 1994; Gass, 1991b) by comparing item endorsement of various populations and selecting items unique to the CHI population. The present study assessed the validity of the correction factors by relating these to indices of head- injury severity and to scores on standard neuropsychological measures. Results revealed no significant associations between the correction factors and duration of loss of consciousness (LOC) and posttraumatic amnesia (PTA). In addition, no significant associations were found between correction factors and performance on neuropsychological tests. Significant correlations were found, however, between correction factors and the MMPI-2 depression content scale. These results suggest that the correction factors proposed for interpreting MMPI-2 protocols of head-injured individuals may be more sensitive to depression than to closed head injury.	Univ Victoria, Dept Psychol, Victoria, BC V8V 3P5, Canada		Brulot, MM (corresponding author), Univ Victoria, Dept Psychol, POB 3050, Victoria, BC V8V 3P5, Canada.						Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; ARTZY G, 1994, THESIS U VICTORIA BR; Ben-Porath Y. S., 1991, PSYCHOL ASSESSMENT J, V3, P634; BENPORATH YS, 1993, J PERS ASSESS, V61, P557, DOI 10.1207/s15327752jpa6103_12; Benton A. L, 1989, MILD HEAD INJURY, P3; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BOONE DE, 1994, PSYCHOL REP, V74, P159, DOI 10.2466/pr0.1994.74.1.159; Brickenkamp R., 1981, TEST D2 AUFMERKSAMKE, V7th ed.; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BURTON LA, 1994, J NEUROLOGICAL REHAB, V8, P63, DOI DOI 10.1177/136140969400800202; BUTCHER JN, 1992, CAN PSYCHOL, V33, P61, DOI 10.1037/h0078693; Cohen J., 2013, STAT POWER ANAL BEHA; CRIPE LI, 1989, REHABIL PSYCHOL, V34, P93; DIKMEN S, 1974, PERCEPT MOTOR SKILL, V39, P831, DOI 10.2466/pms.1974.39.2.831; DIKMEN SS, 1989, MILD HEAD INJURY, P229; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GASS CS, 1992, ARCH CLIN NEUROPSYCH, V7, P17, DOI 10.1016/0887-6177(92)90015-F; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1991, J CLIN PSYCHOL, V47, P100, DOI 10.1002/1097-4679(199101)47:1<100::AID-JCLP2270470116>3.0.CO;2-H; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTILINI M, 1989, MILD HEAD INJURY, P163; GRAHAM JR, 1993, MMPI 2 ASSESSING PER; GRAVES RE, 1985, REY VISUAL DESIGN LE; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; Hathaway S.R., 1989, MINNESOTA MULTIPHASI; KARLSEN B, 1984, STANFORD DIAGNOSTIC; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; OHARA C, 1988, COGNITIVE REHABILITA, V6, P26; OJILE JR, 1995, ANN M INT NEUR SOC S; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; PARTINGTON JE, 1949, PSYCHOL SERVICE CTR, V1, P9; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; POPE KS, 1993, MMPI MMPI 2 MMPI A C; Regard M, 1981, THESIS U VICTORIA BR; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Reitan RM, 1997, CLIN NEUROPSYCHOL, V11, P69, DOI 10.1080/13854049708407031; REITAN RM, 1969, UNPUB MANUAL ADM NEU; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Smith A., 1982, SYMBOL DIGIT MODALIT; SPEARBASSETT S, 1990, J PEDIATR PSYCHOL, V15, P225; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Tiffin, 1968, PURDUE PEGBOARD EXAM; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wechsler, 1997, WECHSLER ADULT INTEL; Western Psychological Services, 1983, HOOP VIS ORG TEST VO; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; [No title captured]; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	61	19	19	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	1997	11	4					391	401		10.1080/13854049708400468			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	136GW	WOS:000076851900006					2022-02-06	
J	Nilsson, F; Nilsson, T; Edvinsson, L; Bjorkman, S; Nordstrom, CH				Nilsson, F; Nilsson, T; Edvinsson, L; Bjorkman, S; Nordstrom, CH			Effects of dihydroergotamine and sumatriptan on isolated human cerebral and peripheral arteries and veins	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						human; cerebral arteries; cerebral veins; dihydroergotamine; sumatriptan; in vitro	SEVERE HEAD-INJURY; EXPERIMENTAL INTRACRANIAL HYPERTENSION; TRAUMATIC BRAIN-LESIONS; BLOOD-FLOW; 5-HT1-LIKE RECEPTOR; HEALTHY-SUBJECTS; BASILAR ARTERY; 5-HYDROXYTRYPTAMINE; INDOMETHACIN; VASOCONSTRICTION	Background: Pharmacological cerebral vasoconstriction has recently been suggested as treatment for patients with increased intracranial pressure (ICP) after severe traumatic brain lesions. Hypothetically, a moderate constriction of precapillary resistance vessels might be advantageous since it decreases intracapillary blood pressure, and a contraction of cerebral veins might effectively reduce intracranial blood volume and ICP. This report examines the in vitro effects of two vasoconstrictors, dihydroergotamine (DHE) and sumatriptan, which may be considered for treatment of increased ICP. Methods: The reactivity of isolated small human cerebral, subcutaneous and omental arteries and veins were studied during exposure to different concentrations of DHE and sumatriptan. Results: Both sumatriptan and DHE induced concentration-dependent contractions in human cerebral arteries and veins and 50% of maximum contractions were obtained at significantly lower concentrations of DHE than of sumatriptan. The maximum contraction of cerebral arteries was significantly higher with sumatriptan than with DHE. Both drugs caused contractions of subcutaneous arteries at concentrations of 10(-7)-10(-6)M, which is within the therapeutic concentration range of sumatriptan, while no effect was obtained in omental vessels. Conclusions: Both DHE and sumatriptan cause contraction of isolated human cortical arteries and veins at very low concentrations. The differences observed between the two drugs may be explained by the fact that DHE is an or-adrenergic as well as a 5-HT agonist while sumatriptan acts specifically on 5-HT receptors. The study supports the hypothesis underlying the use of DHE for the treatment of increased ICP in patients with severe traumatic brain lesions.	MALMO UNIV HOSP,DEPT ANAESTHESIA & INTENS CARE & EXPT RES,MALMO,SWEDEN; MALMO UNIV HOSP,HOSP PHARM,MALMO,SWEDEN; UNIV LUND HOSP,DEPT INTERNAL MED,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT NEUROSURG,S-22185 LUND,SWEDEN					Edvinsson, Lars/0000-0002-1805-1346			ANDERSEN AR, 1987, STROKE, V18, P120, DOI 10.1161/01.STR.18.1.120; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P922, DOI 10.1111/j.1399-6576.1995.tb04199.x; AUER LM, 1984, CEREBRAL VENOUS SYST, P169; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRADLEY PB, 1986, NEUROPHARMACOLOGY, V25, P563, DOI 10.1016/0028-3908(86)90207-8; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; CONNOR HE, 1989, BRIT J PHARMACOL, V96, P379, DOI 10.1111/j.1476-5381.1989.tb11828.x; CUNNINGHAM M, 1984, BRIT J SURG, V71, P829, DOI 10.1002/bjs.1800711106; EDVINSSON L, 1971, ACTA PHYSIOL SCAND, V83, P42, DOI 10.1111/j.1748-1716.1971.tb05049.x; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P253; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P354; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FENIUK W, 1989, BRIT J PHARMACOL, V96, P83, DOI 10.1111/j.1476-5381.1989.tb11787.x; FOWLER PA, 1991, EUR NEUROL, V31, P291, DOI 10.1159/000116756; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; HACHINSKI V, 1978, STROKE, V9, P594, DOI 10.1161/01.STR.9.6.594; HARDEBO JE, 1987, J CEREBR BLOOD F MET, V7, P612, DOI 10.1038/jcbfm.1987.113; HOGESTATT ED, 1983, ACTA PHYSIOL SCAND, V117, P49, DOI 10.1111/j.1748-1716.1983.tb07178.x; HOYER D, 1994, PHARMACOL REV, V46, P157; HUMPHREY PPA, 1991, TRENDS PHARMACOL SCI, V12, P444, DOI 10.1016/0165-6147(91)90630-B; JANSEN I, 1993, ACTA PHYSIOL SCAND, V147, P141, DOI 10.1111/j.1748-1716.1993.tb09483.x; JANSEN I, 1992, CEPHALALGIA, V12, P202, DOI 10.1046/j.1468-2982.1992.1204202.x; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENSEN K, 1991, ACTA NEUROCHIR, V108, P116, DOI 10.1007/BF01418518; LEE TJF, 1994, AM J PHYSIOL, V266, pH1000, DOI 10.1152/ajpheart.1994.266.3.H1000; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P545, DOI 10.1001/archneur.1969.00480170117012; MCCARTHY BG, 1989, HEADACHE, V29, P420, DOI 10.1111/j.1526-4610.1989.hed2907420.x; MELLANDER S, 1970, CLIN SCI, V39, P183, DOI 10.1042/cs0390183; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MILLER JD, 1994, INTENS CARE MED, V20, P249, DOI 10.1007/BF01708957; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MULLER H, 1988, PHARMACOLOGY, V37, P248, DOI 10.1159/000138473; NILSSON F, 1995, ANESTHESIOLOGY, V83, P1283, DOI 10.1097/00000542-199512000-00019; Nilsson F, 1996, ACTA ANAESTH SCAND, V40, P612, DOI 10.1111/j.1399-6576.1996.tb04497.x; NILSSON F, 1995, ACTA ANAESTH SCAND, V39, P916, DOI 10.1111/j.1399-6576.1995.tb04198.x; OWMAN CH, 1983, CEREBRAL VEINS, P203; PARSONS AA, 1989, BRIT J PHARMACOL, V96, P434, DOI 10.1111/j.1476-5381.1989.tb11835.x; RORARIUS M, 1985, ANN CLIN RES, V17, P306; SAYAMA I, 1983, CEREBRAL VEINS, P273; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SCHUTTA HS, 1968, BRAIN, V91, P281, DOI 10.1093/brain/91.2.281; WALSHE JJ, 1979, ANN INTERN MED, V91, P47, DOI 10.7326/0003-4819-91-1-47; Wennmalm A, 1984, Arch Toxicol Suppl, V7, P350; WYSS PA, 1991, EUR J CLIN PHARMACOL, V41, P597, DOI 10.1007/BF00314992; YADA K, 1973, J NEUROSURG, V39, P723, DOI 10.3171/jns.1973.39.6.0723	49	19	20	0	1	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	NOV	1997	41	10					1257	1262		10.1111/j.1399-6576.1997.tb04641.x			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	YJ915	WOS:A1997YJ91500005	9422289				2022-02-06	
J	Raskin, SA				Raskin, SA			The relationship between sexual abuse and mild traumatic brain injury	BRAIN INJURY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; URINARY CATECHOLAMINE EXCRETION; HEAD-INJURY; SCALE; NORADRENALINE; CONCUSSION; SURVIVORS; SYMPTOMS	It remains unclear why some individuals with mild traumatic brain injury (MTBI) complain of cognitive deficits many months after the injury. Given neuropathological changes associated with prolonged stress, such as occurs with repeated sexual abuse (SA), it seems possible that individuals who experienced SA might be predisposed to greater deficits after MTBI. Four groups of subjects were administered measures of cognitive and emotional functioning. These groups were those with MTBI (n = 10), those with a history of SA (n = 10), those with both MTBI and SA (n = 10), and normal control (NC) subjects (n = 10). Copared to the NC subjects, those with MTBI demonstrated deficits in working memory, those with SA demonstrated deficits in executive functioning, and those with both MTBI and SA demonstrated the greatest number of deficits which were in working memory, executive functioning and memory. Tests of anxiety, depression and post-traumatic stress disorder, while demonstrating significant symptoms in all clinical groups, did not correlate with the neuropsychological tests that differentiated the groups.	TRINITY COLL, PROGRAM NEUROSCI, HARTFORD, CT 06106 USA		Raskin, SA (corresponding author), TRINITY COLL, DEPT PSYCHOL, LIFE SCI CTR, HARTFORD, CT 06106 USA.		Raskin, Sarah/T-1420-2019	Raskin, Sarah/0000-0002-4310-4278			BECK A, 1997, BECK ANXIETY INVENTO; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Blake D.D., 1990, CLIN ADM PTSD SCALE; BLANCHARD H, 1986, J NERV MENT DIS, V174, P727; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; DAVIDOFF DA, 1988, COGNITIVE REHABILITA, V6, P8; DEBELLIS MD, 1994, J AM ACAD CHILD PSY, V33, P320, DOI 10.1097/00004583-199403000-00004; DELIS D, 1983, CALIFORNIA VERBAL LE; Derogatis L. R., 1983, SCL 90 R; DINKLAGE D, 1993, 21 ANN M INT NEUR SO; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; FADEN A, SCIENCE, V244, P798; FISHER JM, 1994, SEMIN NEUROL, V14, P53, DOI 10.1055/s-2008-1041059; Gil T., 1990, J TRAUMA STRESS, V3, P29, DOI DOI 10.1002/JTS.2490030104; GLAVIN GB, 1985, NEUROSCI BIOBEHAV R, V9, P233, DOI 10.1016/0149-7634(85)90048-X; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; KAY T, 1992, REHABILITATION POST, P109; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KOLB LC, 1987, AM J PSYCHIAT, V144, P989; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V48, P556; LYETH BG, 1992, J NEUROTRAUMA S2, V9, P463; McNair DM, 1981, EITS MANUAL PROFILE; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOORE A, 1993, 21 ANN M INT NEUR SO; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; RASKIN S, 1994, INT NEUR SOC ANG FRA; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SANDEL ME, 1990, ARCH PHYS MED REHAB, V71, P523; SAPORTA JA, 1993, CLIN PRAC, V27, P101; SARNO JE, 1973, ARCH PHYS MED REHAB, V54, P214; SHERMAN AD, 1980, BEHAV NEURAL BIOL, V30, P119, DOI 10.1016/S0163-1047(80)91005-5; SHIPLEY WC, 1939, SHIPLEY I LIVING SCA; SIMSON PE, 1988, NEUROPSYCHOPHARMACOL, V1, P287; Smith, 1973, SYMBOL DIGIT MODALIT; SOHLBERG M, 1989, ATTENTION PROCESS TE; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; SUTKER PB, 1995, NEUROPSYCHOLOGY, V9, P118, DOI 10.1037/0894-4105.9.1.118; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; TSUDA A, 1985, BEHAV NEUROSCI, V99, P802; VANDERKOLK B, 1985, BIOL PSYCHIAT, V20, P314, DOI 10.1016/0006-3223(85)90061-7; Wechsler, 1997, WECHSLER ADULT INTEL; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; YEHUDA R, 1995, AM J PSYCHIAT, V152, P982; [No title captured]; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	53	19	19	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	1997	11	8					587	603		10.1080/026990597123287			17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XL930	WOS:A1997XL93000004	9251867				2022-02-06	
J	Bostrom, L				Bostrom, L			Injury panorama and medical consequences for 1158 persons assaulted in the central part of Stockholm, Sweden	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article							VIOLENCE; BLUNT	This retrospective study describes assaults, type of trauma, injury panorama, the abbreviated injury scale score and medical consequences for 1158 assaulted persons. All patients were examined by surgeons at the Emergency Department, Sabbatsberg's hospital, Stockholm, Sweden, which is open around the clock. The police were not notified. The study group included all assaulted patients who attended and were examined at the Emergency Department from 1 April 1992 to 31 March 1993: 84% men and 16% women. Their median age was 25 years (range 13-86 years). Sixty-eight percent arrived at the Emergency Department between 11 p.m. and 4 a.m. In 44% the hospital staff registered in the case notes that the victims were drunk. Blunt trauma of low-energy type predominated, 44% were hit by fists and 30% by kicks. Penetrating trauma occurred in 10% of the assaults (knife 8%), and a combination of blunt and/or cutting trauma (bottle/glass) in 10%. Eighty-two percent of the victims suffered an injury to the head, resulting in concussion in 116 cases, 4 skull fractures, 1 intracerebral contusion, 74 fractures of nose bones, 17 fractures of other face bones, and 6 mandible fractures. Two persons died because of knifestab wounds. Eighty-two percent of the victims had minor injuries, and 16% had moderate injuries according to the score on the Abbreviated Injury Scale (AIS). The present study shows that assault in the central part of Stockholm, Sweden, is mainly a problem involving young men, especially late in the evening, and that many of the victims are drunk. Injuries to the head due to low-energy trauma are the most common (hit by fists and kicks), but severe injuries seldom occur.			Bostrom, L (corresponding author), KAROLINSKA INST,SODER HOSP,DEPT SURG,S-11883 STOCKHOLM,SWEDEN.						ASSOCIATION OF THE EUROPEAN SELF MEDICATION INDUSTRY. AESGP, 1990, ABBR INJ SCAL, P1; Bostrom L, 1994, Lakartidningen, V91, P3801; Bostrom L, 1994, Lakartidningen, V91, P3981; BROWN CRS, 1993, INJURY, V24, P25, DOI 10.1016/0020-1383(93)90077-J; CESARE J, 1990, J TRAUMA, V30, P176, DOI 10.1097/00005373-199002000-00007; DYSTING M, 1993, FACE STREET VIOLENCE, P1; GROLEAU GA, 1993, J TRAUMA, V34, P366, DOI 10.1097/00005373-199303000-00010; LAYTON S, 1994, INJURY, V25, P523, DOI 10.1016/0020-1383(94)90094-9; Lenke L., 1990, ALCOHOL CRIMINAL VIO; LIDBERG L, 1994, LAKARTIDNINGEN, V92, P2739; MURDOCH D, 1990, INT J ADDICT, V25, P1065, DOI 10.3109/10826089009058873; ORD RA, 1995, J ORAL MAXIL SURG, V53, P514, DOI 10.1016/0278-2391(95)90061-6; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; VANGELDERMALSEN AA, 1993, J TROP MED HYG, V96, P93; Wilhelmson B, 1994, Lakartidningen, V91, P4792	15	19	20	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	JUL	1997	116	6-7					315	320					6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	XM777	WOS:A1997XM77700001	9266031				2022-02-06	
J	SchmitterEdgecombe, M; Rogers, WA				SchmitterEdgecombe, M; Rogers, WA			Automatic process development following severe closed head injury	NEUROPSYCHOLOGY			English	Article							PERFORMANCE; SEARCH; MEMORY; CATEGORY; CONSISTENCY; SKILL; TASK	Automatic process development was investigated in a closed head injury (CHI) population. Ten severe CHI participants (>1 year postinjury) and 10 matched controls completed consistent mapping (CM) and varied mapping (VM) semantic-category memory search tasks. In VM search, despite a similar pattern of serial memory search, the CHI participants responded slower than controls and exhibited slower memory search rates throughout practice (1,800 trials). In CM search, after extensive practice (1,800 trials) both groups showed the performance characteristics indicative of automatic process development, that is, near-zero slopes and large reductions in response times. However, the CHI participants were slower to automatize the task. These results indicate that for memory-based search tasks the effects of a CHI may slow down the speed with which automatic processes develop but that CHI participants can acquire and use automatic processes in task performance.	UNIV GEORGIA,DEPT PSYCHOL,ATHENS,GA 30602		SchmitterEdgecombe, M (corresponding author), WASHINGTON STATE UNIV,DEPT PSYCHOL,BOX 644820,PULLMAN,WA 99164, USA.				NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG07654] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [G42658S1] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG007654] Funding Source: NIH RePORTER		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BATTIG WF, 1969, J EXPT PSYCHOL MON 2, V80; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; CATTELL RB, 1973, HDB INDIVIDUAL GROUP; CLARK JL, 1994, P HUM FACT ERG SOC 3; COLLEN A, 1975, J EXP PSYCHOL-HUM L, V1, P629; Craik FI., 1986, HUMAN MEMORY COGNITI, V5, P409; Ekstrom RB., 1976, MANUAL KIT FACTOR RE; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; Fisk A. D., 1991, MULTIPLE TASK PERFOR, P415; FISK AD, 1992, COGNITIVE APPROACHES TO AUTOMATED INSTRUCTION, P171; FISK AD, 1992, HUM FACTORS, V34, P693, DOI 10.1177/001872089203400604; FISK AD, 1991, HUM FACTORS, V33, P267, DOI 10.1177/001872089103300303; FISK AD, 1988, HUM FACTORS, V30, P703, DOI 10.1177/001872088803000606; FISK AD, 1983, J EXP PSYCHOL LEARN, V9, P177, DOI 10.1037/0278-7393.9.2.177; FISK AD, 1987, HUMAN FACTORS PSYCHO, P159; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; Kaplan E., 1987, MANUAL CALIFORNIA VE; KRAMER AF, 1990, J EXP PSYCHOL HUMAN, V16, P505; KRAMER AF, 1991, PSYCHOPHYSIOLOGY, V28, P425, DOI 10.1111/j.1469-8986.1991.tb00726.x; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LOGAN GD, 1985, CAN J PSYCHOL, V39, P367, DOI 10.1037/h0080066; Miller E, 1970, Cortex, V6, P121; Newell A., 1981, COGN SKILLS ACQUISIT, V1, P1; ROGERS WA, 1994, J EXP PSYCHOL LEARN, V20, P710, DOI 10.1037/0278-7393.20.3.710; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHNEIDER W, 1988, BEHAV RES METH INSTR, V20, P206, DOI 10.3758/BF03203833; SCHNEIDER W, 1984, J EXP PSYCHOL LEARN, V10, P1; SCHNEIDER W, 1982, PERCEPT PSYCHOPHYS, V31, P160, DOI 10.3758/BF03206216; SCHNEIDER W, 1985, ATTENTION PERFORM, V11, P475; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHIFFRIN RM, 1988, STEVENS HDB EXPT PSY, V1, P739; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; STERNBERG S, 1975, Q J EXP PSYCHOL, V27, P1, DOI 10.1080/14640747508400459; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; STRAYER DL, 1994, PSYCHOL AGING, V9, P589, DOI 10.1037/0882-7974.9.4.589; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; Wechsler, 1997, WECHSLER ADULT INTEL; WHALEY CJ, 1993, HUM FACTORS, V35, P639; [No title captured]; [No title captured]	48	19	19	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	APR	1997	11	2					296	308		10.1037/0894-4105.11.2.296			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WT569	WOS:A1997WT56900013	9110336				2022-02-06	
J	Osberg, JS; Brooke, MM; Baryza, MJ; Rowe, K; Lash, M; Kahn, P				Osberg, JS; Brooke, MM; Baryza, MJ; Rowe, K; Lash, M; Kahn, P			Impact of childhood brain injury on work and family finances	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; FOLLOW-UP; CHILDREN; TRAUMA; MORBIDITY; VIOLENCE	Parents of children who suffer brain injuries are often surprised by the extent to which work and family finances are disrupted In this paper, work and financial problems are described, predictors are identified, and ways to minimize problems are discussed. Eighty-two children treated at two Massachusetts trauma centres were given an extensive battery of medical, functional and psychosocial tests during hospitalization. At 1 and 6 months post-discharge they were retested and their parents were surveyed about work and financial difficulties. Trouble maintaining regular work schedules and injury-related financial problems were common. At highest risk for work and financial problems were families of children with severe injuries who had four to nine impairments, along with children hospitalized >2 weeks who were not discharged to home. Surprisingly, families with HMO coverage reported significantly fewer financial problems, and this relationshp was not due to differences in socioeconomic status or injury severity. Health-care providers need to pay more attention to the potential impact of injury on work and family finances. Providers can help at-risk families muster child-care services, deal effectively with employers and insurance companies, and plan for the future.	TUFTS UNIV, SCH MED, DEPT PHYS MED & REHABIL, BOSTON, MA 02111 USA; SHRINERS BURN INST, BOSTON, MA 02114 USA		Osberg, JS (corresponding author), TUFTS UNIV NEW ENGLAND MED CTR, DEPT PHYS MED & REHABIL, 750 WASHINGTON ST, 75K-R, BOSTON, MA 02111 USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR102330] Funding Source: Medline		*AM PSYCH ASS, 1994, DSM3R683 AM PSYCH AS; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BACHYRITA, 1989, COMPREHENSIVE NEUROL, V2; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; DEJONG G, 1983, SCI AM, V248, P40, DOI 10.1038/scientificamerican0683-40; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GLECKMAN AD, 1995, BRAIN INJURY, V9, P385, DOI 10.3109/02699059509005778; GRABOW JD, 1984, AM J PUBLIC HEALTH, V74, P710, DOI 10.2105/AJPH.74.7.710; Greenspan A I, 1989, Md Med J, V38, P239; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HARRIS BH, 1989, J PEDIATR SURG, V24, P103, DOI 10.1016/S0022-3468(89)80311-2; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; HORN L, 1992, PHYS MED REHABILITAT, P475; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KRAUS JF, 1987, PEDIATRICS, V79, P501; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; Livingston MG., 1990, REHABILITATION ADULT, P225; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; OSBERG JS, 1988, AM J PHYS MED REHAB, V67, P66, DOI 10.1097/00002060-198804000-00006; OSBERG JS, 1996, IN PRESS PEDIATRICS; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pope AM, 1991, DISABILITY AM NATL A; RESNICK C, 1993, SOC WORK HEALTH CARE, V18, P49, DOI 10.1300/J010v18n02_03; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; ROSENTHAL M, 1989, COMPREHENSIVE NEUROL, V2, P191; ROSENTHAL M, 1990, REHABILITATION ADULT; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SCHUMAN D, 1994, KAN L REV, V43, P39; SHALALA DE, 1993, HEALTH AFFAIR, V12, P30, DOI 10.1377/hlthaff.12.4.30; STEIN REK, 1985, TABLE DOCUMENTING PS; Testani-Dufour L, 1992, J Neurosci Nurs, V24, P317; WALKER B, 1992, J NATL MED ASSOC, V84, P490	35	19	19	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	1997	11	1					11	24					14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WB723	WOS:A1997WB72300002	9012548				2022-02-06	
J	DAmato, RC; Rothlisberg, BA				DAmato, RC; Rothlisberg, BA			How education should respond to students with traumatic brain injury	JOURNAL OF LEARNING DISABILITIES			English	Article							LEARNING-DISABILITIES; TRANSITION; CHILDREN	This article focuses on the educational implications of traumatic brain injury (TBI). It details the conceptual issues surrounding TBI and discusses how assessment of this group differs from that of other groups with disabilities. Finally, the article offers suggestions for an integrated intervention approach based on the idea of bringing order to the life experiences of these students. The S. O. S. (Structure, Organization, and Strategy) Approach offers a framework from which to consider the variable needs of these learners.	BALL STATE UNIV,MA EDS PROGRAM SCH PSYCHOL,MUNCIE,IN 47306		DAmato, RC (corresponding author), UNIV NO COLORADO,SCH PSYCHOL PROGRAM,PPSY DIV,CLIN NEUROPSYCHOL LAB,MCKEE 248,GREELEY,CO 80639, USA.						ADAMS L, 1991, GUIDELINES PAPER TRA; BEGALI V, 1994, ED DIMENSIONS ACQUIR, P453; Bigler E. D., 1989, HDB CLIN CHILD NEURO, P557; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; BLOSSER JL, 1994, ED DIMENSIONS ACQUIR, P413; Bruce D., 1990, REHABILITATION ADULT, P521; Cohen S. B., 1986, J HEAD TRAUMA REHAB, V1, P22; Crisp R, 1992, Aust Occup Ther J, V39, P15, DOI 10.1111/j.1440-1630.1992.tb01730.x; D'Amato R.C., 1990, SCH PSYCHOL Q, V5, P141, DOI [10.1037/h0090608, DOI 10.1037/H0090608]; DAMATO RC, 1987, PROFESSIONAL SCH PSY, V2, P93; DAMATO RC, IN PRESS HDB CLIN CH; DAMATO RC, 1991, ANN M NAT ASS SCH PS; DAMATO RC, 1992, PSYCHOL PERSPECTIVES; DEAN RS, 1990, HDB PSYCHOL ED ASSES, P371; Deaton A., 1990, TRAUMATIC BRAIN INJU, P231; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; EWINGCOBBS L, 1986, J HEAD TRAUMA REHAB, V1, P57; FLETCHER JM, 1984, J CLIN NEUROPSYCHOL, V6, P39, DOI 10.1080/01688638408401195; Gaddes W.H., 1994, LEARNING DISABILITIE; GRAY JW, 1989, HDB CLIN CHILD NEURO, P397; HALEY SM, 1990, J HEAD TRAUMA REHAB, V5, P77; HAMMILL D, 1991, DETROIT TESTS LEARNI; HARRINGTON DE, 1990, REHABILITATION ADULT, P476; HARTLAGE LC, 1983, J LEARN DISABIL, V16, P521, DOI 10.1177/002221948301600904; HILL RB, 1994, UNPUB INTERACTION TE; HYND GW, 1988, PEDIAT NEUROPSYCHOLO; Kaufman, 1979, INTELLIGENT TESTING; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KAUFMAN AS, 1979, J RES DEV EDUC, V12, P96; Kreutzer J, 1988, J HEAD TRAUMA REHAB, V3, P51, DOI DOI 10.1097/00001199-198812000-00008; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEU PW, 1994, ANN M NAT ASS SCH PS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; *LOS AM RES ED I, 1990, RANCH LOS AM SCAL CO; *MED EC DAT, 1993, PDR FAM GUID PRESCR; Merrell K. W., 1994, ASSESSMENT BEHAV SOC; POSTHILL SM, 1991, J LEARN DISABIL, V24, P619, DOI 10.1177/002221949102401005; PRIGATANO GP, 1990, TRAUMATIC BRAIN INJU, P273; REIFF HB, 1992, LEARN DISABILITY Q, V15, P237, DOI 10.2307/1511316; REYNOLDS CR, 1989, HDB CLIN CHILD NEURO; ROJEWSKI JW, 1992, LEARN DISABILITY Q, V15, P135, DOI 10.2307/1511015; Rosen CD, 1986, HEAD TRAUMA ED REINT; Russell N, 1993, LANG SPEECH HEAR SER, V24, P67; RUTTER M, 1983, DEV NEUROPSYCHIATRY; SACHS PR, 1993, REHABIL PSYCHOL, V38, P87, DOI 10.1037/h0080294; Savage R. C., 1994, ED DIMENSIONS ACQUIR; Savage RC, 1987, J HEAD TRAUMA REHAB, V2, P1; SCAHS PR, 1991, TREATING FAMILIES BR; SCUCCIMARRA DJ, 1990, J LEARN DISABIL, V23, P213, DOI 10.1177/002221949002300403; SOAR RS, 1979, RES TEACHING CONCEPT, P271; TAYLOR HG, 1987, DEV NEUROPSYCHOL, V3, P153, DOI 10.1080/87565648709540371; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1985, NEUROPSYCHOLOGY INDI, P271; TELZROW CF, 1990, TRAUMATIC BRAIN INJU, P251; *UT TBI TASK FORC, 1994, UT TRAUM BRAIN INJ T; WEDDING D, 1986, HDB CLIN BEHAV NEURO; WHITTEN JC, 1992, PSYCHOL PERSPECTIVES, P112; YLVISAKER M, 1990, REHABILITATION ADULT, P521; [No title captured]; [No title captured]	61	19	19	0	4	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897	0022-2194			J LEARN DISABIL	J. Learn. Disabil.	NOV	1996	29	6					670	683		10.1177/002221949602900611			14	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	VU234	WOS:A1996VU23400011	8942311				2022-02-06	
J	Kehle, TJ; Clark, E; Jenson, WR				Kehle, TJ; Clark, E; Jenson, WR			Interventions for students with traumatic brain injury: Managing behavioral disturbances	JOURNAL OF LEARNING DISABILITIES			English	Article							CLOSED HEAD-INJURY; CHILDREN; SEQUELAE; ADOLESCENTS; MORBIDITY; MILD	The present article provides information about the behavioral sequelae that are commonly seen in children and adolescents following a traumatic brain injury (TBI) and ways that educators can begin to address these problems. Because, for the most part, behavioral interventions have not been empirically validated for use with TBI populations, this article focuses on the unique needs of these students and the factors that should be considered in designing intervention strategies. Emphasis is placed on the cognitive sequelae of TBI that can cause further behavioral problems and interfere with interventions (e.g., impaired attention, executive function, reasoning and problem solving, and learning and memory).	UNIV UTAH,SCH PSYCHOL PROGRAM,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT EDUC PSYCHOL,SALT LAKE CITY,UT 84112								ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Begali V., 1992, HEAD INJURY CHILDREN; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bond M. R., 1990, REHABILITATION ADULT, P179; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CASEY R, 1986, PEDIATRICS, V78, P497; Clarke E, 1990, SCHOOL PSYCHOL INT, V11, P227; COPE DN, 1987, J HEAD TRAUMA REHABI, V2, P2; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; Deaton A, 1994, ED DIMENSIONS ACQUIR, P257; DEMPSTER FN, 1988, AM PSYCHOL, V43, P627, DOI 10.1037/0003-066X.43.8.627; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FOXX RM, 1978, J APPL BEHAV ANAL, V11, P125, DOI 10.1901/jaba.1978.11-125; FRANZEN MD, 1987, PSYCHIAT ANN, V17, P389, DOI 10.3928/0048-5713-19870601-10; GLENN MB, 1987, J HEAD TRAUMA REHAB, V2, P71; GLENN MB, 1987, J HEAD TRAUMA REHABI, V2, P80; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; HAAS JF, 1985, ARCH PHYS MED REHAB, V66, P472; HELLER MS, 1975, J EDUC PSYCHOL, V67, P769; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KEHLE TJ, 1986, SCHOOL PSYCHOL REV, V15, P289; KEHLE TJ, 1994, ANN M NAT ASS SCH PS; KEHLE TJ, 1991, PRACTICAL GUIDE VIDE, P221; KEHLE TJ, 1992, SCHOOL PSYCHOL INT, V13, P307; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; LEVIN HS, 1987, HEAD INJURY; MALEC J, 1984, BEHAVIORAL ASSESSMEN, P121; MAPOU RL, 1992, HDB HEAD TRAUMA ACUT, P75; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P522; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Reavis H. K., 1993, UTAHS BEST PROJECT B; Rhode G., 1993, TOUGH KID BOOK PRACT; ROSE MJ, 1988, J HEAD TRAUMA REHAB, V3, P7; SHUTTE RC, 1970, J APPL BEHAV ANAL, V3, P117; SIASSI I, 1982, J CLIN PSYCHIAT, V45, P482; SILVER JM, 1987, PSYCHIAT ANN, V17, P367, DOI 10.3928/0048-5713-19870601-06; THOMAS DR, 1968, J APPL BEHAV ANAL, V1, P35, DOI 10.1901/jaba.1968.1-35; TOMPKINS CA, 1990, BRAIN COGNITION, V13, P86, DOI 10.1016/0278-2626(90)90042-M; VANHOUTEN R, 1982, J APPL BEHAV ANAL, V15, P65, DOI 10.1901/jaba.1982.15-65; VANHOUTEN R, 1983, EFFECTS PUNISHMENT H, P45; WHITE MA, 1975, J APPL BEHAV ANAL, V8, P367, DOI 10.1901/jaba.1975.8-367; Wood R. L., 1987, BRAIN INJURY REHABIL; YUDOFSKY SC, 1987, PSYCHIAT ANN, V17, P397, DOI 10.3928/0048-5713-19870601-11; [No title captured]	50	19	19	0	4	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897	0022-2194			J LEARN DISABIL	J. Learn. Disabil.	NOV	1996	29	6					633	642		10.1177/002221949602900607			10	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	VU234	WOS:A1996VU23400007	8942307				2022-02-06	
J	Li, GH; Baker, SP; DiScala, C; Fowler, C; Ling, J; Kelen, GD				Li, GH; Baker, SP; DiScala, C; Fowler, C; Ling, J; Kelen, GD			Factors associated with the intent of firearm-related injuries in pediatric trauma patients	ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE			English	Article							CLOSED HEAD-INJURY; GUNSHOT WOUNDS; PREVENTION PROGRAM; CHILDREN; EXPERIENCE; IMPACT; MOTOR	Objective: To examine the characteristics of unintentional and assaultive firearm-related pediatric injuries treated in trauma centers. Design: Comparative analysis of patients 14 years or younger who were admitted to the trauma centers because of unintentional firearm-related injuries (n=292) vs assaultive firearm-related injuries (n=457). Setting: Sixty-eight trauma centers or children's hospitals in the continental United States and Canada that reported data to the National Pediatric Trauma Registry from January 1, 1990, through December 31, 1994. Main Outcome Measures: Frequency distributions of firearm-related injuries in relation to intent and injury circumstances, odds ratios (ORs) on the intent of injury being assaultive, injury severity scales, and in-hospital fatality rates. Results: The frequency of unintentional firearm-related injuries rose in the afternoons peaking between 4 and 5 PM; they predominantly occurred at home (89%). Assaultive firearm-related injuries peaked sharply between 8 and 9 PM and usually occurred on roads or in other public places (63%). About 3 times as many boys as girls were harmed in firearm-related injuries, Given a firearm-related injury resulting in admission to a trauma center, the adjusted OR of it being assaultive was 2.8 (95% confidence interval [CI], 1.6-4.6) if the victim was a girl, 4.9 (95% CI, 3.1-7.8) if the shooting occurred at night, 2.6 (95% CI, 1.6-4.2) if the shooting occurred on a weekday, and 21.1 (95% CI, 9.1-49.4) if the shooting occurred on a road. Injury patterns and severity were similar between patients with unintentional and assaultive injuries. Overall, 19% of the patients sustained head injuries, which contributed to 90% of the in-hospital deaths. Conclusions: Marked differences in injury circumstances exist between unintentional and assaultive firearm-related injuries among children. The late afternoon hours when many children have come home from school but their parents may still be working have the highest frequency of unintentional firearm-related injuries. The evening peak of assaultive injuries may be related to drug-related and gang-related violence, While it is important to reduce the access of firearms to children, school-based extracurricular and community-based social services should be considered in developing intervention programs.	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,CTR INJURY RES & POLICY,BALTIMORE,MD 21287; TUFTS UNIV,SCH MED,DEPT PHYS MED & REHABIL,BOSTON,MA 02111		Li, GH (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT EMERGENCY MED,600 N WOLFE ST,BALTIMORE,MD 21287, USA.			Kelen, Gabor/0000-0002-3236-8286	NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R29AA09963-02] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR302486] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R29AA009963] Funding Source: NIH RePORTER		Alexander C S, 1995, Inj Prev, V1, P15, DOI 10.1136/ip.1.1.15; ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; BAKER SP, 1996, INJURY CHILDREN TEEN; BAKER SP, 1992, INJURY FACT BOOK, P149; BARLOW B, 1982, J PEDIATR SURG, V17, P927, DOI 10.1016/S0022-3468(82)80469-7; CHOI E, 1994, J FORENSIC SCI, V39, P685; CHRISTOFFEL KK, 1991, PEDIATRICS, V88, P294; *CTR DIS CONTR PRE, 1995, INJ MORT NAT SUMM IN; DAVIDSON LL, 1994, AM J PUBLIC HEALTH, V84, P580, DOI 10.2105/AJPH.84.4.580; DODGE GG, 1994, AM SURGEON, V60, P401; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; FEERO S, 1995, ANN EMERG MED, V25, P788, DOI 10.1016/S0196-0644(95)70209-1; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; HAKANSON R, 1994, ORTHOPEDICS, V17, P519; Hosmer D, 1989, APPL LOGISTIC REGRES; KIZER KW, 1995, JAMA-J AM MED ASSOC, V273, P1768, DOI 10.1001/jama.273.22.1768; KUHN L, 1994, AM J EPIDEMIOL, V140, P943, DOI 10.1093/oxfordjournals.aje.a117183; LARAQUE D, 1995, J PEDIATR SURG, V30, P1072, DOI 10.1016/0022-3468(95)90344-5; LESCOHIER I, 1993, PEDIATRICS, V91, P721; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; Li, 1995, Adolesc Med, V6, P135; LI G, 1994, J TRAUMA, V38, P871; Moloney-Harmon P A, 1994, Crit Care Nurs Clin North Am, V6, P525; NANCE ML, 1994, J PEDIATR SURG, V29, P39, DOI 10.1016/0022-3468(94)90519-3; OSBERG JS, 1992, AM J PUBLIC HEALTH, V82, P422, DOI 10.2105/AJPH.82.3.422; OSBERG JS, 1990, AM J PHYS MED REHABI, V69, P66; Rice DP, 1989, COST INJURY US REPOR; RIVARA FP, 1995, ANN EMERG MED, V26, P609, DOI 10.1016/S0196-0644(95)70013-7; Rosenberg M. L., 1991, VIOLENCE AM PUBLIC H; RUNYAN CW, 1989, JAMA-J AM MED ASSOC, V262, P2273, DOI 10.1001/jama.262.16.2273; SAS Institute Inc, 1989, SAS STAT US GUID VER; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; TEPAS JJ, 1989, J PEDIATR SURG, V24, P156, DOI 10.1016/S0022-3468(89)80237-4	35	19	19	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	1072-4710			ARCH PEDIAT ADOL MED	Arch. Pediatr. Adolesc. Med.	NOV	1996	150	11					1160	1165		10.1001/archpedi.1996.02170360050008			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	VQ855	WOS:A1996VQ85500007	8904856				2022-02-06	
